Uniprot protein ID,Swiss-Prot protein ID,Protein names,Gene names,Score,Delta score,Swiss-Prot phosphosite,Sequence window,Modified sequence,EGF_1 min_Rep1,EGF_1 min_Rep2,EGF_8 min_Rep1,EGF_8 min_Rep2,EGF_40 min_Rep1,EGF_40 min_Rep2,EGF_90 min_Rep1,EGF_90 min_Rep2,TGFalfa_1 min_Rep1,TGFalfa_1 min_Rep2,TGFalfa_8 min_Rep1,TGFalfa _8 min_Rep2,TGFalfa_40 min_Rep1,TGFalfa_40 min_Rep2,TGFalfa_90 min_Rep1,TGFalfa_90 min_Rep2,EGF_1 min average ratio,EGF_8 min average ratio,EGF_40 min average ratio,EGF_90  min average ratio,TGFalfa_1 min average ratio,TGFalfa_8 min average ratio,TGFalfa_40 min average ratio,TGFalfa_90 min average ratio,Regulated by EGF,Regulated by TGFalfa,Kinase_Family,E3 ligases_Family,Dub_Family,pTyrPhosphatase,Cluster (regulated by EGF),Cluster (regulated by TGFalfa),S_score,GO  CC,GO  MF,GO  BP,doubly modified and regulated,EGFR interactors
F8VZ44,Q9NRG9,Aladin,AAAS,96.31,73,S495,AHIPLYFVNAQFPRFSPVLGRAQEPPAGGGG,_FS(ph)PVLGR_,-0.11,-0.15,-0.31,-0.19,-0.05,0.09,-0.28,-0.3,-0.17,-0.21,-0.38,-0.34,-0.23,-0.11,-0.4,-0.5,-0.13,-0.25,0.02,-0.29,-0.19,-0.36,-0.17,-0.45,,,,,,,0,,,centrosome,,,,
E9PG46,Q2M2I8,AP2-associated protein kinase 1,AAK1,146.33,146.33,T620,TTPPPAVQGQKVGSLTPPSSPKTQRAGHRRI,_VGSLT(ph)PPS(ph)SPK_, , ,-0.26,-0.01,0.01,0.09,0.12,0.07, , ,0.17,0.12,-0.01,0,0.12,0.13,,-0.13,0.05,0.1,,0.14,0,0.12,,,Other,,,,NA,NA,,,ATP binding,,,
B9A003,E9PB15,Putative protein PTGES3L,AARSD1,64.21,63.91,S157,STKRPPPAMDDLDDDSDSADDATSN______,_RPPPAMDDLDDDS(ph)DS(ph)ADDATSN_, , , , ,-0.94,-0.85,-0.88,-0.85, , , , ,-0.21,-0.06,-0.09,0.08,,,-0.89,-0.86,,,-0.13,0,,,,,,,NA,NA,,,,,,
B9A003,E9PB15,Putative protein PTGES3L,AARSD1,64.21,63.91,S159,KRPPPAMDDLDDDSDSADDATSN________,_RPPPAMDDLDDDS(ph)DS(ph)ADDATSN_, , , , ,-0.94,-0.85,-0.88,-0.85, , , , ,-0.21,-0.06,-0.09,0.08,,,-0.89,-0.86,,,-0.13,0,,,,,,,NA,NA,,,,,,
Q9NY61,Q9NY61,Protein AATF,AATF,198.63,198.63,S316,PDTRYLVDGTKPNAGSEEISSEDDELVEEKK,_YLVDGTKPNAGS(ph)EEIS(ph)S(ph)EDDELVEEK_,-0.04,-0.02,0.05,0.06,-0.01,-0.24,-0.49,-0.28,-0.21,-0.12,-0.4,-0.32,-0.09,-0.07,-0.24,-0.18,-0.03,0.05,-0.12,-0.38,-0.16,-0.36,-0.08,-0.21,,,,,,,0,0,,centrosome,sequence-specific DNA binding transcription factor activity,apoptotic signaling pathway,,
Q9NY61,Q9NY61,Protein AATF,AATF,198.63,198.63,S320,YLVDGTKPNAGSEEISSEDDELVEEKKQQRR,_YLVDGTKPNAGS(ph)EEIS(ph)S(ph)EDDELVEEK_,0.51,0.33,0.05,0.06,0.44,-0.24,-1.05,0.03,0.04,-0.15,-0.4,-0.32,-0.13,-0.07,-1.18,-0.09,0.42,0.05,0.14,-0.41,-0.05,-0.36,-0.1,-0.53,,,,,,,0,0,,centrosome,sequence-specific DNA binding transcription factor activity,apoptotic signaling pathway,,
Q9NY61,Q9NY61,Protein AATF,AATF,198.63,198.63,S321,LVDGTKPNAGSEEISSEDDELVEEKKQQRRR,_YLVDGTKPNAGS(ph)EEIS(ph)S(ph)EDDELVEEK_,0.51,0.33,0.05,0.06,0.44,-0.24,-1.05,0.03,0.04,-0.15,-0.4,-0.32,-0.13,-0.07,-1.18,-0.09,0.42,0.05,0.14,-0.41,-0.05,-0.36,-0.1,-0.53,,,,,,,0,0,,centrosome,sequence-specific DNA binding transcription factor activity,apoptotic signaling pathway,,
Q9BZC7,Q9BZC7,ATP-binding cassette sub-family A member 2,ABCA2,122.68,119.4,S2419,ADEPEDLDTEDEGLISFEEERAQLSFNTDTL,_ALVADEPEDLDT(ph)EDEGLIS(ph)FEEER_, , , , ,0.54,0.75, , , , , , ,0.21,0.29, , ,,,0.65,,,,0.25,,,,,,,,NA,NA,,ATP-binding cassette (ABC) transporter complex,ATP binding,cholesterol homeostasis,,
Q9BZC7,Q9BZC7,ATP-binding cassette sub-family A member 2,ABCA2,122.68,119.4,T2412,TELRALVADEPEDLDTEDEGLISFEEERAQL,_ALVADEPEDLDT(ph)EDEGLIS(ph)FEEER_, , , , ,0.54,0.75, , , , , , ,0.21,0.29, , ,,,0.65,,,,0.25,,,,,,,,NA,NA,,ATP-binding cassette (ABC) transporter complex,ATP binding,cholesterol homeostasis,,
Q9BZC7,Q9BZC7,ATP-binding cassette sub-family A member 2,ABCA2,284.71,262.76,S1327,TTLEEVFLKVSEEDQSLENSEADVKESRKDV,_VSEEDQS(ph)LENS(ph)EADVK_, , , , ,0.66,0.79,0.68,1.23, , , , ,1.18,0.72,0.49,0.43,,,0.73,0.98,,,0.96,0.46,,,,,,,NA,NA,,ATP-binding cassette (ABC) transporter complex,ATP binding,cholesterol homeostasis,,
Q9BZC7,Q9BZC7,ATP-binding cassette sub-family A member 2,ABCA2,284.71,262.76,S1331,EVFLKVSEEDQSLENSEADVKESRKDVLPGA,_VSEEDQS(ph)LENS(ph)EADVK_, , , , ,0.66,0.79,0.68,1.23, , , , ,1.18,0.72,0.49,0.43,,,0.73,0.98,,,0.96,0.46,,,,,,,NA,NA,,ATP-binding cassette (ABC) transporter complex,ATP binding,cholesterol homeostasis,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,117.82,115.52,S917,VTDSAGKQLQRQLSSSSSYSGDISRHHNSTA,_QLSSS(ph)SS(ph)YSGDISR_, , , , ,1.13, ,0.79,0.55, , , , ,1.28, ,0.83,0.33,,,1.13,0.67,,,1.28,0.6, +, +,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,128.79,98.62,S915,MLVTDSAGKQLQRQLSSSSSYSGDISRHHNS,_QLS(ph)SSS(ph)S(ph)YSGDISR_, , ,0.83,1.03,-0.21,-0.39,-0.38,-0.32, , ,0.96,1.37,0.14,-0.18,-0.01,-0.32,,0.93,-0.3,-0.35,,1.18,-0.01,-0.15,, +,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,122.3,109.51,S921,AGKQLQRQLSSSSSYSGDISRHHNSTAELQK,_QLSSSS(ph)SYS(ph)GDISR_, , , , ,0.51,0.67,0.56,-1.13, , , , ,0.73,1.33,0,-0.55,,,0.59,-0.05,,,1.06,-0.25,, +,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,147.64,145.34,S916,LVTDSAGKQLQRQLSSSSSYSGDISRHHNST,_QLSS(ph)SSSYS(ph)GDISR_, , , , ,0.37,0.98,0.67,0.08, , , , ,0.72,0.59,0.45,-0.28,,,0.71,0.41,,,0.66,0.13,,,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,147.64,145.34,S918,TDSAGKQLQRQLSSSSSYSGDISRHHNSTAE,_QLS(ph)SSS(ph)S(ph)YSGDISR_, , , , ,0.45,0.92,0.55,0.51, , , , ,0.54,0.62,0.29,0.33,,,0.71,0.53,,,0.58,0.31,,,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
P33527-6,P33527,Multidrug resistance-associated protein 1,ABCC1,120.15,117.85,S919,DSAGKQLQRQLSSSSSYSGDISRHHNSTAEL,_(gl)QLSS(ph)SS(ph)S(ph)YSGDISR_, , , , ,0.3,0.84,0.48,0.51, , , , ,0.26,1.19,0.45,0.32,,,0.6,0.49,,,0.8,0.39,,,,,,,NA,NA,,Golgi apparatus,ATP binding,arachidonic acid metabolic process,,
O15438-2,O15438,Canalicular multispecific organic anion transporter 2,ABCC3,107.58,107.58,S908,DPVTYVVQKQFMRQLSALSSDGEGQGRPVPR,_(gl)QLS(ph)ALS(ph)SDGEGQGRPVPR_, , ,2.94,2.16,0.3, ,0.49,0.1, , ,2.36,1.57,0.78, ,0.78,0.22,,2.6,0.3,0.3,,2.02,0.78,0.53, +, +,,,,,NA,NA,,integral to plasma membrane,ATP binding,bile acid and bile salt transport,,
O15438-2,O15438,Canalicular multispecific organic anion transporter 2,ABCC3,107.58,107.58,S911,TYVVQKQFMRQLSALSSDGEGQGRPVPRRHL,_(gl)QLS(ph)ALS(ph)SDGEGQGRPVPR_, , ,2.94,2.16,0.3, ,0.49,0.1, , ,2.36,1.57,0.78, ,0.78,0.22,,2.6,0.3,0.3,,2.02,0.78,0.53, +, +,,,,,NA,NA,,integral to plasma membrane,ATP binding,bile acid and bile salt transport,,
O15438-2,O15438,Canalicular multispecific organic anion transporter 2,ABCC3,60.4,31.27,S166,PFRSKILLAKAEGEISDPFRFTTFYIHFALV,_AEGEIS(ph)DPFR_, , , ,-3.75, , , , , , , ,-0.98, , , , ,,-3.75,,,,-0.98,,, +,,,,,,NA,NA,,integral to plasma membrane,ATP binding,bile acid and bile salt transport,,
O15439,O15439,Multidrug resistance-associated protein 4,ABCC4,137.87,136.25,T646,LKKDNEESEQPPVPGTPTLRNRTFSESSVWS,_DNEESEQPPVPGT(ph)PTLR_, , ,0.54,0.7,0.17,0.21,1.76,1.46, , ,0.45,0.61,-0.15,-0.18,0.17,0.1,,0.62,0.19,1.62,,0.53,-0.17,0.14, +,,,,,,NA,NA,,integral to membrane,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,529.2,526.08,S228,PPKQGKEKAKKAEQGSEEEGEGEEEEEEGGE,_KAEQGS(ph)EEEGEGEEEEEEGGESK_,-0.06,-0.1,-0.18,-0.18,-0.25,-0.08,-0.11,-0.04,0.01,-0.03,-0.04,-0.14,0.09,0.06,-0.02,0.02,-0.08,-0.18,-0.17,-0.08,-0.01,-0.09,0.07,0,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,238.69,235.3,S140,KTKGGNVFAALIQDQSEEEEEEEKHPPKPAK,_GGNVFAALIQDQS(ph)EEEEEEEK_,-0.12,-0.13,0.17,-0.11,-0.3,-0.14,-0.13,-0.14,0.02,-0.02,-0.09,-0.13,0,0,0.02,-0.12,-0.13,0.04,-0.22,-0.14,0,-0.11,0,-0.05,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,198.69,198.44,S105,DDGEEKELMERLKKLSVPTSDEEDEVPAPKP,_KLS(ph)VPT(ph)S(ph)DEEDEVPAPKPR_,0.04,0.03,0.17,0.12,0.17,0.25,0.1,0.12,-0.02,0.01,0.2,0.25,0.07,0.17,0.06,0.02,0.03,0.15,0.21,0.11,-0.01,0.22,0.12,0.04,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,230.75,230.75,S109,EKELMERLKKLSVPTSDEEDEVPAPKPRGGK,_LSVPT(ph)S(ph)DEEDEVPAPKPR_,-0.04,-0.08,-0.34,-0.17,-0.33,-0.25,-0.05,-0.05,-0.19,0,-0.27,-0.34,-0.24,-0.29,0.08,0.1,-0.06,-0.25,-0.29,-0.05,-0.09,-0.3,-0.26,0.09,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,329.29,327.11,S22,QQPPEPEWIGDGESTSPSDKVVKKGKKDKKI,_QQPPEPEWIGDGESTS(ph)PSDK_,-0.13,-0.12,-0.25,-0.25,-0.25,-0.27,-0.14,-0.28,-0.13,-0.05,-0.03,-0.11,-0.09,-0.05,0,-0.01,-0.13,-0.25,-0.26,-0.21,-0.09,-0.07,-0.07,-0.01,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8NE71,Q8NE71,ATP-binding cassette sub-family F member 1,ABCF1,230.75,230.75,T108,EEKELMERLKKLSVPTSDEEDEVPAPKPRGG,_KLS(ph)VPT(ph)S(ph)DEEDEVPAPKPR_,0.03,0,-0.29,-0.25,0.08,0.05,-0.24,0.12,-0.21,-0.23,-0.56,-0.66,0.21,0.24,-0.15,-0.25,0.02,-0.27,0.06,-0.05,-0.22,-0.61,0.22,-0.2,,,,,,,0,0,,nuclear envelope,ATP binding,ATP catabolic process,,
Q8IZP0-10,Q8IZP0,Abl interactor 1,ABI1,171.07,171.07,Y213,YKTLEPVKPPTVPNDYMTSPARLGSQHSPGR,_TLEPVKPPTVPNDY(ph)MTSPAR_,1.96, ,0.61, ,0.57,0.52, ,0.18,1.61, ,0.07, ,0.62,0.33, ,0.34,1.96,0.61,0.55,0.18,1.61,0.07,0.48,0.34, +, +,,,,,5,5,22,cell junction,cytoskeletal protein binding,actin polymerization or depolymerization,,
Q9NYB9-3,Q9NYB9,Abl interactor 2,ABI2,100.28,100.28,Y213,YRTLEPVRPPVVPNDYVPSPTRNMAPSQQSP,_TLEPVRPPVVPNDY(ph)VPSPTR_,2.21, ,0.82,0.35, , ,-0.32, ,1.54, ,-0.12,0.2, , ,-0.46, ,2.21,0.6,,-0.32,1.54,0.04,,-0.46, +, +,,,,,NA,NA,,cell-cell adherens junction,cytoskeletal adaptor activity,actin polymerization or depolymerization,,
P00519,P00519,Tyrosine-protein kinase ABL1,ABL1,84.03,73.42,S805,NEEAADEVFKDIMESSPGSSPPNLTPKPLRR,_DIMESS(ph)PGSS(ph)PPNLTPK_, , , , ,-0.23,-0.26,-0.6,-0.38, , , , ,-0.07,0.01,-0.06,-0.16,,,-0.25,-0.48,,,-0.03,-0.11,,,Tyr,,,,NA,NA,,actin cytoskeleton,actin monomer binding,actin cytoskeleton organization,,
P00519,P00519,Tyrosine-protein kinase ABL1,ABL1,40.99,37.01,S808,AADEVFKDIMESSPGSSPPNLTPKPLRRQVT,_DIMESSPGS(ph)S(ph)PPNLTPK_, , , , ,-0.27,-0.26,0.04,-0.51, , , , ,0.02,0.01,0.08,-0.22,,,-0.26,-0.21,,,0.01,-0.06,,,Tyr,,,,NA,NA,,actin cytoskeleton,actin monomer binding,actin cytoskeleton organization,,
P00519,P00519,Tyrosine-protein kinase ABL1,ABL1,84.03,73.42,S809,ADEVFKDIMESSPGSSPPNLTPKPLRRQVTV,_DIMESS(ph)PGSS(ph)PPNLT(ph)PK_, , , , ,-0.25, ,-0.39,-0.45, , , , ,-0.02, ,-0.04,-0.19,,,-0.25,-0.42,,,-0.02,-0.12,,,Tyr,,,,NA,NA,,actin cytoskeleton,actin monomer binding,actin cytoskeleton organization,,
P00519,P00519,Tyrosine-protein kinase ABL1,ABL1,79.43,76.81,T814,KDIMESSPGSSPPNLTPKPLRRQVTVAPASG,_DIMESS(ph)PGSS(ph)PPNLT(ph)PK_, , , , , , , ,0.46, , , , , , , ,0.09,,,,0.46,,,,0.09,,,Tyr,,,,NA,NA,,actin cytoskeleton,actin monomer binding,actin cytoskeleton organization,,
P42684-9,P42684,Abelson tyrosine-protein kinase 2,ABL2,136.93,127.19,S936,PVLPTTHNHKVPVLISPTLKHTPADVQLIGT,_VPVLIS(ph)PTLK_,0.3,0.18,1.79,1.91, , , , ,0.2,-0.19,1.56,1.68, , , , ,0.24,1.85,,,0.02,1.62,,, +, +,Tyr,,,,NA,NA,,actin cytoskeleton,actin filament binding,actin filament bundle assembly,,
P42684-9,P42684,Abelson tyrosine-protein kinase 2,ABL2,128.57,108.36,S631,ASSGSPALPRKQRDKSPSSLLEDAKETCFTR,_S(ph)PSSLLEDAK_, , , , ,0.26,0.68,0.78,0.54, , , , ,-0.12,0.4,0.59,0.4,,,0.48,0.67,,,0.16,0.5,,,Tyr,,,,NA,NA,,actin cytoskeleton,actin filament binding,actin filament bundle assembly,,
O14639-4,O14639,Actin-binding LIM protein 1,ABLIM1,90.48,87.98,S706,LPDGHMPAMRMDRGVSMPNMLEPKIFPYEML,_GVS(ph)MPNMLEPK_,0.26,-0.31,-0.31, , ,-0.49,-0.2, ,-0.07,-0.5,-0.33, , ,-1.4,-0.27, ,0,-0.31,-0.49,-0.2,-0.27,-0.33,-1.4,-0.27,, +,,,,,0,6,19.7,actin cytoskeleton,actin binding,axon guidance,,
O14639-4,O14639,Actin-binding LIM protein 1,ABLIM1,157.42,156.48,S431,DKQERQSLGESPRTLSPTPSAEGYQDVRDRM,_TLS(ph)PTPSAEGYQDVR_,-0.51,-0.47,-0.51,-0.48,-0.27,-0.2,-0.12,-0.18,-0.45,-0.6,-0.2,-0.24,-0.44,-0.12,-0.13,-0.18,-0.49,-0.5,-0.24,-0.15,-0.53,-0.22,-0.27,-0.15,,,,,,,0,0,,actin cytoskeleton,actin binding,axon guidance,,
O14639-4,O14639,Actin-binding LIM protein 1,ABLIM1,108.28,92.23,S435,RQSLGESPRTLSPTPSAEGYQDVRDRMIHRS,_TLS(ph)PTPS(ph)AEGYQDVR_, , , , ,-0.31,0.02, , , , , , ,0.06,0.39, , ,,,-0.14,,,,0.24,,,,,,,,NA,NA,,actin cytoskeleton,actin binding,axon guidance,,
Q13085,Q13085,Acetyl-CoA carboxylase 1,ACACA,346.35,325.87,S23,AQPLELNQHSRFIIGSVSEDNSEDEISNLVK,_FIIGS(ph)VS(ph)EDNS(ph)EDEISNLVK_, , ,0.41,1.26,0.4,0.2,0.94,2.06, , ,0.37,1.65,-0.06,0.08,0.93,1.93,,0.9,0.31,1.6,,1.15,0.01,1.51, +, +,,,,,NA,NA,,cytosol,acetyl-CoA carboxylase activity,acetyl-CoA metabolic process,,
Q13085,Q13085,Acetyl-CoA carboxylase 1,ACACA,302.71,285.61,S25,PLELNQHSRFIIGSVSEDNSEDEISNLVKLD,_FIIGS(ph)VS(ph)EDNS(ph)EDEISNLVK_,0.14,0.31,0.97, ,1.88,1.31,0.43,0.21,0,0.17,1.03, ,2.01,1.37,0.54,0.23,0.23,0.97,1.62,0.32,0.09,1.03,1.72,0.39, +, +,,,,,1,1,43.1,cytosol,acetyl-CoA carboxylase activity,acetyl-CoA metabolic process,,
Q13085,Q13085,Acetyl-CoA carboxylase 1,ACACA,122.68,119.88,S5,___________MDEPSPLAQPLELNQHSRFI,_(ac)MDEPS(ph)PLAQPLELNQHSR_,0.31,0.14,1.32,0.59,0.46,1.17,0.85,0.66,-0.05,-0.34,0.8,0.33,0.24,0.86,0.85,0.94,0.23,1,0.86,0.76,-0.19,0.59,0.58,0.89, +,,,,,,1,0,22.15,cytosol,acetyl-CoA carboxylase activity,acetyl-CoA metabolic process,,
Q13085,Q13085,Acetyl-CoA carboxylase 1,ACACA,346.35,325.87,S29,NQHSRFIIGSVSEDNSEDEISNLVKLDLLEE,_FIIGS(ph)VS(ph)EDNS(ph)EDEISNLVK_,0.2,0.17,-0.6,-0.51,0.07,0.04,0.06,0.02,0.13,0.13,-0.55,-0.54,0.09,-0.01,0.12,0.11,0.18,-0.55,0.05,0.04,0.13,-0.55,0.04,0.12,,,,,,,0,0,,cytosol,acetyl-CoA carboxylase activity,acetyl-CoA metabolic process,,
Q13085,Q13085,Acetyl-CoA carboxylase 1,ACACA,105.83,105.35,S2343,PTQRAEVIRILSTMDSPST____________,_ILSTMDS(ph)PST_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,acetyl-CoA carboxylase activity,acetyl-CoA metabolic process,,
Q15057,Q15057,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2",ACAP2,132.01,115.33,S521,KYVERKFVDKYSISLSPPEQQKKFVSKSSEE,_YSISLS(ph)PPEQQK_,0.25,0.22,0.24, ,0.25,-0.05,-0.11, ,0.08,0.06,-0.02, ,0.04,0.04,-0.08, ,0.23,0.24,0.11,-0.11,0.07,-0.02,0.04,-0.08,,,,,,,0,0,,,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q5T8E0,Q5T8D3,Acyl-CoA-binding domain-containing protein 5,ACBD5,330.84,325.03,S196,TPNAKTVNGKAESSDSGAESEEEEAQEEVKG,_AESSDS(ph)GAES(ph)EEEEAQEEVK_,0,-0.19,0.06,0.17, ,0.09,0.17,0.15,0.09,-0.15,0,-0.06, ,0.08,0.09,0.21,-0.09,0.12,0.09,0.16,-0.03,-0.03,0.08,0.15,,,,,,,0,0,,,fatty-acyl-CoA binding,,,
Q5T8E0,Q5T8D3,Acyl-CoA-binding domain-containing protein 5,ACBD5,330.84,325.03,S200,KTVNGKAESSDSGAESEEEEAQEEVKGAEQS,_AESSDS(ph)GAES(ph)EEEEAQEEVK_,0,-0.19,0.06,0.17, ,0.11,0.23,0.15,0.09,-0.15,0,-0.06, ,-0.01,0.11,0.21,-0.09,0.12,0.11,0.19,-0.03,-0.03,-0.01,0.16,,,,,,,0,0,,,fatty-acyl-CoA binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,109.23,105.69,S240,ERRSSRVRQARAAKLSEGSQPAEEEEDQETP,_LS(ph)EGS(ph)QPAEEEEDQETPSR_, , , , ,1.93,2.25,1.75,2.02, , , , ,2.3,2.57,2.35,3.07,,,2.1,1.89,,,2.44,2.75, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,162.75,161.06,S243,SSRVRQARAAKLSEGSQPAEEEEDQETPSRN,_LS(ph)EGS(ph)QPAEEEEDQETPSR_, , , , ,1.93,2.25,-0.11,0.89, , , , ,2.3,2.57,0.53,0.68,,,2.1,0.47,,,2.44,0.61, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,220.06,171.62,S710,ERTSTSSSSVQARRLSQPESAEKHVTQRLQP,_RLS(ph)QPESAEK_, , , ,2.46,1.86,1.97,1.4,1.16, , , ,2.49,2.47,2.2,1.71,1.47,,2.46,1.92,1.29,,2.49,2.34,1.6, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,101.71,101.71,S328,RVKPEEMMDERPKTRSQEQEVLERGGRFTRS,_TRS(ph)QEQEVLER_, ,-0.3,-0.65, , , ,1.41, , ,-0.02,-0.05, , , ,1.07, ,-0.3,-0.65,,1.41,-0.02,-0.05,,1.07, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,215.6,214.59,S490,GGLSPLSSPSDTKAESPAEKVPEESVLPLVQ,_AES(ph)PAEKVPEESVLPLVQK_,-0.34,-0.34,-0.07,-0.46,-0.13,-0.18,-0.28, ,-0.23,-0.17,0.02,-0.17,0.15,-0.09,-0.1, ,-0.34,-0.25,-0.16,-0.28,-0.2,-0.07,0.03,-0.1,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,134.64,134.11,S410,DRKKASLVALPEQTASEEETPPPLLTKEASS,_ASLVALPEQTAS(ph)EEET(ph)PPPLLTK_,-0.1,-0.15,-0.1,0.22,-0.73,-0.37,-0.36,-0.6,0.04,-0.1,-0.23,-0.15,0.11,-0.05,-0.09,-0.02,-0.12,0.07,-0.54,-0.47,-0.03,-0.19,0.03,-0.05,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,86.45,82.59,S386,EREIKSSQGLKEKSKSPSPPRLTEDRKKASL,_SKS(ph)PS(ph)PPRLTEDR_,-0.1,-0.14,0.04,0.01,-0.12,-0.1,-0.29,-0.79,-0.23,-0.21,-0.11,-0.13,-0.1,-0.07,-0.17,-0.55,-0.12,0.02,-0.11,-0.52,-0.22,-0.12,-0.09,-0.35,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,86.45,82.59,S388,EIKSSQGLKEKSKSPSPPRLTEDRKKASLVA,_SKS(ph)PS(ph)PPRLTEDR_,-0.1,-0.14,0.04,0.01,-0.12,-0.1,-0.29,-0.79,-0.23,-0.21,-0.11,-0.13,-0.1,-0.07,-0.17,-0.55,-0.12,0.02,-0.11,-0.52,-0.22,-0.12,-0.09,-0.35,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,101.71,49.32,S655,RSRSRSRSASSNSRKSLSPGVSRDSSTSYTE,_S(ph)LS(ph)PGVSR_, , , , ,-0.25,-0.22,-0.41,-0.59, , , , ,-0.19,0.08,-0.08,-0.39,,,-0.24,-0.5,,,-0.05,-0.23,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,101.71,49.32,S657,RSRSRSASSNSRKSLSPGVSRDSSTSYTETK,_S(ph)LS(ph)PGVSR_, , , , ,-0.25,-0.22,-0.41,-0.59, , , , ,-0.19,0.08,-0.08,-0.39,,,-0.24,-0.5,,,-0.05,-0.23,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,126.16,100.34,S365,SHLARQQQEKEMKTTSPLEEEEREIKSSQGL,_TTS(ph)PLEEEEREIK_, , ,-0.96, , , , , , , ,-0.28, , , , , ,,-0.96,,,,-0.28,,,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7EQT4,Q9UKV3,Apoptotic chromatin condensation inducer in the nucleus,ACIN1,134.64,134.11,T414,ASLVALPEQTASEEETPPPLLTKEASSPPPH,_ASLVALPEQTAS(ph)EEET(ph)PPPLLTK_,-0.17,-0.11,-0.37, ,-0.32,-0.21,-0.33,-0.41,-0.18,0.04,-0.01, ,-0.2,0.13,-0.25,-0.15,-0.14,-0.37,-0.27,-0.37,-0.06,-0.01,-0.02,-0.2,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
P53396,P53396,ATP-citrate synthase,ACLY,187.57,187.57,S455,NASGSTSTPAPSRTASFSESRADEVAPAKKA,_TAS(ph)FSESRADEVAPAKK_,0.54,0.52,0.56,0.68,1.41,1.37,1.01,0.94,0.53,0.53,0.8,0.89,1.28,1.05,1.02,1.08,0.53,0.62,1.39,0.97,0.53,0.85,1.17,1.05, +, +,,,,,2,1,33.31,citrate lyase complex,ATP binding,ATP catabolic process,,
P53396,P53396,ATP-citrate synthase,ACLY,171.03,150.24,S481,PAKKAKPAMPQDSVPSPRSLQGKSTTLFSRH,_PAMPQDSVPS(ph)PR_,0.1,0.05,0.21,-0.03,-0.09,0.36,-0.05,0.02,0.15,0.11,0.29,0.11,-0.08,0.02,-0.33,-0.08,0.07,0.1,0.15,-0.01,0.13,0.2,-0.03,-0.2,,,,,,,0,0,,citrate lyase complex,ATP binding,ATP catabolic process,,
P53396,P53396,ATP-citrate synthase,ACLY,164.39,164.39,Y682,SNELNNIISRTTDGVYEGVAIGGDRYPGSTF,_TTDGVY(ph)EGVAIGGDRYPGSTFMDHVLR_,0, , , ,-0.23,0,-0.14,-0.16,-0.21, , , ,-0.22,-0.23,-0.14,-0.25,0,,-0.11,-0.15,-0.21,,-0.22,-0.19,,,,,,,NA,NA,,citrate lyase complex,ATP binding,ATP catabolic process,,
F6WZD5,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,116.46,116.27,S267,HLGRAELGMGDSTSQSPPIKRSCPDVQISWN,_AELGMGDSTSQS(ph)PPIK_, , , , , ,-0.8,-0.22,-0.53, , , , , ,-0.41,-0.24,-0.32,,,-0.8,-0.37,,,-0.41,-0.28,,,,,,,NA,NA,,,,,,
F6WZD5,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,101.53,101.53,S30,RGQEEAGAGGRARSWSPPPEVSRSAHVPSLQ,_SWS(ph)PPPEVSR_,0.34,0.36,0.21, ,-0.32,-0.29,-0.18,-0.07,0.12,0.15,0.08, ,-0.27,-0.28,-0.2,-0.19,0.35,0.21,-0.3,-0.12,0.14,0.08,-0.27,-0.19,,,,,,,0,0,,,,,,
O96019-2,O96019,Actin-like protein 6A,ACTL6A,145.18,145.18,S233,VPPYMIASKEAVREGSPANWKRKEKLPQVTR,_EAVREGS(ph)PANWK_,-0.35,-0.14,-0.27,0.04,-0.29, ,-0.1, ,-0.04,-0.05,-0.17,-0.18,0.03, ,0.03, ,-0.24,-0.11,-0.29,-0.1,-0.04,-0.18,0.03,0.03,,,,,,,0,0,,Ino80 complex,ATP binding,chromatin remodeling,,
O43707,P12814,Alpha-actinin-2,ACTN2,137.61,97.34,S140,GMIWTIILRFAIQDISVEETSAKEGLLLWCQ,_FAIQDIS(ph)VEETSAK_,-1.33,-1.52,-1.45,-1.16,-1.15,-0.93,-0.96,-1.05,-0.92,-0.82,-0.53,-0.52,-0.88,-0.97,-0.29,-0.35,-1.42,-1.3,-1.04,-1.01,-0.87,-0.53,-0.93,-0.32, +,,,,,,3,0,12.38,cortical cytoskeleton,actin filament binding,actin crosslink formation,,
O43707,P12814,Alpha-actinin-4,ACTN4,77.8,77.8,Y246,ARPDEKAIMTYVSSFYHAFSGAQKAETAANR,_AIMTYVSSFY(ph)HAFSGAQK_,-1.17, , , ,-0.55,-0.68,-0.71,-0.47,-0.85, , , ,0.16,-0.31,0.31,-0.03,-1.17,,-0.61,-0.59,-0.85,,-0.06,0.15, +,,,,,,NA,NA,,cortical cytoskeleton,actin filament binding,actin crosslink formation,,
P78536,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,174.24,173.05,S791,GFEKDPFPNSSTAAKSFEDLTDHPVTRSEKA,_S(ph)FEDLTDHPVTR_,0.3,0.38,-0.2,0.1, ,0.22,-0.32,-0.22,0.06,-0.04,-0.44,-0.19, ,0.17,0.24,0.07,0.34,-0.04,0.22,-0.27,0.01,-0.31,0.17,0.15,,,,,,,0,0,,actin cytoskeleton,metalloendopeptidase activity,B cell differentiation,,
Q13443,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,119.09,118.93,Y815,QGNLIPARPAPAPPLYSSLT___________,_VSSQGNLIPARPAPAPPLY(ph)SSLT_,0.62, , , ,0.09,0.13,-0.12, ,0.39, , , ,0.4,0.44,0.03, ,0.62,,0.11,-0.12,0.39,,0.42,0.03,,,,,,,NA,NA,,cytoplasm,collagen binding,activation of MAPKK activity,,
Q13443,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,97.54,97.54,S758,QANPSRQPGSVPRHVSPVTPPREVPIYANRF,_HVS(ph)PVT(ph)PPREVPIYANR_,-0.6,-0.64,-0.56, , , , , ,-0.33,-0.48,-0.39, , , , , ,-0.62,-0.56,,,-0.4,-0.39,,,,,,,,,NA,NA,,cytoplasm,collagen binding,activation of MAPKK activity,,
Q13443,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,97.54,97.54,T761,PSRQPGSVPRHVSPVTPPREVPIYANRFAVP,_HVS(ph)PVT(ph)PPREVPIYANR_,-0.6,-0.64,-0.56, , , , , ,-0.33,-0.48,-0.39, , , , , ,-0.62,-0.56,,,-0.4,-0.39,,,,,,,,,NA,NA,,cytoplasm,collagen binding,activation of MAPKK activity,,
C9JUP4,P78563,Double-stranded RNA-specific editase 1,ADARB1,63.46,63.36,S10,______MDIEDEENMSSSSTDVKENRNLDNV,_(ac)MDIEDEENMS(ph)SSS(ph)TDVK_, , , , , , ,-0.17,-0.34, , , , , , ,-0.03,-0.27,,,,-0.26,,,,-0.15,,,,,,,NA,NA,,,double-stranded RNA binding,adenosine to inosine editing,,
P35611-2,P35611,Alpha-adducin,ADD1,208.58,208.58,S464,NSGRGDEASEEGQNGSSPKSKTKWTKEDGHR,_WLNSGRGDEASEEGQNGS(ph)SPK_, ,-0.11, ,-0.37, , , , , ,-0.09, ,-0.21, , , , ,-0.11,-0.37,,,-0.09,-0.21,,,,,,,,,NA,NA,,cytosol,actin filament binding,actin filament bundle assembly,,
P35611-2,P35611,Alpha-adducin,ADD1,248.02,248.02,S465,SGRGDEASEEGQNGSSPKSKTKWTKEDGHRT,_WLNSGRGDEASEEGQNGSS(ph)PK_,-0.27,-0.28,-0.49,-0.27,-0.06,-0.01,0.07,-0.04,-0.07,-0.1,-0.2,-0.28,-0.1,-0.25,-0.06,-0.21,-0.27,-0.38,-0.03,0.02,-0.09,-0.24,-0.17,-0.13,,,,,,,0,0,,cytosol,actin filament binding,actin filament bundle assembly,,
Q9UEY8,Q9UEY8,Gamma-adducin,ADD3,240.79,240.79,S677,IKSPEKIEEVLSPEGSPSKSPSKKKKKFRTP,_IEEVLS(ph)PEGS(ph)PSKS(ph)PSK_,-0.04,-1.57,-2.38,-0.16,0.14,-1.21,3.04,0.05,0.03,-1.53,-2.44,-0.18,0.15,-1.05,0.5,0.2,-0.61,-0.88,-0.38,2.21,-0.55,-0.91,-0.33,0.36, +,,,,,,2,0,14.91,cell cortex,metal ion binding,,,
Q9UEY8,Q9UEY8,Gamma-adducin,ADD3,203.79,203.79,S673,IEITIKSPEKIEEVLSPEGSPSKSPSKKKKK,_IEEVLS(ph)PEGS(ph)PSKS(ph)PSK_,0.12,0.01,0.02,-0.16,-0.26,-0.25,-0.19,-0.23,-0.11,-0.11,0.07,-0.63,-0.06,-0.1,-0.05,-0.06,0.07,-0.07,-0.25,-0.21,-0.11,-0.24,-0.08,-0.06,,,,,,,0,0,,cell cortex,metal ion binding,,,
Q9UEY8,Q9UEY8,Gamma-adducin,ADD3,240.79,240.79,S681,EKIEEVLSPEGSPSKSPSKKKKKFRTPSFLK,_IEEVLS(ph)PEGS(ph)PSKS(ph)PSK_,-0.29,-0.26,-0.9,-0.47,0.41,-0.19,-0.17,0.38,0.25,0.2,0.09,0.22,0.52,-0.02,0.11,0.23,-0.27,-0.67,0.14,0.13,0.22,0.16,0.28,0.17,,,,,,,0,0,,cell cortex,metal ion binding,,,
Q9UEY8,Q9UEY8,Gamma-adducin,ADD3,81.89,79.59,S42,RINENDPEYIRERNMSPDLRQDFNMMEQRKR,_NMS(ph)PDLRQDFNMMEQR_, ,0.04, , , , , , , ,-0.36, , , , , , ,0.04,,,,-0.36,,,,,,,,,,NA,NA,,cell cortex,metal ion binding,,,
Q9H2P0,Q9H2P0,Activity-dependent neuroprotector homeobox protein,ADNP,288.19,287.84,S953,TIHLTEEPTKLMHNASDSEVDQDDVVEWKDG,_LMHNAS(ph)DS(ph)EVDQDDVVEWK_,-0.07,-0.08,-0.25,-0.29,-0.43,-0.3,-0.35,-0.36,0.19,0.97,-0.12,-0.26,-0.26,-0.02,-0.19,-0.16,-0.08,-0.27,-0.36,-0.36,0.63,-0.19,-0.13,-0.17,,,,,,,0,0,,extracellular space,chromatin binding,negative regulation of neuron apoptotic process,,
Q9H2P0,Q9H2P0,Activity-dependent neuroprotector homeobox protein,ADNP,288.19,287.84,S955,HLTEEPTKLMHNASDSEVDQDDVVEWKDGAS,_LMHNAS(ph)DS(ph)EVDQDDVVEWK_,-0.14,-0.1,-0.35,-0.29,-0.2,-0.3,-0.35,-0.36,0.16,0.16,0.14,0.09,0.01,-0.02,-0.19,-0.16,-0.12,-0.32,-0.25,-0.36,0.16,0.12,0,-0.17,,,,,,,0,0,,extracellular space,chromatin binding,negative regulation of neuron apoptotic process,,
Q9H2P0,Q9H2P0,Activity-dependent neuroprotector homeobox protein,ADNP,119.58,118.33,S98,SKFFSAYKSHFRNVHSEDFENRILLNCPYCT,_NVHS(ph)EDFENR_,0.05,0.06,-0.12,-0.02,-0.41,-0.91, , ,-0.07,0.02,-0.28,-0.29,-0.61,-1.06, , ,0.05,-0.07,-0.64,,-0.02,-0.29,-0.82,,,,,,,,NA,NA,,extracellular space,chromatin binding,negative regulation of neuron apoptotic process,,
Q16186,Q16186,Proteasomal ubiquitin receptor ADRM1,ADRM1,135.61,134.37,S405,KEGDTKDKKDEEEDMSLD_____________,_DKKDEEEDMS(ph)LD_,-1.05,-0.13, , , , , , ,-0.84,0.02, , , , , , ,-0.51,,,,-0.35,,,,,,,,,,NA,NA,,cytoplasm,endopeptidase activator activity,proteasome assembly,,
P30566,P30566,Adenylosuccinate lyase,ADSL,174.76,159.71,S9,_______MAAGGDHGSPDSYRSPLASRYASP,_(ac)AAGGDHGS(ph)PDSYRSPLASR_,-0.06,-0.05,0.06,-0.12,-0.04,0.05,0.84,-0.21,-0.13,-0.09,-0.13,-0.12,-0.75,-0.21,-0.06,-0.65,-0.06,-0.03,0,0.41,-0.11,-0.12,-0.45,-0.33,,,,,,,0,0,,cytosol,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,de novo' AMP biosynthetic process,,
B3KXA1,Q6ZN18,Zinc finger protein AEBP2,AEBP2,144.69,144.69,S206,TGGGGSSATSGGRRGSLEMSSDGEPLSRMDS,_RGS(ph)LEMS(ph)S(ph)DGEPLSR_,-0.14,-0.1,1.31,1.22,0.71,0.67,0.56,0.45,0.37,-0.01,0.97,0.78,0.64,0.56,0.68,0.56,-0.12,1.27,0.69,0.51,0.19,0.88,0.6,0.62, +,,,,,,4,0,27.17,,nucleic acid binding,,,
B3KXA1,Q6ZN18,Zinc finger protein AEBP2,AEBP2,84.13,81.1,S210,GSSATSGGRRGSLEMSSDGEPLSRMDSEDSI,_RGS(ph)LEMS(ph)S(ph)DGEPLSR_,-0.28,-0.33,0.25,0.41,0.87,1.1,-2.25,1.05,0.64,0.34,0.29,0.68,0.61,0.87,-2.55,1.04,-0.3,0.33,0.99,0.19,0.5,0.5,0.75,0.16,,,,,,,0,0,,,nucleic acid binding,,,
B3KXA1,Q6ZN18,Zinc finger protein AEBP2,AEBP2,84.13,81.1,S211,SSATSGGRRGSLEMSSDGEPLSRMDSEDSIS,_RGS(ph)LEMS(ph)S(ph)DGEPLSR_, , ,0.62, ,0.36,0.21,-2.25,0.77, , ,0.64, ,0.39,0.18,-2.55,0.84,,0.62,0.29,-0.06,,0.64,0.29,-0.03,,,,,,,NA,NA,,,nucleic acid binding,,,
Q8N556,Q8N556,Actin filament-associated protein 1,AFAP1,62.94,62.3,S664,GGVTLGLAIEPKSGTSSPQSPVFRHRTLENS,_SGTS(ph)SPQS(ph)PVFR_, , , , , ,-0.17,-0.8,-0.64, , , , , ,-0.07,-0.67,-0.61,,,-0.17,-0.72,,,-0.07,-0.64,,,,,,,NA,NA,,actin cytoskeleton,phospholipid binding,,,
Q8N556,Q8N556,Actin filament-associated protein 1,AFAP1,67.25,66.06,S665,GVTLGLAIEPKSGTSSPQSPVFRHRTLENSP,_SGT(ph)SS(ph)PQS(ph)PVFR_, , , , ,-1.15,-0.16,-0.22,-0.84, , , , ,-1.07,-0.19,-0.34,-0.57,,,-0.57,-0.5,,,-0.56,-0.45,,,,,,,NA,NA,,actin cytoskeleton,phospholipid binding,,,
Q8N556,Q8N556,Actin filament-associated protein 1,AFAP1,82.58,81.07,S668,LGLAIEPKSGTSSPQSPVFRHRTLENSPISS,_SGT(ph)SS(ph)PQS(ph)PVFR_, , , , ,-0.24,-0.53,-0.15,-0.28, , , , ,-0.2,-1.11,0.08,-0.36,,,-0.38,-0.22,,,-0.59,-0.12,,,,,,,NA,NA,,actin cytoskeleton,phospholipid binding,,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,56.12,31.87,S814,ESSKQSAAKEKDLLPSPAGPVPSKDPKTEHG,_DLLPS(ph)PAGPVPSK_,0.55,1.36, , ,0.29,-0.02,0.41,0.14,0.99,-0.05, , ,-0.05,-0.11,0.08,0.04,1.01,,0.14,0.28,0.56,,-0.08,0.06, +,,,,,,NA,NA,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,95.85,93.64,S1058,SPGLGSKAVGMPSPVSPKLSPGNSGNYSSGA,_AVGMPS(ph)PVS(ph)PK_, , ,0.82,0.76,0.7, ,0.1,0.34, , ,0.32,2.75,0.21, ,0.11,0.2,,0.79,0.7,0.22,,2,0.21,0.15,, +,,,,,NA,NA,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,62.06,62.06,S1055,QAPSPGLGSKAVGMPSPVSPKLSPGNSGNYS,_AVGMPS(ph)PVS(ph)PK_, , , , ,0.71, , ,0.52, , , , ,0.52, , ,0.36,,,0.71,0.52,,,0.52,0.36,,,,,,,NA,NA,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,139.47,139.47,S703,FRQRMFSPMEEKELLSPLSEPDDRYPLIVKI,_ELLS(ph)PLS(ph)EPDDRYPLIVK_,-0.07,0.03,0,1.3,0.43,0.53,0.92,0.29,-0.04,-0.06,0.2,0.82,0.56,0.26,0.57,0.24,-0.02,0.79,0.48,0.64,-0.05,0.54,0.42,0.42,,,,,,,0,0,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,139.47,139.47,S706,RMFSPMEEKELLSPLSEPDDRYPLIVKIDLN,_ELLS(ph)PLS(ph)EPDDRYPLIVK_,-0.07,0.03,0, ,0.58,0.53,0.92,0.29,-0.04,-0.06,0.2, ,0.4,0.26,0.57,0.24,-0.02,0,0.56,0.64,-0.05,0.2,0.33,0.42,,,,,,,0,0,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
Q9UHB7,Q9UHB7,AF4/FMR2 family member 4,AFF4,136.96,114.18,S694,SSVEEEDSFFRQRMFSPMEEKELLSPLSEPD,_MFS(ph)PMEEK_,0.42,0.15,0.56,0.39, ,0.84,0.44,0.51,0.34,-0.2,0.26,0.37, ,0.72,0.36,0.17,0.29,0.48,0.84,0.47,0.09,0.32,0.72,0.26,,,,,,,0,0,,mitochondrion,sequence-specific DNA binding transcription factor activity,spermatid development,,
B8ZZI9,Q6ULP2,Aftiphilin,AFTPH,139.19,138.9,S409,QSPNIDPTEENDLDDSLSVKNGDSSNDFVTC,_FTNFQSPNIDPTEENDLDDS(ph)LS(ph)VK_, , , , ,0.14, , ,-0.29, , , , ,-0.19, , ,-0.13,,,0.14,-0.29,,,-0.19,-0.13,,,,,,,NA,NA,,,,,,
B8ZZI9,Q6ULP2,Aftiphilin,AFTPH,139.19,138.9,S411,PNIDPTEENDLDDSLSVKNGDSSNDFVTCND,_FTNFQSPNIDPTEENDLDDS(ph)LS(ph)VK_, , , , ,0.14, , , , , , , ,-0.19, , , ,,,0.14,,,,-0.19,,,,,,,,NA,NA,,,,,,
P52594-2,P52594,Arf-GAP domain and FG repeat-containing protein 1,AGFG1,74.48,68.99,S181,DSAPTLHLNKGTPSQSPVVGRSQGQQQEKKQ,_GTPSQS(ph)PVVGR_, , , , , , , ,-0.71, , , , , , , ,-0.35,,,,-0.71,,,,-0.35,,,,,,,NA,NA,,cytoplasmic membrane-bounded vesicle,ARF GTPase activator activity,cell differentiation,,
Q8N302-2,Q8N302,Angiogenic factor with G patch and FHA domains 1,AGGF1,180.74,180.74,S7,_________MASEAPSPPRSPPPPTSPEPEL,_(ac)ASEAPS(ph)PPRS(ph)PPPPTS(ph)PEPELAQLR_, , , , ,-0.1,0.17,0.05,0.18, , , , ,-0.04,-0.02,-0.59,-0.24,,,0.04,0.12,,,-0.03,-0.4,,,,,,,NA,NA,,extracellular region,nucleic acid binding,angiogenesis,,
Q8N302-2,Q8N302,Angiogenic factor with G patch and FHA domains 1,AGGF1,180.74,180.74,S11,_____MASEAPSPPRSPPPPTSPEPELAQLR,_(ac)ASEAPS(ph)PPRS(ph)PPPPTS(ph)PEPELAQLR_, , , , ,-0.1,0.17,0.05,0.18, , , , ,-0.04,-0.02,-0.59,-0.24,,,0.04,0.12,,,-0.03,-0.4,,,,,,,NA,NA,,extracellular region,nucleic acid binding,angiogenesis,,
Q8N302-2,Q8N302,Angiogenic factor with G patch and FHA domains 1,AGGF1,180.74,180.74,S17,ASEAPSPPRSPPPPTSPEPELAQLRRKVEKL,_(ac)ASEAPS(ph)PPRS(ph)PPPPTS(ph)PEPELAQLR_, , , , ,-0.07,0.17,0.01,0.18, , , , ,0.01,-0.02,-0.14,-0.1,,,0.05,0.1,,,-0.01,-0.12,,,,,,,NA,NA,,extracellular region,nucleic acid binding,angiogenesis,,
Q8WYP5,Q8WYP5,Protein ELYS,AHCTF1,84.66,74.23,S1283,EWLKSKDRTTSFFLNSPEKEHQEMDEGSQSL,_DRTTSFFLNS(ph)PEK_,0.18,-0.06,-0.04, , , , , ,0.11,0.44,0.19, , , , , ,0.06,-0.04,,,0.29,0.19,,,,,,,,,NA,NA,,condensed chromosome kinetochore,DNA binding,cytokinesis,,
Q8WYP5,Q8WYP5,Protein ELYS,AHCTF1,61.86,60.1,S2222,KESAWSPPPIEIRLISPLASPADGVKSKPRK,_LIS(ph)PLAS(ph)PADGVK_, , , , ,-0.67,-0.6, , , , , , ,-0.07,-0.51, , ,,,-0.64,,,,-0.28,,,,,,,,NA,NA,,condensed chromosome kinetochore,DNA binding,cytokinesis,,
Q8WYP5,Q8WYP5,Protein ELYS,AHCTF1,61.86,60.1,S2226,WSPPPIEIRLISPLASPADGVKSKPRKTTEV,_LIS(ph)PLAS(ph)PADGVK_, , , , ,-0.67,-0.6, , , , , , ,-0.07,-0.51, , ,,,-0.64,,,,-0.28,,,,,,,,NA,NA,,condensed chromosome kinetochore,DNA binding,cytokinesis,,
Q8WYP5,Q8WYP5,Protein ELYS,AHCTF1,60.71,58.23,S1541,EKLEAQDSGEEARNLSFNELYPSGTLKLQYN,_NLS(ph)FNELYPSGTLK_, , , ,-0.35, , , , , , , ,0.37, , , , ,,-0.35,,,,0.37,,,,,,,,,NA,NA,,condensed chromosome kinetochore,DNA binding,cytokinesis,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,167.69,146.02,Y836,PDVDLHLKGPNVKGEYDVTMPKVESEIKVPD,_GPNVKGEY(ph)DVTMPK_,4.19, , , , , , , ,3.04, , , , , , , ,4.19,,,,3.04,,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,77.89,74.55,Y1469,PDVGLHLKGPKMKGDYDVTVPKVEGEIKAPD,_MKGDY(ph)DVTVPK_,1.78, ,2.16, , , , , ,1.15, ,1.42, , , , , ,1.78,2.16,,,1.15,1.42,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,85.55,66.42,Y964,PDVDLHMKGPKVKGEYDMTVPKLEGDLKGPK,_VKGEY(ph)DMTVPK_, , ,2.4, , , , , , , ,1.96, , , , , ,,2.4,,,,1.96,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,93.35,81.08,Y715,PDVDLHVKGTKVKGEYDVTVPKLEGELKGPK,_VKGEY(ph)DVTVPK_,2.64, , , , , , , ,1.74, , , , , , , ,2.64,,,,1.74,,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,155.38,155.38,S5110,FDIKSPKFKAEAPLPSPKLEGELQAPDLELS,_FKAEAPLPS(ph)PK_,-0.08,-0.1,1.95,1.96,1.61,1.56,1.54,1.47,0.78,0.97,2.32,2.33,1.87,1.79,2.07,1.92,-0.09,1.96,1.58,1.51,0.87,2.33,1.83,2, +, +,,,,,1,1,25.14,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,219.57,219.57,S5749,ASISGSKGDLKSSKASLGSLEGEAEAEASSP,_AS(ph)LGS(ph)LEGEAEAEASS(ph)PK_,-0.44,-0.65,-1.42,-1.53,-0.84,-0.85,-0.6,-0.43,-0.3,-0.8,-0.83,-1.27,-1.13,-1.19,-0.78,-0.62,-0.55,-1.48,-0.85,-0.51,-0.53,-1.03,-1.16,-0.7, +, +,,,,,3,6,19.7,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,102.52,84.7,S5830,GKHGKLKFGTFGGLGSKSKGHYEVTGSDDET,_FGTFGGLGS(ph)K_, , , , ,1.91,1.96,1.33,-0.26, , , , ,1.29,1.35,0.84,-1.02,,,1.93,0.75,,,1.32,0.19, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,160.42,147.85,S5780,KGKFSLFKSKKPRHRSNSFSDEREFSGPSTP,_HRS(ph)NS(ph)FSDER_,-0.18,0.24,2.47, ,2.22,2.15,1.89,1.9,0.8,1.02,2.92, ,2.26,2.2,2.25,2.26,0.04,2.47,2.19,1.89,0.92,2.92,2.23,2.26, +, +,,,,,1,1,30.22,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,229.63,153.28,S5782,KFSLFKSKKPRHRSNSFSDEREFSGPSTPTG,_HRSNS(ph)FSDER_,-0.14,-0.16,-1.38,-1.58,-0.97,-0.84,-0.95,-0.84,0.14,0.14,-1.27,-1.15,-0.98,-0.74,-0.71,-0.71,-0.15,-1.48,-0.9,-0.89,0.14,-1.21,-0.85,-0.71, +, +,,,,,3,3,33.5,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,356.96,302.84,S210,VDVETQSGKTVIRLPSGSGAASPTGSAVDIR,_LPS(ph)GSGAASPTGSAVDIR_,-0.04,-0.02,2.3,2.32,1.7,1.9,1.22,0.93,0.23,0.2,2.68,2.63,1.87,2.01,1.28,1.17,-0.03,2.31,1.8,1.08,0.22,2.66,1.94,1.23, +, +,,,,,1,1,46.15,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,339.1,284.79,S212,VETQSGKTVIRLPSGSGAASPTGSAVDIRAG,_LPSGS(ph)GAAS(ph)PTGSAVDIR_,-0.17,0.02,2.33,2.19,-0.02,0.09,-0.18,-0.27,-0.16,0.08,2.73,2.27,0.15,0.4,-0.02,-0.01,-0.07,2.27,0.04,-0.22,-0.03,2.51,0.28,-0.01, +, +,,,,,4,4,34.65,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,88.42,86.38,S5857,DDETGKLQGSGVSLASKKSRLSSSSSNDSGN,_LQGSGVSLAS(ph)K_,0.9, , , ,1.09,0.92,0.82, ,2.05, , , ,0.33,0.36,-0.03, ,0.9,,1.01,0.82,2.05,,0.34,-0.03, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,71.08,37.24,S1068,PKFKMPEMHFRAPKMSLPDVDLDLKGPKMKG,_MS(ph)LPDVDLDLK_, , ,2.33, , , , , , , ,3.49, , , , , ,,2.33,,,,3.49,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,173.21,168.99,S5099,MFGKMYFPDVEFDIKSPKFKAEAPLPSPKLE,_MYFPDVEFDIKS(ph)PK_, , ,2.56,1.83,-0.38, , , , , ,3.22,2.67,-0.75, , , ,,2.24,-0.38,,,2.97,-0.75,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,172.12,172.12,S3426,SSPKVSMPDVELNLKSPKVKGDLDIAGPNLE,_VSMPDVELNLKS(ph)PK_, , ,2.55,1.9, , , , , , ,3.32,2.9, , , , ,,2.26,,,,3.13,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,126.04,99.01,T4100,PKADIDVSGPKVDIDTPDIDIHGPEGKLKGP,_VDIDT(ph)PDIDIHGPEGK_,-1.8,-0.94,0.59,0.51,-0.03,-0.22,-0.37,-0.15,-0.12,0.52,2.12,1.89,-0.09,0.05,0.08,0.29,-1.31,0.55,-0.13,-0.26,0.24,2.01,-0.02,0.19, +, +,,,,,4,4,13.03,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,98.11,68.34,Y160,ETQSRTITVTRRVTAYTVDVTGREGAKDIDI,_VTAY(ph)TVDVTGR_,3.59, , , , , , , ,2.85, , , , , , , ,3.59,,,,2.85,,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,131.98,120.19,S2397,KAPKISMPDLDLHLKSPKAKGEVDVDVPKLE,_ISMPDLDLHLKS(ph)PK_, , ,3.86, , , , , , , ,2.82, , , , , ,,3.86,,,,2.82,,, +, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,376.07,311.18,S135,EYQRIYTTKIKPRLKSEDGVEGDLGETQSRT,_S(ph)EDGVEGDLGETQSR_,-0.3,-0.12,3.19,3.14,2.71,2.54,2.19,2.24,0.81,0.98,3.17,3.32,2.72,2.57,2.51,2.57,-0.21,3.16,2.62,2.22,0.9,3.24,2.65,2.54, +, +,,,,,1,1,31.54,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,143.06,142.79,S5746,SPEASISGSKGDLKSSKASLGSLEGEAEAEA,_S(ph)S(ph)KASLGS(ph)LEGEAEAEASSPK_, , , , , , , ,4.19, , , , , , , ,-0.89,,,,4.19,,,,-0.89, +,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,99.6,96.84,T3716,KGPEVDIKGPKVDIDTPDINIEGSEGKFKGP,_VDIDT(ph)PDINIEGSEGK_, , , , ,-0.92,-1.23, , , , , , ,0.15,-0.78, , ,,,-1.07,,,,-0.24,, +,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,248.78,247.85,S41,AQRDDGVFVQEVTQNSPAARTGVVKEGDQIV,_DDGVFVQEVTQNS(ph)PAAR_,-1.02,-1.27,-0.31,-0.12,-0.58,-0.53,-0.7,-0.78,-0.15,-0.07,0.64,0.5,-0.23,-0.16,-0.44,-0.37,-1.14,-0.21,-0.55,-0.74,-0.11,0.57,-0.2,-0.4, +,,,,,,6,0,9.59,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,140.63,113.2,S177,VDVTGREGAKDIDISSPEFKIKIPRHELTEI,_DIDIS(ph)S(ph)PEFK_,-0.28,-0.07,-0.05,0.01,0.5,0.02,-0.03,-0.31,-0.09,0.01,0.29,0.23,1.44,0.36,0.36,0,-0.17,-0.02,0.28,-0.16,-0.04,0.26,1,0.19,, +,,,,,0,2,24.26,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,163.63,144.25,S5790,KPRHRSNSFSDEREFSGPSTPTGTLEFEGGE,_EFS(ph)GPSTPTGTLEFEGGEVSLEGGK_, , , , ,0.63,1.24,0.9,0.76, , , , ,0.87,1.14,1.48,1.18,,,0.97,0.83,,,1.01,1.34,, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,112,110.91,S5739,GKGGVTGSPEASISGSKGDLKSSKASLGSLE,_GGVTGS(ph)PEASISGS(ph)K_, , , , ,-0.45,-1.12,-0.69, , , , , ,-1,-1.49,-0.4, ,,,-0.74,-0.69,,,-1.22,-0.4,, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,68.68,64.06,S793,VDISGPKIDVTAPDVSIEEPEGKLKGPKFKM,_IDVTAPDVS(ph)IEEPEGK_, , ,0.16, , , , , , , ,1.22, , , , , ,,0.16,,,,1.22,,,, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,211.4,177,S511,QKPKISMQDVDLSLGSPKLKGDIKVSAPGVQ,_ISMQDVDLSLGS(ph)PK_,-0.44,-0.29,0.42,0.47,0.54,0.39,0.3,0.15,0.2,0.35,0.97,1.07,0.8,0.73,0.89,0.92,-0.36,0.45,0.47,0.23,0.28,1.02,0.76,0.91,, +,,,,,0,1,10.68,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,132.5,128.89,S570,PRLGSPSGKTGTCRISMSEVDLNVAAPKVKG,_IS(ph)MSEVDLNVAAPK_,0.31,0.35,0.74,0.86,0.53,0.39,0.71,0.53,0.45,0.51,1.17,1.01,0.6,0.7,0.51,0.53,0.33,0.8,0.46,0.62,0.48,1.09,0.65,0.52,, +,,,,,0,4,26.81,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,163.63,144.25,T5794,RSNSFSDEREFSGPSTPTGTLEFEGGEVSLE,_EFS(ph)GPST(ph)PTGTLEFEGGEVSLEGGK_, , , , ,0.7,0.4,0.74,1.03, , , , ,0.84,0.83,1.08,1.1,,,0.56,0.89,,,0.83,1.09,, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,109.91,106.37,T4766,KGPEADIKGPKVDINTPDVDVHGPDWHLKMP,_VDINT(ph)PDVDVHGPDWHLK_, , ,0.51,0.83, , , , , , ,2.09,1.83, , , , ,,0.68,,,,1.96,,,, +,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,315.51,306.18,S5752,SGSKGDLKSSKASLGSLEGEAEAEASSPKGK,_SSKAS(ph)LGS(ph)LEGEAEAEASSPK_,0.08,0.07,-0.15,-0.08,-0.67,-0.71,-0.48,-0.43,0.25,0.24,0.07,0.09,-0.5,-0.47,-0.55,-0.44,0.08,-0.11,-0.69,-0.46,0.24,0.08,-0.49,-0.49,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,315.51,306.18,S5762,KASLGSLEGEAEAEASSPKGKFSLFKSKKPR,_ASLGS(ph)LEGEAEAEAS(ph)SPK_,0.16, ,0.18,0.12,0.01,-0.06,-0.07,0.1,0.31, ,0.34,0.38,0.27,0.33,0.47,0.52,0.16,0.15,-0.02,0.01,0.31,0.36,0.3,0.49,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,290.15,239.19,S5763,ASLGSLEGEAEAEASSPKGKFSLFKSKKPRH,_ASLGSLEGEAEAEASS(ph)PK_,-0.05,0.03,0.15,0.18,0.04,0,0.03,0.11,0.24,0.3,0.42,0.43,0.36,0.37,0.47,0.48,-0.01,0.17,0.02,0.07,0.27,0.43,0.37,0.48,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,81.9,81.9,S176,TVDVTGREGAKDIDISSPEFKIKIPRHELTE,_DIDIS(ph)S(ph)PEFK_, , , , ,0.5,-0.15, , , , , , ,1.44,0.14, , ,,,0.21,,,,0.93,,,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,194.1,178.59,S5731,KFNFSKPKGKGGVTGSPEASISGSKGDLKSS,_GGVTGS(ph)PEASISGSK_,-0.03,-0.08,-0.1,-0.1,-0.5,-0.41,-0.54,-0.55,0.05,0.01,-0.02,-0.05,-0.25,-0.34,-0.35,-0.38,-0.06,-0.1,-0.45,-0.54,0.03,-0.03,-0.29,-0.37,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,330.13,313.87,S5841,GGLGSKSKGHYEVTGSDDETGKLQGSGVSLA,_GHYEVTGS(ph)DDETGK_,-0.05,-0.01,-0.1,-0.07,-0.22,-0.2,-0.08,-0.14,0.16,0.16,0.14,0.13,0.04,0.12,0.16,0.16,-0.03,-0.08,-0.21,-0.11,0.16,0.13,0.08,0.16,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,56.37,55.21,S5552,AAPDISVKGPAFNMASPESDFGINLKGPKIK,_GPAFNMAS(ph)PESDFGINLK_, , , , ,-0.41, , , , , , , ,-0.05, , , ,,,-0.41,,,,-0.05,,,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,169.84,165.59,S5448,LKGPGVDVNLKGPRISAPNVDFNLEGPKVKG,_IS(ph)APNVDFNLEGPK_,-0.16,-0.1,-0.13,-0.16,0.23,0.23,0.36,0.13,0.18,0.23,0.23,0.13,0.13,0.24,0.01,0.21,-0.13,-0.15,0.23,0.25,0.21,0.18,0.18,0.11,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,372.73,309.5,S216,SGKTVIRLPSGSGAASPTGSAVDIRAGAISA,_LPSGSGAAS(ph)PTGSAVDIR_,-0.32,-0.31,-0.57,-0.49,-0.41,-0.33,-0.36,-0.38,-0.16,-0.16,-0.27,-0.18,-0.1,-0.06,-0.06,-0.02,-0.31,-0.53,-0.37,-0.37,-0.16,-0.22,-0.08,-0.04,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,184.14,160.94,S220,VIRLPSGSGAASPTGSAVDIRAGAISASGPE,_LPSGSGAAS(ph)PTGS(ph)AVDIR_, , , , ,-0.32,-0.1,-0.21,0.01, , , , ,-0.61,-0.52,-0.28,-0.06,,,-0.21,-0.1,,,-0.56,-0.17,,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,179.66,158.25,T4430,KGPEIDIKGPSLDIDTPDVNIEGPEGKLKGP,_GPSLDIDT(ph)PDVNIEGPEGK_, , , , , ,-0.14,-0.22, , , , , , ,-0.29,0.01, ,,,-0.14,-0.22,,,-0.29,0.01,,,,,,,NA,NA,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,119.87,119.87,T490,ATGGLEGKMKGTKVKTPEMIIQKPKISMQDV,_VKT(ph)PEMIIQK_,-0.26,-0.29,-0.64,-0.57,-0.46,-0.23,-0.39,-0.46,-0.02,0.11,-0.36,-0.04,0.08,-0.13,-0.01,-0.37,-0.28,-0.6,-0.34,-0.42,0.05,-0.19,-0.03,-0.18,,,,,,,0,0,,nucleus,,nervous system development,,
Q09666,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,237.16,237.16,S93,GHHTVGLKLHRKGDRSPEPGQTWTREVFSSC,_KGDRS(ph)PEPGQTWTR_,-0.48,-0.46,0.1,0.17,0.3,0.22,0.2,0.29,0.22,-0.03,0.46,0.52,0.43,0.34,0.56,0.49,-0.47,0.13,0.26,0.25,0.1,0.49,0.39,0.53,,,,,,,0,0,,nucleus,,nervous system development,,
Q8IVF2-3,Q8IVF2,Protein AHNAK2,AHNAK2,86.5,33.05,S3408,KVEMPSFKMPKVDLKSPQVDIKGPKLDLKVP,_VDLKS(ph)PQVDIK_, , ,1.42,2.08, , , , , , ,2.61,3.01, , , , ,,1.79,,,,2.82,,, +, +,,,,,NA,NA,,nucleus,,,,
Q8IVF2-3,Q8IVF2,Protein AHNAK2,AHNAK2,72.52,70.37,S842,TAKDSKFKMPKFKMPSFGVSAPGKSMEDSVD,_MPS(ph)FGVSAPGK_, ,0.89, , ,-0.41,-0.07,0.12,0.03, ,1.74, , ,-0.29,-0.19,0.27,0.53,0.89,,-0.23,0.08,1.74,,-0.24,0.4,, +,,,,,NA,NA,,nucleus,,,,
Q8IVF2-3,Q8IVF2,Protein AHNAK2,AHNAK2,268.76,267.3,S294,HSSSEAYEPRDAHDVSPTSTDTEAQLTVERQ,_DAHDVS(ph)PTSTDTEAQLTVER_,-0.33,-0.26,-0.47,-0.31,-0.17,-0.26,-0.19,-0.2,0.01,-0.14,-0.02,0.02,-0.1,-0.14,-0.23,-0.15,-0.29,-0.39,-0.21,-0.2,-0.07,0,-0.12,-0.19,,,,,,,0,0,,nucleus,,,,
Q8IVF2-3,Q8IVF2,Protein AHNAK2,AHNAK2,121.45,95.83,S593,GQIRMPKFKIPSLGWSPSKHTKTGREKATED,_IPSLGWS(ph)PSK_,0.3,-0.2,-0.71,-0.91,-0.55,-0.53,-0.45,-0.65,-0.37,-0.29,-0.78,-1.11,-0.65,-0.48,-0.26,-0.48,0.07,-0.81,-0.54,-0.55,-0.33,-0.94,-0.56,-0.36,,,,,,,0,0,,nucleus,,,,
O95831-3,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,56.87,28.24,Y347,QLFPEKGNMGKILPEYLSNWTMEKVRREGVK,_ILPEY(ph)LS(ph)NWTMEK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,DNA binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
O95831-3,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,103.55,17.87,S268,YEKCLIATGGTPRSLSAIDRAGAEVKSRTTL,_SLS(ph)AIDR_, , ,0.34, ,0.21,0.58,-0.06, , , ,0.11, ,0,0.08,-0.17, ,,0.34,0.41,-0.06,,0.11,0.04,-0.17,,,,,,,NA,NA,,cytosol,DNA binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q96IF1,Q96IF1,LIM domain-containing protein ajuba,AJUBA,92.53,75.36,S119,SLPPDFRLEPTAPALSPRSSFASSSASDASK,_LEPTAPALS(ph)PR_,-0.06,-0.08,0.34,0.25, ,0.05,0.14,0.08,-0.1,-0.27,0.4,0.29, ,-0.53,0.14,0.17,-0.07,0.3,0.05,0.11,-0.18,0.35,-0.53,0.16,,,,,,,0,0,,cell-cell junction,alpha-catenin binding,calcium-dependent cell-cell adhesion,,
Q92667-2,Q92667,"A-kinase anchor protein 1, mitochondrial",AKAP1,86.19,36.08,S445,PPPKTYVSCLKSLLSSPTKDSKPNISAHHIS,_SLLSS(ph)PTK_,0.4, ,0.53, ,0.65,0.74,0.61,0.91,-0.02, ,0.08, ,0.28,0.4,0.57,0.14,0.4,0.53,0.69,0.77,-0.02,0.08,0.34,0.37,,,,,,,0,0,,cytosol,RNA binding,blood coagulation,,
Q9UKA4,Q9UKA4,A-kinase anchor protein 11,AKAP11,122.64,91.35,S448,SPRPVKASREDSGLFSPIRSSAFSPLGGCTP,_EDSGLFS(ph)PIR_, , , , , , , ,1.88, , , , , , , ,1.69,,,,1.88,,,,1.69, +, +,,,,,NA,NA,,cytoplasm,protein kinase A binding,intracellular protein kinase cascade,,
Q9UKA4,Q9UKA4,A-kinase anchor protein 11,AKAP11,166.66,161.33,S1242,KVKNPCLNVQSQRSVSPTFLNPSDENLKTLC,_SVS(ph)PTFLNPSDENLK_,-0.09, ,-0.17,-0.24,-0.13,0.04,-0.14, ,-0.22, ,-1.86,1.9,0.86,-0.49,-0.73, ,-0.09,-0.21,-0.04,-0.14,-0.22,1,0.34,-0.73,, +,,,,,0,4,3.71,cytoplasm,protein kinase A binding,intracellular protein kinase cascade,,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,187.79,176.08,Y374,QEPAESAHEPRLSAEYEKVELPSEEQVSGSQ,_LTASEQAHPQEPAESAHEPRLS(ph)AEY(ph)EK_,3.08, ,0.82, , , , , ,1.24, ,-0.99, , , , , ,3.08,0.82,,,1.24,-0.99,,, +, +,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,117.48,110.44,S612,TSDGEKKREGVTPWASFKKMVTPKKRVRRPS,_EGVTPWAS(ph)FKK_,1.31,1.29,0.58,0.82,-0.09,-0.57,-0.28,-0.56,1.25,0.73,0.88,0.97,0.21,0.4,0.68,0.56,1.3,0.7,-0.31,-0.41,1.01,0.92,0.3,0.62, +, +,,,,,5,5,14.6,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,401.28,400.71,S598,LAEVQQDGEAEEGATSDGEKKREGVTPWASF,_GLAEVQQDGEAEEGATS(ph)DGEK_,0.33,0.39,0.44,0.53,-1.33,-1.08,-1.07,-1.2,-0.14,-0.09,-0.13,-0.09,-0.35,-0.34,-0.11,-0.07,0.36,0.49,-1.2,-1.13,-0.12,-0.11,-0.35,-0.09, +,,,,,,6,0,5.24,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,180.31,180.31,S629,KKMVTPKKRVRRPSESDKEDELDKVKSATLS,_RPS(ph)ES(ph)DKEDELDK_,0.23,0.55,0.45, ,-1.05,-0.82,-1.03,-0.97,-0.12,0.09,-0.16, ,-0.15,0.04,0.11,0.05,0.4,0.45,-0.93,-1,-0.01,-0.16,-0.05,0.08, +,,,,,,6,0,5.58,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,177.29,176.51,S286,EKQEKEPSKSAESPTSPVTSETGSTFKKFFT,_SAESPTS(ph)PVTSETGSTFK_,0.49,0.36,1.22,0.8,0.04,-0.9,-0.38,-0.19,0.35,0.22,0.7,0.57,0.97,-0.04,0.95,1,0.43,1.03,-0.36,-0.28,0.29,0.64,0.55,0.98, +,,,,,,4,0,3.26,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,102.75,91.99,S388,EYEKVELPSEEQVSGSQGPSEEKPAPLATEV,_VELPS(ph)EEQVSGS(ph)QGPSEEK_,-0.57,0.14, , ,-1.01,-1.07,-0.94,-1.13,-0.09,-0.1, , ,-0.82,-0.39,-0.02,-0.21,-0.17,,-1.04,-1.03,-0.09,,-0.59,-0.11, +,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,90.56,88.41,T285,EEKQEKEPSKSAESPTSPVTSETGSTFKKFF,_SAESPT(ph)SPVTSETGSTFK_, , ,1.78, ,-0.37, , , , , ,0.62, ,-0.08, , , ,,1.78,-0.37,,,0.62,-0.08,, +,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,170.27,166.37,T646,KEDELDKVKSATLSSTESTASEMQEEMKGSV,_SATLSST(ph)ESTAS(ph)EMQEEMK_, , , , ,-1.1, ,-0.97,-1.13, , , , ,-0.32, ,-0.34,-0.21,,,-1.1,-1.05,,,-0.32,-0.27, +,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,276.9,276.9,S371,AHPQEPAESAHEPRLSAEYEKVELPSEEQVS,_LTASEQAHPQEPAESAHEPRLS(ph)AEYEK_,0.95,0.66,0.29,0.31, , , , ,0.02,-0.03,-0.11,-0.2, , , , ,0.81,0.3,,,-0.01,-0.15,,,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,271.68,271.68,S627,SFKKMVTPKKRVRRPSESDKEDELDKVKSAT,_RPS(ph)ES(ph)DKEDELDK_,0.48,0.48,0.58,0.45,-0.87,-0.86,-0.72,-0.54,0.06,0.12,0.17,0.12,-0.1,-0.11,0.19,0.1,0.48,0.52,-0.86,-0.63,0.09,0.15,-0.11,0.15,,,,,,,0,0,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,98.89,96.82,S283,EGEEKQEKEPSKSAESPTSPVTSETGSTFKK,_SAES(ph)PTS(ph)PVTSETGSTFK_, , , , ,0.31,-0.32,-1.54,-0.52, , , , ,-0.01,0.62,0.3,0.12,,,0.03,-0.94,,,0.34,0.21,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,152.34,147.39,S648,DELDKVKSATLSSTESTASEMQEEMKGSVEE,_SATLS(ph)STES(ph)TAS(ph)EMQEEMK_, , , , ,-1.22,-0.68,-1.37,-0.5, , , , ,0.03,-0.37,-0.06,0.37,,,-0.93,-0.87,,,-0.16,0.17,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,170.27,166.37,S651,DKVKSATLSSTESTASEMQEEMKGSVEEPKP,_SATLSSTES(ph)TAS(ph)EMQEEMK_, , , , ,-1.1,-0.82,-0.97,-0.93, , , , ,-0.32,-0.32,-0.34,0.01,,,-0.95,-0.95,,,-0.32,-0.15,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,70.7,70.2,S780,LVTPRKKSKSKLEEKSEDSIAGSGVEHSTPD,_S(ph)EDS(ph)IAGSGVEHSTPDTEPGK_, , , , , , ,-0.73,-1.09, , , , , , ,-0.4,-0.04,,,,-0.9,,,,-0.21,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,70.7,70.2,S783,PRKKSKSKLEEKSEDSIAGSGVEHSTPDTEP,_S(ph)EDS(ph)IAGSGVEHSTPDTEPGK_, , , , , , ,-0.73,-1.09, , , , , , ,-0.4,-0.04,,,,-0.9,,,,-0.21,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,170.49,170.23,S381,HEPRLSAEYEKVELPSEEQVSGSQGPSEEKP,_VELPS(ph)EEQVSGSQGPSEEK_,0.33,0.34,0.41,0.45,-0.83,-0.83,-0.68,-0.72,0.17,-0.07,0,0.09,0.05,0.05,0.24,0.2,0.34,0.43,-0.83,-0.7,0.06,0.05,0.05,0.22,,,,,,,0,0,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
Q02952-3,Q02952,A-kinase anchor protein 12,AKAP12,123.24,93.7,T1116,AKTEPFTQGKVVGQTTPESFEKAPQVTESIE,_VVGQTT(ph)PESFEK_, ,0.02,0.22, , , , , , ,-0.35,0.84, , , , , ,0.02,0.22,,,-0.35,0.84,,,,,,,,,NA,NA,,cell cortex,protein kinase A binding,G-protein coupled receptor signaling pathway,+,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,116.61,111.85,S2728,PSIAKSGSLDSELSVSPKRNSISRTHKDKGP,_SGSLDSELSVS(ph)PK_,-0.81,-0.63,-1.2, , , ,-0.4,-0.2,-0.91,-0.74,-1.23, , , ,-0.32,-0.22,-0.71,-1.2,,-0.3,-0.82,-1.23,,-0.27, +, +,,,,,NA,NA,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,121.32,78.27,S1929,GNDENMSNTWKFLSHSTDSLNKISKVNESTE,_FLSHS(ph)TDS(ph)LNK_,-0.34, , ,-0.48,-0.09,0.24,0.05,0.13,-0.22, , ,-0.55,0.02,0.32,-0.69,0.27,-0.34,-0.48,0.08,0.09,-0.22,-0.55,0.18,-0.13,,,,,,,0,0,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,121.32,78.27,S1932,ENMSNTWKFLSHSTDSLNKISKVNESTESLT,_FLSHS(ph)TDS(ph)LNK_, , , , ,0.17,0.24,0.49,0.03, , , , ,0.28,0.32,0.3,0.18,,,0.2,0.28,,,0.3,0.24,,,,,,,NA,NA,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,64.84,61.14,S1559,VPANCSVLRSSMRSLSPFRRHSWGPGKNAAS,_SLS(ph)PFRR_,-0.26, ,-0.49,-0.69, , , , ,-0.23, ,-0.55,-0.56, , , , ,-0.26,-0.59,,,-0.23,-0.55,,,,,,,,,NA,NA,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,139.51,123.15,S1642,AEELRHPFSGEERVDSLVSLSEEDLESDQRE,_VDS(ph)LVS(ph)LSEEDLESDQR_, , , , ,-0.19,-0.41,0.19,0.06, , , , ,0.23,0.1,0.29,0.55,,,-0.3,0.12,,,0.17,0.43,,,,,,,NA,NA,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,217.86,214.83,S1645,LRHPFSGEERVDSLVSLSEEDLESDQREHRM,_VDSLVS(ph)LS(ph)EEDLESDQR_, , , , ,-0.17,-0.11,0.08,0.02, , , , ,0.23,0.17,-0.06,0.33,,,-0.14,0.05,,,0.2,0.15,,,,,,,NA,NA,,,,,,
H0Y4V5,Q12802,A-kinase anchor protein 13,AKAP13,217.86,214.83,S1647,HPFSGEERVDSLVSLSEEDLESDQREHRMFD,_VDSLVS(ph)LS(ph)EEDLESDQR_, , , , ,0.01,0.18,-0.01,-0.02, , , , ,0.32,0.4,-0.37,0,,,0.1,-0.02,,,0.36,-0.17,,,,,,,NA,NA,,,,,,
Q9Y2D5-5,Q9Y2D5,A-kinase anchor protein 2,AKAP2,161.25,159.37,S720,MVGPFKLRSRKQRTLSMIEEEIRAAQEREEE,_TLS(ph)MIEEEIR_,0.19,-0.07,1.36,1.45,0.8,0.95,0.8,0.57,0.27,0.38,1.62,1.68,0.87,1.01,0.96,1.15,0.06,1.41,0.88,0.69,0.33,1.65,0.94,1.06, +, +,,,,,1,1,29.75,,enzyme binding,,,
Q9Y2D5-5,Q9Y2D5,A-kinase anchor protein 2,AKAP2,217.29,211.48,S152,SQPRDALGDSLQVPVSPSSTTSSRCSSRDGE,_DALGDSLQVPVS(ph)PSSTTS(ph)SR_,-0.76,-0.27,0.29,0.3,0.57,0.71,0.53,0.49,-0.2,0.04,0.59,0.69,0.7,0.92,0.81,0.82,-0.5,0.3,0.64,0.51,-0.07,0.64,0.81,0.82,,,,,,,0,0,,,enzyme binding,,,
Q9Y2D5-5,Q9Y2D5,A-kinase anchor protein 2,AKAP2,151.6,149.8,S393,GPPEDSGASAAKGQKSPGALETPSAAGSQGN,_S(ph)PGALETPSAAGSQGNTASQGK_, ,-0.54,0.03,0.23,-0.01,0.11,0.03,0.24, ,0.17,-0.12,-0.07,0.3,0.25,0.48,0.42,-0.54,0.13,0.05,0.14,0.17,-0.09,0.27,0.45,,,,,,,0,0,,,enzyme binding,,,
O43823,O43823,A-kinase anchor protein 8,AKAP8,249.93,248.8,S323,FQLYEEPDTKLARVDSEGDFSENDDAAGDFR,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_, , , , ,-0.15,-0.18,-0.37,-0.39, , , , ,-0.3,-0.22,-0.55,-0.5,,,-0.17,-0.38,,,-0.26,-0.53,,,,,,,NA,NA,,condensed chromosome,double-stranded DNA binding,mitosis,,
O43823,O43823,A-kinase anchor protein 8,AKAP8,249.93,248.8,S328,EPDTKLARVDSEGDFSENDDAAGDFRSGDEE,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_,-0.41,-0.26,-0.54,-0.26,-0.38,-0.3,-0.37,-0.28,-0.29,-0.12,-0.34,-0.14,-0.19,-0.38,-0.55,-0.33,-0.33,-0.39,-0.34,-0.33,-0.2,-0.24,-0.28,-0.44,,,,,,,0,0,,condensed chromosome,double-stranded DNA binding,mitosis,,
O43823,O43823,A-kinase anchor protein 8,AKAP8,247.61,247.61,S339,EGDFSENDDAAGDFRSGDEEFKGEDELCDSG,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_, , , , ,0.03,0.52,0.08,-0.27, , , , ,-0.15,0.04,-0.32,-0.67,,,0.3,-0.08,,,-0.05,-0.48,,,,,,,NA,NA,,condensed chromosome,double-stranded DNA binding,mitosis,,
Q9ULX6,Q9ULX6,A-kinase anchor protein 8-like,AKAP8L,106.87,105.96,S552,KKLERYLKGENPFTDSPEEEKEQEEAEGGAL,_GENPFTDS(ph)PEEEK_, , , , ,0.46, ,0.22,0.02, , , , ,0.3, ,0.01,-0.05,,,0.46,0.12,,,0.3,-0.02,,,,,,,NA,NA,,cytoplasm,DEAD/H-box RNA helicase binding,,,
P42330,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,191.65,191.5,Y319,HYFNSDSFASHPNYPYSDEY___________,_NLHYFNSDSFASHPNYPY(ph)SDEY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,cellular response to cadmium ion,,
G3V3K5,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,82.9,80.29,S122,ADGLKKQEEEEMDFRSGSPSDNSGAEEMEVS,_S(ph)GSPS(ph)DNS(ph)GAEEMEVSLAK_,0.39, , , , ,0.4,0.37, ,0.15, , , , ,0.34,0.8, ,0.39,,0.4,0.37,0.15,,0.34,0.8,,,AGC,,,,NA,NA,,cytosol,ATP binding,aging,,
G3V3K5,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,224.77,217.64,S124,GLKKQEEEEMDFRSGSPSDNSGAEEMEVSLA,_SGS(ph)PSDNS(ph)GAEEMEVSLAK_,0.39, , , ,-0.18,0.17,0.14,0.08,0.15, , , ,0.32,0.25,0.39,0.34,0.39,,0,0.11,0.15,,0.29,0.36,,,AGC,,,,NA,NA,,cytosol,ATP binding,aging,,
G3V3K5,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,184.66,177.01,S126,KKQEEEEMDFRSGSPSDNSGAEEMEVSLAKP,_SGS(ph)PS(ph)DNS(ph)GAEEMEVSLAK_,0.39, , , ,0.38,0.26,0.44,0.51,0.15, , , ,0.56,0.18,0.36,0.37,0.39,,0.32,0.48,0.15,,0.38,0.36,,,AGC,,,,NA,NA,,cytosol,ATP binding,aging,,
G3V3K5,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,224.77,217.64,S129,EEEEMDFRSGSPSDNSGAEEMEVSLAKPKHR,_SGS(ph)PS(ph)DNS(ph)GAEEMEVSLAK_,0.39, , , ,0.13,0.17,0.15,0.09,0.15, , , ,0.1,0.25,0.37,0.35,0.39,,0.15,0.12,0.15,,0.18,0.36,,,AGC,,,,NA,NA,,cytosol,ATP binding,aging,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,177.57,134.07,T246,EDTQVFGDLPRPRLNTSDFQKLKRKY_____,_LNT(ph)SDFQK_,1.5,1.11,1.34,1.2,2.46,3.41,2.08,3.06,1.78,1.66,1.63,1.8,2.53,3.2,1.95,2.9,1.32,1.27,3.01,2.65,1.72,1.72,2.9,2.5, +, +,,,,,2,2,38.05,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,195.29,195.29,S88,TAARPPAPPPAPQPPSPTPSPPRPTLAREDN,_AATAARPPAPPPAPQPPS(ph)PTPS(ph)PPRPTLAR_,0.17,0.23,0.18,0.19, , , , ,-0.48,-0.25,-0.31,-0.29, , , , ,0.2,0.19,,,-0.36,-0.3,,,,,,,,,NA,NA,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,195.29,195.29,S92,PPAPPPAPQPPSPTPSPPRPTLAREDNEEDE,_AATAARPPAPPPAPQPPS(ph)PTPS(ph)PPRPTLAR_,0.17,0.23,0.18,0.19, , , , ,-0.48,-0.25,-0.31,-0.29, , , , ,0.2,0.19,,,-0.36,-0.3,,,,,,,,,NA,NA,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,263.04,263.04,S202,SVPVWGFKEKRTEARSSDEENGPPSSPDLDR,_TEARS(ph)S(ph)DEENGPPSS(ph)PDLDR_,-0.15,0.07,-0.32,-0.2,-0.01,0.01,-0.09,0.21,-0.32,-0.25,-0.47,-0.34,-0.19,-0.09,-0.22,-0.4,-0.04,-0.26,0,0.07,-0.28,-0.4,-0.14,-0.31,,,,,,,0,0,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,263.04,263.04,S203,VPVWGFKEKRTEARSSDEENGPPSSPDLDRI,_RTEARS(ph)S(ph)DEENGPPS(ph)SPDLDR_,0.07,0.39,-0.03,0.07,-0.08,0.03,0.02,0.01,-0.11,0.1,-0.13,0.11,0,0.05,0.03,0.04,0.24,0.02,-0.03,0.02,0,-0.01,0.03,0.03,,,,,,,0,0,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,263.04,263.04,S211,KRTEARSSDEENGPPSSPDLDRIAASMRALV,_RTEARS(ph)S(ph)DEENGPPS(ph)SPDLDR_,0.07,0.07, ,0.07,-0.28,0.11,-0.05,0,-0.19,-0.25, ,0.11,-0.03,-0.03,0.03,0.04,0.07,0.07,-0.07,-0.02,-0.22,0.11,-0.03,0.03,,,,,,,0,0,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,230.67,221.76,S212,RTEARSSDEENGPPSSPDLDRIAASMRALVL,_SSDEENGPPSS(ph)PDLDR_,-0.03,0.11,0.08,-0.02,0.2,0.34,0.23,0.14,-0.19,-0.09,-0.17,-0.09,0,-0.02,-0.03,0.2,0.04,0.03,0.27,0.19,-0.14,-0.13,-0.01,0.09,,,,,,,0,0,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
Q96B36,Q96B36,Proline-rich AKT1 substrate 1,AKT1S1,80.51,79.79,S183,SVPPASALPTQQYAKSLPVSVPVWGFKEKRT,_S(ph)LPVSVPVWGFK_, ,0.73, , , , , , , ,0.43, , , , , , ,0.73,,,,0.43,,,,,,,,,,NA,NA,,cytosolic part,,epidermal growth factor receptor signaling pathway,,
P04075,P04075,Fructose-bisphosphate aldolase A,ALDOA,82.45,42.17,S36,HRIVAPGKGILAADESTGSIAKRLQSIGTEN,_GILAADES(ph)TGSIAK_,0.6, ,0.47,0.79, , ,0.19,0,-0.27, ,1.14,0.02, , ,-0.17,-0.13,0.6,0.64,,0.1,-0.27,0.68,,-0.15,,,,,,,NA,NA,,actin cytoskeleton,actin binding,actin filament organization,,
F5H6G2,Q6P6C2,Probable alpha-ketoglutarate-dependent dioxygenase ABH5,ALKBH5,261.93,261.93,S64,EPYPVSGAKRKYQEDSDPERSDYEEQQLQKE,_YQEDS(ph)DPERS(ph)DYEEQQLQK_,-0.3,-0.12,-0.43,-0.53,-0.17,0.18,0.1,-0.31,-0.26,0.03,-0.25,-0.36,0.02,0.11,0.17,-0.05,-0.21,-0.48,0.02,-0.09,-0.11,-0.31,0.07,0.06,,,,,,,0,0,,,,,,
F5H6G2,Q6P6C2,Probable alpha-ketoglutarate-dependent dioxygenase ABH5,ALKBH5,261.93,261.93,S69,SGAKRKYQEDSDPERSDYEEQQLQKEEEARK,_YQEDS(ph)DPERS(ph)DYEEQQLQK_,-0.06,-0.09,0.02,-0.07,0.15,0.18,0.1,0.21,0.09,0.08,0.26,0.31,0.05,0.11,0.17,-0.06,-0.08,-0.02,0.17,0.16,0.09,0.29,0.08,0.06,,,,,,,0,0,,,,,,
Q86V81,Q86V81,THO complex subunit 4,ALYREF,100.69,90.55,S8,________MADKMDMSLDDIIKLNRSQRGGR,_MDMS(ph)LDDIIK_, , , , ,-0.47,-0.43,-0.16,-0.25, , , , ,-0.76,-0.73,-0.32,-0.47,,,-0.45,-0.2,,,-0.75,-0.39,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,intronless viral mRNA export from host nucleus,,
Q9UKV5,Q9UKV5,E3 ubiquitin-protein ligase AMFR,AMFR,81.53,81.53,S542,EGETSAQTERVPLDLSPRLEETLDFGEVEVE,_VPLDLS(ph)PR_, ,-0.46,0.76, ,0.73,0.75,-0.06,0.46, ,0.01,0.97, ,0.64,1.15,0.7,0.93,-0.46,0.76,0.74,0.22,0.01,0.97,0.92,0.82,,,,RING finger,,,0,0,,integral to endoplasmic reticulum membrane,receptor activity,cellular component movement,,
Q01433-3,Q01433,AMP deaminase 2,AMPD2,211.09,194.67,S168,IEQLEERRQRLERQISQDVKLEPDILLRAKQ,_QIS(ph)QDVKLEPDILLR_,-0.33,-0.12,0.89,0.91, , , , ,-0.18,-0.03,1.58,1.37, , , , ,-0.22,0.9,,,-0.1,1.48,,,, +,,,,,NA,NA,,cytosol,AMP deaminase activity,IMP salvage,,
Q9H1A4,Q9H1A4,Anaphase-promoting complex subunit 1,ANAPC1,176.09,159.74,S688,DRLAWTRNFDFEGSLSPVIAPKKARPSETGS,_NFDFEGSLS(ph)PVIAPK_,0.11,0.32, ,1,0.59,0.75,0.46,-2.42,0.21,0.24, ,0.69,0.52,0.61,0.36,-1.15,0.22,1,0.67,-0.36,0.22,0.69,0.57,-0.2,,,,,,,0,0,,anaphase-promoting complex,,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,+
Q9UJX6-2,Q9UJX6,Anaphase-promoting complex subunit 2,ANAPC2,86.08,85.21,S732,EEERPQDRDNMVLIDSDDESDSGMASQADQK,_DNMVLIDS(ph)DDES(ph)DSGMASQADQK_, , , , ,-0.16,-0.02,-0.06,-0.09, , , , ,-0.15,0.07,0.05,-0.01,,,-0.09,-0.08,,,-0.04,0.02,,,,,,,NA,NA,,anaphase-promoting complex,ubiquitin-protein ligase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q9UJX6-2,Q9UJX6,Anaphase-promoting complex subunit 2,ANAPC2,86.08,85.21,S736,PQDRDNMVLIDSDDESDSGMASQADQKEEEL,_DNM(ox)VLIDS(ph)DDES(ph)DSGMASQADQK_, , , , ,-0.12,-0.02,0,-0.1, , , , ,-0.12,0.07,0.03,-0.02,,,-0.07,-0.05,,,-0.02,0.01,,,,,,,NA,NA,,anaphase-promoting complex,ubiquitin-protein ligase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
E9PF56,Q8IWZ3,Ankyrin repeat and KH domain-containing protein 1,ANKHD1,131.52,49.99,S1679,VSLPLSSPNIKLNLTSPKRGQKREEGWKEVV,_LNLTS(ph)PK_,0.33,0.31,0.07,0.16,0.34,0.24,0.08,0.65,0.14,0.15,-0.09,-0.09,0.41,0.25,0.47,0.69,0.32,0.12,0.29,0.4,0.15,-0.09,0.33,0.59,,,,,,,0,0,,,,,,
F5H2H5,Q86XL3,Ankyrin repeat and LEM domain-containing protein 2,ANKLE2,119.48,118.11,S662,SLEEIKNRQNAARNNSPPTVGAFGHTRCSAF,_NNS(ph)PPTVGAFGHTR_,0.09,0.12,0.04,-0.03,-0.32, ,-0.57,-0.41,-0.47,-1.03,-1.44,-0.91,-0.39, ,-0.07,-0.4,0.11,0,-0.32,-0.49,-0.72,-1.15,-0.39,-0.23,, +,,,,,0,3,7.62,cytoplasm,ATP binding,apoptotic process,,
Q6UB99,Q6UB99,Ankyrin repeat domain-containing protein 11,ANKRD11,120.31,36.66,S1792,QAPARPLSTNLYRSVSVDIRRTPEEEFSVGD,_SVS(ph)VDIR_, ,-0.26,2.96,2.47,1.84, , , , ,1.12,3.43,2.67,1.31, , , ,-0.26,2.74,1.84,,1.12,3.1,1.31,, +, +,,,,,NA,NA,,nucleus,,bone development,,
Q6UB99,Q6UB99,Ankyrin repeat domain-containing protein 11,ANKRD11,65.28,57.63,S834,NKNQFLENEDTKFSLSDDQRDRWFSDLSDSS,_FSLS(ph)DDQR_,-0.19, , , ,-0.13,0.03,-0.63,-0.53,-0.14, , , ,0.09,0.12,-0.66,-0.61,-0.19,,-0.05,-0.58,-0.14,,0.1,-0.63,,,,,,,NA,NA,,nucleus,,bone development,,
Q6UB99,Q6UB99,Ankyrin repeat domain-containing protein 11,ANKRD11,135.09,101.73,S857,FSDLSDSSFDFKGEDSWDSPVTDYRDMKSDS,_GEDS(ph)WDS(ph)PVTDYR_, , , , , ,-0.42,0.08,-0.97, , , , , ,0.12,-0.76,-0.98,,,-0.42,-0.36,,,0.12,-0.87,,,,,,,NA,NA,,nucleus,,bone development,,
Q6UB99,Q6UB99,Ankyrin repeat domain-containing protein 11,ANKRD11,135.09,101.73,S860,LSDSSFDFKGEDSWDSPVTDYRDMKSDSVAK,_GEDS(ph)WDS(ph)PVTDYR_, , , , , ,-0.42,0.08,-0.97, , , , , ,0.12,-0.76,-0.98,,,-0.42,-0.36,,,0.12,-0.87,,,,,,,NA,NA,,nucleus,,bone development,,
G5E964,O75179,Ankyrin repeat domain-containing protein 17,ANKRD17,123.55,122.62,S2401,NDSSAQSVSSGVRAPSPAPSSVPLGSEKPSN,_APS(ph)PAPSSVPLGSEK_, , , , ,0, ,0.5,0.42, , , , ,-0.38, ,0.27,0.27,,,0,0.46,,,-0.38,0.27,,,,,,,NA,NA,,,,,,
G5E964,O75179,Ankyrin repeat domain-containing protein 17,ANKRD17,107.71,99.68,S2045,PMPTAKEHYPVSSPSSPSPPAQPGGVSRNSP,_EHYPVSSPSS(ph)PS(ph)PPAQPGGVSR_,0.33,0.37,0.39, ,0.87,-0.31,0.37,0.01,-0.06,-0.05,-0.03, ,0.74,-0.68,0.07,-0.02,0.35,0.39,0.4,0.2,-0.05,-0.03,0.2,0.03,,,,,,,0,0,,,,,,
G5E964,O75179,Ankyrin repeat domain-containing protein 17,ANKRD17,107.71,99.68,S2047,PTAKEHYPVSSPSSPSPPAQPGGVSRNSPLD,_EHYPVSS(ph)PSS(ph)PS(ph)PPAQPGGVSR_,0.33,0.37,0.34, ,0.87,0.32,0.37,0.02,-0.06,-0.05,-0.09, ,0.74,0.11,0.07,0.03,0.35,0.34,0.62,0.21,-0.05,-0.09,0.46,0.05,,,,,,,0,0,,,,,,
E9PDW0,Q9ULJ7,Ankyrin repeat domain-containing protein 50,ANKRD50,63.44,63.44,S1167,GLPNGPTHAFSSPSESPDSTVDRQKSSLSNN,_GLPNGPTHAFSS(ph)PSES(ph)PDSTVDR_, , , , ,-0.69,-0.61,-0.59,-0.2, , , , ,-0.23,-0.11,-0.41,-0.52,,,-0.65,-0.38,,,-0.17,-0.46,,,,,,,NA,NA,,,,,,
Q92625,Q92625,Ankyrin repeat and SAM domain-containing protein 1A,ANKS1A,299.31,295.21,Y455,PRIHGSAAREEDEHPYELLLTAETKKVVLVD,_EEDEHPY(ph)ELLLTAETKK_,1.82,1.83,1.14, ,0.64,0.67,0.58,0.48,1.5,1.56,0.76, ,1.01,1.06,0.86,0.58,1.83,1.14,0.66,0.53,1.53,0.76,1.03,0.72, +, +,,,,,5,5,21.65,cytoplasm,,ephrin receptor signaling pathway,,
Q92625,Q92625,Ankyrin repeat and SAM domain-containing protein 1A,ANKS1A,151.95,151.95,Y834,LGHRKRIIASLADRPYEEPPQKPPRFSQLRC,_IIASLADRPY(ph)EEPPQKPPR_,4.71, , , , , , , ,4.48, , , , , , , ,4.71,,,,4.48,,,, +, +,,,,,NA,NA,,cytoplasm,,ephrin receptor signaling pathway,,
Q92625,Q92625,Ankyrin repeat and SAM domain-containing protein 1A,ANKS1A,224.07,213.33,S663,LSNCSIGKKRLEKSPSFASEWDEIEKIMSSI,_SPS(ph)FASEWDEIEK_,-0.2,-0.22,-0.48,-0.41,-0.2,-0.29,-0.21,-0.4,-0.13,-0.09,-0.27,-0.32,-0.05,-0.08,-0.1,-0.08,-0.21,-0.45,-0.24,-0.3,-0.11,-0.3,-0.07,-0.09,,,,,,,0,0,,cytoplasm,,ephrin receptor signaling pathway,,
Q6ZW76,Q6ZW76,Ankyrin repeat and SAM domain-containing protein 3,ANKS3,124.08,116.84,S2,______________MSELSDEASEPELLNRS,_(ac)S(ph)ELS(ph)DEAS(ph)EPELLNR_, , , , ,0.13,0.41,0.08,-0.02, , , , ,0.51,0.27,-0.01,0.07,,,0.28,0.03,,,0.4,0.03,,,,,,,NA,NA,,,,,,
Q6ZW76,Q6ZW76,Ankyrin repeat and SAM domain-containing protein 3,ANKS3,124.08,116.84,S5,___________MSELSDEASEPELLNRSLSM,_(ac)S(ph)ELS(ph)DEAS(ph)EPELLNR_, , , , ,0.13,0.41,0.08,-0.02, , , , ,0.51,0.27,-0.01,0.07,,,0.28,0.03,,,0.4,0.03,,,,,,,NA,NA,,,,,,
Q6ZW76,Q6ZW76,Ankyrin repeat and SAM domain-containing protein 3,ANKS3,124.08,116.84,S9,_______MSELSDEASEPELLNRSLSMWHGL,_(ac)S(ph)ELS(ph)DEAS(ph)EPELLNR_, , , , , ,-0.4,0.08,-0.02, , , , , ,-0.43,-0.01,0.07,,,-0.4,0.03,,,-0.43,0.03,,,,,,,NA,NA,,,,,,
Q9NQW6-2,Q9NQW6,Actin-binding protein anillin,ANLN,137.87,117.96,S553,NSSTEPKEVIREIEMSVDDDDINSSKVINDL,_EIEMS(ph)VDDDDINS(ph)SK_, , , , ,-0.66,-0.67,-0.66,-0.64, , , , ,-0.33,-0.72,-0.46,-0.46,,,-0.66,-0.65,,,-0.51,-0.46,,,,,,,NA,NA,,actomyosin contractile ring,actin binding,cytokinesis,,
Q9NQW6-2,Q9NQW6,Actin-binding protein anillin,ANLN,49.78,47.73,S449,ELACLRGRFDKGNIWSAEKGGNSKSKQLETK,_GNIWS(ph)AEK_, , , , ,-0.63,-0.4,-0.43,-0.6, , , , ,-0.81,-0.89,-0.41,-0.88,,,-0.51,-0.51,,,-0.85,-0.63,,,,,,,NA,NA,,actomyosin contractile ring,actin binding,cytokinesis,,
Q9NQW6-2,Q9NQW6,Actin-binding protein anillin,ANLN,142.55,59.09,S323,SCEGQNPELLPKTPISPLKTGVSKPIVKSTL,_TPIS(ph)PLK_,-0.13,0.18,0.09,0.01,-0.35,-0.31,-0.28,-0.03,-0.11,0.01,-0.13,-0.14,-0.04,-0.1,0.12,0.06,0.03,0.05,-0.33,-0.15,-0.05,-0.13,-0.07,0.09,,,,,,,0,0,,actomyosin contractile ring,actin binding,cytokinesis,,
Q9NQW6-2,Q9NQW6,Actin-binding protein anillin,ANLN,30.81,30.39,S54,RARQPLSEASNQQPLSGGEEKSCTKPSPSKK,_QPLSEASNQQPLS(ph)GGEEK_, , , , ,-0.17, , ,-0.52, , , , ,-0.27, , ,-0.63,,,-0.17,-0.52,,,-0.27,-0.63,,,,,,,NA,NA,,actomyosin contractile ring,actin binding,cytokinesis,,
P39687,P39687,Acidic leucine-rich nuclear phosphoprotein 32 family member A,ANP32A,118.21,118.21,Y148,ENVFKLLPQLTYLDGYDRDDKEAPDSDAEGY,_LLPQLTYLDGY(ph)DRDDK_, , ,-0.2, ,-0.02,0.21,0.32,0.37, , ,-0.13, ,1.13,0.73,0.28,0.42,,-0.2,0.1,0.34,,-0.13,0.94,0.35,,,,,,,NA,NA,,endoplasmic reticulum,,gene expression,,
Q9H6X2,Q9H6X2,Anthrax toxin receptor 1,ANTXR1,171.73,119.49,Y425,LEKAKNARVKMPEQEYEFPEPRNLNNNMRRP,_MPEQEY(ph)EFPEPR_,3.46, ,2.2, , , , , ,0.32, ,0.55, , , , , ,3.46,2.2,,,0.32,0.55,,, +,,,,,,NA,NA,,filopodium membrane,actin filament binding,actin cytoskeleton reorganization,,
Q9H6X2,Q9H6X2,Anthrax toxin receptor 1,ANTXR1,81.8,58.51,S362,CTVIIKEVPPPPAEESEEEDDDGLPKKKWPT,_EVPPPPAEES(ph)EEEDDDGLPKK_,0.26,0.17,0.27,0.13,-0.19, ,-0.49,-0.55,-0.46,-0.18,-0.53,-0.65,-0.5, ,0.16,0.23,0.21,0.21,-0.19,-0.52,-0.32,-0.59,-0.5,0.19,,,,,,,0,0,,filopodium membrane,actin filament binding,actin cytoskeleton reorganization,,
P04083,P04083,Annexin A1,ANXA1,91.14,89.78,Y21,EFLKQAWFIENEEQEYVQTVKSSKGGPGSAV,_QAWFIENEEQEY(ph)VQTVK_,1.58, , , , , , , ,1.51, , , , , , , ,1.58,,,,1.51,,,, +, +,,,,,NA,NA,,basolateral plasma membrane,calcium ion binding,alpha-beta T cell differentiation,,
P07355,P07355,Annexin,ANXA2,89.35,87.25,Y188,ALAKGRRAEDGSVIDYELIDQDARDLYDAGV,_RAEDGSVIDY(ph)ELIDQDAR_, , ,2.87, ,1.84, , , , , ,1.84, ,2.08, , , ,,2.87,1.84,,,1.84,2.08,, +, +,,,,,NA,NA,,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,79.88,79.88,Y238,PHLQKVFDRYKSYSPYDMLESIRKEVKGDLE,_SYSPY(ph)DMLESIRK_,0.29,0.88,0.98,1.29,0.81,1.23,1.07,1.27,0.18,1.09,1.21,0.59,1.28,1.42,1.35,1.53,0.61,1.14,1.03,1.17,0.7,0.93,1.35,1.44, +, +,,,,,1,1,26.76,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,221.81,221.81,Y30,GDHSTPPSAYGSVKAYTNFDAERDALNIETA,_AY(ph)TNFDAERDALNIETAIK_,0.83,1.09,2.35, ,1.19,1.15,0.43,0.49,0.67,0.85,1.92, ,1.96,1.85,0.74,0.79,0.96,2.35,1.17,0.46,0.76,1.92,1.9,0.77, +, +,,,,,4,1,18.19,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,355.49,328.22,Y24,CKLSLEGDHSTPPSAYGSVKAYTNFDAERDA,_LSLEGDHSTPPSAY(ph)GSVK_,1.07,1.06,1.05,1.18,0.09,0.19,-0.13,-0.03,0.84,0.84,0.9,1.01,0.73,0.81,0.29,0.2,1.07,1.12,0.14,-0.08,0.84,0.95,0.77,0.25, +,,,,,,5,0,12.96,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,169.41,157.44,T19,VHEILCKLSLEGDHSTPPSAYGSVKAYTNFD,_LSLEGDHST(ph)PPSAYGSVK_,-0.56,-0.7,-0.91,-1.1,-0.91,-0.9,-0.72,-0.7,0.08,-0.07,-0.11,0.07,-0.34,-0.2,-0.75,-0.49,-0.63,-1,-0.91,-0.71,0.01,-0.01,-0.27,-0.62, +,,,,,,3,0,13.23,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,192.09,180.72,S184,KLMVALAKGRRAEDGSVIDYELIDQDARDLY,_AEDGS(ph)VIDYELIDQDAR_,-0.69, , , , , ,-0.23,-0.02,-0.29, , , , , ,-0.63,-0.55,-0.69,,,-0.12,-0.29,,,-0.59,,,,,,,NA,NA,,basement membrane,calcium ion binding,angiogenesis,+,
P07355,P07355,Annexin,ANXA2,51.39,49.67,S12,____MSTVHEILCKLSLEGDHSTPPSAYGSV,_LS(ph)LEGDHSTPPSAYGSVK_, , , , , , , ,-0.44, , , , , , , ,0.04,,,,-0.44,,,,0.04,,,,,,,NA,NA,,basement membrane,calcium ion binding,angiogenesis,+,
E5RJ68,O00203,AP-3 complex subunit beta-1,AP3B1,144.51,144.51,S276,KEGDELEDNGKNFYESDDDQKEKTDKKKKPY,_NFYES(ph)DDDQK_,0.08,0.18,0.02,0.01,0.11,0.12,0.04,0.17,0.12,0.13,0.01,-0.02,0.14,0.11,0.07,0.11,0.13,0.02,0.12,0.11,0.12,-0.01,0.13,0.09,,,,,,,0,0,,AP-3 adaptor complex,,anterograde axon cargo transport,,
O14617,O14617,AP-3 complex subunit delta-1,AP3D1,167.97,167.01,S658,AVFHEEEQRRPKHRPSEADEEELARRREARK,_HRPS(ph)EADEEELAR_, , ,1.83, , , , , , , ,1.84, , , , , ,,1.83,,,,1.84,,, +, +,,,,,NA,NA,,endosome membrane,protein transporter activity,anterograde axon cargo transport,,
O14617,O14617,AP-3 complex subunit delta-1,AP3D1,133.04,133.04,S759,KKRKEKEKKGKRRHSSLPTESDEDIAPAQQV,_HSS(ph)LPT(ph)ES(ph)DEDIAPAQQVDIVTEEMPENALPS(ph)DEDDKDPNDPYR_, , , , , , , ,-0.06, , , , , , , ,0.7,,,,-0.06,,,,0.7,,,,,,,NA,NA,,endosome membrane,protein transporter activity,anterograde axon cargo transport,,
O14617,O14617,AP-3 complex subunit delta-1,AP3D1,189.78,189.78,S764,KEKKGKRRHSSLPTESDEDIAPAQQVDIVTE,_HSS(ph)LPT(ph)ES(ph)DEDIAPAQQVDIVTEEMPENALPS(ph)DEDDKDPNDPYR_, , , , ,0.48, , ,-0.06, , , , ,0.68, , ,0.7,,,0.48,-0.06,,,0.68,0.7,,,,,,,NA,NA,,endosome membrane,protein transporter activity,anterograde axon cargo transport,,
O14617,O14617,AP-3 complex subunit delta-1,AP3D1,189.78,189.78,S788,QVDIVTEEMPENALPSDEDDKDPNDPYRALD,_HSSLPT(ph)ES(ph)DEDIAPAQQVDIVTEEMPENALPS(ph)DEDDKDPNDPYR_, , , , ,0.48, , ,-0.08, , , , ,0.68, , ,0.4,,,0.48,-0.08,,,0.68,0.4,,,,,,,NA,NA,,endosome membrane,protein transporter activity,anterograde axon cargo transport,,
O14617,O14617,AP-3 complex subunit delta-1,AP3D1,189.78,189.78,T762,KEKEKKGKRRHSSLPTESDEDIAPAQQVDIV,_HSS(ph)LPT(ph)ES(ph)DEDIAPAQQVDIVTEEMPENALPS(ph)DEDDKDPNDPYR_, , , , ,0.48, , ,-0.06, , , , ,0.68, , ,0.7,,,0.48,-0.06,,,0.68,0.7,,,,,,,NA,NA,,endosome membrane,protein transporter activity,anterograde axon cargo transport,,
P25054-2,P25054,Adenomatous polyposis coli protein,APC,180.56,180.56,S1042,YSLKYSDEQLNSGRQSPSQNERWARPKHIIE,_YSDEQLNSGRQS(ph)PSQNER_,-0.15,-0.29,-0.24,-0.07, , , , ,-0.21,-0.26,-0.38,-0.3, , , , ,-0.22,-0.16,,,-0.23,-0.34,,,,,,,,,NA,NA,,adherens junction,microtubule plus-end binding,anterior/posterior pattern specification,,
P13798,P13798,Acylamino-acid-releasing enzyme,APEH,121.32,118.9,S185,RPKAESFFQTKALDVSASDDEIARLKKPDQA,_ALDVS(ph)ASDDEIAR_, , ,-0.37,-0.29,0.19, ,-0.09, , , ,0.35,0.42,-0.02, ,-0.06, ,,-0.33,0.19,-0.09,,0.38,-0.02,-0.06,,,,,,,NA,NA,,cytoplasm,serine-type endopeptidase activity,proteolysis,,
P13798,P13798,Acylamino-acid-releasing enzyme,APEH,120.59,120.59,S187,KAESFFQTKALDVSASDDEIARLKKPDQAIK,_ALDVSAS(ph)DDEIAR_, , ,-0.35,-0.21,0.19,0.18, ,-0.03, , ,0.37,0.59,-0.02,-0.15, ,-0.16,,-0.28,0.18,-0.03,,0.49,-0.08,-0.16,,,,,,,NA,NA,,cytoplasm,serine-type endopeptidase activity,proteolysis,,
Q9UKG1,Q9UKG1,DCC-interacting protein 13-alpha,APPL1,177.38,175.65,S401,TAARVNQSALEAVTPSPSFQQRHESLRPAAG,_VNQSALEAVTPS(ph)PSFQQR_,0.01,-0.3,-0.99,-0.95, ,-1.36, , ,-0.27,-0.28,-0.73,-0.82, ,-0.83, , ,-0.14,-0.97,-1.36,,-0.28,-0.77,-0.83,, +,,,,,,NA,NA,,cytosol,phospholipid binding,apoptotic process,+,
Q96P48-3,Q96P48,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1",ARAP1,257.54,243.26,Y737,TEVPRLDSMKPLEKHYSVVLPTVSHSGFLYK,_HY(ph)SVVLPTVSHSGFLYK_,2.92, ,1.32, , , , , ,2.85, ,-0.45, , , , , ,2.92,1.32,,,2.85,-0.45,,, +, +,,,,,NA,NA,,cytosol,ARF GTPase activator activity,actin filament reorganization involved in cell cycle,,
Q96P48-3,Q96P48,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1",ARAP1,155.8,155.18,S229,EIPPKPVRLFPEFDDSDYDEVPEEGPGAPAR,_LFPEFDDS(ph)DYDEVPEEGPGAPAR_, , ,-0.63, ,-0.31,-0.32,-0.28,-0.1, , ,-0.02, ,-0.11,-0.07,-0.26,0.03,,-0.63,-0.31,-0.19,,-0.02,-0.09,-0.11,,,,,,,NA,NA,,cytosol,ARF GTPase activator activity,actin filament reorganization involved in cell cycle,,
E9PMU9,Q8N6H7,ADP-ribosylation factor GTPase-activating protein 2,ARFGAP2,188.91,183.81,S432,ESSEARQKFAGAKAISSDMFFGREVDAEYEA,_AIS(ph)SDMFFGR_,0.18,0.28,-1.02,-0.91,-0.31,-0.38,-0.43,-0.76,0,0.01,-0.69,-0.59,-0.6,-0.41,-0.33,-0.44,0.23,-0.96,-0.34,-0.59,0,-0.64,-0.51,-0.39,,,,,,,0,0,,,ARF GTPase activator activity,regulation of ARF GTPase activity,,
E9PMU9,Q8N6H7,ADP-ribosylation factor GTPase-activating protein 2,ARFGAP2,153.18,148.08,S368,LSFIRYKDNPFSLGESFGSRWDTDAAWGMDR,_DNPFSLGES(ph)FGSR_, , , , ,0.17,0.28,0,-0.17, , , , ,0.29,0.28,-0.2,-0.44,,,0.22,-0.08,,,0.29,-0.32,,,,,,,NA,NA,,,ARF GTPase activator activity,regulation of ARF GTPase activity,,
Q9Y6D6,Q9Y6D6,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ARFGEF1,52.38,52.18,S286,DVDKSLQDDTEPENGSDISSAENEQTEADQA,_SLQDDTEPENGS(ph)DIS(ph)S(ph)AENEQTEADQATAAETLSK_, , , , , , , ,-0.24, , , , , , , ,-0.34,,,,-0.24,,,,-0.34,,,,,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D6,Q9Y6D6,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ARFGEF1,52.38,52.18,S289,KSLQDDTEPENGSDISSAENEQTEADQATAA,_SLQDDTEPENGS(ph)DIS(ph)S(ph)AENEQTEADQATAAETLSK_, , , , , , , ,-0.24, , , , , , , ,-0.34,,,,-0.24,,,,-0.34,,,,,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D6,Q9Y6D6,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ARFGEF1,52.38,52.18,S290,SLQDDTEPENGSDISSAENEQTEADQATAAE,_SLQDDTEPENGS(ph)DIS(ph)S(ph)AENEQTEADQATAAETLSK_, , , , , , , ,-0.24, , , , , , , ,-0.34,,,,-0.24,,,,-0.34,,,,,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D6,Q9Y6D6,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,ARFGEF1,101.38,83.71,S1569,PSPVSEKPLDTISQKSVDIHDSIQPRSVDNR,_S(ph)VDIHDSIQPR_,-0.46,-0.45,-0.72,-0.97,0.14, , ,0.64,0.08,-0.04,-0.23,-0.27,0.8, , ,0.91,-0.45,-0.84,0.14,0.64,0.02,-0.25,0.8,0.91,,,,,,,0,0,,cytosol,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,174.72,160.51,S1528,SSIDKNPSERGQSQLSNPTDDSWKGRPYANQ,_GQS(ph)QLS(ph)NPT(ph)DDSWK_,0.2,0.14,0.45,0.34,0.31,1.21,1.22,1.29,0.02,0.19,0.44,0.32,0,1.38,0.73,0.88,0.17,0.4,0.83,1.26,0.11,0.38,0.85,0.81, +,,,,,,2,0,24.45,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,174.72,160.51,S1525,QSLSSIDKNPSERGQSQLSNPTDDSWKGRPY,_GQS(ph)QLS(ph)NPT(ph)DDSWK_,0.1,0.06,-0.15, ,0.23,0.1,0.15,0.22,-0.06,-0.04,-0.43, ,0.25,0.07,0.22,0.26,0.08,-0.15,0.17,0.19,-0.05,-0.43,0.16,0.24,,,,,,,0,0,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,93.55,84.89,S1534,PSERGQSQLSNPTDDSWKGRPYANQKLFASL,_GQSQLS(ph)NPTDDS(ph)WK_, , , , ,0.39,0.16, , , , , , ,-0.25,-0.47, , ,,,0.28,,,,-0.36,,,,,,,,NA,NA,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,123.17,123.17,S1511,EDSSEKHLDVDLDRQSLSSIDKNPSERGQSQ,_HLDVDLDRQS(ph)LS(ph)SIDK_,0.18,0.09,-0.49,-0.4,0.29,0.16,0.06,-0.05,-0.23,-0.2,-0.23,-0.03,0.03,0.03,-0.28,-0.22,0.14,-0.44,0.23,0.01,-0.21,-0.13,0.03,-0.25,,,,,,,0,0,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,107.82,107.82,S1513,SSEKHLDVDLDRQSLSSIDKNPSERGQSQLS,_HLDVDLDRQS(ph)LS(ph)SIDK_, , , , , , ,0.06,-0.05, , , , , , ,-0.28,-0.22,,,,0.01,,,,-0.25,,,,,,,NA,NA,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,123.17,123.17,S1514,SEKHLDVDLDRQSLSSIDKNPSERGQSQLSN,_HLDVDLDRQS(ph)LSS(ph)IDK_,0.18,0.09,-0.49,-0.4,0.32,0.16, , ,-0.23,-0.2,-0.23,-0.03,0.06,0.03, , ,0.14,-0.44,0.24,,-0.21,-0.13,0.05,,,,,,,,NA,NA,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,128.88,110.26,T1531,DKNPSERGQSQLSNPTDDSWKGRPYANQKLF,_GQS(ph)QLS(ph)NPT(ph)DDSWK_, , , , , , ,0.27,-0.07, , , , , , ,0.17,0.14,,,,0.11,,,,0.16,,,,,,,NA,NA,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,178.76,157.91,S277,KVSTENGDAPRERGSSLSGTDDGAQEVVKDI,_GSS(ph)LSGTDDGAQEVVK_,0.32,0.22,0.2,0.33,0.41,0.56,0.6,0.82,0.73,0.28,0.24,0.27,0.52,0.58,0.47,0.51,0.27,0.27,0.49,0.72,0.53,0.25,0.55,0.49,,,,,,,0,0,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,224.01,224.01,S218,QEARELEKPIQSKPQSPVIQAAAVSPKFVRL,_PIQSKPQS(ph)PVIQAAAVS(ph)PK_,0.44,0.31,0.56,0.59,0.55,0.63, , ,0.14,0.07,0.48,0.53,0.5,0.41, , ,0.37,0.57,0.59,,0.11,0.5,0.46,,,,,,,,NA,NA,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9Y6D5,Q9Y6D5,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,ARFGEF2,224.01,224.01,S227,IQSKPQSPVIQAAAVSPKFVRLKHSQAQSKP,_PQSPVIQAAAVS(ph)PK_,0.4,0.25,0,0.04,0.05,-0.01,0.21,0.27,0.2,0.09,-0.22,-0.14,-0.34,-0.12,0.15,-0.09,0.33,0.02,0.02,0.24,0.14,-0.18,-0.23,0.03,,,,,,,0,0,,asymmetric synapse,ARF guanyl-nucleotide exchange factor activity,endomembrane system organization,,
Q9NWB6,Q9NWB6,Arginine and glutamate-rich protein 1,ARGLU1,157.68,157.68,S77,NTAVSRRERDRERASSPPDRIDIFGRTVSKR,_ASS(ph)PPDRIDIFGR_,0.02,0.06,0.08,0.08,0,0.03,0.12,0.07,-0.14,-0.11,-0.18,-0.16,-0.07,0.06,0.04,0.16,0.04,0.08,0.02,0.1,-0.13,-0.17,0,0.1,,,,,,,0,0,,nucleus,,"regulation of transcription, DNA-dependent",,
Q07960,Q07960,Rho GTPase-activating protein 1,ARHGAP1,101.45,96.73,S51,DEMPDFPKSDDSKSSSPELVTHLKWDDPYYD,_SSS(ph)PELVTHLK_,0.18,-0.07,0.09,0.18,-0.03,0.03,-0.18,-0.37,0.15,0.1,0.29,0.32,0.2,-0.24,0.05,0.09,0.06,0.14,0,-0.27,0.13,0.31,0,0.07,,,,,,,0,0,,cytosol,Rac GTPase activator activity,Rho protein signal transduction,,
Q8IWW6-3,Q8IWW6,Rho GTPase-activating protein 12,ARHGAP12,155.68,155.68,S240,EQIRATTPPNQGRPDSPVYANLQELKISQSA,_ATT(ph)PPNQGRPDS(ph)PVYANLQELK_,-0.74,0.11,-0.57,-0.76,0.09,0.21,0.29,0.12,-0.69,-0.1,-0.62,-0.89,0.02,0.2,0.19,0.17,-0.26,-0.67,0.15,0.21,-0.37,-0.75,0.12,0.18,,,,,,,0,0,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q8IWW6-3,Q8IWW6,Rho GTPase-activating protein 12,ARHGAP12,84.21,84,S215,DSAGEGSERIHQDSESGDELSSSSTEQIRAT,_IHQDSES(ph)GDELSSSSTEQIR_, ,0.59, ,0.4, , , , , ,-0.65, ,-0.92, , , , ,0.59,0.4,,,-0.65,-0.92,,,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q8IWW6-3,Q8IWW6,Rho GTPase-activating protein 12,ARHGAP12,85.33,85.02,S592,QAVETDEGIEEEIPDSPGIEKHDKEKEQKDP,_VLSSTINNQAVETDEGIEEEIPDS(ph)PGIEK_, , , , , , , ,0.73, , , , , , , ,0.53,,,,0.73,,,,0.53,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q8IWW6-3,Q8IWW6,Rho GTPase-activating protein 12,ARHGAP12,155.68,155.68,T231,GDELSSSSTEQIRATTPPNQGRPDSPVYANL,_ATT(ph)PPNQGRPDS(ph)PVYANLQELK_,-0.74,0.11,-0.57,-0.76,0.09,0.21,0.29,0.12,-0.69,-0.1,-0.62,-0.89,0.02,0.2,0.19,0.17,-0.26,-0.67,0.15,0.21,-0.37,-0.75,0.12,0.18,,,,,,,0,0,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,337.85,337.85,S575,SSAGILEQGPSPGDGSPPKPKDPVSAAVPAP,_AESSSGGGTVPSSAGILEQGPSPGDGS(ph)PPKPK_,0.22,0.23,0.04,0.19,0.42,0.12,0.29,0.32,0.06,0.02,0.02,-0.16,-0.03,0.31,-0.03,-0.04,0.23,0.12,0.28,0.3,0.04,-0.07,0.15,-0.04,,,,,,,0,0,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,106.94,106.07,S674,TSQHPPSLSPKPPTRSPSPPTQHTGQPPGQP,_S(ph)PS(ph)PPTQHTGQPPGQPSAPSQLSAPR_, ,0.43,0.35, , , , ,0.24, ,0.26,0.43, , , , ,-0.35,0.43,0.35,,0.24,0.26,0.43,,-0.35,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,138.61,138.61,S676,QHPPSLSPKPPTRSPSPPTQHTGQPPGQPSA,_S(ph)PS(ph)PPTQHTGQPPGQPSAPSQLSAPR_,0.04,-0.01,-0.09,-0.14, ,-0.1,0.12,0.24,0.21,0.43,0.22,0.16, ,-0.11,0.03,-0.35,0.02,-0.11,-0.1,0.18,0.32,0.19,-0.11,-0.15,,,,,,,0,0,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,75.14,74.85,T753,PMALPSEHGLEQPSHTPPQTPTPPSTPPLGK,_PNSQGPPNPMALPSEHGLEQPSHT(ph)PPQT(ph)PT(ph)PPST(ph)PPLGK_, , , , , , ,0.93,0.44, , , , , , ,0.9,0.5,,,,0.7,,,,0.72,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,75.14,74.85,T757,PSEHGLEQPSHTPPQTPTPPSTPPLGKQNPS,_PNSQGPPNPMALPSEHGLEQPSHT(ph)PPQT(ph)PT(ph)PPS(ph)TPPLGK_, , , , , , ,0.93,0.44, , , , , , ,0.9,0.5,,,,0.7,,,,0.72,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q68EM7,Q68EM7,Rho GTPase-activating protein 17,ARHGAP17,75.14,74.85,T759,EHGLEQPSHTPPQTPTPPSTPPLGKQNPSLP,_PNSQGPPNPMALPSEHGLEQPSHT(ph)PPQT(ph)PT(ph)PPS(ph)TPPLGK_, , , , , , ,0.93,0.44, , , , , , ,0.9,0.5,,,,0.7,,,,0.72,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q5T5U3,Q5T5U3,Rho GTPase-activating protein 21,ARHGAP21,77.51,77.51,S880,PSLDAQPNSKTERSKSYDEGLDDYREDAKLS,_S(ph)YDEGLDDYREDAK_,-0.22,-0.14,1.53, ,1.22,1.84,0.78,0.36,-0.33,0.02,1.54, ,0.72,0.94,0.69,0.52,-0.18,1.53,1.56,0.59,-0.15,1.54,0.84,0.61, +, +,,,,,1,4,32.17,cell junction,GTPase activator activity,establishment of Golgi localization,,
Q5T5U3,Q5T5U3,Rho GTPase-activating protein 21,ARHGAP21,46.82,41.69,S1432,SRKRKKPKEKAQPSSSEDELDNVFFKKENVE,_AQPSS(ph)S(ph)EDELDNVFFK_, , , , , , , ,-0.18, , , , , , , ,-0.33,,,,-0.18,,,,-0.33,,,,,,,NA,NA,,cell junction,GTPase activator activity,establishment of Golgi localization,,
Q9P227-2,Q9P227,Rho GTPase-activating protein 23,ARHGAP23,84.16,84.16,S361,WHRARSDDYLSRATRSAEALGPGALVSPRFE,_S(ph)AEALGPGALVS(ph)PR_, , , , , , , ,0.05, , , , , , , ,-0.69,,,,0.05,,,,-0.69,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
Q9P227-2,Q9P227,Rho GTPase-activating protein 23,ARHGAP23,84.16,84.16,S372,RATRSAEALGPGALVSPRFERCGWASQRSSA,_S(ph)AEALGPGALVS(ph)PR_, , , , , , , ,0.05, , , , , , , ,-0.69,,,,0.05,,,,-0.69,,,,,,,NA,NA,,cytosol,GTPase activator activity,positive regulation of GTPase activity,,
F8VWZ8,Q52LW3,Rho GTPase-activating protein 29,ARHGAP29,83.08,61.71,S913,SIGVVDQGCFPKPLLSPEERDIERSMKSLFF,_PLLS(ph)PEER_, , , , ,1.2, ,1.53, , , , , ,1.62, ,1.78, ,,,1.2,1.53,,,1.62,1.78, +, +,,,,,NA,NA,,intracellular,metal ion binding,intracellular signal transduction,,
F8VWZ8,Q52LW3,Rho GTPase-activating protein 29,ARHGAP29,133.15,129.9,S171,GNDSLLRLPVSRETKSFENVSVESVDSSSEK,_S(ph)FENVS(ph)VESVDSSSEK_, , , , ,-0.9,-1.1, ,-0.83, , , , ,-0.23,-0.42, ,-0.07,,,-1,-0.83,,,-0.32,-0.07,,,,,,,NA,NA,,intracellular,metal ion binding,intracellular signal transduction,,
F8VWZ8,Q52LW3,Rho GTPase-activating protein 29,ARHGAP29,133.15,129.9,S176,LRLPVSRETKSFENVSVESVDSSSEKGNFSP,_S(ph)FENVS(ph)VESVDSSSEK_, , , , ,-0.9,-1.1, ,-0.83, , , , ,-0.23,-0.42, ,-0.07,,,-1,-0.83,,,-0.32,-0.07,,,,,,,NA,NA,,intracellular,metal ion binding,intracellular signal transduction,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,209.12,208.22,S1176,RCTRLGRFASYRTSFSVGSDDELGPIRKKEE,_TSFS(ph)VGS(ph)DDELGPIR_, ,-0.19,1.74,1.72,1.21,1.35,1.19,1.01, ,-0.18,2.2,2.13,1.14,1.22,1.08,0.95,-0.19,1.73,1.28,1.1,-0.18,2.16,1.18,1.02, +, +,,,,,1,4,37.96,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,74.13,38.48,S589,ISSRFIRPSDRNQKNSLSDPNIDRINLVILG,_NS(ph)LSDPNIDR_, , , , ,3.65,2.67,3.85,3.07, , , , ,3.72,2.86,4.09,3.44,,,3.24,3.51,,,3.36,3.8, +, +,,,,,NA,NA,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,272.31,270.86,Y1105,PMDAVVKPRNEEENIYSVPHDSTQGKIITIR,_NEEENIY(ph)SVPHDSTQGK_,0.19,0.14,0.35,0.52,0.54,0.62,0.58,0.62,0.17,0.17,-0.01,0.26,0.58,0.56,0.71,0.71,0.17,0.44,0.58,0.6,0.17,0.13,0.57,0.71,,,,,,,0,0,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,157.66,157.66,Y1087,SSSPWLPQDGFDPSDYAEPMDAVVKPRNEEE,_SVSSSPWLPQDGFDPSDY(ph)AEPMDAVVKPR_,0.11, ,0.14, ,0.32,0.4,0.53,0.53,-0.26, ,-0.33, ,0.33,0.29,0.29,0.44,0.11,0.14,0.36,0.53,-0.26,-0.33,0.31,0.37,,,,,,,0,0,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,44.17,44.03,S975,ACSTTEEVFNSPRAGSPLCNSNLQDSEEDIE,_AGS(ph)PLCNSNLQDS(ph)EEDIEPSYSLFR_, , , , , , , ,0.12, , , , , , , ,-0.28,,,,0.12,,,,-0.28,,,,,,,NA,NA,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,44.17,44.03,S985,SPRAGSPLCNSNLQDSEEDIEPSYSLFREDT,_AGS(ph)PLCNSNLQDS(ph)EEDIEPSYSLFR_, , , , , , , ,0.12, , , , , , , ,-0.28,,,,0.12,,,,-0.28,,,,,,,NA,NA,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,351.04,348.08,S1134,IRNINKAQSNGSGNGSDSEMDTSSLERGRKV,_AQSNGSGNGS(ph)DSEMDTSSLER_,-0.42,-0.49,-0.46,-0.54,-0.16,-0.14,-0.15,-0.01,0.36,0.08,0.08,0.24,0.01,-0.01,0.11,0.1,-0.46,-0.5,-0.15,-0.08,0.22,0.16,0,0.11,,,,,,,0,0,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,73.24,72.82,S1070,DLSYLDQGHRDGQRKSVSSSPWLPQDGFDPS,_S(ph)VSSSPWLPQDGFDPSDY(ph)AEPMDAVVKPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cytoskeleton,DNA binding,axon guidance,,
Q9NRY4-2,Q9NRY4,Rho GTPase-activating protein 35,ARHGAP35,214.39,213.49,S1179,RLGRFASYRTSFSVGSDDELGPIRKKEEDQA,_TSFS(ph)VGS(ph)DDELGPIR_,-0.18,-0.2,-0.48,-0.47,-0.32,-0.46,-0.23,-0.28,-0.2,-0.21,-0.32,-0.32,-0.42,-0.3,-0.3,-0.45,-0.19,-0.47,-0.39,-0.25,-0.2,-0.32,-0.36,-0.37,,,,,,,0,0,,actin cytoskeleton,DNA binding,axon guidance,,
Q9C0H5,Q9C0H5,Rho GTPase-activating protein 39,ARHGAP39,101.32,89.4,Y448,PCLLRDQRLGVKSGDYSTMEGPELRHSQPPT,_SGDY(ph)STMEGPELR_,0.22, , , , , , , ,-1.21, , , , , , , ,0.22,,,,-1.21,,,,, +,,,,,NA,NA,,cytoskeleton,,axon guidance,,
E9PJK4,A6NI28,Rho GTPase-activating protein 42,ARHGAP42,105.06,105.06,Y376,NRKLWLEAMDGKEPIYTLPAIISKKEEMYLN,_LWLEAMDGKEPIY(ph)TLPAIISK_,-1.01, ,-0.77, , , , , ,-0.62, ,0.03, , , , , ,-1.01,-0.77,,,-0.62,0.03,,, +,,,,,,NA,NA,,intracellular,GTPase activator activity,positive regulation of GTPase activity,,
E9PJK4,A6NI28,Rho GTPase-activating protein 42,ARHGAP42,106.86,106.86,Y792,KMCRRLRLDTASSNGYQRPGSVVAAKAQLFE,_LRLDTASSNGY(ph)QRPGSVVAAK_,-0.71, ,-1.56, , , ,-0.15,-0.17,0.19, ,-0.79, , , ,0.17,0.14,-0.71,-1.56,,-0.16,0.19,-0.79,,0.15, +,,,,,,NA,NA,,intracellular,GTPase activator activity,positive regulation of GTPase activity,,
Q13017-2,Q13017,Rho GTPase-activating protein 5,ARHGAP5,208.39,205.86,Y1109,PIDTIFKQKGYSDEIYVVPDDSQNRIKIRNS,_GYSDEIY(ph)VVPDDSQNR_,2.26, , , , , , , ,1.57, , , , , , , ,2.26,,,,1.57,,,, +, +,,,,,NA,NA,,cytosol,GTP binding,cell adhesion,,
Q13017-2,Q13017,Rho GTPase-activating protein 5,ARHGAP5,150.36,150.36,S1218,PVETWKGGIDNPAITSDQELDDKKMKKKTHK,_GGIDNPAITS(ph)DQELDDKK_,-0.21,-0.1,-0.03,-0.05,0.5,0.2,0.35,0.4,0,0.04,0.2,0.22,0.5,0.16,0.41,0.48,-0.16,-0.04,0.36,0.38,0.02,0.21,0.34,0.45,,,,,,,0,0,,cytosol,GTP binding,cell adhesion,,
Q13017-2,Q13017,Rho GTPase-activating protein 5,ARHGAP5,161.41,161.41,S1173,KTLFSKAKSYYRRTHSDASDDEAFTTSKTKR,_RTHS(ph)DAS(ph)DDEAFTTSK_,-0.34,-0.33,0.37,0.17,0.39,0.51,1.05,0.54,0,0.15,0.4,0.76,0.49,0.33,0.62,0.81,-0.33,0.27,0.45,0.82,0.08,0.59,0.41,0.72,,,,,,,0,0,,cytosol,GTP binding,cell adhesion,,
Q13017-2,Q13017,Rho GTPase-activating protein 5,ARHGAP5,161.41,161.41,S1176,FSKAKSYYRRTHSDASDDEAFTTSKTKRKGR,_RTHS(ph)DAS(ph)DDEAFTTSK_,-0.34,-0.33,0.37,0.17,0.39,0.51,1.05,0.54,0,0.15,0.4,0.76,0.49,0.33,0.62,0.81,-0.33,0.27,0.45,0.82,0.08,0.59,0.41,0.72,,,,,,,0,0,,cytosol,GTP binding,cell adhesion,,
P52565,P52565,Rho GDP-dissociation inhibitor 1,ARHGDIA,74.38,74.38,S24,EQLAQIAAENEEDEHSVNYKPPAQKSIQEIQ,_(ac)AEQEPTAEQLAQIAAENEEDEHS(ph)VNYKPPAQK_,0.21, ,-0.38, , , , , ,-0.07, ,-0.22, , , , , ,0.21,-0.38,,,-0.07,-0.22,,,,,,,,,NA,NA,,cytoskeleton,GTPase activator activity,cellular component movement,,
Q92888,Q92888,Rho guanine nucleotide exchange factor 1,ARHGEF1,47.09,38.49,S863,GPPRDGDGVPGGGPLSPARTQEIQENLLSLE,_DGDGVPGGGPLS(ph)PAR_,-0.56, , , ,0.21, ,0.27,0.61,0.73, , , ,0.4, ,0.83,0.95,-0.56,,0.21,0.45,0.73,,0.4,0.89,,,,,,,NA,NA,,cytosol,GTPase activator activity,cell proliferation,,
O15013-7,O15013,Rho guanine nucleotide exchange factor 10,ARHGEF10,131.95,129.06,S1283,LGDSLGSMTQKSDLSSSSGSLSLSHGSSSLE,_SDLSS(ph)SSGS(ph)LSLSHGSSSLEHR_,0.02,-0.09,-0.63,-0.49, , , , ,-0.09,-0.15,-0.74,-0.64, , , , ,-0.03,-0.56,,,-0.12,-0.69,,,,,,,,,NA,NA,,centrosome,Rho guanyl-nucleotide exchange factor activity,centrosome duplication,,
O15013-7,O15013,Rho guanine nucleotide exchange factor 10,ARHGEF10,103.52,102.91,S1284,GDSLGSMTQKSDLSSSSGSLSLSHGSSSLEH,_SDLSSS(ph)SGS(ph)LSLSHGSSSLEHR_, , ,0.14,-0.95, , ,0.13, , , ,-0.8,-0.4, , ,-0.23, ,,-0.31,,0.13,,-0.59,,-0.23,,,,,,,NA,NA,,centrosome,Rho guanyl-nucleotide exchange factor activity,centrosome duplication,,
O15013-7,O15013,Rho guanine nucleotide exchange factor 10,ARHGEF10,131.95,129.06,S1287,LGSMTQKSDLSSSSGSLSLSHGSSSLEHRSE,_SDLSS(ph)SSGS(ph)LSLSHGSSSLEHR_,0.02,-0.09,-0.63,-0.72, , ,0.13,0.3,-0.09,-0.15,-0.74,-0.52, , ,-0.23,0.27,-0.03,-0.68,,0.22,-0.12,-0.62,,0.04,,,,,,,NA,NA,,centrosome,Rho guanyl-nucleotide exchange factor activity,centrosome duplication,,
O15013-7,O15013,Rho guanine nucleotide exchange factor 10,ARHGEF10,159.95,159.95,S59,TNNNEEEEGEQFDFDSGDEIPEADRQAPSAP,_YDTNNNEEEEGEQFDFDS(ph)GDEIPEADR_, , ,-0.28,-0.34,0.03,0.13,0.05,0.09, , ,0.01,-0.07,0,0,-0.02,-0.03,,-0.31,0.08,0.07,,-0.03,0,-0.02,,,,,,,NA,NA,,centrosome,Rho guanyl-nucleotide exchange factor activity,centrosome duplication,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,50.22,50.08,S1458,ELAHRELLKSLGGESSGGTTPVGSFHTEAAR,_SLGGESS(ph)GGT(ph)TPVGSFHTEAAR_, , , , ,1.45, , , , , , , ,1.27, , , ,,,1.45,,,,1.27,, +, +,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,174.05,152.49,S245,FPSLSESLMNRNSVLSDPGLDSPRTSPVIMA,_NSVLS(ph)DPGLDS(ph)PRTS(ph)PVIMAR_, , , , ,-0.49, ,0.96, , , , , ,-0.77, ,0.07, ,,,-0.49,0.96,,,-0.77,0.07,,,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,174.05,152.49,S251,SLMNRNSVLSDPGLDSPRTSPVIMARVAQHH,_NSVLSDPGLDS(ph)PRT(ph)SPVIMAR_, , , , ,0.04,0.15,0.21,0.26, , , , ,0.01,-0.05,0.12,0.1,,,0.1,0.24,,,-0.02,0.11,,,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,174.05,152.49,S255,RNSVLSDPGLDSPRTSPVIMARVAQHHRRQG,_NSVLS(ph)DPGLDS(ph)PRTS(ph)PVIMAR_, , , , ,0.04,0.15,0.29,0.26, , , , ,0.01,-0.05,0.2,0.06,,,0.1,0.27,,,-0.02,0.13,,,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,66.89,57.09,S663,LHQSASSSTSSLSTRSLENPTPPFTPKMGRR,_S(ph)LENPT(ph)PPFTPK_, , , , ,0.07,0.19,-0.06,-0.01, , , , ,0.09,-0.15,-0.11,0.03,,,0.13,-0.04,,,-0.02,-0.04,,,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
O15085,O15085,Rho guanine nucleotide exchange factor 11,ARHGEF11,66.89,57.09,T668,SSSTSSLSTRSLENPTPPFTPKMGRRSIESP,_S(ph)LENPT(ph)PPFTPK_, , , , ,0.07,0.19,-0.06,-0.01, , , , ,0.09,-0.15,-0.11,0.03,,,0.13,-0.04,,,-0.02,-0.04,,,,,,,NA,NA,,cytosol,G-protein coupled receptor binding,actin cytoskeleton organization,,
E9PMR6,Q9NZN5,Rho guanine nucleotide exchange factor 12,ARHGEF12,47.81,47.34,S341,KSETIQDTDTQSLVGSPSTRIAPHIIGAEDD,_SETIQDTDTQS(ph)LVGS(ph)PSTR_, , , , ,1.6, , , , , , , ,2.36, , , ,,,1.6,,,,2.36,, +, +,,,,,NA,NA,,cytoplasm,phospholipid binding,intracellular signal transduction,,
Q5VV41,Q5VV41,Rho guanine nucleotide exchange factor 16,ARHGEF16,110.48,102.44,S6,__________MAQRHSDSSLEEKLLGHRFHS,_(ac)AQRHS(ph)DSSLEEK_, , , , ,0.91, , ,1.18, , , , ,0.64, , ,0.84,,,0.91,1.18,,,0.64,0.84, +,,,,,,NA,NA,,cytosol,phospholipid binding,activation of Cdc42 GTPase activity,,
Q5VV41,Q5VV41,Rho guanine nucleotide exchange factor 16,ARHGEF16,129.88,122.3,S227,DPQLYQEIQERGLNTSQESDDDILDESSSPE,_GLNTS(ph)QES(ph)DDDILDESSSPEGTQK_,0.49,0.55,0.25, ,0.06,0.06,0.07,0.03,0.41,0.12,-0.11, ,-0.12,0.05,-0.05,0.02,0.52,0.25,0.06,0.05,0.27,-0.11,-0.03,-0.01,,,,,,,0,0,,cytosol,phospholipid binding,activation of Cdc42 GTPase activity,,
Q5VV41,Q5VV41,Rho guanine nucleotide exchange factor 16,ARHGEF16,189.11,188.14,S230,LYQEIQERGLNTSQESDDDILDESSSPEGTQ,_GLNTSQES(ph)DDDILDESSSPEGTQK_,0.6,0.46,0.43,0.46,0.05,-0.17,0.28,0.23,0.88,-0.01,0.62,0.99,0.11,0.14,-0.03,-0.02,0.53,0.45,-0.06,0.26,0.51,0.82,0.12,-0.02,,,,,,,0,0,,cytosol,phospholipid binding,activation of Cdc42 GTPase activity,,
Q5VV41,Q5VV41,Rho guanine nucleotide exchange factor 16,ARHGEF16,152.1,152.1,S240,NTSQESDDDILDESSSPEGTQKVDATIVVKS,_GLNTS(ph)QES(ph)DDDILDESSS(ph)PEGTQK_, , , , ,-0.2,-0.24,-0.07,0.25, , , , ,-0.36,-0.15,-0.04,0.07,,,-0.22,0.1,,,-0.25,0.02,,,,,,,NA,NA,,cytosol,phospholipid binding,activation of Cdc42 GTPase activity,,
Q96PE2,Q96PE2,Rho guanine nucleotide exchange factor 17,ARHGEF17,92.87,59.68,S735,SELSNGEAGEAYRSLSDPIPQRHRAATSEEP,_SLS(ph)DPIPQR_, , , , ,-1.07, , ,-0.33, , , , ,-0.61, , ,-0.68,,,-1.07,-0.33,,,-0.61,-0.68, +,,,,,,NA,NA,,cytosol,guanyl-nucleotide exchange factor activity,actin cytoskeleton organization,,
Q6ZSZ5-2,Q6ZSZ5,Rho guanine nucleotide exchange factor 18,ARHGEF18,110.64,78.92,S1103,LMGKDESTSRNRRSLSPILPGRHSPAPPPDP,_S(ph)LS(ph)PILPGR_,-0.32,-0.29,-1.09,-1.08,-0.15,0.01,-0.15,-0.9,-0.19,0.38,-0.79,-0.65,1.13,1.64,0.91,-0.65,-0.3,-1.09,-0.07,-0.48,0.12,-0.72,1.41,0.33, +, +,,,,,3,2,14.58,apical part of cell,guanyl-nucleotide exchange factor activity,actin cytoskeleton organization,,
Q6ZSZ5-2,Q6ZSZ5,Rho guanine nucleotide exchange factor 18,ARHGEF18,110.64,78.92,S1101,NKLMGKDESTSRNRRSLSPILPGRHSPAPPP,_S(ph)LS(ph)PILPGR_,-0.36,-0.26, ,-0.5,-1.16,-0.51,-0.86,-0.9,0.05,-0.05, ,-0.31,-0.92,0.19,-0.46,-0.65,-0.31,-0.5,-0.8,-0.88,0,-0.31,-0.26,-0.55,,,,,,,0,0,,apical part of cell,guanyl-nucleotide exchange factor activity,actin cytoskeleton organization,,
Q92974-3,Q92974,Rho guanine nucleotide exchange factor 2,ARHGEF2,217.37,212.47,S696,REPALPLEPDSGGNTSPGVTANGEARTFNGS,_EPALPLEPDSGGNTS(ph)PGVTANGEAR_,1.54,1.28,0.16,0.4,1.18,1.41,1.29,1.25,0.39,0.4,-0.26,-0.62,1.08,1.03,1.1,1.14,1.42,0.29,1.3,1.27,0.39,-0.43,1.05,1.12, +, +,,,,,2,2,21.47,cytosol,microtubule binding,actin filament organization,,
Q92974-3,Q92974,Rho guanine nucleotide exchange factor 2,ARHGEF2,73.08,28.47,S932,SVHRNFEDRERQELGSPEERLQDSSDPDTGS,_QELGS(ph)PEER_, , , , , , , ,0.53, , , , , , , ,0.44,,,,0.53,,,,0.44,,,,,,,NA,NA,,cytosol,microtubule binding,actin filament organization,,
Q96DR7-3,Q96DR7,Rho guanine nucleotide exchange factor 26,ARHGEF26,129.25,111.09,S392,AVLYQNYKEKALDIDSDEESEPKEQKSDEKI,_ALDIDS(ph)DEESEPK_,0.59,0.38, , , , ,0.04,-0.19,-0.33,-0.22, , , , ,-0.07,-0.04,0.49,,,-0.07,-0.28,,,-0.05,,,,,,,NA,NA,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
Q8TER5-4,Q8TER5,Rho guanine nucleotide exchange factor 40,ARHGEF40,168.17,167.73,Y242,PGDGHNAPVEGPEGEYVELLEVTLPVRGSPT,_SPGDGHNAPVEGPEGEY(ph)VELLEVTLPVR_, , ,1.84, , , , , , , ,1.8, , , , , ,,1.84,,,,1.8,,, +, +,,,,,NA,NA,,cytoplasm,phospholipid binding,regulation of Rho protein signal transduction,,
Q8TER5-4,Q8TER5,Rho guanine nucleotide exchange factor 40,ARHGEF40,95.61,59.78,S1513,RGILGLSRQSHARALSDPTTPL_________,_ALS(ph)DPTTPL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,phospholipid binding,regulation of Rho protein signal transduction,,
C9J591,Q12774,Rho guanine nucleotide exchange factor 5,ARHGEF5,124.67,89.71,Y1140,SSPRQPRKALVSSESYLQRLSMASSGSLWQE,_ALVSSESY(ph)LQR_,1.79, , , , , , , ,1.62, , , , , , , ,1.79,,,,1.62,,,, +, +,,,,,NA,NA,,,,,,
Q14155-1,Q15052,Rho guanine nucleotide exchange factor 6,ARHGEF7,135.16,110.34,S488,LFPNVLLMLSASPRMSGFIYQGKLPTTGMTI,_M(ox)S(ph)GFIYQGK_,0.07,0.17,-0.05,0,0.27,0.27,0.27,0.29,0.23,0.46,1.52,1.26,0.04,0.03,0.16,0.08,0.12,-0.03,0.27,0.28,0.35,1.4,0.03,0.12,, +,,,,,0,4,9.12,cell cortex,guanyl-nucleotide exchange factor activity,apoptotic signaling pathway,,
O14497-3,O14497,AT-rich interactive domain-containing protein 1A,ARID1A,82.15,79.2,S696,FSPHTSPHLPGIRGPSPSPVGSPASVAQSRS,_GPS(ph)PSPVGSPASVAQSR_, , , , , , ,-0.59, , , , , , , ,-0.31, ,,,,-0.59,,,,-0.31,,,,,,,NA,NA,,nBAF complex,DNA binding,androgen receptor signaling pathway,,
O14497-3,O14497,AT-rich interactive domain-containing protein 1A,ARID1A,149.62,148.55,S1755,GQRTLLDPGRFSKVSSPAPMEGGEEEEELLG,_VSS(ph)PAPMEGGEEEEELLGPK_,-0.17,-0.26,-0.12,-0.09,-0.34,-0.19,0.12,-0.22,0.16,-0.01,0.07,0.11,0.21,0.06,0.38,0.32,-0.22,-0.1,-0.26,-0.04,0.08,0.09,0.14,0.35,,,,,,,0,0,,nBAF complex,DNA binding,androgen receptor signaling pathway,,
Q99856,Q99856,AT-rich interactive domain-containing protein 3A,ARID3A,129.89,128.79,S77,LAAMRAAAAGLGHPASPGGSEDGPPGSEEED,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_, , , , , , ,-0.25,-0.18, , , , , , ,-0.25,-0.1,,,,-0.21,,,,-0.17,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of transcription from RNA polymerase II promoter,,
Q99856,Q99856,AT-rich interactive domain-containing protein 3A,ARID3A,129.89,128.79,S81,RAAAAGLGHPASPGGSEDGPPGSEEEDAARE,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_, , , , , , ,-0.25,-0.18, , , , , , ,-0.25,-0.1,,,,-0.21,,,,-0.17,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of transcription from RNA polymerase II promoter,,
Q99856,Q99856,AT-rich interactive domain-containing protein 3A,ARID3A,129.89,128.79,S88,GHPASPGGSEDGPPGSEEEDAAREGTPGSPG,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_, , , , , , ,-0.25,-0.18, , , , , , ,-0.25,-0.1,,,,-0.21,,,,-0.17,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of transcription from RNA polymerase II promoter,,
P29374-3,P29374,AT-rich interactive domain-containing protein 4A,ARID4A,118.51,52.54,S427,HHEPKVKEEKKDLEESMEEALKLDQEMPLTE,_DLEES(ph)MEEALK_,0.67,-0.13,-0.06,-0.08, , , , ,0.2,0.07,0.18,-0.09, , , , ,0.32,-0.07,,,0.14,0.05,,,,,,,,,NA,NA,,transcriptional repressor complex,DNA binding,"negative regulation of transcription, DNA-dependent",,
P29374-3,P29374,AT-rich interactive domain-containing protein 4A,ARID4A,165.94,165.94,S159,RRSSLPVTEDEKEEESSEEEDEDKRRLNDEL,_SSLPVTEDEKEEES(ph)S(ph)EEEDEDK_,-0.42,-0.24, , , , ,-0.35,-0.3,-0.08,0.03, , , , ,-0.65,-0.75,-0.33,,,-0.32,-0.03,,,-0.7,,,,,,,NA,NA,,transcriptional repressor complex,DNA binding,"negative regulation of transcription, DNA-dependent",,
P29374-3,P29374,AT-rich interactive domain-containing protein 4A,ARID4A,165.94,165.94,S160,RSSLPVTEDEKEEESSEEEDEDKRRLNDELL,_SSLPVTEDEKEEES(ph)S(ph)EEEDEDK_,-0.42,-0.24, , , , ,-0.35,-0.3,-0.08,0.03, , , , ,-0.65,-0.75,-0.33,,,-0.32,-0.03,,,-0.7,,,,,,,NA,NA,,transcriptional repressor complex,DNA binding,"negative regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,76.1,75.1,S1029,SGSNSVLNTPPTTPESPSSVTVTEGSRQQSS,_AEFPSSGSNSVLNT(ph)PPTT(ph)PES(ph)PSSVTVTEGSR_, , , , ,0.15,0.46, , , , , , ,0.08,0.47, , ,,,0.32,,,,0.29,,,,,,,,NA,NA,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,262.59,232.62,S790,VSKSPERLRKDIEVLSEDTDYEEDEVTKKRK,_DIEVLS(ph)EDT(ph)DYEEDEVTKK_,0.07,-0.2,-0.31,-0.06,0,-0.16,0.08,0.06,0.24,0.09,-0.07,0.02,0.12,0.1,0.16,0.06,-0.06,-0.18,-0.08,0.07,0.17,-0.03,0.11,0.11,,,,,,,0,0,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,124.31,115.65,S295,EEEEEEDDEKEKEDNSSEEEEEIEPFPEERE,_EKEDNS(ph)S(ph)EEEEEIEPFPEER_,-0.25, , , ,0.32, ,0.09,-0.12,-0.24, , , ,0.13, ,-0.1,0.02,-0.25,,0.32,-0.01,-0.24,,0.13,-0.04,,,,,,,NA,NA,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,124.31,115.65,S296,EEEEEDDEKEKEDNSSEEEEEIEPFPEEREN,_EKEDNS(ph)S(ph)EEEEEIEPFPEER_,-0.25, , , ,0.32,-0.12,-0.09,0.08,-0.24, , , ,0.13,0,-0.1,0.12,-0.25,,0.12,0,-0.24,,0.07,0.01,,,,,,,NA,NA,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,76.1,75.1,T1022,RKAEFPSSGSNSVLNTPPTTPESPSSVTVTE,_AEFPSSGSNSVLNT(ph)PPTT(ph)PES(ph)PSSVTVTEGSR_, , , , ,0.15,0.46, , , , , , ,0.08,0.47, , ,,,0.32,,,,0.29,,,,,,,,NA,NA,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,76.1,75.1,T1026,FPSSGSNSVLNTPPTTPESPSSVTVTEGSRQ,_AEFPSSGSNSVLNT(ph)PPTT(ph)PES(ph)PSSVTVTEGSR_, , , , ,0.15,0.46, , , , , , ,0.08,0.47, , ,,,0.32,,,,0.29,,,,,,,,NA,NA,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
Q4LE39-3,Q4LE39,AT-rich interactive domain-containing protein 4B,ARID4B,262.59,232.62,T793,SPERLRKDIEVLSEDTDYEEDEVTKKRKDVK,_DIEVLS(ph)EDT(ph)DYEEDEVTK_,0.07,-0.2,-0.31,-0.06,0,-0.16,0.08,0.06,0.24,0.09,-0.07,0.02,0.12,0.1,0.16,0.06,-0.06,-0.18,-0.08,0.07,0.17,-0.03,0.11,0.11,,,,,,,0,0,,cytoplasm,DNA binding,"regulation of transcription, DNA-dependent",,
F5GYV5,Q66PJ3,ADP-ribosylation factor-like protein 6-interacting protein 4,ARL6IP4,269.85,251.67,S332,QVEALPGPSLDQWHRSAGEEEDGPVLTDEQK,_S(ph)AGEEEDGPVLTDEQK_,0.15,-0.07,0.07,0.16,0.23,0.19,0,0.03,-0.24,-0.18,-0.02,0.12,0.34,0.27,0.15,0.04,0.04,0.12,0.21,0.01,-0.21,0.05,0.3,0.1,,,,,,,0,0,,,,,,
Q8N6S5,Q8N6S5,ADP-ribosylation factor-like protein 6-interacting protein 6,ARL6IP6,69.08,68.05,S60,EEGCDQVARDLRAEFSAGAWSEPRKRSVLPP,_AEFS(ph)AGAWS(ph)EPR_, , , , ,-0.61,-0.71, ,-0.29, , , , ,-0.83,-0.34, ,-0.2,,,-0.66,-0.29,,,-0.57,-0.2,,,,,,,NA,NA,,integral to membrane,,,,
Q8N6S5,Q8N6S5,ADP-ribosylation factor-like protein 6-interacting protein 6,ARL6IP6,69.08,68.05,S65,QVARDLRAEFSAGAWSEPRKRSVLPPDGNGS,_AEFS(ph)AGAWS(ph)EPR_, , , , ,-0.61,-0.71, ,-0.29, , , , ,-0.83,-0.34, ,-0.2,,,-0.66,-0.29,,,-0.57,-0.2,,,,,,,NA,NA,,integral to membrane,,,,
Q9UH62,Q9UH62,Armadillo repeat-containing X-linked protein 3,ARMCX3,62.87,62.87,S110,RARATRARRAVQKRASPNSDDTVLSPQELQK,_RAS(ph)PNSDDTVLSPQELQK_,0.29, ,0.18, , , , , ,0.31, ,1.18, , , , , ,0.29,0.18,,,0.31,1.18,,,, +,,,,,NA,NA,,integral to mitochondrial outer membrane,,cellular protein localization,,
Q9UH62,Q9UH62,Armadillo repeat-containing X-linked protein 3,ARMCX3,267.21,242.71,S61,VDDAGDCSGARYNDWSDDDDDSNESKSIVWY,_YNDWS(ph)DDDDDS(ph)NESK_,-0.01,0.1,0.1,0.01,0.28,0.27,0.42,0.37,0.18,0.1,0.25,0.28,0.23,0.17,0.25,0.24,0.05,0.05,0.28,0.4,0.14,0.26,0.2,0.24,,,,,,,0,0,,integral to mitochondrial outer membrane,,cellular protein localization,,
Q9UH62,Q9UH62,Armadillo repeat-containing X-linked protein 3,ARMCX3,133.48,133.48,S67,CSGARYNDWSDDDDDSNESKSIVWYPPWARI,_YNDWS(ph)DDDDDS(ph)NESK_, , , , , ,0.62,0.62,0.53, , , , , ,0.46,0.43,0.41,,,0.62,0.58,,,0.46,0.42,,,,,,,NA,NA,,integral to mitochondrial outer membrane,,cellular protein localization,,
P56211,P56211,cAMP-regulated phosphoprotein 19,ARPP19,115.24,86.61,S23,AASAEEQKEMEDKVTSPEKAEEAKLKARYPH,_EMEDKVTS(ph)PEK_, , ,-0.39, , , , , , , ,0.35, , , , , ,,-0.39,,,,0.35,,,,,,,,,NA,NA,,cytoplasm,phosphatase inhibitor activity,cell division,,
O43150-2,O43150,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2",ASAP2,222.59,212.22,S701,HVEYEWRLLHEDLDESDDDMDEKLQPSPNRR,_LLHEDLDES(ph)DDDMDEK_,-0.17,-0.19,-0.32,-0.35,-0.02,0.14,0.14,0.07,-0.01,0.06,0,0,0.14,0.12,0.3,0.31,-0.18,-0.34,0.06,0.1,0.03,0,0.13,0.31,,,,,,,0,0,,Golgi cisterna membrane,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9UBL3,Q9UBL3,Set1/Ash2 histone methyltransferase complex subunit ASH2,ASH2L,107.18,100.89,S101,EGAGDTSEVMDTQAGSVDEENGRQLGEVELQ,_DTLEGAGDTSEVMDTQAGS(ph)VDEENGR_, , , , ,0.13,-0.31, ,-0.84, , , , ,-0.21,-0.34, ,-0.58,,,-0.07,-0.84,,,-0.27,-0.58,,,,,,,NA,NA,,Set1C/COMPASS complex,metal ion binding,hemopoiesis,,
E7ER97,O95671,N-acetylserotonin O-methyltransferase-like protein,ASMTL,238.6,234.8,S239,VKHDSIPAADTFEDLSDVEGGGSEPTQRDAG,_HDSIPAADTFEDLS(ph)DVEGGGSEPTQR_,0.21,0.17,0.38,0.36,0.21,-0.47,0.25, ,0.03,0.14,0.16,0.14,-0.16,-0.52,0, ,0.19,0.37,-0.09,0.25,0.09,0.15,-0.33,0,,,,,,,0,0,,cytoplasm,O-methyltransferase activity,,,
Q5T6L6,P00966,Argininosuccinate synthase,ASS1,44.63,36.54,S189,TPKNPWSMDENLMHISYEAGILENP______,_NPWSM(ox)DENLMHIS(ph)YEAGILENP_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,argininosuccinate synthase activity,arginine biosynthetic process,,
P17544-4,P17544,Cyclic AMP-dependent transcription factor ATF-7,ATF7,169.06,164.44,T112,EKKAAAGPLDMSLPSTPDIKIKEEEPVEVDS,_AAAGPLDMS(ph)LPST(ph)PDIK_, , ,1.26, , ,-0.32,-0.69,-1.1, , ,1.64, , ,-0.78,-1,-1.65,,1.26,-0.32,-0.88,,1.64,-0.78,-1.29, +, +,,,,,NA,NA,,cytoplasm,mitogen-activated protein kinase binding,"transcription, DNA-dependent",,
P17544-4,P17544,Cyclic AMP-dependent transcription factor ATF-7,ATF7,163.68,139.61,S108,ADEDEKKAAAGPLDMSLPSTPDIKIKEEEPV,_AAAGPLDMS(ph)LPST(ph)PDIK_, , , , , ,-0.32,-0.69,-1.1, , , , , ,-0.78,-1,-1.65,,,-0.32,-0.88,,,-0.78,-1.29,, +,,,,,NA,NA,,cytoplasm,mitogen-activated protein kinase binding,"transcription, DNA-dependent",,
A8MV73,Q6VMQ6,Activating transcription factor 7-interacting protein 1,ATF7IP,117.03,110.42,S496,QESSESLPKEAFLVLSDEEDISGEKDESEVI,_EAFLVLS(ph)DEEDISGEK_, , , , ,-0.16,-0.29,-0.1,-0.48, , , , ,0,-0.26,-0.01,-0.19,,,-0.23,-0.28,,,-0.13,-0.1,,,,,,,NA,NA,,transcription factor complex,ATPase activity,negative regulation of transcription from RNA polymerase II promoter,,
A8MV73,Q6VMQ6,Activating transcription factor 7-interacting protein 1,ATF7IP,99.64,98.62,S57,KLLNGNHENGDLDPTSPLENMDYIKDKEEVN,_LLNGNHENGDLDPTS(ph)PLENMDYIK_,-0.18,-0.03,0.13, ,0.14,0.05, , ,-0.05,-0.06,-0.19, ,0.3,0.29, , ,-0.1,0.13,0.09,,-0.06,-0.19,0.3,,,,,,,,NA,NA,,transcription factor complex,ATPase activity,negative regulation of transcription from RNA polymerase II promoter,,
Q96BY7,Q96BY7,Autophagy-related protein 2 homolog B,ATG2B,92.24,74.3,S497,HPTPLQKTSLPSRSVSVDESRPELIFRLAVG,_SVS(ph)VDESRPELIFR_, , ,2.66,0.14, , , , , , ,2.76,1.35, , , , ,,1.89,,,,2.22,,, +, +,,,,,NA,NA,,lipid particle,,autophagy,,
Q9Y4P1,Q9Y4P1,Cysteine protease ATG4B,ATG4B,276.51,247.7,S383,SLDSSDVERLERFFDSEDEDFEILSL_____,_FFDS(ph)EDEDFEILSL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,cysteine-type peptidase activity,autophagic vacuole assembly,,
Q7Z3C6,Q7Z3C6,Autophagy-related protein 9A,ATG9A,70.55,53.89,Y8,________MAQFDTEYQRLEASYSDSPPGEE,_(ac)AQFDTEY(ph)QR_, , ,3.94, , , , , , , ,1.31, , , , , ,,3.94,,,,1.31,,, +, +,,,,,NA,NA,,autophagic vacuole membrane,,autophagic vacuole assembly,,
Q7Z3C6,Q7Z3C6,Autophagy-related protein 9A,ATG9A,155.74,150.88,S14,__MAQFDTEYQRLEASYSDSPPGEEDLLVHV,_LEAS(ph)YSDS(ph)PPGEEDLLVHVAEGSK_, , , , ,-0.08, , ,-2.25, , , , ,-0.37, , ,-1.2,,,-0.08,-2.25,,,-0.37,-1.2, +, +,,,,,NA,NA,,autophagic vacuole membrane,,autophagic vacuole assembly,,
Q7Z3C6,Q7Z3C6,Autophagy-related protein 9A,ATG9A,155.74,150.88,S18,QFDTEYQRLEASYSDSPPGEEDLLVHVAEGS,_LEAS(ph)YSDS(ph)PPGEEDLLVHVAEGSK_, , , , ,-0.08, , ,-2.25, , , , ,-0.37, , ,-1.2,,,-0.08,-2.25,,,-0.37,-1.2, +, +,,,,,NA,NA,,autophagic vacuole membrane,,autophagic vacuole assembly,,
Q7Z3C6,Q7Z3C6,Autophagy-related protein 9A,ATG9A,45.88,45.68,S828,GQSASRHPEPVPEEGSEDELPPQVHKV____,_HPEPVPEEGS(ph)EDELPPQVHKV_, , ,-0.87, , , , , , , ,0.09, , , , , ,,-0.87,,,,0.09,,,,,,,,,NA,NA,,autophagic vacuole membrane,,autophagic vacuole assembly,,
P54259,P54259,Atrophin-1,ATN1,173.73,164.87,S77,ASTPKVNKQGRSEEISESESEETNAPKKTKT,_SEEIS(ph)ES(ph)ESEETNAPK_, , , , ,0.24,0.29,0.28,0.46, , , , ,0.23,0.24,0.22,0.25,,,0.27,0.38,,,0.23,0.24,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,173.73,164.87,S79,TPKVNKQGRSEEISESESEETNAPKKTKTEQ,_SEEIS(ph)ES(ph)ESEETNAPK_, , , , ,0.24,0.29,0.28,0.46, , , , ,0.23,0.24,0.22,0.25,,,0.27,0.38,,,0.23,0.24,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,136.8,134.3,S101,APKKTKTEQELPRPQSPSDLDSLDGRSLNDD,_TEQELPRPQS(ph)PS(ph)DLDS(ph)LDGR_, , , , ,0,-0.21,0.02,-0.14, , , , ,-0.19,-0.05,-0.08,0,,,-0.1,-0.06,,,-0.12,-0.04,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,95.89,95.89,S103,KKTKTEQELPRPQSPSDLDSLDGRSLNDDGS,_TEQELPRPQS(ph)PS(ph)DLDS(ph)LDGR_, , , , , ,-0.22, , , , , , , ,0.16, , ,,,-0.22,,,,0.16,,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,136.8,134.3,S107,TEQELPRPQSPSDLDSLDGRSLNDDGSSDPR,_TEQELPRPQS(ph)PS(ph)DLDS(ph)LDGR_, , , , ,0,-0.21,0.02,-0.14, , , , ,-0.19,-0.05,-0.08,0,,,-0.1,-0.06,,,-0.12,-0.04,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,63.76,63.76,S739,TQIKQEPAEEYETPESPVPPARSPSPPPKVV,_QEPAEEYETPES(ph)PVPPARS(ph)PS(ph)PPPK_, , , , ,0.32, , ,0.26, , , , ,0.08, , ,-0.07,,,0.32,0.26,,,0.08,-0.07,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,63.76,63.76,S746,AEEYETPESPVPPARSPSPPPKVVDVPSHAS,_QEPAEEYETPES(ph)PVPPARS(ph)PS(ph)PPPK_, , , , ,0.32, , ,0.26, , , , ,0.08, , ,-0.07,,,0.32,0.26,,,0.08,-0.07,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
P54259,P54259,Atrophin-1,ATN1,63.76,63.76,S748,EYETPESPVPPARSPSPPPKVVDVPSHASQS,_QEPAEEYETPES(ph)PVPPARS(ph)PS(ph)PPPK_, , , , ,0.32, , ,0.26, , , , ,0.08, , ,-0.07,,,0.32,0.26,,,0.08,-0.07,,,,,,,NA,NA,,cell junction,transcription corepressor activity,cell migration,,
Q8NB49,Q8NB49,Probable phospholipid-transporting ATPase IG,ATP11C,144.73,143.73,S445,DGHKYKGVTQEVDGLSQTDGTLTYFDKVDKN,_GVTQEVDGLS(ph)QTDGTLTYFDK_,-0.33,-0.5,-0.24,-0.43, ,-0.72,0.1,0.18,-0.04,-0.36,0.01,0.02, ,0.08,0.26,0.09,-0.41,-0.33,-0.72,0.14,-0.19,0.01,0.08,0.17,,,,,,,0,0,,endoplasmic reticulum,ATP binding,ion transmembrane transport,,
Q8NB49,Q8NB49,Probable phospholipid-transporting ATPase IG,ATP11C,152.04,152.04,S1126,LSARPSVRPLLLRTFSDESNVL_________,_TFS(ph)DESNVL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endoplasmic reticulum,ATP binding,ion transmembrane transport,,
Q8NB49,Q8NB49,Probable phospholipid-transporting ATPase IG,ATP11C,99.75,82.28,S1129,RPSVRPLLLRTFSDESNVL____________,_TFS(ph)DES(ph)NVL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endoplasmic reticulum,ATP binding,ion transmembrane transport,,
Q9H7F0-2,Q9H7F0,Probable cation-transporting ATPase 13A3,ATP13A3,122.08,116.58,S817,SAIDPEAIPVKLVHDSLEDLQMTRYHFAMNG,_LVHDS(ph)LEDLQMTR_,0.69,0.4,0.05,0.39, , , , ,-0.14,-0.12,-0.26,-0.21, , , , ,0.55,0.23,,,-0.13,-0.24,,,,,,,,,NA,NA,,integral to membrane,ATP binding,ATP catabolic process,,
P16615-5,P16615,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,ATP2A2,155.09,153.65,S663,TSKAFTGREFDELNPSAQRDACLNARCFARV,_EFDELNPS(ph)AQR_,0.6,0.42,0.56,0.44,0.16,0.22,0.25,0.26,0.28,0.13,0.21,0.41,0.67,0.81,0.71,0.49,0.51,0.5,0.19,0.26,0.21,0.31,0.74,0.6,,,,,,,0,0,,integral to plasma membrane,ATP binding,blood coagulation,,
H0YHH6,P20020,Plasma membrane calcium-transporting ATPase 1,ATP2B1,229.56,226.99,S1193,SIHNFMTHPEFRIEDSEPHIPLIDDTDAEDD,_IEDS(ph)EPHIPLIDDT(ph)DAEDDAPTK_,0.01,0.16,-0.19,-0.01,-0.09,-0.29,-0.07,0.02,0.06,0.12,-0.09,-0.11,-0.18,-0.29,0.01,-0.06,0.08,-0.1,-0.19,-0.03,0.09,-0.1,-0.24,-0.02,,,,,,,0,0,,,calcium-transporting ATPase activity,,,
H0YHH6,P20020,Plasma membrane calcium-transporting ATPase 1,ATP2B1,203.53,202.8,T1203,FRIEDSEPHIPLIDDTDAEDDAPTKRNSSPP,_IEDS(ph)EPHIPLIDDT(ph)DAEDDAPTK_, , , , ,0.1,0.05,0.26,0.44, , , , ,-0.16,-0.24,0.16,0.07,,,0.07,0.35,,,-0.2,0.12,,,,,,,NA,NA,,,calcium-transporting ATPase activity,,,
Q59HD1,Q04656,Copper-transporting ATPase 1,ATP7A,79.36,79.25,S357,LYRVSITSEVESTSNSPSSSSLQKIPLNVVS,_VSITSEVESTSNS(ph)PSSSSLQK_, , ,0.27, , ,-0.01,0.15,0.26, , ,0.84, , ,-0.14,0.11,0.2,,0.27,-0.01,0.2,,0.84,-0.14,0.15,,,,,,,NA,NA,,,copper ion binding,copper ion transport,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,60.32,51.83,S890,SSDDAERKQERETFSSAEGTVDKDTTIMELR,_ETFS(ph)S(ph)AEGTVDK_, , , , ,-1.05,-1.16, , , , , , ,-1.23,-1.4, , ,,,-1.1,,,,-1.31,, +, +,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,186.06,180.84,S1990,NNPSVSLKLEESKATSSSNPSSPAPDWYKDF,_ATS(ph)SSNPSS(ph)PAPDWYK_,-0.6,-0.01, , , , , ,0.25,0.04,-0.01, , , , , ,-0.05,-0.27,,,0.25,0.01,,,-0.05,,,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,199.29,178.73,S1992,PSVSLKLEESKATSSSNPSSPAPDWYKDFVT,_ATSSS(ph)NPSS(ph)PAPDWYK_,0.18,-0.08, , , , , , ,0.09,-0.02, , , , , , ,0.06,,,,0.04,,,,,,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,199.29,178.73,S1996,LKLEESKATSSSNPSSPAPDWYKDFVTDADA,_ATS(ph)SSNPSS(ph)PAPDWYK_,0.18,-0.08, ,-0.24,0.24,0.23,0.28,0.24,0.09,-0.02, ,0.02,-0.05,-0.03,0.11,0.02,0.06,-0.24,0.23,0.26,0.04,0.02,-0.04,0.07,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,149.63,123.81,S594,TAKVTKELYVKLTPVSLSNSPIKGADCQEVP,_LTPVS(ph)LSNS(ph)PIK_,-0.01,-0.09,-0.75,-0.78,-0.39,-0.38,-0.21,-0.4,0.05,-0.02,-0.42,-0.46,-0.7,-0.61,-0.55,-0.64,-0.05,-0.76,-0.38,-0.3,0.02,-0.44,-0.65,-0.59,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,152.17,117.05,S598,TKELYVKLTPVSLSNSPIKGADCQEVPQDKD,_LTPVSLSNS(ph)PIK_,0.05,0.15,0.08,0.17,0.36,0.28,0.43,0.41,-0.19,-0.15,-0.01,-0.06,0.39,0.24,0.31,0.36,0.1,0.12,0.32,0.42,-0.17,-0.03,0.32,0.34,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,159.41,137.36,S889,GSSDDAERKQERETFSSAEGTVDKDTTIMEL,_ETFS(ph)SAEGTVDK_,0.45,0.37,0.26,0.29,0.27,0.05,-0.09, ,0.19,0.18,0.25,0.08,-0.05,0.11,0.1, ,0.41,0.27,0.16,-0.09,0.18,0.17,0.03,0.1,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,251.11,235.12,S1348,KPRYRHRLLRHKLTVSDGESGEEKKTKPKEH,_LTVS(ph)DGES(ph)GEEK_,0.1,-0.4,-0.29,-0.2,0.32,0.34,0.32,0.69,-0.45,-0.24,-0.45,-0.01,0.29,0.19,0.18,0.06,-0.13,-0.24,0.33,0.52,-0.34,-0.21,0.24,0.12,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,251.11,235.12,S1352,RHRLLRHKLTVSDGESGEEKKTKPKEHKEVK,_LTVS(ph)DGES(ph)GEEKK_,0.09,0.06,-0.1,-0.11,0.32,0.34,0.32,0.45,0.32,0.31,0.02,0.05,0.29,0.19,0.18,0.29,0.07,-0.1,0.33,0.39,0.32,0.04,0.24,0.24,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,132.81,132.81,S1061,SKKIRDKTSKKKDELSDYAEKSTGKGDSCDS,_KKDELS(ph)DYAEK_,0.42,0.03,0.28,0.03,-2.11,0.73,0.64,0.27,0.3,0.08,0.29,-0.11,-2.14,0.72,0.42,-0.03,0.24,0.16,-0.08,0.47,0.19,0.1,-0.1,0.21,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,98.11,97.65,S25,KLNTLVQKLHDFLAHSSEESEETSSPPRLAM,_LHDFLAHS(ph)S(ph)EES(ph)EETS(ph)SPPR_, , , , , ,0.07,-0.14,0.06, , , , , ,0,-0.08,-0.06,,,0.07,-0.04,,,0,-0.07,,,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,98.11,97.65,S26,LNTLVQKLHDFLAHSSEESEETSSPPRLAMN,_LHDFLAHS(ph)S(ph)EES(ph)EETS(ph)SPPR_, , , , , ,0.07,-0.14,0.06, , , , , ,0,-0.08,-0.06,,,0.07,-0.04,,,0,-0.07,,,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,98.11,97.65,S29,LVQKLHDFLAHSSEESEETSSPPRLAMNQNT,_LHDFLAHS(ph)S(ph)EES(ph)EETS(ph)SPPR_, , , , , ,0.07,-0.14,0.06, , , , , ,0,-0.08,-0.06,,,0.07,-0.04,,,0,-0.07,,,,RING finger,,,NA,NA,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,266.31,237.21,S729,NKLPKSKQSETVDQNSDSDEMLAILKEVSRM,_(gl)QSETVDQNS(ph)DS(ph)DEM(ox)LAILK_,-0.03,0.1,0.1, ,0.01,-0.5,0.18,1.31,0.31,0.09,0.09, ,0,-0.01,0.12,0.76,0.04,0.1,-0.22,0.85,0.21,0.09,-0.01,0.48,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,266.31,237.21,S731,LPKSKQSETVDQNSDSDEMLAILKEVSRMSH,_(gl)QSETVDQNS(ph)DS(ph)DEM(ox)LAILK_,-0.03,0.1,0.1, ,0.01,0.07,0.15,0.05,0.31,0.09,0.09, ,0,0.05,-0.01,0.01,0.04,0.1,0.04,0.1,0.21,0.09,0.02,0,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,161.84,161.84,S92,SRSKRKPSIVTKYVESDDEKPLDDETVNEDA,_YVES(ph)DDEKPLDDETVNEDAS(ph)NENS(ph)ENDITMQSLPK_,-0.29,-0.59,-0.3, ,0.17,0.07,-0.11,-0.06,-0.29,-0.15,-0.11, ,-0.25,0.28,-0.28,-0.2,-0.43,-0.3,0.12,-0.08,-0.22,-0.11,0.04,-0.24,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,161.84,161.84,S108,DDEKPLDDETVNEDASNENSENDITMQSLPK,_YVES(ph)DDEKPLDDETVNEDAS(ph)NENS(ph)ENDITMQSLPK_,-0.34,-0.23,-0.83, ,0.17,0.07,-0.11,-0.06,0.33,0.14,-0.35, ,-0.25,0.28,-0.28,-0.2,-0.28,-0.83,0.12,-0.08,0.24,-0.35,0.04,-0.24,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
P46100-4,P46100,Transcriptional regulator ATRX,ATRX,161.84,161.84,S112,PLDDETVNEDASNENSENDITMQSLPKEDGL,_YVES(ph)DDEKPLDDETVNEDAS(ph)NENS(ph)ENDITMQSLPK_,-0.34,-0.23,-0.83, ,0.17,0.07,-0.11,-0.06,0.33,0.14,-0.35, ,-0.25,0.28,-0.28,-0.2,-0.28,-0.83,0.12,-0.08,0.24,-0.35,0.04,-0.24,,,,RING finger,,,0,0,,nuclear heterochromatin,ATP binding,DNA methylation,,
Q9UBB4-2,Q9UBB4,Ataxin-10,ATXN10,60.06,58.8,S430,TQWVIYAIRNLTEDNSQNQDLIAKMEEQGLA,_NLTEDNS(ph)QNQDLIAK_, , , , , ,-0.15, ,-0.26, , , , , ,-0.09, ,-0.12,,,-0.15,-0.26,,,-0.09,-0.12,,,,,,,NA,NA,,cytosol,,cell death,,
H0YH87,Q99700,Ataxin-2,ATXN2,97.77,97.08,S861,ENSSSNCTSGSSKPNSPSISPSILSNTEHKR,_PNS(ph)PSIS(ph)PSILSNTEHK_, , , , ,0.62,0.01,0.09,0.01, , , , ,0.4,0.1,-0.07,0.21,,,0.34,0.05,,,0.26,0.08,,,,,,,NA,NA,,cytoplasm,,,,
H0YH87,Q99700,Ataxin-2,ATXN2,97.77,97.08,S865,SNCTSGSSKPNSPSISPSILSNTEHKRGPEV,_PNS(ph)PSIS(ph)PSILSNTEHK_, , , , ,0.62,0.01,0.09,0.06, , , , ,0.4,0.1,-0.07,0.34,,,0.34,0.08,,,0.26,0.15,,,,,,,NA,NA,,cytoplasm,,,,
H0YH87,Q99700,Ataxin-2,ATXN2,138.05,138.05,S772,NSPAGNKENIKPNETSPSFSKAENKGISPVV,_ENIKPNETS(ph)PSFSK_,0.32,0.22,0.33,0.3,0.26, ,0.01,0.13,0.02,-0.09,0.12,-0.07,0.31, ,0,0.12,0.27,0.31,0.26,0.07,-0.03,0.03,0.31,0.06,,,,,,,0,0,,cytoplasm,,,,
H0YH87,Q99700,Ataxin-2,ATXN2,95.95,95.95,T771,QNSPAGNKENIKPNETSPSFSKAENKGISPV,_ENIKPNET(ph)SPSFSK_, , ,0.28, , , , , , , ,-0.1, , , , , ,,0.28,,,,-0.1,,,,,,,,,NA,NA,,cytoplasm,,,,
Q8WWM7-6,Q8WWM7,Ataxin-2-like protein,ATXN2L,291.57,287.93,S111,IGSARGQSTGKGPPQSPVFEGVYNNSRMLHF,_GPPQS(ph)PVFEGVYNNSR_,0.09,0.04,0.92,0.82,0.98,1.1,1.36,0.99,0.04,0.23,0.77,0.68,1.01,0.94,1.36,1.21,0.07,0.87,1.04,1.19,0.14,0.73,0.97,1.28, +, +,,,,,1,2,40.87,cytoplasmic stress granule,,regulation of cytoplasmic mRNA processing body assembly,,
Q8WWM7-6,Q8WWM7,Ataxin-2-like protein,ATXN2L,298.47,250.57,S594,KEKEVDGLLTSEPMGSPVSSKTESVSDKEDK,_EVDGLLTSEPMGS(ph)PVSSK_,0.12,0.06,0.09,0.19,0.02,0.03,0.13,0.07,-0.01,-0.03,-0.01,-0.02,0.12,0.03,0.1,0.18,0.09,0.14,0.03,0.1,-0.02,-0.01,0.08,0.14,,,,,,,0,0,,cytoplasmic stress granule,,regulation of cytoplasmic mRNA processing body assembly,,
Q8WWM7-6,Q8WWM7,Ataxin-2-like protein,ATXN2L,139.59,117.92,S559,ELRKFGAQFKLQPSSSPENSLDPFPPRILKE,_LQPSSS(ph)PENSLDPFPPR_,0.12,0.11,0.03,-0.02,-0.35,-0.15,-0.13,-0.04,-0.09,-0.16,-0.18,-0.19,-0.11,-0.14,-0.39,-0.09,0.12,0,-0.25,-0.08,-0.13,-0.18,-0.13,-0.23,,,,,,,0,0,,cytoplasmic stress granule,,regulation of cytoplasmic mRNA processing body assembly,,
Q8WWM7-6,Q8WWM7,Ataxin-2-like protein,ATXN2L,89.17,89.17,S449,SVPPPPAVGRMYPPRSPKSAAPAPISASCPE,_MYPPRS(ph)PK_,0.24,0.16,0.92, ,0.46,0.68,0.68,0.68,0.17,0.25,0.85, ,0.49,0.63,0.37,0.84,0.2,0.92,0.57,0.68,0.21,0.85,0.56,0.62,,,,,,,0,0,,cytoplasmic stress granule,,regulation of cytoplasmic mRNA processing body assembly,,
Q8WWM7-6,Q8WWM7,Ataxin-2-like protein,ATXN2L,130.02,103.31,S339,EEKHSAVQRQGSGRESPSLASREGKYIPLPQ,_QGSGRES(ph)PSLASR_,0.19, , , ,-0.08,-0.4, ,-0.12,-0.03, , , ,-0.33,-0.33, ,-0.18,0.19,,-0.23,-0.12,-0.03,,-0.33,-0.18,,,,,,,NA,NA,,cytoplasmic stress granule,,regulation of cytoplasmic mRNA processing body assembly,,
Q14CW9,Q14CW9,Ataxin-7-like protein 3,ATXN7L3,54.05,48.6,S129,RIANRRIANSNNMNKSESDQEDNDDINDNDW,_S(ph)ES(ph)DQEDNDDINDNDWSYGSEK_, , , , , ,-0.23,-0.11, , , , , , ,-0.03,-0.16, ,,,-0.23,-0.11,,,-0.03,-0.16,,,,,,,NA,NA,,SAGA complex,ligand-dependent nuclear receptor transcription coactivator activity,histone deubiquitination,,
Q14CW9,Q14CW9,Ataxin-7-like protein 3,ATXN7L3,54.05,48.6,S131,ANRRIANSNNMNKSESDQEDNDDINDNDWSY,_S(ph)ES(ph)DQEDNDDINDNDWSYGSEK_, , , , , ,-0.23,-0.11, , , , , , ,-0.03,-0.16, ,,,-0.23,-0.11,,,-0.03,-0.16,,,,,,,NA,NA,,SAGA complex,ligand-dependent nuclear receptor transcription coactivator activity,histone deubiquitination,,
Q14CW9,Q14CW9,Ataxin-7-like protein 3,ATXN7L3,146.25,126.58,S281,QALISRLQWDGSSDLSPSDSGSSKTSENQGW,_LQWDGSSDLS(ph)PSDSGSSK_, ,-0.08, , , , , , , ,-0.07, , , , , , ,-0.08,,,,-0.07,,,,,,,,,,NA,NA,,SAGA complex,ligand-dependent nuclear receptor transcription coactivator activity,histone deubiquitination,,
Q9NQS1,Q9NQS1,Cell death regulator Aven,AVEN,143.24,143.24,S94,PGGWGAGASAPVEDDSDAETYGEENDEQGNY,_REPGGWGAGASAPVEDDS(ph)DAETYGEENDEQGNYSK_, , , , ,-0.09,0.25,-0.07,0.05, , , , ,-0.04,-0.18,-0.12,-0.11,,,0.09,-0.01,,,-0.11,-0.12,,,,,,,NA,NA,,endomembrane system,,apoptotic process,,
P30530-2,P30530,Tyrosine-protein kinase receptor UFO,AXL,80.44,57.12,Y702,CVADFGLSKKIYNGDYYRQGRIAKMPVKWIA,_IYNGDY(ph)YR_,-0.64, ,-0.1, , , ,-0.76,-0.66,-0.62, ,-0.22, , , ,-0.3,-0.43,-0.64,-0.1,,-0.71,-0.62,-0.22,,-0.36,,,Tyr,,,,NA,NA,,cell surface,ATP binding,apoptotic cell clearance,,
O75752,O75752,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1",B3GALNT1,40.97,38.87,Y293,KVNIHIPEDTNLFFLYRIHLDVCQLRRVIAA,_VNIHIPEDT(ph)NLFFLY(ph)R_, , ,2.96, , , , , , , ,3.09, , , , , ,,2.96,,,,3.09,,, +, +,,,,,NA,NA,,Golgi membrane,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,oligosaccharide biosynthetic process,,
Q9NWV8-3,Q9NWV8,BRISC and BRCA1-A complex member 1,BABAM1,240.41,240.41,S8,________MEVAEPSSPTEEEEEEEEHSAEP,_(ac)M(ox)EVAEPSS(ph)PTEEEEEEEEHSAEPRPR_,0.1,0.1,0.03,0.13,0.36,0.24,0.16,0.22,-0.18,-0.04,0.03,0.09,-0.01,0.01,-0.02,0.09,0.1,0.08,0.3,0.19,-0.11,0.06,0,0.04,,,,,,,0,0,,BRCA1-A complex,,chromatin modification,,
F5GY71,Q92934,Bcl2 antagonist of cell death,BAD,178.23,175.66,S75,HHGGAGAVEIRSRHSSYPAGTEDDEGMGEEP,_HSS(ph)YPAGTEDDEGMGEEPSPFR_,0.24,0.32,1.23, , , , , ,0.62,0.46,1.26, , , , , ,0.28,1.23,,,0.54,1.26,,, +, +,,,,,NA,NA,,,,,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,157.26,145.34,S377,VEVKVPPAPVPCPPPSPGPSAVPSSPKSVAT,_VPPAPVPCPPPS(ph)PGPSAVPS(ph)SPK_, , ,-0.33, ,1.02,1.14,1.26,0.5, , ,0.52, ,1.13,1.09,1.24,0.77,,-0.33,1.08,0.93,,0.52,1.11,1.02, +, +,,,,,NA,NA,,cytosol,,brain development,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,135.69,134.25,S289,SSREGSPARSSTPLHSPSPIRVHTVVDRPQQ,_SST(ph)PLHS(ph)PSPIR_, ,-1.2, , ,-0.01,-0.01,0.09,0.25, ,-0.06, , ,-0.22,-0.41,-0.03,0.12,-1.2,,-0.01,0.17,-0.06,,-0.31,0.05, +,,,,,,NA,NA,,cytosol,,brain development,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,135.69,134.25,T285,VQGASSREGSPARSSTPLHSPSPIRVHTVVD,_SST(ph)PLHS(ph)PSPIR_, ,-1.2, , ,-0.01,-0.2,0.24,0.27, ,-0.06, , ,-0.22,-0.36,0.03,0.16,-1.2,,-0.1,0.25,-0.06,,-0.29,0.1, +,,,,,,NA,NA,,cytosol,,brain development,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,63.58,63.42,S173,AAAQPPASHGPERSQSPAASDCSSSSSSASL,_SQS(ph)PAASDCSSSSSSASLPSSGR_, , , , , , , ,-0.61, , , , , , , ,-0.47,,,,-0.61,,,,-0.47,,,,,,,NA,NA,,cytosol,,brain development,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,114.53,114.53,S275,LRAASPFRSSVQGASSREGSPARSSTPLHSP,_SSVQGASS(ph)REGS(ph)PAR_, , , , ,-0.08,-0.4,-0.12,0.13, , , , ,-0.31,-0.57,-0.45,-0.23,,,-0.23,0.01,,,-0.43,-0.34,,,,,,,NA,NA,,cytosol,,brain development,,
O95817,O95817,BAG family molecular chaperone regulator 3,BAG3,114.53,114.53,S279,SPFRSSVQGASSREGSPARSSTPLHSPSPIR,_SSVQGASS(ph)REGS(ph)PAR_, , , , ,-0.23,-0.4,-0.08,-0.08, , , , ,-0.38,-0.57,-0.49,-0.31,,,-0.31,-0.08,,,-0.47,-0.39,,,,,,,NA,NA,,cytosol,,brain development,,
B4DWA1,Q9UQB8,Brain-specific angiogenesis inhibitor 1-associated protein 2,BAIAP2,65.04,35.5,S454,GSDRLHMSLQQGKSSSTGNLLDKDDLAIPPP,_SSS(ph)TGNLLDK_, , , , ,-1.33,-1.25, , , , , , ,-1.88,-1.64, , ,,,-1.29,,,,-1.76,, +, +,,,,,NA,NA,,cell junction,ferric-chelate reductase activity,filopodium assembly,,
B4DWA1,Q9UQB8,Brain-specific angiogenesis inhibitor 1-associated protein 2,BAIAP2,59.8,49.09,S366,NSYATTENKTLPRSSSMAAGLERNGRMRVKA,_SSS(ph)MAAGLER_, , , , ,0.37, , ,0.78, , , , ,-0.76, , ,0.12,,,0.37,0.78,,,-0.76,0.12,,,,,,,NA,NA,,cell junction,ferric-chelate reductase activity,filopodium assembly,,
Q9UHR4,Q9UHR4,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,BAIAP2L1,254.27,252.69,S261,IKTPASTPVSGTPQASPMIERSNVVRKDYDT,_TPASTPVSGT(ph)PQAS(ph)PMIER_, , , , ,0.5,0.3,0.49,0.54, , , , ,0.34,1.54,0.24,0.5,,,0.4,0.52,,,1.06,0.38,, +,,,,,NA,NA,,cell junction,proline-rich region binding,filopodium assembly,,
Q9UHR4,Q9UHR4,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,BAIAP2L1,173.35,167.68,S255,MNMIEEIKTPASTPVSGTPQASPMIERSNVV,_TPASTPVS(ph)GTPQAS(ph)PMIER_, , , , , ,0.61,-0.44,0.45, , , , , ,0.18,0.48,0.5,,,0.61,0.07,,,0.18,0.49,,,,,,,NA,NA,,cell junction,proline-rich region binding,filopodium assembly,,
Q9UHR4,Q9UHR4,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,BAIAP2L1,174.73,174.28,T248,IKVPEKIMNMIEEIKTPASTPVSGTPQASPM,_IMNMIEEIKT(ph)PAST(ph)PVSGT(ph)PQAS(ph)PMIER_, , , , ,-0.67,-0.32,-0.5,-0.21, , , , ,-0.35,-1.03,-0.41,0.06,,,-0.48,-0.35,,,-0.65,-0.16,,,,,,,NA,NA,,cell junction,proline-rich region binding,filopodium assembly,,
Q9UHR4,Q9UHR4,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,BAIAP2L1,174.73,174.28,T252,EKIMNMIEEIKTPASTPVSGTPQASPMIERS,_IMNMIEEIKT(ph)PAST(ph)PVSGT(ph)PQAS(ph)PMIER_, , , , ,-0.5,-0.32,-0.43,-0.18, , , , ,-0.5,-1.03,-0.55,-0.52,,,-0.4,-0.3,,,-0.74,-0.53,,,,,,,NA,NA,,cell junction,proline-rich region binding,filopodium assembly,,
Q9UHR4,Q9UHR4,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,BAIAP2L1,254.27,252.69,T257,MIEEIKTPASTPVSGTPQASPMIERSNVVRK,_TPASTPVSGT(ph)PQAS(ph)PMIER_, , , , ,0.5,0.39,0.49,0.63, , , , ,0.34,0.16,0.24,0.5,,,0.44,0.57,,,0.25,0.38,,,,,,,NA,NA,,cell junction,proline-rich region binding,filopodium assembly,,
E9PB29,Q8IXM2,Chromatin complexes subunit BAP18,BAP18,97.95,95.8,S96,KRKVYEDSGIPLPAESPKKGPKKVASGVLSP,_VYEDSGIPLPAES(ph)PKK_, ,-0.16,-0.26,-0.16, , , , , ,0.05,0.09,0.15, , , , ,-0.16,-0.21,,,0.05,0.12,,,,,,,,,NA,NA,,,,,,
P80723,P80723,Brain acid soluble protein 1,BASP1,249.29,219.21,T36,EKDKKAEGAATEEEGTPKESEPQAAAEPAEA,_KAEGAATEEEGT(ph)PK_,0.3,0.46,0.31,0.28,0.38,0.29,0.18,0.22,0.4,0.43,0.38,0.27,0.28,-0.21,0.17,0.25,0.38,0.3,0.33,0.2,0.41,0.33,0.05,0.21,,,,,,,0,0,,cytoplasm,transcription corepressor activity,diaphragm development,,
P46379-2,P46379,Large proline-rich protein BAG6,BAT3,117.94,117.94,S964,PLPEEPMEVQGAERASPEPQRENASPAPGTT,_AS(ph)PEPQRENAS(ph)PAPGTTAEEAMSR_,0.58,0.09,0.02,-0.02,-0.24,-0.02,-0.4,-0.21,-0.08,-0.08,-0.24,-0.36,-0.14,-0.26,-0.37,-0.3,0.36,0,-0.13,-0.3,-0.08,-0.3,-0.2,-0.33,,,,,,,0,0,,BAT3 complex,polyubiquitin binding,brain development,,
P46379-2,P46379,Large proline-rich protein BAG6,BAT3,141.41,134.35,S973,QGAERASPEPQRENASPAPGTTAEEAMSRGP,_ENAS(ph)PAPGTTAEEAMSR_,-0.11,0.1,0.06,0.13,-0.12,-0.2,-0.22,-0.11,-0.42,-0.11,-0.12,-0.23,-0.1,-0.05,-0.24,-0.14,0,0.09,-0.16,-0.16,-0.26,-0.18,-0.07,-0.19,,,,,,,0,0,,BAT3 complex,polyubiquitin binding,brain development,,
Q9NRL2,Q9NRL2,Bromodomain adjacent to zinc finger domain protein 1A,BAZ1A,132.72,131.27,T731,ESKDTEQKELDQDMVTEDEDDPGSHKRGRRG,_ELDQDMVT(ph)EDEDDPGSHK_,-0.1,-0.05,-0.32,-0.39,-0.3,-0.35, , ,0.03,0.16,-0.15,-0.21,-0.29,-0.41, , ,-0.08,-0.35,-0.33,,0.1,-0.18,-0.35,,,,,,,,NA,NA,,ACF complex,zinc ion binding,chromatin remodeling,,
Q9UIG0-2,Q9UIG0,Tyrosine-protein kinase BAZ1B,BAZ1B,179.7,177.26,S1468,KRKKFPDRLAEDEGDSEPEAVGQSRGRRQKK,_LAEDEGDS(ph)EPEAVGQSR_, , , , ,-0.73, ,-1.19,-0.87, , , , ,-0.45, ,-0.6,-0.63,,,-0.73,-1.02,,,-0.45,-0.62, +,,,,,,NA,NA,,centromeric heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,131.4,130.87,Y249,YDIPRHLLAPGPQDIYDVPPVRGLLPSQYGQ,_HLLAPGPQDIY(ph)DVPPVR_,-1.51, ,-0.62, ,2.72,0.41,0.1,0.15,-1.02, ,0.06, ,0.62,0.47,0.39,0.57,-1.51,-0.62,1.98,0.13,-1.02,0.06,0.55,0.48, +, +,,,,,2,2,12.92,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,126.91,126.55,Y234,GQGYVYEAAQPEQDEYDIPRHLLAPGPQDIY,_VGQGYVYEAAQPEQDEY(ph)DIPR_,-1.41, ,-0.92, ,0.14,0.2,0.04,0.05,-0.69, ,-0.14, ,0.35,0.26,0.49,0.36,-1.41,-0.92,0.17,0.05,-0.69,-0.14,0.3,0.43, +,,,,,,3,0,16.52,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,73.29,73.2,Y128,SVYLVPTPSKAQQGLYQVPGPSPQFQSPPAK,_AQQGLY(ph)QVPGPSPQFQSPPAK_,-0.58, , , ,0.44,0.51,0.25,0.42,-0.2, , , ,0.34,0.72,0.77,0.71,-0.58,,0.48,0.34,-0.2,,0.55,0.74,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,68.41,68.31,Y306,PSVEKGLPPSNHHAVYDVPPSVSKDVPDGPL,_GLPPSNHHAVY(ph)DVPPSVSK_,-0.83, ,-0.46, ,0.21, , ,0.22,-0.15, ,0.06, ,0.07, , ,0.64,-0.83,-0.46,0.21,0.22,-0.15,0.06,0.07,0.64,,,,,,,0,0,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,94.63,94.63,Y327,VSKDVPDGPLLREETYDVPPAFAKAKPFDPA,_DVPDGPLLREETY(ph)DVPPAFAK_, , ,-0.84, , , ,0.02,0, , ,-0.22, , , ,-0.15,0.29,,-0.84,,0.01,,-0.22,,0.09,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,102.98,97.77,Y267,PPVRGLLPSQYGQEVYDTPPMAVKGPNGRDP,_GLLPSQYGQEVY(ph)DTPPMAVK_, , ,-0.41, ,0.16,0.24,0.43,0.29, , ,0.47, ,0.4,0.42,0.44,0.62,,-0.41,0.2,0.36,,0.47,0.41,0.53,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,61.35,61.35,Y287,MAVKGPNGRDPLLEVYDVPPSVEKGLPPSNH,_GPNGRDPLLEVY(ph)DVPPSVEK_,-0.5, , , ,0.48,0.5,0.7,0.52,-0.27, , , ,0.2,0.6,0.51,0.4,-0.5,,0.49,0.61,-0.27,,0.42,0.45,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,189.3,189.3,Y387,YDVPPGLRRPGPGTLYDVPRERVLPPEVADG,_RPGPGTLY(ph)DVPR_,-0.13,0.14,-0.3, ,0.29,0.47,0.12,0.05,-0.64,-0.57,-0.36, ,0.52,0.56,0.3,0.29,0.01,-0.3,0.38,0.08,-0.61,-0.36,0.54,0.3,,,,,,,0,0,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,78.27,76.7,Y410,LPPEVADGGVVDSGVYAVPPPAEREAPAEGK,_VLPPEVADGGVVDSGVY(ph)AVPPPAER_,-0.97, , , ,0.02, ,-0.05,0.07,-0.3, , , ,0.27, ,0.15,0.42,-0.97,,0.02,0.01,-0.3,,0.27,0.29,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
F5H855,P56945,Breast cancer anti-estrogen resistance protein 1,BCAR1,87.35,87.35,T326,SVSKDVPDGPLLREETYDVPPAFAKAKPFDP,_DVPDGPLLREET(ph)YDVPPAFAK_, , , , ,0.02,0.16,-0.11, , , , , ,0.27,0.34,0.35, ,,,0.09,-0.11,,,0.3,0.35,,,,,,,NA,NA,,lamellipodium,cysteine-type endopeptidase activity,G-protein coupled receptor signaling pathway,,
O75815,O75815,Breast cancer anti-estrogen resistance protein 3,BCAR3,67.17,17.96,Y212,QHFKINRTVLRLSEAYSRVQYQFEMESFDSI,_LSEAY(ph)SR_, , ,1.45, , , , , , , ,0.91, , , , , ,,1.45,,,,0.91,,, +,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,response to drug,,
O75815,O75815,Breast cancer anti-estrogen resistance protein 3,BCAR3,200.07,199.43,S83,SHMGTLPHSKSPRQNSPVTQDGIQESPWQDR,_QNS(ph)PVTQDGIQESPWQDR_,-0.11,0.11,0.9,0.76,0.69,0.57,0.71,0.43,-0.08,0.35,0.54,0.47,1.07,0.95,1.23,0.89,0.01,0.83,0.63,0.58,0.15,0.5,1.01,1.07,, +,,,,,0,2,13.63,intracellular,guanyl-nucleotide exchange factor activity,response to drug,,
O75815,O75815,Breast cancer anti-estrogen resistance protein 3,BCAR3,67.3,67.3,Y117,TFTFRDPHLLDPTVEYVKFSKERHIMDRTPE,_HGETFTFRDPHLLDPTVEY(ph)VK_,-0.55, , , ,0.32,0.47,0.52,0.37,0.51, , , ,0.67,0.64,0.61,0.63,-0.55,,0.4,0.45,0.51,,0.66,0.62,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,response to drug,,
Q9P287,Q9P287,BRCA2 and CDKN1A-interacting protein,BCCIP,185.85,182.5,S42,EEEKEVENEDEDDDDSDKEKDEEDEVIDEEV,_EVENEDEDDDDS(ph)DKEK_, , , , , ,-0.05,-0.11,-0.07, , , , , ,-0.23,-0.02,-0.03,,,-0.05,-0.09,,,-0.23,-0.03,,,,,,,NA,NA,,nuclear cyclin-dependent protein kinase holoenzyme complex,kinase regulator activity,cell cycle,,
P12694,P12694,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial",BCKDHA,273.44,258.17,S337,QPFLIEAMTYRIGHHSTSDDSSAYRSVDEVN,_IGHHS(ph)TSDDSSAYR_,0.96,-0.44,-0.6, ,0,0.13,0.12,0.16,-0.17,-0.14,-0.19, ,-0.11,0.04,0.16,0.06,0.43,-0.6,0.07,0.14,-0.16,-0.19,-0.03,0.12,,,,,,,0,0,,mitochondrial alpha-ketoglutarate dehydrogenase complex,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,branched-chain amino acid catabolic process,,
P12694,P12694,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial",BCKDHA,122.9,122.9,S347,RIGHHSTSDDSSAYRSVDEVNYWDKQDHPIS,_S(ph)VDEVNYWDK_,0.55,0.55,0.3,0.2,0.05,0.13,-0.14,0.06,0.43,0.56,0.24,0.21,0.13,0.08,0.02,0.14,0.55,0.25,0.09,-0.04,0.5,0.22,0.1,0.08,,,,,,,0,0,,mitochondrial alpha-ketoglutarate dehydrogenase complex,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,branched-chain amino acid catabolic process,,
Q3SY13,Q9HB09,Bcl-2-like protein 12,BCL2L12,194.48,194.48,S242,KLASDPALRSKLVRLSSDSFARLVELFCSRD,_LVRLS(ph)SDSFAR_,-0.18,0.02,-0.36,-0.26,-0.57,-0.91, , ,-0.1,-0.1,-0.13,-0.31,-0.31,-0.35, , ,-0.08,-0.31,-0.73,,-0.1,-0.22,-0.33,,,,,,,,NA,NA,,,,,,
Q9BQE9-2,Q9BQE9,B-cell CLL/lymphoma 7 protein family member B,BCL7B,188.66,178.86,S112,VSDVYQLKVDSSTNSSPSPQQSESLSPAHTS,_VDSSTNSS(ph)PSPQQSESLS(ph)PAHTSDFR_, ,-0.08, , ,-0.05, , , , ,-0.23, , ,0.21, , , ,-0.08,,-0.05,,-0.23,,0.21,,,,,,,,NA,NA,,,actin binding,,,
Q9BQE9-2,Q9BQE9,B-cell CLL/lymphoma 7 protein family member B,BCL7B,188.66,178.86,S122,SSTNSSPSPQQSESLSPAHTSDFRTDDSQPP,_VDSSTNSSPS(ph)PQQSESLS(ph)PAHTSDFR_, ,-0.08,-0.2, , , , , , ,-0.23,-0.37, , , , , ,-0.08,-0.2,,,-0.23,-0.37,,,,,,,,,NA,NA,,,actin binding,,,
Q8WUZ0,Q8WUZ0,B-cell CLL/lymphoma 7 protein family member C,BCL7C,104.61,104.2,S114,QSFHSEGSLQKGTEPSPGGTPQPSRPVSPAG,_GTEPS(ph)PGGT(ph)PQPSRPVS(ph)PAGPPEGVPEEAQPPR_,0.03,-0.36,-0.43, ,-0.49,0.36,-0.22,-0.77,-0.15,-0.35,-0.14, ,-1,0.35,-0.11,-0.81,-0.15,-0.43,-0.01,-0.47,-0.25,-0.14,-0.17,-0.42,,,,,,,0,0,,,,apoptotic process,,
Q8WUZ0,Q8WUZ0,B-cell CLL/lymphoma 7 protein family member C,BCL7C,104.61,104.2,S126,TEPSPGGTPQPSRPVSPAGPPEGVPEEAQPP,_GTEPS(ph)PGGT(ph)PQPSRPVS(ph)PAGPPEGVPEEAQPPR_,0.03,-0.36,-0.43, ,-0.49,0.36,-0.22, ,-0.15,-0.35,-0.14, ,-1,0.35,-0.11, ,-0.15,-0.43,-0.01,-0.22,-0.25,-0.14,-0.17,-0.11,,,,,,,0,0,,,,apoptotic process,,
Q8WUZ0,Q8WUZ0,B-cell CLL/lymphoma 7 protein family member C,BCL7C,104.61,104.2,T118,SEGSLQKGTEPSPGGTPQPSRPVSPAGPPEG,_GTEPS(ph)PGGT(ph)PQPSRPVS(ph)PAGPPEGVPEEAQPPR_,0.03,-0.36,-0.43, ,-0.49, ,-0.22,-0.77,-0.15,-0.35,-0.14, ,-1, ,-0.11,-0.81,-0.15,-0.43,-0.49,-0.47,-0.25,-0.14,-1,-0.42,,,,,,,0,0,,,,apoptotic process,,
O00512,O00512,B-cell CLL/lymphoma 9 protein,BCL9,142.45,111.38,S687,GNNPIFPRIPVEGPLSPSRGDFPKGIPPQMG,_IPVEGPLS(ph)PSR_,0.2,0.08,0.37,-0.18, , , , ,-0.15,-0.08,0.04,-0.07, , , , ,0.14,0.12,,,-0.11,-0.02,,,,,,,,,NA,NA,,cytoplasm,,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,200.76,197.45,S942,PGMGHLKSPTLSQVHSPLVTSPSANLKSPQT,_S(ph)PTLSQVHS(ph)PLVTS(ph)PSANLK_, , , , ,1.38,1.24,1.33,1.22, , , , ,1.18,0.99,0.91,1.03,,,1.31,1.27,,,1.09,0.97, +, +,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,200.76,197.45,S947,LKSPTLSQVHSPLVTSPSANLKSPQTPSQMV,_SPT(ph)LSQVHS(ph)PLVTS(ph)PSANLK_, , ,0.72, ,1.19,1.16,1.45,1.33, , ,0.39, ,1.4,1.53,1.01,1.45,,0.72,1.18,1.39,,0.39,1.46,1.25, +, +,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,200.76,197.45,T936,INQMGSPGMGHLKSPTLSQVHSPLVTSPSAN,_SPT(ph)LSQVHS(ph)PLVTS(ph)PSANLK_, , ,0.72, ,1.26,1.06,1.79,1.33, , ,0.39, ,1.43,1.27,1.43,1.45,,0.72,1.16,1.58,,0.39,1.36,1.44, +, +,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,180.21,178.8,S975,QMVPLPSANPPGPLKSPQVLGSSLSVRSPTG,_S(ph)PQVLGSSLSVRS(ph)PTGS(ph)PSR_,-0.27,-0.28,0.91,1.06,0.22,0.38,1,0.67,-0.03,0.1,1.37,1.24,0.37,0.48,0.49,0.56,-0.27,0.98,0.31,0.85,0.03,1.3,0.43,0.53,, +,,,,,0,4,19.3,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,89.5,74.53,S21,NKTRLPHPRRREAPGSPPLSPRGHCPPAPAK,_EAPGS(ph)PPLS(ph)PR_, , , , , ,0.47,0.78,0.96, , , , , ,0.41,0.13,0.33,,,0.47,0.87,,,0.41,0.24,,,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,89.5,74.53,S25,LPHPRRREAPGSPPLSPRGHCPPAPAKPMHP,_EAPGS(ph)PPLS(ph)PR_, , , , , ,0.47,0.78,0.96, , , , , ,0.41,0.13,0.33,,,0.47,0.87,,,0.41,0.24,,,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,180.21,178.8,S987,PLKSPQVLGSSLSVRSPTGSPSRLKSPSMAV,_S(ph)PQVLGSSLSVRS(ph)PTGS(ph)PSR_, , , , ,0.25,0.38,0.27,0.22, , , , ,0.41,0.48,0.5,0.43,,,0.32,0.25,,,0.45,0.47,,,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,180.21,178.8,S991,PQVLGSSLSVRSPTGSPSRLKSPSMAVPSPG,_S(ph)PQVLGSSLSVRS(ph)PTGS(ph)PSR_, , , , ,0.25,0.38,0.27,0.22, , , , ,0.41,0.48,0.5,0.43,,,0.32,0.25,,,0.45,0.47,,,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,95.68,92.6,S997,SLSVRSPTGSPSRLKSPSMAVPSPGWVASPK,_S(ph)PSMAVPSPGWVAS(ph)PK_, , , , ,0.06,-0.01,0.15,1.09, , , , ,0.01,-0.44,-0.21,-0.14,,,0.03,0.7,,,-0.2,-0.17,,,,,,,NA,NA,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,95.68,92.6,S1004,TGSPSRLKSPSMAVPSPGWVASPKTAMPSPG,_S(ph)PSMAVPS(ph)PGWVAS(ph)PK_,-0.63,-0.53,0.02,-0.54,-0.44,-0.01,0.15,1.13,0.01,0.11,0.75,0.62,-0.58,-0.44,-0.21,-0.13,-0.58,-0.24,-0.21,0.72,0.06,0.68,-0.51,-0.17,,,,,,,0,0,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q86UU0-3,Q86UU0,B-cell CLL/lymphoma 9-like protein,BCL9L,95.68,92.6,S1010,LKSPSMAVPSPGWVASPKTAMPSPGVSQNKQ,_S(ph)PSMAVPS(ph)PGWVAS(ph)PK_,-0.63,-0.53,0.02,-0.54,0.06,-0.01,0.15,1.13,0.01,0.11,0.75,0.62,0.01,-0.44,-0.21,-0.13,-0.58,-0.24,0.03,0.72,0.06,0.68,-0.2,-0.17,,,,,,,0,0,,nucleus,beta-catenin binding,canonical Wnt receptor signaling pathway,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,147.9,143.26,S268,SAKNTPSQHSHSIQHSPERSGSGSVGNGSSR,_NTPSQHSHSIQHS(ph)PER_,-0.38,-0.37,-0.43,-0.19,-0.11,-0.33,-0.3,1.69,-0.36,-0.41,-0.51,-0.47,0.02,0.18,-0.29,1.9,-0.38,-0.31,-0.22,1.01,-0.39,-0.49,0.1,1.19, +, +,,,,,2,2,31.65,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,94.4,94.4,S648,TSYQKATEEHSTRQKSPEIHRRIDISPSTLR,_(gl)QKS(ph)PEIHRR_,-0.3,-0.18, , , ,-0.15, , ,0,-0.01, , , ,-0.07, , ,-0.24,,-0.15,,-0.01,,-0.07,,,,,,,,NA,NA,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,278.79,277.1,S385,RAEGEWEDQEALDYFSDKESGKQKFNDSEGD,_AEGEWEDQEALDYFS(ph)DKES(ph)GK_,0.09,-0.43,0.46,-0.13,-0.16,-0.1,-0.15,-0.11,0.3,-0.14,0.44,-0.34,-0.03,0.09,0.02,-0.1,-0.15,0.2,-0.13,-0.13,0.1,0.1,0.03,-0.04,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,181.59,181.59,S389,EWEDQEALDYFSDKESGKQKFNDSEGDDTEE,_AEGEWEDQEALDYFS(ph)DKES(ph)GK_, , , , ,-0.39,-0.29,-0.45,-0.33, , , , ,-0.39,-0.33,-0.35,-0.22,,,-0.34,-0.39,,,-0.36,-0.28,,,,,,,NA,NA,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,153,134.07,S512,PEQVKSEKLKDLFDYSPPLHKNLDAREKSTF,_DLFDYS(ph)PPLHK_,-0.32,-0.32,-0.32,-0.3,-0.13,-0.16,-0.27,-0.32,-0.24,-0.25,-0.26,-0.25,-0.06,-0.13,-0.18,-0.18,-0.32,-0.31,-0.14,-0.29,-0.24,-0.26,-0.1,-0.18,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,365.2,364.37,S397,DYFSDKESGKQKFNDSEGDDTEETEDYRQFR,_QKFNDS(ph)EGDDTEETEDYR_,-0.43,-0.39,-0.45,-0.36,-0.28,-0.34,-0.47,-0.39,-0.32,-0.28,-0.33,-0.36,-0.2,-0.26,-0.37,-0.28,-0.41,-0.4,-0.31,-0.43,-0.3,-0.34,-0.23,-0.33,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,194.48,122.39,S658,STRQKSPEIHRRIDISPSTLRKHTRLAGEER,_IDIS(ph)PSTLR_,-0.29,-0.28,-0.29,-0.29,-0.24,-0.14,-0.35,-0.35,-0.23,-0.21,-0.25,-0.28,-0.21,-0.12,-0.24,-0.18,-0.28,-0.29,-0.19,-0.35,-0.22,-0.26,-0.17,-0.21,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,310.47,310.47,T402,KESGKQKFNDSEGDDTEETEDYRQFRKSVLA,_FNDS(ph)EGDDT(ph)EETEDYR_,-0.57,-0.38,-0.42,-0.36,-0.52,-0.4,-0.7,-0.64,-0.3,-0.22,-0.13,-0.27,-0.28,-0.3,-0.54,-0.6,-0.47,-0.39,-0.46,-0.67,-0.26,-0.2,-0.29,-0.57,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,288.58,288.58,S177,QEKQTKKAEGEPQEESPLKSKSQEEPKDTFE,_KAEGEPQEES(ph)PLK_,-0.27,-0.22,-0.31,-0.25,-0.19,-0.13,-0.11,-0.19,-0.11,-0.15,-0.18,-0.15,0.05,0,-0.01,-0.17,-0.24,-0.28,-0.16,-0.15,-0.13,-0.16,0.03,-0.09,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,235.21,233.35,S198,SQEEPKDTFEHDPSESIDEFNKSSATSGDIW,_DTFEHDPSES(ph)IDEFNK_,-0.45,-0.27,-0.27,0.11,-0.32,-0.43,-0.46,-0.3,-0.23,-0.39,-0.05,0.05,-0.05,-0.39,-0.1,-0.12,-0.35,-0.07,-0.38,-0.38,-0.31,0,-0.21,-0.11,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,167.05,167.05,S531,HKNLDAREKSTFREESPLRIKMIASDSHRPE,_STFREES(ph)PLRIK_,-0.31,-0.4,-0.28,-0.4,-0.31,-0.33,-0.36,-0.4,-0.2,-0.33,-0.34,-0.44,-0.49,-0.31,-0.34,-0.38,-0.35,-0.34,-0.32,-0.38,-0.26,-0.39,-0.4,-0.36,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,101.43,100.96,S222,ATSGDIWPGLSAYDNSPRSPHSPSPIATPPS,_SSAT(ph)S(ph)GDIWPGLSAYDNS(ph)PR_,-0.5,-0.4,-0.6,-0.64,-0.84,-0.23,-0.74,-0.64,-0.24,-0.15,-0.34,-0.38,-0.19,-0.18,-0.19,-0.21,-0.45,-0.62,-0.5,-0.69,-0.2,-0.36,-0.18,-0.2,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,143.21,141.21,T257,CSDAPMLSTVHSAKNTPSQHSHSIQHSPERS,_NT(ph)PSQHSHSIQHS(ph)PER_,-0.27, ,0.15, ,-0.26,-0.36,-0.1,-0.57,-0.08, ,-0.03, ,-0.37,-0.29,-0.31,-0.38,-0.27,0.15,-0.31,-0.32,-0.08,-0.03,-0.33,-0.34,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,79.93,79.03,S285,ERSGSGSVGNGSSRYSPSQNSPIHHIPSRRS,_YS(ph)PSQNS(ph)PIHHIPSR_,-0.01,-0.37, ,0.25,-0.26,0.08,-0.31,-0.42,-0.12,-0.9, ,-0.29,-0.45,-0.06,-0.59,-0.57,-0.18,0.25,-0.08,-0.36,-0.46,-0.29,-0.24,-0.58,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q9NYF8-2,Q9NYF8,Bcl-2-associated transcription factor 1,BCLAF1,79.93,79.03,S290,GSVGNGSSRYSPSQNSPIHHIPSRRSPAKTI,_YS(ph)PSQNS(ph)PIHHIPSR_,-0.01,-0.42, ,0.25,-0.45,-0.51,-0.43,-0.42,-0.12,-0.37, ,-0.29,-0.49,-0.46,-0.38,-0.57,-0.2,0.25,-0.48,-0.43,-0.24,-0.29,-0.47,-0.48,,,,,,,0,0,,cytoplasm,DNA binding,induction of apoptosis,,
Q6W2J9-4,Q6W2J9,BCL-6 corepressor,BCOR,62.09,49.05,S423,GHARKTAVQDRKDGSSPPLLEKQTVTKDVTD,_DGSS(ph)PPLLEK_, , , , , ,0.08,-0.06,0.46, , , , , ,-0.23,-0.06,0.19,,,0.08,0.22,,,-0.23,0.07,,,,,,,NA,NA,,nucleus,heat shock protein binding,heart development,,
Q9Y276,Q9Y276,Mitochondrial chaperone BCS1,BCS1L,92.26,92.26,Y181,TVMYTAVGSEWRPFGYPRRRRPLNSVVLQQG,_TVMYTAVGSEWRPFGY(ph)PR_,-0.35, ,-0.2, ,-0.27,-0.42,-0.14,-0.27,-0.8, ,-0.43, ,-0.09,-0.07,-0.1,-0.18,-0.35,-0.2,-0.34,-0.21,-0.8,-0.43,-0.08,-0.14,,,,,,,0,0,,integral to membrane,ATP binding,mitochondrial respiratory chain complex I assembly,,
G3V3R5,Q9BUH8,Brain-enriched guanylate kinase-associated protein,BEGAIN,141.34,123.01,S502,LAEPCFLRAGGDLSLSPGRSADPLPGYAPSE,_AGGDLS(ph)LS(ph)PGR_,-0.01,-0.27,-1.21, ,-0.49,0.15,-0.36,0.15,-0.3,-0.34,-1.19, ,-0.36,0.04,-0.24,0.25,-0.14,-1.21,-0.14,-0.08,-0.32,-1.19,-0.15,0.03, +, +,,,,,3,3,26.93,dendrite,kinase activity,,,
G3V3R5,Q9BUH8,Brain-enriched guanylate kinase-associated protein,BEGAIN,62.73,62.73,S246,TALYCPEERRRDRRPSVDAPVTDVGFLRAQN,_DRRPS(ph)VDAPVTDVGFLR_, , , ,1.06, , , , , , , ,0.91, , , , ,,1.06,,,,0.91,,, +,,,,,,NA,NA,,dendrite,kinase activity,,,
G3V3R5,Q9BUH8,Brain-enriched guanylate kinase-associated protein,BEGAIN,113.65,95.67,S500,GHLAEPCFLRAGGDLSLSPGRSADPLPGYAP,_AGGDLS(ph)LS(ph)PGR_, , , , ,-0.73,0.15,-0.37, , , , , ,-0.1,0.04,-0.1, ,,,-0.23,-0.37,,,-0.02,-0.1,,,,,,,NA,NA,,dendrite,kinase activity,,,
Q5T5X7,Q5T5X7,BEN domain-containing protein 3,BEND3,153.39,108.11,S379,DPGHFLDNKDQEEALSLDRSSTIASDHVVDT,_DQEEALS(ph)LDR_, , , , ,-0.2,0.21, , , , , , ,-0.42,-0.17, , ,,,0.02,,,,-0.29,,,,,,,,NA,NA,,,,,,
O00499-9,O00499,Myc box-dependent-interacting protein 1,BIN1,99.07,98.49,T307,KGNKSPSPPDGSPAATPEIRVNHEPEPAGGA,_SPSPPDGS(ph)PAAT(ph)PEIR_, , , , ,-1.4, , , , , , , ,-1.53, , , ,,,-1.4,,,,-1.53,, +, +,,,,,NA,NA,,actin cytoskeleton,,cell proliferation,,
O00499-9,O00499,Myc box-dependent-interacting protein 1,BIN1,174.26,174.26,S296,VKAQPSDNAPAKGNKSPSPPDGSPAATPEIR,_GNKS(ph)PS(ph)PPDGS(ph)PAATPEIR_,0.47,0.38,0.27, ,-0.92,-0.44,-0.18,-0.07,0.05,-0.05,-0.02, ,0.66,0,-0.31,-0.25,0.42,0.27,-0.66,-0.12,0,-0.02,0.37,-0.28,,,,,,,0,0,,actin cytoskeleton,,cell proliferation,,
O00499-9,O00499,Myc box-dependent-interacting protein 1,BIN1,257.77,257.77,S298,AQPSDNAPAKGNKSPSPPDGSPAATPEIRVN,_GNKS(ph)PS(ph)PPDGS(ph)PAATPEIR_,-0.24,-0.21,-0.32,-0.25,-0.14,0.08,0,0,-0.09,-0.06,-0.06,-0.08,-0.12,-0.17,0.05,0.02,-0.23,-0.29,-0.03,0,-0.08,-0.07,-0.14,0.03,,,,,,,0,0,,actin cytoskeleton,,cell proliferation,,
O00499-9,O00499,Myc box-dependent-interacting protein 1,BIN1,257.77,257.77,S303,NAPAKGNKSPSPPDGSPAATPEIRVNHEPEP,_SPS(ph)PPDGS(ph)PAATPEIR_,-0.07,0,-0.31,-0.16,-0.38,-0.19,0,-0.17,-0.08,-0.05,0.01,0.19,-0.29,-0.38,-0.2,-0.3,-0.04,-0.24,-0.28,-0.08,-0.07,0.1,-0.33,-0.25,,,,,,,0,0,,actin cytoskeleton,,cell proliferation,,
Q9NR09,Q9NR09,Baculoviral IAP repeat-containing protein 6,BIRC6,96.29,95.68,S473,EDSSSCSDIPKLEGDSDDLLEDSDSEEHSRS,_LEGDS(ph)DDLLEDS(ph)DSEEHSR_, , , , , ,-0.83,-0.33,0.18, , , , , ,-0.44,-0.23,-0.09,,,-0.83,-0.05,,,-0.44,-0.16,,,,,,,NA,NA,,endosome,cysteine-type endopeptidase inhibitor activity,apoptotic process,,
Q9NR09,Q9NR09,Baculoviral IAP repeat-containing protein 6,BIRC6,234.3,234.3,S480,DIPKLEGDSDDLLEDSDSEEHSRSDSVTGHT,_LEGDSDDLLEDS(ph)DSEEHSR_,-0.18,-0.02,0.11,-0.09,0.21,0.24,-0.04,-0.06,-0.1,0,0.17,-0.17,0.28,0.1,0.04,-0.04,-0.1,0.01,0.23,-0.05,-0.05,0.01,0.19,0,,,,,,,0,0,,endosome,cysteine-type endopeptidase inhibitor activity,apoptotic process,,
Q9NR09,Q9NR09,Baculoviral IAP repeat-containing protein 6,BIRC6,157.96,157.96,S482,PKLEGDSDDLLEDSDSEEHSRSDSVTGHTSQ,_LEGDSDDLLEDS(ph)DS(ph)EEHSR_, , , ,-0.01,0.06,-0.04,0.39,-0.25, , , ,-0.16,-0.25,0.04,0.22,-0.15,,-0.01,0.01,0.1,,-0.16,-0.1,0.04,,,,,,,NA,NA,,endosome,cysteine-type endopeptidase inhibitor activity,apoptotic process,,
Q9NR09,Q9NR09,Baculoviral IAP repeat-containing protein 6,BIRC6,72.16,69.72,S486,GDSDDLLEDSDSEEHSRSDSVTGHTSQKEAM,_LEGDSDDLLEDSDS(ph)EEHS(ph)R_, , , , , ,-0.04,0.47, , , , , , ,0.04,0.43, ,,,-0.04,0.47,,,0.04,0.43,,,,,,,NA,NA,,endosome,cysteine-type endopeptidase inhibitor activity,apoptotic process,,
Q6QNY0,Q6QNY0,Biogenesis of lysosome-related organelles complex 1 subunit 3,BLOC1S3,306.61,305.64,S65,RPTGLRVAGEAAETDSEPEPEPEPTAAPRDL,_VAGEAAET(ph)DS(ph)EPEPEPEPTAAPR_,0.16,0.12,0.13,0.17,0.04,-0.02,0.14,-0.03,0.08,0.12,0,0.02,0.15,0.02,0.06,0.04,0.14,0.15,0.01,0.06,0.1,0.01,0.08,0.05,,,,,,,0,0,,BLOC-1 complex,,anterograde axon cargo transport,,
Q6QNY0,Q6QNY0,Biogenesis of lysosome-related organelles complex 1 subunit 3,BLOC1S3,306.61,305.64,T63,RGRPTGLRVAGEAAETDSEPEPEPEPTAAPR,_VAGEAAET(ph)DS(ph)EPEPEPEPTAAPR_,0.16,0.12,0.13,0.17,0.04,-0.02,0.14,-0.03,0.08,0.12,0,0.02,0.15,0.02,0.06,0.04,0.14,0.15,0.01,0.06,0.1,0.01,0.08,0.05,,,,,,,0,0,,BLOC-1 complex,,anterograde axon cargo transport,,
Q5T8Z2,P35226,Polycomb complex protein BMI-1,BMI1,79.33,78.37,S251,ISHQRDGLTNAGELESDSGSDKANSPAGGIP,_DGLTNAGELES(ph)DS(ph)GS(ph)DK_, , , , , ,0.03, ,-0.13, , , , , ,0.48, ,-0.88,,,0.03,-0.13,,,0.48,-0.88,,,,RING finger,,,NA,NA,,,zinc ion binding,,,
Q5T8Z2,P35226,Polycomb complex protein BMI-1,BMI1,79.33,78.37,S253,HQRDGLTNAGELESDSGSDKANSPAGGIPST,_DGLTNAGELES(ph)DS(ph)GS(ph)DK_, , , , , ,0.03, ,-0.13, , , , , ,0.48, ,0.09,,,0.03,-0.13,,,0.48,0.09,,,,RING finger,,,NA,NA,,,zinc ion binding,,,
Q5T8Z2,P35226,Polycomb complex protein BMI-1,BMI1,79.33,78.37,S255,RDGLTNAGELESDSGSDKANSPAGGIPSTSS,_DGLTNAGELES(ph)DS(ph)GS(ph)DK_, , , , , ,0.03, ,-0.13, , , , , ,0.48, ,-0.88,,,0.03,-0.13,,,0.48,-0.88,,,,RING finger,,,NA,NA,,,zinc ion binding,,,
Q12982,Q12982,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,BNIP2,310.55,272.41,S114,DDLPKPKTTEVIRKGSITEYTAAEEKEDGRR,_KGS(ph)ITEYTAAEEK_,0.48,0.55,0.89,0.84,0.62,0.57,0.37,0.47,-0.13,-0.03,0.53,0.39,0.39,0.67,0.52,0.18,0.52,0.87,0.59,0.42,-0.08,0.46,0.54,0.36,,,,,,,0,0,,cytosol,calcium ion binding,apoptotic process,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,101.38,75.28,S1531,SVATSTEGKDKDVTLSPVKAGPATTTSSETR,_DVTLS(ph)PVK_,0.32,0.26,0.23,0.42,0.21,0.22,0.26,0.24,0.11,0.15,0.19,0.25,0.22,0.19,0.25,0.25,0.29,0.33,0.21,0.25,0.13,0.22,0.21,0.25,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,320.77,314.4,S2779,EERHMPKRKRKQHYLSSEDEPDDNPDVLDSR,_(gl)QHYLS(ph)S(ph)EDEPDDNPDVLDSR_, ,0.03,-0.61,0.12,-0.34,0.08,0.19,0.01, ,0.03,-0.39,0.47,-0.26,-0.21,-0.12,-0.06,0.03,-0.2,-0.11,0.1,0.03,0.1,-0.24,-0.09,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,320.77,314.4,S2780,ERHMPKRKRKQHYLSSEDEPDDNPDVLDSRI,_(gl)QHYLS(ph)S(ph)EDEPDDNPDVLDSR_, ,0.03,-0.61,0.12,-0.34,0.08,0.19,0.01, ,0.03,-0.39,0.47,-0.26,-0.21,-0.12,-0.06,0.03,-0.2,-0.11,0.1,0.03,0.1,-0.24,-0.09,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,306.2,306.2,S482,RHAYVHKPYLYSKYYSDSDDELTVEQRRQSI,_YYS(ph)DS(ph)DDELTVEQR_,0.03,0.11,0.19,-0.31,-0.09,-0.07,-0.04,-0.13,-0.32,-0.25,-0.58,-0.09,-0.17,-0.2,0.47,-0.19,0.07,-0.04,-0.08,-0.09,-0.28,-0.31,-0.19,0.18,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,306.2,306.2,S484,AYVHKPYLYSKYYSDSDDELTVEQRRQSIAK,_YYS(ph)DS(ph)DDELTVEQRR_,-0.16,-0.09,-0.23,-0.31,-0.09,-0.07,-0.06,-0.13,0.06,0.07,0.02,-0.09,-0.17,-0.2,-0.18,-0.19,-0.13,-0.27,-0.08,-0.1,0.06,-0.03,-0.19,-0.19,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,226.04,226.04,S2986,QKSVSDPVEDKKEQESDEEEEEEEEDEPSGA,_KEQES(ph)DEEEEEEEEDEPSGATTR_,-0.19,-0.06,-0.08,-0.23, ,0.07,0.03,0.02,-0.06,0.05,0.02,-0.09, ,-0.06,-0.09,0.01,-0.12,-0.16,0.07,0.02,0,-0.03,-0.06,-0.04,,,,,,,0,0,,,DNA binding,,,
Q8NFC6,Q8NFC6,Biorientation of chromosomes in cell division protein 1-like 1,BOD1L1,65.88,48.45,S3019,RSTTRSEAQRSKTQLSPSIKRKREVSPPGAR,_TQLS(ph)PSIK_,0.01, , , , , , , ,0.82, , , , , , , ,0.01,,,,0.82,,,,,,,,,,NA,NA,,,DNA binding,,,
E9PIF8,Q14137,Ribosome biogenesis protein BOP1,BOP1,289.97,281.62,S126,TEMASARIGDEYAEDSSDEEDIRNTVGNVPL,_IGDEYAEDS(ph)S(ph)DEEDIR_,-0.27,-0.25,-0.21,-0.2,-0.19,-0.17,-0.13,-0.1,-0.13,-0.13,-0.1,-0.09,-0.28,-0.31,-0.4,-0.34,-0.26,-0.2,-0.18,-0.12,-0.13,-0.09,-0.3,-0.37,,,,,,,0,0,,,,rRNA processing,,
E9PIF8,Q14137,Ribosome biogenesis protein BOP1,BOP1,289.97,281.62,S127,EMASARIGDEYAEDSSDEEDIRNTVGNVPLE,_IGDEYAEDS(ph)S(ph)DEEDIR_,-0.27,-0.25,-0.21,-0.2,-0.19,-0.17,-0.13,-0.1,-0.13,-0.13,-0.1,-0.09,-0.28,-0.31,-0.4,-0.34,-0.26,-0.2,-0.18,-0.12,-0.13,-0.09,-0.3,-0.37,,,,,,,0,0,,,,rRNA processing,,
E7EP70,P38398,Breast cancer type 1 susceptibility protein,BRCA1,222.28,222.28,S1336,SKQMRHQSESQGVGLSDKELVSDDEERGTGL,_HQSESQGVGLS(ph)DK_,0.07,0,-0.27, ,0.57,0.35,0.52, ,0.15,0.04,-0.02, ,0.98,0.31,0.26, ,0.03,-0.27,0.47,0.52,0.09,-0.02,0.68,0.26,,,,RING finger,,,0,0,,nucleus,DNA binding,DNA repair,,
E7EP70,P38398,Breast cancer type 1 susceptibility protein,BRCA1,72.91,72.76,S395,QKVNEWFSRSDELLGSDDSHDGESESNAKVA,_SDELLGS(ph)DDS(ph)HDGESESNAK_, , , , , , ,0.1,-0.28, , , , , , ,-0.14,-0.02,,,,-0.08,,,,-0.08,,,,RING finger,,,NA,NA,,nucleus,DNA binding,DNA repair,,
E7EP70,P38398,Breast cancer type 1 susceptibility protein,BRCA1,72.91,72.76,S398,NEWFSRSDELLGSDDSHDGESESNAKVADVL,_SDELLGS(ph)DDS(ph)HDGESESNAK_, , , , , , ,0.1,-0.24, , , , , , ,-0.14,0.19,,,,-0.06,,,,0.04,,,,RING finger,,,NA,NA,,nucleus,DNA binding,DNA repair,,
C9IYC8,O95696,Bromodomain-containing protein 1,BRD1,123.73,123.26,S1052,DRAMNHLSRVHGEPTSDLSDID_________,_VHGEPTS(ph)DLS(ph)DID_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
C9IYC8,O95696,Bromodomain-containing protein 1,BRD1,123.73,123.26,S1055,MNHLSRVHGEPTSDLSDID____________,_VHGEPTS(ph)DLS(ph)DID_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
P25440,P25440,Bromodomain-containing protein 2,BRD2,62.01,61.84,S298,ADTTTPTPTAILAPGSPASPPGSLEPKAARL,_ADTTTPTPTAILAPGS(ph)PAS(ph)PPGSLEPK_, , , , , ,0.16,0.32,0.02, , , , , ,0.23,0.07,0.09,,,0.16,0.18,,,0.23,0.08,,,,,,,NA,NA,,cytoplasm,chromatin binding,chromatin modification,,
P25440,P25440,Bromodomain-containing protein 2,BRD2,62.01,61.84,S301,TTPTPTAILAPGSPASPPGSLEPKAARLPPM,_ADTTTPTPTAILAPGS(ph)PAS(ph)PPGSLEPK_, , , , , ,0.16,0.32,0.02, , , , , ,0.23,0.07,0.09,,,0.16,0.18,,,0.23,0.08,,,,,,,NA,NA,,cytoplasm,chromatin binding,chromatin modification,,
P25440,P25440,Bromodomain-containing protein 2,BRD2,115,108.13,S633,KATKTAPPALPTGYDSEEEEESRPMSYDEKR,_TAPPALPTGYDS(ph)EEEEESRPMSYDEK_, , , , ,-0.3,0,-0.04, , , , , ,-0.26,-0.24,-0.09, ,,,-0.14,-0.04,,,-0.25,-0.09,,,,,,,NA,NA,,cytoplasm,chromatin binding,chromatin modification,,
Q15059,Q15059,Bromodomain-containing protein 3,BRD3,56.29,40.37,S263,TTTPTTSAITASRSESPPPLSDPKQAKVVAR,_SES(ph)PPPLSDPK_,-0.01,0.8,1.25,-0.23,0.08,0.26,-0.15,0.05,-0.23,0,0.41,-0.12,-0.13,-0.58,0.18,-0.06,0.45,0.69,0.17,-0.05,-0.11,0.16,-0.34,0.07,,,,,,,0,0,,nucleus,chromatin binding,chromatin modification,,
Q15059,Q15059,Bromodomain-containing protein 3,BRD3,131.5,128.57,S558,TTTAGRQLKKGGKQASASYDSEEEEEGLPMS,_QAS(ph)ASYDS(ph)EEEEEGLPMSYDEK_, ,-0.39, , ,0.35,-0.37,-0.21,0.17, ,-0.49, , ,0.39,-0.21,-0.16,0,-0.39,,0.03,-0.01,-0.49,,0.12,-0.08,,,,,,,NA,NA,,nucleus,chromatin binding,chromatin modification,,
Q15059,Q15059,Bromodomain-containing protein 3,BRD3,190.19,183.53,S563,RQLKKGGKQASASYDSEEEEEGLPMSYDEKR,_QASASYDS(ph)EEEEEGLPMSYDEK_, , ,-0.48,-0.39,-0.29,-0.3,-0.4,-0.16, , ,-0.23,-0.15,-0.22,-0.12,0.08,0.05,,-0.43,-0.29,-0.27,,-0.19,-0.17,0.07,,,,,,,NA,NA,,nucleus,chromatin binding,chromatin modification,,
O60885-2,O60885,Bromodomain-containing protein 4,BRD4,87.65,87.65,S601,KEPAPMKSKPPPTYESEEEDKCKPMSYEEKR,_SKPPPTYES(ph)EEEDK_, , , , ,0.03,-0.06,0.19, , , , , ,-0.27,-0.01,0.04, ,,,-0.02,0.19,,,-0.14,0.04,,,,,,,NA,NA,,condensed nuclear chromosome,DNA binding,chromosome segregation,,
Q9H0E9,Q9H0E9,Bromodomain-containing protein 8,BRD8,60.26,23.08,S1152,APGYKDVVKRPMDLTSLKRNLSKGRIRTMAQ,_PMDLT(ph)S(ph)LKR_, ,-9.38,-8.64,-9.37, , , , , ,0.37,0.15,0.18, , , , ,-9.38,-8.96,,,0.37,0.17,,, +,,,,,,NA,NA,,mitochondrion,thyroid hormone receptor activity,cell surface receptor signaling pathway,,
Q9H0E9-3,Q9H0E9,Bromodomain-containing protein 8,BRD8,105.51,98.96,S637,QIKDAPGEDEEEDGVSEAASLEEPKEEDQGE,_DAPGEDEEEDGVS(ph)EAAS(ph)LEEPK_, , , , ,-0.49,-0.26,-0.45,-0.32, , , , ,-0.26,-0.35,-0.67,-0.85,,,-0.37,-0.39,,,-0.3,-0.76,,,,,,,NA,NA,,mitochondrion,thyroid hormone receptor activity,cell surface receptor signaling pathway,,
Q9H0E9-3,Q9H0E9,Bromodomain-containing protein 8,BRD8,105.51,98.96,S641,APGEDEEEDGVSEAASLEEPKEEDQGEGYLS,_DAPGEDEEEDGVS(ph)EAAS(ph)LEEPK_, , , , ,-0.49,-0.26,-0.45,-0.32, , , , ,-0.26,-0.35,-0.67,-0.85,,,-0.37,-0.39,,,-0.3,-0.76,,,,,,,NA,NA,,mitochondrion,thyroid hormone receptor activity,cell surface receptor signaling pathway,,
E9PJF5,Q9HCU9,Breast cancer metastasis-suppressor 1,BRMS1,86.19,86.19,S19,QPPSKDTEEMEAEGDSAAEMNGEEEESEEER,_DTEEMEAEGDS(ph)AAEMNGEEEES(ph)EEER_, , , , , ,-0.05, , , , , , , ,0.32, , ,,,-0.05,,,,0.32,,,,,,,,NA,NA,,,,cellular process,,
E9PJF5,Q9HCU9,Breast cancer metastasis-suppressor 1,BRMS1,86.19,86.19,S30,AEGDSAAEMNGEEEESEEERSGSQTESEEES,_DTEEMEAEGDS(ph)AAEMNGEEEES(ph)EEER_, , , , , ,-0.05, , , , , , , ,0.32, , ,,,-0.05,,,,0.32,,,,,,,,NA,NA,,,,cellular process,,
P55201-4,P55201,Peregrin,BRPF1,279.3,279.3,S460,DIHTPPGSARRLPALSHSEGEEDEDEEEDEG,_RLPALS(ph)HS(ph)EGEEDEDEEEDEGK_, ,-0.6,-0.26, ,-0.27,-0.15,-0.15,-0.72, ,0.07,-0.26, ,-0.13,-0.11,-0.19,-0.32,-0.6,-0.26,-0.21,-0.41,0.07,-0.26,-0.12,-0.25,,,,,,,0,0,,cytoplasm,DNA binding,histone H3 acetylation,,
P55201-4,P55201,Peregrin,BRPF1,279.3,279.3,S462,HTPPGSARRLPALSHSEGEEDEDEEEDEGKG,_RLPALS(ph)HS(ph)EGEEDEDEEEDEGK_, ,-0.6,-0.26, ,-0.27,-0.15,-0.15,-0.72, ,0.07,-0.26, ,-0.13,-0.11,-0.19,-0.32,-0.6,-0.26,-0.21,-0.41,0.07,-0.26,-0.12,-0.25,,,,,,,0,0,,cytoplasm,DNA binding,histone H3 acetylation,,
Q9NSI6-3,Q9NSI6,Bromodomain and WD repeat-containing protein 1,BRWD1,94.5,93.35,S2018,SEGSTKVLSQALNGDSDSEDMLNSEHKHRHT,_VLSQALNGDS(ph)DS(ph)EDMLNSEHK_,0.55,0.63,0.81, , , , , ,0.18,0.3,0.3, , , , , ,0.59,0.81,,,0.24,0.3,,,,,,,,,NA,NA,,cytoplasm,,cytoskeleton organization,,
Q9NSI6-3,Q9NSI6,Bromodomain and WD repeat-containing protein 1,BRWD1,94.5,93.35,S2020,GSTKVLSQALNGDSDSEDMLNSEHKHRHTNI,_VLSQALNGDS(ph)DS(ph)EDMLNSEHK_,0.55,0.63,0.81, , , , , ,0.18,0.3,0.3, , , , , ,0.59,0.81,,,0.24,0.3,,,,,,,,,NA,NA,,cytoplasm,,cytoskeleton organization,,
D3YLG5,P35613,Basigin,BSG,121.94,119.84,S362,KRRKPEDVLDDDDAGSAPLKSSGQHQNDKGK,_RKPEDVLDDDDAGS(ph)APLK_,0.16,0.23,0.45,0.21,0.19,0.43,0.31,0.34,0.14,0.22,0.6,0.22,0.12,0.09,0.36,-0.14,0.2,0.34,0.32,0.33,0.18,0.42,0.11,0.13,,,,,,,0,0,,,,,,
P20290-2,P20290,Transcription factor BTF3,BTF3,133.31,127.64,S201,DDDEVPDLVENFDEASKNEAN__________,_APLATGEDDDDEVPDLVENFDEAS(ph)K_, , , , , , ,-0.54, , , , , , , ,-0.03, ,,,,-0.54,,,,-0.03,,,,,,,NA,NA,,nucleus,,in utero embryonic development,,
Q9BRD0,Q9BRD0,BUD13 homolog,BUD13,84.75,74.11,S163,PDPSPRRARHDTPDPSPLRGARHDSDTSPPR,_HDT(ph)PDPS(ph)PLR_, , , , , , , ,-0.32, , , , , , , ,-0.18,,,,-0.32,,,,-0.18,,,,,,,NA,NA,,RES complex,,mRNA export from nucleus,,
Q9BRD0,Q9BRD0,BUD13 homolog,BUD13,58.89,58.89,S325,LSFPKNSKYEYDPDISPPRKKQAKSHFGDKK,_YEYDPDIS(ph)PPR_,0.19, , , , , , , ,0.42, , , , , , , ,0.19,,,,0.42,,,,,,,,,,NA,NA,,RES complex,,mRNA export from nucleus,,
Q9BRD0,Q9BRD0,BUD13 homolog,BUD13,84.75,74.11,T159,RHDTPDPSPRRARHDTPDPSPLRGARHDSDT,_HDT(ph)PDPS(ph)PLR_, , , , , , , ,-0.32, , , , , , , ,-0.18,,,,-0.32,,,,-0.18,,,,,,,NA,NA,,RES complex,,mRNA export from nucleus,,
Q13895,Q13895,Bystin,BYSL,325.1,324.2,S98,RERTTRLGPRMPQDGSDDEDEEWPTLEKAAT,_MPQDGS(ph)DDEDEEWPTLEK_,0.17,0.17,0.26,0.31,0,-0.15,-0.09,0.02,0.08,0.08,0.19,0.18,0.08,0.16,0.14,0.07,0.17,0.29,-0.07,-0.03,0.08,0.18,0.12,0.11,,,,,,,0,0,,cytoplasm,,cell adhesion,,
Q7L1Q6-2,Q7L1Q6,Basic leucine zipper and W2 domain-containing protein 1,BZW1,216.71,216.36,S411,QMKKFVEWLKNAEEESESEAEEGD_______,_NAEEES(ph)ES(ph)EAEEGD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,"regulation of transcription, DNA-dependent",,
Q7L1Q6-2,Q7L1Q6,Basic leucine zipper and W2 domain-containing protein 1,BZW1,141.84,141.84,S413,KKFVEWLKNAEEESESEAEEGD_________,_NAEEES(ph)ES(ph)EAEEGD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,"regulation of transcription, DNA-dependent",,
Q9Y6E2,Q9Y6E2,Basic leucine zipper and W2 domain-containing protein 2,BZW2,222.69,222.69,S412,QMKKFVEWLQNAEEESESEGEEN________,_KFVEWLQNAEEES(ph)ES(ph)EGEEN_, ,-0.8, ,-0.44,-0.27,-0.17,-0.18,-0.12, ,-0.05, ,-0.1,0.04,0.08,0.04,0.09,-0.8,-0.44,-0.22,-0.15,-0.05,-0.1,0.06,0.07,,,,,,,0,0,,,,cell differentiation,,
Q9Y6E2,Q9Y6E2,Basic leucine zipper and W2 domain-containing protein 2,BZW2,222.69,222.69,S414,KKFVEWLQNAEEESESEGEEN__________,_KFVEWLQNAEEES(ph)ES(ph)EGEEN_, ,-0.8, ,-0.44,-0.27,-0.17,-0.18,-0.12, ,-0.05, ,-0.1,0.04,0.08,0.04,0.09,-0.8,-0.44,-0.22,-0.15,-0.05,-0.1,0.06,0.07,,,,,,,0,0,,,,cell differentiation,,
Q86WR7-2,Q86WR7,Uncharacterized protein C10orf47,C10orf47,111.63,111.63,S43,RGGSLESRSSSSRSRSFTLDDESLKYLTHEE,_SRS(ph)FTLDDESLK_,0.11,0.25,1.89,2.5, , , , ,0.77,1.01,2.91,3.2, , , , ,0.18,2.23,,,0.89,3.06,,, +, +,,,,,NA,NA,,,,,,
Q9BUA3,Q9BUA3,Uncharacterized protein C11orf84,C11orf84,72.47,69.15,S308,PKDREVAEGGLPRAESPSPAPPPGLRGTLDL,_AES(ph)PSPAPPPGLR_, , , , , ,2.01, , , , , , , ,-0.29, , ,,,2.01,,,,-0.29,, +,,,,,,NA,NA,,,,,,
Q9BUA3,Q9BUA3,Uncharacterized protein C11orf84,C11orf84,166.07,165.5,S248,GRPMTKNLDPDPEPPSPDSPTETFAAPAEVR,_NLDPDPEPPS(ph)PDS(ph)PTETFAAPAEVR_,-0.47,-0.25,0.26,-0.05,0.53,0.37,0.55,0.59,0.48,-0.08,0.38,0.1,0.6,0.38,0.43,0.53,-0.36,0.11,0.46,0.57,0.23,0.24,0.5,0.48,,,,,,,0,0,,,,,,
Q9BUA3,Q9BUA3,Uncharacterized protein C11orf84,C11orf84,166.07,165.5,S251,MTKNLDPDPEPPSPDSPTETFAAPAEVRHFT,_NLDPDPEPPS(ph)PDS(ph)PTETFAAPAEVR_,0.07,0.2,0.26,-0.05,0.53,0.42,0.55,0.59,0.02,0.14,0.38,0.1,0.6,0.43,0.43,0.53,0.14,0.11,0.48,0.57,0.08,0.24,0.52,0.48,,,,,,,0,0,,,,,,
G3V5D0,Q9NWQ4,Uncharacterized protein C14orf118,C14orf118,176.53,175.21,S86,EATKDCREVAPVTNFSDSDDTMVAKRHPALN,_EVAPVTNFS(ph)DS(ph)DDTMVAK_, , , , ,-0.06,0.05,-0.04,-0.18, , , , ,0.23,0.88,0.05,0.18,,,0,-0.11,,,0.59,0.11,,,,,,,NA,NA,,,,,,
G3V5D0,Q9NWQ4,Uncharacterized protein C14orf118,C14orf118,176.53,175.21,S88,TKDCREVAPVTNFSDSDDTMVAKRHPALNAI,_EVAPVTNFS(ph)DS(ph)DDTMVAK_, , , , ,-0.06,0.05,-0.07,-0.18, , , , ,0.23,0.88,0.04,0.18,,,0,-0.12,,,0.59,0.11,,,,,,,NA,NA,,,,,,
Q9HAS0,Q9HAS0,Protein Njmu-R1,C17orf75,252.37,240.32,S18,PSLQESMDGDEKELESSEEGGSAEERRLEPP,_ELES(ph)SEEGGSAEER_,0.28,0.33,0.34,0.3, ,0.05,-0.07,-0.29,-0.05,-0.05,-0.08,-0.25, ,-0.03,-0.16,-0.28,0.31,0.32,0.05,-0.18,-0.05,-0.16,-0.03,-0.22,,,,,,,0,0,,,,spermatogenesis,,
Q53F19,Q53F19,Uncharacterized protein C17orf85,C17orf85,75.44,74.03,S25,SVKAEAPAGPALGLPSPEAESGVDRGEPEPM,_AEAPAGPALGLPS(ph)PEAESGVDR_,0.16,0.03, ,-0.1, , ,-0.22, ,-0.22,-0.09, ,-0.53, , ,-0.41, ,0.1,-0.1,,-0.22,-0.16,-0.53,,-0.41,,,,,,,NA,NA,,,nucleotide binding,,,
Q96B23-2,Q96B23,Uncharacterized protein C18orf25,C18orf25,196.41,196.41,S66,VISSMPCLLMELRRDSSESQLASTESDKPTT,_RDS(ph)S(ph)ESQLASTESDKPTTGR_, , ,1.62,1.59,1.82,1.47, , , , ,1.47,1.77,1.88,1.23, , ,,1.61,1.66,,,1.63,1.59,, +, +,,,,,NA,NA,,,,,,
Q96B23-2,Q96B23,Uncharacterized protein C18orf25,C18orf25,196.41,196.41,S69,SMPCLLMELRRDSSESQLASTESDKPTTGRV,_RDS(ph)SES(ph)QLASTESDKPTTGR_, , , , ,1.85, ,2.63, , , , , ,1.46, ,2.07, ,,,1.85,2.63,,,1.46,2.07, +, +,,,,,NA,NA,,,,,,
Q96B23-2,Q96B23,Uncharacterized protein C18orf25,C18orf25,251.74,251.74,S145,GVSGATVGRKSRRSRSESETSTMAAKKNRQS,_SRS(ph)ESETSTMAAK_, , , , ,1.21,1.45,1.28, , , , , ,1.19,2.32,1.56, ,,,1.34,1.28,,,1.86,1.56, +, +,,,,,NA,NA,,,,,,
Q8IVT2,Q8IVT2,Uncharacterized protein C19orf21,C19orf21,218.41,217.63,S394,DWVSEGPQPGLRRALSSDSILSPAPDARAAD,_ALS(ph)SDSILS(ph)PAPDAR_,-0.4,-0.47,-0.33,-0.37,-0.06,0.1,-0.1,-0.13,-0.23,-0.44,0,0.11,-0.35,-0.13,-0.29,-0.33,-0.43,-0.35,0.02,-0.11,-0.33,0.06,-0.24,-0.31,,,,,,,0,0,,,,,,
Q8IVT2,Q8IVT2,Uncharacterized protein C19orf21,C19orf21,218.41,217.63,S400,PQPGLRRALSSDSILSPAPDARAADPAPEVR,_ALS(ph)SDSILS(ph)PAPDAR_, , , , ,0.4,0.21,0.15, , , , , ,0.26,0.07,0.47, ,,,0.31,0.15,,,0.17,0.47,,,,,,,NA,NA,,,,,,
Q9BVV8,Q9BVV8,Uncharacterized membrane protein C19orf24,C19orf24,349.92,347.42,S117,RYGLLANTEDPTEMASLDSDEETVFESRNLR,_YGLLANTEDPTEMAS(ph)LDS(ph)DEETVFESR_,-0.08, , , ,-0.03,0.11,-0.07,-0.1,0.03, , , ,0.07,0.03,0.05,0.03,-0.08,,0.04,-0.08,0.03,,0.05,0.04,,,,,,,NA,NA,,cytoplasm,,,,
Q9BVV8,Q9BVV8,Uncharacterized membrane protein C19orf24,C19orf24,349.92,347.42,S120,LLANTEDPTEMASLDSDEETVFESRNLR___,_RYGLLANTEDPTEMAS(ph)LDS(ph)DEETVFESR_,-0.08, , , ,-0.03,0.11,-0.07,-0.1,0.03, , , ,0.07,0.03,0.05,0.03,-0.08,,0.04,-0.08,0.03,,0.05,0.04,,,,,,,NA,NA,,cytoplasm,,,,
Q7Z422-2,Q7Z422-2,UPF0485 protein C1orf144,C1orf144,88.58,85.57,S17,RRSLRAGKRRQTAGKSKSPPKVPIVIQDDSL,_S(ph)KS(ph)PPKVPIVIQDDSLPAGPPPQIR_, , ,0.61, , , , , , , ,-0.27, , , , , ,,0.61,,,,-0.27,,,,,,,,,NA,NA,,,,,,
Q7Z422-2,Q7Z422-2,UPF0485 protein C1orf144,C1orf144,88.58,85.57,S19,SLRAGKRRQTAGKSKSPPKVPIVIQDDSLPA,_S(ph)KS(ph)PPKVPIVIQDDSLPAGPPPQIR_, , ,0.61, , , , , , , ,-0.27, , , , , ,,0.61,,,,-0.27,,,,,,,,,NA,NA,,,,,,
Q8N6N3,Q8N6N3,UPF0690 protein C1orf52,C1orf52,233.37,214.08,S158,AKKARLLPEGEETLESDDEKDEHTSKKRKVE,_LLPEGEET(ph)LES(ph)DDEK_,0.08,0.06,0.1,0.15,0.14,0.16,0.22,0.09,0.15,0.17,0.16,0.15,0.06,0.14,0.34,0.11,0.07,0.13,0.15,0.16,0.16,0.15,0.1,0.23,,,,,,,0,0,,,,,,
Q6IQ49-3,Q6IQ49,UPF0667 protein C1orf55,C1orf55,79.59,78.37,S278,PSGSQRARVVNTDHGSPEQLQIPVTDSGRHI,_VVNTDHGS(ph)PEQLQIPVTDSGR_, ,-0.13,0.45, , , , , , ,-0.02,-0.09, , , , , ,-0.13,0.45,,,-0.02,-0.09,,,,,,,,,NA,NA,,,,,,
Q5JW53,Q9H410,Kinetochore-associated protein DSN1 homolog,C20orf172,63,55.27,S81,DLSHQERLQSKSLHLSPQEQSASYQDRRQSW,_SLHLS(ph)PQEQSASYQDR_, , ,-0.79,-0.22, , , , , , ,-0.67,-0.82, , , , ,,-0.48,,,,-0.74,,,,,,,,,NA,NA,,,,apoptotic process,,
E7ET27,Q8N357,Transmembrane protein C2orf18,C2orf18,96.18,96.18,T365,LAEESEQERLLGGTRTPINDAS_________,_LLGGTRT(ph)PINDAS_,0.08,0.2,0.04,0.09,-0.36,-0.12,-0.24,-0.23,0.14,0.31,0.11,0.07,-0.45,-0.27,-0.26,-0.32,0.14,0.07,-0.23,-0.23,0.23,0.09,-0.36,-0.29,,,,,,,0,0,,,,,,
Q9H6R7,Q9H6R7,WD repeat-containing protein C2orf44,C2orf44,102.79,87.21,S690,GSLSRSDVFRDSFSHSPGAVSSLKVFTGLAA,_DSFSHS(ph)PGAVSSLK_,-0.06,-0.27,0.52,0.61,0.88, ,1.29, ,0.2,0.21,0.79,0.56,1.05, ,1.37, ,-0.16,0.57,0.88,1.29,0.2,0.68,1.05,1.37, +, +,,,,,2,2,38.57,,,,,
Q9BVC5,Q9BVC5,Ashwin,C2orf49,255.25,249.14,S189,NHDLTHRKSPSGPVKSPPLSPVGTTPVKLKR,_SPSGPVKS(ph)PPLS(ph)PVGTTPVK_,0.31,0.09,-0.55,2.12,1.09,1.18,0.78,0.54,0.2,0.43,-0.74,2.01,1.1,1.13,0.77,0.64,0.2,1.33,1.14,0.66,0.32,1.21,1.12,0.71, +, +,,,,,1,1,46.99,tRNA-splicing ligase complex,,,,
Q9BVC5,Q9BVC5,Ashwin,C2orf49,255.25,249.14,S193,THRKSPSGPVKSPPLSPVGTTPVKLKRAAPK,_SPSGPVKS(ph)PPLS(ph)PVGTTPVK_,-0.06,0.27,1.4,2.12,1.49,1.05,0.91,0.56,0.46,0.27,1.47,2.01,1.6,1.37,0.82,0.65,0.11,1.81,1.29,0.75,0.37,1.77,1.49,0.74, +, +,,,,,1,1,47.68,tRNA-splicing ligase complex,,,,
Q9BVC5,Q9BVC5,Ashwin,C2orf49,125.14,125.14,S182,NNNDAKQNHDLTHRKSPSGPVKSPPLSPVGT,_S(ph)PSGPVKS(ph)PPLS(ph)PVGTTPVK_, , , , ,1.49,0.5,1.05,1.27, , , , ,1.6,0.26,0.12,0.89,,,1.08,1.17,,,1.08,0.56, +, +,,,,,NA,NA,,tRNA-splicing ligase complex,,,,
Q9BVC5,Q9BVC5,Ashwin,C2orf49,132.51,131.04,T197,SPSGPVKSPPLSPVGTTPVKLKRAAPKEEAE,_S(ph)PPLSPVGT(ph)TPVK_, , , , ,0.78,0.5, ,1.21, , , , ,1.18,0.26, ,0.63,,,0.64,1.21,,,0.79,0.63, +,,,,,,NA,NA,,tRNA-splicing ligase complex,,,,
Q9BVC5,Q9BVC5,Ashwin,C2orf49,92.89,92.89,T198,PSGPVKSPPLSPVGTTPVKLKRAAPKEEAEA,_S(ph)PPLS(ph)PVGTT(ph)PVK_, , , , , ,0.24,1.05,1.03, , , , , ,0.6,0.12,0.48,,,0.24,1.04,,,0.6,0.31, +,,,,,,NA,NA,,tRNA-splicing ligase complex,,,,
Q96GV9,Q96GV9,UNC119-binding protein C5orf30,C5orf30,127.56,89.56,S167,PLPLCLLKGKRAHSKSLDYLNLDKMIKEPAD,_S(ph)LDYLNLDK_,0.02,0.44,0.07,0.45,0.87, , , ,-0.24,-0.04,-0.4,-0.25,0.63, , , ,0.24,0.28,0.87,,-0.14,-0.32,0.63,,,,,,,,NA,NA,,ciliary transition zone,,cilium morphogenesis,,
P0DJ93,P0DJ93,UPF0766 protein C6orf228,C6orf228,143.54,132.61,S58,ELVGDTGSQEGDHEPSGSETEEDTSSSPHRI,_ELVGDTGSQEGDHEPS(ph)GS(ph)ET(ph)EEDTSSSPHR_,-0.1,-0.22,-0.76,-0.2,-0.48,0,-0.27,-0.23,0.11,-0.37,-0.27,0.4,-0.05,0.39,-0.06,-0.27,-0.16,-0.46,-0.22,-0.25,-0.11,0.1,0.19,-0.16,,,,,,,0,0,,integral to membrane,metal ion binding,cilium morphogenesis,,
P0DJ93,P0DJ93,UPF0766 protein C6orf228,C6orf228,143.54,132.61,S60,VGDTGSQEGDHEPSGSETEEDTSSSPHRIRS,_ELVGDTGSQEGDHEPS(ph)GS(ph)ET(ph)EEDTSSSPHR_,-0.1,-0.22,-0.76,-0.2,-0.41,0,-0.27,-0.23,0.11,-0.37,-0.27,0.4,-0.19,0.39,-0.06,-0.27,-0.16,-0.46,-0.19,-0.25,-0.11,0.1,0.13,-0.16,,,,,,,0,0,,integral to membrane,metal ion binding,cilium morphogenesis,,
P0DJ93,P0DJ93,UPF0766 protein C6orf228,C6orf228,82.33,79.46,T62,DTGSQEGDHEPSGSETEEDTSSSPHRIRSAR,_ELVGDTGSQEGDHEPS(ph)GS(ph)ET(ph)EEDTSSSPHR_,-0.1,0.56,0.24,0.29,-0.56,0.26,0.54,0.23,0.11,0.04,0.42,0.18,0.1,0.65,0.59,0.05,0.27,0.26,-0.09,0.39,0.07,0.3,0.4,0.35,,,,,,,0,0,,integral to membrane,metal ion binding,cilium morphogenesis,,
Q9BRJ6,Q9BRJ6,Uncharacterized protein C7orf50,C7orf50,237.46,236.38,S175,VQKAEALMRELDEEGSDPPLPGRAQRIRQVL,_ELDEEGS(ph)DPPLPGR_,-0.01,0.01,-0.29,-0.26,-0.16,-0.2,-0.17,-0.06,0.1,0.12,-0.05,-0.01,-0.28,-0.28,-0.37,-0.3,0,-0.28,-0.18,-0.12,0.11,-0.03,-0.28,-0.34,,,,,,,0,0,,,,,,
Q9BRJ6,Q9BRJ6,Uncharacterized protein C7orf50,C7orf50,225.81,225.81,S59,GEAVLRPGLDAEPELSPEEQRVLERKLKKER,_GEAVLRPGLDAEPELS(ph)PEEQR_,-0.05,-0.2,-0.07,0.51,-0.17,0.01,0.25,-0.08,0.05,-0.06,-0.13,0.13,-0.42,0,-0.42,-0.54,-0.13,0.25,-0.08,0.1,0,0.01,-0.2,-0.47,,,,,,,0,0,,,,,,
Q9BUH6,Q9BUH6,Uncharacterized protein C9orf142,C9orf142,200.77,149.97,S148,WSLERRLAAAEETAVSPRKSPRPAGPQLFLP,_LAAAEETAVS(ph)PR_,0.85,0.77,0.98,0.91,0.99,0.6,0.04,0.49,0.24,0.13,0.44,0.32,0.2,0.19,0.24,0.52,0.81,0.95,0.81,0.28,0.19,0.38,0.2,0.39,,,,,,,0,0,,,,,,
Q9BUH6,Q9BUH6,Uncharacterized protein C9orf142,C9orf142,85.78,85.78,S152,RRLAAAEETAVSPRKSPRPAGPQLFLPDPDP,_S(ph)PRPAGPQLFLPDPDPQR_,-0.25,0.05,0.44,0.39,0.61, , , ,-0.33,-0.13,0.21,0.11,0.8, , , ,-0.09,0.42,0.61,,-0.23,0.16,0.8,,,,,,,,NA,NA,,,,,,
Q9BUW7,Q9BUW7,UPF0184 protein C9orf16,C9orf16,133.93,133.17,S79,RQTRLEFQQQLGEAPSDASP___________,_LEFQQQLGEAPS(ph)DAS(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q9BUW7,Q9BUW7,UPF0184 protein C9orf16,C9orf16,195.55,190.64,S82,RLEFQQQLGEAPSDASP______________,_LEFQQQLGEAPS(ph)DAS(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q8IW50-3,Q8IW50,Protein FAM219A,C9orf25,279.15,263.61,S115,DQSPDEKPLVALDTDSDDDFDMSRYSSSGYS,_PLVALDT(ph)DS(ph)DDDFDMSR_, , , , ,0.23,-0.08,0.19,0.17, , , , ,-0.23,-0.01,0.05,-0.3,,,0.09,0.18,,,-0.12,-0.11,,,,,,,NA,NA,,,,,,
Q8IW50-3,Q8IW50,Protein FAM219A,C9orf25,279.15,263.61,T113,SLDQSPDEKPLVALDTDSDDDFDMSRYSSSG,_PLVALDT(ph)DS(ph)DDDFDMSR_, , , , ,0.23,-0.08,0.19,0.17, , , , ,-0.23,-0.01,0.05,-0.3,,,0.09,0.18,,,-0.12,-0.11,,,,,,,NA,NA,,,,,,
Q9NZ63,Q9NZ63,Uncharacterized protein C9orf78,C9orf78,383.69,383.69,S15,_MPVVRKIFRRRRGDSESEEDEQDSEEVRLK,_RRGDS(ph)ES(ph)EEDEQDSEEVR_,-0.16,-0.23,-0.24,-0.21,-0.13,-0.04,-0.03,-0.05,-0.18,-0.16,-0.21,-0.2,-0.29,-0.1,-0.13,-0.19,-0.2,-0.23,-0.08,-0.04,-0.17,-0.2,-0.19,-0.16,,,,,,,0,0,,cytoplasm,,,,
Q9NZ63,Q9NZ63,Uncharacterized protein C9orf78,C9orf78,383.69,383.69,S17,PVVRKIFRRRRGDSESEEDEQDSEEVRLKLE,_RRGDS(ph)ES(ph)EEDEQDSEEVR_,-0.14,-0.14,-0.17,-0.21,-0.13,-0.02,-0.03,-0.05,-0.17,-0.16,-0.21,-0.18,-0.29,-0.1,-0.14,-0.19,-0.14,-0.19,-0.08,-0.04,-0.16,-0.19,-0.19,-0.17,,,,,,,0,0,,cytoplasm,,,,
Q9NZ63,Q9NZ63,Uncharacterized protein C9orf78,C9orf78,315.51,315.51,S24,RRRRGDSESEEDEQDSEEVRLKLEETREVQN,_RRGDS(ph)ESEEDEQDS(ph)EEVR_,-0.39,-0.22,-0.26,-0.1, ,-0.15,-0.06, ,-0.41,-0.16,-0.2,-0.35, ,-0.12,-0.01, ,-0.3,-0.18,-0.15,-0.06,-0.28,-0.27,-0.12,-0.01,,,,,,,0,0,,cytoplasm,,,,
Q9NZ63,Q9NZ63,Uncharacterized protein C9orf78,C9orf78,263.9,263.9,S261,RPLRVGDTEKPEPERSPPNRKRPANEKATDD,_VGDTEKPEPERS(ph)PPNR_,-0.07,-0.17,0.19,-0.18,0.27,0.06,0.26, ,0.13,0.31,0.08,0.3,0.46,0.14,0.36, ,-0.12,0.02,0.17,0.26,0.22,0.2,0.31,0.36,,,,,,,0,0,,cytoplasm,,,,
Q9NZ63,Q9NZ63,Uncharacterized protein C9orf78,C9orf78,77.97,77.97,T253,RNKEEPKARPLRVGDTEKPEPERSPPNRKRP,_VGDT(ph)EKPEPERSPPNR_, , , , ,0.08, , , , , , , ,-0.32, , , ,,,0.08,,,,-0.32,,,,,,,,NA,NA,,cytoplasm,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,240.82,240.82,S596,DTQRRADDFPVRDDPSDVTDEDEGPAEPPPP,_RADDFPVRDDPS(ph)DVT(ph)DEDEGPAEPPPPPK_,-0.05,0.04,-0.02,-0.13,0.02,-0.03,0,-0.11,-0.06,0.02,-0.1,-0.01,-0.09,-0.16,-0.36,-0.2,0,-0.07,-0.01,-0.06,-0.02,-0.05,-0.13,-0.28,,,,,,,0,0,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,336.66,336.66,S640,SDLFGLGLEEAGPKESSEEGKEGKTPSKEKK,_NDSDLFGLGLEEAGPKES(ph)S(ph)EEGK_,0.03,0.07,-0.54,-0.33,-0.39,-0.12,-0.18,-0.09,0.05,0.02,0.1,-0.09,-0.49,-0.27,-0.04,-0.17,0.05,-0.43,-0.25,-0.13,0.03,0.01,-0.37,-0.1,,,,,,,0,0,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,336.66,336.66,S641,DLFGLGLEEAGPKESSEEGKEGKTPSKEKKK,_NDSDLFGLGLEEAGPKES(ph)S(ph)EEGK_,-0.5,-0.02,-0.54,-0.73,-0.39,-0.12,-0.1,-0.09,0.31,0.38,0.1,-0.11,-0.49,-0.27,0.01,-0.17,-0.24,-0.63,-0.25,-0.1,0.35,0,-0.37,-0.08,,,,,,,0,0,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,240.82,240.82,T599,RRADDFPVRDDPSDVTDEDEGPAEPPPPPKL,_RADDFPVRDDPS(ph)DVT(ph)DEDEGPAEPPPPPK_,-0.05,0.04,-0.02,-0.13,0.02,-0.03,0,-0.11,-0.06,0.02,-0.1,-0.01,-0.09,-0.16,-0.36,-0.2,0,-0.07,-0.01,-0.06,-0.02,-0.05,-0.13,-0.28,,,,,,,0,0,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,59.26,59.2,S425,ARDEKKVGAKAAQQDSDSDGEALGGNPMVAG,_AAQQDS(ph)DS(ph)DGEALGGNPM(ox)VAGFQDDVDLEDQPR_, , , , , , ,-0.77,-0.09, , , , , , ,-0.18,-0.06,,,,-0.39,,,,-0.12,,,,,,,NA,NA,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,59.26,59.2,S427,DEKKVGAKAAQQDSDSDGEALGGNPMVAGFQ,_AAQQDS(ph)DS(ph)DGEALGGNPM(ox)VAGFQDDVDLEDQPR_, , , , , , ,-0.77,-0.09, , , , , , ,-0.18,-0.06,,,,-0.39,,,,-0.12,,,,,,,NA,NA,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,107.1,106.96,S454,AGFQDDVDLEDQPRGSPPLPAGPVPSQDITL,_GS(ph)PPLPAGPVPSQDITLS(ph)S(ph)EEEAEVAAPTK_, , , , , ,0.02,0.05, , , , , , ,0.02,0.05, ,,,0.02,0.05,,,0.02,0.05,,,,,,,NA,NA,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,115.9,115.73,S470,PPLPAGPVPSQDITLSSEEEAEVAAPTKGPA,_GSPPLPAGPVPSQDITLS(ph)S(ph)EEEAEVAAPTK_, , , , , ,0,-0.14,-0.32, , , , , ,-0.52,-0.35,-0.69,,,0,-0.22,,,-0.52,-0.51,,,,,,,NA,NA,,,,,,
G8JLF3,Q3YEC7,Rab-like protein 1,C9orf86,115.9,115.73,S471,PLPAGPVPSQDITLSSEEEAEVAAPTKGPAP,_GSPPLPAGPVPSQDITLS(ph)S(ph)EEEAEVAAPTK_, , , , , ,0,-0.14,-0.32, , , , , ,-0.52,-0.35,-0.69,,,0,-0.22,,,-0.52,-0.51,,,,,,,NA,NA,,,,,,
B4DWT4,Q9H8G2,Caspase activity and apoptosis inhibitor 1,CAAP1,316.51,311.47,S203,EKKILKILEGDNGMDSDMEEEADDGSKMGSD,_ILEGDNGMDS(ph)DMEEEADDGSK_,0.04,0.04,-0.15,-0.22,-0.23,-0.18,-0.19,-0.13,-0.07,-0.13,-0.16,-0.02,-0.16,0,-0.09,0.04,0.04,-0.19,-0.21,-0.16,-0.1,-0.09,-0.08,-0.02,,,,,,,0,0,,,,,,
Q8TDN4-2,Q8TDN4,CDK5 and ABL1 enzyme substrate 1,CABLES1,150.68,147.53,S291,IYADFPIRRLISQRSSLETLEDIEENAPLRR,_SS(ph)LETLEDIEENAPLRR_, ,0.21,-0.15, , , , , , ,-0.49,-0.52, , , , , ,0.21,-0.15,,,-0.49,-0.52,,,,,,,,,NA,NA,,cytosol,cyclin-dependent protein kinase regulator activity,blood coagulation,,
F8VPD4,P27708,CAD protein,CAD,90.4,90.4,S1859,LPDGRFHLPPRIHRASDPGLPAEEPKEKSSR,_IHRAS(ph)DPGLPAEEPK_,0.93,1.09,1.28,1.48,1.46,1.49,1.78,1.52,0.31,0.41,0.92,0.98,1.5,1.35,1.69,1.79,1.01,1.38,1.47,1.66,0.36,0.95,1.43,1.74, +, +,,,,,1,2,30.34,,amino acid binding,de novo' pyrimidine nucleobase biosynthetic process,,
O43852,O43852,Calumenin,CALU,59.54,58.07,Y47,PQLSDKVHNDAQSFDYDHDAFLGAEEAKTFD,_VHNDAQS(ph)FDY(ph)DHDAFLGAEEAK_, , , ,-1.5, , , , , , , ,-1.05, , , , ,,-1.5,,,,-1.05,,, +, +,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,platelet activation,,
O43852,O43852,Calumenin,CALU,59.54,58.07,S44,HHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK,_VHNDAQS(ph)FDY(ph)DHDAFLGAEEAK_, , , ,-1.5, , , , , , , ,-1.05, , , , ,,-1.5,,,,-1.05,,, +, +,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,platelet activation,,
O43852,O43852,Calumenin,CALU,84.51,74.15,Y106,DELKDWIKFAQKRWIYEDVERQWKGHDLNED,_RWIY(ph)EDVER_, , , , , , ,0.23,-1.77, , , , , , ,-1.37,-1.51,,,,-0.45,,,,-1.44,, +,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,platelet activation,,
Q5T5Y3-2,Q5T5Y3,Calmodulin-regulated spectrin-associated protein 1,CAMSAP1,119.41,119.41,S563,ADVVPQQADPEFPRASPRALGLTANARSPQG,_ADVVPQQADPEFPRAS(ph)PR_,-0.4,-0.28,-0.72,-0.71,-0.5,0.21,0.31,0.1,-0.43,-0.26,-0.77,-0.93,-0.27,0.53,0.61,0.29,-0.34,-0.72,-0.1,0.21,-0.34,-0.85,0.18,0.46,,,,,,,0,0,,cytoplasm,,cytoskeleton organization,,
Q5T5Y3-2,Q5T5Y3,Calmodulin-regulated spectrin-associated protein 1,CAMSAP1,151.41,150.05,S722,ADEDTEGRLYVSCSKSPNSHDSEPWTLLRQD,_S(ph)PNSHDSEPWTLLR_,-0.63,-0.62,0.07,-0.26, , ,0.11, ,-1.12,-0.24,0.14,0.13, , ,0.14, ,-0.62,-0.09,,0.11,-0.61,0.13,,0.14,,,,,,,NA,NA,,cytoplasm,,cytoskeleton organization,,
Q08AD1-2,Q08AD1,Calmodulin-regulated spectrin-associated protein 2,CAMSAP2,118.96,106.47,S1313,DNESVHSGKRTPRSESVEGFLSPSRCGSRNG,_SES(ph)VEGFLS(ph)PSR_,-0.71, ,-1.08, ,-0.16,-0.31,-0.5,0,-0.49, ,-0.35, ,-0.84,-0.43,-0.39,-0.36,-0.71,-1.08,-0.23,-0.23,-0.49,-0.35,-0.62,-0.38, +,,,,,,3,0,8.16,cytoplasm,,,,
Q08AD1-2,Q08AD1,Calmodulin-regulated spectrin-associated protein 2,CAMSAP2,111.7,107.96,S599,QEMSILNSNIKLNQSSPDNVTDTKGALSPIT,_LNQSS(ph)PDNVTDTK_,-0.04, , , ,0.15, ,0.1,0.15,0.47, , , ,0.26, ,0.1,0.02,-0.04,,0.15,0.13,0.47,,0.26,0.06,,,,,,,NA,NA,,cytoplasm,,,,
Q08AD1-2,Q08AD1,Calmodulin-regulated spectrin-associated protein 2,CAMSAP2,118.96,106.47,S1319,SGKRTPRSESVEGFLSPSRCGSRNGEKDWEN,_SESVEGFLS(ph)PSR_,-0.4, ,-0.56,-0.51,-0.16,-0.13,-0.11,-0.11,-0.51, ,-0.46,-0.49,-0.84,-0.15,-0.3,-0.27,-0.4,-0.53,-0.15,-0.11,-0.51,-0.48,-0.45,-0.29,,,,,,,0,0,,cytoplasm,,,,
Q08AD1-2,Q08AD1,Calmodulin-regulated spectrin-associated protein 2,CAMSAP2,174.22,166.9,S464,SVQRSTPNRGITRSISNEGLTLNNSHVSKHI,_SIS(ph)NEGLTLNNSHVSK_,0.18,0.41,0.79,0.84,0.66,0.14, , ,0.1,0.2,0.9,1.01,0.79,0.69, , ,0.3,0.82,0.42,,0.15,0.95,0.74,,,,,,,,NA,NA,,cytoplasm,,,,
Q08AD1-2,Q08AD1,Calmodulin-regulated spectrin-associated protein 2,CAMSAP2,283.64,258.46,S1148,PPEKADVPVEKYDGESDKEQFDDDQKVCCGF,_YDGES(ph)DKEQFDDDQK_,-0.01,-0.02,0.02,-0.09,-0.1,-0.06,0.14,0.16,0.05,0.1,0.18,0.06,-0.22,0.14,0.09,0.36,-0.01,-0.03,-0.08,0.15,0.08,0.12,-0.03,0.23,,,,,,,0,0,,cytoplasm,,,,
Q86VP6,Q86VP6,Cullin-associated NEDD8-dissociated protein 1,CAND1,74.28,74.18,S335,ENAMDADGGDDDDQGSDDEYSDDDDMSWKVR,_YLTYDPNYNYDDEDEDENAMDADGGDDDDQGS(ph)DDEYS(ph)DDDDMSWK_, , , , , ,-0.74, , , , , , , ,0.32, , ,,,-0.74,,,,0.32,,,,,,,,NA,NA,,cullin-RING ubiquitin ligase complex,,cell differentiation,,
Q86VP6,Q86VP6,Cullin-associated NEDD8-dissociated protein 1,CAND1,74.28,74.18,S340,ADGGDDDDQGSDDEYSDDDDMSWKVRRAAAK,_YLTYDPNYNYDDEDEDENAMDADGGDDDDQGS(ph)DDEYS(ph)DDDDMSWK_, , , , , ,-0.74, , , , , , , ,0.32, , ,,,-0.74,,,,0.32,,,,,,,,NA,NA,,cullin-RING ubiquitin ligase complex,,cell differentiation,,
P27824,P27824,Calnexin,CANX,342.28,323.35,S583,EDRKPKAEEDEILNRSPRNRKPRRE______,_AEEDEILNRS(ph)PR_,0.19,0.18,0.18,0.15,0.06,0.09,0.13,0.15,-0.05,-0.02,-0.08,-0.07,-0.02,-0.02,0,-0.01,0.18,0.17,0.07,0.14,-0.04,-0.07,-0.02,0,,,,,,,0,0,,axon,calcium ion binding,aging,,
P27824,P27824,Calnexin,CANX,427.3,427.3,S554,DEEEEGEEKLEEKQKSDAEEDGGTVSQEEED,_S(ph)DAEEDGGTVS(ph)QEEEDRKPK_,0.16,0.3,0.08,-0.04,0.23,0.34,0.29,0.07,0.07,0.12,0.06,-0.12,0.45,0.11,0.16,-0.02,0.23,0.02,0.29,0.18,0.09,-0.03,0.29,0.07,,,,,,,0,0,,axon,calcium ion binding,aging,,
P27824,P27824,Calnexin,CANX,409.68,409.68,S564,EEKQKSDAEEDGGTVSQEEEDRKPKAEEDEI,_S(ph)DAEEDGGTVS(ph)QEEEDRKPK_,0.2,0.22,-0.01,-0.05,0.03,-0.16,0.07,0.07,0.16,0.21,0.08,0.03,-0.12,0.16,-0.07,0.03,0.21,-0.03,-0.06,0.07,0.19,0.06,0.03,-0.02,,,,,,,0,0,,axon,calcium ion binding,aging,,
Q01518,Q01518,Adenylyl cyclase-associated protein 1,CAP1,229.05,229.05,S308,VRSGPKPFSAPKPQTSPSPKRATKKEPAVLE,_PFSAPKPQTS(ph)PS(ph)PK_,0.04,-0.06,-0.32,-0.39,-0.34,-0.29,-0.32,-0.18,0.06,0.07,-0.14,-0.14,-0.22,-0.18,-0.28,-0.04,-0.01,-0.36,-0.31,-0.25,0.06,-0.14,-0.2,-0.16,,,,,,,0,0,,cortical actin cytoskeleton,,actin cytoskeleton organization,,
Q01518,Q01518,Adenylyl cyclase-associated protein 1,CAP1,229.05,229.05,S310,SGPKPFSAPKPQTSPSPKRATKKEPAVLELE,_PFSAPKPQTS(ph)PS(ph)PK_,-0.1,-0.08,-0.17,-0.13,-0.26,-0.25,-0.27,-0.28,-0.04,-0.01,-0.06,0.01,0,0.1,-0.07,-0.05,-0.09,-0.15,-0.26,-0.28,-0.03,-0.02,0.05,-0.06,,,,,,,0,0,,cortical actin cytoskeleton,,actin cytoskeleton organization,,
P52907,P52907,F-actin-capping protein subunit alpha-1,CAPZA1,99.04,78.77,S9,_______MADFDDRVSDEEKVRIAAKFITHA,_(ac)ADFDDRVS(ph)DEEK_,0.12,-0.03,0.47,0.4,-1.48,-1.08,0.11,-0.17,0.11,0.05,0.23,0.06,-0.23,-0.04,0.97,0.93,0.05,0.44,-1.27,-0.02,0.08,0.15,-0.13,0.95, +,,,,,,6,0,2.7,cytosol,actin binding,actin cytoskeleton organization,,
P47755,P47755,F-actin-capping protein subunit alpha-2,CAPZA2,145.94,137.33,S9,_______MADLEEQLSDEEKVRIAAKFIIHA,_(ac)ADLEEQLS(ph)DEEK_,-0.11,-0.02,0.07,0.29,0.27,0.2,0.3,0.2,0.02,-0.09,0.05,-0.11,0.08,-0.09,-0.01,-0.08,-0.06,0.18,0.23,0.25,-0.04,-0.03,0,-0.05,,,,,,,0,0,,cortical cytoskeleton,,actin cytoskeleton organization,,
Q9Y2V2,Q9Y2V2,Calcium-regulated heat stable protein 1,CARHSP1,236.29,236.29,S41,SRERSPSPLRGNVVPSPLPTRRTRTFSATVR,_ERS(ph)PS(ph)PLRGNVVPS(ph)PLPTR_,-1.81,-2.73,-0.32,0.16,-0.05,0.32,0.05,0.15,2.07,1.58,-0.45,-0.48,-1.11,0.79,-0.14,0.16,-2.19,-0.06,0.14,0.1,1.85,-0.46,0.13,0.02, +, +,,,,,2,5,19.77,cytoplasmic mRNA processing body,DNA binding,intracellular signal transduction,,
Q9Y2V2,Q9Y2V2,Calcium-regulated heat stable protein 1,CARHSP1,236.29,236.29,S30,QASVGLLDTPRSRERSPSPLRGNVVPSPLPT,_S(ph)PS(ph)PLRGNVVPS(ph)PLPTRR_,-0.33,-0.35,0.67,0.78,-0.05,0.2,-0.24,-0.14,-0.35,-0.36,0.39,0.67,-1.11,-0.76,-0.14,0.15,-0.34,0.73,0.08,-0.19,-0.36,0.54,-0.92,0.01,,,,,,,0,0,,cytoplasmic mRNA processing body,DNA binding,intracellular signal transduction,,
Q9Y2V2,Q9Y2V2,Calcium-regulated heat stable protein 1,CARHSP1,236.29,236.29,S32,SVGLLDTPRSRERSPSPLRGNVVPSPLPTRR,_S(ph)PS(ph)PLRGNVVPS(ph)PLPTR_,-0.33,-0.35,0.67,0.78,-0.05,0.2,-0.24,-0.14,-0.35,-0.36,0.39,0.67,-1.11,-0.76,-0.14,0.15,-0.34,0.73,0.08,-0.19,-0.36,0.54,-0.92,0.01,,,,,,,0,0,,cytoplasmic mRNA processing body,DNA binding,intracellular signal transduction,,
Q9Y2V2,Q9Y2V2,Calcium-regulated heat stable protein 1,CARHSP1,168.26,47.39,S52,NVVPSPLPTRRTRTFSATVRASQGPVYKGVC,_TFS(ph)ATVR_,-0.08,-0.09,-0.13,-0.04,0.43,0.45,0.39,0.44,0.15,0.05,0.22,0.25,-0.47,-0.51,0.26,0.39,-0.08,-0.08,0.44,0.41,0.1,0.23,-0.49,0.33,,,,,,,0,0,,cytoplasmic mRNA processing body,DNA binding,intracellular signal transduction,,
O15234,O15234,Protein CASC3,CASC3,103.71,103.71,S265,PDDIKPRRIRKPRYGSPPQRDPNWNGERLNK,_YGS(ph)PPQRDPNWNGER_,0.81,0.33,0.66,1.5,0.09,-0.67,-0.06, ,-0.43,-0.03,-0.26,-0.21,-0.24,-0.6,-0.42, ,0.59,1.14,-0.24,-0.06,-0.21,-0.24,-0.41,-0.42, +,,,,,,4,0,2.88,cytosol,identical protein binding,gene expression,,
O15234,O15234,Protein CASC3,CASC3,164.68,164.68,S363,SYRSRRLEQTSVRDPSPEADAPVLGSPEKEE,_DPS(ph)PEADAPVLGS(ph)PEK_,0.22,0.22,0.05,0.3,-0.27,0.11,0.01,0.27,-0.03,-0.25,-0.09,0.09,-0.11,0.17,0.15,0.25,0.22,0.18,-0.07,0.15,-0.13,0,0.04,0.2,,,,,,,0,0,,cytosol,identical protein binding,gene expression,,
O15234,O15234,Protein CASC3,CASC3,134.29,134.29,S373,SVRDPSPEADAPVLGSPEKEEAASEPPAAAP,_RLEQTSVRDPS(ph)PEADAPVLGS(ph)PEK_, , , , ,0.03,0.12,0.01,0.27, , , , ,-0.14,-0.34,0.15,0.25,,,0.08,0.15,,,-0.24,0.2,,,,,,,NA,NA,,cytosol,identical protein binding,gene expression,,
O15234,O15234,Protein CASC3,CASC3,308.8,308.8,S148,EEKPDTKSTVTGERQSGDGQESTEPVENKVG,_STVTGERQS(ph)GDGQESTEPVENK_,0.22,0.08,0.2,0.2,0.03,-0.13,0.13,0.05,0.07,-0.05,0.09,0.01,0.04,-0.16,0.19,0,0.15,0.2,-0.05,0.09,0.01,0.05,-0.05,0.1,,,,,,,0,0,,cytosol,identical protein binding,gene expression,,
Q8WXE0-2,Q8WXE0,Caskin-2,CASKIN2,210.43,210.24,Y253,RLLLEGGVDVNIRNTYNQTALDIVNQFTTSQ,_NTY(ph)NQTALDIVNQFTTSQASR_, , ,0.07, ,0.31, , , , , ,-0.19, ,0.02, , , ,,0.07,0.31,,,-0.19,0.02,,,,,,,,NA,NA,,cytoplasm,,,,
Q8WXE0-2,Q8WXE0,Caskin-2,CASKIN2,119.67,119.14,S403,PRVGLSPDSPAGDRNSVGSEGSVGSIRSAGS,_VGLSPDSPAGDRNS(ph)VGS(ph)EGS(ph)VGSIR_, , , , ,-0.24, ,-0.68,-0.51, , , , ,-0.2, ,-0.44,-0.13,,,-0.24,-0.6,,,-0.2,-0.28,,,,,,,NA,NA,,cytoplasm,,,,
Q8WXE0-2,Q8WXE0,Caskin-2,CASKIN2,119.67,119.14,S406,GLSPDSPAGDRNSVGSEGSVGSIRSAGSGQS,_VGLSPDSPAGDRNS(ph)VGS(ph)EGS(ph)VGSIR_, , , , ,-0.24, ,-0.68,-0.51, , , , ,-0.2, ,-0.44,-0.13,,,-0.24,-0.6,,,-0.2,-0.28,,,,,,,NA,NA,,cytoplasm,,,,
Q8WXE0-2,Q8WXE0,Caskin-2,CASKIN2,119.67,119.14,S409,PDSPAGDRNSVGSEGSVGSIRSAGSGQSSEG,_VGLSPDSPAGDRNS(ph)VGS(ph)EGS(ph)VGSIR_, , , , ,-0.24, ,-0.68,-0.51, , , , ,-0.2, ,-0.44,-0.13,,,-0.24,-0.6,,,-0.2,-0.28,,,,,,,NA,NA,,cytoplasm,,,,
G5E9D3,P20810,Calpastatin,CAST,213.03,213.03,S575,TSQSDKDLDDALDKLSDSLGQRQPDPDENKP,_DLDDALDKLS(ph)DSLGQR_,0.07,0.09,0.03,0.01,-0.29,0.04,-0.08,-0.06,-0.07,-0.09,-0.25,-0.26,-0.31,-0.37,-0.2,-0.04,0.08,0.02,-0.11,-0.07,-0.08,-0.26,-0.34,-0.12,,,,,,,0,0,,,,,,
G5E9D3,P20810,Calpastatin,CAST,173.37,152.27,S366,PLLPEPEEKPKPRSESELIDELSEDFDRSEC,_SES(ph)ELIDELSEDFDR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q03135,Q03135,Caveolin-1,CAV1,74.85,71.08,Y6,__________MSGGKYVDSEGHLYTVPIREQ,_Y(ph)VDSEGHLY(ph)TVPIR_, , ,1.88, , , , , , , ,1.38, , , , , ,,1.88,,,,1.38,,, +, +,,,,,NA,NA,,acrosomal membrane,cholesterol binding,angiogenesis,+,
Q03135,Q03135,Caveolin-1,CAV1,225.32,222.07,Y14,__MSGGKYVDSEGHLYTVPIREQGNIYKPNN,_YVDSEGHLY(ph)TVPIREQGNIYKPNNK_,-0.96, ,-0.77,-0.31,-0.25,-0.56,-0.38,-0.26,-0.42, ,-0.34,-0.4,0.1,-0.11,0.11,0.14,-0.96,-0.52,-0.4,-0.32,-0.42,-0.37,0,0.13,,,,,,,0,0,,acrosomal membrane,cholesterol binding,angiogenesis,+,
Q03135,Q03135,Caveolin-1,CAV1,76.36,75.18,S37,GNIYKPNNKAMADELSEKQVYDAHTKEIDLV,_AM(ox)ADELS(ph)EK_, ,-0.78, ,-0.58,-0.25, , ,0.02, ,-0.68, ,-0.33,-0.27, , ,0.3,-0.78,-0.58,-0.25,0.02,-0.68,-0.33,-0.27,0.3,,,,,,,0,0,,acrosomal membrane,cholesterol binding,angiogenesis,+,
C9JJZ4,P51636,Caveolin,CAV2,94.68,93.41,S18,LETEKADVQLFMDDDSYSHHSGLEYADPEKF,_ADVQLFMDDDS(ph)YS(ph)HHS(ph)GLEYADPEK_, , , , ,-0.5,-0.51, ,-0.17, , , , ,-0.2,-0.04, ,0.35,,,-0.51,-0.17,,,-0.12,0.35,,,,,,,NA,NA,,,,,,
C9JJZ4,P51636,Caveolin,CAV2,94.68,93.41,S20,TEKADVQLFMDDDSYSHHSGLEYADPEKFAD,_ADVQLFMDDDSYS(ph)HHS(ph)GLEYADPEK_, , , , ,-0.51, , ,-0.15, , , , ,-0.3, , ,0.34,,,-0.51,-0.15,,,-0.3,0.34,,,,,,,NA,NA,,,,,,
C9JJZ4,P51636,Caveolin,CAV2,94.68,93.41,S23,ADVQLFMDDDSYSHHSGLEYADPEKFADSDQ,_ADVQLFMDDDSYS(ph)HHS(ph)GLEYADPEK_, , , , ,-0.51,-0.51, ,-0.15, , , , ,-0.3,-0.04, ,0.34,,,-0.51,-0.15,,,-0.16,0.34,,,,,,,NA,NA,,,,,,
P22681,P22681,E3 ubiquitin-protein ligase CBL,CBL,160.67,155.04,Y674,CDHPKIKPSSSANAIYSLAARPLPVPKLPPG,_IKPSSSANAIY(ph)SLAAR_,2.06,3.61,4.87,3.79,2.9, , , ,1.77,3.24,3.38,2.14,3.32, , , ,3.03,4.43,2.9,,2.68,2.89,3.32,, +, +,,RING finger,,,NA,NA,,cytosol,calcium ion binding,epidermal growth factor receptor signaling pathway,,+
P22681,P22681,E3 ubiquitin-protein ligase CBL,CBL,270.23,269.71,Y700,KLPPGEQCEGEEDTEYMTPSSRPLRPLDTSQ,_LPPGEQCEGEEDTEY(ph)MTPSSRPLRPLDTSQSSR_,5.17, ,5.02, , , , , ,4.91, ,3.86, , , , , ,5.17,5.02,,,4.91,3.86,,, +, +,,RING finger,,,NA,NA,,cytosol,calcium ion binding,epidermal growth factor receptor signaling pathway,,+
P22681,P22681,E3 ubiquitin-protein ligase CBL,CBL,228.58,220.55,Y455,GSLLRQGAEGAPSPNYDDDDDERADDTLFMM,_QGAEGAPSPNY(ph)DDDDDERADDTLFMMK_, , ,1.36, , , , , , , ,-0.37, , , , , ,,1.36,,,,-0.37,,, +,,,RING finger,,,NA,NA,,cytosol,calcium ion binding,epidermal growth factor receptor signaling pathway,,+
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,142.72,138.37,Y665,EGAKVFSNGHLGSEEYDVPPRLSPPPPVTTL,_VFSNGHLGSEEY(ph)DVPPR_,2.77, ,0.96, , , , , ,2.7, ,1.02, , , , , ,2.77,0.96,,,2.7,1.02,,, +, +,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,65.18,57.57,Y763,GPSSEKKSNIPDLSIYLKGDVFDSASDPVPL,_SNIPDLSIY(ph)LK_,3.58, ,1.99, , , , , ,3.33, ,0.8, , , , , ,3.58,1.99,,,3.33,0.8,,, +, +,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,187.79,185.98,Y889,RLPGENVKTNRTSQDYDQLPSCSDGSQAPAR,_TSQDY(ph)DQLPSCSDGSQAPARPPKPR_,3.88, ,3.45, , , , , ,3.75, ,2.74, , , , , ,3.88,3.45,,,3.75,2.74,,, +, +,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,118.32,117.49,S476,MNRLANVRKCTDRQNSPVTSPGSSPLAQRRK,_QNS(ph)PVTS(ph)PGSS(ph)PLAQR_, , , , ,-0.71,-0.88,-0.71,-0.5, , , , ,0.07,-0.35,-0.44,-0.39,,,-0.79,-0.6,,,-0.12,-0.42,,,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,118.32,117.49,S480,ANVRKCTDRQNSPVTSPGSSPLAQRRKPQPD,_(gl)QNS(ph)PVTS(ph)PGS(ph)SPLAQR_, , , , ,-0.87,-0.7,-0.63,-0.68, , , , ,0.37,-0.43,-0.62,-0.32,,,-0.78,-0.66,,,0.02,-0.46,,,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13191,Q13191,E3 ubiquitin-protein ligase CBL-B,CBLB,118.32,117.49,S484,KCTDRQNSPVTSPGSSPLAQRRKPQPDPLQI,_(gl)QNS(ph)PVTS(ph)PGSS(ph)PLAQR_, , , , ,-0.54,-0.88,-0.79,-0.68, , , , ,-0.22,-0.35,-0.27,-0.32,,,-0.7,-0.73,,,-0.28,-0.3,,,,RING finger,,,NA,NA,,cytosol,calcium ion binding,cell surface receptor signaling pathway,,
Q13185,Q13185,Chromobox protein homolog 3,CBX3,110.51,98.59,S176,PQIVIAFYEERLTWHSCPEDEAQ________,_LTWHS(ph)CPEDEAQ_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,"condensed chromosome, centromeric region",,chromatin remodeling,,
Q13185,Q13185,Chromobox protein homolog 3,CBX3,176.85,176.85,S93,NSQKAGKEKDGTKRKSLSDSESDDSKSKKKR,_RKS(ph)LS(ph)DSESDDSK_,-0.33, ,0.72, , ,0.53,0.87,0.69,-0.33, ,0.68, , ,0.58,0.78,0.63,-0.33,0.72,0.53,0.78,-0.33,0.68,0.58,0.71,,,,,,,0,0,,"condensed chromosome, centromeric region",,chromatin remodeling,,
Q13185,Q13185,Chromobox protein homolog 3,CBX3,207.8,194.46,S95,QKAGKEKDGTKRKSLSDSESDDSKSKKKRDA,_SLS(ph)DSESDDSK_,-0.35, ,0.3, , ,0.56,1.17,0.59,-0.13, ,0.5, , ,0.7,0.49,0.41,-0.35,0.3,0.56,0.91,-0.13,0.5,0.7,0.45,,,,,,,0,0,,"condensed chromosome, centromeric region",,chromatin remodeling,,
G3V1X9,P45973,Chromobox protein homolog 5,CBX5,62.19,62.19,S11,_____MGKKTKRTADSSSSEDEEEYVVEKVL,_TADS(ph)S(ph)S(ph)S(ph)EDEEEYVVEK_, , , , , , , ,-0.1, , , , , , , ,0.25,,,,-0.1,,,,0.25,,,,,,,NA,NA,,,,,,
G3V1X9,P45973,Chromobox protein homolog 5,CBX5,73.28,72.44,S12,____MGKKTKRTADSSSSEDEEEYVVEKVLD,_TADS(ph)S(ph)S(ph)S(ph)EDEEEYVVEK_, , , , , ,0.1,0.13,-0.1, , , , , ,-0.08,0.26,0.25,,,0.1,0.02,,,-0.08,0.25,,,,,,,NA,NA,,,,,,
G3V1X9,P45973,Chromobox protein homolog 5,CBX5,73.28,72.44,S13,___MGKKTKRTADSSSSEDEEEYVVEKVLDR,_TADS(ph)S(ph)S(ph)S(ph)EDEEEYVVEK_, , , , , ,0.1,0.13,-0.1, , , , , ,-0.08,0.26,0.25,,,0.1,0.02,,,-0.08,0.25,,,,,,,NA,NA,,,,,,
G3V1X9,P45973,Chromobox protein homolog 5,CBX5,73.28,72.44,S14,__MGKKTKRTADSSSSEDEEEYVVEKVLDRR,_TADS(ph)S(ph)S(ph)S(ph)EDEEEYVVEK_, , , , , ,0.1,0.13,-0.1, , , , , ,-0.08,0.26,0.25,,,0.1,0.02,,,-0.08,0.25,,,,,,,NA,NA,,,,,,
Q6ZU64,Q6ZU64,Coiled-coil domain-containing protein 108,CCDC108,53.04,35.75,S1509,VAPEETVPFVVTLRASVHASFYSADLVCKLY,_AS(ph)VHASFYS(ph)ADLVCK_, , , , ,1.4, , ,0.38, , , , ,-1.11, , ,-0.6,,,1.4,0.38,,,-1.11,-0.6, +, +,,,,,NA,NA,,integral to membrane,structural molecule activity,,,
Q6ZU64,Q6ZU64,Coiled-coil domain-containing protein 108,CCDC108,53.04,35.75,S1516,PFVVTLRASVHASFYSADLVCKLYSQQLMRQ,_AS(ph)VHASFYS(ph)ADLVCK_, , , , ,1.4, , ,0.38, , , , ,-1.11, , ,-0.6,,,1.4,0.38,,,-1.11,-0.6, +, +,,,,,NA,NA,,integral to membrane,structural molecule activity,,,
B4DTU2,Q96HB5,Coiled-coil domain-containing protein 120,CCDC120,78.67,72.38,S360,SDRASLFVARTRRSNSSEALLVDRAAGGGAG,_SNS(ph)SEALLVDR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q96CT7,Q96CT7,Coiled-coil domain-containing protein 124,CCDC124,279.62,235.11,Y38,KAAADAKKQKELEDAYWKDDDKHVMRKEQRK,_ELEDAY(ph)WKDDDK_,3.5, ,3.38, , , , , ,2.79, ,3.2, , , , , ,3.5,3.38,,,2.79,3.2,,, +, +,,,,,NA,NA,,,,,,
Q86WR0,Q86WR0,Coiled-coil domain-containing protein 25,CCDC25,205.96,197.62,S204,LMKVENMSSNQDGNDSDEFM___________,_VENM(ox)SSNQDGNDS(ph)DEFM(ox)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q96MW1,Q96MW1,Coiled-coil domain-containing protein 43,CCDC43,290.54,281.68,T139,EKQRKAALLAQYADVTDEEDEADEKDDSGAT,_AALLAQYADVT(ph)DEEDEADEK_,0.04,0.22,0.09,-0.13,-0.08,0.12,0.25,0.08,0.07,0.09,-0.02,-0.01,-0.03,0.02,-0.11,0.02,0.13,-0.02,0.02,0.17,0.08,-0.01,0,-0.04,,,,,,,0,0,,,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,142.91,125.66,Y140,KKRKKHFPEFPATRAYADSYYYEDGGMKPRV,_AY(ph)ADSY(ph)YYEDGGMKPR_, , ,3.66, , , , , , , ,2.01, , , , , ,,3.66,,,,2.01,,, +, +,,,,,NA,NA,,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,297.97,293.62,Y144,KHFPEFPATRAYADSYYYEDGGMKPRVMKEA,_AYADSY(ph)YYEDGGMKPR_,3.48,2.21,6.13,6.11,2.67, , ,0.67,2.88,1.34,4.64,4.67,3.64, , ,1.7,2.98,6.12,2.67,0.67,2.31,4.66,3.64,1.7, +, +,,,,,4,4,18.46,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,259.96,236.96,Y145,HFPEFPATRAYADSYYYEDGGMKPRVMKEAV,_AYADSY(ph)Y(ph)YEDGGM(ox)KPR_,4.86,2.21,-0.92, , , , , ,4.1,1.34,-2.97, , , , , ,4.07,-0.92,,,3.3,-2.97,,, +, +,,,,,NA,NA,,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,177.58,176.8,Y174,AVSTPSRMAHRDQEWYDAEIARKLQEEELLA,_MAHRDQEWY(ph)DAEIAR_,4.34, , , , , , , ,3.55, , , , , , , ,4.34,,,,3.55,,,, +, +,,,,,NA,NA,,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,466.39,463.66,Y279,ARPPPPIMTDGEDADYTHFTNQQSSTRHFSK,_NERPARPPPPIMTDGEDADY(ph)THFTNQQSSTR_,4.96,3.22,5.27, , , , , ,4.18,2.4,3.18, , , , , ,4.33,5.27,,,3.55,3.18,,, +, +,,,,,NA,NA,,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,128.06,120.35,Y146,FPEFPATRAYADSYYYEDGGMKPRVMKEAVS,_AYADSY(ph)Y(ph)Y(ph)EDGGM(ox)KPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
Q8IVM0,Q8IVM0,Coiled-coil domain-containing protein 50,CCDC50,226.93,207.24,S143,KKHFPEFPATRAYADSYYYEDGGMKPRVMKE,_AYADS(ph)YY(ph)YEDGGMKPR_,0.86, , , , , , , ,0.12, , , , , , , ,0.86,,,,0.12,,,,,,,,,,NA,NA,,cytoplasm,,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,152.86,99.75,S244,RILQEKLDQPVSAPPSPRDISMEIDSPENMM,_LDQPVS(ph)APPS(ph)PR_,-0.74,-0.04,1.18,0.84,1.05,1.03,1.27,1.45,0.11,0.15,1.18,0.83,1.03,0.97,1.33,1.31,-0.35,1.02,1.04,1.36,0.13,1.01,1,1.32, +, +,,,,,1,1,39.9,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,98.68,96.54,S327,MERREALCRQLSESESSLEMDDERYFNEMSA,_QLS(ph)ESES(ph)S(ph)LEMDDER_, , , , , , , ,1.79, , , , , , , ,1.35,,,,1.79,,,,1.35, +, +,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,138.46,129.4,S249,KLDQPVSAPPSPRDISMEIDSPENMMRHIRF,_DIS(ph)MEIDS(ph)PENMMR_, , , , , , ,-1.43, , , , , , , ,-0.89, ,,,,-1.43,,,,-0.89, +,,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,152.86,99.75,S240,EAEKRILQEKLDQPVSAPPSPRDISMEIDSP,_LDQPVS(ph)APPS(ph)PR_,-0.18,-0.14,0.22,0.22,1.05,1.03,0.95,0.95,0.03,0.1,0.32,0.38,1.03,0.97,0.86,0.98,-0.16,0.22,1.04,0.95,0.07,0.35,1,0.92, +,,,,,,2,0,46.06,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,174.82,174.82,S323,LQREMERREALCRQLSESESSLEMDDERYFN,_QLS(ph)ESES(ph)S(ph)LEMDDER_, , , , ,0.18,0.58,1.18,0.7, , , , ,0.11,0.64,1.26,0.83,,,0.39,0.96,,,0.4,1.06,, +,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,174.82,174.82,S328,ERREALCRQLSESESSLEMDDERYFNEMSAQ,_QLS(ph)ESES(ph)S(ph)LEMDDER_, , , , ,0.59,0.63,0.68,1.25, , , , ,0.3,0.65,1.05,1.09,,,0.61,0.99,,,0.48,1.07,, +,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,204.69,193.57,S254,VSAPPSPRDISMEIDSPENMMRHIRFLKNEV,_DIS(ph)MEIDS(ph)PENMMR_,-0.69,-0.84,-0.93,-0.74,-0.42,-0.09,-0.18,-0.19,-0.25,-0.1,-0.21,-0.21,-0.11,-0.4,-0.31,-0.31,-0.76,-0.83,-0.24,-0.19,-0.18,-0.21,-0.25,-0.31,,,,,,,0,0,,cytoplasm,structural constituent of cytoskeleton,,,
Q16204,Q16204,Coiled-coil domain-containing protein 6,CCDC6,97.83,97.12,S325,REMERREALCRQLSESESSLEMDDERYFNEM,_(gl)QLS(ph)ES(ph)ESS(ph)LEMDDER_, , , , ,0.99,0.84,0.74,0.48, , , , ,0.48,0.65,0.84,0.59,,,0.92,0.62,,,0.57,0.72,,,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,,,
F5GZQ6,Q9Y6R9,Coiled-coil domain-containing protein 61,CCDC61,125.31,115.45,S373,IWHLREQQQQRNRLGSGGSGDGPSVSWSRQT,_LGS(ph)GGS(ph)GDGPSVSWSR_, , ,0.96, ,-0.58,-0.19, , , , ,0.78, ,-0.84,-0.82, , ,,0.96,-0.37,,,0.78,-0.83,,,,,,,,NA,NA,,,,,,
F5GZQ6,Q9Y6R9,Coiled-coil domain-containing protein 61,CCDC61,125.31,115.45,S376,LREQQQQRNRLGSGGSGDGPSVSWSRQTQPP,_LGS(ph)GGS(ph)GDGPSVSWSR_, , ,0.96, ,-0.58,-0.19, , , , ,0.78, ,-0.84,-0.82, , ,,0.96,-0.37,,,0.78,-0.83,,,,,,,,NA,NA,,,,,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,150.44,150.44,S66,VQRAGLGSPERPPKTSPGSPRLQQGAGLESP,_AGLGSPERPPKTS(ph)PGS(ph)PR_,0.01,-0.05,0.02,0.11,-0.75, ,-0.65,-0.26,-0.24,-0.25,-0.34,-0.26,-0.95, ,-0.94,-1.21,-0.02,0.07,-0.75,-0.44,-0.25,-0.3,-0.95,-1.07,, +,,,,,0,6,16.83,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,150.44,150.44,S69,AGLGSPERPPKTSPGSPRLQQGAGLESPQGQ,_AGLGS(ph)PERPPKTS(ph)PGS(ph)PR_,-0.02,-0.05,0.02,0.11,-0.73, ,-0.65,-0.26,-0.25,-0.24,-0.33,-0.26,-0.94, ,-0.94,-1.21,-0.04,0.07,-0.73,-0.44,-0.24,-0.29,-0.94,-1.07,, +,,,,,0,6,16.88,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,196.64,190.97,S110,QQDLHLESPQRQPEYSPESPRCQPKPSEEAP,_(gl)QQDLHLES(ph)PQRQPEYS(ph)PES(ph)PR_, ,0.23, , ,-0.16,-0.13,-0.5,-0.18, ,-0.13, , ,0.09,0.09,-0.79,-0.54,0.23,,-0.15,-0.33,-0.13,,0.09,-0.66,,,,,,,NA,NA,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,196.64,190.97,S113,LHLESPQRQPEYSPESPRCQPKPSEEAPKCS,_(gl)QQDLHLES(ph)PQRQPEYS(ph)PES(ph)PR_, ,-0.01, , ,-0.16,0.47,-0.07,0.09, ,-0.23, , ,0.09,-0.27,-0.17,-0.04,-0.01,,0.19,0.01,-0.23,,-0.08,-0.1,,,,,,,NA,NA,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,196.64,190.97,S102,PGAASPQRQQDLHLESPQRQPEYSPESPRCQ,_(gl)QQDLHLES(ph)PQRQPEYS(ph)PES(ph)PR_, ,-0.01, , ,-0.16,-0.13,-0.07,-0.29, ,-0.23, , ,0.09,0.09,-0.17,-0.52,-0.01,,-0.15,-0.17,-0.23,,0.09,-0.33,,,,,,,NA,NA,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,267.26,261.95,S80,TSPGSPRLQQGAGLESPQGQPEPGAASPQRQ,_LQQGAGLES(ph)PQGQPEPGAAS(ph)PQR_,0.13,0.07,0.16,0.22,-0.16,-0.22,-0.2,-0.27,-0.07,-0.07,-0.15,-0.1,0.06,0.05,-0.2,-0.19,0.1,0.19,-0.19,-0.23,-0.07,-0.13,0.05,-0.19,,,,,,,0,0,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,302.29,299.79,S91,AGLESPQGQPEPGAASPQRQQDLHLESPQRQ,_LQQGAGLES(ph)PQGQPEPGAAS(ph)PQR_,-0.03,-0.01,-0.1,-0.1,-0.18,-0.2,-0.34,-0.32,-0.04,-0.05,-0.19,-0.18,-0.12,-0.17,-0.26,-0.26,-0.02,-0.1,-0.19,-0.33,-0.04,-0.19,-0.14,-0.26,,,,,,,0,0,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,150.44,150.44,S58,REPGSPPSVQRAGLGSPERPPKTSPGSPRLQ,_AGLGS(ph)PERPPK_,0.35,0.37,0.41,0.27,0.35, ,0.22,0.15,0.09,0.06,-0.34,-0.53,0.44, ,0.07,-0.39,0.36,0.34,0.35,0.19,0.08,-0.43,0.44,-0.14,,,,,,,0,0,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,233.37,233.37,S47,LVEFESNPEETREPGSPPSVQRAGLGSPERP,_ALVEFESNPEETREPGS(ph)PPSVQR_,-0.02,0.03,-0.03,0.04,0,0.13,-0.13,0.12,-0.21,-0.19,-0.31,-0.33,0.02,0.19,-0.17,-0.16,0,0,0.07,0,-0.2,-0.32,0.11,-0.16,,,,,,,0,0,,nucleolus,,virus-host interaction,,
Q9H6F5,Q9H6F5,Coiled-coil domain-containing protein 86,CCDC86,288.92,288.92,S18,TPLRRSRRLGGLRPESPESLTSVSRTRRALV,_LGGLRPES(ph)PESLTSVSR_,-0.04,-0.02,-0.09,-0.04,-0.05,0.18,-0.14,-0.16,-0.16,-0.19,-0.24,-0.31,-0.33,-0.29,-0.4,-0.44,-0.03,-0.07,0.07,-0.15,-0.17,-0.27,-0.31,-0.42,,,,,,,0,0,,nucleolus,,virus-host interaction,,
B7ZM78,Q3V6T2,Girdin,CCDC88A,101.04,98.07,S1702,LEESNKLTSVQIKSSSQENLLDEVMKSLSVS,_SSS(ph)QENLLDEVMK_, , ,-0.25, ,-0.05,-0.42,0.06,-0.23, , ,-0.96, ,-1.09,-1.19,-0.86,-0.5,,-0.25,-0.23,-0.08,,-0.96,-1.14,-0.67,, +,,,,,NA,NA,,,,,,
F5GXE9,Q9Y3X0,Coiled-coil domain-containing protein 9,CCDC9,59.37,59.36,S376,YSDHDDRWETKEGAASPAPETPQPTSPETSP,_EGAAS(ph)PAPETPQPTS(ph)PET(ph)SPK_, , , , , , ,-0.36,-0.35, , , , , , ,-0.23,-0.03,,,,-0.35,,,,-0.13,,,,,,,NA,NA,,,,,,
F5GXE9,Q9Y3X0,Coiled-coil domain-containing protein 9,CCDC9,115.92,114.41,S386,KEGAASPAPETPQPTSPETSPKETPMQPPEI,_EGAASPAPETPQPTS(ph)PETS(ph)PK_, , , , ,0.2,0.24,0.22,0.21, , , , ,0.24,0.68,0.28,0.59,,,0.22,0.22,,,0.47,0.45,,,,,,,NA,NA,,,,,,
F8W9X7,Q567U6,Coiled-coil domain-containing protein 93,CCDC93,125.61,84.98,S305,VSEYAEKQSELSAEESPEKLGTSQLHRRKVI,_QSELSAEES(ph)PEK_, , ,0.18, ,-0.41,-0.22,-0.25, , , ,0.47, ,-0.16,1.3,-0.33, ,,0.18,-0.31,-0.25,,0.47,0.75,-0.33,,,,,,,NA,NA,,,,,,
Q9BW85,Q9BW85,Coiled-coil domain-containing protein 94,CCDC94,203.85,203.72,S211,AALLEEARKRRLLEDSDSEDEAAPSPLQPAL,_LLEDS(ph)DS(ph)EDEAAPSPLQPALRPNPTAILDEAPKPK_,-0.48,-0.19,0.05,-0.13,0.4,-0.29, , ,0.58,0.96,0.45,0.61, ,0.06, , ,-0.33,-0.04,0.1,,0.78,0.53,0.06,,,,,,,,NA,NA,,,,,,
Q9BW85,Q9BW85,Coiled-coil domain-containing protein 94,CCDC94,203.85,203.72,S213,LLEEARKRRLLEDSDSEDEAAPSPLQPALRP,_LLEDS(ph)DS(ph)EDEAAPSPLQPALRPNPTAILDEAPKPK_,-0.48,-0.19,0.05,-0.13,0.4,-0.29, , ,0.58,0.96,0.45,0.61, ,0.06, , ,-0.33,-0.04,0.1,,0.78,0.53,0.06,,,,,,,,NA,NA,,,,,,
Q96F63,Q96F63,Coiled-coil domain-containing protein 97,CCDC97,172.96,172.4,S337,EEERYFDEEEPEDAPSPELDGD_________,_YFDEEEPEDAPS(ph)PELDGD_,-0.09,-0.03,-0.23,-0.26, , , ,-0.27,0.07,0.11,-0.04,-0.07, , , ,-0.04,-0.06,-0.24,,-0.27,0.09,-0.06,,-0.04,,,,,,,NA,NA,,,,,,
C9JUH3,Q9BSQ5,Malcavernin,CCM2,123.01,86.58,S384,LETIGVKDGRGIITDSFGRHRRALSTTSSST,_GIITDS(ph)FGR_,0.61, ,-0.02, ,0.46,0.3, ,0.7,0.99, ,0.69, ,-0.29,0.7, ,0.45,0.61,-0.02,0.38,0.7,0.99,0.69,0.29,0.45,,,,,,,0,0,,,,,,
D6RHI7,P51946,Cyclin-H,CCNH,214.54,213.94,S322,SKHEEEEWTDDDLVESL______________,_HEEEEWT(ph)DDDLVES(ph)L_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,TFIIK complex,cyclin-dependent protein kinase regulator activity,phosphorylation,,
D6RHI7,P51946,Cyclin-H,CCNH,226.93,204.1,T315,DDYVSKKSKHEEEEWTDDDLVESL_______,_HEEEEWT(ph)DDDLVES(ph)L_,0.05,-0.12,-0.03,0.09,-0.03,-0.25, ,0.09,0.02,0,-0.2,-0.12,0.12,0.12, ,-0.21,-0.04,0.03,-0.14,0.09,0.01,-0.16,0.12,-0.21,,,,,,,0,0,,TFIIK complex,cyclin-dependent protein kinase regulator activity,phosphorylation,,
O75909-1,O75909,Cyclin-K,CCNK,92.77,92.77,S340,PQPSSPRQVKRAVVVSPKEENKAAEPAPSQH,_RAVVVS(ph)PKEENK_,0.21,2.84,0.64,1.22,0.84,1.29, , ,0.09,0.07,-0.06,0.11,0.13,0.14, , ,2.06,0.96,1.09,,0.08,0.03,0.14,, +,,,,,,NA,NA,,cyclin K-CDK12 complex,cyclin-dependent protein kinase activity,cell division,,
Q9UK58,Q9UK58,Cyclin-L1,CCNL1,220.86,188.7,S352,ASKPSSPREVKAEEKSPISINVKTVKKEPED,_S(ph)PIS(ph)INVK_,0.23,0.23,0.54,0.42,0.29,0.22,0.28,0.41,0.03,0,0.41,0.13,0.17,0.23,0.32,0.3,0.23,0.48,0.25,0.35,0.02,0.28,0.2,0.31,,,,,,,0,0,,nuclear speck,,regulation of cyclin-dependent protein kinase activity,,
Q9UK58,Q9UK58,Cyclin-L1,CCNL1,89.43,43.08,S355,PSSPREVKAEEKSPISINVKTVKKEPEDRQQ,_S(ph)PIS(ph)INVK_, ,0.25, ,0.37,-0.28,-0.24,0.15,0.31, ,0.81, ,-0.01,-0.58,-0.39,0.21,0.21,0.25,0.37,-0.26,0.23,0.81,-0.01,-0.48,0.21,,,,,,,0,0,,nuclear speck,,regulation of cyclin-dependent protein kinase activity,,
Q9UK58,Q9UK58,Cyclin-L1,CCNL1,182.26,182.14,S335,LNPDGTPALSTLGGFSPASKPSSPREVKAEE,_GLNPDGTPALSTLGGFS(ph)PAS(ph)KPS(ph)SPR_,0.36,0.39,0.54,0.5,0.37,0.7,1.02,0.14,-0.26,0.16,0.19,-0.02,0.31,0.02,-0.27,-0.17,0.37,0.52,0.55,0.65,-0.03,0.09,0.18,-0.22,,,,,,,0,0,,nuclear speck,,regulation of cyclin-dependent protein kinase activity,,
Q9UK58,Q9UK58,Cyclin-L1,CCNL1,161.46,161.31,S338,DGTPALSTLGGFSPASKPSSPREVKAEEKSP,_GLNPDGTPALSTLGGFS(ph)PAS(ph)KPS(ph)SPR_,-0.14, , , ,-0.24,0.06,-0.02,0.14,-0.25, , , ,-0.38,-0.13,-0.35,-0.17,-0.14,,-0.08,0.06,-0.25,,-0.25,-0.25,,,,,,,NA,NA,,nuclear speck,,regulation of cyclin-dependent protein kinase activity,,
B7Z8E4,Q8ND76,Cyclin-Y,CCNY,135.14,113.04,S326,DKYKDLRRSARKRSASADNLTLPRWSPAIIS,_SAS(ph)ADNLTLPR_,-0.01,-0.12,0.03,-0.13,-0.48, ,-0.43,-0.16,-0.28,0.16,0.13,0.06,-0.29, ,0.09,0.07,-0.06,-0.05,-0.48,-0.29,-0.05,0.09,-0.29,0.08,,,,,,,0,0,,endoplasmic reticulum,ATP binding,regulation of cyclin-dependent protein kinase activity,,
Q8N7R7-3,Q8N7R7,Cyclin-Y-like protein 1,CCNYL1,213.52,211.71,S344,CEDKDLCRAAMRRSFSADNFIGIQRSKAILS,_SFS(ph)ADNFIGIQR_,0.17,0.21,0.11,0.18,-0.06,0.16,0.11,-0.08,0.12,0.08,0.2,0.2,0.01,0.05,0.46,-0.08,0.19,0.14,0.05,0.02,0.1,0.2,0.03,0.21,,,,,,,0,0,,,,regulation of cyclin-dependent protein kinase activity,,
Q6YHK3-4,Q6YHK3,CD109 antigen,CD109,60.49,56.74,Y650,ECGLWVLTDANLTKDYIDGVYDNAEYAERFM,_DY(ph)IDGVYDNAEYAER_, ,-0.31, ,-0.21, , , , , ,-0.42, ,-0.55, , , , ,-0.31,-0.21,,,-0.42,-0.55,,,,,,,,,NA,NA,,anchored to membrane,serine-type endopeptidase inhibitor activity,negative regulation of endopeptidase activity,,
Q9Y5K6,Q9Y5K6,CD2-associated protein,CD2AP,168.98,164.37,S458,SKLKLDSEQLPLRPKSVDFDSLTVRTSKETD,_S(ph)VDFDSLTVR_,-2.93,-2.66,-1.34,-1.31,-0.43,-0.17,-0.03,0.01,-2.41,-2.19,-1.43,-1.3,-0.85,-0.61,-0.37,-0.41,-2.79,-1.33,-0.29,-0.01,-2.3,-1.36,-0.72,-0.39, +, +,,,,,3,3,23.9,cytoplasm,structural constituent of cytoskeleton,cell division,,
Q9Y5K6,Q9Y5K6,CD2-associated protein,CD2AP,94.28,70.65,Y88,ERHGNVASLVQRISTYGLPAGGIQPHPQTKN,_ISTY(ph)GLPAGGIQPHPQTK_, , ,1.55, , , , , , , , , , , , , ,,1.55,,,,,,, +,,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,cell division,,
Q9Y5K6,Q9Y5K6,CD2-associated protein,CD2AP,125.84,77.95,Y548,SELKKDTCYSPKPSVYLSTPSSASKANTTAF,_PSVY(ph)LSTPSSASK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,structural constituent of cytoskeleton,cell division,,
Q9Y5K6,Q9Y5K6,CD2-associated protein,CD2AP,78.17,68.54,S510,KMPGRRLPGRFNGGHSPTHSPEKILKLPKEE,_FNGGHS(ph)PTHS(ph)PEK_,-0.17,0.09,-0.03,-0.42,0.24,-0.39,0.08,-0.7,-0.19,0.2,0.01,-0.31,0.23,-0.21,0.2,-0.19,-0.04,-0.21,-0.04,-0.26,0.02,-0.14,0.03,0.02,,,,,,,0,0,,cytoplasm,structural constituent of cytoskeleton,cell division,,
Q9Y5K6,Q9Y5K6,CD2-associated protein,CD2AP,69.02,65.98,S514,RRLPGRFNGGHSPTHSPEKILKLPKEEDSAN,_FNGGHS(ph)PTHS(ph)PEK_,-0.42,-0.08,-0.43,-0.42,-0.45,-0.39,-0.45,-0.7,-0.22,0.3,-0.17,-0.31,-0.21,-0.21,-0.18,-0.19,-0.24,-0.43,-0.42,-0.57,0.06,-0.24,-0.21,-0.18,,,,,,,0,0,,cytoplasm,structural constituent of cytoskeleton,cell division,,
O95400,O95400,CD2 antigen cytoplasmic tail-binding protein 2,CD2BP2,193.26,193.26,S195,ARGGGKGRKGPGQPSSPQRLDRLSGLADQMV,_GPGQPSS(ph)PQRLDR_,-0.23,-0.1,-0.29,-0.19,-0.31,-0.31,-0.29,-0.22,-0.2,-0.19,-0.16,-0.14,-0.24,-0.27,-0.34,-0.31,-0.16,-0.24,-0.31,-0.25,-0.2,-0.15,-0.25,-0.32,,,,,,,0,0,,cytoplasm,ribonucleoprotein complex binding,assembly of spliceosomal tri-snRNP,,
O95400,O95400,CD2 antigen cytoplasmic tail-binding protein 2,CD2BP2,404.34,392.9,S49,SGGPGSRFKGKHSLDSDEEEDDDDGGSSKYD,_HSLDS(ph)DEEEDDDDGGSSK_,0.06,-0.15,-0.16,-0.11, ,-0.15,-0.12,-0.15,0.22,0.13,0,0.03, ,-0.11,-0.09,-0.05,-0.04,-0.14,-0.15,-0.14,0.17,0.01,-0.11,-0.07,,,,,,,0,0,,cytoplasm,ribonucleoprotein complex binding,assembly of spliceosomal tri-snRNP,,
O15446,O15446,DNA-directed RNA polymerase I subunit RPA34,CD3EAP,97.29,95.39,S490,TVPQEEMPGPPLNSESGEEAPTGRDKKRKQQ,_MPETVPQEEMPGPPLNSES(ph)GEEAPTGR_, , , , , , ,0.53, , , , , , , ,-0.56, ,,,,0.53,,,,-0.56,,,,,,,NA,NA,,chromosome,DNA-directed RNA polymerase activity,rRNA transcription,,
O15446,O15446,DNA-directed RNA polymerase I subunit RPA34,CD3EAP,310.03,295.44,S285,KQEQINTEPLEDTVLSPTKKRKRQKGTEGME,_QEQINTEPLEDTVLS(ph)PTK_,-0.03,-0.12,0,0.04,-0.23,-0.3, ,-0.35,-0.17,-0.12,-0.31,-0.23,0.11,0.01, ,0.01,-0.08,0.02,-0.26,-0.35,-0.14,-0.27,0.06,0.01,,,,,,,0,0,,chromosome,DNA-directed RNA polymerase activity,rRNA transcription,,
H0YD13,P16070,CD44 antigen,CD44,194.13,163.31,S706,VEDRKPSGLNGEASKSQEMVHLVNKESSETP,_S(ph)QEMVHLVNK_,0.18,0.13,-0.04,-0.06,0.06,-0.15,0,0.1,-0.3,-0.05,-0.41,-0.37,0.06,0.07,-0.14,0,0.16,-0.05,-0.05,0.05,-0.17,-0.39,0.07,-0.07,,,,,,,0,0,,membrane,hyaluronic acid binding,cell adhesion,,
H0YD13,P16070,CD44 antigen,CD44,87.35,85.28,T720,KSQEMVHLVNKESSETPDQFMTADETRNLQN,_ESSET(ph)PDQFMTADETR_, , , , ,-0.95, , , , , , , ,-0.55, , , ,,,-0.95,,,,-0.55,,,,,,,,NA,NA,,membrane,hyaluronic acid binding,cell adhesion,,
F5H3G2,P48960,CD97 antigen,CD97,140.57,118.24,S831,TTSGTGHNQTRALRASESGI___________,_ALRAS(ph)ESGI_,0.88,0.85,2.88,2.85,1.71,1.72,1.73,1.53,0.54,0.43,2.69,2.69,1.67,1.81,1.97,1.68,0.86,2.86,1.71,1.63,0.49,2.69,1.74,1.83, +, +,,,,,4,1,36.93,,,,,
Q9UJX2,Q9UJX2,Cell division cycle protein 23 homolog,CDC23,207.43,205.99,S588,LPASLSANNTPTRRVSPLNLSSVTP______,_RVS(ph)PLNLS(ph)SVT(ph)P_,-0.22,-0.26,-0.47,-0.5,-0.11,-0.3,-0.3,-0.16,-0.16,-0.16,-0.35,-0.41,-0.41,-0.45,-0.4,-0.51,-0.24,-0.48,-0.2,-0.23,-0.16,-0.38,-0.43,-0.45,,,,,,,0,0,,anaphase-promoting complex,ubiquitin-protein ligase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q9UJX2,Q9UJX2,Cell division cycle protein 23 homolog,CDC23,178.51,178.15,S593,SANNTPTRRVSPLNLSSVTP___________,_VSPLNLS(ph)SVT(ph)P_, , , , , ,-0.62,-0.53,-0.57, , , , , ,-0.5,-0.79,-0.77,,,-0.62,-0.55,,,-0.5,-0.78,,,,,,,NA,NA,,anaphase-promoting complex,ubiquitin-protein ligase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q9UJX2,Q9UJX2,Cell division cycle protein 23 homolog,CDC23,232.35,217.57,T596,NTPTRRVSPLNLSSVTP______________,_RVS(ph)PLNLS(ph)SVT(ph)P_,-0.08,-0.16,-0.15,-0.24,-0.14,-0.06,-0.45,-0.27,-0.35,-0.29,-0.35,-0.47,-0.12,-0.11,-0.41,-0.38,-0.12,-0.2,-0.1,-0.36,-0.32,-0.41,-0.12,-0.39,,,,,,,0,0,,anaphase-promoting complex,ubiquitin-protein ligase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
G8JLH2,P30305,M-phase inducer phosphatase 2,CDC25B,72.21,45.56,S249,LMCLSPDRKMEVEELSPLALGRFSLTPAEGD,_MEVEELS(ph)PLALGR_, ,-0.27,0.75, , , , , , ,0.51,1.69, , , , , ,-0.27,0.75,,,0.51,1.69,,,, +,,,,Class III Cys-Based PTPs,NA,NA,,intracellular,protein tyrosine phosphatase activity,peptidyl-tyrosine dephosphorylation,,
Q8NHZ8,Q8NHZ8,Anaphase-promoting complex subunit CDC26,CDC26,104.82,40.56,S82,YKPQPKPNNRSSQFGSLEF____________,_SSQFGS(ph)LEF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,anaphase-promoting complex,,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
G5EA36,P30260,Cell division cycle protein 27 homolog,CDC27,90.73,51.56,S435,QPNINDSLEITKLDSSIISEGKISTITPQIQ,_LDSS(ph)IIS(ph)EGK_, , , , ,-0.65,-0.2,-0.17,-0.12, , , , ,-0.78,-0.18,-0.93,-0.95,,,-0.41,-0.14,,,-0.45,-0.94,,,,,,,NA,NA,,anaphase-promoting complex,ligand-dependent nuclear receptor transcription coactivator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
G5EA36,P30260,Cell division cycle protein 27 homolog,CDC27,90.73,51.56,S438,INDSLEITKLDSSIISEGKISTITPQIQAFN,_LDSS(ph)IIS(ph)EGK_, , , , ,-0.65,-0.2,-0.17,-0.12, , , , ,-0.78,-0.18,-0.93,-0.95,,,-0.41,-0.14,,,-0.45,-0.94,,,,,,,NA,NA,,anaphase-promoting complex,ligand-dependent nuclear receptor transcription coactivator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q5VT25-3,Q5VT25,Serine/threonine-protein kinase MRCK alpha,CDC42BPA,63.4,41.71,S1719,NLSSPPSPASPRKTKSLSLESTDRGSWDP__,_S(ph)LSLESTDR_,-0.49,-0.06,0.66, ,0.18,1.15, , ,-0.54,0.17,0.81, ,0.74,1.36, , ,-0.26,0.66,0.74,,-0.14,0.81,1.08,,, +,AGC,,,,NA,NA,,actomyosin,ATP binding,actin cytoskeleton reorganization,,
Q5VT25-3,Q5VT25,Serine/threonine-protein kinase MRCK alpha,CDC42BPA,134.04,134.04,S1721,SSPPSPASPRKTKSLSLESTDRGSWDP____,_SLS(ph)LES(ph)TDRGSWDP_, ,0.64, , ,0.04,0.07,0.15,0.17, ,0.28, , ,-0.38,-0.11,0.19,0.12,0.64,,0.05,0.16,0.28,,-0.24,0.15,,,AGC,,,,NA,NA,,actomyosin,ATP binding,actin cytoskeleton reorganization,,
Q5VT25-3,Q5VT25,Serine/threonine-protein kinase MRCK alpha,CDC42BPA,134.04,134.04,S1724,PSPASPRKTKSLSLESTDRGSWDP_______,_SLS(ph)LES(ph)TDRGSWDP_, , , , ,0.04,0.15,0.15,0.26, , , , ,-0.38,-0.26,0.19,0.07,,,0.1,0.21,,,-0.31,0.13,,,AGC,,,,NA,NA,,actomyosin,ATP binding,actin cytoskeleton reorganization,,
Q00587-2,Q00587,Cdc42 effector protein 1,CDC42EP1,157.35,146.97,S350,DARQERVEVLPQARASWESLDEEWRAPQAGS,_AS(ph)WES(ph)LDEEWRAPQAGSR_,-0.36,-0.71,-1.88,-1.2,-0.04,0.26,-0.02,0.37,-0.62,-0.58,-1.17,-1.57,-0.45,-0.62,-0.32,-0.01,-0.53,-1.5,0.12,0.19,-0.6,-1.36,-0.53,-0.16, +, +,,,,,3,3,25.14,actin cytoskeleton,,positive regulation of pseudopodium assembly,,
Q00587-2,Q00587,Cdc42 effector protein 1,CDC42EP1,157.35,146.97,S353,QERVEVLPQARASWESLDEEWRAPQAGSRTP,_AS(ph)WES(ph)LDEEWRAPQAGSR_, , , , ,-0.04,0.26,-0.02,0.37, , , , ,-0.45,-0.62,-0.32,-0.01,,,0.12,0.19,,,-0.53,-0.16,,,,,,,NA,NA,,actin cytoskeleton,,positive regulation of pseudopodium assembly,,
Q00587-2,Q00587,Cdc42 effector protein 1,CDC42EP1,178.95,149.18,S192,RDGSFPSEPGLRRSDSLLSFRLDLDLGPSLL,_SDS(ph)LLSFR_, , , , , ,0.58,1.02,0.66, , , , , ,-0.65,0.09,-0.08,,,0.58,0.85,,,-0.65,0.01,,,,,,,NA,NA,,actin cytoskeleton,,positive regulation of pseudopodium assembly,,
C9JEZ4,Q9UKI2,Cdc42 effector protein 3,CDC42EP3,298.5,295.78,S89,HLGQFPGHNEFFRANSTSDSVFTETPSPVLK,_ANS(ph)TSDSVFTETPS(ph)PVLK_, , , , ,2.69,3.41,2.72,1.39, , , , ,2.87,3.57,3.18,1.9,,,3.09,2.2,,,3.26,2.68, +, +,,,,,NA,NA,,,,,,
C9JEZ4,Q9UKI2,Cdc42 effector protein 3,CDC42EP3,298.5,295.78,S100,FRANSTSDSVFTETPSPVLKNAISLPTIGGS,_ANS(ph)TSDSVFTETPS(ph)PVLK_, , , , ,2.7,2.68,2.2,2.4, , , , ,2.89,2.64,2.55,1.64,,,2.69,2.3,,,2.77,2.16, +, +,,,,,NA,NA,,,,,,
Q9H3Q1,Q9H3Q1,Cdc42 effector protein 4,CDC42EP4,204.65,204.12,S64,DTSFLNSKAGEPDGESLDEQPSSSSSKRSLL,_AGEPDGES(ph)LDEQPSSSSSK_, , , , ,1.15,0.64,0.68,0.79, , , , ,0.81,0.18,0.52,0.56,,,0.92,0.74,,,0.53,0.54,,,,,,,NA,NA,,actin cytoskeleton,GTP-Rho binding,positive regulation of pseudopodium assembly,,
Q9H3Q1,Q9H3Q1,Cdc42 effector protein 4,CDC42EP4,168.13,166.6,S292,PSHALEDEGWAAAAPSPGSARSMGSHTTRDS,_AGPDLPSLPSHALEDEGWAAAAPS(ph)PGS(ph)AR_,0.1,0.14,-0.92,-0.98,-0.09,0.62,0.31,-0.1,0.08,0.11,-0.39,-0.3,-0.96,0.04,0.02,0.07,0.12,-0.95,0.31,0.12,0.09,-0.34,-0.37,0.04,,,,,,,0,0,,actin cytoskeleton,GTP-Rho binding,positive regulation of pseudopodium assembly,,
Q9H3Q1,Q9H3Q1,Cdc42 effector protein 4,CDC42EP4,168.13,166.6,S295,ALEDEGWAAAAPSPGSARSMGSHTTRDSSSL,_AGPDLPSLPSHALEDEGWAAAAPS(ph)PGS(ph)AR_,0.1,0.14,-0.03,-0.98,-0.04,-0.01,0.31,-0.1,0.08,0.11,0.12,-0.3,-0.44,-0.34,0.02,0.07,0.12,-0.43,-0.03,0.12,0.09,-0.08,-0.39,0.04,,,,,,,0,0,,actin cytoskeleton,GTP-Rho binding,positive regulation of pseudopodium assembly,,
C9J911,O75419,Cell division control protein 45 homolog,CDC45,105.36,103.25,S144,AYEDIFRDEEEDEEHSGNDSDGSEPSEKRTR,_QDDDLEVPAYEDIFRDEEEDEEHS(ph)GNDS(ph)DGS(ph)EPSEK_, , , , , , ,-0.18,-0.33, , , , , , ,-0.24,-0.03,,,,-0.25,,,,-0.14,,,,,,,NA,NA,,centrosome,metal ion binding,DNA replication initiation,,
C9J911,O75419,Cell division control protein 45 homolog,CDC45,105.36,103.25,S148,IFRDEEEDEEHSGNDSDGSEPSEKRTRLEEE,_QDDDLEVPAYEDIFRDEEEDEEHS(ph)GNDS(ph)DGS(ph)EPSEK_, , , , , , ,-0.18,-0.33, , , , , , ,-0.24,-0.03,,,,-0.25,,,,-0.14,,,,,,,NA,NA,,centrosome,metal ion binding,DNA replication initiation,,
C9J911,O75419,Cell division control protein 45 homolog,CDC45,105.36,103.25,S151,DEEEDEEHSGNDSDGSEPSEKRTRLEEEIVE,_QDDDLEVPAYEDIFRDEEEDEEHS(ph)GNDS(ph)DGS(ph)EPSEK_, , , , , , ,-0.18,-0.33, , , , , , ,-0.24,-0.03,,,,-0.25,,,,-0.14,,,,,,,NA,NA,,centrosome,metal ion binding,DNA replication initiation,,
E7EUB4,Q99459,Cell division cycle 5-like protein,CDC5L,80.45,80.45,T385,MALTNVDTPLKGGLNTPLHESDFSGVTPQRQ,_GGLNT(ph)PLHESDFSGVT(ph)PQR_, , , , ,0.2,0.57, ,-0.11, , , , ,0.36,0.44, ,0.1,,,0.39,-0.11,,,0.4,0.1,,,,,,,NA,NA,,,,,,
E7EUB4,Q99459,Cell division cycle 5-like protein,CDC5L,80.45,80.45,T396,GGLNTPLHESDFSGVTPQRQVVQTPNTVLST,_GGLNT(ph)PLHESDFSGVT(ph)PQR_, , , , ,0.2,0.57, ,-0.11, , , , ,0.36,0.44, ,0.1,,,0.39,-0.11,,,0.4,0.1,,,,,,,NA,NA,,,,,,
F5GX58,Q99618,Cell division cycle-associated protein 3,CDCA3,63.68,62.43,S87,GIARTPMKTSSGDPPSPLVKQLSEVFETEDS,_TSSGDPPS(ph)PLVK_, , ,-0.05,-0.07,0.29,-0.02,0.31,-0.14, , ,0.22,0.48,0.08,0.21,0.43,0.66,,-0.06,0.14,0.1,,0.36,0.15,0.55,,,,,,,NA,NA,,,,,,
C9JFL7,Q96GN5,Cell division cycle-associated 7-like protein,CDCA7L,60.13,46.53,S114,EVMVVESDLSDDGKASLVSEEEEDEEEDKAT,_AS(ph)LVS(ph)EEEEDEEEDK_, , , , , , , ,-0.02, , , , , , , ,-0.55,,,,-0.02,,,,-0.55,,,,,,,NA,NA,,,,,,
C9JFL7,Q96GN5,Cell division cycle-associated 7-like protein,CDCA7L,219.66,216.02,S117,VVESDLSDDGKASLVSEEEEDEEEDKATP__,_AS(ph)LVS(ph)EEEEDEEEDK_,-0.98,-0.87,-0.92,-0.73, ,0.11,-0.2,0.4,-0.28,-0.19,-0.16,-0.15, ,0.18,0.02,0,-0.93,-0.82,0.11,0.13,-0.23,-0.15,0.18,0.01,,,,,,,0,0,,,,,,
Q53HL2,Q53HL2,Borealin,CDCA8,89.92,85.7,S219,TPAAGERIYNISGNGSPLADSKEIFLTVPVG,_IYNISGNGS(ph)PLADSK_, ,0.02, , , , , , , ,0.25, , , , , , ,0.02,,,,0.25,,,,,,,,,,NA,NA,,chromocenter,,cell division,,
Q9H5V8,Q9H5V8,CUB domain-containing protein 1,CDCP1,204.35,204.35,Y806,EEPPPRSPPESESEPYTFSHPNNGDVSSKDT,_SPPESESEPY(ph)TFSHPNNGDVSSK_,0.99, ,0.75, , , , , ,-0.6, ,-0.24, , , , , ,0.99,0.75,,,-0.6,-0.24,,,,,,,,,NA,NA,,extracellular region,,,,
P55285,P55285,Cadherin-6,CDH6,69.13,50.66,S786,GPRFKKLADMYGGVDSDKDS___________,_LADMYGGVDS(ph)DKDS_, , , , ,0, , ,0.02, , , , ,0.69, , ,0.26,,,0,0.02,,,0.69,0.26,,,,,,,NA,NA,,cytoplasm,calcium ion binding,adherens junction organization,,
P06493,P06493,Cyclin-dependent kinase 1,CDK1,195.79,96.77,Y15,_MEDYTKIEKIGEGTYGVVYKGRHKTTGQVV,_IGEGT(ph)Y(ph)GVVYK_,0.13,0.12,0.24,0.53,0.4,0.32,0.02,0.14,-0.21,-0.21,0.06,0.2,0.91,0.85,0.22,0.3,0.13,0.39,0.36,0.08,-0.21,0.14,0.88,0.27,,,CMGC,,,,0,0,,cytosol,ATP binding,activation of MAPK activity,,
P06493,P06493,Cyclin-dependent kinase 1,CDK1,123.62,55.08,Y19,YTKIEKIGEGTYGVVYKGRHKTTGQVVAMKK,_IGEGTYGVVY(ph)K_,-0.55,-0.6, ,-0.31,-0.15,-0.06,-0.2,-0.06,-0.37,-0.1, ,0.1,-0.14,-0.14,-0.31,-0.17,-0.58,-0.31,-0.1,-0.13,-0.22,0.1,-0.14,-0.24,,,CMGC,,,,0,0,,cytosol,ATP binding,activation of MAPK activity,,
P06493,P06493,Cyclin-dependent kinase 1,CDK1,182.72,81.27,T14,__MEDYTKIEKIGEGTYGVVYKGRHKTTGQV,_IGEGT(ph)Y(ph)GVVYK_,-0.18,-0.22,-0.61,-0.47,-0.43,-0.21,-0.23,-0.04,-0.23,-0.28,-0.63,-0.52,-1.13,-0.81,-0.49,0.04,-0.2,-0.54,-0.32,-0.13,-0.26,-0.57,-0.96,-0.2,,,CMGC,,,,0,0,,cytosol,ATP binding,activation of MAPK activity,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,81.95,31.15,S577,GILKVGDFGLAREYGSPLKAYTPVVVTLWYR,_EYGS(ph)PLK_,0.17,0.21,0.26, ,0.27,0.1,0.44, ,0.17,0.27,0.14, ,0.15,-0.02,0.64, ,0.19,0.26,0.19,0.44,0.22,0.14,0.07,0.64,,,CMGC,,,,0,0,,cytoplasm,ATP binding,apoptotic process,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,185.37,185.37,S740,TWPAKSEQQRVKRGTSPRPPEGGLGYSQLGD,_RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK_,1.14,0.56,1.15,0.64, , , ,0.16,0.12,0.05,0.24,0.17, , , ,0.35,0.88,0.91,,0.16,0.09,0.21,,0.35,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,185.37,185.37,T739,PTWPAKSEQQRVKRGTSPRPPEGGLGYSQLG,_RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK_,1.14,0.56,1.15,0.64, , , ,0.16,0.12,0.05,0.24,0.17, , , ,0.35,0.88,0.91,,0.16,0.09,0.21,,0.35,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,225.08,215.28,S265,RKPVKEEKMEERDLLSDLQDISDSERKTSSA,_DLLS(ph)DLQDIS(ph)DSER_, , , , ,-0.14,0.08,0.27,0.15, , , , ,-0.07,0.07,0.06,-0.05,,,-0.02,0.21,,,0,0.01,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,271.31,225.7,S271,EKMEERDLLSDLQDISDSERKTSSAESSSAE,_DLLS(ph)DLQDIS(ph)DSER_,-0.12,-0.08,-0.1,-0.12,-0.14,-0.07,0.04,0.02,-0.18,-0.1,-0.19,-0.21,-0.12,0.04,-0.1,-0.11,-0.1,-0.11,-0.1,0.03,-0.14,-0.2,-0.04,-0.1,,,CMGC,,,,0,0,,cytoplasm,ATP binding,apoptotic process,,
P21127-8,Q9UQ88,Cyclin-dependent kinase 11B,CDK11B,89.51,71.81,S47,IKRLKNSDDRDSKRDSLEEGELRDHRMEITI,_RDS(ph)LEEGELR_, ,-0.23, , , , , , , ,-0.46, , , , , , ,-0.23,,,,-0.46,,,,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,97.12,88.62,S291,SPPYKEPSAYQSSTRSPSPYSRRQRSVSPYS,_EPSAYQSSTRS(ph)PS(ph)PYSR_, , , , , ,0.75,0.24,0.09, , , , , ,0.35,0.33,0.18,,,0.75,0.17,,,0.35,0.26,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,78.56,40.83,S423,AAAAAAKMDGKESKGSPVFLPRKENSSVEAK,_GS(ph)PVFLPR_,-0.05,-0.1,-0.17,-0.15,-0.32,-0.28,-0.28,-0.19,0.03,-0.08,0.01,0.07,-0.44,-0.64,-0.5,-0.55,-0.08,-0.16,-0.3,-0.23,-0.03,0.04,-0.53,-0.52,,,CMGC,,,,0,0,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,63.99,63.46,S681,LTDLPLPPELPGGDLSPPDSPEPKAITPPQQ,_HLLTDLPLPPELPGGDLS(ph)PPDS(ph)PEPK_, , , , ,-0.91,-0.56,-0.47,-0.33, , , , ,-0.46,0.18,-0.22,0.11,,,-0.72,-0.4,,,-0.1,-0.05,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,63.99,63.46,S685,PLPPELPGGDLSPPDSPEPKAITPPQQPYKK,_HLLTDLPLPPELPGGDLS(ph)PPDS(ph)PEPK_, , , , ,-0.91,-0.56,-0.47,-0.33, , , , ,-0.46,0.18,-0.22,0.11,,,-0.72,-0.4,,,-0.1,-0.05,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,119.37,119.37,S383,SHSKKKRSSSRSRHSSISPVRLPLNSSLGAE,_HSS(ph)IS(ph)PVRLPLNSSLGAELSR_, , , ,0.27,0.04, , , , , , ,-0.31,-0.16, , , ,,0.27,0.04,,,-0.31,-0.16,,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,119.37,119.37,S385,SKKKRSSSRSRHSSISPVRLPLNSSLGAELS,_HSS(ph)IS(ph)PVRLPLNSSLGAELSR_, , , ,0.27,0.04, , , , , , ,-0.31,-0.16, , , ,,0.27,0.04,,,-0.31,-0.16,,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,318.88,318.41,S236,RSPHRKWSDSSKQDDSPSGASYGQDYDLSPS,_QDDS(ph)PSGASYGQDYDLS(ph)PSR_, ,-0.22, , ,-0.05,-0.03,0.05,-0.06, ,-0.42, , ,-0.08,-0.11,-0.09,-0.08,-0.22,,-0.04,0,-0.42,,-0.1,-0.08,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,318.88,318.41,S249,DDSPSGASYGQDYDLSPSRSHTSSNYDSYKK,_QDDS(ph)PSGASYGQDYDLS(ph)PSR_, ,-0.22, , ,-0.05,-0.03,0.05,-0.04, ,-0.42, , ,-0.08,-0.11,-0.09,-0.14,-0.22,,-0.04,0.01,-0.42,,-0.1,-0.11,,,CMGC,,,,NA,NA,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,116.58,116.58,S332,GSYSGRSPSPYGRRRSSSPFLSKRSLSRSPL,_RRS(ph)SS(ph)PFLSK_,0.04,-0.2,-0.19,0.03,-0.01,0.23,0.47,0.26,-0.22,-0.32,-0.4,-0.31,-0.38,-0.09,0.17,0.16,-0.08,-0.08,0.12,0.37,-0.27,-0.36,-0.23,0.17,,,CMGC,,,,0,0,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,116.58,116.58,S334,YSGRSPSPYGRRRSSSPFLSKRSLSRSPLPS,_S(ph)SS(ph)PFLSK_,0.04,-0.2,-1.96,0.03,0.13,0.28,0.45,0.22,-0.22,-0.32,-1.64,-0.31,-0.19,-0.09,0.1,0,-0.08,-0.64,0.21,0.34,-0.27,-0.83,-0.14,0.05,,,CMGC,,,,0,0,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q9NYV4-2,Q9NYV4,Cyclin-dependent kinase 12,CDK12,284.23,284.23,T893,FGLARLYNSEESRPYTNKVITLWYRPPELLL,_LYNSEESRPYT(ph)NK_,-0.12,0.05,-0.27,-0.18,0.16,-0.01,0.43,-0.28,-0.03,-0.01,-0.38,0,-0.67,-0.24,-0.19,-0.27,-0.03,-0.23,0.08,0.12,-0.02,-0.17,-0.44,-0.23,,,CMGC,,,,0,0,,cyclin K-CDK12 complex,ATP binding,mRNA processing,,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,99.6,97.6,S385,YSRHSSYERGGDVSPSPYSSSSWRRSRSPYS,_GGDVS(ph)PS(ph)PYSSSSWR_, , , , ,-0.29,-0.22,-0.37,-1.22, , , , ,-0.1,0.16,1.19,1.96,,,-0.25,-0.73,,,0.03,1.62,, +,CMGC,,,,NA,NA,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,195.46,192.79,S383,PSYSRHSSYERGGDVSPSPYSSSSWRRSRSP,_GGDVS(ph)PS(ph)PYSSSSWR_,0,-0.07,-0.11,-0.03,0.02,1.42,-0.12,0.06,-0.04,-0.03,-0.17,-0.2,-0.12,-0.31,0.08,-0.09,-0.04,-0.07,0.88,-0.02,-0.04,-0.18,-0.21,-0.01,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,165.45,162.7,S437,SRSRHRLSRSRSRHSSISPSTLTLKSSLAAE,_HSS(ph)IS(ph)PSTLTLK_,0.01,0.02,-0.1,-0.09,0.3,0.23,0.27,0.29,0.06,0.04,-0.1,-0.06,0.1,0.25,0.11,0.13,0.02,-0.09,0.27,0.28,0.05,-0.08,0.18,0.12,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,165.45,162.7,S439,SRHRLSRSRSRHSSISPSTLTLKSSLAAELN,_HSS(ph)IS(ph)PSTLTLK_,0.01,0.02,-0.1,-0.09,0.3,0.23,0.27,0.29,0.06,0.04,-0.1,-0.06,0.1,0.25,0.11,0.13,0.02,-0.09,0.27,0.28,0.05,-0.08,0.18,0.12,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,89.3,89.3,S315,YREDKTEPKAYRRRRSLSPLGGRDDSPVSHR,_S(ph)LS(ph)PLGGRDDS(ph)PVSHR_,-0.18,0.05,-0.12,-0.06, ,-0.15,-0.11,-0.06,-0.52,-0.28,-0.76,-0.1, ,0.05,0.04,-0.01,-0.06,-0.09,-0.15,-0.08,-0.4,-0.39,0.05,0.02,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,89.3,89.3,S317,EDKTEPKAYRRRRSLSPLGGRDDSPVSHRAS,_S(ph)LS(ph)PLGGRDDS(ph)PVSHR_,-0.18,0.05,-0.12,-0.06, ,-0.15,-0.11,-0.06,-0.52,-0.28,-0.76,-0.1, ,0.05,0.04,-0.01,-0.06,-0.09,-0.15,-0.08,-0.4,-0.39,0.05,0.02,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,89.3,89.3,S325,YRRRRSLSPLGGRDDSPVSHRASQSLRSRKS,_S(ph)LS(ph)PLGGRDDS(ph)PVSHR_,-0.1,-0.09,-0.29,-0.06, , ,-0.11,-0.06,-0.17,-0.14,-0.36,-0.1, , ,0.04,-0.01,-0.09,-0.17,,-0.08,-0.16,-0.22,,0.02,,,CMGC,,,,NA,NA,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,79.04,67.12,S395,GDVSPSPYSSSSWRRSRSPYSPVLRRSGKSR,_S(ph)RS(ph)PYS(ph)PVLR_, , , , ,0.01, , ,-0.24, , , , ,0.01, , ,-0.57,,,0.01,-0.24,,,0.01,-0.57,,,CMGC,,,,NA,NA,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,79.04,67.12,S397,VSPSPYSSSSWRRSRSPYSPVLRRSGKSRSR,_S(ph)RS(ph)PYS(ph)PVLR_, , , , ,0.01, , ,-0.24, , , , ,0.01, , ,-0.57,,,0.01,-0.24,,,0.01,-0.57,,,CMGC,,,,NA,NA,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,156.24,115.97,T1246,QDDLIQHQDMRILELTPEPDRPRILPPDQRP,_ILELT(ph)PEPDRPR_,-0.05,-0.04,-0.15,-0.15,-0.28,-0.3,-0.06, ,0.03,0.18,0.15,0.58,-0.41,0.21,-0.45, ,-0.05,-0.15,-0.29,-0.06,0.11,0.38,-0.06,-0.45,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
Q14004-2,Q14004,Cyclin-dependent kinase 13,CDK13,230.69,230.69,T871,FGLARLYSSEESRPYTNKVITLWYRPPELLL,_LYSSEESRPYT(ph)NK_,-0.04,0.1,-0.14,0.06,0.35,0.14,0.07,0.13,0.02,-0.04,-0.06,0.04,-0.29,-0.3,-0.25,-0.25,0.03,-0.04,0.25,0.1,-0.01,-0.01,-0.29,-0.25,,,CMGC,,,,0,0,,cyclin K-CDK13 complex,ATP binding,"alternative mRNA splicing, via spliceosome",,
E5RGN0,Q00536,Cyclin-dependent kinase 16,CDK16,139.7,118.92,S138,DIRLPEGYLEKLTLNSPIFDKPLSRRLRRVS,_LTLNS(ph)PIFDK_, , , , , , , ,1.76, , , , , , , ,0.66,,,,1.76,,,,0.66, +,,CMGC,,,,NA,NA,,,ATP binding,,,
E5RGN0,Q00536,Cyclin-dependent kinase 16,CDK16,91.93,79.44,S153,SPIFDKPLSRRLRRVSLSEIGFGKLETYIKL,_RVS(ph)LSEIGFGK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,CMGC,,,,NA,NA,,,ATP binding,,,
E5RGN0,Q00536,Cyclin-dependent kinase 16,CDK16,128.62,127.62,S78,LSSAPEIVHEDLKMGSDGESDQASATSSDEV,_MGS(ph)DGESDQASATSSDEVQS(ph)PVR_, , , , ,0.56,0.66,0.18,0.34, , , , ,0.45,0.22,0.41,0.41,,,0.61,0.26,,,0.34,0.41,,,CMGC,,,,NA,NA,,,ATP binding,,,
E5RGN0,Q00536,Cyclin-dependent kinase 16,CDK16,128.62,127.62,S95,GESDQASATSSDEVQSPVRVRMRNHPPRKIS,_MGS(ph)DGESDQASATSSDEVQS(ph)PVR_, , , , ,0.56,0.66,0.18,0.34, , , , ,0.45,0.22,0.41,0.41,,,0.61,0.26,,,0.34,0.41,,,CMGC,,,,NA,NA,,,ATP binding,,,
E5RGN0,Q00536,Cyclin-dependent kinase 17,CDK17,85.81,46.03,Y176,KLETYIKLDKLGEGTYATVYKGKSKLTDNLV,_LGEGTY(ph)ATVYK_, , , , ,0.46, , ,0.85, , , , ,-0.41, , ,0.56,,,0.46,0.85,,,-0.41,0.56,,,CMGC,,,,NA,NA,,,ATP binding,,,
E7ESI2,P24941,Cyclin-dependent kinase 2,CDK2,195.79,96.77,Y15,_MENFQKVEKIGEGTYGVVYKARNKLTGEVV,_IGEGT(ph)Y(ph)GVVYK_,0.13,0.12,0.31,0.53,0.4,0.32,0.02,0.14,-0.21,-0.21,0.07,0.2,0.91,0.85,0.22,0.3,0.13,0.42,0.36,0.08,-0.21,0.14,0.88,0.27,,,CMGC,,,,0,0,,,ATP binding,,,
E7ESI2,P24941,Cyclin-dependent kinase 2,CDK2,123.62,55.08,Y19,FQKVEKIGEGTYGVVYKARNKLTGEVVALKK,_IGEGTYGVVY(ph)K_,-0.55,-0.6, ,-0.31,-0.15,-0.06,-0.2,-0.06,-0.37,-0.1, ,0.1,-0.14,-0.14,-0.31,-0.17,-0.58,-0.31,-0.1,-0.13,-0.22,0.1,-0.14,-0.24,,,CMGC,,,,0,0,,,ATP binding,,,
E7ESI2,P06493,Cyclin-dependent kinase 2,CDK2,182.72,81.27,T14,__MENFQKVEKIGEGTYGVVYKARNKLTGEV,_IGEGT(ph)Y(ph)GVVYK_,-0.18,-0.22,-0.61,-0.47,-0.43,-0.21,-0.23,-0.04,-0.23,-0.28,-0.63,-0.52,-1.13,-0.81,-0.49,0.04,-0.2,-0.54,-0.32,-0.13,-0.26,-0.57,-0.96,-0.2,,,CMGC,,,,0,0,,,ATP binding,,,
Q00535,Q00535,Cyclin-dependent kinase 5,CDK5,113.22,113.22,Y15,_MQKYEKLEKIGEGTYGTVFKAKNRETHEIV,_IGEGTY(ph)GTVFK_,0.58, ,0.9, ,1.33,0.75, ,0.98,0.56, ,0.45, ,1.85,1.21, ,1.5,0.58,0.9,1.07,0.98,0.56,0.45,1.57,1.5, +, +,CMGC,,,,1,2,17.77,axon,acetylcholine receptor activator activity,axon extension,,
D6RAD4,P50613,Cyclin-dependent kinase 7,CDK7,129.62,129.62,S164,GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR,_SFGS(ph)PNRAYT(ph)HQVVTR_,-0.34,-0.12,-0.24,0.15,0.6,0.4, ,-0.38,0.08,0.42,0.13,0.72,1.42,0.36, ,-0.29,-0.23,-0.03,0.5,-0.38,0.26,0.46,0.99,-0.29,,,CMGC,,,,0,0,,mitochondrion,ATP binding,,,
D6RAD4,P50613,Cyclin-dependent kinase 7,CDK7,129.62,129.62,T170,DFGLAKSFGSPNRAYTHQVVTRWYRAPELLF,_SFGS(ph)PNRAYT(ph)HQVVTR_,-0.34,-0.12,-0.24,0.15,0.6,0.4, ,-0.38,0.08,0.42,0.13,0.72,1.42,0.36, ,-0.29,-0.23,-0.03,0.5,-0.38,0.26,0.46,0.99,-0.29,,,CMGC,,,,0,0,,mitochondrion,ATP binding,,,
O76039,O76039,Cyclin-dependent kinase-like 5,CDKL5,302.44,282.67,Y171,FARNLSEGNNANYTEYVATRWYRSPELLLGA,_NLSEGNNANYTEY(ph)VATR_,-0.1, ,-0.11, ,-0.02, ,0.14,-0.13,0.24, ,0.12, ,-0.13, ,0.14,-0.52,-0.1,-0.11,-0.02,0.01,0.24,0.12,-0.13,-0.15,,,CMGC,,,,0,0,,dendrite cytoplasm,ATP binding,neuron migration,,
Q9UKY7,Q9UKY7,Protein CDV3 homolog,CDV3,294,248.88,Y244,EVSKNQALKLQLDNQYAVLENQKSSHSQYN_,_LQLDNQY(ph)AVLENQK_,3.21, , , , , , , ,2.64, , , , , , , ,3.21,,,,2.64,,,, +, +,,,,,NA,NA,,cytoplasm,,cell proliferation,,
Q9UKY7,Q9UKY7,Protein CDV3 homolog,CDV3,237.14,237.14,S107,EVDYSGLRVQAMQISSEKEEDDNEKRQDPGD,_VQAMQISS(ph)EKEEDDNEK_,0.03,0.04,0.22,0.28,0.08,-0.01,-0.09, ,0.03,0.02,0.08,0.19,0.01,-0.12,-0.31, ,0.04,0.25,0.04,-0.09,0.03,0.14,-0.05,-0.31,,,,,,,0,0,,cytoplasm,,cell proliferation,,
Q9UKY7,Q9UKY7,Protein CDV3 homolog,CDV3,197.28,197.27,Y190,RLTTTRKTPQGPPEIYSDTQFPSLQSTAKHV,_KTPQGPPEIY(ph)SDTQFPSLQSTAK_,0.13, ,-0.56, , , , , ,0.01, ,-0.38, , , , , ,0.13,-0.56,,,0.01,-0.38,,,,,,,,,NA,NA,,cytoplasm,,cell proliferation,,
Q9Y232-2,Q9Y232,Chromodomain Y-like protein,CDYL,181.81,178.28,S216,SPVKSRTAVDGFQSESPEKLDPVEQGQEDTV,_TAVDGFQSES(ph)PEK_,-0.16,-0.04,-0.31, ,-0.42, ,-0.55,-0.52,0.03,0.01,0.2, ,-0.5, ,-0.5,-0.45,-0.1,-0.31,-0.42,-0.54,0.02,0.2,-0.5,-0.47,,,,,,,0,0,,nucleus,histone acetyltransferase activity,histone acetylation,,
F5H3Y6,Q03701,CCAAT/enhancer-binding protein zeta,CEBPZ,135.84,135.84,S629,KAKPGLRSQLDDHPESDDEENFIDANDDEDM,_SQLDDHPES(ph)DDEENFIDANDDEDMEK_, ,-0.41,-0.57,-0.32,-0.67,-0.65,-0.5,-0.8, ,-0.06,-0.2,-0.14,-0.32,-0.25,0.07,0.06,-0.41,-0.44,-0.66,-0.64,-0.06,-0.17,-0.29,0.07,,,,,,,0,0,,,,,,
P49454,P49454,Centromere protein F,CENPF,82.94,35.32,S1747,LELEVARLQLQGLDLSSRSLLGIDTEDAIQG,_LQLQGLDLS(ph)S(ph)R_, , ,-1.57, ,-0.44,-0.72, ,-0.6, , ,0, ,-0.25,-0.44, ,-1.09,,-1.57,-0.57,-0.6,,0,-0.34,-1.09, +, +,,,,,NA,NA,,condensed chromosome outer kinetochore,chromatin binding,cell differentiation,,
P49454,P49454,Centromere protein F,CENPF,82.94,35.32,S1748,ELEVARLQLQGLDLSSRSLLGIDTEDAIQGR,_LQLQGLDLS(ph)S(ph)R_, , ,-1.57, ,-0.44,-0.72, ,-0.6, , ,0, ,-0.25,-0.44, ,-1.09,,-1.57,-0.57,-0.6,,0,-0.34,-1.09, +, +,,,,,NA,NA,,condensed chromosome outer kinetochore,chromatin binding,cell differentiation,,
P49454,P49454,Centromere protein F,CENPF,76.73,76.73,S3119,ATRTSPRLAAQKLALSPLSLGKENLAESSKP,_LALS(ph)PLSLGK_, ,0.45,-0.34,1.09, , , , , ,-0.19,0.51,-0.04, , , , ,0.45,0.54,,,-0.19,0.26,,,,,,,,,NA,NA,,condensed chromosome outer kinetochore,chromatin binding,cell differentiation,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,99.97,99.56,S930,DEGPDTPSYNRDNSISPESDVDTASTISLVT,_DNSIS(ph)PES(ph)DVDTASTISLVTGETERK_, , , , , , ,1.89, , , , , , , ,0.4, ,,,,1.89,,,,0.4, +,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,99.97,99.56,S933,PDTPSYNRDNSISPESDVDTASTISLVTGET,_DNSIS(ph)PES(ph)DVDTASTISLVTGETERK_, , , , , , ,1.89, , , , , , , ,0.4, ,,,,1.89,,,,0.4, +,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,137.01,67.81,S838,GGDKKESSKSLVRQGSFTIEKPSPNIPIELI,_(gl)QGS(ph)FTIEK_,0.37,0.42,0.34,0.04,0.28,0.24,0.29,0.29,0.24,0.34,0.45,0.25,0.09,0.39,0.26,0.39,0.4,0.2,0.26,0.29,0.29,0.35,0.25,0.33,,,,,,,0,0,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,104.95,102.95,S881,SLALTSASRIRERSESLDPDSSMDTTLILKD,_SES(ph)LDPDSSMDTTLILK_, , , , ,0.37,-0.33,-0.23, , , , , ,0.19,0.11,0.49, ,,,0.07,-0.23,,,0.15,0.49,,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,91.82,91.82,Y502,TSEKDNDDDQSDKGTYTIELENPNSEEVEAR,_DNDDDQS(ph)DKGTY(ph)T(ph)IELENPNSEEVEAR_, , , , ,0.47,0.25,-0.19,-0.18, , , , ,-0.19,-0.41,-0.28,-0.45,,,0.36,-0.19,,,-0.3,-0.36,,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,210.48,186.22,S497,QATSATSEKDNDDDQSDKGTYTIELENPNSE,_DNDDDQS(ph)DKGT(ph)YTIELENPNSEEVEAR_, , , , ,0.09,0.24,0.48,0.57, , , , ,-0.35,-0.39,0.27,0.16,,,0.17,0.52,,,-0.37,0.22,,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,110.09,109.1,S1112,PTRTSLLRRARLGEASDSELADADKASVASE,_LGEAS(ph)DSELADADK_, ,0.45, , ,0.37,-0.29,0.18,0.18, ,0.46, , ,0.16,0.09,0.2,0.08,0.45,,0.08,0.18,0.46,,0.13,0.14,,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,139.12,139.12,S356,NPPQMLWERTEEDSKSIKSDVPVYLKRLKGN,_S(ph)IKS(ph)DVPVYLK_,0.73,0.53,-0.11,0.32,-0.26,-0.2,-0.07,-0.04,0.44,0.3,-0.38,-0.27,-0.52,-0.43,-0.08,-0.16,0.63,0.12,-0.23,-0.06,0.37,-0.32,-0.48,-0.12,,,,,,,0,0,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,139.12,139.12,S359,QMLWERTEEDSKSIKSDVPVYLKRLKGNKHD,_S(ph)IKS(ph)DVPVYLK_,0.73,0.53,-0.11,0.32,-0.26,-0.2,-0.07,-0.04,0.44,0.3,-0.38,-0.27,-0.52,-0.43,-0.08,-0.16,0.63,0.12,-0.23,-0.06,0.37,-0.32,-0.48,-0.12,,,,,,,0,0,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,210.48,186.22,T501,ATSEKDNDDDQSDKGTYTIELENPNSEEVEA,_DNDDDQS(ph)DKGT(ph)YTIELENPNSEEVEAR_, , , , ,0.1,0.24,0.48,0.57, , , , ,-0.33,-0.39,0.27,0.16,,,0.17,0.52,,,-0.36,0.22,,,,,,,NA,NA,,,,,,
H0Y2V6,Q5SW79,Centrosomal protein of 170 kDa,CEP170,91.82,91.82,T503,SEKDNDDDQSDKGTYTIELENPNSEEVEARK,_DNDDDQS(ph)DKGTY(ph)T(ph)IELENPNSEEVEAR_, , , , ,0.47, , ,-0.18, , , , ,-0.19, , ,-0.45,,,0.47,-0.18,,,-0.19,-0.45,,,,,,,NA,NA,,,,,,
Q96G23,Q96G23,Ceramide synthase 2,CERS2,250.66,250.66,S341,MAHKFITGKLVEDERSDREETESSEGEEAAA,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,0.06,0.21,0.13,0.14,-0.19,0.16,-0.25,-0.34,0.16,0.07,-0.03,0.11,0,0.29,-0.06,-0.18,0.14,0.14,0,-0.3,0.11,0.04,0.15,-0.12,,,,,,,0,0,,endoplasmic reticulum membrane,sequence-specific DNA binding,ceramide biosynthetic process,,
Q96G23,Q96G23,Ceramide synthase 2,CERS2,250.66,250.66,S348,GKLVEDERSDREETESSEGEEAAAGGGAKSR,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,0.06,0.21,0.13,0.14,-0.19,0.22,0.13,0.06,0.16,0.07,-0.03,0.11,0,0.23,0.07,0.12,0.14,0.14,0.03,0.1,0.11,0.04,0.12,0.09,,,,,,,0,0,,endoplasmic reticulum membrane,sequence-specific DNA binding,ceramide biosynthetic process,,
Q96G23,Q96G23,Ceramide synthase 2,CERS2,250.66,250.66,S349,KLVEDERSDREETESSEGEEAAAGGGAKSRP,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,0.06,0.21,0.13,0.14,-0.19,0.22,0.13,0.06,0.16,0.07,-0.03,0.11,0,0.23,0.07,0.12,0.14,0.14,0.03,0.1,0.11,0.04,0.12,0.09,,,,,,,0,0,,endoplasmic reticulum membrane,sequence-specific DNA binding,ceramide biosynthetic process,,
Q96G23,Q96G23,Ceramide synthase 2,CERS2,250.66,250.66,T346,ITGKLVEDERSDREETESSEGEEAAAGGGAK,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,0.06,0.21,0.13,0.14,-0.19,0.22,0.13,0.06,0.16,0.07,-0.03,0.11,0,0.23,0.07,0.12,0.14,0.14,0.03,0.1,0.11,0.04,0.12,0.09,,,,,,,0,0,,endoplasmic reticulum membrane,sequence-specific DNA binding,ceramide biosynthetic process,,
P41208,P41208,Centrin-2,CETN2,181.64,181.64,S20,FKKANMASSSQRKRMSPKPELTEEQKQEIRE,_RMS(ph)PKPELTEEQK_,-0.2,0.21,-0.09,0.12,0.34,0.58, , ,-0.01,0.25,0.28,0.21,0.28,0.73, , ,0.02,0.02,0.46,,0.13,0.25,0.53,,,,,,,,NA,NA,,centriole,ATP binding,cell division,,
P23528,P23528,Cofilin-1,CFL1,228.02,188.68,S3,_____________MASGVAVSDGVIKVFNDM,_(ac)AS(ph)GVAVSDGVIK_,-0.3,-0.26,-0.23,-0.2,-0.03,-0.04,-0.1,-0.11,0.23,0.23,0.5,0.46,-0.1,-0.16,0.04,0.17,-0.28,-0.22,-0.03,-0.1,0.23,0.48,-0.13,0.1,,,,,,,0,0,,cortical actin cytoskeleton,,actin cytoskeleton organization,,
Q9Y281,Q9Y281,Cofilin-2,CFL2,165.49,146.67,S3,_____________MASGVTVNDEVIKVFNDM,_(ac)AS(ph)GVTVNDEVIK_,0.1,0.1,0.14,0.25,0.01,0.11,0.09,0.05,0.4,0.41,0.81,0.91,0.15,0.11,0.22,0.31,0.1,0.2,0.06,0.07,0.41,0.86,0.13,0.27,,,,,,,0,0,,actin cytoskeleton,,actin filament depolymerization,,
Q13111,Q13111,Chromatin assembly factor 1 subunit A,CHAF1A,114.27,100.47,S772,FQEHCRRGLLSNHTGSPRSPSTTYLHTPTPS,_GLLSNHTGS(ph)PR_,-0.04,-0.36,-0.42,-0.28, , , , ,-0.24,-0.2,0.35,-0.65, , , , ,-0.19,-0.35,,,-0.22,-0.06,,,,,,,,,NA,NA,,CAF-1 complex,chromatin binding,cell cycle,,
Q13111,Q13111,Chromatin assembly factor 1 subunit A,CHAF1A,81.55,79.27,S777,RRGLLSNHTGSPRSPSTTYLHTPTPSEDAAI,_SPS(ph)TTYLHTPTPSEDAAIPSK_, , ,0.35, , , , , , , ,0.69, , , , , ,,0.35,,,,0.69,,,,,,,,,NA,NA,,CAF-1 complex,chromatin binding,cell cycle,,
Q13111,Q13111,Chromatin assembly factor 1 subunit A,CHAF1A,160.27,160.27,S141,QPDSLVDHNKLNSEASPSREAINGQREDTGD,_LNSEAS(ph)PSREAINGQR_,-0.24,-0.37,-0.33,-0.1,0.42,-0.52, ,0.27,-0.29,-0.21,-0.22,0.31,0.65,-0.49, ,-0.16,-0.3,-0.21,0.02,0.27,-0.25,0.07,0.19,-0.16,,,,,,,0,0,,CAF-1 complex,chromatin binding,cell cycle,,
Q13112,Q13112,Chromatin assembly factor 1 subunit B,CHAF1B,112.64,111.56,S410,PDTAKKTKSQTHRGSSPGPRPVEGTPASRTQ,_GSS(ph)PGPRPVEGTPASR_,-0.16,-0.22, , , , , , ,0,-0.18, , , , , , ,-0.19,,,,-0.09,,,,,,,,,,NA,NA,,CAF-1 complex,chromatin binding,cell cycle,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,50.09,21.18,S416,APTLSPEHWKAVPPVSPELRKPGPPLSPEIR,_AVPPVS(ph)PELR_,-0.02, ,0.08,0.19, , , , ,-0.37, ,0.12,0.13, , , , ,-0.02,0.14,,,-0.37,0.12,,,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,150.73,148.97,S627,LFPSSKKLKKDNQESSDAELSSSEYIKTDLD,_DNQESS(ph)DAELS(ph)SSEYIK_, ,-0.64,-0.61, ,0.01,-0.06,-0.06,0.37, ,-0.12,0.21, ,0.03,0.05,-0.45,0.11,-0.64,-0.61,-0.02,0.17,-0.12,0.21,0.04,-0.14,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,150.73,148.97,S632,KKLKKDNQESSDAELSSSEYIKTDLDAMDIK,_DNQESS(ph)DAELS(ph)S(ph)SEYIK_, , , , ,-0.11,-0.06,-0.13,0.02, , , , ,0,0.08,-0.3,-0.2,,,-0.08,-0.05,,,0.04,-0.25,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,88.5,81.73,S633,KLKKDNQESSDAELSSSEYIKTDLDAMDIKG,_DNQESS(ph)DAELS(ph)S(ph)SEYIK_, , , , , , , ,0.42, , , , , , , ,0.04,,,,0.42,,,,0.04,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,128.52,93.08,S476,ASLDFPESQKSSRGGSPDLWKSSFFIEPQKP,_GGS(ph)PDLWK_,-0.02,-0.01,-0.06,-0.04,0.18,0.17,0.13,-0.01,0,0.07,0.06,0.18,0.06,0.12,-0.06,0,-0.02,-0.05,0.18,0.06,0.04,0.12,0.09,-0.03,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,177.71,177.71,S651,YIKTDLDAMDIKGQESSSDQEQVDVESIDFS,_GQES(ph)S(ph)S(ph)DQEQVDVESIDFSK_,-0.2,-0.37, , ,-0.11,-0.1,-0.15,-0.14,-0.03,-0.05, , ,-0.13,-0.06,-0.1,-0.27,-0.28,,-0.1,-0.15,-0.04,,-0.1,-0.18,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,113.3,113.3,S652,IKTDLDAMDIKGQESSSDQEQVDVESIDFSK,_GQES(ph)S(ph)S(ph)DQEQVDVESIDFSK_,-0.2,-0.2,-0.46,-0.26, ,-0.48, ,-0.27,-0.03,-0.09,-0.11,0.03, ,0.11, ,-0.27,-0.2,-0.36,-0.48,-0.27,-0.06,-0.04,0.11,-0.27,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,177.71,177.71,S653,KTDLDAMDIKGQESSSDQEQVDVESIDFSKE,_GQES(ph)S(ph)S(ph)DQEQVDVESIDFSK_,-0.2,-0.28,-0.46,-0.26,-0.11,-0.07,-0.15,-0.11,-0.03,-0.07,-0.11,0.03,-0.13,-0.07,-0.1,-0.26,-0.24,-0.36,-0.09,-0.13,-0.05,-0.04,-0.1,-0.18,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,62.12,61.18,S662,KGQESSSDQEQVDVESIDFSKENKMDMTSPE,_GQES(ph)S(ph)SDQEQVDVES(ph)IDFSK_, , , , , , , ,-0.71, , , , , , , ,-0.26,,,,-0.71,,,,-0.26,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,186.49,185.46,S427,VPPVSPELRKPGPPLSPEIRSPAGSPELRKP,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,-0.19,-0.35,-0.06,0.44,0.31,0.49,0.07,-0.04,-0.24,-0.73,0,0.41,0.45,0.19,-0.05,0.03,-0.27,0.21,0.4,0.01,-0.46,0.22,0.33,-0.01,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,186.49,185.46,S432,PELRKPGPPLSPEIRSPAGSPELRKPSGSPD,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,-0.19,-0.35,-0.06,0.44,0.31,0.49,0.07,-0.04,-0.24,-0.73,0,0.41,0.45,0.19,-0.05,0.03,-0.27,0.21,0.4,0.01,-0.46,0.22,0.33,-0.01,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,186.49,185.46,S436,KPGPPLSPEIRSPAGSPELRKPSGSPDLWKL,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,-0.19,-0.35,-0.06,0.44,0.31,0.49,0.07,-0.04,-0.24,-0.73,0,0.41,0.45,0.19,-0.05,0.03,-0.27,0.21,0.4,0.01,-0.46,0.22,0.33,-0.01,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,223.53,223.53,S445,IRSPAGSPELRKPSGSPDLWKLSPDQRKTSP,_KPSGS(ph)PDLWKLS(ph)PDQR_,0.22,0.45,0.16,0.12,0.23,0.44,0.21, ,0.7,0.5,0.71,0.58,0.58,0,-0.14, ,0.34,0.14,0.34,0.21,0.6,0.64,0.32,-0.14,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,223.53,223.53,S452,PELRKPSGSPDLWKLSPDQRKTSPASLDFPE,_KPSGS(ph)PDLWKLS(ph)PDQR_,-0.22,0.09,-0.14,0.21,0.23,0.44,0.21, ,-0.41,-0.16,-0.17,0.16,0.58,0,-0.14, ,-0.05,0.04,0.34,0.21,-0.28,0.01,0.32,-0.14,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,94.57,94.29,S282,SRKSARTTSPEPRKPSPSESPEPWKPFPAVS,_KPS(ph)PSES(ph)PEPWKPFPAVS(ph)PEPR_,0.37,0.52,0.29, , , , , ,-0.08,-0.34,-0.05, , , , , ,0.45,0.29,,,-0.21,-0.05,,,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,94.57,94.29,S286,ARTTSPEPRKPSPSESPEPWKPFPAVSPEPR,_KPS(ph)PSES(ph)PEPWKPFPAVS(ph)PEPR_,0.37,0.52,0.29, , , , , ,-0.08,-0.34,-0.05, , , , , ,0.45,0.29,,,-0.21,-0.05,,,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,94.57,94.29,S297,SPSESPEPWKPFPAVSPEPRRPAPAVSPGSW,_KPS(ph)PSES(ph)PEPWKPFPAVS(ph)PEPR_,0.37,0.52,0.29, , , , , ,-0.08,-0.34,-0.05, , , , , ,0.45,0.29,,,-0.21,-0.05,,,,,,,,,NA,NA,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,105.7,105.7,S204,KSVPVCESQKLAPVPSPEPQKPAPVSPESVK,_LAPVPS(ph)PEPQKPAPVS(ph)PESVK_,-0.05,-0.2,-0.18,0.02,0.21,0.12,0.16,0.17,0.01,-0.11,0.04,0.06,0.02,-0.03,0,-0.01,-0.12,-0.08,0.16,0.16,-0.05,0.05,-0.01,0,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
Q96JM3,Q96JM3,Chromosome alignment-maintaining phosphoprotein 1,CHAMP1,105.7,105.7,S214,LAPVPSPEPQKPAPVSPESVKATLSNPKPQK,_LAPVPS(ph)PEPQKPAPVS(ph)PESVK_,-0.05,-0.03,0,-0.05,0.21,0.15,0.16,0.31,-0.14,-0.09,-0.09,-0.13,0.02,-0.01,0,0.13,-0.04,-0.03,0.18,0.23,-0.11,-0.11,0,0.07,,,,,,,0,0,,condensed chromosome kinetochore,nucleic acid binding,protein localization to kinetochore,,
G3V1K1,Q9NX63,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial",CHCHD3,159.4,157.31,S50,RMKESSPSGSKSQRYSGAYGASVSDEELKRR,_YS(ph)GAYGASVSDEELK_, ,0.04, ,-0.65,0.43,0.3,0.33,0.21, ,-0.02, ,-0.18,-0.01,-0.06,0.13,0.12,0.04,-0.65,0.37,0.27,-0.02,-0.18,-0.03,0.12,,,,,,,0,0,,mitochondrion,,,,
O14646-2,O14646,Chromodomain-helicase-DNA-binding protein 1,CHD1,261.28,261.28,S215,KNGKKILGQKKRQIDSSEEDDDEEDYDNDKR,_RQIDS(ph)S(ph)EEDDDEEDYDNDKR_,0.23,0.35,0.19,0.27,0.21,-0.02,-0.11,0.09,0.04,0.05,0.01,0.38,0.07,-0.2,0.06,0.03,0.29,0.23,0.1,-0.01,0.04,0.21,-0.06,0.05,,,,,,,0,0,,cytoplasm,ATP binding,chromatin remodeling,,
O14646-2,O14646,Chromodomain-helicase-DNA-binding protein 1,CHD1,261.28,261.28,S216,NGKKILGQKKRQIDSSEEDDDEEDYDNDKRS,_RQIDS(ph)S(ph)EEDDDEEDYDNDKR_,0.23,0.35,0.19,0.27,0.21,-0.02,-0.11,0.09,0.04,0.05,0.01,0.38,0.07,-0.2,0.06,0.03,0.29,0.23,0.1,-0.01,0.04,0.21,-0.06,0.05,,,,,,,0,0,,cytoplasm,ATP binding,chromatin remodeling,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,231.04,230.46,S713,YKKKKKELQGDGPPSSPTNDPTVKYETQPRF,_ELQGDGPPSS(ph)PTNDPTVK_,-0.26,-0.16,-0.09,0.2,0.49,0.43,0.07,0.17,-0.01,0.12,0.11,0.26,0.1,0.2,0.23,0,-0.21,0.06,0.46,0.12,0.06,0.19,0.15,0.12,,,,,,,0,0,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,115.83,115.83,S597,QRKNDMDEPPPLDYGSGEDDGKSDKRKVKDP,_NDMDEPPPLDYGS(ph)GEDDGK_,-0.17,-0.26,-0.6,-0.37,0.35,-0.03,0.25,0.19,-0.05,-0.27,-0.1,-0.07,-0.4,-0.59,-0.24,0.09,-0.22,-0.48,0.18,0.22,-0.15,-0.09,-0.49,-0.07,,,,,,,0,0,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,232.18,229.04,S1601,NSRIGEKMETEADAPSPAPSLGERLEPRKIP,_M(ox)ETEADAPS(ph)PAPS(ph)LGERLEPR_,-0.19,-0.2,-0.5,-0.53,0.43,0.32,0.2,0.2,0.05,-0.01,-0.09,-0.13,0.02,0.04,-0.34,-0.61,-0.2,-0.52,0.37,0.2,0.02,-0.11,0.03,-0.47,,,,,,,0,0,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,232.18,229.04,S1605,GEKMETEADAPSPAPSLGERLEPRKIPLEDE,_M(ox)ETEADAPS(ph)PAPS(ph)LGERLEPR_,-0.19,-0.2,-0.5,-0.53,-0.24,-0.18,-0.28,-0.13,0.05,-0.01,-0.09,-0.13,-0.63,-0.76,-0.31,-0.36,-0.2,-0.52,-0.21,-0.2,0.02,-0.11,-0.69,-0.33,,,,,,,0,0,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,205.38,205.38,S1361,QVNYNDAAQEDQDNQSEYSVGSEEEDEDFDE,_QVNYNDAAQEDQDNQS(ph)EYS(ph)VGS(ph)EEEDEDFDERPEGR_, , , , , ,0.29,0.28,0.11, , , , , ,-0.15,0.11,-0.25,,,0.29,0.2,,,-0.15,-0.06,,,,,,,NA,NA,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,205.38,205.38,S1364,YNDAAQEDQDNQSEYSVGSEEEDEDFDERPE,_QVNYNDAAQEDQDNQS(ph)EYS(ph)VGS(ph)EEEDEDFDERPEGR_, , , , , ,0.2,0.28,0.05, , , , , ,-0.06,0.11,-0.13,,,0.2,0.17,,,-0.06,-0.01,,,,,,,NA,NA,,centrosome,ATP binding,centrosome organization,,
Q12873-2,Q12873,Chromodomain-helicase-DNA-binding protein 3,CHD3,205.38,205.38,S1367,AAQEDQDNQSEYSVGSEEEDEDFDERPEGRR,_QVNYNDAAQEDQDNQS(ph)EYS(ph)VGS(ph)EEEDEDFDERPEGR_, , , , , ,0.2,0.28,0.05, , , , , ,-0.06,0.11,-0.13,,,0.2,0.17,,,-0.06,-0.01,,,,,,,NA,NA,,centrosome,ATP binding,centrosome organization,,
F5H2G1,Q14839,Chromodomain-helicase-DNA-binding protein 4,CHD4,77.51,77.11,S1367,DRDWQDDQSDNQSDYSVASEEGDEDFDERSE,_DWQDDQSDNQSDY(ph)S(ph)VAS(ph)EEGDEDFDER_, , , , , , , ,-0.68, , , , , , , ,0.04,,,,-0.68,,,,0.04,,,,,,,NA,NA,,,,,,
F5H2G1,Q14839,Chromodomain-helicase-DNA-binding protein 4,CHD4,77.51,77.11,S1370,WQDDQSDNQSDYSVASEEGDEDFDERSEAPR,_DWQDDQSDNQSDY(ph)S(ph)VAS(ph)EEGDEDFDER_, , , , , , , ,-0.68, , , , , , , ,0.04,,,,-0.68,,,,0.04,,,,,,,NA,NA,,,,,,
F5H2G1,Q14839,Chromodomain-helicase-DNA-binding protein 4,CHD4,84.09,73.63,T1653,AADVEKVEEKSAIDLTPIVVEDKEEKKEEEE,_SAIDLT(ph)PIVVEDK_, , , , , , ,0.16, , , , , , , ,-0.78, ,,,,0.16,,,,-0.78,,,,,,,NA,NA,,,,,,
F5H2G1,Q14839,Chromodomain-helicase-DNA-binding protein 4,CHD4,57.96,56.94,T1553,PKTPTPSTPGDTQPNTPAPVPPAEDGIKIEE,_T(ph)PTPSTPGDTQPNT(ph)PAPVPPAEDGIK_, , , , ,-0.35, , , , , , , ,-0.54, , , ,,,-0.35,,,,-0.54,,,,,,,,NA,NA,,,,,,
F5H2G1,Q14839,Chromodomain-helicase-DNA-binding protein 4,CHD4,101.03,100.59,S319,KRKRSSSEDDDLDVESDFDDASINSYSVSDG,_SSS(ph)EDDDLDVES(ph)DFDDASINSYSVSDGSTSR_, , , , , , ,-0.37,-0.64, , , , , , ,-0.48,-0.43,,,,-0.5,,,,-0.46,,,,,,,NA,NA,,,,,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,180.9,168.67,S1577,TRLYSAVKEDELMEFSDLESDSEEKPCAKPR,_EDELMEFS(ph)DLES(ph)DSEEK_, , , , ,-0.08, ,0.1,-0.31, , , , ,-0.17, ,-0.19,-0.2,,,-0.08,-0.09,,,-0.17,-0.19,,,,,,,NA,NA,,nucleolus,ATP binding,adult heart development,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,180.9,168.67,S1581,SAVKEDELMEFSDLESDSEEKPCAKPRRPQD,_EDELMEFS(ph)DLES(ph)DSEEK_, , , , ,-0.08, ,0.1,-0.31, , , , ,-0.17, ,-0.19,-0.2,,,-0.08,-0.09,,,-0.17,-0.19,,,,,,,NA,NA,,nucleolus,ATP binding,adult heart development,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,92.93,86.66,S2272,PEAGAVSRGKNFDEESNASMSTARDETRDGF,_NFDEES(ph)NAS(ph)MSTAR_, , , , ,-0.36,-0.12, ,-0.5, , , , ,-0.9,-0.09, ,-0.32,,,-0.23,-0.5,,,-0.44,-0.32,,,,,,,NA,NA,,nucleolus,ATP binding,adult heart development,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,92.93,86.66,S2275,GAVSRGKNFDEESNASMSTARDETRDGFYME,_NFDEES(ph)NAS(ph)MSTAR_, , , , ,-0.36,-0.12, ,-0.5, , , , ,-0.9,-0.09, ,-0.32,,,-0.23,-0.5,,,-0.44,-0.32,,,,,,,NA,NA,,nucleolus,ATP binding,adult heart development,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,184.5,181.03,S2956,KAEGGPFKDGETLEGSDAEESLDKTAESSLL,_DGETLEGS(ph)DAEESLDK_,0.06,-0.09,-0.29,0.31,0.3,0.15,0.07,-0.1,0.16,0.02,-0.39,-0.01,-0.39,-0.04,0.16,0.07,-0.01,0.04,0.23,-0.01,0.09,-0.18,-0.21,0.12,,,,,,,0,0,,nucleolus,ATP binding,adult heart development,,
Q9P2D1,Q9P2D1,Chromodomain-helicase-DNA-binding protein 7,CHD7,52.46,46.63,S2961,PFKDGETLEGSDAEESLDKTAESSLLEDEIA,_DGETLEGS(ph)DAEES(ph)LDK_, , , , , , ,-0.46,-0.1, , , , , , ,-0.4,-0.14,,,,-0.27,,,,-0.26,,,,,,,NA,NA,,nucleolus,ATP binding,adult heart development,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,87.01,87.01,S549,NTITPVVGKKRKRNTSSDNSDVEVMPAQSPR,_NTS(ph)SDNS(ph)DVEVMPAQS(ph)PREDEESSIQK_, , , , ,-1.1,-0.76,-1.38,-0.9, , , , ,-0.9,-0.53,-0.72,-0.68,,,-0.92,-1.12,,,-0.7,-0.7, +,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,120.34,120.34,S553,PVVGKKRKRNTSSDNSDVEVMPAQSPREDEE,_NTS(ph)SDNS(ph)DVEVMPAQSPR_, , , , ,-1.1,-0.96,-0.4,-0.9, , , , ,-0.9,-0.96,-0.42,-0.68,,,-1.03,-0.63,,,-0.93,-0.54, +,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,87.13,86.87,S2551,PEEDDDEDEEDDDDLSQGYDSSERDFSLIDD,_LPPLQPEEDDDEDEEDDDDLS(ph)QGYDS(ph)SER_, , , , ,-0.09,-0.15, ,0.16, , , , ,1.79,4.51, ,-0.12,,,-0.12,0.16,,,3.72,-0.12,, +,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,87.13,86.87,S2556,DEDEEDDDDLSQGYDSSERDFSLIDDPMMPA,_LPPLQPEEDDDEDEEDDDDLS(ph)QGYDS(ph)S(ph)ER_, , , , , ,-0.15, ,0.16, , , , , ,4.51, ,-0.12,,,-0.15,0.16,,,4.51,-0.12,, +,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,70.35,69.02,S2557,EDEEDDDDLSQGYDSSERDFSLIDDPMMPAN,_LPPLQPEEDDDEDEEDDDDLS(ph)QGYDS(ph)S(ph)ER_, , , , ,-0.09, , ,0.16, , , , ,1.79, , ,-0.12,,,-0.09,0.16,,,1.79,-0.12,, +,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,229.05,224,S2069,VSRSVPPVKLEDEDDSDSELDLSKLSPSSSS,_LEDEDDS(ph)DS(ph)ELDLSK_, , , , , ,0.11,0.19,0.19, , , , , ,-0.02,0.21,0.23,,,0.11,0.19,,,-0.02,0.22,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,229.05,224,S2071,RSVPPVKLEDEDDSDSELDLSKLSPSSSSSS,_LEDEDDS(ph)DS(ph)ELDLSK_, , , , , ,0.11,0.19,0.19, , , , , ,-0.02,0.21,0.23,,,0.11,0.19,,,-0.02,0.22,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,120.34,120.34,S562,NTSSDNSDVEVMPAQSPREDEESSIQKRRSN,_NTS(ph)SDNS(ph)DVEVMPAQS(ph)PREDEESSIQK_, , , , ,-0.47,-0.76,-0.31,-0.4, , , , ,-0.82,-0.53,-0.35,-0.03,,,-0.61,-0.35,,,-0.67,-0.18,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,143.91,143.13,S2008,TASPLPLRPDAPVEKSPEETATQVPSLESLT,_S(ph)PEETATQVPSLESLTLK_, , , , , ,0.11,-0.19, , , , , , ,0.32,-0.02, ,,,0.11,-0.19,,,0.32,-0.02,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,38.98,35.9,S2046,VARSRPTPQDYEMRVSPSDTTPLVSRSVPPV,_VS(ph)PSDTTPLVSR_, , , , ,-0.36, ,-0.48,-0.37, , , , ,0.03, ,-0.09,-0.3,,,-0.36,-0.42,,,0.03,-0.19,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,267.18,267.18,S1420,TRHFSTLKDDDLVEFSDLESEDDERPRSRRH,_DDDLVEFS(ph)DLES(ph)EDDERPR_, , , , ,-0.08,-0.01,-0.3,0.18, , , , ,-0.08,0.03,0.12,0.17,,,-0.04,-0.04,,,-0.02,0.14,,,,,,,NA,NA,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q9HCK8,Q9HCK8,Chromodomain-helicase-DNA-binding protein 8,CHD8,267.18,267.18,S1424,STLKDDDLVEFSDLESEDDERPRSRRHDRHH,_DDDLVEFS(ph)DLES(ph)EDDERPR_,0.84,-0.12, ,-0.01,-0.08,-0.01,1.14,0.76,-0.26,-0.17, ,0.09,-0.08,0.03,-0.31,-0.87,0.44,-0.01,-0.04,0.96,-0.21,0.09,-0.02,-0.57,,,,,,,0,0,,MLL1 complex,ATP binding,ATP-dependent chromatin remodeling,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,194.97,190.3,S1468,QTRPFSATKDELAELSEAESEGDEKPKLRRP,_DELAELS(ph)EAES(ph)EGDEKPK_,0.23,0.12,0.06,0.09,-0.05,0.32,-0.02,0.13,0.21,0.05,0.07,-0.11,-0.02,0.4,0.16,0.11,0.18,0.07,0.15,0.05,0.14,-0.02,0.2,0.13,,,,,,,0,0,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,194.97,190.3,S1472,FSATKDELAELSEAESEGDEKPKLRRPCDRS,_DELAELS(ph)EAES(ph)EGDEKPK_,0.23,0.12,0.06,0.09,-0.05,0.32,-0.02,0.13,0.21,0.05,0.07,-0.11,-0.02,0.4,0.16,0.11,0.18,0.07,0.15,0.05,0.14,-0.02,0.2,0.13,,,,,,,0,0,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,112.48,111.9,S2058,EEMKVKSENLKEEPQSSEEESMSSVETRTLI,_EEPQS(ph)S(ph)EEESMSSVETR_, , , , ,-0.37,-0.31,-0.38,-0.73, , , , ,-0.16,0.1,0.09,0.12,,,-0.34,-0.55,,,-0.03,0.11,,,,,,,NA,NA,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,112.48,111.9,S2059,EMKVKSENLKEEPQSSEEESMSSVETRTLIK,_EEPQS(ph)S(ph)EEESMSSVETR_, , , , ,-0.37,-0.31,-0.38,-0.73, , , , ,-0.16,0.1,0.09,0.12,,,-0.34,-0.55,,,-0.03,0.11,,,,,,,NA,NA,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,44.72,44.56,S611,KLIITLGKKQKRKNESSDEISDAEQMPQHTL,_NES(ph)S(ph)DEIS(ph)DAEQMPQHTLK_, , , , , ,0.01,-0.12,-0.17, , , , , ,-0.11,0.08,0.25,,,0.01,-0.14,,,-0.11,0.17,,,,,,,NA,NA,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,44.72,44.56,S612,LIITLGKKQKRKNESSDEISDAEQMPQHTLK,_NES(ph)S(ph)DEIS(ph)DAEQMPQHTLK_, , , , , ,0.01,-0.12,-0.17, , , , , ,-0.11,0.08,0.25,,,0.01,-0.14,,,-0.11,0.17,,,,,,,NA,NA,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q3L8U1-2,Q3L8U1,Chromodomain-helicase-DNA-binding protein 9,CHD9,44.72,44.56,S616,LGKKQKRKNESSDEISDAEQMPQHTLKDQDS,_NES(ph)S(ph)DEIS(ph)DAEQMPQHTLK_, , , , , ,0.01,-0.12,-0.17, , , , , ,-0.11,0.08,0.25,,,0.01,-0.14,,,-0.11,0.17,,,,,,,NA,NA,,cytoplasm,ATP binding,cellular lipid metabolic process,,
Q8IWX8,Q8IWX8,Calcium homeostasis endoplasmic reticulum protein,CHERP,169.01,165.47,S815,SRSKSYSPGRRRRSRSRSPTPPSSAGLGSNS,_S(ph)RS(ph)PT(ph)PPSSAGLGSNSAPPIPDSR_,-0.14,-0.2,-0.49, ,-0.14,-0.17, ,-0.18,-0.33,-0.36,-0.61, ,-0.3,-0.38, ,-0.16,-0.17,-0.49,-0.16,-0.18,-0.35,-0.61,-0.34,-0.16,,,,,,,0,0,,perinuclear region of cytoplasm,RNA binding,negative regulation of cell proliferation,,
Q8IWX8,Q8IWX8,Calcium homeostasis endoplasmic reticulum protein,CHERP,169.01,165.47,S817,SKSYSPGRRRRSRSRSPTPPSSAGLGSNSAP,_S(ph)RS(ph)PT(ph)PPSSAGLGSNSAPPIPDSR_,-0.14,-0.2,-0.49, ,-0.14,-0.17, ,-0.18,-0.33,-0.36,-0.61, ,-0.3,-0.38, ,-0.16,-0.17,-0.49,-0.16,-0.18,-0.35,-0.61,-0.34,-0.16,,,,,,,0,0,,perinuclear region of cytoplasm,RNA binding,negative regulation of cell proliferation,,
Q8IWX8,Q8IWX8,Calcium homeostasis endoplasmic reticulum protein,CHERP,169.01,165.47,T819,SYSPGRRRRSRSRSPTPPSSAGLGSNSAPPI,_S(ph)RS(ph)PT(ph)PPSSAGLGSNSAPPIPDSR_,-0.14,-0.2,-0.49, ,-0.14,-0.17, ,-0.18,-0.33,-0.36,-0.61, ,-0.3,-0.38, ,-0.16,-0.17,-0.49,-0.16,-0.18,-0.35,-0.61,-0.34,-0.16,,,,,,,0,0,,perinuclear region of cytoplasm,RNA binding,negative regulation of cell proliferation,,
B4DJG8,Q9UQN3,Charged multivesicular body protein 2b,CHMP2B,187.62,182.31,S199,AARSLPSASTSKATISDEEIERQLKALGVD_,_ATIS(ph)DEEIER_,-0.02,0.05,0.01,0.06,0.24,0.09,0.1,0.05,-0.04,-0.08,-0.14,-0.03,-0.15,-0.03,-0.03,-0.18,0.02,0.03,0.17,0.08,-0.06,-0.09,-0.09,-0.1,,,,,,,0,0,,,,,,
Q9Y3E7-2,Q9Y3E7,Charged multivesicular body protein 3,CHMP3,105.94,105.2,S200,TDALPEPEPPGAMAASEDEEEEEEALEAMQS,_VTDALPEPEPPGAMAAS(ph)EDEEEEEEALEAMQSR_,-0.2,-0.32,-0.26,-0.53,0.05,-0.09,0.23,-0.18,0.19,0.09,0.34,0.11,-0.06,0.17,0.08,-0.02,-0.26,-0.39,-0.02,0.04,0.14,0.23,0.06,0.03,,,,,,,0,0,,cytosol,"phosphatidylinositol-4,5-bisphosphate binding",apoptotic process,,
Q9H444,Q9H444,Charged multivesicular body protein 4b,CHMP4B,133.91,125.11,S223,EEEDDDMKELENWAGSM______________,_ELENWAGS(ph)M(ox)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,,cellular membrane organization,,
Q8WUX9,Q8WUX9,Charged multivesicular body protein 7,CHMP7,94.45,90.88,S417,PRNRHFTNSVPNPRISDAELEAELEKLSLSE,_IS(ph)DAELEAELEK_, ,-0.01,0.17, ,1.26,0.74, ,0.8, ,0.17,0.16, ,0.79,0.59, ,0.6,-0.01,0.17,1.02,0.8,0.17,0.16,0.7,0.6, +,,,,,,2,0,32.12,cytosol,protein transporter activity,cellular membrane organization,,
Q9NRG0,Q9NRG0,Chromatin accessibility complex protein 1,CHRAC1,255.58,253.86,S124,EEKREEDEENDNDNESDHDEADS________,_REEDEENDNDNES(ph)DHDEADS_, ,-0.1,-0.09,-0.13,-0.29,0.03,0.17,0.06, ,0.3,-0.07,-0.04,0.17,0.01,-0.01,0.05,-0.1,-0.11,-0.12,0.11,0.3,-0.05,0.09,0.02,,,,,,,0,0,,CHRAC,DNA binding,chromatin remodeling,,
Q8WVB6,Q8WVB6,Chromosome transmission fidelity protein 18 homolog,CHTF18,84.66,82.1,S871,AEASARVENSPQVDGSPPGLEGLLGGIGEKG,_VENSPQVDGS(ph)PPGLEGLLGGIGEK_, , , , ,-0.03, , , , , , , ,0.41, , , ,,,-0.03,,,,0.41,,,,,,,,NA,NA,,cytoplasm,ATP binding,cell cycle,,
Q6FI81-3,Q6FI81,Anamorsin,CIAPIN1,86.74,47.01,S305,YLGMPAFKPGEKVLLSDSNLHDA________,_VLLS(ph)DSNLHDA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,iron-sulfur cluster binding,apoptotic process,,
Q96RK0,Q96RK0,Protein capicua homolog,CIC,112.5,79.31,S173,PEIQLPLPPGKRRTQSLSALPKERDSSSEKD,_TQS(ph)LSALPK_, ,-0.38,0.77, ,0.9, , ,1.03, ,-0.81,0.75, ,0.93, , ,1.04,-0.38,0.77,0.9,1.03,-0.81,0.75,0.93,1.04, +, +,,,,,1,1,48.32,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q96RK0,Q96RK0,Protein capicua homolog,CIC,146.68,145.93,S1409,RKNSTDLDSAPEDPTSPKRKMRRRSSCSSEP,_NSTDLDSAPEDPTS(ph)PK_, ,-0.09,0.03, ,0.57, ,-2.23,0.93, ,0.41,0.24, ,1.09, ,0.95, ,-0.09,0.03,0.57,0.09,0.41,0.24,1.09,0.95,, +,,,,,0,2,8.51,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q96RK0,Q96RK0,Protein capicua homolog,CIC,126.24,83.77,S496,GEDPEGNKGFGRKVFSPVIRSSFTHCRPPLD,_VFS(ph)PVIR_,-0.52,-0.39,0.71,0.71, , , , ,0.01,-0.26,0.95,0.9, , , , ,-0.45,0.71,,,-0.12,0.93,,,,,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q86X95,Q86X95,Corepressor interacting with RBPJ 1,CIR1,117.23,116.61,S202,GRNLTANDPSQEYVASEGEEDPEVEFLKSLT,_NLTANDPSQEYVAS(ph)EGEEDPEVEFLK_, , , , ,0.09,0.49,0.26,0.34, , , , ,0.3,0.33,0.2,0.52,,,0.3,0.3,,,0.32,0.37,,,,,,,NA,NA,,cytoplasm,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity,mRNA processing,,
P33552,P33552,Cyclin-dependent kinases regulatory subunit 2,CKS2,177.06,148.86,Y17,AHKQIYYSDKYFDEHYEYRHVMLPRELSKQV,_YFDEHY(ph)EYR_,2.44, ,4.53, , , , , ,1.75, ,3.06, , , , , ,2.44,4.53,,,1.75,3.06,,, +, +,,,,,NA,NA,,,cyclin-dependent protein kinase regulator activity,cell division,,
Q7Z460-2,Q7Z460,CLIP-associating protein 1,CLASP1,225.39,205.69,S1091,LLHNHLKNSSNTSVGSPSNTIGRTPSRHTSS,_NSSNTSVGS(ph)PSNTIGR_,-0.48, , , ,-0.2,-0.18,0.04,0.13,-0.57, , , ,-0.37,-0.32,-0.01,-0.06,-0.48,,-0.19,0.08,-0.57,,-0.35,-0.03,,,,,,,NA,NA,,centrosomal corona,kinetochore binding,axon guidance,,
Q7Z460-2,Q7Z460,CLIP-associating protein 1,CLASP1,170.27,170.27,S600,STKSVSTTGSLQRSRSDIDVNAAASAKSKVS,_SRS(ph)DIDVNAAASAK_,0.24,-0.22,-0.24,-0.43,0.19,0.43,0.36,0.42,0.14,0.01,0.05,-0.02,0.13,0.09,0.21,0.19,0.03,-0.33,0.32,0.39,0.08,0.01,0.11,0.2,,,,,,,0,0,,centrosomal corona,kinetochore binding,axon guidance,,
E3W994,O75122,CLIP-associating protein 2,CLASP2,204.12,181.58,S596,RLSSSVSAMRVLNTGSDVEEAVADALKKPAR,_VLNTGS(ph)DVEEAVADALK_, , , , ,0.28, ,0.55, , , , , ,0.58, ,0.23, ,,,0.28,0.55,,,0.58,0.23,,,,,,,NA,NA,,,,,,
E3W994,O75122,CLIP-associating protein 2,CLASP2,165.1,109.66,S370,SSKASSLPGSLQRSRSDIDVNAAAGAKAHHA,_SRS(ph)DIDVNAAAGAK_, , , , ,0.67,0.42,0.48,-1.97, , , , ,0.28,-0.02,0.11,-2.44,,,0.55,-0.28,,,0.14,-0.66,,,,,,,NA,NA,,,,,,
Q96S66-4,Q96S66,Chloride channel CLIC-like protein 1,CLCC1,103.77,103.77,S438,LRERDVDLRFQTGNKSPEVLRAFDVPDAEAR,_FQTGNKS(ph)PEVLR_, , ,1.38,1.39, , , , , , ,1.41,1.48, , , , ,,1.39,,,,1.44,,, +, +,,,,,NA,NA,,endoplasmic reticulum,,,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,229.03,222.14,S204,TKTASESISNLSEAGSIKKGERELKIGDRVL,_TASES(ph)ISNLS(ph)EAGS(ph)IK_,1.53,0.71, ,-0.03,0.11,0.04,0.12,0.2,-0.16,0.18, ,-0.82,-0.23,-0.17,0.13,0.14,1.18,-0.03,0.07,0.16,0.02,-0.82,-0.2,0.14, +,,,,,,5,0,14.65,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,74.53,69.71,S143,VQAEDEANGLQTTPASRATSPLCTSTASMVS,_VQAEDEANGLQTTPAS(ph)R_, , , , , , ,0.59, , , , , , , ,0.1, ,,,,0.59,,,,0.1,,,,,,,NA,NA,,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,225.96,222.04,S195,SATPPISNLTKTASESISNLSEAGSIKKGER,_TASES(ph)ISNLS(ph)EAGS(ph)IK_, ,0.05, , ,0.3,0.36,0.17,0.26, ,0.78, , ,0.66,0.49,0.52,0.25,0.05,,0.33,0.22,0.78,,0.58,0.39,,,,,,,NA,NA,,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,229.03,222.14,S200,ISNLTKTASESISNLSEAGSIKKGERELKIG,_TASES(ph)ISNLS(ph)EAGS(ph)IK_,0.88,0.71, ,-0.03,0.21,0.17,0.14,0.23,0.43,0.18, ,-0.82,-0.23,0.14,0.34,0.2,0.79,-0.03,0.19,0.19,0.31,-0.82,-0.04,0.27,,,,,,,0,0,,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,117.38,84.01,S44,VVAPVEKTISSEKASSTPSSETQEEFVDDFR,_ASS(ph)TPSS(ph)ETQEEFVDDFR_, , , , , , ,-0.62,-0.44, , , , , , ,-0.8,0.01,,,,-0.53,,,,-0.34,,,,,,,NA,NA,,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P30622-2,P30622,CAP-Gly domain-containing linker protein 1,CLIP1,117.38,84.01,S48,VEKTISSEKASSTPSSETQEEFVDDFRVGER,_ASS(ph)TPSS(ph)ETQEEFVDDFR_, , , , , , ,-0.62,-0.44, , , , , , ,-0.8,0.01,,,,-0.53,,,,-0.34,,,,,,,NA,NA,,centrosome,microtubule plus-end binding,microtubule bundle formation,,
P49761-2,P49761,Dual specificity protein kinase CLK3,CLK3,78.71,73.18,S224,YRERRDSDTYRCEERSPSFGEDYYGPSRSRH,_S(ph)PS(ph)FGEDYYGPSR_, , , , , , , ,0.22, , , , , , , ,-0.18,,,,0.22,,,,-0.18,,,CMGC,,,,NA,NA,,acrosomal vesicle,ATP binding,peptidyl-tyrosine phosphorylation,,
P49761-2,P49761,Dual specificity protein kinase CLK3,CLK3,78.71,73.18,S226,ERRDSDTYRCEERSPSFGEDYYGPSRSRHRR,_S(ph)PS(ph)FGEDYYGPSR_, , , , , , , ,0.22, , , , , , , ,-0.18,,,,0.22,,,,-0.18,,,CMGC,,,,NA,NA,,acrosomal vesicle,ATP binding,peptidyl-tyrosine phosphorylation,,
P49761-2,P49761,Dual specificity protein kinase CLK3,CLK3,97.1,93.12,S157,_______MHHCKRYRSPEPDPYLSYRWKRRR,_YRS(ph)PEPDPYLSYR_, , ,0.01,0.33, , , ,-0.54, , ,-0.1,0.12, , , ,-0.87,,0.18,,-0.54,,0.01,,-0.87,,,CMGC,,,,NA,NA,,acrosomal vesicle,ATP binding,peptidyl-tyrosine phosphorylation,,
Q9NWW5,Q9NWW5,Ceroid-lipofuscinosis neuronal protein 6,CLN6,239.31,211.63,S31,PGAQLGASFLQARHGSVSADEAARTAPFHLD,_HGS(ph)VSADEAAR_, , , , ,0.46,0.48,1.23,1.42, , , , ,1.16,0.36,1.32,1.66,,,0.47,1.33,,,0.81,1.5, +, +,,,,,NA,NA,,endoplasmic reticulum lumen,protein homodimerization activity,cell death,,
P54105,P54105,Methylosome subunit pICln,CLNS1A,426.26,426.19,S102,EEESKEPVADEEEEDSDDDVEPITEFRFVPS,_FEEESKEPVADEEEEDS(ph)DDDVEPITEFR_,0.09,0.08,0.13,0.08,-0.08,-0.05,-0.07,0.01,-0.01,-0.01,-0.02,0.02,-0.14,-0.01,-0.04,-0.02,0.08,0.11,-0.07,-0.03,-0.01,0,-0.07,-0.03,,,,,,,0,0,,cytoskeleton,,blood circulation,,
Q9HAW4-2,Q9HAW4,Claspin,CLSPN,94.69,94.69,S810,RGTSFFPTAGGFRSPSPGLFRASLVSSASKS,_SPS(ph)PGLFR_, , , , ,0.01,0.23,0.21,0.27, , , , ,-0.4,-0.13,0.22,0.29,,,0.12,0.24,,,-0.26,0.25,,,,,,,NA,NA,,nucleoplasm,DNA binding,activation of protein kinase activity,,
Q9HAW4-2,Q9HAW4,Claspin,CLSPN,39.48,37.86,S642,GFEEEEEEEEEMTDESEEDGEEKVEKEEKEE,_LDNEDGFEEEEEEEEEMT(ph)DES(ph)EEDGEEK_, , , , , ,0.05, , , , , , , ,0.15, , ,,,0.05,,,,0.15,,,,,,,,NA,NA,,nucleoplasm,DNA binding,activation of protein kinase activity,,
Q9HAW4-2,Q9HAW4,Claspin,CLSPN,187.72,181.4,S65,IFVSKKLKNRKVLQDSDSETEDTNASPEKTT,_VLQDS(ph)DS(ph)ETEDTNASPEK_, , , , ,0.01,0.07,0.17,0.16, , , , ,0.07,0.3,0.45,0.26,,,0.04,0.16,,,0.19,0.36,,,,,,,NA,NA,,nucleoplasm,DNA binding,activation of protein kinase activity,,
Q9HAW4-2,Q9HAW4,Claspin,CLSPN,187.72,181.4,S67,VSKKLKNRKVLQDSDSETEDTNASPEKTTYD,_VLQDS(ph)DS(ph)ETEDTNASPEK_, , , , ,0.01,0.07,0.17,0.08, , , , ,0.07,0.3,0.45,0.22,,,0.04,0.13,,,0.19,0.34,,,,,,,NA,NA,,nucleoplasm,DNA binding,activation of protein kinase activity,,
B4DFY1,Q96AJ1,Clusterin-associated protein 1,CLUAP1,91.09,83.23,S409,TKPNRRVRKSEPLDESDNDF___________,_SEPLDES(ph)DNDF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B4DFY1,Q96AJ1,Clusterin-associated protein 1,CLUAP1,100.07,97.65,S314,KEEEKRLLKSGSNDDSDIDIQEDDESDSELE,_SGSNDDS(ph)DIDIQEDDES(ph)DSELEER_, , , , , ,0.37,0.44,0.02, , , , , ,-0.13,0.21,-0.16,,,0.37,0.24,,,-0.13,0.03,,,,,,,NA,NA,,,,,,
B4DFY1,Q96AJ1,Clusterin-associated protein 1,CLUAP1,100.07,97.65,S324,GSNDDSDIDIQEDDESDSELEERRLPKPQTA,_SGSNDDS(ph)DIDIQEDDES(ph)DSELEER_, , , , , ,0.37,0.44,0.02, , , , , ,-0.13,0.21,-0.16,,,0.37,0.24,,,-0.13,0.03,,,,,,,NA,NA,,,,,,
G3V160,Q969H4,Connector enhancer of kinase suppressor of ras 1,CNKSR1,145.43,138.06,S305,PPQTPPQVLDSPHQRSPSLSLAPLSPRAPSE,_S(ph)PSLSLAPLS(ph)PR_, , , , ,0.36,0.28,0.41,0.51, , , , ,0.36,0.13,0.38,0.41,,,0.32,0.46,,,0.25,0.4,,,,,,,NA,NA,,,kinase activity,,,
G3V160,Q969H4,Connector enhancer of kinase suppressor of ras 1,CNKSR1,145.43,138.06,S314,DSPHQRSPSLSLAPLSPRAPSEDVFAFDLSS,_S(ph)PSLSLAPLS(ph)PR_, , , , ,0.36,0.28,0.41,0.51, , , , ,0.36,0.13,0.38,0.41,,,0.32,0.46,,,0.25,0.4,,,,,,,NA,NA,,,kinase activity,,,
F8WA86,Q15417,Calponin-3,CNN3,95.98,95.98,S323,YHGEYQDDYPRDYQYSDQGIDY_________,_DYQYS(ph)DQGIDY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,actomyosin structure organization,,
Q9NZN8-5,Q9NZN8,CCR4-NOT transcription complex subunit 2,CNOT2,96.38,92.58,S165,GIPSRTNSMSSSGLGSPNRSSPSIICMPKQQ,_TNSMSSSGLGS(ph)PNR_,0.03,-0.06, , ,-0.13,0.3,0.17, ,0.32,0.33, , ,-0.23,0.38,0.1, ,-0.01,,0.1,0.17,0.32,,0.11,0.1,,,,,,,NA,NA,,CCR4-NOT complex,RNA polymerase II transcription cofactor activity,gene silencing by RNA,,
O75128-2,O75128,Protein cordon-bleu,COBL,81.3,36.22,S455,SDQDLAGTPDLGPQKSPLWEKNGSENSHLRT,_S(ph)PLWEK_,0.27,0.46,1.16,1.1,0.77,0.8,1.11,1.22,0.18,0.8,1.43,1.37,0.57,0.6,1.34,1.6,0.37,1.13,0.78,1.17,0.52,1.4,0.59,1.48, +, +,,,,,1,1,29,actin filament,actin monomer binding,actin filament network formation,,
P38432,P38432,Coilin,COIL,136.34,120.56,S566,TVFWKELIDPRLIIESPSNTSSTEPA_____,_LIIES(ph)PSNTSSTEPA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,Cajal body,disulfide oxidoreductase activity,,,
Q9Y5P4-2,Q9Y5P4,Collagen type IV alpha-3-binding protein,COL4A3BP,54.26,53.95,S9,_______MSDNQSWNSSGSEEDPETESGPPV,_(ac)SDNQSWNS(ph)S(ph)GS(ph)EEDPETESGPPVER_, , , , , , , ,-0.12, , , , , , , ,0.52,,,,-0.12,,,,0.52,,,,,,,NA,NA,,cytosol,ceramide binding,cell morphogenesis,,
Q9Y5P4-2,Q9Y5P4,Collagen type IV alpha-3-binding protein,COL4A3BP,54.26,53.95,S10,______MSDNQSWNSSGSEEDPETESGPPVE,_(ac)SDNQSWNS(ph)S(ph)GS(ph)EEDPETESGPPVER_, , , , , , , ,-0.12, , , , , , , ,0.52,,,,-0.12,,,,0.52,,,,,,,NA,NA,,cytosol,ceramide binding,cell morphogenesis,,
Q9Y5P4-2,Q9Y5P4,Collagen type IV alpha-3-binding protein,COL4A3BP,54.26,53.95,S12,____MSDNQSWNSSGSEEDPETESGPPVERC,_(ac)SDNQSWNS(ph)S(ph)GS(ph)EEDPETESGPPVER_, , , , , , , ,-0.12, , , , , , , ,0.52,,,,-0.12,,,,0.52,,,,,,,NA,NA,,cytosol,ceramide binding,cell morphogenesis,,
P53621,P53621,Coatomer subunit alpha,COPA,163.9,160.78,S173,TVRVWDISGLRKKNLSPGAVESDVRGITGVD,_NLS(ph)PGAVESDVR_,-0.26,-0.4,-0.38,-0.36,-0.47,-0.45,-0.41,0.04,-0.12,-0.04,-0.11,0.01,-0.29,-0.22,-0.27,-0.66,-0.33,-0.37,-0.46,-0.17,-0.08,-0.05,-0.25,-0.45,,,,,,,0,0,,COPI vesicle coat,structural molecule activity,COPI coating of Golgi vesicle,,
B4DZI8,P35606,Coatomer subunit beta',COPB2,315.17,315.17,S859,PSRSTAQQELDGKPASPTPVIVASHTANKEE,_STAQQELDGKPAS(ph)PTPVIVASHTANK_,0.18,0.13,0.18,0.13,0.02,0.15,-0.27, ,0.02,0.11,0.08,0.05,0.07,0.27,-0.11, ,0.15,0.15,0.08,-0.27,0.06,0.06,0.18,-0.11,,,,,,,0,0,,actin cytoskeleton,structural molecule activity,intracellular protein transport,,
F5H0M8,O75976,Carboxypeptidase D,CPD,245.17,244.3,T1368,TGSKKSLLSHEFQDETDTEEETLYSSKH___,_SLLSHEFQDET(ph)DT(ph)EEETLYSSK_,0.19,0.06,0.01,0.01,0.48,0.14,0.13,0.13,0.36,0.21,-0.1,0.05,0.41,-0.11,0.32,0,0.13,0.01,0.32,0.13,0.29,-0.02,0.18,0.17,,,,,,,0,0,,,,,,
F5H0M8,O75976,Carboxypeptidase D,CPD,245.17,244.3,T1370,SKKSLLSHEFQDETDTEEETLYSSKH_____,_SLLSHEFQDET(ph)DT(ph)EEETLYSSK_,0.19,0.06,0.01,0.01,0.04,0.14,0.13,0.13,0.36,0.21,-0.1,0.05,0.13,-0.11,0.32,0,0.13,0.01,0.09,0.13,0.29,-0.02,0.02,0.17,,,,,,,0,0,,,,,,
B3KMI0,Q9P2I0,Cleavage and polyadenylation specificity factor subunit 2,CPSF2,212.27,212.27,S419,EAAKKLEQSKEADIDSSDESDIEEDIDQPSA,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,-0.32, ,-0.38,-0.31,-0.17,-0.12,-0.23,-0.21,-0.05, ,-0.09,-0.07,-0.06,0.05,0.09,0.12,-0.32,-0.34,-0.15,-0.22,-0.05,-0.08,0,0.1,,,,,,,0,0,,mRNA cleavage and polyadenylation specificity factor complex,hydrolase activity,mRNA cleavage,,
B3KMI0,Q9P2I0,Cleavage and polyadenylation specificity factor subunit 2,CPSF2,212.27,212.27,S420,AAKKLEQSKEADIDSSDESDIEEDIDQPSAH,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,-0.32, ,-0.38,-0.31,-0.17,-0.12,-0.23,-0.21,-0.05, ,-0.09,-0.07,-0.06,0.05,0.09,0.12,-0.32,-0.34,-0.15,-0.22,-0.05,-0.08,0,0.1,,,,,,,0,0,,mRNA cleavage and polyadenylation specificity factor complex,hydrolase activity,mRNA cleavage,,
B3KMI0,Q9P2I0,Cleavage and polyadenylation specificity factor subunit 2,CPSF2,212.27,212.27,S423,KLEQSKEADIDSSDESDIEEDIDQPSAHKTK,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,-0.32, ,-0.38,-0.31,-0.17,-0.12,-0.23,-0.21,-0.05, ,-0.09,-0.07,-0.06,0.05,0.09,0.12,-0.32,-0.34,-0.15,-0.22,-0.05,-0.08,0,0.1,,,,,,,0,0,,mRNA cleavage and polyadenylation specificity factor complex,hydrolase activity,mRNA cleavage,,
G5E9W3,Q9UKF6,Cleavage and polyadenylation specificity factor subunit 3,CPSF3,82.83,53.87,T681,REMVELAAQRLYEALTPVH____________,_LYEALT(ph)PVH_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,5'-3' exonuclease activity,,,
Q16630-3,Q16630,Cleavage and polyadenylation specificity factor subunit 6,CPSF6,188.25,188.25,T407,RGDYGPPGREMDTARTPLSEAEFEEIMNRNR,_EMDTART(ph)PLSEAEFEEIMNR_, ,0.07, ,0.08,0.41, , , , ,-0.27, ,-0.06,0.42, , , ,0.07,0.08,0.41,,-0.27,-0.06,0.42,,,,,,,,NA,NA,,mRNA cleavage factor complex,mRNA binding,mRNA polyadenylation,,
Q8N684-2,Q8N684,Cleavage and polyadenylation specificity factor subunit 7,CPSF7,101.9,101.12,Y451,RRHRDLLHNEDRHDDYFQERNREHERHRDRE,_DLLHNEDRHDDY(ph)FQER_, , ,2.44, , , , , , , ,0.47, , , , , ,,2.44,,,,0.47,,, +,,,,,,NA,NA,,mRNA cleavage factor complex,nucleotide binding,mRNA 3'-end processing,,
Q8N684-2,Q8N684,Cleavage and polyadenylation specificity factor subunit 7,CPSF7,63.49,63.49,T203,RAHSRDSSDSADGRATPSENLVPSSARVDKP,_DSSDSADGRAT(ph)PSENLVPSSAR_, , , , , , ,0.58, , , , , , , ,0.16, ,,,,0.58,,,,0.16,,,,,,,NA,NA,,mRNA cleavage factor complex,nucleotide binding,mRNA 3'-end processing,,
Q96SW2,Q96SW2,Protein cereblon,CRBN,43.09,42.77,S25,AAHNMGNHLPLLPAESEEEDEMEVEDQDSKE,_(ac)AGEGDQQDAAHNMGNHLPLLPAES(ph)EEEDEMEVEDQDSK_, , , , ,-0.03, , ,-1.08, , , , ,0.24, , ,-0.02,,,-0.03,-1.08,,,0.24,-0.02, +,,,,,,NA,NA,,Cul4A-RING ubiquitin ligase complex,ATP-dependent peptidase activity,negative regulation of ion transmembrane transport,,
Q92793,Q92793,CREB-binding protein,CREBBP,115.63,114.15,S121,QPNSANMASLSAMGKSPLSQGDSSAPSLPKQ,_S(ph)PLSQGDSSAPSLPK_, , , , ,-0.55,0.12,-0.06, , , , , ,-0.67,-0.02,-0.41, ,,,-0.18,-0.06,,,-0.31,-0.41,,,,,,,NA,NA,,condensed chromosome outer kinetochore,chromatin binding,cellular lipid metabolic process,,
Q9NS37,Q9NS37,CREB/ATF bZIP transcription factor,CREBZF,57.22,57.22,S50,LTRAAAGEEETAAAGSPGRKQQFGDEGELEA,_AAAGEEETAAAGS(ph)PGRK_, , , , , , ,0.35, , , , , , , ,-0.44, ,,,,0.35,,,,-0.44,,,,,,,NA,NA,,nucleus,DNA binding,"negative regulation of gene expression, epigenetic",,
Q9NZV1,Q9NZV1,Cysteine-rich motor neuron 1 protein,CRIM1,61.77,27.51,Y1019,RMLRIAEPDARFSGFYSMQKQNHLQADNFYQ,_FSGFY(ph)SMQK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,extracellular region,insulin-like growth factor-activated receptor activity,negative regulation of catalytic activity,,
Q9NZV1,Q9NZV1,Cysteine-rich motor neuron 1 protein,CRIM1,101.39,98.73,Y1033,FYSMQKQNHLQADNFYQTV____________,_QNHLQADNFY(ph)QTV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,extracellular region,insulin-like growth factor-activated receptor activity,negative regulation of catalytic activity,,
H0YFA4,P52943,Cysteine-rich protein 2,CRIP2,74.79,69.42,Y75,TLFGPKGVNIGGAGSYIYEKPLAEGPQVTGP,_GVNIGGAGSY(ph)IYEK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,zinc ion binding,,,
H0YFA4,P52943,Cysteine-rich protein 2,CRIP2,106.14,96.6,Y77,FGPKGVNIGGAGSYIYEKPLAEGPQVTGPIE,_GVNIGGAGSYIY(ph)EK_,0.42, ,0.09, , , , , ,0.29, ,0.19, , , , , ,0.42,0.09,,,0.29,0.19,,,,,,,,,NA,NA,,,zinc ion binding,,,
H0YFA4,P52943,Cysteine-rich protein 2,CRIP2,76.3,75.12,Y198,FGPKGVNTGAVGSYIYDRDPEGKVQP_____,_GVNTGAVGSYIY(ph)DRDPEGK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,zinc ion binding,,,
P46108,P46108,Adapter molecule crk,CRK,41.74,25.21,Y108,EFDSLPALLEFYKIHYLDTTTLIEPVSRSRQ,_IHY(ph)LDTTTLIEPVSR_, , ,0.31, ,2.3, , ,2.23, , ,0.34, ,2.42, , ,2.59,,0.31,2.3,2.23,,0.34,2.42,2.59, +, +,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
P46108,P46108,Adapter molecule crk,CRK,108.18,106.62,Y136,SRQGSGVILRQEEAEYVRALFDFNGNDEEDL,_(gl)QGSGVILRQEEAEY(ph)VR_,4.88, ,5.16, , , , , ,4.52, ,4.36, , , , , ,4.88,5.16,,,4.52,4.36,,, +, +,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
P46108,P46108,Adapter molecule crk,CRK,347.18,346.61,Y221,EGSHPQPLGGPEPGPYAQPSVNTPLPNLQNG,_YRPASASVSALIGGNQEGSHPQPLGGPEPGPY(ph)AQPSVNTPLPNLQNGPIYAR_,1.21,1.41,1.28, ,0.82,0.85,0.25,0.35,1.44,1.01,1.03, ,0.65,0.88,0.58,0.64,1.32,1.28,0.83,0.3,1.24,1.03,0.77,0.61, +, +,,,,,5,5,23.18,cytosol,,activation of MAPKK activity,,
P46108,P46108,Adapter molecule crk,CRK,101,99.27,S41,LLQGQRHGVFLVRDSSTSPGDYVLSVSENSR,_DSS(ph)TSPGDYVLSVSENSR_, ,-0.14, , ,-0.13,-0.34,-0.18,-0.06, ,-0.03, , ,-0.62,-0.33,0.12,0.14,-0.14,,-0.23,-0.12,-0.03,,-0.46,0.13,,,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
P46109,P46109,Crk-like protein,CRKL,291.02,291.01,Y207,NRNSNSYGIPEPAHAYAQPQTTTPLPAVSGS,_HGNRNS(ph)NSYGIPEPAHAY(ph)AQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAK_,1.55, ,-0.13, ,1.25,-0.13, ,-0.05,2.39, ,0.49, ,0.54,-0.18, ,0.54,1.55,-0.13,0.72,-0.05,2.39,0.49,0.22,0.54, +, +,,,,,5,5,11.37,cytosol,SH3/SH2 adaptor activity,activation of MAPKK activity,,
P46109,P46109,Crk-like protein,CRKL,119.75,95.78,Y251,GPVFAKAIQKRVPCAYDKTALALEVGDIVKV,_VPCAY(ph)DK_,2.36, ,1.9, , , , , ,2.21, ,1.45, , , , , ,2.36,1.9,,,2.21,1.45,,, +, +,,,,,NA,NA,,cytosol,SH3/SH2 adaptor activity,activation of MAPKK activity,,
P46109,P46109,Crk-like protein,CRKL,82.3,81.8,Y127,SVSAPNLPTAEDNLEYVRTLYDFPGNDAEDL,_YPSPPMGSVSAPNLPTAEDNLEY(ph)VR_, , , , ,1.95,1.36, ,1.16, , , , ,1.45,0.81, ,1.18,,,1.68,1.16,,,1.17,1.18, +, +,,,,,NA,NA,,cytosol,SH3/SH2 adaptor activity,activation of MAPKK activity,,
P46109,P46109,Crk-like protein,CRKL,291.02,291.01,S195,KLVRSSPHGKHGNRNSNSYGIPEPAHAYAQP,_HGNRNS(ph)NSYGIPEPAHAY(ph)AQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAK_,1.55, ,0.83, , , , , ,2.39, ,0.96, , , , , ,1.55,0.83,,,2.39,0.96,,, +, +,,,,,NA,NA,,cytosol,SH3/SH2 adaptor activity,activation of MAPKK activity,,
E9PD68,Q14194,Dihydropyrimidinase-related protein 1,CRMP1,85.49,82.35,Y504,FGLQGVSRGMYDGPVYEVPATPKYATPAPSA,_GMYDGPVY(ph)EVPATPK_,0.29, , , , , , , ,0.55, , , , , , , ,0.29,,,,0.55,,,,,,,,,,NA,NA,,cytoplasm,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",pyrimidine nucleobase catabolic process,,
P67809,P67809,DNA-binding protein A,CSDA,226.44,224.77,S102,HQTAIKKNNPRKYLRSVGDGETVEFDVVEGE,_S(ph)VGDGETVEFDVVEGEK_, , , , ,1.35,1.32, , , , , , ,1.54,2.02, , ,,,1.33,,,,1.8,, +, +,,,,,NA,NA,,CRD-mediated mRNA stability complex,double-stranded DNA binding,CRD-mediated mRNA stabilization,,
P16989,P16989,DNA-binding protein A,CSDA,90.38,73.79,S370,GEAPTENPAPPTQQSSAE_____________,_AGEAPTENPAPPTQQSS(ph)AE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,double-stranded DNA binding,3'-UTR-mediated mRNA stabilization,,
P16989,P16989,DNA-binding protein A,CSDA,139.52,139.22,S201,RGPPRNYAGEEEEEGSGSSEGFDPPATDRQF,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_,-0.11,0.14,0.09, ,-0.23,-0.27,-0.22,-0.33,-0.01,0.2,-0.11, ,-0.11,-0.06,-0.13,-0.19,0.02,0.09,-0.25,-0.28,0.1,-0.11,-0.08,-0.16,,,,,,,0,0,,nucleus,double-stranded DNA binding,3'-UTR-mediated mRNA stabilization,,
P16989,P16989,DNA-binding protein A,CSDA,158.15,146.95,S203,PPRNYAGEEEEEGSGSSEGFDPPATDRQFSG,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_,-0.11,0.14,0.09, ,-0.25,-0.3,-0.01,-0.3,-0.01,0.2,-0.11, ,-0.15,-0.01,-0.09,-0.15,0.02,0.09,-0.28,-0.15,0.1,-0.11,-0.08,-0.12,,,,,,,0,0,,nucleus,double-stranded DNA binding,3'-UTR-mediated mRNA stabilization,,
P16989,P16989,DNA-binding protein A,CSDA,139.52,139.22,S204,PRNYAGEEEEEGSGSSEGFDPPATDRQFSGA,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_, , , , ,-0.21,-0.23,-0.12,-0.33, , , , ,-0.06,-0.11,-0.11,-0.19,,,-0.22,-0.22,,,-0.09,-0.15,,,,,,,NA,NA,,nucleus,double-stranded DNA binding,3'-UTR-mediated mRNA stabilization,,
Q9Y534,Q9Y534,Cold shock domain-containing protein C2,CSDC2,81.63,81.63,S47,SRVWERGGVPPRDLPSPLPTKRTRTYSATAR,_DLPS(ph)PLPTK_,-0.3,-0.02,-0.29,-0.44,0.28,0.22,0.23,0.21,0.04,0.23,0.36,0.12,-0.76,-0.77,0.03,0.25,-0.16,-0.36,0.25,0.22,0.13,0.25,-0.77,0.14,,,,,,,0,0,,cytoplasm,DNA binding,histone mRNA 3'-end processing,,
P09603-3,P09603,Macrophage colony-stimulating factor 1,CSF1,73.46,68.49,S533,YRWRRRSHQEPQRADSPLEQPEGSPLTQDDR,_ADS(ph)PLEQPEGSPLTQDDR_, , , , , , ,-0.32, , , , , , , ,-0.18, ,,,,-0.32,,,,-0.18,,,,,,,NA,NA,,extracellular space,cytokine activity,branching involved in mammary gland duct morphogenesis,,
Q71TU5,Q8N752,Casein kinase I isoform alpha,CSNK1A1,99.04,96.7,Y294,QLFRILFRTLNHQYDYTFDWTMLKQKAAQQA,_TLNHQYDY(ph)TFDWTMLK_, , , , , , ,2.54,1.52, , , , , , ,2.25,1.32,,,,2.12,,,,1.86, +, +,CK1,,,,NA,NA,,,ATP binding,,,
B4DIJ9,P48730,Casein kinase I isoform delta,CSNK1D,110.64,88.21,S382,RKVSMRLHRGAPVNISSSDLTGRQDTSRMST,_GAPVNIS(ph)SS(ph)DLTGR_, , , , , ,-0.39,-0.28,-0.62, , , , , ,-0.62,-0.66,-0.45,,,-0.39,-0.44,,,-0.62,-0.55,,,CK3,,,,NA,NA,,,ATP binding,,,
B4DIJ9,P48730,Casein kinase I isoform delta,CSNK1D,110.64,88.21,S384,VSMRLHRGAPVNISSSDLTGRQDTSRMSTSQ,_GAPVNIS(ph)SS(ph)DLTGR_, , , , , ,-0.39,-0.25,-0.62, , , , , ,-0.62,-0.7,-0.45,,,-0.39,-0.42,,,-0.62,-0.57,,,CK3,,,,NA,NA,,,ATP binding,,,
E9PP21,P21291,Cysteine and glycine-rich protein 1,CSRP1,172.82,170.7,Y73,CKSCYGKKYGPKGYGYGQGAGTLSTDKGESL,_GYGY(ph)GQGAGTLSTDK_,1.88, ,2.05, , , , , ,1.61, ,0.91, , , , , ,1.88,2.05,,,1.61,0.91,,, +, +,,,,,NA,NA,,,zinc ion binding,,,
E9PP21,P21291,Cysteine and glycine-rich protein 1,CSRP1,277.69,275.62,S192,PKGFGFGQGAGALVHSE______________,_GFGFGQGAGALVHS(ph)E_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,zinc ion binding,,,
P04080,P04080,Cystatin-B,CSTB,92.73,92.73,Y97,LSNYQTNKAKHDELTYF______________,_AKHDELTY(ph)F_,0.34, ,1.82, ,2.27, ,2.1,2.23,-0.07, ,1.16, ,1.32, ,1.98,2.43,0.34,1.82,2.27,2.17,-0.07,1.16,1.32,2.22, +, +,,,,,1,2,34.24,cytoplasm,cysteine-type endopeptidase inhibitor activity,adult locomotory behavior,,
O15320-8,Q96RT6,Cutaneous T-cell lymphoma-associated antigen 5,CTAGE5,113.07,81.58,S616,ARLSGPAELRSFNMPSLDKMDGSMPSEMESS,_SFNMPS(ph)LDK_,0.96,1.05,0.4,0.1,0.12, ,0.35, ,0.45,0.6,-0.08,-0.54,-0.11, ,-0.19, ,1.01,0.26,0.12,0.35,0.53,-0.29,-0.11,-0.19, +,,,,,,5,0,14.94,,enzyme activator activity,,,
O15320-8,O15320,Cutaneous T-cell lymphoma-associated antigen 5,CTAGE5,100.14,91.07,S517,PYALDVPNTAFGREHSPYGPSPLGWPSSETR,_EHS(ph)PYGPS(ph)PLGWPSSETR_, , , , ,-0.27,-0.81,-0.07,-0.01, , , , ,-0.94,-1,-0.06,-0.38,,,-0.52,-0.04,,,-0.97,-0.22,,,,,,,NA,NA,,,enzyme activator activity,,,
O15320-8,O15320,Cutaneous T-cell lymphoma-associated antigen 5,CTAGE5,100.14,91.07,S522,VPNTAFGREHSPYGPSPLGWPSSETRAFLSP,_EHS(ph)PYGPS(ph)PLGWPSSETR_, , , , ,-0.27,-0.81,0.06,-0.01, , , , ,-0.94,-1,0.02,-0.38,,,-0.52,0.03,,,-0.97,-0.17,,,,,,,NA,NA,,,enzyme activator activity,,,
Q9Y5B0-3,Q9Y5B0,RNA polymerase II subunit A C-terminal domain phosphatase,CTDP1,253.57,244.27,S869,LESMDKEVDDILGEGSDDSDSEKRRPEEQEE,_EVDDILGEGS(ph)DDS(ph)DS(ph)EKR_,0.15,-0.14,-0.19,-0.04,0.01,0.02,-0.03,0.01,-0.25,-0.23,-0.12,-0.1,-0.34,-0.18,-0.03,-0.08,0.01,-0.11,0.01,-0.01,-0.24,-0.11,-0.26,-0.05,,,,,,,0,0,,actin cytoskeleton,CTD phosphatase activity,cell division,,
Q9Y5B0-3,Q9Y5B0,RNA polymerase II subunit A C-terminal domain phosphatase,CTDP1,253.57,244.27,S872,MDKEVDDILGEGSDDSDSEKRRPEEQEEEPQ,_EVDDILGEGS(ph)DDS(ph)DS(ph)EKR_,0.15,-0.14,-0.19,-0.04,0.01,0,-0.04,0.03,-0.25,-0.23,-0.12,-0.1,-0.27,-0.11,-0.05,-0.01,0.01,-0.11,0,0,-0.24,-0.11,-0.19,-0.03,,,,,,,0,0,,actin cytoskeleton,CTD phosphatase activity,cell division,,
Q9Y5B0-3,Q9Y5B0,RNA polymerase II subunit A C-terminal domain phosphatase,CTDP1,118.08,118.08,S874,KEVDDILGEGSDDSDSEKRRPEEQEEEPQPR,_EVDDILGEGS(ph)DDS(ph)DS(ph)EKR_,0.44, , , ,-0.09, ,-0.03,0.01,-0.3, , , ,-0.55, ,-0.01,-0.11,0.44,,-0.09,-0.01,-0.3,,-0.55,-0.06,,,,,,,NA,NA,,actin cytoskeleton,CTD phosphatase activity,cell division,,
O43310,O43310,CBP80/20-dependent translation initiation factor,CTIF,72.71,43.4,S18,NSSAASASSEAGSSRSQEIEELERFIDSYVL,_S(ph)QEIEELER_, , , , ,-0.8, ,-1, , , , , ,-0.38, ,-0.42, ,,,-0.8,-1,,,-0.38,-0.42, +,,,,,,NA,NA,,perinuclear region of cytoplasm,DNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P35221,P35221,Catenin alpha-1,CTNNA1,343.81,343.81,S652,ELDDSDFETEDFDVRSRTSVQTEDDQLIAGQ,_TPEELDDS(ph)DFETEDFDVRS(ph)R_,-0.69,-0.56,-0.78,-0.78,0.12,0.16,0.38,0.36,-0.01,0.07,0.27,0.24,-0.19,-0.15,-0.08,0.11,-0.62,-0.78,0.14,0.37,0.03,0.25,-0.17,0.02,,,,,,,0,0,,acrosomal vesicle,structural molecule activity,adherens junction organization,,
P35221,P35221,Catenin alpha-1,CTNNA1,498.75,460.01,S641,RKAVLMIRTPEELDDSDFETEDFDVRSRTSV,_TPEELDDS(ph)DFETEDFDVRS(ph)R_,-0.18,-0.24,-0.25,-0.23,-0.26,-0.26,-0.23,-0.01,-0.07,-0.07,-0.11,-0.12,-0.05,-0.04,-0.04,-0.06,-0.21,-0.24,-0.26,-0.11,-0.07,-0.12,-0.05,-0.05,,,,,,,0,0,,acrosomal vesicle,structural molecule activity,adherens junction organization,,
P35221,P35221,Catenin alpha-2,CTNNA2,111.82,111.82,T658,FEQEDYDVRSRTSVQTEDDQLIAGQSARAIM,_TS(ph)VQT(ph)EDDQLIAGQSAR_,-1.05,-0.47,-1.09,-0.95,0.13,0.25,-0.08,-0.04,-0.45,-0.46,-0.49,-0.49,0.04,-0.07,-0.24,-0.04,-0.73,-1.02,0.19,-0.06,-0.45,-0.49,-0.02,-0.14, +,,,,,,3,0,27.05,acrosomal vesicle,structural molecule activity,adherens junction organization,,
P26232-2,P26232,Catenin alpha-2,CTNNA2,198.93,198.93,S651,LEDDSDFEQEDYDVRSRTSVQTEDDQLIAGQ,_S(ph)RTS(ph)VQTEDDQLIAGQSAR_,-0.55,-0.56,-0.5,-0.22,0.22,0.31,0.57,0.42,-0.29,0.07,0.35,0.17,-0.17,-0.18,0.03,0.06,-0.56,-0.35,0.27,0.5,-0.1,0.26,-0.17,0.04,,,,,,,0,0,,actin cytoskeleton,structural constituent of cytoskeleton,axonogenesis,,
P35221,P35221,Catenin alpha-2,CTNNA2,205.26,205.26,S655,DSDFEQEDYDVRSRTSVQTEDDQLIAGQSAR,_S(ph)RTS(ph)VQTEDDQLIAGQSAR_,-0.89,-0.7,-0.35,-0.43,0.22,0.31,0.57,0.41,-0.44,0.01,0.33,0.26,-0.17,-0.18,0.03,0.05,-0.79,-0.39,0.27,0.49,-0.2,0.3,-0.17,0.04,,,,,,,0,0,,acrosomal vesicle,structural molecule activity,adherens junction organization,,
P35221,P26232,Catenin alpha-2,CTNNA2,205.26,205.26,T653,DDSDFEQEDYDVRSRTSVQTEDDQLIAGQSA,_SRT(ph)S(ph)VQTEDDQLIAGQSAR_,-0.65,-0.83,-0.59,-0.64,-0.03,0.06,0.13,0.19,-0.29,-0.06,0.34,0.35,-0.15,-0.1,0.02,0.08,-0.74,-0.61,0.02,0.16,-0.17,0.35,-0.12,0.05,,,,,,,0,0,,acrosomal vesicle,structural molecule activity,adherens junction organization,,
E7ERS9,P35222,Catenin beta-1,CTNNB1,124.85,124.85,S552,VQLLVRAHQDTQRRTSMGGTQQQFVEGVRME,_RTS(ph)MGGTQQQFVEGVR_, , ,-0.34,-0.57, , , , , , ,0.25,0.18, , , , ,,-0.45,,,,0.22,,,,,,,,,NA,NA,,,,,,
E7ERS9,P35222,Catenin beta-1,CTNNB1,93.26,93.26,T551,LVQLLVRAHQDTQRRTSMGGTQQQFVEGVRM,_RT(ph)SMGGTQQQFVEGVR_,-0.86, , , , , , , ,0.08, , , , , , , ,-0.86,,,,0.08,,,,,,,,,,NA,NA,,,,,,
O60716-5,O60716,Catenin delta-1,CTNND1,140.01,129.16,Y280,VGGSSVDLHRFHPEPYGLEDDQRSMGYDDLD,_FHPEPY(ph)GLEDDQR_,3.92, ,1.72, , , , , ,3.01, ,0.74, , , , , ,3.92,1.72,,,3.01,0.74,,, +, +,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,87.52,60.75,S899,DREEIQMSNMGSNTKSLDNNYSTPNERGDHN,_S(ph)LDNNYSTPNER_, , , , ,-0.32, ,-1.36, , , , , ,-0.15, ,-0.55, ,,,-0.32,-1.36,,,-0.15,-0.55, +,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,177.3,177.3,S349,YYWAPLAQHERGSLASLDSLRKGGPPPPNWR,_GS(ph)LAS(ph)LDS(ph)LRK_,-1.23,-0.97,-0.67,-0.27,-0.12,0.01,-0.13,-0.38,-0.33,0.02,0.34,1.15,-0.01,0.19,0.25,0.08,-1.1,-0.46,-0.05,-0.25,-0.14,0.8,0.09,0.17, +,,,,,,3,0,7.92,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,258.05,255.48,S230,RHYEDGYPGGSDNYGSLSRVTRIEERYRPSM,_HYEDGYPGGSDNYGS(ph)LSR_, , , , ,0.38,0.38,1.04,1.18, , , , ,-0.41,-0.44,0.19,0.47,,,0.38,1.11,,,-0.42,0.34, +,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,123.16,123.16,S920,STPNERGDHNRTLDRSGDLGDMEPLKGTTPL,_S(ph)GDLGDMEPLK_,-0.5,-0.56,-1.32,-1.16,-0.11,-0.28, ,0.42,-0.41,-0.1,-1.05,-0.72,-0.07,0.11, ,0.75,-0.53,-1.24,-0.19,0.42,-0.25,-0.88,0.02,0.75, +,,,,,,3,0,28.6,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,173.87,171.8,Y96,SDLKLNGPQDHSHLLYSTIPRMQEPGQIVET,_LNGPQDHSHLLY(ph)STIPR_,0.1,0.18,-0.2, ,0.42, ,0.16,0.1,1.59,0.89,1.15, ,0.61, ,0.77,0.65,0.14,-0.2,0.42,0.13,1.28,1.15,0.61,0.71,, +,,,,,0,5,2.55,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,218.66,215.86,Y228,YSRHYEDGYPGGSDNYGSLSRVTRIEERYRP,_HYEDGYPGGSDNY(ph)GSLSR_,0.93,0.85,0.31,0.51,-0.6,-0.29,-0.82,-0.6,0.62,0.45,0.88,0.96,0.4,0.46,-0.1,0.18,0.89,0.42,-0.44,-0.71,0.54,0.92,0.43,0.05,,,,,,,0,0,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,172.66,152.06,Y291,HPEPYGLEDDQRSMGYDDLDYGMMSDYGTAR,_SMGY(ph)DDLDYGMMSDYGTAR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,49.71,49.24,Y296,GLEDDQRSMGYDDLDYGMMSDYGTARRTGTP,_SMGYDDLDY(ph)GMMSDYGTAR_, , , , ,-0.32, , , , , , , ,0.59, , , ,,,-0.32,,,,0.59,,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,121.42,121.42,S346,SDQYYWAPLAQHERGSLASLDSLRKGGPPPP,_GS(ph)LAS(ph)LDS(ph)LRK_, , , , ,-0.12,0.11,0.7,-0.05, , , , ,-0.54,-0.57,0.34,0.11,,,0,0.38,,,-0.55,0.23,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,177.3,177.3,S352,APLAQHERGSLASLDSLRKGGPPPPNWRQPE,_GS(ph)LAS(ph)LDS(ph)LRK_, , , , ,0.23,0.15,0.52,0.95, , , , ,-0.61,-0.55,0.06,0.28,,,0.19,0.75,,,-0.58,0.18,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,245.92,223.66,S288,HRFHPEPYGLEDDQRSMGYDDLDYGMMSDYG,_S(ph)MGYDDLDYGMMSDYGTAR_, , , , ,-0.23,-0.25,0.03,0.04, , , , ,-0.14,-0.48,-0.25,0.02,,,-0.24,0.03,,,-0.3,-0.11,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,78.29,78.29,S268,RQDVYGPQPQVRVGGSSVDLHRFHPEPYGLE,_VGGS(ph)S(ph)VDLHR_, , , , ,-0.29,-0.34,-0.34, , , , , ,-0.1,-0.6,-0.23, ,,,-0.31,-0.34,,,-0.33,-0.23,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
O60716-5,O60716,Catenin delta-1,CTNND1,78.29,78.29,S269,QDVYGPQPQVRVGGSSVDLHRFHPEPYGLED,_VGGS(ph)S(ph)VDLHR_, , , , ,-0.29,-0.34,-0.34, , , , , ,-0.1,-0.6,-0.23, ,,,-0.31,-0.34,,,-0.33,-0.23,,,,,,,NA,NA,,cell-cell adherens junction,,adherens junction organization,,
P17812,P17812,CTP synthase 1,CTPS1,164.65,164.65,S568,HYLQKGCRLSPRDTYSDRSGSSSPDSEITEL,_DTYS(ph)DRS(ph)GSS(ph)SPDSEITELK_,-0.06,-0.01,0.2, ,-0.04,-0.02,0.03,0.3,-0.1,-0.05,-0.12, ,-0.09,0,-0.11,-0.07,-0.04,0.2,-0.03,0.17,-0.07,-0.12,-0.04,-0.09,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
P17812,P17812,CTP synthase 1,CTPS1,177.73,177.73,S571,QKGCRLSPRDTYSDRSGSSSPDSEITELKFP,_DTYS(ph)DRS(ph)GSS(ph)S(ph)PDSEITELK_,0.03,0.07,-0.16,0,-0.01,0.02,0.03,0.11,0.12,0.04,-0.04,-0.13,-0.01,0.08,0.01,0,0.05,-0.08,0.01,0.07,0.08,-0.09,0.04,0.01,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
P17812,P17812,CTP synthase 1,CTPS1,207.76,207.76,S573,GCRLSPRDTYSDRSGSSSPDSEITELKFPSI,_DTYSDRSGS(ph)SS(ph)PDSEITELK_,0.02,0.02,-0.2,-0.04,-0.04,0.08,0,0.03,-0.11,-0.01,-0.04,-0.05,-0.05,-0.04,-0.07,-0.08,0.02,-0.12,0.02,0.02,-0.06,-0.04,-0.04,-0.07,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
P17812,P17812,CTP synthase 1,CTPS1,207.76,207.76,S574,CRLSPRDTYSDRSGSSSPDSEITELKFPSIN,_SGS(ph)S(ph)S(ph)PDSEITELK_,-0.01,0.06,-0.01,0.03,-0.12,0.05,-0.04,-0.01,0.08,0.08,0.12,0.07,0,0.27,0.34,0.2,0.03,0.01,-0.03,-0.03,0.08,0.09,0.14,0.27,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
P17812,P17812,CTP synthase 1,CTPS1,195.64,195.64,S575,RLSPRDTYSDRSGSSSPDSEITELKFPSINH,_SGSS(ph)S(ph)PDSEITELK_,0.07,0.13,0.3,0.24,0.24,0.22,0.47,0.23,0.03,0.04,0.13,-0.06,0.19,0.3,0.59,0.35,0.1,0.27,0.23,0.36,0.04,0.03,0.24,0.48,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
P17812,P17812,CTP synthase 1,CTPS1,65.18,61.87,S578,PRDTYSDRSGSSSPDSEITELKFPSINHD__,_SGSS(ph)S(ph)PDS(ph)EITELK_, , , , ,0.1,-0.06, ,0.17, , , , ,0.03,0.81, ,0.34,,,0.02,0.17,,,0.47,0.34,,,,,,,NA,NA,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
Q9NRF8,Q9NRF8,CTP synthase 2,CTPS2,178.95,178.92,S568,AYLQQGCKLSSSDRYSDASDDSFSEPRIAEL,_LSSSDRYS(ph)DAS(ph)DDSFSEPR_,-0.07,-0.05,-0.15,-0.11,0.05,0.06,-0.01,-0.17,-0.06,-0.15,-0.26,-0.15,-0.06,-0.08,0.12,-0.09,-0.06,-0.13,0.05,-0.09,-0.1,-0.21,-0.07,0.02,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
Q9NRF8,Q9NRF8,CTP synthase 2,CTPS2,178.95,178.92,S571,QQGCKLSSSDRYSDASDDSFSEPRIAELEIS,_LSSSDRYS(ph)DAS(ph)DDS(ph)FSEPR_,-0.07,-0.05,-0.15,-0.11,0.11,0.06,-0.15,-0.15,-0.06,-0.15,-0.26,-0.15,-0.02,-0.08,0.08,0.01,-0.06,-0.13,0.08,-0.15,-0.1,-0.21,-0.05,0.05,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
Q9NRF8,Q9NRF8,CTP synthase 2,CTPS2,167.26,167.26,S574,CKLSSSDRYSDASDDSFSEPRIAELEIS___,_LSSSDRYS(ph)DAS(ph)DDS(ph)FSEPR_,0.01,0.09,-0.13,-0.12,0,0,0.04,-0.03,-0.1,0,-0.01,-0.07,-0.22,-0.07,-0.08,-0.04,0.05,-0.12,0,0.01,-0.05,-0.04,-0.14,-0.06,,,,,,,0,0,,cytosol,ATP binding,de novo' CTP biosynthetic process,,
Q6PD62,Q6PD62,RNA polymerase-associated protein CTR9 homolog,CTR9,128.79,128.79,S970,RKKKKRRRHPKGEEGSDDDETENGPKPKKRR,_GEEGS(ph)DDDETENGPKPK_, , , , , , ,0.08,-0.38, , , , , , ,0.42,0.27,,,,-0.13,,,,0.35,,,,,,,NA,NA,,Cdc73/Paf1 complex,,cellular response to lipopolysaccharide,,
Q6PD62,Q6PD62,RNA polymerase-associated protein CTR9 homolog,CTR9,187.21,185.98,S941,DDDLPISKKKKRRKGSGSEQEGEDEEGGERK,_RKGS(ph)GS(ph)EQEGEDEEGGER_, , ,-0.2, , ,0.05,0.22,-0.03, , ,0.25, , ,0.08,0.05,-0.19,,-0.2,0.05,0.1,,0.25,0.08,-0.07,,,,,,,NA,NA,,Cdc73/Paf1 complex,,cellular response to lipopolysaccharide,,
Q6PD62,Q6PD62,RNA polymerase-associated protein CTR9 homolog,CTR9,187.21,185.98,S943,DLPISKKKKRRKGSGSEQEGEDEEGGERKKK,_RKGS(ph)GS(ph)EQEGEDEEGGER_, , ,-0.2, , ,0.05,0.22,-0.03, , ,0.25, , ,0.08,0.05,-0.19,,-0.2,0.05,0.1,,0.25,0.08,-0.07,,,,,,,NA,NA,,Cdc73/Paf1 complex,,cellular response to lipopolysaccharide,,
Q6PD62,Q6PD62,RNA polymerase-associated protein CTR9 homolog,CTR9,262.66,262.66,T925,RSKKGGEFDEFVNDDTDDDLPISKKKKRRKG,_KGGEFDEFVNDDT(ph)DDDLPISK_,-0.23,-0.23,-0.3,-0.16,-0.13,-0.08,-0.26,-0.04,-0.01,0.09,0.1,-0.19,0.04,0,-0.05,0.07,-0.23,-0.23,-0.11,-0.15,0.04,-0.04,0.02,0.01,,,,,,,0,0,,Cdc73/Paf1 complex,,cellular response to lipopolysaccharide,,
Q14247,Q14247,Src substrate cortactin,CTTN,368.97,368.97,Y446,LSYRGPVSGTEPEPVYSMEAADYREASSQQG,_GPVSGTEPEPVY(ph)SMEAADYR_,1.93, ,0.5,-1.46,-0.03, ,-0.21,-0.49,1.21, ,-0.28,-0.37,0.25, ,-0.51,-0.21,1.93,-0.17,-0.03,-0.34,1.21,-0.32,0.25,-0.35, +, +,,,,,5,5,37.61,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,89.86,86.52,Y453,SGTEPEPVYSMEAADYREASSQQGLAYATEA,_GPVSGTEPEPVYSMEAADY(ph)R_,2.54, ,0.61, , , ,0.1,0.02,1.95, ,-0.22, , , ,0.48,0.39,2.54,0.61,,0.06,1.95,-0.22,,0.44, +, +,,,,,NA,NA,,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,273.73,273.73,S417,PPVSPAPQPTEERLPSSPVYEDAASFKAELS,_TQT(ph)PPVS(ph)PAPQPTEERLPS(ph)SPVYEDAASFK_,0.07,0.17,0.63,0.48,1.11,1.36,1.35,0.96,0.02,0.26,0.2,0.12,1.21,1.12,1.43,1,0.12,0.56,1.24,1.17,0.15,0.16,1.17,1.23, +, +,,,,,2,2,34.58,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,264.8,264.8,S418,PVSPAPQPTEERLPSSPVYEDAASFKAELSY,_LPSS(ph)PVYEDAASFK_,-0.16,-0.27,0.61,0.71,1,1.16,1.14,0.99,0.01,-0.14,0.67,0.69,1.16,1.2,1.19,1.26,-0.21,0.66,1.08,1.07,-0.07,0.68,1.18,1.23, +, +,,,,,1,2,43.29,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,168.45,168.45,T411,RAKTQTPPVSPAPQPTEERLPSSPVYEDAAS,_TQT(ph)PPVSPAPQPT(ph)EERLPSSPVYEDAASFK_, , , , ,1.16, ,0.94,0.87, , , , ,1.02, ,0.81,0.84,,,1.16,0.9,,,1.02,0.82, +, +,,,,,NA,NA,,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,258.54,257.8,Y421,PAPQPTEERLPSSPVYEDAASFKAELSYRGP,_LPSSPVY(ph)EDAASFK_,1.56, ,0, ,-1.08, ,-1.77,-1.11,0.69, ,-0.55, ,-0.62, ,-1.29,-0.6,1.56,0,-1.08,-1.4,0.69,-0.55,-0.62,-0.9, +,,,,,,6,0,24.15,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,178.46,177.73,S447,SYRGPVSGTEPEPVYSMEAADYREASSQQGL,_GPVSGTEPEPVYS(ph)MEAADYR_,-1.06,-1.22,-1.19, ,-0.56,-0.18, , ,-0.19,-0.34,-0.52, ,0,-0.04, , ,-1.14,-1.19,-0.35,,-0.26,-0.52,-0.02,, +,,,,,,NA,NA,,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,273.73,273.73,S405,KLEEQARAKTQTPPVSPAPQPTEERLPSSPV,_TQT(ph)PPVS(ph)PAPQPTEERLPSS(ph)PVYEDAASFK_,-0.33,-0.24,0.83,0.83,1.14,0.87,-0.4,1.07,-0.16,-0.06,0.7,0.87,1.08,0.75,-0.36,1.18,-0.28,0.83,1.01,0.52,-0.11,0.79,0.93,0.6, +,,,,,,1,0,40.99,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,273.73,273.73,T401,EARRKLEEQARAKTQTPPVSPAPQPTEERLP,_TQT(ph)PPVS(ph)PAPQPTEERLPSS(ph)PVYEDAASFK_,-0.4,-0.43,-1.25,-1,-0.66,-0.68,-0.05,0.02,-0.59,-0.63,-1.69,0.36,-0.07,-0.92,-0.13,-0.04,-0.41,-1.12,-0.67,-0.02,-0.61,-0.33,-0.44,-0.08, +,,,,,,3,0,6.7,cell cortex,,,,
Q14247,Q14247,Src substrate cortactin,CTTN,112.39,111.4,S426,TEERLPSSPVYEDAASFKAELSYRGPVSGTE,_LPSS(ph)PVYEDAAS(ph)FK_, , ,-0.81, , , ,0.62, , , ,-1.35, , , ,0.55, ,,-0.81,,0.62,,-1.35,,0.55,, +,,,,,NA,NA,,cell cortex,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,80.6,73.91,S557,PRGDTSHSPTPGKVSSPLSPLSPGIKSPTIP,_VSS(ph)PLSPLS(ph)PGIK_, , , , ,0.98,1.45,1.25,1.06, , , , ,1.1,1.88,1.77,1.66,,,1.23,1.16,,,1.54,1.72, +, +,,,,,NA,NA,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,126.81,121.71,S560,DTSHSPTPGKVSSPLSPLSPGIKSPTIPRAE,_VSSPLS(ph)PLS(ph)PGIK_, , ,-0.47, ,1.77,1.32,1.22,1.06, , ,0.86, ,1.84,1.64,1.74,1.58,,-0.47,1.56,1.14,,0.86,1.74,1.66, +, +,,,,,NA,NA,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,126.81,121.71,S563,HSPTPGKVSSPLSPLSPGIKSPTIPRAERGN,_VSSPLS(ph)PLS(ph)PGIK_, , ,0.05, ,2.55,2.24,1.25,1.3, , ,1.02, ,2.58,2.5,1.71,1.73,,0.05,2.41,1.27,,1.02,2.54,1.72, +, +,,,,,NA,NA,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,71.3,68.73,S568,GKVSSPLSPLSPGIKSPTIPRAERGNPPPIP,_VSSPLSPLS(ph)PGIKS(ph)PTIPR_, , ,0.56, , , , , , , ,1.19, , , , , ,,0.56,,,,1.19,,,, +,,,,,NA,NA,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,147.93,147.93,S488,DQQASGLQSPPSRDLSPTLIDNSAAKQLARN,_DLS(ph)PTLIDNSAAK_,0.12,0.02,-0.21,0.03,-0.63,-0.27,-0.16,-0.23,1.25,0,-0.09,0.05,-0.11,-0.04,0.02,0.07,0.07,-0.09,-0.44,-0.19,0.75,-0.02,-0.07,0.05,,,,,,,0,0,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,147.93,147.93,S481,FQSQADQDQQASGLQSPPSRDLSPTLIDNSA,_FQSQADQDQQASGLQS(ph)PPS(ph)RDLS(ph)PTLIDNSAAK_, , , , ,0.21, ,0.7,0.5, , , , ,-0.18, ,-0.03,0.26,,,0.21,0.6,,,-0.18,0.12,,,,,,,NA,NA,,actin cytoskeleton,,,,
Q9P2B4,Q9P2B4,CTTNBP2 N-terminal-like protein,CTTNBP2NL,147.93,147.93,S484,QADQDQQASGLQSPPSRDLSPTLIDNSAAKQ,_FQSQADQDQQASGLQS(ph)PPS(ph)RDLS(ph)PTLIDNSAAK_, , , , ,0.21, ,0.7,0.5, , , , ,-0.18, ,-0.03,0.26,,,0.21,0.6,,,-0.18,0.12,,,,,,,NA,NA,,actin cytoskeleton,,,,
Q9NWM3,Q9NWM3,CUE domain-containing protein 1,CUEDC1,160.36,141.23,Y230,MAGPGPGDQESRWKQYLEDERIALFLQNEEF,_WKQY(ph)LEDER_, , ,5.18, , , , , , , ,9.64, , , , , ,,5.18,,,,9.64,,, +, +,,,,,NA,NA,,,,,,
Q9P013,Q9P013,Protein CWC15 homolog,CWC15,57.22,56.96,S121,DDPLTDEEDEDFEEESDDDDTAALLAELEKI,_LDQIPAANLDADDPLT(ph)DEEDEDFEEES(ph)DDDDTAALLAELEK_, , , , , , , ,-0.65, , , , , , , ,-0.24,,,,-0.65,,,,-0.24,,,,,,,NA,NA,,catalytic step 2 spliceosome,RNA binding,"mRNA splicing, via spliceosome",,
Q9P013,Q9P013,Protein CWC15 homolog,CWC15,57.22,56.96,T110,LDQIPAANLDADDPLTDEEDEDFEEESDDDD,_LDQIPAANLDADDPLT(ph)DEEDEDFEEES(ph)DDDDTAALLAELEK_, , , , , , , ,-0.65, , , , , , , ,-0.24,,,,-0.65,,,,-0.24,,,,,,,NA,NA,,catalytic step 2 spliceosome,RNA binding,"mRNA splicing, via spliceosome",,
Q9HCG8,Q9HCG8,Pre-mRNA-splicing factor CWC22 homolog,CWC22,162.22,162.22,S866,RSKSKEMNRKHSGSRSDEDRYQNGAERRWEK,_HSGSRS(ph)DEDRYQNGAER_,-0.19, , , , , , ,-1.15,-0.15, , , , , , ,-1.29,-0.19,,,-1.15,-0.15,,,-1.29, +, +,,,,,NA,NA,,catalytic step 2 spliceosome,DNA binding,"mRNA splicing, via spliceosome",,
Q9HCG8,Q9HCG8,Pre-mRNA-splicing factor CWC22 homolog,CWC22,69.35,52.68,S829,NKHGDPKKKRGERRNSFSENEKHTHRIKDSE,_RNS(ph)FSENEK_, , , , ,2.59, , , , , , , ,1.32, , , ,,,2.59,,,,1.32,, +, +,,,,,NA,NA,,catalytic step 2 spliceosome,DNA binding,"mRNA splicing, via spliceosome",,
P61073,P61073,C-X-C chemokine receptor type 4,CXCR4,246.5,245.95,S339,SSLKILSKGKRGGHSSVSTESESSSFHSS__,_RGGHSS(ph)VSTESESSSFHSS_, , ,1.62,1.51,-0.27, , ,0.91, , ,1.41,1.38,0.17, , ,0.71,,1.57,-0.27,0.91,,1.4,0.17,0.71, +, +,,,,,NA,NA,,cell leading edge,actin binding,activation of MAPK activity,,
P61073,P61073,C-X-C chemokine receptor type 4,CXCR4,118.15,115.72,S325,KTSAQHALTSVSRGSSLKILSKGKRGGHSSV,_TSAQHALTSVS(ph)RGSS(ph)LK_, , ,1.13, , , , , , , ,-0.19, , , , , ,,1.13,,,,-0.19,,, +,,,,,,NA,NA,,cell leading edge,actin binding,activation of MAPK activity,,
P61073,P61073,C-X-C chemokine receptor type 4,CXCR4,220.86,219.99,S348,KRGGHSSVSTESESSSFHSS___________,_RGGHSSVSTESESSS(ph)FHSS(ph)_,0.23,0.35,0.35,0.19,-0.68,-0.73,-0.44,-0.21,-0.02,0.01,-0.05,-0.42,-0.31,-0.1,-0.36,-0.11,0.29,0.27,-0.7,-0.32,0,-0.22,-0.2,-0.23,,,,,,,0,0,,cell leading edge,actin binding,activation of MAPK activity,,
P25106,P25106,C-X-C chemokine receptor type 7,CXCR7,121.23,115.56,S347,FKYSAKTGLTKLIDASRVSETEYSALEQSTK,_LIDAS(ph)RVS(ph)ETEYS(ph)ALEQSTK_, , , , ,0.52, , , , , , , ,1.32, , , ,,,0.52,,,,1.32,,, +,,,,,NA,NA,,early endosome,C-X-C chemokine receptor activity,angiogenesis,,
P25106,P25106,C-X-C chemokine receptor type 7,CXCR7,121.23,115.56,S350,SAKTGLTKLIDASRVSETEYSALEQSTK___,_LIDAS(ph)RVS(ph)ETEYS(ph)ALEQSTK_, , , , ,0.52, , , , , , , ,1.32, , , ,,,0.52,,,,1.32,,, +,,,,,NA,NA,,early endosome,C-X-C chemokine receptor activity,angiogenesis,,
P25106,P25106,C-X-C chemokine receptor type 7,CXCR7,121.23,115.56,S355,LTKLIDASRVSETEYSALEQSTK________,_LIDAS(ph)RVS(ph)ETEYS(ph)ALEQSTK_, , , , ,0.52, , , , , , , ,1.32, , , ,,,0.52,,,,1.32,,, +,,,,,NA,NA,,early endosome,C-X-C chemokine receptor activity,angiogenesis,,
P25106,P25106,C-X-C chemokine receptor type 7,CXCR7,160.5,99.16,Y354,GLTKLIDASRVSETEYSALEQSTK_______,_VSETEY(ph)SALEQSTK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome,C-X-C chemokine receptor activity,angiogenesis,,
Q9P0U4,Q9P0U4,CpG-binding protein,CXXC1,42.29,35.98,S6,__________MEGDGSDPEPPDAGEDSKSEN,_(ac)MEGDGS(ph)DPEPPDAGEDS(ph)K_, , , , ,-0.21,-0.01,0,0.4, , , , ,0.11,0.24,-0.21,0.24,,,-0.11,0.22,,,0.17,0.03,,,,,,,NA,NA,,nuclear matrix,unmethylated CpG binding,activation of signaling protein activity involved in unfolded protein response,,
Q9NQC7-2,Q9NQC7,Ubiquitin carboxyl-terminal hydrolase CYLD,CYLD,98.05,60.49,Y15,_MSSGLWSQEKVTSPYWEERIFYLLLQECSV,_VTSPY(ph)WEER_,4.36, ,3.97, , , , , ,3.76, ,2.36, , , , , ,4.36,3.97,,,3.76,2.36,,, +, +,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytosol,ubiquitin thiolesterase activity,cell cycle,,
P98082,P98082,Disabled homolog 2,DAB2,175.07,174.06,Y761,SQASVASSQPVSSEMYRDPFGNPFA______,_DSFGSSQASVASSQPVSSEMY(ph)RDPFGNPFA_, , ,2.99, , , , , , , ,1.85, , , , , ,,2.99,,,,1.85,,, +, +,,,,,NA,NA,,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
P98082,P98082,Disabled homolog 2,DAB2,363.91,356.45,Y342,SSTPLSNGPLNGDVDYFGQQFDQISNRTGKQ,_ENSSSSSTPLSNGPLNGDVDY(ph)FGQQFDQISNR_,5.37, ,3.55, , , , , ,4.26, ,2.29, , , , , ,5.37,3.55,,,4.26,2.29,,, +, +,,,,,NA,NA,,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
P98082,P98082,Disabled homolog 2,DAB2,151.58,151.58,Y685,KGEQTSSGTLSAFASYFNSKVGIPQENADHD,_KGEQTSSGTLSAFASY(ph)FNSK_,2.72, ,2.05, , , , , ,1.79, ,1.21, , , , , ,2.72,2.05,,,1.79,1.21,,, +, +,,,,,NA,NA,,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
P98082,P98082,Disabled homolog 2,DAB2,286.29,269.37,S227,QMDLFGDMSTPPDLNSPTESKDILLVDLNSE,_SGVDQMDLFGDMSTPPDLNS(ph)PTESK_, , ,1.94, ,1.14,0.66,1.49,0.03, , ,1.85, ,1.12,0.54,1.4,-0.05,,1.94,0.92,0.94,,1.85,0.86,0.85, +, +,,,,,NA,NA,,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
P98082,P98082,Disabled homolog 2,DAB2,107.15,107.15,S394,NGVSEREQNGFSVKSSPNPFVGSPPKGLSIQ,_SS(ph)PNPFVGS(ph)PPK_,-0.22,1.01,1.04,1.08,1.06,1.18,0.95,0.82,-0.37,0.86,1.22,1.08,0.73,0.75,0.57,0.67,0.52,1.06,1.12,0.89,0.37,1.15,0.74,0.62, +, +,,,,,1,4,22.61,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
P98082,P98082,Disabled homolog 2,DAB2,132.63,132.63,S401,QNGFSVKSSPNPFVGSPPKGLSIQNGVKQDL,_S(ph)SPNPFVGS(ph)PPK_,1.5,1.57,1.79,1.39,1.84,2.01,2.02,2,0.96,1.02,1.32,0.99,1.55,1.69,1.58,1.87,1.54,1.61,1.93,2.01,0.99,1.17,1.62,1.73, +, +,,,,,1,1,35.01,apical plasma membrane,cargo receptor activity,activation of JUN kinase activity,,
Q5VWQ8-3,Q5VWQ8,Disabled homolog 2-interacting protein,DAB2IP,54.67,51.09,S992,DSPELKPRAVHKQGPSPVSPNALDRTAAWLL,_QGPS(ph)PVS(ph)PNALDR_, , , , , ,0.58,0.4, , , , , , ,0.64,0.58, ,,,0.58,0.4,,,0.64,0.58,,,,,,,NA,NA,,cerebellar mossy fiber,14-3-3 protein binding,activation of JUN kinase activity,,
Q5VWQ8-3,Q5VWQ8,Disabled homolog 2-interacting protein,DAB2IP,106.44,89.2,S995,ELKPRAVHKQGPSPVSPNALDRTAAWLLTMN,_QGPS(ph)PVS(ph)PNALDR_, , ,1.22,0.06, ,0.58,0.4, , , ,1.38,0.28, ,0.64,0.58, ,,0.75,0.58,0.4,,0.94,0.64,0.58,,,,,,,NA,NA,,cerebellar mossy fiber,14-3-3 protein binding,activation of JUN kinase activity,,
Q5VWQ8-3,Q5VWQ8,Disabled homolog 2-interacting protein,DAB2IP,141.07,136.92,S747,ANEPDLQMANGGKSLSMVDLQDARTLDGEAG,_SLS(ph)MVDLQDAR_,-0.04,0.05,0.72,0.4, ,-0.09,0.39,-0.12,0.21,0.13,0.51,0.53, ,0.38,-0.44,-0.06,0.01,0.57,-0.09,0.16,0.17,0.52,0.38,-0.24,,,,,,,0,0,,cerebellar mossy fiber,14-3-3 protein binding,activation of JUN kinase activity,,
P51397,P51397,Death-associated protein 1,DAP,420.05,420.05,S51,TKEEKDKDDQEWESPSPPKPTVFISGVIARG,_DKDDQEWESPS(ph)PPKPTVFISGVIAR_,0.4,0.44,0.19,0.35,0.44,0.48, , ,0.2,0.08,-0.14,0.02,-0.26,3.69, , ,0.42,0.27,0.46,,0.14,-0.06,2.78,,, +,,,,,NA,NA,,,,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
P51397,P51397,Death-associated protein 1,DAP,128.15,128.15,S3,_____________MSSPPEGKLETKAGHPPA,_(ac)SS(ph)PPEGKLETK_,0.55,0.91,0.89,0.89,0.92,0.97,0.95,1,0.45,0.61,0.58,0.66,0.82,0.94,1.01,1.21,0.74,0.89,0.94,0.98,0.53,0.62,0.88,1.11,, +,,,,,0,2,27.67,,,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
F5H082,Q9UER7,Death domain-associated protein 6,DAXX,174.62,174.62,S495,EDEEEEAAAGKDGDKSPMSSLQISNEKNLEP,_DGDKS(ph)PMSSLQISNEK_,0.1,0.24,0.37,0.76,0.14,-0.07,0.22,0.07,-0.11,0.09,-0.02,-0.03,0.13,0.68,-0.05,0.19,0.17,0.58,0.04,0.15,-0.01,-0.03,0.43,0.07,,,,,,,0,0,,,,,,
P07108,P07108,Acyl-CoA-binding protein,DBI,90.35,90.35,Y29,RHLKTKPSDEEMLFIYGHYKQATVGDINTER,_TKPSDEEMLFIY(ph)GHYK_,-0.12, ,-0.68, , , ,0.31, ,-0.27, ,-0.56, , , ,-0.16, ,-0.12,-0.68,,0.31,-0.27,-0.56,,-0.16,,,,,,,NA,NA,,endoplasmic reticulum,benzodiazepine receptor binding,hair follicle development,,+
Q16643,Q16643,Drebrin,DBN1,123.86,84.86,S142,GAIGQRLSNGLARLSSPVLHRLRLREDENAE,_LSS(ph)PVLHR_,-1.17,-1.02,-0.93,-0.8,-0.62,-0.73,-0.65,-0.93,-1.03,-0.92,-0.7,-0.78,-0.56,-0.7,-0.52,-0.52,-1.09,-0.87,-0.67,-0.78,-0.97,-0.74,-0.63,-0.52, +,,,,,,3,0,29.66,actomyosin,actin binding,actin filament organization,,
Q9UJU6,Q9UJU6,Drebrin-like protein,DBNL,196.75,196.75,S232,AARREQRYQEQGGEASPQRTWEQQQEVVSRN,_YQEQGGEAS(ph)PQRTWEQQQEVVSR_,-0.3,-0.23,-0.16, , , , , ,-0.35,-0.12,-0.21, , , , , ,-0.27,-0.16,,,-0.23,-0.21,,,,,,,,,NA,NA,,cell cortex,actin filament binding,activation of JUN kinase activity,,
Q58WW2,Q58WW2,DDB1- and CUL4-associated factor 6,DCAF6,95.76,92.32,S336,PRARPESERERDGEQSPNVSLMQRMSDMLSR,_DGEQS(ph)PNVSLMQR_, , ,0.23, , , ,-2.91, , , ,0.95, , , ,-0.17, ,,0.23,,-2.91,,0.95,,-0.17, +,,,,,,NA,NA,,Cul4-RING ubiquitin ligase complex,ligand-dependent nuclear receptor transcription coactivator activity,positive regulation of transcription from RNA polymerase II promoter,,
Q58WW2,Q58WW2,DDB1- and CUL4-associated factor 6,DCAF6,211.11,211.11,S847,ASLNHIRADRLEGDRSEGSGQENENEDEE__,_ADRLEGDRS(ph)EGS(ph)GQENENEDEE_, ,-0.57, , , ,-0.59,-0.59,-0.57, ,-0.77, , , ,-0.33,-0.66,-0.59,-0.57,,-0.59,-0.58,-0.77,,-0.33,-0.63,,,,,,,NA,NA,,Cul4-RING ubiquitin ligase complex,ligand-dependent nuclear receptor transcription coactivator activity,positive regulation of transcription from RNA polymerase II promoter,,
Q58WW2,Q58WW2,DDB1- and CUL4-associated factor 6,DCAF6,211.11,211.11,S850,NHIRADRLEGDRSEGSGQENENEDEE_____,_ADRLEGDRS(ph)EGS(ph)GQENENEDEE_, ,-0.57, , , ,-0.59,-0.59,-0.57, ,-0.77, , , ,-0.33,-0.66,-0.59,-0.57,,-0.59,-0.58,-0.77,,-0.33,-0.63,,,,,,,NA,NA,,Cul4-RING ubiquitin ligase complex,ligand-dependent nuclear receptor transcription coactivator activity,positive regulation of transcription from RNA polymerase II promoter,,
Q58WW2,Q58WW2,DDB1- and CUL4-associated factor 6,DCAF6,221.55,215.52,S657,EETSTRDSALQDTDDSDDDPVLIPGARYRAG,_DSALQDT(ph)DDS(ph)DDDPVLIPGAR_,-0.48,-0.46,-0.8, ,-0.07,-0.1,-0.14,-0.14,-0.16,-0.11,-0.2, ,-0.02,-0.08,-0.11,-0.07,-0.47,-0.8,-0.09,-0.14,-0.13,-0.2,-0.05,-0.09,,,,,,,0,0,,Cul4-RING ubiquitin ligase complex,ligand-dependent nuclear receptor transcription coactivator activity,positive regulation of transcription from RNA polymerase II promoter,,
Q58WW2,Q58WW2,DDB1- and CUL4-associated factor 6,DCAF6,221.55,215.52,T654,SAHEETSTRDSALQDTDDSDDDPVLIPGARY,_DSALQDT(ph)DDS(ph)DDDPVLIPGAR_,-0.48,-0.46,-0.8, ,-0.07,-0.1,-0.14,-0.14,-0.16,-0.11,-0.2, ,-0.02,-0.08,-0.11,-0.07,-0.47,-0.8,-0.09,-0.14,-0.13,-0.2,-0.05,-0.09,,,,,,,0,0,,Cul4-RING ubiquitin ligase complex,ligand-dependent nuclear receptor transcription coactivator activity,positive regulation of transcription from RNA polymerase II promoter,,
B7Z8C9,Q5TAQ9,DDB1- and CUL4-associated factor 8,DCAF8,446.51,438.3,S99,TGHYSINDENRVHDRSEEEEEEEEEEEEEQP,_VHDRS(ph)EEEEEEEEEEEEEQPR_,-0.02,-0.13,-0.2,-0.12, ,-0.22,-0.07,-0.36,-0.03,-0.1,-0.17,-0.11, ,-0.22,-0.11,-0.53,-0.08,-0.16,-0.22,-0.21,-0.07,-0.14,-0.22,-0.3,,,,,,,0,0,,,,,,
Q8N8Z6,Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",DCBLD1,267.93,267.93,Y652,GGFSPVAGVGAQDGDYQRPHSAQPADRGYDR,_HSLSSGGFSPVAGVGAQDGDY(ph)QRPHSAQPADR_,1.68, ,0.28, , , , , ,1.31, ,-0.24, , , , , ,1.68,0.28,,,1.31,-0.24,,, +, +,,,,,NA,NA,,integral to membrane,,cell adhesion,,
Q8N8Z6,Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",DCBLD1,229.17,229.17,S657,VAGVGAQDGDYQRPHSAQPADRGYDRPKAVS,_HSLSSGGFSPVAGVGAQDGDYQRPHS(ph)AQPADR_,1.66, ,0.25, , , , , ,1.02, ,0.35, , , , , ,1.66,0.25,,,1.02,0.35,,, +, +,,,,,NA,NA,,integral to membrane,,cell adhesion,,
Q8N8Z6,Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",DCBLD1,60.64,57.99,Y600,GRHEYALPLAPPEPEYATPIVERHVLRAHTF,_HEYALPLAPPEPEY(ph)ATPIVER_,0.86, , , , , ,-0.01,0.22,1.03, , , , , ,0.38,-0.02,0.86,,,0.11,1.03,,,0.19,, +,,,,,NA,NA,,integral to membrane,,cell adhesion,,
Q8N8Z6,Q8N8Z6,"Discoidin, CUB and LCCL domain-containing protein 1",DCBLD1,118.15,118.14,Y578,TDAEEAGVSTDAGGHYDCPQRAGRHEYALPL,_GSTFRPMDTDAEEAGVSTDAGGHY(ph)DCPQR_,0.52, ,0.1, , , , , ,0.4, ,0, , , , , ,0.52,0.1,,,0.4,0,,,,,,,,,NA,NA,,integral to membrane,,cell adhesion,,
Q9NPI6,Q9NPI6,mRNA-decapping enzyme 1A,DCP1A,97.62,97.22,T531,DLERKASSPSPLTIGTPESQRKPSIILSKSQ,_ASS(ph)PS(ph)PLTIGT(ph)PESQR_, , , , ,-1.57,-0.87,-1.19, , , , , ,-1.22,-1.45,-0.92, ,,,-1.18,-1.19,,,-1.33,-0.92, +, +,,,,,NA,NA,,cytoplasmic mRNA processing body,hydrolase activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
Q9NPI6,Q9NPI6,mRNA-decapping enzyme 1A,DCP1A,134.52,133.85,S525,TVTRSSDLERKASSPSPLTIGTPESQRKPSI,_ASS(ph)PS(ph)PLTIGTPESQR_,-0.07,0.03,-1.06,-1.19,-0.04,-0.19,0.04,0.32,-0.1,-0.07,-0.64,-0.56,-0.32,-0.49,-0.15,-0.06,-0.02,-1.12,-0.11,0.19,-0.08,-0.6,-0.41,-0.11, +,,,,,,3,0,16.91,cytoplasmic mRNA processing body,hydrolase activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
Q9NPI6,Q9NPI6,mRNA-decapping enzyme 1A,DCP1A,137.61,130.84,S523,QQTVTRSSDLERKASSPSPLTIGTPESQRKP,_ASS(ph)PS(ph)PLTIGTPESQR_,-0.28,-0.31,-1.02,-0.73,-1.19,-0.6,-0.77,-0.63,-0.27,-0.36,-1.03,-0.53,-1.09,-1.02,-1.07,-0.72,-0.3,-0.87,-0.86,-0.7,-0.32,-0.76,-1.05,-0.88,, +,,,,,0,6,29.24,cytoplasmic mRNA processing body,hydrolase activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
Q9NPI6,Q9NPI6,mRNA-decapping enzyme 1A,DCP1A,120.33,118.9,T528,RSSDLERKASSPSPLTIGTPESQRKPSIILS,_ASSPS(ph)PLT(ph)IGTPESQR_,0.21,0.06,-0.84,-0.77,-0.38,-0.49,0.96, ,0.57,0.29,-0.05,0.52,-0.57,-1.17,0.41, ,0.13,-0.81,-0.43,0.96,0.43,0.26,-0.84,0.41,,,,,,,0,0,,cytoplasmic mRNA processing body,hydrolase activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
Q92466,Q92466,DNA damage-binding protein 2,DDB2,159.75,76.43,S24,TQKTSEIVLRPRNKRSRSPLELEPEAKKLCA,_S(ph)RS(ph)PLELEPEAK_,-0.37,-0.01,-0.4,0.04,0.25,-0.34,-0.46,-0.47,0.02,0.05,-0.07,0.2,-0.13,-0.07,-0.33,-0.42,-0.18,-0.16,-0.02,-0.46,0.04,0.07,-0.1,-0.38,,,,,,,0,0,,nucleoplasm,damaged DNA binding,"nucleotide-excision repair, DNA damage removal",,
Q92466,Q92466,DNA damage-binding protein 2,DDB2,162.81,162.81,S26,KTSEIVLRPRNKRSRSPLELEPEAKKLCAKG,_S(ph)RS(ph)PLELEPEAK_,-0.06,0.01,-0.34,0.01,0.24,0.1,-0.12,-0.04,0.03,0.11,0.08,0.1,-0.13,-0.17,-0.17,-0.08,-0.02,-0.15,0.17,-0.08,0.07,0.09,-0.15,-0.12,,,,,,,0,0,,nucleoplasm,damaged DNA binding,"nucleotide-excision repair, DNA damage removal",,
Q8NEL9-3,Q8NEL9,Phospholipase DDHD1,DDHD1,99.91,98.76,S723,EPTSVSENEGISTIPSPVTSPVLSRRHYGES,_EPTSVSENEGISTIPS(ph)PVTS(ph)PVLSR_, ,0.13, , ,-0.09,0,-0.04,0.14, ,-0.01, , ,-0.09,-0.01,0.02,-0.05,0.13,,-0.04,0.05,-0.01,,-0.05,-0.02,,,,,,,NA,NA,,cytoplasm,hydrolase activity,lipid catabolic process,,
Q8NEL9-3,Q8NEL9,Phospholipase DDHD1,DDHD1,116.13,116.13,S727,VSENEGISTIPSPVTSPVLSRRHYGESITNI,_EPTSVSENEGISTIPS(ph)PVTS(ph)PVLSR_, ,0.16, , ,-0.16,0,-0.04,0.11, ,0.01, , ,-0.2,-0.01,0.02,0,0.16,,-0.07,0.04,0.01,,-0.1,0.01,,,,,,,NA,NA,,cytoplasm,hydrolase activity,lipid catabolic process,,
Q5TDH0-2,Q5TDH0,Protein DDI1 homolog 2,DDI2,112.68,109.3,T104,PNLPRIDFSSIAVPGTSSPRQRQPPGTQQSH,_IDFSSIAVPGT(ph)SSPR_, , , , , ,0.33, , , , , , , ,0.67, , ,,,0.33,,,,0.67,,,,,,,,NA,NA,,,aspartic-type endopeptidase activity,proteolysis,,
Q92499,Q92499,ATP-dependent RNA helicase DDX1,DDX1,182.43,182.43,S481,TDDVHAKDNTRPGANSPEMWSEAIKILKGEY,_DNTRPGANS(ph)PEMWSEAIK_,0,0.19,0.14,0.13, , ,-0.23, ,0.11,0.05,0.23,0.1, , ,-0.41, ,0.1,0.14,,-0.23,0.08,0.17,,-0.41,,,,,,,NA,NA,,cleavage body,ATP binding,DNA duplex unwinding,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,134.09,110.15,S703,TPVDDRISLEQPPNGSDTPNPEKYQESPGIQ,_ISLEQPPNGS(ph)DTPNPEK_,0.23,0.01,-0.12,-0.21,0.16,0.07,0.28,0.14,0.22,-0.01,-0.02,0.07,-0.03,-0.19,-0.06,-0.09,0.13,-0.17,0.11,0.21,0.11,0.03,-0.11,-0.08,,,,,,,0,0,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,157.47,154.6,S672,DSYSSRTSSQSKGNKSYLEGSSDNQLKDSES,_S(ph)YLEGS(ph)S(ph)DNQLK_, , , ,0.15,0.02,-0.18,-0.07,-0.06, , , ,-0.09,-0.14,-0.08,-0.03,0.09,,0.15,-0.08,-0.06,,-0.09,-0.11,0.03,,,,,,,NA,NA,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,157.47,154.6,S677,RTSSQSKGNKSYLEGSSDNQLKDSESTPVDD,_S(ph)YLEGS(ph)S(ph)DNQLK_,0.05,0.21,0.28,0.19,0.32,0.1,0.02,0.03,-0.04,-0.06,0.19,0.1,0.35,0.32,-0.1,-0.01,0.13,0.24,0.22,0.02,-0.05,0.14,0.34,-0.05,,,,,,,0,0,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,157.47,154.6,S678,TSSQSKGNKSYLEGSSDNQLKDSESTPVDDR,_S(ph)YLEGS(ph)S(ph)DNQLK_,0.78,0.31,0.27,0.12,-0.03,0.61,-0.07,0.02,0.15,0.13,-0.07,-0.11,-0.08,0.03,-0.04,0,0.56,0.19,0.32,-0.02,0.14,-0.09,-0.02,-0.02,,,,,,,0,0,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,89.75,70.47,S714,PPNGSDTPNPEKYQESPGIQMKTRLKEGASQ,_YQES(ph)PGIQMK_, , , , , , ,0.36, , , , , , , ,0.25, ,,,,0.36,,,,0.25,,,,,,,NA,NA,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9UHI6,Q9UHI6,Probable ATP-dependent RNA helicase DDX20,DDX20,58.5,58.05,T705,VDDRISLEQPPNGSDTPNPEKYQESPGIQMK,_ISLEQPPNGSDT(ph)PNPEK_, , , , , , ,-0.13, , , , , , , ,-0.46, ,,,,-0.13,,,,-0.46,,,,,,,NA,NA,,Cajal body,ATP binding,assembly of spliceosomal tri-snRNP,,
Q9NR30,Q9NR30,Nucleolar RNA helicase 2,DDX21,213.36,213.36,S89,SKKAKKKEEPSQNDISPKTKSLRKKKEPIEK,_KKEEPSQNDIS(ph)PK_,0,0.02,-0.15,0.07,-0.22,-0.06,-0.16,-0.35,-0.11,-0.17,-0.12,0.12,-0.25,0.03,-0.04,-0.51,0.01,-0.03,-0.14,-0.25,-0.14,0,-0.1,-0.26,,,,,,,0,0,,nucleolus,ATP binding,response to exogenous dsRNA,,
Q9NR30,Q9NR30,Nucleolar RNA helicase 2,DDX21,140.35,140.35,S121,VVSSKTKKVTKNEEPSEEEIDAPKPKKMKKE,_NEEPS(ph)EEEIDAPKPK_,-0.28,-0.3,-0.27,-0.36,-0.3,-0.36,-0.46,-0.32,-0.25,-0.27,-0.21,-0.22,-0.54,0.14,-0.2,-0.39,-0.29,-0.31,-0.33,-0.39,-0.26,-0.22,-0.16,-0.29,,,,,,,0,0,,nucleolus,ATP binding,response to exogenous dsRNA,,
G3V529,Q9GZR7,ATP-dependent RNA helicase DDX24,DDX24,244.86,244.86,S82,SLFSKEAPKRKAQAVSEEEEEEEGKSSSPKK,_AQAVS(ph)EEEEEEEGK_,-0.04,0.08,-0.05,0.08,0.09,0.1,-0.01,-0.15,0.16,0.01,0.09,0.17,0.09,0.21,0.12,0.04,0.02,0.01,0.1,-0.08,0.08,0.13,0.15,0.08,,,,,,,0,0,,cytoplasm,ATP binding,,,
G3V529,Q9GZR7,ATP-dependent RNA helicase DDX24,DDX24,69.87,69.57,S295,EAGAETRSPGKAEAESDALPDDTVIESEALP,_AEAES(ph)DALPDDTVIESEALPSDIAAEAR_, , , , , , , ,-0.27, , , , , , , ,-0.12,,,,-0.27,,,,-0.12,,,,,,,NA,NA,,cytoplasm,ATP binding,,,
Q9UJV9,Q9UJV9,Probable ATP-dependent RNA helicase DDX41,DDX41,79.77,78.62,S21,PERKRARTDEVPAGGSRSEAEDEDDEDYVPY,_TDEVPAGGS(ph)RS(ph)EAEDEDDEDYVPYVPLR_, , , , ,0.65,0.25,-0.31, , , , , ,0.31,0.01,-0.76, ,,,0.46,-0.31,,,0.17,-0.76,,,,,,,NA,NA,,catalytic step 2 spliceosome,ATP binding,apoptotic process,,
Q9UJV9,Q9UJV9,Probable ATP-dependent RNA helicase DDX41,DDX41,79.77,78.62,S23,RKRARTDEVPAGGSRSEAEDEDDEDYVPYVP,_TDEVPAGGS(ph)RS(ph)EAEDEDDEDYVPYVPLR_, , , , ,0.65,0.25,-0.31, , , , , ,0.31,0.01,-0.76, ,,,0.46,-0.31,,,0.17,-0.76,,,,,,,NA,NA,,catalytic step 2 spliceosome,ATP binding,apoptotic process,,
Q86XP3,Q86XP3,ATP-dependent RNA helicase DDX42,DDX42,199.85,198.95,S109,ENSPTRQQFHSKPVDSDSDDDPLEAFMAEVE,_PVDS(ph)DS(ph)DDDPLEAFMAEVEDQAAR_,-0.05, , , ,-0.27, ,0.14,-0.18,0.03, , , ,-0.14, ,0.25,-0.02,-0.05,,-0.27,-0.01,0.03,,-0.14,0.12,,,,,,,NA,NA,,Cajal body,ATP binding,protein localization,,
Q86XP3,Q86XP3,ATP-dependent RNA helicase DDX42,DDX42,199.85,198.95,S111,SPTRQQFHSKPVDSDSDDDPLEAFMAEVEDQ,_PVDS(ph)DS(ph)DDDPLEAFMAEVEDQAAR_,-0.05, , , ,-0.27, ,0.14,-0.18,0.03, , , ,-0.14, ,0.25,-0.02,-0.05,,-0.27,-0.01,0.03,,-0.14,0.12,,,,,,,NA,NA,,Cajal body,ATP binding,protein localization,,
Q86XP3,Q86XP3,ATP-dependent RNA helicase DDX42,DDX42,66.68,66.34,S185,AGVVQEEEEDNLEYDSDGNPIAPTKKIIDPL,_YMAENPTAGVVQEEEEDNLEYDS(ph)DGNPIAPTK_, , , , ,0.04, ,-0.12,0.5, , , , ,-0.1, ,0.96,0.81,,,0.04,0.22,,,-0.1,0.88,,,,,,,NA,NA,,Cajal body,ATP binding,protein localization,,
Q7L014,Q7L014,Probable ATP-dependent RNA helicase DDX46,DDX46,154.58,154.51,S804,NERKKLQKAALGLQDSDDEDAAVDIDEQIES,_AALGLQDS(ph)DDEDAAVDIDEQIESMFNSK_,-0.21,-0.29,-0.4,-0.42,-0.15,-0.13,0.2,0.03,0.18,0.04,-0.09,-0.08,-0.07,-0.09,-0.01,-0.08,-0.25,-0.41,-0.14,0.11,0.11,-0.09,-0.08,-0.04,,,,,,,0,0,,Cajal body,ATP binding,mRNA processing,,
Q9H0S4,Q9H0S4,Probable ATP-dependent RNA helicase DDX47,DDX47,94.02,93.45,S9,_______MAAPEEHDSPTEASQPIVEEEETK,_(ac)AAPEEHDS(ph)PTEASQPIVEEEETK_,-0.24,-0.35,-0.19,0.17,-0.24, ,-0.45,-0.41,-0.13,-0.09,0.17,0.01,-0.07, ,-0.27,-0.3,-0.3,0,-0.24,-0.43,-0.11,0.09,-0.07,-0.29,,,,,,,0,0,,nucleolus,ATP binding,extrinsic apoptotic signaling pathway via death domain receptors,,
Q8TDD1,Q8TDD1,ATP-dependent RNA helicase DDX54,DDX54,214.49,214.49,S782,LYQKWKQKQKIDDRDSDEEGASDRRGPERRG,_(gl)QKIDDRDS(ph)DEEGASDR_,0.25,0.29,0.21,0.16,1.73,-0.08,-0.19,-0.66,-0.26,-0.3,-0.09,-0.29,1.87,-0.42,-0.55,-0.75,0.27,0.19,1.09,-0.4,-0.28,-0.19,1.14,-0.65, +, +,,,,,5,2,23.61,nucleolus,ATP binding,intracellular estrogen receptor signaling pathway,,
Q8TDD1,Q8TDD1,ATP-dependent RNA helicase DDX54,DDX54,203.53,190.63,S39,KGLRKRRGAASQARGSDSEDGEFEIQAEDDA,_GS(ph)DS(ph)EDGEFEIQAEDDAR_, , , , ,-0.5,-0.37,1.19,-0.6, , , , ,-0.41,-0.37,-0.57,-0.84,,,-0.43,0.56,,,-0.39,-0.7,,,,,,,NA,NA,,nucleolus,ATP binding,intracellular estrogen receptor signaling pathway,,
Q8TDD1,Q8TDD1,ATP-dependent RNA helicase DDX54,DDX54,203.53,190.63,S41,LRKRRGAASQARGSDSEDGEFEIQAEDDARA,_GS(ph)DS(ph)EDGEFEIQAEDDAR_, , , , ,-0.5,-0.37,1.19,-0.6, , , , ,-0.41,-0.37,-0.57,-0.84,,,-0.43,0.56,,,-0.39,-0.7,,,,,,,NA,NA,,nucleolus,ATP binding,intracellular estrogen receptor signaling pathway,,
Q8IYH0,Q8NHQ9,ATP-dependent RNA helicase DDX55,DDX55,343.85,330.03,S544,EKKKKMNEKRKREEGSDIEDEDMEELLNDTR,_EEGS(ph)DIEDEDMEELLNDTR_, ,0.15,-0.17,-0.08,0.11,-0.15,-0.14,-0.18, ,0.04,0.07,-0.24,0.06,-0.06,0.01,-0.02,0.15,-0.12,-0.01,-0.16,0.04,-0.07,0,-0.01,,,,,,,0,0,,,,,,
P26196,P26196,Probable ATP-dependent RNA helicase DDX6,DDX6,83.4,82.04,Y473,KPIPSNIDKSLYVAEYHSEPVEDEKP_____,_SLYVAEY(ph)HSEPVEDEKP_, , ,2.49, , , , , , , ,1.02, , , , , ,,2.49,,,,1.02,,, +, +,,,,,NA,NA,,cytoplasmic mRNA processing body,ATP binding,cytoplasmic mRNA processing body assembly,,
P26196,P26196,Probable ATP-dependent RNA helicase DDX6,DDX6,101.78,81.73,S475,IPSNIDKSLYVAEYHSEPVEDEKP_______,_SLYVAEYHS(ph)EPVEDEKP_, , ,2.68, , , , , , , ,1.24, , , , , ,,2.68,,,,1.24,,, +, +,,,,,NA,NA,,cytoplasmic mRNA processing body,ATP binding,cytoplasmic mRNA processing body assembly,,
P35659,P35659,Protein DEK,DEK,90.15,17.22,S51,EDEDDEEEEEEEKEKSLIVEGKREKKKVERL,_S(ph)LIVEGKR_,-0.11,0.01,-0.4, ,0.04,-0.11,0.14,-0.13,0.15,0.1,0.24, ,-0.09,-0.17,-0.31,-0.25,-0.05,-0.4,-0.03,0.01,0.12,0.24,-0.13,-0.28,,,,,,,0,0,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,451.31,451.31,S32,PASEKEPEMPGPREESEEEEDEDDEEEEEEE,_EPEM(ox)PGPREES(ph)EEEEDEDDEEEEEEEK_,-0.11,-0.16,-0.3,-0.19,-0.1,-0.11,0.03,-0.07,0.07,0.09,0.06,0.03,-0.14,-0.13,-0.22,-0.21,-0.14,-0.24,-0.1,-0.02,0.08,0.05,-0.13,-0.21,,,,,,,0,0,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,130.3,130.3,S301,DSSTTKKNQNSSKKESESEDSSDDEPLIKKL,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_, , , , , ,0.21, ,0.25, , , , , ,-0.07, ,-0.11,,,0.21,0.25,,,-0.07,-0.11,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,130.3,130.3,S303,STTKKNQNSSKKESESEDSSDDEPLIKKLKK,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_, , , , , ,0.21, ,0.25, , , , , ,-0.07, ,-0.11,,,0.21,0.25,,,-0.07,-0.11,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,130.3,130.3,S306,KKNQNSSKKESESEDSSDDEPLIKKLKKPPT,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_, , , , , ,0.21, ,0.25, , , , , ,-0.07, ,-0.11,,,0.21,0.25,,,-0.07,-0.11,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,130.3,130.3,S307,KNQNSSKKESESEDSSDDEPLIKKLKKPPTD,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_, , , , , ,0.21, ,0.25, , , , , ,-0.07, ,-0.11,,,0.21,0.25,,,-0.07,-0.11,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
P35659,P35659,Protein DEK,DEK,259.53,259.53,T13,___MSASAPAAEGEGTPTQPASEKEPEMPGP,_(ac)SASAPAAEGEGT(ph)PTQPASEKEPEMPGPR_,-0.06,-0.2,-0.24,-0.16,-0.14,-0.22,-0.09,0,0.03,-0.04,-0.02,0.06,-0.14,-0.43,-0.57,-0.67,-0.13,-0.2,-0.18,-0.04,-0.01,0.02,-0.28,-0.62,,,,,,,0,0,,nucleus,DNA binding,chromatin modification,,
Q8TEH3,Q8TEH3,DENN domain-containing protein 1A,DENND1A,79.49,79.49,S592,NLDMEAALQPLGQAKSLEDLRAPKDLREQPG,_S(ph)LEDLRAPK_,0.31,0.37,0.21,-0.1,0.68,-0.13, ,0.44,0.22,0.24,0.26,0.09,0.13,0.23, ,0.3,0.34,0.06,0.33,0.44,0.23,0.18,0.18,0.3,,,,,,,0,0,,cell junction,Rab guanyl-nucleotide exchange factor activity,endocytosis,,
Q7Z401,Q7Z401,C-myc promoter-binding protein,DENND4A,59.42,56.23,S731,QAKKNKLPSKSSSPNSPLPMFRRTKQEIKSA,_SS(ph)SPNS(ph)PLPMFR_, , , , , ,-1.42, , , , , , , ,-1.07, , ,,,-1.42,,,,-1.07,, +, +,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q7Z401,Q7Z401,C-myc promoter-binding protein,DENND4A,66.47,61.41,S1098,GKPPLRSKRDSLEKESSDDDTPFDGSNYLAD,_ES(ph)S(ph)DDDTPFDGSNYLADK_, , , , ,-0.29,-0.54,0.16,1.01, , , , ,-0.1,-0.42,0.03,0.52,,,-0.41,0.65,,,-0.25,0.3,,,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q7Z401,Q7Z401,C-myc promoter-binding protein,DENND4A,118.46,110.25,S1099,KPPLRSKRDSLEKESSDDDTPFDGSNYLADK,_ES(ph)S(ph)DDDTPFDGSNYLADK_,0.34,0.05,-0.02,-0.36,-0.08,-0.54,-0.3,-0.51,0.2,-0.05,-0.19,-0.24,-0.51,-0.42,-0.22,-0.47,0.2,-0.18,-0.3,-0.4,0.08,-0.21,-0.47,-0.34,,,,,,,0,0,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
B7Z660,Q5VZ89,DENN domain-containing protein 4C,DENND4C,105.98,20.3,S989,ECTGGKTPDSEDKLFSPVIARNLADEIESYM,_LFS(ph)PVIAR_, , ,2.2,2.6, , , , , , ,2.39,2.87, , , , ,,2.41,,,,2.65,,, +, +,,,,,NA,NA,,,,,,
B7Z660,Q5VZ89,DENN domain-containing protein 4C,DENND4C,79.95,73.45,S732,EVCDASAIVAKHSQPSPEPHSPTEPPAWGSS,_HSQPS(ph)PEPHS(ph)PTEPPAWGSSIVK_, , , , , , ,-0.22, , , , , , , ,-0.09, ,,,,-0.22,,,,-0.09,,,,,,,NA,NA,,,,,,
B7Z660,Q5VZ89,DENN domain-containing protein 4C,DENND4C,79.95,73.45,S737,SAIVAKHSQPSPEPHSPTEPPAWGSSIVKVP,_HSQPS(ph)PEPHS(ph)PTEPPAWGSSIVK_, , , , , , ,-0.22, , , , , , , ,-0.09, ,,,,-0.22,,,,-0.09,,,,,,,NA,NA,,,,,,
O43583,O43583,Density-regulated protein,DENR,291.79,291.79,S73,EKNFPNEFAKLTVENSPKQEAGISEGQGTAG,_LTVENS(ph)PKQEAGISEGQGTAGEEEEK_,-0.1,0.03,-0.23,-0.25,0.83,-0.06,-0.14,-0.14,-0.03,0.01,-0.17,-0.11,-0.23,0.04,-0.29,-0.32,-0.03,-0.24,0.45,-0.14,-0.01,-0.14,-0.08,-0.31,,,,,,,0,0,,,translation initiation factor activity,,,
E7EV87,Q8TB45,DEP domain-containing mTOR-interacting protein,DEPTOR,92.27,91.83,S265,KQSHDNRKSTSFMSVSPSKEIKIVSAVRRSS,_STSFMSVS(ph)PSK_, ,-0.19, ,-0.23, , , , , ,-0.3, ,-0.61, , , , ,-0.19,-0.23,,,-0.3,-0.61,,,,,,,,,NA,NA,,,,intracellular signal transduction,,
Q96DF8,Q96DF8,Protein DGCR14,DGCR14,117.18,71.56,S391,RRVTENLASLTPKGLSPAMSPALQRLVSRTA,_GLS(ph)PAMS(ph)PALQR_, , , , , ,0.32,-0.05, , , , , , ,0.45,0.19, ,,,0.32,-0.05,,,0.45,0.19,,,,,,,NA,NA,,catalytic step 2 spliceosome,,"mRNA splicing, via spliceosome",,
Q96DF8,Q96DF8,Protein DGCR14,DGCR14,117.18,71.56,S395,ENLASLTPKGLSPAMSPALQRLVSRTASKYT,_GLS(ph)PAMS(ph)PALQR_, , , , , ,0.32,-0.05, , , , , , ,0.45,0.19, ,,,0.32,-0.05,,,0.45,0.19,,,,,,,NA,NA,,catalytic step 2 spliceosome,,"mRNA splicing, via spliceosome",,
Q8WYQ5-3,Q8WYQ5,Microprocessor complex subunit DGCR8,DGCR8,145.83,130.58,S373,MKDNEEREQSSDLTPSGDVSPVKPLSRSAEL,_EQSSDLTPS(ph)GDVS(ph)PVK_, , , , ,-0.28,-0.04,0.46,-0.31, , , , ,-0.06,-0.31,-0.75,-0.72,,,-0.16,0.13,,,-0.18,-0.73,,,,,,,NA,NA,,cytoplasm,double-stranded RNA binding,primary miRNA processing,,
Q8WYQ5-3,Q8WYQ5,Microprocessor complex subunit DGCR8,DGCR8,145.83,130.58,S377,EEREQSSDLTPSGDVSPVKPLSRSAELEFPL,_EQSSDLTPS(ph)GDVS(ph)PVK_, , , , ,-0.28,-0.04,0.76,-0.31, , , , ,-0.06,-0.31,-0.03,-0.72,,,-0.16,0.32,,,-0.18,-0.34,,,,,,,NA,NA,,cytoplasm,double-stranded RNA binding,primary miRNA processing,,
Q8WYQ5-3,Q8WYQ5,Microprocessor complex subunit DGCR8,DGCR8,205.8,203.9,S271,CAPKKRRTEEKYGGDSDHPSDGETSVQPMMT,_YGGDS(ph)DHPS(ph)DGETSVQPMMTK_,0.12,0.22,-0.08,-0.1,-0.27,-0.28,-0.24,0.02,0.14,0.23,-0.08,0.06,-0.24,0,-0.21,-0.22,0.17,-0.09,-0.28,-0.11,0.19,-0.01,-0.12,-0.22,,,,,,,0,0,,cytoplasm,double-stranded RNA binding,primary miRNA processing,,
Q8WYQ5-3,Q8WYQ5,Microprocessor complex subunit DGCR8,DGCR8,205.8,203.9,S275,KRRTEEKYGGDSDHPSDGETSVQPMMTKIKT,_YGGDS(ph)DHPS(ph)DGETSVQPMMTK_,0.12,0.22,-0.08,-0.1,-0.27,-0.28,-0.24,0.02,0.14,0.23,-0.08,0.06,-0.24,0,-0.21,-0.22,0.17,-0.09,-0.28,-0.11,0.19,-0.01,-0.12,-0.22,,,,,,,0,0,,cytoplasm,double-stranded RNA binding,primary miRNA processing,,
Q9UBM7,Q9UBM7,7-dehydrocholesterol reductase,DHCR7,128.88,71.72,S14,__MAAKSQPNIPKAKSLDGVTNDRTASQGQW,_S(ph)LDGVTNDR_, , , ,-0.62,-0.38,-0.1,-0.51,-0.67, , , ,-0.22,0.16,0.25,-0.16,-0.2,,-0.62,-0.23,-0.59,,-0.22,0.21,-0.18,,,,,,,NA,NA,,endoplasmic reticulum membrane,7-dehydrocholesterol reductase activity,blood vessel development,,
O60231,O60231,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,DHX16,300.28,300.28,S160,KKKTGGSKQQTEKPESEDEWERTERERLQDL,_(gl)QQTEKPES(ph)EDEWER_,-0.08,-0.18,-0.02,-0.36,-0.17,0.13,0.39,1.4,-0.09,-0.22,-0.09,-0.33,-0.23,0.04,0.07,-0.11,-0.13,-0.18,-0.01,0.98,-0.15,-0.21,-0.09,-0.02,,,,,,,0,0,,nucleus,ATP binding,mRNA processing,,
O60231,O60231,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,DHX16,311.54,307.32,S103,RALLEKNRSYRLLEDSEESSEETVSRAGSSL,_LLEDS(ph)EES(ph)S(ph)EETVSR_,0.2,-0.12,0.05,-0.23,-0.63,-1.02,-0.9,-0.49,-0.2,-0.16,-0.29,-0.39,-0.29,-0.33,-0.74,-0.48,0.05,-0.08,-0.81,-0.68,-0.18,-0.34,-0.31,-0.6,,,,,,,0,0,,nucleus,ATP binding,mRNA processing,,
O60231,O60231,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,DHX16,311.54,307.32,S106,LEKNRSYRLLEDSEESSEETVSRAGSSLQKK,_LLEDS(ph)EES(ph)S(ph)EETVSR_,-0.17,-0.1,-0.1,-0.09,-0.12,-0.16,-0.12,-0.07,0.02,0.02,0.06,-0.04,-0.09,-0.05,-0.01,-0.07,-0.13,-0.1,-0.14,-0.1,0.02,0.01,-0.07,-0.04,,,,,,,0,0,,nucleus,ATP binding,mRNA processing,,
O60231,O60231,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16,DHX16,222.32,214.01,S107,EKNRSYRLLEDSEESSEETVSRAGSSLQKKR,_LLEDS(ph)EES(ph)S(ph)EETVSR_,-0.13,-0.23,-0.22,-0.17,-0.37,-0.23,-0.07,-0.26,-0.16,0.14,-0.1,-0.16,-0.17,-0.16,0,-0.22,-0.18,-0.19,-0.3,-0.16,0,-0.13,-0.16,-0.11,,,,,,,0,0,,nucleus,ATP binding,mRNA processing,,
Q14147,Q14147,Probable ATP-dependent RNA helicase DHX34,DHX34,115.01,111.32,S749,RRRKVLRLQEEQDGGSSDEDRAGPAPPGASD,_LQEEQDGGS(ph)S(ph)DEDRAGPAPPGASDGVDIQDVK_, , , , ,0.12,-0.14,0.04,-0.38, , , , ,0.23,-0.32,-0.29,-0.53,,,-0.01,-0.16,,,-0.02,-0.41,,,,,,,NA,NA,,,ATP binding,,,
Q14147,Q14147,Probable ATP-dependent RNA helicase DHX34,DHX34,115.01,111.32,S750,RRKVLRLQEEQDGGSSDEDRAGPAPPGASDG,_LQEEQDGGS(ph)S(ph)DEDRAGPAPPGASDGVDIQDVK_, , , , ,0.12,-0.14,0.04,-0.38, , , , ,0.23,-0.32,-0.29,-0.53,,,-0.01,-0.16,,,-0.02,-0.41,,,,,,,NA,NA,,,ATP binding,,,
Q6P158,Q6P158,Putative ATP-dependent RNA helicase DHX57,DHX57,205.88,178.45,S127,KALLRDLQEQDADAGSERGLSGEEEDDEPDC,_DLQEQDADAGS(ph)ER_,-0.34,-0.09,-0.63,-0.91,-0.53,-0.07,-0.21,-0.13,0.17,-0.08,-0.56,-0.82,-0.5,-0.13,-0.09,-0.16,-0.21,-0.76,-0.28,-0.17,0.05,-0.69,-0.3,-0.12,,,,,,,0,0,,,ATP binding,,,
Q14562,Q14562,ATP-dependent RNA helicase DHX8,DHX8,130.15,118.44,S460,EPPFLRGHTKQSMDMSPIKIVKNPDGSLSQA,_(gl)QSMDMS(ph)PIK_,0.3,0.18,0.22,0.19,0.14,0.16,-0.01,0.31,0.04,0.02,0.1,0.05,0.14,0.07,-0.06,0.31,0.24,0.21,0.15,0.16,0.03,0.08,0.1,0.14,,,,,,,0,0,,catalytic step 2 spliceosome,ATP binding,"mRNA splicing, via spliceosome",,
Q9NSV4-7,Q9NSV4,Protein diaphanous homolog 3,DIAPH3,122.39,104.38,S1091,RDRRKRTPMPKDVRQSLSPMSQRPVLKVCNH,_DVRQS(ph)LS(ph)PMSQRPVLK_,0.27,0.43,0.43, ,-0.49,-0.27,-0.45,-1.42,-0.1,-0.18,0.08, ,-0.11,0.01,-0.39,-1.3,0.35,0.43,-0.37,-0.85,-0.14,0.08,-0.05,-0.77,,,,,,,0,0,,cytosol,,actin cytoskeleton organization,,
Q9NSV4-7,Q9NSV4,Protein diaphanous homolog 3,DIAPH3,122.39,104.38,S1093,RRKRTPMPKDVRQSLSPMSQRPVLKVCNHGN,_DVRQS(ph)LS(ph)PMSQRPVLK_,0.27,0.43,0.43, ,-0.49,-0.27,-0.45,-1.42,-0.1,-0.18,0.08, ,-0.11,0.01,-0.39,-1.3,0.35,0.43,-0.37,-0.85,-0.14,0.08,-0.05,-0.77,,,,,,,0,0,,cytosol,,actin cytoskeleton organization,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,67.5,65.6,S152,ASSEKVKGGDDHDDTSDSDSDGLTLKELQNR,_GGDDHDDT(ph)S(ph)DS(ph)DSDGLTLK_,-0.44,-0.02,-0.15, , ,-0.73,-0.62,-0.05,-0.1,0.3,0.3, , ,-0.05,-0.38,-0.22,-0.22,-0.15,-0.73,-0.31,0.11,0.3,-0.05,-0.3,,,,,,,0,0,,cytoplasm,zinc ion binding,apoptotic process,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,67.5,65.6,S154,SEKVKGGDDHDDTSDSDSDGLTLKELQNRLR,_GGDDHDDT(ph)S(ph)DS(ph)DSDGLTLK_,-0.44,-0.02,-0.15, , ,-0.73,-0.62,-0.05,-0.1,0.3,0.3, , ,-0.05,-0.38,-0.22,-0.22,-0.15,-0.73,-0.31,0.11,0.3,-0.05,-0.3,,,,,,,0,0,,cytoplasm,zinc ion binding,apoptotic process,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,358.38,356.56,S805,KKTAPRQEAIPDLEDSPPVSDSEEQQESARA,_QEAIPDLEDS(ph)PPVS(ph)DSEEQQESAR_,-0.02,-0.07,-0.17,-0.13,0.07,0.08,-0.08,-0.14,0.18,0.05,0.06,0.06,0,-0.05,-0.26,-0.26,-0.04,-0.15,0.07,-0.11,0.11,0.06,-0.03,-0.26,,,,,,,0,0,,cytoplasm,zinc ion binding,apoptotic process,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,358.38,356.56,S809,PRQEAIPDLEDSPPVSDSEEQQESARAVPEK,_(gl)QEAIPDLEDS(ph)PPVS(ph)DSEEQQESAR_,-0.02,-0.07,-0.17,-0.13,0.07,0.08,-0.1,-0.12,0.18,0.05,0.06,0.06,-0.05,-0.09,-0.3,-0.3,-0.04,-0.15,0.07,-0.11,0.11,0.06,-0.07,-0.3,,,,,,,0,0,,cytoplasm,zinc ion binding,apoptotic process,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,52.86,52.86,S1040,LSVPPSPNISTSESRSPPEGDTTLFLSRLST,_S(ph)PPEGDTTLFLSR_, ,0.23, , , , , , , ,0.01, , , , , , ,0.23,,,,0.01,,,,,,,,,,NA,NA,,cytoplasm,zinc ion binding,apoptotic process,,
Q9BTC0,Q9BTC0,Death-inducer obliterator 1,DIDO1,67.5,65.6,T151,PASSEKVKGGDDHDDTSDSDSDGLTLKELQN,_GGDDHDDT(ph)S(ph)DS(ph)DSDGLTLK_,-0.44,-0.02,-0.15, , ,-0.73,-0.62,-0.05,-0.1,0.3,0.3, , ,-0.05,-0.38,-0.22,-0.22,-0.15,-0.73,-0.31,0.11,0.3,-0.05,-0.3,,,,,,,0,0,,cytoplasm,zinc ion binding,apoptotic process,,
O60832,O60832,H/ACA ribonucleoprotein complex subunit 4,DKC1,76.44,66.49,S485,KKKSKKDKKAKAGLESGAEPGDGDSDTTKKK,_AGLES(ph)GAEPGDGDS(ph)DTTK_, , , , ,0.14,0.26,-0.02,-0.49, , , , ,-0.17,-0.32,-0.86,-0.6,,,0.2,-0.24,,,-0.24,-0.72,,,,,,,NA,NA,,Cajal body,pseudouridine synthase activity,cell proliferation,,
O60832,O60832,H/ACA ribonucleoprotein complex subunit 4,DKC1,196.77,176.15,S513,KKKKKKKKAKEVELVSE______________,_EVELVS(ph)E_,0.49,0.16,0.29,0.16, , , , ,-0.04,0.03,-0.12,-0.11, , , , ,0.33,0.23,,,-0.01,-0.12,,,,,,,,,NA,NA,,Cajal body,pseudouridine synthase activity,cell proliferation,,
O60832,O60832,H/ACA ribonucleoprotein complex subunit 4,DKC1,136.72,136.72,S451,QVVAEAAKTAKRKRESESESDETPPAAPQLI,_KRES(ph)ES(ph)ESDETPPAAPQLIK_, , , , ,-0.82,0.29,0.29, , , , , ,-1.25,0.13,0.16, ,,,-0.16,0.29,,,-0.4,0.16,,,,,,,NA,NA,,Cajal body,pseudouridine synthase activity,cell proliferation,,
O60832,O60832,H/ACA ribonucleoprotein complex subunit 4,DKC1,136.72,136.72,S453,VAEAAKTAKRKRESESESDETPPAAPQLIKK,_KRES(ph)ES(ph)ESDETPPAAPQLIK_, , ,0.15, ,-0.82,0.29,0.29, , , ,0.38, ,-1.25,0.13,0.16, ,,0.15,-0.16,0.29,,0.38,-0.4,0.16,,,,,,,NA,NA,,Cajal body,pseudouridine synthase activity,cell proliferation,,
Q7L890,Q9NQG6,Mitochondrial dynamic protein MID51,DKFZp434E0130,71.08,54.65,S55,GIATLAVKRMYDRAISAPTSPTRLSHSGKRS,_AIS(ph)APTS(ph)PTR_, , , , ,0.16, , , , , , , ,-0.43, , , ,,,0.16,,,,-0.43,,,,,,,,NA,NA,,,,,,
Q5JPD5,Q9HC77,Centromere protein J,DKFZp667E025,103.46,101.42,S759,TRTQEDKRRDVDLDLSDKDYSSDESIMESIK,_DVDLDLS(ph)DK_, , , ,0.44,0.21, ,0.33,0.51, , , ,0.19,0.43, ,0.27,0.42,,0.44,0.21,0.43,,0.19,0.43,0.35,,,,,,,NA,NA,,,,,,
Q5JPD5,Q9HC77,Centromere protein J,DKFZp667E025,145.79,144.09,S764,DKRRDVDLDLSDKDYSSDESIMESIKHKVSE,_DYS(ph)S(ph)DESIMESIK_, , , , ,0.16,0.59,0.18,0.35, , , , ,0.46,0.29,0.29,0.44,,,0.39,0.27,,,0.37,0.37,,,,,,,NA,NA,,,,,,
Q5JPD5,Q9HC77,Centromere protein J,DKFZp667E025,145.79,144.09,S765,KRRDVDLDLSDKDYSSDESIMESIKHKVSEP,_DYS(ph)S(ph)DESIMESIK_, , , , ,0.16,0.59,0.18,0.35, , , , ,0.46,0.29,0.29,0.44,,,0.39,0.27,,,0.37,0.37,,,,,,,NA,NA,,,,,,
Q6N039,O94876,Transmembrane and coiled-coil domains protein 1,DKFZp686H13261,157.67,133.87,S382,SKPREIASLIRNKFGSADNIPNLKDSLEEGQ,_FGS(ph)ADNIPNLK_,-0.86,-0.87,-0.48,-1.11,0,0.35,0.2,0,-0.47,-0.47,-0.42,-0.77,-0.17,0.03,0.23,0.17,-0.86,-0.76,0.19,0.1,-0.47,-0.58,-0.07,0.2,,,,,,,0,0,,integral to membrane,,,,
B4E0H1,Q92796,Disks large homolog 3,DLG3,226.65,221.71,Y673,HTTRPRRDNEVDGQDYHFVVSREQMEKDIQD,_RDNEVDGQDY(ph)HFVVSR_,4.21,2.26,4.94,1.58, , , ,1.94,3.62,1.61,3.86,0.69, , , ,2.26,3.54,4.08,,1.94,2.94,3.02,,2.26, +, +,,,,,NA,NA,,,,,,
Q9Y2H0-3,Q9Y2H0,Disks large-associated protein 4,DLGAP4,136.83,135.32,S973,KRLLAAKRAASVRQNSATESADSIEIYVPEA,_(gl)QNS(ph)ATESADSIEIYVPEAQTR_, , , , ,0, , , , , , , ,0.36, , , ,,,0,,,,0.36,,,,,,,,NA,NA,,membrane,,cell-cell signaling,,
Q9Y2H0-3,Q9Y2H0,Disks large-associated protein 4,DLGAP4,163.84,142.49,T915,DELYHLKANSWQLVETPEKRKEEKKPPPPVP,_ANSWQLVET(ph)PEK_,0.1,0.11, ,0.01,-0.4,-0.2,-0.13,-0.18,1.26,-0.14, ,0.56,-0.11,0.39,0.12,0,0.1,0.01,-0.3,-0.16,0.72,0.56,0.16,0.06,,,,,,,0,0,,membrane,,cell-cell signaling,,
Q15398-1,Q15398,Disks large-associated protein 5,DLGAP5,56.44,55.19,S662,VSQSRNEMGIPQQTTSPENAGPQNTKSEHVK,_NEMGIPQQTTS(ph)PENAGPQNTK_, ,-0.27,-0.44, ,-0.56,-0.28, , , ,-0.21,-0.26, , ,1.84, , ,-0.27,-0.44,-0.41,,-0.21,-0.26,1.84,,, +,,,,,NA,NA,,cytoplasm,phosphoprotein phosphatase activity,cell proliferation,,
Q15398-1,Q15398,Disks large-associated protein 5,DLGAP5,66.14,63.38,S774,TSQDVLMSSPEKNTASQNSILEEGETKISQS,_NTAS(ph)QNS(ph)ILEEGETK_, , , , , , ,0.44, , , , , , , ,-0.69, ,,,,0.44,,,,-0.69,,,,,,,NA,NA,,cytoplasm,phosphoprotein phosphatase activity,cell proliferation,,
Q15398-1,Q15398,Disks large-associated protein 5,DLGAP5,250.39,232.07,S777,DVLMSSPEKNTASQNSILEEGETKISQSELF,_NTASQNS(ph)ILEEGETK_,-0.07,-0.11,-0.22, ,-0.5, ,0.44,-0.9,0.21,0.02,-0.1, ,-0.39, ,-0.69,-0.48,-0.09,-0.22,-0.5,-0.08,0.12,-0.1,-0.39,-0.58,,,,,,,0,0,,cytoplasm,phosphoprotein phosphatase activity,cell proliferation,,
Q9NPF5,Q9NPF5,DNA methyltransferase 1-associated protein 1,DMAP1,82.89,58.83,T445,PDPKDTIIDVVGAPLTPNSRKRRESASSSSS,_DTIIDVVGAPLT(ph)PNSRK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,chromatin remodeling,,
Q9Y485,Q9Y485,DmX-like protein 1,DMXL1,291.78,272.11,S1970,PSVVFQDDSLELKWDSDNDEENEDVPISMKE,_WDS(ph)DNDEENEDVPISMK_,0.01,-0.06,-0.19,-0.26,0.04,0.06,0.06,0.29,0.05,0.07,0.08,-0.06,-0.25,0.1,0.02,0.09,-0.03,-0.22,0.05,0.18,0.06,0.01,-0.06,0.06,,,,,,,0,0,,,,,,
P31689,P31689,DnaJ homolog subfamily A member 1,DNAJA1,130.61,122.27,Y381,FDPNQERRRHYNGEAYEDDEHHPRGGVQCQT,_HYNGEAY(ph)EDDEHHPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,membrane,ATP binding,androgen receptor signaling pathway,,
P31689,P31689,DnaJ homolog subfamily A member 1,DNAJA1,202.79,197.69,S335,LIIEFKVNFPENGFLSPDKLSLLEKLLPERK,_VNFPENGFLS(ph)PDK_,0.08,0.1,0.47,0.33,-0.24,-0.24,0.01,-0.24,-0.26,-0.2,-0.17,-0.28,0,0.04,-0.19,-0.05,0.09,0.4,-0.24,-0.11,-0.23,-0.22,0.02,-0.12,,,,,,,0,0,,membrane,ATP binding,androgen receptor signaling pathway,,
Q96KC8,Q96KC8,DnaJ homolog subfamily C member 1,DNAJC1,238.17,216.22,S479,RAKRQKDFDIAEQNESSDEESLRKERARSAE,_DFDIAEQNES(ph)S(ph)DEESLRK_,-0.13,0.05,-2.63,0.08,0.25,0.26,0.38,0.22,-0.1,-0.08,-2.7,-0.05,0.07,0.18,0.29,0.28,-0.04,-0.72,0.25,0.3,-0.09,-0.84,0.13,0.28,,,,,,,0,0,,endoplasmic reticulum,ATPase activator activity,negative regulation of proteolysis,,
Q96KC8,Q96KC8,DnaJ homolog subfamily C member 1,DNAJC1,238.17,216.22,S480,AKRQKDFDIAEQNESSDEESLRKERARSAEE,_DFDIAEQNES(ph)S(ph)DEESLRK_,-0.13,0.05,-2.63,0.08,0.25,0.26,0.38,0.22,-0.1,-0.08,-2.7,-0.05,0.07,0.18,0.29,0.28,-0.04,-0.72,0.25,0.3,-0.09,-0.84,0.13,0.28,,,,,,,0,0,,endoplasmic reticulum,ATPase activator activity,negative regulation of proteolysis,,
Q9UKB3,Q9UKB3,DnaJ homolog subfamily C member 12,DNAJC12,140.21,139.39,S160,EKTEQKEPKPLEKSVSPQNSDSSGFADVNGW,_SVS(ph)PQNSDSSGFADVNGWHLR_, , ,0.32,0.45, , , , , , ,0.16,0.6, , , , ,,0.39,,,,0.39,,,,,,,,,NA,NA,,,,,,
H0YLQ7,Q9NVM6,DnaJ homolog subfamily C member 17,DNAJC17,349.53,342.85,S112,KLDLEARERQAQAQESEEEEESRSTRTLEQE,_QAQAQES(ph)EEEEESR_,-0.02,-0.07,0.09,0.01, ,-0.25,-0.38,-0.38,-0.07,-0.14,-0.05,-0.16, ,-0.27,-0.4,-0.32,-0.04,0.05,-0.25,-0.38,-0.11,-0.11,-0.27,-0.36,,,,,,,0,0,,,,,,
Q99543-2,Q99543,DnaJ homolog subfamily C member 2,DNAJC2,244.18,244.18,S49,WFEAFVKRRNRNASASFQELEDKKELSEESE,_NAS(ph)AS(ph)FQELEDKK_,0.05,0.08,-0.97,-0.7,1.83,1.84,1.75,1.62,0.14,-0.04,-0.8,-0.72,2.06,1.87,1.66,1.59,0.06,-0.83,1.84,1.68,0.05,-0.76,1.97,1.63, +, +,,,,,2,2,57,cytosol,chromatin binding,de novo' cotranslational protein folding,,
Q99543-2,Q99543,DnaJ homolog subfamily C member 2,DNAJC2,218.06,217.22,S60,NASASFQELEDKKELSEESEDEELQLEEFPM,_KELS(ph)EES(ph)EDEELQLEEFPMLK_, , , , ,-0.11,-0.14,-0.07,0.08, , , , ,-0.06,-0.07,0.05,-0.08,,,-0.13,0.01,,,-0.07,-0.01,,,,,,,NA,NA,,cytosol,chromatin binding,de novo' cotranslational protein folding,,
Q99543-2,Q99543,DnaJ homolog subfamily C member 2,DNAJC2,218.06,217.22,S63,ASFQELEDKKELSEESEDEELQLEEFPMLKT,_KELS(ph)EES(ph)EDEELQLEEFPMLK_, , , , ,-0.11,-0.14,-0.07,0.08, , , , ,-0.06,-0.07,0.05,-0.08,,,-0.13,0.01,,,-0.07,-0.01,,,,,,,NA,NA,,cytosol,chromatin binding,de novo' cotranslational protein folding,,
Q99543-2,Q99543,DnaJ homolog subfamily C member 2,DNAJC2,244.18,244.18,S47,GRWFEAFVKRRNRNASASFQELEDKKELSEE,_NAS(ph)AS(ph)FQELEDKK_,0.2,0.06,0.05,0.03,-0.54,-0.43,-0.23,-0.21,0.94,0.51,0.87,0.47,-0.79,-0.54,-0.38,-0.17,0.13,0.04,-0.48,-0.22,0.74,0.68,-0.66,-0.27,,,,,,,0,0,,cytosol,chromatin binding,de novo' cotranslational protein folding,,
Q5F1R6,Q5F1R6,DnaJ homolog subfamily C member 21,DNAJC21,293.12,272.17,S283,LQEMEARYEKEFGDGSDENEMEEHELKDEED,_EFGDGS(ph)DENEM(ox)EEHELK_,0.11,0.14,-0.06,0.1,0.09,0.26,0.26,0.26,0.12,0.2,0.06,0.11,0.16,0.22,0.09,0.24,0.13,0.02,0.18,0.26,0.16,0.09,0.19,0.17,,,,,,,0,0,,ribosome,nucleic acid binding,protein folding,,
Q5F1R6,Q5F1R6,DnaJ homolog subfamily C member 21,DNAJC21,452.33,452.33,S370,NFSRPQIDENPLDDNSEEEMEDAPKQKLSKK,_(gl)QQLEEEEENFSRPQIDENPLDDNS(ph)EEEMEDAPK_,0.04,0.11,-0.01,-0.01,0.06,0.12,0.11,0.31,-0.09,-0.1,-0.16,-0.1,0.06,-0.01,-0.06,0.04,0.07,-0.01,0.09,0.21,-0.09,-0.13,0.02,-0.01,,,,,,,0,0,,ribosome,nucleic acid binding,protein folding,,
Q5F1R6,Q5F1R6,DnaJ homolog subfamily C member 21,DNAJC21,67.61,65.99,S423,EGVKVDPEDTNLNQDSAKELEDSPQENVSVT,_VDPEDTNLNQDS(ph)AK_, , , , , ,-0.25, ,0.07, , , , , ,-0.28, ,0.04,,,-0.25,0.07,,,-0.28,0.04,,,,,,,NA,NA,,ribosome,nucleic acid binding,protein folding,,
Q9H3Z4,Q9H3Z4,DnaJ homolog subfamily C member 5,DNAJC5,284.34,239.2,S10,______MADQRQRSLSTSGESLYHVLGLDKN,_SLS(ph)TSGESLYHVLGLDK_,-0.02,0.1,-0.1,0.01,-0.05,0.14,0.24, ,0.12,0.16,0,0.01,-0.04,0.06,-0.13, ,0.04,-0.04,0.05,0.24,0.14,0,0.01,-0.13,,,,,,,0,0,,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,,cell death,,
O00429-4,O00429,Dynamin-1-like protein,DNM1L,73.74,73.74,S616,LLAEEKSKPIPIMPASPQKGHAVNLLDVPVP,_SKPIPIMPAS(ph)PQK_,0.57,0.14,0.46,0.2, , , , ,-0.2,-0.1,0.21,-0.05, , , , ,0.37,0.34,,,-0.15,0.09,,,,,,,,,NA,NA,,cytosol,GTP binding,cellular component disassembly involved in execution phase of apoptosis,,
P26358,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,245.49,245.04,S714,ADDDEEVDDNIPEMPSPKKMHQGKKKKQNKN,_EADDDEEVDDNIPEMPS(ph)PKK_,0.13,0.1,0,0.04,0.13,0.01,0.13,0.34,-0.04,-0.02,-0.1,-0.11,0.27,0.03,0.15,0.19,0.11,0.02,0.07,0.24,-0.03,-0.1,0.15,0.17,,,,,,,0,0,,centromeric heterochromatin,DNA (cytosine-5-)-methyltransferase activity,cellular response to amino acid stimulus,,
Q14185,Q14185,Dedicator of cytokinesis protein 1,DOCK1,159.65,159.43,Y1811,ADVPPPLPLKGSVADYGNLMENQDLLGSPTP,_GSVADY(ph)GNLMENQDLLGSPTPPPPPPHQR_,1.53, , , ,0.43, ,-0.32,0.11,0.82, , , ,0.48, ,0.39,0.25,1.53,,0.43,-0.09,0.82,,0.48,0.32, +,,,,,,NA,NA,,cytosol,GTPase activator activity,apoptotic process,,
B3FL70,Q96BY6,Dedicator of cytokinesis protein 10,DOCK10.2,107.07,90.75,S1292,AISTVNHADSRASLASLDSNPSTNEKSSEKT,_ASLAS(ph)LDS(ph)NPSTNEK_, , , , , , , ,-0.01, , , , , , , ,-0.07,,,,-0.01,,,,-0.07,,,,,,,NA,NA,,,guanyl-nucleotide exchange factor activity,small GTPase mediated signal transduction,,
B3FL70,Q96BY6,Dedicator of cytokinesis protein 10,DOCK10.2,107.07,90.75,S1295,TVNHADSRASLASLDSNPSTNEKSSEKTDNC,_ASLAS(ph)LDS(ph)NPSTNEK_, , , , , , , ,-0.01, , , , , , , ,-0.07,,,,-0.01,,,,-0.07,,,,,,,NA,NA,,,guanyl-nucleotide exchange factor activity,small GTPase mediated signal transduction,,
Q8N1I0,Q8N1I0,Dedicator of cytokinesis protein 4,DOCK4,62.2,51.86,Y1727,ENSCLSPRERPCSAIYPTPVEPSQRMLFNHI,_ERPCSAIY(ph)PTPVEPSQR_,2.09, , , , , , , ,0.19, , , , , , , ,2.09,,,,0.19,,,, +,,,,,,NA,NA,,cytosol,guanyl-nucleotide exchange factor activity,cell chemotaxis,,
Q9H7D0,Q9H7D0,Dedicator of cytokinesis protein 5,DOCK5,145.91,82.29,S1766,EPDLMSPTRKAQRPKSLQLMDNRLSPFHGSS,_S(ph)LQLMDNR_,-0.27,-0.07,-0.35,-0.27,0.26,0.24,0.28,0.24,0.23,-0.09,0.34,-0.14,0.3,0.28,0.1,0.11,-0.17,-0.31,0.25,0.26,0.08,0.12,0.29,0.1,,,,,,,0,0,,cytoplasm,guanyl-nucleotide exchange factor activity,small GTPase mediated signal transduction,,
Q96N67-4,Q96N67,Dedicator of cytokinesis protein 7,DOCK7,215.98,215.5,S910,RSLSNSNPDISGTPTSPDDEVRSIIGSKAMD,_SLSNS(ph)NPDISGTPTS(ph)PDDEVR_, , ,-0.34, ,1.32,2.09,0.63,-0.24, , ,0.01, ,1.62,2.53,0.57,-0.46,,-0.34,1.76,0.26,,0.01,2.14,0.15, +, +,,,,,NA,NA,,axon,guanyl-nucleotide exchange factor activity,activation of Rac GTPase activity,,
Q96N67-4,Q96N67,Dedicator of cytokinesis protein 7,DOCK7,182.89,174.69,T907,NRSRSLSNSNPDISGTPTSPDDEVRSIIGSK,_SLS(ph)NSNPDISGT(ph)PTSPDDEVR_, , , , ,2.5,3.89,0.34, , , , , ,2.73,4.44,0.06, ,,,3.36,0.34,,,3.82,0.06, +, +,,,,,NA,NA,,axon,guanyl-nucleotide exchange factor activity,activation of Rac GTPase activity,,
Q96N67-4,Q96N67,Dedicator of cytokinesis protein 7,DOCK7,113.38,111.66,S896,RSAVRPASLNLNRSRSLSNSNPDISGTPTSP,_S(ph)LSNS(ph)NPDISGTPTSPDDEVR_, , , , ,-0.46, , ,-0.18, , , , ,-0.33, , ,-0.21,,,-0.46,-0.18,,,-0.33,-0.21,,,,,,,NA,NA,,axon,guanyl-nucleotide exchange factor activity,activation of Rac GTPase activity,,
Q96N67-4,Q96N67,Dedicator of cytokinesis protein 7,DOCK7,182.89,174.69,S898,AVRPASLNLNRSRSLSNSNPDISGTPTSPDD,_SLS(ph)NSNPDISGT(ph)PTSPDDEVR_, ,-0.25, , ,-0.84,0.95,-0.41,0.8, ,-0.13, , ,-0.69,1.19,-0.46,0.9,-0.25,,0.32,0.32,-0.13,,0.53,0.37,,,,,,,NA,NA,,axon,guanyl-nucleotide exchange factor activity,activation of Rac GTPase activity,,
Q96N67-4,Q96N67,Dedicator of cytokinesis protein 7,DOCK7,269.94,268.37,S900,RPASLNLNRSRSLSNSNPDISGTPTSPDDEV,_SLSNS(ph)NPDISGTPTSPDDEVR_,-0.23,-0.28,-0.62, ,-0.82,-0.77,-0.36,-0.32,0,-0.01,-0.53, ,-0.75,-0.76,-0.41,-0.24,-0.25,-0.62,-0.79,-0.34,-0.01,-0.53,-0.76,-0.32,,,,,,,0,0,,axon,guanyl-nucleotide exchange factor activity,activation of Rac GTPase activity,,
Q9BZ29-4,Q9BZ29,Dedicator of cytokinesis protein 9,DOCK9,69.92,48.37,S927,RSYVKYAYKAEPYVASEYKTVHEELTKSMTT,_AEPYVAS(ph)EYK_,-0.12,0.04,-0.11,-0.35,0.04,-0.14,0.17, ,0.19,0.38,0.23,0.12,0.15,0.4,0.38, ,-0.04,-0.22,-0.05,0.17,0.29,0.18,0.28,0.38,,,,,,,0,0,,cytosol,phospholipid binding,blood coagulation,,
Q99704-3,Q99704,Docking protein 1,DOK1,154.7,154.61,Y409,KEEGYELPYNPATDDYAVPPPRSTKPLLAPK,_VKEEGYELPYNPATDDY(ph)AVPPPR_,3.38, , , , , , , ,2.75, , , , , , , ,3.38,,,,2.75,,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,insulin receptor signaling pathway,,
Q8N350,Q8N350,Protein Dos,DOS,100.71,100.42,S719,EPVVATPALVAAAPTSPDHSPA_________,_LAEPVVATPALVAAAPTS(ph)PDHS(ph)PA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q8N350,Q8N350,Protein Dos,DOS,100.71,100.42,S723,ATPALVAAAPTSPDHSPA_____________,_LAEPVVATPALVAAAPTS(ph)PDHS(ph)PA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q92785,Q92785,Zinc finger protein ubi-d4,DPF2,159.5,155.51,S142,PLEKRGAPDPRVDDDSLGEFPVTNSRARKRI,_VDDDS(ph)LGEFPVTNSR_,-0.26,-0.54,-0.18,-0.49,-0.24,-0.14,0.2,0,-0.39,-0.33,-0.57,-0.55,-0.73,-0.53,0.13,0.37,-0.39,-0.33,-0.19,0.1,-0.36,-0.56,-0.62,0.25,,,,,,,0,0,,centrosome,zinc ion binding,apoptotic signaling pathway,,
H0YCR5,Q9BQC3,Diphthamide biosynthesis protein 2,DPH2,111.79,94.54,S488,VSGRRGIAIAYEDEGSG______________,_GIAIAYEDEGS(ph)G_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,,
O60762,O60762,Dolichol-phosphate mannosyltransferase,DPM1,117.2,117.2,S7,_________MASLEVSRSPRRSRRELEVRSP,_(ac)ASLEVS(ph)RSPRR_, ,0.15,-0.23,-0.12,0.27,0.45, , , ,0.23,0.17,0.21,-0.1,0.11, , ,0.15,-0.17,0.36,,0.23,0.19,0.01,,,,,,,,NA,NA,,dolichol-phosphate-mannose synthase complex,alcohol binding,C-terminal protein lipidation,,
O60762,O60762,Dolichol-phosphate mannosyltransferase,DPM1,216.27,216.27,S9,_______MASLEVSRSPRRSRRELEVRSPRQ,_(ac)ASLEVSRS(ph)PR_,0.09,0.09,-0.18,-0.2,0.18,0.24,0.21,0.2,0.08,0.1,0.07,0.08,-0.12,-0.13,-0.07,-0.07,0.09,-0.19,0.21,0.2,0.09,0.07,-0.12,-0.07,,,,,,,0,0,,dolichol-phosphate-mannose synthase complex,alcohol binding,C-terminal protein lipidation,,
B4DR31,Q16555,Dihydropyrimidinase-related protein 2,DPYSL2,95.82,69.12,S570,TQRIVAPPGGRANITSLG_____________,_ANITS(ph)LG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B4DR31,Q16555,Dihydropyrimidinase-related protein 2,DPYSL2,123.61,123.24,T509,VPRGLYDGPVCEVSVTPKTVTPASSAKTSPA,_GLYDGPVCEVSVT(ph)PK_,-0.45, , , ,-0.58,-0.4, , ,-0.13, , , ,-0.54,-0.4, , ,-0.45,,-0.48,,-0.13,,-0.47,,,,,,,,NA,NA,,,,,,
Q14195-2,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,157.62,156.98,T509,VPRGMYDGPVFDLTTTPKGGTPAGSARGSPT,_GMYDGPVFDLTTT(ph)PK_,-0.31,-0.4,-0.88,-0.82, ,-1.52,-0.97,-0.97,-0.3,-0.27,-0.48,-0.55, ,-1.39,-0.65,-0.55,-0.36,-0.85,-1.52,-0.97,-0.29,-0.52,-1.39,-0.6, +, +,,,,,6,6,27.1,cell body,chondroitin sulfate binding,actin crosslink formation,,
Q14195-2,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,118.66,117.76,T507,HAVPRGMYDGPVFDLTTTPKGGTPAGSARGS,_GM(ox)YDGPVFDLT(ph)TTPK_, ,-0.49, ,-1.02, , , , , ,0.23, ,-0.52, , , , ,-0.49,-1.02,,,0.23,-0.52,,, +,,,,,,NA,NA,,cell body,chondroitin sulfate binding,actin crosslink formation,,
Q14195-2,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,102.24,102.24,S518,VFDLTTTPKGGTPAGSARGSPTRPNPPVRNL,_GGT(ph)PAGS(ph)ARGS(ph)PTRPNPPVR_,0, ,-0.64, ,-0.84,-0.37,-0.91,-0.33,-0.25, ,-0.25, ,-0.59,-0.55,-1.16,-0.36,0,-0.64,-0.59,-0.59,-0.25,-0.25,-0.57,-0.71,,,,,,,0,0,,cell body,chondroitin sulfate binding,actin crosslink formation,,
Q14195-2,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,102.24,102.24,S522,TTTPKGGTPAGSARGSPTRPNPPVRNLHQSG,_GGTPAGS(ph)ARGS(ph)PTRPNPPVR_,0, ,-0.64, ,-0.84,-0.37,-0.91,-0.33,-0.25, ,-0.25, ,-0.59,-0.55,-1.16,-0.36,0,-0.64,-0.59,-0.59,-0.25,-0.25,-0.57,-0.71,,,,,,,0,0,,cell body,chondroitin sulfate binding,actin crosslink formation,,
Q14195-2,Q14195,Dihydropyrimidinase-related protein 3,DPYSL3,107.71,107.37,T514,YDGPVFDLTTTPKGGTPAGSARGSPTRPNPP,_GGT(ph)PAGS(ph)ARGS(ph)PTRPNPPVR_, , , , ,-0.54,-1.52,-0.28,-0.33, , , , ,-0.36,-1.39,-0.35,-0.36,,,-0.95,-0.3,,,-0.78,-0.36,,,,,,,NA,NA,,cell body,chondroitin sulfate binding,actin crosslink formation,,
Q01658,Q01658,Protein Dr1,DR1,147.09,130.73,S4,____________MASSSGNDDDLTIPRAAIN,_(ac)ASS(ph)SGNDDDLTIPR_, , , , ,-0.43, , , , , , , ,-0.41, , , ,,,-0.43,,,,-0.41,,,,,,,,NA,NA,,Ada2/Gcn5/Ada3 transcription activator complex,DNA binding,histone H3 acetylation,,
Q14126,Q14126,Desmoglein-2,DSG2,160.52,159.2,Y1013,GSNPLEGTQHLQDVPYVMVRERESFLAPSSG,_VIQPHGGGSNPLEGTQHLQDVPY(ph)VMVR_,3.07, , , , , , , ,2.37, , , , , , , ,3.07,,,,2.37,,,, +, +,,,,,NA,NA,,cell-cell junction,calcium ion binding,bundle of His cell to Purkinje myocyte communication,,
P15924,P15924,Desmoplakin,DSP,71.81,64.36,S2815,LRLLEAASVSSKGLPSPYNMSSAPGSRSGSR,_GLPS(ph)PYNMSS(ph)APGS(ph)R_, , , , ,1.01,1.2,0.69, , , , , ,1.04,1.25,0.8, ,,,1.11,0.69,,,1.15,0.8, +, +,,,,,NA,NA,,basolateral plasma membrane,"protein binding, bridging",adherens junction organization,,
P15924,P15924,Desmoplakin,DSP,106.86,104.86,S2820,AASVSSKGLPSPYNMSSAPGSRSGSRSGSRS,_GLPSPYNM(ox)S(ph)SAPGS(ph)R_, , ,0.85,0.6,0.51, , ,0.64, , ,0.23,0.37,0.42, , ,0.87,,0.73,0.51,0.64,,0.3,0.42,0.87,,,,,,,NA,NA,,basolateral plasma membrane,"protein binding, bridging",adherens junction organization,,
P15924,P15924,Desmoplakin,DSP,203.75,194.81,S2821,ASVSSKGLPSPYNMSSAPGSRSGSRSGSRSG,_GLPSPYNMSS(ph)APGS(ph)R_,-0.38,-0.24,0.71,0.78,0.55,0.6,0.66,0.57,-0.04,-0.07,0.32,0.4,0.46,0.52,0.79,0.71,-0.31,0.75,0.58,0.61,-0.05,0.36,0.49,0.75,,,,,,,0,0,,basolateral plasma membrane,"protein binding, bridging",adherens junction organization,,
P15924,P15924,Desmoplakin,DSP,203.75,194.81,S2825,SKGLPSPYNMSSAPGSRSGSRSGSRSGSRSG,_GLPSPYNMSS(ph)APGS(ph)R_,0.39,0.28,1.02,0.82,0.53,0.6,0.63,0.58,0.06,0.41,0.81,0.62,0.45,0.52,0.76,0.71,0.34,0.92,0.57,0.61,0.24,0.72,0.48,0.74,,,,,,,0,0,,basolateral plasma membrane,"protein binding, bridging",adherens junction organization,,
E7ERU0,Q03001,Dystonin,DST,198.97,176.9,S3968,ADDINGLMTKLKRQKSFSEDVISHKGDLRYI,_S(ph)FSEDVISHK_,-0.23,0.04,-0.35,0.06,-0.71,-0.66,-0.59,-0.29,-0.09,-0.07,-0.28,-0.22,-0.53,-1.02,-0.38,-0.54,-0.09,-0.13,-0.69,-0.43,-0.08,-0.25,-0.75,-0.46,,,,,,,0,0,,,calcium ion binding,cell cycle arrest,,
F6RFD5,P60981,Destrin,DSTN,210.37,201.96,S3,_____________MASGVQVADEVCRIFYDM,_(ac)AS(ph)GVQVADEVCR_,-0.72,-0.75,-0.63,-0.64,-0.29,-0.17,-0.26,-0.27,0.05,0.13,0.44,0.48,-0.27,-0.16,-0.02,0.04,-0.73,-0.63,-0.23,-0.26,0.09,0.46,-0.21,0.01,,,,,,,0,0,,actin cytoskeleton,,actin filament depolymerization,,
Q8TEA8,Q8TEA8,D-tyrosyl-tRNA(Tyr) deacylase 1,DTD1,187.22,177.7,S197,SKERNTPRKEDRSASSGAEGDVSSEREP___,_SAS(ph)S(ph)GAEGDVSSEREP_, , ,-2.22,-2.96,-0.34,-0.15,-0.16,0.06, , ,-2.54,-3.27,-0.21,0.04,-0.12,-0.14,,-2.55,-0.24,-0.05,,-2.86,-0.08,-0.13, +, +,,,,,NA,NA,,cytoplasm,"hydrolase activity, acting on ester bonds",D-amino acid catabolic process,,
Q8TEA8,Q8TEA8,D-tyrosyl-tRNA(Tyr) deacylase 1,DTD1,143.04,131.93,S196,SSKERNTPRKEDRSASSGAEGDVSSEREP__,_SAS(ph)S(ph)GAEGDVSSEREP_, , , , ,-0.6, ,0.98, , , , , ,-0.42, ,0.92, ,,,-0.6,0.98,,,-0.42,0.92,,,,,,,NA,NA,,cytoplasm,"hydrolase activity, acting on ester bonds",D-amino acid catabolic process,,
E7ERQ0,Q9NZJ0,Denticleless protein homolog,DTL,69.13,68.31,S511,SFKMSIRNWVTRTPSSSPPITPPASETKIMS,_TPSS(ph)SPPIT(ph)PPASETK_, , , , ,0.02, , , , , , , ,0.18, , , ,,,0.02,,,,0.18,,,,,,,,NA,NA,,,,,,
E7ERQ0,Q9NZJ0,Denticleless protein homolog,DTL,119.38,98.28,S512,FKMSIRNWVTRTPSSSPPITPPASETKIMSP,_TPSSS(ph)PPIT(ph)PPASETK_, , , , ,-0.03,-0.02,-0.26,0.05, , , , ,0.09,0.16,-0.1,0.07,,,-0.02,-0.1,,,0.12,-0.01,,,,,,,NA,NA,,,,,,
E7ERQ0,Q9NZJ0,Denticleless protein homolog,DTL,119.38,98.28,T516,IRNWVTRTPSSSPPITPPASETKIMSPRKAL,_TPSSS(ph)PPIT(ph)PPASETK_, , , , ,0,-0.09,-0.26,0.05, , , , ,0.13,0.12,-0.1,0.07,,,-0.05,-0.1,,,0.13,-0.01,,,,,,,NA,NA,,,,,,
Q14204,Q14204,Cytoplasmic dynein 1 heavy chain 1,DYNC1H1,173.71,173.71,S4368,DDLAYAETEKKTRTDSTSDGRPAWMRTLHTT,_TDS(ph)TSDGRPAWMR_,-0.08,0.09,0.55,0.53, ,1.47, , ,-0.23,-0.07,0.47,0.45, ,1.45, , ,0.01,0.54,1.47,,-0.15,0.46,1.45,, +, +,,,,,NA,NA,,centrosome,ATP binding,antigen processing and presentation of exogenous peptide antigen via MHC class II,,
Q9Y6G9,Q9Y6G9,Cytoplasmic dynein 1 light intermediate chain 1,DYNC1LI1,275.65,275.62,S516,RITRKPVTVSPTTPTSPTEGEAS________,_KPVTVSPTTPTS(ph)PTEGEAS_,0.02,0.15,1.19,1.11,1.36,1.46,1.34,1.39,0.36,0.42,1.28,1.27,1.47,1.47,1.36,1.37,0.08,1.15,1.41,1.36,0.39,1.28,1.47,1.36, +, +,,,,,1,1,56.47,centrosome,ATP binding,cell division,,
Q9Y6G9,Q9Y6G9,Cytoplasmic dynein 1 light intermediate chain 1,DYNC1LI1,152.27,151.8,T513,ELDRITRKPVTVSPTTPTSPTEGEAS_____,_KPVTVSPTT(ph)PTS(ph)PTEGEAS_, , ,1.4, ,1.96,1.98,1.14,1.37, , ,1.74, ,2.06,2.19,1.35,1.52,,1.4,1.97,1.26,,1.74,2.12,1.44, +, +,,,,,NA,NA,,centrosome,ATP binding,cell division,,
Q9Y6G9,Q9Y6G9,Cytoplasmic dynein 1 light intermediate chain 1,DYNC1LI1,118.04,115.82,S421,PRTPNRSVSSNVASVSPIPAGSKKIDPNMKA,_SVSSNVASVS(ph)PIPAGSK_,-0.69,-0.2, ,-0.39,-0.25,-0.88,-1.51, ,-0.36,-0.27, ,-0.03,-0.35,-0.17,-0.65, ,-0.42,-0.39,-0.53,-1.51,-0.31,-0.03,-0.26,-0.65, +,,,,,,6,0,20.51,centrosome,ATP binding,cell division,,
Q9Y6G9,Q9Y6G9,Cytoplasmic dynein 1 light intermediate chain 1,DYNC1LI1,247.22,247.22,S510,VHAELDRITRKPVTVSPTTPTSPTEGEAS__,_KPVTVS(ph)PTTPTS(ph)PTEGEAS_,0,-0.05,0.05,-0.29,-0.29,-0.11,0.11,0.67,-0.01,-0.04,-0.09,-0.09,-0.25,-0.25,-0.09,0.71,-0.03,-0.11,-0.2,0.42,-0.02,-0.09,-0.25,0.36,,,,,,,0,0,,centrosome,ATP binding,cell division,,
Q9Y6G9,Q9Y6G9,Cytoplasmic dynein 1 light intermediate chain 1,DYNC1LI1,261.97,261.97,S207,RDFQEYVEPGEDFPASPQRRNTASQEDKDDS,_LIRDFQEYVEPGEDFPAS(ph)PQRR_,-0.09,0.01,0.08,0.14,-0.12,-0.07,-0.2,0.01,-0.19,-0.1,-0.14,-0.14,-0.09,-0.12,-0.2,-0.07,-0.04,0.11,-0.1,-0.09,-0.15,-0.14,-0.11,-0.13,,,,,,,0,0,,centrosome,ATP binding,cell division,,
B4DZP4,O43237,Cytoplasmic dynein 1 light intermediate chain 2,DYNC1LI2,111.6,110.78,S194,KDFQDYMEPEEGCQGSPQRRGPLTSGSDEEN,_DFQDYMEPEEGCQGS(ph)PQR_, ,0.29, , , , , ,-0.56, ,0.24, , , , , ,-0.18,0.29,,,-0.56,0.24,,,-0.18,,,,,,,NA,NA,,,motor activity,,,
Q13627-3,Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,171.53,132.78,Y321,VDFGSSCQLGQRIYQYIQSRFYRSPEVLLGM,_IYQY(ph)IQSR_,-0.22,-0.23,-0.4,-0.32,-0.22,-0.29,-0.23,-0.12,-0.05,-0.08,-0.07,-0.13,-0.22,-0.29,-0.33,-0.22,-0.22,-0.36,-0.26,-0.17,-0.07,-0.1,-0.26,-0.27,,,CMGC,,,,0,0,,nuclear speck,ATP binding,circadian rhythm,,
O43781-2,O43781,Dual specificity tyrosine-phosphorylation-regulated kinase 3,DYRK3,78.26,60.44,Y369,IDFGSSCFEYQKLYTYIQSRFYRAPEIILGS,_LYTY(ph)IQSR_,-0.16, ,0.07, ,-0.64, , , ,-0.5, ,-0.6, ,-0.72, , , ,-0.16,0.07,-0.64,,-0.5,-0.6,-0.72,,,,CMGC,,,,NA,NA,,nucleus,ATP binding,erythrocyte differentiation,,
Q9NR20-2,Q9NR20,Dual specificity tyrosine-phosphorylation-regulated kinase 4,DYRK4,65.22,45.44,Y264,IDFGSSCYEHQKVYTYIQSRFYRSPEVILGH,_VYTY(ph)IQSR_, , ,-0.23, , , , , , , ,2.02, , , , , ,,-0.23,,,,2.02,,,, +,CMGC,,,,NA,NA,,Golgi apparatus,ATP binding,,,
B4E3F5,Q96JC9,ELL-associated factor 1,EAF1,123.92,108.38,S165,KPPVGPKTSPLKDNPSPEPQLDDIKRELRAE,_DNPS(ph)PEPQLDDIKR_,0.09,0.3,0.16,0.26,0.3,0.11,0.08,0.2,-0.09,-0.08,-0.02,-0.12,0.19,0.03,0.1,0,0.2,0.21,0.21,0.14,-0.08,-0.07,0.11,0.05,,,,,,,0,0,,ELL-EAF complex,,"regulation of transcription, DNA-dependent",,
Q56P03,Q56P03,E2F-associated phosphoprotein,EAPP,231.49,231.04,S109,VATAPTRYYDDIYFDSDSEDEDRAVQVTKKK,_YYDDIYFDS(ph)DS(ph)EDEDRAVQVTK_,-0.3,-0.31,-0.3,-0.1,-0.11,-0.12,-0.04,-0.04,-0.17,-0.1,-0.21,-0.15,-0.16,-0.12,-0.09,-0.19,-0.3,-0.2,-0.12,-0.04,-0.13,-0.18,-0.14,-0.14,,,,,,,0,0,,Golgi apparatus,,negative regulation of transcription elongation from RNA polymerase II promoter,,
Q56P03,Q56P03,E2F-associated phosphoprotein,EAPP,231.49,231.04,S111,TAPTRYYDDIYFDSDSEDEDRAVQVTKKKKK,_YYDDIYFDS(ph)DS(ph)EDEDR_,-0.3,-0.31,-0.3,-0.1,-0.11,-0.12,-0.04,-0.04,-0.17,-0.1,-0.21,-0.15,-0.16,-0.12,-0.09,-0.19,-0.3,-0.2,-0.12,-0.04,-0.13,-0.18,-0.14,-0.14,,,,,,,0,0,,Golgi apparatus,,negative regulation of transcription elongation from RNA polymerase II promoter,,
E9PJ38,O00559,Receptor-binding cancer antigen expressed on SiSo cells,EBAG9,119.8,117.24,S36,FLKRLICRSGRGRKLSGDQITLPTTVDYSSV,_KLS(ph)GDQITLPTTVDYSSVPK_,0.35,0.38,0.31,0.35,0.33,0.29, , ,0.1,0.31,0.25,0.31,0.04,0.3, , ,0.36,0.33,0.31,,0.21,0.28,0.18,,,,,,,,NA,NA,,secretory granule,,,,
Q5VYK3,Q5VYK3,Proteasome-associated protein ECM29 homolog,ECM29,154.6,153.16,S833,GEIGRNGPLPIPSEGSGFTKLHLVESLLSRI,_NGPLPIPSEGS(ph)GFTK_,2.03,2.01,3.09,2.21, , , , ,0.69,0.74,1.18,0.55, , , , ,2.02,2.72,,,0.71,0.9,,, +,,,,,,NA,NA,,centrosome,,ER-associated protein catabolic process,,
Q6P2E9-2,Q6P2E9,Enhancer of mRNA-decapping protein 4,EDC4,213.57,210.29,S879,HLLQQRDSQDASAEQSDHDDEVASLASASGG,_DSQDASAEQS(ph)DHDDEVASLASASGGFGTK_,0.2, , ,-0.49,0.09, , ,0.57,0.12, , ,0.01,0.79, , ,0.75,0.2,-0.49,0.09,0.57,0.12,0.01,0.79,0.75,,,,,,,0,0,,cytoplasmic mRNA processing body,,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
P68104,P68104,Elongation factor 1-alpha 1,EEF1A1,70.94,65.96,Y29,GHVDSGKSTTTGHLIYKCGGIDKRTIEKFEK,_STTTGHLIY(ph)K_,-0.12, , , , , , , ,-0.32, , , , , , , ,-0.12,,,,-0.32,,,,,,,,,,NA,NA,,cytosol,GTP binding,GTP catabolic process,,
P68104,P68104,Elongation factor 1-alpha 1,EEF1A1,134.56,132.54,Y141,GISKNGQTREHALLAYTLGVKQLIVGVNKMD,_EHALLAY(ph)TLGVK_,-0.32, , , ,-0.46,-0.23,0.47,0.14,0.03, , , ,0.01,0.33,0.19,0.23,-0.32,,-0.34,0.31,0.03,,0.18,0.21,,,,,,,NA,NA,,cytosol,GTP binding,GTP catabolic process,,
P24534,P24534,Elongation factor 1-beta,EEF1B2,557.22,557.22,S106,GATDSKDDDDIDLFGSDDEEESEEAKRLREE,_YGPADVEDTTGSGATDSKDDDDIDLFGS(ph)DDEEESEEAK_,0.21,0.17,0.22,0.21,-0.25,-0.18,-0.13,-0.12,0.08,0.05,-0.08,0,-0.08,-0.09,-0.07,-0.12,0.19,0.21,-0.22,-0.12,0.06,-0.04,-0.08,-0.1,,,,,,,0,0,,cytosol,translation elongation factor activity,,,
P24534,P24534,Elongation factor 1-beta,EEF1B2,151.12,148.19,S112,DDDDIDLFGSDDEEESEEAKRLREERLAQYE,_DDDDIDLFGS(ph)DDEEES(ph)EEAK_, , , , , ,0.22,0.67, , , , , , ,0.17,0.1, ,,,0.22,0.67,,,0.17,0.1,,,,,,,NA,NA,,cytosol,translation elongation factor activity,,,
P24534,P24534,Elongation factor 1-beta,EEF1B2,233.97,233.33,S90,ALGKYGPADVEDTTGSGATDSKDDDDIDLFG,_YGPADVEDTTGS(ph)GAT(ph)DSK_, , , , ,0.09,-0.06,-0.46,0.07, , , , ,0.01,-0.26,-0.48,0.05,,,0.01,-0.17,,,-0.12,-0.19,,,,,,,NA,NA,,cytosol,translation elongation factor activity,,,
P24534,P24534,Elongation factor 1-beta,EEF1B2,400.14,389.71,S95,GPADVEDTTGSGATDSKDDDDIDLFGSDDEE,_YGPADVEDTTGS(ph)GAT(ph)DS(ph)K_,0.22,0.28,0.15,0.13,-0.24,-0.26,-0.21,-0.21,0.08,0.24,-0.02,-0.03,-0.11,-0.18,-0.26,-0.2,0.25,0.14,-0.25,-0.21,0.16,-0.03,-0.14,-0.23,,,,,,,0,0,,cytosol,translation elongation factor activity,,,
P24534,P24534,Elongation factor 1-beta,EEF1B2,233.97,233.33,T93,KYGPADVEDTTGSGATDSKDDDDIDLFGSDD,_YGPADVEDTTGS(ph)GAT(ph)DS(ph)K_, , , , ,0.07,-0.32,-0.3,-0.28, , , , ,-0.08,-0.27,-0.42,-0.19,,,-0.11,-0.29,,,-0.17,-0.3,,,,,,,NA,NA,,cytosol,translation elongation factor activity,,,
P29692,P29692,Elongation factor 1-delta,EEF1D,440.41,440.41,S162,TPAEDDEDDDIDLFGSDNEEEDKEAAQLREE,_PATPAEDDEDDDIDLFGS(ph)DNEEEDK_,0.28,0.37,0.4,0.33,-0.02,0,0.14,-0.01,0.05,0.05,0,-0.02,0.05,-0.05,0.01,0.06,0.32,0.37,-0.01,0.07,0.05,-0.01,0,0.04,,,,,,,0,0,,cytosol,DNA binding,positive regulation of I-kappaB kinase/NF-kappaB cascade,,
P29692,P29692,Elongation factor 1-delta,EEF1D,382.86,382.86,T147,VSPMRQVEPPAKKPATPAEDDEDDDIDLFGS,_KPAT(ph)PAEDDEDDDIDLFGS(ph)DNEEEDK_,0.13,0.06,0.07,0.29,-0.39,-0.37,-0.36,-0.41,-0.13,-0.05,-0.26,-0.08,-0.37,-0.28,-0.41,-0.43,0.1,0.19,-0.38,-0.39,-0.09,-0.17,-0.33,-0.42,,,,,,,0,0,,cytosol,DNA binding,positive regulation of I-kappaB kinase/NF-kappaB cascade,,
P29692,P29692,Elongation factor 1-delta,EEF1D,171.03,171.03,S133,SSPGHRATAPQTQHVSPMRQVEPPAKKPATP,_ATAPQTQHVS(ph)PMR_,0.2,0.31,0.21,0.21,-0.32,-0.3,-0.45,-0.42,-0.1,-0.06,-0.2,-0.13,-0.23,-0.38,-0.42,-0.42,0.26,0.21,-0.31,-0.44,-0.08,-0.16,-0.3,-0.42,,,,,,,0,0,,cytosol,DNA binding,positive regulation of I-kappaB kinase/NF-kappaB cascade,,
P13639,P13639,Elongation factor 2,EEF2,125.82,121.8,T57,KAGIIASARAGETRFTDTRKDEQERCITIKS,_AGETRFT(ph)DTR_,0.83,0.73,0.1,0,0.27,0.14,0.14,0.21,0.42,0.42,-0.63,-0.64,-0.11,-0.06,-1.2,-1.27,0.78,0.05,0.21,0.18,0.42,-0.63,-0.08,-1.24,, +,,,,,0,6,5.81,cytosol,GTP binding,translational elongation,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,98.58,81.41,S18,DEDLIFRLEGVDGGQSPRAGHDGDSDGDSDD,_LEGVDGGQS(ph)PR_,-0.19, , , , ,-0.13, ,1.15,-0.24, , , , ,0.96, ,2.13,-0.19,,-0.13,1.15,-0.24,,0.96,2.13, +, +,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,63.87,63.61,S78,LTKSERYSSSGSPANSFHFKEAWKHAIQKAK,_YSSS(ph)GS(ph)PANS(ph)FHFK_, , , , , ,2.9, ,2.29, , , , , ,2.04, ,1.46,,,2.9,2.29,,,2.04,1.46, +, +,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,127.91,126.9,S72,NKYYSNLTKSERYSSSGSPANSFHFKEAWKH,_YSSS(ph)GS(ph)PANSFHFK_,0.22,0.26, , ,1.17,0.97,1.19,1.3,-0.3,-0.11, , ,0.78,0.74,0.74,0.84,0.24,,1.08,1.25,-0.2,,0.76,0.79, +,,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,127.91,126.9,S74,YYSNLTKSERYSSSGSPANSFHFKEAWKHAI,_YSSS(ph)GS(ph)PANSFHFK_,0.22,0.26, , ,1.34,1.11,0.91,1.28,-0.3,-0.11, , ,1.01,0.86,0.63,0.77,0.24,,1.23,1.11,-0.2,,0.93,0.7, +,,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,160.47,144.23,S470,EPREHGHSYSNRKYESDEDSLGSSGRVCVEK,_KYES(ph)DEDS(ph)LGSSGR_, , , , , ,0.84, , , , , , , ,0.68, , ,,,0.84,,,,0.68,,,,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,160.47,144.23,S474,HGHSYSNRKYESDEDSLGSSGRVCVEKWNLL,_KYES(ph)DEDS(ph)LGSSGR_, , , , , ,0.84, , , , , , , ,0.68, , ,,,0.84,,,,0.68,,,,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
O00418,O00418,Eukaryotic elongation factor 2 kinase,EEF2K,71.89,39.93,T348,RDAVNQNTKLLQSAKTILRGTEEKCGSPQVR,_T(ph)ILRGTEEK_,0.22,0.05,-1.04,-0.57, , , , ,0.49,0.17,0.16,0.45, , , , ,0.14,-0.78,,,0.34,0.31,,,,,Atypical,,,,NA,NA,,cytosol,ATP binding,insulin receptor signaling pathway,,
B5MEE4,P52799,Ephrin-B2,EFNB2,79.09,74.37,Y304,IIIPLRTADSVFCPHYEKVSGDYGHPVYIVQ,_TADSVFCPHY(ph)EK_,0.13, ,0.36, , , , , ,-0.52, ,0.17, , , , , ,0.13,0.36,,,-0.52,0.17,,,,,,,,,NA,NA,,,,,,
Q14156-3,Q14156,Protein EFR3 homolog A,EFR3A,153.83,153.83,S694,LSVPYVPQVTDEDRLSRRKSIVDTVSIQVDI,_LSVPYVPQVTDEDRLS(ph)R_,-0.46,-0.52,-0.42,-0.39,-0.41,-0.46,-0.22, ,-0.22,-0.23,-0.27,-0.14,-0.41,-0.41,-0.05, ,-0.49,-0.4,-0.44,-0.22,-0.22,-0.21,-0.41,-0.05,,,,,,,0,0,,intracellular,,,,
Q15029,Q15029,116 kDa U5 small nuclear ribonucleoprotein component,EFTUD2,233,233,S19,DLYDEFGNYIGPELDSDEDDDELGRETKDLD,_(ac)M(ox)DTDLYDEFGNYIGPELDS(ph)DEDDDELGR_,-0.13,-0.14,-0.2,0.16,-0.16,-0.19,-0.22,-0.26,-0.09,0.05,-0.14,-0.16,-0.06,0,-0.14,-0.24,-0.14,-0.01,-0.18,-0.24,-0.02,-0.15,-0.03,-0.19,,,,,,,0,0,,Cajal body,GTP binding,"mRNA splicing, via spliceosome",,
P00533,P00533,Epidermal growth factor receptor,EGFR,399.04,388.77,Y1172,WAQKGSHQISLDNPDYQQDFFPKEAKPNGIF,_GSHQISLDNPDY(ph)QQDFFPK(gl)EAKPNGIFK_,2.38,2.82,2.48,3.04,1.6,2.36,0.46,1.13,2.19,2.42,0.67,1.59,2.32,2.64,1.53,2.18,2.62,2.79,2.03,0.84,2.31,1.2,2.49,1.89, +, +,Tyr,,,,5,5,9.81,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,184.24,166.18,Y1197,KPNGIFKGSTAENAEYLRVAPQSSEFIGA__,_GSTAENAEY(ph)LR_,5.28,4.99,3.38,2.52, , , , ,5.06,4.5,1.87,0.62, , , , ,5.14,3.01,,,4.8,1.38,,, +, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,346.56,345.03,Y1110,QSVPKRPAGSVQNPVYHNQPLNPAPSRDPHY,_RPAGSVQNPVY(ph)HNQ(de)PLNPAPSR_,5.11,4.84,3.96,4.54,2.5,3.12,0.81,1.72,4.81,4.29,2.33,2.9,2.78,3.24,1.8,2.39,4.98,4.28,2.84,1.34,4.58,2.64,3.03,2.12, +, +,Tyr,,,,5,5,20.84,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,370.87,360.97,S1166,FDSPAHWAQKGSHQISLDNPDYQQDFFPKEA,_GSHQIS(ph)LDNPDY(ph)QQDFFPK_,2.46,2.17, , , , , , ,1.75,1, , , , , , ,2.32,,,,1.42,,,, +, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,179.58,135.63,Y869,TDFGLAKLLGAEEKEYHAEGGKVPIKWMALE,_LLGAEEKEY(ph)HAEGGKVPIK_, , ,2.78,2.69, , , , , , ,2.28,2.02, , , , ,,2.73,,,,2.16,,, +, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,242.97,240.11,Y998,GDERMHLPSPTDSNFYRALMDEEDMDDVVDA,_MHLPSPTDSNFY(ph)R_,2.81,2.95,4.05,3.3,3.09,3.23,-0.35,2.08,2.4,2.35,2.39,1.1,3.59,3.5,0.52,2.76,2.88,3.72,3.17,1.33,2.38,1.88,3.55,2.03, +, +,Tyr,,,,4,1,15.47,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,162.94,160.93,S991,QRYLVIQGDERMHLPSPTDSNFYRALMDEED,_MHLPS(ph)PTDS(ph)NFYR_,-0.4,0.48,1.03, ,1.1,1.7, , ,-0.22,0.34,0.82, ,1.38,1.23, , ,0.1,1.03,1.43,,0.09,0.82,1.31,, +, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,153.98,153.15,S995,VIQGDERMHLPSPTDSNFYRALMDEEDMDDV,_MHLPS(ph)PTDS(ph)NFYR_,-0.4,2.6,1.03, ,1.1,1.7, , ,-0.22,1.94,0.82, ,1.38,1.23, , ,1.77,1.03,1.43,,1.23,0.82,1.31,, +, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,252.32,243.04,T693,TLRRLLQERELVEPLTPSGEAPNQALLRILK,_ELVEPLT(ph)PSGEAPNQALLR_,-0.28,0.84,1.91,2.65,0.35,0.9,-0.84,-0.14,0.47,1.15,1.88,2.49,0.93,1.41,0.31,0.8,0.39,2.33,0.65,-0.45,0.85,2.22,1.19,0.58, +, +,Tyr,,,,4,4,24.04,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,177.8,177.37,Y1092,LTEDSIDDTFLPVPEYINQSVPKRPAGSVQN,_YSSDPTGALTEDSIDDTFLPVPEY(ph)INQSVPK_,1.27, ,1.44, , , , , ,0.91, ,0.07, , , , , ,1.27,1.44,,,0.91,0.07,,, +,,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,282.45,281.73,Y1125,YHNQPLNPAPSRDPHYQDPHSTAVGNPEYLN,_DPHY(ph)QDPHSTAVGNPEY(ph)LNTVQPTCVNSTFDSPAHWAQK_,0.47, ,0.74, , , , , ,-0.01, ,-1.33, , , , , ,0.47,0.74,,,-0.01,-1.33,,,, +,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,320.8,320.44,Y1138,PHYQDPHSTAVGNPEYLNTVQPTCVNSTFDS,_DPHYQDPHSTAVGNPEY(ph)LNTVQPTCVNSTFDSPAHWAQK_,0.58, ,0.65, , , , , ,0.21, ,-0.71, , , , , ,0.58,0.65,,,0.21,-0.71,,,,,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,183.25,178.77,S1064,CIDRNGLQSCPIKEDSFLQRYSSDPTGALTE,_N(de)GLQSCPIKEDS(ph)FLQR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
P00533,P00533,Epidermal growth factor receptor,EGFR,177.49,172.61,S1039,FSSPSTSRTPLLSSLSATSNNSTVACIDRNG,_TPLLSSLS(ph)ATSNNSTVACIDR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Tyr,,,,NA,NA,,basolateral plasma membrane,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,+,+
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,169.51,162.74,S171,CIFLREGKATDEDMQSLASLMSMKQADIGNL,_ATDEDMQS(ph)LAS(ph)LMSMK_, , , , , ,-1.02,-0.13,0.06, , , , , , ,-0.01,0.4,,,-1.02,-0.03,,,,0.21, +,,,,,,NA,NA,,cytoplasm,,,,
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,169.51,162.74,S174,LREGKATDEDMQSLASLMSMKQADIGNLDDF,_ATDEDM(ox)QS(ph)LAS(ph)LMS(ph)MK_, , , , , ,-1.02,-0.13,0.06, , , , , , ,-0.01,0.4,,,-1.02,-0.03,,,,0.21, +,,,,,,NA,NA,,cytoplasm,,,,
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,100.14,99.61,S177,GKATDEDMQSLASLMSMKQADIGNLDDFEED,_ATDEDM(ox)QS(ph)LAS(ph)LMS(ph)MK_, , , , , ,-1.02, ,0.06, , , , , , , ,0.4,,,-1.02,0.06,,,,0.4, +,,,,,,NA,NA,,cytoplasm,,,,
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,141.66,141.66,S428,VLNENTVSAGKDLSTSPKPSPIPSPVLGRKP,_DLSTS(ph)PKPS(ph)PIPS(ph)PVLGR_, ,-0.31,-0.14,-0.31,-0.35,-0.42,-0.03,0.1, ,0.02,0.05,0.1,-0.1,0.06,0.13,0.05,-0.31,-0.22,-0.38,0.04,0.02,0.08,-0.02,0.09,,,,,,,0,0,,cytoplasm,,,,
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,141.66,141.66,S432,NTVSAGKDLSTSPKPSPIPSPVLGRKPNASQ,_DLSTS(ph)PKPS(ph)PIPS(ph)PVLGR_,-0.02,-0.31,-0.5,-0.61,-0.17,-0.22,-0.03,0.3,-0.01,0.02,-0.14,-0.08,-0.24,-0.13,0.21,0.23,-0.16,-0.56,-0.19,0.15,0,-0.11,-0.18,0.22,,,,,,,0,0,,cytoplasm,,,,
Q8NDI1-3,Q8NDI1,EH domain-binding protein 1,EHBP1,141.66,141.66,S436,AGKDLSTSPKPSPIPSPVLGRKPNASQSLLV,_DLSTS(ph)PKPS(ph)PIPS(ph)PVLGR_,-0.02,0.08,-0.17,-0.61,-0.54,-0.42,-0.39,-0.33,-0.01,-0.21,-0.14,-0.08,-0.21,0.06,0.01,-0.29,0.03,-0.38,-0.48,-0.36,-0.11,-0.11,-0.07,-0.13,,,,,,,0,0,,cytoplasm,,,,
Q9H4M9,Q9H4M9,EH domain-containing protein 1,EHD1,143.47,143.47,S456,VGKDKPTYDEIFYTLSPVNGKITGANAKKEM,_DKPTYDEIFYTLS(ph)PVNGK_,-0.08,-0.12,-0.1,-0.01, , , , ,-0.06,-0.01,-0.21,0.02, , , , ,-0.1,-0.06,,,-0.03,-0.09,,,,,,,,,NA,NA,,early endosome membrane,ATP binding,blood coagulation,,
F5H559,Q9NZN4,EH domain-containing protein 2,EHD2,338.97,337.13,S438,VERGPDEAMEDGEEGSDDEAEWVVTKDKSKY,_GPDEAM(ox)EDGEEGS(ph)DDEAEWVVTK_,-0.55,-0.45,-0.77,-0.65,-0.42,-0.36,-0.36,-0.38,0,-0.01,-0.29,-0.08,-0.07,-0.09,-0.05,-0.02,-0.5,-0.71,-0.39,-0.37,0,-0.18,-0.08,-0.03,,,,,,,0,0,,,,,,
Q9H9B1-2,Q9H9B1,Histone-lysine N-methyltransferase EHMT1,EHMT1,50.72,50.65,S395,ESMSEADRAQKMDGESEEEQESVDTGEEEEG,_MDGES(ph)EEEQES(ph)VDT(ph)GEEEEGGDESDLSSESSIK_, , , , , , , ,-0.55, , , , , , , ,-0.38,,,,-0.55,,,,-0.38,,,,,,,NA,NA,,chromosome,histone methyltransferase activity (H3-K27 specific),DNA methylation,,
Q9H9B1-2,Q9H9B1,Histone-lysine N-methyltransferase EHMT1,EHMT1,50.72,50.65,S401,DRAQKMDGESEEEQESVDTGEEEEGGDESDL,_MDGES(ph)EEEQES(ph)VDT(ph)GEEEEGGDESDLSSESSIK_, , , , , , , ,-0.55, , , , , , , ,-0.38,,,,-0.55,,,,-0.38,,,,,,,NA,NA,,chromosome,histone methyltransferase activity (H3-K27 specific),DNA methylation,,
Q9H9B1-2,Q9H9B1,Histone-lysine N-methyltransferase EHMT1,EHMT1,50.72,50.65,T404,QKMDGESEEEQESVDTGEEEEGGDESDLSSE,_MDGES(ph)EEEQES(ph)VDT(ph)GEEEEGGDESDLSSESSIK_, , , , , , , ,-0.55, , , , , , , ,-0.38,,,,-0.55,,,,-0.38,,,,,,,NA,NA,,chromosome,histone methyltransferase activity (H3-K27 specific),DNA methylation,,
O14681,O14681,Etoposide-induced protein 2.4 homolog,EI24,114.31,100.62,S326,LQSALSSSTSAEKFPSPHPSPAKLKATAGH_,_FPS(ph)PHPS(ph)PAK_, , , , ,0.28,0.17,0.18,0.27, , , , ,0.28,0.15,0.26,0.32,,,0.22,0.22,,,0.21,0.29,,,,,,,NA,NA,,endoplasmic reticulum membrane,,apoptotic process,,
O14681,O14681,Etoposide-induced protein 2.4 homolog,EI24,114.31,100.62,S330,LSSSTSAEKFPSPHPSPAKLKATAGH_____,_FPS(ph)PHPS(ph)PAK_, , , , ,0.28,0.17,0.18,0.27, , , , ,0.28,0.15,0.26,0.32,,,0.22,0.22,,,0.21,0.29,,,,,,,NA,NA,,endoplasmic reticulum membrane,,apoptotic process,,
P41567,P41567,Eukaryotic translation initiation factor 1,EIF1,83.54,82.05,Y30,DASKGDDLLPAGTEDYIHIRIQQRNGRKTLT,_GDDLLPAGTEDY(ph)IHIR_, , ,-0.32, ,2.06,1.61,2.2,1.47, , ,-0.84, ,1.82,1.35,2.31,1.85,,-0.32,1.85,1.88,,-0.84,1.6,2.1, +, +,,,,,NA,NA,,cytoplasm,translation initiation factor activity,regulation of translational initiation,,
E9PNH5,Q8N9N8,Probable RNA-binding protein EIF1AD,EIF1AD,302.64,197.11,S155,DSDLFVNTNRRQYHESEEESEEEEAA_____,_(gl)QYHES(ph)EEES(ph)EEEEAA_,0.06,0.1,0.18,0.31,0.03,-0.1,-0.23,-0.04,0,-0.2,-0.21,-0.16,0.12,0.04,0.05,0.2,0.08,0.24,-0.04,-0.13,-0.1,-0.19,0.08,0.13,,,,,,,0,0,,,translation initiation factor activity,,,
E9PNH5,Q8N9N8,Probable RNA-binding protein EIF1AD,EIF1AD,302.64,197.11,S159,FVNTNRRQYHESEEESEEEEAA_________,_RQYHES(ph)EEES(ph)EEEEAA_,0.06,0.1,0.18,0.31,0.03,-0.1,-0.23,-0.04,0,-0.2,-0.21,-0.16,0.12,0.04,0.05,0.2,0.08,0.24,-0.04,-0.13,-0.1,-0.19,0.08,0.13,,,,,,,0,0,,,translation initiation factor activity,,,
B4DQ14,Q9BY44,Eukaryotic translation initiation factor 2A,EIF2A,234.21,234.21,S506,HEAKKAAKQEARSDKSPDLAPTPAPQSTPRN,_S(ph)PDLAPTPAPQSTPR_,0.19,0.45,0.24,0.16,0.28,0.2,-0.1,0.08,-0.08,0.01,-0.01,-0.05,-0.3,-0.27,-0.4,-0.07,0.33,0.2,0.24,-0.01,-0.03,-0.03,-0.28,-0.22,,,,,,,0,0,,cytoplasmic membrane-bounded vesicle,translation initiation factor activity,cholesterol catabolic process,,
H0YGE6,Q13144,Translation initiation factor eIF-2B subunit epsilon,EIF2B5,77.78,51.66,S544,SEQSMDSEEPDSRGGSPQMDDIKVFQNEVLG,_GGS(ph)PQMDDIK_,0.16,0.24,-0.1,0.18, , ,0.23,0.52,0.08,0,-0.3,0.05, , ,-0.08,-0.06,0.2,0.04,,0.38,0.04,-0.12,,-0.07,,,,,,,NA,NA,,,,,,
P20042,P20042,Eukaryotic translation initiation factor 2 subunit 2,EIF2S2,154.88,154.88,T111,EGVKDLKIESDVQEPTEPEDDLDIMLGNKKK,_IES(ph)DVQEPT(ph)EPEDDLDIM(ox)LGNK_, , ,1.39, ,-0.01,0.25,-0.09,0.08, , ,-0.18, ,0.28,0.55,-0.06,-0.06,,1.39,0.12,0,,-0.18,0.42,-0.06, +,,,,,,NA,NA,,cytosol,metal ion binding,,,
P20042,P20042,Eukaryotic translation initiation factor 2 subunit 2,EIF2S2,237.34,207.3,S67,KDLEADEEDTRKKDASDDLDDLNFFNQKKKK,_DAS(ph)DDLDDLNFFNQK_, , , , , ,0.23,0.46,0.11, , , , , ,0.29,0.32,0.03,,,0.23,0.3,,,0.29,0.18,,,,,,,NA,NA,,cytosol,metal ion binding,,,
P20042,P20042,Eukaryotic translation initiation factor 2 subunit 2,EIF2S2,34.57,34.43,S105,DIDEAEEGVKDLKIESDVQEPTEPEDDLDIM,_IES(ph)DVQEPT(ph)EPEDDLDIM(ox)LGNK_, , , , , , ,-0.3,0.6, , , , , , ,-0.34,0.09,,,,0.22,,,,-0.11,,,,,,,NA,NA,,cytosol,metal ion binding,,,
P20042,P20042,Eukaryotic translation initiation factor 2 subunit 2,EIF2S2,205.98,205.98,S2,______________MSGDEMIFDPTMSKKKK,_(ac)S(ph)GDEM(ox)IFDPTMSKK_,0.03,0.1,0.05,0.07,-0.07,-0.03,-0.08,0,0.04,0.06,0.03,0,-0.01,0.02,-0.02,0.02,0.07,0.06,-0.05,-0.04,0.05,0.02,0,0,,,,,,,0,0,,cytosol,metal ion binding,,,
P55884,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,84.15,82.78,S152,EAEPRALENGDADEPSFSDPEDFVDDVSEEE,_ALENGDADEPS(ph)FS(ph)DPEDFVDDVS(ph)EEELLGDVLK_, , ,-0.34, ,0.05, ,-0.86, , , ,0.02, ,0.03, ,-1.43, ,,-0.34,0.05,-0.86,,0.02,0.03,-1.43,, +,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,+,
P55884,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,175.14,174.8,S83,TEPAAEAEAASGPSESPSPPAAEELPGSHAE,_TEPAAEAEAASGPSES(ph)PSPPAAEELPGSHAEPPVPAQGEAPGEQAR_,0.15,0.19,0.24, ,-0.32,0.32, , ,0.44,0.32,0.26, ,0.01,0.49, , ,0.17,0.24,0.03,,0.38,0.26,0.27,,,,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,+,
P55884,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,99.73,99.73,S85,PAAEAEAASGPSESPSPPAAEELPGSHAEPP,_TEPAAEAEAASGPSES(ph)PS(ph)PPAAEELPGSHAEPPVPAQGEAPGEQAR_, , , , ,-0.32,0.32, , , , , , ,0.01,0.49, , ,,,0.03,,,,0.27,,,,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,+,
P55884,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,116.52,115.88,S154,EPRALENGDADEPSFSDPEDFVDDVSEEELL,_ALENGDADEPS(ph)FS(ph)DPEDFVDDVS(ph)EEELLGDVLK_, , ,-0.34, ,0.05,-0.35,-0.51, , , ,0.02, ,0.03,0.07,0.05, ,,-0.34,-0.14,-0.51,,0.02,0.05,0.05,,,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,+,
P55884,P55884,Eukaryotic translation initiation factor 3 subunit B,EIF3B,116.52,115.88,S164,DEPSFSDPEDFVDDVSEEELLGDVLKDRPQE,_ALENGDADEPS(ph)FS(ph)DPEDFVDDVS(ph)EEELLGDVLK_, , ,-0.34, , ,-0.35,-0.51, , , ,0.02, , ,0.07,0.05, ,,-0.34,-0.35,-0.51,,0.02,0.07,0.05,,,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,+,
B4DVQ5,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,155.88,153.59,S178,PEQSADEDAEKNEEDSEGSSDEDEDEDGVSA,_NEEDS(ph)EGS(ph)S(ph)DEDEDEDGVSAATFLKK_,0,-0.09,-0.06, ,-0.45,-0.18,-0.01,0.28,-0.07,-0.21,-0.09, ,-0.12,-0.02,0.02,0.08,-0.04,-0.06,-0.31,0.14,-0.14,-0.09,-0.07,0.05,,,,,,,0,0,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVQ5,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,155.88,153.59,S181,SADEDAEKNEEDSEGSSDEDEDEDGVSAATF,_NEEDS(ph)EGS(ph)S(ph)DEDEDEDGVSAATFLKK_,0,-0.09,-0.06, ,0.64,-0.18,-0.01,0.28,-0.07,-0.21,-0.09, ,0.68,-0.02,0.02,0.08,-0.04,-0.06,0.29,0.14,-0.14,-0.09,0.37,0.05,,,,,,,0,0,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVQ5,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,155.88,153.59,S182,ADEDAEKNEEDSEGSSDEDEDEDGVSAATFL,_NEEDS(ph)EGS(ph)S(ph)DEDEDEDGVSAATFLKK_,0,-0.09,-0.06, ,0.64,-0.18,-0.01,0.28,-0.07,-0.21,-0.09, ,0.68,-0.02,0.02,0.08,-0.04,-0.06,0.29,0.14,-0.14,-0.09,0.37,0.05,,,,,,,0,0,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVQ5,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,136.39,126.47,S166,DFESHITSYKQNPEQSADEDAEKNEEDSEGS,_(gl)QNPEQS(ph)ADEDAEK_, ,0.4, , , ,0.08,0.08,0.12, ,0.03, , , ,0.15,0.25,0.13,0.4,,0.08,0.1,0.03,,0.15,0.2,,,,,,,NA,NA,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVQ5,Q99613,Eukaryotic translation initiation factor 3 subunit C,EIF3C,289.5,272.73,S39,TKPVGGNYGKQPLLLSEDEEDTKRVVRSAKD,_(gl)QPLLLS(ph)EDEEDTKR_,0.23,0.24,0.57,0.16,-0.02,-0.12,0.09,0.08,0.19,-0.07,0.38,0.36,-0.15,-0.06,0.08,-0.01,0.24,0.38,-0.07,0.08,0.07,0.37,-0.11,0.04,,,,,,,0,0,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVY1,O15371,Eukaryotic translation initiation factor 3 subunit D,EIF3D,157.64,151.81,S528,NKQVIRVYSLPDGTFSSDEDEEEEEEEEEEE,_VYSLPDGTFS(ph)S(ph)DEDEEEEEEEEEEEEEEET_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
B4DVY1,O15371,Eukaryotic translation initiation factor 3 subunit D,EIF3D,157.64,151.81,S529,KQVIRVYSLPDGTFSSDEDEEEEEEEEEEEE,_VYSLPDGTFS(ph)S(ph)DEDEEEEEEEEEEEEEEET_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,eukaryotic 43S preinitiation complex,translation initiation factor activity,formation of translation preinitiation complex,,
O75821,O75821,Eukaryotic translation initiation factor 3 subunit G,EIF3G,132.75,128.55,S42,TSELLKGIPLATGDTSPEPELLPGAPLPPPK,_GIPLATGDTS(ph)PEPELLPGAPLPPPK_,-0.02,-0.02,-0.1,0, , , , ,0.14,0.13,0,0.04, , , , ,-0.02,-0.05,,,0.14,0.02,,,,,,,,,NA,NA,,cytosol,nucleotide binding,formation of translation preinitiation complex,,
O15372,O15372,Eukaryotic translation initiation factor 3 subunit H,EIF3H,130.79,98.04,S183,RLTPKLMEVCKEKDFSPEALKKANITFEYMF,_DFS(ph)PEALKK_,0.02,-0.07,-0.04,-0.08,0.08,-0.07,-0.09,0.3,0.07,0.01,0.12,-0.02,-0.5,0.18,-0.16,0.04,-0.02,-0.06,0.01,0.12,0.04,0.05,-0.12,-0.06,,,,,JAMM Domain Proteases ,,0,0,,cytosol,translation initiation factor activity,formation of translation preinitiation complex,,
O75822,O75822,Eukaryotic translation initiation factor 3 subunit J,EIF3J,384.11,384.11,S11,_____MAAAAAAAGDSDSWDADAFSVEDPVR,_(ac)AAAAAAAGDS(ph)DS(ph)WDADAFSVEDPVRK_,0.23,0.28,0.3,0.36,-0.28,-0.28,-0.22,-0.17,-0.03,-0.05,-0.07,-0.1,-0.11,-0.15,-0.23,-0.16,0.25,0.33,-0.28,-0.2,-0.04,-0.08,-0.13,-0.19,,,,,,,0,0,,cytosol,translation initiation factor activity,formation of translation preinitiation complex,,
O75822,O75822,Eukaryotic translation initiation factor 3 subunit J,EIF3J,275.96,274.25,S13,___MAAAAAAAGDSDSWDADAFSVEDPVRKV,_(ac)AAAAAAAGDS(ph)DS(ph)WDADAFSVEDPVRK_,0.1,0.27,0.49,0.4,-0.32,-0.53,-0.56,-0.4,0.11,-0.01,-0.05,-0.24,-0.12,-0.33,-0.28,-0.41,0.19,0.45,-0.42,-0.48,0.05,-0.14,-0.22,-0.34,,,,,,,0,0,,cytosol,translation initiation factor activity,formation of translation preinitiation complex,,
O75822,O75822,Eukaryotic translation initiation factor 3 subunit J,EIF3J,174.59,148.68,T109,EIKKRLEEPEEPKVLTPEEQLADKLRLKKLQ,_VLT(ph)PEEQLADK_,-0.04,0.04,-0.17,-0.18,-0.62,-0.37,-0.52,-0.51,-0.02,0.16,-0.13,-0.03,-0.23,-0.13,-0.52,-0.49,0,-0.18,-0.49,-0.51,0.07,-0.08,-0.18,-0.5,,,,,,,0,0,,cytosol,translation initiation factor activity,formation of translation preinitiation complex,,
Q9UBQ5,Q9UBQ5,Eukaryotic translation initiation factor 3 subunit K,EIF3K,133.96,133.02,S217,VEKIDFDSVSSIMASSQ______________,_IDFDSVSSIMASS(ph)Q_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,ribosome binding,formation of translation preinitiation complex,,
P38919,P38919,Eukaryotic initiation factor 4A-III,EIF4A3,193.8,146.18,S10,______MATTATMATSGSARKRLLKEEDMTK,_(ac)ATTATMATS(ph)GSARK_,-0.22, ,0.23, ,-0.43, , , ,-0.13, ,-0.14, ,-0.38, , , ,-0.22,0.23,-0.43,,-0.13,-0.14,-0.38,,,,,,,,NA,NA,,catalytic step 2 spliceosome,ATP binding,cytokine-mediated signaling pathway,,
P38919,P38919,Eukaryotic initiation factor 4A-III,EIF4A3,193.19,183.91,S12,____MATTATMATSGSARKRLLKEEDMTKVE,_(ac)ATTATMATSGS(ph)ARK_, ,-0.04,-0.37,-0.11, ,-0.66, ,-0.54, ,-0.17,-0.27,0.03, ,-0.82, ,-0.59,-0.04,-0.23,-0.66,-0.54,-0.17,-0.11,-0.82,-0.59,,,,,,,0,0,,catalytic step 2 spliceosome,ATP binding,cytokine-mediated signaling pathway,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,184.58,84.01,S445,STTSSRNARRRESEKSLENETLNKEEDCHSP,_S(ph)LENETLNK_,1.01,1.06,1.34,1.36,2.27,2.6,2.37,2.3,0.61,0.72,0.92,0.86,2.36,2.51,2.41,2.48,1.04,1.35,2.45,2.33,0.67,0.89,2.44,2.45, +, +,,,,,2,2,39.72,,,,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,201.52,195.6,S422,WRSEETQERERSRTGSESSQTGTSTTSSRNA,_TGS(ph)ESSQTGTSTTSSR_, , ,2.23,2.48,2.23,2.28,1.4, , , ,2.25,2.49,2.58,2.3,1.66, ,,2.36,2.26,1.4,,2.38,2.45,1.66, +, +,,,,,NA,NA,,,,,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,91.31,90.8,Y211,DTDWRARPATDSFDDYPPRRGDDSFGDKYRD,_ARPATDSFDDY(ph)PPR_, , ,2.27, , , , , , , ,0.48, , , , , ,,2.27,,,,0.48,,, +,,,,,,NA,NA,,,,,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,162.72,162.72,S406,LDEPKLERRPRERHPSWRSEETQERERSRTG,_ERHPS(ph)WR_,0.08,0.19,0.56,0.5,0.28,0.19,0.25,0.41,-0.02,0.04,0.46,0.41,0.11,0,0.12,0.11,0.13,0.53,0.23,0.33,0.01,0.44,0.06,0.11,,,,,,,0,0,,,,,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,162.72,162.72,S409,PKLERRPRERHPSWRSEETQERERSRTGSES,_ERHPS(ph)WRS(ph)EETQER_, , , , ,0.69, ,0.44,0.94, , , , ,0.9, ,1.04,0.76,,,0.69,0.71,,,0.9,0.91,,,,,,,NA,NA,,,,,,
E7EPC9,P23588,Eukaryotic translation initiation factor 4B,EIF4B,254.39,251.97,S597,NPASKFSSASKYAALSVDGEDENEGEDYAE_,_YAALS(ph)VDGEDENEGEDYAE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q13541,Q13541,Eukaryotic translation initiation factor 4E-binding protein 1,EIF4EBP1,59.63,59.63,S65,TRIIYDRKFLMECRNSPVTKTPPRDLPTIPG,_FLMECRNS(ph)PVTK_,0.77, , ,0.36, ,2.11,0.76, ,0.21, , ,0.09, ,1.11,0.88, ,0.77,0.36,2.11,0.76,0.21,0.09,1.11,0.88, +, +,,,,,2,2,23.4,cytosol,,G1/S transition of mitotic cell cycle,,
Q13541,Q13541,Eukaryotic translation initiation factor 4E-binding protein 1,EIF4EBP1,183.48,183.48,T37,VLGDGVQLPPGDYSTTPGGTLFSTTPGGTRI,_VVLGDGVQLPPGDYSTT(ph)PGGTLFSTT(ph)PGGTRIIYDRK_,0.44,0.59,0.66,0.74,0.24, ,1.35, ,-0.13,0.04,0.19,0.22,-0.02, ,-0.44, ,0.52,0.7,0.24,1.35,-0.04,0.2,-0.02,-0.44, +,,,,,,1,0,8.96,cytosol,,G1/S transition of mitotic cell cycle,,
Q13541,Q13541,Eukaryotic translation initiation factor 4E-binding protein 1,EIF4EBP1,183.48,183.48,T46,PGDYSTTPGGTLFSTTPGGTRIIYDRKFLME,_VVLGDGVQLPPGDYSTT(ph)PGGTLFSTT(ph)PGGTRIIYDRK_, ,0.46,0.67,0.74,0.66, ,1.35, , ,0.11,0.1,0.22,-0.07, ,-0.44, ,0.46,0.71,0.66,1.35,0.11,0.16,-0.07,-0.44, +,,,,,,1,0,10.12,cytosol,,G1/S transition of mitotic cell cycle,,
Q13541,Q13541,Eukaryotic translation initiation factor 4E-binding protein 1,EIF4EBP1,136.38,134.87,T77,CRNSPVTKTPPRDLPTIPGVTSPSSDEPPME,_TPPRDLPT(ph)IPGVTSPSSDEPPMEAS(ph)QSHLRNSPEDK_, , ,0.69, , , , , , , ,-0.06, , , , , ,,0.69,,,,-0.06,,,,,,,,,NA,NA,,cytosol,,G1/S transition of mitotic cell cycle,,
B4DR76,Q9NRA8,Eukaryotic translation initiation factor 4E transporter,EIF4ENIF1,76.85,76.85,S342,LGEGSVSASRFSRWFSNPSRSGSRSSSLGST,_WFS(ph)NPS(ph)R_, , , , ,1.89,2.56, ,0.87, , , , ,2.02,2.31, ,0.77,,,2.26,0.87,,,2.17,0.77, +, +,,,,,NA,NA,,intracellular membrane-bounded organelle,translation initiation factor activity,,,
B4DR76,Q9NRA8,Eukaryotic translation initiation factor 4E transporter,EIF4ENIF1,76.85,76.85,S345,GSVSASRFSRWFSNPSRSGSRSSSLGSTPHE,_WFS(ph)NPS(ph)R_,-0.24,-0.07,0.02,-0.18,0.19,0.17,0.34,0.37,-0.22,-0.13,-0.29,-0.34,-0.08,0,0.12,0.26,-0.16,-0.08,0.18,0.36,-0.18,-0.31,-0.04,0.19,,,,,,,0,0,,intracellular membrane-bounded organelle,translation initiation factor activity,,,
Q04637-3,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,186.76,144.83,S1209,SRERPSQPEGLRKAASLTEDRDRGRDAVKRE,_AAS(ph)LTEDRDR_,0.32,0.42, , ,-1,-1.21,-1.1,-1.17,0.16,-0.14, , ,-1.17,-0.99,-1.17,-1.22,0.37,,-1.1,-1.13,0.02,,-1.08,-1.2, +, +,,,,,NA,NA,,cytosol,DNA binding,cell death,,
Q04637-3,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,137.73,137.73,S1231,RGRDAVKREAALPPVSPLKAALSEEELEKKS,_REAALPPVS(ph)PLK_,0.09,0.17,1.38,1.42,1.6,1.56,1.71,1.42,0.34,0.46,1.26,1.3,1.62,1.61,1.64,1.56,0.13,1.4,1.58,1.57,0.4,1.28,1.62,1.6, +, +,,,,,1,1,47.95,cytosol,DNA binding,cell death,,
Q04637-3,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,98.68,95.23,S1145,VPTESTDNRRVVQRSSLSRERGEKAGDRGDR,_VVQRSS(ph)LS(ph)RER_,0.06, , ,-0.14,-0.96,-0.65,-0.69, ,-0.13, , ,-0.33,-0.64,-0.61,-0.57, ,0.06,-0.14,-0.8,-0.69,-0.13,-0.33,-0.62,-0.57,,,,,,,0,0,,cytosol,DNA binding,cell death,,
Q04637-3,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,101.75,101.75,S1147,TESTDNRRVVQRSSLSRERGEKAGDRGDRLE,_VVQRSS(ph)LS(ph)RER_,0.06,0.11,-0.2,-0.17,-0.85,-0.6,-0.68,-0.42,-0.13,-0.18,0.32,-0.34,-0.72,-0.64,-0.57,-0.51,0.08,-0.19,-0.72,-0.54,-0.16,0.02,-0.68,-0.54,,,,,,,0,0,,cytosol,DNA binding,cell death,,
Q04637-3,Q04637,Eukaryotic translation initiation factor 4 gamma 1,EIF4G1,187.56,187.52,S1596,SVTAFFKWLREAEEESDHN____________,_WLREAEEES(ph)DHN_,0.06,0.06,0.06,0.07,-0.26,-0.18,-0.15,-0.24,-0.07,-0.11,-0.14,-0.13,-0.11,-0.14,-0.1,-0.13,0.06,0.06,-0.22,-0.19,-0.09,-0.13,-0.12,-0.12,,,,,,,0,0,,cytosol,DNA binding,cell death,,
P78344,P78344,Eukaryotic translation initiation factor 4 gamma 2,EIF4G2,46.57,45.94,T508,QITMIPPSAQPPRTQTPPLGQTPQLGLKTNP,_TQT(ph)PPLGQTPQLGLK_,0.24,0.03,-0.99, , ,-1.36, , ,-0.09,0.03,-1.2, , ,-0.84, , ,0.14,-0.99,-1.36,,-0.03,-1.2,-0.84,, +, +,,,,,NA,NA,,cytosol,DNA binding,cell cycle arrest,,
F5H564,O43432,Eukaryotic translation initiation factor 4 gamma 3,EIF4G3,126.01,126.01,S495,QTEEILDSQNLNSRRSPVPAQIAITVPKTWK,_S(ph)PVPAQIAITVPK_,0.09,0.14,-0.04,-0.13, , ,0.19,0.32,-0.14,0.01,-0.2,-0.36, , ,0.06,0.33,0.11,-0.08,,0.25,-0.07,-0.28,,0.2,,,,,,,NA,NA,,cytoplasm,DNA binding,positive regulation of protein phosphorylation,,
Q15056-2,Q15056,Eukaryotic translation initiation factor 4H,EIF4H,261.76,245.02,Y7,_________MADFDTYDDRAYSSFGGGRGSR,_(ac)ADFDTY(ph)DDRAYSSFGGGR_,4.04, , , , , , , ,3.35, , , , , , , ,4.04,,,,3.35,,,, +, +,,,,,NA,NA,,cytosol,nucleotide binding,developmental growth,,
Q15056-2,Q15056,Eukaryotic translation initiation factor 4H,EIF4H,171.79,157.84,Y12,____MADFDTYDDRAYSSFGGGRGSRGSAGG,_(ac)ADFDTYDDRAY(ph)SSFGGGR_,1.72, , , , , , , ,0.72, , , , , , , ,1.72,,,,0.72,,,, +,,,,,,NA,NA,,cytosol,nucleotide binding,developmental growth,,
P55010,P55010,Eukaryotic translation initiation factor 5,EIF5,256.31,256.31,S389,KAEPFIKWLKEAEEESSGGEEEDEDENIEVV,_EAEEES(ph)S(ph)GGEEEDEDENIEVVYSK_, ,0.39,-0.04, ,-0.2,-0.17,-0.2,-0.2, ,-0.1,-0.05, ,-0.1,-0.12,-0.18,-0.1,0.39,-0.04,-0.18,-0.2,-0.1,-0.05,-0.11,-0.14,,,,,,,0,0,,cytosol,GTP binding,regulation of translational initiation,,
P55010,P55010,Eukaryotic translation initiation factor 5,EIF5,256.31,256.31,S390,AEPFIKWLKEAEEESSGGEEEDEDENIEVVY,_EAEEES(ph)S(ph)GGEEEDEDENIEVVYSK_, ,0.39,-0.04, ,-0.2,-0.17,-0.2,-0.2, ,-0.1,-0.05, ,-0.1,-0.12,-0.18,-0.1,0.39,-0.04,-0.18,-0.2,-0.1,-0.05,-0.11,-0.14,,,,,,,0,0,,cytosol,GTP binding,regulation of translational initiation,,
P55010,P55010,Eukaryotic translation initiation factor 5,EIF5,124.62,124.62,S419,VYSKAASVPKVETVKSDNKDDDIDIDAI___,_S(ph)DNKDDDIDIDAI_,0.79,0.64,0.32, , , , , ,0.1,0.16,0.28, , , , , ,0.72,0.32,,,0.13,0.28,,,,,,,,,NA,NA,,cytosol,GTP binding,regulation of translational initiation,,
P55010,P55010,Eukaryotic translation initiation factor 5,EIF5,110.92,87.77,S229,RRMDEISDHAKVLTLSDDLERTIEERVNILF,_VLTLS(ph)DDLER_,0.13,0.2,0.36,0.22, , ,-0.46,-0.34,0.4,0.2,0.41,0.23, , ,0.2,0,0.17,0.29,,-0.4,0.3,0.33,,0.1,,,,,,,NA,NA,,cytosol,GTP binding,regulation of translational initiation,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,299.85,299.85,S107,TSKDKKKKGQKGKKQSFDDNDSEELEDKDSK,_(gl)QS(ph)FDDNDS(ph)EELEDK_,0.96,0.88,1.46,1.44,0.99,1.16,1,0.98,0.86,0.79,1.29,1.21,0.71,1.11,1.12,1.2,0.92,1.45,1.07,0.99,0.83,1.25,0.92,1.16, +, +,,,,,1,1,31.49,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,71.51,59.02,S1168,KGQEVCVKIEPIPGESPKMFGRHFEATDILV,_IEPIPGES(ph)PK_,0.57,0.48,1.14,1.43, , ,1.81, ,0.2,0.08,0.34,-0.11, , ,0, ,0.52,1.29,,1.81,0.14,0.13,,0, +,,,,,,NA,NA,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,135.61,132.06,S511,EDTEDAGLDDWEAMASDEETEKVEGNKVHIE,_EETPPPVEPEEEEDT(ph)EDAGLDDWEAMAS(ph)DEETEK_, , , , ,-0.37,-0.09,-0.43, , , , , ,0.04,0.07,0.13, ,,,-0.22,-0.43,,,0.05,0.13,,,,,,,NA,NA,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,235.69,229.56,S182,DEDNSKKIKERSRINSSGESGDESDEFLQSR,_INS(ph)S(ph)GES(ph)GDESDEFLQSR_,-0.14,0.03,-0.03, ,-0.03,-0.08,0.51,0.35,-0.05,-0.19,-0.24, ,0.01,-0.02,0.35,0.2,-0.05,-0.03,-0.05,0.43,-0.12,-0.24,0,0.28,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,231.4,223.06,S183,EDNSKKIKERSRINSSGESGDESDEFLQSRK,_INS(ph)S(ph)GES(ph)GDESDEFLQSR_,-0.14,0.03,-0.03, ,0.03,-0.08,0.51,0.04,-0.05,-0.19,-0.24, ,0.09,-0.02,0.35,-0.06,-0.05,-0.03,-0.02,0.29,-0.12,-0.24,0.04,0.16,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,243.52,241.84,S186,SKKIKERSRINSSGESGDESDEFLQSRKGQK,_INS(ph)S(ph)GES(ph)GDESDEFLQSR_,-0.32,-0.16,-0.03, ,0,-0.08,0.51,-0.63,0.09,0.12,-0.24, ,0.05,-0.02,0.35,-0.38,-0.24,-0.03,-0.04,0.05,0.1,-0.24,0.02,0.03,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,221.38,218.58,S190,KERSRINSSGESGDESDEFLQSRKGQKKNQK,_INS(ph)S(ph)GES(ph)GDES(ph)DEFLQSR_,-0.14,0.03,-0.03, ,-0.28,-0.11,-0.1,-0.32,-0.05,-0.19,-0.24, ,-0.06,-0.09,-0.08,-0.16,-0.05,-0.03,-0.19,-0.21,-0.12,-0.24,-0.08,-0.12,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,398.19,398.19,S113,KKGQKGKKQSFDDNDSEELEDKDSKSKKTAK,_QSFDDNDS(ph)EELEDKDSK_,0.13,0.15,0.12,0.13,-0.03,-0.1,-0.06,-0.02,0.11,0.08,0.04,0.16,0.02,0.01,-0.07,-0.07,0.14,0.13,-0.06,-0.04,0.09,0.1,0.02,-0.07,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,366.05,326.66,S164,KAKGKAQKSNKKWDGSEEDEDNSKKIKERSR,_KWDGS(ph)EEDEDNSKK_,0.13,0.19,0.19,0.23,0.16,0.19,0.07,0.23,0.05,0.11,0.06,0.09,0.21,0.23,0.2,0.28,0.16,0.21,0.17,0.15,0.08,0.08,0.22,0.24,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,283.4,283.4,S214,GQKKNQKNKPGPNIESGNEDDDASFKIKTVA,_PGPNIES(ph)GNEDDDASFK_,0.23,0.22,0.33,0.36,0.11,0.15,0.29,0.19,0.1,0.12,0.04,0.08,0.15,0.1,0.17,0.13,0.23,0.34,0.13,0.24,0.11,0.06,0.12,0.15,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,268.45,268.45,S135,DSKSKKTAKPKVEMYSGSDDDDDFNKLPKKA,_VEMYS(ph)GS(ph)DDDDDFNKLPK_,-0.01,0.06,0.11,0.11,-0.06,-0.27,0.08,-0.01,0,0.04,-0.08,0.04,-0.03,-0.12,0.06,0.06,0.03,0.11,-0.16,0.04,0.02,-0.02,-0.08,0.06,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,268.45,268.45,S137,KSKKTAKPKVEMYSGSDDDDDFNKLPKKAKG,_VEMYS(ph)GS(ph)DDDDDFNKLPK_,-0.08,-0.19,-0.36,-0.28,-0.2,-0.25,-0.08,0.11,-0.04,0.12,-0.36,-0.22,-0.08,-0.14,0,-0.03,-0.13,-0.32,-0.22,0.02,0.04,-0.29,-0.11,-0.01,,,,,,,0,0,,cytosol,GTP binding,GTP catabolic process,,
O60841,O60841,Eukaryotic translation initiation factor 5B,EIF5B,108.13,104.81,T498,KEETPPPVEPEEEEDTEDAGLDDWEAMASDE,_EETPPPVEPEEEEDT(ph)EDAGLDDWEAMAS(ph)DEETEK_, , , , ,-0.34,-0.95,-0.43, , , , , ,-0.09, ,-0.03, ,,,-0.62,-0.43,,,-0.09,-0.03,,,,,,,NA,NA,,cytosol,GTP binding,GTP catabolic process,,
P56537,P56537,Eukaryotic translation initiation factor 6,EIF6,138.4,114.55,S243,QPSTIATSMRDSLIDSLT_____________,_DSLIDS(ph)LT_, , , , ,-0.16,-0.88, , , , , , ,-0.64,-0.74, , ,,,-0.47,,,,-0.69,,,,,,,,NA,NA,,cytoplasm,ribosomal large subunit binding,mature ribosome assembly,,
Q99607,Q99607,ETS-related transcription factor Elf-4,ELF4,96.78,92.26,S188,KSKKRIRKTKGNRSTSPVTDPSIPIRKKSKD,_STS(ph)PVTDPSIPIR_,-0.41,-0.28,-0.54,-0.84, , , , ,0.07,0,-0.12,0.22, , , , ,-0.35,-0.68,,,0.04,0.06,,,,,,,,,NA,NA,,PML body,sequence-specific DNA binding,natural killer cell proliferation,,
Q5JW01,Q96JJ3,Engulfment and cell motility protein 2,ELMO2,82.42,70.83,Y717,APPPIPKEPSSYDFVYHYG____________,_EPSSYDFVY(ph)HYG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoskeleton,,phagocytosis,,
B4DXV1,Q9H9T3,Elongator complex protein 3,ELP3,60.45,59.31,Y202,RNLHDALSGHTSNNIYEAVKYSERSLTKCIG,_NLHDALSGHTSNNIY(ph)EAVK_, , ,0.04, , , , , , , ,-0.82, , , , , ,,0.04,,,,-0.82,,,,,,,,,NA,NA,,,iron-sulfur cluster binding,metabolic process,,
P50402,P50402,Emerin,EMD,280.5,278.43,Y94,KEDALLYQSKGYNDDYYEESYFTTRTYGEPE,_GYNDDY(ph)YEESYFTTR_,4.79, ,2.03, , , , , ,3.32, ,-1.29, , , , , ,4.79,2.03,,,3.32,-1.29,,, +, +,,,,,NA,NA,,endoplasmic reticulum,actin binding,cellular response to growth factor stimulus,,
P50402,P50402,Emerin,EMD,180.03,180.03,S171,GRDSAYQSITHYRPVSASRSSLDLSYYPTSS,_DSAYQSITHYRPVS(ph)ASR_,0.41,0.44,1.22,1.04,1.34, , , ,0.54,-1.94,1.66,1.4,1.89, , , ,0.43,1.13,1.34,,-0.22,1.54,1.89,, +, +,,,,,NA,NA,,endoplasmic reticulum,actin binding,cellular response to growth factor stimulus,,
P50402,P50402,Emerin,EMD,166.48,92,Y161,ECKDRERPMYGRDSAYQSITHYRPVSASRSS,_DSAY(ph)QSITHYRPVSASR_, , ,1.47, , , , , , , ,-0.35, , , , , ,,1.47,,,,-0.35,,, +,,,,,,NA,NA,,endoplasmic reticulum,actin binding,cellular response to growth factor stimulus,,
Q96AY2,Q96AY2,Crossover junction endonuclease EME1,EME1,77.19,49.46,S111,LAQRLTCKFLTHKQLSPEDSSSPVKSVLDHQ,_(gl)QLS(ph)PEDSS(ph)SPVK_,-0.2, , , ,-0.05, , , ,1.11, , , ,-0.5, , , ,-0.2,,-0.05,,1.11,,-0.5,,, +,,,,,NA,NA,,nucleolus,DNA binding,DNA recombination,,
Q96AY2,Q96AY2,Crossover junction endonuclease EME1,EME1,143.57,143.16,S84,EIAETVTQTQPVRLLSSESEDEEEFIPLAQR,_LLS(ph)S(ph)ES(ph)EDEEEFIPLAQR_,0.3,0.34,0.44, ,-0.77,-0.5, ,-0.3,0.19,0.08,0.4, ,-1.22,-1.22, ,0.11,0.32,0.44,-0.63,-0.3,0.14,0.4,-1.22,0.11,, +,,,,,0,6,14.55,nucleolus,DNA binding,DNA recombination,,
Q96AY2,Q96AY2,Crossover junction endonuclease EME1,EME1,143.57,143.16,S85,IAETVTQTQPVRLLSSESEDEEEFIPLAQRL,_LLS(ph)S(ph)ES(ph)EDEEEFIPLAQR_,0.3,0.34,0.44, ,-0.8,-0.78, ,-0.23,0.19,0.08,0.4, ,-1.19,-1.07, ,0.1,0.32,0.44,-0.79,-0.23,0.14,0.4,-1.13,0.1,, +,,,,,0,6,19.29,nucleolus,DNA binding,DNA recombination,,
Q96AY2,Q96AY2,Crossover junction endonuclease EME1,EME1,143.57,143.16,S87,ETVTQTQPVRLLSSESEDEEEFIPLAQRLTC,_LLS(ph)S(ph)ES(ph)EDEEEFIPLAQR_,0.3,0.34,0.44, ,-0.8,-0.78, ,-0.24,0.19,0.08,0.4, ,-1.19,-1.07, ,0.11,0.32,0.44,-0.79,-0.24,0.14,0.4,-1.13,0.11,, +,,,,,0,6,18.81,nucleolus,DNA binding,DNA recombination,,
Q32P44,Q32P44,Echinoderm microtubule-associated protein-like 3,EML3,124.81,124.81,S892,PAPATPSRTPSLSPASSLDV___________,_TPS(ph)LSPAS(ph)SLDV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
Q32P44,Q32P44,Echinoderm microtubule-associated protein-like 3,EML3,140.01,128.84,S176,SPSERPRQKLSRKAISSANLLVRSGSTESRG,_AIS(ph)SANLLVR_,0.75,0.74,0.69,0.82,0.51,0.69,0.7, ,0.61,0.67,0.77,0.8,-0.16,0.18,0.51, ,0.74,0.76,0.6,0.7,0.64,0.79,0.02,0.51,,,,,,,0,0,,cytoplasm,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,104.75,102.75,S144,KEESHSNDQSPQIRASPSPQPSSQPLQIHRQ,_AS(ph)PS(ph)PQPSSQPLQIHR_, ,-0.19, , ,-0.7, ,-0.12, , ,-0.05, , ,-0.11, ,-0.17, ,-0.19,,-0.7,-0.12,-0.05,,-0.11,-0.17,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,104.75,102.75,S146,ESHSNDQSPQIRASPSPQPSSQPLQIHRQTP,_AS(ph)PS(ph)PQPSSQPLQIHR_,-0.41,-0.19,-0.72, ,-0.7, ,-0.12, ,-0.32,-0.05,-0.62, ,-0.11, ,-0.17, ,-0.3,-0.72,-0.7,-0.12,-0.18,-0.62,-0.11,-0.17,,,,,,,0,0,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,165.53,164.98,S11,_____MDGFAGSLDDSISAASTSDVQDRLSA,_(ac)MDGFAGSLDDS(ph)IS(ph)AAS(ph)TSDVQDR_,-0.15, , , ,0, ,-0.42,-0.23,0.42, , , ,-0.56, ,-0.35,-0.27,-0.15,,0,-0.32,0.42,,-0.56,-0.31,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,79.07,79.05,S13,___MDGFAGSLDDSISAASTSDVQDRLSALE,_(ac)MDGFAGSLDDS(ph)IS(ph)AAS(ph)TSDVQDR_,-0.15, , , , , , , ,0.42, , , , , , , ,-0.15,,,,0.42,,,,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,165.53,164.98,S16,MDGFAGSLDDSISAASTSDVQDRLSALESRV,_(ac)MDGFAGSLDDS(ph)IS(ph)AAS(ph)TSDVQDR_,-0.15, , , ,0, ,-0.49,-0.23,0.42, , , ,-0.56, ,-0.57,-0.27,-0.15,,0,-0.36,0.42,,-0.56,-0.42,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,93.77,89.62,S978,KEQAKATLLEDQQDPSPSS____________,_ATLLEDQQDPS(ph)PSS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,112.95,112.6,T897,TKAPVSSTESVIQSNTPTPPPSQPLNETAEE,_APVSSTESVIQSNT(ph)PT(ph)PPPSQPLNETAEEESR_, , , , ,-0.19,-0.39, , , , , , ,0.08,-0.41, , ,,,-0.29,,,,-0.14,,,,,,,,NA,NA,,,,,,
B5MBZ0,Q9HC35,Echinoderm microtubule-associated protein-like 4,EML4,112.95,112.6,T899,APVSSTESVIQSNTPTPPPSQPLNETAEEES,_APVSSTESVIQSNT(ph)PT(ph)PPPSQPLNETAEEESR_, , , , ,0.03,-0.39, , , , , , ,0.24,-0.41, , ,,,-0.16,,,,-0.05,,,,,,,,NA,NA,,,,,,
H0YH67,Q8N8S7,Protein enabled homolog,ENAH,59.21,52.99,S125,VLNSQETGPTLPRQNSQLPAQVQNGPSQEEL,_(gl)QNS(ph)QLPAQVQNGPSQEELEIQR_, , , , , ,0.12, , , , , , , ,0.1, , ,,,0.12,,,,0.1,,,,,,,,NA,NA,,,,,,
P06733,P06733,Alpha-enolase,ENO1,162.44,162.44,Y44,GLFRAAVPSGASTGIYEALELRDNDKTRYMG,_AAVPSGASTGIY(ph)EALELRDNDK_,0.31, ,0.13, ,0.13,0.33,0,0.3,0.07, ,-0.09, ,-0.1,-0.08,0.43,0.79,0.31,0.13,0.23,0.16,0.07,-0.09,-0.09,0.62,,,,,,,0,0,,cytosol,DNA binding,gluconeogenesis,,
O43768-2,P56211,Alpha-endosulfine,ENSA,67.14,67.14,S62,DFLMKRLQKGQKYFDSGDYNMAKAKMKNKQL,_YFDS(ph)GDYNMAK_,-1.03,0.55,-0.82, , , , , ,-1.14,-0.05,-1.2, , , , , ,-0.03,-0.82,,,-0.49,-1.2,,,, +,,,,,NA,NA,,cytoplasm,ion channel inhibitor activity,cell division,,
O43768-2,O43768,Alpha-endosulfine,ENSA,304.04,304.04,S2,______________MSQKQEEENPAEETGEE,_(ac)S(ph)QKQEEENPAEETGEEK_,-0.71,-0.42,-0.72, , , ,0.07, ,-0.03,-0.24,-0.68, , , ,-0.56, ,-0.56,-0.72,,0.07,-0.13,-0.68,,-0.56,,,,,,,NA,NA,,cytoplasm,ion channel inhibitor activity,cell division,,
P11171-4,P11171,Protein 4.1,EPB41,142.43,112.68,Y660,EAWKKKRERLDGENIYIRHSNLMLEDLDKSQ,_LDGENIY(ph)IR_,1.8, ,0.14, , , , , ,0.61, ,-1.08, , , , , ,1.8,0.14,,,0.61,-1.08,,, +, +,,,,,NA,NA,,extrinsic to membrane,1-phosphatidylinositol binding,actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,197.7,197.7,S648,FEDFSRSLPELDRDKSDSDTEGLLFSRDLNK,_S(ph)DS(ph)DTEGLLFSR_,-0.45,1.8,-0.44,-0.31,-0.35,-0.48,-0.79,-0.88,0.09,-0.02,0.03,-0.52,-0.65,-0.61,-0.87,-0.9,1.08,-0.37,-0.41,-0.84,0.03,-0.22,-0.63,-0.89, +,,,,,,6,0,25.06,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,115.54,115.54,S461,HDAGPDGDKRDEDGESGGQRSEAEEGEVRTP,_RDEDGES(ph)GGQRS(ph)EAEEGEVR_,0.14, , , , ,-0.86,-0.96,-0.86,0.32, , , , ,-1.89,-0.82,-1.15,0.14,,-0.86,-0.91,0.32,,-1.89,-0.98,, +,,,,,NA,NA,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,115.54,115.54,S466,DGDKRDEDGESGGQRSEAEEGEVRTPTKIKE,_RDEDGES(ph)GGQRS(ph)EAEEGEVR_,0.14, , , , ,-0.86,-0.92,-0.86,0.32, , , , ,-1.89,-0.36,-1.15,0.14,,-0.86,-0.89,0.32,,-1.89,-0.7,, +,,,,,NA,NA,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,115.57,51.17,S784,MIPGPQTVATEIRSLSPIIGKDVLTSTYGAT,_SLS(ph)PIIGK_,0.18,0.19,-0.05,0.04,0.08,0.17,0.02,-0.1,0.14,0.25,0.12,0.11,0.15,0.25,0.05,0.07,0.19,-0.01,0.12,-0.04,0.2,0.11,0.2,0.06,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,178.11,153.09,S678,KGAPSQDDESGGIEDSPDRGACSTPDMPQFE,_GAPSQDDESGGIEDS(ph)PDR_, , , , ,-0.15,-0.29,-0.16,-0.01, , , , ,-0.08,-0.58,-0.06,0.01,,,-0.22,-0.08,,,-0.31,-0.02,,,,,,,NA,NA,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,240.8,240.8,S578,GSEEKVKPPRPRAPESDTGDEDQDQERDTVF,_APES(ph)DT(ph)GDEDQDQERDTVFLK_,0.04,-0.2,-0.17,-0.16,-0.31,-0.09,-0.16,-0.47,0.01,-0.12,0.07,-0.09,-0.06,-0.16,-0.3,-0.33,-0.07,-0.16,-0.2,-0.3,-0.05,0,-0.11,-0.31,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,252.02,252.02,S650,DFSRSLPELDRDKSDSDTEGLLFSRDLNKGA,_S(ph)DS(ph)DTEGLLFSR_,-0.07,-0.04,-0.48,-0.45,-0.56,-0.56,-0.51,-0.49,0.16,0.02,0.24,-0.14,-0.72,-0.58,-0.58,-0.45,-0.06,-0.46,-0.56,-0.5,0.1,0.06,-0.65,-0.51,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,171.39,171.39,S546,DWERERRLPSSPASPSPKGTPEKANEPVKTE,_RLPSSPASPS(ph)PKGT(ph)PEK_,0.25,0.44,-0.11,-0.14,-0.8,-0.37,-0.51,-0.36,0,0.16,-0.02,-0.48,-0.92,-0.84,-0.77,-0.63,0.35,-0.13,-0.57,-0.43,0.08,-0.23,-0.88,-0.7,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,201.92,201.92,T580,EEKVKPPRPRAPESDTGDEDQDQERDTVFLK,_APES(ph)DT(ph)GDEDQDQERDTVFLK_,-0.05,-0.04,-0.37,-0.45,-1.39,-0.5,-0.55,-0.47,-0.04,0.05,-0.12,-0.65,-1.88,-0.44,-0.62,-0.33,-0.04,-0.41,-0.88,-0.51,0,-0.36,-0.99,-0.47,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,171.39,171.39,T550,ERRLPSSPASPSPKGTPEKANEPVKTETMTV,_RLPSSPASPS(ph)PKGT(ph)PEK_,0.25,0.44,-0.11,-0.14,-0.8,-0.37,-0.51,-0.36,0,0.16,-0.02,-0.48,-0.92,-0.84,-0.77,-0.63,0.35,-0.13,-0.57,-0.43,0.08,-0.23,-0.88,-0.7,,,,,,,0,0,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,142.94,111.85,T475,ESGGQRSEAEEGEVRTPTKIKELKFLDKPED,_SEAEEGEVRT(ph)PTK_, , ,-0.15, , , , , , , ,0.25, , , , , ,,-0.15,,,,0.25,,,,,,,,,NA,NA,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
Q9H4G0-3,Q9H4G0,Band 4.1-like protein 1,EPB41L1,91.64,78.22,S75,___MEEKDYSEADGLSERTTPSKAQKSPQKI,_DYSEADGLS(ph)ER_, , , , , , , ,0.1, , , , , , , ,-0.33,,,,0.1,,,,-0.33,,,,,,,NA,NA,,cytoskeleton,structural molecule activity,cortical actin cytoskeleton organization,,
O43491,O43491,Band 4.1-like protein 2,EPB41L2,95.64,46.17,S87,RGISRFIPPWLKKQKSYTLVVAKDGGDKKEP,_S(ph)YTLVVAK_,1.08,0.95,0.26,0.11,0.86,0.87,0.11,0.61,0.53,0.67,0.24,0.05,0.34,0.68,0.22,0.61,1.02,0.19,0.87,0.38,0.61,0.15,0.52,0.43, +,,,,,,5,0,30.23,cell junction,structural molecule activity,cortical actin cytoskeleton organization,,
O43491,O43491,Band 4.1-like protein 2,EPB41L2,157.86,157.86,Y623,IEGKKNSLRVEGDNIYVRHSNLMLEELDKAQ,_VEGDNIY(ph)VR_,0.35, ,-0.49, , , , , ,-0.37, ,-1.11, , , , , ,0.35,-0.49,,,-0.37,-1.11,,,, +,,,,,NA,NA,,cell junction,structural molecule activity,cortical actin cytoskeleton organization,,
O43491,O43491,Band 4.1-like protein 2,EPB41L2,135.63,72.45,T89,ISRFIPPWLKKQKSYTLVVAKDGGDKKEPTQ,_SYT(ph)LVVAK_,0.91,0.79,0.02,0.26,0.15,0.22,0.07,0.17,0.68,0.61,0.06,0.17,0.21,0.3,0.05,0.32,0.85,0.14,0.19,0.12,0.64,0.12,0.26,0.19,,,,,,,0,0,,cell junction,structural molecule activity,cortical actin cytoskeleton organization,,
O43491,O43491,Band 4.1-like protein 2,EPB41L2,98.68,29.01,S715,KDERVITEEMNGKEISPGSGPGEIRKVEPVT,_EIS(ph)PGS(ph)GPGEIR_, , , , ,0.91,-0.33,-0.19,0.83, , , , ,-0.43,-0.29,-0.25,-0.43,,,0.42,0.41,,,-0.36,-0.34,,,,,,,NA,NA,,cell junction,structural molecule activity,cortical actin cytoskeleton organization,,
O43491,O43491,Band 4.1-like protein 2,EPB41L2,68.79,60.38,S718,RVITEEMNGKEISPGSGPGEIRKVEPVTQKD,_EIS(ph)PGS(ph)GPGEIR_, , , , ,-0.56,-0.67,-0.51,-0.55, , , , ,-0.61,-0.65,-0.42,-0.56,,,-0.62,-0.53,,,-0.63,-0.49,,,,,,,NA,NA,,cell junction,structural molecule activity,cortical actin cytoskeleton organization,,
Q9HCS5,Q9HCS5,Band 4.1-like protein 4A,EPB41L4A,51.29,25.81,S389,MENGENEGTIKIIAPSPVKSFKKAKNENSPD,_IIAPS(ph)PVK_,-0.12,0.19, , ,0.45,0.75,0.14,0.42,0.3,0.25, , ,0.22,-0.02,-0.07,0.64,0.04,,0.61,0.29,0.28,,0.1,0.33,,,,,,,NA,NA,,cytoplasm,,,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,156.96,109.73,S897,KTLADFDPRVSIRLPSTSGSEGVPFRTVSEW,_LPS(ph)TSGS(ph)EGVPFR_, , , , ,1.57,1.74,2.1,1.92, , , , ,2.03,2.19,2.43,2.29,,,1.66,2.01,,,2.11,2.36, +, +,Tyr,,,,NA,NA,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,148.22,105.26,S899,LADFDPRVSIRLPSTSGSEGVPFRTVSEWLE,_LPS(ph)TS(ph)GSEGVPFR_, , , , ,1.62,1.77,2.12,2.02, , , , ,2.06,2.23,2.43,2.42,,,1.7,2.08,,,2.15,2.42, +, +,Tyr,,,,NA,NA,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,156.96,109.73,S901,DFDPRVSIRLPSTSGSEGVPFRTVSEWLESI,_LPS(ph)TSGS(ph)EGVPFR_, , , , ,1.52,1.71, , , , , , ,2,2.15, , ,,,1.62,,,,2.07,, +, +,Tyr,,,,NA,NA,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,102.4,102.4,Y575,RRRKNQRARQSPEDVYFSKSEQLKPLKTYVD,_QSPEDVY(ph)FSK_,0.16,0.36,0.68,-0.9,-0.1,0.03,0.44,0.41,0.14,0.13,-0.16,-0.72,-0.27,-0.16,0.67,0.63,0.26,0.09,-0.03,0.42,0.14,-0.42,-0.22,0.65,,,Tyr,,,,0,0,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,250.27,250.27,Y588,DVYFSKSEQLKPLKTYVDPHTYEDPNQAVLK,_TY(ph)VDPHTYEDPNQAVLK_,0.02,0.61,0.34,0.67,-0.54,-0.64, ,0.23,0.03,0.55,0.28,0.12,-0.04,-0.08, ,0.54,0.35,0.52,-0.59,0.23,0.31,0.2,-0.06,0.54,,,Tyr,,,,0,0,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,250.27,244.15,Y594,SEQLKPLKTYVDPHTYEDPNQAVLKFTTEIH,_T(ph)YVDPHTY(ph)EDPNQAVLK_,-0.02,0.01,0.48,0.67,-0.54,-0.28,-0.1,0.05,-0.29,-0.14,-0.31,0.12,-0.1,-0.4,0.42,0.45,0,0.58,-0.4,-0.02,-0.21,-0.08,-0.25,0.44,,,Tyr,,,,0,0,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,63.09,54.68,Y628,VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV,_VIGAGEFGEVY(ph)K_, , ,0.37, , , , , , , ,-0.35, , , , , ,,0.37,,,,-0.35,,,,,Tyr,,,,NA,NA,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,230.38,210.1,Y772,DFGLSRVLEDDPEATYTTSGGKIPIRWTAPE,_VLEDDPEATY(ph)TTSGGK_,0.6,0.38,0.91,1.07,-0.26,-0.25,0.07,0.05,0.48,0.25,0.16,0.13,-0.04,-0.1,0.37,0.36,0.49,1,-0.26,0.06,0.37,0.14,-0.07,0.37,,,Tyr,,,,0,0,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
P29317,P29317,Ephrin type-A receptor 2,EPHA2,250.27,244.15,T587,EDVYFSKSEQLKPLKTYVDPHTYEDPNQAVL,_T(ph)YVDPHTY(ph)EDPNQAVLK_,0.17, ,0.64,0.67, , ,0.05,-0.13,-0.06, ,0.11,0.12, , ,0.43,0.25,0.17,0.66,,-0.04,-0.06,0.11,,0.34,,,Tyr,,,,NA,NA,,focal adhesion,ATP binding,activation of Rac GTPase activity,,
F8W9W0,P54756,Ephrin type-A receptor 5,EPHA5,220.28,201.66,Y650,MHFHNGHIKLPGVRTYIDPHTYEDPNQAVHE,_TY(ph)IDPHT(ph)YEDPNQAVHEFAK_,-0.42, ,-0.51, ,-0.68,-0.78,-0.15,0.09,0.23, ,0.09, ,-0.67,-0.55,0.32,0.43,-0.42,-0.51,-0.73,-0.03,0.23,0.09,-0.61,0.38,,,Tyr,,,,0,0,,integral to membrane,ATP binding,,,
F8W9W0,P54756,Ephrin type-A receptor 5,EPHA5,276.08,268.45,T655,GHIKLPGVRTYIDPHTYEDPNQAVHEFAKEI,_TY(ph)IDPHT(ph)YEDPNQAVHEFAK_,-0.47, ,-0.52, , , ,-0.13,0.09,0.22, ,0.36, , , ,0.4,0.43,-0.47,-0.52,,-0.02,0.22,0.36,,0.42,,,Tyr,,,,NA,NA,,integral to membrane,ATP binding,,,
F8W9W0,P29320,Ephrin type-A receptor 5,EPHA5,208.27,177.38,Y779,DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE,_VLEDDPEAAY(ph)TTR_,-0.2,-0.46,-0.57, , ,-0.68,-0.32, ,-0.01,-0.36,-0.53, , ,-0.28,-0.32, ,-0.33,-0.57,-0.68,-0.32,-0.18,-0.53,-0.28,-0.32,,,Tyr,,,,0,0,,integral to membrane,ATP binding,,,
Q15375-2,Q15375,Ephrin type-A receptor 7,EPHA7,63.97,57.5,Y614,HFKFPGTKTYIDPETYEDPNRAVHQFAKELD,_TYIDPETY(ph)EDPNR_,-0.11, , , , , , , ,-0.08, , , , , , , ,-0.11,,,,-0.08,,,,,,Tyr,,,,NA,NA,,dendrite,ATP binding,brain development,,
Q15375-2,Q15375,Ephrin type-A receptor 7,EPHA7,155.1,140.49,Y791,DFGLSRVIEDDPEAVYTTTGGKIPVRWTAPE,_VIEDDPEAVY(ph)TTTGGK_,0.06, ,-0.71,-1.05,0.36,0.47,0.43,0.46,0.21, ,-0.34,-0.25,0.12,0.21,-0.26,-0.09,0.06,-0.87,0.42,0.44,0.21,-0.29,0.17,-0.17,,,Tyr,,,,0,0,,dendrite,ATP binding,brain development,,
Q96L35,P54760,Ephrin type-B receptor 4,EPHB4,75.83,38.98,Y614,PNEAVREFAKEIDVSYVKIEEVIGAGEFGEV,_EIDVSY(ph)VK_, , ,0.58,-2.25, , , , , , ,0.72,0.48, , , , ,,-0.23,,,,0.6,,,,,Tyr,,,,NA,NA,,integral to plasma membrane,ATP binding,,,
Q96L35,P54760,Ephrin type-B receptor 4,EPHB4,246.69,246.28,Y774,FGLSRFLEENSSDPTYTSSLGGKIPIRWTAP,_FLEENSSDPTY(ph)TSSLGGK_,-0.1, ,0.17, ,-0.03, ,-0.5,-0.37,-0.35, ,-0.15, ,0.28, ,0.23,0.2,-0.1,0.17,-0.03,-0.43,-0.35,-0.15,0.28,0.22,,,Tyr,,,,0,0,,integral to plasma membrane,ATP binding,,,
Q9Y6I3-3,Q9Y6I3,Epsin-1,EPN1,185.2,147.26,Y17,STSSLRRQMKNIVHNYSEAEIKVREATSNDP,_NIVHNY(ph)SEAEIK_, , ,4.89, ,3.41, , , , , ,4.6, ,4.02, , , ,,4.89,3.41,,,4.6,4.02,, +, +,,,,,NA,NA,,coated pit,lipid binding,embryonic organ development,,
E7EMC3,O95208,Epsin-2,EPN2,91.62,86.33,Y17,TTSSIRRQMKNIVNNYSEAEIKVREATSNDP,_NIVNNY(ph)SEAEIK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,clathrin coat of endocytic vesicle,,endocytosis,,
P58107,P58107,Epiplakin,EPPK1,229.06,227.26,S2716,ERLSKVSFRGLRRQVSASELHTSGILGPETL,_(gl)QVS(ph)ASELHTSGILGPETLR_,-0.97,-1.07,0.11,0.23,1.05,1.13, , ,-0.82,-0.72,0.96,1.07,0.87,0.9, , ,-1.02,0.17,1.09,,-0.77,1.01,0.89,, +, +,,,,,NA,NA,,cytoplasm,structural molecule activity,,,
P07814,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,220.83,219.64,S882,KTGKEYIPGQPPLSQSSDSSPTRNSEPAGLE,_EYIPGQPPLSQS(ph)SDSS(ph)PTR_,0.14,0.17,-0.07,0.16,-0.21,-0.2,-0.27,-0.28,-0.06,-0.17,-0.14,-0.13,-0.3,-0.24,-0.41,-0.42,0.15,0.05,-0.21,-0.28,-0.11,-0.14,-0.27,-0.41,,,,,,,0,0,,cytosol,ATP binding,cellular response to interferon-gamma,,
P07814,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,131.24,130.43,S883,TGKEYIPGQPPLSQSSDSSPTRNSEPAGLET,_EYIPGQPPLSQS(ph)S(ph)DS(ph)SPTR_,0.14, , , ,0.25,0.09,0,-0.02,0, , , ,-0.07,0.01,-0.18,-0.21,0.14,,0.17,-0.01,0,,-0.03,-0.19,,,,,,,NA,NA,,cytosol,ATP binding,cellular response to interferon-gamma,,
P07814,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,243.45,243.45,S885,KEYIPGQPPLSQSSDSSPTRNSEPAGLETPE,_EYIPGQPPLSQSSDS(ph)SPTRNSEPAGLETPEAK_,0.14,0.09,0.28,0.16,-0.04,0.16,0,0.01,-0.03,0.05,0.27,-0.06,0.04,-0.01,-0.02,-0.04,0.12,0.22,0.06,0.01,0.01,0.11,0.02,-0.03,,,,,,,0,0,,cytosol,ATP binding,cellular response to interferon-gamma,,
P07814,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,281.48,273.01,S886,EYIPGQPPLSQSSDSSPTRNSEPAGLETPEA,_EYIPGQPPLSQSSDSS(ph)PTRNSEPAGLETPEAK_,0.18,0.22,0.09,0.14,-0.03,0.04,-0.01,0.04,0,-0.03,0.11,-0.06,-0.03,0.01,0.01,-0.03,0.2,0.11,0.01,0.02,-0.02,0.03,-0.01,-0.01,,,,,,,0,0,,cytosol,ATP binding,cellular response to interferon-gamma,,
B1AUU8,P42566,Epidermal growth factor receptor substrate 15,EPS15,173.55,167.33,Y849,TNKEADPSNFANFSAYPSEEDMIEWAKRESE,_EADPSNFANFSAY(ph)PSEEDMIEWAK_, , ,2.59, , , , , , , ,1.33, , , , , ,,2.59,,,,1.33,,, +, +,,,,,NA,NA,,cytoplasm,calcium ion binding,,+,
B1AUU8,P42566,Epidermal growth factor receptor substrate 15,EPS15,171.87,132.25,S796,PCPLPPGKRSINKLDSPDPFKLNDPFQPFPG,_S(ph)INKLDS(ph)PDPFK_,-0.17,-0.15,1.14,0.93,0.73,0.71,0.57,0.52,0,0.09,1.25,1.24,0.47,0.46,0.44,0.55,-0.16,1.04,0.72,0.54,0.04,1.24,0.47,0.5, +, +,,,,,1,4,29.9,cytoplasm,calcium ion binding,,+,
B1AUU8,P42566,Epidermal growth factor receptor substrate 15,EPS15,139.46,134.56,S790,IGTPTRPCPLPPGKRSINKLDSPDPFKLNDP,_S(ph)INKLDS(ph)PDPFK_, , ,1.75, , , , , , , ,3.85, , , , , ,,1.75,,,,3.85,,, +, +,,,,,NA,NA,,cytoplasm,calcium ion binding,,+,
B1AUU8,P42566,Epidermal growth factor receptor substrate 15,EPS15,205.36,186.5,S814,PFKLNDPFQPFPGNDSPKEKDPEIFCDPFTS,_LNDPFQPFPGNDS(ph)PK_,-0.08,-0.03,0.04,0.07,0.65,0.6,0.33,0.72,0.53,0.36,0.28,0.24,0.76,0.49,0.65,0.73,-0.06,0.06,0.62,0.54,0.45,0.26,0.63,0.69,,,,,,,0,0,,cytoplasm,calcium ion binding,,+,
Q9UBC2-2,Q9UBC2,Epidermal growth factor receptor substrate 15-like 1,EPS15L1,65.3,62.16,S49,VGASEAALFLKKSGLSDIILGKIWDLADPEG,_SGLS(ph)DIILGK_,-0.92,-0.96,-1.22,-0.96, , , , ,-0.51,-0.49,-0.45,-0.61, , , , ,-0.94,-1.08,,,-0.5,-0.52,,, +,,,,,,NA,NA,,coated pit,calcium ion binding,endocytosis,+,
Q9UBC2-2,Q9UBC2,Epidermal growth factor receptor substrate 15-like 1,EPS15L1,165.87,165.83,Y564,QLHESRQEAHRSLEQYDQVLDGAHGASLTDL,_SLEQY(ph)DQVLDGAHGASLTDLANLSEGVSLAER_, , ,0.79, , , , , , , ,0.53, , , , , ,,0.79,,,,0.53,,,,,,,,,NA,NA,,coated pit,calcium ion binding,endocytosis,+,
Q9UBC2-2,Q9UBC2,Epidermal growth factor receptor substrate 15-like 1,EPS15L1,82.48,82.01,S253,STPSHGSVSSLNSTGSLSPKHSLKQTQPTVN,_STPSHGSVSSLNSTGS(ph)LSPK_, ,0.14,0.04, , , , , , ,0.16,-0.11, , , , , ,0.14,0.04,,,0.16,-0.11,,,,,,,,,NA,NA,,coated pit,calcium ion binding,endocytosis,+,
Q9UBC2-2,Q9UBC2,Epidermal growth factor receptor substrate 15-like 1,EPS15L1,120.27,119.8,S255,PSHGSVSSLNSTGSLSPKHSLKQTQPTVNWV,_STPSHGSVSSLNSTGSLS(ph)PK_,0.11,0.38,0.13,0.02,-0.03, ,-0.03, ,-0.02,0.25,0.07,-0.17,0.08, ,0.03, ,0.25,0.08,-0.03,-0.03,0.12,-0.04,0.08,0.03,,,,,,,0,0,,coated pit,calcium ion binding,endocytosis,+,
B4DX66,Q12929,Epidermal growth factor receptor kinase substrate 8,EPS8,284.76,260.21,S811,IMRRRQEKISAAASDSGVESFDEGSSH____,_ISAAASDS(ph)GVES(ph)FDEGSSH_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,N-methyl-D-aspartate selective glutamate receptor complex,kinase activity,actin cytoskeleton reorganization,,
B4DX66,Q12929,Epidermal growth factor receptor kinase substrate 8,EPS8,284.76,260.21,S815,RQEKISAAASDSGVESFDEGSSH________,_ISAAASDS(ph)GVES(ph)FDEGSSH_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,N-methyl-D-aspartate selective glutamate receptor complex,kinase activity,actin cytoskeleton reorganization,,
P04626-3,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,106.39,105.42,Y1005,QNEDLGPASPLDSTFYRSLLEDDDMGDLVDA,_FVVIQNEDLGPASPLDSTFY(ph)R_,2.55, , , , , , , ,1.43, , , , , , , ,2.55,,,,1.43,,,, +, +,Tyr,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,+,
P04626-3,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,135.47,101.88,Y877,TDFGLARLLDIDETEYHADGGKVPIKWMALE,_LLDIDETEY(ph)HADGGK_,2.95, ,1.9, , , ,-0.58,-0.42,2.21, ,0.53, , , ,-0.37,-0.16,2.95,1.9,,-0.5,2.21,0.53,,-0.26, +, +,Tyr,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,+,
P04626-3,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,107.79,104.35,S1054,AGGMVHHRHRSSSTRSGGGDLTLGLEPSEEE,_S(ph)GGGDLTLGLEPSEEEAPR_, , , , , , , ,-2.56, , , , , , , ,-1.58,,,,-2.56,,,,-1.58, +, +,Tyr,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,+,
P04626-3,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,116.86,113.41,Y1248,PPSTFKGTPTAENPEYLGLDVPV________,_GTPTAENPEY(ph)LGLDVPV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Tyr,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,+,
P04626-3,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,75.31,74.8,Y1139,TDGYVAPLTCSPQPEYVNQPDVRPQPPSPRE,_YSEDPTVPLPSETDGY(ph)VAPLTCSPQPEY(ph)VNQPDVRPQPPSPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Tyr,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,+,
Q96RT1-7,Q96RT1,Protein LAP2,ERBB2IP,87.72,85.84,Y1104,GDPGSTRRAQIPEGDYLSYREFHSAGRTPPM,_AQIPEGDY(ph)LSYR_, , , , ,0.63,1.14,0.61,2.62, , , , ,-0.22,0,0.31,0.72,,,0.91,1.94,,,-0.11,0.53, +,,,,,,NA,NA,,basal plasma membrane,ErbB-2 class receptor binding,basal protein localization,,
Q96RT1-7,Q96RT1,Protein LAP2,ERBB2IP,198.63,198.63,S715,ENFNSLLQNGDILNSSTEEKFKAHDKKDFNL,_IRQEDENFNSLLQNGDILNS(ph)S(ph)TEEK_, ,2.41, , ,-0.43,0.05, ,0.11, ,-0.21, , ,-0.82,-0.42, ,-0.47,2.41,,-0.17,0.11,-0.21,,-0.6,-0.47, +,,,,,,NA,NA,,basal plasma membrane,ErbB-2 class receptor binding,basal protein localization,,
Q96RT1-7,Q96RT1,Protein LAP2,ERBB2IP,94.61,90.26,Y884,KSHSITNMEIGGLKIYDILSDNGPQQPSTTV,_IY(ph)DILSDNGPQQPSTTVK_,0.14, ,-0.26, ,-0.25,-0.32, ,-0.28,-0.25, ,-0.1, ,-0.04,0.14, ,0.25,0.14,-0.26,-0.29,-0.28,-0.25,-0.1,0.05,0.25,,,,,,,0,0,,basal plasma membrane,ErbB-2 class receptor binding,basal protein localization,,
Q96RT1-7,Q96RT1,Protein LAP2,ERBB2IP,198.63,198.63,S714,DENFNSLLQNGDILNSSTEEKFKAHDKKDFN,_IRQEDENFNSLLQNGDILNS(ph)S(ph)TEEK_, , , , ,-0.43,0.05, ,0.11, , , , ,-0.82,-0.42, ,-0.47,,,-0.17,0.11,,,-0.6,-0.47,,,,,,,NA,NA,,basal plasma membrane,ErbB-2 class receptor binding,basal protein localization,,
G8JLD3,Q8IUD2,ELKS/Rab6-interacting/CAST family member 1,ERC1,138.63,117.59,Y987,LKQQTQNRMKLMADNYEDDHFKSSHSNQTNH,_LMADNY(ph)EDDHFK_,4.93, , , , , , , ,4.38, , , , , , , ,4.93,,,,4.38,,,, +, +,,,,,NA,NA,,,,,,
G8JLD3,O15083,ELKS/Rab6-interacting/CAST family member 1,ERC1,88.13,54.05,S187,DSKLGSSMNSIKTFWSPELKKERVLRKEEAA,_TFWS(ph)PELK_,0.05,-0.06,-0.2,-0.1, , , , ,0.59,0.51,0.93,0.41, , , , ,-0.01,-0.15,,,0.55,0.69,,,,,,,,,NA,NA,,,,,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,55.55,55.19,S382,RQARGRNAPAAVDEGSISPRTLSAIKRALDD,_NAPAAVDEGS(ph)IS(ph)PR_, , , , , , ,0.52, , , , , , , ,1.32, ,,,,0.52,,,,1.32,, +,,,,,NA,NA,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,178.93,177.55,S156,NDLYVLPPLQEEEKHSSEEEDEKEWQERMNQ,_ENDLYVLPPLQEEEKHS(ph)S(ph)EEEDEK_,-0.1, ,-0.61,-0.13,0.4,-0.15,-0.08,-0.08,-0.24, ,-0.33,-0.43,-0.19,-0.17,-0.18,-0.19,-0.1,-0.35,0.15,-0.08,-0.24,-0.38,-0.18,-0.19,,,,,,,0,0,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,178.93,177.55,S157,DLYVLPPLQEEEKHSSEEEDEKEWQERMNQK,_ENDLYVLPPLQEEEKHS(ph)S(ph)EEEDEK_,-0.1, ,-0.61,-0.13,0.4,-0.15,-0.08,-0.08,-0.24, ,-0.33,-0.43,-0.19,-0.17,-0.18,-0.19,-0.1,-0.35,0.15,-0.08,-0.24,-0.38,-0.18,-0.19,,,,,,,0,0,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,91.55,86.58,S559,EQQNELCPYESKFDSSLLSSDDETKCKPNSA,_FDSS(ph)LLS(ph)S(ph)DDETK_, , , , , ,-0.38,-0.31,-0.38, , , , , ,-0.23,-0.19,-0.42,,,-0.38,-0.34,,,-0.23,-0.3,,,,,,,NA,NA,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,218.11,203.15,S562,NELCPYESKFDSSLLSSDDETKCKPNSASEV,_FDSSLLS(ph)S(ph)DDETK_,0.01,0.03,0.07,0.19,0.24,0.41,0.18,0.22,0.12,0.08,0.2,0.27,0.3,0.44,0.13,0.13,0.02,0.13,0.33,0.2,0.1,0.23,0.37,0.13,,,,,,,0,0,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,218.11,203.15,S563,ELCPYESKFDSSLLSSDDETKCKPNSASEVI,_FDSSLLS(ph)S(ph)DDETK_,-0.09,0,-0.31,-0.41,-0.96,-0.42,-0.04,-0.04,0.09,-0.01,-0.21,-0.31,-1.49,-0.61,-0.02,0.02,-0.04,-0.36,-0.67,-0.04,0.04,-0.26,-0.98,0,,,,,,,0,0,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
P28715,P28715,DNA repair protein complementing XP-G cells,ERCC5,216.16,210.69,S384,ARGRNAPAAVDEGSISPRTLSAIKRALDDDE,_NAPAAVDEGS(ph)IS(ph)PR_,-0.26,-0.11,-0.56,-0.24,-0.03,-0.12,-0.07,-0.15,-0.1,-0.03,-0.27,0.01,-0.19,-0.1,-0.3,-0.04,-0.18,-0.39,-0.08,-0.11,-0.06,-0.13,-0.15,-0.17,,,,,,,0,0,,nucleoplasm,bubble DNA binding,determination of adult lifespan,,
Q03468,Q03468,DNA excision repair protein ERCC-6,ERCC6,228.24,225.53,S486,LRLQDKEKRLKLEDDSEESDAEFDEGFKVPG,_LKLEDDS(ph)EES(ph)DAEFDEGFK_, , ,-0.76, ,0.14,-0.02,0.23,0.16, , ,-0.81, ,1.07,0.28,0.17,0.15,,-0.76,0.06,0.19,,-0.81,0.73,0.16,,,,,,,NA,NA,,nucleolus,ATP binding,activation of JNKK activity,,
Q03468,Q03468,DNA excision repair protein ERCC-6,ERCC6,228.24,225.53,S489,QDKEKRLKLEDDSEESDAEFDEGFKVPGFLF,_LKLEDDS(ph)EES(ph)DAEFDEGFK_, , ,-0.76, ,0.14,-0.02,0.23,0.16, , ,-0.81, ,1.07,0.28,0.17,0.15,,-0.76,0.06,0.19,,-0.81,0.73,0.16,,,,,,,NA,NA,,nucleolus,ATP binding,activation of JNKK activity,,
B5MDQ0,Q2NKX8,DNA excision repair protein ERCC-6-like,ERCC6L,148.09,148.09,S1134,EAKGPEDYPEEGVEESSGEASKYTEEDPSGE,_GPEDYPEEGVEES(ph)S(ph)GEASK_, , , , , ,-0.02,0.28,0.04, , , , , ,-0.15,0.06,-0.31,,,-0.02,0.16,,,-0.15,-0.11,,,,,,,NA,NA,,cytosol,ATP binding,apoptotic process,,
B5MDQ0,Q2NKX8,DNA excision repair protein ERCC-6-like,ERCC6L,148.09,148.09,S1135,AKGPEDYPEEGVEESSGEASKYTEEDPSGET,_GPEDYPEEGVEES(ph)S(ph)GEASK_, , , , , ,-0.02,0.28,0.04, , , , , ,-0.15,0.06,-0.31,,,-0.02,0.16,,,-0.15,-0.11,,,,,,,NA,NA,,cytosol,ATP binding,apoptotic process,,
B5MDQ0,Q2NKX8,DNA excision repair protein ERCC-6-like,ERCC6L,203.52,195.54,S1028,VVVKAKIRSKARRIVSDGEDEDDSFKDTSSI,_IVS(ph)DGEDEDDSFK_,-0.04,0.03,0.69,0.36,0.75,0.81,0.6,0.73,0.29,0.32,1.01,0.93,0.79,0.89,0.25,0.47,0,0.53,0.78,0.67,0.3,0.97,0.84,0.36,,,,,,,0,0,,cytosol,ATP binding,apoptotic process,,
P50548,P50548,ETS domain-containing transcription factor ERF,ERF,107.16,103.59,S431,LAPPPPPPQIKVEPISEGESEEVEVTDISDE,_VEPIS(ph)EGESEEVEVT(ph)DIS(ph)DEDEEDGEVFK_, , , , , , ,-0.48, , , , , , , ,-0.07, ,,,,-0.48,,,,-0.07,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding,cell cycle,,
P50548,P50548,ETS domain-containing transcription factor ERF,ERF,107.16,103.59,S444,PISEGESEEVEVTDISDEDEEDGEVFKTPRA,_VEPIS(ph)EGESEEVEVT(ph)DIS(ph)DEDEEDGEVFK_, , , , , , ,-0.48, , , , , , , ,-0.07, ,,,,-0.48,,,,-0.07,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding,cell cycle,,
P50548,P50548,ETS domain-containing transcription factor ERF,ERF,107.16,103.59,T441,KVEPISEGESEEVEVTDISDEDEEDGEVFKT,_VEPIS(ph)EGESEEVEVT(ph)DIS(ph)DEDEEDGEVFK_, , , , , , ,-0.48, , , , , , , ,-0.07, ,,,,-0.48,,,,-0.07,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding,cell cycle,,
E5RHA3,Q86X53,Glutamate-rich protein 1,ERICH1,59.35,51.31,S238,EEDVKDTREEDGADASEEDLTRARQEEGADA,_EEDGADAS(ph)EEDLTR_, , , , , ,0.13,0.11,-0.15, , , , , ,-0.06,0.17,-0.32,,,0.13,-0.01,,,-0.06,-0.05,,,,,,,NA,NA,,,,,,
Q9UJM3,Q9UJM3,ERBB receptor feedback inhibitor 1,ERRFI1,174.87,170.97,Y394,ILPIIENGKKVSSTHYYLLPERPPYLDKYEK,_VSSTHY(ph)YLLPERPPYLDK_,3.8, ,2.87, ,3.04,1.33,5.05,4.04,3.26, ,1.89, ,2.94,1.22,4.96,3.94,3.8,2.87,2.42,4.63,3.26,1.89,2.32,4.54, +, +,,,,,5,2,42.37,cytoplasm,Rho GTPase activator activity,lung alveolus development,,
Q9H501,Q9H501,ESF1 homolog,ESF1,112.47,111.87,S657,KKRLKRKQKALAEEASEEELPSDVDLNDPYF,_ALAEEAS(ph)EEELPS(ph)DVDLNDPYFAEEVK_, , , , ,-1.25,-1.06,-0.71,-0.54, , , , ,-1,-0.84,-0.29,-0.42,,,-1.15,-0.62,,,-0.91,-0.35, +,,,,,,NA,NA,,nucleolus,,"regulation of transcription, DNA-dependent",,
Q9H501,Q9H501,ESF1 homolog,ESF1,112.47,111.87,S663,KQKALAEEASEEELPSDVDLNDPYFAEEVKQ,_ALAEEAS(ph)EEELPS(ph)DVDLNDPYFAEEVK_, , , , ,-1.25,-1.06,-0.71,-0.54, , , , ,-1,-0.84,-0.29,-0.42,,,-1.15,-0.62,,,-0.91,-0.35, +,,,,,,NA,NA,,nucleolus,,"regulation of transcription, DNA-dependent",,
Q9BSJ8,Q9BSJ8,Extended synaptotagmin-1,ESYT1,132.84,131.35,Y822,AEDLPLRKGTKHLSPYATLTVGDSSHKTKTI,_HLSPY(ph)ATLTVGDSSHK_,0.24, ,0.22, ,0.34, ,0.26,0.67,-0.14, ,-0.07, ,0.3, ,0.36,0.52,0.24,0.22,0.34,0.48,-0.14,-0.07,0.3,0.44,,,,,,,0,0,,integral to membrane,,,,
Q9BSJ8,Q9BSJ8,Extended synaptotagmin-1,ESYT1,81.92,59.28,S1034,NRGTKRRTSQKKRTLSPEFNERFEWELPLDE,_TLS(ph)PEFNER_,-0.3,-0.38, ,-0.54, , , ,-0.89,-0.2,-0.19, ,-0.37, , , ,-0.44,-0.34,-0.54,,-0.89,-0.2,-0.37,,-0.44,,,,,,,NA,NA,,integral to membrane,,,,
A0FGR8-2,A0FGR8,Extended synaptotagmin-2,ESYT2,187.75,185.72,S755,LLASPGHISVKEPTPSIASDISLPIATQELR,_EPTPS(ph)IASDIS(ph)LPIATQELR_,-0.09,-0.13,-0.23,-0.17,-0.17,-1.1,-0.7,-0.43,-0.18,-0.19,-0.31,-0.17,-0.79,-0.58,-0.35,-0.19,-0.11,-0.2,-0.56,-0.56,-0.19,-0.24,-0.68,-0.27,,,,,,,0,0,,integral to membrane,,,,
A0FGR8-2,A0FGR8,Extended synaptotagmin-2,ESYT2,292.19,291.9,S758,SPGHISVKEPTPSIASDISLPIATQELRQRL,_EPT(ph)PSIAS(ph)DIS(ph)LPIATQELR_,0.02,-0.02,-0.21,-0.2,-0.19,-0.23,-0.17,-0.32,-0.17,-0.14,-0.32,-0.22,-0.23,-0.27,-0.28,-0.1,0,-0.21,-0.21,-0.24,-0.15,-0.27,-0.25,-0.18,,,,,,,0,0,,integral to membrane,,,,
A0FGR8-2,A0FGR8,Extended synaptotagmin-2,ESYT2,292.19,291.9,S761,HISVKEPTPSIASDISLPIATQELRQRLRQL,_EPTPSIAS(ph)DIS(ph)LPIATQELR_,0.02,-0.02,-0.22,-0.19,-0.19,-0.43,-0.18,-0.37,-0.17,-0.14,-0.32,-0.2,-0.23,-0.35,-0.29,-0.09,0,-0.2,-0.3,-0.27,-0.15,-0.26,-0.29,-0.19,,,,,,,0,0,,integral to membrane,,,,
O60447,O60447,Ecotropic viral integration site 5 protein homolog,EVI5,138.42,132.39,S805,SNQVVQKERPPRRRESYSTTV__________,_RRES(ph)YSTTV_, , ,0.09,1.98,-2.64, , , , , ,0.66,2.96,-2.13, , , ,,1.33,-2.64,,,2.23,-2.13,, +, +,,,,,NA,NA,,cytoplasm,Rab GTPase activator activity,cell cycle,,
O60447,O60447,Ecotropic viral integration site 5 protein homolog,EVI5,152.93,152.81,S776,GKSGSMSLDPAVADGSESETEDSVLETRESN,_SGSMSLDPAVADGS(ph)ES(ph)ETEDSVLETR_, , , , ,0.19,-0.06,0.13,0.15, , , , ,0.23,-0.02,0.02,0.08,,,0.07,0.14,,,0.11,0.05,,,,,,,NA,NA,,cytoplasm,Rab GTPase activator activity,cell cycle,,
O60447,O60447,Ecotropic viral integration site 5 protein homolog,EVI5,152.93,152.81,S778,SGSMSLDPAVADGSESETEDSVLETRESNQV,_SGSMSLDPAVADGS(ph)ES(ph)ETEDSVLETR_, , , , ,0.19,-0.06,0.13,0.16, , , , ,0.23,-0.02,0.02,0.08,,,0.07,0.14,,,0.11,0.05,,,,,,,NA,NA,,cytoplasm,Rab GTPase activator activity,cell cycle,,
Q06265-3,Q06265,Exosome complex component RRP45,EXOSC9,48,47.83,S353,QIGEGVENSWGDLEDSEKEDDEGGGDQAIIL,_AEEIIAEAEPPSEVVSTPVLWTPGTAQIGEGVENSWGDLEDS(ph)EK_, , , , , , ,0.5, , , , , , , ,0.03, ,,,,0.5,,,,0.03,,,,,,,NA,NA,,cytosol,3'-5'-exoribonuclease activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
Q06265-3,Q06265,Exosome complex component RRP45,EXOSC9,227.47,218.05,S306,QRITAFKMEKAPIDTSDVEEKAEEIIAEAEP,_APIDTS(ph)DVEEK_,0.17,0.17,0.11,0.07,0.12,0.07,-0.01,0.04,0.17,0.29,0.21,0.32,0.18,0.18,0.05,0.01,0.17,0.09,0.1,0.02,0.23,0.27,0.18,0.03,,,,,,,0,0,,cytosol,3'-5'-exoribonuclease activity,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,,
O95677-3,O95677,Eyes absent homolog 4,EYA4,114.06,113.36,S361,SSGSKSRGRGRKNNPSPPPDSDLERVFVWDL,_NNPS(ph)PPPDSDLER_,-0.28, ,-0.34, ,-0.1,0.26,-0.03,-0.05,-0.3, ,-0.05, ,-0.15,0.12,-0.16,-0.15,-0.28,-0.34,0.09,-0.04,-0.3,-0.05,-0.01,-0.16,,,,,,,0,0,,cytoplasm,metal ion binding,anatomical structure morphogenesis,,
Q15910-5,Q15910,Histone-lysine N-methyltransferase EZH2,EZH2,81.73,81.73,T487,KESSIIAPAPAEDVDTPPRKKKRKHRLWAAH,_ESSIIAPAPAEDVDT(ph)PPRK_,0.02,0.12,0.17,-0.05,0.01,-0.17, , ,-0.18,0.17,0.19,0.08,-0.19,-0.42, , ,0.07,0.06,-0.08,,0,0.14,-0.3,,,,,,,,NA,NA,,ESC/E(Z) complex,chromatin binding,cerebellar cortex development,,
Q15910-5,Q15910,Histone-lysine N-methyltransferase EZH2,EZH2,72.91,72.91,T367,GRRRGRLPNNSSRPSTPTINVLESKDTDSDR,_LPNNSSRPS(ph)T(ph)PTINVLESK_, , , , , , ,-0.73,-0.48, , , , , , ,-1.08,-0.63,,,,-0.6,,,,-0.84,,,,,,,NA,NA,,ESC/E(Z) complex,chromatin binding,cerebellar cortex development,,
Q13158,Q13158,Protein FADD,FADD,95.83,93.48,S190,DLVQEVQQARDLQNRSGAMSPMSWNSDASTS,_S(ph)GAMS(ph)PMSWNSDASTSEAS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,CD95 death-inducing signaling complex,death receptor binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q13158,Q13158,Protein FADD,FADD,172.99,172.79,S194,EVQQARDLQNRSGAMSPMSWNSDASTSEAS_,_S(ph)GAMS(ph)PMSWNSDASTSEAS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,CD95 death-inducing signaling complex,death receptor binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q9UNN5,Q9UNN5,FAS-associated factor 1,FAF1,98.41,68.2,S582,EENAEPVSKLRIRTPSGEFLERRFLASNKLQ,_TPS(ph)GEFLER_,-0.07,-0.11,0.08, , , , ,0.27,-0.17,-0.21,0.2, , , , ,-0.13,-0.09,0.08,,0.27,-0.19,0.2,,-0.13,,,,,,,NA,NA,,CD95 death-inducing signaling complex,heat shock protein binding,apoptotic process,,
Q96CS3,Q96CS3,FAS-associated factor 2,FAF2,100.38,100.38,Y79,PPSRPLQVNTADHRIYSYVVSRPQPRGLLGW,_IY(ph)SYVVSRPQPR_,1.51, ,1.32, , , , , ,0.54, ,-0.06, , , , , ,1.51,1.32,,,0.54,-0.06,,, +,,,,,,NA,NA,,Cdc48p-Npl4p-Ufd1p AAA ATPase complex,ubiquitin binding,response to unfolded protein,,
Q5T8I3-2,Q5T8I3,Protein FAM102B,FAM102B,274.97,273.51,S320,DIVEKILQSQDFSLDSSAEEEGLRLFVGPGG,_ILQSQDFSLDS(ph)S(ph)AEEEGLR_,0.59,0.27,0.38, ,0.11,0.12,0.05,0.15,0.24,0.37,0.22, ,0.3,0.39,0.28,0.26,0.44,0.38,0.11,0.1,0.3,0.22,0.34,0.27,,,,,,,0,0,,,,,,
Q5T8I3-2,Q5T8I3,Protein FAM102B,FAM102B,274.97,273.51,S321,IVEKILQSQDFSLDSSAEEEGLRLFVGPGGS,_ILQSQDFSLDS(ph)S(ph)AEEEGLR_,0.59,0.27,0.38, ,0.11,0.12,0.05,0.15,0.24,0.37,0.22, ,0.3,0.39,0.28,0.26,0.44,0.38,0.11,0.1,0.3,0.22,0.34,0.27,,,,,,,0,0,,,,,,
Q96BN8,Q96BN8,Protein FAM105B,FAM105B,249.97,249.38,Y56,PRPEMQCPAEHEEDMYRAADEIEKEKELLIH,_AAASGQPRPEMQCPAEHEEDMY(ph)RAADEIEK_,1.4, ,1.75, , , , , ,0.39, ,-0.61, , , , , ,1.4,1.75,,,0.39,-0.61,,, +,,,,,,NA,NA,,,,,,
F8WCJ2,Q9H098,Protein FAM107B,FAM107B,248.18,247.28,Y6,__________MAEPDYIEDDNPELIRPQKLI,_(ac)AEPDY(ph)IEDDNPELIRPQK_,4.26, , , , , , , ,3.47, , , , , , , ,4.26,,,,3.47,,,, +, +,,,,,NA,NA,,,,,,
Q8IWE2,Q8IWE2,Protein NOXP20,FAM114A1,105.4,105.4,S196,VPEITDAATDQGPAESPPTSPSSASRGMLSA,_IHGVNSGSSEGAQPNTENGVPEITDAATDQGPAES(ph)PPT(ph)SPSSASR_, ,-0.35,0.62,0.68,1.07,1.31,1.42,1, ,0.4,1.04,1.82,1.38,1.44,1.95,1.37,-0.35,0.65,1.2,1.22,0.4,1.48,1.41,1.69, +, +,,,,,2,1,21.3,cytoplasm,nucleotide binding,mRNA 3'-end processing,,
Q9NZB2-4,Q9NZB2,Constitutive coactivator of PPAR-gamma-like protein 1,FAM120A,144.55,143.99,S1044,KELKSKSGESKSSAMSSDGSLAENGVMAEEK,_SSAMS(ph)S(ph)DGS(ph)LAENGVMAEEK_, , , , ,0.02,-0.28,-0.02,-0.12, , , , ,-0.05,-0.39,-0.01,-0.07,,,-0.12,-0.07,,,-0.21,-0.04,,,,,,,NA,NA,,cytoplasm,RNA binding,,,
Q9NZB2-4,Q9NZB2,Constitutive coactivator of PPAR-gamma-like protein 1,FAM120A,144.55,143.99,S1045,ELKSKSGESKSSAMSSDGSLAENGVMAEEKP,_SSAMS(ph)S(ph)DGS(ph)LAENGVMAEEK_, , , , ,0.02,-0.28,-0.02,-0.12, , , , ,-0.05,-0.39,-0.01,-0.07,,,-0.12,-0.07,,,-0.21,-0.04,,,,,,,NA,NA,,cytoplasm,RNA binding,,,
Q9NZB2-4,Q9NZB2,Constitutive coactivator of PPAR-gamma-like protein 1,FAM120A,144.55,143.99,S1048,SKSGESKSSAMSSDGSLAENGVMAEEKPAPQ,_SSAMS(ph)S(ph)DGS(ph)LAENGVMAEEK_, , , , ,0.02,-0.28,-0.02,-0.12, , , , ,-0.05,-0.39,-0.01,-0.07,,,-0.12,-0.07,,,-0.21,-0.04,,,,,,,NA,NA,,cytoplasm,RNA binding,,,
Q96E09,Q96E09,Protein FAM122A,FAM122A,101.3,101.3,S143,VEKSASPKRIDFIPVSPAPSPTRGIGKQCFS,_RIDFIPVS(ph)PAPS(ph)PTR_,-0.33,-0.42,0.5,0.6,-0.52,-0.52,-0.41,-0.19,0.22,0.18,1.34,1.47,-0.91,-0.6,-0.26,-0.32,-0.37,0.55,-0.52,-0.29,0.2,1.41,-0.75,-0.29,, +,,,,,0,4,38.34,,,,,
Q96E09,Q96E09,Protein FAM122A,FAM122A,101.3,101.3,S147,ASPKRIDFIPVSPAPSPTRGIGKQCFSPSLQ,_RIDFIPVS(ph)PAPS(ph)PTR_,-0.33,-0.42,0.5,0.6,-0.39,-0.52,-0.34,-0.19,0.22,0.18,1.34,1.47,-0.92,-0.6,-0.24,-0.32,-0.37,0.55,-0.45,-0.26,0.2,1.41,-0.75,-0.28,, +,,,,,0,4,28.33,,,,,
Q7Z309-5,Q7Z309,Protein FAM122B,FAM122B,140.4,140.4,S115,PEKLYSPKRIDFTPVSPAPSPTRGFGKMFVS,_RIDFTPVS(ph)PAPS(ph)PTR_,0.65,0.46,0.78,1.01,0.18,0.17,0.33,0.39,-0.09,-0.04,0.46,0.57,-0.12,-0.44,-0.12,-0.21,0.56,0.9,0.18,0.36,-0.06,0.51,-0.27,-0.16,,,,,,,0,0,,,,,,
Q7Z309-5,Q7Z309,Protein FAM122B,FAM122B,140.4,140.4,S119,YSPKRIDFTPVSPAPSPTRGFGKMFVSSSGL,_RIDFTPVS(ph)PAPS(ph)PTR_,0.7,0.46,0.78,0.97,0.18,0.29,0.32,0.52,-0.1,-0.04,0.46,0.29,-0.12,-0.39,-0.08,-0.18,0.59,0.88,0.24,0.43,-0.07,0.38,-0.25,-0.13,,,,,,,0,0,,,,,,
Q7Z309-5,Q7Z309,Protein FAM122B,FAM122B,122.97,122.97,T121,PKRIDFTPVSPAPSPTRGFGKMFVSSSGLPP,_RIDFTPVS(ph)PAPSPT(ph)R_, , , , , , ,0.34,0.09, , , , , , ,-0.16,-0.43,,,,0.22,,,,-0.29,,,,,,,NA,NA,,,,,,
E9PLL0,Q96EY5,Multivesicular body subunit 12A,FAM125A,166.38,152.96,S170,PVPKPRGLSRDMQGLSLDAASQPSKGGLLER,_DMQGLS(ph)LDAASQPSK_, , , , ,0.25, ,0.45,0.5, , , , ,0.23, ,0.42,0.68,,,0.25,0.47,,,0.23,0.56,,,,,,,NA,NA,,cytoplasm,,,,
Q9BZQ8,Q9BZQ8,Protein Niban,FAM129A,120.9,111.84,S926,VKEGEGGQESFPELPSEE_____________,_EGEGGQESFPELPS(ph)EE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,negative regulation of protein phosphorylation,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,257.36,255.37,S692,PAGESPQPKAAPEASSPPASPLQHLLPGKAV,_AAPEASS(ph)PPAS(ph)PLQHLLPGK_,0.05,0.29,-0.33,-0.25,1.03,1.11,1.25,1.2,-0.04,0.27,-0.42,-0.23,0.78,0.95,1.45,1.4,0.17,-0.29,1.07,1.22,0.12,-0.32,0.86,1.42, +, +,,,,,2,2,35.49,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,257.36,255.37,S696,SPQPKAAPEASSPPASPLQHLLPGKAVDLGP,_AAPEASS(ph)PPAS(ph)PLQHLLPGK_,0.14,0.23,1.37,1.5,1.42,1.44,1.27,1.21,0.33,0.38,1.36,1.35,1.51,1.6,1.48,1.42,0.18,1.44,1.43,1.24,0.36,1.35,1.56,1.45, +, +,,,,,1,1,37.61,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,228.5,228.16,S624,SATLSEKRRRAKQVVSVVQDEEVGLPFEASP,_QVVS(ph)VVQDEEVGLPFEASPES(ph)PPPAS(ph)PDGVTEIR_, , , , ,2.38,1.43,1.67,0.87, , , , ,2.07,1.16,0.51,0.86,,,1.98,1.32,,,1.69,0.7, +, +,,,,,NA,NA,,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,165.09,164.99,S638,VSVVQDEEVGLPFEASPESPPPASPDGVTEI,_(gl)QVVSVVQDEEVGLPFEAS(ph)PES(ph)PPPASPDGVTEIR_, ,0.3, , , , ,1.55, , ,0.68, , , , ,1.8, ,0.3,,,1.55,0.68,,,1.8, +, +,,,,,NA,NA,,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,235.85,235.34,S641,VQDEEVGLPFEASPESPPPASPDGVTEIRGL,_QVVS(ph)VVQDEEVGLPFEASPES(ph)PPPAS(ph)PDGVTEIR_,0.36,0.05,2.13,1.2,1.82,1.17,1.58,1.5,0.61,0.87,2,1.29,1.99,1.09,1.76,1.74,0.21,1.74,1.53,1.54,0.75,1.69,1.61,1.75, +, +,,,,,1,1,32.21,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,235.85,235.34,S646,VGLPFEASPESPPPASPDGVTEIRGLLAQGL,_QVVS(ph)VVQDEEVGLPFEASPES(ph)PPPAS(ph)PDGVTEIR_,-0.06,0.18,1.33,1.29,1.82,0.98,1.19,1.47,0.73,0.91,1.15,1.12,1.99,0.96,1.12,1.35,0.07,1.31,1.46,1.34,0.82,1.14,1.57,1.24, +, +,,,,,1,1,26.35,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,326.62,326.62,S665,VTEIRGLLAQGLRPESPPPAGPLLNGAPAGE,_GLLAQGLRPES(ph)PPPAGPLLNGAPAGESPQPK_,0.19,0.26,0.47,0.56,0.69,0.52,0.27, ,0.04,0.11,0.42,0.42,0.52,0.52,0.11, ,0.23,0.52,0.61,0.27,0.07,0.42,0.52,0.11,,,,,,,0,0,,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
Q96TA1-2,Q96TA1,Niban-like protein 1,FAM129B,326.62,326.62,S681,PPPAGPLLNGAPAGESPQPKAAPEASSPPAS,_GLLAQGLRPES(ph)PPPAGPLLNGAPAGES(ph)PQPK_,0.07,0.01,0.16,0.18,-0.03,0.12,0.27, ,-0.11,-0.15,-0.06,-0.09,0.15,0.15,0.11, ,0.04,0.17,0.04,0.27,-0.13,-0.08,0.15,0.11,,,,,,,0,0,,adherens junction,phospholipid binding,negative regulation of apoptotic process,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,272.31,265.37,S385,DLLGRPQALSRQALDSEEEEEDVAAKETLLR,_(gl)QALDS(ph)EEEEEDVAAK_,-0.17,-0.19,-0.21,-0.19,0,0.15,-0.07,0.01,0.15,-0.01,0.05,0.04,0.01,0.31,0.11,0.04,-0.18,-0.2,0.08,-0.03,0.07,0.04,0.17,0.08,,,,,,,0,0,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,116.64,115.75,S337,GFSVSRATTPQLTDVSEDLDQQSLPSEPEET,_ATT(ph)PQLT(ph)DVS(ph)EDLDQQSLPSEPEETLSR_, , , , , ,0.31,-0.2,0.41, , , , , ,0.14,-0.06,-0.05,,,0.31,0.14,,,0.14,-0.05,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,144.14,142.96,S344,TTPQLTDVSEDLDQQSLPSEPEETLSRDLGE,_ATT(ph)PQLTDVSEDLDQQS(ph)LPS(ph)EPEETLSR_, , , , ,0.07, , ,0.18, , , , ,-0.03, , ,0.33,,,0.07,0.18,,,-0.03,0.33,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,144.14,142.96,S347,QLTDVSEDLDQQSLPSEPEETLSRDLGEGEE,_ATT(ph)PQLTDVSEDLDQQS(ph)LPS(ph)EPEETLSR_, , , , ,0.07, , ,0.18, , , , ,-0.03, , ,0.33,,,0.07,0.18,,,-0.03,0.33,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,116.64,115.75,T334,ESGGFSVSRATTPQLTDVSEDLDQQSLPSEP,_ATT(ph)PQLT(ph)DVS(ph)EDLDQQSLPSEPEETLSR_, , , , , ,0.31,-0.2,0.41, , , , , ,0.14,-0.06,-0.05,,,0.31,0.14,,,0.14,-0.05,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,103.73,95.84,S281,KNAPPGGDEPLAETESESEAELAGFSPVVDV,_NAPPGGDEPLAET(ph)ES(ph)ES(ph)EAELAGFSPVVDVK_, , , , ,-0.09,0.02,-0.39,-0.2, , , , ,0.05,-0.01,-0.19,-0.02,,,-0.04,-0.29,,,0.02,-0.1,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,73.04,73.01,S283,APPGGDEPLAETESESEAELAGFSPVVDVKK,_NAPPGGDEPLAET(ph)ES(ph)ES(ph)EAELAGFSPVVDVK_, , , , ,-0.09,0.02, ,-0.34, , , , ,0.05,-0.01, ,0.32,,,-0.04,-0.34,,,0.02,0.32,,,,,,,NA,NA,,,,,,
E7EUL4,Q8NC44,Protein FAM134A,FAM134A,103.73,95.84,T279,QGKNAPPGGDEPLAETESESEAELAGFSPVV,_NAPPGGDEPLAET(ph)ES(ph)ES(ph)EAELAGFSPVVDVK_, , , , ,-0.09,0.02,-0.39,-0.2, , , , ,0.05,-0.01,-0.19,-0.02,,,-0.04,-0.29,,,0.02,-0.1,,,,,,,NA,NA,,,,,,
Q86VR2,Q86VR2,Protein FAM134C,FAM134C,164.77,164.77,S313,GTFNLSRGQTPLTEGSEDLDGHSDPEESFAR,_GQT(ph)PLT(ph)EGS(ph)EDLDGHS(ph)DPEESFAR_,-0.22,0.01,-0.24,-0.31,0.04,-0.03,0.01,-0.02,-0.16,-0.08,-0.11,-0.23,-0.16,-0.09,-0.19,-0.22,-0.1,-0.28,0.01,0,-0.12,-0.17,-0.12,-0.2,,,,,,,0,0,,integral to membrane,,,,
Q86VR2,Q86VR2,Protein FAM134C,FAM134C,202.81,189.98,S320,GQTPLTEGSEDLDGHSDPEESFARDLPDFPS,_GQTPLTEGSEDLDGHS(ph)DPEESFAR_,-0.22,-0.3,-0.34,-0.37,-0.22,-0.02,-0.05,-0.22,-0.16,-0.1,0.02,-0.14,0.04,0.05,0.06,0.17,-0.26,-0.35,-0.11,-0.13,-0.13,-0.06,0.05,0.12,,,,,,,0,0,,integral to membrane,,,,
Q86VR2,Q86VR2,Protein FAM134C,FAM134C,144.55,133.44,T307,VSCTDNGTFNLSRGQTPLTEGSEDLDGHSDP,_GQT(ph)PLT(ph)EGS(ph)EDLDGHS(ph)DPEESFAR_,-0.17,-0.17, , ,-0.4,-0.14,-0.24,-0.02,-0.13,-0.21, , ,-0.48,0.04,-0.15,0.05,-0.17,,-0.26,-0.12,-0.17,,-0.2,-0.05,,,,,,,NA,NA,,integral to membrane,,,,
Q86VR2,Q86VR2,Protein FAM134C,FAM134C,140.61,140.61,T310,TDNGTFNLSRGQTPLTEGSEDLDGHSDPEES,_GQT(ph)PLT(ph)EGS(ph)EDLDGHS(ph)DPEESFAR_,-0.17,-0.04,0.45,0.05,0.06,-0.13,0.04,0.07,-0.13,-0.08,0.31,0.27,-0.08,0.03,-0.21,-0.13,-0.1,0.27,-0.03,0.05,-0.11,0.29,-0.02,-0.17,,,,,,,0,0,,integral to membrane,,,,
Q86VR2,Q86VR2,Protein FAM134C,FAM134C,56.76,56.71,T440,RATRGFLRSPSSDLDTDAEGDDFELLDQSEL,_SPS(ph)S(ph)DLDT(ph)DAEGDDFELLDQSELSQLDPASSR_, , , , ,0.45, , ,0.21, , , , ,0.53, , ,0.21,,,0.45,0.21,,,0.53,0.21,,,,,,,NA,NA,,integral to membrane,,,,
D6RB01,Q9Y6X4,Protein FAM169A,FAM169A,56.77,54.95,S635,EQLDQFTQSAEKAVDSSSEEIEVEVPVVDRR,_AVDS(ph)S(ph)SEEIEVEVPVVDRR_, , , , ,1.17, , , , , , , ,3.65, , , ,,,1.17,,,,3.65,, +, +,,,,,NA,NA,,,,,,
D6RB01,Q9Y6X4,Protein FAM169A,FAM169A,56.77,54.95,S636,QLDQFTQSAEKAVDSSSEEIEVEVPVVDRRN,_AVDS(ph)S(ph)SEEIEVEVPVVDRR_, , , , ,1.17, , , , , , , ,3.65, , , ,,,1.17,,,,3.65,, +, +,,,,,NA,NA,,,,,,
D6REL5,Q6UWZ7,BRCA1-A complex subunit Abraxas,FAM175A,133.13,129.81,S406,DEEIEKMKGFGEYSRSPTF____________,_GFGEYSRS(ph)PTF_,-0.02,0.02,0.08,-0.08,-0.02, ,-0.08, ,-0.05,0.01,-0.07,-0.31,-0.18, ,-0.32, ,0,0,-0.02,-0.08,-0.02,-0.19,-0.18,-0.32,,,,,,,0,0,,,,,,
Q15018,Q15018,BRISC complex subunit Abro1,FAM175B,95.15,94.42,Y342,RSVFMPRPQAVGSSNYASTSAGLKYPGSGAD,_SVFMPRPQAVGSSNY(ph)ASTSAGLK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,BRISC complex,polyubiquitin binding,,,
B8ZZF5,Q9H8M9,Protein FAM176A,FAM176A,109.83,93.65,S114,RHRRFERTLNKNVFTSAEELERAQRLEERER,_NVFTS(ph)AEELER_,-0.83,0.46,1.17, , , ,-1.17,-1.54,-0.87,-0.98,-1.42, , , ,-0.76,-0.92,-0.05,1.17,,-1.34,-0.92,-1.42,,-0.84, +, +,,,,,NA,NA,,intracellular membrane-bounded organelle,,,,
G3V583,Q8N128,Protein FAM177A1,FAM177A1,93.57,93.26,S70,RRVIHFVSGETMEEYSTDEDEVDGLEKKDVL,_VIHFVSGETMEEYS(ph)T(ph)DEDEVDGLEK_, , , , ,-1.21,-0.3, ,-0.26, , , , ,-0.34,-0.07, ,-0.03,,,-0.69,-0.26,,,-0.2,-0.03,,,,,,,NA,NA,,,,,,
G3V583,Q8N128,Protein FAM177A1,FAM177A1,93.57,93.26,T71,RVIHFVSGETMEEYSTDEDEVDGLEKKDVLP,_VIHFVSGETMEEYS(ph)T(ph)DEDEVDGLEK_, , , , ,-1.21,-0.3, ,-0.26, , , , ,-0.34,-0.07, ,-0.03,,,-0.69,-0.26,,,-0.2,-0.03,,,,,,,NA,NA,,,,,,
Q8IX21,Q8IX21,Protein FAM178A,FAM178A,52.42,51.86,S710,QGRGIKSPIRIGEEDSTDDEDGLLEEHKEFL,_IGEEDS(ph)T(ph)DDEDGLLEEHK_,-0.26,-0.11,0.28, ,-0.14, ,0.21,0.43,0.04,0.15,0.03, ,0.22, ,0.46,0.42,-0.18,0.28,-0.14,0.32,0.1,0.03,0.22,0.44,,,,,,,0,0,,,,,,
Q8IX21,Q8IX21,Protein FAM178A,FAM178A,52.42,51.86,T711,GRGIKSPIRIGEEDSTDDEDGLLEEHKEFLK,_IGEEDS(ph)T(ph)DDEDGLLEEHK_,-0.26,-0.11,0.28, ,-0.14, ,0.21,0.43,0.04,0.15,0.03, ,0.22, ,0.46,0.42,-0.18,0.28,-0.14,0.32,0.1,0.03,0.22,0.44,,,,,,,0,0,,,,,,
Q96ET8-3,Q9NYZ1,Protein FAM18B1,FAM18B1,199.3,199.3,S6,__________MLQQDSNDDTEDVSLFDAEEE,_(ac)MLQQDS(ph)NDDTEDVSLFDAEEETTNRPR_, , , , , , ,0.54,0.91, , , , , , ,0.39,0.57,,,,0.73,,,,0.48,,,,,,,NA,NA,,integral to membrane,,,,
Q9UK61-2,Q9UK61,Protein FAM208A,FAM208A,70.03,69.79,S633,KLKELFEENRKLQQFSPLSDYEGQEEEMNGT,_LQQFS(ph)PLS(ph)DYEGQEEEMNGTK_, , , , ,-0.39,-0.4,-0.07,-0.09, , , , ,-0.32,-0.09,0.05,-0.2,,,-0.39,-0.08,,,-0.2,-0.07,,,,,,,NA,NA,,,,,,
Q9UK61-2,Q9UK61,Protein FAM208A,FAM208A,70.03,69.79,S636,ELFEENRKLQQFSPLSDYEGQEEEMNGTKMK,_LQQFS(ph)PLS(ph)DYEGQEEEMNGTK_, , , , ,-0.39,-0.4,-0.07,-0.09, , , , ,-0.32,-0.09,0.05,-0.2,,,-0.39,-0.08,,,-0.2,-0.07,,,,,,,NA,NA,,,,,,
O75063,O75063,Glycosaminoglycan xylosylkinase,FAM20B,47.77,45.78,Y138,KPKRYSRDHVVEGEPYAGYDRHNAEVAAFHL,_DHVVEGEPY(ph)AGYDR_, , ,-0.37, , , , , , , ,-0.75, , , , , ,,-0.37,,,,-0.75,,,,,,,,,NA,NA,,Golgi apparatus,ATP binding,,,
Q5XKK7,Q5XKK7,Protein FAM219B,FAM219B,171.23,169.61,S125,TALSQSPDENLVSLDSDSDGELGSRYSSGYS,_GYTALSQSPDENLVSLDS(ph)DS(ph)DGELGSR_, , , , ,-0.61,-0.67,-0.64,-0.56, , , , ,-0.01,-0.34,-0.12,-0.43,,,-0.64,-0.6,,,-0.17,-0.27,,,,,,,NA,NA,,,,,,
Q5XKK7,Q5XKK7,Protein FAM219B,FAM219B,171.23,169.61,S127,LSQSPDENLVSLDSDSDGELGSRYSSGYSSA,_GYTALSQSPDENLVSLDS(ph)DS(ph)DGELGSR_, , , , ,-0.61,-0.67,-0.64,-0.56, , , , ,-0.01,-0.34,-0.12,-0.43,,,-0.64,-0.6,,,-0.17,-0.27,,,,,,,NA,NA,,,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,110.35,104.07,S802,SPWDKGTKPRTKTVLSLFDEEEDKMEDQNII,_TVLS(ph)LFDEEEDK_, , , , , , , ,2.39, , , , , , , ,1.61,,,,2.39,,,,1.61, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,124.37,118.1,S284,EEDIEDIEENTRPKRSRPTSFADELAARIKG,_S(ph)RPTS(ph)FADELAAR_, , ,3.23,2.52,1.47,1.75,1.76,1.63, , ,3.43,2.56,1.67,2.17,2.13,1.69,,2.92,1.62,1.7,,3.06,1.94,1.93, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,124.37,118.1,S288,EDIEENTRPKRSRPTSFADELAARIKGDAMG,_S(ph)RPTS(ph)FADELAAR_, , ,3.6,2.8,1.12,1.72,1.97,1.24, , ,3.7,2.82,1.21,2.17,2.13,1.24,,3.25,1.45,1.65,,3.33,1.77,1.75, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,122.87,120.44,T287,IEDIEENTRPKRSRPTSFADELAARIKGDAM,_S(ph)RPT(ph)SFADELAAR_, , ,3.23,2.52,1.47,3.02,1.76,1.63, , ,3.23,2.56,1.67,3.35,2.13,1.69,,2.92,2.44,1.7,,2.93,2.74,1.93, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,205.83,204.9,S158,VLDSAFEQLDIKAGNSDSEEDDANGRVELIL,_AGNS(ph)DS(ph)EEDDANGRVELILEPK_, , , , ,0.17,-1.95,-1.29,-1.72, , , , ,-0.32,-2.18,-1.23,-1.81,,,-0.53,-1.49,,,-0.96,-1.49, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,205.83,204.9,S160,DSAFEQLDIKAGNSDSEEDDANGRVELILEP,_AGNS(ph)DS(ph)EEDDANGRVELILEPK_, , , , ,0.17,-1.95,-1.29,-1.72, , , , ,-0.32,-2.18,-1.23,-1.81,,,-0.53,-1.49,,,-0.96,-1.49, +, +,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,305.63,300.91,S333,KPRKTLKEKKERRTPSDDEEDNLFAPPKLTD,_TPS(ph)DDEEDNLFAPPK_,0.04,0.05,0.07,-0.01,0.12,0.12,-0.03,0.13,2.4,1.01,0.4,0.28,0.23,0.28,0.23,0.24,0.04,0.03,0.12,0.05,1.86,0.34,0.26,0.23,, +,,,,,0,5,2.11,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,174.06,170.82,S230,RGSIVDTEEEKEEEESDEDFAHHSDNEQNRH,_EEEES(ph)DEDFAHHS(ph)DNEQNR_,-0.07,0,0.05,-0.31,-0.05,0.13,-0.07,0,-0.11,0.02,0.06,-0.29,0.2,0.11,0.1,-0.07,-0.03,-0.12,0.04,-0.04,-0.04,-0.1,0.16,0.01,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,174.06,170.82,S238,EEKEEEESDEDFAHHSDNEQNRHTTQMSDEE,_EEEES(ph)DEDFAHHS(ph)DNEQNR_,-0.07,0,0.05,-0.31,-0.05,0.13,-0.07,0,-0.11,0.02,0.06,-0.29,0.2,0.11,0.1,-0.07,-0.03,-0.12,0.04,-0.04,-0.04,-0.1,0.16,0.01,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,307.94,305.45,S539,NLKPSSETKTQKGLFSDEEDSEDLFSSQSAS,_GLFS(ph)DEEDSEDLFSSQSASK_,0.23,0.11,0.61, ,-0.22,0.05,0.06,0.13,-0.06,-0.06,0.41, ,0.19,0.13,-0.1,0.17,0.17,0.61,-0.08,0.1,-0.06,0.41,0.16,0.04,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,201.84,200.07,S619,KASELSKKKASALLFSSDEEDQWNIPASQTH,_ASALLFS(ph)S(ph)DEEDQWNIPASQTHLASDSR_,0,-0.12,-0.06,0.12,0.26,0.3,0.09,-0.16,-0.19,-0.16,0.04,0.1,0.59,0.04,0.11,-0.02,-0.06,0.04,0.28,-0.03,-0.17,0.07,0.34,0.05,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,201.84,200.07,S620,ASELSKKKASALLFSSDEEDQWNIPASQTHL,_ASALLFS(ph)S(ph)DEEDQWNIPASQTHLASDSR_,0,-0.12,-0.06,0.12,0.26,0.3,0.09,-0.16,-0.19,-0.16,0.04,0.1,0.59,0.04,0.11,-0.02,-0.06,0.04,0.28,-0.03,-0.17,0.07,0.34,0.05,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,140.73,128.98,S728,TKKKETVSEAPPLLFSDEEEKEAQLGVKSVD,_ETVSEAPPLLFS(ph)DEEEK_,0.19,0.04,0.31,0.44,0.41,0.46,0.28,0.36,0.29,0.15,0.55,0.45,0.58,0.86,0.44,0.41,0.12,0.38,0.43,0.32,0.22,0.5,0.73,0.42,,,,,,,0,0,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,36.48,34.09,S498,FGDEEGDLFKEKAVASPEATVSQTDENKARA,_AVAS(ph)PEATVSQTDENK_, , , , , , ,-0.17, , , , , , , ,-0.29, ,,,,-0.17,,,,-0.29,,,,,,,NA,NA,,WASH complex,,,,
E7ESD2,Q641Q2,WASH complex subunit FAM21A,FAM21A,249.85,247.55,S352,EDNLFAPPKLTDEDFSPFGSGGGLFSGGKGL,_LTDEDFS(ph)PFGSGGGLFSGGK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,WASH complex,,,,
F5H0J6,Q9Y4E1,WASH complex subunit FAM21C,FAM21C,313.03,306.67,S539,NLKPSSETKTQKGLFSDEEDSEDLFSSQSAS,_GLFS(ph)DEEDSEDLFSSQSASNLK_, , , , ,-0.17,-0.37,-0.15,-0.09, , , , ,0.08,0.07,0.02,0.17,,,-0.27,-0.12,,,0.07,0.1,,,,,,,NA,NA,,,,,,
Q5VY60,Q7Z4H7,HAUS augmin-like complex subunit 6,FAM29A,50.24,50.24,T584,SLGSNPFLTRNQIPRTPENLITEIRSSWRKA,_NQIPRT(ph)PENLITEIR_, , ,0.99, , , , , , , ,1.09, , , , , ,,0.99,,,,1.09,,,, +,,,,,NA,NA,,centrosome,,centrosome organization,,
Q5VY60,Q7Z4H7,HAUS augmin-like complex subunit 6,FAM29A,108.77,106.92,S552,QDHLVEEVARAVLSDSPQLSEGKEIKLEELI,_AVLSDS(ph)PQLSEGK_, , ,0.32, ,-0.13, ,-0.19,0, , ,0.03, ,-0.22, ,-0.29,-0.16,,0.32,-0.13,-0.09,,0.03,-0.22,-0.22,,,,,,,NA,NA,,centrosome,,centrosome organization,,
Q5VSL9,Q5VSL9,Protein FAM40A,FAM40A,108.39,107.63,S59,PGGKAREFNRNQRKDSEGYSESPDLEFEYAD,_KDS(ph)EGYSESPDLEFEYADTDK_, , ,1.68,1.5, , , , , , ,1.86,1.6, , , , ,,1.59,,,,1.74,,, +, +,,,,,NA,NA,,cytoplasm,,cortical actin cytoskeleton organization,,
Q5VSL9,Q5VSL9,Protein FAM40A,FAM40A,192.12,191.45,S335,LPEDSIKVIRNMRAASPPASASDLIEQQQKR,_AAS(ph)PPASASDLIEQQQK_,0.07,0.15,0.01,0.01,-0.03,0.09,0.11,0.13,0.05,0.12,0.01,0.03,0.05,0.22,0.19,0.18,0.11,0.01,0.03,0.12,0.09,0.02,0.14,0.18,,,,,,,0,0,,cytoplasm,,cortical actin cytoskeleton organization,,
Q9NYF3,Q9NYF3,Protein FAM53C,FAM53C,105.06,105.06,S232,SDAESLSPCPPQRRFSLSPSLGPQASRFLPS,_FS(ph)LS(ph)PSLGPQASR_,0.28,0.62,0.21,0.37,0.18,0.16,-0.05,0.23,-0.1,-0.04,-0.23,-0.1,-0.31,0.12,0.03,0.2,0.46,0.29,0.17,0.1,-0.07,-0.16,-0.08,0.12,,,,,,,0,0,,,,,,
Q9NYF3,Q9NYF3,Protein FAM53C,FAM53C,105.06,105.06,S234,AESLSPCPPQRRFSLSPSLGPQASRFLPSAR,_RFS(ph)LS(ph)PSLGPQASR_,0.28,0.62,0.18,0.37,0.18,0.29,-0.05,0.23,-0.1,-0.04,-0.15,-0.1,-0.31,0.18,0.03,0.2,0.46,0.28,0.24,0.1,-0.07,-0.12,-0.04,0.12,,,,,,,0,0,,,,,,
Q9NYF3,Q9NYF3,Protein FAM53C,FAM53C,86.94,75.23,S299,GVKRRHEEDPRRLRPSLDFDKMNQKPYSGGL,_LRPS(ph)LDFDK_,0.31, , , , , , , ,0.89, , , , , , , ,0.31,,,,0.89,,,,,,,,,,NA,NA,,,,,,
Q9NYF3,Q9NYF3,Protein FAM53C,FAM53C,77.64,77.64,S122,PVPPAPPSKRHCRSLSVPVDLSRWQPVWRPA,_SLS(ph)VPVDLSR_,-0.18,-0.01,0.25,0.16,-0.03,0.07,0.22,0.46,-0.04,0.09,0.39,0.61,-0.41,-0.03,0.14,0.27,-0.1,0.21,0.02,0.35,0.03,0.5,-0.21,0.21,,,,,,,0,0,,,,,,
Q9H706-3,Q9H706,Protein FAM59A,FAM59A,108.47,32.4,Y74,RQWTTITAHSLEEGHYVIGPKIEIPVHYAGQ,_QWTTITAHSLEEGHY(ph)VIGPK_,1.72, , , , , , , ,1.51, , , , , , , ,1.72,,,,1.51,,,, +, +,,,,,NA,NA,,plasma membrane,proline-rich region binding,cellular response to epidermal growth factor stimulus,,
Q9H706-3,Q9H706,Protein FAM59A,FAM59A,222.92,222.73,Y453,ASEESAGIPGKSELPYEELWLEEGKPSHQPL,_SELPY(ph)EELWLEEGKPSHQPLTR_,4.36,4.21,4.14,3.56,4.06,4.24,3.82,3.84,4.38,4.35,4.25,3.52,4.02,4.17,4,3.9,4.29,3.88,4.15,3.83,4.37,3.93,4.1,3.95, +, +,,,,,5,5,65.16,plasma membrane,proline-rich region binding,cellular response to epidermal growth factor stimulus,,
Q9H706-3,Q9H706,Protein FAM59A,FAM59A,89.62,86.55,Y767,EEDPKSGSPDLSEDQYFVKKGMQDIFSASYP,_SGSPDLSEDQY(ph)FVKK_,2.46, , , , , , , ,2.64, , , , , , , ,2.46,,,,2.64,,,, +, +,,,,,NA,NA,,plasma membrane,proline-rich region binding,cellular response to epidermal growth factor stimulus,,
Q7L4E1,Q7L4E1,Protein FAM73B,FAM73B,174.39,168.89,S276,LLDLERTLMLPLTEGSLRLRADDEDSLTSED,_TLMLPLTEGS(ph)LR_,0.25,0.3,0.15,-0.05, ,0.2,0.31, ,0.19,0.15,0.06,0, ,-0.35,0.13, ,0.27,0.05,0.2,0.31,0.17,0.03,-0.35,0.13,,,,,,,0,0,,integral to membrane,,,,
Q5HYJ3-2,Q5HYJ3,Protein FAM76B,FAM76B,264.66,264.66,S193,HHHRHSSSHHKISNLSPEEEQGLWKQSHKSS,_ISNLS(ph)PEEEQGLWK_,-0.23,-0.24,-0.4,-0.28,0.25,0.09,-0.14,-0.01,-0.17,-0.12,-0.24,-0.19,0.16,-0.09,0.03,-0.11,-0.24,-0.34,0.17,-0.08,-0.14,-0.22,0.04,-0.04,,,,,,,0,0,,nuclear speck,,,,
H0YNE5,Q96TC7,Regulator of microtubule dynamics protein 3,FAM82A2,254.11,253.66,S46,YSQRWKRTQRHGRSQSLPNSLDYTQTSDPGR,_SQS(ph)LPNSLDYTQTSDPGR_,0.22,0.25,0.08,0.09,0.39,0.66,0.66,0.19,0.24,0.29,0.13,0.2,0.48,0.73,0.89,0.6,0.24,0.08,0.53,0.44,0.26,0.17,0.61,0.75,,,,,,,0,0,,,,,,
Q9BXW9-2,Q9BXW9,Fanconi anemia group D2 protein,FANCD2,173.4,171.07,S1412,EEIKSQNSQESTADESEDDMSSQASKSKATE,_SQNSQESTADES(ph)EDDMSSQASK_,-0.27,-0.48,-0.4, ,-0.12,-0.1,-0.17,-0.26,0.08,-0.12,0.2, ,-0.08,0.01,-0.05,-0.09,-0.37,-0.4,-0.11,-0.21,-0.02,0.2,-0.03,-0.07,,,,,,,0,0,,condensed chromosome,,DNA repair,,
Q9HB96,Q9HB96,Fanconi anemia group E protein,FANCE,120.73,118.86,S249,PEHKSLESLADGGSASPIKDQPVMAVKTGED,_SLESLADGGSAS(ph)PIK_, ,-0.26,0,-0.29,-0.38, , ,-0.06, ,-0.27,0,-0.38,-0.31, , ,0.13,-0.26,-0.14,-0.38,-0.06,-0.27,-0.18,-0.31,0.13,,,,,,,0,0,,Fanconi anaemia nuclear complex,,DNA repair,,
F8W7R3,Q9NVI1,Fanconi anemia group I protein,FANCI,99.16,75.45,S407,SYGPKKVLDGKTIETSPSLSRMPNQHACKLG,_TIETS(ph)PSLSR_,0.05,0.12, , , , , , ,-0.2,-0.05, , , , , , ,0.09,,,,-0.12,,,,,,,,,,NA,NA,,nucleus,,DNA repair,,
Q9Y4F1-2,Q9Y4F1,"FERM, RhoGEF and pleckstrin domain-containing protein 1",FARP1,59.74,49.39,S20,EQRPTPGSRLGAPENSGISTLERGQKPPPTP,_LGAPENS(ph)GIS(ph)T(ph)LER_, , , , , , , ,-1.1, , , , , , , ,-0.54,,,,-1.1,,,,-0.54, +,,,,,,NA,NA,,cell junction,phospholipid binding,dendrite morphogenesis,,
Q9Y4F1-2,Q9Y4F1,"FERM, RhoGEF and pleckstrin domain-containing protein 1",FARP1,59.74,49.39,S23,PTPGSRLGAPENSGISTLERGQKPPPTPSGK,_LGAPENS(ph)GIS(ph)T(ph)LER_, , , , , , , ,-1.1, , , , , , , ,-0.54,,,,-1.1,,,,-0.54, +,,,,,,NA,NA,,cell junction,phospholipid binding,dendrite morphogenesis,,
Q9Y4F1-2,Q9Y4F1,"FERM, RhoGEF and pleckstrin domain-containing protein 1",FARP1,181.94,166.4,T24,TPGSRLGAPENSGISTLERGQKPPPTPSGKL,_LGAPENS(ph)GIS(ph)T(ph)LER_,-0.14,-0.13,-0.33,-0.3,-0.19,-0.39,-0.14,-0.13,0.89,0.99,1.07,1.12,-0.13,-0.25,-0.11,-0.13,-0.13,-0.32,-0.28,-0.14,0.94,1.1,-0.19,-0.12,, +,,,,,0,5,14.23,cell junction,phospholipid binding,dendrite morphogenesis,,
Q9Y4F1-2,Q9Y4F1,"FERM, RhoGEF and pleckstrin domain-containing protein 1",FARP1,306.33,304.26,S889,PDNKSPDEATAADQESEDDLSASRTSLERQA,_SPDEATAADQES(ph)EDDLSASR_,-0.27,-0.3,-0.42,-0.58,-0.63,-0.65,-0.67,-0.54,-0.1,-0.05,-0.21,-0.38,-0.29,-0.31,-0.15,-0.15,-0.29,-0.5,-0.64,-0.6,-0.07,-0.29,-0.3,-0.15,,,,,,,0,0,,cell junction,phospholipid binding,dendrite morphogenesis,,
P49327,P49327,Fatty acid synthase,FASN,157.11,151.47,Y2034,FSSVSCGRGNAGQSNYGFANSAMERICEKRR,_GNAGQSNY(ph)GFANSAMER_,-0.04, ,-0.36, , , , , ,-0.13, ,0.08, , , , , ,-0.04,-0.36,,,-0.13,0.08,,,,,,,,,NA,NA,,cytosol,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,acetyl-CoA metabolic process,,
P49327,P49327,Fatty acid synthase,FASN,108.96,94.74,T2204,ELSSKADEASELACPTPKEDGLAQQQTQLNL,_ADEASELACPT(ph)PK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,acetyl-CoA metabolic process,,
Q6V0I7-2,Q6V0I7,Protocadherin Fat 4,FAT4,271.34,264.74,S4876,MVYTSRMPKLSQVNESDADDEDNYGARLKPR,_LSQVNES(ph)DADDEDNYGAR_,-0.94, , , ,-0.52,-0.43,-0.29,-0.31,-0.15, , , ,-0.42,-0.24,-0.37,-0.33,-0.94,,-0.48,-0.3,-0.15,,-0.32,-0.35,,,,,,,NA,NA,,integral to membrane,calcium ion binding,homophilic cell adhesion,,
Q6PIJ6-2,Q6PIJ6,F-box only protein 38,FBXO38,128.03,124.89,S736,ASQSPDFVRTVNSGGSSEPSPTEVDVSRQCA,_TVNSGGS(ph)SEPS(ph)PTEVDVSR_, , , , ,-0.14, ,0, , , , , ,-0.11, ,-0.04, ,,,-0.14,0,,,-0.11,-0.04,,,,F box,,,NA,NA,,cytoplasm,,,,
Q6PIJ6-2,Q6PIJ6,F-box only protein 38,FBXO38,128.03,124.89,S740,PDFVRTVNSGGSSEPSPTEVDVSRQCACSPG,_TVNSGGS(ph)SEPS(ph)PTEVDVSR_, , , , ,-0.14,-0.21,0, , , , , ,-0.11,-0.03,-0.04, ,,,-0.18,0,,,-0.07,-0.04,,,,F box,,,NA,NA,,cytoplasm,,,,
D6RAU6,Q9UKT5,F-box only protein 4,FBXO4,135.43,134.57,S12,____MAGSEPRSGTNSPPPPFSDWGRLEAAI,_SGTNS(ph)PPPPFSDWGR_,0.44,0.9,0.53,1.02,-0.44,-0.59,0.41,-0.05,-0.08,-0.02,-0.11,-0.46,-0.94,-1.05,-0.36,-0.31,0.69,0.8,-0.51,0.2,-0.05,-0.27,-0.99,-0.34,,,,F box,,,0,0,,,,,,
Q5XUX1-3,Q5XUX1,F-box/WD repeat-containing protein 9,FBXW9,101.47,101.47,S59,GLAFSRPSQLSTPAASPSASEPRAASRVSAV,_SGLAFSRPSQLST(ph)PAAS(ph)PSASEPR_, ,0.03, , , , , , , ,-0.4, , , , , , ,0.03,,,,-0.4,,,,,,,,,,NA,NA,,,,,,
Q5XUX1-3,Q5XUX1,F-box/WD repeat-containing protein 9,FBXW9,340.53,339.62,S18,LPLGRCDDSRTWDDDSDPESETDPDAQAKAY,_TWDDDS(ph)DPESETDPDAQAK_,0.12,0.25,-0.06,0,-0.12,-0.31,-0.32,-0.03,0.59,0.39,0.48,0.68,-0.18,-0.09,0.25,0.22,0.18,-0.03,-0.21,-0.17,0.49,0.58,-0.14,0.24,,,,,,,0,0,,,,,,
Q5XUX1-3,Q5XUX1,F-box/WD repeat-containing protein 9,FBXW9,89.27,88.53,S22,RCDDSRTWDDDSDPESETDPDAQAKAYVARV,_TWDDDS(ph)DPES(ph)ETDPDAQAK_, , , , , ,-0.1, , , , , , , ,0.12, , ,,,-0.1,,,,0.12,,,,,,,,NA,NA,,,,,,
Q5XUX1-3,Q5XUX1,F-box/WD repeat-containing protein 9,FBXW9,101.47,101.47,T55,PPKSGLAFSRPSQLSTPAASPSASEPRAASR,_SGLAFSRPSQLST(ph)PAAS(ph)PSASEPR_, ,0.03, , , , , , , ,-0.4, , , , , , ,0.03,,,,-0.4,,,,,,,,,,NA,NA,,,,,,
E9PG79,Q0JRZ9,FCH domain only protein 2,FCHO2,94.75,56.27,S403,PAISRHSPVQMNRNLSNEELTKSKPSAPPNE,_NLS(ph)NEELTK_,0.2,0.2,-0.55,-0.21,0.35,0.47,0.24, ,0.01,0.26,0.07,0.37,0.32,0.52,0.42, ,0.2,-0.37,0.41,0.24,0.14,0.23,0.43,0.42,,,,,,,0,0,,,,,,
O94868,O94868,FCH and double SH3 domains protein 2,FCHSD2,146.76,145.66,Y659,SPSPKPHASLPPLPLYDQPPSSPYPSPDKRS,_PHASLPPLPLY(ph)DQPPSSPYPSPDK_,-0.5, ,-1.8, , , ,1.72,0.75,-0.05, ,-0.89, , , ,-0.77,-0.74,-0.5,-1.8,,1.31,-0.05,-0.89,,-0.76, +,,,,,,NA,NA,,,,,,
P16591-2,P16591,Tyrosine-protein kinase Fer,FER,251.13,251.13,Y402,KVQENDGKEPPPVVNYEEDARSVTSMERKER,_VQENDGKEPPPVVNY(ph)EEDAR_,0.27, ,-0.19, ,-0.76,-0.7,-0.4,-0.66,0.12, ,-0.19, ,-0.25,-0.27,-0.16,-0.27,0.27,-0.19,-0.73,-0.52,0.12,-0.19,-0.26,-0.21,,,Tyr,,,,0,0,,cell cortex,ATP binding,actin cytoskeleton reorganization,,
P16591-2,P16591,Tyrosine-protein kinase Fer,FER,69.26,64.75,Y714,KISDFGMSRQEDGGVYSSSGLKQIPIKWTAP,_(gl)QEDGGVY(ph)SSSGLK_,0.82, ,0.56, , , , , ,-0.29, ,0.21, , , , , ,0.82,0.56,,,-0.29,0.21,,,,,Tyr,,,,NA,NA,,cell cortex,ATP binding,actin cytoskeleton reorganization,,
Q96AC1,Q96AC1,Fermitin family homolog 2,FERMT2,223.32,222.62,S666,GGYIFLSTRAKDQNESLDEEMFYKLTSGWV_,_DQNES(ph)LDEEMFYK_,-0.85,-0.86,-1.15,-1.16,-0.51,-0.48,-0.64,-0.63,-0.05,-0.31,-0.46,-0.24,-0.15,-0.25,-0.6,-0.47,-0.86,-1.15,-0.5,-0.63,-0.18,-0.35,-0.2,-0.54, +,,,,,,3,0,15.98,cell cortex,"phosphatidylinositol-3,4,5-trisphosphate binding",actin cytoskeleton organization,,
Q96AC1,Q96AC1,Fermitin family homolog 2,FERMT2,141.05,126.97,S339,INKLSIMTSENHLNNSDKEVDEVDAALSDLE,_LSIMTSENHLNNS(ph)DK_,-0.76,-0.81,-1.22,-1.29,-0.41,-0.58,-0.23,-0.13,-0.08,0.03,-0.01,-0.15,-0.05,-0.19,-0.06,-0.13,-0.78,-1.25,-0.5,-0.18,-0.03,-0.08,-0.12,-0.1, +,,,,,,3,0,6.69,cell cortex,"phosphatidylinositol-3,4,5-trisphosphate binding",actin cytoskeleton organization,,
Q96AC1,Q96AC1,Fermitin family homolog 2,FERMT2,153.55,152.87,Y179,LELEGPLITPGSGSIYSSPGLYSKTMTPTYD,_KLDDQSEDEALELEGPLITPGSGSIY(ph)SSPGLYSK_,-0.24, ,-0.15, ,0.74,1.05,0.75,0.34,-0.29, ,0.17, ,0.46,0.96,0.4,0.2,-0.24,-0.15,0.91,0.56,-0.29,0.17,0.73,0.3,,,,,,,0,0,,cell cortex,"phosphatidylinositol-3,4,5-trisphosphate binding",actin cytoskeleton organization,,
Q96AC1,Q96AC1,Fermitin family homolog 2,FERMT2,175.77,175.38,S159,PRDPTKKKKKKLDDQSEDEALELEGPLITPG,_KLDDQS(ph)EDEALELEGPLITPGSGSIYSSPGLYSK_, , ,-0.14, ,-0.37,0.35,0.35, , , ,0, ,0,0.16,-0.21, ,,-0.14,0.04,0.35,,0,0.08,-0.21,,,,,,,NA,NA,,cell cortex,"phosphatidylinositol-3,4,5-trisphosphate binding",actin cytoskeleton organization,,
Q9UID3,Q9UID3,Protein fat-free homolog,FFR,185.49,185.49,S18,AAAAAGPSPGSGPGDSPEGPEGEAPERRRKA,_(ac)AAAAAAGPSPGSGPGDS(ph)PEGPEGEAPER_,0.2,-0.01,-0.16,-0.32, ,-0.09,0.01,0.05,0.08,-0.05,-0.09,-0.04, ,0.03,-0.12,-0.36,0.1,-0.24,-0.09,0.03,0.02,-0.06,0.03,-0.23,,,,,,,0,0,,GARP complex,,autophagy,,
P98174,P98174,"FYVE, RhoGEF and PH domain-containing protein 1",FGD1,129.68,129.04,S715,LLNSTNREDEDTPPNSPNVDLGKRAPTPIRE,_LLNSTNREDEDT(ph)PPNS(ph)PNVDLGK_, , , , ,0.81, , , , , , , ,3.58, , , ,,,0.81,,,,3.58,,, +,,,,,NA,NA,,cytoskeleton,guanyl-nucleotide exchange factor activity,actin cytoskeleton organization,,
P98174,P98174,"FYVE, RhoGEF and PH domain-containing protein 1",FGD1,129.68,129.04,T711,ETFKLLNSTNREDEDTPPNSPNVDLGKRAPT,_LLNSTNREDEDT(ph)PPNS(ph)PNVDLGK_, , , , ,0.81, , , , , , , ,3.58, , , ,,,0.81,,,,3.58,,, +,,,,,NA,NA,,cytoskeleton,guanyl-nucleotide exchange factor activity,actin cytoskeleton organization,,
O95684-2,O95684,FGFR1 oncogene partner,FGFR1OP,152.52,152.52,S156,GPTTGEGALDLSDVHSPPKSPEGKTSAQTTP,_GPTTGEGALDLSDVHS(ph)PPKS(ph)PEGK_, , , , ,-0.16,0.19, ,0.51, , , , ,0.43,0.29, ,-0.07,,,0.02,0.51,,,0.36,-0.07,,,,,,,NA,NA,,centrosome,protein homodimerization activity,G2/M transition of mitotic cell cycle,,
O95684-2,O95684,FGFR1 oncogene partner,FGFR1OP,152.52,152.52,S160,GEGALDLSDVHSPPKSPEGKTSAQTTPSKKA,_GPTTGEGALDLSDVHS(ph)PPKS(ph)PEGK_, , , , ,-0.16,0.19, ,0.51, , , , ,0.43,0.29, ,-0.07,,,0.02,0.51,,,0.36,-0.07,,,,,,,NA,NA,,centrosome,protein homodimerization activity,G2/M transition of mitotic cell cycle,,
Q9Y613,Q9Y613,FH1/FH2 domain-containing protein 1,FHOD1,89.2,89.2,S523,QRSLAPEPKEPLIPASPKAEPIWELPTRAPR,_SLAPEPKEPLIPAS(ph)PK_,0.28,0.67,1.86,2.33,1.94,2.12,2.09,1.62,0.28,0.23,1.48,1.75,1.54,1.67,1.65,1.57,0.49,2.12,2.03,1.87,0.25,1.62,1.61,1.61, +, +,,,,,1,1,44.09,bleb,,actin cytoskeleton organization,,
Q9Y613,Q9Y613,FH1/FH2 domain-containing protein 1,FHOD1,100.98,95.09,S486,PNEAGGHPDARQLWDSPETAPAARTPQSPAP,_QLWDS(ph)PETAPAAR_, ,0.03,0.07, , , , , , ,-0.11,0.13, , , , , ,0.03,0.07,,,-0.11,0.13,,,,,,,,,NA,NA,,bleb,,actin cytoskeleton organization,,
Q6UN15-3,Q6UN15,Pre-mRNA 3'-end-processing factor FIP1,FIP1L1,74.79,53.73,S259,SEKETALPSTKAEFTSPPSLFKTGLPPSRRL,_AEFTS(ph)PPSLFK_,-0.39,-0.14,0.02,-0.35, , , , ,-0.71,-0.22,-0.28,-0.43, , , , ,-0.26,-0.15,,,-0.44,-0.35,,,,,,,,,NA,NA,,mRNA cleavage and polyadenylation specificity factor complex,RNA binding,mRNA processing,,
Q6UN15-3,Q6UN15,Pre-mRNA 3'-end-processing factor FIP1,FIP1L1,265.7,265.7,S492,RERERTRERERERDHSPTPSVFNSDEERYRY,_DHS(ph)PTPSVFNS(ph)DEERYR_,-0.24,-0.1,-0.1,-0.15,-0.21,-0.1,-0.32,-0.1,-0.29,-0.29,-0.32,-0.39,-0.12,0.15,-0.24,-0.26,-0.17,-0.12,-0.16,-0.21,-0.29,-0.35,0.02,-0.25,,,,,,,0,0,,mRNA cleavage and polyadenylation specificity factor complex,RNA binding,mRNA processing,,
Q6UN15-3,Q6UN15,Pre-mRNA 3'-end-processing factor FIP1,FIP1L1,80,80,S496,RTRERERERDHSPTPSVFNSDEERYRYREYA,_DHS(ph)PTPS(ph)VFNS(ph)DEER_, , , , ,-0.05,0.05,0.24,-0.42, , , , ,-0.17,-0.32,0.09,-0.56,,,0,-0.05,,,-0.24,-0.2,,,,,,,NA,NA,,mRNA cleavage and polyadenylation specificity factor complex,RNA binding,mRNA processing,,
Q6UN15-3,Q6UN15,Pre-mRNA 3'-end-processing factor FIP1,FIP1L1,265.7,265.7,S500,RERERDHSPTPSVFNSDEERYRYREYAERGY,_DHS(ph)PTPSVFNS(ph)DEERYR_,-0.4,-0.46,-0.27,-0.5,-0.31,-0.23,-0.59,-0.56,-0.45,-0.48,-0.57,-0.51,-0.18,-0.22,-0.28,-0.47,-0.43,-0.38,-0.27,-0.57,-0.47,-0.54,-0.2,-0.37,,,,,,,0,0,,mRNA cleavage and polyadenylation specificity factor complex,RNA binding,mRNA processing,,
Q5T1M5-2,Q5T1M5,FK506-binding protein 15,FKBP15,75.77,73.67,S1114,TSDPEEGDPLALGPESPGEPQPPQLKKDDVT,_LSLTSDPEEGDPLALGPES(ph)PGEPQPPQLK_,0.12, , , , ,-1.07,-0.54,1.44,-0.47, , , , ,-0.71,-0.68,1.86,0.12,,-1.07,0.77,-0.47,,-0.71,1.09, +, +,,,,,NA,NA,,actin filament,,endocytosis,,
Q5T1M5-2,Q5T1M5,FK506-binding protein 15,FKBP15,137.81,137.81,S1162,VAGAALRPSHHSQRSSLSGDEEDELFKGATL,_SS(ph)LS(ph)GDEEDELFK_,0.13,0.02,0.23,1.76,0.48,0.5,0.63,0.53,0.44,0.17,0.28,1.67,0.56,0.51,0.65,0.64,0.07,1.19,0.49,0.58,0.31,1.14,0.54,0.65, +, +,,,,,4,4,36.5,actin filament,,endocytosis,,
Q5T1M5-2,Q5T1M5,FK506-binding protein 15,FKBP15,135.69,135.69,S956,SEEEEEKAEERPRRPSQEQSASASSGQPQAP,_RPS(ph)QEQSASASSGQPQAPLNR_, , , , ,1.2, ,0.81,0.79, , , , ,0.98, ,0.39,0.71,,,1.2,0.8,,,0.98,0.56, +,,,,,,NA,NA,,actin filament,,endocytosis,,
Q5T1M5-2,Q5T1M5,FK506-binding protein 15,FKBP15,179.94,175.18,S1164,GAALRPSHHSQRSSLSGDEEDELFKGATLKA,_SSLS(ph)GDEEDELFK_,0.12,0.06,-0.3,0.14,-0.64,-0.6,-0.79,-1.03,0,-0.09,-0.2,0.34,-0.65,-0.55,-0.82,-1.03,0.09,-0.07,-0.62,-0.91,-0.04,0.1,-0.6,-0.92,,,,,,,0,0,,actin filament,,endocytosis,,
Q8NFG4,Q8NFG4,Folliculin,FLCN,63.2,62.3,S298,LVQMEKLADLEEESESWDNSEAEEEEKAPVL,_LADLEEESES(ph)WDNS(ph)EAEEEEK_, , , , , ,-0.42,-0.31, , , , , , ,-0.37,-0.61, ,,,-0.42,-0.31,,,-0.37,-0.61,,,,,,,NA,NA,,cytoplasm,protein complex binding,cell-cell junction assembly,,
Q8NFG4,Q8NFG4,Folliculin,FLCN,63.2,62.3,S302,EKLADLEEESESWDNSEAEEEEKAPVLPEST,_LADLEEESES(ph)WDNS(ph)EAEEEEK_, , , , , ,-0.42,-0.31, , , , , , ,-0.37,-0.61, ,,,-0.42,-0.31,,,-0.37,-0.61,,,,,,,NA,NA,,cytoplasm,protein complex binding,cell-cell junction assembly,,
Q13045,Q13045,Protein flightless-1 homolog,FLII,277.69,253.76,S856,VLTVDYTRNAEAVLQSPGLSGKVKRDAEKKD,_NAEAVLQS(ph)PGLSGK_,0.16,0.16,-0.06,0.13,-0.19,-0.2,-0.16,-0.21,0.06,-0.05,-0.08,-0.05,-0.14,-0.15,-0.15,-0.31,0.16,0.04,-0.19,-0.18,0,-0.06,-0.14,-0.23,,,,,,,0,0,,centrosome,actin binding,multicellular organismal development,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,199.01,190.81,S546,KDEETEDVLASNGYESDEQEKSAYQEYDSDS,_DEETEDVLASNGYES(ph)DEQEK_,-0.33,0.01, ,-0.14,0.16,0.11,0.04,0.2,-0.13,0.07, ,-0.07,0.19,0.29,0.08,0.22,-0.15,-0.14,0.13,0.12,-0.03,-0.07,0.24,0.15,,,,,,,0,0,,,,,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,169.62,169.62,S492,NFSILQLHEFKFMEQSRSPSVSPSKQPVSTS,_FMEQS(ph)RSPSVS(ph)PSK_,0.24,0.27,-0.07,0.06,0.01,-0.03,0.08,0.12,-0.13,0.13,-0.12,0,0.01,0.31,0.13,0.22,0.26,-0.01,-0.01,0.1,0.01,-0.06,0.16,0.18,,,,,,,0,0,,,,,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,197.15,184.4,S494,SILQLHEFKFMEQSRSPSVSPSKQPVSTSSK,_FMEQSRS(ph)PSVS(ph)PSK_,0.46,-0.13, , , ,0.15, ,0,0.12,-0.16, , , ,0.11, ,0.13,0.19,,0.15,0,-0.02,,0.11,0.13,,,,,,,NA,NA,,,,,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,197.15,184.4,S498,LHEFKFMEQSRSPSVSPSKQPVSTSSKTVTL,_FMEQSRS(ph)PSVS(ph)PSK_,0.18,-0.07,-0.07,0.06,0.06,0.15,0.02,0.03,0.07,0.13,-0.12,0,0.01,0.18,0.22,0.14,0.06,-0.01,0.1,0.03,0.1,-0.06,0.1,0.18,,,,,,,0,0,,,,,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,174.01,152.31,S559,YESDEQEKSAYQEYDSDSDVPEELKRDYVDE,_SAYQEYDS(ph)DS(ph)DVPEELK_,-0.07,-0.17,-0.32,-0.17,0.15,0.17,0.11,0.45,-0.03,-0.16,-0.19,0.13,-0.15,0.24,0.09,0.42,-0.12,-0.24,0.16,0.29,-0.09,-0.02,0.06,0.27,,,,,,,0,0,,,,,,
Q75N11,Q96JG6,Coiled-coil domain-containing protein 132,FLJ20097,166.83,166.83,S561,SDEQEKSAYQEYDSDSDVPEELKRDYVDEQT,_SAYQEYDS(ph)DS(ph)DVPEELK_,-0.06,-0.04, ,0.08,0.31,0.38,0.49,0.55,-0.12,-0.18, ,-0.03,0.14,0.18,0.24,0.23,-0.05,0.08,0.34,0.52,-0.15,-0.03,0.16,0.23,,,,,,,0,0,,,,,,
P21333-2,P21333,Filamin-A,FLNA,172.2,172.2,S2152,EGRVKESITRRRRAPSVANVGSHCDLSLKIP,_RAPS(ph)VANVGSHCDLSLK_, , , , ,2.09, ,1.33, , , , , ,2.56, ,1.81, ,,,2.09,1.33,,,2.56,1.81, +, +,,,,,NA,NA,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
P21333-2,P21333,Filamin-A,FLNA,190.57,168.76,S1084,KVKAFGPGLQGGSAGSPARFTIDTKGAGTGG,_AFGPGLQGGSAGS(ph)PAR_,-0.42,-0.3,-0.79,-0.79,-0.61,-0.58,-0.66,-0.72,-0.12,-0.28,-0.28,-0.27,-0.46,-0.58,-0.64,-0.61,-0.36,-0.79,-0.59,-0.69,-0.2,-0.27,-0.52,-0.62,,,,,,,0,0,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
P21333-2,P21333,Filamin-A,FLNA,119.54,110.18,S1459,DVTDASKVKCSGPGLSPGMVRANLPQSFQVD,_CSGPGLS(ph)PGMVR_,-0.5,-0.48,-0.36,-0.71,-0.32,-0.52,-0.45,0.03,-0.02,-0.01,0.13,-0.17,0.01,-0.21,-0.32,0.12,-0.49,-0.53,-0.42,-0.19,-0.02,-0.01,-0.1,-0.08,,,,,,,0,0,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
P21333-2,P21333,Filamin-A,FLNA,167.27,166.43,S1533,PYSISVLYGDEEVPRSPFKVKVLPTHDASKV,_EGPYSISVLYGDEEVPRS(ph)PFK_, , , , ,0.33,-0.09,-0.48, , , , , ,0.16,0.35,0.03, ,,,0.14,-0.48,,,0.26,0.03,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
P21333-2,P21333,Filamin-A,FLNA,108.72,98.53,S2284,GGLAIAVEGPSKAEISFEDRKDGSCGVAYVV,_AEIS(ph)FEDRK_, ,0.12,0.04,-0.18, , , , , ,0.01,0.32,0.07, , , , ,0.12,-0.06,,,0.01,0.2,,,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
P21333-2,P21333,Filamin-A,FLNA,63.2,59.21,S2327,NEEHIPDSPFVVPVASPSGDARRLTVSSLQE,_FNEEHIPDSPFVVPVAS(ph)PSGDAR_,-0.29,-0.27,-0.46,-0.45,-0.32, ,-0.36,-0.9,0.42,0.31,0.5,0.19,0.14, ,0.11,-0.84,-0.28,-0.46,-0.32,-0.6,0.37,0.35,0.14,-0.29,,,,,,,0,0,,actin cytoskeleton,actin filament binding,actin crosslink formation,+,
B2ZZ83,O75369,Filamin-B,FLNB,150.11,108.63,S983,TRGAGGQGKLDVTILSPSRKVVPCLVTPVTG,_LDVTILS(ph)PSRK_,-0.28,-0.85,-1.38,-0.88,-0.33,-0.67, , ,-0.56,-0.4,-0.32,-0.28,-0.15,-0.29, , ,-0.54,-1.11,-0.49,,-0.48,-0.3,-0.22,, +,,,,,,NA,NA,,,,,,
B2ZZ83,B2ZZ83,Filamin-B,FLNB,274.59,246.87,S1474,VLGPRADDTDSQSWRSPLKALSEFFKGDPKG,_ADDTDSQSWRS(ph)PLK_,-0.27,-0.12,0.65,0.61,0.63,0.83,0.92,0.86,-0.07,0.14,0.62,0.63,0.64,0.72,1.06,1.08,-0.19,0.63,0.73,0.89,0.04,0.62,0.68,1.07,, +,,,,,0,1,31.31,,,,,
B2ZZ83,O75369,Filamin-B,FLNB,142.45,142.45,S1505,PYMVSVKYADEEIPRSPFKVKVLPTYDASKV,_YADEEIPRS(ph)PFK_,-0.43,-0.22,-0.01,0.15,0.31, ,-0.02,0.26,0.21,0.16,0.32,0.37,0.21, ,0.3,0.11,-0.32,0.08,0.31,0.13,0.18,0.35,0.21,0.21,,,,,,,0,0,,,,,,
Q14315-2,Q14315,Filamin-C,FLNC,112.84,107.06,S2233,FPAVFGDFLGRERLGSFGSITRQQEGEASSQ,_LGS(ph)FGSITR_,0.78,0.36,0.83,0.71,1.29,1.18,0.83,0.7,1.56,1.17,1.66,1.54,1.55,1.49,1.15,1.28,0.59,0.77,1.24,0.77,1.38,1.6,1.52,1.22, +, +,,,,,1,1,18.88,costamere,,cell junction assembly,,
O95466-2,O95466,Formin-like protein 1,FMNL1,141.74,135.37,S184,DNGASNSEKNKPLEQSVEDLSKGPPSSVPKS,_NKPLEQS(ph)VEDLSK_, , , , ,0.11,0.62,0.83,0.46, , , , ,0.18,-0.01,0.53,0.46,,,0.38,0.65,,,0.09,0.49,,,,,,,NA,NA,,bleb,actin filament binding,actin filament severing,,
Q96PY5,Q96PY5,Formin-like protein 2,FMNL2,128.38,53.39,S171,STVESSVDKSKPWSRSIEDLHRGSNLPSPVG,_S(ph)IEDLHR_,0.13,-0.07,-0.04,-0.01,-0.35,-0.45,-0.03,-0.75,-0.16,-0.23,-0.25,-0.33,-0.1,0.08,0.06,-0.19,0.03,-0.02,-0.4,-0.35,-0.2,-0.29,-0.01,-0.06,,,,,,,0,0,,cytoplasm,,cortical actin cytoskeleton organization,,
F5H2B3,Q06828,Fibromodulin,FMOD,83.65,36.42,T168,KLRHLERLYLDHNNLTRMPGPLPRSLRELHL,_LYLDHNNLT(ph)R_,-1.81,-1.5,-1.72, , , , , ,-5.15,-5.67,-5.22, , , , , ,-1.65,-1.72,,,-5.39,-5.22,,, +, +,,,,,NA,NA,,,,,,
F2Z2U3,Q96RU3,Formin-binding protein 1,FNBP1,83.12,81.44,S296,DIEFEDYTQPMKRTVSDNSLSNSRGEGKPDL,_TVS(ph)DNS(ph)LSNSRGEGKPDLK_, , , , ,0.23, , , , , , , ,0.68, , , ,,,0.23,,,,0.68,,,,,,,,NA,NA,,,,,,
F2Z2U3,Q96RU3,Formin-binding protein 1,FNBP1,83.12,81.44,S299,FEDYTQPMKRTVSDNSLSNSRGEGKPDLKFG,_TVS(ph)DNS(ph)LSNSRGEGKPDLK_, , , , ,0.23, , , , , , , ,0.68, , , ,,,0.23,,,,0.68,,,,,,,,NA,NA,,,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,227.36,221.14,S432,ELRALEEGDGSVSGSSPRSDISQPASQDGMR,_ALEEGDGSVSGSS(ph)PR_,-0.28,-0.23,-0.15,-0.17,0.23,0.33,0.13, ,-0.36,-0.47,-0.15,-0.48,0.11,0.15,0.09, ,-0.25,-0.16,0.28,0.13,-0.41,-0.3,0.13,0.09,,,,,,,0,0,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,89.11,86.07,S435,ALEEGDGSVSGSSPRSDISQPASQDGMRRLM,_ALEEGDGSVSGS(ph)SPRS(ph)DIS(ph)QPASQDGMR_, , , , ,-0.18,-0.2, , , , , , ,0.5,0.22, , ,,,-0.19,,,,0.37,,,,,,,,NA,NA,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,89.11,86.07,S438,EGDGSVSGSSPRSDISQPASQDGMRRLMSKR,_ALEEGDGSVSGS(ph)SPRS(ph)DIS(ph)QPASQDGMR_, , , , ,-0.18,-0.2, , , , , , ,0.5,0.22, , ,,,-0.19,,,,0.37,,,,,,,,NA,NA,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,66.4,66.22,S116,VKATGGLCLLGAYADSDDDDNDVSEKLAQSK,_ATGGLCLLGAYADS(ph)DDDDNDVSEK_, , , , , , , ,-0.16, , , , , , , ,-0.1,,,,-0.16,,,,-0.1,,,,,,,NA,NA,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,336.66,336.66,S508,EKIDENSDKEMEVEESPEKIKVQTTPKVEEE,_IDENS(ph)DKEMEVEES(ph)PEK_,0.15,0.08,0.07,0.01,-0.02, , ,0.05,0.26,0.21,0.09,0.02,-0.69, , ,0.82,0.12,0.04,-0.02,0.05,0.23,0.05,-0.69,0.82,,,,,,,0,0,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,336.66,336.66,S499,ETAIGAENSEKIDENSDKEMEVEESPEKIKV,_IDENS(ph)DKEMEVEESPEK_,0.15,0.08,0.54,0.01,-0.02, , ,0.09,0.26,0.21,0.23,0.02,-0.69, , ,-0.16,0.12,0.3,-0.02,0.09,0.23,0.13,-0.69,-0.16,,,,,,,0,0,,nucleus,,,,
Q8N3X1,Q8N3X1,Formin-binding protein 4,FNBP4,174.61,174.61,T479,SPESTSRSSSKTGRDTPENGETAIGAENSEK,_TGRDT(ph)PENGETAIGAENSEK_,0.03,0.12,-0.09,-0.18,0.07,0.13,0.18,0.18,0.16,0.11,0.18,0.16,-0.05,-0.2,-0.02,-0.02,0.07,-0.13,0.1,0.18,0.14,0.17,-0.12,-0.02,,,,,,,0,0,,nucleus,,,,
Q53EP0-2,Q53EP0,Fibronectin type III domain-containing protein 3B,FNDC3B,97.08,82.1,S208,KKLKDRQIDRQNRLNSPPSSIYKSSCTTVYN,_LNS(ph)PPSSIYK_,-0.03,0.03,-0.48,0.13,-0.19, ,0.02,-0.02,0.11,-0.16,-0.82,0.07,0.12, ,0.49,0.53,0,-0.14,-0.19,0,-0.02,-0.31,0.12,0.51,,,,,,,0,0,,endoplasmic reticulum,,positive regulation of fat cell differentiation,,
P15407,P15407,Fos-related antigen 1,FOSL1,74.53,74.13,S265,KSSSSSGDPSSDPLGSPTLLAL_________,_S(ph)SSSSGDPSSDPLGS(ph)PTLLAL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,RNA polymerase II regulatory region sequence-specific DNA binding,cellular defense response,,
P15408-3,P15408,Fos-related antigen 2,FOSL2,70.05,68.42,S320,RRSSSSGDQSSDSLNSPTLLAL_________,_RSSSS(ph)GDQSSDSLNS(ph)PTLLAL_, , , , , , ,2.52, , , , , , , ,2.59, ,,,,2.52,,,,2.59, +, +,,,,,NA,NA,,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,cell death,,
P15408-3,P15408,Fos-related antigen 2,FOSL2,267.54,255.58,S230,SVGAVVVKQEPLEEDSPSSSSAGLDKAQRSV,_QEPLEEDS(ph)PSSSSAGLDK_,-0.28,-0.2,-0.08,-0.12,-0.19,-0.02,-0.4,-0.35,0.1,0.06,0.2,0.12,-0.03,0.02,0.01,-0.06,-0.24,-0.1,-0.1,-0.37,0.08,0.16,-0.01,-0.02,,,,,,,0,0,,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,cell death,,
P15408-3,P15408,Fos-related antigen 2,FOSL2,114.56,114.56,S120,TIGTTVGRRRRDEQLSPEEEEKRRIRRERNK,_RRDEQLS(ph)PEEEEK_,-0.04,-0.16,-0.04,-0.11, , , , ,0.15,0.09,0.23,0.25, , , , ,-0.1,-0.07,,,0.12,0.24,,,,,,,,,NA,NA,,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,cell death,,
P15408-3,P15408,Fos-related antigen 2,FOSL2,113.07,109.4,S200,VAHGPVCKISPEERRSPPAPGLQPMRSGGGS,_S(ph)PPAPGLQPMR_,-0.31,-0.23,-0.09, ,-0.15,-0.08,-0.24,0.05,-0.23,-0.23,-0.15, ,-0.06,-0.23,-0.1,0.09,-0.27,-0.09,-0.11,-0.09,-0.23,-0.15,-0.14,0,,,,,,,0,0,,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,cell death,,
Q99958,Q99958,Forkhead box protein C2,FOXC2,58.64,55.46,S219,PKEAEKKVVIKSEAASPALPVITKVETLSPE,_SEAAS(ph)PALPVITK_, , ,0.28,0.28, , ,0.46,0.24, , ,0.3,0.51, , ,0.04,-0.2,,0.28,,0.35,,0.41,,-0.07,,,,,,,NA,NA,,transcription factor complex,chromatin DNA binding,artery morphogenesis,,
Q99958,Q99958,Forkhead box protein C2,FOXC2,266.16,265.43,S232,AASPALPVITKVETLSPESALQGSPRSAAST,_VETLS(ph)PESALQGS(ph)PR_,-0.03,0.03,-0.63,-0.09,0.03,0.05,-0.05,-0.04,-0.32,-0.53,-1.07,-0.27,-0.09,-0.09,-0.18,-0.23,0,-0.33,0.04,-0.04,-0.42,-0.62,-0.09,-0.2,,,,,,,0,0,,transcription factor complex,chromatin DNA binding,artery morphogenesis,,
Q99958,Q99958,Forkhead box protein C2,FOXC2,170.11,161.98,S235,PALPVITKVETLSPESALQGSPRSAASTPAG,_VETLS(ph)PES(ph)ALQGS(ph)PR_, , , , ,0.75,0.34,0.74,0.69, , , , ,0,-0.27,0.21,0.27,,,0.56,0.72,,,-0.13,0.24,,,,,,,NA,NA,,transcription factor complex,chromatin DNA binding,artery morphogenesis,,
Q99958,Q99958,Forkhead box protein C2,FOXC2,266.16,265.43,S240,ITKVETLSPESALQGSPRSAASTPAGSPDGS,_VETLS(ph)PES(ph)ALQGS(ph)PR_,-0.46,-0.26,-0.49,-0.64,-0.9,-0.53,-0.08,-0.1,-0.23,-0.04,-0.2,-0.29,-0.1,-0.51,-0.19,0.17,-0.35,-0.56,-0.7,-0.09,-0.13,-0.24,-0.29,0,,,,,,,0,0,,transcription factor complex,chromatin DNA binding,artery morphogenesis,,
C9JXI1,Q9UPW0,Forkhead box protein J3,FOXJ3,185.23,143.69,S223,TNKVTLYNTDQDGSDSPRSSLNNSLSDQSLA,_VTLYNTDQDGSDS(ph)PR_,0.85,0.8, , ,-0.68, , ,0.4,-0.33,-0.19, , ,-0.45, , ,-0.75,0.82,,-0.68,0.4,-0.26,,-0.45,-0.75,,,,,,,NA,NA,,,,,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,145.73,138.31,S428,SSRSAPASPTHPGLMSPRSGGLQTPECLSRE,_S(ph)APAS(ph)PTHPGLMS(ph)PR_, ,0.09,1.02, ,0.36,0.45,0.14,0.06, ,0.9,2.37, ,0.53,0.49,0.36,0.35,0.09,1.02,0.41,0.1,0.9,2.37,0.51,0.35, +, +,,,,,4,4,17.55,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,78.53,76.9,S239,PLKIHIPEPDLRSMVSPVPSPTGTISVPNSC,_SMVS(ph)PVPSPTGT(ph)ISVPNSCPAS(ph)PR_, , , , ,1.2, , , , , , , ,1.31, , , ,,,1.2,,,,1.31,, +, +,,,,,NA,NA,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,78.53,76.9,S257,PSPTGTISVPNSCPASPRGAGSSSYRFVQNV,_SMVS(ph)PVPSPTGT(ph)ISVPNSCPAS(ph)PR_, , , , ,1.2, , , , , , , ,1.31, , , ,,,1.2,,,,1.31,, +, +,,,,,NA,NA,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,191.15,191.15,S213,KIQFTSLYHKEEAPASPLRPLYPQISPLKIH,_EEAPAS(ph)PLRPLYPQIS(ph)PLK_,0.01,0.02,0.22,0.43,-0.02,0.07,0.28,0.44,0.04,-0.05,0.39,0.64,-0.19,-0.05,0.14,0.52,0.02,0.33,0.03,0.36,0,0.52,-0.12,0.34,,,,,,,0,0,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,191.15,191.15,S223,EEAPASPLRPLYPQISPLKIHIPEPDLRSMV,_EEAPAS(ph)PLRPLYPQIS(ph)PLK_,-0.18,-0.24,-0.45,-0.44,-0.02,0.07,0.28,0.44,-0.6,-0.47,-0.74,-0.92,-0.19,-0.05,0.14,0.52,-0.21,-0.45,0.03,0.36,-0.53,-0.83,-0.12,0.34,,,,,,,0,0,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,108.96,107.3,S445,RSGGLQTPECLSREGSPIPHDPEFGSKLASV,_EGS(ph)PIPHDPEFGSK_,0.17,0.16,0.32,0.32,0.31,0.84,0.32,0.15,0.49,0.44,0.57,0.59,-0.01,0.09,0.18,0.01,0.17,0.32,0.6,0.24,0.47,0.58,0.04,0.1,,,,,,,0,0,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,171.83,164.46,S416,GVSCFRTPFGPLSSRSAPASPTHPGLMSPRS,_S(ph)APAS(ph)PTHPGLMS(ph)PR_,-0.22,0.01,-0.67,-0.62,-0.08,-0.01,0.26,0.34,0.12,0.26,-0.31,-0.07,-0.33,-0.22,-0.31,-0.28,-0.1,-0.64,-0.05,0.3,0.19,-0.19,-0.27,-0.29,,,,,,,0,0,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,171.83,164.46,S420,FRTPFGPLSSRSAPASPTHPGLMSPRSGGLQ,_S(ph)APAS(ph)PTHPGLMSPR_,-0.18,0.09,0.18,-0.62,0.1,0.02,0.06,0.31,0.36,0.36,0.87,-0.07,0.51,0.13,0.52,-0.26,-0.04,-0.16,0.06,0.19,0.36,0.47,0.33,0.18,,,,,,,0,0,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,48.69,47.95,S243,HIPEPDLRSMVSPVPSPTGTISVPNSCPASP,_SMVSPVPS(ph)PTGT(ph)IS(ph)VPNSCPASPR_,-0.17,-0.34, , , , , , ,-0.3,-0.29, , , , , , ,-0.25,,,,-0.29,,,,,,,,,,NA,NA,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,48.69,47.95,S249,LRSMVSPVPSPTGTISVPNSCPASPRGAGSS,_SMVSPVPS(ph)PTGT(ph)IS(ph)VPNSCPASPR_,-0.17,-0.34, , , , , , ,-0.3,-0.29, , , , , , ,-0.25,,,,-0.29,,,,,,,,,,NA,NA,,nucleolus,"DNA binding, bending",cell differentiation,,
P85037-2,P85037,Forkhead box protein K1,FOXK1,78.53,76.9,T247,PDLRSMVSPVPSPTGTISVPNSCPASPRGAG,_SMVSPVPS(ph)PTGT(ph)IS(ph)VPNSCPASPR_,-0.17,-0.34, , , , , , ,-0.3,-0.29, , , , , , ,-0.25,,,,-0.29,,,,,,,,,,NA,NA,,nucleolus,"DNA binding, bending",cell differentiation,,
F5H5V5,Q01167,Forkhead box protein K2,FOXK2,173.79,159.35,S398,HSSGAQTPESLSREGSPAPLEPEPGAAQPKL,_EGS(ph)PAPLEPEPGAAQPK_,0.06,0.14,-0.17,-0.01,-0.13,-0.46,-0.03,0.33,0.02,0.05,-0.09,0.18,-0.58,-0.51,-0.29,-0.25,0.1,-0.09,-0.28,0.16,0.04,0.05,-0.55,-0.27,,,,,,,0,0,,,,,,
O43524,O43524,Forkhead box protein O3,FOXO3,113.77,113.69,S7,_________MAEAPASPAPLSPLEVELDPEF,_(ac)AEAPAS(ph)PAPLS(ph)PLEVELDPEFEPQSRPR_, , , , ,-0.36, , ,-0.42, , , , ,-0.19, , ,-0.1,,,-0.36,-0.42,,,-0.19,-0.1,,,,,,,NA,NA,,cytosol,"DNA binding, bending",antral ovarian follicle growth,,
O43524,O43524,Forkhead box protein O3,FOXO3,113.77,113.69,S12,____MAEAPASPAPLSPLEVELDPEFEPQSR,_(ac)AEAPAS(ph)PAPLS(ph)PLEVELDPEFEPQSRPR_, , , , ,-0.36, , ,-0.42, , , , ,-0.19, , ,-0.1,,,-0.36,-0.42,,,-0.19,-0.1,,,,,,,NA,NA,,cytosol,"DNA binding, bending",antral ovarian follicle growth,,
Q70Z53,Q70Z53,Protein FRA10AC1,FRA10AC1,81.3,81.03,S278,GHSSSKKSEDSLLRNSDEEESASESELWKGP,_SEDSLLRNS(ph)DEEES(ph)AS(ph)ESELWK_, , , , , ,-0.46, ,-1.06, , , , , ,-0.46, ,-0.12,,,-0.46,-1.06,,,-0.46,-0.12, +,,,,,,NA,NA,,nucleus,,,,
Q70Z53,Q70Z53,Protein FRA10AC1,FRA10AC1,81.3,81.03,S283,KKSEDSLLRNSDEEESASESELWKGPLPETD,_SEDSLLRNS(ph)DEEES(ph)AS(ph)ESELWK_, , , , , ,-0.46, ,-1.06, , , , , ,-0.46, ,-0.12,,,-0.46,-1.06,,,-0.46,-0.12, +,,,,,,NA,NA,,nucleus,,,,
Q70Z53,Q70Z53,Protein FRA10AC1,FRA10AC1,81.3,81.03,S285,SEDSLLRNSDEEESASESELWKGPLPETDEK,_SEDSLLRNS(ph)DEEES(ph)AS(ph)ESELWK_, , , , , ,-0.46, ,-1.06, , , , , ,-0.46, ,-0.12,,,-0.46,-1.06,,,-0.46,-0.12, +,,,,,,NA,NA,,nucleus,,,,
Q96NE9-3,Q96NE9,FERM domain-containing protein 6,FRMD6,101.35,83.21,S544,TICRKPKTSTDRHSLSLDDIRLYQKDFLRIA,_HSLS(ph)LDDIR_, , , , ,-0.24,-0.09, , , , , , ,-0.28,1.26, , ,,,-0.16,,,,0.69,,,,,,,,NA,NA,,apical junction complex,,apical constriction,,
H0Y9X0,O94915,Protein furry homolog-like,FRYL,128.29,126.84,S2272,VVPSDIPKTYGGDTGSPEISFTKIFNNVSKE,_TYGGDTGS(ph)PEISFTK_,-0.04, ,-0.13, , , , , ,0.7, ,1.06, , , , , ,-0.04,-0.13,,,0.7,1.06,,,, +,,,,,NA,NA,,,,,,
H0Y9X0,O94915,Protein furry homolog-like,FRYL,102.52,102.52,T1959,LSLIGDRRGDRRRSNTLDIMDGRINHSSSLA,_SNT(ph)LDIMDGR_,-0.02, ,-0.29,-0.08,0.07,-0.03,0.25,0.34,0.24, ,-0.06,-0.51,0.01,0.04,0.12,0.16,-0.02,-0.18,0.02,0.29,0.24,-0.27,0.02,0.14,,,,,,,0,0,,,,,,
G3V1D1,P02794,Ferritin,FTH1,125.97,125.97,S179,SGLAEYLFDKHTLGDSDNES___________,_HTLGDS(ph)DNES_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,ferric iron binding,cellular iron ion homeostasis,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,66.33,64.09,S584,QLPQTPPSCLKTEIMSPLYQDEAPKGTEASS,_TEIMS(ph)PLYQDEAPK_, , ,0.97,0.14, ,-0.7, , , , ,2.41,0.28, ,-0.67, , ,,0.61,-0.7,,,1.71,-0.67,,, +,,,,,NA,NA,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,98.63,92.3,S333,YVAKKLKEQAKALDISLSSGEEDEGDEEDST,_ALDIS(ph)LS(ph)S(ph)GEEDEGDEEDSTAGTTK_, , , , , ,-0.39,-0.94,-0.64, , , , , ,-0.22,-0.47,-0.27,,,-0.39,-0.78,,,-0.22,-0.37,,,,,,,NA,NA,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,318.27,315.14,S335,AKKLKEQAKALDISLSSGEEDEGDEEDSTAG,_ALDIS(ph)LS(ph)S(ph)GEEDEGDEEDSTAGTTK_,-0.17,-0.19,-0.26, ,-0.24,-0.19,-0.17,-0.29,-0.01,0.07,-0.15, ,0,-0.05,0.04,-0.09,-0.18,-0.26,-0.21,-0.23,0.03,-0.15,-0.02,-0.02,,,,,,,0,0,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,318.27,315.14,S336,KKLKEQAKALDISLSSGEEDEGDEEDSTAGT,_ALDIS(ph)LS(ph)S(ph)GEEDEGDEEDSTAGTTK_,-0.17,-0.19,-0.26, ,-0.24,-0.19,-0.17,-0.29,-0.01,0.07,-0.15, ,0,-0.05,0.04,-0.09,-0.18,-0.26,-0.21,-0.23,0.03,-0.15,-0.02,-0.02,,,,,,,0,0,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,194.63,193.68,S347,ISLSSGEEDEGDEEDSTAGTTKQPSKEEEEE,_ALDISLS(ph)S(ph)GEEDEGDEEDS(ph)TAGTTK_, , , , ,-0.43,-0.36,0.03,-0.52, , , , ,-0.36,-0.1,-0.2,-0.21,,,-0.4,-0.22,,,-0.22,-0.21,,,,,,,NA,NA,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,155.98,155.98,S688,VIASSKKAKRDLIDNSFNRYTFNEDEGELPE,_DLIDNS(ph)FNR_, , , , ,-0.51,-0.47,-0.53,-0.78, , , , ,-0.55,-0.67,-1.09,-0.84,,,-0.49,-0.65,,,-0.61,-0.96,,,,,,,NA,NA,,nucleolus,methyltransferase activity,RNA methylation,,
Q8IY81,Q8IY81,Putative rRNA methyltransferase 3,FTSJ3,50.23,48.97,S644,SWEPLRGKKRSRGPKSDDDGFEIVPIEDPAK,_S(ph)DDDGFEIVPIEDPAK_, , , , , , ,-0.77, , , , , , , ,0.49, ,,,,-0.77,,,,0.49,,,,,,,NA,NA,,nucleolus,methyltransferase activity,RNA methylation,,
Q8N1G2,Q8N1G2,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,FTSJD2,189.34,172.34,S63,TSLSGSDSETEGKQHSSDSFDDAFKADSLVE,_(gl)QHS(ph)SDS(ph)FDDAFK_, , , , ,-0.39,-0.26,-0.08,-0.66, , , , ,-0.19,-0.14,-0.07,-0.53,,,-0.33,-0.34,,,-0.17,-0.28,,,,,,,NA,NA,,cytoplasm,mRNA (nucleoside-2'-O-)-methyltransferase activity,7-methylguanosine mRNA capping,,
Q8N1G2,Q8N1G2,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1,FTSJD2,189.34,172.34,S66,SGSDSETEGKQHSSDSFDDAFKADSLVEGTS,_(gl)QHS(ph)SDS(ph)FDDAFK_, , , , ,-0.39,-0.26,-0.08,-0.66, , , , ,-0.19,-0.14,-0.07,-0.53,,,-0.33,-0.34,,,-0.17,-0.28,,,,,,,NA,NA,,cytoplasm,mRNA (nucleoside-2'-O-)-methyltransferase activity,7-methylguanosine mRNA capping,,
B4E0X8,Q96AE4,Far upstream element-binding protein 1,FUBP1,269.29,268.6,S630,WAEYYRQQAAYYAQTSPQGMPQHPPAPQGQ_,_QQAAYYAQTS(ph)PQGMPQHPPAPQGQ_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,RNA binding,cell division,,
Q8IVP5,Q8IVP5,FUN14 domain-containing protein 1,FUNDC1,202.87,202.62,S13,___MATRNPPPQDYESDDDSYEVLDLTEYAR,_NPPPQDYES(ph)DDDSYEVLDLTEYAR_, , , ,0.19,0.4, ,0.88,0.51, , , ,-0.04,0.09, ,0.39,0.18,,0.19,0.4,0.71,,-0.04,0.09,0.29,,,,,,,NA,NA,,integral to mitochondrial outer membrane,,mitochondrion degradation,,
P51114,P51114,Fragile X mental retardation syndrome-related protein 1,FXR1,225.57,223.04,Y477,KSSISSVLKDPDSNPYSLLDNTESDQTADTD,_DPDSNPY(ph)SLLDNTESDQTADTDASESHHSTNR_, , ,1.67, , , , , , , ,0.91, , , , , ,,1.67,,,,0.91,,, +,,,,,,NA,NA,,costamere,G-quadruplex RNA binding,apoptotic process,,
P51114,P51114,Fragile X mental retardation syndrome-related protein 1,FXR1,107.41,106.42,S420,LSNPSETESERKDELSDWSLAGEDDRDSRHQ,_DELS(ph)DWS(ph)LAGEDDR_, , , , ,-0.1,0.22,0.1,0.58, , , , ,0.51,0.37,-0.42,-0.15,,,0.07,0.36,,,0.44,-0.28,,,,,,,NA,NA,,costamere,G-quadruplex RNA binding,apoptotic process,,
P51114,P51114,Fragile X mental retardation syndrome-related protein 1,FXR1,107.41,106.42,S423,PSETESERKDELSDWSLAGEDDRDSRHQRDS,_DELS(ph)DWS(ph)LAGEDDR_, , , , ,-0.1,0.22,0.1,0.58, , , , ,0.51,0.37,-0.42,-0.15,,,0.07,0.36,,,0.44,-0.28,,,,,,,NA,NA,,costamere,G-quadruplex RNA binding,apoptotic process,,
P51116,P51116,Fragile X mental retardation syndrome-related protein 2,FXR2,198.15,198.15,S601,NRSRRRRNRGNRTDGSISGDRQPVTVADYIS,_TDGS(ph)IS(ph)GDRQPVTVADYISR_,-0.3,-0.37,-0.64,-0.52,0.13,-0.11,-0.01,-0.09,-0.28,-0.32,-0.09,-0.39,0.02,0.36,-0.48,-0.31,-0.34,-0.58,0.02,-0.05,-0.3,-0.23,0.2,-0.39,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,,,
P51116,P51116,Fragile X mental retardation syndrome-related protein 2,FXR2,198.15,198.15,S603,SRRRRNRGNRTDGSISGDRQPVTVADYISRA,_TDGS(ph)IS(ph)GDRQPVTVADYISR_,-0.05,-0.06,-0.11,-0.16,0.13,0.22,-0.01,0.04,-0.02,-0.09,-0.09,-0.11,0.02,-0.05,-0.48,-0.31,-0.06,-0.14,0.17,0.02,-0.06,-0.1,-0.01,-0.39,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,,,
Q13283,Q13283,Ras GTPase-activating protein-binding protein 1,G3BP1,312.14,311.7,S149,QDEVFGGFVTEPQEESEEEVEEPEERQQTPE,_YQDEVFGGFVTEPQEES(ph)EEEVEEPEER_,-0.09,-0.12,-0.26,-0.13,-0.08,0.04,-0.01,-0.05,0.14,0.08,0.01,-0.02,0.03,-0.01,-0.09,-0.03,-0.11,-0.2,-0.02,-0.03,0.11,-0.01,0.01,-0.06,,,,,,,0,0,,cytoplasm,ATP binding,negative regulation of canonical Wnt receptor signaling pathway,,
Q13283,Q13283,Ras GTPase-activating protein-binding protein 1,G3BP1,328.83,293.5,S232,PVLEETAPEDAQKSSSPAPADIAQTVQEDLR,_SSS(ph)PAPADIAQTVQEDLR_,-0.1,-0.09,-0.17,-0.14,-0.03,-0.03,-0.07,-0.06,-0.08,-0.05,-0.11,-0.13,-0.1,-0.1,-0.16,-0.12,-0.09,-0.15,-0.03,-0.06,-0.06,-0.12,-0.1,-0.14,,,,,,,0,0,,cytoplasm,ATP binding,negative regulation of canonical Wnt receptor signaling pathway,,
Q9UN86-2,Q9UN86,Ras GTPase-activating protein-binding protein 2,G3BP2,242.83,239.51,S141,VHNDMFRYEDEVFGDSEPELDEESEDEVEEE,_YEDEVFGDS(ph)EPELDEES(ph)EDEVEEEQEER_, ,-0.24,-0.46, ,-0.22,-0.11,-0.26,-0.22, ,0.33,0.09, ,-0.01,0.41,-0.09,-0.05,-0.24,-0.46,-0.17,-0.24,0.33,0.09,0.22,-0.07,,,,,,,0,0,,cytosol,nucleotide binding,cytoplasmic sequestering of NF-kappaB,,
Q9UN86-2,Q9UN86,Ras GTPase-activating protein-binding protein 2,G3BP2,242.83,239.51,S149,EDEVFGDSEPELDEESEDEVEEEQEERQPSP,_YEDEVFGDSEPELDEES(ph)EDEVEEEQEER_, ,-0.24,-0.01,0.06,-0.27,-0.29,-0.36,-0.32, ,0.33,-0.08,-0.02,-0.14,-0.4,0,0.03,-0.24,0.03,-0.28,-0.34,0.33,-0.05,-0.26,0.01,,,,,,,0,0,,cytosol,nucleotide binding,cytoplasmic sequestering of NF-kappaB,,
P11413,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,96.75,84.8,Y507,ADELMKRVGFQYEGTYKWVNPHKL_______,_RVGFQYEGTY(ph)K_,1.48, ,1.93, , , , , ,1.19, ,0.79, , , , , ,1.48,1.93,,,1.19,0.79,,, +, +,,,,,NA,NA,,centrosome,glucose binding,cellular response to oxidative stress,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,287.48,263.13,Y259,SPPSRAPSASVDSSLYNLPRSYSHDVLPKVS,_APSASVDSSLY(ph)NLPR_,3.26, ,1.18, , , , , ,3.3, ,1.47, , , , , ,3.26,1.18,,,3.3,1.47,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,166.7,154.78,Y406,VDLNKLRKDASSQDCYDIPRAFPSDRSSSLE,_DASSQDCY(ph)DIPR_,2.37, ,0.67, , , , , ,2.5, ,1.06, , , , , ,2.37,0.67,,,2.5,1.06,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,60.33,56.44,Y307,GTSSVETQMRHVSISYDIPPTPGNTYQIPRT,_HVSISY(ph)DIPPTPGNTYQIPR_,1.84, , , , , , , ,1.45, , , , , , , ,1.84,,,,1.45,,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,126.09,124.62,Y627,GSSPMIKPKGDKQVEYLDLDLDSGKSTPPRK,_QVEY(ph)LDLDLDSGK_,3.15, , , ,3.02, , , ,3.28, , , ,3.58, , , ,3.15,,3.02,,3.28,,3.58,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,272.84,197.96,Y659,KSSGSGSSVADERVDYVVVDQQKTLALKSTR,_VDY(ph)VVVDQQK_,3.79,0.96,2.76, ,2.44,2.79,0.49,1.78,4.63,1.18,2.99, ,3.03,3.22,1.21,2.43,2.98,2.76,2.62,1.28,3.75,2.99,3.13,1.94, +, +,,,,,5,5,33.04,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,181.24,167.97,Y285,LPKVSPSSTEADGELYVFNTPSGTSSVETQM,_VSPSSTEADGELY(ph)VFNTPSGTSSVETQMR_,2.09, , , , , , , ,2.07, , , , , , , ,2.09,,,,2.07,,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q13480,Q13480,GRB2-associated-binding protein 1,GAB1,120.71,119.2,Y373,ETCSIPRTASDTDSSYCIPTAGMSPSRSNTI,_TASDTDSSY(ph)CIPTAGMSPSR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,phospholipid binding,activation of JUN kinase activity,,
Q9UQC2-2,Q9UQC2,GRB2-associated-binding protein 2,GAB2,335.54,330.02,Y293,TKGSLTGSETDNEDVYTFKTPSNTLCREFGD,_GSLTGSETDNEDVY(ph)TFK_,3.4, , , , , , , ,3.64, , , , , , , ,3.4,,,,3.64,,,, +, +,,,,,NA,NA,,cytosol,"phosphatidylinositol-3,4,5-trisphosphate binding",cell migration,,
Q9UQC2-2,Q9UQC2,GRB2-associated-binding protein 2,GAB2,260.93,252.95,Y614,GTNSPAPKKSTGSVDYLALDFQPSSPSPHRK,_STGSVDY(ph)LALDFQPSS(ph)PSPHRKPSTSSVTSDEK_,4.92, , , , , , , ,4.83, , , , , , , ,4.92,,,,4.83,,,, +, +,,,,,NA,NA,,cytosol,"phosphatidylinositol-3,4,5-trisphosphate binding",cell migration,,
Q9UQC2-2,Q9UQC2,GRB2-associated-binding protein 2,GAB2,260.93,252.95,S623,STGSVDYLALDFQPSSPSPHRKPSTSSVTSD,_STGSVDY(ph)LALDFQPSS(ph)PSPHRKPSTSSVTSDEK_,4.92, , , , , , , ,4.83, , , , , , , ,4.92,,,,4.83,,,, +, +,,,,,NA,NA,,cytosol,"phosphatidylinositol-3,4,5-trisphosphate binding",cell migration,,
E9PGR2,O14976,Cyclin-G-associated kinase,GAK,122.47,120.85,S826,SSKESESALMEDRDESEVSDEGGSPISSEGQ,_DES(ph)EVS(ph)DEGGSPISSEGQEPR_, , , , ,0.14,0.13,-0.02,-0.06, , , , ,0.29,0.43,0.15,0.04,,,0.13,-0.04,,,0.36,0.09,,,Other,,,,NA,NA,,,ATP binding,,,
E9PGR2,O14976,Cyclin-G-associated kinase,GAK,122.47,120.85,S829,ESESALMEDRDESEVSDEGGSPISSEGQEPR,_DES(ph)EVS(ph)DEGGSPISSEGQEPR_, , , , ,0.14,0.13,-0.02,-0.06, , , , ,0.29,0.43,0.15,0.04,,,0.13,-0.04,,,0.36,0.09,,,Other,,,,NA,NA,,,ATP binding,,,
P22466,P22466,Galanin peptides,GAL,163.41,162.78,S116,EAGALDRLLDLPAAASSEDIERS________,_LLDLPAAAS(ph)SEDIERS_,0.83,0.89,0.85,0.96,0.14,0.32,0.59,0.22,0.22,0.27,-0.01,0.41,1.88,-0.69,-0.1,0.03,0.86,0.91,0.24,0.42,0.24,0.21,1.1,-0.03,, +,,,,,0,2,1.41,extracellular region,neuropeptide hormone activity,feeding behavior,,
P04406,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,156.24,156.24,S83,VINGNPITIFQERDPSKIKWGDAGAEYVVES,_LVINGNPITIFQERDPS(ph)K_,0.35,0.56, ,0.27,-0.15,-0.23, , ,2.14,0.68, ,0.54,-0.31,-0.23, , ,0.46,0.27,-0.19,,1.59,0.54,-0.27,,, +,,,,,NA,NA,,cytosol,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,cellular response to interferon-gamma,,
Q14C86-4,Q14C86,GTPase-activating protein and VPS9 domain-containing protein 1,GAPVD1,93.42,93.09,S1019,DDLGPDRFSTLTDDPSPRLSAQAQVAEDILD,_FSTLTDDPS(ph)PR_,-0.32,-0.42,-0.18,-0.08,-0.92, , ,-0.05,-0.49,-0.44,-0.04,-0.37,-0.51, , ,0.21,-0.37,-0.13,-0.92,-0.05,-0.47,-0.2,-0.51,0.21,,,,,,,0,0,,cytosol,GTPase activating protein binding,endocytosis,,
Q14C86-4,Q14C86,GTPase-activating protein and VPS9 domain-containing protein 1,GAPVD1,185.96,184.9,S1096,ESAHDSPRDEALQNISADDLPDSASQAAHPQ,_DEALQNIS(ph)ADDLPDSASQAAHPQDSAFSYR_, ,0.03, ,-0.25, , , , , ,0.04,-0.23,-0.17, , , , ,0.03,-0.25,,,0.04,-0.19,,,,,,,,,NA,NA,,cytosol,GTPase activating protein binding,endocytosis,,
Q14C86-4,Q14C86,GTPase-activating protein and VPS9 domain-containing protein 1,GAPVD1,144.69,144.69,S761,STSDDTDVREVSSRPSTPGLSVVSGISATSE,_EVSS(ph)RPS(ph)TPGLSVVSGISATSEDIPNK_, , , , , ,0.27,0.11,0.29, , , , , ,-0.07,-0.23,-0.87,,,0.27,0.2,,,-0.07,-0.51,,,,,,,NA,NA,,cytosol,GTPase activating protein binding,endocytosis,,
Q14C86-4,Q14C86,GTPase-activating protein and VPS9 domain-containing protein 1,GAPVD1,105.39,105.39,S902,FKQRHSYPERLVRSRSSDIVSSVRRPMSDPS,_SRS(ph)SDIVSSVR_, ,0.48, ,0.51,0.41, , , , ,0.36, ,0.88,0.24, , , ,0.48,0.51,0.41,,0.36,0.88,0.24,,,,,,,,NA,NA,,cytosol,GTPase activating protein binding,endocytosis,,
Q14C86-4,Q14C86,GTPase-activating protein and VPS9 domain-containing protein 1,GAPVD1,125.8,125.8,T762,TSDDTDVREVSSRPSTPGLSVVSGISATSED,_EVSS(ph)RPST(ph)PGLSVVSGISATSEDIPNK_, , , , ,0.16, ,0.23, , , , , ,-0.19, ,-0.26, ,,,0.16,0.23,,,-0.19,-0.26,,,,,,,NA,NA,,cytosol,GTPase activating protein binding,endocytosis,,
Q86YP4-2,Q86YP4,Transcriptional repressor p66-alpha,GATAD2A,257.99,257.99,S100,MRTSHSDMKSERRPPSPDVIVLSDNEQPSSP,_RPPS(ph)PDVIVLS(ph)DNEQPS(ph)SPR_,-0.32,-0.02,-0.12,-0.11,-0.4,0.44,0.1,0.41,-0.4,-0.27,-0.52,-0.33,-0.67,0.16,0.06,0.14,-0.16,-0.12,0.08,0.26,-0.34,-0.42,-0.19,0.1,,,,,,,0,0,,nuclear speck,"protein binding, bridging",anterior neuropore closure,,
Q86YP4-2,Q86YP4,Transcriptional repressor p66-alpha,GATAD2A,257.99,257.99,S107,MKSERRPPSPDVIVLSDNEQPSSPRVNGLTT,_RPPS(ph)PDVIVLS(ph)DNEQPSS(ph)PR_,-0.05,0.24,-0.05,-0.09,0.65,0.55,0.35,0.52,-0.21,-0.23,-0.12,-0.05,0.69,0.37,0.29,0.27,0.1,-0.07,0.6,0.43,-0.22,-0.08,0.53,0.28,,,,,,,0,0,,nuclear speck,"protein binding, bridging",anterior neuropore closure,,
Q86YP4-2,Q86YP4,Transcriptional repressor p66-alpha,GATAD2A,257.99,257.99,S114,PSPDVIVLSDNEQPSSPRVNGLTTVALKETS,_RPPS(ph)PDVIVLS(ph)DNEQPSS(ph)PR_,-0.32,-0.28,-0.19,-0.11,-0.3,-0.46,-0.32,-0.25,-0.4,-0.31,-0.37,-0.33,-0.33,-0.96,-0.4,-0.37,-0.3,-0.15,-0.37,-0.29,-0.36,-0.35,-0.61,-0.39,,,,,,,0,0,,nuclear speck,"protein binding, bridging",anterior neuropore closure,,
Q8WXI9,Q8WXI9,Transcriptional repressor p66-beta,GATAD2B,255.52,255.52,S122,MSARRSEPERGRLTPSPDIIVLSDNEASSPR,_GRLT(ph)PS(ph)PDIIVLSDNEASS(ph)PR_,-0.26,-0.46,-0.42,-0.28,-0.12,0,0.53,-0.28,0.13,-0.01,0.02,0.68,0.01,0.16,0.56,-0.34,-0.36,-0.35,-0.06,0.18,0.06,0.39,0.09,0.18,,,,,,,0,0,,nuclear speck,sequence-specific DNA binding,"transcription, DNA-dependent",,
Q8WXI9,Q8WXI9,Transcriptional repressor p66-beta,GATAD2B,255.52,255.52,S129,PERGRLTPSPDIIVLSDNEASSPRSSSRMEE,_GRLT(ph)PSPDIIVLS(ph)DNEASS(ph)PR_,-0.19,-0.07,-0.66,-0.49,0.05,0.01,-0.33,-0.36,0.05,0.29,-0.26,0.17,0.22,0.18,-0.27,-0.41,-0.12,-0.58,0.03,-0.35,0.18,-0.02,0.2,-0.34,,,,,,,0,0,,nuclear speck,sequence-specific DNA binding,"transcription, DNA-dependent",,
Q8WXI9,Q8WXI9,Transcriptional repressor p66-beta,GATAD2B,202.97,199.82,S134,LTPSPDIIVLSDNEASSPRSSSRMEERLKAA,_LTPSPDIIVLS(ph)DNEAS(ph)SPR_,-0.33,-0.21,-0.37,-0.13,-0.08,0.15,-0.33,0.61,-0.13,-0.02,0.62,-0.26,0.15,0,-0.32,-0.6,-0.27,-0.25,0.04,0.21,-0.08,0.25,0.08,-0.45,,,,,,,0,0,,nuclear speck,sequence-specific DNA binding,"transcription, DNA-dependent",,
Q8WXI9,Q8WXI9,Transcriptional repressor p66-beta,GATAD2B,255.52,255.52,S135,TPSPDIIVLSDNEASSPRSSSRMEERLKAAN,_GRLT(ph)PS(ph)PDIIVLS(ph)DNEASS(ph)PR_,-0.28,-0.32,-0.4,-0.38,-0.16,-0.16,0.16,-0.01,-0.09,-0.22,-0.21,-0.15,0.06,-0.25,-0.75,-0.67,-0.3,-0.39,-0.16,0.07,-0.15,-0.18,-0.09,-0.71,,,,,,,0,0,,nuclear speck,sequence-specific DNA binding,"transcription, DNA-dependent",,
Q8WXI9,Q8WXI9,Transcriptional repressor p66-beta,GATAD2B,255.52,255.52,T120,VDMSARRSEPERGRLTPSPDIIVLSDNEASS,_GRLT(ph)PS(ph)PDIIVLSDNEASS(ph)PR_,-0.26,-0.38,-0.55,-0.33,-0.26,-0.16,0.13,-0.01,0.13,0.07,0.13,0.59,-0.26,-0.25,0.1,-0.67,-0.32,-0.43,-0.21,0.06,0.1,0.38,-0.26,-0.24,,,,,,,0,0,,nuclear speck,sequence-specific DNA binding,"transcription, DNA-dependent",,
Q92538,Q92538,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,GBF1,235.21,235.21,S1298,LQATARADAPDAGAQSDSELPSYHQNDVSLD,_ADAPDAGAQS(ph)DSELPSYHQNDVSLDR_,-0.1,-0.21,-0.33,-0.45,-0.22,-0.05,-0.05,-0.15,0.03,0.06,-0.07,0.1,-0.1,-0.01,-0.05,-0.18,-0.15,-0.39,-0.13,-0.1,0.04,0.02,-0.06,-0.12,,,,,,,0,0,,cis-Golgi network,ARF guanyl-nucleotide exchange factor activity,COPI coating of Golgi vesicle,,
Q92538,Q92538,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,GBF1,129.25,129.11,S314,QTTSKEDLTDLEQPGSPGYSTATEPGSSELG,_EDLTDLEQPGS(ph)PGYSTATEPGSSELGVPEQPDLQEGTHVEK_, , ,0.48,0.66, , , , , , ,0.75,1.01, , , , ,,0.58,,,,0.89,,,,,,,,,NA,NA,,cis-Golgi network,ARF guanyl-nucleotide exchange factor activity,COPI coating of Golgi vesicle,,
Q92538,Q92538,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1,GBF1,114.46,114.46,S1318,PSYHQNDVSLDRGYTSDSEVYTDHGRPGKIH,_GYTS(ph)DSEVYTDHGRPGK_,-0.03,0.06,-0.1,-0.19,-0.18,-0.05,-0.21,-0.03,0.35,0.47,-0.16,0.56,-0.02,0.18,-0.14,-0.07,0.02,-0.14,-0.11,-0.12,0.41,0.24,0.08,-0.1,,,,,,,0,0,,cis-Golgi network,ARF guanyl-nucleotide exchange factor activity,COPI coating of Golgi vesicle,,
Q9Y5B6-2,Q9Y5B6,GC-rich sequence DNA-binding factor 1,GCFC1,67.79,63.59,S154,YKEDLEKSKIKTELNSSAESEQPLDKTGHVK,_TELNS(ph)S(ph)AESEQPLDK_, , , , , ,-0.8,-1.13, , , , , , ,-0.29,-0.19, ,,,-0.8,-1.13,,,-0.29,-0.19, +,,,,,,NA,NA,,cytosol,DNA binding,muscle organ development,,
Q9Y5B6-2,Q9Y5B6,GC-rich sequence DNA-binding factor 1,GCFC1,67.79,63.59,S155,KEDLEKSKIKTELNSSAESEQPLDKTGHVKD,_TELNS(ph)S(ph)AESEQPLDK_, , , , , ,-0.8,-1.13, , , , , , ,-0.29,-0.19, ,,,-0.8,-1.13,,,-0.29,-0.19, +,,,,,,NA,NA,,cytosol,DNA binding,muscle organ development,,
Q9Y5B6-2,Q9Y5B6,GC-rich sequence DNA-binding factor 1,GCFC1,184.2,184.2,S262,EPGKGRLVREDENDASDDEDDDEKRRIVFSV,_LVREDENDAS(ph)DDEDDDEK_,-0.03,-0.09,-0.18,-0.14, ,0.4,-0.17,0.25,-0.36,-0.2,-0.12,-0.25, ,0.43,-0.14,0.3,-0.06,-0.16,0.4,0.05,-0.28,-0.18,0.43,0.1,,,,,,,0,0,,cytosol,DNA binding,muscle organ development,,
Q9Y5B6-2,Q9Y5B6,GC-rich sequence DNA-binding factor 1,GCFC1,213.35,206.18,S557,AREQTGKMADHLEGLSSDDEETSTDITNFNL,_M(ox)ADHLEGLS(ph)S(ph)DDEETSTDITNFNLEK_,-0.16,-0.18,-0.31,-0.36,-0.36,-0.14,-0.18,-0.04,-0.08,-0.15,-0.16,-0.1,-0.24,0.08,-0.06,0.11,-0.17,-0.34,-0.25,-0.11,-0.12,-0.13,-0.07,0.03,,,,,,,0,0,,cytosol,DNA binding,muscle organ development,,
Q9Y5B6-2,Q9Y5B6,GC-rich sequence DNA-binding factor 1,GCFC1,213.35,206.18,S558,REQTGKMADHLEGLSSDDEETSTDITNFNLE,_MADHLEGLS(ph)S(ph)DDEETSTDITNFNLEK_,-0.16,-0.18,-0.31,-0.36,-0.36,-0.14,-0.18,-0.04,-0.08,-0.15,-0.16,-0.1,-0.24,0.08,-0.06,0.11,-0.17,-0.34,-0.25,-0.11,-0.12,-0.13,-0.07,0.03,,,,,,,0,0,,cytosol,DNA binding,muscle organ development,,
P16383,P16383,GC-rich sequence DNA-binding factor 2,GCFC2,80,80,S174,LDVQHTSSISGMKRESEDDPESEPDDHEKRI,_RES(ph)EDDPES(ph)EPDDHEK_, , , , , ,-0.13, ,-0.08, , , , , ,0.28, ,0.1,,,-0.13,-0.08,,,0.28,0.1,,,,,,,NA,NA,,nucleus,DNA binding,"negative regulation of transcription, DNA-dependent",,
P16383,P16383,GC-rich sequence DNA-binding factor 2,GCFC2,80,80,S180,SSISGMKRESEDDPESEPDDHEKRIPFTLRP,_RES(ph)EDDPES(ph)EPDDHEK_, , , , , ,-0.13, ,-0.08, , , , , ,0.28, ,0.1,,,-0.13,-0.08,,,0.28,0.1,,,,,,,NA,NA,,nucleus,DNA binding,"negative regulation of transcription, DNA-dependent",,
P16383,P16383,GC-rich sequence DNA-binding factor 2,GCFC2,118.21,116.44,S96,APRADEGSESRTLDVSTDEEDKIHHSSESKD,_TLDVS(ph)T(ph)DEEDK_,-0.02, , , , ,-0.83,-0.15,-0.01,0.09, , , , ,-0.14,0.03,0.13,-0.02,,-0.83,-0.08,0.09,,-0.14,0.08,,,,,,,NA,NA,,nucleus,DNA binding,"negative regulation of transcription, DNA-dependent",,
P16383,P16383,GC-rich sequence DNA-binding factor 2,GCFC2,118.21,116.44,T97,PRADEGSESRTLDVSTDEEDKIHHSSESKDD,_TLDVS(ph)T(ph)DEEDK_,-0.02, , , , ,-0.83,-0.15,-0.01,0.09, , , , ,-0.14,0.03,0.13,-0.02,,-0.83,-0.08,0.09,,-0.14,0.08,,,,,,,NA,NA,,nucleus,DNA binding,"negative regulation of transcription, DNA-dependent",,
P0CAP1-11,Q9BZD3,Putative GRINL1B complex locus protein 2,GCOM2,106.67,106.67,S364,SSGRYREVRDEDDDWSSDEF___________,_YREVRDEDDDWS(ph)S(ph)DEF_,-0.13,0.35,-0.2,0.05,-0.54,0.39,0.01,-0.34,0.22,0.51,-0.02,0.22,-0.26,0.36,-0.15,-0.15,0.13,-0.07,0,-0.15,0.37,0.1,0.08,-0.15,,,,,,,0,0,,cell junction,,intracellular signal transduction,,
P0CAP1-11,Q9BZD3,Putative GRINL1B complex locus protein 2,GCOM2,106.67,106.67,S365,SGRYREVRDEDDDWSSDEF____________,_YREVRDEDDDWS(ph)S(ph)DEF_,-0.13,0.35,-0.2,0.05,-0.54,0.39,0.01,-0.34,0.22,0.51,-0.02,0.22,-0.26,0.36,-0.15,-0.15,0.13,-0.07,0,-0.15,0.37,0.1,0.08,-0.15,,,,,,,0,0,,cell junction,,intracellular signal transduction,,
P50395,P50395,Rab GDP dissociation inhibitor beta,GDI2,81.7,50.8,S61,ITPLEDLYKRFKIPGSPPESMGRGRDWNVDL,_IPGS(ph)PPESMGR_,1.38,1.7,0.3,-0.02, ,-0.21,-0.17,0.35,0.05,-0.04,-0.08,-0.1, ,-0.27,-0.46,-0.26,1.55,0.15,-0.21,0.11,0.01,-0.09,-0.27,-0.36, +,,,,,,5,0,7.25,cell surface,Rab GDP-dissociation inhibitor activity,protein transport,,
Q8TEQ6,Q8TEQ6,Gem-associated protein 5,GEMIN5,122.16,101.8,S757,KKKKKPTLRTPVKLESIDGNEEESMKENSGP,_LES(ph)IDGNEEESMK_, , , , , , , ,-0.01, , , , , , , ,0.31,,,,-0.01,,,,0.31,,,,,,,NA,NA,,Cajal body,snRNA binding,ncRNA metabolic process,,
Q06210-2,Q06210,Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1,GFPT1,114.54,111.07,S261,TGKDKKGSCNLSRVDSTTCLFPVEEKAVEYY,_VDS(ph)TTCLFPVEEK_, , , , , , ,-0.28,0.02, , , , , , ,-0.42,-0.23,,,,-0.12,,,,-0.32,,,,,,,NA,NA,,cytosol,amino acid binding,activation of signaling protein activity involved in unfolded protein response,,
Q6Y7W6,Q6Y7W6,PERQ amino acid-rich with GYF domain-containing protein 2,GIGYF2,151.6,151.6,S26,GPEWLRALSSGGSITSPPLSPALPKYKLADY,_ALSSGGSITS(ph)PPLS(ph)PALPK_,0.2,0.27,0.7,0.7,0.65,1.73,1.77,1.88,0.3,0.16,0.53,0.5,0.72,1.26,1.48,1.52,0.24,0.7,1.29,1.82,0.23,0.52,1.01,1.5, +, +,,,,,2,2,50.35,,,adult locomotory behavior,,
Q6Y7W6,Q6Y7W6,PERQ amino acid-rich with GYF domain-containing protein 2,GIGYF2,151.6,151.6,S30,LRALSSGGSITSPPLSPALPKYKLADYRYGR,_ALSSGGSITS(ph)PPLS(ph)PALPK_,0.58, ,1.75, ,1.76,1.73,1.78,1.86,1.92, ,2.56, ,1.47,1.26,1.49,1.5,0.58,1.75,1.75,1.82,1.92,2.56,1.37,1.5, +, +,,,,,1,4,16.36,,,adult locomotory behavior,,
Q6Y7W6,Q6Y7W6,PERQ amino acid-rich with GYF domain-containing protein 2,GIGYF2,173.33,173.33,S236,RLAGSRRDGERWRPHSPDGPRSAGWREHMER,_WRPHS(ph)PDGPR_,0.08,0.16,0.44,0.46,-0.46,-0.01,-0.17,0.13,0.15,0.1,0.3,0.22,-0.99,0,-0.1,0.02,0.12,0.45,-0.22,-0.02,0.13,0.26,-0.41,-0.04,,,,,,,0,0,,,,adult locomotory behavior,,
Q6Y7W6,Q6Y7W6,PERQ amino acid-rich with GYF domain-containing protein 2,GIGYF2,336.87,336.87,T382,SEETPQTSSSSARPGTPSDHQSQEASQFERK,_VGVEASEETPQTSSSSARPGT(ph)PSDHQSQEASQFER_,0.15,0.1,0.15,0.18,-0.28,0.16, ,-0.26,-0.03,-0.15,-0.13,-0.14,0.12,0.46, ,-0.02,0.13,0.16,-0.04,-0.26,-0.09,-0.14,0.3,-0.02,,,,,,,0,0,,,,adult locomotory behavior,,
Q9Y248,Q9Y248,DNA replication complex GINS protein PSF2,GINS2,147.53,145.31,S182,MYKLRTNLQPLESTQSQDF____________,_LRTNLQPLESTQS(ph)QDF_,-0.53,-0.48,-0.73,0.03, , ,0.26, ,-0.08,0,-0.4,0.11, , ,0.11, ,-0.51,-0.3,,0.26,-0.04,-0.12,,0.11,,,,,,,NA,NA,,nucleoplasm,,DNA strand elongation involved in DNA replication,,
Q9BRT9,Q9BRT9,DNA replication complex GINS protein SLD5,GINS4,88.28,88.21,S12,____MTEEVDFLGQDSDGGSEEVVLTPAELI,_(ac)M(ox)TEEVDFLGQDS(ph)DGGS(ph)EEVVLTPAELIER_,-0.21,-0.31,-0.42,-0.44,-0.14,-0.09,-0.44,0.07,0.12,0.28,0,0.05,0.16,-0.24,-0.59,0.03,-0.26,-0.43,-0.12,-0.17,0.2,0.03,-0.03,-0.25,,,,,,,0,0,,cytoplasm,,DNA strand elongation involved in DNA replication,,
Q9BRT9,Q9BRT9,DNA replication complex GINS protein SLD5,GINS4,88.28,88.21,S16,MTEEVDFLGQDSDGGSEEVVLTPAELIERLE,_(ac)M(ox)TEEVDFLGQDS(ph)DGGS(ph)EEVVLTPAELIER_,-0.21,-0.31,-0.42,-0.44,-0.14,-0.09,-0.44,0.07,0.12,0.28,0,0.05,0.16,-0.24,-0.59,0.03,-0.26,-0.43,-0.12,-0.17,0.2,0.03,-0.03,-0.25,,,,,,,0,0,,cytoplasm,,DNA strand elongation involved in DNA replication,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,223.07,222.9,Y598,HTSKLSRHGSGADSDYENTQSGDPLLGLEGK,_HGSGADSDY(ph)ENTQSGDPLLGLEGK_,-0.55, ,-0.94, ,-0.22,-0.11,0.17,-0.1,-0.02, ,-0.32, ,-0.18,-0.36,-0.14,-0.41,-0.55,-0.94,-0.16,0.04,-0.02,-0.32,-0.27,-0.27,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,189.39,178.11,Y545,RLQPFHSTELEDDAIYSVHVPAGLYRIRKGV,_LQPFHSTELEDDAIY(ph)SVHVPAGLYR_, , ,-0.36,0.01,0.84,0.38,0.58,0.39, , ,-0.07,0.41,0.9,0.31,0.52,0.28,,-0.16,0.63,0.49,,0.19,0.64,0.41,,,,,,,NA,NA,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,51.4,50.52,Y383,ELSLRSQSDLDDQHDYDSVASDEDTDQEPLR,_SQSDLDDQHDY(ph)DS(ph)VAS(ph)DEDTDQEPLR_, , , , , ,0.51, , , , , , , ,0.32, , ,,,0.51,,,,0.32,,,,,,,,NA,NA,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,240.52,240.52,S592,SQEGSRHTSKLSRHGSGADSDYENTQSGDPL,_HGS(ph)GADS(ph)DYENTQSGDPLLGLEGK_,0.04,-0.03,-0.07,0.42,0.68,0.76,0.05,0.65,0.29,0.35,0.44,0.53,0.6,0.45,-0.04,0.59,0,0.2,0.72,0.38,0.32,0.49,0.53,0.31,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,240.52,240.52,S596,SRHTSKLSRHGSGADSDYENTQSGDPLLGLE,_HGS(ph)GADS(ph)DYENTQSGDPLLGLEGK_,0.04,-0.03, ,0.42,0.68,0.76,0.73,0.65,0.29,0.35, ,0.53,0.6,0.45,0.55,0.59,0,0.42,0.72,0.69,0.32,0.53,0.53,0.57,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,140.46,132.42,S362,ILSEAKRRQQGKSLSSPTDNLELSLRSQSDL,_SLSS(ph)PTDNLELSLR_,0.11,0.17,0.12,-1.05,0.1,-1.39,-0.56,0.09,0.09,0.05,0.04,-0.93,-0.19,-1.6,-0.68,-0.08,0.14,-0.35,-0.46,-0.2,0.07,-0.37,-0.73,-0.34,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,143.54,142.06,S375,LSSPTDNLELSLRSQSDLDDQHDYDSVASDE,_SQS(ph)DLDDQHDYDS(ph)VAS(ph)DEDTDQEPLR_, , , , ,0.48,0.33,0.38,0.58, , , , ,0.53,0.13,0.28,0.29,,,0.41,0.48,,,0.35,0.29,,,,,,,NA,NA,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,228.73,227.37,S385,SLRSQSDLDDQHDYDSVASDEDTDQEPLRST,_SQSDLDDQHDYDS(ph)VAS(ph)DEDTDQEPLR_,0.07,0.03,-0.09, ,0.16,0.12,0.19,0.16,-0.04,0.09,-0.18, ,-0.01,-0.17,-0.09,0.06,0.05,-0.09,0.14,0.18,0.03,-0.18,-0.09,-0.01,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
Q9Y2X7,Q9Y2X7,ARF GTPase-activating protein GIT1,GIT1,299.38,296.48,S388,SQSDLDDQHDYDSVASDEDTDQEPLRSTGAT,_SQSDLDDQHDYDS(ph)VAS(ph)DEDTDQEPLR_,-0.09,-0.24,-0.35,-0.44,0.16,0.12,0.19,-0.01,0.05,-0.37,-0.23,-0.53,-0.01,-0.17,-0.09,0.35,-0.16,-0.4,0.14,0.1,-0.14,-0.37,-0.09,0.15,,,,,,,0,0,,cytoplasm,ARF GTPase activator activity,positive regulation of GTPase activity,,
F5H882,Q14161,ARF GTPase-activating protein GIT2,GIT2,134.03,134.03,Y592,HASRLEKQNSTPESDYDNTPNDMEPDGMGSS,_QNSTPESDY(ph)DNTPNDMEPDGMGSSRK_,-0.51, ,-0.23, ,0.63, , , ,-0.07, ,-0.05, ,0.49, , , ,-0.51,-0.23,0.63,,-0.07,-0.05,0.49,,,,,,,,NA,NA,,,,,,
F5H882,Q14161,ARF GTPase-activating protein GIT2,GIT2,95.89,95.31,S394,QHSVESQDNDQPDYDSVASDEDTDLETTASK,_TINNQHSVESQDNDQPDYDS(ph)VAS(ph)DEDTDLETTASK_, , , , , , ,-0.38, , , , , , , ,-0.22, ,,,,-0.38,,,,-0.22,,,,,,,NA,NA,,,,,,
F5H882,Q14161,ARF GTPase-activating protein GIT2,GIT2,95.89,95.31,S397,VESQDNDQPDYDSVASDEDTDLETTASKTNR,_TINNQHSVESQDNDQPDYDS(ph)VAS(ph)DEDTDLETTASK_,-0.08, , , , , ,-0.38, ,0.2, , , , , ,-0.22, ,-0.08,,,-0.38,0.2,,,-0.22,,,,,,,NA,NA,,,,,,
Q86VQ1,Q86VQ1,Glucocorticoid-induced transcript 1 protein,GLCCI1,177.24,174.18,S105,ASLGSLPGPGAARGPSPSSPTPPAAAAPAEQ,_GPS(ph)PSS(ph)PTPPAAAAPAEQAPR_,-0.33,-0.3,-0.18, ,-0.1,0.01,-0.1,-0.14,-0.42,-0.24,-0.5, ,-0.12,-0.08,-0.14,-0.14,-0.31,-0.18,-0.04,-0.12,-0.33,-0.5,-0.1,-0.14,,,,,,,0,0,,cytoplasm,,,,
Q86VQ1,Q86VQ1,Glucocorticoid-induced transcript 1 protein,GLCCI1,159.2,159.18,S107,LGSLPGPGAARGPSPSSPTPPAAAAPAEQAP,_GPS(ph)PS(ph)SPTPPAAAAPAEQAPR_,-0.33,-0.3,-0.18, ,-0.11,-0.12,-0.23,-0.14,-0.42,-0.35,-0.5, ,-0.2,-0.18,-0.36,-0.13,-0.32,-0.18,-0.11,-0.18,-0.38,-0.5,-0.19,-0.24,,,,,,,0,0,,cytoplasm,,,,
Q86VQ1,Q86VQ1,Glucocorticoid-induced transcript 1 protein,GLCCI1,177.24,174.18,S108,GSLPGPGAARGPSPSSPTPPAAAAPAEQAPR,_GPS(ph)PSS(ph)PTPPAAAAPAEQAPR_, ,-0.33,0.5, ,-0.08,0.01,-0.1,-0.04, ,-0.21,-0.59, ,-0.04,-0.08,-0.14,-0.04,-0.33,0.5,-0.03,-0.07,-0.21,-0.59,-0.06,-0.09,,,,,,,0,0,,cytoplasm,,,,
Q86VQ1,Q86VQ1,Glucocorticoid-induced transcript 1 protein,GLCCI1,117.08,115.57,S223,WAEEGAEKRSHQRSASWGSADQLKEQIAKLR,_SAS(ph)WGSADQLK_,0.48,0.2,0.19,0.21,0.26,0.41,0.34,0.24,0.36,0.29,0.25,0.08,0.3,0.04,0.42,0.17,0.35,0.2,0.34,0.29,0.32,0.17,0.17,0.3,,,,,,,0,0,,cytoplasm,,,,
B4DUT7,P49915,GMP synthase [glutamine-hydrolyzing],GMPS,141.34,113.06,S332,RTPRKRISKTLNMTTSPEEKRKIIGDTFVKI,_TLNMTTS(ph)PEEK_,0.38,0.8,0.51, ,0.36,0.95,0.44,0.04,0.09,0.26,0.16, ,0.06,1,0.21,0.28,0.61,0.51,0.68,0.25,0.18,0.16,0.61,0.25,,,,,,,0,0,,,ATP binding,GMP biosynthetic process,,
P36915,P36915,Guanine nucleotide-binding protein-like 1,GNL1,114.46,112.88,S51,SRSGSRERREEQTDTSDGESVTHHIRRLNQQ,_REEQT(ph)DTS(ph)DGESVTHHIR_,0.5,-0.11,-0.59,-0.25,-0.46,-0.07,-0.09,-0.12,0.18,-0.23,-0.35,-0.45,0.09,0.72,0.02,0.01,0.23,-0.41,-0.25,-0.11,-0.01,-0.4,0.44,0.02,,,,,,,0,0,,cytosol,GTP binding,response to DNA damage stimulus,,
P36915,P36915,Guanine nucleotide-binding protein-like 1,GNL1,83.6,82.95,T48,SSNSRSGSRERREEQTDTSDGESVTHHIRRL,_EEQT(ph)DTS(ph)DGESVTHHIR_,0.4,0.59,0.21, ,0,-0.24,-0.03,0.15,0.15,0.44,0.33, ,-0.23,-0.15,-0.32,0.12,0.5,0.21,-0.12,0.07,0.3,0.33,-0.19,-0.09,,,,,,,0,0,,cytosol,GTP binding,response to DNA damage stimulus,,
P36915,P36915,Guanine nucleotide-binding protein-like 1,GNL1,79.87,79.54,S324,EKIARDVAGATWGNGSGEEEEEEDGPAVLVE,_DVAGATWGNGS(ph)GEEEEEEDGPAVLVEQQTDSAMEPTGPTQER_, , , , ,-0.63, , , , , , , ,-0.04, , , ,,,-0.63,,,,-0.04,,,,,,,,NA,NA,,cytosol,GTP binding,response to DNA damage stimulus,,
Q92805,Q92805,Golgin subfamily A member 1,GOLGA1,196.41,196.41,S36,GATRIPRSVSKESVASMGADSGDDFASDGSS,_ESVAS(ph)MGADS(ph)GDDFASDGSSSR_, , , , ,-0.14,0.07, , , , , , ,-0.09,0.13, , ,,,-0.03,,,,0.02,,,,,,,,NA,NA,,Golgi apparatus,,protein targeting to Golgi,,
Q92805,Q92805,Golgin subfamily A member 1,GOLGA1,324.55,313.94,S41,PRSVSKESVASMGADSGDDFASDGSSSREDL,_ESVASMGADS(ph)GDDFASDGSSSR_,0.17,0.06,0.17,-0.05,-0.85,-0.31, , ,0.03,0.07,-0.05,-0.04,-0.04,-0.18, , ,0.12,0.06,-0.56,,0.05,-0.04,-0.11,,,,,,,,NA,NA,,Golgi apparatus,,protein targeting to Golgi,,
Q08379,Q08379,Golgin subfamily A member 2,GOLGA2,104.21,85.37,S438,EEKECSMSRVQELETSLAELRNQMAEPPPPE,_VQELETS(ph)LAELR_, ,-0.42,-0.35, , , , , , ,0.31,-0.43, , , , , ,-0.42,-0.35,,,0.31,-0.43,,,,,,,,,NA,NA,,cis-Golgi network,,mitotic cell cycle,,
Q13439-3,Q13439,Golgin subfamily A member 4,GOLGA4,113.22,88.97,S71,GDTQSFAQKLQLRVPSVESLFRSPIKESLFR,_VPS(ph)VESLFR_, ,0.04,-1.05, ,1.02,0.74,0.28, , ,-0.3,-0.7, ,0.12,0.45,-0.03, ,0.04,-1.05,0.89,0.28,-0.3,-0.7,0.29,-0.03, +,,,,,,3,0,20.16,Golgi apparatus,,Golgi to plasma membrane protein transport,,
Q13439-3,Q13439,Golgin subfamily A member 4,GOLGA4,142.39,114.68,S41,SSNSSTPTRMRSRTSSFTEQLDEGTPNRESG,_TSS(ph)FTEQLDEGTPNR_, , , , ,0.78, ,0.57,1.61, , , , ,0.56, ,0.19,-0.53,,,0.78,1.18,,,0.56,-0.12, +,,,,,,NA,NA,,Golgi apparatus,,Golgi to plasma membrane protein transport,,
Q13439-3,Q13439,Golgin subfamily A member 4,GOLGA4,197.1,183.62,S266,LEPQAEVFTKEENPESDGEPVVEDGTSVKTL,_EENPES(ph)DGEPVVEDGTSVK_,-0.23,-0.05,-0.05,-0.02,-0.06,0.02,-0.03,-0.01,-0.02,0.01,-0.03,0,0.2,0.29,-0.04,0,-0.14,-0.04,-0.02,-0.02,-0.01,-0.01,0.24,-0.02,,,,,,,0,0,,Golgi apparatus,,Golgi to plasma membrane protein transport,,
F8W785,O00461,Golgi integral membrane protein 4,GOLIM4,85.88,80.01,Y673,QEVRDDNRPKGREEHYEEEEEEEEDGAAVAE,_GREEHY(ph)EEEEEEEEDGAAVAEK_, , , ,-0.71, , , , , , , ,-0.26, , , , ,,-0.71,,,,-0.26,,,,,,,,,NA,NA,,Golgi apparatus,,,,
F8W785,O00461,Golgi integral membrane protein 4,GOLIM4,165.4,143.17,T640,LTEEKKRELEHNAEETYGENDENTDDKNNDG,_ELEHNAEET(ph)YGENDENTDDK_,0.01,0.43,0.39,0.34, ,-0.07, ,0.24,0.01,0.19,-0.09,-0.05, ,-0.28, ,-0.25,0.23,0.36,-0.07,0.24,0.1,-0.07,-0.28,-0.25,,,,,,,0,0,,Golgi apparatus,,,,
F8W785,O00461,Golgi integral membrane protein 4,GOLIM4,115.87,109.24,T648,LEHNAEETYGENDENTDDKNNDGEEQEVRDD,_ELEHNAEETYGENDENT(ph)DDK_,0.64, , , , , , , ,0.24, , , , , , , ,0.64,,,,0.24,,,,,,,,,,NA,NA,,Golgi apparatus,,,,
Q9H8Y8-2,Q9H8Y8,Golgi reassembly-stacking protein 2,GORASP2,73.25,68.34,T222,FEEGKKISLPGQMAGTPITPLKDGFTEVQLS,_ISLPGQMAGT(ph)PIT(ph)PLK_, , , , , ,1.62, , , , , , , ,1.54, , ,,,1.62,,,,1.54,, +, +,,,,,NA,NA,,Golgi membrane,,mitotic cell cycle,,
Q9H8Y8-2,Q9H8Y8,Golgi reassembly-stacking protein 2,GORASP2,73.25,68.34,T225,GKKISLPGQMAGTPITPLKDGFTEVQLSSVN,_ISLPGQMAGT(ph)PIT(ph)PLK_, , , , , ,1.62, , , , , , , ,1.54, , ,,,1.62,,,,1.54,, +, +,,,,,NA,NA,,Golgi membrane,,mitotic cell cycle,,
Q9H8Y8-2,Q9H8Y8,Golgi reassembly-stacking protein 2,GORASP2,274.96,274.96,S451,SEKPVSAAVDANASESP______________,_VGDST(ph)PVSEKPVSAAVDANASES(ph)P_,0.13,0.16,0.12,0.18,-0.27,-0.29,-0.43,-0.15,0.09,0.09,-0.01,0.03,-0.23,0.25,-0.22,-0.01,0.14,0.15,-0.28,-0.28,0.09,0.01,0.03,-0.11,,,,,,,0,0,,Golgi membrane,,mitotic cell cycle,,
Q9BRR8,Q9BRR8,G patch domain-containing protein 1,GPATCH1,315.26,315.26,S6,__________MAARDSDSEEDLVSYGTGLEP,_(ac)AARDS(ph)DS(ph)EEDLVSYGTGLEPLEEGERPK_, , , , ,0.32,0.22,-0.13,0.43, , , , ,-0.01,0.2,0.24,0.2,,,0.27,0.18,,,0.1,0.22,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleic acid binding,"mRNA splicing, via spliceosome",,
Q9BRR8,Q9BRR8,G patch domain-containing protein 1,GPATCH1,315.26,315.26,S8,________MAARDSDSEEDLVSYGTGLEPLE,_(ac)AARDS(ph)DS(ph)EEDLVSYGTGLEPLEEGERPK_, , , , ,0.32,0.22,-0.13,0.43, , , , ,-0.01,0.2,0.24,0.2,,,0.27,0.18,,,0.1,0.22,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleic acid binding,"mRNA splicing, via spliceosome",,
Q9NW75-2,Q9NW75,G patch domain-containing protein 2,GPATCH2,267.26,252.37,S115,SKDYRENHNNNKKDHSDSDDQMLVAKRRPSS,_DHS(ph)DS(ph)DDQMLVAK_,0.31, ,-0.17, ,-0.16,-0.27,0.02,-0.25,0.18, ,-0.08, ,-0.22,-0.14,0.01,0.1,0.31,-0.17,-0.22,-0.11,0.18,-0.08,-0.18,0.06,,,,,,,0,0,,,nucleic acid binding,negative regulation of phosphatase activity,,
Q9NW75-2,Q9NW75,G patch domain-containing protein 2,GPATCH2,267.26,252.37,S117,DYRENHNNNKKDHSDSDDQMLVAKRRPSSNL,_DHS(ph)DS(ph)DDQMLVAK_,0.31, ,-0.17, ,-0.16,-0.27,0.02,-0.25,0.18, ,-0.08, ,-0.22,-0.14,0.01,0.1,0.31,-0.17,-0.22,-0.11,0.18,-0.08,-0.18,0.06,,,,,,,0,0,,,nucleic acid binding,negative regulation of phosphatase activity,,
Q9NW75-2,Q9NW75,G patch domain-containing protein 2,GPATCH2,134.93,121.51,S284,GLFTNDEGRQGDDEQSDWFYEKESGGACGIT,_QGDDEQS(ph)DWFYEK_,0.64,0.49,0.33,0.67, , ,0.38, ,0.43,0.16,0.08,0.26, , ,0.33, ,0.57,0.51,,0.38,0.3,0.18,,0.33,,,,,,,NA,NA,,,nucleic acid binding,negative regulation of phosphatase activity,,
Q9UKJ3-2,Q9UKJ3,G patch domain-containing protein 8,GPATCH8,56.87,56.87,S1033,RHSGRRDFIRSKIYRSQSPHYFRSGRGEGPG,_IYRS(ph)QS(ph)PHYFR_,0.33, ,-0.11, ,0.2,0.09,0.33,0.81,0.13, ,-0.77, ,-0.29,-0.24,-0.07,0.16,0.33,-0.11,0.14,0.59,0.13,-0.77,-0.27,0.05,,,,,,,0,0,,,nucleic acid binding,,,
Q9UKJ3-2,Q9UKJ3,G patch domain-containing protein 8,GPATCH8,56.87,56.87,S1035,SGRRDFIRSKIYRSQSPHYFRSGRGEGPGKK,_IYRS(ph)QS(ph)PHYFR_,0.33, ,-0.11, ,0.2,0.09,0.33,0.81,0.13, ,-0.77, ,-0.29,-0.24,-0.07,0.16,0.33,-0.11,0.14,0.59,0.13,-0.77,-0.27,0.05,,,,,,,0,0,,,nucleic acid binding,,,
Q9UKJ3-2,Q9UKJ3,G patch domain-containing protein 8,GPATCH8,114.31,114.31,S1009,RSTRSPSQRSGSRKRSWGHESPEERHSGRRD,_S(ph)WGHES(ph)PEER_, , , , ,-0.06,0.37,0.26, , , , , ,0.09,0.18,0.13, ,,,0.17,0.26,,,0.14,0.13,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9UKJ3-2,Q9UKJ3,G patch domain-containing protein 8,GPATCH8,114.31,114.31,S1014,PSQRSGSRKRSWGHESPEERHSGRRDFIRSK,_S(ph)WGHES(ph)PEER_,-0.04,0,-0.54,-0.48,-0.06,0.37,0.26,-0.06,-0.09,0.12,-0.32,-0.35,0.09,0.18,0.13,-0.93,-0.02,-0.51,0.17,0.11,0.02,-0.34,0.14,-0.3,,,,,,,0,0,,,nucleic acid binding,,,
H0YJ30,Q9NQX3,Gephyrin,GPHN,144.89,144.18,S188,IVKVKEVHDELEDLPSPPPPLSPPPTTSPHK,_EVHDELEDLPS(ph)PPPPLS(ph)PPPTTS(ph)PHK_, , ,0.08, ,0.1,-0.15, ,0.25, , ,0.13, ,0.19,-0.03, ,0.11,,0.08,-0.02,0.25,,0.13,0.08,0.11,,,,,,,NA,NA,,,,Mo-molybdopterin cofactor biosynthetic process,,
H0YJ30,Q9NQX3,Gephyrin,GPHN,144.89,144.18,S194,VHDELEDLPSPPPPLSPPPTTSPHKQTEDKG,_EVHDELEDLPS(ph)PPPPLS(ph)PPPTTS(ph)PHK_, , ,0.08, ,0.1,-0.15, ,0.3, , ,0.13, ,0.19,-0.03, ,0.15,,0.08,-0.02,0.3,,0.13,0.08,0.15,,,,,,,NA,NA,,,,Mo-molybdopterin cofactor biosynthetic process,,
P06744,P06744,Glucose-6-phosphate isomerase,GPI,64.84,59.06,T109,EGRAVLHVALRNRSNTPILVDGKDVMPEVNK,_SNT(ph)PILVDGK_,0.44,0.38,0.18,0.12, , , , ,-0.05,-0.07,0.14,0.03, , , , ,0.41,0.15,,,-0.06,0.08,,,,,,,,,NA,NA,,cytosol,glucose-6-phosphate isomerase activity,aldehyde catabolic process,,
Q9HCN4,Q9HCN4,GPN-loop GTPase 1,GPN1,436.58,433.67,S338,ILTRGTLDEEDEEADSDTDDIDHRVTEESHE,_GTLDEEDEEADS(ph)DTDDIDHR_,0,0.01,-0.06,-0.05,-0.11,-0.15,-0.13,-0.08,-0.07,-0.03,-0.1,-0.1,-0.05,-0.03,-0.08,-0.06,0,-0.06,-0.13,-0.11,-0.05,-0.1,-0.04,-0.07,,,,,,,0,0,,cytoplasm,GTP binding,,,
F5H144,Q9Y653,G-protein coupled receptor 56,GPR56,201.06,201.06,S687,LKSNSDSARLPISSGSTSSSRI_________,_LPISSGS(ph)TS(ph)SSRI_, , , , ,0.97,1.02,0.56,0.51, , , , ,0.79,0.84,0.38,0.49,,,1,0.54,,,0.81,0.44,,,,,,,NA,NA,,integral to membrane,G-protein coupled receptor activity,neuropeptide signaling pathway,,
F5H144,Q9Y653,G-protein coupled receptor 56,GPR56,80.46,80.46,S678,LQARGGPSPLKSNSDSARLPISSGSTSSSRI,_SNSDS(ph)ARLPISSGS(ph)TSS(ph)SRI_, , , , ,0.9,0.87, , , , , , ,0.29,0.51, , ,,,0.89,,,,0.4,,,,,,,,NA,NA,,integral to membrane,G-protein coupled receptor activity,neuropeptide signaling pathway,,
Q8NFJ5,Q8NFJ5,Retinoic acid-induced protein 3,GPRC5A,74.17,74.17,Y347,QKEFSIPRAHAWPSPYKDYEVKKEGS_____,_AHAWPSPY(ph)K_, , ,2.1, , , , , , , ,1.43, , , , , ,,2.1,,,,1.43,,, +, +,,,,,NA,NA,,cytoplasmic vesicle membrane,G-protein coupled receptor activity,,,
Q8NFJ5,Q8NFJ5,Retinoic acid-induced protein 3,GPRC5A,68.21,36.07,S336,STHFQLQNQPPQKEFSIPRAHAWPSPYKDYE,_EFS(ph)IPR_, ,-1.5,-1.05, ,0.76,0.47,0.43,0.52, ,-0.46,-0.1, ,0.45,0.17,0.36,0.3,-1.5,-1.05,0.62,0.47,-0.46,-0.1,0.32,0.33, +,,,,,,2,0,26.6,cytoplasmic vesicle membrane,G-protein coupled receptor activity,,,
Q8NFJ5,Q8NFJ5,Retinoic acid-induced protein 3,GPRC5A,87.67,86.61,Y317,QEEITQGFEETGDTLYAPYSTHFQLQNQPPQ,_AYSQEEITQGFEETGDTLY(ph)APYSTHFQLQNQPPQK_, , , , , , , ,-0.52, , , , , , , ,-0.38,,,,-0.52,,,,-0.38,,,,,,,NA,NA,,cytoplasmic vesicle membrane,G-protein coupled receptor activity,,,
Q13098-5,Q13098,COP9 signalosome complex subunit 1,GPS1,55.05,55.05,S474,VLRNQIHVKSPPREGSQGELTPANSQSRMST,_SPPREGS(ph)QGELTPANSQSR_,-0.19,-0.1,-0.19,-0.27,0.37,0.2, , ,0.6,-0.33,0.43,0.85,0.4,0.07, , ,-0.15,-0.23,0.28,,0.21,0.65,0.24,,,,,,,,NA,NA,,cytoplasm,GTPase inhibitor activity,cell cycle,,
Q96CP6-2,Q96CP6,GRAM domain-containing protein 1A,GRAMD1A,198.65,147.35,S263,VIALSDITSSGAADRSQEPSPVGSRRGHVTP,_EVGDVIALSDITSSGAADRS(ph)QEPS(ph)PVGSR_, , , , ,-0.18, ,0.17, , , , , ,-0.32, ,-0.88, ,,,-0.18,0.17,,,-0.32,-0.88,,,,,,,NA,NA,,integral to membrane,,,,
Q96CP6-2,Q96CP6,GRAM domain-containing protein 1A,GRAMD1A,198.65,147.35,S267,SDITSSGAADRSQEPSPVGSRRGHVTPNLSR,_EVGDVIALSDITSSGAADRS(ph)QEPS(ph)PVGSR_, , , , ,-0.18, ,0.17, , , , , ,-0.32, ,-0.88, ,,,-0.18,0.17,,,-0.32,-0.88,,,,,,,NA,NA,,integral to membrane,,,,
B1B0M1,Q4V328,GRIP1-associated protein 1,GRIPAP1,96.88,90.6,S666,SEMNSPSRTQTGDSSSISSFSYREILREKES,_TQTGDSSS(ph)ISS(ph)FSYR_, , , , ,0.6,0.29, , , , , , ,0.24,-0.74, , ,,,0.45,,,,-0.17,,,,,,,,NA,NA,,,,,,
B1B0M1,Q4V328,GRIP1-associated protein 1,GRIPAP1,96.88,90.6,S669,NSPSRTQTGDSSSISSFSYREILREKESSAV,_TQTGDSSS(ph)ISS(ph)FSYR_, , , , ,0.6,0.29, , , , , , ,0.24,-0.74, , ,,,0.45,,,,-0.17,,,,,,,,NA,NA,,,,,,
B4DPB3,P34947,G protein-coupled receptor kinase 6,GRK5,166.77,131.3,S484,PRAVYCKDVLDIEQFSTVKGVNLDHTDDDFY,_DVLDIEQFS(ph)T(ph)VK_, , , , ,0.26,1.18,0.36,1.46, , , , ,-0.07,-0.37,-0.67,0.36,,,0.79,1.01,,,-0.21,-0.07, +,,AGC,,,,NA,NA,,,ATP binding,signal transduction,,
B4DPB3,P34947,G protein-coupled receptor kinase 6,GRK5,166.77,131.3,T485,RAVYCKDVLDIEQFSTVKGVNLDHTDDDFYS,_DVLDIEQFS(ph)T(ph)VK_, , , , ,0.26,1.18,0.36,1.46, , , , ,-0.07,-0.37,-0.67,0.36,,,0.79,1.01,,,-0.21,-0.07, +,,AGC,,,,NA,NA,,,ATP binding,signal transduction,,
A8MT37,P49840,Glycogen synthase kinase-3 alpha,GSK3A,192.96,192.96,Y279,FGSAKQLVRGEPNVSYICSRYYRAPELIFGA,_(gl)QLVRGEPNVSY(ph)ICSR_,-0.28,-0.27,-0.02, ,0.04,-0.06,0.02,0.06,-0.11,-0.07,-0.12, ,-0.06,-0.08,-0.09,-0.12,-0.28,-0.02,-0.01,0.04,-0.09,-0.12,-0.07,-0.1,,,CMGC,,,,0,0,,,ATP binding,,,
A8MT37,P49840,Glycogen synthase kinase-3 alpha,GSK3A,95.5,94.84,S278,DFGSAKQLVRGEPNVSYICSRYYRAPELIFG,_GEPNVS(ph)YICSR_,-0.56, , , , , , ,0.1,-0.51, , , , , , ,-0.11,-0.56,,,0.1,-0.51,,,-0.11,,,CMGC,,,,NA,NA,,,ATP binding,,,
A8MT37,P49840,Glycogen synthase kinase-3 alpha,GSK3A,78.08,73.11,S282,AKQLVRGEPNVSYICSRYYRAPELIFGATDY,_GEPNVSY(ph)ICS(ph)R_,0.01, ,-0.22, , , ,0.17,0.11,-0.13, ,-0.46, , , ,-0.02,-0.01,0.01,-0.22,,0.14,-0.13,-0.46,,-0.01,,,CMGC,,,,NA,NA,,,ATP binding,,,
P09211,P09211,Glutathione S-transferase P,GSTP1,65.23,59.08,Y8,________MPPYTVVYFPVRGRCAALRMLLA,_PPYTVVY(ph)FPVR_, , , , , , , ,-0.49, , , , , , , ,0.39,,,,-0.49,,,,0.39,,,,,,,NA,NA,,cytosol,dinitrosyl-iron complex binding,cellular response to lipopolysaccharide,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,104.67,104.67,S385,PKRERKPSGGSSRGNSRPGTPSAEGGSTSST,_GNS(ph)RPGT(ph)PSAEGGSTSSTLR_,-0.02,0.14,-0.27,0.09,-0.09,0.06,0.3,0.25,0.01,0.34,0.14,0.36,-0.39,-0.21,0.04,-0.02,0.06,-0.08,-0.01,0.28,0.19,0.25,-0.29,0.01,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,104.67,104.67,T389,RKPSGGSSRGNSRPGTPSAEGGSTSSTLRAA,_GNS(ph)RPGT(ph)PSAEGGSTSSTLR_,-0.02,0.14,-0.27,0.09,-0.09,0.06,0.3,0.25,0.01,0.34,0.14,0.36,-0.39,-0.21,0.04,-0.02,0.06,-0.08,-0.01,0.28,0.19,0.25,-0.29,0.01,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,230.17,230.17,S217,ASELRIHDLEDDLEMSSDASDASGEEGGRVP,_IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGGRVPK_,-0.07,0.07,-0.35,0.01,-0.34,0.11,-0.01,0.12,-0.12,-0.05,-0.54,-0.03,-0.4,0.01,0.22,-0.02,0,-0.16,-0.1,0.06,-0.08,-0.26,-0.18,0.1,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,230.17,230.17,S218,SELRIHDLEDDLEMSSDASDASGEEGGRVPK,_IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGGRVPK_,-0.07,0.07,-0.35,0.01,-0.34,0.11,-0.01,0.11,-0.12,-0.07,-0.54,-0.03,-0.4,0.01,0.22,-0.05,0,-0.16,-0.1,0.05,-0.1,-0.26,-0.18,0.09,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,230.17,230.17,S221,RIHDLEDDLEMSSDASDASGEEGGRVPKAKK,_IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGGRVPK_,-0.07,0.06,-0.35,0.01,-0.34,0.11,-0.01,0.11,0.01,-0.05,-0.54,-0.03,-0.4,0.01,0.22,-0.05,0,-0.16,-0.1,0.05,-0.02,-0.26,-0.18,0.09,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
P35269,P35269,General transcription factor IIF subunit 1,GTF2F1,230.17,230.17,S224,DLEDDLEMSSDASDASGEEGGRVPKAKKKAP,_IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGGRVPK_,-0.07,0.06,-0.35,0.01,-0.34,-0.71,-0.01,0.11,0.01,-0.05,-0.54,-0.03,-0.4,-0.77,0.22,-0.05,0,-0.16,-0.51,0.05,-0.02,-0.26,-0.58,0.09,,,,,,,0,0,,cell junction,catalytic activity,7-methylguanosine mRNA capping,,
Q9UHL9-2,Q9UHL9,General transcription factor II-I repeat domain-containing protein 1,GTF2IRD1,135.49,112.86,S448,TGNKFTKDTTKLEPASPPEDTSAEVSRATVL,_LEPAS(ph)PPEDTSAEVSR_,-0.28,-0.21,-0.49, ,0.25,0.18,0.25,0.17,1.02,0.43,1.13, ,1.17,1.85,0.59,0.05,-0.24,-0.49,0.22,0.21,0.76,1.13,1.55,0.35,, +,,,,,0,1,6.8,cytoplasm,DNA binding,embryo development,,
Q12789-3,Q12789,General transcription factor 3C polypeptide 1,GTF3C1,106.26,94.8,S1865,QAPPSHSPRGTKRRASWASENGETDAEGTQM,_RRAS(ph)WAS(ph)ENGETDAEGTQMTPAK_, , ,0.82, , , , , , , ,1.91, , , , , ,,0.82,,,,1.91,,,, +,,,,,NA,NA,,nucleolus,DNA binding,5S class rRNA transcription from RNA polymerase III type 1 promoter,,
Q12789-3,Q12789,General transcription factor 3C polypeptide 1,GTF3C1,106.26,94.8,S1868,PSHSPRGTKRRASWASENGETDAEGTQMTPA,_RRAS(ph)WAS(ph)ENGETDAEGTQMTPAK_, , ,0.82, , , , , , , ,1.91, , , , , ,,0.82,,,,1.91,,,, +,,,,,NA,NA,,nucleolus,DNA binding,5S class rRNA transcription from RNA polymerase III type 1 promoter,,
Q12789-3,Q12789,General transcription factor 3C polypeptide 1,GTF3C1,222.18,220.67,S1611,SMVENEVIKSLGKDGSLEDDEDEEDDLDEGV,_DGS(ph)LEDDEDEEDDLDEGVGGK_, , , , , ,-0.01,-0.39,0.01, , , , , ,-0.05,-0.22,-0.15,,,-0.01,-0.18,,,-0.05,-0.18,,,,,,,NA,NA,,nucleolus,DNA binding,5S class rRNA transcription from RNA polymerase III type 1 promoter,,
Q9Y5Q9,Q9Y5Q9,General transcription factor 3C polypeptide 3,GTF3C3,131.84,131.84,S43,RKTREKKSLQEKGKLSAEENPDDSEVPSSSG,_GKLS(ph)AEENPDDSEVPSSSGINSTK_,0.21,0.21,0.02,-0.03,0.35,0.01,0.03,0.21,0.16,0.16,0.04,0.02,0.24,-0.06,-0.02,0.06,0.21,0,0.19,0.13,0.16,0.03,0.1,0.02,,,,,,,0,0,,transcription factor TFIIIC complex,DNA binding,5S class rRNA transcription from RNA polymerase III type 1 promoter,,
Q9UKN8,Q9UKN8,General transcription factor 3C polypeptide 4,GTF3C4,273.43,269.02,S611,LWKPTHEDSKILLVDSPGMGNADDEQQEEGT,_ILLVDS(ph)PGM(ox)GNADDEQQEEGTSSK_,-0.11,-0.2,-0.17,-0.32,-0.32,-0.22,-0.21,-0.25,0.09,0.1,0.11,0.17,-0.35,-0.03,-0.17,-0.16,-0.15,-0.24,-0.27,-0.23,0.1,0.14,-0.18,-0.17,,,,,,,0,0,,transcription factor TFIIIC complex,DNA binding,5S class rRNA transcription from RNA polymerase III type 1 promoter,,
O00178,O00178,GTP-binding protein 1,GTPBP1,107.23,106.62,S12,____MATERSRSAMDSPVPASMFAPEPSSPG,_SAMDS(ph)PVPASMFAPEPS(ph)SPGAAR_, , , , ,-0.89,-0.87,-0.92,-1.19, , , , ,-0.3,-0.96,-0.08,-0.54,,,-0.88,-1.05,,,-0.59,-0.29, +,,,,,,NA,NA,,cytoplasmic exosome (RNase complex),GTP binding,immune response,,
O00178,O00178,GTP-binding protein 1,GTPBP1,56.66,55.17,S44,ARAAAAAARLHGGFDSDCSEDGEALNGEPEL,_LHGGFDS(ph)DCS(ph)EDGEALNGEPELDLTSK_, , , , , , , ,-0.69, , , , , , , ,0.01,,,,-0.69,,,,0.01,,,,,,,NA,NA,,cytoplasmic exosome (RNase complex),GTP binding,immune response,,
O00178,O00178,GTP-binding protein 1,GTPBP1,56.66,55.17,S47,AAAAARLHGGFDSDCSEDGEALNGEPELDLT,_LHGGFDS(ph)DCS(ph)EDGEALNGEPELDLTSK_, , , , , , , ,-0.69, , , , , , , ,0.01,,,,-0.69,,,,0.01,,,,,,,NA,NA,,cytoplasmic exosome (RNase complex),GTP binding,immune response,,
O00178,O00178,GTP-binding protein 1,GTPBP1,124.91,123.45,S25,MDSPVPASMFAPEPSSPGAARAAAAAARLHG,_SAMDSPVPASMFAPEPSS(ph)PGAAR_, , ,-0.15,-0.08,-1.03,-0.92,-0.15,-0.04, , ,-0.14,0.05,-0.8,-0.82,0.19,-0.31,,-0.11,-0.97,-0.1,,-0.04,-0.81,-0.04,,,,,,,NA,NA,,cytoplasmic exosome (RNase complex),GTP binding,immune response,,
Q9NYZ3,Q9NYZ3,G2 and S phase-expressed protein 1,GTSE1,80.82,58.82,S715,PLIQLSPEADKENVDSPLLKF__________,_ENVDS(ph)PLLKF_, , , , , ,-0.59,-0.86,-0.59, , , , , ,-0.78,-0.87,-1.22,,,-0.59,-0.72,,,-0.78,-1.04,, +,,,,,NA,NA,,cytoplasmic microtubule,,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",,
Q9NYZ3,Q9NYZ3,G2 and S phase-expressed protein 1,GTSE1,93.5,92.75,S575,TRESNRKTDSRLVDVSPDRGSPPSRVPQALN,_LVDVS(ph)PDRGS(ph)PPSR_, ,-0.26, , ,0.67,-0.18, ,-0.29, ,-0.33, , ,0.53,-0.47, ,-0.28,-0.26,,0.31,-0.29,-0.33,,0.11,-0.28,,,,,,,NA,NA,,cytoplasmic microtubule,,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",,
Q9NYZ3,Q9NYZ3,G2 and S phase-expressed protein 1,GTSE1,93.5,92.75,S580,RKTDSRLVDVSPDRGSPPSRVPQALNFSPEE,_LVDVS(ph)PDRGS(ph)PPSR_, , , , ,-0.19,-0.7, ,-0.29, , , , ,-0.32,-0.62, ,-0.28,,,-0.42,-0.29,,,-0.46,-0.28,,,,,,,NA,NA,,cytoplasmic microtubule,,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",,
B7Z806,P13807,"Glycogen [starch] synthase, muscle",GYS1,51.97,42.22,S657,VPPSPSLSRHSSPHQSEDEEDPRNGPLEEDG,_HSS(ph)PHQS(ph)EDEEDPR_, , , , , ,0.11,0.37,1.14, , , , , ,0.01,0.25,0.63,,,0.11,0.8,,,0.01,0.45,,,,,,,NA,NA,,cell cortex,glycogen (starch) synthase activity,glycogen biosynthetic process,,
B7Z806,P13807,"Glycogen [starch] synthase, muscle",GYS1,136.55,136.55,S727,DTATSSSLSTPSEPLSPTSSLGEERN_____,_RNSVDTATSSSLSTPSEPLS(ph)PTSS(ph)LGEERN_, , , , ,0.8,0.57,0.88,0.92, , , , ,1.2,0.23,1.17,0.75,,,0.69,0.9,,,0.79,0.97,,,,,,,NA,NA,,cell cortex,glycogen (starch) synthase activity,glycogen biosynthetic process,,
B7Z806,P13807,"Glycogen [starch] synthase, muscle",GYS1,136.55,136.55,S731,SSSLSTPSEPLSPTSSLGEERN_________,_RNSVDTATSSSLSTPSEPLS(ph)PTSS(ph)LGEERN_, , , , ,0.8,0.57,0.87,0.92, , , , ,1.2,0.23,0.64,0.75,,,0.69,0.9,,,0.79,0.69,,,,,,,NA,NA,,cell cortex,glycogen (starch) synthase activity,glycogen biosynthetic process,,
Q92522,Q92522,Histone H1x,H1FX,131.41,126.54,S2,______________MSVELEEALPVTTAEGM,_(ac)S(ph)VELEEALPVTTAEGMAK_,-2.21,-0.91, , ,-0.24,-0.34,-0.49, ,-0.23,0.01, , ,-0.42,-0.02,-0.31, ,-1.42,,-0.29,-0.49,-0.11,,-0.21,-0.31, +,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
Q92522,Q92522,Histone H1x,H1FX,175.66,127.56,S31,GMAKKVTKAGGSAALSPSKKRKNSKKKNQPG,_AGGSAALS(ph)PSK_, , , , ,0.07,0.26,-0.04,-0.26, , , , ,0.36,-0.01,-0.13,-0.16,,,0.17,-0.14,,,0.19,-0.14,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
O75367-2,O75367,Core histone macro-H2A.1,H2AFY,134.51,117.04,S173,SKKKQGEVSKAASADSTTEGTPADGFTVLST,_AAS(ph)ADS(ph)TTEGTPADGFTVLSTK_,-1.29, , , ,-0.39,-0.37,-0.34,-0.12,0.22, , , ,-0.15,0.05,-0.23,-0.21,-1.29,,-0.38,-0.23,0.22,,-0.05,-0.22, +,,,,,,NA,NA,,Barr body,chromatin binding,chromatin modification,,
O75367-2,O75367,Core histone macro-H2A.1,H2AFY,134.51,117.04,S170,ARKSKKKQGEVSKAASADSTTEGTPADGFTV,_AAS(ph)ADS(ph)TTEGTPADGFTVLSTK_,-1.29,-0.46, , ,-0.27,-0.32,-0.21,0.31,0.22,0.69, , ,-0.13,0,-0.19,-0.21,-0.82,,-0.3,0.08,0.47,,-0.06,-0.2,,,,,,,NA,NA,,Barr body,chromatin binding,chromatin modification,,
B4DDY8,B4DDY8,"Probable histidine--tRNA ligase, mitochondrial",HARSL,113.61,105.85,S42,CTGAVRCQSQGTRDLSPQHMVVREKILDLVI,_DLS(ph)PQHMVVR_,-0.06,0.14,-0.19,-0.56,-0.48,0.41,0.18, ,-0.07,0.16,-0.19,-0.4,-0.61,0.24,0.06, ,0.05,-0.36,0.04,0.18,0.05,-0.29,-0.13,0.06,,,,,,,0,0,,cytoplasm,ATP binding,histidyl-tRNA aminoacylation,,
O14929,O14929,Histone acetyltransferase type B catalytic subunit,HAT1,135.77,22.27,S361,EQYRSYRLDIKRRLISPYKKKQRDLAKMRKC,_LIS(ph)PYK_,-0.37,-0.71,-0.53,-0.15, , , ,0.41,0.01,-0.12,-0.09,0.15, , , ,0.05,-0.53,-0.33,,0.41,-0.05,0.04,,0.05,,,,,,,NA,NA,,cytoplasm,histone acetyltransferase activity,chromatin silencing at telomere,,
Q9Y450,Q9Y450,HBS1-like protein,HBS1L,113.73,113.62,S67,PVEEYDYEDLKESSNSVSNHQLSGFDQARLY,_ESSNS(ph)VSNHQLSGFDQAR_,-0.14,0.26,1.38,1.44,1.51, ,0.79, ,0.02,0.68,1.51,1.55,1.72, ,1.07, ,0.08,1.41,1.51,0.79,0.39,1.53,1.72,1.07, +, +,,,,,1,1,35.05,,GTP binding,GTP catabolic process,,
Q9Y450,Q9Y450,HBS1-like protein,HBS1L,108.71,108.25,Y56,IYSRRDKPSVEPVEEYDYEDLKESSNSVSNH,_DKPSVEPVEEY(ph)DYEDLK_,3.67, , , , , , , ,3.05, , , , , , , ,3.67,,,,3.05,,,, +, +,,,,,NA,NA,,,GTP binding,GTP catabolic process,,
Q9Y450,Q9Y450,HBS1-like protein,HBS1L,141.6,141.25,Y58,SRRDKPSVEPVEEYDYEDLKESSNSVSNHQL,_DKPSVEPVEEYDY(ph)EDLK_,3.65, ,2.72, , , , , ,3.1, ,0.8, , , , , ,3.65,2.72,,,3.1,0.8,,, +, +,,,,,NA,NA,,,GTP binding,GTP catabolic process,,
P51610-2,P51610,Host cell factor 1,HCFC1,77.46,77.36,S1507,PVPGPSVPPPEELQVSPGPRQQLPPRQLLQS,_AVTTVTQSTPVPGPSVPPPEELQVS(ph)PGPR_,0.02, ,0.32,0.26, , , , ,0.42, ,0.49,0.55, , , , ,0.02,0.29,,,0.42,0.52,,,,,,,,,NA,NA,,histone acetyltransferase complex,chromatin binding,cell cycle,,
Q13547,Q13547,Histone deacetylase 1,HDAC1,254.87,242.86,S421,SICSSDKRIACEEEFSDSEEEGEGGRKNSSN,_IACEEEFS(ph)DS(ph)EEEGEGGRK_, , , , ,0.02,-0.18,-0.38,-0.18, , , , ,-0.5,0.13,-0.05,0.26,,,-0.08,-0.27,,,-0.15,0.11,,,,,,,NA,NA,,cytosol,core promoter binding,blood coagulation,,
Q13547,Q13547,Histone deacetylase 1,HDAC1,254.87,242.86,S423,CSSDKRIACEEEFSDSEEEGEGGRKNSSNFK,_IACEEEFS(ph)DS(ph)EEEGEGGRK_, , , , ,0.02,-0.18,-0.38,-0.18, , , , ,-0.5,0.13,-0.05,0.26,,,-0.08,-0.27,,,-0.15,0.11,,,,,,,NA,NA,,cytosol,core promoter binding,blood coagulation,,
Q13547,Q13547,Histone deacetylase 1,HDAC1,225.36,225.32,S393,GVQMQAIPEDAIPEESGDEDEDDPDKRISIC,_MLPHAPGVQMQAIPEDAIPEES(ph)GDEDEDDPDKR_,-0.04,-0.13,-0.21,-0.25,0.12,0.35,0.08,0.13,-0.07,-0.08,-0.08,-0.05,-0.07,0.19,0.13,0.21,-0.09,-0.23,0.24,0.1,-0.08,-0.07,0.07,0.17,,,,,,,0,0,,cytosol,core promoter binding,blood coagulation,,
B3KRS5,Q92769,Histone deacetylase,HDAC2,278.52,272.15,S422,SIRASDKRIACDEEFSDSEDEGEGGRRNVAD,_RIACDEEFS(ph)DS(ph)EDEGEGGRR_,-0.37,-0.34,-0.18,-0.21,-0.2,-0.2,-0.33,-0.18,-0.27,-0.36,-0.24,-0.54,-0.22,-0.27,-0.27,-0.18,-0.36,-0.19,-0.2,-0.26,-0.32,-0.38,-0.24,-0.23,,,,,,,0,0,,heterochromatin,chromatin DNA binding,dendrite development,,
B3KRS5,Q92769,Histone deacetylase,HDAC2,278.52,272.15,S424,RASDKRIACDEEFSDSEDEGEGGRRNVADHK,_RIACDEEFS(ph)DS(ph)EDEGEGGRR_,-0.37,-0.34,-0.18,-0.21,-0.2,-0.2,-0.33,-0.18,-0.27,-0.36,-0.24,-0.54,-0.22,-0.27,-0.27,-0.18,-0.36,-0.19,-0.2,-0.26,-0.32,-0.38,-0.24,-0.23,,,,,,,0,0,,heterochromatin,chromatin DNA binding,dendrite development,,
B3KRS5,Q92769,Histone deacetylase,HDAC2,208.56,206.17,S394,GVQMQAIPEDAVHEDSGDEDGEDPDKRISIR,_M(ox)LPHAPGVQMQAIPEDAVHEDS(ph)GDEDGEDPDKR_,-0.1,0.17,0.2,-0.11,-0.13,0.08,0.27, ,0.03,-0.44,-0.14,-0.25,0.03,-0.1,0.6, ,0.04,0.05,-0.02,0.27,-0.19,-0.19,-0.03,0.6,,,,,,,0,0,,heterochromatin,chromatin DNA binding,dendrite development,,
F5H0Q9,P56524,Histone deacetylase 4,HDAC4,150.94,150.94,S565,AHAQAGVQVKQEPIESDEEEAEPPREVEPGQ,_QEPIES(ph)DEEEAEPPREVEPGQR_,0.09,0.09,-0.18,-0.09,0.15,0.23, ,0.22,-0.08,-0.16,-0.28,-0.28,0.02,-0.04, ,0.41,0.09,-0.14,0.19,0.22,-0.12,-0.28,-0.01,0.41,,,,,,,0,0,,,,,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,142.74,135.69,S239,ATKEDAEAPGIRDHESL______________,_EDAEAPGIRDHES(ph)L_,-0.46,-0.39,-0.5,-0.82,-0.11,-0.1,-0.39,-0.29,0.3,0.25,-0.17,0,-0.32,-0.52,-0.62,-0.44,-0.42,-0.65,-0.11,-0.34,0.27,-0.08,-0.41,-0.53,,,,,,,0,0,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,213.98,213.98,S165,EKGALKRRAGDLLEDSPKRPKEAENPEGEEK,_RRAGDLLEDS(ph)PK_,0.19,0.15,0.14,0.12,0.27,0.21,0.29,0.18,0.12,0.13,0.12,0.11,0.11,0.13,0.03,0.14,0.17,0.13,0.24,0.24,0.13,0.11,0.12,0.09,,,,,,,0,0,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,396.11,396.11,S132,EAAEGDGDKKGNAEGSSDEEGKLVIDEPAKE,_KGNAEGS(ph)S(ph)DEEGKLVIDEPAK_,-0.04,-0.06,-0.11,-0.42,-0.03,-0.13,0.11,-0.12,0.09,0.06,-0.12,-0.58,-0.08,-0.12,-0.45,-0.27,-0.05,-0.26,-0.08,0,0.07,-0.33,-0.1,-0.35,,,,,,,0,0,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,396.11,396.11,S133,AAEGDGDKKGNAEGSSDEEGKLVIDEPAKEK,_KGNAEGS(ph)S(ph)DEEGKLVIDEPAK_,-0.04,-0.06,0.22,-0.42,-0.03,-0.13,0.11,-0.12,0.09,0.06,0.38,-0.58,-0.08,-0.12,-0.45,-0.27,-0.05,-0.07,-0.08,0,0.07,-0.02,-0.1,-0.35,,,,,,,0,0,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,76.03,75.67,S202,VERPLPMEVEKNSTPSEPGSGRGPPQEEEEE,_NST(ph)PS(ph)EPGS(ph)GRGPPQEEEEEEDEEEEATK_, , , , ,-0.01,-0.13,-0.04,0.24, , , , ,0.03,0,-0.39,-0.29,,,-0.07,0.11,,,0.02,-0.34,,,,,,,NA,NA,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,88.63,88.56,S206,LPMEVEKNSTPSEPGSGRGPPQEEEEEEDEE,_NST(ph)PS(ph)EPGS(ph)GRGPPQEEEEEEDEEEEATK_, , , , ,0.04,-0.13,-0.08,0.09, , , , ,0.03,0,-0.53,-0.15,,,-0.04,0.01,,,0.02,-0.33,,,,,,,NA,NA,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,111.66,108.32,T184,PKEAENPEGEEKEAATLEVERPLPMEVEKNS,_EAAT(ph)LEVERPLPMEVEK_, , , , ,0.01,-0.13, , , , , , ,0.13,0.41, , ,,,-0.06,,,,0.28,,,,,,,,NA,NA,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
P51858,P51858,Hepatoma-derived growth factor,HDGF,88.63,88.56,T200,LEVERPLPMEVEKNSTPSEPGSGRGPPQEEE,_NST(ph)PSEPGSGR_, , , , ,0.1, ,-0.58,-0.13, , , , ,0.02, ,-0.55,-0.22,,,0.1,-0.34,,,0.02,-0.38,,,,,,,NA,NA,,cytoplasm,DNA binding,activation of signaling protein activity involved in unfolded protein response,,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,168,168,S454,KQQAKPVKVERTRKRSEGFSMDRKVEKKKEP,_KRS(ph)EGFSMDR_,-0.02,0.49,2.32,2.69,2.36,2.05,2.56,1.78,0.23,0.5,2.6,2.81,2.34,1.88,2.67,1.77,0.26,2.52,2.21,2.22,0.37,2.71,2.13,2.29, +, +,,,,,1,1,53.83,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,145.39,134.13,S664,RPGSDRQERERARGDSEALDEES________,_ARGDS(ph)EALDEES_,-0.09,0.09, ,0.41, ,0.99,0.69,0.81,-0.07,0.07, ,0.56, ,0.85,0.75,0.9,0.01,0.41,0.99,0.75,0,0.56,0.85,0.83,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,72.06,72.06,S652,DLHDVREGPDLDRPGSDRQERERARGDSEAL,_EGPDLDRPGS(ph)DRQER_, ,0.11, , , , , , , ,-0.17, , , , , , ,0.11,,,,-0.17,,,,,,,,,,NA,NA,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,153.48,126.89,S625,KGESAEDKEHEEGRDSEEGPRCGSSEDLHDV,_EHEEGRDS(ph)EEGPR_,-0.09, ,0.45, , ,-0.1,-0.07,-0.11,0, ,0.31, , ,-0.21,-0.18,-0.13,-0.09,0.45,-0.1,-0.09,0,0.31,-0.21,-0.16,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,202.16,202.16,S240,KKKAPSASDSDSKADSDGAKPEPVAMARSAS,_ADS(ph)DGAKPEPVAM(ox)AR_,-0.06,-0.01,-0.06,-0.26,0.13,0.26,0.24,0.16,0.08,0.13,0.07,-0.1,0.1,0.05,-0.03,0.01,-0.04,-0.16,0.2,0.21,0.1,-0.01,0.08,-0.01,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,168.88,168.88,S366,ERRRERADRGEAERGSGGSSGDELREDDEPV,_GS(ph)GGS(ph)S(ph)GDELREDDEPVK_,-0.11,-0.06,-0.1,-0.05,-0.23,0.04,0.22,-0.01,-0.05,-0.02,0.04,0.01,-0.36,-0.04,-0.02,-0.19,-0.08,-0.08,-0.09,0.11,-0.03,0.02,-0.19,-0.11,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,168.88,168.88,S369,RERADRGEAERGSGGSSGDELREDDEPVKKR,_GS(ph)GGS(ph)S(ph)GDELREDDEPVK_,-0.11,-0.06,-0.1,-0.05,-0.23,0.04,0.22,-0.01,-0.05,-0.02,0.04,0.01,-0.36,-0.04,-0.02,-0.19,-0.08,-0.08,-0.09,0.11,-0.03,0.02,-0.19,-0.11,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q7Z4V5-2,Q7Z4V5,Hepatoma-derived growth factor-related protein 2,HDGFRP2,168.88,168.88,S370,ERADRGEAERGSGGSSGDELREDDEPVKKRG,_GS(ph)GGS(ph)S(ph)GDELREDDEPVK_,-0.11,-0.06,-0.1,-0.05,-0.23,0.04,0.22,-0.01,-0.05,-0.02,0.04,0.01,-0.36,-0.04,-0.02,-0.19,-0.08,-0.08,-0.09,0.11,-0.03,0.02,-0.19,-0.11,,,,,,,0,0,,nucleus,DNA binding,"transcription, DNA-dependent",,
Q9Y3E1,Q9Y3E1,Hepatoma-derived growth factor-related protein 3,HDGFRP3,107.92,107.92,S121,SSSETEGEGGNTADASSEEEGDRVEEDGKGK,_FTGYQAIQQQSSSET(ph)EGEGGNTADAS(ph)S(ph)EEEGDRVEEDGK_, , , , ,-0.77,-0.21,-0.43,-0.48, , , , ,-0.01,-0.04,-0.29,-0.56,,,-0.46,-0.45,,,-0.02,-0.42,,,,,,,NA,NA,,cytoplasm,,cell proliferation,,
Q9Y3E1,Q9Y3E1,Hepatoma-derived growth factor-related protein 3,HDGFRP3,107.92,107.92,S122,SSETEGEGGNTADASSEEEGDRVEEDGKGKR,_FTGYQAIQQQSSS(ph)ETEGEGGNTADAS(ph)S(ph)EEEGDRVEEDGK_, , , , ,-0.77,-0.21,-0.43,-0.48, , , , ,-0.01,-0.04,-0.29,-0.56,,,-0.46,-0.45,,,-0.02,-0.42,,,,,,,NA,NA,,cytoplasm,,cell proliferation,,
Q00341,Q00341,Vigilin,HDLBP,270.05,270.05,S31,RSGLVPQQIKVATLNSEEESDPPTYKDAFPP,_VATLNS(ph)EEESDPPTYK_,0.21,0.21,0.16,0.08,0.28,0.05,0.21,0.28,0.34,0.3,0.4,0.36,0.5,0.31,0.26,0.12,0.21,0.12,0.17,0.25,0.32,0.38,0.41,0.19,,,,,,,0,0,,cytoplasm,lipid binding,cholesterol metabolic process,,
E7ESB9,Q6AI08,HEAT repeat-containing protein 6,HEATR6,207.38,206.75,S643,KKAPAGPSLEETSVSSPKGSSEPCWLIRLCI,_APAGPSLEETSVSS(ph)PK_, ,-0.14, ,-0.57, , , , , ,-0.32, ,-1.05, , , , ,-0.14,-0.57,,,-0.32,-1.05,,,, +,,,,,NA,NA,,,,,,
E7ESB9,Q6AI08,HEAT repeat-containing protein 6,HEATR6,185.53,184.61,S642,WKKAPAGPSLEETSVSSPKGSSEPCWLIRLC,_APAGPSLEETSVS(ph)SPK_,-0.15, ,-0.51, ,-0.32, ,-0.29,-0.32,-0.24, ,-0.31, ,-0.48, ,-0.42,-0.49,-0.15,-0.51,-0.32,-0.3,-0.24,-0.31,-0.48,-0.45,,,,,,,0,0,,,,,,
Q9ULT8,Q9ULT8,E3 ubiquitin-protein ligase HECTD1,HECTD1,130.69,130.69,S632,RLGVISKVSTLAGPSSDDENEEESKPEKEDE,_VSTLAGPSS(ph)DDENEEESKPEK_, , , , ,-0.05, ,0.21,0.14, , , , ,0.26, ,0.06,0.17,,,-0.05,0.17,,,0.26,0.12,,,,HECT,,,NA,NA,,cytoplasm,metal ion binding,neural tube closure,,
C9JHL2,Q9P2P5,E3 ubiquitin-protein ligase HECW2,HECW2,82.9,78.75,S48,AQSSMPENMTLQRANSDTDLVTSESRSSLTA,_ANS(ph)DTDLVTSESR_, , , , ,-1.13,-1.12, , , , , , ,-0.74,-1.46, , ,,,-1.13,,,,-1.06,, +, +,,HECT,,,NA,NA,,,,,,
Q15751,Q15751,Probable E3 ubiquitin-protein ligase HERC1,HERC1,67.29,66.6,S2710,PTRRAQTPPISSLPTSPSDEVGRRQSLTSPD,_AQT(ph)PPISS(ph)LPTS(ph)PSDEVGR_, , , , , , ,0.2,0.26, , , , , , ,0.6,0.21,,,,0.23,,,,0.42,,,,HECT,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,transport,,
Q15751,Q15751,Probable E3 ubiquitin-protein ligase HERC1,HERC1,67.29,66.6,T2701,SSYPTTTVLPTRRAQTPPISSLPTSPSDEVG,_AQT(ph)PPISSLPT(ph)S(ph)PSDEVGRR_, , , , , , ,0.2,0.26, , , , , , ,0.6,0.21,,,,0.23,,,,0.42,,,,HECT,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,transport,,
Q15751,Q15751,Probable E3 ubiquitin-protein ligase HERC1,HERC1,92.79,92.55,S1521,RLIKSRSESDLSQPESDEEGYALSGRRNVDL,_SRS(ph)ESDLSQPES(ph)DEEGYALSGR_, , , , ,0.01,0.04,0.28,0.32, , , , ,-0.56,-0.89,-0.12,-0.58,,,0.03,0.3,,,-0.71,-0.33,,,,HECT,,,NA,NA,,cytosol,ARF guanyl-nucleotide exchange factor activity,transport,,
O95714,O95714,E3 ubiquitin-protein ligase HERC2,HERC2,51.89,51.89,S2928,IRAEEEDLAAVPFLASDNEEEEDEKGNSGSL,_IRAEEEDLAAVPFLAS(ph)DNEEEEDEK_, , , , , , ,0.94,0.71, , , , , , ,-0.04,-0.48,,,,0.83,,,,-0.25,,,,HECT,,,NA,NA,,centriole,guanyl-nucleotide exchange factor activity,DNA repair,,
O95714,O95714,E3 ubiquitin-protein ligase HERC2,HERC2,140.38,140.27,S1942,KLAELPAAAQPSAEDSDTEDDSEAEQTERNI,_LAELPAAAQPSAEDS(ph)DT(ph)EDDSEAEQTER_, , , , ,0.03,-0.08,0.02,0.01, , , , ,-0.09,-0.08,-0.06,-0.08,,,-0.03,0.01,,,-0.08,-0.07,,,,HECT,,,NA,NA,,centriole,guanyl-nucleotide exchange factor activity,DNA repair,,
O95714,O95714,E3 ubiquitin-protein ligase HERC2,HERC2,112.32,110.41,S1948,AAAQPSAEDSDTEDDSEAEQTERNIHPTAMM,_LAELPAAAQPSAEDS(ph)DT(ph)EDDS(ph)EAEQTER_, , , , ,0.23,-0.24,0.02,0.14, , , , ,0.27,0.44,-0.16,-0.07,,,0.01,0.08,,,0.36,-0.11,,,,HECT,,,NA,NA,,centriole,guanyl-nucleotide exchange factor activity,DNA repair,,
O95714,O95714,E3 ubiquitin-protein ligase HERC2,HERC2,140.38,140.27,T1944,AELPAAAQPSAEDSDTEDDSEAEQTERNIHP,_LAELPAAAQPSAEDS(ph)DT(ph)EDDS(ph)EAEQTER_, , , , ,0.03,-0.08,0.02,0.01, , , , ,-0.09,-0.08,-0.06,-0.08,,,-0.03,0.01,,,-0.08,-0.07,,,,HECT,,,NA,NA,,centriole,guanyl-nucleotide exchange factor activity,DNA repair,,
O94992,O94992,Protein HEXIM1,HEXIM1,177.6,176.31,S237,TGLYSKRAAAKSDDTSDDDFMEEGGEEDGGS,_SDDT(ph)S(ph)DDDFMEEGGEEDGGS(ph)DGMGGDGSEFLQR_, , , , ,-0.22,0,0.17,0.02, , , , ,-0.05,0.51,0.15,0.22,,,-0.1,0.1,,,0.25,0.19,,,,,,,NA,NA,,cytoplasm,cyclin-dependent protein kinase inhibitor activity,heart development,,
O94992,O94992,Protein HEXIM1,HEXIM1,146.51,146.48,S252,SDDDFMEEGGEEDGGSDGMGGDGSEFLQRDF,_SDDT(ph)S(ph)DDDFMEEGGEEDGGS(ph)DGMGGDGSEFLQR_, , , , ,0,-0.15,-0.37,-0.28, , , , ,0.01,0.02,-0.02,-0.18,,,-0.07,-0.32,,,0.01,-0.1,,,,,,,NA,NA,,cytoplasm,cyclin-dependent protein kinase inhibitor activity,heart development,,
O94992,O94992,Protein HEXIM1,HEXIM1,177.6,176.31,T236,KTGLYSKRAAAKSDDTSDDDFMEEGGEEDGG,_SDDT(ph)S(ph)DDDFMEEGGEEDGGS(ph)DGMGGDGSEFLQR_, , , , ,-0.04,0,0.36,0.02, , , , ,0.13,0.51,0.13,0.22,,,-0.02,0.2,,,0.33,0.17,,,,,,,NA,NA,,cytoplasm,cyclin-dependent protein kinase inhibitor activity,heart development,,
Q96MH2,Q96MH2,Protein HEXIM2,HEXIM2,131,130.53,S51,RHDSGGSLPLTPRMESHSEDEDLAGAVGGLG,_MES(ph)HS(ph)EDEDLAGAVGGLGWNSR_, , , , ,0.24, ,1.1,0.21, , , , ,0.47, ,0.77,0.98,,,0.24,0.73,,,0.47,0.88,,,,,,,NA,NA,,cytoplasm,cyclin-dependent protein kinase inhibitor activity,negative regulation of cyclin-dependent protein kinase activity,,
Q96MH2,Q96MH2,Protein HEXIM2,HEXIM2,131,130.53,S53,DSGGSLPLTPRMESHSEDEDLAGAVGGLGWN,_MES(ph)HS(ph)EDEDLAGAVGGLGWNSR_, , , , ,0.24, ,1.1,0.21, , , , ,0.47, ,0.77,0.98,,,0.24,0.73,,,0.47,0.88,,,,,,,NA,NA,,cytoplasm,cyclin-dependent protein kinase inhibitor activity,negative regulation of cyclin-dependent protein kinase activity,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,180.09,172.48,Y334,AEDIDPELARYLNRNYWEKKQEEARKSPTPS,_Y(ph)LNRNY(ph)WEK_,2.38, ,7.07,1.11,2.76, , , ,1.49, ,4.73,-1.03,2.22, , , ,2.38,6.09,2.76,,1.49,3.76,2.22,, +, +,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,138.19,136.74,Y308,EPMPSASSAPPASSLYSSPVNSSAPLAEDID,_AEPMPSASSAPPASSLY(ph)SSPVNSSAPLAEDIDPELAR_, , ,-1.23, , , , , , , , , , , , , ,,-1.23,,,,,,, +,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,80.03,79.63,Y237,KAEGKATSTTELPPEYLTSPLSQQSQLPPKR,_ATSTTELPPEY(ph)LTSPLSQQSQLPPK_, , ,2.05, , , , , , , ,0.38, , , , , ,,2.05,,,,0.38,,, +,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,120.15,67.44,Y286,QSEAEEKERLRQKSTYTSYPKAEPMPSASSA,_STY(ph)TSYPK_, , ,1.65, , , , , , , ,-0.42, , , , , ,,1.65,,,,-0.42,,, +,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,98.05,94.93,Y132,HAFRNEPKYKVVQDTYQIMKVEGHVFPEFKE,_VVQDTY(ph)QIMK_, , ,1.72, ,1.43,0.68, , , , ,0.4, ,0.08,-0.92, , ,,1.72,1.1,,,0.4,-0.34,, +,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,163.88,124.25,Y329,SSAPLAEDIDPELARYLNRNYWEKKQEEARK,_Y(ph)LNRNY(ph)WEK_, , ,3.37, , , , , , , ,0.32, , , , , ,,3.37,,,,0.32,,, +,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,93.84,42.08,Y466,PQLLELLNQLDERRLYYEGLQDKLAQIRDAR,_RLY(ph)YEGLQDK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
F5H5Y5,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,120.15,67.44,Y289,AEEKERLRQKSTYTSYPKAEPMPSASSAPPA,_STY(ph)TSY(ph)PK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q86Z02-2,Q86Z02,Homeodomain-interacting protein kinase 1,HIPK1,110.39,108.63,Y352,DFGSASHVSKAVCSTYLQSRYYRAPEIILGL,_AVCSTY(ph)LQSR_,-0.56, ,-0.25, , , , , ,-0.74, ,-0.25, , , , , ,-0.56,-0.25,,,-0.74,-0.25,,,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,anterior/posterior pattern specification,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,147.49,146.55,S359,PTAKGSRKMARLGSTSGEESDLEREVSDSEA,_LGS(ph)T(ph)S(ph)GEES(ph)DLER_, , , , ,-2.17,-1.19,-0.81,-1.46, , , , , ,-1.26,-1.03,-2.56,,,-1.6,-1.1,,,-1.26,-1.6, +, +,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,147.49,146.55,S363,GSRKMARLGSTSGEESDLEREVSDSEAGGGP,_LGS(ph)T(ph)S(ph)GEES(ph)DLER_, , , , ,-2.17,-1.82,-0.81,-1.36, , , , , ,-1.97,-1.03,-1.21,,,-1.98,-1.06,,,-1.97,-1.12, +, +,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,73.42,73.3,S370,LGSTSGEESDLEREVSDSEAGGGPQGERKNR,_LGST(ph)S(ph)GEES(ph)DLEREVS(ph)DSEAGGGPQGER_, , , , , , , ,-1.84, , , , , , , ,-2.68,,,,-1.84,,,,-2.68, +, +,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,147.49,146.55,T358,EPTAKGSRKMARLGSTSGEESDLEREVSDSE,_LGS(ph)T(ph)S(ph)GEES(ph)DLER_, , , , ,-2.17,-1.82,-0.81,-1.36, , , , , ,-1.97,-1.03,-1.21,,,-1.98,-1.06,,,-1.97,-1.12, +, +,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,158.61,155.41,S530,GEAAPPGELYRRTLDSDEERPRPAPPDWSHM,_TLDS(ph)DEERPRPAPPDWSHMR_,0.18,0.02,-0.24, , , , , ,0.24,1.73,0.02, , , , , ,0.11,-0.24,,,1.17,0.02,,,, +,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,64.32,64.32,S159,DEERQRDLPAQRGEESSEEEEKGYKGKTRKK,_DLPAQRGEES(ph)S(ph)EEEEK_,-0.09,-0.28,-0.43,-0.54,-0.09,0.22,-0.1,-0.45,-0.05,-0.26,0,-0.61,-0.17,-0.26,-0.4,-0.11,-0.18,-0.49,0.07,-0.26,-0.15,-0.27,-0.21,-0.25,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,64.32,64.32,S160,EERQRDLPAQRGEESSEEEEKGYKGKTRKKP,_DLPAQRGEES(ph)S(ph)EEEEK_,-0.09,-0.28,-0.43,-0.54,-0.09,0.22,-0.1,-0.45,-0.05,-0.26,0,-0.61,-0.17,-0.26,-0.4,-0.11,-0.18,-0.49,0.07,-0.26,-0.15,-0.27,-0.21,-0.25,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,201.85,201.85,S196,APGKASVSRKQAREESEESEAEPVQRTAKKV,_(gl)QAREES(ph)EES(ph)EAEPVQR_,-0.16,-0.27,-0.37,-0.41,0.12,0.23,0.08,0.2,-0.07,-0.05,-0.34,-0.23,-0.19,-0.06,0.01,0.07,-0.22,-0.39,0.18,0.14,-0.06,-0.28,-0.12,0.04,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,201.85,201.85,S199,KASVSRKQAREESEESEAEPVQRTAKKVEGN,_(gl)QAREES(ph)EES(ph)EAEPVQR_,-0.16,-0.27,-0.37,-0.41,0.12,0.23,0.08,0.2,-0.07,-0.05,-0.34,-0.23,-0.19,-0.06,0.01,0.07,-0.22,-0.39,0.18,0.14,-0.06,-0.28,-0.12,0.04,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,291.24,291.24,S223,AKKVEGNKGTKSLKESEQESEEEILAQKKEQ,_SLKES(ph)EQES(ph)EEEILAQKK_,0.72,0.33,0.5,0.25,0.17,0.07,0.47,0.33,0.54,0.51,-0.08,0.43,-0.29,-0.28,0.31,0.31,0.54,0.38,0.12,0.4,0.53,0.2,-0.29,0.31,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,291.24,291.24,S227,EGNKGTKSLKESEQESEEEILAQKKEQREEE,_SLKES(ph)EQES(ph)EEEILAQKK_,0.15,0.15,-0.11,-0.06,0.28,0.59,0.24,0.35,0.16,0.19,0.01,-0.02,-0.36,-0.21,0.1,0.1,0.15,-0.08,0.44,0.3,0.18,-0.01,-0.28,0.1,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,100.39,100.39,S357,GEPTAKGSRKMARLGSTSGEESDLEREVSDS,_LGS(ph)T(ph)S(ph)GEES(ph)DLER_, , , , , ,0.4,0.39,0.44, , , , , ,0.29,0.18,0.3,,,0.4,0.42,,,0.29,0.24,,,,,,,NA,NA,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,233.35,233.35,S289,RSCKQKSQAKRLLGDSDSEEEQKEAASSGDD,_RLLGDS(ph)DS(ph)EEEQK_,-0.15,-0.08,-0.3,-0.36,0.22,0.25,0.16,0.15,0,0.04,-0.09,-0.29,-0.01,0.15,0.2,0.01,-0.12,-0.33,0.23,0.16,0.02,-0.19,0.07,0.11,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,233.35,233.35,S291,CKQKSQAKRLLGDSDSEEEQKEAASSGDDSG,_RLLGDS(ph)DS(ph)EEEQK_,-0.15,-0.08,-0.3,-0.36,0.22,0.25,0.16,0.15,0,0.04,-0.09,-0.29,-0.01,0.15,0.2,0.01,-0.12,-0.33,0.23,0.16,0.02,-0.19,0.07,0.11,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
Q9BW71,Q9BW71,HIRA-interacting protein 3,HIRIP3,123.76,118.85,S125,DYFGPPAKNGVAAEVSPAKEENPRRASKAVE,_NGVAAEVS(ph)PAK_,-0.02,0,-0.17,-0.3,0.41,0.59,0.28,0.29,0,0.14,0.05,-0.14,0.24,0.23,0.16,0.12,-0.01,-0.24,0.5,0.29,0.07,-0.04,0.23,0.14,,,,,,,0,0,,nucleus,,chromatin assembly or disassembly,,
P16401,P16401,Histone H1.5,HIST1H1B,204.71,204.24,S2,______________MSETAPAETATPAPVEK,_(ac)S(ph)ETAPAETATPAPVEK_,0.11,0,-0.5,-0.59,0.09,0.03,-0.15,-0.12,0.46,0.66,0.22,0.25,-0.12,-0.26,-0.37,-0.41,0.06,-0.54,0.06,-0.13,0.56,0.23,-0.19,-0.39,,,,,,,0,0,,nuclear chromatin,DNA binding,nucleosome assembly,,
P16401,P16401,Histone H1.5,HIST1H1B,300.25,300.25,S18,ETAPAETATPAPVEKSPAKKKATKKAAGAGA,_(ac)SETAPAETATPAPVEKS(ph)PAK_,0.08,0.06,-0.1,-0.02, ,-0.23, , ,0.2,0.16,-0.19,-0.23, ,0.05, , ,0.07,-0.06,-0.23,,0.18,-0.21,0.05,,,,,,,,NA,NA,,nuclear chromatin,DNA binding,nucleosome assembly,,
P16401,P16401,Histone H1.5,HIST1H1B,112.53,110.61,T11,_____MSETAPAETATPAPVEKSPAKKKATK,_(ac)S(ph)ETAPAETAT(ph)PAPVEK_, , , , ,0.32,0.39,0.06,-0.2, , , , ,-0.31,0.01,-0.67,-1.2,,,0.35,-0.06,,,-0.14,-0.91,,,,,,,NA,NA,,nuclear chromatin,DNA binding,nucleosome assembly,,
P16402,P16402,Histone H1.3,HIST1H1D,130.36,129.81,S2,______________MSETAPLAPTIPAPAEK,_(ac)S(ph)ETAPLAPTIPAPAEK_,0.48,0.44,0.01,-0.22,-0.05,0.06,-0.15,-0.37,0.82,0.84,0.43,1.54,-0.12,-0.07,-0.17,-0.39,0.46,-0.1,0.01,-0.26,0.83,1.09,-0.09,-0.27,, +,,,,,0,5,19.04,nuclear chromatin,DNA binding,nucleosome assembly,,
P10412,P10412,Histone H1.4,HIST1H1E,195.39,195.39,T18,ETAPAAPAAPAPAEKTPVKKKARKSAGAAKR,_(ac)SETAPAAPAAPAPAEKT(ph)PVK_,0.27,0.35,0.1,0.09,0.22,0.27,-0.03,-0.16,0.5,0.56,0.3,0.28,-0.16,-0.02,-0.23,-0.38,0.31,0.09,0.25,-0.09,0.53,0.29,-0.09,-0.31,,,,,,,0,0,,nucleosome,DNA binding,nucleosome assembly,,
P15822,P15822,Zinc finger protein 40,HIVEP1,113.68,112.92,S487,GLFLSHESPKALSIHSDVEDSGESEEEGATD,_ALSIHS(ph)DVEDS(ph)GES(ph)EEEGATDER_, , , , ,0.11,0,-0.07,-0.11, , , , ,0.25,0.21,0.12,0.14,,,0.05,-0.09,,,0.23,0.13,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
P15822,P15822,Zinc finger protein 40,HIVEP1,113.68,112.92,S492,HESPKALSIHSDVEDSGESEEEGATDERQHD,_ALSIHS(ph)DVEDS(ph)GES(ph)EEEGATDER_, , , , ,0.11,0,-0.07,-0.11, , , , ,0.25,0.21,0.12,0.14,,,0.05,-0.09,,,0.23,0.13,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
P15822,P15822,Zinc finger protein 40,HIVEP1,113.68,112.92,S495,PKALSIHSDVEDSGESEEEGATDERQHDLGA,_ALSIHS(ph)DVEDS(ph)GES(ph)EEEGATDER_, , , , ,0.11,0,-0.07,-0.11, , , , ,0.25,0.21,0.12,0.14,,,0.05,-0.09,,,0.23,0.13,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
C9JWC4,Q8NCD3,Holliday junction recognition protein,HJURP,55.74,46.21,S473,LPDSWAMNMYRGGPASPGGLQGLETRRLSLP,_GGPAS(ph)PGGLQGLETR_, , , , ,0.07, ,0.28, , , , , ,-0.41, ,-0.01, ,,,0.07,0.28,,,-0.41,-0.01,,,,,,,NA,NA,,nucleus,,,,
C9JWC4,Q8NCD3,Holliday junction recognition protein,HJURP,66.96,63.4,S412,NLDEENRFRTLKWLISPVKIVSRPTIRQGHG,_WLIS(ph)PVK_,-0.17,-0.04,-0.38,-0.43, ,-0.34, , ,-0.1,0.05,-0.16,-0.18, ,-0.17, , ,-0.11,-0.4,-0.34,,-0.02,-0.17,-0.17,,,,,,,,NA,NA,,nucleus,,,,
P30490,P30462,"HLA class I histocompatibility antigen, B-50 alpha chain",HLA-B,64.5,49.23,S343,ATVMCRRKSSGGKGGSYSQAASSDSAQGSDV,_GGS(ph)YSQAASSDSAQGSDVSLTA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome membrane,,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",,
P30490,P01892,"HLA class I histocompatibility antigen, B-50 alpha chain",HLA-B,165.36,153.55,S352,SGGKGGSYSQAASSDSAQGSDVSLTA_____,_GGSYSQAASSDS(ph)AQGSDVS(ph)LTA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome membrane,,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",,
P30490,P01892,"HLA class I histocompatibility antigen, B-50 alpha chain",HLA-B,214.85,214.85,S356,GGSYSQAASSDSAQGSDVSLTA_________,_GGSYSQAASSDSAQGS(ph)DVS(ph)LTA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome membrane,,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",,
P30490,P30462,"HLA class I histocompatibility antigen, B-50 alpha chain",HLA-B,214.85,214.85,S359,YSQAASSDSAQGSDVSLTA____________,_GGSYSQAASSDSAQGS(ph)DVS(ph)LTA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome membrane,,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",,
Q14527-2,Q14527,Helicase-like transcription factor,HLTF,83,82.94,S397,SSRPKRRKTAVQYIESSDSEEIETSELPQKM,_TAVQYIES(ph)S(ph)DS(ph)EEIETSELPQK_, , , , , ,0.05, ,0.08, , , , , ,0.51, ,0.08,,,0.05,0.08,,,0.51,0.08,,,,RING finger,,,NA,NA,,nucleus,ATP binding,chromatin modification,,
Q14527-2,Q14527,Helicase-like transcription factor,HLTF,83,82.94,S398,SRPKRRKTAVQYIESSDSEEIETSELPQKMK,_TAVQYIES(ph)S(ph)DS(ph)EEIETSELPQK_, , , , , ,0.05, ,0.08, , , , , ,0.51, ,0.08,,,0.05,0.08,,,0.51,0.08,,,,RING finger,,,NA,NA,,nucleus,ATP binding,chromatin modification,,
Q14527-2,Q14527,Helicase-like transcription factor,HLTF,83,82.94,S400,PKRRKTAVQYIESSDSEEIETSELPQKMKGK,_TAVQYIES(ph)S(ph)DS(ph)EEIETSELPQK_, , , , , ,0.05, ,0.08, , , , , ,0.51, ,0.08,,,0.05,0.08,,,0.51,0.08,,,,RING finger,,,NA,NA,,nucleus,ATP binding,chromatin modification,,
P17096,P17096,High mobility group protein HMG-I/HMG-Y,HMGA1,133.15,133.15,S99,RGRPKKLEKEEEEGISQESSEEEQ_______,_LEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_, , , , ,-0.42,-0.96,-1.18,-0.85, , , , ,-1.14,-1.24,-1.23,-1.14,,,-0.67,-1.01,,,-1.19,-1.19, +, +,,,,,NA,NA,,cytosol,5'-deoxyribose-5-phosphate lyase activity,base-excision repair,,
P17096,P17096,High mobility group protein HMG-I/HMG-Y,HMGA1,246.95,230.94,S102,PKKLEKEEEEGISQESSEEEQ__________,_LEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_, ,-0.18, , ,-0.42,-0.27,-0.14,-0.71, ,0.01, , ,-1.14,-1.24,-1.17,-1.29,-0.18,,-0.34,-0.4,0.01,,-1.19,-1.22,, +,,,,,NA,NA,,cytosol,5'-deoxyribose-5-phosphate lyase activity,base-excision repair,,
P17096,P17096,High mobility group protein HMG-I/HMG-Y,HMGA1,226.74,221.62,S103,KKLEKEEEEGISQESSEEEQ___________,_LEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_, ,-0.18, , ,-0.42,-0.27,-0.14,-0.71, ,0.01, , ,-1.14,-1.24,-1.17,-1.29,-0.18,,-0.34,-0.4,0.01,,-1.19,-1.22,, +,,,,,NA,NA,,cytosol,5'-deoxyribose-5-phosphate lyase activity,base-excision repair,,
Q9UGU5,Q9UGU5,HMG domain-containing protein 4,HMGXB4,131.82,130.28,S502,KVKASSVGVLSPQKKSPPTTMLLPASPAKAP,_S(ph)PPTTMLLPAS(ph)PAK_, ,-0.21, , ,0.43,-0.11,1.59,-0.15, ,0.01, , ,0.38,-0.14,1.6,-0.04,-0.21,,0.18,0.97,0.01,,0.14,1.01,, +,,,,,NA,NA,,NURF complex,DNA binding,endosome to lysosome transport,,
Q9UGU5,Q9UGU5,HMG domain-containing protein 4,HMGXB4,131.82,130.28,S512,SPQKKSPPTTMLLPASPAKAPETEPIDVAAH,_S(ph)PPTTMLLPAS(ph)PAK_, ,-0.21, , ,0.43,-0.11,1.59,-0.15, ,0.01, , ,0.38,-0.14,1.6,-0.04,-0.21,,0.18,0.97,0.01,,0.14,1.01,, +,,,,,NA,NA,,NURF complex,DNA binding,endosome to lysosome transport,,
P09601,P09601,Heme oxygenase 1,HMOX1,137.21,137.21,S229,FEELQELLTHDTKDQSPSRAPGLRQRASNKV,_DQS(ph)PSRAPGLR_,0.8,0.6,0.77,0.82,-0.06,-0.06,0.24,0.06,0.21,0.15,0.07,0.1,0,0.01,-0.3,-0.49,0.7,0.8,-0.06,0.16,0.18,0.09,0.01,-0.39,,,,,,,0,0,,caveola,enzyme binding,angiogenesis,,
A6NHT5,A6NHT5,Homeobox protein HMX3,HMX3,67.66,65.56,S180,KELDSKSPDEIILEESDSEESKKEGEAAPGA,_ELDS(ph)KSPDEIILEES(ph)DSEESK_, , , , , ,0.23, , , , , , , ,1.67, , ,,,0.23,,,,1.67,,, +,,,,,NA,NA,,nucleus,sequence-specific DNA binding,brain development,,
A6NHT5,A6NHT5,Homeobox protein HMX3,HMX3,80.02,72.45,S144,LPRPEASEKALLRDSSPASGTDRDSPEPLLK,_DSS(ph)PASGTDRDS(ph)PEPLLK_,-0.39,-0.15, ,-0.35,0.29,0.43,0.25,0.53,-0.1,-0.03, ,0.12,0.18,0.27,0.25,0.36,-0.27,-0.35,0.36,0.4,-0.07,0.12,0.22,0.31,,,,,,,0,0,,nucleus,sequence-specific DNA binding,brain development,,
A6NHT5,A6NHT5,Homeobox protein HMX3,HMX3,60.38,60.38,S147,PEASEKALLRDSSPASGTDRDSPEPLLKADP,_DSS(ph)PAS(ph)GT(ph)DRDSPEPLLK_, ,-0.15, ,-0.35,-0.57, ,-0.6,-0.73, ,-0.03, ,0.12,-0.39, ,-0.58,-0.58,-0.15,-0.35,-0.57,-0.66,-0.03,0.12,-0.39,-0.58,,,,,,,0,0,,nucleus,sequence-specific DNA binding,brain development,,
A6NHT5,A6NHT5,Homeobox protein HMX3,HMX3,124.39,124.39,S153,ALLRDSSPASGTDRDSPEPLLKADPDHKELD,_DSSPASGTDRDS(ph)PEPLLK_,0.1,0.14,0.06,-0.57,0.87,0.57,0.64,0.82,0.07,0.26,-0.05,-0.3,0.6,0.37,0.83,0.95,0.12,-0.22,0.73,0.73,0.17,-0.17,0.49,0.89,,,,,,,0,0,,nucleus,sequence-specific DNA binding,brain development,,
A6NHT5,A6NHT5,Homeobox protein HMX3,HMX3,68.31,68.31,T149,ASEKALLRDSSPASGTDRDSPEPLLKADPDH,_DSS(ph)PAS(ph)GT(ph)DRDSPEPLLK_,-0.44,-0.24, ,-0.35,0.54,0.43,0.25,-0.69,-0.16,0.02, ,0.12,0.33,0.27,0.25,-0.55,-0.33,-0.35,0.49,-0.14,-0.07,0.12,0.3,-0.09,,,,,,,0,0,,nucleus,sequence-specific DNA binding,brain development,,
Q9UK76,Q9UK76,Hematological and neurological expressed 1 protein,HN1,134.28,126.35,S88,GREDLESSGLQRRNSSEASSGDFLDLKGEGD,_RNS(ph)S(ph)EAS(ph)SGDFLDLK_, , , ,1.09, ,0.9, ,1.13, , , ,0.81, ,2.39, ,0.54,,1.09,0.9,1.13,,0.81,2.39,0.54, +, +,,,,,NA,NA,,nucleus,,,,
Q9UK76,Q9UK76,Hematological and neurological expressed 1 protein,HN1,111.45,111.45,S71,EENQASWAKSAGAKSSGGREDLESSGLQRRN,_SS(ph)GGREDLESSGLQR_,-0.47,-0.43,-0.36,-0.2,-1.15, , ,-1.05,-0.21,-0.46,-0.27,-0.27,-1.38, , ,-1.45,-0.45,-0.28,-1.15,-1.05,-0.33,-0.27,-1.38,-1.45, +, +,,,,,6,6,33.49,nucleus,,,,
Q9UK76,Q9UK76,Hematological and neurological expressed 1 protein,HN1,134.28,126.35,S91,DLESSGLQRRNSSEASSGDFLDLKGEGDIHE,_RNS(ph)S(ph)EAS(ph)SGDFLDLK_, , , , , ,0.2, ,1.13, , , , , ,0.61, ,0.54,,,0.2,1.13,,,0.61,0.54, +,,,,,,NA,NA,,nucleus,,,,
Q9UK76,Q9UK76,Hematological and neurological expressed 1 protein,HN1,280.47,280.47,S87,GGREDLESSGLQRRNSSEASSGDFLDLKGEG,_RNS(ph)S(ph)EAS(ph)SGDFLDLK_,0.03,0.04,0.7,0.64,0.67,0.77,0.7,0.67,0.09,0.12,0.67,0.65,-0.15,-0.09,0.46,0.53,0.04,0.67,0.72,0.69,0.1,0.66,-0.12,0.5,,,,,,,0,0,,nucleus,,,,
Q9UK76,Q9UK76,Hematological and neurological expressed 1 protein,HN1,210.6,188.56,T54,EQPVRKNKMASNIFGTPEENQASWAKSAGAK,_MASNIFGT(ph)PEENQASWAK_,-1.08,-0.6,-0.53,-0.54,-0.41,-0.04,-0.43, ,-0.08,0,0.16,0.07,-0.7,-1.07,-0.79, ,-0.82,-0.53,-0.21,-0.43,-0.04,0.11,-0.87,-0.79,,,,,,,0,0,,nucleus,,,,
A6NGP5,Q9H910,Hematological and neurological expressed 1-like protein,HN1L,155.92,148.51,S97,QHLNPPGGKTSDIFGSPVTATSRLAHPNKPK,_TSDIFGS(ph)PVTATSR_,-0.2,-0.2,-0.47,-0.12,-0.44,-0.54,-0.18,-0.53,-0.24,-0.13,-0.09,-0.1,-0.67,-0.61,-0.53,-0.48,-0.2,-0.28,-0.49,-0.34,-0.18,-0.09,-0.64,-0.5,,,,,,,0,0,,cytoplasm,sequence-specific DNA binding,cellular response to peptide hormone stimulus,,
P09651,P09651,Heterogeneous nuclear ribonucleoprotein A1,HNRNPA1,198.85,143.97,S6,__________MSKSESPKEPEQLRKLFIGGL,_S(ph)ES(ph)PKEPEQLRK_,0.15,0.32,0.2,0.32,0.37,0.39,0.24,0.1,0.18,0.18,0.11,0.18,0.34,0.39,0.2,0.23,0.24,0.26,0.38,0.17,0.18,0.14,0.37,0.22,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
P22626,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,228.76,225.35,S259,YNGYGGGPGGGNFGGSPGYGGGRGGYGGGGP,_GFGDGYNGYGGGPGGGNFGGS(ph)PGYGGGR_, ,0.23, , ,-0.18,-0.16,-0.16,-0.42, ,0.5, , ,0.22,-0.01,-0.31,-0.15,0.23,,-0.17,-0.29,0.5,,0.11,-0.23,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
P22626,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,66.47,65.87,S341,NMGGPYGGGNYGPGGSGGSGGYGGRSRY___,_NMGGPYGGGNYGPGGS(ph)GGS(ph)GGYGGR_, , , , ,-0.22,-0.18,0.04, , , , , ,-0.03,0.13,0.98, ,,,-0.2,0.04,,,0.05,0.98,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
P22626,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,145.79,139.3,S344,GPYGGGNYGPGGSGGSGGYGGRSRY______,_NMGGPYGGGNYGPGGS(ph)GGS(ph)GGYGGR_, ,0.02, , ,0.15,-0.18,-0.08, , ,0.56, , ,0.09,0.13,-0.42, ,0.02,,-0.01,-0.08,0.56,,0.11,-0.42,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
P51991,P51991,Heterogeneous nuclear ribonucleoprotein A3,HNRNPA3,303.48,298.96,S358,YGPMKGGSFGGRSSGSPYGGGYGSGGGSGGY,_SSGS(ph)PYGGGYGSGGGSGGYGSR_, , , , ,-0.16,-0.14,-0.49,-0.41, , , , ,-0.07,-0.1,-0.55,-0.49,,,-0.15,-0.45,,,-0.08,-0.52,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
G3V4C1,P07910,Heterogeneous nuclear ribonucleoproteins C1/C2,HNRNPC,415.78,415.78,S253,SSSSVKKDETNVKMESEGGADDSAEEGDLLD,_MES(ph)EGGADDS(ph)AEEGDLLDDDDNEDRGDDQLELIKDDEK_, ,0.14,-0.59,-0.16,-0.34,-0.11,-0.63,-0.7, ,0.12,-0.04,0.41,-0.23,-0.03,-0.57,-0.49,0.14,-0.36,-0.22,-0.67,0.12,0.2,-0.13,-0.53,,,,,,,0,0,,,nucleic acid binding,,,
G3V4C1,P07910,Heterogeneous nuclear ribonucleoproteins C1/C2,HNRNPC,561.37,561.37,S260,DETNVKMESEGGADDSAEEGDLLDDDDNEDR,_MES(ph)EGGADDS(ph)AEEGDLLDDDDNEDRGDDQLELIKDDEK_,-0.16,-0.1,-0.27,-0.21,-0.13,-0.21,-0.5,-0.66,0.06,0.02,-0.21,-0.06,-0.16,-0.02,-0.41,-0.39,-0.13,-0.24,-0.17,-0.57,0.04,-0.13,-0.09,-0.4,,,,,,,0,0,,,nucleic acid binding,,,
G3V4C1,P07910,Heterogeneous nuclear ribonucleoproteins C1/C2,HNRNPC,370.65,370.65,S299,KDDEKEAEEGEDDRDSANGEDDS________,_EAEEGEDDRDS(ph)ANGEDDS_,-0.25,-0.26,-0.31,-0.36,-0.29,-0.19,-0.3,-0.72,-0.05,-0.06,-0.24,-0.2,-0.18,-0.09,-0.34,-0.48,-0.26,-0.33,-0.24,-0.49,-0.06,-0.22,-0.13,-0.41,,,,,,,0,0,,,nucleic acid binding,,,
Q14103-3,Q14103,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,290.36,290.36,S82,KIDASKNEEDEGHSNSSPRHSEAATAQREEW,_IDASKNEEDEGHSNS(ph)SPR_,-0.22,-0.31, ,-0.64, , , , ,0.06,-0.18, ,-0.35, , , , ,-0.26,-0.64,,,-0.06,-0.35,,,,,,,,,NA,NA,,cytosol,nucleotide binding,"mRNA splicing, via spliceosome",,
Q14103-3,Q14103,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,346.04,346.04,S83,IDASKNEEDEGHSNSSPRHSEAATAQREEWK,_NEEDEGHSNSS(ph)PR_,-0.58,-0.47,-0.47,-1.27, ,-0.28,-0.08, ,-0.49,-0.2,-0.17,-0.3, ,-0.35,-0.59, ,-0.53,-0.82,-0.28,-0.08,-0.34,-0.23,-0.35,-0.59,,,,,,,0,0,,cytosol,nucleotide binding,"mRNA splicing, via spliceosome",,
E9PCY7,P31943,Heterogeneous nuclear ribonucleoprotein H,HNRNPH1,291.97,245.62,S104,NNVEMDWVLKHTGPNSPDTANDGFVRLRGLP,_HTGPNS(ph)PDTANDGFVR_,-0.19,-0.09,-0.02,-0.12,0.24,0.4,0.34,0.27,0,0.1,0.23,0.19,0.38,0.3,0.27,0.2,-0.14,-0.07,0.32,0.31,0.05,0.21,0.34,0.23,,,,,,,0,0,,actin cytoskeleton,nucleic acid binding,,,
P61978-3,P61978,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,141.91,132.13,S284,GGRPMPPSRRDYDDMSPRRGPPPPPPGRGGR,_RDYDDMS(ph)PR_,0.11,0.11,0.09,0.06,-0.05,0.01,0.13,0.15,0.49,0.49,0.79,0.78,-0.17,-0.18,-0.14,-0.25,0.11,0.08,-0.02,0.14,0.49,0.79,-0.17,-0.19,,,,,,,0,0,,catalytic step 2 spliceosome,RNA binding,"mRNA splicing, via spliceosome",,
P61978-3,P61978,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,225.31,217.94,S216,RVVECIKIILDLISESPIKGRAQPYDPNFYD,_IILDLISES(ph)PIK_,-0.55,-0.12,-0.23,-0.1,-0.02,0.08,0.09,0.13,-0.06,-0.01,-0.04,0.03,0.19,0.2,0.07,0.24,-0.32,-0.16,0.03,0.11,-0.03,0,0.2,0.16,,,,,,,0,0,,catalytic step 2 spliceosome,RNA binding,"mRNA splicing, via spliceosome",,
Q00839-2,Q00839,Heterogeneous nuclear ribonucleoprotein U,HNRNPU,302.42,302.42,S59,DEEAGGRPAMEPGNGSLDLGGDSAGRSGAGL,_LQAALDDEEAGGRPAMEPGNGS(ph)LDLGGDS(ph)AGR_,-0.37,-0.37,-0.64,-0.83,-0.04,-0.11,-0.2,-0.24,0.28,0.19,-0.16,-0.1,-0.64,-0.57,-0.79,-0.82,-0.37,-0.73,-0.07,-0.22,0.23,-0.13,-0.61,-0.8,,,,,,,0,0,,catalytic step 2 spliceosome,ATP binding,CRD-mediated mRNA stabilization,,
Q00839-2,Q00839,Heterogeneous nuclear ribonucleoprotein U,HNRNPU,80.25,73.12,Y824,QFWGQKPWSQHYHQGYY______________,_PWSQHYHQGY(ph)Y_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,ATP binding,CRD-mediated mRNA stabilization,,
Q00839-2,Q00839,Heterogeneous nuclear ribonucleoprotein U,HNRNPU,145.23,142.15,Y825,FWGQKPWSQHYHQGYY_______________,_PWSQHYHQGYY(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,ATP binding,CRD-mediated mRNA stabilization,,
Q00839-2,Q00839,Heterogeneous nuclear ribonucleoprotein U,HNRNPU,68.55,68.55,S4,____________MSSSPVNVKKLKVSELKEE,_(ac)SSS(ph)PVNVKK_,0.02,0.11,-0.07,-0.1,-0.18,0.14,-0.48,-0.22,0.26,0.2,0.04,0.05,-0.16,-0.03,-0.2,-0.17,0.06,-0.08,-0.01,-0.34,0.23,0.04,-0.09,-0.18,,,,,,,0,0,,catalytic step 2 spliceosome,ATP binding,CRD-mediated mRNA stabilization,,
Q1KMD3,Q1KMD3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,HNRNPUL2,274.29,274.29,S161,EQGLGKREEDEPEERSGDETPGSEVPGDKAA,_EEDEPEERS(ph)GDET(ph)PGS(ph)EVPGDK_,-0.22,-0.13,-0.25,-0.25,-0.44,-0.32,-0.49,-0.54,-0.03,0.01,-0.19,-0.16,-0.1,-0.07,-0.08,-0.34,-0.17,-0.25,-0.38,-0.52,-0.01,-0.18,-0.08,-0.2,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q1KMD3,Q1KMD3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,HNRNPUL2,62.57,62.57,S168,EEDEPEERSGDETPGSEVPGDKAAEEQGDDQ,_EEDEPEERS(ph)GDET(ph)PGS(ph)EVPGDK_, , , , , , , ,-0.78, , , , , , , ,-0.07,,,,-0.78,,,,-0.07,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q1KMD3,Q1KMD3,Heterogeneous nuclear ribonucleoprotein U-like protein 2,HNRNPUL2,68.94,68.94,T165,GKREEDEPEERSGDETPGSEVPGDKAAEEQG,_EEDEPEERS(ph)GDET(ph)PGS(ph)EVPGDK_, , , , , ,-0.46, ,-0.59, , , , , ,-0.07, ,-0.06,,,-0.46,-0.59,,,-0.07,-0.06,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
O14979-3,O14979,Heterogeneous nuclear ribonucleoprotein D-like,HNRPDL,143.52,95.09,S241,LKGKEPPKKVFVGGLSPDTSEEQIKEYFGAF,_VFVGGLS(ph)PDTSEEQIK_,-0.48,-0.23,-0.37,-0.26, ,0.21,0.22, ,-0.21,-0.11,-0.2,0.02, ,0.19,0.14, ,-0.35,-0.32,0.21,0.22,-0.16,-0.09,0.19,0.14,,,,,,,0,0,,cytoplasm,DNA binding,regulation of gene expression,,
Q5JB52,Q8WVV9,Heterogeneous nuclear ribonucleoprotein L-like,HNRPLL,36.17,36.17,S35,SQAKRLKTEEGEIDYSAEEGENRREATPRGG,_TEEGEIDYS(ph)AEEGENRR_, ,-0.35, , , , , , , ,0.06, , , , , , ,-0.35,,,,0.06,,,,,,,,,,NA,NA,,nucleus,nucleotide binding,mRNA processing,,
Q5SSJ5,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,114.33,114.33,S441,KEPDDSRDEDEDEDESSEEDSEDEEPPPKRR,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,0.42,0.31, , , ,0,-0.7,-0.76,0.46,0.52, , , ,-0.43,-0.79,-0.76,0.36,,0,-0.73,0.49,,-0.43,-0.77,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
Q5SSJ5,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,114.33,114.33,S442,EPDDSRDEDEDEDESSEEDSEDEEPPPKRRL,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,0.42,0.31, , , ,0,-0.7,-0.76,0.46,0.52, , , ,-0.43,-0.79,-0.76,0.36,,0,-0.73,0.49,,-0.43,-0.77,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
Q5SSJ5,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,114.33,114.33,S446,SRDEDEDEDESSEEDSEDEEPPPKRRLQKKT,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,0.42,0.31, , , ,0,-0.7,-0.76,0.46,0.52, , , ,-0.43,-0.79,-0.76,0.36,,0,-0.73,0.49,,-0.43,-0.77,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
Q5SSJ5,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,145.17,144.45,Y379,LKKYVLENHPGTNSNYQMHLLKKTLQKCEKN,_YVLENHPGTNSNY(ph)QMHLLK_,0.33, ,-0.15, , , , ,-0.31,0.74, ,0.39, , , , ,-0.08,0.33,-0.15,,-0.31,0.74,0.39,,-0.08,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
Q5SSJ5,Q5SSJ5,Heterochromatin protein 1-binding protein 3,HP1BP3,97.13,92.79,S6,__________MATDTSQGELVHPKALPLIVG,_(ac)ATDTS(ph)QGELVHPK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleosome,DNA binding,nucleosome assembly,,
P35367,P35367,Histamine H1 receptor,HRH1,96.37,59.69,S230,KAVRQHCQHRELINRSLPSFSEIKLRPENPK,_S(ph)LPS(ph)FSEIK_, , , , ,0.43,0.48,1.17,0.44, , , , ,0.2,0.58,0.85,0.69,,,0.45,0.85,,,0.4,0.77,,,,,,,NA,NA,,cytoplasm,histamine receptor activity,cellular response to histamine,,
P35367,P35367,Histamine H1 receptor,HRH1,96.37,59.69,S233,RQHCQHRELINRSLPSFSEIKLRPENPKGDA,_S(ph)LPS(ph)FSEIK_, , , , ,0.43,0.48,1.17,0.44, , , , ,0.2,0.58,0.85,0.69,,,0.45,0.85,,,0.4,0.77,,,,,,,NA,NA,,cytoplasm,histamine receptor activity,cellular response to histamine,,
P51659,P51659,Peroxisomal multifunctional enzyme type 2,HSD17B4,102.97,102.97,S3,_____________MGSPLRFDGRVVLVTGAG,_(ac)GS(ph)PLRFDGR_,-0.31,-0.18,-0.39,-0.48, ,-0.32, , ,-0.17,-0.16,-0.32,-0.33, ,-0.16, , ,-0.24,-0.44,-0.32,,-0.17,-0.32,-0.16,,,,,,,,NA,NA,,peroxisomal matrix,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,alpha-linolenic acid metabolic process,,
E9PMQ6,Q00613,Heat shock factor protein 1,HSF1,88.47,83.85,S303,PLSSSPLVRVKEEPPSPPQSPRVEEASPGRP,_VKEEPPS(ph)PPQS(ph)PR_,0.17,0.2,0.84,0.54,0.34,0.38,0.34,0.37,-0.01,0.2,0.45,0.56,0.18,0.32,0.19,0.2,0.18,0.7,0.36,0.35,0.1,0.51,0.25,0.2,,,,,,,0,0,,nucleus,sequence-specific DNA binding,response to heat,,
E9PMQ6,Q00613,Heat shock factor protein 1,HSF1,88.47,83.85,S307,SPLVRVKEEPPSPPQSPRVEEASPGRPSSVD,_VKEEPPS(ph)PPQS(ph)PR_,0.17,0.2,0.84,0.54,0.34,0.38,0.34,0.37,-0.01,0.2,0.45,0.56,0.18,0.32,0.19,0.2,0.18,0.7,0.36,0.35,0.1,0.51,0.25,0.2,,,,,,,0,0,,nucleus,sequence-specific DNA binding,response to heat,,
P07900,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,335.42,335.42,S231,YPITLFVEKERDKEVSDDEAEEKEDKEEEKE,_EVS(ph)DDEAEEKEDKEEEK_,0.21,0.32,0.34,0.33,0.46,0.23,0.11,0.36,0.05,0.04,0.04,0.09,0.25,-0.1,-0.14,0.2,0.27,0.34,0.35,0.24,0.05,0.07,0.08,0.04,,,,,,,0,0,,apical plasma membrane,ATP binding,axon guidance,,
P07900,Q14568,Heat shock protein HSP 90-alpha,HSP90AA1,538.79,538.79,S263,EEKESEDKPEIEDVGSDEEEEKKDGDKKKKK,_PEIEDVGS(ph)DEEEEKK_,0.35,0.26,0.4,0.38,0.29,0.21,0.34,0.4,0.11,0.16,0.09,0.1,0.28,0.31,0.12,0.15,0.31,0.39,0.25,0.37,0.14,0.09,0.29,0.14,,,,,,,0,0,,apical plasma membrane,ATP binding,axon guidance,,
Q14568,Q14568,Putative heat shock protein HSP 90-alpha A2,HSP90AA2,181.86,172.29,S263,EEKESKDKPEIEDVGSDEEEEKKDGDKKKKK,_PEIEDVGS(ph)DEEEEKK_, , , , , , ,0.47,0.38, , , , , , ,-0.14,0.15,,,,0.43,,,,0.01,,,,,,,NA,NA,,cytoplasm,ATP binding,protein folding,,
P08238,Q58FF8,Heat shock protein HSP 90-beta,HSP90AB1,390.97,390.97,S177,EDKDDEEKPKIEDVGSDEEDDSGKDKKKKTK,_PKIEDVGS(ph)DEEDDS(ph)GK_,0.31,0.33,0.37,0.39,0,0.02,0.11,0.06,0.14,0.12,0.1,0.08,0.19,0.21,0.05,0.09,0.32,0.38,0.01,0.09,0.13,0.09,0.2,0.07,,,,,,,0,0,,apical plasma membrane,ATP binding,axon guidance,,
P08238,Q58FF8,Heat shock protein HSP 90-beta,HSP90AB1,148.44,148.44,S183,EKPKIEDVGSDEEDDSGKDKKKKTKKIKEKY,_PKIEDVGS(ph)DEEDDS(ph)GK_, , , , ,0.23,0.2,0.49,0.27, , , , ,0.18,0.33,0.51,0.18,,,0.21,0.38,,,0.26,0.36,,,,,,,NA,NA,,apical plasma membrane,ATP binding,axon guidance,,
P08238,P08238,Heat shock protein HSP 90-beta,HSP90AB1,334.43,289.22,S226,YPITLYLEKEREKEISDDEAEEEKGEKEEED,_EKEIS(ph)DDEAEEEK_,0.02,0.19,0.22,0.18,-0.16,0.29,0.4,0.55,-0.05,0.03,-0.02,0.01,0.1,-0.42,0.03,0.39,0.11,0.2,0.08,0.47,-0.01,0,-0.14,0.22,,,,,,,0,0,,apical plasma membrane,ATP binding,axon guidance,,
P14625,P14625,Endoplasmin,HSP90B1,243.61,240.7,S306,EPMEEEEAAKEEKEESDDEAAVEEEEEEKKP,_EES(ph)DDEAAVEEEEEEK_,-0.08,0.29,0.16,0.18, ,-0.44,-0.35,-0.3,-0.48,-0.22,-0.52,-0.46, ,0.21,-0.24,-0.27,0.12,0.17,-0.44,-0.33,-0.34,-0.49,0.21,-0.26,,,,,,,0,0,,cytosol,ATP binding,actin rod assembly,,
P14625,P14625,Endoplasmin,HSP90B1,66.88,65.28,T786,TEDTEQDEDEEMDVGTDEEEETAKESTAEKD,_VEEEPEEEPEETAEDTTEDTEQDEDEEMDVGT(ph)DEEEETAK_, , , , , , , ,-0.07, , , , , , , ,-0.05,,,,-0.07,,,,-0.05,,,,,,,NA,NA,,cytosol,ATP binding,actin rod assembly,,
P04792,P04792,Heat shock protein beta-1,HSPB1,133.81,106.13,S15,_MTERRVPFSLLRGPSWDPFRDWYPHSRLFD,_GPS(ph)WDPFR_,-0.13,-0.14,3.32,2.95,1.55, , , ,0.35,0.43,4.11,3.86,1.72, , , ,-0.13,3.15,1.55,,0.39,3.99,1.72,, +, +,,,,,NA,NA,,cell surface,protein kinase C binding,cell death,,
P04792,P04792,Heat shock protein beta-1,HSPB1,198.1,124.2,S82,AVAAPAYSRALSRQLSSGVSEIRHTADRWRV,_QLS(ph)SGVSEIR_,-0.14,-0.11,2.23,2.21,0.88,0.93,0.02,-0.19,0.21,0.23,2.93,2.9,1.16,1.23,0.25,0.17,-0.13,2.22,0.9,-0.08,0.22,2.92,1.19,0.21, +, +,,,,,4,4,34.48,cell surface,protein kinase C binding,cell death,,
P10809,P10809,"60 kDa heat shock protein, mitochondrial",HSPD1,136.63,103.36,S70,MGPKGRTVIIEQSWGSPKVTKDGVTVAKSID,_TVIIEQSWGS(ph)PK_, , ,0.13, ,1.22,0.3,-0.04,0, , ,1.33, ,0.08,0.57,0.31,0.22,,0.13,0.83,-0.02,,1.33,0.34,0.27,, +,,,,,NA,NA,,cell surface,ATP binding,de novo' protein folding,+,
Q92598-3,Q92598,Heat shock protein 105 kDa,HSPH1,122.77,111.3,S852,EPPHQNGECYPNEKNSVNMDLD_________,_NS(ph)VNMDLD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,ATP binding,chaperone mediated protein folding requiring cofactor,,
Q92598-3,Q92598,Heat shock protein 105 kDa,HSPH1,247.23,247.23,S557,PQVQTDAQQTSQSPPSPELTSEENKIPDADK,_NVQQDNSEAGTQPQVQTDAQQTSQSPPS(ph)PELTSEENKIPDADK_, , ,0.39,0.27,0.58,0.39,0.41, , , ,0.2,0.11,0.35,0.15,-0.34, ,,0.33,0.49,0.41,,0.16,0.25,-0.34,,,,,,,NA,NA,,cytoplasm,ATP binding,chaperone mediated protein folding requiring cofactor,,
Q92598-3,Q92598,Heat shock protein 105 kDa,HSPH1,125.23,33.59,S809,NTCEPVVTQPKPKIESPKLERTPNGPNIDKK,_IES(ph)PKLER_,0.33,0.36,0.53,0.52,0.49,0.47,0.56,0.72,0.13,0.17,0.22,0.13,0.2,0.16,0.16,0.36,0.34,0.52,0.48,0.64,0.15,0.18,0.18,0.26,,,,,,,0,0,,cytoplasm,ATP binding,chaperone mediated protein folding requiring cofactor,,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,223.89,174.71,S529,ENGLAKESEDDLNKESEEEVGPTKESEEDDS,_ESEDDLNKES(ph)EEEVGPTK_,0.08,0.2,-1.12, ,0.33, ,0.35,0.36,0.22,0.17, , ,-0.08, ,0.13,0.06,0.14,-1.12,0.33,0.36,0.2,,-0.08,0.1, +,,,,,,3,NA,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,124.51,110.41,S557,DDSEKESDEDCSEKQSEDGSEREFEENGLEK,_(gl)QS(ph)EDGS(ph)EREFEENGLEK_, , , , ,0.09,0.44,1.68,2.3, , , , ,-0.24,-0.29,0.25,0.11,,,0.28,2.02,,,-0.27,0.18, +,,,,,,NA,NA,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,124.51,110.41,S561,KESDEDCSEKQSEDGSEREFEENGLEKDLDE,_(gl)QS(ph)EDGS(ph)EREFEENGLEK_, , , , ,0.09,0.44,1.68,2.3, , , , ,-0.24,-0.29,0.25,0.11,,,0.28,2.02,,,-0.27,0.18, +,,,,,,NA,NA,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,371.01,346.38,S676,KKAEEGDADEKLFEESDDKEDEDADGKEVED,_LFEES(ph)DDKEDEDADGKEVEDADEK_,0.07,0.12,0.1,0.12,0.47,0.53,0.32,0.52,0.16,0.13,0.1,0.14,0.23,0.3,0.14,0.22,0.1,0.11,0.5,0.42,0.14,0.12,0.27,0.18,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,137.4,136.27,S579,EFEENGLEKDLDEEGSEKELHENVLDKELEE,_DLDEEGS(ph)EK_,0.23,0.18,-0.32,0.07,0.23,0.33,0.4,0.39,0.15,0.04,0.22,-0.16,0.2,0.13,0.31,0.56,0.21,-0.11,0.28,0.4,0.09,0.04,0.17,0.44,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,519.82,519.82,S624,KVLDEEGSEREFDEDSDEKEEEEDTYEKVFD,_VLDEEGS(ph)EREFDEDS(ph)DEKEEEEDTYEK_,0.13,0.16,0.01,0.05,0.14,0.41,0.37,0.31,0.17,0.1,0.01,0.13,-0.1,0.35,0.28,0.16,0.15,0.03,0.28,0.34,0.14,0.07,0.14,0.22,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,257.82,257.82,S597,ELHENVLDKELEENDSENSEFEDDGSEKVLD,_ELEENDS(ph)ENS(ph)EFEDDGSEK_,-0.09,-0.05,-0.06,-0.06,0.15,0.6,0.34,0.45,0.15,0.19,0.08,0.11,0.07,0.53,0.3,0.27,-0.07,-0.06,0.4,0.4,0.17,0.09,0.32,0.28,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,257.82,257.82,S600,ENVLDKELEENDSENSEFEDDGSEKVLDEEG,_ELEENDS(ph)ENS(ph)EFEDDGS(ph)EK_,-0.09,-0.05,-0.06,-0.06,0.15,0.6,0.34,0.45,0.15,0.19,0.08,0.11,0.07,0.53,0.3,0.27,-0.07,-0.06,0.4,0.4,0.17,0.09,0.32,0.28,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,257.56,257.56,S607,LEENDSENSEFEDDGSEKVLDEEGSEREFDE,_ELEENDS(ph)ENS(ph)EFEDDGS(ph)EK_,0.08,-0.08,-0.18,-0.16,0.15,0.19,0.23,0.23,0.27,0.09,0.03,0.06,0.07,0.01,0.07,0.08,0,-0.17,0.17,0.23,0.18,0.04,0.04,0.07,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,262.78,262.78,S498,KESEEGNPVRGSEEDSPKKESKKKTLKNDCE,_ESEEGNPVRGSEEDS(ph)PKK_,0.24,0.19,0.13,0.33,0.65,0.56,0.63,0.34,0.08,0.11,0.13,0.12,0.07,0.32,0.1,0.06,0.22,0.23,0.6,0.49,0.1,0.12,0.2,0.08,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,147.74,83.09,S721,LFDEEEDSSEKLFDDSDERGTLGGFGSVEEG,_LFDEEEDS(ph)S(ph)EKLFDDS(ph)DER_,-0.07,-0.14,-0.17,-0.13,0.18,0.2,0.05,0.12,-0.1,-0.13,-0.11,-0.04,0,0.07,-0.14,-0.15,-0.11,-0.15,0.19,0.09,-0.11,-0.07,0.03,-0.14,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,228.25,184.49,S713,EDDDSNEKLFDEEEDSSEKLFDDSDERGTLG,_LFDEEEDS(ph)S(ph)EKLFDDS(ph)DER_,0.02,0.03,-0.07,-0.1,0.41,0.36,0.39,0.38,0.09,0.05,0.03,-0.02,0.13,0.03,0.18,0.03,0.03,-0.08,0.38,0.38,0.07,0,0.08,0.11,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,213.69,188.55,S714,DDDSNEKLFDEEEDSSEKLFDDSDERGTLGG,_LFDEEEDS(ph)S(ph)EKLFDDS(ph)DER_,-0.08,-0.28,-0.12,-0.2,0.41,0.33,0.29,0.38,0.03,-0.03,0.08,0.06,0.22,0.05,0.16,0.14,-0.17,-0.16,0.37,0.34,0,0.07,0.14,0.15,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,208.51,127.81,S702,KEVEDADEKLFEDDDSNEKLFDEEEDSSEKL,_LFEDDDS(ph)NEK_,0.03,0.11,0.09,0.03,0.3,0.43,0.37,0.44,0.13,0.17,0.18,0.08,0.1,0.12,0.19,0.1,0.07,0.06,0.37,0.4,0.15,0.13,0.11,0.15,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,347.92,347.92,S452,GGEFEEGASENNAKESSPEKEAEEGCPEKES,_TEDGGEFEEGASENNAKES(ph)S(ph)PEK_,-0.18,0.01,0.02,0.08,0.45,0.54,0.52,0.51,0.03,0.03,0.08,0.02,0.28,0.2,0.28,0.26,-0.08,0.05,0.49,0.51,0.03,0.05,0.24,0.27,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,347.92,347.92,S453,GEFEEGASENNAKESSPEKEAEEGCPEKESE,_TEDGGEFEEGASENNAKES(ph)S(ph)PEK_,-0.18,0.01,0.02,0.08,0.45,0.54,0.52,0.51,0.03,0.03,0.08,0.02,0.28,0.2,0.28,0.26,-0.08,0.05,0.49,0.51,0.03,0.05,0.24,0.27,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,419.37,419.37,S642,KEEEEDTYEKVFDDESDEKEDEEYADEKGLE,_VFDDES(ph)DEKEDEEYADEK_,0.08,0.03,-0.03,-0.01,0.37,0.38,0.4,0.48,0.07,0.09,0.1,0.12,0.27,0.23,0.15,0.42,0.05,-0.02,0.37,0.44,0.08,0.11,0.25,0.29,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
O43719,O43719,HIV Tat-specific factor 1,HTATSF1,519.82,519.82,S616,EFEDDGSEKVLDEEGSEREFDEDSDEKEEEE,_VLDEEGS(ph)EREFDEDS(ph)DEKEEEEDTYEK_,-0.02,0.13,-0.23,-0.05,0.47,0.31,0.11,0.24,-0.05,0.05,-0.08,-0.06,0.08,0.06,-0.07,-0.05,0.06,-0.14,0.39,0.18,0,-0.07,0.07,-0.06,,,,,,,0,0,,nucleus,nucleotide binding,"regulation of DNA-dependent transcription, elongation",,
P42858,P42858,Huntingtin,HTT,143,116.64,S1874,KRHSLSSTKLLSPQMSGEEEDSDLAAKLGMC,_LLSPQMS(ph)GEEEDSDLAAK_, , , ,0.66, ,1.04,1.1,1.06, , , ,1.55, ,0.84,1.1,1.09,,0.66,1.04,1.08,,1.55,0.84,1.1, +, +,,,,,NA,NA,,autophagic vacuole,beta-tubulin binding,anterior/posterior pattern specification,,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,106.28,54.31,S1903,VANCCIRIALPAPRGSGTASDDEFENLRIKG,_IALPAPRGS(ph)GTAS(ph)DDEFENLR_, , ,-0.73, ,1.19,1.66,1.87, , , ,0.05, ,1.36,1.41,1.59, ,,-0.73,1.44,1.87,,0.05,1.38,1.59, +, +,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,104.55,104.55,S3919,RESQLAHIKDEPPPLSPAPLTPATPSSLDPF,_DEPPPLS(ph)PAPLT(ph)PAT(ph)PSSLDPFFSR_, , ,1.98, ,1.01,1.18,0.75,0.72, , ,1.61, ,0.62,1.17,0.68,0.81,,1.98,1.1,0.73,,1.61,0.92,0.75, +, +,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,104.55,104.55,T3924,AHIKDEPPPLSPAPLTPATPSSLDPFFSREP,_DEPPPLS(ph)PAPLT(ph)PAT(ph)PSSLDPFFSR_, , ,1.98, ,1.44,1.18,0.75,0.72, , ,1.61, ,1.35,1.17,0.68,0.81,,1.98,1.32,0.73,,1.61,1.26,0.75, +, +,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,104.55,104.55,T3927,KDEPPPLSPAPLTPATPSSLDPFFSREPSSM,_DEPPPLS(ph)PAPLT(ph)PAT(ph)PSSLDPFFSR_, , ,1.89, ,1.44,1.18,0.75,0.72, , ,1.63, ,1.35,1.17,0.68,0.81,,1.89,1.32,0.73,,1.63,1.26,0.75, +, +,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,64.71,63.59,S2887,GDTSAAGSSEQPRAGSSTPGDAPPAVAEVQG,_AGS(ph)STPGDAPPAVAEVQGR_, , , , ,-0.05,0.37,0.13,0.12, , , , ,-0.52,0.12,-0.25,-0.18,,,0.18,0.13,,,-0.17,-0.21,,,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,178.23,176.93,S2362,ELEDLIDELLERDGGSGNSTIIVSRSGEDES,_DGGS(ph)GNS(ph)TIIVSR_,-0.37,-0.17,-0.07,-0.04,0.31,0.27,0.22,0.21,-0.37,-0.26,-0.24,-0.06,0.17,0.12,-0.2,-0.15,-0.27,-0.05,0.29,0.21,-0.31,-0.15,0.15,-0.18,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,178.23,176.93,S2365,DLIDELLERDGGSGNSTIIVSRSGEDESQED,_DGGS(ph)GNS(ph)TIIVSR_,0.2,0.2,0.01,0.06,0.11,0.33,0.22,0.21,-0.08,-0.15,-0.15,-0.28,-0.29,-0.19,-0.2,-0.15,0.2,0.03,0.22,0.21,-0.11,-0.21,-0.24,-0.18,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,278.19,255.85,S1907,CIRIALPAPRGSGTASDDEFENLRIKGPNAV,_GSGTAS(ph)DDEFENLR_,0,-0.04,-0.01,0.03,0.24,0.29,0.35,0.37,0,-0.09,-0.09,0.01,0.01,0.01,0.06,0.07,-0.02,0.01,0.27,0.36,-0.05,-0.04,0.01,0.07,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,82.55,82.48,S2391,ESQEDVLMDEAPSNLSQASTLQANREDSMNI,_SGEDESQEDVLMDEAPSNLS(ph)QAS(ph)TLQANR_, , , , ,0.26,-0.51,0.3,0.38, , , , ,0.26,-0.17,0.14,0.59,,,-0.08,0.34,,,0.06,0.39,,,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,82.55,82.48,S2394,EDVLMDEAPSNLSQASTLQANREDSMNILDP,_SGEDESQEDVLMDEAPSNLS(ph)QAS(ph)TLQANR_, , , , ,0.26,-0.51,0.3,0.36, , , , ,0.26,-0.17,0.14,0.67,,,-0.08,0.33,,,0.06,0.43,,,,HECT,,,NA,NA,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,90.71,90.23,T2889,TSAAGSSEQPRAGSSTPGDAPPAVAEVQGRS,_AGSS(ph)T(ph)PGDAPPAVAEVQGR_,0.27, ,0.47, ,1.17,0.37,0.01,0.45,-0.28, ,-0.31, ,0.22,0.12,-0.41,-0.04,0.27,0.47,0.82,0.25,-0.28,-0.31,0.17,-0.21,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,96.67,73.04,S1368,LTHPPPIMGGVVRDLSMSEEDQMMRAIAMSL,_DLS(ph)MSEEDQMMR_,-0.32,-0.74,0.12,0.2,0.06, ,0.6, ,-0.25,0.17,0.74,0.63,-0.17, ,0.48, ,-0.51,0.17,0.06,0.6,-0.03,0.69,-0.17,0.48,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
Q7Z6Z7-2,Q7Z6Z7,E3 ubiquitin-protein ligase HUWE1,HUWE1,312.45,312.45,S3816,ASVRREESPMDVDQPSPSAQDTQSIASDGTP,_REESPMDVDQPS(ph)PSAQDTQSIASDGTPQGEK_,0.26,0.12,0.29,0.14,0.33,0.22,0.23,0.44,0.73,-0.02,-0.2,-0.37,0.15,-0.03,0.23,0.1,0.19,0.22,0.27,0.34,0.4,-0.28,0.06,0.17,,,,HECT,,,0,0,,cytoplasm,DNA binding,base-excision repair,+,
P41252,P41252,"Isoleucine--tRNA ligase, cytoplasmic",IARS,136.66,136.66,S1047,FIFTTIKAPLKPYPVSPSDKVLIQEKTQLKG,_APLKPYPVS(ph)PSDK_,0.07,0.12,0.23, ,0.07,0.23,0.26, ,0.09,0.06,0.06, ,0.3,0.48,0.08, ,0.09,0.23,0.15,0.26,0.08,0.06,0.39,0.08,,,,,,,0,0,,cytosol,aminoacyl-tRNA editing activity,isoleucyl-tRNA aminoacylation,,
P41252,P41252,"Isoleucine--tRNA ligase, cytoplasmic",IARS,141,141,S1049,FTTIKAPLKPYPVSPSDKVLIQEKTQLKGSE,_APLKPYPVSPS(ph)DK_,0.46,0.26,0.21,0.37, ,0.15,0.15,0.2,0.07,0.05,0.18,-0.2, ,-0.66,0.13,0.66,0.36,0.29,0.15,0.17,0.06,0,-0.66,0.42,,,,,,,0,0,,cytosol,aminoacyl-tRNA editing activity,isoleucyl-tRNA aminoacylation,,
E9PDR5,Q9P2D0,Inhibitor of Bruton tyrosine kinase,IBTK,113.23,103.72,S1045,SEGSYAGVGSPRDLQSPDFTTGFHSDKIEAK,_DLQS(ph)PDFTTGFHSDK_,0.23,0.17,0.38,0.23,0.1,-0.08,0.11,0.15,0.07,0.13,0.08,0.07,0.36,0.08,0.18,0.18,0.2,0.31,0.01,0.13,0.1,0.07,0.22,0.18,,,,BTB,,,0,0,,nucleus,,,,
Q9UPZ9-2,Q9UPZ9,Serine/threonine-protein kinase ICK,ICK,68.97,68.97,Y159,FGLAREIRSKPPYTDYVSTRWYRAPEVLLRS,_SKPPYTDY(ph)VSTR_, , ,0.97, , , , , , , ,0.67, , , , , ,,0.97,,,,0.67,,,,,CMGC,,,,NA,NA,,cytosol,ATP binding,intracellular protein kinase cascade,,
Q16666-3,Q16666,Gamma-interferon-inducible protein 16,IFI16,189.12,186.15,S153,GPKGSKVSEEQTQPPSPAGAGMSTAMGRSPS,_VSEEQTQPPS(ph)PAGAGMSTAMGR_,0.44,0.42,0.36,0.39,0.16,0.26,0.29,0.53,0.27,0.3,0.26,0.14,0.16,0.35,0.27,0.32,0.43,0.37,0.21,0.42,0.29,0.2,0.26,0.3,,,,,,,0,0,,cytosol,double-stranded DNA binding,activation of cysteine-type endopeptidase activity,,
Q16666-3,Q16666,Gamma-interferon-inducible protein 16,IFI16,73.92,72.05,S168,SPAGAGMSTAMGRSPSPKTSLSAPPNSSSTE,_VSEEQTQPPS(ph)PAGAGMS(ph)TAMGRSPS(ph)PK_, , , , ,0.17, , , , , , , ,-0.03, , , ,,,0.17,,,,-0.03,,,,,,,,NA,NA,,cytosol,double-stranded DNA binding,activation of cysteine-type endopeptidase activity,,
Q16666-3,Q16666,Gamma-interferon-inducible protein 16,IFI16,90.77,89.03,S780,KNKKDILNPDSSMETSPDFFF__________,_DILNPDSSMETS(ph)PDFFF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,double-stranded DNA binding,activation of cysteine-type endopeptidase activity,,
Q01629,Q01629,Interferon-induced transmembrane protein 2,IFITM2,165.41,165.01,Y19,IVQTFSPVNSGQPPNYEMLKEEQEVAMLGVP,_(ac)MNHIVQTFSPVNSGQPPNY(ph)EMLK_, , ,1.7, , , , , , , ,-0.23, , , , , ,,1.7,,,,-0.23,,, +,,,,,,NA,NA,,integral to membrane,,defense response to virus,,
Q01628,C9JQL5,Interferon-induced transmembrane protein 3,IFITM3,264.52,264.51,Y20,VQTFFSPVNSGQPPNYEMLKEEHEVAVLGAP,_(ac)M(ox)NHTVQTFFSPVNSGQPPNY(ph)EMLK_,1.36, ,2.74, ,0.34,0.19,-0.02,0.12,0.26, ,0.49, ,0.73,0.88,0.37,1.08,1.36,2.74,0.27,0.05,0.26,0.49,0.81,0.77, +,,,,,,4,0,0.98,integral to membrane,,defense response to virus,,
B4DNT3,P17181,Interferon alpha/beta receptor 1,IFNAR1,80.18,80.18,S495,EYFSEQPLKNLLLSTSEEQIEKCFIIENIST,_NLLLSTS(ph)EEQIEK_, ,0.41,0.13, , , , , , ,0.01,0.18, , , , , ,0.41,0.13,,,0.01,0.18,,,,,,,,,NA,NA,,,interferon receptor activity,defense response to virus,,
F5H5M7,P15260,Interferon gamma receptor 1,IFNGR1,70.89,69.95,Y479,VDLLVDDSGKESLIGYRPTEDSKEFS_____,_ESLIGY(ph)RPTEDSK_, , ,1.34, , , , , , , ,0.05, , , , , ,,1.34,,,,0.05,,, +,,,,,,NA,NA,,membrane,,,,
Q96FT9,Q96FT9,Intraflagellar transport protein 43 homolog,IFT43,88.11,69.2,S78,WAGDSVKASKFRRKASEEIEDFRLRPQSLNG,_KAS(ph)EEIEDFR_,0.78, , , , , , , ,1.03, , , , , , , ,0.78,,,,1.03,,,,, +,,,,,NA,NA,,cytoplasm,,cilium morphogenesis,,
P11717,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,252.47,251.59,S2409,KSVKALSSLHGDDQDSEDEVLTIPEVKVHSG,_ALSSLHGDDQDS(ph)EDEVLTIPEVK_,0.18,0.07,-0.06,-0.07,-0.42,-0.23,-0.26,-0.18,0.07,0.09,-0.06,-0.19,-0.12,-0.01,0.02,0.09,0.12,-0.07,-0.32,-0.22,0.08,-0.12,-0.06,0.05,,,,,,,0,0,,cell surface,glycoprotein binding,receptor-mediated endocytosis,,
P11717,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,308.73,292.15,S2479,SSSAQQKTVSSTKLVSFHDDSDEDLLHI___,_LVS(ph)FHDDS(ph)DEDLLHI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell surface,glycoprotein binding,receptor-mediated endocytosis,,
P11717,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,308.73,292.15,S2484,QKTVSSTKLVSFHDDSDEDLLHI________,_LVS(ph)FHDDS(ph)DEDLLHI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell surface,glycoprotein binding,receptor-mediated endocytosis,,
B3KRB7,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,83.44,81.21,S672,LLKIACSKVRGPVSGSPDSMNASRLSQPGQL,_VRGPVSGS(ph)PDSMNASR_,1.98,1.75,0.95, , , , , ,0.26,0.02,-0.25, , , , , ,1.87,0.95,,,0.15,-0.25,,, +,,Other,,,,NA,NA,,cytoplasm,IkappaB kinase activity,I-kappaB phosphorylation,,
G5E9M5,G5E9M5,Interleukin enhancer-binding factor 3,ILF3,124.35,124.21,S482,LPTGAEGRDSSKGEDSAEETEAKPAVVAPAP,_GEDS(ph)AEETEAKPAVVAPAPVVEAVSTPSAAFPSDATAENVK_,0.06,-0.02,-0.25, ,-0.35,-0.2,-0.03, ,0.08,0,-0.36, ,1.65,-0.11,-0.2, ,0.02,-0.25,-0.27,-0.03,0.04,-0.36,1.02,-0.2,, +,,,,,0,2,4.35,,,,,
G5E9M5,Q12906,Interleukin enhancer-binding factor 3,ILF3,112.48,112.48,S476,VLQDMGLPTGAEGRDSSKGEDSAEETEAKPA,_VLQDMGLPTGAEGRDS(ph)S(ph)K_,0.32,0.3, , ,0.11,-0.01,-0.04,-0.21,0.26,0.39, , ,0.04,0.06,-0.09,0.02,0.31,,0.05,-0.13,0.33,,0.05,-0.04,,,,,,,NA,NA,,,,,,
G5E9M5,Q12906,Interleukin enhancer-binding factor 3,ILF3,112.48,112.48,S477,LQDMGLPTGAEGRDSSKGEDSAEETEAKPAV,_VLQDMGLPTGAEGRDS(ph)S(ph)K_,0.32,0.3, , ,0.11,-0.01,-0.04,-0.21,0.26,0.39, , ,0.04,0.06,-0.09,0.02,0.31,,0.05,-0.13,0.33,,0.05,-0.04,,,,,,,NA,NA,,,,,,
G5E9M5,Q12906,Interleukin enhancer-binding factor 3,ILF3,267.62,226.76,S382,ITPMKRPMEEDGEEKSPSKKKKKIQKKEEKA,_RPMEEDGEEKS(ph)PSK_,-0.15,-0.1,0.76,-0.08,-0.25,-0.09,-0.29,-0.04,0.1,0.07,-0.15,0.01,-0.28,-0.04,-0.14,-0.11,-0.12,0.4,-0.16,-0.16,0.08,-0.07,-0.15,-0.12,,,,,,,0,0,,,,,,
G5E9M5,Q12906,Interleukin enhancer-binding factor 3,ILF3,110.12,106.41,T592,KAYAALAALEKLFPDTPLALDANKKKRAPVP,_LFPDT(ph)PLALDANK_,-0.33,-0.22,-0.33,-0.29,-0.61,-0.45,-0.71,-0.73,-0.12,-0.09,-0.18,-0.19,-0.34,-0.35,-0.87,-0.72,-0.27,-0.31,-0.53,-0.72,-0.11,-0.18,-0.34,-0.79,,,,,,,0,0,,,,,,
Q9H0C8,Q9H0C8,Integrin-linked kinase-associated serine/threonine phosphatase 2C,ILKAP,180.83,180.83,S13,___MDLFGDLPEPERSPRPAAGKEAQKGPLL,_(ac)M(ox)DLFGDLPEPERS(ph)PRPAAGK_,-0.01,0.19,0.88,1.29,-0.6,-0.45, , ,0.2,0.51,0.87,1.01,-0.35,0.37, , ,0.09,1.1,-0.52,,0.37,0.94,0.06,, +,,,,,,NA,NA,,cytoplasm,metal ion binding,negative regulation of cell cycle,,
H0Y4R1,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,107.99,107.99,S416,FFSDGIRLKKYRGMGSLDAMDKHLSSQNRYF,_GMGS(ph)LDAMDK_,0.15,0.17,0.08,0.59,0.22,0.07,0.11,0.35,0.04,0.2,0.06,0.51,-0.02,-0.25,0,0.21,0.16,0.36,0.15,0.23,0.12,0.3,-0.13,0.11,,,,,,,0,0,,,IMP dehydrogenase activity,purine nucleotide biosynthetic process,,
F8W8B3,Q8NI35,InaD-like protein,INADL,85.56,82.25,S645,PFTLVCCRRLFDDEASVDEPRRTETSLPETE,_LFDDEAS(ph)VDEPR_,0.52,0.45,0.15,0.06, ,0.02, , ,-0.08,0.2,0.01,-0.07, ,-0.58, , ,0.48,0.11,0.02,,0.07,-0.03,-0.58,,,,,,,,NA,NA,,,,,,
Q9NQS7-2,Q9NQS7,Inner centromere protein,INCENP,83.2,83.2,Y73,KTPSQKNRRKKRRISYVQDENRDPIRRRLSR,_ISY(ph)VQDENRDPIR_,-0.03, ,0.28, , , , , ,-1.12, ,-0.6, , , , , ,-0.03,0.28,,,-1.12,-0.6,,,, +,,,,,NA,NA,,central element,,chromosome segregation,,
Q9NQS7-2,Q9NQS7,Inner centromere protein,INCENP,102.09,101.78,S828,APPKINPDNYGMDLNSDDSTDDEAHPRKPIP,_INPDNYGMDLNS(ph)DDS(ph)T(ph)DDEAHPR_, , , , ,-0.44,-0.3,-0.42,-0.35, , , , ,0.08,0.3,-0.05,-0.37,,,-0.37,-0.39,,,0.19,-0.2,,,,,,,NA,NA,,central element,,chromosome segregation,,
Q9NQS7-2,Q9NQS7,Inner centromere protein,INCENP,102.09,101.78,S831,KINPDNYGMDLNSDDSTDDEAHPRKPIPTWA,_INPDNYGMDLNS(ph)DDS(ph)T(ph)DDEAHPR_, , , , ,-0.44,-0.3,-0.42,-0.35, , , , ,0.08,0.3,-0.05,-0.37,,,-0.37,-0.39,,,0.19,-0.2,,,,,,,NA,NA,,central element,,chromosome segregation,,
Q9NQS7-2,Q9NQS7,Inner centromere protein,INCENP,102.09,101.78,T832,INPDNYGMDLNSDDSTDDEAHPRKPIPTWAR,_INPDNYGMDLNS(ph)DDS(ph)T(ph)DDEAHPR_, , , , ,-0.44,-0.3,-0.42,-0.35, , , , ,0.08,0.3,-0.05,-0.37,,,-0.37,-0.39,,,0.19,-0.2,,,,,,,NA,NA,,central element,,chromosome segregation,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,133.47,132.89,S1192,EDTAPESALDTSLDKSFSEDAVTDSSGSGTL,_S(ph)FS(ph)EDAVTDSSGSGTLPR_, , , , ,0.3,0.5,0.37,1.45, , , , ,0,0.45,0.2,0.22,,,0.4,1.01,,,0.24,0.21, +,,,,,,NA,NA,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,275.92,275.92,S1183,PGGDEDEDEEDTAPESALDTSLDKSFSEDAV,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,-0.02,0,0.01,0.02,-0.12,-0.1,-0.51,-0.58,-0.24,-0.27,-0.12,-0.12,-0.01,0.01,-0.35,-0.28,-0.01,0.01,-0.11,-0.54,-0.26,-0.12,0,-0.31,,,,,,,0,0,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,291.6,291.6,S1188,DEDEEDTAPESALDTSLDKSFSEDAVTDSSG,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,0.08,0.04,-0.01,-0.14,-0.08,-0.05,-0.68,-0.49,-0.23,0,-0.32,-0.34,0.13,0.12,-0.33,-0.41,0.06,-0.07,-0.06,-0.58,-0.11,-0.33,0.12,-0.37,,,,,,,0,0,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,133.47,132.89,S1194,TAPESALDTSLDKSFSEDAVTDSSGSGTLPR,_S(ph)FS(ph)EDAVTDSSGSGTLPR_, , , , ,0.27,0.5,0.37,0.45, , , , ,0.45,0.45,0.2,0.16,,,0.39,0.41,,,0.45,0.18,,,,,,,NA,NA,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,291.6,291.6,T1179,PAAGPGGDEDEDEEDTAPESALDTSLDKSFS,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,-0.27,-0.19,-0.17,-0.03,-0.08,-0.08,-0.57,-0.49,-0.69,-0.72,-0.83,-0.65,0.13,0.03,-0.37,-0.41,-0.23,-0.1,-0.08,-0.53,-0.71,-0.74,0.08,-0.39,,,,,,,0,0,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q27J81-2,Q27J81,Inverted formin-2,INF2,217.16,217.16,T1187,EDEDEEDTAPESALDTSLDKSFSEDAVTDSS,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_, , , , ,0.24,0.56,0.43,0.64, , , , ,0.36,0.05,0.2,0.22,,,0.41,0.54,,,0.21,0.21,,,,,,,NA,NA,,endoplasmic reticulum,,actin cytoskeleton organization,,
Q9C086,Q9C086,INO80 complex subunit B,INO80B,136.14,132.12,S351,RINLQMRLGGPEGPGSPLLAT__________,_LGGPEGPGS(ph)PLLAT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,metal ion binding,DNA recombination,,
Q8NBZ0,Q8NBZ0,INO80 complex subunit E,INO80E,78.25,77.68,S223,MPPPTILSTVPRQMFSDAGSGDDALDGDDDL,_QMFS(ph)DAGS(ph)GDDALDGDDDLVIDIPE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,Ino80 complex,,DNA recombination,,
Q8NBZ0,Q8NBZ0,INO80 complex subunit E,INO80E,78.25,77.68,S227,TILSTVPRQMFSDAGSGDDALDGDDDLVIDI,_QMFS(ph)DAGS(ph)GDDALDGDDDLVIDIPE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,Ino80 complex,,DNA recombination,,
Q5W135,Q9Y2H2,Phosphatidylinositide phosphatase SAC2,INPP5F,80.84,78.74,S827,KVNFLKPNLKVNLWKSDSSLETMENTGVMDK,_S(ph)DSS(ph)LETMENTGVMDK_, , , , ,-0.51, , , , , , , ,0.03, , , ,,,-0.51,,,,0.03,,,,,,,,NA,NA,,,,,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,141.13,141.13,Y886,KVRVPTERLGTRERLYEWISIDKDEAGAKSK,_LY(ph)EWISIDK_,1.19, ,0.89, ,0.3,0.08,0.45,0.81,1.27, ,-0.05, ,0.42,0.28,0.51,0.79,1.19,0.89,0.19,0.64,1.27,-0.05,0.35,0.66, +, +,,,,,5,5,24.56,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,306.47,305.95,Y986,GVAAPPPKNSFNNPAYYVLEGVPHQLLPPEP,_NSFNNPAY(ph)Y(ph)VLEGVPHQLLPPEPPSPAR_,4.06,3.64,3.54, ,1.97,1.92,1.21,1.49,3.55,3.07,2.9, ,3.15,3.02,1.68,1.53,3.87,3.54,1.95,1.36,3.33,2.9,3.09,1.61, +, +,,,,,5,5,24.7,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,303.52,303.5,S1003,VLEGVPHQLLPPEPPSPARAPVPSATKNKVA,_NSFNNPAY(ph)YVLEGVPHQLLPPEPPS(ph)PAR_,3.13, ,3.63, , , , , ,2.52, ,3.13, , , , , ,3.13,3.63,,,2.52,3.13,,, +, +,,,,,NA,NA,,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,62.06,62.06,Y1162,PGPLELQPPRGLPSDYGRPLSFPPPRIRESI,_GLPSDY(ph)GRPLSFPPPR_,3.24, ,1.23, , , , , ,2.5, ,0.09, , , , , ,3.24,1.23,,,2.5,0.09,,, +, +,,,,,NA,NA,,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,216.34,156.09,Y1135,SCSVLQMAKTLSEVDYAPAGPARSALLPGPL,_TLSEVDY(ph)APAGPAR_,6.41,4.13,3.73,1.99,2.14,2.08,1.3,1.12,5.96,3.52,2.06,0.68,2.73,2.73,1.51,1.5,5.68,3.11,2.11,1.21,5.2,1.53,2.73,1.5, +, +,,,,,5,5,25.22,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,199.81,199.09,Y987,VAAPPPKNSFNNPAYYVLEGVPHQLLPPEPP,_NSFNNPAY(ph)Y(ph)VLEGVPHQLLPPEPPSPAR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
O15357,O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",INPPL1,156.13,156.13,S132,VEGEREPDPPDDRDASDGEDEKPPLPPRSGS,_DAS(ph)DGEDEKPPLPPR_,0.21,0.61,0.41,0.33,0.18,0.35,0.25,0.3,-0.15,-0.06,-0.03,0.13,0.3,0.12,0.16,0.07,0.42,0.37,0.27,0.28,-0.1,0.05,0.21,0.11,,,,,,,0,0,,cytoskeleton,inositol-polyphosphate 5-phosphatase activity,actin filament organization,,
Q9NVR2,Q9NVR2,Integrator complex subunit 10,INTS10,170.29,169.17,S231,IENQHQGAQDTSDLMSPSKRSSQKYIIEGLT,_STQIENQHQGAQDTSDLMS(ph)PSK_,-0.3,-0.3,0.26,0.28, , , , ,0,-0.04,0.23,0.12, , , , ,-0.3,0.27,,,-0.02,0.18,,,,,,,,,NA,NA,,cytoplasm,,snRNA processing,,
O15397,O15397,Importin-8,IPO8,160.04,160.04,S902,RSKAEKADMEENEEISSDEEETNVTAQAMQS,_ADMEENEEIS(ph)S(ph)DEEETNVTAQAMQSNNGR_, , , , ,-0.11,-0.08,-0.08,-0.14, , , , ,-0.01,0.15,0.22,0.17,,,-0.1,-0.11,,,0.08,0.19,,,,,,,NA,NA,,cytoplasm,protein transporter activity,intracellular protein transport,,
O15397,O15397,Importin-8,IPO8,160.04,160.04,S903,SKAEKADMEENEEISSDEEETNVTAQAMQSN,_ADMEENEEIS(ph)S(ph)DEEETNVTAQAMQSNNGR_, , , , ,-0.11,-0.08,-0.08,-0.14, , , , ,-0.01,0.15,0.22,0.17,,,-0.1,-0.11,,,0.08,0.19,,,,,,,NA,NA,,cytoplasm,protein transporter activity,intracellular protein transport,,
Q96P70,Q96P70,Importin-9,IPO9,129.05,124,Y889,DDKRLQDIRVKGEEIYSMDEGIRTRSKSAKN,_VKGEEIY(ph)SM(ox)DEGIR_,2.05, , , , , , , ,0.94, , , , , , , ,2.05,,,,0.94,,,, +,,,,,,NA,NA,,cytoplasm,histone binding,protein import into nucleus,,
P46940,P46940,Ras GTPase-activating-like protein IQGAP1,IQGAP1,213.84,213.84,S2,______________MSAADEVDGLGVARPHY,_(ac)S(ph)AADEVDGLGVARPHYGSVLDNER_,0.01,0.01,0.04,0.15,0.07,-0.26,-0.04, ,-0.21,-0.29,-0.12,-0.04,0.1,-0.3,0.04, ,0.01,0.1,-0.09,-0.04,-0.25,-0.08,-0.09,0.04,,,,,,,0,0,,actin filament,calcium ion binding,cellular response to calcium ion,,
Q13576,Q13576,Ras GTPase-activating-like protein IQGAP2,IQGAP2,71.81,56.71,S16,MPHEELPSLQRPRYGSIVDDERLSAEEMDER,_YGS(ph)IVDDER_,0.97,0.6,3.52, , , ,2.58,3.38,1.36,1.11,3.84, , , ,1.61,2.62,0.8,3.52,,3.04,1.24,3.84,,2.2, +, +,,,,,NA,NA,,actin cytoskeleton,actin binding,positive regulation of Ras GTPase activity,,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,72.08,72.08,S455,ASKDANQVHSTTRRNSNSPPSPSSMNQRRLG,_RNS(ph)NS(ph)PPS(ph)PSSMNQR_, , , , ,1.22,0.94, ,-2.62, , , , ,1.16,0.8, ,-2.87,,,1.09,-2.62,,,0.99,-2.87, +, +,,,,,NA,NA,,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,245.48,245.48,S240,GSAQPTDLGAHKRPASVSSSAAVEHEQREAA,_RPAS(ph)VSSSAAVEHEQR_,-0.06,-0.26,1.4,1.25,0.7, ,0.87,0.73,-0.03,-0.16,1.51,1.83,0.38, ,1.11,0.88,-0.16,1.33,0.7,0.81,-0.09,1.68,0.38,1, +, +,,,,,1,4,28.22,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,191.61,191.61,S175,NGFSKLEEPPELNRQSPNPRRGHAVPPTLVP,_LEEPPELNRQS(ph)PNPR_,-0.09,-0.11,-0.3,-0.23,-0.15,-0.16,0.11,0.17,-0.07,-0.07,-0.05,-0.02,-0.32,-0.07,0.07,0.15,-0.1,-0.27,-0.16,0.14,-0.07,-0.03,-0.19,0.11,,,,,,,0,0,,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,130.43,130.43,S457,KDANQVHSTTRRNSNSPPSPSSMNQRRLGPR,_RNS(ph)NS(ph)PPS(ph)PSSMNQR_, , , , ,-0.39,-0.06,0.08,-0.28, , , , ,-0.11,-0.05,-0.13,-0.13,,,-0.22,-0.09,,,-0.08,-0.13,,,,,,,NA,NA,,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,130.43,130.43,S460,NQVHSTTRRNSNSPPSPSSMNQRRLGPREVG,_NSNS(ph)PPS(ph)PSSMNQR_, , , , ,-0.39,-0.06,0.08,-0.28, , , , ,-0.11,-0.05,-0.13,-0.13,,,-0.22,-0.09,,,-0.08,-0.13,,,,,,,NA,NA,,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q7Z5L9-2,Q7Z5L9,Interferon regulatory factor 2-binding protein 2,IRF2BP2,173.36,173.36,S360,PALTAVARTARKRKPSPEPEGEVGPPKINGE,_RKPS(ph)PEPEGEVGPPK_,0.28,0.22,0.26,0.13, , , , ,0.1,0.12,0.1,0.02, , , , ,0.25,0.2,,,0.11,0.06,,,,,,,,,NA,NA,,cytoplasm,metal ion binding,"regulation of transcription, DNA-dependent",,
Q9H1B7,Q9H1B7,Interferon regulatory factor 2-binding protein-like,IRF2BPL,191.2,191.2,S659,SSVHSTTASARRNSSSPVSPASVPGQRRLAS,_NSSS(ph)PVS(ph)PASVPGQR_,-0.17,-0.09, ,0,-0.38,-2.4,-0.96,-0.72,0.2,-0.12, ,-0.13,0.02,-1.97,-1.35,-0.57,-0.13,0,-1.07,-0.83,0.05,-0.13,-0.66,-0.91, +,,,RING finger,,,6,0,28.06,nucleus,metal ion binding,,,
Q9H1B7,Q9H1B7,Interferon regulatory factor 2-binding protein-like,IRF2BPL,191.2,191.2,S662,HSTTASARRNSSSPVSPASVPGQRRLASRNG,_RNS(ph)SS(ph)PVS(ph)PASVPGQR_, , , , ,-1.47,-1.91,1.73,-1.36, , , , ,-0.2,-0.8,0.62,-0.06,,,-1.68,0.89,,,-0.47,0.32, +,,,RING finger,,,NA,NA,,nucleus,metal ion binding,,,
Q9H1B7,Q9H1B7,Interferon regulatory factor 2-binding protein-like,IRF2BPL,191.2,191.2,S657,DGSSVHSTTASARRNSSSPVSPASVPGQRRL,_RNS(ph)SS(ph)PVS(ph)PASVPGQR_, , , , ,0.47,0.48,0.56,0.76, , , , ,0.28,0.47,0.45,0.48,,,0.48,0.66,,,0.38,0.46,,,,RING finger,,,NA,NA,,nucleus,metal ion binding,,,
Q9H1B7,Q9H1B7,Interferon regulatory factor 2-binding protein-like,IRF2BPL,121.39,121.39,S547,PSGRGAAASLRKRKASPEPPDSAEGALKLGE,_RKAS(ph)PEPPDSAEGALK_,0.09,0.16,0.06,0.12, , ,-0.14,0.02,0.25,0.54,0.36,0.7, , ,0,0.24,0.13,0.09,,-0.06,0.4,0.54,,0.12,,,,RING finger,,,NA,NA,,nucleus,metal ion binding,,,
P35568,P35568,Insulin receptor substrate 1,IRS1,81.85,80.87,S3,_____________MASPPESDGFSDVRKVGY,_(ac)AS(ph)PPESDGFSDVRK_,-0.33,-0.22, , , , ,0,-0.04,1.28,0.82, , , , ,0.5,0.66,-0.27,,,-0.02,1.07,,,0.58,, +,,,,,NA,NA,,caveola,phosphatidylinositol 3-kinase binding,epidermal growth factor receptor signaling pathway,,
P35568,P35568,Insulin receptor substrate 1,IRS1,92.59,90.82,S629,PMSPGVAPVPSGRKGSGDYMPMSPKSVSAPQ,_KGS(ph)GDYMPMS(ph)PK_, , , , ,0.61, , , , , , , ,1.09, , , ,,,0.61,,,,1.09,,, +,,,,,NA,NA,,caveola,phosphatidylinositol 3-kinase binding,epidermal growth factor receptor signaling pathway,,
P35568,P35568,Insulin receptor substrate 1,IRS1,92.59,90.82,S636,PVPSGRKGSGDYMPMSPKSVSAPQQIINPIR,_KGS(ph)GDYMPMS(ph)PK_, , , , ,0.61, , , , , , , ,1.09, , , ,,,0.61,,,,1.09,,, +,,,,,NA,NA,,caveola,phosphatidylinositol 3-kinase binding,epidermal growth factor receptor signaling pathway,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,166.6,164.03,Y632,PASSPKVAYHPYPEDYGDIEIGSHRSSSSNL,_VAYHPYPEDY(ph)GDIEIGSHR_,3.34, , , , , , , ,2.43, , , , , , , ,3.34,,,,2.43,,,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,78.98,72.67,S523,GDLRAFCSHRSNTPESIAETPPARDGGGGGE,_SNT(ph)PES(ph)IAET(ph)PPAR_, , , , ,1.36,1.25, , , , , , ,1.36,1.3, , ,,,1.31,,,,1.33,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,78.98,72.67,T520,SSPGDLRAFCSHRSNTPESIAETPPARDGGG,_SNT(ph)PES(ph)IAET(ph)PPAR_, , , , ,1.36,1.25, , , , , , ,1.36,1.3, , ,,,1.31,,,,1.33,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,78.98,72.67,T527,AFCSHRSNTPESIAETPPARDGGGGGEFYGY,_SNT(ph)PES(ph)IAET(ph)PPAR_, , , , ,1.36,1.25, , , , , , ,1.36,1.3, , ,,,1.31,,,,1.33,, +, +,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,127.32,123.68,Y823,RSYKAPYTCGGDSDQYVLMSSPVGRILEEER,_APYTCGGDSDQY(ph)VLMSSPVGR_,1.19, ,0.83, , , , , ,0.87, ,0.09, , , , , ,1.19,0.83,,,0.87,0.09,,, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,106.57,102.26,Y598,RQRPVPQPSSASLDEYTLMRATFSGSAGRLC,_QRPVPQPSSASLDEY(ph)TLMR_,1.28, ,1.01, , , , ,0.32,0.78, ,0.31, , , , ,-0.04,1.28,1.01,,0.32,0.78,0.31,,-0.04, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,143.93,138.22,S388,AGAAAAGARPVSVAGSPLSPGPVRAPLSRSH,_PVSVAGS(ph)PLS(ph)PGPVR_, , ,0.83, ,1.08,0.98,0.76,1.22, , ,0.49, ,0.86,1,0.66,0.85,,0.83,1.03,1.01,,0.49,0.93,0.76, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,143.93,138.22,S391,AAAGARPVSVAGSPLSPGPVRAPLSRSHTLS,_PVSVAGS(ph)PLS(ph)PGPVR_, , ,0.83, ,1.08,0.98,0.76,1.22, , ,0.49, ,0.86,1,0.66,0.85,,0.83,1.03,1.01,,0.49,0.93,0.76, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,104.26,85.15,S594,TTPARQRPVPQPSSASLDEYTLMRATFSGSA,_QRPVPQPSSAS(ph)LDEYTLMR_, , ,3.41, , , , , , , ,0.44, , , , , ,,3.41,,,,0.44,,, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,66.07,66.07,S560,MDRPLSHCGRSYRRVSGDAAQDLDRGLRKRT,_RVS(ph)GDAAQDLDR_,0.79,0.93,1.32,1.31, , , , ,0.06,0.24,0.62,0.83, , , , ,0.86,1.31,,,0.16,0.73,,, +,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,130.81,123.29,Y675,AALAGSGSGSCRSDDYMPMSPASVSAPKQIL,_SDDY(ph)MPMSPASVSAPK_,0.9, ,0.22, ,0.36,0.34,0.28,0.37,0.69, ,-0.21, ,0.12,0.08,0.03,-0.05,0.9,0.22,0.35,0.32,0.69,-0.21,0.1,-0.01,,,,,,,0,0,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,128.01,122.55,Y653,GSHRSSSSNLGADDGYMPMTPGAALAGSGSG,_SSSSNLGADDGY(ph)MPMTPGAALAGSGSGSCR_,0.73, ,0.4, , , , , ,0.22, ,0.16, , , , , ,0.73,0.4,,,0.22,0.16,,,,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,166.61,164.14,S731,AGRTFPASGGGYKASSPAESSPEDSGYMRMW,_ASS(ph)PAESS(ph)PEDSGYMR_, , , , ,0.49,0.38,0.76,0.27, , , , ,0.32,0.24,0.63,0.4,,,0.44,0.53,,,0.28,0.52,,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,122.87,122.87,S735,FPASGGGYKASSPAESSPEDSGYMRMWCGSK,_ASS(ph)PAES(ph)S(ph)PEDSGYMR_, , , , ,0.59,0.64,0.77,0.67, , , , ,0.65,0.7,0.54,0.63,,,0.62,0.72,,,0.67,0.59,,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,166.61,164.14,S736,PASGGGYKASSPAESSPEDSGYMRMWCGSKL,_ASS(ph)PAES(ph)S(ph)PEDSGYMR_, , , , ,0.49,0.38,0.76,0.27, , , , ,0.32,0.24,0.63,0.4,,,0.44,0.53,,,0.28,0.52,,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
Q9Y4H2,Q9Y4H2,Insulin receptor substrate 2,IRS2,165.06,146.48,S915,SLPSMHEYPLPPEPKSPGEYINIDFGEPGAR,_S(ph)PGEYINIDFGEPGAR_, ,-0.36, , ,-0.38,0.01,0.2,-0.47, ,-0.04, , ,-0.19,0.12,0.14,-0.51,-0.36,,-0.17,-0.1,-0.04,,-0.03,-0.15,,,,,,,NA,NA,,cytosol,phospholipid binding,brain development,,
E7EWZ6,P06756,Integrin alpha-V,ITGAV,233.46,205.31,S1046,QEREQLQPHENGEGNSET_____________,_EQLQPHENGEGNS(ph)ET_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
P05556,P05556,Integrin beta-1,ITGB1,108.1,98.53,Y783,KEKMNAKWDTGENPIYKSAVTTVVNPKYEGK,_WDTGENPIY(ph)K_,-0.02, ,0.65, ,0.18, ,-0.34,-0.62,-0.06, ,0.67, ,1.07, ,0.32,0.04,-0.02,0.65,0.18,-0.47,-0.06,0.67,1.07,0.19,, +,,,,,0,1,8.05,acrosomal vesicle,actin binding,axon guidance,,
P16144-4,P16144,Integrin beta-4,ITGB4,76.3,74.98,S1457,LVNGRMDFAFPGSTNSLHRMTTTSAAAYGTH,_MDFAFPGST(ph)NS(ph)LHR_, , , , ,0.64, , ,1.15, , , , ,0.05, , ,0.51,,,0.64,1.15,,,0.05,0.51, +,,,,,,NA,NA,,basal plasma membrane,receptor activity,cell adhesion,,
Q9NZM3-4,Q9NZM3,Intersectin-2,ITSN2,162.41,162.41,Y968,IIPGSEVKREEPEALYAAVNKKPTSAAYSVG,_REEPEALY(ph)AAVNK_,1.04,1.03,-0.41,-0.03,-1.07,-1.11,-1.56,-1.59,1.21,1.07,0.12,1.08,-0.96,-1,-1.11,-1.24,1.04,-0.21,-1.09,-1.57,1.14,0.68,-0.98,-1.18, +, +,,,,,6,6,25.6,cytoplasm,calcium ion binding,endocytosis,,
Q9NZM3-4,Q9NZM3,Intersectin-2,ITSN2,101.25,51.81,Y553,KQLQQELQEYQNKLIYLVPEKQLLNERIKNM,_LIY(ph)LVPEK_,0.56, ,0.06, ,2.34,2.35,1.15,1.17,1.4, ,-0.36, ,2.79,2.74,1.43,1.41,0.56,0.06,2.35,1.16,1.4,-0.36,2.76,1.42, +, +,,,,,2,2,28,cytoplasm,calcium ion binding,endocytosis,,
Q9NZM3-4,Q9NZM3,Intersectin-2,ITSN2,60.53,60.53,S884,VNTSWQKKSAFTRTVSPGSVSPIHGQGQVVE,_TVS(ph)PGSVS(ph)PIHGQGQVVENLK_, , , , ,-0.38,-0.47, ,-0.74, , , , ,-0.39,-0.52, ,-0.31,,,-0.42,-0.74,,,-0.45,-0.31,,,,,,,NA,NA,,cytoplasm,calcium ion binding,endocytosis,,
Q9NZM3-4,Q9NZM3,Intersectin-2,ITSN2,60.53,60.53,S889,QKKSAFTRTVSPGSVSPIHGQGQVVENLKAQ,_TVS(ph)PGSVS(ph)PIHGQGQVVENLK_, , , , ,-0.38,-0.47, ,-0.74, , , , ,-0.39,-0.52, ,-0.31,,,-0.42,-0.74,,,-0.45,-0.31,,,,,,,NA,NA,,cytoplasm,calcium ion binding,endocytosis,,
A8MVR0,Q9Y6Y0,Influenza virus NS1A-binding protein,IVNS1ABP,181.94,181.31,S338,PQSSPTSTPKLSKSLSFEMQQDELIEKPMSP,_SLS(ph)FEMQQDELIEK_, , , , ,0.31,0.21,0.16,-0.04, , , , ,0.58,0.98,0.27,0.26,,,0.26,0.06,,,0.79,0.26,,,,BTB,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,113.65,112.38,S11,_____MDSEYYSGDQSDDGGATPVQDERDSG,_(ac)MDSEYYSGDQS(ph)DDGGAT(ph)PVQDER_, , , , ,-0.05,-0.09,-0.32,-0.17, , , , ,0.42,0.35,0.12,-0.12,,,-0.07,-0.25,,,0.39,0,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,113.65,112.38,T17,DSEYYSGDQSDDGGATPVQDERDSGSDGEDD,_(ac)MDSEYYSGDQS(ph)DDGGAT(ph)PVQDER_, , , , ,-0.05,-0.09,-0.32,-0.22, , , , ,0.42,0.35,0.12,0.03,,,-0.07,-0.27,,,0.39,0.07,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,145.54,144.17,S398,EGEEEKVAKRKAAVLSDSEDEEKASAKKSRV,_AAVLS(ph)DS(ph)EDEEK_,-0.25,-0.32,-0.35,-0.24,-0.06,-0.03,-0.19,-0.09,-0.39,-0.16,-0.06,-0.25,0.06,-0.12,-0.07,-0.1,-0.29,-0.29,-0.05,-0.14,-0.27,-0.15,-0.03,-0.08,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,145.54,144.17,S400,EEEKVAKRKAAVLSDSEDEEKASAKKSRVVS,_AAVLS(ph)DS(ph)EDEEK_,-0.25,-0.32,-0.35,-0.24,-0.06,-0.03,-0.19,-0.09,-0.39,-0.16,-0.06,-0.25,0.06,-0.12,-0.07,-0.1,-0.29,-0.29,-0.05,-0.14,-0.27,-0.15,-0.03,-0.08,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,91.1,91.1,S363,SFHSDSHMDRKKFHSSDSEEEEHKKQKMDSD,_FHSS(ph)DS(ph)EEEEHK_,-0.24,-0.07,0.23, ,0.32,0.1,-0.03,-0.07,-0.24,-0.38,0.29, ,0.37,-0.03,-0.07,0.06,-0.15,0.23,0.21,-0.05,-0.31,0.29,0.18,-0.01,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,91.1,91.1,S365,HSDSHMDRKKFHSSDSEEEEHKKQKMDSDED,_FHSS(ph)DS(ph)EEEEHK_,-0.24,-0.07,0.23, ,0.32,0.14,-0.03,0,-0.24,-0.38,0.29, ,0.37,0.12,-0.07,0.14,-0.15,0.23,0.23,-0.02,-0.31,0.29,0.25,0.04,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,118.9,118.63,S348,SDRENKGEDTEMQNDSFHSDSHMDRKKFHSS,_GEDTEMQNDS(ph)FHS(ph)DSHMDR_, , , , ,-0.18,-0.05,-0.24, , , , , ,-0.21,0.37,-0.02, ,,,-0.12,-0.24,,,0.11,-0.02,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,118.9,118.63,S351,ENKGEDTEMQNDSFHSDSHMDRKKFHSSDSE,_GEDTEMQNDS(ph)FHS(ph)DSHMDR_, , , , ,-0.18,-0.05,-0.4, , , , , ,-0.21,0.37,0.11, ,,,-0.12,-0.4,,,0.11,0.11,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,189.84,189.84,S287,RISDSESEDPPRNQASDSENEELPKPRVSDS,_NQAS(ph)DS(ph)ENEELPKPR_,-0.1,0.01,-0.23, ,0.51,-0.04,-0.04,-0.11,0.08,-0.16,-0.41, ,-0.03,-0.09,-0.17,-0.14,-0.05,-0.23,0.26,-0.07,-0.03,-0.41,-0.06,-0.15,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,189.84,189.84,S289,SDSESEDPPRNQASDSENEELPKPRVSDSES,_NQAS(ph)DS(ph)ENEELPKPR_,-0.1,0.01,-0.23, ,0.51,-0.04,-0.04,-0.11,0.08,-0.16,-0.41, ,-0.03,-0.09,-0.17,-0.14,-0.05,-0.23,0.26,-0.07,-0.03,-0.41,-0.06,-0.15,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,60.62,58.73,S438,DAVSDKSGKREKTIASDSEEEAGKELSDKKN,_TIAS(ph)DS(ph)EEEAGK_, , , ,-0.02, ,-0.04,-0.22,-0.42, , , ,-0.14, ,-0.47,-0.22,-0.01,,-0.02,-0.04,-0.32,,-0.14,-0.47,-0.11,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,60.62,58.73,S440,VSDKSGKREKTIASDSEEEAGKELSDKKNEE,_TIAS(ph)DS(ph)EEEAGK_, , , ,-0.02, ,-0.04,-0.22,-0.42, , , ,-0.14, ,-0.47,-0.22,-0.01,,-0.02,-0.04,-0.32,,-0.14,-0.47,-0.11,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,252.88,221.53,S157,HASDSENEDVGKHPASDSEIEELQKSPASDS,_HPAS(ph)DS(ph)EIEELQK_,0.04,0,-0.11, ,0.05,0.09,0.11,-0.04,0.15,0.17,0.07, ,0.07,-0.09,0.05,-0.07,0.02,-0.11,0.07,0.04,0.16,0.07,-0.01,-0.01,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,252.88,221.53,S159,SDSENEDVGKHPASDSEIEELQKSPASDSET,_HPAS(ph)DS(ph)EIEELQK_,0.04,0,-0.11, ,0.05,0.09,0.11,-0.04,0.15,0.17,0.07, ,0.07,-0.09,0.05,-0.07,0.02,-0.11,0.07,0.04,0.16,0.07,-0.01,-0.01,,,,,,,0,0,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,216.44,216.44,S235,QVSDSESEEPPRHQASDSENEELPKPRISDS,_HQAS(ph)DS(ph)ENEELPKPR_,-0.18,0.06, , ,-0.04,-0.03,-0.12,-0.03,-0.04,0.13, , ,-0.06,0.1,-0.03,-0.2,-0.06,,-0.03,-0.08,0.05,,0.02,-0.11,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,216.44,216.44,S237,SDSESEEPPRHQASDSENEELPKPRISDSES,_HQAS(ph)DS(ph)ENEELPKPR_,-0.18,0.06, , ,-0.04,-0.03,-0.12,-0.03,-0.04,0.13, , ,-0.06,0.1,-0.03,-0.2,-0.06,,-0.03,-0.08,0.05,,0.02,-0.11,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,138.82,138.82,S196,QISDSESEEPPRHQASDSENEEPPKPRMSDS,_HQAS(ph)DS(ph)ENEEPPKPR_, , , , ,0.08,0.08,-0.15,-0.28, , , , ,-0.04,-0.03,-0.34,-0.08,,,0.08,-0.22,,,-0.04,-0.2,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,138.82,138.82,S198,SDSESEEPPRHQASDSENEEPPKPRMSDSES,_HQAS(ph)DS(ph)ENEEPPKPR_, , , , ,0.08,0.08,-0.15,-0.28, , , , ,-0.04,-0.03,-0.34,-0.08,,,0.08,-0.22,,,-0.04,-0.2,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,68.58,54.35,S248,QASDSENEELPKPRISDSESEDPPRHQASDS,_IS(ph)DS(ph)ESEDPPR_, , , , ,0.09,-0.37,-0.02,-0.34, , , , ,-0.19,-0.35,-0.23,-0.46,,,-0.12,-0.17,,,-0.27,-0.34,,,,,,,NA,NA,,,,,,
E7EX51,Q96ST2,Protein IWS1 homolog,IWS1,68.58,54.35,S250,SDSENEELPKPRISDSESEDPPRHQASDSEN,_IS(ph)DS(ph)ESEDPPR_, , , , ,0.09,-0.37,-0.02,-0.34, , , , ,-0.19,-0.35,-0.23,-0.46,,,-0.12,-0.17,,,-0.27,-0.34,,,,,,,NA,NA,,,,,,
F5H5U8,O60674,Tyrosine-protein kinase,JAK2,90.35,89.25,Y570,TFTKIFKGVRREVGDYGQLHETEVLLKVLDK,_EVGDY(ph)GQLHETEVLLK_, , ,0.01, , , , , , , ,0.04, , , , , ,,0.01,,,,0.04,,,,,Tyr,,,,NA,NA,,caveola,ATP binding,activation of MAPKK activity,,
Q9BR39,Q9BR39,Junctophilin-2,JPH2,93.49,93.49,S486,QLHERETPRPEGGSPSPAGTPPQPKRPRPGV,_ETPRPEGGS(ph)PS(ph)PAGT(ph)PPQPK_, , , , ,0.03,-0.74,-0.61,-0.33, , , , ,0.38,-0.74,0.63,0.38,,,-0.3,-0.46,,,-0.08,0.51,,,,,,,NA,NA,,integral to membrane,calcium-release channel activity,calcium ion transport into cytosol,,
Q9BR39,Q9BR39,Junctophilin-2,JPH2,93.49,93.49,T490,RETPRPEGGSPSPAGTPPQPKRPRPGVSKDG,_ETPRPEGGSPS(ph)PAGT(ph)PPQPK_, , , , ,0.03,-0.74,-0.61,-0.33, , , , ,0.38,-0.74,0.63,0.38,,,-0.3,-0.46,,,-0.08,0.51,,,,,,,NA,NA,,integral to membrane,calcium-release channel activity,calcium ion transport into cytosol,,
P05412,P05412,Transcription factor AP-1,JUN,100,96.19,S243,EPQTVPEMPGETPPLSPIDMESQERIKAERK,_EEPQTVPEMPGETPPLS(ph)PIDMESQER_, , , , ,0.45, ,0.73,1.59, , , , ,0.05, ,1.6,0.8,,,0.45,1.23,,,0.05,1.26, +, +,,,,,NA,NA,,cytosol,cAMP response element binding,aging,,
P05412,P05412,Transcription factor AP-1,JUN,160.64,148.1,S63,SLKPHLRAKNSDLLTSPDVGLLKLASPELER,_NSDLLTS(ph)PDVGLLK_, , , ,3.27, , , , , , , ,2.44, , , , ,,3.27,,,,2.44,,, +, +,,,,,NA,NA,,cytosol,cAMP response element binding,aging,,
P05412,P17535,Transcription factor AP-1,JUN,84.69,18.5,S100,DGLLASPDLGLLKLASPELERLIIQSNGLVT,_LAS(ph)PELER_, , , , ,1.25, , , , , , , ,1.41, , , ,,,1.25,,,,1.41,, +, +,,,,,NA,NA,,cytosol,cAMP response element binding,aging,,
P05412,P05412,Transcription factor AP-1,JUN,47.75,47.59,T239,ALKEEPQTVPEMPGETPPLSPIDMESQERIK,_EEPQTVPEMPGET(ph)PPLS(ph)PIDMESQER_, , , , , , ,1.56,1.59, , , , , , ,0.69,0.8,,,,1.57,,,,0.75, +,,,,,,NA,NA,,cytosol,cAMP response element binding,aging,,
P17275,P17275,Transcription factor jun-B,JUNB,215.5,215.5,S259,QTVPEARSRDATPPVSPINMEDQERIKVERK,_S(ph)RDAT(ph)PPVS(ph)PINM(ox)EDQER_,0.16,-0.1,0.49,-0.07,0.58,0.62,1.13,0.87,0.06,-0.03,0.43,0.11,0.73,0.68,1.33,1.08,0.03,0.24,0.6,1.01,0.01,0.28,0.7,1.21, +, +,,,,,2,2,62.96,chromatin,DNA binding,cellular response to calcium ion,,
P17275,P17275,Transcription factor jun-B,JUNB,215.5,215.5,S251,ASTFKEEPQTVPEARSRDATPPVSPINMEDQ,_S(ph)RDAT(ph)PPVS(ph)PINM(ox)EDQER_,-0.06,0.05,-0.12,-0.25,-0.19,0.03,0.53,-0.01,-0.17,0.1,0.4,0,-0.69,-1.4,0.54,-0.04,0,-0.18,-0.07,0.29,-0.03,0.21,-1,0.28,, +,,,,,0,6,21.86,chromatin,DNA binding,cellular response to calcium ion,,
P17275,P17275,Transcription factor jun-B,JUNB,215.5,215.5,T255,KEEPQTVPEARSRDATPPVSPINMEDQERIK,_S(ph)RDAT(ph)PPVS(ph)PINM(ox)EDQER_,0.16,0.53,0.49,0.29,0.45,0.3,1.13,0.74,0.06,0.65,0.43,0.57,0.54,0.33,1.33,0.92,0.36,0.39,0.38,0.95,0.38,0.5,0.44,1.14,, +,,,,,0,2,49.67,chromatin,DNA binding,cellular response to calcium ion,,
P17535,P17535,Transcription factor jun-D,JUND,136.33,135.57,S255,KDEPQTVPDVPSFGESPPLSPIDMDTQERIK,_DEPQTVPDVPSFGES(ph)PPLS(ph)PIDMDTQER_, , ,0.33, ,-0.1,0.33,0.25,-0.31, , ,1.09, ,0.12,0.42,0.37,-0.29,,0.33,0.13,0,,1.09,0.28,0.08,, +,,,,,NA,NA,,chromatin,double-stranded DNA binding,aging,,
P17535,P17535,Transcription factor jun-D,JUND,136.33,135.57,S259,QTVPDVPSFGESPPLSPIDMDTQERIKAERK,_DEPQTVPDVPSFGES(ph)PPLS(ph)PIDMDTQER_, , ,0.33, ,-0.1,0.33,0.25,0.7, , ,1.09, ,0.12,0.42,0.37,0.35,,0.33,0.13,0.49,,1.09,0.28,0.36,, +,,,,,NA,NA,,chromatin,double-stranded DNA binding,aging,,
O75962-4,O75962,Kalirin,KALRN,85.86,63.07,S1779,PGPKRPGNTLRKWLTSPVRRLSSGKADGHVK,_WLTS(ph)PVR_,-0.48,-0.57,-1.08, ,-0.66,-0.43,-0.31,-0.4,-0.11,-0.04,-0.39, ,-0.35,-0.36,-0.35,-0.41,-0.53,-1.08,-0.54,-0.35,-0.07,-0.39,-0.35,-0.38, +,,CAMK,,,,3,0,21.11,cytosol,ATP binding,apoptotic signaling pathway,,
A2A2W8,Q14678,KN motif and ankyrin repeat domain-containing protein 1,KANK1,149.82,147.16,S325,AASQINVCGVRKRSYSAGNASQLEQLSRARR,_SYS(ph)AGNASQLEQLSR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q63ZY3-3,Q63ZY3,KN motif and ankyrin repeat domain-containing protein 2,KANK2,149.74,140.69,S375,YGTGLRALAMPGRPESPPVFRSQEVVETMCP,_ALAMPGRPES(ph)PPVFR_,0.15,0.03,-0.8,-0.62,-0.92,-0.27, , ,-0.03,-0.04,-0.27,-0.33,-0.76,-0.36, , ,0.09,-0.71,-0.56,,-0.04,-0.3,-0.55,,,,,,,,NA,NA,,mitochondrion,,apoptotic process,,
F8VUX5,Q9H9L4,KAT8 regulatory NSL complex subunit 2,KANSL2,200.74,198.12,S168,QEPITVDQTWRGDPDSEADSIDSDQEDPLKH,_GDPDS(ph)EADS(ph)IDS(ph)DQEDPLK_, , , , ,-0.16,-0.28,-0.24,-0.27, , , , ,-0.21,-0.03,-0.05,-0.05,,,-0.22,-0.25,,,-0.12,-0.05,,,,,,,NA,NA,,histone acetyltransferase complex,,,,
F8VUX5,Q9H9L4,KAT8 regulatory NSL complex subunit 2,KANSL2,200.74,198.12,S172,TVDQTWRGDPDSEADSIDSDQEDPLKHAGVY,_GDPDS(ph)EADS(ph)IDS(ph)DQEDPLK_, , , , ,-0.16,-0.28,-0.24,-0.27, , , , ,-0.21,-0.03,-0.05,-0.05,,,-0.22,-0.25,,,-0.12,-0.05,,,,,,,NA,NA,,histone acetyltransferase complex,,,,
F8VUX5,Q9H9L4,KAT8 regulatory NSL complex subunit 2,KANSL2,200.74,198.12,S175,QTWRGDPDSEADSIDSDQEDPLKHAGVYTAE,_GDPDS(ph)EADS(ph)IDS(ph)DQEDPLK_, , , , ,-0.16,-0.28,-0.24,-0.27, , , , ,-0.21,-0.03,-0.05,-0.05,,,-0.22,-0.25,,,-0.12,-0.05,,,,,,,NA,NA,,histone acetyltransferase complex,,,,
F8VUX5,Q9H9L4,KAT8 regulatory NSL complex subunit 2,KANSL2,195.27,188.77,S147,PESSRSEASRILDEDSWSDGEQEPITVDQTW,_ILDEDS(ph)WS(ph)DGEQEPITVDQTWR_, , , , ,-0.32,-0.42,-0.52,-0.41, , , , ,-0.05,-0.05,0,0,,,-0.37,-0.46,,,-0.05,0,,,,,,,NA,NA,,histone acetyltransferase complex,,,,
F8VUX5,Q9H9L4,KAT8 regulatory NSL complex subunit 2,KANSL2,195.27,188.77,S149,SSRSEASRILDEDSWSDGEQEPITVDQTWRG,_ILDEDS(ph)WS(ph)DGEQEPITVDQTWR_, , , , ,-0.32,-0.42,-0.52,-0.41, , , , ,-0.05,-0.05,0,0,,,-0.37,-0.46,,,-0.05,0,,,,,,,NA,NA,,histone acetyltransferase complex,,,,
G5E9K7,O95251,Histone acetyltransferase KAT7,KAT7,151.02,147.79,S99,PTPVTPKKYPLRQTRSSGSETEQVVDFSDRE,_(gl)QTRS(ph)S(ph)GS(ph)ETEQVVDFSDR_, , , , ,0.31,0.34,0.19,0.33, , , , ,0.09,0.38,-0.03,0.13,,,0.32,0.26,,,0.24,0.05,,,,,,,NA,NA,,,,,,
G5E9K7,O95251,Histone acetyltransferase KAT7,KAT7,151.02,147.79,S100,TPVTPKKYPLRQTRSSGSETEQVVDFSDRET,_(gl)QTRS(ph)S(ph)GS(ph)ETEQVVDFSDR_, , , , ,0.31,0.34,0.19,0.33, , , , ,0.09,0.38,-0.03,0.13,,,0.32,0.26,,,0.24,0.05,,,,,,,NA,NA,,,,,,
G5E9K7,O95251,Histone acetyltransferase KAT7,KAT7,151.02,147.79,S102,VTPKKYPLRQTRSSGSETEQVVDFSDRETKN,_(gl)QTRS(ph)S(ph)GS(ph)ETEQVVDFSDR_, , , , ,0.31,0.34,0.19,0.33, , , , ,0.09,0.38,-0.03,0.13,,,0.32,0.26,,,0.24,0.05,,,,,,,NA,NA,,,,,,
G5E9K7,O95251,Histone acetyltransferase KAT7,KAT7,123.49,123.17,S111,QTRSSGSETEQVVDFSDRETKNTADHDESPP,_(gl)QTRS(ph)S(ph)GS(ph)ETEQVVDFS(ph)DRETK_, , , , , , , ,0.24, , , , , , , ,0.09,,,,0.24,,,,0.09,,,,,,,NA,NA,,,,,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,137.3,136.97,T196,LASRSPSGGAAGPLLTPSQSLDGSRRSGYIT,_SPS(ph)GGAAGPLLT(ph)PSQSLDGSR_, ,-0.11,0.89,0.27,-1.02,-0.64,-0.91,-1.09, ,-0.37,1.56,0.71,-0.51,-0.59,-0.64,-0.78,-0.11,0.61,-0.82,-1,-0.37,1.2,-0.55,-0.71,, +,,BTB,,,0,4,22.52,cell junction,,protein homooligomerization,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,74.82,74.22,S151,GPGPPPSRRGVHKEGSLGDELLPLGYSEPEQ,_EGS(ph)LGDELLPLGYSEPEQQEGASAGAPS(ph)PTLELASR_, , , , ,0.39, ,-0.88, , , , , ,0, ,0.21, ,,,0.39,-0.88,,,0,0.21,,,,BTB,,,NA,NA,,cell junction,,protein homooligomerization,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,110.86,109.94,S171,LLPLGYSEPEQQEGASAGAPSPTLELASRSP,_EGSLGDELLPLGYSEPEQQEGAS(ph)AGAPS(ph)PTLELASR_, , , , ,-0.05, , , , , , , ,0.49, , , ,,,-0.05,,,,0.49,,,,,BTB,,,NA,NA,,cell junction,,protein homooligomerization,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,110.86,109.94,S176,YSEPEQQEGASAGAPSPTLELASRSPSGGAA,_EGS(ph)LGDELLPLGYSEPEQQEGAS(ph)AGAPS(ph)PTLELASR_, ,-0.33, , ,0.17, ,-0.88, , ,0.4, , ,0.24, ,0.21, ,-0.33,,0.17,-0.88,0.4,,0.24,0.21,,,,BTB,,,NA,NA,,cell junction,,protein homooligomerization,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,337.4,336.58,S185,ASAGAPSPTLELASRSPSGGAAGPLLTPSQS,_S(ph)PSGGAAGPLLT(ph)PSQSLDGSRR_,-0.41,-0.45,-0.51,-0.44,-0.56,0.73,-0.5,0.71,-0.22,-0.26,-0.28,-0.27,-0.32,-0.25,-0.32,-0.47,-0.43,-0.47,0.22,0.23,-0.24,-0.27,-0.28,-0.39,,,,BTB,,,0,0,,cell junction,,protein homooligomerization,,
Q96CX2,Q96CX2,BTB/POZ domain-containing protein KCTD12,KCTD12,213.39,212.81,S187,AGAPSPTLELASRSPSGGAAGPLLTPSQSLD,_SPS(ph)GGAAGPLLTPSQSLDGSR_,-0.3,-0.41,-0.54,-0.58,-0.63,-0.65,-0.64,-0.57,-0.34,-0.15,-0.21,-0.26,-0.35,-0.44,-0.32,-0.27,-0.36,-0.56,-0.64,-0.6,-0.24,-0.23,-0.39,-0.29,,,,BTB,,,0,0,,cell junction,,protein homooligomerization,,
O60341,O60341,Lysine-specific histone demethylase 1A,KDM1A,80.61,80.44,S166,LPPPPPQAPPEEENESEPEEPSGVEGAAFQS,_KLPPPPPQAPPEEENES(ph)EPEEPSGVEGAAFQSR_, , ,0.02, , , , , , , ,0, , , , , ,,0.02,,,,0,,,,,,,,,NA,NA,,nuclear chromatin,androgen receptor binding,blood coagulation,,
O60341,O60341,Lysine-specific histone demethylase 1A,KDM1A,107.95,107.37,S126,SRRKRAKVEYREMDESLANLSEDEYYSEEER,_EMDES(ph)LANLS(ph)EDEYYS(ph)EEER_, , , , , ,-0.47, ,-0.13, , , , , ,-0.74, ,-0.64,,,-0.47,-0.13,,,-0.74,-0.64,,,,,,,NA,NA,,nuclear chromatin,androgen receptor binding,blood coagulation,,
O60341,O60341,Lysine-specific histone demethylase 1A,KDM1A,340.14,332.11,S131,AKVEYREMDESLANLSEDEYYSEEERNAKAE,_EM(ox)DESLANLS(ph)EDEYYS(ph)EEER_,-0.14,-0.12,-0.07,-0.12,-0.22,-0.16,0.21,0.87,-0.15,-0.21,-0.64,-0.26,-0.03,0.02,-0.17,-0.06,-0.13,-0.09,-0.19,0.58,-0.18,-0.44,0,-0.11,,,,,,,0,0,,nuclear chromatin,androgen receptor binding,blood coagulation,,
O60341,O60341,Lysine-specific histone demethylase 1A,KDM1A,340.14,332.11,S137,EMDESLANLSEDEYYSEEERNAKAEKEKKLP,_EM(ox)DESLANLS(ph)EDEYYS(ph)EEER_,-0.14,-0.12,-0.07,-0.12,-0.22,-0.16,-0.28,-0.73,-0.15,-0.21,-0.64,-0.26,-0.03,0.02,-0.07,-0.08,-0.13,-0.09,-0.19,-0.49,-0.18,-0.44,0,-0.07,,,,,,,0,0,,nuclear chromatin,androgen receptor binding,blood coagulation,,
O60341,O60341,Lysine-specific histone demethylase 1A,KDM1A,125.41,122.33,S849,YTLPRQATPGVPAQQSPSM____________,_QATPGVPAQQS(ph)PSM_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nuclear chromatin,androgen receptor binding,blood coagulation,,
H0YH24,Q7LBC6,Lysine-specific demethylase 3B,KDM3B,99.53,47.58,S798,FSQENKAPFEAVKRFSLDERSLACRQDSDSS,_RFS(ph)LDER_, , ,1.44,0.81, , , , , , ,2.12,1.65, , , , ,,1.16,,,,1.9,,, +, +,,,,,NA,NA,,,,,,
F5H3T1,P41229,Lysine-specific demethylase 5C,KDM5C,208.47,206.25,S1359,MPKVQGLLENGDSVTSPEKVAPEEGSDLELL,_VQGLLENGDSVTS(ph)PEK_,0.09,0.08,0.1,0.21, ,0.37,0.41,0.4,-0.23,-0.44,-0.26,-0.29, ,0.2,0.08,0.38,0.09,0.15,0.37,0.41,-0.33,-0.27,0.2,0.24,,,,,,,0,0,,,,,,
F5H3T1,P41229,Lysine-specific demethylase 5C,KDM5C,188.19,139.29,T1358,DMPKVQGLLENGDSVTSPEKVAPEEGSDLEL,_VQGLLENGDSVT(ph)SPEK_, , , , ,0.59, , , , , , , ,0.81, , , ,,,0.59,,,,0.81,,,,,,,,NA,NA,,,,,,
Q92945-2,Q92945,Far upstream element-binding protein 2,KHSRP,173.28,151.25,S181,QINKIQQDSGCKVQISPDSGGLPERSVSLTG,_VQIS(ph)PDS(ph)GGLPER_,-0.1,0.14,-0.15, ,0,-0.17,-0.28,-0.15,-0.17,-0.11,-0.12, ,-0.37,-0.49,-0.43,-0.24,0.02,-0.15,-0.08,-0.21,-0.14,-0.12,-0.43,-0.33,,,,,,,0,0,,cytoplasmic stress granule,DNA binding,mRNA processing,,
Q92945-2,Q92945,Far upstream element-binding protein 2,KHSRP,104.68,73.81,S184,KIQQDSGCKVQISPDSGGLPERSVSLTGAPE,_VQIS(ph)PDS(ph)GGLPER_, , , , ,-0.3, , ,-0.56, , , , ,0.19, , ,-0.09,,,-0.3,-0.56,,,0.19,-0.09,,,,,,,NA,NA,,cytoplasmic stress granule,DNA binding,mRNA processing,,
H0Y613,Q14687,Genetic suppressor element 1,KIAA0182,60.8,58.87,S762,RREAQEKGYYYDLDDSYDESDEEEVRAHLRC,_GYYYDLDDS(ph)YDES(ph)DEEEVR_, , , , , , , ,0.18, , , , , , , ,0.37,,,,0.18,,,,0.37,,,,,,,NA,NA,,,,,,
H0Y613,Q14687,Genetic suppressor element 1,KIAA0182,60.8,58.87,S766,QEKGYYYDLDDSYDESDEEEVRAHLRCVAEQ,_GYYYDLDDS(ph)YDES(ph)DEEEVR_, , , , , , , ,0.18, , , , , , , ,0.37,,,,0.18,,,,0.37,,,,,,,NA,NA,,,,,,
H0Y613,Q14687,Genetic suppressor element 1,KIAA0182,50.19,19.95,S970,VRPQELSRVQELAPASGEKARLSEAPGGKKS,_VQELAPAS(ph)GEK_, ,-0.15, , ,0.07,-0.59,0.49, , ,0.04, , ,-0.01,-1.38,-0.51, ,-0.15,,-0.22,0.49,0.04,,-0.54,-0.51,,,,,,,NA,NA,,,,,,
E9PFC1,Q9Y4F5,Protein KIAA0284,KIAA0284,50.99,49.1,S986,PSPTTPQPLRAQKEMSPSPPAAQDPGGTALV,_EMS(ph)PS(ph)PPAAQDPGGTALVSAR_, , , , , ,-2.2,-2.13, , , , , , ,-1.11,-1.04, ,,,-2.2,-2.13,,,-1.11,-1.04, +, +,,,,,NA,NA,,,,,,
E9PFC1,Q9Y4F5,Protein KIAA0284,KIAA0284,50.99,49.1,S988,PTTPQPLRAQKEMSPSPPAAQDPGGTALVSA,_EMS(ph)PS(ph)PPAAQDPGGTALVSAR_, , , , , ,-2.2,-2.13, , , , , , ,-1.11,-1.04, ,,,-2.2,-2.13,,,-1.11,-1.04, +, +,,,,,NA,NA,,,,,,
E9PFC1,Q9Y4F5,Protein KIAA0284,KIAA0284,75.91,74.72,S969,SDVDTASTVSLRSGKSGPSPTTPQPLRAQKE,_S(ph)GPS(ph)PTTPQPLR_, , , , , , , ,0.01, , , , , , , ,0.02,,,,0.01,,,,0.02,,,,,,,NA,NA,,,,,,
E9PFC1,Q9Y4F5,Protein KIAA0284,KIAA0284,75.91,74.72,S972,DTASTVSLRSGKSGPSPTTPQPLRAQKEMSP,_S(ph)GPS(ph)PTTPQPLR_, , , , , , , ,0.01, , , , , , , ,0.02,,,,0.01,,,,0.02,,,,,,,NA,NA,,,,,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,109.99,108.1,S293,THSSGPSTPLKNQTYSFSPSKSYSRQSSSSD,_NQTYS(ph)FS(ph)PSK_, , , , ,2.53,2.45,2.45,1.97, , , , ,3.11,2.95,2.53,2.34,,,2.49,2.23,,,3.03,2.44, +, +,,,,,NA,NA,,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,109.99,108.1,S295,SSGPSTPLKNQTYSFSPSKSYSRQSSSSDTD,_NQTYS(ph)FS(ph)PSK_,-0.82,-1.86,-1.66,-2.08,-1.02,-1.26,-1.82,1.97,-0.84,-1.94,-1.92,-2.17,-0.92,-1.49,-1.94,2.34,-1.25,-1.86,-1.14,1.07,-1.29,-2.04,-1.18,1.41, +, +,,,,,3,3,51.29,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,117.5,116.3,S659,PIPEPRQRSRLLRSQSESSDEVTELDLSHGK,_SQS(ph)ESS(ph)DEVTELDLSHGK_,0.17, ,0.41,0.12,1.15,1.22,1.08,1.17,0.32, ,0.61,0.16,1.09,1.35,1.15,1.24,0.17,0.27,1.18,1.12,0.32,0.4,1.23,1.2, +, +,,,,,2,2,47.6,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,117.5,116.3,S662,EPRQRSRLLRSQSESSDEVTELDLSHGKKDA,_SQS(ph)ESS(ph)DEVTELDLSHGKK_,0.17, ,0.26,0.12,0.91,0.45,1.08,1.21,0.32, ,0.39,0.16,0.9,0.84,1.15,1.24,0.17,0.19,0.7,1.14,0.32,0.28,0.87,1.2, +, +,,,,,2,2,45.75,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,105.38,90.74,S280,MKEIPFNEDPNPNTHSSGPSTPLKNQTYSFS,_EIPFNEDPNPNTHS(ph)S(ph)GPST(ph)PLK_, , , , ,0.73,0.79,0.66,0.79, , , , ,0.82,0.72,0.85,0.92,,,0.76,0.73,,,0.77,0.88,,,,,,,NA,NA,,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,114.35,99.54,S281,KEIPFNEDPNPNTHSSGPSTPLKNQTYSFSP,_EIPFNEDPNPNTHS(ph)S(ph)GPST(ph)PLK_, , , , ,-0.44,0.62,0.9,0.66, , , , ,0.03,0.88,1.03,0.76,,,0.19,0.78,,,0.52,0.9,,,,,,,NA,NA,,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,114.35,99.54,S284,PFNEDPNPNTHSSGPSTPLKNQTYSFSPSKS,_EIPFNEDPNPNTHSS(ph)GPS(ph)T(ph)PLK_, , , , , ,0.55,0.66,0.73, , , , , ,0.88,0.85,0.93,,,0.55,0.7,,,0.88,0.89,,,,,,,NA,NA,,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q86YS7,Q86YS7,Uncharacterized protein KIAA0528,KIAA0528,114.35,99.54,T285,FNEDPNPNTHSSGPSTPLKNQTYSFSPSKSY,_EIPFNEDPNPNTHSS(ph)GPST(ph)PLK_, , , , ,0.27,0.52,0.49,0.99, , , , ,0.52,0.8,0.5,1.15,,,0.4,0.77,,,0.67,0.86,,,,,,,NA,NA,,cell cortex,calcium ion binding,insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade,,
Q96AT1,Q96AT1,Uncharacterized protein KIAA1143,KIAA1143,84.9,83.31,S143,QDSVKKNSQKQIKNSSLLSFDNEDENE____,_NSS(ph)LLSFDNEDENE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q96AT1,Q96AT1,Uncharacterized protein KIAA1143,KIAA1143,185.3,179.93,S146,VKKNSQKQIKNSSLLSFDNEDENE_______,_NSSLLS(ph)FDNEDENE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q5T5P2-4,Q5T5P2,Sickle tail protein homolog,KIAA1217,78.95,72.83,Y393,DMSGKNIAMYRNEGFYADPYLYHEGRMSIAS,_NEGFY(ph)ADPYLYHEGR_,0.43,0.26,0.04, ,0,0.04,0.04,-0.02,0.54,0.8,0.55, ,0.19,0.36,0.52,0.38,0.35,0.04,0.02,0.01,0.68,0.55,0.28,0.45,,,,,,,0,0,,cytoplasm,,embryonic skeletal system development,,
Q69YN4,Q69YN4,Protein virilizer homolog,KIAA1429,108.96,108.96,S173,NPKHADGEKEDQFNGSPPRPQPRGPRTPPGP,_EDQFNGS(ph)PPRPQPR_,-0.16,-0.21, , , , , , ,-0.53,-0.57, , , , , , ,-0.18,,,,-0.55,,,,,,,,,,NA,NA,,nucleus,,mRNA processing,,
Q69YN4,Q69YN4,Protein virilizer homolog,KIAA1429,132.24,109.13,S1579,DLHSELERSFLSEPSSPGRTKTTKGFKLGKH,_SFLSEPSS(ph)PGR_, , ,-0.16, ,-0.39,-0.35,-0.6,-0.51, , ,-0.23, ,-0.14,0.28,0,-0.01,,-0.16,-0.37,-0.56,,-0.23,0.08,0,,,,,,,NA,NA,,nucleus,,mRNA processing,,
Q4ADV7,Q4ADV7,Protein RIC1 homolog,KIAA1432,160.77,159.15,T992,HMIRFLKAIGSGESETPPSTPTAQEPSSSGG,_AIGSGESET(ph)PPST(ph)PTAQEPSSSGGFEFFR_, , , , ,1.56,1.77,2.02,1.27, , , , ,1.31,1.83,1.9,1.55,,,1.67,1.69,,,1.59,1.73, +, +,,,,,NA,NA,,integral to membrane,,,,
Q4ADV7,Q4ADV7,Protein RIC1 homolog,KIAA1432,160.77,159.15,T996,FLKAIGSGESETPPSTPTAQEPSSSGGFEFF,_AIGSGESET(ph)PPST(ph)PTAQEPSSSGGFEFFR_, , , , ,1.56,1.77,2.12,1.27, , , , ,1.31,1.83,2,1.55,,,1.67,1.75,,,1.59,1.79, +, +,,,,,NA,NA,,integral to membrane,,,,
A2RU67,A2RU67,Uncharacterized protein KIAA1467,KIAA1467,118.51,118.07,S16,MATVLSRALKLPGKKSPDLGEYDPLTQADSD,_S(ph)PDLGEYDPLTQADS(ph)DES(ph)EDDLVLNLQK_, , , , ,-0.23, , , , , , , ,-0.14, , , ,,,-0.23,,,,-0.14,,,,,,,,NA,NA,,integral to membrane,,,,
A2RU67,A2RU67,Uncharacterized protein KIAA1467,KIAA1467,118.51,118.07,S30,KSPDLGEYDPLTQADSDESEDDLVLNLQKNG,_S(ph)PDLGEYDPLTQADS(ph)DES(ph)EDDLVLNLQK_, , , , ,-0.23, , , , , , , ,-0.14, , , ,,,-0.23,,,,-0.14,,,,,,,,NA,NA,,integral to membrane,,,,
A2RU67,A2RU67,Uncharacterized protein KIAA1467,KIAA1467,118.51,118.07,S33,DLGEYDPLTQADSDESEDDLVLNLQKNGGVK,_S(ph)PDLGEYDPLTQADS(ph)DES(ph)EDDLVLNLQK_, , , , ,-0.23, , , , , , , ,-0.14, , , ,,,-0.23,,,,-0.14,,,,,,,,NA,NA,,integral to membrane,,,,
Q9P260,Q9P260,LisH domain and HEAT repeat-containing protein KIAA1468,KIAA1468,215.55,207.76,S20,APGGSGSGGGVNPFLSDSDEDDDEVAATEER,_(ac)AAMAPGGSGSGGGVNPFLS(ph)DS(ph)DEDDDEVAATEERR_, , , , ,0.18,-0.09,0.04,0.07, , , , ,0.19,0.29,0.03,0.19,,,0.05,0.06,,,0.24,0.11,,,,,,,NA,NA,,,,,,
Q9P260,Q9P260,LisH domain and HEAT repeat-containing protein KIAA1468,KIAA1468,215.55,207.76,S22,GGSGSGGGVNPFLSDSDEDDDEVAATEERRA,_(ac)AAMAPGGSGSGGGVNPFLS(ph)DS(ph)DEDDDEVAATEERR_, , , , ,0.18,-0.09,0.04,0.07, , , , ,0.19,0.29,0.03,0.19,,,0.05,0.06,,,0.24,0.11,,,,,,,NA,NA,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,100.92,99.56,S669,TLTPLQESPVISKDQSPPPSPPPSYHPPPPP,_DQS(ph)PPPS(ph)PPPSYHPPPPPTK_, , ,0.14,0.13,0.09,0.14,0.02,0.02, , ,0.08,0.83,0.43,0.27,0.08,0.1,,0.14,0.12,0.02,,0.51,0.35,0.09,,,,,,,NA,NA,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,100.92,99.56,S673,LQESPVISKDQSPPPSPPPSYHPPPPPTKKP,_DQS(ph)PPPS(ph)PPPSYHPPPPPTK_, , ,0.14,0.13,0.09,0.14,0.02,0.02, , ,0.08,0.83,0.43,0.27,0.08,0.1,,0.14,0.12,0.02,,0.51,0.35,0.09,,,,,,,NA,NA,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,90.71,54.29,S545,GTPTLPPKGLAGPPASPGKAQPPKPERVTSL,_GLAGPPAS(ph)PGK_,-0.19,-0.19,-0.58,-0.66,0,-0.16,0.18,-0.37,0.29,0.06,-0.15,-0.13,0.02,-0.04,0.33,0.33,-0.19,-0.62,-0.08,-0.07,0.18,-0.14,-0.01,0.33,,,,,,,0,0,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,168.55,165.88,S404,SNSVVPPPQGGSGRGSPSGGSTAEASDTLSI,_GS(ph)PS(ph)GGS(ph)TAEASDTLSIR_, , , , ,0.62,0.62,0.6,0.49, , , , ,0.7,0.74,0.63,0.61,,,0.62,0.55,,,0.72,0.62,,,,,,,NA,NA,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,168.55,165.88,S409,PPPQGGSGRGSPSGGSTAEASDTLSIRSSGQ,_GS(ph)PSGGS(ph)TAEASDTLSIR_, , , , ,0.62,0.62,0.6,0.49, , , , ,0.7,0.74,0.63,0.61,,,0.62,0.55,,,0.72,0.62,,,,,,,NA,NA,,,,,,
Q9P206,Q9P206,Uncharacterized protein KIAA1522,KIAA1522,249.32,239.19,S929,IFSKGSRKLQLERPVSPETQADLQRNLVAEL,_LQLERPVS(ph)PETQADLQR_,0.02,0.04,-0.04,-0.03,-0.05,0.09,0,-0.32,-0.12,-0.18,0.01,-0.17,0.49,0.46,0.32,-0.01,0.03,-0.04,0.02,-0.15,-0.15,-0.07,0.47,0.16,,,,,,,0,0,,,,,,
A0MZ66-7,A0MZ66,Shootin-1,KIAA1598,241.15,229.83,S494,RILRRRKVTAEADSSSPTGILATSESKSMPV,_VTAEADSSS(ph)PTGILATSESK_, , ,-0.04,0.18,-0.02,-0.13,-0.13,-0.5, , ,0.3,0.37,0.02,-0.02,-0.09,-0.13,,0.08,-0.07,-0.3,,0.34,0,-0.11,,,,,,,NA,NA,,axon,,axon guidance,,
Q9BY89,Q9BY89,Uncharacterized protein KIAA1671,KIAA1671,92.37,90.63,S1757,VDSPGETPSWAPQPKSPKSPFQPGVLGSRVL,_S(ph)PKS(ph)PFQPGVLGSR_, , , , ,1.14, , , , , , , ,1.6, , , ,,,1.14,,,,1.6,, +, +,,,,,NA,NA,,,,,,
Q9BY89,Q9BY89,Uncharacterized protein KIAA1671,KIAA1671,92.37,90.63,S1760,PGETPSWAPQPKSPKSPFQPGVLGSRVLPSS,_S(ph)PKS(ph)PFQPGVLGSR_, , , , ,1.14, , , , , , , ,1.6, , , ,,,1.14,,,,1.6,, +, +,,,,,NA,NA,,,,,,
Q8IXQ4,Q8IXQ4,Uncharacterized protein KIAA1704,KIAA1704,178.33,178.33,S140,KSDKGRDDPGQQETDSSEDEDIIGPMPAKGP,_GRDDPGQQET(ph)DS(ph)S(ph)EDEDIIGPM(ox)PAK_, , , , ,0.27,0.41,0.27,0.29, , , , ,-0.04,-0.05,0.1,0.09,,,0.34,0.28,,,-0.04,0.09,,,,,,,NA,NA,,,,,,
Q8IXQ4,Q8IXQ4,Uncharacterized protein KIAA1704,KIAA1704,178.33,178.33,S141,SDKGRDDPGQQETDSSEDEDIIGPMPAKGPV,_GRDDPGQQET(ph)DS(ph)S(ph)EDEDIIGPM(ox)PAK_, , , , ,0.27,0.41,0.27,0.29, , , , ,-0.04,-0.05,0.1,0.09,,,0.34,0.28,,,-0.04,0.09,,,,,,,NA,NA,,,,,,
Q8IXQ4,Q8IXQ4,Uncharacterized protein KIAA1704,KIAA1704,178.33,178.33,T138,TQKSDKGRDDPGQQETDSSEDEDIIGPMPAK,_GRDDPGQQET(ph)DS(ph)S(ph)EDEDIIGPM(ox)PAK_, , , , ,0.27,0.41,0.27,0.29, , , , ,-0.04,-0.05,0.1,0.09,,,0.34,0.28,,,-0.04,0.09,,,,,,,NA,NA,,,,,,
Q9C0D2,Q9C0D2,Centrosomal protein KIAA1731,KIAA1731,50.96,38.82,S1809,IRHADRNNSDDNHLASEDTSAKQSGEHLEKD,_NNSDDNHLAS(ph)EDT(ph)S(ph)AK_,-0.06, , , , , , , ,-0.03, , , , , , , ,-0.06,,,,-0.03,,,,,,,,,,NA,NA,,centrosome,,,,
Q9C0D2,Q9C0D2,Centrosomal protein KIAA1731,KIAA1731,50.96,38.82,S1813,DRNNSDDNHLASEDTSAKQSGEHLEKDLGRR,_NNSDDNHLAS(ph)EDT(ph)S(ph)AK_,-0.06, , , , , , , ,-0.03, , , , , , , ,-0.06,,,,-0.03,,,,,,,,,,NA,NA,,centrosome,,,,
Q8N163,Q8N163,DBIRD complex subunit KIAA1967,KIAA1967,318.28,318.28,S678,FAGAKLEDSEVRSVASNQSEMEFSSLQDMPK,_S(ph)VAS(ph)NQS(ph)EMEFSSLQDMPK_,1.21,1.36,0.96,0.76,0.01,0.14,-0.19,-0.2,-0.01,0.09,-0.23,-0.04,0.04,0.11,-0.17,-0.23,1.28,0.86,0.07,-0.2,0.04,-0.13,0.08,-0.2, +,,,,,,5,0,22.26,DBIRD complex,enzyme inhibitor activity,mitochondrial fragmentation involved in apoptotic process,,
Q8N163,Q8N163,DBIRD complex subunit KIAA1967,KIAA1967,318.28,318.28,S675,EEEFAGAKLEDSEVRSVASNQSEMEFSSLQD,_S(ph)VAS(ph)NQS(ph)EMEFSSLQDMPK_,-0.18,-0.09,-0.28,-0.85,-0.1,-0.04,-0.31,-0.27,-0.05,0.09,0.02,-0.16,-0.04,-0.02,-0.17,-0.2,-0.13,-0.54,-0.07,-0.29,0.02,-0.07,-0.03,-0.19,,,,,,,0,0,,DBIRD complex,enzyme inhibitor activity,mitochondrial fragmentation involved in apoptotic process,,
Q8N163,Q8N163,DBIRD complex subunit KIAA1967,KIAA1967,264.87,262.66,S681,AKLEDSEVRSVASNQSEMEFSSLQDMPKELD,_S(ph)VAS(ph)NQS(ph)EMEFSSLQDMPK_,0.31,0.1,0.06,-0.15,0.47,0.33,0.07,0.12,0.34,0.37,-0.4,0.14,0.23,0.28,-0.09,-0.15,0.21,-0.04,0.4,0.1,0.36,-0.1,0.26,-0.12,,,,,,,0,0,,DBIRD complex,enzyme inhibitor activity,mitochondrial fragmentation involved in apoptotic process,,
Q8N163,Q8N163,DBIRD complex subunit KIAA1967,KIAA1967,68.49,68.35,T484,DALEQAADTSRRNAETPEATTQQETDTDLPE,_NAET(ph)PEATTQQETDTDLPEAPPPPLEPAVIAR_, , , , , ,0.45,-0.11,0.11, , , , , ,0.14,0,0.15,,,0.45,0,,,0.14,0.08,,,,,,,NA,NA,,DBIRD complex,enzyme inhibitor activity,mitochondrial fragmentation involved in apoptotic process,,
Q9ULH0,Q9ULH0,Kinase D-interacting substrate of 220 kDa,KIDINS220,141.78,139.51,S1521,DLKLKGSGLRYQKLPSDEDESGTEESDNTPL,_LPS(ph)DEDES(ph)GTEESDNTPLLK_, , , , , ,-0.53,-0.08,0.16, , , , , ,0.52,0.06,0.13,,,-0.53,0.05,,,0.52,0.1,,,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
Q9ULH0,Q9ULH0,Kinase D-interacting substrate of 220 kDa,KIDINS220,141.78,139.51,S1526,GSGLRYQKLPSDEDESGTEESDNTPLLKDDK,_LPS(ph)DEDES(ph)GTEESDNTPLLK_, , , , , ,0.44,0.65,0.16, , , , , ,0.28,0.54,0.13,,,0.44,0.43,,,0.28,0.35,,,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
Q9ULH0,Q9ULH0,Kinase D-interacting substrate of 220 kDa,KIDINS220,53.24,42.53,S918,TYRRRQMQRTITRQMSFDLTKLLVTEDWFSD,_QMS(ph)FDLTK_, , , , , , ,0.26,0.51, , , , , , ,0.47,0.73,,,,0.39,,,,0.61,,,,,,,NA,NA,,cytosol,,activation of MAPKK activity,,
O60333-2,O60333,Kinesin-like protein KIF1B,KIF1B,76.6,71.55,S1487,VRGEENLAGWRPRGDSLILEHQWELEKLELL,_GDS(ph)LILEHQWELEK_, ,0.54,0.72,0.85, , , , , ,-0.77,-0.64,-0.89, , , , ,0.54,0.78,,,-0.77,-0.76,,,,,,,,,NA,NA,,cytoplasmic vesicle membrane,ATP binding,anterograde axon cargo transport,,
O60333-2,O60333,Kinesin-like protein KIF1B,KIF1B,148.78,112.26,S1057,NQSDFSSVAMTRSGLSLEELRIVEGQGQSSE,_SGLS(ph)LEELR_,0.17,0.02,-0.43, , ,-0.67,-0.38,-0.5,0.05,0.06,-0.26, , ,-0.74,-0.41,-0.5,0.09,-0.43,-0.67,-0.44,0.05,-0.26,-0.74,-0.46,,,,,,,0,0,,cytoplasmic vesicle membrane,ATP binding,anterograde axon cargo transport,,
B4DL79,O95235,Kinesin-like protein KIF20A,KIF20A,103.04,97.32,S532,FPSLHSFIKEHSLQVSPSLEKGAKADTGLDD,_EHSLQVS(ph)PSLEK_, , ,0.33,0.6, , , , , , ,-0.21,0.02, , , , ,,0.47,,,,-0.09,,,,,,,,,NA,NA,,Golgi apparatus,ATP binding,cytokinesis,,
H0YHT2,Q7Z4S6,Kinesin-like protein KIF21A,KIF21A,261.52,261.14,S1662,TVRIWKARNLQDGQISDTGDLGEDIASN___,_NLQDGQIS(ph)DTGDLGEDIAS(ph)N_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
H0YHT2,Q7Z4S6,Kinesin-like protein KIF21A,KIF21A,261.52,261.14,S1673,DGQISDTGDLGEDIASN______________,_NLQDGQIS(ph)DTGDLGEDIAS(ph)N_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
H0YHT2,Q7Z4S6,Kinesin-like protein KIF21A,KIF21A,215.39,208.22,T1664,RIWKARNLQDGQISDTGDLGEDIASN_____,_NLQDGQISDT(ph)GDLGEDIASN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
H0YHT2,Q7Z4S6,Kinesin-like protein KIF21A,KIF21A,110.25,101.43,S1212,MNTETSGTSAREKELSPPPGLPSKIGSISRQ,_ELS(ph)PPPGLPSK_,0.33,0.36,0.36,0.48, , , ,0.67,0.11,0.06,0.1,-0.01, , , ,0.1,0.34,0.42,,0.67,0.09,0.05,,0.1,,,,,,,NA,NA,,,,,,
B4E1K0,Q02241,Kinesin-like protein KIF23,KIF23,94.39,94.3,S867,LAKCEKYMLTHQELASDGEIETKLIKGDIYK,_YMLTHQELAS(ph)DGEIETK_,0.06,0.14,0.06,0.35,-0.95, ,-0.33, ,0.19,0.18,0.23,0.3,-0.58, ,-0.32, ,0.1,0.21,-0.95,-0.33,0.19,0.26,-0.58,-0.32,,,,,,,0,0,,microtubule,ATP binding,microtubule-based movement,,
O95239-2,O95239,Chromosome-associated kinesin KIF4A,KIF4A,75.42,56.98,S801,ESGENPPPKLRRRTFSLTEVRGQVSESEDSI,_TFS(ph)LTEVR_, , , ,0.57, , , , , , , ,1.3, , , , ,,0.57,,,,1.3,,,, +,,,,,NA,NA,,chromosome,ATP binding,anterograde axon cargo transport,,
A2BEW4,Q9BW19,Kinesin-like protein KIFC1,KIFC1,117.18,117.18,S6,__________MDPQRSPLLEVKGNIELKRPL,_(ac)M(ox)DPQRS(ph)PLLEVK_,-0.11,-0.14,-0.65,0.1,-0.38,0.09,-0.32,-0.17,0.02,-0.16,-0.08,-0.12,-0.3,0.45,-0.28,-0.21,-0.13,-0.23,-0.13,-0.24,-0.07,-0.1,0.12,-0.25,,,,,,,0,0,,centrosome,nucleotide binding,mRNA processing,,
B4DN67,Q96J84,Kin of IRRE-like protein 1,KIRREL,69.86,68.3,Y721,LGYPQAPPSGLERTPYEAYDPIGKYATATRF,_TPY(ph)EAYDPIGK_, , ,1.09, , , , , , , ,0.98, , , , , ,,1.09,,,,0.98,,, +,,,,,,NA,NA,,membrane,,,,
B4DN67,Q96J84,Kin of IRRE-like protein 1,KIRREL,58.08,58.08,Y647,RFDGRPSSRLSHSSGYAQLNTYSRGPASDYG,_LSHSSGY(ph)AQLNTYSR_, , ,0.27, , , , , , , ,1, , , , , ,,0.27,,,,1,,,, +,,,,,NA,NA,,membrane,,,,
B4DN67,Q96J84,Kin of IRRE-like protein 1,KIRREL,153.25,153.25,Y724,PQAPPSGLERTPYEAYDPIGKYATATRFSYT,_TPYEAY(ph)DPIGK_,0.34, ,0.44, , , , ,0.69,0.02, ,0.48, , , , ,1.1,0.34,0.44,,0.69,0.02,0.48,,1.1,, +,,,,,NA,NA,,membrane,,,,
B4DN67,Q96J84,Kin of IRRE-like protein 1,KIRREL,87.18,62.55,Y622,NVRAHEDRPSSRAVLYADYRAPGPARFDGRP,_AVLY(ph)ADYR_,-0.19, ,0.21, , , ,0.01,0.4,-0.35, ,0.29, , , ,0.32,0.55,-0.19,0.21,,0.22,-0.35,0.29,,0.44,,,,,,,NA,NA,,membrane,,,,
Q07866-7,Q07866,Kinesin light chain 1,KLC1,121.45,83.66,S460,SFGEYGGWYKACKVDSPTVTTTLKNLGALYR,_VDS(ph)PTVTTTLK_,0.05,0.43,-0.11,0.03,-0.42,-0.61,-0.48,-0.62,0.03,0.68,-0.03,0.33,-0.52,-0.4,-0.62,-0.4,0.25,-0.04,-0.51,-0.55,0.39,0.16,-0.46,-0.5,,,,,,,0,0,,cytosol,microtubule motor activity,antigen processing and presentation of exogenous peptide antigen via MHC class II,,
A8MXL7,Q9H0B6,Kinesin light chain 2,KLC2,68.79,52.56,S582,GTPQEPPNPRMKRASSLNFLNKSVEEPTQPG,_ASS(ph)LNFLNK_, , , , , ,0.83, , , , , , , ,1.95, , ,,,0.83,,,,1.95,,, +,,,,,NA,NA,,,,,,
A8MXL7,Q9H0B6,Kinesin light chain 2,KLC2,74.97,54.23,S610,QPGGTGLSDSRTLSSSSMDLSRRSSLVG___,_TLSSS(ph)SMDLSR_, , ,-0.39, ,1.05,-0.24,0.91,0.77, , ,0.42, ,0.25,-0.92,0.36,0.05,,-0.39,0.54,0.84,,0.42,-0.22,0.21,,,,,,,NA,NA,,,,,,
Q6P597-2,Q6P597,Kinesin light chain 3,KLC3,109.1,70.09,S502,LDKAPRTLSASTQDLSPH_____________,_TLSASTQDLS(ph)PH_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,ciliary rootlet,cardiolipin synthase activity,,,
B4DME9,Q9NSK0,Kinesin light chain 4,KLC4,106.29,88.23,S609,LNQPSAAPLQVSRGLSASTMDLSSSS_____,_GLS(ph)ASTM(ox)DLSSSS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,kinesin complex,microtubule motor activity,,,
B4DME9,Q9NSK0,Kinesin light chain 4,KLC4,76.01,71.46,S460,PYAEYGGWYKACKVSSPTVNTTLRNLGALYR,_VSS(ph)PTVNTTLR_,0.33, , , ,-0.37,0.13, , ,0.17, , , ,-0.54,-0.1, , ,0.33,,-0.09,,0.17,,-0.3,,,,,,,,NA,NA,,kinesin complex,microtubule motor activity,,,
P57682-2,P57682,Krueppel-like factor 3,KLF3,37.21,37.21,S92,NSPSSLKFPSSHRRASPGLSMPSSSPPIKKY,_RAS(ph)PGLSMPSS(ph)SPPIK_,0.09, , , , , , , ,-0.5, , , , , , , ,0.09,,,,-0.5,,,,,,,,,,NA,NA,,nucleus,DNA binding,multicellular organismal development,,
Q8TBB5-2,Q8TBB5,Kelch domain-containing protein 4,KLHDC4,182.48,175.12,S413,IKQVLTAPGSAGQPRSEDEDSLEEAGSPAPG,_S(ph)EDEDS(ph)LEEAGSPAPGPCPR_, , , , ,-0.18,-0.22,-0.12,-0.36, , , , ,-0.07,0.13,0,0.29,,,-0.2,-0.24,,,0.03,0.15,,,,,,,NA,NA,,,,,,
Q8TBB5-2,Q8TBB5,Kelch domain-containing protein 4,KLHDC4,182.48,175.12,S418,TAPGSAGQPRSEDEDSLEEAGSPAPGPCPRS,_S(ph)EDEDS(ph)LEEAGSPAPGPCPR_, , , , ,-0.18,-0.22,-0.12,-0.36, , , , ,-0.07,0.13,0,0.29,,,-0.2,-0.24,,,0.03,0.15,,,,,,,NA,NA,,,,,,
P52292,P52292,Importin subunit alpha-2,KPNA2,256.81,251.52,S62,MLKRRNVSSFPDDATSPLQENRNNQGTVNWS,_NVSSFPDDATS(ph)PLQENR_,-0.22,-0.16,-0.04,0.03,-0.34,-0.32,-0.5,-0.44,-0.31,-0.33,-0.18,-0.11,-0.24,-0.15,-0.47,-0.49,-0.19,0,-0.33,-0.47,-0.32,-0.14,-0.19,-0.48,,,,,,,0,0,,cytosol,nuclear localization sequence binding,cytokine-mediated signaling pathway,,
O00505,O00505,Importin subunit alpha-3,KPNA3,71.3,71.02,S56,RDEHLLKKRNVPQEESLEDSDVDADFKAQNV,_NVPQEES(ph)LEDS(ph)DVDADFK_, , , , ,-0.32, ,-0.25,-1, , , , ,-0.09, ,-0.14,-0.75,,,-0.32,-0.58,,,-0.09,-0.42,,,,,,,NA,NA,,cytosol,nuclear localization sequence binding,cytokine-mediated signaling pathway,,
O00505,O00505,Importin subunit alpha-3,KPNA3,205.13,204.02,S60,LLKKRNVPQEESLEDSDVDADFKAQNVTLEA,_RNVPQEESLEDS(ph)DVDADFK_,0.08,0.08,0.07,0.09,-0.12,-0.23,-0.03,0.14,0.08,0.13,0.02,0.08,-0.03,-0.18,-0.11,-0.1,0.08,0.08,-0.17,0.05,0.11,0.05,-0.1,-0.1,,,,,,,0,0,,cytosol,nuclear localization sequence binding,cytokine-mediated signaling pathway,,
O60684,O60684,Importin subunit alpha-7,KPNA6,206.27,184.26,S6,__________METMASPGKDNYRMKSYKNNA,_(ac)METMAS(ph)PGK_,0.08,0.03,-0.21,-0.18,-0.26,-0.39,-0.23,-0.26,-0.09,0.01,-0.09,-0.2,-0.54,-0.23,-0.08,-0.11,0.05,-0.2,-0.32,-0.24,-0.04,-0.15,-0.38,-0.09,,,,,,,0,0,,cytoplasm,protein transporter activity,NLS-bearing substrate import into nucleus,,
D3YTE0,Q8N9T8,Protein KRI1 homolog,KRI1,76.1,76,S628,QRQLPALDGSLMGPESPPAQEEEAPVSPHKK,_QLPALDGSLMGPES(ph)PPAQEEEAPVS(ph)PHK_,-0.5, , , ,-0.37,-0.26,-0.65, ,-0.09, , , ,0.04,-0.04,-0.06, ,-0.5,,-0.32,-0.65,-0.09,,0,-0.06,,,,,,,NA,NA,,,,,,
D3YTE0,Q8N9T8,Protein KRI1 homolog,KRI1,76.1,76,S639,MGPESPPAQEEEAPVSPHKKPAPQKRRRAKK,_QLPALDGSLMGPES(ph)PPAQEEEAPVS(ph)PHK_,-0.5, , , ,-0.38,-0.26,-0.65, ,-0.09, , , ,0.06,-0.04,-0.06, ,-0.5,,-0.32,-0.65,-0.09,,0.01,-0.06,,,,,,,NA,NA,,,,,,
D3YTE0,Q8N9T8,Protein KRI1 homolog,KRI1,190.19,188.88,S171,EQKQLKESFRAFVEDSEDEDGAGEGGSSLLQ,_AFVEDS(ph)EDEDGAGEGGSSLLQK_,-0.06,-0.07,-0.49,-0.46,-0.36,-0.34,-0.61, ,0.04,0.09,-0.31,-0.15,-0.64,-0.44,-0.26, ,-0.07,-0.48,-0.35,-0.61,0.06,-0.22,-0.54,-0.26,,,,,,,0,0,,,,,,
D3YTE0,Q8N9T8,Protein KRI1 homolog,KRI1,149.42,149.42,S136,KVILEKAGKYVDEENSDGETSNHRLQETSSQ,_YVDEENS(ph)DGETSNHR_,-0.18, ,-0.66, ,-0.74,-0.51,-0.66,-0.87,-0.08, ,-0.53, ,-0.6,-0.37,-0.42,-0.49,-0.18,-0.66,-0.62,-0.76,-0.08,-0.53,-0.48,-0.46,,,,,,,0,0,,,,,,
Q13601-2,Q13601,KRR1 small subunit processome component homolog,KRR1,99.16,93.16,S3,_____________MASPSLERPEKGAGKSEF,_(ac)AS(ph)PSLERPEK_,0.77,0.35,0.15, ,-1.04,-1, , ,0.2,0.03,-0.39, ,-1.06,-1.19, , ,0.57,0.15,-1.02,,0.12,-0.39,-1.12,, +, +,,,,,NA,NA,,cytoplasm,RNA binding,rRNA processing,,
A8MY87,Q8IVT5,Kinase suppressor of Ras 1,KSR1,88.28,87.38,S404,CRISFLPLTRLRRTESVPSDINNPVDRAAEP,_TES(ph)VPSDINNPVDR_, , , , ,0.57, ,0.47,0.82, , , , ,-0.07, ,0.57,0.46,,,0.57,0.65,,,-0.07,0.52,,,TKL,,,,NA,NA,,Golgi apparatus,ATP binding,intracellular signal transduction,,
Q17RZ5,Q86UP2,Kinectin,KTN1,114.3,114.3,S79,KKEIQNGNLHESDSESVPRDFKLSDALAVED,_EIQNGNLHES(ph)DSES(ph)VPR_,0.35,0.35,0.39, ,-0.26,-0.3,-0.12,-0.24,0.24,0.21,-1.05, ,-0.15,0.01,0.01,-0.1,0.35,0.39,-0.28,-0.18,0.23,-1.05,-0.07,-0.04,, +,,,,,0,3,5.38,,,,,
Q17RZ5,Q86UP2,Kinectin,KTN1,357.71,357.08,S75,KKNKKKEIQNGNLHESDSESVPRDFKLSDAL,_EIQNGNLHES(ph)DS(ph)ESVPR_,-0.18,-0.16,-0.26,-0.23,0.11,-0.01,0.05,0.08,-0.13,-0.04,-0.08,-0.05,0.01,0,-0.01,-0.15,-0.17,-0.25,0.06,0.07,-0.08,-0.06,0.01,-0.08,,,,,,,0,0,,,,,,
Q17RZ5,Q86UP2,Kinectin,KTN1,240.49,239.8,S77,NKKKEIQNGNLHESDSESVPRDFKLSDALAV,_EIQNGNLHES(ph)DS(ph)ESVPR_,-0.05,0.08,-0.39,-0.2,0.05,-0.03,0.25,0.04,0.2,0.25,0.08,0.13,0.18,0.33,0.06,0.3,0.02,-0.29,0.01,0.15,0.23,0.11,0.25,0.19,,,,,,,0,0,,,,,,
Q17RZ5,Q86UP2,Kinectin,KTN1,125.15,110.63,S1313,VKAAGDTTVIENSDVSPETESSEKETMSVSL,_AAGDTTVIENSDVS(ph)PETESSEK_, , , ,-0.55,-0.25, ,0.09,-0.13,0.29, , ,0.07,-0.34, ,-0.08,-0.12,,-0.55,-0.25,-0.01,0.29,0.07,-0.34,-0.1,,,,,,,NA,0,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,98.89,97.74,S1190,ETFGEYSDNEEKAFGSSQPSLNGDIKPLGSD,_AFGS(ph)S(ph)QPS(ph)LNGDIK_, , , , ,0.08,0.14,0.42,0.6, , , , ,-0.58,-0.49,-0.21,-0.05,,,0.11,0.51,,,-0.53,-0.13,,,,,,,NA,NA,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,85.17,82.85,S1191,TFGEYSDNEEKAFGSSQPSLNGDIKPLGSDD,_AFGS(ph)S(ph)QPS(ph)LNGDIK_, , , , , , ,0.62,0.49, , , , , , ,0.04,0.04,,,,0.56,,,,0.04,,,,,,,NA,NA,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,98.89,97.74,S1194,EYSDNEEKAFGSSQPSLNGDIKPLGSDDSLA,_AFGS(ph)S(ph)QPS(ph)LNGDIK_, , , , ,0.08,0.14,0.42,0.6, , , , ,-0.58,-0.49,-0.21,-0.05,,,0.11,0.51,,,-0.53,-0.13,,,,,,,NA,NA,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,223.87,223.3,S1243,QYSGKKEKEAAGGNDSSGATSPINPAVALE_,_EAAGGNDS(ph)S(ph)GATSPINPAVALE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,183.91,180.67,S1244,YSGKKEKEAAGGNDSSGATSPINPAVALE__,_EAAGGNDS(ph)S(ph)GATSPINPAVALE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
G3XAF4,P32004,Neural cell adhesion molecule L1,L1CAM,130.69,118.02,S1248,KEKEAAGGNDSSGATSPINPAVALE______,_EAAGGNDS(ph)SGATS(ph)PINPAVALE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q969R5,Q969R5,Lethal(3)malignant brain tumor-like protein 2,L3MBTL2,85.18,80.8,S689,VKEEHLDVASPDKASSPELPVSVENIKQETD,_ASS(ph)PELPVSVENIK_, ,0.58, ,0.33,-0.73,-0.17,-0.06,0.2, ,0.06, ,-0.18,-0.4,0.03,0.22,-0.1,0.58,0.33,-0.43,0.08,0.06,-0.18,-0.17,0.07,,,,,,,0,0,,nucleus,methylated histone residue binding,chromatin modification,,
Q6IAA8,Q6IAA8,Ragulator complex protein LAMTOR1,LAMTOR1,146.96,145.29,S27,SDQDREERKLLLDPSSPPTKALNGAEPNYHS,_LLLDPSS(ph)PPTK_,-0.19,-0.21,-0.23,-0.13, ,-0.55,-0.24,-0.31,-0.29,-0.29,-0.18,-0.18, ,-0.15,0,-0.04,-0.2,-0.18,-0.55,-0.28,-0.29,-0.18,-0.15,-0.02,,,,,,,0,0,,Golgi apparatus,,cell growth,,
Q86VI4-2,Q86VI4,Lysosomal-associated transmembrane protein 4B,LAPTM4B,112.41,109.8,Y367,DDATVNGAAKEPPPPYVSA____________,_EPPPPY(ph)VSA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endomembrane system,,transport,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,194.32,194.32,S766,ANKLFGAPEPSTIARSLPTTVPESPNYRNTR,_S(ph)LPTTVPES(ph)PNYR_,0.12,0.24,0.11,0.26,1.19,1.35,1.21,1.12,0.12,0.12,0.12,0.16,0.88,0.97,0.61,0.58,0.18,0.19,1.27,1.17,0.12,0.14,0.93,0.6, +,,,,,,2,0,27.16,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,256.72,256.72,S90,SPRPLQLPGAEGPAISDGEEGGGEPGAGGGA,_ESPRPLQLPGAEGPAIS(ph)DGEEGGGEPGAGGGAAGAAGAGRR_,0.24,0.35,0.24,0.48,0.63,0.15,0.07,0.36,-0.18,0.09,-0.12,-0.09,0.1,-0.4,-0.17,-0.07,0.29,0.37,0.41,0.22,-0.04,-0.11,-0.13,-0.12,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,112.9,112.49,S143,TKNALPPVLTTVNGQSPPEHSAPAKVVRAAV,_NALPPVLTTVNGQS(ph)PPEHSAPAK_,-0.03,0.01,-0.07,-0.08,-0.18,-0.02, ,0.07,0.06,-0.07,-0.13,-0.03,-0.47,0.22, ,0.03,-0.01,-0.08,-0.1,0.07,0,-0.08,-0.09,0.03,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,411.33,411.33,S627,EMEQMDGRKNTFTAWSDEESDYEIDDRDVNK,_NTFTAWS(ph)DEES(ph)DYEIDDRDVNK_,0.27,0.25,-0.16,-0.15,0,-0.19,-0.16,0.02,0.24,0.26,-0.06,0.03,0,-0.33,0.12,0.11,0.26,-0.16,-0.09,-0.07,0.25,-0.02,-0.16,0.12,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,411.33,411.33,S631,MDGRKNTFTAWSDEESDYEIDDRDVNKILIV,_NTFTAWS(ph)DEES(ph)DYEIDDRDVNK_,0.07,0.02,0.05,0.1,0.12,0.13,0.15,0.08,-0.2,-0.14,-0.19,-0.15,0.01,0,0,-0.04,0.04,0.08,0.13,0.12,-0.17,-0.17,0,-0.02,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,57.34,56.82,S517,CPEFVPRQHYQKETESAPGSPRAVTPVPTKT,_ETES(ph)APGS(ph)PR_, , , , , ,-0.33, ,-0.17, , , , , ,0.05, ,0.06,,,-0.33,-0.17,,,0.05,0.06,,,,,,,NA,NA,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,57.34,56.82,S521,VPRQHYQKETESAPGSPRAVTPVPTKTEEVS,_ETES(ph)APGS(ph)PR_, , , , , ,-0.33, ,-0.17, , , , , ,0.05, ,0.06,,,-0.33,-0.17,,,0.05,0.06,,,,,,,NA,NA,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,220.49,220.49,S774,EPSTIARSLPTTVPESPNYRNTRTPRTPRTP,_S(ph)LPTTVPES(ph)PNYR_,0.03,0.08,0.08,0.1,-0.57,-0.49,-0.28,-0.27,-0.01,0.01,-0.1,-0.04,-0.07,-0.3,-0.31,-0.24,0.05,0.09,-0.53,-0.27,0,-0.07,-0.18,-0.28,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,128.38,128.38,T526,YQKETESAPGSPRAVTPVPTKTEEVSNLKTL,_AVT(ph)PVPTKTEEVSNLK_,-0.63,-0.35,-0.24,-0.14, ,-0.33, ,0.46,-0.62,-0.52,-0.34,-0.53, ,0.05, ,0.23,-0.48,-0.19,-0.33,0.46,-0.57,-0.43,0.05,0.23,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,102.65,102.65,T770,FGAPEPSTIARSLPTTVPESPNYRNTRTPRT,_SLPTT(ph)VPESPNYR_, , , , , ,-0.48, , , , , , , ,-0.37, , ,,,-0.48,,,,-0.37,,,,,,,,NA,NA,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,143.14,138.47,S546,KTEEVSNLKTLPKGLSASLPDLDSENWIEVK,_GLS(ph)ASLPDLDSENWIEVK_, , , , , ,0.34, , , , , , , ,0.28, , ,,,0.34,,,,0.28,,,,,,,,NA,NA,,,RNA binding,positive regulation of macroautophagy,,
Q6PKG0,Q6PKG0,La-related protein 1,LARP1,253.21,231.26,S548,EEVSNLKTLPKGLSASLPDLDSENWIEVKKR,_GLSAS(ph)LPDLDSENWIEVK_,-0.04,-0.17,0.92,0.02,0.2,0.11,0.26,0.18,0.1,0.04,0.18,0.17,0.13,0.07,0.24,0.28,-0.1,0.54,0.16,0.22,0.07,0.18,0.1,0.26,,,,,,,0,0,,,RNA binding,positive regulation of macroautophagy,,
Q659C4-9,Q659C4,La-related protein 1B,LARP1B,88.53,87.96,S432,EEIEQIGRKNTFTDWSDNDSDYEIDDQDLNK,_NTFTDWS(ph)DNDS(ph)DYEIDDQDLNK_, , , , ,-0.67,-0.02,0, , , , , ,-1.14,0.21,-0.34, ,,,-0.31,0,,,-0.31,-0.34,,,,,,,NA,NA,,,RNA binding,,,
Q659C4-9,Q659C4,La-related protein 1B,LARP1B,88.53,87.96,S436,QIGRKNTFTDWSDNDSDYEIDDQDLNKILIV,_NTFTDWS(ph)DNDS(ph)DYEIDDQDLNK_, , , , ,-0.67,-0.02,0, , , , , ,-1.14,0.21,-0.34, ,,,-0.31,0,,,-0.31,-0.34,,,,,,,NA,NA,,,RNA binding,,,
H0Y641,Q92615,La-related protein 4B,LARP4B,117.8,97.07,S601,VPASCAVSATYERSPSPAHLPDDPKVAEKQR,_SPS(ph)PAHLPDDPK_,0.03,0.05,-0.36,-0.37,0.02, ,0.19,0.16,0.09,-0.1,-0.08,-0.05,-0.12, ,0.02,-0.01,0.04,-0.36,0.02,0.17,0,-0.07,-0.12,0.01,,,,,,,0,0,,,,,,
Q9BRS8,Q9BRS8,La-related protein 6,LARP6,158.31,158.31,S447,WVRRRRQAEMGTQEKSPGTSPLLSRKMQTAD,_S(ph)PGTS(ph)PLLSR_, , , , ,-1.04,-1.1,-0.62,-0.61, , , , ,-1.23,-1.23,-0.71,-0.89,,,-1.07,-0.62,,,-1.23,-0.8, +, +,,,,,NA,NA,,Golgi apparatus,nucleotide binding,regulation of translation,,
Q9BRS8,Q9BRS8,La-related protein 6,LARP6,158.31,158.31,S451,RRQAEMGTQEKSPGTSPLLSRKMQTADGLPV,_S(ph)PGTS(ph)PLLSR_, , , , ,-1.04,-1.1,-0.62,-0.61, , , , ,-1.23,-1.23,-0.71,-0.89,,,-1.07,-0.62,,,-1.23,-0.8, +, +,,,,,NA,NA,,Golgi apparatus,nucleotide binding,regulation of translation,,
Q9BRS8,Q9BRS8,La-related protein 6,LARP6,136.64,134.64,S56,RGAGDPARYLSPGWGSASEEEPSRGHSGTTA,_YLSPGWGS(ph)AS(ph)EEEPSR_,0.17,0.06,0.38,0.15,-1.03,-0.87,-0.94,-0.86,-0.2,-0.37,-0.58,-0.31,-0.7,-0.71,-0.82,-0.81,0.12,0.27,-0.95,-0.9,-0.28,-0.44,-0.71,-0.82,,,,,,,0,0,,Golgi apparatus,nucleotide binding,regulation of translation,,
Q9BRS8,Q9BRS8,La-related protein 6,LARP6,136.64,134.64,S58,AGDPARYLSPGWGSASEEEPSRGHSGTTASG,_YLSPGWGS(ph)AS(ph)EEEPSR_,0.17,0.06,0.38,0.15,-1.03,-0.87,-0.94,-0.86,-0.2,-0.37,-0.58,-0.31,-0.7,-0.71,-0.82,-0.81,0.12,0.27,-0.95,-0.9,-0.28,-0.44,-0.71,-0.82,,,,,,,0,0,,Golgi apparatus,nucleotide binding,regulation of translation,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,158.52,156.77,S298,EASSLPEVRTGKRKRSSSEDAESLAPRSKVK,_KRS(ph)S(ph)SEDAESLAPR_, , , , ,1.41,0.78,2.85,2.87, , , , ,1.46,0.98,2.79,2.81,,,1.13,2.86,,,1.24,2.8, +, +,,,,,NA,NA,,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,158.52,156.77,S299,ASSLPEVRTGKRKRSSSEDAESLAPRSKVKK,_SS(ph)SEDAESLAPR_, ,0.15,2.03,2.01,4.01,0.78,1.66,1.74, ,0.56,1.83,1.81,3.99,1.2,1.52,1.78,0.15,2.02,3.16,1.7,0.56,1.82,3.18,1.66, +, +,,,,,1,1,46.18,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,138.81,121.68,S300,SSLPEVRTGKRKRSSSEDAESLAPRSKVKKI,_S(ph)SS(ph)EDAESLAPR_,0, , , ,4.22,0.78,2.85,2.87,0.36, , , ,4.18,1.2,2.79,2.81,0,,3.35,2.86,0.36,,3.36,2.8, +, +,,,,,NA,NA,,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,113.25,113.25,S337,KEASEASKENRDIEISTEEEKDTGDLKDSSL,_DIEIS(ph)T(ph)EEEK_,0.15,0.17,0.11,0.93,-0.65,-0.1,0.03,0.05,0.18,0.12,0.05,-0.06,0.12,-0.18,-0.62,0.13,0.16,0.58,-0.35,0.04,0.15,0,-0.02,-0.2,,,,,,,0,0,,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,113.25,113.25,T338,EASEASKENRDIEISTEEEKDTGDLKDSSLL,_DIEIS(ph)T(ph)EEEK_,0.15,0.17,0.11,0.16,-0.65,-0.02,0,0.05,0.18,0.12,0.05,0.08,0.12,0.16,0.16,0.13,0.16,0.14,-0.3,0.03,0.15,0.06,0.14,0.14,,,,,,,0,0,,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,241.7,241.7,S258,TSNTSISKMKRSRPTSEGSDIESTEPQKQCS,_SRPTS(ph)EGS(ph)DIESTEPQK_,0.16,0.26,0.59,0.43,0.3,0.33,0.34,0.42,-0.13,-0.03,0.38,0.53,0.38,0.4,0.24,0.19,0.21,0.51,0.32,0.38,-0.08,0.46,0.39,0.22,,,,,,,0,0,,cytoplasm,nucleotide binding,RNA processing,,
Q4G0J3,Q4G0J3,La-related protein 7,LARP7,241.7,241.7,S261,TSISKMKRSRPTSEGSDIESTEPQKQCSKKK,_SRPTS(ph)EGS(ph)DIESTEPQK_,0.02,0.12,0.52,0.07,0.23,0.4,0.34,0.39,-0.47,-0.16,0.32,-0.15,0.27,0.41,0.24,0.22,0.07,0.31,0.31,0.37,-0.31,0.1,0.34,0.23,,,,,,,0,0,,cytoplasm,nucleotide binding,RNA processing,,
Q9Y4W2-2,Q9Y4W2,Ribosomal biogenesis protein LAS1L,LAS1L,126.52,122.65,S560,SFGSEAKAQQQEEQGSVNDVKEEEKEEKEVL,_AQQQEEQGS(ph)VNDVKEEEK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,rRNA processing,,
Q9Y4W2-2,Q9Y4W2,Ribosomal biogenesis protein LAS1L,LAS1L,213.71,212.09,S617,EEDRMEVGPFSTGQESPTAENARLLAQKRGA,_MEVGPFSTGQES(ph)PTAENAR_,-0.01,0.39,0.29, ,0.44, ,-0.09,-0.16,0.02,0.36,0.23, ,0.32, ,-0.06,-0.23,0.21,0.29,0.44,-0.12,0.2,0.23,0.32,-0.14,,,,,,,0,0,,cytoplasm,,rRNA processing,,
Q14847,Q14847,LIM and SH3 domain protein 1,LASP1,138.28,138.28,Y171,LEQQQPHHIPTSAPVYQQPQQQPVAQSYGGY,_RPLEQQQPHHIPTSAPVY(ph)QQPQQQPVAQSYGGYK_,0.37, ,-0.1, , , , ,-0.21,0.47, ,0.13, , , , ,0,0.37,-0.1,,-0.21,0.47,0.13,,0,,,,,,,NA,NA,,cortical actin cytoskeleton,ion transmembrane transporter activity,,,
Q14847,Q14847,LIM and SH3 domain protein 1,LASP1,177.38,175.56,S146,MGPSGGEGMEPERRDSQDGSSYRRPLEQQQP,_MGPSGGEGMEPERRDS(ph)QDGSSYR_,-0.52,-0.87,-0.19,-0.19, ,0.61,0.18, ,-0.46,-0.44,0.24,0.39, ,0.14,0.07, ,-0.68,-0.19,0.61,0.18,-0.45,0.32,0.14,0.07,,,,,,,0,0,,cortical actin cytoskeleton,ion transmembrane transporter activity,,,
Q14847,Q14847,LIM and SH3 domain protein 1,LASP1,135.24,134.45,T63,EKKPYCNAHYPKQSFTMVADTPENLRLKQQS,_QSFT(ph)MVADTPENLR_, , , , ,-0.65, , ,-0.38, , , , ,-0.47, , ,-0.63,,,-0.65,-0.38,,,-0.47,-0.63,,,,,,,NA,NA,,cortical actin cytoskeleton,ion transmembrane transporter activity,,,
Q14847,Q14847,LIM and SH3 domain protein 1,LASP1,157.58,155.73,T68,CNAHYPKQSFTMVADTPENLRLKQQSELQSQ,_(gl)QSFTMVADT(ph)PENLR_, , , , ,-0.65,-0.23,0.01,-0.27, , , , ,-0.63,-0.44,-0.6,-0.53,,,-0.43,-0.13,,,-0.53,-0.56,,,,,,,NA,NA,,cortical actin cytoskeleton,ion transmembrane transporter activity,,,
Q14847,Q14847,LIM and SH3 domain protein 1,LASP1,140.8,132.51,T104,EFEKNKGKGFSVVADTPELQRIKKTQDQISN,_GFSVVADT(ph)PELQR_, , , , ,-0.2,-0.04,-0.07,-0.02, , , , ,-0.76,-0.89,-0.55,-0.59,,,-0.12,-0.05,,,-0.82,-0.57,,,,,,,NA,NA,,cortical actin cytoskeleton,ion transmembrane transporter activity,,,
O95835,O95835,Serine/threonine-protein kinase LATS1,LATS1,165.02,162.23,S464,HEIPTWQPNIPVRSNSFNNPLGNRASHSANS,_SNS(ph)FNNPLGNR_,0.3,0.15,-0.56,-0.14,-0.06,-0.15,1.73,-0.1,0.68,0.39,0.18,-0.33,0.1,-0.3,0.08,-0.07,0.22,-0.34,-0.1,1.09,0.54,-0.06,-0.09,0.01, +,,AGC,,,,2,0,0.99,cytosol,ATP binding,cell division,,
B5MBX5,Q53QV2,Protein LBH,LBH,175.43,175.43,S63,PSDFDRCCKLKDRLPSIVVEPTEGEVESGEL,_DRLPS(ph)IVVEPTEGEVESGELR_,0.18,0.27,1.26,0.83, , , , ,0.74,1.01,2.73,2.67, , , , ,0.23,1.06,,,0.88,2.7,,, +, +,,,,,NA,NA,,nucleolus,,"positive regulation of transcription, DNA-dependent",,
Q14739,Q14739,Lamin-B receptor,LBR,160.63,119.23,S99,SRSPGRPPKSARRSASASHQADIKEARREVE,_SAS(ph)ASHQADIK_,0.54,0.48,0.55,0.81,0.3,0.36,0.33,0.4,0.4,0.41,0.48,0.66,0.12,0.38,0.26,0.15,0.51,0.69,0.33,0.37,0.4,0.57,0.26,0.2,,,,,,,0,0,,integral to nuclear inner membrane,DNA binding,cholesterol biosynthetic process,,
P07947,P06239,Tyrosine-protein kinase Lck,LCK,146.11,144.86,Y394,KIADFGLARLIEDNEYTAREGAKFPIKWTAP,_LIEDNEY(ph)TAR_,0.72,0.62,0.21, ,-0.19,-0.16,-0.49,-0.49,0.49,0.47,-0.08, ,0.16,0.34,-0.09,-0.1,0.67,0.21,-0.18,-0.49,0.48,-0.08,0.25,-0.09,,,Tyr,,,,0,0,,cytosol,ATP binding,blood coagulation,,
P00338,P00338,L-lactate dehydrogenase A chain,LDHA,89.3,70.17,Y239,KEQWKEVHKQVVESAYEVIKLKGYTSWAIGL,_QVVESAY(ph)EVIK_,-0.19, ,-0.37, ,-0.24,-0.09, ,0.3,-0.04, ,-0.18, ,-0.3,-0.08, ,0.04,-0.19,-0.37,-0.16,0.3,-0.04,-0.18,-0.19,0.04,,,,,,,0,0,,cytosol,L-lactate dehydrogenase activity,cellular carbohydrate metabolic process,,
P07195,P07195,L-lactate dehydrogenase B chain,LDHB,73.44,68.14,Y240,SENWKEVHKMVVESAYEVIKLKGYTNWAIGL,_MVVESAY(ph)EVIK_,-0.16, ,-0.06, ,0.06,0.06,-0.02,0.13,-0.09, ,0, ,-0.09,0.02,0.06,0.08,-0.16,-0.06,0.06,0.06,-0.09,0,-0.03,0.07,,,,,,,0,0,,cytosol,L-lactate dehydrogenase activity,cellular carbohydrate metabolic process,,
B4DJZ8,P01130,Low-density lipoprotein receptor,LDLR,252.77,250.9,Y845,KTTEDEVHICHNQDGYSYPSRQMVSLEDDVA,_TTEDEVHICHNQDGY(ph)S(ph)YPSR_, , ,1.87, , , , , , , ,0.77, , , , , ,,1.87,,,,0.77,,, +,,,,,,NA,NA,,,,,,
B4DJZ8,P01130,Low-density lipoprotein receptor,LDLR,80.14,79.38,Y847,TEDEVHICHNQDGYSYPSRQMVSLEDDVA__,_TTEDEVHICHNQDGY(ph)SY(ph)PSR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B4DJZ8,P01130,Low-density lipoprotein receptor,LDLR,252.77,250.9,S846,TTEDEVHICHNQDGYSYPSRQMVSLEDDVA_,_TTEDEVHICHNQDGY(ph)S(ph)YPSR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B4DJZ8,P01130,Low-density lipoprotein receptor,LDLR,108.66,83.73,Y828,WRLKNINSINFDNPVYQKTTEDEVHICHNQD,_NINSINFDNPVY(ph)QK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
A8MS91,Q8NC56,LEM domain-containing protein 2,LEMD2,177.49,177.49,S138,PARPAQLRRRASVRGSSEEDEDARTPDRATQ,_ASVRGS(ph)S(ph)EEDEDARTPDR_,-0.11,0.4,-0.27,0.1,-1.19,-1.39,-0.7, ,-0.12,-0.06,-0.42,-0.22,-1,-1.3,-0.81, ,0.17,-0.07,-1.28,-0.7,-0.09,-0.32,-1.14,-0.81, +, +,,,,,6,6,34.32,,,,,
A8MS91,Q8NC56,LEM domain-containing protein 2,LEMD2,177.49,177.49,S139,ARPAQLRRRASVRGSSEEDEDARTPDRATQG,_ASVRGS(ph)S(ph)EEDEDARTPDR_,-0.11,0.4,-0.27,0.1,-1.19,-1.39,-0.7, ,-0.12,-0.06,-0.42,-0.22,-1,-1.3,-0.81, ,0.17,-0.07,-1.28,-0.7,-0.09,-0.32,-1.14,-0.81, +, +,,,,,6,6,34.32,,,,,
A8MS91,Q8NC56,LEM domain-containing protein 2,LEMD2,95.98,86.98,S5,___________MAGLSDLELRRELQALGFQP,_(ac)AGLS(ph)DLELRR_,-0.01,0.26,0.06,-0.02, , , , ,-0.13,0.08,-0.12,0.87, , , , ,0.13,0.02,,,-0.02,0.46,,,,,,,,,NA,NA,,,,,,
A8MS91,Q8NC56,LEM domain-containing protein 2,LEMD2,80.41,80.41,S499,GEDMLVWRWTKPSSFSDSER___________,_WTKPSSFS(ph)DSER_,-0.32,-0.04,0.16,0.29,0.76,0.42,0.34, ,-0.26,-0.04,0.23,0.44,0.39,0.36,-0.06, ,-0.17,0.23,0.6,0.34,-0.15,0.34,0.38,-0.06,,,,,,,0,0,,,,,,
Q9Y2U8,Q9Y2U8,Inner nuclear membrane protein Man1,LEMD3,165.65,162.08,S259,VNGSRLVPYSCRENYSDSEEEDDDDVASSRQ,_ENYS(ph)DS(ph)EEEDDDDVASSR_,-0.2,-0.28,-0.36, ,-0.28,-0.18,-0.29,-0.23,-0.12,-0.12,0.49, ,-0.05,-0.03,-0.04,-0.05,-0.24,-0.36,-0.23,-0.26,-0.12,0.49,-0.04,-0.05,,,,,,,0,0,,integral to nuclear inner membrane,DNA binding,negative regulation of activin receptor signaling pathway,,
Q9Y2U8,Q9Y2U8,Inner nuclear membrane protein Man1,LEMD3,165.65,162.08,S261,GSRLVPYSCRENYSDSEEEDDDDVASSRQVL,_ENYS(ph)DS(ph)EEEDDDDVASSR_,-0.2,-0.28,-0.36, ,-0.28,-0.19,-0.42,0.03,-0.12,-0.12,0.49, ,-0.05,-1.16,0.04,0.11,-0.24,-0.36,-0.24,-0.18,-0.12,0.49,-0.5,0.08,,,,,,,0,0,,integral to nuclear inner membrane,DNA binding,negative regulation of activin receptor signaling pathway,,
Q9Y2U8,Q9Y2U8,Inner nuclear membrane protein Man1,LEMD3,116.94,116.16,S140,ASAAPAAGSKVLLGFSSDESDVEASPRDQAG,_VLLGFS(ph)S(ph)DESDVEASPR_,0.05,-0.42,-0.04, ,-0.35,-0.36, , ,-0.27,-0.28,-0.52, ,0.12,0.29, , ,-0.16,-0.04,-0.35,,-0.27,-0.52,0.21,,,,,,,,NA,NA,,integral to nuclear inner membrane,DNA binding,negative regulation of activin receptor signaling pathway,,
Q9Y2U8,Q9Y2U8,Inner nuclear membrane protein Man1,LEMD3,143.47,122.89,S141,SAAPAAGSKVLLGFSSDESDVEASPRDQAGG,_VLLGFS(ph)S(ph)DESDVEASPR_,0.05,-0.42,-0.04, ,-0.42,-0.29,-0.22,-0.15,-0.27,-0.28,-0.52, ,-0.09,0.09,0.08,0.16,-0.16,-0.04,-0.35,-0.19,-0.27,-0.52,0.01,0.12,,,,,,,0,0,,integral to nuclear inner membrane,DNA binding,negative regulation of activin receptor signaling pathway,,
Q9Y2U8,Q9Y2U8,Inner nuclear membrane protein Man1,LEMD3,143.47,122.89,S144,PAAGSKVLLGFSSDESDVEASPRDQAGGGGR,_VLLGFSS(ph)DES(ph)DVEASPR_, , , , ,-0.43,-0.29,-0.22,-0.67, , , , ,-0.13,-0.02,0.08,0.34,,,-0.36,-0.43,,,-0.07,0.21,,,,,,,NA,NA,,integral to nuclear inner membrane,DNA binding,negative regulation of activin receptor signaling pathway,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,161.51,161.51,S212,SDDERQQLSEEEKANSDDERPVASDNDDEKQ,_ANS(ph)DDERPVAS(ph)DNDDEK_,-0.88, ,-0.2, , ,-0.1,-0.02,-0.4,0.08, ,-0.06, , ,0.14,-0.12,-0.12,-0.88,-0.2,-0.1,-0.19,0.08,-0.06,0.14,-0.12,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,161.51,161.51,S220,SEEEKANSDDERPVASDNDDEKQNSDDEEQP,_ANS(ph)DDERPVAS(ph)DNDDEK_,-0.88, ,-0.2, , ,-0.1,-0.02,-0.4,0.08, ,-0.06, , ,0.14,-0.12,-0.12,-0.88,-0.2,-0.1,-0.19,0.08,-0.06,0.14,-0.12,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,188.07,179.95,S229,DERPVASDNDDEKQNSDDEEQPQLSDEEKMQ,_QNS(ph)DDEEQPQLS(ph)DEEK_,-0.25,-0.2,-0.25,-0.09,-0.3,-0.13,-0.13,-0.14,-0.28,-0.07,-0.37,-0.31,-0.23,0,0.03,-0.04,-0.22,-0.17,-0.21,-0.14,-0.17,-0.34,-0.11,-0.01,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,188.07,179.95,S238,DDEKQNSDDEEQPQLSDEEKMQNSDDERPQA,_QNS(ph)DDEEQPQLS(ph)DEEK_,-0.25,-0.2,-0.25,-0.09,-0.3,-0.13,-0.13,-0.14,-0.28,-0.07,-0.37,-0.31,-0.23,0,0.03,-0.04,-0.22,-0.17,-0.21,-0.14,-0.17,-0.34,-0.11,-0.01,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,241.6,226.71,S10,______MADMEDLFGSDADSEAERKDSDSGS,_(ac)ADMEDLFGS(ph)DADS(ph)EAER_, , , , ,-0.21,-0.22,-0.32,-0.22, , , , ,-0.08,-0.21,-0.17,-0.23,,,-0.22,-0.27,,,-0.14,-0.2,,,,,,,NA,NA,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,241.6,226.71,S14,__MADMEDLFGSDADSEAERKDSDSGSDSDS,_(ac)ADMEDLFGS(ph)DADS(ph)EAER_, , , , ,-0.21,-0.22,-0.32,-0.22, , , , ,-0.08,-0.21,-0.17,-0.23,,,-0.22,-0.27,,,-0.14,-0.2,,,,,,,NA,NA,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,206.61,206.61,S630,EEDKAQRLLKAKKLTSDEEGEPSGKRKAEDD,_KLTS(ph)DEEGEPSGK_,0.35,1.34,0.41, ,0.48,0.07, ,0.3,0.02,0.09,-0.12, ,0.4,0.08, ,0.18,0.93,0.41,0.29,0.3,0.05,-0.12,0.25,0.18,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,210.63,210.63,S294,SEDEVLRMKRKNAIASDSEADSDTEVPKDNS,_NAIAS(ph)DS(ph)EADS(ph)DTEVPK_,-0.14,0.18,0.09,-0.06,-0.19,0.09,-0.18,-0.2,-0.05,0.07,-0.04,0.05,0.36,0.47,0.07,0.08,0.03,0.02,-0.05,-0.19,0.01,0,0.42,0.08,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,210.63,210.63,S296,DEVLRMKRKNAIASDSEADSDTEVPKDNSGT,_NAIAS(ph)DS(ph)EADS(ph)DTEVPK_,-0.14,0.18,0.09,-0.06,-0.09,-0.17,-0.15,-0.18,-0.05,0.07,-0.04,0.05,-0.04,0.22,-0.01,-0.06,0.03,0.02,-0.13,-0.17,0.01,0,0.09,-0.04,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,210.63,210.63,S300,RMKRKNAIASDSEADSDTEVPKDNSGTMDLF,_KNAIAS(ph)DS(ph)EADS(ph)DTEVPK_,-0.14,0.18,0.09,-0.06,-0.19,-0.17,-0.18,-0.2,-0.05,0.07,-0.04,0.05,0.36,0.22,0.07,0.08,0.03,0.02,-0.18,-0.19,0.01,0,0.29,0.08,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,342.74,332.09,S658,EDDDKANKKHKKYVISDEEEEDDD_______,_YVIS(ph)DEEEEDDD_,-0.12,-0.11,-0.17,-0.04,0.09,0.47,0.1,-0.01,-0.13,-0.19,-0.18,-0.24,0.11,0.51,0.17,0.03,-0.11,-0.1,0.29,0.05,-0.16,-0.21,0.32,0.1,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,382.27,382.27,S197,DEKMQNTDDEERPQLSDDERQQLSEEEKANS,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,-0.02,0.17,0.13,0.01,-0.36,-0.31,-0.28,0.06,-0.15,-0.34,0.01,-0.38,-0.03,0,-0.44,-0.01,0.08,0.07,-0.33,-0.1,-0.24,-0.17,-0.02,-0.21,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,382.27,382.27,S205,DEERPQLSDDERQQLSEEEKANSDDERPVAS,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,-0.08,-0.09,-0.07,0.02,-0.08,0.42,-0.2,-0.3,-0.11,-0.29,-0.23,-0.03,-0.38,-0.55,-0.13,-0.39,-0.08,-0.03,0.19,-0.25,-0.2,-0.12,-0.46,-0.26,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,97.26,97.26,S273,HRHSDDEEEQDHKSESARGSDSEDEVLRMKR,_SES(ph)ARGS(ph)DS(ph)EDEVLR_, , , , , ,-0.23,-0.29,-0.45, , , , , ,-0.26,-0.47,-0.08,,,-0.23,-0.36,,,-0.26,-0.26,,,,,,,NA,NA,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,139.45,131.52,S277,DDEEEQDHKSESARGSDSEDEVLRMKRKNAI,_SES(ph)ARGS(ph)DS(ph)EDEVLR_,0.08,-0.04,0.02,0.03,-0.89,-0.71,-0.31,0.17,0.01,-0.24,-0.35,-0.09,-0.73,-0.32,-0.16,-0.14,0.02,0.02,-0.8,-0.05,-0.11,-0.22,-0.51,-0.15,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,139.45,131.52,S279,EEEQDHKSESARGSDSEDEVLRMKRKNAIAS,_SESARGS(ph)DS(ph)EDEVLR_,0.08,-0.04,0.02,0.03,-0.89,-0.71,-0.31,0.17,0.01,-0.24,-0.35,-0.09,-0.73,-0.32,-0.16,-0.14,0.02,0.02,-0.8,-0.05,-0.11,-0.22,-0.51,-0.15,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,117.22,117.22,S151,EKAHSDDEKWGREDKSDQSDDEKIQNSDDEE,_WGREDKS(ph)DQS(ph)DDEK_,0.16,-1.07,0.1, , ,-0.41, , ,0.27,0.25,0.07, , ,0.01, , ,-0.33,0.1,-0.41,,0.26,0.07,0.01,,,,,,,,NA,NA,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,117.22,117.22,S154,HSDDEKWGREDKSDQSDDEKIQNSDDEERAQ,_WGREDKS(ph)DQS(ph)DDEK_,0.16,-1.07,0.1, , ,-0.41, , ,0.27,0.25,0.07, , ,0.01, , ,-0.33,0.1,-0.41,,0.26,0.07,0.01,,,,,,,,NA,NA,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
Q8WVC0-2,Q8WVC0,RNA polymerase-associated protein LEO1,LEO1,382.27,382.27,T188,EDKLQNSDDDEKMQNTDDEERPQLSDDERQQ,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,0.03,-0.12,-0.3,0.01,-0.21,-0.13,-0.21,-0.2,0.06,-0.1,-0.19,-0.38,-0.16,0.08,-0.22,-0.23,-0.04,-0.14,-0.17,-0.21,-0.02,-0.28,-0.04,-0.22,,,,,,,0,0,,Cdc73/Paf1 complex,,endodermal cell fate commitment,,
P18858,P18858,DNA ligase 1,LIG1,234.21,233.18,S911,LYRKQSQIQNQQGEDSGSDPEDTY_______,_QSQIQNQQGEDS(ph)GS(ph)DPEDTY_, , , , ,0.27, , , , , , , ,-0.34, , , ,,,0.27,,,,-0.34,,,,,,,,NA,NA,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,234.21,233.18,S913,RKQSQIQNQQGEDSGSDPEDTY_________,_QSQIQNQQGEDS(ph)GS(ph)DPEDTY_, , , , ,0.27, , , , , , , ,-0.34, , , ,,,0.27,,,,-0.34,,,,,,,,NA,NA,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,264.59,264.59,S141,KQLPKRTIQEVLEEQSEDEDREAKRKKEEEE,_TIQEVLEEQS(ph)EDEDREAKR_,-0.1,-0.03,-0.38,-0.17,0.04,0.02,-0.09,0.2,0.03,0.13,0.16,0.23,-0.02,0,-0.09,0.14,-0.07,-0.27,0.03,0.06,0.08,0.2,-0.01,0.03,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,209.61,209.61,T183,EVATEKEGEDGDQPTTPPKPLKTSKAETPTE,_EGEDGDQPTT(ph)PPKPLK_,-0.11,-0.15,-0.24,-0.69,0.15,0.02,0.23,0.08,0.05,-0.05,0.07,-0.16,-0.06,0.09,-0.06,0.19,-0.13,-0.44,0.09,0.16,0,-0.04,0.02,0.07,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,195.97,187.63,S201,KPLKTSKAETPTESVSEPEVATKQELQEEEE,_AET(ph)PTESVS(ph)EPEVATK_, , , , ,-0.16,-0.26,-0.29,-0.34, , , , ,-0.11,-0.39,-0.27,-0.21,,,-0.21,-0.31,,,-0.24,-0.24,,,,,,,NA,NA,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,163.15,162.98,S47,EPPPKAALKEWNGVVSESDSPVKRPGRKAAR,_EWNGVVS(ph)ESDS(ph)PVK_, , , , ,-0.18, ,-0.05,-0.04, , , , ,0.29, ,-0.03,-0.07,,,-0.18,-0.04,,,0.29,-0.05,,,,,,,NA,NA,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,222.11,221.85,S51,KAALKEWNGVVSESDSPVKRPGRKAARVLGS,_EWNGVVSESDS(ph)PVK_,0.04,0.08,-0.29,-0.2,-0.2,-0.13,-0.09,0.15,0.5,0.61,0.42,0.66,-0.12,-0.2,-0.14,0.06,0.06,-0.25,-0.16,0.04,0.56,0.54,-0.16,-0.04,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,345.48,343.74,S66,SPVKRPGRKAARVLGSEGEEEDEALSPAKGQ,_VLGS(ph)EGEEEDEALS(ph)PAK_,-0.22,-0.24,-0.25,-0.21,0.39,0.13,0.25,0.01,0.11,0.18,0.16,0.2,0.37,0.12,-0.07,-0.15,-0.23,-0.23,0.27,0.13,0.14,0.18,0.25,-0.11,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,345.48,343.74,S76,ARVLGSEGEEEDEALSPAKGQKPALDCSQVS,_VLGS(ph)EGEEEDEALS(ph)PAK_,-0.31,-0.33,-0.61,-0.57,-0.24,-0.29,-0.22,-0.23,-0.13,-0.15,-0.2,-0.19,-0.45,-0.61,-0.18,-0.14,-0.32,-0.59,-0.26,-0.22,-0.14,-0.2,-0.52,-0.16,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P18858,P18858,DNA ligase 1,LIG1,231.21,228.55,T195,QPTTPPKPLKTSKAETPTESVSEPEVATKQE,_AET(ph)PTESVSEPEVATK_,-0.03,-0.05,-0.3,-0.18,-0.16,-0.08,0.06,-0.02,0.08,0.09,0.03,0.03,-0.21,-0.22,0.14,0.12,-0.04,-0.24,-0.12,0.02,0.08,0.03,-0.21,0.13,,,,,,,0,0,,chromosome,ATP binding,anatomical structure morphogenesis,,
P49916-2,P49916,DNA ligase 3,LIG3,187.71,187.71,S242,SGFSAKPNNSGEAPSSPTPKRSLSSSKCDPR,_FSGFSAKPNNSGEAPSS(ph)PTPK_, , ,0.56,0.53, , , , , , ,0.53,0.4, , , , ,,0.54,,,,0.47,,,,,,,,,NA,NA,,chromosome,ATP binding,base-excision repair,,
P49916-2,P49916,DNA ligase 3,LIG3,131.4,103.97,S210,KAVVQAKLTTTGQVTSPVKGASFVTSTNPRK,_LTTTGQVTS(ph)PVK_,0.12,0.31,0.33,0.47,0.7,0.95,1.12,0.54,0.17,0,0.25,0.26,0.46,0.69,0.33,0.2,0.22,0.4,0.83,0.86,0.08,0.26,0.58,0.27,,,,,,,0,0,,chromosome,ATP binding,base-excision repair,,
F8VS07,Q9UHB6,LIM domain and actin-binding protein 1,LIMA1,94.95,94.01,S692,ENLVENGADSDEDDNSFLKQQSPQEPKSLNW,_EGHSLEMENENLVENGADS(ph)DEDDNS(ph)FLK_, , , , ,-0.56, , ,-1.32, , , , ,-0.79, , ,-0.28,,,-0.56,-1.32,,,-0.79,-0.28, +,,,,,,NA,NA,,,zinc ion binding,,,
F8VS07,Q9UHB6,LIM domain and actin-binding protein 1,LIMA1,118.15,118.15,S490,LERPAQLANARETPHSPGVEDAPIAKVGVLA,_ETPHS(ph)PGVEDAPIAK_,-1.19,-1.09,-1.04,-0.95, ,-0.53,-0.61,-0.51,-0.57,-0.47,-0.16,-0.16, ,-0.02,0.4,0.33,-1.14,-1,-0.53,-0.56,-0.52,-0.16,-0.02,0.36, +,,,,,,3,0,12.2,,zinc ion binding,,,
F8VS07,Q9UHB6,LIM domain and actin-binding protein 1,LIMA1,118.51,91.74,S362,QVKSEVQQPVHPKPLSPDSRASSLSESSPPK,_SEVQQPVHPKPLS(ph)PDSR_,-0.01, ,-1.46, , , , , ,-0.8, ,-0.48, , , , , ,-0.01,-1.46,,,-0.8,-0.48,,, +,,,,,,NA,NA,,,zinc ion binding,,,
F8VS07,Q9UHB6,LIM domain and actin-binding protein 1,LIMA1,165,164.28,S686,SLEMENENLVENGADSDEDDNSFLKQQSPQE,_EGHSLEMENENLVENGADS(ph)DEDDNS(ph)FLK_, , , , ,-0.56, , ,-0.68, , , , ,-0.79, , ,-0.1,,,-0.56,-0.68,,,-0.79,-0.1,,,,,,,NA,NA,,,zinc ion binding,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,105.52,52.4,S377,DKWQDDLARWKSRRRSVSQDLIKKEEERKKM,_S(ph)VSQDLIK_, , ,2.97,4.79,1.08,1.76,1.97,2.34, , ,2.7,3.95,0.82,1.31,1.74,1.95,,4.15,1.46,2.17,,3.46,1.08,1.85, +, +,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,168.84,168.84,S297,APLRKKKAEREEYRKSWSTATSPLGGERPFR,_S(ph)WSTATS(ph)PLGGERPFR_, , ,1.74,1.69,2.33,2.47,2.21,1.83, , ,2.89,2.93,1.63,1.59,1.5,1.42,,1.72,2.4,2.03,,2.91,1.61,1.46, +, +,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,168.84,168.84,S303,KAEREEYRKSWSTATSPLGGERPFRYGPRTP,_SWSTATS(ph)PLGGERPFR_,-0.49,-0.03,0.12,1.2,0.94,-0.66,0.41,1.76,0.28,0.45,1.69,1.54,0.67,-0.1,0.51,1.41,-0.24,0.76,0.35,1.24,0.37,1.62,0.34,1.03, +, +,,,,,1,4,18.16,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,146.2,113.28,S875,LGNCQDEKQDRRWKKSFQGDDSDLLLKTRES,_S(ph)FQGDDSDLLLK_, , ,2.56,2.37,1.84,1.46,1.44,1.64, , ,3.23,2.75,2.05,1.63,1.92,1.99,,2.47,1.66,1.55,,3.01,1.85,1.96, +, +,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,78.41,76.54,S750,EANQLHLPNLNSQVDSPSSEKSPVMTPFKFW,_MPEANQLHLPNLNSQVDS(ph)PSSEK_, , ,2.28, , , , , , , ,1, , , , , ,,2.28,,,,1,,, +,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,90.16,90.16,S212,GRDDSFDSLDSFGSRSRQTPSPDVVLRGSSD,_S(ph)RQT(ph)PS(ph)PDVVLR_, , , , , , , ,-1.01, , , , , , , ,-0.18,,,,-1.01,,,,-0.18, +,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,157.53,142.14,S521,TIARASVLDTSMSAGSGSPSKTVTPKAVPML,_ASVLDTSM(ox)SAGS(ph)GSPSK_, , , ,-0.19,-0.39, ,-0.58, , , , ,-0.06,-0.4, ,-0.2, ,,-0.19,-0.39,-0.58,,-0.06,-0.4,-0.2,,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,196.14,179.77,S523,ARASVLDTSMSAGSGSPSKTVTPKAVPMLTP,_ASVLDTSM(ox)SAGSGS(ph)PSK_,0.02,-0.08,-0.22, ,-0.54,-0.69, ,-0.59,-0.05,-0.18,-0.28, ,-0.47,-0.43, ,-0.21,-0.03,-0.22,-0.61,-0.59,-0.12,-0.28,-0.45,-0.21,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,184.61,167.68,S718,GKVELVLSQKVVKPKSPEPEATLTFPFLDKM,_S(ph)PEPEATLTFPFLDK_,0.02,0.01,0.44,0.51,0.59,0.4,0.36,0.63,0.02,0.12,0.62,0.52,0.6,0.34,0.53,0.61,0.01,0.48,0.49,0.5,0.07,0.57,0.48,0.57,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,84.61,45.43,S601,LTKSQMFEGVARVHGSPLELKQDNGSIEINI,_VHGS(ph)PLELK_,-0.26,-0.5,-0.49,-0.4, , , , ,-0.11,-0.26,0.15,0.24, , , , ,-0.38,-0.44,,,-0.19,0.2,,,,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,208.07,184.62,S973,PKTLPLDKSINHQIESPSERRKSISGKKLCS,_SINHQIES(ph)PSER_,0.11,0.07,-0.49,-0.55,-0.48,-0.53,-0.78,-0.85,-0.05,-0.34,-0.55,-0.5,-0.62,-0.42,-0.5,-0.62,0.09,-0.52,-0.5,-0.82,-0.19,-0.52,-0.52,-0.56,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,86.19,84.88,S201,ERSDSLSPPRHGRDDSFDSLDSFGSRSRQTP,_DDS(ph)FDS(ph)LDS(ph)FGSR_,-0.01,-0.01,-0.04,0.01, , , , ,-0.65,-0.8,-0.66,-0.48, , , , ,-0.01,-0.02,,,-0.72,-0.57,,,,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,102.84,102.84,S204,DSLSPPRHGRDDSFDSLDSFGSRSRQTPSPD,_HGRDDS(ph)FDS(ph)LDS(ph)FGSR_,-0.01,-0.01,-0.04,0.01,-0.52,-0.68, ,-0.75,-0.65,-0.8,-0.66,-0.48,-0.22,-0.18, ,-0.09,-0.01,-0.02,-0.6,-0.75,-0.72,-0.57,-0.2,-0.09,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,97.71,96.09,S207,SPPRHGRDDSFDSLDSFGSRSRQTPSPDVVL,_DDSFDSLDS(ph)FGS(ph)R_,-0.01,-0.01,-0.04,0.01, ,-0.68,-0.55,-0.98,-0.65,-0.8,-0.66,-0.48, ,-0.18,0,-0.32,-0.01,-0.02,-0.68,-0.75,-0.72,-0.57,-0.18,-0.15,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,102.84,102.84,S210,RHGRDDSFDSLDSFGSRSRQTPSPDVVLRGS,_DDSFDSLDS(ph)FGS(ph)R_, , , , ,-0.52,-0.68,-0.55,-0.75, , , , ,-0.22,-0.18,0,-0.09,,,-0.6,-0.65,,,-0.2,-0.04,,,,,,,NA,NA,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,162.37,155.22,S217,FDSLDSFGSRSRQTPSPDVVLRGSSDGRGSD,_S(ph)RQT(ph)PS(ph)PDVVLR_,0.08,0.04,0.14,0.12,0.1,0.18,0.03,-0.01,0.03,0.05,0.06,0.02,0.17,0.23,0.15,0.17,0.06,0.13,0.14,0.01,0.04,0.04,0.2,0.16,,,,,,,0,0,,,,,,
E9PHM7,Q9UPQ0,LIM and calponin homology domains-containing protein 1,LIMCH1,162.37,155.22,T215,DSFDSLDSFGSRSRQTPSPDVVLRGSSDGRG,_S(ph)RQT(ph)PS(ph)PDVVLR_,0.12,-0.01,-0.02,-0.11,-0.56,-0.63,-0.72,-0.74,-0.23,-0.15,-0.33,-0.34,-0.43,-0.42,-0.36,-0.45,0.05,-0.07,-0.59,-0.73,-0.19,-0.34,-0.43,-0.41,,,,,,,0,0,,,,,,
Q6MZP7-3,Q6MZP7,Protein lin-54 homolog,LIN54,132.5,132.5,S310,STLNSTTQTPNKIAISPLKSPNKAVKSTVQT,_IAIS(ph)PLKS(ph)PNK_,0.35,0.09,0.24,-0.3,0.15,0.17,-0.16,0.5,0.09,0.09,0.22,-0.21,-0.05,0.06,0.27,0.46,0.22,-0.01,0.16,0.21,0.09,0.02,0.01,0.36,,,,,,,0,0,,nucleoplasm,DNA binding,mitotic cell cycle,,
Q6MZP7-3,Q6MZP7,Protein lin-54 homolog,LIN54,132.5,132.5,S314,STTQTPNKIAISPLKSPNKAVKSTVQTITVG,_IAIS(ph)PLKS(ph)PNK_,0.12,0.22,-0.29,-0.3,0.15,0.17,0.49,0.5,0.24,0.27,-0.44,-0.21,-0.05,0.06,0.13,0.46,0.17,-0.3,0.16,0.49,0.26,-0.32,0.01,0.3,,,,,,,0,0,,nucleoplasm,DNA binding,mitotic cell cycle,,
Q5TKA1-2,Q5TKA1,Protein lin-9 homolog,LIN9,80.05,49.47,S65,AVEMPFRNSKRSRLFSDEDDRQINTRSPKRN,_LFS(ph)DEDDRQINTR_, , ,-0.34,1.21, , , , , , ,-1.54,0.42, , , , ,,0.63,,,,-0.25,,,,,,,,,NA,NA,,nucleoplasm,,DNA replication,,
Q15334,Q15334,Lethal(2) giant larvae protein homolog 1,LLGL1,83.05,83.05,S659,LAMEGPLSRVKSLKKSLRQSFRRIRKSRVSG,_S(ph)LRQS(ph)FRR_,2.91,0.31,-0.07,0.22,0.31, ,0.18, ,0.32,0.21,-0.06,0.15,-0.02, ,0.07, ,2.13,0.09,0.31,0.18,0.27,0.05,-0.02,0.07, +,,,,,,5,0,20.09,axon,protein kinase binding,axonogenesis,,
Q15334,Q15334,Lethal(2) giant larvae protein homolog 1,LLGL1,83.05,83.05,S663,GPLSRVKSLKKSLRQSFRRIRKSRVSGKKRA,_S(ph)LRQS(ph)FRR_,2.91,0.31,-0.07,0.22,0.31, ,0.18, ,0.32,0.21,-0.06,0.15,-0.02, ,0.07, ,2.13,0.09,0.31,0.18,0.27,0.05,-0.02,0.07, +,,,,,,5,0,20.09,axon,protein kinase binding,axonogenesis,,
Q9NUN5-3,Q9NUN5,Probable lysosomal cobalamin transporter,LMBRD1,114.92,114.5,S528,CCKGKKSVIEGVDEDSDISDDEPSVYSA___,_SVIEGVDEDS(ph)DIS(ph)DDEPSVYSA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,cobalamin binding,transport,,
Q9NUN5-3,Q9NUN5,Probable lysosomal cobalamin transporter,LMBRD1,114.92,114.5,S531,GKKSVIEGVDEDSDISDDEPSVYSA______,_SVIEGVDEDS(ph)DIS(ph)DDEPSVYSA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,cobalamin binding,transport,,
P02545,P02545,Prelamin-A/C,LMNA,149,139.16,S404,LSPSPTSQRSRGRASSHSSQTQGGGSVTKKR,_ASS(ph)HSS(ph)QTQGGGSVTK_, , , , ,1.47,1.73,1.52, , , , , ,1.36,1.55,1.45, ,,,1.6,1.52,,,1.46,1.45, +, +,,,,,NA,NA,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,149,139.16,S407,SPTSQRSRGRASSHSSQTQGGGSVTKKRKLE,_ASS(ph)HSS(ph)QTQGGGSVTK_, , , , ,1.47,1.63,1.52, , , , , ,1.36,1.38,1.45, ,,,1.55,1.52,,,1.37,1.45, +, +,,,,,NA,NA,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,199.07,199.07,S392,RKLLEGEEERLRLSPSPTSQRSRGRASSHSS,_LSPS(ph)PTSQR_,-0.36,-0.2,-0.48,-0.4,-0.15,-0.08,-0.3,-0.32,-0.3,0.85,-0.49,0.76,1.02,2.01,0.62,-0.42,-0.28,-0.44,-0.12,-0.31,0.39,0.27,1.6,0.19,, +,,,,,0,2,7.47,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,226.56,225.73,S632,ASSVTVTRSYRSVGGSGGGSFGDNLVTRSYL,_SVGGS(ph)GGGS(ph)FGDNLVTR_,0.06,-0.01,-0.3,-0.11,-0.68,-0.56,-0.7,-0.59,0.3,-0.01,-0.14,-0.01,-0.6,-0.44,-0.24,-0.25,0.02,-0.2,-0.62,-0.65,0.15,-0.07,-0.52,-0.25,,,,,,,0,0,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,219.25,218.18,S636,TVTRSYRSVGGSGGGSFGDNLVTRSYLLGNS,_SVGGS(ph)GGGS(ph)FGDNLVTR_,-0.58,-0.29,-0.63,-0.37,-0.76,-0.94,-0.7,-0.79,-0.18,-0.07,-0.35,-0.37,-0.54,-0.66,-0.14,0.06,-0.43,-0.5,-0.85,-0.75,-0.12,-0.36,-0.59,-0.04,,,,,,,0,0,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,176.17,174.87,S18,TPSQRRATRSGAQASSTPLSPTRITRLQEKE,_SGAQASS(ph)TPLSPTR_,-0.14, , , , , , , ,-0.12, , , , , , , ,-0.14,,,,-0.12,,,,,,,,,,NA,NA,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,204.37,204.37,S22,RRATRSGAQASSTPLSPTRITRLQEKEDLQE,_SGAQASST(ph)PLS(ph)PTR_,-0.45,-0.31,0.12,0.12,0.03,0.1,-0.13,-0.4,-0.15,-0.12,0.55,0.55,0.52,0.51,-0.1,-0.2,-0.38,0.12,0.07,-0.26,-0.14,0.55,0.51,-0.15,,,,,,,0,0,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,181.63,180.64,T19,PSQRRATRSGAQASSTPLSPTRITRLQEKED,_SGAQASST(ph)PLS(ph)PTR_, , ,0.11, ,-0.54,-0.5,-0.38,-0.51, , ,0.61, ,-0.56,-0.4,-0.67,-0.93,,0.11,-0.52,-0.44,,0.61,-0.48,-0.79,,,,,,,NA,NA,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,248.81,240.89,S458,EEVDEEGKFVRLRNKSNEDQSMGNWQIKRQN,_S(ph)NEDQSMGNWQIK_,0.15, , , ,0.18,0.41,-0.28,0.2,-0.12, , , ,0.15,0.41,-0.18,-0.11,0.15,,0.3,-0.02,-0.12,,0.29,-0.15,,,,,,,NA,NA,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P02545,P02545,Prelamin-A/C,LMNA,199.07,199.07,S390,AYRKLLEGEEERLRLSPSPTSQRSRGRASSH,_LRLS(ph)PS(ph)PTSQR_,-0.17,-0.11,-0.24,-0.23,-0.15,-0.14,-0.2,-0.38,0.08,0.02,0.09,0.11,-0.32,-0.34,-0.31,-0.36,-0.14,-0.24,-0.15,-0.28,0.05,0.1,-0.33,-0.34,,,,,,,0,0,,cytosol,structural molecule activity,activation of signaling protein activity involved in unfolded protein response,+,
P20700,P20700,Lamin-B1,LMNB1,127.88,124.73,S23,PPRMGSRAGGPTTPLSPTRLSRLQEKEELRE,_AGGPTT(ph)PLS(ph)PTR_,0.07, ,-0.8,-0.01,-0.61,-2.74,-0.53,-0.59,-0.01, ,-0.28,0.04,-0.6,-2.51,-0.82,-0.65,0.07,-0.35,-1.32,-0.56,-0.01,-0.11,-1.26,-0.73, +, +,,,,,6,6,28.9,lamin filament,structural molecule activity,cellular component disassembly involved in execution phase of apoptosis,,
P20700,P20700,Lamin-B1,LMNB1,71.28,67.64,S210,ENRCQSLTEDLEFRKSMYEEEINETRRKHET,_S(ph)MYEEEINETR_, ,0.33,-0.11, , , , , , ,0.06,-0.15, , , , , ,0.33,-0.11,,,0.06,-0.15,,,,,,,,,NA,NA,,lamin filament,structural molecule activity,cellular component disassembly involved in execution phase of apoptosis,,
P20700,P20700,Lamin-B1,LMNB1,127.88,124.73,T20,TPVPPRMGSRAGGPTTPLSPTRLSRLQEKEE,_AGGPTT(ph)PLS(ph)PTR_,0.07, ,-0.17,-0.01,-0.61,-0.55,-0.62,-0.54,-0.01, ,0.1,0.04,-0.6,-0.53,-0.78,-0.73,0.07,-0.08,-0.58,-0.58,-0.01,0.07,-0.56,-0.75,,,,,,,0,0,,lamin filament,structural molecule activity,cellular component disassembly involved in execution phase of apoptosis,,
P20700,P20700,Lamin-B1,LMNB1,175.27,175.27,S391,AYRKLLEGEEERLKLSPSPSSRVTVSRASSS,_LKLS(ph)PS(ph)PSSR_,0.06,0.13,-0.04,0.03,0.2,0.31,-0.5,-0.01,0.11,0.14,0.02,0.06,0.13,0.17,-0.25,-0.12,0.09,0,0.26,-0.23,0.12,0.04,0.15,-0.18,,,,,,,0,0,,lamin filament,structural molecule activity,cellular component disassembly involved in execution phase of apoptosis,,
P20700,P20700,Lamin-B1,LMNB1,175.27,175.27,S393,RKLLEGEEERLKLSPSPSSRVTVSRASSSRS,_LKLS(ph)PS(ph)PSSR_,-0.09,-0.04,-0.11,-0.06,-0.19,-0.29,-0.52,-0.1,-0.09,-0.06,-0.03,0,0,-0.12,-0.26,-0.2,-0.07,-0.09,-0.24,-0.29,-0.07,-0.02,-0.06,-0.23,,,,,,,0,0,,lamin filament,structural molecule activity,cellular component disassembly involved in execution phase of apoptosis,,
Q03252,Q03252,Lamin-B2,LMNB2,122.56,110.83,S17,ATPLPGRAGGPATPLSPTRLSRLQEKEELRE,_AGGPAT(ph)PLS(ph)PTR_, , , , ,-0.51,-0.18,-0.13, , , , , ,-0.57,-0.4,-0.96, ,,,-0.34,-0.13,,,-0.48,-0.96,,,,,,,NA,NA,,intermediate filament,structural molecule activity,,,
Q03252,Q03252,Lamin-B2,LMNB2,117.18,96.21,T14,__MATPLPGRAGGPATPLSPTRLSRLQEKEE,_AGGPAT(ph)PLS(ph)PTR_, , , , ,-0.51,-0.18,-0.13, , , , , ,-0.57,-0.4,-0.96, ,,,-0.34,-0.13,,,-0.48,-0.96,,,,,,,NA,NA,,intermediate filament,structural molecule activity,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,153.41,153.41,S1510,NKEPVSLPGIMRRGESLDNLDSPRSNSWRQP,_RGES(ph)LDNLDSPR_,1.02,0.68,1.62,1.46,1.23,1.16,0.85,0.94,0.99,0.34,1.38,0.81,0.81,0.73,0.8,0.81,0.86,1.54,1.2,0.9,0.7,1.12,0.77,0.8, +, +,,,,,4,1,35.63,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,211.25,210.61,S988,QKEVAATEEDVTRLPSPTSPFSSLSQDQAAT,_EVAATEEDVTRLPS(ph)PTS(ph)PFSSLSQDQAATSK_, , , , ,0.75,1.09,1.09,1.11, , , , ,0.72,0.8,1.13,1.13,,,0.93,1.1,,,0.76,1.13, +, +,,,,,NA,NA,,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,145.71,144.08,S805,SQNQKSTVPSRRRMYSFDDVLEEGKRPPTMT,_MYS(ph)FDDVLEEGK_, , , , ,0.78,-0.29,1.02,1.26, , , , ,0.7,0.11,1.05,1.32,,,0.34,1.15,,,0.43,1.19, +, +,,,,,NA,NA,,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,161.68,159.96,S867,KREDRVTTEIQLPSQSPVEEQSPASLSSLRS,_VTTEIQLPSQS(ph)PVEEQSPASLSSLR_,-0.68,-0.41,0.41,0.34,0.39, , ,-0.56,-0.26,-0.14,0.67,0.59,0.43, , ,-0.52,-0.54,0.37,0.39,-0.56,-0.2,0.63,0.43,-0.52,,,,,,,0,0,,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,151.67,149.68,S873,TTEIQLPSQSPVEEQSPASLSSLRSRSTQME,_VTTEIQLPSQS(ph)PVEEQS(ph)PASLSSLR_, , , , ,-0.65, , ,-0.56, , , , , , , ,-0.52,,,-0.65,-0.56,,,,-0.52,,,,,,,NA,NA,,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,211.25,210.61,S991,VAATEEDVTRLPSPTSPFSSLSQDQAATSKA,_EVAATEEDVTRLPS(ph)PTS(ph)PFSSLSQDQAATSK_, , , , ,0.55,0.74,1.22,0.04, , , , ,0.72,0.77,1.02,0.66,,,0.65,0.75,,,0.75,0.85,,,,,,,NA,NA,,,zinc ion binding,,,
E9PMS6,Q8WWI1,LIM domain only protein 7,LMO7,89.68,89.68,T990,EVAATEEDVTRLPSPTSPFSSLSQDQAATSK,_LPS(ph)PT(ph)SPFSSLSQDQAATSK_, , , , ,0.24,0.63,0.75, , , , , ,0.62,0.65,0.9, ,,,0.45,0.75,,,0.64,0.9,,,,,,,NA,NA,,,zinc ion binding,,,
Q9C0E8-2,Q9C0E8,Protein lunapark,LNP,55.63,55.42,S177,PGQEIRQRTAAQRNLSPTPASPNQGPPPQVP,_NLS(ph)PTPAS(ph)PNQGPPPQVPVS(ph)PGPPK_, , , , ,-0.35, ,-0.18, , , , , ,-0.13, ,-0.43, ,,,-0.35,-0.18,,,-0.13,-0.43,,,,,,,NA,NA,,integral to membrane,,blood coagulation,,
Q9C0E8-2,Q9C0E8,Protein lunapark,LNP,55.63,55.42,S194,TPASPNQGPPPQVPVSPGPPKDSSAPGGPPE,_NLS(ph)PTPAS(ph)PNQGPPPQVPVS(ph)PGPPK_, , , , ,-0.35, ,-0.18, , , , , ,-0.13, ,-0.43, ,,,-0.35,-0.18,,,-0.13,-0.43,,,,,,,NA,NA,,integral to membrane,,blood coagulation,,
Q9UIQ6,Q9UIQ6,Leucyl-cystinyl aminopeptidase,LNPEP,131.56,104.28,Y46,AKEPCLHPLEPDEVEYEPRGSRLLVRGLGEH,_EPCLHPLEPDEVEY(ph)EPR_, , ,2.82, , , , , , , ,1.21, , , , , ,,2.82,,,,1.21,,, +, +,,,,,NA,NA,,cytoplasmic vesicle membrane,aminopeptidase activity,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",,
Q9UIQ6,Q9UIQ6,Leucyl-cystinyl aminopeptidase,LNPEP,173.28,172.31,Y70,VRGLGEHEMEEDEEDYESSAKLLGMSFMNRS,_GLGEHEMEEDEEDY(ph)ESSAK_, , ,2.02, , , , , , , ,-0.13, , , , , ,,2.02,,,,-0.13,,, +,,,,,,NA,NA,,cytoplasmic vesicle membrane,aminopeptidase activity,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",,
Q93052,Q93052,Lipoma-preferred partner,LPP,88.39,84.29,Y317,AAGPGYGGRNDSDPTYGQQGHPNTWKREPGY,_NDSDPTY(ph)GQQGHPNTWK_,1.03, ,-0.07, , , , , ,0.89, ,0.36, , , , , ,1.03,-0.07,,,0.89,0.36,,, +,,,,,,NA,NA,,cytoplasm,zinc ion binding,cell adhesion,,
Q93052,Q93052,Lipoma-preferred partner,LPP,60.81,60.65,Y273,VSGQCPPPSTRGGMDYAYIPPPGLQPEPGYG,_GGMDY(ph)AYIPPPGLQPEPGYGYAPNQGR_, , , , , , ,0.9,0.8, , , , , , ,0.61,0.74,,,,0.85,,,,0.68,,,,,,,NA,NA,,cytoplasm,zinc ion binding,cell adhesion,,
P50851-2,P50851,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,95.14,95.14,S10,______MASEDNRVPSPPPTGDDGGGGGREE,_(ac)ASEDNRVPS(ph)PPPTGDDGGGGGR_,0.09, ,0.45, ,0.05,-0.01,0.06,0.04,-0.43, ,-0.06, ,-0.12,0.37,0.19,0.15,0.09,0.45,0.02,0.05,-0.43,-0.06,0.14,0.17,,,,,,,0,0,,cytoplasmic membrane-bounded vesicle,,,,
P50851-2,P50851,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,133.77,123.78,S1118,EEEEDDDYVELKVEGSPTEEANLPTELQDNS,_VEGS(ph)PTEEANLPTELQDNSLSPAASEAGEK_, , , , ,0.21,0.04,-0.06,0.19, , , , ,-0.14,0.06,0.22,0.23,,,0.13,0.07,,,-0.04,0.22,,,,,,,NA,NA,,cytoplasmic membrane-bounded vesicle,,,,
P50851-2,P50851,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,76.46,75.36,S1133,SPTEEANLPTELQDNSLSPAASEAGEKLDMF,_VEGS(ph)PTEEANLPTELQDNS(ph)LS(ph)PAASEAGEK_, , , , ,-0.09,-0.39, ,-0.3, , , , ,-0.63,0.01, ,-0.16,,,-0.23,-0.3,,,-0.27,-0.16,,,,,,,NA,NA,,cytoplasmic membrane-bounded vesicle,,,,
P50851-2,P50851,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,157.61,150.38,S1135,TEEANLPTELQDNSLSPAASEAGEKLDMFGN,_VEGSPTEEANLPTELQDNSLS(ph)PAAS(ph)EAGEK_,-0.01, ,-0.35, ,-0.09,0.15,0.51,0.61,0.26, ,0, ,-0.63,0.23,0.24,0.67,-0.01,-0.35,0.04,0.56,0.26,0,-0.14,0.47,,,,,,,0,0,,cytoplasmic membrane-bounded vesicle,,,,
P50851-2,P50851,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,157.61,150.38,S1139,NLPTELQDNSLSPAASEAGEKLDMFGNDDKL,_VEGSPTEEANLPTELQDNSLS(ph)PAAS(ph)EAGEK_,-0.01, ,-0.35, ,-0.09,0.43,0.51,0.61,0.26, ,0, ,-0.63,0.23,0.24,0.65,-0.01,-0.35,0.19,0.56,0.26,0,-0.14,0.46,,,,,,,0,0,,cytoplasmic membrane-bounded vesicle,,,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,79.59,79.59,S1288,PQKPRTASRPDDIPDSPSSPKVALLPPVLKK,_TASRPDDIPDS(ph)PS(ph)SPK_, , , , ,1.01, ,1.33, , , , , ,1.23, ,1.6, ,,,1.01,1.33,,,1.23,1.6, +, +,,,,,NA,NA,,cytosol,,actin filament organization,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,79.59,79.59,S1291,PRTASRPDDIPDSPSSPKVALLPPVLKKVPS,_TASRPDDIPDS(ph)PSS(ph)PK_,-0.04,0.27,1.24, ,1.01, ,1.33, ,0.21,0.61,1.24, ,1.23, ,1.6, ,0.12,1.24,1.01,1.33,0.42,1.24,1.23,1.6, +, +,,,,,1,1,33.94,cytosol,,actin filament organization,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,129.9,129.9,S1094,KSERPPTILMTEEPSSPKGAVRSPPVDCPRK,_SERPPTILMTEEPSS(ph)PK_,0.2,0.06,0.92,0.8, ,0.93,0.67, ,0.32,0.25,1,0.75, ,1.38,1.17, ,0.13,0.86,0.93,0.67,0.29,0.88,1.38,1.17,, +,,,,,0,1,22.84,cytosol,,actin filament organization,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,126.55,126.55,S968,IEDPPFPSLRQEKRSSGFISELPSEEGKKLE,_RSS(ph)GFISELPSEEGK_,-0.11,0.08,-0.11,-0.28, ,-0.03,0.51,0.39,0.14,0.28,-0.39,0.04, ,0.06,0.25,0.31,-0.01,-0.19,-0.03,0.45,0.21,-0.16,0.06,0.28,,,,,,,0,0,,cytosol,,actin filament organization,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,214.54,209.68,S1331,PQPSPRTFSQEVSRRSWGQQAQEYQEQKQRS,_S(ph)WGQQAQEYQEQK_,-0.54,-0.3,-0.35,-0.13,0.35,0.96,0.26,0.18,0.07,0.14,0.25,0.13,0.62,0.69,0.37,0.33,-0.41,-0.24,0.68,0.22,0.1,0.19,0.66,0.35,,,,,,,0,0,,cytosol,,actin filament organization,,
Q5VZK9-2,Q5VZK9,Leucine-rich repeat-containing protein 16A,LRRC16A,108.4,78.01,T1228,LAEMKAKQENRFGLGTPEKNTKAEPKAEAGS,_FGLGT(ph)PEK_,-0.04,-0.19,-0.61, , , , , ,-0.02,0.38,-0.95, , , , , ,-0.11,-0.61,,,0.19,-0.95,,,,,,,,,NA,NA,,cytosol,,actin filament organization,,
Q8N1G4,Q8N1G4,Leucine-rich repeat-containing protein 47,LRRC47,231.2,231.05,S518,MAEMKKYTLENKEEGSLSDTEADAVSGQLPD,_EEGS(ph)LS(ph)DTEADAVSGQLPDPTTNPSAGK_,0.19, ,0.09, ,0.05,-0.02,0.14,0.13,0.12, ,0.15, ,-0.07,0.03,0.38,0.1,0.19,0.09,0.01,0.14,0.12,0.15,-0.02,0.25,,,,,,,0,0,,,phenylalanine-tRNA ligase activity,,,
Q8N1G4,Q8N1G4,Leucine-rich repeat-containing protein 47,LRRC47,167.06,165.42,S520,EMKKYTLENKEEGSLSDTEADAVSGQLPDPT,_EEGS(ph)LS(ph)DTEADAVSGQLPDPTTNPSAGK_, , , , ,0.25,0.21,-0.02,0.27, , , , ,0.1,0.1,0.04,0.23,,,0.23,0.13,,,0.1,0.14,,,,,,,NA,NA,,,phenylalanine-tRNA ligase activity,,,
Q8IWT6,Q8IWT6,Leucine-rich repeat-containing protein 8A,LRRC8A,138.55,138.55,S217,SEDVEATVPMLQRTKSRIEQGIVDRSETGVL,_S(ph)RIEQGIVDR_,0.22,0.29,0.45,0.17,0.44, ,0.41,0.07,0.46,0.38,0.59,0.28,0.17, ,0.62,0.24,0.25,0.32,0.44,0.25,0.42,0.44,0.17,0.44,,,,,,,0,0,,integral to membrane,,pre-B cell differentiation,,
Q9Y608,Q9Y608,Leucine-rich repeat flightless-interacting protein 2,LRRFIP2,124.17,121.9,S328,ASATTPLSGNSSRRGSGDTSSLIDPDTSLSE,_RGS(ph)GDTSSLIDPDTSLSELR_,3.13, ,2.38, ,0.73,1.04, , ,-0.04, ,0.35, ,0.37,0.51, , ,3.13,2.38,0.89,,-0.04,0.35,0.44,, +,,,,,,NA,NA,,,,Wnt receptor signaling pathway,,
Q9UFC0,Q9UFC0,Leucine-rich repeat and WD repeat-containing protein 1,LRWD1,131.02,131.02,S243,RLAALKRPDDVPLSLSPSKRACASPSAQVEG,_RPDDVPLSLS(ph)PSK_,0.52,0.39,0.31,0.14,0.28,0.17,0.51, ,0.18,0.16,0.08,0.27,0.16,-0.11,0.1, ,0.46,0.23,0.23,0.51,0.17,0.18,0.03,0.1,,,,,,,0,0,,centromeric heterochromatin,chromatin binding,chromatin modification,,
Q8ND56-2,Q8ND56,Protein LSM14 homolog A,LSM14A,119.52,119.52,S178,GSAFTQDTRSLKTQLSQGRSSPQLDPLRKSP,_TQLS(ph)QGRS(ph)SPQLDPLRK_,0.4, ,2.26, , ,0.92,0.93, ,0.62, ,2.95, , ,0.81,0.37, ,0.4,2.26,0.92,0.93,0.62,2.95,0.81,0.37, +, +,,,,,4,4,21.5,cytoplasmic mRNA processing body,,cytoplasmic mRNA processing body assembly,,
Q8ND56-2,Q8ND56,Protein LSM14 homolog A,LSM14A,134.21,134.21,S192,LSQGRSSPQLDPLRKSPTMEQAVQTASAHLP,_S(ph)PTMEQAVQTASAHLPAPAAVGR_, , , ,-0.01,0.05,0.22, , , , , ,0.45,-0.24,0.69, , ,,-0.01,0.14,,,0.45,0.3,,,,,,,,NA,NA,,cytoplasmic mRNA processing body,,cytoplasmic mRNA processing body assembly,,
Q8ND56-2,Q8ND56,Protein LSM14 homolog A,LSM14A,185.2,145.67,S216,TASAHLPAPAAVGRRSPVSTRPLPSASQKAG,_S(ph)PVSTRPLPSASQK_,0.06,0.02,-0.06,0.17,0.1,0.05,0.28,0.07,-0.02,-0.04,-0.09,-0.02,-0.07,-0.03,-0.01,0.12,0.04,0.06,0.08,0.18,-0.03,-0.05,-0.05,0.06,,,,,,,0,0,,cytoplasmic mRNA processing body,,cytoplasmic mRNA processing body assembly,,
Q8ND56-2,Q8ND56,Protein LSM14 homolog A,LSM14A,121.21,121.21,S183,QDTRSLKTQLSQGRSSPQLDPLRKSPTMEQA,_SS(ph)PQLDPLRK_,0.17,0.12,-0.1,-0.07,0.19,0.11,0.03,0.12,0.1,0.11,-0.21,-0.31,0.04,-0.06,0.1,0.09,0.15,-0.08,0.15,0.08,0.11,-0.26,-0.01,0.1,,,,,,,0,0,,cytoplasmic mRNA processing body,,cytoplasmic mRNA processing body assembly,,
B4DKL4,Q86X29,Lipolysis-stimulated lipoprotein receptor,LSR,120.32,120.32,S643,SQASRERRLKKNLALSRESLVV_________,_NLALS(ph)RES(ph)LVV_, ,-0.88, ,0.54,0.03,0.2,0.33,0.91, ,-1.05, ,-0.81,-1.21,-1.18,-0.17,-0.04,-0.88,0.54,0.12,0.65,-1.05,-0.81,-1.2,-0.1,, +,,,,,0,3,4.47,,,,,
B4DKL4,Q86X29,Lipolysis-stimulated lipoprotein receptor,LSR,120.32,120.32,S646,SRERRLKKNLALSRESLVV____________,_NLALS(ph)RES(ph)LVV_, , , , ,0.03,0.2,0.33,0.91, , , , ,-1.21,-1.18,-0.17,-0.04,,,0.12,0.65,,,-1.2,-0.1,, +,,,,,NA,NA,,,,,,
B4DKL4,Q86X29,Lipolysis-stimulated lipoprotein receptor,LSR,81.51,78.02,Y535,SRAYMPPRSRSRDDLYDQDDSRDFPRSRDPH,_SRDDLY(ph)DQDDSRDFPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,323.37,323.37,S182,ANKATGEEEGMDIQKSENEDDSEWEDVDDEK,_S(ph)ENEDDS(ph)EWEDVDDEK_,0.36,0.81, ,0.85,0.49,-0.07,-0.49,-0.39,-0.24,0.34, ,-0.11,0.32,0.23,0.08,0.06,0.6,0.85,0.24,-0.44,0.08,-0.11,0.27,0.07,,,,,,,0,0,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,323.37,323.37,S188,EEEGMDIQKSENEDDSEWEDVDDEKGDSNDD,_S(ph)ENEDDS(ph)EWEDVDDEK_,0.79,0.68,0.4,0.55,0.49,-0.16,-0.01,0.13,0.46,0.43,0.12,0.27,0.32,-0.14,0.28,0.28,0.73,0.48,0.2,0.06,0.44,0.2,0.11,0.28,,,,,,,0,0,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,111.78,109.39,S247,WSEETKSRFTEYSMTSSVMRRNEQLTLHDER,_FTEYSMTS(ph)S(ph)VMR_, , , , ,0.22,-0.02,0.95,0.65, , , , ,0.39,0,0.65,0.23,,,0.11,0.81,,,0.21,0.46,,,,,,,NA,NA,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,111.78,109.39,S248,SEETKSRFTEYSMTSSVMRRNEQLTLHDERF,_FTEYSMTS(ph)S(ph)VMR_, , , , ,0.22,-0.02,0.95,0.65, , , , ,0.39,0,0.65,0.23,,,0.11,0.81,,,0.21,0.46,,,,,,,NA,NA,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,71.45,69.73,S200,EDDSEWEDVDDEKGDSNDDYDSAGLLSDEDC,_GDS(ph)NDDYDS(ph)AGLLS(ph)DEDCMSVPGK_, , , , ,-0.73, , ,-0.41, , , , ,-0.16, , ,-0.01,,,-0.73,-0.41,,,-0.16,-0.01,,,,,,,NA,NA,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,71.45,69.73,S206,EDVDDEKGDSNDDYDSAGLLSDEDCMSVPGK,_GDS(ph)NDDYDS(ph)AGLLS(ph)DEDCMSVPGK_, , , , ,-0.73, , ,-0.41, , , , ,-0.16, , ,-0.01,,,-0.73,-0.41,,,-0.16,-0.01,,,,,,,NA,NA,,cytoplasm,,,,
Q96GA3,Q96GA3,Protein LTV1 homolog,LTV1,71.45,69.73,S211,EKGDSNDDYDSAGLLSDEDCMSVPGKTHRAI,_GDS(ph)NDDYDS(ph)AGLLS(ph)DEDCMSVPGK_, , , , ,-0.73, , ,-0.41, , , , ,-0.16, , ,-0.01,,,-0.73,-0.41,,,-0.16,-0.01,,,,,,,NA,NA,,cytoplasm,,,,
Q9Y383,Q9Y383,Putative RNA-binding protein Luc7-like 2,LUC7L2,120.49,75.95,S383,KRSYESANGRSEDRRSSEEREAGEI______,_S(ph)SEEREAGEI_,-1.8,-1.91,-0.59,-1.85, , ,-0.21,-0.36,-1.76,-1.88,-0.74,-1.87, , ,-0.44,0.87,-1.85,-1.09,,-0.28,-1.82,-1.2,,0.35, +, +,,,,,NA,NA,,nuclear speck,,,,
Q9Y383,Q9Y383,Putative RNA-binding protein Luc7-like 2,LUC7L2,170.47,170.47,S384,RSYESANGRSEDRRSSEEREAGEI_______,_RSS(ph)EEREAGEI_,0.12,0.31,0.05,0.1,-0.26, , , ,-0.04,-0.19,-0.26,-0.26,-0.35, , , ,0.22,0.08,-0.26,,-0.11,-0.26,-0.35,,,,,,,,NA,NA,,nuclear speck,,,,
O95232,O95232,Luc7-like protein 3,LUC7L3,275.43,275.16,S425,SDTKNEVNGTSEDIKSEGDTQSN________,_NEVNGTSEDIKS(ph)EGDTQS(ph)N_,-0.03,0.17,-0.04,0.33,-0.27,0.42,0.2,-0.02,-0.21,0.15,0.01,0.03,0.21,0.09,0.32,0.12,0.08,0.16,0.12,0.09,-0.02,0.02,0.15,0.22,,,,,,,0,0,,focal adhesion,DNA binding,apoptotic process,,
O95232,O95232,Luc7-like protein 3,LUC7L3,275.43,275.16,S431,VNGTSEDIKSEGDTQSN______________,_NEVNGTSEDIKS(ph)EGDTQS(ph)N_,-0.1, ,-0.23,-0.03,-0.22,-0.02,-0.18,0.08,0.18, ,-0.14,0.18,-0.15,0.13,-0.18,-0.1,-0.1,-0.13,-0.12,-0.05,0.18,0.03,0,-0.14,,,,,,,0,0,,focal adhesion,DNA binding,apoptotic process,,
Q86V48-2,Q86V48,Leucine zipper protein 1,LUZP1,146.15,144.84,S659,LRCRVIKSSGREKPDSDDDLDIASLVTAKLV,_EKPDS(ph)DDDLDIASLVTAK_,-0.36,0.64,-0.36,0.14,-0.21, ,0.19,0.11,-0.38,-0.45,-0.48,-0.45,-0.32, ,-0.21,0.19,0.23,-0.09,-0.21,0.15,-0.41,-0.46,-0.32,0.01,,,,,,,0,0,,nucleus,,artery development,,
P07948-2,P07948,Tyrosine-protein kinase Lyn,LYN,162.67,141.93,S13,___MGCIKSKGKDSLSDDGVDLKTQPVPESQ,_DSLS(ph)DDGVDLK_, , ,-2.94, ,-1.55,-0.43,-0.29,0.42, , ,-3.01, ,-1.53,-0.26,-0.24,0.34,,-2.94,-0.88,0.11,,-3.01,-0.76,0.08, +, +,Tyr,,,,NA,NA,,alpha2-beta1 integrin complex,ATP binding,apoptotic nuclear changes,,
P07948-2,P07948,Tyrosine-protein kinase Lyn,LYN,79.09,75.03,Y194,VIKHYKIRSLDNGGYYISPRITFPCISDMIK,_SLDNGGYY(ph)ISPR_, , , , , , ,0, , , , , , , ,0.66, ,,,,0,,,,0.66,,,Tyr,,,,NA,NA,,alpha2-beta1 integrin complex,ATP binding,apoptotic nuclear changes,,
P07948-2,P08631,Tyrosine-protein kinase Lyn,LYN,100.88,99.51,Y411,KIADFGLARVIEDNEYTAREGAKFPIKWTAP,_VIEDNEY(ph)TAR_,0.68, , , , , , , ,0.55, , , , , , , ,0.68,,,,0.55,,,,,,Tyr,,,,NA,NA,,alpha2-beta1 integrin complex,ATP binding,apoptotic nuclear changes,,
Q96S90-2,Q96S90,LysM and putative peptidoglycan-binding domain-containing protein 1,LYSMD1,217.01,208.88,S99,IPILTEPRDLFNGLDSEEEKDGEEKVHPSNS,_DLFNGLDS(ph)EEEK_,0.2,0.45,0.29,0.22,0.28,0.29,0.3,0.21,0.11,0.32,0.29,0.45,0.39,0.31,0.23,0.25,0.33,0.26,0.28,0.25,0.22,0.37,0.35,0.24,,,,,,,0,0,,,,cell wall macromolecule catabolic process,,
Q8IV50,Q8IV50,LysM and putative peptidoglycan-binding domain-containing protein 2,LYSMD2,80.31,63.64,S5,___________MADSSPALSLREGGPRAPRP,_(ac)ADSS(ph)PALSLR_, , ,-0.8, ,-1.16,-0.98,-0.82, , , ,-1.19, ,-1.18,-1.21,-1.08, ,,-0.8,-1.06,-0.82,,-1.19,-1.19,-1.08, +, +,,,,,NA,NA,,,,cell wall macromolecule catabolic process,,
Q8IV50,Q8IV50,LysM and putative peptidoglycan-binding domain-containing protein 2,LYSMD2,143.46,124.88,Y208,AAKKLKEESRDEESPYATSLYHS________,_LKEESRDEESPY(ph)ATSLYHS_,2.08, ,1.22, , , , , ,1.49, , , , , , , ,2.08,1.22,,,1.49,,,, +, +,,,,,NA,NA,,,,cell wall macromolecule catabolic process,,
Q9BRK4,Q9BRK4,Leucine zipper putative tumor suppressor 2,LZTS2,65.04,31.17,S570,SDEAKVQRAAAGVGGSLRAQVERLRVELQRE,_AAAGVGGS(ph)LR_, , , , , , ,-0.47,-0.47, , , , , , ,0.02,-0.1,,,,-0.47,,,,-0.04,,,,,,,NA,NA,,cytoplasm,,cell division,,
P20645,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,71.68,71.41,S267,PAAYRGVGDDQLGEESEERDDHLLPM_____,_GVGDDQLGEES(ph)EERDDHLLPM_,-0.31,-0.22,-0.13,-0.24, ,-0.22, , ,-0.16,0.11,0.04,-0.05, ,0, , ,-0.27,-0.18,-0.22,,-0.02,0,0,,,,,,,,NA,NA,,cell surface,mannose binding,endosome to lysosome transport,,
Q9UPN3,Q9UPN3,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5",MACF1,166.04,115.55,S4521,QAESNKAFLAELEQNSPKIQKVKEALAGLLV,_AFLAELEQNS(ph)PK_,-0.11,-0.08,-0.48,-0.59,-0.19,-0.68,-0.41,-0.44,0.15,0.02,-0.12,-0.03,0.15,0.14,-0.21,-0.17,-0.1,-0.54,-0.41,-0.43,0.09,-0.07,0.15,-0.19,,,,,,,0,0,,actin cytoskeleton,actin filament binding,cell cycle arrest,,
B3KR41,Q9Y6D9,Mitotic spindle assembly checkpoint protein MAD1,MAD1L1,81.97,81.19,S428,AILGSYDSELTPAEYSPQLTRRMREAEDMVQ,_AILGSYDSELTPAEYS(ph)PQLTR_, , , , ,-0.5,-0.79, , , , , , ,-0.48,-0.07, , ,,,-0.64,,,,-0.26,,,,,,,,NA,NA,,actin cytoskeleton,,mitotic cell cycle spindle assembly checkpoint,,
F8W8U2,Q8WXG6,MAP kinase-activating death domain protein,MADD,214.95,213.8,S1239,GGEGSVHLASSRGTLSDSEIETNSATSTIFG,_GTLS(ph)DSEIETNSATSTIFGK_,0.02,-0.07,0.44, ,0.14,0.4,0.26,0.23,0.46,0.2,0.92, ,0.07,0.38,-0.02,-0.16,-0.02,0.44,0.27,0.24,0.33,0.92,0.24,-0.09,,,,,,,0,0,,plasma membrane,,,,
E9PR76,Q9H063,Repressor of RNA polymerase III transcription MAF1 homolog,MAF1,166.77,161.88,S75,SPPQTSGLSPSRLSKSQGGEEEGPLSDKCSR,_S(ph)QGGEEEGPLSDK_,0.39,0.39,1.05,1.18, ,0.62,0.69,0.81,0.09,0.18,0.92,0.87, ,0.73,0.59,0.82,0.39,1.12,0.62,0.75,0.14,0.9,0.73,0.71, +,,,,,,4,0,32.41,nucleus,,negative regulation of transcription from RNA polymerase III promoter,,
Q9UNF1,Q9UNF1,Melanoma-associated antigen D2,MAGED2,116.98,47.72,S247,TRLAAWARRALLSLRSPKARRGKARRRAAKL,_ALLSLRS(ph)PK_,-0.13,-0.04,-0.14,-0.15, , , , ,0.12,0.13,-0.03,-0.09, , , , ,-0.08,-0.14,,,0.12,-0.06,,,,,,,,,NA,NA,,,,,,
Q9UNF1,Q9UNF1,Melanoma-associated antigen D2,MAGED2,42.06,38.95,S194,KVKHLDGEEDGSSDQSQASGTTGGRRVSKAL,_HLDGEEDGSS(ph)DQS(ph)QAS(ph)GTTGGR_, , , , , ,0.11,-0.08,-1.2, , , , , ,-0.24,-0.24,-0.41,,,0.11,-0.53,,,-0.24,-0.32,,,,,,,NA,NA,,,,,,
Q9UNF1,Q9UNF1,Melanoma-associated antigen D2,MAGED2,42.06,38.95,S197,HLDGEEDGSSDQSQASGTTGGRRVSKALMAS,_HLDGEEDGSS(ph)DQS(ph)QAS(ph)GTTGGR_, , , , , ,0.11,-0.08,-1.2, , , , , ,-0.24,-0.24,-0.41,,,0.11,-0.53,,,-0.24,-0.32,,,,,,,NA,NA,,,,,,
Q9BXY0,Q9BXY0,Protein MAK16 homolog,MAK16,129.82,123.45,S229,DVGKREFVEDGEVDESDISDFEDMDKLDASS,_EFVEDGEVDES(ph)DIS(ph)DFEDMDK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,,,,
Q9BXY0,Q9BXY0,Protein MAK16 homolog,MAK16,129.82,123.45,S232,KREFVEDGEVDESDISDFEDMDKLDASSDED,_EFVEDGEVDES(ph)DIS(ph)DFEDMDK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,,,,
Q92585,Q92585,Mastermind-like protein 1,MAML1,103.13,103.13,S45,CRRHHSTCEARYEAVSPERLELERQHTFALH,_YEAVS(ph)PERLELER_,0.11,0.07,-0.06,0.01, ,0.47, , ,-0.69,-0.18,-0.29,-0.28, ,0.08, , ,0.09,-0.03,0.47,,-0.41,-0.28,0.08,,,,,,,,NA,NA,,MAML1-RBP-Jkappa- ICN1 complex,peptide antigen binding,atrioventricular node cell development,,
P78559,P78559,Microtubule-associated protein 1A,MAP1A,65.3,31.55,S2022,AGRNTSAEKELSSPISPKSLQSDTPTFSYAA,_ELSS(ph)PIS(ph)PK_,-0.63, , , ,-0.41,1.83, ,-0.18,0.18, , , ,-0.48,2.26, ,-1.08,-0.63,,1.11,-0.18,0.18,,1.46,-1.08, +, +,,,,,NA,NA,,cytosol,hydrolase activity,microtubule cytoskeleton organization,,
P78559,P78559,Microtubule-associated protein 1A,MAP1A,144.55,126.68,S667,VIEKAELEEMEEVHPSDEEEEDATKAEGFYQ,_AELEEMEEVHPS(ph)DEEEEDATK_,-0.54,-0.61, , , , , , ,0.07,0.06, , , , , , ,-0.57,,,,0.07,,,,,,,,,,NA,NA,,cytosol,hydrolase activity,microtubule cytoskeleton organization,,
P78559,P78559,Microtubule-associated protein 1A,MAP1A,37.74,37.24,S1776,SSPQKGLEVERWLAESPVGLPPEEEDKLTRS,_WLAES(ph)PVGLPPEEEDK_, ,-0.01, , , , , , , ,0.01, , , , , , ,-0.01,,,,0.01,,,,,,,,,,NA,NA,,cytosol,hydrolase activity,microtubule cytoskeleton organization,,
P78559,P78559,Microtubule-associated protein 1A,MAP1A,113.13,113.13,S526,TVPLPTISGHRELVLSSPEDLTQDFEEMKRE,_ELVLS(ph)S(ph)PEDLTQDFEEMKR_,0.17, ,-0.71, , , , , ,-0.05, ,-0.98, , , , , ,0.17,-0.71,,,-0.05,-0.98,,,,,,,,,NA,NA,,cytosol,hydrolase activity,microtubule cytoskeleton organization,,
P78559,P78559,Microtubule-associated protein 1A,MAP1A,113.13,113.13,S527,VPLPTISGHRELVLSSPEDLTQDFEEMKREE,_ELVLS(ph)S(ph)PEDLTQDFEEMKR_,0.17, ,-0.71, , , , , ,-0.05, ,-0.98, , , , , ,0.17,-0.71,,,-0.05,-0.98,,,,,,,,,NA,NA,,cytosol,hydrolase activity,microtubule cytoskeleton organization,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,269.99,235.24,S1256,DSISAVSSEKVSPSKSPSLSPSPPSPLEKTP,_S(ph)PSLS(ph)PSPPS(ph)PLEK_,0.58,0.28,0.15,-0.24,0.14,-0.23,-1.61,-2.31,-0.49,-0.48,0.11,-0.07,0.31,0.31,-2.11,-2.27,0.44,-0.04,-0.03,-1.92,-0.49,0.02,0.31,-2.19, +, +,,,,,6,4,24.86,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,272.09,270.7,S1260,AVSSEKVSPSKSPSLSPSPPSPLEKTPLGER,_S(ph)PSLS(ph)PSPPS(ph)PLEK_,0.46,0.04,3.1,-0.01,1.53,1.32,0.87,0.64,-0.08,0.09,1.5,-0.07,1.16,1.19,0.97,0.89,0.27,2.26,1.43,0.76,0.01,0.92,1.18,0.93, +, +,,,,,4,1,19.26,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,352.64,322.07,S1265,KVSPSKSPSLSPSPPSPLEKTPLGERSVNFS,_SPSLSPSPPS(ph)PLEK_,0.31,0.38,1.15,1.17,0.97,1,0.99,0.99,0.39,0.45,1.04,1.04,1.07,1.1,1.04,1.05,0.35,1.16,0.99,0.99,0.42,1.04,1.08,1.05, +, +,,,,,1,1,41.9,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,88.63,88.14,S1792,KLSPKSDISPLTPRESSPLYSPTFSDSTSAV,_ES(ph)SPLYS(ph)PTFSDSTSAVK_, , , ,-0.54,0.64, ,-1.27,-0.97, , , ,-0.68,0.97, ,-1.14,-1.05,,-0.54,0.64,-1.11,,-0.68,0.97,-1.09, +, +,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,193.45,186.67,S1793,LSPKSDISPLTPRESSPLYSPTFSDSTSAVK,_ESS(ph)PLYSPTFSDSTSAVK_,0.08,0.05,-0.58,-0.57,-1.3,-1.33,-1.11,-1.2,-0.04,-0.08,-0.57,-0.56,-1.07,-0.97,-0.91,-1.03,0.07,-0.57,-1.31,-1.16,-0.06,-0.57,-1.02,-0.97, +, +,,,,,6,6,42.14,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,203.66,177.7,S1797,SDISPLTPRESSPLYSPTFSDSTSAVKEKTA,_ESSPLYS(ph)PTFSDSTSAVK_,0.1,0.22,1.25,1.57,1.8,1.7,1.54,0.85,0.47,0.52,1.29,1.55,1.84,1.94,1.92,1.2,0.16,1.42,1.75,1.24,0.5,1.42,1.89,1.61, +, +,,,,,1,1,31.96,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,273.35,273.35,S992,SAKAEADAYIREKRESVASGDDRAEEDMDEA,_RES(ph)VAS(ph)GDDRAEEDM(ox)DEAIEK_,0.07,-0.01,2.09,2.27,1.22,-1.29,0.52,1.32,-0.06,0.14,2.18,2.5,1.58,-0.35,1.25,1.85,0.03,2.18,0.45,0.98,0.04,2.35,0.92,1.58, +, +,,,,,4,1,27.37,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,137.56,136.37,S1280,SPLEKTPLGERSVNFSLTPNEIKVSAEAEVA,_S(ph)VNFS(ph)LT(ph)PNEIK_, , , , , ,-0.66,-0.94,-1.1, , , , , ,-0.3,-0.97,-1.04,,,-0.66,-1.02,,,-0.3,-1, +, +,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,245.11,231.45,S832,IGPAKELEAERSLMSSPEDLTKDFEELKAEE,_SLMS(ph)S(ph)PEDLTK_,-0.16,0.1,0.23,0.14,-0.03,-0.07,0.17,0.18,0.83,0.08,0.83,1.28,1,0.74,0.87,0.68,-0.03,0.19,-0.05,0.17,0.5,1.07,0.87,0.77,, +,,,,,0,1,6.07,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,179.71,172.78,S1801,PLTPRESSPLYSPTFSDSTSAVKEKTATCHS,_ESSPLYS(ph)PTFS(ph)DSTSAVK_,-0.03,0.18,0.01,-0.09,0.1,1.16,0.78,0.57,-0.2,0.48,0.24,0.13,0.53,1.54,1.14,1.01,0.08,-0.04,0.73,0.68,0.18,0.19,1.12,1.07,, +,,,,,0,2,33.75,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,203.21,203.21,T1270,KSPSLSPSPPSPLEKTPLGERSVNFSLTPNE,_S(ph)PSLS(ph)PSPPS(ph)PLEKT(ph)PLGER_, ,0.23,0.2, , ,0.44,0.14,0.13, ,-0.46,-0.19, , ,1.17,1.26,1.11,0.23,0.2,0.44,0.13,-0.46,-0.19,1.17,1.19,, +,,,,,0,2,3.69,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,55.41,54,S343,IAELEEEQSQGSTTNSDWMKNLISPDLGVVF,_IAELEEEQS(ph)QGS(ph)TTNS(ph)DWMK_, , , , , ,0.05,1.36,0.02, , , , , ,0.33,1.65,0.41,,,0.05,0.84,,,0.33,1.16,, +,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,115.93,115.05,S1376,VSFEFSDAKDENERASVSPMDEPVPDSESPI,_DENERAS(ph)VS(ph)PMDEPVPDSESPIEK_,0.1,-0.11,-0.02,0.06,0.1,-0.08,-0.09,-0.13,0.14,-0.01,0.02,-0.07,0.12,0.04,0.14,0.34,0,0.02,0.01,-0.11,0.07,-0.02,0.08,0.24,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,319.09,306.05,S1378,FEFSDAKDENERASVSPMDEPVPDSESPIEK,_DENERAS(ph)VS(ph)PMDEPVPDSESPIEK_,0.07,0.07,0.03,0.15,-0.14,-0.1,-0.16,-0.1,0.06,0.08,0.08,0.08,0.11,0.05,0.12,0.17,0.07,0.09,-0.12,-0.13,0.07,0.08,0.08,0.15,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,238.8,234.11,S1389,RASVSPMDEPVPDSESPIEKVLSPLRSPPLI,_ASVS(ph)PMDEPVPDSES(ph)PIEK_,0.24,0.24,0.32,0.36,-0.12,-0.09,-0.52,0.04,0.15,0.18,0.21,0.2,0.26,0.16,0.17,0.46,0.24,0.34,-0.1,-0.21,0.16,0.2,0.21,0.32,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,253.89,253.89,S1252,LDIKDSISAVSSEKVSPSKSPSLSPSPPSPL,_VS(ph)PSKS(ph)PSLS(ph)PSPPS(ph)PLEK_,0.1,0.16,0.08,-0.08,-0.37,0.04,-0.18,-0.14,0.26,0.29,0.32,0.13,-0.13,0.3,0.22,0.64,0.13,0,-0.15,-0.16,0.27,0.23,0.1,0.44,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,208.63,186.22,S1258,ISAVSSEKVSPSKSPSLSPSPPSPLEKTPLG,_SPS(ph)LS(ph)PSPPS(ph)PLEK_, , , ,-0.08,1.35,-0.05,0.06,0.36, , , ,-0.23,0.96,0.3,0.47,0.56,,-0.08,0.81,0.22,,-0.23,0.67,0.52,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,117.22,115.71,S1262,SSEKVSPSKSPSLSPSPPSPLEKTPLGERSV,_S(ph)PSLSPS(ph)PPS(ph)PLEK_, , , , ,0.17, ,0.37,-0.06, , , , ,0.33, ,0.22,0.63,,,0.17,0.17,,,0.33,0.44,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,121.41,119.69,S1144,EPTPMDEMSTPRDVMSDETNNEETESPSQEF,_DVMS(ph)DET(ph)NNEETES(ph)PSQEFVNITK_, , , , ,-0.25,-0.02,0.2,0.26, , , , ,-0.09,-0.03,0.15,0.2,,,-0.13,0.23,,,-0.06,0.18,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,266.2,266,S1154,PRDVMSDETNNEETESPSQEFVNITKYESSL,_DVMSDETNNEETES(ph)PSQEFVNITK_,-0.15,-0.08,-0.03,-0.07,-0.35,-0.32,-0.3,-0.22,-0.03,-0.07,0.03,-0.02,-0.01,0.04,-0.01,0.05,-0.12,-0.05,-0.33,-0.26,-0.05,0.01,0.02,0.02,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,246.17,245.28,S1208,DATDGKDYNASASTISPPSSMEEDKFSRSAL,_DYNASASTIS(ph)PPSSMEEDK_,-0.32,-0.41,-0.33,-0.42,-0.33,-0.26,-0.22,-0.21,-0.07,-0.46,-0.12,-0.15,-0.15,0.07,0.07,0.01,-0.37,-0.38,-0.29,-0.22,-0.25,-0.13,-0.04,0.04,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,152.34,151.82,S1618,ETEMSPSKEECPRPMSISPPDFSPKTAKSRT,_EECPRPMS(ph)IS(ph)PPDFS(ph)PK_, , , , ,-0.5,-0.63,-0.57,-0.18, , , , ,0.14,-0.31,-0.56,-0.23,,,-0.56,-0.36,,,-0.07,-0.38,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,152.34,151.82,S1620,EMSPSKEECPRPMSISPPDFSPKTAKSRTPV,_EECPRPMS(ph)IS(ph)PPDFS(ph)PK_, , , , ,-0.5,-0.63,-0.57,-0.18, , , , ,0.14,-0.31,-0.56,-0.23,,,-0.56,-0.36,,,-0.07,-0.38,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,152.34,151.82,S1625,KEECPRPMSISPPDFSPKTAKSRTPVQDHRS,_EECPRPMS(ph)IS(ph)PPDFS(ph)PK_, , , , ,-0.5,-0.63,-0.57,-0.18, , , , ,0.14,-0.31,-0.56,-0.23,,,-0.56,-0.36,,,-0.07,-0.38,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,245.11,231.45,S828,GIAAIGPAKELEAERSLMSSPEDLTKDFEEL,_S(ph)LMS(ph)S(ph)PEDLTK_,-0.06,-0.02,-0.67,-0.47,-0.06,-0.13,0.2,0.33,-0.16,0.18,-0.5,-0.22,0,-0.04,0.44,0.32,-0.04,-0.57,-0.1,0.27,0.02,-0.35,-0.02,0.38,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,245.11,231.45,S831,AIGPAKELEAERSLMSSPEDLTKDFEELKAE,_SLMS(ph)S(ph)PEDLTK_,0.13,0.1,0.12,0.03,0.09,-0.09,0.02,-0.05,0.09,0.08,0.09,0.05,0.3,0.19,0.22,0.16,0.11,0.07,0,-0.02,0.09,0.07,0.25,0.19,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,273.35,273.35,S995,AEADAYIREKRESVASGDDRAEEDMDEAIEK,_RES(ph)VAS(ph)GDDRAEEDM(ox)DEAIEK_,0.45,0.22,-0.62,-0.6,-1.37,1.04,-0.73,-0.36,0.26,0,-0.72,-0.78,-1.4,1.75,-0.72,-0.53,0.34,-0.61,0.29,-0.53,0.14,-0.75,0.9,-0.62,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,228.36,228.36,S936,DDIEKFEDEGAGFEESSETGDYEEKAETEEA,_FEDEGAGFEES(ph)S(ph)ETGDYEEK_,0.04,-0.2,-0.01, ,-0.1,-0.27,-0.21,-0.17,0.14,-0.05,0.17, ,0.17,0.11,0.23,0.25,-0.08,-0.01,-0.18,-0.19,0.05,0.17,0.14,0.24,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,318.18,318.18,S937,DIEKFEDEGAGFEESSETGDYEEKAETEEAE,_FEDEGAGFEES(ph)S(ph)ETGDYEEK_,-0.14,-0.15,-0.17,-0.07,-0.29,-0.31,-0.26,-0.23,-0.08,0.04,0,0.03,0.06,0.06,0.17,0.13,-0.15,-0.12,-0.3,-0.25,-0.02,0.02,0.06,0.15,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,151.13,146.07,S1427,SFLSADDKASGRGAESPFEEKSGKQGSPDQV,_GAES(ph)PFEEK_,-0.4,-0.22,-0.57,-0.51,-0.54,-0.56,-0.44,-0.4,0.09,0.13,-0.18,-0.26,-0.28,-0.26,-0.04,-0.12,-0.31,-0.54,-0.55,-0.42,0.11,-0.22,-0.27,-0.08,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,416.53,416.53,S1016,EEDMDEAIEKGEAEQSEEEADEEDKAEDARE,_GEAEQS(ph)EEEADEEDKAEDAREEEYEPEK_,-0.02,-0.03,-0.03,0.04, ,0,-0.09,0.11,-0.01,-0.02,0.01,-0.06, ,0.21,0.28,0.17,-0.03,0.01,0,0.01,-0.02,-0.02,0.21,0.22,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,88.42,88.42,S2209,TYKHMDPPPAPVQDRSPSPRHPDVSMVDPEA,_HMDPPPAPVQDRS(ph)PS(ph)PR_,-0.62, ,-0.7,-0.92, , ,-0.55,-0.67,-0.37, ,-0.66,-0.64, , ,-0.22,-0.24,-0.62,-0.81,,-0.61,-0.37,-0.65,,-0.23,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,88.42,88.42,S2211,KHMDPPPAPVQDRSPSPRHPDVSMVDPEALA,_HMDPPPAPVQDRS(ph)PS(ph)PR_,-0.62, ,-0.7,-0.92, , ,-0.55,-0.67,-0.37, ,-0.66,-0.64, , ,-0.22,-0.24,-0.62,-0.81,,-0.61,-0.37,-0.65,,-0.23,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,232.86,229.42,S1501,SQPALALDERKLGDVSPTQIDVSQFGSFKED,_LGDVS(ph)PTQIDVSQFGSFK_,0.2,0.04,-0.02,0.07,-0.18, ,-0.07, ,0.3,0.11,0.18,0.28,0.1, ,0.29, ,0.12,0.03,-0.18,-0.07,0.21,0.23,0.1,0.29,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,48.5,48.5,S1994,RSRRLLDDISNGYDDSEDGGHTLGDPSYSYE,_LLDDISNGYDDS(ph)EDGGHTLGDPSYSYETTEK_, ,-0.06, , , , , , , ,0.3, , , , , , ,-0.06,,,,0.3,,,,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,323.72,322.88,S1779,SLTSEKVQSLEGEKLSPKSDISPLTPRESSP,_VQSLEGEKLS(ph)PKS(ph)DIS(ph)PLT(ph)PR_,0.3,0.34,0.37,0.36,-0.15,-0.16,-0.08,-0.36,0.23,0.23,0.35,0.38,0.05,0.02,-0.01,-0.21,0.32,0.37,-0.15,-0.21,0.23,0.36,0.04,-0.11,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,323.72,322.88,S1782,SEKVQSLEGEKLSPKSDISPLTPRESSPLYS,_VQSLEGEKLS(ph)PKS(ph)DIS(ph)PLT(ph)PR_,0.48,0.36,0.09,-0.03,0.06,0.26,0.29,-0.58,0.35,0.22,-0.38,-0.27,-0.12,0.24,0.09,-0.14,0.42,0.03,0.16,-0.08,0.28,-0.32,0.08,-0.02,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,260.68,260.68,S1785,VQSLEGEKLSPKSDISPLTPRESSPLYSPTF,_VQSLEGEKLS(ph)PKS(ph)DIS(ph)PLT(ph)PR_,-0.15,-0.23,-0.88,-0.67,-0.09,-0.67,-0.6,-0.82,-0.15,-0.09,-1.1,-0.71,-0.11,-0.26,-0.48,-0.65,-0.19,-0.77,-0.35,-0.7,-0.12,-0.89,-0.18,-0.56,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,304.17,270.76,S1438,RGAESPFEEKSGKQGSPDQVSPVSEMTSTSL,_(gl)QGS(ph)PDQVS(ph)PVSEMTSTSLYQDK_,0.39,0.2,-0.09,0.23,-0.31,0.16,-0.04,-0.17,-0.12,0.02,-0.08,0,0.02,0.01,-0.04,0.14,0.29,0.08,-0.06,-0.1,-0.05,-0.04,0.02,0.05,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,304.17,270.76,S1443,PFEEKSGKQGSPDQVSPVSEMTSTSLYQDKQ,_QGS(ph)PDQVS(ph)PVSEMTSTSLYQDK_,0.15,0.06,0.23,0.9,0.21,-0.06,-0.39,-0.38,0.01,0.15,0.13,0.5,-0.28,0.22,0.11,0.07,0.11,0.6,0.08,-0.39,0.08,0.33,-0.01,0.09,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,150.04,147,S1653,HRSEQSSMSIEFGQESPEQSLAMDFSRQSPD,_SEQSSMSIEFGQES(ph)PEQSLAMDFSR_, , , , , , , ,0.5, , , , , , , ,0.1,,,,0.5,,,,0.1,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,89.46,88.65,S1881,GDFSYAYQKPEETTRSPDEEDYDYESYEKTT,_S(ph)PDEEDYDYESYEK_, ,-0.45, , , , , ,-0.1, ,-0.41, , , , , ,0.25,-0.45,,,-0.1,-0.41,,,0.25,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,290.95,290.95,S1915,DVGGYYYEKIERTTKSPSDSGYSYETIGKTT,_S(ph)PSDSGYSYETIGK_,0.08,0,0.24,0.18,-0.1,0.01,-0.01,-0.11,0.1,0.07,0.19,0.16,0.36,0.47,0.15,0.23,0.04,0.21,-0.04,-0.06,0.08,0.17,0.42,0.19,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,186.72,186.06,S1917,GGYYYEKIERTTKSPSDSGYSYETIGKTTKT,_SPS(ph)DSGYSYETIGK_, , , , , ,-0.07, , , , , , , ,0.66, , ,,,-0.07,,,,0.66,,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,159.5,159.5,S1919,YYYEKIERTTKSPSDSGYSYETIGKTTKTPE,_S(ph)PSDS(ph)GYSYETIGK_, , , , ,-0.51, ,-0.74, , , , , ,-0.34, ,-0.22, ,,,-0.51,-0.74,,,-0.34,-0.22,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,178.52,174.94,S1276,PSPPSPLEKTPLGERSVNFSLTPNEIKVSAE,_S(ph)VNFS(ph)LT(ph)PNEIK_,-0.48,-0.52,-0.79,-0.42,-0.45,-0.56,-0.65,-0.61,-0.28,-0.13,-0.22,-0.09,-0.3,-0.34,-0.54,-0.62,-0.5,-0.59,-0.5,-0.63,-0.2,-0.15,-0.32,-0.58,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,186.81,186.81,S1322,EEHCASPEDKTLEVVSPSQSVTGSAGHTPYY,_TLEVVS(ph)PSQS(ph)VTGS(ph)AGHTPYYQSPTDEK_,-0.27,-0.59,-0.31,-0.11,-0.12,0.15,0.26,0.04,-0.28,-0.5,-0.03,0.11,0.15,0.23,0.51,0.21,-0.42,-0.21,0.02,0.16,-0.38,0.04,0.19,0.37,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,119.06,119.06,S1326,ASPEDKTLEVVSPSQSVTGSAGHTPYYQSPT,_TLEVVS(ph)PSQS(ph)VTGS(ph)AGHTPYYQSPTDEK_, ,-0.25, , ,-0.23,-1.91, ,-0.49, ,0.27, , ,0.12,-1.52, ,-0.23,-0.25,,-0.84,-0.49,0.27,,-0.48,-0.23,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,119.06,119.06,S1330,DKTLEVVSPSQSVTGSAGHTPYYQSPTDEKS,_TLEVVS(ph)PSQS(ph)VTGS(ph)AGHTPYYQSPTDEK_, ,-0.25,0.01, ,-0.02,-0.24, ,-0.57, ,0.27,0.31, ,0.17,0.02, ,-0.22,-0.25,0.01,-0.13,-0.57,0.27,0.31,0.1,-0.22,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,186.81,186.81,S1339,SQSVTGSAGHTPYYQSPTDEKSSHLPTEVIE,_TLEVVS(ph)PSQSVTGSAGHTPYYQS(ph)PTDEK_,0.02,0.13,0.17, ,0.2,-0.16,-0.25,0.09,0.4,0.15,0.24, ,0.94,0.72,0.4,0.6,0.08,0.17,0.03,-0.07,0.28,0.24,0.84,0.51,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,129.36,119.58,S1965,PEEGGYSYDISEKTTSPPEVSGYSYEKTERS,_TTS(ph)PPEVSGYSYEK_,0,-0.06,0,-0.06,-0.13,-0.14,-0.1,0.8,0.02,0.06,0.07,0.02,0.17,0.17,0.28,0.25,-0.03,-0.03,-0.13,0.42,0.04,0.04,0.17,0.27,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,302.89,302.79,S1396,DEPVPDSESPIEKVLSPLRSPPLIGSESAYE,_VLS(ph)PLRS(ph)PPLIGSESAYESFLSADDK_,-0.1,0.17,-0.13,0.01,-0.36,1.2,0.79,-0.65,-0.23,0.33,0,-0.02,-0.09,1.29,0.89,-0.84,0.04,-0.06,0.62,0.24,0.08,-0.01,0.76,0.27,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,302.89,302.79,S1400,PDSESPIEKVLSPLRSPPLIGSESAYESFLS,_VLS(ph)PLRS(ph)PPLIGSESAYESFLSADDK_, ,-0.01,0.23,0.22,-0.01,1.2,0.79, , ,0.03,0.15,0.02,-0.01,1.29,0.89, ,-0.01,0.23,0.72,0.79,0.03,0.09,0.79,0.89,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,76.54,76.04,T1147,PMDEMSTPRDVMSDETNNEETESPSQEFVNI,_DVMS(ph)DET(ph)NNEETES(ph)PSQEFVNITK_, , , , , , , ,-0.26, , , , , , , ,-0.07,,,,-0.26,,,,-0.07,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,220.52,211.91,T939,EKFEDEGAGFEESSETGDYEEKAETEEAEEP,_FEDEGAGFEES(ph)SET(ph)GDYEEK_, , , ,-0.07,-0.25,-0.27,-0.36,-0.36, , , ,0.01,-0.09,0.04,0.09,0.24,,-0.07,-0.26,-0.36,,0.01,-0.03,0.16,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,323.72,322.88,T1788,LEGEKLSPKSDISPLTPRESSPLYSPTFSDS,_VQSLEGEKLS(ph)PKS(ph)DIS(ph)PLT(ph)PR_,-0.27,-0.22,-0.87,1.02,0.25,0.31,0.04,0.59,0.03,0.07,-1.32,1.12,0.13,0.18,-0.36,0.76,-0.24,0.37,0.28,0.34,0.05,0.36,0.15,0.31,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,197.7,168.89,T1282,LEKTPLGERSVNFSLTPNEIKVSAEAEVAPV,_S(ph)VNFS(ph)LT(ph)PNEIK_,-0.08,-0.02,0,-0.15,-0.45,-0.59,-0.41,-0.61,-0.11,-0.14,0,-0.07,-0.3,-0.1,-0.02,-0.62,-0.05,-0.08,-0.52,-0.51,-0.12,-0.04,-0.2,-0.29,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,202.34,201.71,T1932,SDSGYSYETIGKTTKTPEDGDYSYEIIEKTT,_T(ph)PEDGDYSYEIIEK_,0.47,0.02, , , , ,-0.51, ,-0.22,-0.07, , , , ,-0.75, ,0.26,,,-0.51,-0.15,,,-0.75,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,192.77,192.77,T1949,EDGDYSYEIIEKTTRTPEEGGYSYDISEKTT,_T(ph)PEEGGYSYDISEK_,0.06,0.01,0.22,0.09,-0.51,-0.27,-0.16, ,-0.01,-0.1,0.05,0.02,-0.2,-0.06,-0.3, ,0.04,0.16,-0.39,-0.16,-0.06,0.04,-0.13,-0.3,,,,,,,0,0,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,60.51,60.51,S614,KPSVTEKEVPSKEEPSPVKAEVAEKQATDVK,_EVPSKEEPS(ph)PVK_,0.22,0.21,-0.02, , , , ,-0.5,0.18,0.19,0.59, , , , ,0.25,0.22,-0.02,,-0.5,0.18,0.59,,0.25,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,85.19,82.69,S336,NSMLQRKIAELEEEQSQGSTTNSDWMKNLIS,_IAELEEEQS(ph)QGS(ph)TTNSDWMK_, , , , , , ,0.42,-0.51, , , , , , ,0.55,0.13,,,,0.03,,,,0.36,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
P46821,P46821,Microtubule-associated protein 1B,MAP1B,85.19,82.69,S339,LQRKIAELEEEQSQGSTTNSDWMKNLISPDL,_IAELEEEQS(ph)QGS(ph)TTNS(ph)DWMK_, , , , , , ,0.89,-0.51, , , , , , ,1.1,0.13,,,,0.35,,,,0.7,,,,,,,NA,NA,,cell junction,hydrolase activity,axonogenesis,,
B4DH53,Q66K74,Microtubule-associated protein 1S,MAP1S,174.53,170.99,S759,EFEHRKAVPMAPAPASPGSSNDSSARSQERA,_AVPMAPAPAS(ph)PGSSNDSSAR_,-0.14,-0.21,-0.11,-0.15,-0.04,0.21,0.1,0.2,-0.29,-0.12,-0.13,0.11,0.27,0.33,0.19,0.18,-0.17,-0.13,0.09,0.15,-0.2,-0.01,0.3,0.19,,,,,,,0,0,,microtubule,hydrolase activity,apoptotic process,,
B4DH53,Q66K74,Microtubule-associated protein 1S,MAP1S,47.73,46.27,S762,HRKAVPMAPAPASPGSSNDSSARSQERAGGL,_AVPMAPAPAS(ph)PGS(ph)SNDSSAR_, , , , ,-0.91, , ,-0.24, , , , ,-0.6, , ,-0.07,,,-0.91,-0.24,,,-0.6,-0.07,,,,,,,NA,NA,,microtubule,hydrolase activity,apoptotic process,,
B4DH53,Q66K74,Microtubule-associated protein 1S,MAP1S,136.27,136.27,S655,SPESHRSPAEGSERLSLSPLRGGEAGPDASP,_LS(ph)LS(ph)PLR_, , , , ,0.08,0.43, ,-0.25, , , , ,0.13,-0.11, ,0.03,,,0.26,-0.25,,,0.02,0.03,,,,,,,NA,NA,,microtubule,hydrolase activity,apoptotic process,,
B4DH53,Q66K74,Microtubule-associated protein 1S,MAP1S,158.76,40.26,S657,ESHRSPAEGSERLSLSPLRGGEAGPDASPTV,_LS(ph)LS(ph)PLR_,-0.15,-0.15,-0.04,-0.04,0.17,0.05,-0.01,-0.01,-0.17,-0.22,-0.06,-0.1,0.12,0.05,-0.01,0.08,-0.15,-0.04,0.11,-0.01,-0.19,-0.08,0.09,0.04,,,,,,,0,0,,microtubule,hydrolase activity,apoptotic process,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,95.68,95.36,S1782,HAKARVDHGAEIITQSPGRSSVASPRRLSNV,_ARVDHGAEIITQS(ph)PGR_,-0.74,-0.6,-0.96,-0.76,-0.57, ,1.23,1.41,-0.2,-0.35,-0.18,-0.35,-1.06, ,0.51,0.35,-0.67,-0.86,-0.57,1.32,-0.27,-0.26,-1.06,0.43, +, +,,,,,3,6,10.84,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,95.68,95.36,S1787,VDHGAEIITQSPGRSSVASPRRLSNVSSSGS,_VDHGAEIITQS(ph)PGRS(ph)S(ph)VAS(ph)PR_, , , , ,-0.57, ,1.23,1.41, , , , ,-1.06, ,0.51,0.35,,,-0.57,1.32,,,-1.06,0.43, +, +,,,,,NA,NA,,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,95.68,95.36,S1790,GAEIITQSPGRSSVASPRRLSNVSSSGSINL,_VDHGAEIITQS(ph)PGRS(ph)S(ph)VAS(ph)PR_, , , , ,-0.57, ,1.23,1.41, , , , ,-1.06, ,0.51,0.35,,,-0.57,1.32,,,-1.06,0.43, +, +,,,,,NA,NA,,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,159.01,157.9,S1347,EVEEAAEAQAEPKDGSPEAPASPEREEVALS,_DGS(ph)PEAPAS(ph)PEREEVALSEYK_,-0.77,-0.72,0.06,-0.67,1.73, ,0.31,1.35,-0.15,-0.11,0.83,-0.06,0.08, ,-0.67,-0.06,-0.74,-0.26,1.73,0.92,-0.13,0.45,0.08,-0.33, +,,,,,,2,0,4.47,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,159.01,157.9,S1353,EAQAEPKDGSPEAPASPEREEVALSEYKTET,_DGS(ph)PEAPAS(ph)PEREEVALSEYK_,-0.77,-0.72,0.06,-0.67,1.73, ,0.31,1.35,-0.15,-0.11,0.83,-0.06,0.08, ,-0.67,-0.06,-0.74,-0.26,1.73,0.92,-0.13,0.45,0.08,-0.33, +,,,,,,2,0,4.47,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,74.53,73.48,S1786,RVDHGAEIITQSPGRSSVASPRRLSNVSSSG,_VDHGAEIITQS(ph)PGRS(ph)S(ph)VAS(ph)PR_, , , , , , ,1.23,1.41, , , , , , ,0.51,0.35,,,,1.32,,,,0.43, +,,,,,,NA,NA,,cytoplasm,structural molecule activity,axonogenesis,,
P11137-3,P11137,Microtubule-associated protein 2,MAP2,82.77,81.92,S1155,LTMESLKADEGKKETSPESSLIQDEIAVKLS,_ETS(ph)PESSLIQDEIAVK_,-0.32, ,-0.38,-0.32, , , , ,-0.27, ,-0.33,-0.28, , , , ,-0.32,-0.35,,,-0.27,-0.3,,,,,,,,,NA,NA,,cytoplasm,structural molecule activity,axonogenesis,,
P36507,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,112.64,69.14,T394,FAGWLCKTLRLNQPGTPTRTAV_________,_LNQPGT(ph)PTR_,-0.09,-0.1,0.49,0.54,0.64,0.69,0.85,0.92,0.32,0.29,0.67,0.6,0.37,0.42,0.39,0.44,-0.1,0.51,0.67,0.88,0.3,0.63,0.39,0.42,,,STE,,,,0,0,,cell cortex,ATP binding,activation of MAPKK activity,,
H0YG34,P45985,Dual specificity mitogen-activated protein kinase kinase 4,MAP2K4,76.45,76.37,S394,CYVCKILDQMPATPSSPMYVD__________,_ILDQMPATPSS(ph)PMYVD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,STE,,,,NA,NA,,,,,,
H0YG34,P45985,Dual specificity mitogen-activated protein kinase kinase 4,MAP2K4,53.04,52.23,T391,EVACYVCKILDQMPATPSSPMYVD_______,_ILDQMPAT(ph)PS(ph)SPMYVD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,STE,,,,NA,NA,,,,,,
Q9Y2U5,Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,92.92,92.87,S239,LDGESYPKSRMPRAQSYPDNHQEFSDYDNPI,_AQS(ph)YPDNHQEFSDYDNPIFEK_, , ,-0.15, ,0.07, , , , , ,0.35, ,0.04, , , ,,-0.15,0.07,,,0.35,0.04,,,,STE,,,,NA,NA,,cytoplasm,ATP binding,activation of JUN kinase activity,,
Q9Y2U5,Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,129.35,128.28,S344,RGSDIDNPTLTVMDISPPSRSPRAPTNWRLG,_GSDIDNPTLTVMDIS(ph)PPS(ph)RSPR_, , , , , ,-0.79, , , , , , , ,-0.8, , ,,,-0.79,,,,-0.8,,,,STE,,,,NA,NA,,cytoplasm,ATP binding,activation of JUN kinase activity,,
O43318-2,O43318,Mitogen-activated protein kinase kinase kinase 7,MAP3K7,150.76,149.32,S389,SSVESLPPTSEGKRMSADMSEIEARIAATTG,_RMS(ph)ADMSEIEAR_,-0.49,-0.76,0.03,-0.05,-0.39,0.45,0.4,0.45,0.06,-0.62,0.17,0.19,-0.47,0.46,0.27,0.34,-0.62,-0.01,0.09,0.43,-0.24,0.18,0.07,0.3,,,STE,,,,0,0,,Ada2/Gcn5/Ada3 transcription activator complex,ATP binding,activation of MAPK activity,,
O43318-2,O43318,Mitogen-activated protein kinase kinase kinase 7,MAP3K7,130.26,126.92,S439,ARIAATTGNGQPRRRSIQDLTVTGTEPGQVS,_S(ph)IQDLTVTGTEPGQVS(ph)SR_, ,-0.23,0.94,0.96,0.29,0.49,-0.7,-0.18, ,-0.15,0.82,0.96,0.33,0.33,-0.32,-0.63,-0.23,0.95,0.39,-0.42,-0.15,0.89,0.33,-0.47,,,STE,,,,0,0,,Ada2/Gcn5/Ada3 transcription activator complex,ATP binding,activation of MAPK activity,,
H0Y7B7,P41279,Mitogen-activated protein kinase kinase kinase 8,MAP3K8,68.68,46.62,S141,DVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQ,_NIGS(ph)DFIPR_,1.49,1.3,1.08,2.42, , ,1.53,0.23,-0.04,0.02,0.11,-0.02, , ,-0.04,0,1.4,1.9,,1.02,-0.01,0.04,,-0.02, +,,STE,,,,NA,NA,,,ATP binding,,,
E7EVA0,E7EVA0,Microtubule-associated protein,MAP4,150.93,150.93,S1679,KGSDSLNKKVDLTLLSPKSENDKLKEISLAC,_KVDLTLLS(ph)PK_,-0.01,0.1,0.57,0.68,1.13,1.05,1.13, ,0.1,0.16,0.54,0.5,1.17,1.03,1.35, ,0.04,0.62,1.09,1.13,0.13,0.52,1.1,1.35, +, +,,,,,2,2,35.57,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,80.28,76.42,T585,VTPAKDVPPLSETEATPVPIKDMEIAQTQKG,_DVPPLSETEAT(ph)PVPIK_,-0.15,-0.1, , , ,-1,-0.51, ,0.03,0.93, , , ,-0.86,-0.59, ,-0.13,,-1,-0.51,0.55,,-0.86,-0.59, +,,,,,,NA,NA,,cytoplasm,,,,
E7EVA0,E7EVA0,Microtubule-associated protein,MAP4,108.75,100.97,S723,TRPKPARVPPELLGGSPPWKTLDHRLGHCSL,_VPPELLGGS(ph)PPWK_,0.32,0.34,0.36,0.37,0.54,0.33,0.21, ,0.07,0.13,0.15,0.16,0.52,0.37,0.69, ,0.33,0.37,0.44,0.21,0.1,0.16,0.45,0.69,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,203.53,198.34,S507,VAPSTVKEVGLLKDMSPLSETEMALGKDVTP,_DM(ox)S(ph)PLS(ph)ETEMALGK_,-0.33,-0.29,-0.41,-0.26,0.07,-0.22,0.12,0.19,-0.13,-0.1,-0.17,0.06,0.14,0.16,0.25,0.16,-0.31,-0.33,-0.07,0.16,-0.12,-0.05,0.15,0.21,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,188.09,184.78,S510,STVKEVGLLKDMSPLSETEMALGKDVTPPPE,_DMS(ph)PLS(ph)ETEMALGK_,-0.3,-0.22,-0.39,-0.51,-0.17,-0.28,-0.06,-0.13,-0.08,0.06,0,-0.12,-0.07,-0.11,0.01,0.03,-0.26,-0.45,-0.22,-0.1,-0.01,-0.06,-0.09,0.02,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,137.39,137.39,S358,APAKDVTLLKETERASPIKMDLAPSKDMGPP,_ETERAS(ph)PIK_,0.56,-0.12,0.13, ,-0.25,-0.12,-0.17,-0.22,0.01,-0.09,-0.15, ,-0.11,-0.3,-0.28,-0.31,0.26,0.13,-0.18,-0.2,-0.04,-0.15,-0.2,-0.29,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,142.72,134.98,T571,APLAKDGVLTLANNVTPAKDVPPLSETEATP,_DGVLTLANNVT(ph)PAK_,-0.48,-0.48,-0.56,-0.6,-0.63, ,-0.73,-0.55,-0.48,0.91,-0.45,-0.33,0.77, ,-0.8,-0.63,-0.48,-0.58,-0.63,-0.64,0.38,-0.39,0.77,-0.71,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,197.15,194.84,T521,MSPLSETEMALGKDVTPPPETEVVLIKNVCL,_DVT(ph)PPPETEVVLIK_,-0.11,-0.1,-0.18,-0.14,-0.04,-0.03,-0.05,0.03,0.02,0.03,0.02,0.05,-0.06,-0.07,-0.1,-0.01,-0.1,-0.16,-0.03,-0.01,0.02,0.03,-0.06,-0.05,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,294.75,294.75,S280,ALATKTEVALAKDMESPTKLDVTLAKDMQPS,_DMES(ph)PTKLDVTLAK_,-0.14,-0.13,-0.13,-0.13,-0.18,-0.25,-0.09,-0.14,-0.19,-0.21,-0.07,-0.11,0.09,-0.33,-0.12,-0.06,-0.14,-0.13,-0.22,-0.11,-0.2,-0.09,-0.1,-0.09,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,104.12,101.27,S14,__MADLSLADALTEPSPDIEGEIKRDFIATL,_(ac)ADLSLADALTEPS(ph)PDIEGEIKR_, , , , , , ,-0.37, , , , , , , ,0.03, ,,,,-0.37,,,,0.03,,,,,,,NA,NA,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,113.88,94.21,S1145,TLSGGGDQREAQTLDSQIQETSI________,_EAQT(ph)LDS(ph)QIQETSI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,150.92,111.41,S1151,DQREAQTLDSQIQETSI______________,_EAQTLDSQIQETS(ph)I_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,113.88,94.21,T1142,GHPTLSGGGDQREAQTLDSQIQETSI_____,_EAQT(ph)LDS(ph)QIQETSI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,112.36,61.89,S825,TTTAAAVASTGPSSRSPSTLLPKKPTAIKTE,_S(ph)PSTLLPK_,0.03,-0.08,-0.24,-0.24,-0.35, ,-0.48,-0.08,-0.13,-0.09,-0.14,-0.19,-0.18, ,-0.24,-0.31,-0.02,-0.24,-0.35,-0.27,-0.11,-0.17,-0.18,-0.28,,,,,,,0,0,,cytoplasm,,,,
E7EVA0,P27816,Microtubule-associated protein,MAP4,126.9,124.76,S1073,SQKLNFKEKAQAKVGSLDNVGHLPAGGAVKT,_VGS(ph)LDNVGHLPAGGAVK_,-0.2,-0.27,-0.46,-0.57,-0.26,-0.23,-0.28,-0.23,-0.04,-0.05,-0.26,-0.44,-0.4,-0.45,-0.07,-0.11,-0.24,-0.52,-0.24,-0.25,-0.04,-0.34,-0.42,-0.09,,,,,,,0,0,,cytoplasm,,,,
E7EN19,O95819,Mitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,66.94,66.94,S324,TRKKRGEKDETEYEYSGSEEEEEEVPEQEGE,_DETEYEYS(ph)GS(ph)EEEEEEVPEQEGEPSSIVNVPGESTLR_, , , , , , , ,-0.37, , , , , , , ,-0.06,,,,-0.37,,,,-0.06,,,STE,,,,NA,NA,,,ATP binding,,,
E7EN19,O95819,Mitogen-activated protein kinase kinase kinase kinase 4,MAP4K4,66.94,66.94,S326,KKRGEKDETEYEYSGSEEEEEEVPEQEGEPS,_DETEYEYS(ph)GS(ph)EEEEEEVPEQEGEPSSIVNVPGESTLR_, , , , , , , ,-0.37, , , , , , , ,-0.06,,,,-0.37,,,,-0.06,,,STE,,,,NA,NA,,,ATP binding,,,
Q9Y4K4,Q9Y4K4,Mitogen-activated protein kinase kinase kinase kinase 5,MAP4K5,241.71,241.11,Y303,VELLDKVNNPDNHAHYTEADDDDFEPHAIIR,_VNNPDNHAHY(ph)TEADDDDFEPHAIIR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,STE,,,,NA,NA,,cytoplasm,ATP binding,activation of JUN kinase activity,,
Q9Y4K4,Q9Y4K4,Mitogen-activated protein kinase kinase kinase kinase 5,MAP4K5,77.28,58.64,S335,TIRSTNRNARAERTASEINFDKLQFEPPLRK,_TAS(ph)EINFDK_,0.01,0.12,0.27,0.49,0.54, ,0.65,0.56,0.18,0.4,0.5,0.09,0.47, ,0.41,0.39,0.07,0.39,0.54,0.6,0.3,0.31,0.47,0.4,,,STE,,,,0,0,,cytoplasm,ATP binding,activation of JUN kinase activity,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,77.03,77.03,S113,PPAMGPRDARPPRRSSQPSPTAVPASDSPPT,_RSS(ph)QPS(ph)PTAVPASDSPPTK_,0.73,0.56,1.35, ,1.41,1.2,1.55,1.46,0.12,0.84,0.81, ,1.12,1.29,1.36,1.55,0.65,1.35,1.31,1.5,0.52,0.81,1.21,1.46, +, +,,,,,1,2,35.74,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,72.79,72.79,S116,MGPRDARPPRRSSQPSPTAVPASDSPPTKQE,_SSQPS(ph)PTAVPASDSPPT(ph)K_,0.73,0.56,1.35, ,-1.02,1.22,1.55,1.46,0.12,0.84,0.81, ,-0.53,1.34,1.36,1.55,0.65,1.35,0.5,1.5,0.52,0.81,0.69,1.46, +, +,,,,,1,1,32.68,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,77.03,77.03,S125,RRSSQPSPTAVPASDSPPTKQEVKKAGERHK,_RSS(ph)QPSPT(ph)AVPASDS(ph)PPTK_, , , , ,1.47,1.5,1.38,1.35, , , , ,1.41,1.54,1.33,1.25,,,1.49,1.37,,,1.47,1.29, +, +,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,98.13,97.23,S34,ARTPPEPRPSPEGDPSPPPPPMSALVPDTPP,_T(ph)PPEPRPSPEGDPS(ph)PPPPPMSALVPDT(ph)PPDT(ph)PPAMK_, , , , , ,0.91, , , , , , , ,-0.49, , ,,,0.91,,,,-0.49,,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,98.13,97.23,T47,DPSPPPPPMSALVPDTPPDTPPAMKNATSSK,_T(ph)PPEPRPSPEGDPS(ph)PPPPPMSALVPDT(ph)PPDT(ph)PPAMK_, , , , , ,0.91, , , , , , , ,-0.49, , ,,,0.91,,,,-0.49,,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,98.13,97.23,T51,PPPPMSALVPDTPPDTPPAMKNATSSKQLPL,_T(ph)PPEPRPSPEGDPS(ph)PPPPPMSALVPDT(ph)PPDT(ph)PPAMK_, , , , , ,0.91, , , , , , , ,-0.49, , ,,,0.91,,,,-0.49,,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,118.52,111.82,S834,PFAEAEAFLKKAVVQSPQVTEVL________,_AVVQS(ph)PQVTEVL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,129.53,129.47,S544,SKRRASNEKESAAPASPAPSPAPSPTPAPPQ,_ESAAPAS(ph)PAPS(ph)PAPS(ph)PTPAPPQK_,0.04, ,-0.45,-0.65,0.59,-0.23,0.12,-0.35,0.03, ,-0.47,-0.42,-0.07,0.58,0.38,0.03,0.04,-0.55,0.24,-0.1,0.03,-0.44,0.29,0.21,,,,,,,0,0,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,129.53,129.47,S548,ASNEKESAAPASPAPSPAPSPTPAPPQKEQP,_ESAAPAS(ph)PAPS(ph)PAPS(ph)PTPAPPQK_,0.04, ,-0.45,-0.65,0.59,-0.23,0.12,-0.35,0.03, ,-0.47,-0.42,-0.07,0.58,0.38,0.03,0.04,-0.55,0.24,-0.1,0.03,-0.44,0.29,0.21,,,,,,,0,0,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,129.53,129.47,S552,KESAAPASPAPSPAPSPTPAPPQKEQPPAET,_ESAAPAS(ph)PAPS(ph)PAPS(ph)PTPAPPQK_,0.04, ,-0.45,-0.65,-0.14,-0.12,0.02,0.03,0.03, ,-0.47,-0.42,0.08,0.09,0.14,0.16,0.04,-0.55,-0.13,0.02,0.03,-0.44,0.09,0.15,,,,,,,0,0,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,215.37,139.3,S460,ASPRARLSASTASELSPKSKARPSSPSTSWH,_LSASTASELS(ph)PK_,0.19,0.21,0.06,0.03,-0.08,-0.18,0.12,0.04,0.01,-0.1,-0.4,-0.28,0.16,0.09,0.37,0.23,0.2,0.05,-0.13,0.08,-0.04,-0.34,0.12,0.3,,,,,,,0,0,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,116.38,116.31,S70,MKNATSSKQLPLEPESPSGQVGPRPAPPQEE,_QLPLEPES(ph)PSGQVGPRPAPPQEES(ph)PSSEAK_, , , , ,0.19,0.08,0.56,0.39, , , , ,0.29,-0.04,0.51,0.43,,,0.14,0.48,,,0.13,0.47,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,187.94,187.94,S72,NATSSKQLPLEPESPSGQVGPRPAPPQEESP,_QLPLEPESPS(ph)GQVGPRPAPPQEES(ph)PSSEAK_, ,0.38,0.25, ,-0.02,-0.15,0.18, , ,0.21,0.56, ,-0.64,0.07,0.06, ,0.38,0.25,-0.08,0.18,0.21,0.56,-0.24,0.06,,,,,,,0,0,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,187.94,187.94,S86,PSGQVGPRPAPPQEESPSSEAKSRGPTPPAM,_QLPLEPES(ph)PSGQVGPRPAPPQEES(ph)PS(ph)SEAK_, ,0.38, , ,0.15, , ,0.39, ,0.34, , ,0.16, , ,0.43,0.38,,0.15,0.39,0.34,,0.16,0.43,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,81.61,55.19,S93,RPAPPQEESPSSEAKSRGPTPPAMGPRDARP,_S(ph)RGPT(ph)PPAMGPR_, , , , ,0.56,0.5,0.54,0.56, , , , ,-0.22,-0.16,-0.08,0.11,,,0.53,0.55,,,-0.19,0.02,,,,,,,NA,NA,,cytoplasm,,,,
Q3KQU3-2,Q3KQU3,MAP7 domain-containing protein 1,MAP7D1,81.61,55.19,T97,PQEESPSSEAKSRGPTPPAMGPRDARPPRRS,_S(ph)RGPT(ph)PPAMGPR_, , , , ,0.56,0.5,0.54,0.56, , , , ,-0.22,-0.16,-0.08,0.11,,,0.53,0.55,,,-0.19,0.02,,,,,,,NA,NA,,cytoplasm,,,,
Q8IWC1-2,Q8IWC1,MAP7 domain-containing protein 3,MAP7D3,59.42,57.42,S441,PKESVKGSPKESMEASPEAMVKASPKTSLEA,_ESMEAS(ph)PEAMVK_, , ,0.6, , , , , , , ,0.11, , , , , ,,0.6,,,,0.11,,,,,,,,,NA,NA,,centrosome,,,,
B4DHN0,P28482,Mitogen-activated protein kinase 1,MAPK1,314.45,311.12,T185,LARVADPDHDHTGFLTEYVATRWYRAPEIML,_VADPDHDHTGFLT(ph)EY(ph)VATR_,2.38,3.92,9.94,12.16,2.73,4.58,1.51,2.41,3.79,5.7,14.11,14.65,2.14,2.91,3.12,4.28,3.15,11.05,3.66,1.96,4.74,14.38,2.52,3.7, +, +,CMGC,,,,5,1,27.7,cytosol,ATP binding,B cell receptor signaling pathway,,
B4DHN0,P28482,Mitogen-activated protein kinase 1,MAPK1,314.45,311.12,Y187,RVADPDHDHTGFLTEYVATRWYRAPEIMLNS,_VADPDHDHTGFLT(ph)EY(ph)VATR_,2.38,3.92,9.94,12.16,2.73,4.58,1.51,2.41,3.79,5.7,14.11,14.65,2.14,2.91,3.12,4.28,3.15,11.05,3.66,1.96,4.74,14.38,2.52,3.7, +, +,CMGC,,,,5,1,27.7,cytosol,ATP binding,B cell receptor signaling pathway,,
B5MDL5,P53778,Mitogen-activated protein kinase 12,MAPK12,210.14,189.55,Y185,LDFGLARQADSEMTGYVVTRWYRAPEVILNW,_QADSEMTGY(ph)VVTR_,-0.35, ,1.74, ,0.31,0.41,-0.15,-0.24,-0.11, ,2.41, ,0.89,1.05,0.36,0.46,-0.35,1.74,0.36,-0.2,-0.11,2.41,0.97,0.41, +, +,CMGC,,,,4,4,26.64,,ATP binding,MAPK cascade,,
Q16539-3,Q16539,Mitogen-activated protein kinase 14,MAPK14,301.38,280.6,Y182,LDFGLARHTDDEMTGYVATRWYRAPEIMLNW,_HTDDEMTGY(ph)VATR_,-1.17,-1.26,2.16,1.51,-0.59,-0.51,-0.77,-0.73,-0.61,-0.63,2.13,1.45,-0.21,-0.14,-0.2,-0.22,0.24,2.37,0.54,0.33,0.43,2.58,0.64,0.71, +, +,CMGC,,,,4,4,33.77,cytosol,ATP binding,3'-UTR-mediated mRNA stabilization,,
Q16539-3,Q16539,Mitogen-activated protein kinase 14,MAPK14,58.98,57.44,T180,KILDFGLARHTDDEMTGYVATRWYRAPEIML,_HTDDEMT(ph)GY(ph)VATR_,-1.07, , , , , , , ,1.2, , , , , , , ,0.24,2.37,0.54,0.33,0.43,2.58,0.64,0.71, +, +,CMGC,,,,4,4,33.77,cytosol,ATP binding,3'-UTR-mediated mRNA stabilization,,
Q16539-3,Q16539,Mitogen-activated protein kinase 14,MAPK14,80.69,80.69,S2,______________MSQERPTFYRQELNKTI,_(ac)S(ph)QERPTFYR_,-0.29,-0.26,-0.37,-0.58,-0.14,-0.2,-0.42, ,0,-0.01,0.01,-0.27,-0.05,0.05,-0.23, ,-0.27,-0.47,-0.17,-0.42,-0.01,-0.12,0,-0.23,,,CMGC,,,,0,0,,cytosol,ATP binding,3'-UTR-mediated mRNA stabilization,,
Q8NDC0,Q8NDC0,MAPK-interacting and spindle-stabilizing protein-like,MAPK1IP1L,326.23,314.57,S15,_MSDEFSLADALPEHSPAKTSAVSNTKPGQP,_(ac)S(ph)DEFSLADALPEHS(ph)PAK_,-2.31,-2.41,-2.89,-2.85,-1.86,-2.08,-1.75,-2.03,-1.68,-1.95,-2.2,-2.19,-1.7,-1.69,-2.16,-2.23,-2.36,-2.87,-1.97,-1.88,-1.81,-2.2,-1.7,-2.19, +, +,,,,,3,3,28.08,,,,,
Q8NDC0,Q8NDC0,MAPK-interacting and spindle-stabilizing protein-like,MAPK1IP1L,165.47,160.85,S2,______________MSDEFSLADALPEHSPA,_(ac)S(ph)DEFSLADALPEHS(ph)PAK_, , , , , ,-1.23,-1.05, , , , , , ,-0.83,-0.88, ,,,-1.23,-1.05,,,-0.83,-0.88, +,,,,,,NA,NA,,,,,,
E9PJF0,P27361,Mitogen-activated protein kinase 3,MAPK3,294.78,289.53,T202,LARIADPEHDHTGFLTEYVATRWYRAPEIML,_IADPEHDHTGFLT(ph)EY(ph)VATR_,2.64,4.93,6.11,3.15,3.78,4.3,1.69,3.09,4.29,5.8,9.84,3.9,3.4,3.2,3.51,5.37,3.78,4.63,4.04,2.39,5.04,6.87,3.3,4.44, +, +,CMGC,,,,5,1,17.94,nucleus,ATP binding,MAPK cascade,,
E9PJF0,P27361,Mitogen-activated protein kinase 3,MAPK3,294.78,289.53,Y204,RIADPEHDHTGFLTEYVATRWYRAPEIMLNS,_IADPEHDHTGFLT(ph)EY(ph)VATR_,2.64,4.93,6.11,3.15,3.78,4.3,1.69,3.09,4.29,5.8,9.84,3.9,3.4,3.2,3.51,5.37,3.78,4.63,4.04,2.39,5.04,6.87,3.3,4.44, +, +,CMGC,,,,5,1,17.94,nucleus,ATP binding,MAPK cascade,,
E9PJF0,P27361,Mitogen-activated protein kinase 3,MAPK3,254.34,238.57,T207,DPEHDHTGFLTEYVATRWYRAPEIMLNSKGY,_IADPEHDHTGFLT(ph)EYVAT(ph)R_, , , ,1.84, , , , , , , ,2.15, , , , ,,1.84,,,,2.15,,, +, +,CMGC,,,,NA,NA,,nucleus,ATP binding,MAPK cascade,,
C9JUK9,Q13164,Mitogen-activated protein kinase 7,MAPK7,269.16,242.75,Y221,GLCTSPAEHQYFMTEYVATRWYRAPELMLSL,_GLCTSPAEHQYFMTEY(ph)VATR_,-0.66, ,3.65, ,2.06,1.99, , ,-0.32, ,3.42, ,2.5,2.6, , ,-0.66,3.65,2.03,,-0.32,3.42,2.55,, +, +,CMGC,,,,NA,NA,,cytosol,ATP binding,apoptotic process,,
H0Y9H3,P45983,Mitogen-activated protein kinase 8,MAPK8,189.09,188.1,Y185,FGLARTAGTSFMMTPYVVTRYYRAPEVILGM,_TAGTSFMMTPY(ph)VVTR_, , ,1.86, , , , , , , ,2.41, , , , , ,,1.86,,,,2.41,,, +, +,CMGC,,,,NA,NA,,,ATP binding,MAPK cascade,,
P45984-3,P45984,Mitogen-activated protein kinase 9,MAPK9,219.52,219.35,Y185,FGLARTACTNFMMTPYVVTRYYRAPEVILGM,_TACTNFMMTPY(ph)VVTR_, , ,2.81, , , , , , , ,2.99, , , , , ,,2.81,,,,2.99,,, +, +,CMGC,,,,NA,NA,,cytosol,ATP binding,cellular response to growth factor stimulus,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,345.23,345.23,S118,VEKEAPAEGEAAEPGSPTAAEGEAASAASST,_EAPAEGEAAEPGS(ph)PTAAEGEAASAASSTSSPK_,-0.81,-0.46,1.18,1.3,1.56,1.55,1.33,1.3,0.19,0.26,1.64,1.58,1.55,1.57,1.51,1.61,-0.63,1.24,1.56,1.31,0.22,1.61,1.56,1.56, +, +,,,,,1,1,27.71,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,153.54,146.17,S128,AAEPGSPTAAEGEAASAASSTSSPKAEDGAT,_EAPAEGEAAEPGSPTAAEGEAAS(ph)AAS(ph)ST(ph)SSPK_, , ,-1.71,-1.59,-1.11,-0.3,-0.09,-0.91, , ,-0.91,-1.06,-1.24,-1.01,-0.37,-0.61,,-1.64,-0.65,-0.44,,-0.98,-1.12,-0.48, +, +,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,166.16,166.16,S135,TAAEGEAASAASSTSSPKAEDGATPSPSNET,_EAPAEGEAAEPGS(ph)PTAAEGEAASAASS(ph)T(ph)SS(ph)PK_, ,-1.07, , ,-1.06,-0.18,-0.65,-0.5, ,-0.34, , ,-0.24,-0.32,-0.42,-0.4,-1.07,,-0.56,-0.58,-0.34,,-0.28,-0.41, +,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,354.14,354.14,S81,AADKEEPAAAGSGAASPSAAEKGEPAAAAAP,_EELQANGSAPAADKEEPAAAGSGAAS(ph)PSAAEK_,-1.08,-0.95,-0.94,-0.97,-0.48,-0.15,-0.18, ,-0.49,-0.44,-0.36,-0.24,-0.69,-0.72,-0.55, ,-1.01,-0.95,-0.3,-0.18,-0.46,-0.3,-0.71,-0.55, +,,,,,,3,0,3.95,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,131.04,100.55,S101,EKGEPAAAAAPEAGASPVEKEAPAEGEAAEP,_GEPAAAAAPEAGAS(ph)PVEK_,-0.15,-0.04,0.38,-0.04,0.72,0.71,0.82,0.88,0.02,0.04,0.52,0.53,0.88,0.71,1.29,1.36,-0.09,0.18,0.71,0.85,0.03,0.53,0.79,1.33,, +,,,,,0,2,25.7,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,101.46,58.74,S170,KKRFSFKKSFKLSGFSFKKNKKEAGEGGEAE,_LSGFS(ph)FK_,0.63,0.6,-0.14,0.15,0.68,0.77,0.96,0.91,1.51,1.66,1.28,1.23,0,-0.05,0.59,0.59,0.62,0.01,0.73,0.93,1.59,1.26,-0.02,0.59,, +,,,,,0,5,6.6,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,109.77,71.4,S145,ASSTSSPKAEDGATPSPSNETPKKKKKRFSF,_AEDGATPS(ph)PSNETPK_, , , , ,-0.44,-0.36,-0.24,-0.43, , , , ,-0.67,-1.22,-0.44,-0.33,,,-0.4,-0.33,,,-0.92,-0.38,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,128.36,103.28,S26,KGEAAAERPGEAAVASSPSKANGQENGHVKV,_GEAAAERPGEAAVAS(ph)SPSK_, , , ,-0.85, ,-0.16, ,-0.69, , , ,-0.59, ,-0.48, ,-0.5,,-0.85,-0.16,-0.69,,-0.59,-0.48,-0.5,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,271.64,271.64,S27,GEAAAERPGEAAVASSPSKANGQENGHVKVN,_GEAAAERPGEAAVASS(ph)PSK_,-0.77,-0.86,-1.02,-0.85,-0.49,-0.53,-0.5,-0.4,-0.54,-0.53,-0.57,-0.62,-0.56,-0.78,-0.48,-0.33,-0.82,-0.93,-0.51,-0.45,-0.54,-0.6,-0.67,-0.4,,,,,,,0,0,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,95.91,56.36,S159,PSPSNETPKKKKKRFSFKKSFKLSGFSFKKN,_RFS(ph)FKK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,133.45,128.07,S46,ANGQENGHVKVNGDASPAAAESGAKEELQAN,_VNGDAS(ph)PAAAESGAK_, , , , ,-0.41,-0.57,-0.58,-0.69, , , , ,-0.58,-0.28,-0.53,-0.32,,,-0.49,-0.63,,,-0.42,-0.42,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P29966,P29966,Myristoylated alanine-rich C-kinase substrate,MARCKS,169.62,169.57,T150,SPKAEDGATPSPSNETPKKKKKRFSFKKSFK,_AEDGATPSPSNET(ph)PKK_, , , , ,0.18,0.41,-0.04,0.23, , , , ,-0.51,-0.4,-0.3,0.13,,,0.3,0.1,,,-0.46,-0.07,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,energy reserve metabolic process,,
P49006,P49006,MARCKS-related protein,MARCKSL1,144.67,144.39,S162,ATPESQEPQAKGAEASAASEEEAGPQATEPS,_GAEAS(ph)AAS(ph)EEEAGPQATEPSTPSGPESGPTPASAEQNE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,positive regulation of cell proliferation,,
P49006,P49006,MARCKS-related protein,MARCKSL1,99.66,99.43,S165,ESQEPQAKGAEASAASEEEAGPQATEPSTPS,_GAEAS(ph)AAS(ph)EEEAGPQATEPSTPSGPESGPTPASAEQNE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,positive regulation of cell proliferation,,
P49006,P49006,MARCKS-related protein,MARCKSL1,191.78,181.93,S22,KAPRGDVTAEEAAGASPAKANGQENGHVKSN,_GDVTAEEAAGAS(ph)PAK_,-0.1,-0.12,-0.32,-0.37,-0.36,-0.37,-0.45,-0.53,-0.05,0,-0.07,0.04,-0.53,-0.48,-0.5,-0.24,-0.11,-0.34,-0.36,-0.49,-0.02,-0.01,-0.5,-0.36,,,,,,,0,0,,cytoplasm,,positive regulation of cell proliferation,,
P49006,P49006,MARCKS-related protein,MARCKSL1,123.79,104.81,S104,KKKFSFKKPFKLSGLSFKRNRKEGGGDSSAS,_LSGLS(ph)FKR_, , , , ,0.6,0.81, , , , , , ,-0.37,0.12, , ,,,0.71,,,,-0.1,,,,,,,,NA,NA,,cytoplasm,,positive regulation of cell proliferation,,
Q7KZI7-10,Q7KZI7,Serine/threonine-protein kinase MARK2,MARK2,65.81,59.5,S486,STNSVLSTSTNRSRNSPLLERASLGQASIQN,_SRNS(ph)PLLER_, ,0.45, , , , , , , ,0.67, , , , , , ,0.45,,,,0.67,,,,,,CAMK,,,,NA,NA,,basal cortex,ATP binding,establishment of cell polarity,,
Q7KZI7-10,Q7KZI7,Serine/threonine-protein kinase MARK2,MARK2,81.63,72.31,S456,RESGRKASSTAKVPASPLPGLERKKTTPTPS,_VPAS(ph)PLPGLER_, , , , ,0.02,0.16,0.31,0.38, , , , ,-0.53,-0.27,-0.12,-0.03,,,0.09,0.35,,,-0.39,-0.07,,,CAMK,,,,NA,NA,,basal cortex,ATP binding,establishment of cell polarity,,
H0YKP9,P27448,MAP/microtubule affinity-regulating kinase 3,MARK3,106.42,101.41,S469,KSSGSAVGGKGIAPASPMLGNASNPNKADIP,_GIAPAS(ph)PMLGNASNPNK_, , , , , ,0.4,0.69,0.56, , , , , ,0.94,1.37,0.51,,,0.4,0.63,,,0.94,1.01,, +,CAMK,,,,NA,NA,,,,,,
A1BQX2,Q8N4S9,MARVEL domain-containing protein 2,MARVELD2,123.01,108.56,Y469,ERERYKAVFQDQFSEYKELSAEVQAVLRKFD,_AVFQDQFSEY(ph)K_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
A1BQX2,Q8N4S9,MARVEL domain-containing protein 2,MARVELD2,87.67,87.31,Y23,RNRDRRYDEVPSDLPYQDTTIRTHPTLHDSE,_RYDEVPSDLPY(ph)QDTTIR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
E9PBM6,Q6P0Q8,Microtubule-associated serine/threonine-protein kinase 2,MAST2,62.21,62.05,S1503,RRESLQKQEAIREVDSSEDDTEEGPENSQGA,_EVDS(ph)S(ph)EDDTEEGPENSQGAQELSLAPHPEVSQSVAPK_, , , , ,-0.07, , ,0.55, , , , ,0.23, , ,0.2,,,-0.07,0.55,,,0.23,0.2,,,AGC,,,,NA,NA,,,,,,
E9PBM6,Q6P0Q8,Microtubule-associated serine/threonine-protein kinase 2,MAST2,62.21,62.05,S1504,RESLQKQEAIREVDSSEDDTEEGPENSQGAQ,_EVDS(ph)S(ph)EDDTEEGPENSQGAQELSLAPHPEVSQSVAPK_, , , , ,-0.07, , ,0.55, , , , ,0.23, , ,0.2,,,-0.07,0.55,,,0.23,0.2,,,AGC,,,,NA,NA,,,,,,
Q96GX5-2,Q96GX5,Serine/threonine-protein kinase greatwall,MASTL,117.3,117.3,S875,TSYFEARNTAQHLTVSGFSL___________,_NTAQHLTVS(ph)GFS(ph)L_, , , , , , , , , , , , , , , , ,,,,,,,,,,,AGC,,,,NA,NA,,centrosome,ATP binding,cell division,,
Q96GX5-2,Q96GX5,Serine/threonine-protein kinase greatwall,MASTL,117.3,117.3,S878,FEARNTAQHLTVSGFSL______________,_NTAQHLTVS(ph)GFS(ph)L_, , , , , , , , , , , , , , , , ,,,,,,,,,,,AGC,,,,NA,NA,,centrosome,ATP binding,cell division,,
P43243,P43243,Matrin-3,MATR3,160.01,160.01,S188,VPRDDWEEKRHFRRDSFDDRGPSLNPVLDYD,_RDS(ph)FDDRGPSLNPVLDYDHGSR_, , , ,1.85,2.54,1.89, , , , , ,2.22,2.43,1.83, , ,,1.85,2.25,,,2.22,2.16,, +, +,,,,,NA,NA,,nuclear inner membrane,nucleotide binding,,,
P43243,P43243,Matrin-3,MATR3,81.88,81.88,S598,GIDLLKKDKSRKRSYSPDGKESPSDKKSKTD,_SYS(ph)PDGKES(ph)PSDKK_, , , , , ,-0.06,-0.38,-0.14, , , , , ,-0.73,-0.51,-0.37,,,-0.06,-0.26,,,-0.73,-0.44,,,,,,,NA,NA,,nuclear inner membrane,nucleotide binding,,,
P43243,P43243,Matrin-3,MATR3,81.88,81.88,S604,KDKSRKRSYSPDGKESPSDKKSKTDGSQKTE,_SYS(ph)PDGKES(ph)PSDKK_, , , , , ,-0.06,-0.38,-0.14, , , , , ,-0.73,-0.51,-0.37,,,-0.06,-0.26,,,-0.73,-0.44,,,,,,,NA,NA,,nuclear inner membrane,nucleotide binding,,,
P43243,P43243,Matrin-3,MATR3,276.37,276.37,S766,ADDPNKDTSENADGQSDENKDDYTIPDEYRI,_DTSENADGQS(ph)DENKDDYTIPDEYR_,0.15,0.07,-0.09,0.13,-0.23,0.08,-0.39, ,0.03,0.1,0.03,-0.11,-0.3,-0.38,-0.31, ,0.11,0.02,-0.06,-0.39,0.07,-0.04,-0.34,-0.31,,,,,,,0,0,,nuclear inner membrane,nucleotide binding,,,
A6NH73,P61244,Protein max,MAX,243.24,243.24,S2,______________MSDNDDIEVESDEEQPR,_(ac)S(ph)DNDDIEVES(ph)DEEQPR_, , , ,0.34,0.21,-0.03,0.07,0.01, , , ,0.13,0.12,-0.19,0.04,-0.13,,0.34,0.09,0.04,,0.13,-0.02,-0.04,,,,,,,NA,NA,,,,,,
A6NH73,P61244,Protein max,MAX,243.24,243.24,S11,_____MSDNDDIEVESDEEQPRFQSAADKRA,_(ac)S(ph)DNDDIEVES(ph)DEEQPR_, ,0.11, ,0.34,0.21,-0.03,0.07,-0.5, ,-0.56, ,0.13,0.12,-0.19,0.04,-0.31,0.11,0.34,0.09,-0.19,-0.56,0.13,-0.02,-0.12,,,,,,,0,0,,,,,,
Q9UBB5-2,Q9UBB5,Methyl-CpG-binding domain protein 2,MBD2,232.62,232.62,S407,LSRAADTEEMDIEMDSGDEA___________,_AADTEEM(ox)DIEM(ox)DS(ph)GDEA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,cellular protein complex assembly,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,359.3,359.3,S139,AGRGLGRMRRGLLYDSDEEDEERPARKRRQV,_GLLYDS(ph)DEEDEERPARK_,-0.13,-0.06,-0.33,-0.25,0.07,0.07,0.02,-0.03,-0.07,-0.5,-0.05,-0.06,0.05,0.01,-0.06,-0.11,-0.1,-0.29,0.07,0,-0.27,-0.05,0.03,-0.08,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,183.6,180.17,S4,____________MAESSESFTMASSPAQRRR,_(ac)AES(ph)S(ph)ESFTMASSPAQR_, , , , ,0.34,0.33,0.24,0.41, , , , ,0.06,0.23,0.25,0.17,,,0.34,0.33,,,0.15,0.21,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,158.08,155.7,S5,___________MAESSESFTMASSPAQRRRG,_(ac)AES(ph)S(ph)ESFTMAS(ph)SPAQR_, , , , ,0.53,0.29,0.26,0.84, , , , ,0.46,0.53,0.27,0.38,,,0.42,0.58,,,0.5,0.32,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,198.84,196.29,S7,_________MAESSESFTMASSPAQRRRGND,_(ac)AES(ph)SES(ph)FTMASS(ph)PAQR_, , , , ,0.3,0.33,-0.43,-0.02, , , , ,0.04,0.23,-0.32,-0.04,,,0.32,-0.21,,,0.14,-0.17,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,299.71,299.71,S12,____MAESSESFTMASSPAQRRRGNDPLTSS,_(ac)AESSESFTMAS(ph)S(ph)PAQR_,-0.15,-0.05, ,-0.37,-0.33,-0.14,-0.34,-0.29,-0.25,-0.03, ,0.43,-0.35,-0.13,-0.25,-0.27,-0.1,-0.37,-0.23,-0.31,-0.14,0.43,-0.23,-0.26,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,329.59,329.59,S13,___MAESSESFTMASSPAQRRRGNDPLTSSP,_(ac)AESSESFTMAS(ph)S(ph)PAQR_,-0.06,-0.2,-0.38,-0.35,-0.22,-0.23,-0.35,-0.38,0.02,-0.06,0.01,0.2,-0.12,-0.23,-0.31,-0.28,-0.13,-0.36,-0.23,-0.37,-0.02,0.11,-0.18,-0.29,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,192.72,149.61,T9,_______MAESSESFTMASSPAQRRRGNDPL,_(ac)AESSESFT(ph)MASSPAQR_, , ,-0.37, , , , , , , ,0.31, , , , , ,,-0.37,,,,0.31,,,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,122.68,119.93,S108,EGLALDDEDVEELTASQREAAERAMRQRDRE,_AIPELDAYEAEGLALDDEDVEELTAS(ph)QR_,-0.1,-0.26,-0.1, , ,-0.09,-0.33, ,-0.25,0.05,-0.68, , ,-0.09,-0.14, ,-0.18,-0.1,-0.09,-0.33,-0.09,-0.68,-0.09,-0.14,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,89.97,89.83,S53,LTSSPGRDLPPFEDESEGLLGTEGPLEEEED,_DLPPFEDES(ph)EGLLGT(ph)EGPLEEEEDGEELIGDGMER_, , , , , , ,0.28,0.14, , , , , , ,0.55,0.36,,,,0.21,,,,0.45,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,71.08,71.08,S26,ASSPAQRRRGNDPLTSSPGRSSRRTDALTSS,_GNDPLTS(ph)S(ph)PGR_,-0.3,-0.36, , ,-0.05, ,-0.36,0.14,-0.38,-0.13, , ,-0.14, ,-0.12,-0.43,-0.33,,-0.05,-0.09,-0.25,,-0.14,-0.27,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,196.18,174.93,S27,SSPAQRRRGNDPLTSSPGRSSRRTDALTSSP,_GNDPLTSS(ph)PGR_,-0.21,-0.18,-0.35,-0.3,0.01,0.08,-0.11,-0.12,-0.14,-0.15,-0.17,-0.08,-0.04,-0.1,-0.16,-0.18,-0.19,-0.32,0.04,-0.11,-0.15,-0.12,-0.07,-0.17,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,139.77,40.22,S40,TSSPGRSSRRTDALTSSPGRDLPPFEDESEG,_RTDALTS(ph)S(ph)PGR_,-0.34,-0.11,-0.59, ,0.32,0.13,-0.04,-0.22,-0.22,0.01,-0.12, ,0.18,-0.1,-0.28,-0.35,-0.22,-0.59,0.23,-0.13,-0.1,-0.12,0.04,-0.32,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,158.35,92.58,S41,SSPGRSSRRTDALTSSPGRDLPPFEDESEGL,_RTDALTS(ph)S(ph)PGR_,-0.34,-0.22,-0.48,-0.47,-0.05,0.05,0,-0.29,-0.15,-0.08,-0.13,-0.03,-0.03,0,-0.21,-0.24,-0.28,-0.47,0,-0.14,-0.12,-0.08,-0.02,-0.23,,,,,,,0,0,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,89.97,89.83,T59,RDLPPFEDESEGLLGTEGPLEEEEDGEELIG,_DLPPFEDES(ph)EGLLGT(ph)EGPLEEEEDGEELIGDGMER_, , , , , , ,0.28,0.14, , , , , , ,0.55,0.36,,,,0.21,,,,0.45,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P49736,P49736,DNA replication licensing factor MCM2,MCM2,124.46,124.46,T25,MASSPAQRRRGNDPLTSSPGRSSRRTDALTS,_RGNDPLT(ph)S(ph)SPGR_,-0.09,0.02, , , , , , ,-0.04,-0.2, , , , , , ,-0.03,,,,-0.12,,,,,,,,,,NA,NA,,chromatin,ATP binding,DNA replication initiation,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,161.14,159.85,S704,RKRRKTRQPDAKDGDSYDPYDFSDTEEEMPQ,_DGDS(ph)YDPYDFS(ph)DTEEEMPQVHT(ph)PK_, , , , , ,-0.09,-0.21,-0.24, , , , , ,0.03,-0.11,-0.24,,,-0.09,-0.22,,,0.03,-0.17,,,,,,,NA,NA,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,293.13,292.61,S711,QPDAKDGDSYDPYDFSDTEEEMPQVHTPKTA,_DGDSYDPYDFS(ph)DT(ph)EEEMPQVHTPK_,-0.22,-0.15,-0.47,-0.39,-0.08,-0.07,-0.31,-0.23,-0.06,-0.06,-0.04,-0.12,-0.01,-0.07,-0.04,-0.04,-0.18,-0.43,-0.07,-0.27,-0.06,-0.08,-0.04,-0.04,,,,,,,0,0,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,224.38,224.38,S668,YFKKVLEKEKKRKKRSEDESETEDEEEKSQE,_KRS(ph)EDES(ph)ET(ph)EDEEEK_, , ,-0.28, , ,0.38, ,0.32, , ,-0.32, , ,0.31, ,0.5,,-0.28,0.38,0.32,,-0.32,0.31,0.5,,,,,,,NA,NA,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,272.3,272.3,S672,VLEKEKKRKKRSEDESETEDEEEKSQEDQEQ,_RSEDES(ph)ET(ph)EDEEEK_,-0.23,-0.2,-0.45,-0.55,-0.13,-0.14,-0.37,-0.47,-0.32,-0.36,-0.48,-0.45,-0.18,-0.01,-0.49,-0.4,-0.22,-0.5,-0.14,-0.42,-0.34,-0.47,-0.09,-0.44,,,,,,,0,0,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,233.71,233.71,T713,DAKDGDSYDPYDFSDTEEEMPQVHTPKTADS,_DGDSYDPYDFS(ph)DT(ph)EEEMPQVHT(ph)PK_,-0.16,-0.11,0.03,-0.03,0.07,0.06,0.1,-0.01,-0.01,0,0.03,-0.16,0.25,0.23,0.16,0.05,-0.14,0,0.06,0.04,0,-0.06,0.24,0.11,,,,,,,0,0,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,238.86,238.15,T722,PYDFSDTEEEMPQVHTPKTADSQETKESQKV,_DGDSYDPYDFS(ph)DT(ph)EEEMPQVHT(ph)PK_,-0.24,-0.18,-0.38,-0.39,-0.07,-0.08,0.08,-0.09,-0.03,-0.02,0.21,-0.05,-0.12,-0.07,-0.1,-0.07,-0.21,-0.38,-0.08,0,-0.02,0.09,-0.1,-0.09,,,,,,,0,0,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
P25205,P25205,DNA replication licensing factor MCM3,MCM3,260.03,260.03,T674,EKEKKRKKRSEDESETEDEEEKSQEDQEQKR,_RSEDES(ph)ET(ph)EDEEEK_,0.11,-0.4,-0.41,-0.36,-0.13,0.1,0.02,-0.16,0.17,-0.47,0.04,0,-0.18,0.09,-0.19,-0.15,-0.12,-0.38,-0.01,-0.07,-0.11,0.02,-0.04,-0.17,,,,,,,0,0,,alpha DNA polymerase:primase complex,ATP binding,DNA duplex unwinding,,
Q14566,Q14566,DNA replication licensing factor MCM6,MCM6,237.39,237.39,S762,ELVNWYLKEIESEIDSEEELINKKRIIEKVI,_EIESEIDS(ph)EEELINK_,0.22,-0.18,-0.38,0.14,0.33,-0.19,0.39,0.06,0.1,0.51,-0.04,0.19,-0.28,-0.4,-0.58,-0.3,0.04,-0.1,0.09,0.23,0.32,0.08,-0.34,-0.43,,,,,,,0,0,,MCM complex,ATP binding,DNA replication initiation,,
Q14566,Q14566,DNA replication licensing factor MCM6,MCM6,44.83,44.83,S13,___MDLAAAAEPGAGSQHLEVRDEVAEKCQK,_(ac)MDLAAAAEPGAGS(ph)QHLEVR_, , ,-0.19, , , , , , , ,0.01, , , , , ,,-0.19,,,,0.01,,,,,,,,,NA,NA,,MCM complex,ATP binding,DNA replication initiation,,
Q9BTE3-2,Q9BTE3,Mini-chromosome maintenance complex-binding protein,MCMBP,54.1,48.89,S167,RVSPSTSYTPSRHKRSYEDDDDMDLQPNKQK,_S(ph)YEDDDDMDLQPNK_, , , , , , ,-0.47, , , , , , , ,0.13, ,,,,-0.47,,,,0.13,,,,,,,NA,NA,,cytoplasm,chromatin binding,cell division,,
Q96EZ8,Q96EZ8,Microspherule protein 1,MCRS1,202.15,185.16,S282,QTVQPLPKGDQVLNFSDAEDLIDDSKLKDMR,_GDQVLNFS(ph)DAEDLIDDSK_, , ,-0.15, , , , , , , ,-0.1, , , , , ,,-0.15,,,,-0.1,,,,,,,,,NA,NA,,cytoplasm,,DNA recombination,,
Q96EZ8,Q96EZ8,Microspherule protein 1,MCRS1,122.24,116.58,S20,SQGLLDSSLMASGTASRSEDEESLAGQKRAS,_DSQGLLDSSLMASGTAS(ph)RS(ph)EDEESLAGQK_, , , , , ,-0.25, , , , , , , ,-0.01, , ,,,-0.25,,,,-0.01,,,,,,,,NA,NA,,cytoplasm,,DNA recombination,,
Q96EZ8,Q96EZ8,Microspherule protein 1,MCRS1,91.21,90.07,S22,GLLDSSLMASGTASRSEDEESLAGQKRASSQ,_DSQGLLDSSLMASGTAS(ph)RS(ph)EDEESLAGQK_, , , , , ,-0.19, , , , , , , ,0.01, , ,,,-0.19,,,,0.01,,,,,,,,NA,NA,,cytoplasm,,DNA recombination,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,125.39,122.33,S329,AEVHLERAQPFGFIDSDTDAEEERIPATPVV,_AQPFGFIDS(ph)DT(ph)DAEEER_, , , , ,0.25,-0.29, , , , , , ,0.48,0.19, , ,,,0,,,,0.34,,,,,,,,NA,NA,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,109.03,97.81,S495,LVRAHSEKDQPPFGDSDDSVEADKSSPGIHL,_DQPPFGDS(ph)DDS(ph)VEADK_, , , , ,-0.22,-0.33,-0.45,-0.6, , , , ,-0.09,-0.11,-0.21,-0.16,,,-0.27,-0.52,,,-0.1,-0.18,,,,,,,NA,NA,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,109.03,97.81,S498,AHSEKDQPPFGDSDDSVEADKSSPGIHLERS,_DQPPFGDS(ph)DDS(ph)VEADK_, , , , ,-0.22,-0.33,-0.45,-0.6, , , , ,-0.09,-0.11,-0.21,-0.16,,,-0.27,-0.52,,,-0.1,-0.18,,,,,,,NA,NA,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,282.44,282.44,S453,RVVLLQRSQTTTERDSDTDVEEEELPVENRE,_SQTTTERDS(ph)DT(ph)DVEEEELPVENR_,0.31,0.26,-0.06, ,0.03,0.14,0.06,-0.03,0.27,0.19,-0.04, ,-0.02,0.09,-0.33,-0.61,0.29,-0.06,0.08,0.02,0.23,-0.04,0.03,-0.46,,,,,,,0,0,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,125.39,122.33,T331,VHLERAQPFGFIDSDTDAEEERIPATPVVIP,_AQPFGFIDS(ph)DT(ph)DAEEER_, , , , ,0.25,-0.29, , , , , , ,0.48,0.19, , ,,,0,,,,0.34,,,,,,,,NA,NA,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,282.44,282.44,T455,VLLQRSQTTTERDSDTDVEEEELPVENREAV,_SQTTTERDS(ph)DT(ph)DVEEEELPVENR_,0.31,0.26,-0.06,0,0.03,0.11,0.01,-0.2,0.27,0.19,-0.04,0.02,-0.02,-0.12,-0.37,-0.63,0.29,-0.03,0.07,-0.09,0.23,-0.01,-0.07,-0.5,,,,,,,0,0,,chromosome,,cell cycle,,
Q14676-4,Q14676,Mediator of DNA damage checkpoint protein 1,MDC1,114.63,112.6,S168,VQGETQPQRLLLAEDSEEEVDFLSERRMVKK,_LLLAEDS(ph)EEEVDFLSER_, , , , , , ,0.06, , , , , , , ,0.22, ,,,,0.06,,,,0.22,,,,,,,NA,NA,,chromosome,,cell cycle,,
C9J784,Q9P1T7,MyoD family inhibitor domain-containing protein,MDFIC,87.06,85.98,S140,APVSQKMHRKIQSSLSVNSDISKKSKVNAVF,_IQSSLS(ph)VNS(ph)DISK_, , , , ,-0.13, , , , , , , ,0.35, , , ,,,-0.13,,,,0.35,,,,,,,,NA,NA,,Golgi apparatus,,negative regulation of protein import into nucleus,,
Q9NU22,Q9NU22,Midasin,MDN1,274.34,274.34,S4538,EERKNEKAEENTDQASPQEDYAGFERLQSGH,_AEENTDQAS(ph)PQEDYAGFER_,-0.6,-0.6,-0.59,-0.5,-0.54,-0.35,-0.75,-0.69,-0.38,-0.21,-0.34,-0.45,-0.37,-0.08,-0.37,-0.46,-0.6,-0.55,-0.44,-0.72,-0.29,-0.39,-0.22,-0.42,,,,,,,0,0,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,127.57,127.57,S5015,ADQGFQPQEEEEREDSDTEEQVPEALERKEH,_EADEEGGENGPADQGFQPQEEEEREDS(ph)DTEEQVPEALER_, , , , , , ,-0.72,-0.35, , , , , , , ,-0.29,,,,-0.52,,,,-0.29,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,74.81,73.78,S4935,HEAEERGETETDQNESQSPQEPEEGPSEDDK,_GETETDQNES(ph)QS(ph)PQEPEEGPSEDDK_, , , , , ,0.28, ,-0.32, , , , , ,0.09, ,-0.47,,,0.28,-0.32,,,0.09,-0.47,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,47.23,47.01,S4937,AEERGETETDQNESQSPQEPEEGPSEDDKAE,_GETETDQNES(ph)QS(ph)PQEPEEGPSEDDK_, , , , , , , ,-0.49, , , , , , , ,-0.55,,,,-0.49,,,,-0.55,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,74.81,73.78,S4946,DQNESQSPQEPEEGPSEDDKAEGEEEMDTGA,_GETETDQNES(ph)QSPQEPEEGPS(ph)EDDK_, , , , , ,0.28,-0.18, , , , , , ,0.09,-0.19, ,,,0.28,-0.18,,,0.09,-0.19,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,283.43,282.52,S4752,MHDGELEEQEEDDEKSDSEGGDLDKHMGDLN,_MHDGELEEQEEDDEKS(ph)DS(ph)EGGDLDK_,-0.06, ,-0.3,-0.21, , , , ,0.32, ,0.01,0.27, , , , ,-0.06,-0.25,,,0.32,0.15,,,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,283.43,282.52,S4754,DGELEEQEEDDEKSDSEGGDLDKHMGDLNGE,_MHDGELEEQEEDDEKS(ph)DS(ph)EGGDLDK_,-0.06, ,-0.3,-0.21, , , , ,0.32, ,0.01,0.27, , , , ,-0.06,-0.25,,,0.32,0.15,,,,,,,,,NA,NA,,nucleolus,ATP binding,protein complex assembly,,
Q9NU22,Q9NU22,Midasin,MDN1,380.81,367.15,T4898,DDLNLDSEDKNGGEDTDNEEGEEENPLEIKE,_NGGEDT(ph)DNEEGEEENPLEIK_,-0.14,-0.24,-0.36,-0.19,-0.26,-0.3,-0.39,-0.53,-0.04,-0.04,-0.16,-0.06,-0.21,-0.06,-0.24,-0.3,-0.19,-0.27,-0.28,-0.46,-0.04,-0.11,-0.13,-0.27,,,,,,,0,0,,nucleolus,ATP binding,protein complex assembly,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,83.41,83.41,S1207,SPSHSRPPGGSDKLASPMKPVPGTPPSSKAK,_LAS(ph)PMKPVPGT(ph)PPSSK_,0.29,0.61,0.74,1.34,-0.01, , ,0.73,0.04,0.04,0.16,0.22,0.17, , ,0.48,0.46,1.07,-0.01,0.73,0.04,0.19,0.17,0.48, +,,,,,,4,0,10.71,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,83.41,83.41,T1215,GGSDKLASPMKPVPGTPPSSKAKSPISSGSG,_LAS(ph)PMKPVPGT(ph)PPSSK_,0.29,0.61,0.74,1.34,-0.01, , ,0.73,0.04,0.04,0.16,0.22,0.17, , ,0.48,0.46,1.07,-0.01,0.73,0.04,0.19,0.17,0.48, +,,,,,,4,0,10.71,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,61.68,57.19,T1051,STGGSKSPGSAGRSQTPPGVATPPIPKITIQ,_SQT(ph)PPGVATPPIPK_, ,0.13, , ,0.31, , , , ,1.21, , ,0.14, , , ,0.13,,0.31,,1.21,,0.14,,, +,,,,,NA,NA,,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,82.27,82.27,S1433,GEGLRPQMASSKNYGSPLISGSTPKHERGSP,_NYGS(ph)PLISGS(ph)TPK_, , , , ,-0.44,-0.24,-0.01,0.37, , , , ,-0.58,-0.82,-0.17,-0.23,,,-0.33,0.19,,,-0.69,-0.2,,,,,,,NA,NA,,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,85.62,85.35,S1475,NLDSESESGSSIAEKSYQNSPSSDDGIRPLP,_S(ph)YQNS(ph)PSS(ph)DDGIRPLPEYSTEK_, , , , , ,-0.29, , , , , , , ,-0.73, , ,,,-0.29,,,,-0.73,,,,,,,,NA,NA,,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,161.04,142.07,S1479,ESESGSSIAEKSYQNSPSSDDGIRPLPEYST,_SYQNS(ph)PSS(ph)DDGIRPLPEYSTEK_, , ,-0.13, ,0.18,0.07,0.14,0.1, , ,-0.23, ,0.01,-0.34,0.11,0.06,,-0.13,0.13,0.12,,-0.23,-0.15,0.09,,,,,,,NA,NA,,mediator complex,chromatin binding,androgen biosynthetic process,,
Q15648,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,161.04,142.07,S1482,SGSSIAEKSYQNSPSSDDGIRPLPEYSTEKH,_SYQNS(ph)PSS(ph)DDGIRPLPEYSTEK_, , ,-0.13, ,0.18,0.07,0.04,0.1, , ,-0.23, ,0.01,-0.34,0.09,0.06,,-0.13,0.13,0.07,,-0.23,-0.15,0.07,,,,,,,NA,NA,,mediator complex,chromatin binding,androgen biosynthetic process,,
F5H3Y1,Q93074,Mediator of RNA polymerase II transcription subunit 12,MED12,66.58,66.58,S635,SRGDLAFGAPGPRPPSPFDDPADDPEHKEAE,_GDLAFGAPGPRPPS(ph)PFDDPADDPEHK_,-0.06,0.41,-0.51,0.56, , , , ,-0.1,-0.2,-0.15,-0.18, , , , ,0.2,0.12,,,-0.15,-0.17,,,,,,,,,NA,NA,,,,,,
Q71F56,Q71F56,Mediator of RNA polymerase II transcription subunit 13-like,MED13L,132.14,132.14,S923,TQLTEFKMEVEDGLGSPKPEEIKDFSYVHKV,_MEVEDGLGS(ph)PKPEEIK_,0.28,-0.46,-0.75,-0.29, ,0.01,0.25, ,-0.26,0.03,-0.5,-0.36, ,-0.18,0.41, ,-0.04,-0.5,0.01,0.25,-0.11,-0.43,-0.18,0.41,,,,,,,0,0,,mediator complex,RNA polymerase II transcription cofactor activity,,,
O60244,O60244,Mediator of RNA polymerase II transcription subunit 14,MED14,52.25,51.67,S1112,YTMVSPSGRAGNWPGSPQVSGPSPAARMPGM,_AGNWPGS(ph)PQVSGPS(ph)PAAR_, , , , , ,-0.8,-0.64,-1.22, , , , , ,-0.62,-0.7,-0.75,,,-0.8,-0.9,,,-0.62,-0.73,,,,,,,NA,NA,,mediator complex,ligand-dependent nuclear receptor transcription coactivator activity,androgen receptor signaling pathway,,
O60244,O60244,Mediator of RNA polymerase II transcription subunit 14,MED14,52.25,51.67,S1119,GRAGNWPGSPQVSGPSPAARMPGMSPANPSL,_AGNWPGS(ph)PQVSGPS(ph)PAAR_, , , , , ,-0.8,-0.64,-1.22, , , , , ,-0.62,-0.7,-0.75,,,-0.8,-0.9,,,-0.62,-0.73,,,,,,,NA,NA,,mediator complex,ligand-dependent nuclear receptor transcription coactivator activity,androgen receptor signaling pathway,,
F8W9R9,O75448,Mediator of RNA polymerase II transcription subunit 24,MED24,286.25,271.62,S862,FPLDDVQPSKLMRLLSSNEDDANILSSPTDR,_LLS(ph)SNEDDANILSS(ph)PTDR_, ,-0.05,2.93,2.3,1.3,0.65,2.04,1.99, ,0.91,3.14,2.27,1.7,0.78,1.93,1.49,-0.05,2.65,1.01,2.02,0.91,2.77,1.31,1.73, +, +,,,,,1,4,27.24,,,,,
F8W9R9,O75448,Mediator of RNA polymerase II transcription subunit 24,MED24,254.44,230.39,S873,MRLLSSNEDDANILSSPTDRSMSSSLSASQL,_LLS(ph)SNEDDANILSS(ph)PTDR_,-0.16,-0.11,-0.8,-0.49,2.12,2.38,0.74,1.99,0.11,0.09,-0.55,-0.74,2.64,2.46,0.81,1.49,-0.14,-0.64,2.25,1.5,0.1,-0.64,2.55,1.19, +, +,,,,,2,2,34.68,,,,,
D6RC63,Q06413,Myocyte-specific enhancer factor 2C,MEF2C,96.2,91.66,S222,GAGTSAGNGYGNPRNSPGLLVSPGNLNKNMQ,_NS(ph)PGLLVSPGNLNK_,-0.7,-0.81, , , , ,0.39,0.71,0.08,0.13, , , , ,-0.44,-0.09,-0.75,,,0.56,0.1,,,-0.26,,,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q14814-6,Q14814,Myocyte-specific enhancer factor 2D,MEF2D,131.32,126.34,S180,TPSLVTSSLTDPRLLSPQQPALQRNSVSPGL,_LLS(ph)PQQPALQR_,-0.66,-0.61,-0.76,-0.74, ,-0.3,1.2,1.07,0.17,-0.25,0.22,0.65, ,-0.25,0.03,0.34,-0.63,-0.75,-0.3,1.14,-0.03,0.45,-0.25,0.19, +,,,,,,3,0,1.57,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,adult heart development,,
Q14814-6,Q14814,Myocyte-specific enhancer factor 2D,MEF2D,60.06,58.21,S231,ACPSPVGNGYVSARASPGLLPVANGNSLNKV,_AS(ph)PGLLPVANGNSLNK_, , , , ,-0.79, ,-0.66,-0.1, , , , ,-0.94, ,-0.15,-0.14,,,-0.79,-0.35,,,-0.94,-0.15,,,,,,,NA,NA,,nucleus,RNA polymerase II regulatory region sequence-specific DNA binding,adult heart development,,
F5H2R4,Q14680,Maternal embryonic leucine zipper kinase,MELK,76.07,66.88,Y438,KENVYTPKSAVKNEEYFMFPEPKTPVNKNQH,_NEEY(ph)FMFPEPK_,3.5, , , , , , , ,2.83, , , , , , , ,3.5,,,,2.83,,,, +, +,CAMK,,,,NA,NA,,,,,,
F5H2R4,Q14680,Maternal embryonic leucine zipper kinase,MELK,97.08,92.36,S356,QASATPFTDIKSNNWSLEDVTASDKNYVAGL,_SNNWS(ph)LEDVTASDK_, , , , ,0.04,-0.52,-0.13,-0.31, , , , ,0.13,-0.24,0.36,-0.08,,,-0.21,-0.21,,,-0.04,0.16,,,CAMK,,,,NA,NA,,,,,,
F5H2R4,Q14680,Maternal embryonic leucine zipper kinase,MELK,107.21,76.61,S529,HMEETPKRKGAKVFGSLERGLDKVITVLTRS,_VFGS(ph)LER_,-0.56,-0.69,-0.53,-0.64,-0.05,-0.15,-0.01,0,0.21,0.14,0.56,0.5,0.02,-0.23,0.14,0.14,-0.62,-0.59,-0.1,0,0.17,0.53,-0.1,0.14,,,CAMK,,,,0,0,,,,,,
Q7L2J0,Q7L2J0,7SK snRNA methylphosphate capping enzyme,MEPCE,94.19,94.19,T213,NSLLDEEVSRTLNAETPKSSPLPAKGRDPVE,_TLNAET(ph)PKS(ph)SPLPAK_, ,0.25, ,0.05,-0.38,-0.13,-0.43,-0.34, ,-0.28, ,0.95,-0.51,-0.27,-0.57,-0.45,0.25,0.05,-0.25,-0.38,-0.28,0.95,-0.38,-0.51,,,,,,,0,0,,,RNA methyltransferase activity,snRNA modification,,
P08581,P08581,Hepatocyte growth factor receptor,MET,257.35,256.77,Y1003,SVSPTTEMVSNESVDYRATFPEDQFPNSSQN,_SVSPTTEMVSNESVDY(ph)R_,-1.59, ,-1.7, ,-0.96,-0.84,-0.86,-0.83,-1.86, ,-1.53, ,-0.87,-0.84,-0.5,-0.56,-1.59,-1.7,-0.9,-0.85,-1.86,-1.53,-0.85,-0.53, +, +,Tyr,,,,3,3,26.12,basal plasma membrane,ATP binding,activation of MAPK activity,,
P08581,P08581,Hepatocyte growth factor receptor,MET,89.75,72.51,Y1234,KVADFGLARDMYDKEYYSVHNKTGAKLPVKW,_EY(ph)Y(ph)SVHNK_,-1.4, ,-1.93, , , , , ,-2.23, ,-1.54, , , , , ,-1.4,-1.93,,,-2.23,-1.54,,, +, +,Tyr,,,,NA,NA,,basal plasma membrane,ATP binding,activation of MAPK activity,,
P08581,P08581,Hepatocyte growth factor receptor,MET,185.34,180.86,S990,VHTPHLDRLVSARSVSPTTEMVSNESVDYRA,_SVS(ph)PTTEMVS(ph)NESVDYR_, , , , ,-0.03,0.57,0.54,0.36, , , , ,0.82,0.66,0.53,0.24,,,0.3,0.45,,,0.74,0.39,,,Tyr,,,,NA,NA,,basal plasma membrane,ATP binding,activation of MAPK activity,,
P08581,P08581,Hepatocyte growth factor receptor,MET,209.41,208.85,S997,RLVSARSVSPTTEMVSNESVDYRATFPEDQF,_SVSPTTEMVS(ph)NES(ph)VDYR_,-0.85,0.02, , ,0.32,0.57,0.54,0.58,-0.51,0.21, , ,0.48,0.47,0.05,-0.04,-0.35,,0.45,0.56,-0.1,,0.48,0.01,,,Tyr,,,,NA,NA,,basal plasma membrane,ATP binding,activation of MAPK activity,,
P08581,P08581,Hepatocyte growth factor receptor,MET,209.41,208.85,S1000,SARSVSPTTEMVSNESVDYRATFPEDQFPNS,_SVSPTTEMVS(ph)NES(ph)VDYR_, ,0.02, , ,0.52,0.57,0.54,0.58, ,0.21, , ,0.21,0.47,0.05,-0.04,0.02,,0.55,0.56,0.21,,0.35,0.01,,,Tyr,,,,NA,NA,,basal plasma membrane,ATP binding,activation of MAPK activity,,
P08581,P08581,Hepatocyte growth factor receptor,MET,83.95,65.72,Y1235,VADFGLARDMYDKEYYSVHNKTGAKLPVKWM,_EY(ph)Y(ph)SVHNK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Tyr,,,,NA,NA,,basal plasma membrane,ATP binding,activation of MAPK activity,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,295.71,295.71,S132,DSEVEGDAWRMEREDSSEEEEEEIDDEEIER,_M(ox)EREDS(ph)S(ph)EEEEEEIDDEEIER_,-0.51,-0.5,-0.57,-0.61,-0.29,-0.27,-0.52,-0.48,-0.28,-0.18,-0.35,-0.44,-0.26,0.13,-0.25,-0.25,-0.5,-0.59,-0.28,-0.5,-0.23,-0.39,-0.05,-0.25,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,295.71,295.71,S133,SEVEGDAWRMEREDSSEEEEEEIDDEEIERR,_M(ox)EREDS(ph)S(ph)EEEEEEIDDEEIER_,-0.51,-0.5,-0.57,-0.61,-0.29,-0.27,-0.52,-0.48,-0.28,-0.18,-0.35,-0.44,-0.26,0.13,-0.25,-0.25,-0.5,-0.59,-0.28,-0.5,-0.23,-0.39,-0.05,-0.25,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,230.77,221.69,S116,LARHRKIVEPEVVGESDSEVEGDAWRMERED,_KIVEPEVVGES(ph)DS(ph)EVEGDAWR_,-0.56,-0.58,-0.52,-0.57,-0.47,-0.08,-0.38,-0.44,-0.4,-0.4,-0.49,-0.47,0.36,0.04,-0.11,0.17,-0.57,-0.54,-0.26,-0.41,-0.4,-0.48,0.21,0.04,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,230.77,221.69,S118,RHRKIVEPEVVGESDSEVEGDAWRMEREDSS,_KIVEPEVVGES(ph)DS(ph)EVEGDAWR_,-0.49,-0.43,-0.49,-0.5,-0.27,0.17,-0.42,-0.46,-0.11,-0.15,-0.29,-0.25,-0.07,-0.09,-0.19,-0.21,-0.46,-0.5,-0.03,-0.44,-0.13,-0.27,-0.08,-0.2,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,322.6,322.6,S52,KRYVSGKRPDYAPMESSDEEDEEFQFIKKAK,_RPDYAPMES(ph)S(ph)DEEDEEFQFIKK_,-0.08,-0.42,-0.53,-0.23,-0.22,-0.18,-0.16,-0.37,0.02,-0.23,-0.15,-0.13,-0.09,-0.05,-0.14,-0.24,-0.24,-0.37,-0.2,-0.26,-0.1,-0.14,-0.07,-0.19,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,322.6,322.6,S53,RYVSGKRPDYAPMESSDEEDEEFQFIKKAKE,_RPDYAPMES(ph)S(ph)DEEDEEFQFIKK_,-0.08,-0.42,-0.53,-0.23,-0.22,-0.18,-0.16,-0.37,0.02,-0.23,-0.15,-0.13,-0.09,-0.05,-0.14,-0.24,-0.24,-0.37,-0.2,-0.26,-0.1,-0.14,-0.07,-0.19,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
P55081,P55081,Microfibrillar-associated protein 1,MFAP1,321.54,305.3,T267,LEENKRSLAALDALNTDDENDEEEYEAWKVR,_SLAALDALNT(ph)DDENDEEEYEAWK_,-0.4,-0.35,-0.39,-0.39,-0.19,-0.46,-0.39,-0.19,-0.32,-0.31,-0.45,-0.31,-0.08,0.05,-0.11,-0.29,-0.37,-0.39,-0.32,-0.28,-0.31,-0.38,-0.01,-0.2,,,,,,,0,0,,microfibril,,extracellular matrix organization,,
Q9GZY8-2,Q9GZY8,Mitochondrial fission factor,MFF,74.84,49.99,S157,EEIRAVGRLKRERSMSENAVRQNGQLVRNDS,_SMS(ph)ENAVR_, , , , ,0.53, ,1.07, , , , , ,0.65, ,0.79, ,,,0.53,1.07,,,0.65,0.79, +,,,,,,NA,NA,,integral to mitochondrial membrane,,mitochondrial fragmentation involved in apoptotic process,,
C9JAZ7,Q6ZSS7,Major facilitator superfamily domain-containing protein 6,MFSD6,95.75,89.55,T10,______MADDKVAILTDDEEEQKRKYVLADP,_VAILT(ph)DDEEEQK_,0.54,0.49, , ,0.5, ,0.3,0.37,1.04,0.89, , ,0.68, ,0.45,0.42,0.51,,0.5,0.33,0.97,,0.68,0.43,,,,,,,NA,NA,,,,,,
O60502,O60502,Bifunctional protein NCOAT,MGEA5,182.4,182.2,S364,EDSTVSIQIKLENEGSDEDIETDVLYSPQMA,_LENEGS(ph)DEDIETDVLYSPQMALK_,0.11,-0.03,-0.2,0.05,-0.93,-0.43,0.38,0.01,-0.02,0.07,-0.12,-0.22,-0.14,-0.35,0,-0.12,0.04,-0.07,-0.66,0.2,0.02,-0.17,-0.24,-0.06,,,,,,,0,0,,cytoplasm,histone acetyltransferase activity,aging,,
Q5JRA6-2,Q5JRA6,Melanoma inhibitory activity protein 3,MIA3,135.24,131.3,S408,GGEETRDTMDLESSSSEEEKEDDDDALVPDS,_DTMDLESSSS(ph)EEEK_, ,0.59,0.02, , , , ,-0.02, ,0.59,0.29, , , , ,0.08,0.59,0.02,,-0.02,0.59,0.29,,0.08,,,,,,,NA,NA,,endoplasmic reticulum membrane,,exocytosis,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,90.44,86.32,S484,TSSPKTKKRPAPRAPSASPLALHASRLSHSE,_APS(ph)AS(ph)PLALHASR_, , , , ,-1.23,-1.49,-0.83,-0.83, , , , ,-0.96,-1.98,-0.88,-0.8,,,-1.36,-0.83,,,-1.38,-0.84, +, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,90.44,86.32,S486,SPKTKKRPAPRAPSASPLALHASRLSHSEPP,_APS(ph)AS(ph)PLALHASR_, , , , ,-1.23,-1.49,-0.83,-0.83, , , , ,-0.96,-1.98,-0.88,-0.8,,,-1.36,-0.83,,,-1.38,-0.84, +, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,101.54,65.2,S578,SGELVEPRVEQMPQASPGLAPRTRGSSGPQP,_VEQMPQAS(ph)PGLAPR_,-0.59,-0.72,-1.23,-0.98,-0.54,-0.9,-0.53,-0.54,-0.54,-0.59,-0.99,-1.17,0.12,-1.13,-0.38,-0.65,-0.66,-1.1,-0.71,-0.54,-0.57,-1.08,-0.38,-0.51, +, +,,,,,3,3,33.49,cytoplasm,zinc ion binding,,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,72.44,70.22,T467,HPESTPKSLHPWYGITPTSSPKTKKRPAPRA,_SLHPWYGIT(ph)PT(ph)SSPK_, , , , ,-0.69,-0.6,-0.36,-0.62, , , , ,-1.23,-1.06,-0.52,-0.6,,,-0.64,-0.48,,,-1.14,-0.56,, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,72.44,70.22,T469,ESTPKSLHPWYGITPTSSPKTKKRPAPRAPS,_SLHPWYGIT(ph)PT(ph)SSPK_, , , , , ,-0.58, , , , , , , ,-1.14, , ,,,-0.58,,,,-1.14,,, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q8N3F8,Q8N3F8,MICAL-like protein 1,MICALL1,68.03,64.09,S418,ENGGTEEVAQPSPTASLESKPYNPFEEEEED,_QVENGGTEEVAQPSPT(ph)AS(ph)LESK_, , , , ,0.24,0.1,0.1,-0.11, , , , ,0.21,0.02,0.21,0.33,,,0.17,0,,,0.12,0.27,,,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,145.85,141.25,S483,FDEKSERPAKRRRVNSNGKESPGSSEFFQEA,_VNS(ph)NGKES(ph)PGSSEFFQEAVSHGK_,-0.04, , , ,1.04,0.85, ,1.07,0.11, , , ,0.85,1.42, ,1.22,-0.04,,0.95,1.07,0.11,,1.16,1.22, +, +,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,145.85,141.25,S488,ERPAKRRRVNSNGKESPGSSEFFQEAVSHGK,_VNS(ph)NGKES(ph)PGSSEFFQEAVSHGK_,-0.04, , , ,1.04,0.44, ,1.07,0.11, , , ,0.85,0.39, ,1.22,-0.04,,0.77,1.07,0.11,,0.64,1.22, +, +,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,84.48,55.58,T510,FQEAVSHGKFEELENTDD_____________,_FEELENT(ph)DD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,175.31,175.31,S369,PGVTDYMDRLLDESESAASSRAPSPPPTASN,_LLDESES(ph)AAS(ph)SRAPS(ph)PPPTASNSSNSQSEK_, , , , ,-0.28, , ,0.17, , , , ,-0.59, , ,-0.54,,,-0.28,0.17,,,-0.59,-0.54,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,175.31,175.31,S372,TDYMDRLLDESESAASSRAPSPPPTASNSSN,_LLDESES(ph)AAS(ph)SRAPS(ph)PPPTASNSSNSQSEK_, , , , ,-0.28, , ,0.17, , , , ,-0.59, , ,-0.54,,,-0.28,0.17,,,-0.59,-0.54,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,175.31,175.31,S377,RLLDESESAASSRAPSPPPTASNSSNSQSEK,_LLDESES(ph)AAS(ph)SRAPS(ph)PPPTASNSSNSQSEK_, , , , ,-0.28, , ,0.17, , , , ,-0.59, , ,-0.54,,,-0.28,0.17,,,-0.59,-0.54,,,,,,,NA,NA,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,302.83,302.83,S160,QEIIRPRRCKYFDTNSEVEEESEEDEDYIPS,_YFDTNS(ph)EVEEES(ph)EEDEDYIPSEDWKK_,-0.43,-0.08,-0.26,-0.32,0.21,0.23,0.04,-0.02,0.23,0.14,0.16,0.47,0.05,0.16,0.11,0.02,-0.24,-0.29,0.22,0.01,0.18,0.32,0.1,0.06,,,,,,,0,0,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q8N108-17,Q8N108,Mesoderm induction early response protein 1,MIER1,302.83,302.83,S166,RRCKYFDTNSEVEEESEEDEDYIPSEDWKKE,_YFDTNS(ph)EVEEES(ph)EEDEDYIPSEDWKK_,-0.43,-0.08,-0.26,-0.32,0.21,0.15,0.04,0.14,0.23,0.14,0.16,0.47,0.05,0.09,0.11,0.31,-0.24,-0.29,0.18,0.09,0.18,0.32,0.07,0.21,,,,,,,0,0,,cytoplasm,chromatin binding,positive regulation of chromatin silencing,,
Q7Z3K6-5,Q7Z3K6,Mesoderm induction early response protein 3,MIER3,100.04,89.43,S52,RTLEEEEMMDEGKNFSSEIEDLEKEGTMPLE,_NFS(ph)S(ph)EIEDLEK_, , , , ,-0.25,0.22,-0.05,-0.13, , , , ,-0.14,0.14,-0.58,-0.17,,,0,-0.09,,,0.01,-0.36,,,,,,,NA,NA,,nucleus,chromatin binding,"regulation of transcription, DNA-dependent",,
Q7Z3K6-5,Q7Z3K6,Mesoderm induction early response protein 3,MIER3,100.04,89.43,S53,TLEEEEMMDEGKNFSSEIEDLEKEGTMPLED,_NFS(ph)S(ph)EIEDLEK_, , , , ,-0.25,0.22,-0.05,-0.13, , , , ,-0.14,0.14,-0.58,-0.17,,,0,-0.09,,,0.01,-0.36,,,,,,,NA,NA,,nucleus,chromatin binding,"regulation of transcription, DNA-dependent",,
Q8N4C8-2,Q8N4C8,Misshapen-like kinase 1,MINK1,375.13,372.37,Y906,TPEEERNLLHADSNGYTNLPDVVQPSHSPTE,_NLLHADSNGY(ph)TNLPDVVQPSHSPTENSK_,2.67, ,2.55, , , , , ,1.73, ,0.65, , , , , ,2.67,2.55,,,1.73,0.65,,, +, +,STE,,,,NA,NA,,axon,ATP binding,actin cytoskeleton reorganization,,
Q9NXC5,Q9NXC5,WD repeat-containing protein mio,MIOS,157.11,155.74,S766,VPHQGRGFSQYGVSGSPTKSKVTSCPGCRKP,_GFSQYGVSGS(ph)PTK_,-0.11,-0.33,-0.26,-0.27,-0.15,-0.17,0.13,0.46,-0.11,-0.05,-0.09,-0.08,-0.32,-0.32,-0.04,-0.07,-0.22,-0.27,-0.16,0.31,-0.08,-0.09,-0.32,-0.05,,,,,,,0,0,,,,,,
D3K197,O75030,Microphthalmia-associated transcription factor,MITF,78.43,77.57,S491,KMGSKLEDILMDDTLSPVGVTDPLLSSVSPG,_LEDILMDDTLS(ph)PVGVTDPLLSSVS(ph)PGAS(ph)K_,0.9, , , , , , , ,0.41, , , , , , , ,0.9,,,,0.41,,,,,,,,,,NA,NA,,,,,,
D3K197,O75030,Microphthalmia-associated transcription factor,MITF,78.43,77.57,S504,TLSPVGVTDPLLSSVSPGASKTSSRRSSMSM,_LEDILMDDTLS(ph)PVGVTDPLLSSVS(ph)PGAS(ph)K_,0.9, , , , , , , ,0.41, , , , , , , ,0.9,,,,0.41,,,,,,,,,,NA,NA,,,,,,
D3K197,O75030,Microphthalmia-associated transcription factor,MITF,78.43,77.57,S508,VGVTDPLLSSVSPGASKTSSRRSSMSMEETE,_LEDILMDDTLS(ph)PVGVTDPLLSSVS(ph)PGAS(ph)K_,0.9, , , , , , , ,0.41, , , , , , , ,0.9,,,,0.41,,,,,,,,,,NA,NA,,,,,,
F5H4V4,P46013,Antigen KI-67,MKI67,168.69,160.94,S308,RPKSGGSGHAVAEPASPEQELDQNKGKGRDV,_SGGSGHAVAEPAS(ph)PEQELDQNK_,0.12,0.06,0.02,-0.09, , , , ,0.2,-0.52,0.07,0.14, , , , ,0.09,-0.03,,,-0.12,0.11,,,,,,,,,NA,NA,,,,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,85.8,83.16,S446,VVVATVASSGVVKFGSTGSTPPVSPTPSERS,_FGS(ph)TGS(ph)T(ph)PPVS(ph)PTPSER_, , , , , ,1.11, ,1.05, , , , , ,1.06, ,1.24,,,1.11,1.05,,,1.06,1.24, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,138.04,132.37,S449,ATVASSGVVKFGSTGSTPPVSPTPSERSLLS,_FGS(ph)TGS(ph)T(ph)PPVS(ph)PTPSER_,0.79,0.03,-0.51, , ,1.11, ,1.05,-0.15,-0.17,-0.29, , ,1.06, ,1.24,0.46,-0.51,1.11,1.05,-0.16,-0.29,1.06,1.24, +, +,,,,,2,2,24.07,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,97.95,86.79,T450,TVASSGVVKFGSTGSTPPVSPTPSERSLLST,_FGS(ph)TGS(ph)T(ph)PPVS(ph)PTPSER_, , , , , ,1.11, ,1.05, , , , , ,1.06, ,1.24,,,1.11,1.05,,,1.06,1.24, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,71.47,63.51,S385,KTELIERLRAYQDQISPVPGAPKAPAATSIL,_AYQDQIS(ph)PVPGAPK_, , , , , ,1.16, , , , , , , ,0.78, , ,,,1.16,,,,0.78,, +,,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,141.29,136.52,S458,KFGSTGSTPPVSPTPSERSLLSTGDENSTPG,_FGST(ph)GSTPPVS(ph)PTPS(ph)ER_, , , , ,-0.58,-0.41,-0.14,-0.62, , , , ,-0.53,-0.34,1.36,1.32,,,-0.5,-0.36,,,-0.43,1.34,, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,141.29,136.52,S454,SGVVKFGSTGSTPPVSPTPSERSLLSTGDEN,_FGST(ph)GSTPPVS(ph)PTPS(ph)ER_,0.79,0.03,-0.51, ,-0.58,0.68,1.2,-0.1,-0.15,-0.17,-0.29, ,-0.53,-0.27,-0.5,-0.28,0.46,-0.51,0.19,0.69,-0.16,-0.29,-0.39,-0.39,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
E7ER32,Q969V6,MKL/myocardin-like protein 1,MKL1,61.1,61.03,S124,VADSSSFDEDSSDALSPEQPASHESQGSVPS,_VADSS(ph)SFDEDS(ph)SDALS(ph)PEQPASHESQGSVPS(ph)PLEAR_, , , , ,0.23,-1.2, ,-0.77, , , , ,0.15,-0.57, ,-0.14,,,-0.31,-0.77,,,-0.16,-0.14,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,,,
Q9ULH7-4,Q9ULH7,MKL/myocardin-like protein 2,MKL2,120.31,120.13,S543,LSSSPLRMTNNEDSLSPTSSTLSNLELDAAE,_MTNNEDSLS(ph)PTSSTLSNLELDAAEK_, , ,-1.28, ,0.02, ,-0.11, , , ,-0.86, ,0.39, ,0.25, ,,-1.28,0.02,-0.11,,-0.86,0.39,0.25, +,,,,,,NA,NA,,cytoplasm,nucleic acid binding,blood vessel morphogenesis,,
Q9ULH7-4,Q9ULH7,MKL/myocardin-like protein 2,MKL2,69.07,69.07,S921,LIKSGEISLPIKEEPSPISKMRPVTASITTM,_SGEISLPIKEEPS(ph)PISK_, , ,1.18, , , , , , , ,0.99, , , , , ,,1.18,,,,0.99,,, +,,,,,,NA,NA,,cytoplasm,nucleic acid binding,blood vessel morphogenesis,,
Q15773,Q15773,Myeloid leukemia factor 2,MLF2,147.36,145.89,S238,RAEGPPRLAIQGPEDSPSRQSRRYDW_____,_LAIQGPEDS(ph)PSR_,-0.42,-0.09,0.18,0.3,-1.43,-1.49,-0.86,-0.74,-0.37,-0.29,-0.67,-0.75,-1.83,-1.63,-0.95,-0.53,-0.25,0.24,-1.46,-0.8,-0.33,-0.71,-1.73,-0.72, +, +,,,,,6,6,22.93,cytoplasm,,defense response,,
Q5TCX8-2,Q5TCX8,Mitogen-activated protein kinase kinase kinase MLK4,MLK4,132.08,94.44,S528,ISLPSDFQHKITVQASPNLDKRRSLNSSSSS,_ITVQAS(ph)PNLDK_,0.04,0.09,-0.09,-0.05,0.43,0.37,0.39,0.43,0.05,0.04,-0.32,-0.38,-0.03,0.04,0.08,0.09,0.06,-0.07,0.4,0.41,0.05,-0.35,0.01,0.08,,,STE,,,,0,0,,,ATP binding,activation of JUN kinase activity,,
O14686,O14686,Histone-lysine N-methyltransferase MLL2,MLL2,70.8,48.92,S1671,GVEHMECEIKLEGPVSPDVEPGKEETEESKK,_LEGPVS(ph)PDVEPGK_, , , ,-0.41, ,0.84,0.48, , , , ,-0.38, ,0.47,0.36, ,,-0.41,0.84,0.48,,-0.38,0.47,0.36,,,,,,,NA,NA,,histone methyltransferase complex,histone-lysine N-methyltransferase activity,chromatin silencing,,
Q03111,Q03111,Protein ENL,MLLT1,186.7,175.94,S359,ESEPREAKKALEVEESNSEDEASFKSESAQS,_ALEVEES(ph)NS(ph)EDEAS(ph)FK_, ,-2.93, , ,0.08,0.15,0.41,-0.28, ,-1.71, , ,0.12,0.11,0.24,-0.2,-2.93,,0.12,0.1,-1.71,,0.12,0.04, +, +,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of protein kinase activity,,
Q03111,Q03111,Protein ENL,MLLT1,186.7,175.94,S361,EPREAKKALEVEESNSEDEASFKSESAQSSP,_ALEVEES(ph)NS(ph)EDEAS(ph)FK_, ,-2.93, , ,0.08,0.15,0.41,-0.28, ,-1.71, , ,0.12,0.11,0.24,-0.2,-2.93,,0.12,0.1,-1.71,,0.12,0.04, +, +,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of protein kinase activity,,
Q03111,Q03111,Protein ENL,MLLT1,79.59,75.75,S366,KKALEVEESNSEDEASFKSESAQSSPSNSSS,_ALEVEES(ph)NS(ph)EDEAS(ph)FK_, , , , , , , ,0.2, , , , , , , ,-0.18,,,,0.2,,,,-0.18,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of protein kinase activity,,
Q03111,Q03111,Protein ENL,MLLT1,76.42,76.02,S411,NHSQGPLRSMVEDLQSEESDEDDSSSGEEAA,_SMVEDLQS(ph)EES(ph)DEDDSS(ph)SGEEAAGK_, , , , , , ,-0.02,-0.04, , , , , , ,0.38,0.04,,,,-0.03,,,,0.22,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of protein kinase activity,,
Q03111,Q03111,Protein ENL,MLLT1,76.42,76.02,S414,QGPLRSMVEDLQSEESDEDDSSSGEEAAGKT,_SMVEDLQS(ph)EES(ph)DEDDSS(ph)SGEEAAGK_, , , , , , ,-0.02,-0.04, , , , , , ,0.38,0.04,,,,-0.03,,,,0.22,,,,,,,NA,NA,,cytoplasm,DNA binding,negative regulation of protein kinase activity,,
B1APT6,B1APT6,Protein AF-9,MLLT3,227.64,227.64,S6,__________MKDLHSDDNEEESDEVEDNDN,_DLHS(ph)DDNEEES(ph)DEVEDNDNDS(ph)EMERPVNR_, ,-0.23, , ,-0.29,-0.44,-0.09,-0.11, ,-0.15, , ,-0.13,-0.47,-0.07,-0.48,-0.23,,-0.36,-0.1,-0.15,,-0.29,-0.26,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
B1APT6,P42568,Protein AF-9,MLLT3,227.64,227.64,S419,___MKDLHSDDNEEESDEVEDNDNDSEMERP,_DLHS(ph)DDNEEES(ph)DEVEDNDNDS(ph)EMERPVNR_, ,-0.23, , ,-0.29,-0.44,-0.09,-0.11, ,-0.15, , ,-0.13,-0.47,-0.07,-0.48,-0.23,,-0.36,-0.1,-0.15,,-0.29,-0.26,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
B1APT6,P42568,Protein AF-9,MLLT3,227.64,227.64,S429,DNEEESDEVEDNDNDSEMERPVNRGGSRSRR,_DLHS(ph)DDNEEES(ph)DEVEDNDNDS(ph)EMERPVNR_, ,-0.23, , ,-0.29,-0.44,-0.09,-0.11, ,-0.15, , ,-0.13,-0.47,-0.07,-0.48,-0.23,,-0.36,-0.1,-0.15,,-0.29,-0.26,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
P55196-3,P55196,Afadin,MLLT4,54.34,24.57,Y1497,QPQQQPRTIERRDLQYITVSKEELSSGDSLS,_DLQY(ph)ITVSK_,2.77, , , , , , , ,1.5, , , , , , , ,2.77,,,,1.5,,,, +, +,,,,,NA,NA,,apical part of cell,protein C-terminus binding,adherens junction organization,,
P55196-3,P55196,Afadin,MLLT4,68.29,64.54,S1779,CRDAKEKRSKSQDADSPGSSGAPENLTFKER,_SQDADS(ph)PGS(ph)SGAPENLTFK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,apical part of cell,protein C-terminus binding,adherens junction organization,,
P55196-3,P55196,Afadin,MLLT4,68.29,64.54,S1782,AKEKRSKSQDADSPGSSGAPENLTFKERQRL,_SQDADS(ph)PGS(ph)SGAPENLTFK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,apical part of cell,protein C-terminus binding,adherens junction organization,,
H0YE99,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,128.75,126.36,S275,PGNPSRARSWLSPRVSPPASPGP________,_SWLSPRVS(ph)PPAS(ph)PGP_, , , , ,0.66,0.88,0.49, , , , , ,0.62,0.94,0.49, ,,,0.77,0.49,,,0.79,0.49,,,,,,,NA,NA,,,,,,
H0YE99,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,128.75,126.36,S279,SRARSWLSPRVSPPASPGP____________,_SWLSPRVS(ph)PPAS(ph)PGP_, , , , ,0.66,0.88,0.49, , , , , ,0.62,0.94,0.49, ,,,0.77,0.49,,,0.79,0.49,,,,,,,NA,NA,,,,,,
Q9BU76,Q9BU76,Multiple myeloma tumor-associated protein 2,MMTAG2,119.48,112.87,S217,KKKDKEHRRPAEATSSPTSPERPRHHHHDSD,_RPAEATSS(ph)PTS(ph)PERPR_,-0.35,-0.19,-0.2, ,0.3,0.29,-0.08,-0.49,-0.59,-0.58,-0.47, ,0.1,-0.1,0.23,-0.01,-0.27,-0.2,0.3,-0.27,-0.59,-0.47,0.01,0.12,,,,,,,0,0,,,,,,
Q9BU76,Q9BU76,Multiple myeloma tumor-associated protein 2,MMTAG2,119.48,112.87,S220,DKEHRRPAEATSSPTSPERPRHHHHDSDSNS,_RPAEATSS(ph)PTS(ph)PERPR_,-0.35,-0.19,-0.23, ,0.3, , ,-0.49,-0.59,-0.58,-0.46, ,0.1, , ,-0.01,-0.27,-0.23,0.3,-0.49,-0.59,-0.46,0.1,-0.01,,,,,,,0,0,,,,,,
Q96EN8,Q96EN8,Molybdenum cofactor sulfurase,MOCOS,70.34,68.53,S528,ADSQADVIPAVMGRRSLSPQEDALTGSRVWN,_S(ph)LS(ph)PQEDALTGSR_, ,1.35, , ,0.03,0.7,-0.53,-0.69, ,0.66, , ,-0.23,0.16,-0.32,-0.78,1.35,,0.41,-0.61,0.66,,-0.02,-0.53, +,,,,,,NA,NA,,cytosol,Mo-molybdopterin cofactor sulfurase activity,Mo-molybdopterin cofactor biosynthetic process,,
Q96EN8,Q96EN8,Molybdenum cofactor sulfurase,MOCOS,147.09,117.74,S530,SQADVIPAVMGRRSLSPQEDALTGSRVWNNS,_S(ph)LS(ph)PQEDALTGSR_,0.45,0.59,0.45,-0.03,0.3,0.19,1.24,0.94,-0.2,0.02,-0.27,-0.83,0.07,-0.22,-0.07,-0.18,0.52,0.23,0.24,1.1,-0.09,-0.53,-0.07,-0.13, +,,,,,,2,0,1.26,cytosol,Mo-molybdopterin cofactor sulfurase activity,Mo-molybdopterin cofactor biosynthetic process,,
E9PKT9,O96007,Molybdopterin synthase catalytic subunit,MOCS2,67.71,67.71,S20,EISSSCFSLETKLPLSPPLVEDSAFEPSRKD,_LPLS(ph)PPLVEDSAFEPSRK_, ,0.04, ,0.49, , , , , ,-0.22, ,0.33, , , , ,0.04,0.49,,,-0.22,0.33,,,,,,,,,NA,NA,,cytoplasm,,Mo-molybdopterin cofactor biosynthetic process,,
Q9Y6X9-2,Q9Y6X9,MORC family CW-type zinc finger protein 2,MORC2,171.42,149.31,S743,KLSPATPSRKRSVAVSDEEEVEEEAERRKER,_S(ph)VAVS(ph)DEEEVEEEAER_,-0.37,-0.53, ,-1.29,-0.41,0.35,0.65,-0.84,-0.33,-0.42, ,-1.56,-0.35,0.21,0.62,-0.71,-0.45,-1.29,0.02,0.09,-0.38,-1.56,-0.05,0.1, +, +,,,,,3,3,42.41,cytosol,ATP binding,,,
Q9Y6X9-2,Q9Y6X9,MORC family CW-type zinc finger protein 2,MORC2,273.22,273.22,S777,GRFVVKEEKKDSNELSDSAGEEDSADLKRAQ,_KDSNELS(ph)DS(ph)AGEEDSADLK_,-0.09,-0.1,-0.12,-0.17,0.09,-0.01,-0.01,-0.21,0.09,-0.02,-0.07,-0.11,-0.09,-0.05,-0.04,-0.11,-0.1,-0.15,0.04,-0.11,0.04,-0.09,-0.07,-0.08,,,,,,,0,0,,cytosol,ATP binding,,,
Q9Y6X9-2,Q9Y6X9,MORC family CW-type zinc finger protein 2,MORC2,273.22,273.22,S779,FVVKEEKKDSNELSDSAGEEDSADLKRAQKD,_KDSNELS(ph)DS(ph)AGEEDSADLK_,-0.09,-0.1,-0.12,-0.17,0.09,-0.01,-0.01,-0.21,0.09,-0.02,-0.07,-0.11,-0.09,-0.05,-0.04,-0.11,-0.1,-0.15,0.04,-0.11,0.04,-0.09,-0.07,-0.08,,,,,,,0,0,,cytosol,ATP binding,,,
Q9Y6X9-2,Q9Y6X9,MORC family CW-type zinc finger protein 2,MORC2,171.42,149.31,S739,ESPIKLSPATPSRKRSVAVSDEEEVEEEAER,_S(ph)VAVS(ph)DEEEVEEEAER_, , , , ,-0.41,0.35,0.65,0.66, , , , ,-0.35,0.21,0.62,0.52,,,0.02,0.66,,,-0.05,0.57,,,,,,,NA,NA,,cytosol,ATP binding,,,
Q9Y6X9-2,Q9Y6X9,MORC family CW-type zinc finger protein 2,MORC2,92.61,52.99,S615,RPSTEEPVRRPQRPRSPPLPAVIRNAPSRPP,_S(ph)PPLPAVIR_,-0.13,-0.09,-0.16,-0.17,-0.08,-0.08,-0.08,-0.01,-0.19,-0.17,-0.21,-0.23,-0.08,-0.17,-0.23,-0.16,-0.11,-0.17,-0.08,-0.05,-0.18,-0.22,-0.12,-0.2,,,,,,,0,0,,cytosol,ATP binding,,,
E7EPZ1,O75970,Multiple PDZ domain protein,MPDZ,140.26,130.98,S483,AELMSREDVTKDADLSPVNASIIKENYEKDE,_DADLS(ph)PVNASIIK_,-0.16,-0.22,-0.01,-0.04,0.16,0.33,0.02,0.35,-0.11,-0.11,0.03,0.04,0.03,0.4,0.16,0.4,-0.19,-0.02,0.25,0.19,-0.11,0.03,0.23,0.29,,,,,,,0,0,,,,,,
O00566,O00566,U3 small nucleolar ribonucleoprotein protein MPP10,MPHOSPH10,201.17,201.04,S139,ADDKEDLEDLEEEEVSDMGNDDPEMGERAEN,_EDLEDLEEEEVS(ph)DMGNDDPEMGER_, , , , ,0.71,0.82,-0.4,0.21, , , , ,0.3,0.21,-0.35,0.27,,,0.76,-0.06,,,0.26,-0.01,,,,,,,NA,NA,,chromosome,,negative regulation of phosphatase activity,,
O00566,O00566,U3 small nucleolar ribonucleoprotein protein MPP10,MPHOSPH10,282.81,282.03,S163,MGERAENSSKSDLRKSPVFSDEDSDLDFDIS,_S(ph)PVFS(ph)DEDS(ph)DLDFDISK_, , , , ,0.28,-0.05,0.11,0.19, , , , ,0.13,0.33,0.32,0.18,,,0.12,0.15,,,0.23,0.25,,,,,,,NA,NA,,chromosome,,negative regulation of phosphatase activity,,
O00566,O00566,U3 small nucleolar ribonucleoprotein protein MPP10,MPHOSPH10,282.81,282.03,S167,AENSSKSDLRKSPVFSDEDSDLDFDISKLEQ,_S(ph)PVFS(ph)DEDS(ph)DLDFDISK_, , , , ,0.28,-0.05,0.11,0.19, , , , ,0.13,0.33,0.32,0.18,,,0.12,0.15,,,0.23,0.25,,,,,,,NA,NA,,chromosome,,negative regulation of phosphatase activity,,
O00566,O00566,U3 small nucleolar ribonucleoprotein protein MPP10,MPHOSPH10,282.81,282.03,S171,SKSDLRKSPVFSDEDSDLDFDISKLEQQSKV,_S(ph)PVFS(ph)DEDS(ph)DLDFDISK_, , , , ,0.28,-0.05,0.11,0.19, , , , ,0.13,0.33,0.32,0.18,,,0.12,0.15,,,0.23,0.25,,,,,,,NA,NA,,chromosome,,negative regulation of phosphatase activity,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,60.25,49.77,S403,GRRLSGEERGLWSTDSAEEDKETKRNESKEK,_GLWS(ph)TDS(ph)AEEDK_, ,1.04, , , ,0.83, ,0.76, ,-0.22, , , ,0.96, ,0.81,1.04,,0.83,0.76,-0.22,,0.96,0.81, +,,,,,,NA,NA,,,,,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,251.52,250.87,S51,EDNDAAARGAEAFGDSEEDGEDVFEVEKILD,_GAEAFGDS(ph)EEDGEDVFEVEK_,-0.5,-0.5,-0.4,-0.35, ,-0.26,-0.23, ,-0.19,-0.04,-0.05,-0.12, ,0.64,-0.06, ,-0.5,-0.37,-0.26,-0.23,-0.12,-0.09,0.64,-0.06,,,,,,,0,0,,,,,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,37.7,32.94,S400,TPKGRRLSGEERGLWSTDSAEEDKETKRNES,_GLWS(ph)TDS(ph)AEEDK_, , , , , ,0.83, , , , , , , ,0.96, , ,,,0.83,,,,0.96,,,,,,,,NA,NA,,,,,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,168.98,167.84,S136,DIQRLSLNNDIFEANSDSDQQSETKEDTSPK,_LSLNNDIFEANS(ph)DS(ph)DQQSETK_, ,-0.88, , ,-0.55,-0.16,-0.07,0.07, ,-0.21, , ,-0.12,0.06,-0.08,0.06,-0.88,,-0.34,0,-0.21,,-0.03,-0.01,,,,,,,NA,NA,,,,,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,168.98,167.84,S138,QRLSLNNDIFEANSDSDQQSETKEDTSPKKK,_LSLNNDIFEANS(ph)DS(ph)DQQS(ph)ETK_, ,-0.88, , ,-0.55,-0.21,-0.07,0.07, ,-0.21, , ,-0.12,-0.11,-0.08,0.06,-0.88,,-0.37,0,-0.21,,-0.12,-0.01,,,,,,,NA,NA,,,,,,
F5H8H9,Q99549,M-phase phosphoprotein 8,MPHOSPH8,115.66,114.08,S142,LNNDIFEANSDSDQQSETKEDTSPKKKKKKL,_LSLNNDIFEANS(ph)DS(ph)DQQS(ph)ETK_, , , , , ,-0.55, ,-0.2, , , , , ,-0.19, ,-0.28,,,-0.55,-0.2,,,-0.19,-0.28,,,,,,,NA,NA,,,,,,
Q6WCQ1,Q6WCQ1,Myosin phosphatase Rho-interacting protein,MPRIP,124.08,124.08,S619,GPGTEDAALRMEVDRSPGLPMSDLKTHNVHV,_MEVDRS(ph)PGLPMSDLK_,-0.87,-0.58,0.07,0.21,1.39, ,1.35, ,0.08,0.21,0.47,0.35,1.15, ,1.62, ,-0.72,0.15,1.39,1.35,0.15,0.41,1.15,1.62, +, +,,,,,2,2,25.13,cytoplasm,phospholipid binding,,,
Q6WCQ1,Q6WCQ1,Myosin phosphatase Rho-interacting protein,MPRIP,120.57,120.2,S220,QEEMRTKDQPDGSSLSPAQSPSQSQPPAASS,_DQPDGSSLS(ph)PAQS(ph)PSQSQPPAASSLREPGLESK_, , , , ,0.37,0.52,0.28,0.22, , , , ,0.27,0.34,0.23,0.14,,,0.45,0.25,,,0.3,0.18,,,,,,,NA,NA,,cytoplasm,phospholipid binding,,,
Q6WCQ1,Q6WCQ1,Myosin phosphatase Rho-interacting protein,MPRIP,120.57,120.2,S224,RTKDQPDGSSLSPAQSPSQSQPPAASSLREP,_DQPDGSSLS(ph)PAQS(ph)PSQSQPPAASSLREPGLESK_, , , , ,0.42,0.52,0.43,0.2, , , , ,0.29,0.4,0.31,0.21,,,0.47,0.32,,,0.35,0.26,,,,,,,NA,NA,,cytoplasm,phospholipid binding,,,
Q6WCQ1,Q6WCQ1,Myosin phosphatase Rho-interacting protein,MPRIP,65.03,62.08,S1016,DRSCVTRQLRNIRSKSVIEQVSWDT______,_S(ph)VIEQVSWDT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,phospholipid binding,,,
O95297-4,O95297,Myelin protein zero-like protein 1,MPZL1,142.23,142.21,Y241,LVKSLPSGSHQGPVIYAQLDHSGGHHSDKIN,_SLPSGSHQGPVIY(ph)AQLDHSGGHHSDK_,-0.45,-0.57,-0.37,-0.15,0.07,0.21, ,0,0.07,0.15,0.15,0.45,0.32,0.37, ,0.32,-0.51,-0.25,0.14,0,0.11,0.31,0.35,0.32,,,,,,,0,0,,integral to plasma membrane,structural molecule activity,cell-cell signaling,,
O95297-4,O95297,Myelin protein zero-like protein 1,MPZL1,131.09,131.09,Y263,GGHHSDKINKSESVVYADIRKN_________,_SESVVY(ph)ADIRK_,-0.14,0.05,-0.03,-0.09,0.31,0.48,0.11,-0.02,0.06,0.15,0.29,0.39,0.3,0.27,0.37,0.27,-0.04,-0.06,0.39,0.05,0.1,0.34,0.28,0.32,,,,,,,0,0,,integral to plasma membrane,structural molecule activity,cell-cell signaling,,
P49959-2,P49959,Double-strand break repair protein MRE11A,MRE11A,330.24,319.49,S688,KIMSQSQVSKGVDFESSEDDDDDPFMNTSSL,_GVDFES(ph)S(ph)EDDDDDPFMNTSSLRR_,0.06,0.07,-0.04,0.02,0.06,0.05,-0.03,0.06,-0.02,-0.07,-0.08,-0.19,0.01,0.04,0.07,0.07,0.06,-0.01,0.05,0.02,-0.04,-0.13,0.03,0.07,,,,,,,0,0,,Mre11 complex,3'-5' exonuclease activity,cell cycle checkpoint,,
P49959-2,P49959,Double-strand break repair protein MRE11A,MRE11A,330.24,319.49,S689,IMSQSQVSKGVDFESSEDDDDDPFMNTSSLR,_GVDFES(ph)S(ph)EDDDDDPFMNTSSLRR_,0.06,0.07,-0.04,0.02,0.06,0.05,-0.03,0.06,-0.02,-0.07,-0.08,-0.19,0.01,0.04,0.07,0.07,0.06,-0.01,0.05,0.02,-0.04,-0.13,0.03,0.07,,,,,,,0,0,,Mre11 complex,3'-5' exonuclease activity,cell cycle checkpoint,,
P49959-2,P49959,Double-strand break repair protein MRE11A,MRE11A,55.25,54.13,S649,NVTTKNYSEVIEVDESDVEEDIFPTTSKTDQ,_NYSEVIEVDES(ph)DVEEDIFPTTSK_, , , , , , ,0.48,0.46, , , , , , ,0.24,0.58,,,,0.47,,,,0.42,,,,,,,NA,NA,,Mre11 complex,3'-5' exonuclease activity,cell cycle checkpoint,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,233.86,233.86,S252,GSRRSSRQIKKRRVISDSESDIGGSDVEFKP,_VIS(ph)DS(ph)ES(ph)DIGGS(ph)DVEFKPDTK_,0.04,0.18,-0.09,-0.93,-0.26,-0.5,-0.19,-0.44,-0.12,-0.06,-0.07,-1.05,0.6,0.27,1.53,0.63,0.11,-0.45,-0.38,-0.31,-0.09,-0.48,0.44,1.15,, +,,,,,0,2,3.5,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,233.86,233.86,S261,KKRRVISDSESDIGGSDVEFKPDTKEEGSSD,_VIS(ph)DS(ph)ESDIGGS(ph)DVEFKPDTK_,-0.13,0.28,-0.09,-0.93,0.2,-0.5,-0.19,-0.44,-0.07,-0.12,-0.07,-1.05,0.06,0.27,1.53,0.63,0.09,-0.45,-0.11,-0.31,-0.09,-0.48,0.17,1.15,, +,,,,,0,2,2.96,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,99.84,99.84,S274,GGSDVEFKPDTKEEGSSDEISSGVGDSESEG,_EEGS(ph)S(ph)DEIS(ph)SGVGDS(ph)ESEGLNSPVK_, , , , ,-0.19,-0.17,0.32,0.27, , , , ,-0.07,0.01,-0.1,-0.05,,,-0.18,0.3,,,-0.03,-0.08,,,,,,,NA,NA,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,140.27,138.95,S275,GSDVEFKPDTKEEGSSDEISSGVGDSESEGL,_EEGS(ph)S(ph)DEIS(ph)SGVGDS(ph)ESEGLNSPVK_, , , , ,-0.19,-0.17,-0.01,0.27, , , , ,-0.07,0.01,0.42,-0.05,,,-0.18,0.14,,,-0.03,0.2,,,,,,,NA,NA,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,99.84,99.84,S279,EFKPDTKEEGSSDEISSGVGDSESEGLNSPV,_EEGS(ph)S(ph)DEIS(ph)S(ph)GVGDS(ph)ESEGLNSPVK_, , , , , , ,0.32,0.05, , , , , , ,-0.1,0.2,,,,0.19,,,,0.06,,,,,,,NA,NA,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,140.27,138.95,S285,KEEGSSDEISSGVGDSESEGLNSPVKVARKR,_EEGSS(ph)DEISSGVGDS(ph)ESEGLNSPVK_, , , , ,0.23,0.29,-0.01,0.36, , , , ,0.35,0.12,0.42,0.65,,,0.26,0.18,,,0.24,0.54,,,,,,,NA,NA,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,233.86,233.86,S254,RRSSRQIKKRRVISDSESDIGGSDVEFKPDT,_VIS(ph)DS(ph)ES(ph)DIGGS(ph)DVEFKPDTK_,-0.13,0.28,-0.09,-0.93,0.2,0.22,0.21,0.02,-0.07,-0.12,-0.07,-1.05,0.06,0.18,0.18,-0.11,0.09,-0.45,0.21,0.11,-0.09,-0.48,0.12,0.04,,,,,,,0,0,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,148.66,148.6,S256,SSRQIKKRRVISDSESDIGGSDVEFKPDTKE,_VIS(ph)DS(ph)ES(ph)DIGGS(ph)DVEFKPDTK_,0.04,0.18,0.17, ,-0.26,0.26,0.37,0.12,-0.12,-0.06,0.3, ,0.6,0.21,0.28,-0.14,0.11,0.17,0.02,0.25,-0.09,0.3,0.42,0.08,,,,,,,0,0,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,308.81,305.04,S219,EEEEMEVGTTYVTDKSEEDNEIESEEEVQPK,_S(ph)EEDNEIES(ph)EEEVQPK_,0.28,0.39,-0.01,0.22,-0.07,0.2,0.08,0.09,0.29,0.3,0.1,0.31,0.07,0.18,0.03,0.15,0.34,0.11,0.07,0.08,0.3,0.21,0.13,0.09,,,,,,,0,0,,,,,,
F5H769,P52701,DNA mismatch repair protein Msh6,MSH6,409.48,396.15,S227,TTYVTDKSEEDNEIESEEEVQPKTQGSRRSS,_S(ph)EEDNEIES(ph)EEEVQPK_,-0.06,0.07,-0.02,-0.17,-0.13,-0.14,-0.14,-0.2,0.07,0.11,-0.08,-0.19,-0.28,-0.26,-0.03,-0.09,0.01,-0.09,-0.13,-0.17,0.09,-0.13,-0.27,-0.06,,,,,,,0,0,,,,,,
P26038,P26038,Moesin,MSN,165.39,165.39,S576,QIRQGNTKQRIDEFESM______________,_(gl)QRIDEFES(ph)M_,-0.33,-0.04,-0.36,-0.26,-0.22,-0.19,-0.36,-0.08,-0.14,-0.02,-0.23,-0.13,-0.23,-0.2,-0.18,-0.04,-0.18,-0.31,-0.21,-0.22,-0.08,-0.18,-0.21,-0.11,,,,,,,0,0,,apical part of cell,structural constituent of cytoskeleton,leukocyte cell-cell adhesion,,
Q13330-3,Q13330,Metastasis-associated protein MTA1,MTA1,88.25,87.34,S576,SSLTPAKVAPVINNGSPTILGKRSYEQHNGV,_VAPVINNGS(ph)PTILGK_,0.09,-0.36,-0.07,0.15, , , , ,-0.07,-0.01,-0.31,-0.28, , , , ,-0.11,0.04,,,-0.04,-0.29,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,secretory granule organization,,
Q96DY7,Q96DY7,Mdm2-binding protein,MTBP,166.9,144.58,S639,PIQKGEKTFVLTPELSPGKLQVLPFEKASVC,_TFVLTPELS(ph)PGK_,0.19,0.14,0.17,0.28, , , , ,-0.17,-0.51,-0.02,-0.25, , , , ,0.16,0.22,,,-0.33,-0.13,,,,,,,,,NA,NA,,,,cell cycle arrest,,
Q86UE4,Q86UE4,Protein LYRIC,MTDH,194.77,124.96,S298,GGGWNEKSVKLSSQISAGEEKWNSVSPASAG,_LSSQIS(ph)AGEEK_, , ,2,1.14,2.53, , , , , ,2.79,2.03,2.22, , , ,,1.63,2.53,,,2.46,2.22,, +, +,,,,,NA,NA,,apical plasma membrane,transcription coactivator activity,lipopolysaccharide-mediated signaling pathway,,
Q86UE4,Q86UE4,Protein LYRIC,MTDH,89.19,86.4,S568,NSVPPSQTKSETSWESPKQIKKKKKARRET_,_SETSWES(ph)PK_, ,0.18, , , , ,0.06, , ,0.31, , , , ,-0.18, ,0.18,,,0.06,0.31,,,-0.18,,,,,,,NA,NA,,apical plasma membrane,transcription coactivator activity,lipopolysaccharide-mediated signaling pathway,,
Q86UE4,Q86UE4,Protein LYRIC,MTDH,294.91,294.91,S426,SLLKSQEPIPDDQKVSDDDKEKGEGALPTGK,_SQEPIPDDQKVS(ph)DDDKEK_,0.25,0.19,0.08,0.22,0.42,0.35,0.41,0.33,0.22,0.18,0.18,0.2,0.25,0.2,0.15,0.15,0.22,0.15,0.38,0.37,0.2,0.19,0.22,0.15,,,,,,,0,0,,apical plasma membrane,transcription coactivator activity,lipopolysaccharide-mediated signaling pathway,,
Q86UE4,Q86UE4,Protein LYRIC,MTDH,83.75,73.4,S308,LSSQISAGEEKWNSVSPASAGKRKTEPSAWS,_WNSVS(ph)PAS(ph)AGK_, , , , , ,-0.97, , , , , , , ,-0.91, , ,,,-0.97,,,,-0.91,,,,,,,,NA,NA,,apical plasma membrane,transcription coactivator activity,lipopolysaccharide-mediated signaling pathway,,
Q86UE4,Q86UE4,Protein LYRIC,MTDH,83.75,73.4,S311,QISAGEEKWNSVSPASAGKRKTEPSAWSQDT,_WNSVS(ph)PAS(ph)AGK_, , , , , ,-0.97, , , , , , , ,-0.91, , ,,,-0.97,,,,-0.91,,,,,,,,NA,NA,,apical plasma membrane,transcription coactivator activity,lipopolysaccharide-mediated signaling pathway,,
B7Z499,Q13496,Myotubularin,MTM1,94.36,94.17,S588,ELQLANSAKLSDPPTSPSSPSQMMPHVQTHF,_LSDPPTS(ph)PSS(ph)PSQMMPHVQTHF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,Myotubularins,NA,NA,,I band,protein tyrosine phosphatase activity,mitochondrion distribution,,
B7Z3D5,Q13613,Myotubularin-related protein 1,MTMR1,70.17,70.17,S653,EVATRAVSSSSERGSSPSHSATSVHTSV___,_GSS(ph)PSHSATSVHTSV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,Myotubularins,NA,NA,,cytoplasm,phosphatidylinositol-3-phosphatase activity,peptidyl-tyrosine dephosphorylation,,
Q9NXD2,Q9NXD2,Myotubularin-related protein 10,MTMR10,182.03,157.77,S769,GTPLSKFLSGAKIWLSTETLANED_______,_IWLS(ph)TETLANED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,Myotubularins,NA,NA,,,phosphatase activity,,,
B7Z291,Q96QG7,Myotubularin-related protein 9,MTMR9,203.93,189.14,S548,RRQLAELETEDGMQESP______________,_(gl)QLAELETEDGMQES(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,Myotubularins,NA,NA,,,enzyme regulator activity,,,
Q765P7,Q765P7,MTSS1-like protein,MTSS1L,134.03,133.6,S264,LKGSDYSWSYQTPPSSPSSSSSRKSSMCSAP,_GSDYSWSYQT(ph)PPSS(ph)PSSSSSR_, , , , ,-0.14,-0.3,-0.16,-0.31, , , , ,-0.18,-0.27,-0.08,-0.13,,,-0.22,-0.23,,,-0.22,-0.1,,,,,,,NA,NA,,,,filopodium assembly,,
Q765P7,Q765P7,MTSS1-like protein,MTSS1L,85.5,70.71,S601,IRPPIVPVKTPTVPDSPGYMGPTRAGSEECV,_TPTVPDS(ph)PGYMGPTR_, , ,0.15, , , , , , , ,0.78, , , , , ,,0.15,,,,0.78,,,,,,,,,NA,NA,,,,filopodium assembly,,
Q765P7,Q765P7,MTSS1-like protein,MTSS1L,134.03,133.6,T260,VIKDLKGSDYSWSYQTPPSSPSSSSSRKSSM,_GSDYSWSYQT(ph)PPSS(ph)PSSSSSR_, , , , ,-0.14,-0.3,-0.16,0.01, , , , ,-0.25,-0.27,-0.08,-0.07,,,-0.22,-0.07,,,-0.26,-0.08,,,,,,,NA,NA,,,,filopodium assembly,,
Q9ULD2-2,Q9ULD2,Microtubule-associated tumor suppressor 1,MTUS1,154.72,154.72,S1264,SAIPLQSPRNSGSFPSPSISPR_________,_NSGSFPS(ph)PSIS(ph)PR_, , , , ,0.73,0.73,0.69,0.92, , , , ,0.51,0.51,0.56,0.73,,,0.73,0.81,,,0.51,0.65,,,,,,,NA,NA,,Golgi apparatus,,cellular response to peptide hormone stimulus,,
Q9ULD2-2,Q9ULD2,Microtubule-associated tumor suppressor 1,MTUS1,154.72,154.72,S1268,LQSPRNSGSFPSPSISPR_____________,_NSGSFPS(ph)PSIS(ph)PR_, , , , ,0.73,0.73,0.69,0.92, , , , ,0.51,0.51,0.56,0.73,,,0.73,0.81,,,0.51,0.65,,,,,,,NA,NA,,Golgi apparatus,,cellular response to peptide hormone stimulus,,
Q9ULD2-2,Q9ULD2,Microtubule-associated tumor suppressor 1,MTUS1,213.49,193.28,S443,MSTPVLEPTKVTFSVSPIEATEKCKKVEKGN,_VTFSVS(ph)PIEATEK_,0.57,0.51,0.46,0.18, , ,-0.69, ,0,0.06,-0.03,-0.12, , ,-0.24, ,0.54,0.33,,-0.69,0.03,-0.07,,-0.24,,,,,,,NA,NA,,Golgi apparatus,,cellular response to peptide hormone stimulus,,
P84157-2,P84157,Matrix-remodeling-associated protein 7,MXRA7,65.01,63.21,S128,RQEEEQDLDGEKGPSSEGPEEEDGEGFSFKY,_GPSS(ph)EGPEEEDGEGFSFK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q9BQG0,Q9BQG0,Myb-binding protein 1A,MYBBP1A,50.49,49.86,S1159,VQRPKLEKKDAKEIPSATQSPISKKRKKKGF,_EIPS(ph)ATQS(ph)PISK_, , , , ,-2.96,-3.04, , , , , , ,-0.12,-0.19, , ,,,-3,,,,-0.15,, +,,,,,,NA,NA,,cytoplasm,DNA-directed DNA polymerase activity,cellular response to glucose starvation,,
Q9BQG0,Q9BQG0,Myb-binding protein 1A,MYBBP1A,98.25,50.23,S1290,KQHQKALPKKGVLGKSPLSALARKKARLSLV,_S(ph)PLSALAR_, ,-0.29, , ,-0.56, ,-0.85, , ,-0.24, , ,-0.28, ,-1.03, ,-0.29,,-0.56,-0.85,-0.24,,-0.28,-1.03,, +,,,,,NA,NA,,cytoplasm,DNA-directed DNA polymerase activity,cellular response to glucose starvation,,
Q9BQG0,Q9BQG0,Myb-binding protein 1A,MYBBP1A,137.39,103.52,S1163,KLEKKDAKEIPSATQSPISKKRKKKGFLPET,_EIPSATQS(ph)PISK_,0.36,0.35,0.3,0.36,0.2,0.18,0.05,-0.15,0.03,-0.05,-0.14,-0.15,0.01,0.13,-0.2,-0.25,0.36,0.33,0.19,-0.04,-0.01,-0.14,0.07,-0.22,,,,,,,0,0,,cytoplasm,DNA-directed DNA polymerase activity,cellular response to glucose starvation,,
Q9BQG0,Q9BQG0,Myb-binding protein 1A,MYBBP1A,80.34,80.34,S1267,QKKNQKPSQVNGAPGSPTEPAGQKQHQKALP,_NQKPSQVNGAPGS(ph)PTEPAGQK_,0.32,0.33,0.06,0.09,0.68,0.28,-0.25, ,0.1,0.18,-0.22,-0.04,0.09,0.09,-0.24, ,0.33,0.08,0.49,-0.25,0.14,-0.13,0.09,-0.24,,,,,,,0,0,,cytoplasm,DNA-directed DNA polymerase activity,cellular response to glucose starvation,,
Q9BQG0,Q9BQG0,Myb-binding protein 1A,MYBBP1A,139.47,136.04,S11,_____MESRDPAQPMSPGEATQSGARPADRY,_DPAQPMS(ph)PGEATQSGARPADR_, ,0.75,0.47,0.55,0.17,0.17,-0.09, , ,0.38,0.48,0.11,-0.1,-0.1,-0.45, ,0.75,0.51,0.17,-0.09,0.38,0.31,-0.1,-0.45,,,,,,,0,0,,cytoplasm,DNA-directed DNA polymerase activity,cellular response to glucose starvation,,
F8W6N6,P10244,Myb-related protein B,MYBL2,210.29,209.46,S241,TNWPSVPPTIKEEENSEEELAAATTSKEQEP,_EEENS(ph)EEELAAATTSK_,-0.32,0.06, , , , , , ,0.03,0.25, , , , , , ,-0.12,,,,0.15,,,,,,,,,,NA,NA,,,chromatin binding,,,
B4E1N7,P01106,Myc proto-oncogene protein,MYC,165.22,165.22,S62,EDIWKKFELLPTPPLSPSRRSGLCSPSYVAV,_KFELLPT(ph)PPLS(ph)PSRR_,0.01,-0.58,0.53,0.46, , , , ,2.57,-0.18,0.49,2.83, , , , ,-0.25,0.49,,,1.77,2.09,,,, +,,,,,NA,NA,,nucleus,sequence-specific DNA binding transcription factor activity,,,
B4E1N7,P01106,Myc proto-oncogene protein,MYC,165.22,165.22,T58,YCDEEDIWKKFELLPTPPLSPSRRSGLCSPS,_KFELLPT(ph)PPLS(ph)PSRR_,0.01,-0.35,0.53,0.46, , , , ,2.57,0.01,0.49,2.73, , , , ,-0.16,0.5,,,1.79,2.01,,,, +,,,,,NA,NA,,nucleus,sequence-specific DNA binding transcription factor activity,,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,149.12,142.84,S3467,ILPARVKAIPRRRVNSGDTEVGSSLLRHPSP,_VNS(ph)GDTEVGSSLLR_, , ,0.86,0.43,0.83,0.82,1.35,1.78, , ,1.06,0.87,1.13,1.07,1.37,1.37,,0.66,0.83,1.58,,0.97,1.1,1.37, +, +,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,127.67,123.87,S2749,LKSDAAKLRSDSHSRSLSPNHNTLQTLKSDG,_S(ph)LS(ph)PNHNTLQTLK_,0.21,0.12,-0.15,-0.23,-0.59, ,-1.32, ,0.07,-0.05,-0.42,-0.89,-0.89, ,-0.65, ,0.17,-0.19,-0.59,-1.32,0.01,-0.64,-0.89,-0.65, +,,,,,,6,0,11.42,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,127.67,123.87,S2751,SDAAKLRSDSHSRSLSPNHNTLQTLKSDGRM,_S(ph)LS(ph)PNHNTLQTLK_,0.21,0.12,-0.72,-0.23,-0.59, ,-1.32, ,0.07,-0.05,-0.99,-0.89,-0.89, ,-0.65, ,0.17,-0.45,-0.59,-1.32,0.01,-0.94,-0.89,-0.65, +,,,,,,6,0,11.16,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,103.16,87.52,S3893,GDAEPTPEQEEKALLSSPEGEEKATSDADLK,_ALLS(ph)S(ph)PEGEEK_, , , , ,0.38,0.41,0.36,0.28, , , , ,0.34,0.42,0.47,0.19,,,0.39,0.32,,,0.38,0.33,,,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,103.16,87.52,S3894,DAEPTPEQEEKALLSSPEGEEKATSDADLKE,_ALLS(ph)S(ph)PEGEEK_, , , , ,0.38,0.41,0.36,0.28, , , , ,0.34,0.42,0.47,0.19,,,0.39,0.32,,,0.38,0.33,,,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,133.13,133.13,S140,KKEISLAAASKNSVQSGESDSDEEEESKEPP,_NSVQS(ph)GES(ph)DS(ph)DEEEESKEPPIK_, , , , ,0.33,-0.02,0.09,0.27, , , , ,-0.22,0.11,0.01,-0.06,,,0.16,0.18,,,-0.04,-0.03,,,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,133.13,133.13,S143,ISLAAASKNSVQSGESDSDEEEESKEPPIKL,_NSVQS(ph)GES(ph)DS(ph)DEEEESKEPPIK_, , , , ,0.29,-0.02,0.21,0.57, , , , ,0.16,0.11,-0.01,0.08,,,0.14,0.4,,,0.14,0.04,,,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
O75592-2,O75592,Probable E3 ubiquitin-protein ligase MYCBP2,MYCBP2,133.13,133.13,S145,LAAASKNSVQSGESDSDEEEESKEPPIKLPK,_NSVQS(ph)GES(ph)DS(ph)DEEEESKEPPIK_, , , , ,0.29,-0.02,0.21,0.57, , , , ,0.16,0.11,-0.01,0.08,,,0.14,0.4,,,0.14,0.04,,,,,,,NA,NA,,axon,ubiquitin-protein ligase activity,branchiomotor neuron axon guidance,,
P35580,P35580,Myosin-10,MYH10,311.52,280.92,S1956,SGRRQLHLEGASLELSDDDTESKTSDVNETQ,_(gl)QLHLEGAS(ph)LELS(ph)DDDTESK_,-1.11,-0.3,-1.47,-0.7,-0.89,-0.69,-0.68,-0.81,-0.03,-0.14,-0.24,-0.06,-0.16,-0.08,-0.13,-0.11,-0.65,-1.03,-0.79,-0.75,-0.08,-0.15,-0.12,-0.12, +,,,,,,3,0,30.73,cell cortex,actin filament binding,actin filament-based movement,,
P35580,P35580,Myosin-10,MYH10,209.79,192.95,S1952,SSSRSGRRQLHLEGASLELSDDDTESKTSDV,_(gl)QLHLEGAS(ph)LELS(ph)DDDTESK_, , , , ,-1.14,-0.84,-0.75,-0.41, , , , ,-0.2,-0.09,-0.02,0.09,,,-0.98,-0.57,,,-0.14,0.04,,,,,,,NA,NA,,cell cortex,actin filament binding,actin filament-based movement,,
P35579,P35579,Myosin-9,MYH9,129.85,95.98,Y754,ACVLMIKALELDSNLYRIGQSKVFFRAGVLA,_ALELDSNLY(ph)R_,-1.01, ,-0.76, , , , , ,-0.75, ,-0.78, , , , , ,-1.01,-0.76,,,-0.75,-0.78,,, +,,,,,,NA,NA,,actomyosin contractile ring,actin filament binding,actin cytoskeleton reorganization,+,
P35579,P35579,Myosin-9,MYH9,133.21,129.46,T1151,DLGEELEALKTELEDTLDSTAAQQELRSKRE,_TELEDT(ph)LDSTAAQQELR_, , ,-0.8, , ,-0.86, , , , ,-0.74, , ,-0.55, , ,,-0.8,-0.86,,,-0.74,-0.55,,,,,,,,NA,NA,,actomyosin contractile ring,actin filament binding,actin cytoskeleton reorganization,+,
P35579,P35579,Myosin-9,MYH9,436.75,436.75,S1943,FVVPRRMARKGAGDGSDEEVDGKADGAEAKP,_GAGDGS(ph)DEEVDGKADGAEAKPAE_,-0.26,-0.3,-0.25,-0.37,-0.53,-0.48,-0.2,-0.5,-0.15,-0.14,-0.05,-0.1,-0.31,-0.17,-0.27,-0.18,-0.28,-0.31,-0.51,-0.34,-0.14,-0.07,-0.24,-0.23,,,,,,,0,0,,actomyosin contractile ring,actin filament binding,actin cytoskeleton reorganization,+,
Q92614-2,Q92614,Unconventional myosin-XVIIIa,MYO18A,194.19,194.19,S1970,MVTKYQKRKNKLEGDSDVDSELEDRVDGVKS,_NKLEGDS(ph)DVDS(ph)ELEDRVDGVK_,-0.11,-0.12,-0.37,-0.04,-0.49,-0.15,0.24,0.09,-0.63,-0.53,-0.15,-0.01,-0.5,-0.1,-0.14,0.3,-0.11,-0.2,-0.31,0.17,-0.58,-0.08,-0.29,0.1,,,,,,,0,0,,actomyosin,ATP binding,actomyosin structure organization,,
Q92614-2,Q92614,Unconventional myosin-XVIIIa,MYO18A,194.19,194.19,S1974,YQKRKNKLEGDSDVDSELEDRVDGVKSWLSK,_NKLEGDS(ph)DVDS(ph)ELEDRVDGVK_,-0.48,-0.86,-0.51,-0.72,-0.49,-0.15,0.24,0.09,-0.16,-0.07,-0.1,-0.17,-0.5,-0.1,-0.14,0.3,-0.66,-0.61,-0.31,0.17,-0.11,-0.13,-0.29,0.1,,,,,,,0,0,,actomyosin,ATP binding,actomyosin structure organization,,
Q92614-2,Q92614,Unconventional myosin-XVIIIa,MYO18A,44.43,44.43,S2007,GPSKAASDDGSLKSSSPTSYWKSLAPDRSDD,_S(ph)SS(ph)PTSYWK_, , , , ,0.05,0.12,-0.03,0.24, , , , ,0.14,0.19,0.06,0.36,,,0.09,0.11,,,0.17,0.22,,,,,,,NA,NA,,actomyosin,ATP binding,actomyosin structure organization,,
Q92614-2,Q92614,Unconventional myosin-XVIIIa,MYO18A,225.69,225.69,S2041,PLDNTSRPRYSHSYLSDSDTEAKLTETNA__,_YSHSYLS(ph)DS(ph)DTEAK_,-0.43,-0.32,-0.36,-0.4,-0.01,0.01,-0.12,-0.1,-0.58,-0.49,-0.4,-0.46,0.1,0.01,-0.02,-0.01,-0.37,-0.38,0,-0.11,-0.53,-0.43,0.05,-0.02,,,,,,,0,0,,actomyosin,ATP binding,actomyosin structure organization,,
Q92614-2,Q92614,Unconventional myosin-XVIIIa,MYO18A,225.69,225.69,S2043,DNTSRPRYSHSYLSDSDTEAKLTETNA____,_YSHSYLS(ph)DS(ph)DTEAK_,-0.43,-0.32,-0.36,-0.4,-0.01,0.01,-0.12,-0.1,-0.58,-0.49,-0.4,-0.46,0.1,0.01,-0.02,-0.01,-0.37,-0.38,0,-0.11,-0.53,-0.43,0.05,-0.02,,,,,,,0,0,,actomyosin,ATP binding,actomyosin structure organization,,
O00159-2,O00159,Unconventional myosin-Ic,MYO1C,138.22,121.31,S408,LVGKINRSLASKDVESPSWRSTTVLGLLDIY,_DVES(ph)PSWR_,-0.41,-0.45,-1.18,-0.87,0.03,-0.18,0.09,0.13,-0.34,-0.18,-0.11,-0.09,0.16,0.07,-0.12,-0.12,-0.43,-1.02,-0.07,0.11,-0.26,-0.1,0.11,-0.12, +,,,,,,3,0,16.34,basal plasma membrane,ATP binding,cellular membrane organization,,
O00159-2,O00159,Unconventional myosin-Ic,MYO1C,121.73,99.09,S864,ELCIKNMVWKYCRSISPEWKQQLQQKAVASE,_SIS(ph)PEWK_,-0.04,0.04,-0.43,-0.59,0.11, ,-0.39,0.38,0.15,0,0.02,-0.01,-0.07, ,-0.29,0.4,0,-0.51,0.11,0.05,0.08,0.01,-0.07,0.1,,,,,,,0,0,,basal plasma membrane,ATP binding,cellular membrane organization,,
Q12965,Q12965,Unconventional myosin-Ie,MYO1E,79.34,78.09,Y971,PPPPGYHQNGVIRNQYVPYPHAPGSQRSNQK,_NQY(ph)VPYPHAPGSQR_,2.34, ,0.1, , , , , ,1.32, ,-0.92, , , , , ,2.34,0.1,,,1.32,-0.92,,, +, +,,,,,NA,NA,,adherens junction,actin filament binding,actin filament-based movement,+,
Q12965,Q12965,Unconventional myosin-Ie,MYO1E,170.66,170.66,Y989,YPHAPGSQRSNQKSLYTSMARPPLPRQQSTS,_SLY(ph)TSMARPPLPR_,0.54, ,-1.14, , , ,-2.32,-1.92,-0.33, ,-1.95, , , ,-1.86,-1.61,0.54,-1.14,,-2.11,-0.33,-1.95,,-1.73, +, +,,,,,NA,NA,,adherens junction,actin filament binding,actin filament-based movement,+,
Q12965,Q12965,Unconventional myosin-Ie,MYO1E,49.3,43.58,Y9,_______MGSKGVYQYHWQSHNVKHSGVDDM,_GVYQY(ph)HWQSHNVK_,3.44, , , , , , , ,2.9, , , , , , , ,3.44,,,,2.9,,,, +, +,,,,,NA,NA,,adherens junction,actin filament binding,actin filament-based movement,+,
Q12965,Q12965,Unconventional myosin-Ie,MYO1E,162.13,162.13,Y7,_________MGSKGVYQYHWQSHNVKHSGVD,_GVY(ph)QYHWQSHNVK_,1.71, ,0.15, , , , , ,0.91, ,-0.47, , , , , ,1.71,0.15,,,0.91,-0.47,,, +,,,,,,NA,NA,,adherens junction,actin filament binding,actin filament-based movement,+,
Q13459-2,Q13459,Unconventional myosin-IXb,MYO9B,165.22,155.99,S1267,TSLALDSRVSPPAPGSAPETPEDKSKPCGSP,_VSPPAPGS(ph)APET(ph)PEDK_, , ,-0.15, ,1.13,1.22,0.5,0.44, , ,-0.33, ,1.06,1.43,0.14,0.07,,-0.15,1.17,0.47,,-0.33,1.26,0.1, +, +,,,,,NA,NA,,cell cortex,actin binding,actin filament-based movement,,
Q13459-2,Q13459,Unconventional myosin-IXb,MYO9B,165.22,155.99,T1271,LDSRVSPPAPGSAPETPEDKSKPCGSPRVQE,_VSPPAPGS(ph)APET(ph)PEDK_, , ,-0.15, ,1.13,1.22,0.5,0.44, , ,-0.33, ,1.06,1.43,0.14,0.07,,-0.15,1.17,0.47,,-0.33,1.26,0.1, +, +,,,,,NA,NA,,cell cortex,actin binding,actin filament-based movement,,
Q86TC9,Q86TC9,Myopalladin,MYPN,239.89,236.92,S928,MNEIEFRLERTPVDESDDEIQHDEIPTGKCI,_TPVDES(ph)DDEIQHDEIPTGK_,0.26,-0.06,-0.07,-0.1,0.15,0.18,0.06, ,1.18,0.37,0.51,0.11,0.42,0.38,0.16, ,0.11,-0.09,0.16,0.06,0.83,0.32,0.4,0.16,,,,,,,0,0,,I band,,sarcomere organization,,
P0CAP1-11,P0CAP1,Myocardial zonula adherens protein,MYZAP,55.78,26.23,S291,KAIEEANKKMQAAEISLEEKDQRIGELDRLI,_KMQAAEIS(ph)LEEK_, ,0.22,0.9, , , , , , ,0.06,-5.14, , , , , ,0.22,0.9,,,0.06,-5.14,,,, +,,,,,NA,NA,,cell junction,,intracellular signal transduction,,
Q6P582,Q6P582,Mitotic-spindle organizing protein 2A,MZT2A,117.21,82.46,S139,RSNHEGSSQRMPRQPSATRLPKGGGPGKSPT,_(gl)QPS(ph)ATRLPK_,0.41,0.22,0.23,0.32,0.34,0.32,-0.02,0.48,0.11,0.09,0.26,0.21,-0.2,-0.12,-0.24,0.38,0.32,0.28,0.33,0.25,0.1,0.24,-0.16,0.1,,,,,,,0,0,,centrosome,,,,
O75113,O75113,NEDD4-binding protein 1,N4BP1,108.68,108.68,S288,EEALSNERICQKRRFSDSEERHTKKQFSLEN,_RRFS(ph)DSEER_,0,0.07,0.72,1.02,1.06, , ,1.28,0.33,0.34,1.01,1.01,0.96, , ,1.53,0.04,0.88,1.06,1.28,0.33,1.01,0.96,1.53, +, +,,,,,1,1,31.02,nucleolus,,cellular response to UV,,
P41227,P41227,N-alpha-acetyltransferase 10,NAA10,168.05,137.74,S213,KGLAAEDSGGDSKDLSEVSETTESTDVKDSS,_DLS(ph)EVS(ph)ETTESTDVK_, , , , ,-0.16,-0.08,-0.21,-0.24, , , , ,-0.66,-0.19,-0.24,-0.37,,,-0.12,-0.23,,,-0.41,-0.3,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,DNA packaging,,
P41227,P41227,N-alpha-acetyltransferase 10,NAA10,168.05,137.74,S216,AAEDSGGDSKDLSEVSETTESTDVKDSSEAS,_DLS(ph)EVS(ph)ETTESTDVK_, , , , ,-0.16,-0.08,-0.19,-0.24, , , , ,-0.66,-0.19,-0.26,-0.37,,,-0.12,-0.22,,,-0.41,-0.31,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,DNA packaging,,
P41227,P41227,N-alpha-acetyltransferase 10,NAA10,131.45,122.65,S182,KGRHVVLGAIENKVESKGNSPPSSGEACREE,_HVVLGAIENKVES(ph)K_,-0.06,0.05,-0.38,-0.67, , , , ,0.35,-0.09,-0.22,-0.4, , , , ,0,-0.52,,,0.15,-0.31,,,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,DNA packaging,,
Q9BXJ9,Q9BXJ9,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",NAA15,79.61,78.92,S588,LTDENKEHEADTANMSDKELKKLRNKQRRAQ,_EHEADTANMS(ph)DK_, , , , ,0.02, ,0.75, , , , , ,0.07, ,0.34, ,,,0.02,0.75,,,0.07,0.34,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,angiogenesis,,
Q9BXJ9,Q9BXJ9,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",NAA15,256.08,251.66,S855,PPGYEEDMKITVNGDSSAEAEELANEI____,_ITVNGDS(ph)S(ph)AEAEELANEI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,angiogenesis,,
Q9BXJ9,Q9BXJ9,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",NAA15,256.08,251.66,S856,PGYEEDMKITVNGDSSAEAEELANEI_____,_ITVNGDS(ph)S(ph)AEAEELANEI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,N-acetyltransferase activity,angiogenesis,,
B4DKG1,Q13506,NGFI-A-binding protein 1,NAB1,152.06,152.06,S403,QHAERRLSAGLYRQSSEEHSPNGLTSDNSDG,_(gl)QSS(ph)EEHSPNGLTSDNSDGQGERPLNLR_,0.17, ,0.3,0.53, ,0.18, , ,0.23, ,0.72,0.72, ,0.17, , ,0.17,0.42,0.18,,0.23,0.72,0.17,,,,,,,,NA,NA,,nucleus,,"negative regulation of transcription, DNA-dependent",,
Q15742-2,Q15742,NGFI-A-binding protein 2,NAB2,128.75,128.75,S159,GHGSPGEKAGSARSFSPKSPLELGEKLSPLP,_SFS(ph)PKS(ph)PLELGEK_,-0.37, ,0.85, ,1.56,1.36, ,1.26,0.28, ,1.28, ,1.59,1.28, ,1.32,-0.37,0.85,1.46,1.26,0.28,1.28,1.44,1.32, +, +,,,,,1,1,32.78,nucleus,transcription corepressor activity,cell proliferation,,
Q15742-2,Q15742,NGFI-A-binding protein 2,NAB2,128.75,128.75,S162,SPGEKAGSARSFSPKSPLELGEKLSPLPGGP,_SFS(ph)PKS(ph)PLELGEK_,-0.37, ,0.85, ,1.56,1.36, ,1.26,0.28, ,1.28, ,1.59,1.28, ,1.32,-0.37,0.85,1.46,1.26,0.28,1.28,1.44,1.32, +, +,,,,,1,1,32.78,nucleus,transcription corepressor activity,cell proliferation,,
F8VZJ2,E9PAV3,Nascent polypeptide-associated complex subunit alpha,NACA,241.74,227.91,S2029,SNIQENTQTPTVQEESEEEEVDETGVEVKDI,_VQGEAVSNIQENTQTPTVQEES(ph)EEEEVDETGVEVK_,-0.03,-0.14,0.03,-0.01,-0.17,-0.2,-0.15,-0.13,-0.01,0.14,-0.04,-0.04,0.08,0.07,0.03,0.07,-0.08,0.01,-0.19,-0.14,0.07,-0.04,0.08,0.05,,,,,,,0,0,,,,,,
F8VZJ2,E9PAV3,Nascent polypeptide-associated complex subunit alpha,NACA,106.76,105.42,T2022,KVQGEAVSNIQENTQTPTVQEESEEEEVDET,_VQGEAVSNIQENTQT(ph)PTVQEES(ph)EEEEVDETGVEVK_, , , , ,-0.68, ,-0.34,0.08, , , , ,-0.43, ,-0.34,-0.14,,,-0.68,-0.12,,,-0.43,-0.24,,,,,,,NA,NA,,,,,,
F8VZJ2,E9PAV3,Nascent polypeptide-associated complex subunit alpha,NACA,188.49,183.58,T2024,QGEAVSNIQENTQTPTVQEESEEEEVDETGV,_VQGEAVSNIQENTQTPT(ph)VQEESEEEEVDETGVEVK_, ,0.07,-0.08,-0.15,-0.27,-0.03,-0.06,0.18, ,0.21,-0.07,-0.07,-0.05,0.11,0.07,0.22,0.07,-0.11,-0.15,0.07,0.21,-0.07,0.03,0.15,,,,,,,0,0,,,,,,
E9PAZ2,Q96HR8,H/ACA ribonucleoprotein complex non-core subunit NAF1,NAF1,166.43,163.95,S315,SWKNDQEPPPEALDFSDDEKEKEAKQRKKSQ,_NDQEPPPEALDFS(ph)DDEK_,0.19,0.26,0.15,0.21,0.02,-0.03,0.08,0.08,0.24,0.21,-0.05,0.19,-0.03,0,-0.01,0.02,0.23,0.18,-0.01,0.08,0.22,0.08,-0.01,0.01,,,,,,,0,0,,,,,,
F8W020,P55209,Nucleosome assembly protein 1-like 1,NAP1L1,136.64,131.17,S69,ERLDGLVETPTGYIESLPRVVKRRVNALKNL,_LDGLVETPTGYIES(ph)LPR_, , , ,1.01, ,-0.05, , , , , ,-0.01, ,-0.17, , ,,1.01,-0.05,,,-0.01,-0.17,, +,,,,,,NA,NA,,nucleus,,nucleosome assembly,+,
F8W020,P55209,Nucleosome assembly protein 1-like 1,NAP1L1,293.3,291.06,S10,______MADIDNKEQSELDQDLDDVEEVEEE,_EQS(ph)ELDQDLDDVEEVEEEETGEETK_, , , , , , ,-0.42,0.14, , , , , , ,-0.07,0.4,,,,-0.11,,,,0.18,,,,,,,NA,NA,,nucleus,,nucleosome assembly,+,
F8W020,P55209,Nucleosome assembly protein 1-like 1,NAP1L1,243.99,240.56,T62,QILAALQERLDGLVETPTGYIESLPRVVKRR,_LDGLVET(ph)PTGYIESLPR_,0.41,0.4,0.38,0.5,-0.57,-0.43,-0.29, ,-0.14,0.17,0,-0.05,-0.68,-0.59,-0.65, ,0.41,0.44,-0.5,-0.29,0.02,-0.02,-0.64,-0.65,,,,,,,0,0,,nucleus,,nucleosome assembly,+,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,101.84,99.88,S304,FFNFFNPLKASGDGESLDEDSEFTLASDFEI,_ASGDGES(ph)LDEDSEFTLASDFEIGHFFR_,-0.29,-0.48, , , , , , ,-0.4,-0.33, , , , , , ,-0.38,,,,-0.36,,,,,,,,,,NA,NA,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,354.12,354.12,S125,ITGDVEPTDAESEWHSENEEEEKLAGDMKSK,_RREFITGDVEPTDAESEWHS(ph)ENEEEEK_,0.02,0.04,0.04,-0.08,-0.09,-0.03,-0.03,-0.05,0.05,-0.04,-0.05,-0.06,-0.23,-0.03,0.02,-0.01,0.03,-0.02,-0.06,-0.04,0,-0.05,-0.13,0,,,,,,,0,0,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,75.53,73.01,S54,AALQERLDNVPHTPSSYIETLPKAVKRRINA,_LDNVPHT(ph)PSS(ph)YIETLPK_, , , , , , , ,-0.68, , , , , , , ,-0.03,,,,-0.68,,,,-0.03,,,,,,,NA,NA,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,83.22,79.58,T51,RVLAALQERLDNVPHTPSSYIETLPKAVKRR,_LDNVPHT(ph)PSS(ph)YIETLPK_,-0.22,-0.68,-0.33, , , , ,-0.68,-1,-0.79,-0.93, , , , ,-0.03,-0.44,-0.33,,-0.68,-0.89,-0.93,,-0.03,,,,,,,NA,NA,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,457.35,452.31,S5,___________MADHSFSDGVPSDSVEAAKN,_(ac)ADHS(ph)FS(ph)DGVPS(ph)DSVEAAK_,-0.14,-0.18,-0.4,-0.36,-0.58,-0.52,-0.47,-0.53,-0.06,-0.17,-0.14,-0.13,-0.61,-0.86,-0.51,-0.55,-0.16,-0.38,-0.55,-0.5,-0.12,-0.13,-0.73,-0.53,,,,,,,0,0,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,381.27,372.43,S7,_________MADHSFSDGVPSDSVEAAKNAS,_(ac)ADHS(ph)FS(ph)DGVPS(ph)DSVEAAK_,-0.04,0.1,0.11,0.35,-0.29,-0.08,-0.01,-0.07,-0.03,-0.03,0.07,0,-0.44,0,-0.15,-0.22,0.03,0.24,-0.18,-0.04,-0.03,0.03,-0.2,-0.19,,,,,,,0,0,,cytoplasm,unfolded protein binding,nucleosome assembly,,
Q99733,Q99733,Nucleosome assembly protein 1-like 4,NAP1L4,333.82,328.29,S12,____MADHSFSDGVPSDSVEAAKNASNTEKL,_(ac)ADHSFSDGVPS(ph)DSVEAAK_,0.11,0.1,-0.06,-0.04,-0.44,-0.38,0.07,0.15,-0.07,-0.03,-0.42,-0.43,-0.58,-0.32,0.19,0.25,0.11,-0.05,-0.41,0.11,-0.05,-0.42,-0.44,0.22,,,,,,,0,0,,cytoplasm,unfolded protein binding,nucleosome assembly,,
P49321,P49321,Nuclear autoantigenic sperm protein,NASP,311.99,311.99,S480,QEREEQMKEGEETEGSEEDDKENDKTEEMPN,_EGEET(ph)EGS(ph)EEDDKENDKTEEMPNDSVLENK_,0.2,0.32,0.32,0.46, , , , ,0.04,0.07,0.04,0.13, , , , ,0.26,0.39,,,0.06,0.08,,,,,,,,,NA,NA,,cytoplasm,Hsp90 protein binding,blastocyst development,,
P49321,P49321,Nuclear autoantigenic sperm protein,NASP,167.29,125.67,S497,EDDKENDKTEEMPNDSVLENKSLQENEEEEI,_TEEMPNDS(ph)VLENK_,0.35,0.11, , ,-0.23,-0.09,0.44,0.17,0.23,0.08, , ,-0.53,-0.57,-0.28,-0.17,0.23,,-0.16,0.31,0.16,,-0.55,-0.23,,,,,,,NA,NA,,cytoplasm,Hsp90 protein binding,blastocyst development,,
P49321,P49321,Nuclear autoantigenic sperm protein,NASP,311.99,311.99,T477,EETQEREEQMKEGEETEGSEEDDKENDKTEE,_EGEET(ph)EGS(ph)EEDDKENDKTEEMPNDSVLENK_,0.2,0.32,0.32,0.46, , , , ,0.04,0.07,0.04,0.13, , , , ,0.26,0.39,,,0.06,0.08,,,,,,,,,NA,NA,,cytoplasm,Hsp90 protein binding,blastocyst development,,
P49321,P49321,Nuclear autoantigenic sperm protein,NASP,50.26,48.94,S127,GVHVEEEEGEKTEDESLVENNDNIDEEAREE,_T(ph)EDES(ph)LVENNDNIDEEAR_,0.09,-0.03,0.16, , ,0.43, ,-0.13,-0.21,-0.55,-0.19, , ,0.67, ,0.04,0.03,0.16,0.43,-0.13,-0.37,-0.19,0.67,0.04,,,,,,,0,0,,cytoplasm,Hsp90 protein binding,blastocyst development,,
P49321,P49321,Nuclear autoantigenic sperm protein,NASP,82.2,81.91,S503,DKTEEMPNDSVLENKSLQENEEEEIGNLELA,_S(ph)LQENEEEEIGNLELAWDMLDLAK_, , ,-0.4,-0.26, , , , , , ,-0.13,-0.27, , , , ,,-0.33,,,,-0.19,,,,,,,,,NA,NA,,cytoplasm,Hsp90 protein binding,blastocyst development,,
Q8NEY1-7,Q8NEY1,Neuron navigator 1,NAV1,205.26,205.26,S199,PLSKAPEAAVSEDGKSDDELLSSKAKAQKSS,_APEAAVSEDGKS(ph)DDELLSSK_,-0.25,-0.2, , , , ,-0.23, ,-0.45,-0.24, , , , ,-0.18, ,-0.22,,,-0.23,-0.34,,,-0.18,,,,,,,NA,NA,,cytoplasm,nucleoside-triphosphatase activity,microtubule bundle formation,,
Q8NEY1-7,Q8NEY1,Neuron navigator 1,NAV1,77.05,65.6,S391,ESLDSDEVDLKSGYMSDSDLMGKTMTEDDDI,_SGYMS(ph)DSDLMGK_,-0.24,-0.2, , ,-0.04,-0.11,-0.15,-0.05,0.08,0.17, , ,-0.68,0.16,0.07,0.11,-0.22,,-0.07,-0.1,0.12,,-0.2,0.09,,,,,,,NA,NA,,cytoplasm,nucleoside-triphosphatase activity,microtubule bundle formation,,
Q8NEY1-7,Q8NEY1,Neuron navigator 1,NAV1,202.52,175.19,S90,RVPGGPPASNLRKQKSLTNLSFLTDSEKKLQ,_S(ph)LTNLSFLTDSEK_,-0.28, , , ,-0.02,-0.28,0.06,0.08,0, , , ,-0.13,0.04,0.17,0.47,-0.28,,-0.15,0.07,0,,-0.04,0.33,,,,,,,NA,NA,,cytoplasm,nucleoside-triphosphatase activity,microtubule bundle formation,,
Q8IVL1-4,Q8IVL1,Neuron navigator 2,NAV2,77.94,70.23,S1484,RTNSVKTTLSESPLSSPAASPKFCRSTLPRK,_TTLSES(ph)PLSS(ph)PAAS(ph)PK_, , , , ,1.13,1.12,0.04, , , , , ,0.74,1.15,0.21, ,,,1.12,0.04,,,0.96,0.21, +,,,,,,NA,NA,,interstitial matrix,ATP binding,glossopharyngeal nerve development,,
Q8IVL1-4,Q8IVL1,Neuron navigator 2,NAV2,77.94,70.23,S1488,VKTTLSESPLSSPAASPKFCRSTLPRKQDSD,_TTLSES(ph)PLSS(ph)PAAS(ph)PK_, , , , ,1.13,1.12,0.04, , , , , ,0.74,1.15,0.21, ,,,1.12,0.04,,,0.96,0.21, +,,,,,,NA,NA,,interstitial matrix,ATP binding,glossopharyngeal nerve development,,
A2RRP1-2,A2RRP1,Neuroblastoma-amplified sequence,NBAS,327.3,320.69,S473,RLETRAGEEDEGEEDSDSDYEISAKARYFGY,_AGEEDEGEEDS(ph)DS(ph)DYEISAK_,-0.19,-0.21,-0.61,-0.52,-0.18,0.03,-0.02,0.46,0.08,0.22,-0.12,0.02,0,-0.08,0.09,0.22,-0.2,-0.57,-0.07,0.24,0.16,-0.05,-0.04,0.15,,,,,,,0,0,,cytoplasm,,,,
A2RRP1-2,A2RRP1,Neuroblastoma-amplified sequence,NBAS,202.33,195.59,S475,ETRAGEEDEGEEDSDSDYEISAKARYFGYIK,_AGEEDEGEEDS(ph)DS(ph)DYEISAK_,-0.28,-0.21,-0.21,-0.09, ,0.04,0.17,0.22,-0.05,0.13,-0.27,-0.13, ,-0.01,-0.08,0.02,-0.25,-0.15,0.04,0.19,0.04,-0.2,-0.01,-0.03,,,,,,,0,0,,cytoplasm,,,,
Q6ZNJ1-3,Q6ZNJ1,Neurobeachin-like protein 2,NBEAL2,91.6,89.24,T1867,LEASALRDNLGEVPLTPTEEASLPLAVTKEA,_DNLGEVPLT(ph)PTEEASLPLAVTK_, , , , , , ,1.5, , , , , , , ,1.91, ,,,,1.5,,,,1.91, +, +,,,,,NA,NA,,endoplasmic reticulum,,platelet formation,,
O60934,O60934,Nibrin,NBN,97.2,65.61,S432,VSNTLAKMRIPNYQLSPTKLPSINKSKDRAS,_IPNYQLS(ph)PTK_,0.12,0.04,-0.18, ,0.36, ,0.49,0.53,-0.19,-0.13,-0.57, ,0.09, ,0.16,0.02,0.08,-0.18,0.36,0.51,-0.16,-0.57,0.09,0.09,,,,,,,0,0,,Mre11 complex,damaged DNA binding,apoptotic process,,
F5GZJ1,Q15021,Condensin complex subunit 1,NCAPD2,163.22,162.9,S1330,SAKKPSTGSRYQPLASTASDNDFVTPEPRRT,_YQPLAS(ph)TAS(ph)DNDFVTPEPR_, , , , ,1.39,0.96,1.09,2.32, , , , ,1.86,1.18,1.3,2.43,,,1.19,1.83,,,1.56,1.97, +, +,,,,,NA,NA,,cytoplasm,,cell division,,
F5GZJ1,Q15021,Condensin complex subunit 1,NCAPD2,163.22,162.9,S1333,KPSTGSRYQPLASTASDNDFVTPEPRRTTRR,_YQPLAS(ph)TAS(ph)DNDFVTPEPR_,0.05,0,0.43,0.24,-0.3,0.64,0.39,0.52,0.32,0.28,0.56,0.23,-0.41,0.75,0.31,0.62,0.02,0.34,0.25,0.46,0.3,0.41,0.28,0.47,,,,,,,0,0,,cytoplasm,,cell division,,
F5GZJ1,Q15021,Condensin complex subunit 1,NCAPD2,77.03,76.58,T1339,RYQPLASTASDNDFVTPEPRRTTRRHPNTQQ,_YQPLASTAS(ph)DNDFVT(ph)PEPR_, , , , ,-0.48,-0.44,-0.52,-0.21, , , , ,-0.53,-0.51,-0.41,-0.34,,,-0.46,-0.36,,,-0.52,-0.38,,,,,,,NA,NA,,cytoplasm,,cell division,,
P42695,P42695,Condensin-2 complex subunit D3,NCAPD3,113.51,108.61,S1382,RHRSRSLGVLPFTLNSGSPEKTCSQVSSYSL,_SLGVLPFTLNS(ph)GSPEK_, , , , ,-0.02, , , , , , , ,-0.45, , , ,,,-0.02,,,,-0.45,,,,,,,,NA,NA,,nuclear centromeric heterochromatin,methylated histone residue binding,cell division,,
P42695,P42695,Condensin-2 complex subunit D3,NCAPD3,187.69,186.82,S530,QTSNRSEPSGEINIDSSGETVGSGERCVMAM,_SEPSGEINIDS(ph)S(ph)GETVGSGER_, ,0, , ,-0.33,-0.53,-0.42,-0.34, ,0.03, , ,-0.23,-0.38,-0.13,-0.09,0,,-0.43,-0.38,0.03,,-0.3,-0.11,,,,,,,NA,NA,,nuclear centromeric heterochromatin,methylated histone residue binding,cell division,,
P42695,P42695,Condensin-2 complex subunit D3,NCAPD3,187.69,186.82,S531,TSNRSEPSGEINIDSSGETVGSGERCVMAML,_SEPSGEINIDS(ph)S(ph)GETVGSGER_, ,0, , ,-0.33,-0.53,-0.43,-0.34, ,0.03, , ,-0.23,-0.38,-0.16,-0.09,0,,-0.43,-0.39,0.03,,-0.3,-0.12,,,,,,,NA,NA,,nuclear centromeric heterochromatin,methylated histone residue binding,cell division,,
Q9BPX3,Q9BPX3,Condensin complex subunit 3,NCAPG,75.63,75.1,S973,VSARTNRRCQTAEADSESDHEVPEPESEMKM,_CQTAEADS(ph)ES(ph)DHEVPEPESEMK_,-0.58, , , ,-0.08,-0.6,-0.26, ,0.26, , , ,0.14,-0.33,-0.04, ,-0.58,,-0.31,-0.26,0.26,,-0.07,-0.04,,,,,,,NA,NA,,actin cytoskeleton,,cell division,,
Q9BPX3,Q9BPX3,Condensin complex subunit 3,NCAPG,75.63,75.1,S975,ARTNRRCQTAEADSESDHEVPEPESEMKMRL,_CQTAEADS(ph)ES(ph)DHEVPEPESEMK_,-0.58, , , ,-0.08,-0.6,-0.26, ,0.26, , , ,0.14,-0.33,-0.04, ,-0.58,,-0.31,-0.26,0.26,,-0.07,-0.04,,,,,,,NA,NA,,actin cytoskeleton,,cell division,,
Q9BPX3,Q9BPX3,Condensin complex subunit 3,NCAPG,89.02,83.62,S674,TKKIKTLHCEGTEINSDDEQESKEVEETATA,_TLHCEGTEINS(ph)DDEQESK_,-0.06,-0.25,-0.26,-0.06,0.42,0.03,0.3,0.14,-0.28,-0.36,-0.35,-0.26,-0.2,-0.21,-0.39,-0.25,-0.15,-0.15,0.24,0.22,-0.32,-0.3,-0.2,-0.32,,,,,,,0,0,,actin cytoskeleton,,cell division,,
E5RJ71,Q6IBW4,Condensin-2 complex subunit H2,NCAPH2,103.63,103.63,S284,EASAPKAALEPKESRSPQQSAALPRRYMLRE,_ESRS(ph)PQQSAALPR_,-0.03,-0.13,-0.07,0.32,0.37, ,-0.16,-0.66,-0.14,-0.21,-0.16,-0.24,0.65, ,-0.4,-0.31,-0.08,0.14,0.37,-0.39,-0.17,-0.2,0.65,-0.35,,,,,,,0,0,,,,,,
C9K098,P16333,Cytoplasmic protein NCK1,NCK1,128.31,126.68,S85,NLKDTLGIGKVKRKPSVPDSASPADDSFVDP,_RKPS(ph)VPDSASPADDSFVDPGER_, , ,2.01,1.55, , , , , , ,2.18,1.64, , , , ,,1.8,,,,1.93,,, +, +,,,,,NA,NA,,vesicle membrane,,actin filament organization,,
C9K098,P16333,Cytoplasmic protein NCK1,NCK1,220.78,219.63,Y105,ASPADDSFVDPGERLYDLNMPAYVKF_____,_LY(ph)DLNMPAYVK_,1.11,1.2,0.4, ,0.08,0.13,0.56,0.61,0.59,0.87,-0.15, ,-0.07,-0.08,0.21,0.53,1.16,0.4,0.11,0.58,0.74,-0.15,-0.07,0.38, +,,,,,,5,0,19.92,vesicle membrane,,actin filament organization,,
C9K098,C9K098,Cytoplasmic protein NCK1,NCK1,57.18,37.52,Y112,FVDPGERLYDLNMPAYVKF____________,_LYDLNMPAY(ph)VK_,0.63, , , , , ,-0.07, ,0.62, , , , , ,-0.85, ,0.63,,,-0.07,0.62,,,-0.85,,,,,,,NA,NA,,vesicle membrane,,actin filament organization,,
Q9HCH0-2,Q9HCH0,Nck-associated protein 5-like,NCKAP5L,93.35,63.8,S763,YSSHSMGARVDLEPVSPRSCLTKVELAKSRL,_VDLEPVS(ph)PR_,-0.29,-0.18,1.47,1.44, , , , ,0.03,0.01,1.58,1.48, , , , ,-0.23,1.45,,,0.02,1.53,,, +, +,,,,,NA,NA,,,,,,
Q9HCH0-2,Q9HCH0,Nck-associated protein 5-like,NCKAP5L,118.44,115.53,S489,PQLPRNSRIPCRNSGSDGSPSPLLARRGLGG,_NSGS(ph)DGSPS(ph)PLLAR_, ,-0.21, ,-0.23, , ,-0.04,-0.78, ,-0.2, ,-0.66, , ,-0.32,-0.37,-0.21,-0.23,,-0.36,-0.2,-0.66,,-0.35,,,,,,,NA,NA,,,,,,
Q9HCH0-2,Q9HCH0,Nck-associated protein 5-like,NCKAP5L,118.44,115.53,S494,NSRIPCRNSGSDGSPSPLLARRGLGGGELSP,_NSGS(ph)DGSPS(ph)PLLAR_, , , , , , ,-0.04, , , , , , , ,-0.32, ,,,,-0.04,,,,-0.32,,,,,,,NA,NA,,,,,,
P19338,P19338,Nucleolin,NCL,142.03,138.84,S580,NARSQPSKTLFVKGLSEDTTEETLKESFDGS,_GLS(ph)EDTTEETLK_,-0.26,-0.44,0.11,0.44, , ,1.82,1.9,-0.14,-0.06,0.69,0.84, , ,-0.03,-0.09,-0.34,0.28,,1.86,-0.1,0.77,,-0.06, +,,,,,,NA,NA,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,151.4,151.4,S184,EIEPAAMKAAAAAPASEDEDDEDDEDDEDDD,_AAAAAPAS(ph)EDEDDEDDEDDEDDDDDEEDDS(ph)EEEAMETTPAK_, , ,-0.36, ,-0.32, , , , , , , ,0.48, , , ,,-0.36,-0.32,,,,0.48,,,,,,,,NA,NA,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,151.4,151.4,S206,DDEDDEDDDDDEEDDSEEEAMETTPAKGKKA,_AAAAAPAS(ph)EDEDDEDDEDDEDDDDDEEDDS(ph)EEEAMETTPAK_,-0.31, ,-0.36, ,-0.32, , ,-0.05,0.22, , , ,0.48, , ,0.45,-0.31,-0.36,-0.32,-0.05,0.22,,0.48,0.45,,,,,,,0,NA,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,192.32,192.32,S563,IEGRAIRLELQGPRGSPNARSQPSKTLFVKG,_LELQGPRGS(ph)PNAR_,-0.03,-0.03,-0.09,-0.08,-0.2,-0.18,-0.2,-0.25,-0.15,-0.16,-0.18,-0.18,-0.22,-0.15,-0.26,-0.34,-0.03,-0.09,-0.19,-0.22,-0.15,-0.18,-0.18,-0.3,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,471.94,471.94,S145,PAKGAKNGKNAKKEDSDEEEDDDSEEDEEDD,_KEDS(ph)DEEEDDDS(ph)EEDEEDDEDEDEDEDEIEPAAMK_,0.19,0.23,0.07,0.16,-0.08,-0.12,-0.07,-0.1,0.04,0.07,-0.08,-0.08,-0.1,-0.09,-0.09,-0.15,0.21,0.12,-0.1,-0.09,0.05,-0.08,-0.1,-0.12,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,471.94,471.94,S153,KNAKKEDSDEEEDDDSEEDEEDDEDEDEDED,_KEDS(ph)DEEEDDDS(ph)EEDEEDDEDEDEDEDEIEPAAMK_,0.19,0.23,0.07,0.16,-0.08,-0.12,-0.07,-0.1,0.04,0.07,-0.08,-0.08,-0.1,-0.09,-0.09,-0.15,0.21,0.12,-0.1,-0.09,0.05,-0.08,-0.1,-0.12,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,409.24,409.24,S28,____MAPPPKEVEEDSEDEEMSEDEEDDSSG,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,0.25,0.34,0.41,0.75,-0.08,-0.08,-0.18,-0.07,0,-0.04,0,-0.05,0.23,-0.25,0.02,-0.01,0.3,0.59,-0.08,-0.12,-0.02,-0.03,0.01,0,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,409.24,409.24,S34,PPPKEVEEDSEDEEMSEDEEDDSSGEEVVIP,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,0.25,0.34,0.41,0.75,-0.08,-0.1,-0.18,-0.09,0,-0.04,0,-0.05,0.23,-0.23,0.02,-0.03,0.3,0.59,-0.09,-0.14,-0.02,-0.03,0.02,-0.01,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,409.24,409.24,S41,EDSEDEEMSEDEEDDSSGEEVVIPQKKGKKA,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,0.19,0.18,0.22,0.75,0.02,-0.1,-0.19,-0.09,0,-0.04,0,-0.08,-0.17,-0.23,0.01,-0.04,0.19,0.51,-0.04,-0.14,-0.02,-0.04,-0.2,-0.02,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,304.73,304.73,S42,DSEDEEMSEDEEDDSSGEEVVIPQKKGKKAA,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,0.01,0.17,0.15,0.12,-0.2,-0.14,-0.22,-0.21,-0.13,0.05,0.06,-0.08,-0.31,-0.2,-0.06,-0.1,0.1,0.13,-0.17,-0.21,-0.04,-0.01,-0.26,-0.08,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
P19338,P19338,Nucleolin,NCL,184.58,124.27,S67,KGKKAAATSAKKVVVSPTKKVAVATPAKKAA,_KVVVS(ph)PTK_,0.8,0.49,0.69,0.85,0.15,0.19,0.14,0.25,0.18,0.23,0.23,0.3,0.25,0.31,0.34,0.23,0.66,0.77,0.17,0.2,0.2,0.27,0.28,0.28,,,,,,,0,0,,cell cortex,nucleotide binding,angiogenesis,,
Q15596,Q15596,Nuclear receptor coactivator 2,NCOA2,144.97,76,S699,KEKHKILHRLLQDSSSPVDLAKLTAEATGKD,_LLQDSSS(ph)PVDLAK_, , ,0.83,0.52,0.52, ,0.45, , , ,0.19,0.28,-0.44, ,0, ,,0.68,0.52,0.45,,0.23,-0.44,0,,,,,,,NA,NA,,cytoplasm,chromatin binding,cellular lipid metabolic process,,
Q9Y6Q9-2,Q9Y6Q9,Nuclear receptor coactivator 3,NCOA3,144.23,123.28,S214,MLMKTPHDILEDINASPEMRQRYETMQCFAL,_TPHDILEDINAS(ph)PEMR_,0.02,0,-0.2,0.03, , , , ,-0.26,-0.28,-0.27,-0.4, , , , ,0.01,-0.08,,,-0.27,-0.33,,,,,,,,,NA,NA,,cytoplasm,androgen receptor binding,androgen receptor signaling pathway,,
Q9HCD5,Q9HCD5,Nuclear receptor coactivator 5,NCOA5,53.86,51.47,S381,YLRERKERLMRSSTDSLPGPISRQPLGATSG,_SS(ph)TDS(ph)LPGPISR_, , , , , , ,0.59,0.14, , , , , , ,3.55,3.11,,,,0.38,,,,3.35,, +,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
G8JL91,Q8NI08,Nuclear receptor coactivator 7,NCOA7,162.77,156.36,S208,ADLARKALKPIERVLSSTSEEDEPGVVKFLK,_VLS(ph)S(ph)TS(ph)EEDEPGVVK_, ,0.69,2.08,1.83,0.5,0.84,0.38,0.04, ,0.58,2.45,1.88,0.66,1.16,-0.01,0.24,0.69,1.96,0.68,0.22,0.58,2.19,0.93,0.12, +, +,,,,,4,4,32.9,,,,,
G8JL91,Q8NI08,Nuclear receptor coactivator 7,NCOA7,131.9,129.59,S209,DLARKALKPIERVLSSTSEEDEPGVVKFLKM,_VLS(ph)S(ph)TS(ph)EEDEPGVVK_, , , , , , ,0.51,0.77, , , , , , ,0.89,1.12,,,,0.64,,,,1.01,, +,,,,,NA,NA,,,,,,
G8JL91,Q8NI08,Nuclear receptor coactivator 7,NCOA7,178.66,164.32,S179,SSTLRLSSSSPGATVSPSSSDAEYDKLPDAD,_LSSSSPGATVS(ph)PSSS(ph)DAEYDK_, , , , ,0.16,0.11,-0.06,0.17, , , , ,0.37,0.22,0.07,-0.03,,,0.13,0.06,,,0.3,0.02,,,,,,,NA,NA,,,,,,
G8JL91,Q8NI08,Nuclear receptor coactivator 7,NCOA7,178.66,164.32,S183,RLSSSSPGATVSPSSSDAEYDKLPDADLARK,_LSSSSPGATVS(ph)PSSS(ph)DAEYDK_, , , , ,0.13, ,-0.06,0.17, , , , ,0.35, ,0.07,-0.03,,,0.13,0.06,,,0.35,0.02,,,,,,,NA,NA,,,,,,
G8JL91,Q8NI08,Nuclear receptor coactivator 7,NCOA7,162.77,156.36,S211,ARKALKPIERVLSSTSEEDEPGVVKFLKMNC,_VLS(ph)STS(ph)EEDEPGVVK_,-0.64,-0.21,-1.12,-0.61,0.12,0.06,-0.15,-0.2,-0.15,0.05,-0.65,-0.33,0.15,0.06,-0.2,-0.04,-0.41,-0.84,0.09,-0.18,-0.05,-0.48,0.11,-0.11,,,,,,,0,0,,,,,,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,136.43,120.44,S1472,SVLRSTLHEAPKAQLSPGIYDDTSARRTPVS,_AQLS(ph)PGIYDDTSAR_,0.03,0.12,0.57,0.45, ,0.25,0.52,0.01,-0.22,-0.11,0.46,0.33, ,0.11,0.15,-0.04,0.08,0.51,0.25,0.28,-0.16,0.4,0.11,0.06,,,,,,,0,0,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,265.27,244.88,S2436,EREPAPLLSAQYETLSDSDD___________,_EPAPLLSAQYETLS(ph)DS(ph)DD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,265.27,244.88,S2438,EPAPLLSAQYETLSDSDD_____________,_EPAPLLSAQYETLS(ph)DS(ph)DD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,69.03,40.59,S2120,SQAQSVHHQRPGSRVSPENLVDKSRGSRPGK,_VS(ph)PENLVDK_,0.19,0.12,0.28,0.36,0.56,0.44,0.57,0.47,0.1,0.03,0.12,0.16,0.14,-0.1,0.33,0.18,0.16,0.32,0.51,0.52,0.06,0.14,0.02,0.25,,,,,,,0,0,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,157.62,157.07,S1977,SSHRYETPSDAIEVISPASSPAPPQEKLQTY,_YETPSDAIEVIS(ph)PASS(ph)PAPPQEK_, ,-0.24,-0.32, ,-0.23,-0.16,-0.01,0.04, ,-0.16,-0.2, ,-0.53,-0.28,-0.21,-0.09,-0.24,-0.32,-0.2,0.02,-0.16,-0.2,-0.4,-0.15,,,,,,,0,0,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,103.12,102.22,S1980,RYETPSDAIEVISPASSPAPPQEKLQTYQPE,_YETPSDAIEVIS(ph)PAS(ph)SPAPPQEK_, ,-0.28,-0.32, , , ,0.2,-0.07, ,-0.23,-0.2, , , ,-0.13,-0.21,-0.28,-0.32,,0.07,-0.23,-0.2,,-0.17,,,,,,,NA,NA,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
O75376-2,O75376,Nuclear receptor corepressor 1,NCOR1,157.62,157.07,S1981,YETPSDAIEVISPASSPAPPQEKLQTYQPEV,_YETPSDAIEVIS(ph)PASS(ph)PAPPQEK_, ,-0.32, , ,-0.13,-0.16,-0.24,0.16, ,-0.3, , ,-0.68,-0.28,-0.36,0.04,-0.32,,-0.14,-0.03,-0.3,,-0.47,-0.15,,,,,,,NA,NA,,cytoplasm,chromatin binding,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,86.5,86.5,S1259,DVLYKGTITRIIGEDSPSRLDRGREDSLPKG,_IIGEDS(ph)PSRLDR_,-0.73,-0.67, ,-0.67,-1.18,-1.21,-0.6,-0.67,-0.56,-0.25, ,-0.1,-1.34,-1.37,-0.59,-0.55,-0.7,-0.67,-1.19,-0.63,-0.39,-0.1,-1.36,-0.57, +, +,,,,,6,6,24.37,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,120.54,120.54,S939,DEVDEAEGGDKNRLLSPRPSLLTPTGDPRAN,_LLS(ph)PRPSLLT(ph)PTGDPR_,-0.17,-0.57,0.67, , , , , ,0.05,-0.18,1.13, , , , , ,-0.36,0.67,,,-0.06,1.13,,,, +,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,170.64,170.19,S2057,QELELRSLGYHGSSYSPEGVEPVSPVSSPSL,_SLGYHGSSYS(ph)PEGVEPVS(ph)PVSS(ph)PSLTHDK_,-0.41,0.03,-1.15,-0.32, , ,0.84, ,-0.17,-0.11,-0.6,0.19, , ,1.09, ,-0.17,-0.67,,0.84,-0.14,-0.16,,1.09,, +,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,120.54,120.54,T946,GGDKNRLLSPRPSLLTPTGDPRANASPQKPL,_LLS(ph)PRPSLLT(ph)PTGDPR_,-0.17,-0.57,0.67, , , , , ,0.05,-0.18,1.13, , , , , ,-0.36,0.67,,,-0.06,1.13,,,, +,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,103.18,58.46,S1487,STTGSKKHDVRSLIGSPGRTFPPVHPLDVMA,_SLIGS(ph)PGR_,-0.35,-0.25,-0.32,-0.39,-0.46,-0.45,-0.17,-0.01,-0.26,-0.15,0.05,-0.1,-0.34,-0.57,-0.14,-0.06,-0.3,-0.35,-0.45,-0.09,-0.21,-0.02,-0.45,-0.1,,,,,,,0,0,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,73.35,73.35,S956,RPSLLTPTGDPRANASPQKPLDLKQLKQRAA,_ANAS(ph)PQKPLDLK_,-0.34,0.04,0.03, , , , ,-0.03,0.02,-0.13,0.11, , , , ,0.03,-0.14,0.03,,-0.03,-0.05,0.11,,0.03,,,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,199.65,198.99,S2522,DEEPKPLLCSQYETLSDSE____________,_PLLCSQYETLS(ph)DS(ph)E_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,199.65,198.99,S2524,EPKPLLCSQYETLSDSE______________,_PLLCSQYETLS(ph)DS(ph)E_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,170.64,170.19,S2065,GYHGSSYSPEGVEPVSPVSSPSLTHDKGLPK,_SLGYHGSSYS(ph)PEGVEPVS(ph)PVSS(ph)PSLTHDK_,-0.25,-0.28,0.32,0.32,0.18, ,0.74, ,-0.22,-0.05,0.57,0.76,0.2, ,0.86, ,-0.26,0.32,0.18,0.74,-0.14,0.67,0.2,0.86,,,,,,,0,0,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,163.97,163.52,S2069,SSYSPEGVEPVSPVSSPSLTHDKGLPKHLEE,_SLGYHGSSYS(ph)PEGVEPVS(ph)PVSS(ph)PSLTHDK_, ,-0.6,-0.21, , , , , , ,0.1,0.34, , , , , ,-0.6,-0.21,,,0.1,0.34,,,,,,,,,NA,NA,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,206.63,206.63,S2269,YRDGEQTEPSRMGSKSPGNTSQPPAFFSKLT,_S(ph)PGNTSQPPAFFSK_,-0.34,-0.34,-0.34,-0.38,-0.01,0.03,-0.07,-0.03,-0.06,-0.07,0.04,0.12,0.04,-0.01,0,0.05,-0.34,-0.36,0.01,-0.05,-0.07,0.08,0.01,0.03,,,,,,,0,0,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,122.81,121.95,S2234,KTSVLGGGEDGIEPVSPPEGMTEPGHSRSAV,_TSVLGGGEDGIEPVS(ph)PPEGMTEPGHSR_,-0.38,-0.31,-0.48, ,-0.14,0.02,0.09,0.02,0.01,0.05,0.16, ,0.44,0.33,0.26,0.22,-0.34,-0.48,-0.06,0.06,0.03,0.16,0.39,0.24,,,,,,,0,0,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,153.64,152.89,S149,DLTKDRSLTGKLEPVSPPSPPHTDPELELVP,_LEPVS(ph)PPS(ph)PPHTDPELELVPPR_,-0.23,-0.21,-0.46,-0.26,-0.05,-0.03,0.08,0,0.17,0.09,0.17,0.14,0.07,0.09,0.03,-0.05,-0.22,-0.36,-0.04,0.04,0.13,0.15,0.08,-0.01,,,,,,,0,0,,nucleus,chromatin binding,,,
C9JE98,Q9Y618,Nuclear receptor corepressor 2,NCOR2,153.64,152.89,S152,KDRSLTGKLEPVSPPSPPHTDPELELVPPRL,_LEPVS(ph)PPS(ph)PPHTDPELELVPPR_,-0.23,-0.21,-0.46,-0.26,-0.03,-0.03,-0.04,0,0.17,0.09,0.17,0.14,0.08,0.09,-0.01,-0.05,-0.22,-0.36,-0.03,-0.02,0.13,0.15,0.09,-0.03,,,,,,,0,0,,nucleus,chromatin binding,,,
Q9NXR1-2,Q9NXR1,Nuclear distribution protein nudE homolog 1,NDE1,145.31,136.61,S282,LESKLASCRNLVYDQSPNRTGGPASGRSSKN,_NLVYDQS(ph)PNR_, , , , ,-0.54,-0.68,-0.71,-0.89, , , , ,-0.5,-0.44,-0.57,-0.5,,,-0.61,-0.8,,,-0.47,-0.53,,,,,,,NA,NA,,cleavage furrow,microtubule binding,cell division,,
Q92597,Q92597,Protein NDRG1,NDRG1,176.65,121.06,T328,GYMPSASMTRLMRSRTASGSSVTSLDGTRSR,_SRT(ph)AS(ph)GSSVTSLDGTR_,-0.53,-0.31,-0.18,-0.16,1.21,1.07,0.68,0.31,-0.09,-0.09,0.33,0.45,1.04,1.07,0.4,0.4,-0.41,-0.17,1.14,0.51,-0.09,0.39,1.06,0.4, +, +,,,,,2,2,23.11,cell-cell adherens junction,cadherin binding,cellular response to hypoxia,,
Q92597,Q92597,Protein NDRG1,NDRG1,97.94,97.94,S2,______________MSREMQDVDLAEVKPLV,_(ac)S(ph)REMQDVDLAEVKPLVEK_,-0.74,-0.61,-1,-1.19,1.26, , , ,0.19,0.15,0.06,0.13,0.25, , , ,-0.67,-1.09,1.26,,0.17,0.1,0.25,, +,,,,,,NA,NA,,cell-cell adherens junction,cadherin binding,cellular response to hypoxia,,
Q92597,Q92597,Protein NDRG1,NDRG1,176.65,121.06,S330,MPSASMTRLMRSRTASGSSVTSLDGTRSRSH,_SRT(ph)AS(ph)GSSVTSLDGTR_,-0.53,-0.56,-0.18,-0.25,0.96,0.54,0.58,0.5,-0.09,-0.08,0.33,0.39,0.67,0.31,-0.16,0.45,-0.54,-0.21,0.77,0.54,-0.08,0.36,0.5,0.18,,,,,,,0,0,,cell-cell adherens junction,cadherin binding,cellular response to hypoxia,,
Q92597,Q92597,Protein NDRG1,NDRG1,205.7,189.67,T366,RSRSHTSEGTRSRSHTSEGAHLDITPNSGAA,_SHT(ph)SEGAHLDITPNSGAAGNSAGPK_,-0.28, ,-0.55,-0.54,0.75,0.85, , ,-0.02, ,-0.07,-0.28,0.4,0, , ,-0.28,-0.54,0.8,,-0.02,-0.17,0.21,,,,,,,,NA,NA,,cell-cell adherens junction,cadherin binding,cellular response to hypoxia,,
Q9UGV2-3,Q9UGV2,Protein NDRG3,NDRG3,63.33,63.33,S331,IPSASMTRLARSRTHSTSSSLGSGESPFSRS,_SRT(ph)HS(ph)TSSSLGSGESPFSR_, , , , ,0.91,1.58,1.36,1.52, , , , ,0.72,0.97,1.07,1.13,,,1.29,1.44,,,0.85,1.1, +, +,,,,,NA,NA,,cytoplasm,,cell differentiation,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,145.55,142.83,S449,NHLIEPQIRRPRSLSSPTVTLSAPLEGAKDS,_SLS(ph)S(ph)PTVTLSAPLEGAK_, ,0.58, ,1.79,0.53,0.27,0.24,0.18, ,-0.01, ,0.23,0.31,0.17,0.33,0.38,0.58,1.79,0.4,0.21,-0.01,0.23,0.24,0.35, +,,,HECT,,,4,0,7.4,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,128.86,128.86,S475,GAKDSPVRRAVKDTLSNPQSPQPSPYNSPKP,_DTLS(ph)NPQS(ph)PQPS(ph)PYNS(ph)PKPQHK_, , , , ,-0.34, ,0.35,-0.22, , , , ,0, ,0.28,-0.2,,,-0.34,0.09,,,0,0.06,,,,HECT,,,NA,NA,,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,128.86,128.86,S479,SPVRRAVKDTLSNPQSPQPSPYNSPKPQHKV,_DTLS(ph)NPQS(ph)PQPS(ph)PYNS(ph)PKPQHK_, , , , ,-0.34, ,0.35,-0.22, , , , ,0, ,0.28,-0.2,,,-0.34,0.09,,,0,0.06,,,,HECT,,,NA,NA,,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,128.86,128.86,S483,RAVKDTLSNPQSPQPSPYNSPKPQHKVTQSF,_DTLS(ph)NPQS(ph)PQPS(ph)PYNS(ph)PKPQHK_, , , , ,-0.34, ,0.35,-0.22, , , , ,0, ,0.28,-0.2,,,-0.34,0.09,,,0,0.06,,,,HECT,,,NA,NA,,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,128.86,128.86,S487,DTLSNPQSPQPSPYNSPKPQHKVTQSFLPPG,_DTLS(ph)NPQS(ph)PQPS(ph)PYNS(ph)PKPQHK_, , , , ,-0.34, ,0.35,-0.22, , , , ,0, ,0.28,-0.2,,,-0.34,0.09,,,0,0.06,,,,HECT,,,NA,NA,,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q96PU5-2,Q96PU5,E3 ubiquitin-protein ligase NEDD4-like,NEDD4L,145.55,142.83,S448,NNHLIEPQIRRPRSLSSPTVTLSAPLEGAKD,_SLS(ph)S(ph)PTVTLSAPLEGAK_,0.42,0.67,0.48,0.58,0.47,0.73,0.77,0.82,0.05,0.32,0.12,0.64,0.39,-0.04,0.33,-0.07,0.55,0.53,0.61,0.79,0.19,0.4,0.19,0.14,,,,HECT,,,0,0,,cytosol,sodium channel inhibitor activity,cellular sodium ion homeostasis,,
Q14511,Q14511,Enhancer of filamentation 1,NEDD9,67.88,66.81,Y345,AETSEKANPQERDGVYDVPLHNPPDAKGSRD,_DGVY(ph)DVPLHNPPDAK_,-1.61, , , , , ,0.05,-0.02,-1.27, , , , , ,0.35,0.37,-1.61,,,0.02,-1.27,,,0.36, +, +,,,,,NA,NA,,cell cortex,,actin filament bundle assembly,,
Q14511,Q14511,Enhancer of filamentation 1,NEDD9,189.12,187.81,Y317,PPPQLGQSVGSQNDAYDVPRGVQFLEPPAET,_HQSLSPNHPPPQLGQSVGSQNDAY(ph)DVPR_,-1.08, ,-1.2, ,-1.13,-1.07,-0.23,0.06,-0.51, ,-0.73, ,-0.78,-0.75,0.26,0.38,-1.08,-1.2,-1.1,-0.08,-0.51,-0.73,-0.76,0.32, +,,,,,,3,0,20.3,cell cortex,,actin filament bundle assembly,,
Q14511,Q14511,Enhancer of filamentation 1,NEDD9,78.81,78.81,Y629,DCSSSDGSERSWMDDYDYVHLQGKEEFERQQ,_SWMDDY(ph)DY(ph)VHLQGK_,-1.4, , , ,-0.96,-1.11,-0.11,0.1,-0.39, , , ,-0.49,-0.48,0.49,0.62,-1.4,,-1.03,0,-0.39,,-0.48,0.56, +,,,,,,NA,NA,,cell cortex,,actin filament bundle assembly,,
Q14511,Q14511,Enhancer of filamentation 1,NEDD9,77.78,77.78,Y631,SSSDGSERSWMDDYDYVHLQGKEEFERQQKE,_SWMDDY(ph)DY(ph)VHLQGK_, , ,-1.91, ,-1, , ,-0.05, , ,-0.68, ,-0.91, , ,0.44,,-1.91,-1,-0.05,,-0.68,-0.91,0.44, +,,,,,,NA,NA,,cell cortex,,actin filament bundle assembly,,
Q14511,Q14511,Enhancer of filamentation 1,NEDD9,61.11,60.12,Y166,GKKVITPVRTGHGYVYEYPSRYQKDVYDIPP,_TGHGYVY(ph)EYPSR_,-0.93, ,-1.26, , , ,0.03,0.07,-0.46, ,-0.72, , , ,0.62,0.6,-0.93,-1.26,,0.05,-0.46,-0.72,,0.61, +,,,,,,NA,NA,,cell cortex,,actin filament bundle assembly,,
Q8TDX7,Q8TDX7,Serine/threonine-protein kinase Nek7,NEK7,129.9,129.41,S195,LGLGRFFSSKTTAAHSLVGTPYYMSPERIHE,_T(ph)TAAHS(ph)LVGTPYYMSPER_,0.56,0.65,-0.48, ,-1.57, , , ,-0.45,-0.26,-2.29, ,-1.72, , , ,0.61,-0.48,-1.57,,-0.35,-2.29,-1.72,, +, +,NEK,,,,NA,NA,,cytoplasm,ATP binding,cytokinesis,,
Q8TDX7,Q8TDX7,Serine/threonine-protein kinase Nek7,NEK7,129.9,129.41,T191,KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE,_TT(ph)AAHS(ph)LVGTPYYMSPER_,0.56,0.65,-0.48, ,-1.57, , , ,-0.45,-0.26,-2.29, ,-1.72, , , ,0.61,-0.48,-1.57,,-0.35,-2.29,-1.72,, +, +,NEK,,,,NA,NA,,cytoplasm,ATP binding,cytokinesis,,
Q8TD19,Q8TD19,Serine/threonine-protein kinase Nek9,NEK9,131.63,128.72,T333,KVTLLNAPTKRPRSSTVTEAPIAVVTSRTSE,_SST(ph)VTEAPIAVVTSR_, , ,2.84,2.68, , , , , , ,2.97,2.96, , , , ,,2.76,,,,2.96,,, +, +,NEK,,,,NA,NA,,cytosol,ATP binding,cell division,,
Q8TD19,Q8TD19,Serine/threonine-protein kinase Nek9,NEK9,80.04,66.32,S2,______________MSVLGEYERHCDSINSD,_(ac)S(ph)VLGEYER_, ,-0.01, , , , , , , ,-0.71, , , , , , ,-0.01,,,,-0.71,,,,,,NEK,,,,NA,NA,,cytosol,ATP binding,cell division,,
G3V5V3,O60524,Nuclear export mediator factor NEMF,NEMF,369.61,324.84,S747,QSGRDELNEELIQEESSEDEGEYEEVRKDQD,_DELNEELIQEES(ph)S(ph)EDEGEYEEVRK_,-0.32,-0.8,-0.76,-0.17,-1.08,-0.94,-0.36,-0.12,1.12,0.81,0.81,0.35,1.04,1.15,1.07,0.15,-0.54,-0.44,-1.01,-0.23,0.97,0.6,1.1,0.68, +, +,,,,,6,5,16.06,cytoplasm,,,,
G3V5V3,O60524,Nuclear export mediator factor NEMF,NEMF,369.61,324.84,S748,SGRDELNEELIQEESSEDEGEYEEVRKDQDS,_DELNEELIQEES(ph)S(ph)EDEGEYEEVRK_,-0.32,-0.8,-0.76,-0.17,-1.08,-0.94,-0.36,-0.12,1.12,0.81,0.81,0.35,1.04,1.15,1.07,0.15,-0.54,-0.44,-1.01,-0.23,0.97,0.6,1.1,0.68, +, +,,,,,6,5,16.06,cytoplasm,,,,
G3V5V3,O60524,Nuclear export mediator factor NEMF,NEMF,88.95,73.17,S831,LSAKERREMKKKKLPSDSGDLEALEGKDKEK,_KLPS(ph)DSGDLEALEGK_, , ,0.41, ,0.99, ,0.9,1.2, , ,0.37, ,1.2, ,0.95,1.74,,0.41,0.99,1.06,,0.37,1.2,1.4, +, +,,,,,NA,NA,,cytoplasm,,,,
G3V5V3,O60524,Nuclear export mediator factor NEMF,NEMF,87.79,85.65,S833,AKERREMKKKKLPSDSGDLEALEGKDKEKES,_KLPSDS(ph)GDLEALEGK_, , , , ,2.18,0.92, , , , , , ,2.91,1.99, , ,,,1.68,,,,2.52,, +, +,,,,,NA,NA,,cytoplasm,,,,
G3V5V3,O60524,Nuclear export mediator factor NEMF,NEMF,156.77,142.34,S417,QTNHVTMLLRNPYLLSEEEDDDVDGDVNVEK,_NPYLLS(ph)EEEDDDVDGDVNVEK_, , , , ,0.35,0.18,0.84, , , , , ,0.5,0.24,0.87, ,,,0.27,0.84,,,0.37,0.87,,,,,,,NA,NA,,cytoplasm,,,,
P48681,P48681,Nestin,NES,82.61,82.61,S768,ETLRTLEKETQQRRRSLGEQDQMTLRPPEKV,_S(ph)LGEQDQMTLRPPEK_, , , , ,1.14, , , , , , , ,0.52, , , ,,,1.14,,,,0.52,, +,,,,,,NA,NA,,cytoplasm,intermediate filament binding,brain development,,
P48681,P48681,Nestin,NES,420.61,420.61,S1409,PQLLLDPAAWDRDGESDGFADEEESGEEGEE,_DGES(ph)DGFADEEES(ph)GEEGEEDQEEGREPGAGR_,-0.23,-0.14,-0.6,-0.87,-0.02,0.25,-0.37,-0.48,-0.18,-0.25,-0.54,-0.69,-0.61,-0.5,-0.9,-0.94,-0.19,-0.73,0.12,-0.42,-0.21,-0.61,-0.55,-0.92,,,,,,,0,0,,cytoplasm,intermediate filament binding,brain development,,
P48681,P48681,Nestin,NES,420.61,420.61,S1418,WDRDGESDGFADEEESGEEGEEDQEEGREPG,_DGES(ph)DGFADEEES(ph)GEEGEEDQEEGREPGAGR_,-0.23,-0.14,-0.6,-0.87,-0.02,0.25,-0.37,-0.48,-0.18,-0.25,-0.54,-0.69,-0.61,-0.5,-0.9,-0.94,-0.19,-0.73,0.12,-0.42,-0.21,-0.61,-0.55,-0.92,,,,,,,0,0,,cytoplasm,intermediate filament binding,brain development,,
P48681,P48681,Nestin,NES,171.28,167.29,S1347,WDPAVLASEGLEAPPSEKEEGEEGEEECGRD,_EGWDPAVLASEGLEAPPS(ph)EK_, , , , ,0.35,0.56,0.06,-0.5, , , , ,-0.51,-0.04,-0.41,-0.84,,,0.46,-0.19,,,-0.26,-0.61,,,,,,,NA,NA,,cytoplasm,intermediate filament binding,brain development,,
P48681,P48681,Nestin,NES,59.63,59.47,S1496,PKTALETESQDSAEPSGSEEESDPVSLERED,_TALET(ph)ES(ph)QDSAEPS(ph)GS(ph)EEESDPVSLER_, , , , ,0.07,-0.05, ,-0.46, , , , ,-0.48,-0.43, ,-0.62,,,0.01,-0.46,,,-0.46,-0.62,,,,,,,NA,NA,,cytoplasm,intermediate filament binding,brain development,,
P48681,P48681,Nestin,NES,59.63,59.47,S1498,TALETESQDSAEPSGSEEESDPVSLEREDKV,_TALET(ph)ES(ph)QDSAEPS(ph)GS(ph)EEESDPVSLER_, , , , ,0.07,-0.05, ,-0.46, , , , ,-0.48,-0.43, ,-0.62,,,0.01,-0.46,,,-0.46,-0.62,,,,,,,NA,NA,,cytoplasm,intermediate filament binding,brain development,,
E7EQF0,Q0ZGT2,Nexilin,NEXN,135.08,134.45,S80,REWNRRKQEIKEMLASDDEEDVSSKVEKAYV,_EMLAS(ph)DDEEDVSSK_,-1.27,-1.15,-1.2,-1.06,-0.64,-0.54,-0.72,-0.94,-0.68,-0.46,-0.35,-0.77,-0.52,-0.29,-0.09,-0.24,-1.21,-1.13,-0.59,-0.83,-0.57,-0.55,-0.4,-0.17, +,,,,,,3,0,13.92,,,regulation of cell migration,,
P35240-4,P35240,Merlin,NF2,152.55,27.31,S518,DSLSFDFKDTDMKRLSMEIEKEKVEYMEKSK,_RLS(ph)MEIEK_, , , , ,0.33,0.4, , , , , , ,2.36,3.17, , ,,,0.37,,,,2.82,,, +,,,,,NA,NA,,adherens junction,,actin cytoskeleton organization,,
Q8NCF5,Q8NCF5,NFATC2-interacting protein,NFATC2IP,124.88,121.86,S84,DEVEVEPPEPPGPVASRDNSNSDSEGEDRRP,_GAADEVEVEPPEPPGPVAS(ph)R_, , , , , ,-0.46,-0.91,-0.76, , , , , ,0.37,-0.29,-1.03,,,-0.46,-0.83,,,0.37,-0.61,,,,,,,NA,NA,,cytoplasm,,cytokine production,,
Q8NCF5,Q8NCF5,NFATC2-interacting protein,NFATC2IP,64.27,64.27,S204,KTEFLDLDNSPLSPPSPRTKSRTHTRALKKL,_KTEFLDLDNSPLSPPS(ph)PR_, , , , ,0.26, , , , , , , ,-0.15, , , ,,,0.26,,,,-0.15,,,,,,,,NA,NA,,cytoplasm,,cytokine production,,
Q14934-18,Q14934,"Nuclear factor of activated T-cells, cytoplasmic 4",NFATC4,48.63,48.58,S311,EPPPPPPLPLARDPGSPGPFDYVGAPPAESI,_DPGS(ph)PGPFDYVGAPPAESIPQK_, , , , , , , ,1.07, , , , , , , ,1.7,,,,1.07,,,,1.7, +, +,,,,,NA,NA,,cytoplasm,DNA binding,cellular respiration,,
Q14934-18,Q14934,"Nuclear factor of activated T-cells, cytoplasmic 4",NFATC4,131.72,116.09,S213,VESELNEAASRFGLGSPLPSPRASPRPWTPE,_FGLGS(ph)PLPS(ph)PR_, , , , , ,-0.71,0.31,0.4, , , , , ,-1.43,-0.06,-0.21,,,-0.71,0.36,,,-1.43,-0.13,, +,,,,,NA,NA,,cytoplasm,DNA binding,cellular respiration,,
Q14934-18,Q14934,"Nuclear factor of activated T-cells, cytoplasmic 4",NFATC4,131.72,116.09,S217,LNEAASRFGLGSPLPSPRASPRPWTPEDPWS,_FGLGS(ph)PLPS(ph)PR_, , , , , ,-0.71,0.31,0.4, , , , , ,-1.43,-0.06,-0.21,,,-0.71,0.36,,,-1.43,-0.13,, +,,,,,NA,NA,,cytoplasm,DNA binding,cellular respiration,,
B1AKN5,Q12857,Nuclear factor 1,NFIA,345.3,345.3,S280,SLPSTSSTSSTKRLKSVEDEMDSPGEEPFYT,_S(ph)VEDEMDS(ph)PGEEPFYTGQGR_, , ,2.1,1.87,1.55,1.99,2.34,1.65, , ,2.58,2.13,1.93,1.86,2.34,1.29,,1.99,1.79,2.04,,2.37,1.89,1.91, +, +,,,,,NA,NA,,cell junction,sequence-specific DNA binding transcription factor activity,DNA replication,,
B1AKN5,Q12857,Nuclear factor 1,NFIA,257.5,254.31,S300,MDSPGEEPFYTGQGRSPGSGSQSSGWHEVEP,_S(ph)PGSGSQSSGWHEVEPGMPS(ph)PTTLK_,0.21,0.1,0.74,0.72,0.04,0.07,0.2,0.02,0.19,0.35,1.12,1.23,0.03,0.26,0.24,0.16,0.16,0.73,0.05,0.11,0.27,1.18,0.15,0.2,, +,,,,,0,4,47.73,cell junction,sequence-specific DNA binding transcription factor activity,DNA replication,,
B1AKN5,Q12857,Nuclear factor 1,NFIA,257.5,254.31,S319,GSQSSGWHEVEPGMPSPTTLKKSEKSGFSSP,_S(ph)PGSGSQSSGWHEVEPGMPS(ph)PTTLK_,-0.27,-0.19,0.67,0.72,0.04,0.07,0.2,0.02,0.31,0.36,1.09,1.23,0.03,0.26,0.13,0.16,-0.23,0.7,0.05,0.11,0.34,1.16,0.15,0.15,, +,,,,,0,4,19.2,cell junction,sequence-specific DNA binding transcription factor activity,DNA replication,,
B1AKN5,Q12857,Nuclear factor 1,NFIA,361.03,361.03,S287,TSSTKRLKSVEDEMDSPGEEPFYTGQGRSPG,_S(ph)VEDEMDS(ph)PGEEPFYTGQGR_,0.01,-0.1,0.17,-0.92,-0.94,-0.71,-0.46,-0.27,0.21,0.21,-0.52,-0.68,-0.46,-0.27,-0.24,-0.06,-0.05,-0.27,-0.82,-0.36,0.21,-0.6,-0.36,-0.15,,,,,,,0,0,,cell junction,sequence-specific DNA binding transcription factor activity,DNA replication,,
Q5VW31,O00712,Nuclear factor 1 B-type,NFIB,237.14,199.98,S333,KPEKPLFSSASPQDSSPRLSTFPQHHHPGIP,_PLFSSAS(ph)PQDSS(ph)PR_,-0.86,-0.85,-0.23, ,-0.41,-0.43,-0.85, ,-0.43,-0.39,0.37, ,-0.49,-0.5,-1.01, ,-0.85,-0.23,-0.42,-0.85,-0.41,0.37,-0.49,-1.01,, +,,,,,0,6,19.49,nucleus,sequence-specific DNA binding transcription factor activity,DNA replication,,
Q5VW31,O00712,Nuclear factor 1 B-type,NFIB,237.14,199.98,S328,PTTMKKPEKPLFSSASPQDSSPRLSTFPQHH,_PLFSSAS(ph)PQDSS(ph)PR_,-0.2,-0.13,-0.33,-0.07,0.94,-0.27,0.12,0.55,-0.43,-0.45,-0.3,-0.37,0.64,-0.49,-0.03,0.14,-0.16,-0.19,0.46,0.35,-0.44,-0.34,0.18,0.06,,,,,,,0,0,,nucleus,sequence-specific DNA binding transcription factor activity,DNA replication,,
Q5VW31,O00712,Nuclear factor 1 B-type,NFIB,211.33,172.61,S332,KKPEKPLFSSASPQDSSPRLSTFPQHHHPGI,_PLFSSAS(ph)PQDS(ph)SPR_,-0.89,-0.45,0,-0.74,-0.25,-0.11,-0.51,-0.76,-0.64,-0.5,0.19,0.08,-0.6,-0.49,-0.62,-0.73,-0.65,-0.33,-0.18,-0.63,-0.57,0.14,-0.54,-0.67,,,,,,,0,0,,nucleus,sequence-specific DNA binding transcription factor activity,DNA replication,,
Q5VW31,O00712,Nuclear factor 1 B-type,NFIB,133.54,132.87,S284,SKRPKTISIDENMEPSPTGDFYPSPSSPAAG,_TISIDENMEPS(ph)PTGDFYPSPSS(ph)PAAGSR_,0.25,-0.09, , ,-0.16,-0.39,-0.33,-0.24,0.16,0.17, , ,-0.25,0.07,-0.35,-0.12,0.09,,-0.27,-0.28,0.17,,-0.08,-0.23,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding transcription factor activity,DNA replication,,
Q5VW31,O00712,Nuclear factor 1 B-type,NFIB,133.54,132.87,S295,NMEPSPTGDFYPSPSSPAAGSRTWHERDQDM,_TISIDENM(ox)EPS(ph)PTGDFYPSPSS(ph)PAAGSR_,0.25,-0.11,-0.48, ,-0.16,-0.39,-0.23,-0.24,0.16,0.55,0, ,-0.25,0.07,-0.26,-0.12,0.08,-0.48,-0.27,-0.23,0.37,0,-0.08,-0.19,,,,,,,0,0,,nucleus,sequence-specific DNA binding transcription factor activity,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,202.07,192.53,S322,TSSSRNWTEDMEGGISSPVKKTEMDKSPFNS,_NWTEDMEGGIS(ph)SPVK_,1.1, , ,0.75,-2.46, ,0.04,-0.25,0.96, , ,1.11,-1.39, ,-0.01,-0.42,1.1,0.75,-2.46,-0.1,0.96,1.11,-1.39,-0.2, +, +,,,,,6,6,24.82,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,57.47,57,S284,RTLPSTSSSGSKRHKSGSMEEDVDTSPGGDY,_S(ph)GS(ph)MEEDVDTS(ph)PGGDYYTSPSS(ph)PTSSSR_, , , , , , , ,1.58, , , , , , , ,1.39,,,,1.58,,,,1.39, +, +,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,155.06,154.5,S286,LPSTSSSGSKRHKSGSMEEDVDTSPGGDYYT,_S(ph)GS(ph)MEEDVDTS(ph)PGGDYYTSPSS(ph)PTSSSR_, , , , ,-0.52,0.6,1.05,1.14, , , , ,0.57,1.16,0.62,0.94,,,0.15,1.09,,,0.9,0.79, +,,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,155.06,154.5,S294,SKRHKSGSMEEDVDTSPGGDYYTSPSSPTSS,_SGSMEEDVDTS(ph)PGGDYYTSPSS(ph)PTSSSR_,1.45,1.09, ,0.49,-0.62,-0.3,0.04,0.01,0.05,0.07, ,-0.46,-0.46,-0.6,-0.39,-0.43,1.28,0.49,-0.45,0.03,0.06,-0.46,-0.53,-0.41, +,,,,,,5,0,6.2,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,228.19,222.44,S343,TEMDKSPFNSPSPQDSPRLSSFTQHHRPVIA,_S(ph)PFNSPS(ph)PQDS(ph)PR_, , , , ,-1.5,-0.33,0.23,-0.57, , , , ,-1.33,-0.85,-0.16,-1.07,,,-0.8,-0.12,,,-1.07,-0.55,, +,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,279.27,279.27,S333,EGGISSPVKKTEMDKSPFNSPSPQDSPRLSS,_S(ph)PFNSPS(ph)PQDS(ph)PR_,0.2, ,-0.28, ,0.47,0.17,0.54,0.59,-0.63, ,0.58, ,-0.07,0.46,0.6,0.55,0.2,-0.28,0.33,0.56,-0.63,0.58,0.22,0.57,,,,,,,0,0,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,133.29,124.45,S337,SSPVKKTEMDKSPFNSPSPQDSPRLSSFTQH,_S(ph)PFNS(ph)PSPQDSPR_, , , , ,-1.75,0.77,0.67, , , , , ,-1.82,1.65,0.91, ,,,0,0.67,,,0.78,0.91,,,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,279.27,279.27,S339,PVKKTEMDKSPFNSPSPQDSPRLSSFTQHHR,_S(ph)PFNSPS(ph)PQDSPR_,-0.13,-0.17,-0.09,-0.21,-0.03,0.08,-0.15,-0.36,-0.32,-0.21,-0.09,-0.37,-0.22,-0.71,-0.66,-0.82,-0.15,-0.15,0.02,-0.25,-0.27,-0.22,-0.45,-0.73,,,,,,,0,0,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,254.32,236.75,S323,SSSRNWTEDMEGGISSPVKKTEMDKSPFNSP,_NWTEDM(ox)EGGISS(ph)PVK_,0.57,0.02,0.3,0.48,0.1,-0.55,-0.24,-0.27,0.56,0.24,0.55,0.78,-0.22,-0.73,-0.12,-0.27,0.32,0.39,-0.19,-0.26,0.41,0.67,-0.45,-0.19,,,,,,,0,0,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,103.46,103.35,S302,MEEDVDTSPGGDYYTSPSSPTSSSRNWTEDM,_SGSMEEDVDT(ph)SPGGDYYTS(ph)PSS(ph)PTSSSR_, , , , ,-0.26,-0.48,-0.46,-0.24, , , , ,-0.39,-0.28,-0.53,-0.39,,,-0.36,-0.35,,,-0.34,-0.46,,,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
P08651-4,P08651,Nuclear factor 1 C-type,NFIC,155.06,154.5,S305,DVDTSPGGDYYTSPSSPTSSSRNWTEDMEGG,_SGSMEEDVDT(ph)SPGGDYYTS(ph)PSS(ph)PTSSSR_,-0.37,-0.14, , ,-0.56,0.6,-0.37,-0.67,-0.02,0.16, , ,-0.32,1.16,-0.35,-0.71,-0.25,,0.13,-0.51,0.07,,0.6,-0.52,,,,,,,NA,NA,,nucleus,DNA binding,DNA replication,,
F8W8H9,Q14938,Nuclear factor 1,NFIX,95.47,95.28,S288,STTKRPKSIDDSEMESPVDDVFYPGTGRSPA,_S(ph)IDDSEMES(ph)PVDDVFYPGTGR_, , , , , ,1.53, , , , , , , ,1.07, , ,,,1.53,,,,1.07,, +, +,,,,,NA,NA,,,,,,
F8W8H9,Q14938,Nuclear factor 1,NFIX,184.93,184.59,S280,SITSPPSTSTTKRPKSIDDSEMESPVDDVFY,_S(ph)IDDSEMESPVDDVFYPGTGR_, , , , ,1,1.53, , , , , , ,0.56,1.07, , ,,,1.29,,,,0.84,, +,,,,,,NA,NA,,,,,,
Q6ZNB6,Q6ZNB6,NF-X1-type zinc finger protein NFXL1,NFXL1,91.41,90.98,S107,ANQAAARKLVEEQFSSSSEEGDEDFEGKQGK,_LVEEQFSS(ph)S(ph)SEEGDEDFEGK_, , , , , ,-0.12, , , , , , , ,0.03, , ,,,-0.12,,,,0.03,,,,,RING finger,,,NA,NA,,integral to membrane,sequence-specific DNA binding transcription factor activity,,,
Q6ZNB6,Q6ZNB6,NF-X1-type zinc finger protein NFXL1,NFXL1,91.41,90.98,S108,NQAAARKLVEEQFSSSSEEGDEDFEGKQGKI,_LVEEQFSS(ph)S(ph)SEEGDEDFEGK_, , , , , ,-0.12, , , , , , , ,0.03, , ,,,-0.12,,,,0.03,,,,,RING finger,,,NA,NA,,integral to membrane,sequence-specific DNA binding transcription factor activity,,,
G3V4G1,Q8NEJ9,Neuroguidin,NGDN,145.26,143.86,S142,PLRFKPHPSNMMSKLSSEDEEEDEAEDDQSE,_LS(ph)S(ph)EDEEEDEAEDDQSEASGKK_, , , , , ,-0.07,0.05,-0.78, , , , , ,0.01,0.04,-0.23,,,-0.07,-0.31,,,0.01,-0.09,,,,,,,NA,NA,,,,,,
G3V4G1,Q8NEJ9,Neuroguidin,NGDN,145.26,143.86,S143,LRFKPHPSNMMSKLSSEDEEEDEAEDDQSEA,_LS(ph)S(ph)EDEEEDEAEDDQSEASGKK_, , , , , ,-0.07,0.05,-0.78, , , , , ,0.01,0.04,-0.23,,,-0.07,-0.31,,,0.01,-0.09,,,,,,,NA,NA,,,,,,
B4DDI2,Q8N5V2,Ephexin-1,NGEF,154.12,130.59,S606,RWMTSLAPNRRTKFVSFTSRLLDCPQVQCVH,_FVS(ph)FTSR_,0.82,0.93,-0.25,-0.03,1.13,1.11,0.62,0.75,1.03,1.18,0.67,0.62,0.52,0.77,0.33,0.42,0.88,-0.14,1.12,0.69,1.11,0.65,0.65,0.38, +, +,,,,,2,5,9.45,intracellular,phospholipid binding,cellular process,,
Q9NPE2-3,Q9NPE2,Neugrin,NGRN,141.3,140.37,S41,GVAGPGPIGREPDPDSDWEPEERELQEVERY,_GVAGPGPIGREPDPDS(ph)DWEPEER_, ,0.82,0.62, , ,-0.45, , , ,0.05,0.23, , ,-0.69, , ,0.82,0.62,-0.45,,0.05,0.23,-0.69,,,,,,,,NA,NA,,extracellular region,,neuron differentiation,,
Q5SYE7-2,Q5SYE7,NHS-like protein 1,NHSL1,37.2,37.2,S1386,VLGRRDSDDDHSRNHSPSPPVTPTGAAPSLA,_NHS(ph)PS(ph)PPVTPTGAAPSLASPK_, , , , , , ,-0.39,-1.01, , , , , , ,0.81,0.63,,,,-0.66,,,,0.73,,,,,,,NA,NA,,,,,,
Q5SYE7-2,Q5SYE7,NHS-like protein 1,NHSL1,37.2,37.2,S1388,GRRDSDDDHSRNHSPSPPVTPTGAAPSLASP,_NHS(ph)PS(ph)PPVTPTGAAPSLASPK_, , , , , , ,-0.39,-1.01, , , , , , ,0.81,0.63,,,,-0.66,,,,0.73,,,,,,,NA,NA,,,,,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,56.9,56.9,S1152,GRRSSGGGRYRNRSPSDSDMEDYSPPPSLSE,_NRS(ph)PS(ph)DS(ph)DMEDYS(ph)PPPSLSEVAR_, , , , , ,-0.08, ,-1.06, , , , , ,-0.27, ,-0.77,,,-0.08,-1.06,,,-0.27,-0.77, +,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,182.22,166.28,S350,EKEQSEKAAMYDIISSPSKDSTKLTLRLSRV,_AAMYDIISS(ph)PSK_,0,0.09,0.4,0.3,0.26,-0.08,-0.07,-0.18,-0.05,-0.03,0.42,0.31,0.04,0.38,0.26,0.02,0.04,0.35,0.1,-0.12,-0.04,0.36,0.22,0.14,,,,,,,0,0,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,121.26,121.26,S318,PCSSPRDVPPDILLDSPERKQKKQKKMKLGK,_DVPPDILLDS(ph)PERK_,0.05,0.38,0.09,-0.16,0.49,-0.46, , ,0.01,-0.01,-0.05,-0.27,0.64,-0.61, , ,0.22,-0.03,0.09,,0,-0.15,0.15,,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,128.82,128.82,S1150,HEGRRSSGGGRYRNRSPSDSDMEDYSPPPSL,_NRS(ph)PS(ph)DS(ph)DMEDYS(ph)PPPSLSEVAR_, , , , ,-0.31,-0.08,-0.4,-0.74, , , , ,-0.41,-0.27,-0.49,-0.45,,,-0.19,-0.56,,,-0.34,-0.47,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,128.82,128.82,S1154,RSSGGGRYRNRSPSDSDMEDYSPPPSLSEVA,_NRS(ph)PS(ph)DS(ph)DMEDYS(ph)PPPSLSEVAR_, , , , ,-0.31, ,-0.4,-0.74, , , , ,-0.41, ,-0.49,-0.45,,,-0.31,-0.56,,,-0.41,-0.47,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,128.82,128.82,S1160,RYRNRSPSDSDMEDYSPPPSLSEVARKMKKK,_NRS(ph)PSDS(ph)DMEDYS(ph)PPPSLSEVAR_, , , , ,-0.31,-0.08,-0.4,-0.54, , , , ,-0.41,-0.27,-0.49,-0.77,,,-0.19,-0.47,,,-0.34,-0.62,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,233.08,231.72,S1089,RKRSTVNEKPKYAEISSDEDNDSDEAFESSR,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSR_, , , , ,0.05,-0.09,-0.33,0.11, , , , ,0.16,0.07,0,0.04,,,-0.02,-0.09,,,0.12,0.02,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,233.08,231.72,S1090,KRSTVNEKPKYAEISSDEDNDSDEAFESSRK,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSR_, , , , ,0.05,-0.09,-0.33,0.11, , , , ,0.16,0.07,0,0.04,,,-0.02,-0.09,,,0.12,0.02,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,233.08,231.72,S1096,EKPKYAEISSDEDNDSDEAFESSRKRHKKDD,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSR_, , , , ,-0.29,-0.27,-0.47,-0.65, , , , ,-0.24,-0.18,-0.28,-0.38,,,-0.28,-0.56,,,-0.21,-0.33,,,,,,,NA,NA,,nucleoplasm,chromatin binding,brain development,,
Q6KC79-2,Q6KC79,Nipped-B-like protein,NIPBL,159.18,129.87,S2658,TNARNKAITSLLGGGSPKNNTAAETEDDESD,_AITSLLGGGS(ph)PK_,-0.22,-0.13,-0.13,-0.13,-0.09,-0.12,-0.18,-0.16,-0.11,-0.1,0.01,-0.04,-0.16,-0.07,-0.06,-0.1,-0.17,-0.13,-0.1,-0.17,-0.1,-0.01,-0.11,-0.08,,,,,,,0,0,,nucleoplasm,chromatin binding,brain development,,
Q9Y2I1,Q9Y2I1,Nischarin,NISCH,46.88,22.95,S721,RILKVLWCFLIHVQGSIRQFAACLVLTDFGI,_VLWCFLIHVQGS(ph)IR_, , , , , , ,4.37, , , , , , , ,-0.01, ,,,,4.37,,,,-0.01, +,,,,,,NA,NA,,cytosol,G-protein coupled amine receptor activity,actin cytoskeleton organization,,
Q8N5F7,Q8N5F7,NF-kappa-B-activating protein,NKAP,126.9,126.9,S149,RERIGELGAPEVWGLSPKNPEPDSDEHTPVE,_IGELGAPEVWGLS(ph)PK_,0.42,0.38,0.37,0.34,0.9,1.23,0.63,-0.25,0.03,0.16,0.1,0.08,0.85,0.81,0.2,0.1,0.4,0.35,1.07,0.25,0.1,0.09,0.83,0.15, +,,,,,,2,0,25.18,cytoplasm,chromatin binding,granulocyte differentiation,,
P30414,P30414,NK-tumor recognition protein,NKTR,76.36,42.69,S463,CRRHKQTKKRRILIPSDIESSKSSTRRMKSS,_ILIPS(ph)DIESSK_,-0.31,-0.27,-0.39,-0.14,0.21,0.38,-0.01,0.23,-0.15,-0.2,-0.18,-0.11,-0.21,0.34,-0.07,0.01,-0.29,-0.26,0.3,0.12,-0.17,-0.14,0.09,-0.03,,,,,,,0,0,,membrane,cyclosporin A binding,protein folding,,
P30414,P30414,NK-tumor recognition protein,NKTR,94.78,86.71,S1146,ICTPDRSSPAKVEETSPLGNARLDTPDINIV,_VEETS(ph)PLGNAR_, , , , , ,-0.48,-0.08, , , , , , ,-0.5,-0.2, ,,,-0.48,-0.08,,,-0.5,-0.2,,,,,,,NA,NA,,membrane,cyclosporin A binding,protein folding,,
Q9NPP4,Q9NPP4,NLR family CARD domain-containing protein 4,NLRC4,60.35,25.83,S461,FQEYTAGRRLSSLLTSHEPEEVTKGNGYLQK,_LSSLLTS(ph)HEPEEVTK_, , , ,-0.04, , ,-0.05,-0.6, , , ,0.17, , ,0.07,-0.24,,-0.04,,-0.3,,0.17,,-0.08,,,,,,,NA,NA,,cytosol,ATP binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q96D46,Q96D46,60S ribosomal export protein NMD3,NMD3,188.24,185.58,S468,RKNVNIYRDSAIPVESDTDDEGAPRISLAEM,_DSAIPVES(ph)DT(ph)DDEGAPR_,1.11,1.14,0.22,0.96,-0.44,-0.27,0.71,2.1,-0.01,-0.04,-0.03,0.13,-0.59,-0.4,-0.15,-0.24,1.12,0.64,-0.35,1.56,-0.02,0.05,-0.49,-0.19, +,,,,,,5,0,3.92,cytoplasm,,protein transport,,
Q96D46,Q96D46,60S ribosomal export protein NMD3,NMD3,188.24,185.58,T470,NVNIYRDSAIPVESDTDDEGAPRISLAEMLE,_DSAIPVES(ph)DT(ph)DDEGAPR_,-0.1,-0.28,0.1,0.17,0.04,-0.14,0.2,0.34,0.02,0.13,0.38,-0.01,0.91,0.52,0.59,0.13,-0.18,0.14,-0.05,0.27,0.08,0.2,0.73,0.38,,,,,,,0,0,,cytoplasm,,protein transport,,
Q96D46,Q96D46,60S ribosomal export protein NMD3,NMD3,78.81,76.95,T235,YKASQRLISQDIHSNTYNYKSTFSVEIVPIC,_LISQDIHSNT(ph)YNYK_,-0.34, ,0.56, ,-0.06, , , ,-0.51, ,0.21, ,0.32, , , ,-0.34,0.56,-0.06,,-0.51,0.21,0.32,,,,,,,,NA,NA,,cytoplasm,,protein transport,,
P30419,P30419,Glycylpeptide N-tetradecanoyltransferase 1,NMT1,78.6,78.6,S47,DCENEEDNSYNRGGLSPANDTGAKKKKKKQK,_GGLS(ph)PANDTGAK_, ,-0.08,-0.05, ,0.24,-0.18,0.61,0.23, ,0.19,-0.16, ,0.07,-0.3,0.06,0.09,-0.08,-0.05,0.04,0.43,0.19,-0.16,-0.1,0.07,,,,,,,0,0,,actin cytoskeleton,catalytic activity,intrinsic apoptotic signaling pathway,,
Q9ULX3,Q9ULX3,RNA-binding protein NOB1,NOB1,322.76,322.76,S201,EEEEEENGFEDRKDDSDDDGGGWITPSNIKQ,_KDDS(ph)DDDGGGWITPSNIK_,0.38,0.39,0.4,0.36,-0.08,0,0,0.03,0.21,0.17,0.03,-0.05,-0.01,0.1,0.07,0.25,0.39,0.38,-0.04,0.01,0.19,-0.01,0.05,0.16,,,,,,,0,0,,nucleus,metal ion binding,,,
Q9ULX3,Q9ULX3,RNA-binding protein NOB1,NOB1,192.1,183.04,S184,HELQELLIDRGEDVPSEEEEEEENGFEDRKD,_NPLPNIDHELQELLIDRGEDVPS(ph)EEEEEEENGFEDR_,0.19,0.1,0.19,0.2,-0.27,-0.15,-0.07,-0.12,0.11,-0.04,-0.06,-0.1,-0.32,-0.02,-0.04,-0.04,0.15,0.19,-0.21,-0.1,0.04,-0.08,-0.16,-0.04,,,,,,,0,0,,nucleus,metal ion binding,,,
Q9Y3T9,Q9Y3T9,Nucleolar complex protein 2 homolog,NOC2L,277.1,276.53,S672,KDEDRKQFKDLFDLNSSEEDDTEGFSERGIL,_DLFDLNS(ph)S(ph)EEDDTEGFSER_,-0.46, , ,-0.74,-0.22,-0.51,-0.63,-0.8,-0.41, , ,-0.07,-0.46,-0.27,-0.29,-0.65,-0.46,-0.74,-0.36,-0.71,-0.41,-0.07,-0.36,-0.46,,,,,,,0,0,,nucleolus,histone binding,apoptotic process,,
Q9Y3T9,Q9Y3T9,Nucleolar complex protein 2 homolog,NOC2L,277.1,276.53,S673,DEDRKQFKDLFDLNSSEEDDTEGFSERGILR,_DLFDLNS(ph)S(ph)EEDDTEGFSER_,-0.46, , ,-0.74,-0.49,-0.51,-0.63,-0.8,-0.41, , ,-0.07,-0.23,-0.27,-0.29,-0.65,-0.46,-0.74,-0.5,-0.71,-0.41,-0.07,-0.25,-0.46,,,,,,,0,0,,nucleolus,histone binding,apoptotic process,,
Q76FK4-3,Q76FK4,Nucleolar protein 8,NOL8,57.99,55.37,S890,TDDRFRMDSRFLETDSEEEQEEVNEKKTAEE,_FLET(ph)DS(ph)EEEQEEVNEK_, , , , , , ,-0.28, , , , , , , ,-0.07, ,,,,-0.28,,,,-0.07,,,,,,,NA,NA,,cytoplasm,nucleotide binding,DNA replication,,
Q76FK4-3,Q76FK4,Nucleolar protein 8,NOL8,57.99,55.37,T888,FGTDDRFRMDSRFLETDSEEEQEEVNEKKTA,_FLET(ph)DS(ph)EEEQEEVNEK_, , , , , , ,-0.28, , , , , , , ,-0.07, ,,,,-0.28,,,,-0.07,,,,,,,NA,NA,,cytoplasm,nucleotide binding,DNA replication,,
Q14978,Q14978,Nucleolar and coiled-body phosphoprotein 1,NOLC1,130.01,126.04,S698,RGGSISVQVNSIKFDSE______________,_GGSISVQVNSIKFDS(ph)E_, , ,-0.03, ,0.18, ,-0.5, , , ,-0.52, ,-0.23, ,-1.11, ,,-0.03,0.18,-0.5,,-0.52,-0.23,-1.11,, +,,,,,NA,NA,,Cajal body,ATP binding,mitosis,,
Q14978,Q14978,Nucleolar and coiled-body phosphoprotein 1,NOLC1,120.76,120.76,S623,PNTFPKRKKGEKRASSPFRRVREEEIEVDSR,_RASS(ph)PFRR_,0.06,0.02, ,-0.21,-0.1, , ,0.91,-0.2,-0.15, ,-0.41,0.05, , ,-0.32,0.04,-0.21,-0.1,0.91,-0.17,-0.41,0.05,-0.32,,,,,,,0,0,,Cajal body,ATP binding,mitosis,,
Q14978,Q14978,Nucleolar and coiled-body phosphoprotein 1,NOLC1,181.97,181.97,T607,AKEAETPQAKKIKLQTPNTFPKRKKGEKRAS,_LQT(ph)PNT(ph)FPK_,0.14,0.16,0.14,0.13,-0.3,-0.35,-0.44,-0.22,-0.09,-0.05,-0.1,0.03,-0.17,-0.28,-0.58,-0.62,0.15,0.13,-0.32,-0.33,-0.07,-0.03,-0.22,-0.6,,,,,,,0,0,,Cajal body,ATP binding,mitosis,,
Q14978,Q14978,Nucleolar and coiled-body phosphoprotein 1,NOLC1,181.97,181.97,T610,AETPQAKKIKLQTPNTFPKRKKGEKRASSPF,_LQT(ph)PNT(ph)FPK_,0.14,0.16,0.14,0.13,-0.3,-0.35,-0.44,-0.22,-0.09,-0.05,-0.1,0.03,-0.17,-0.28,-0.58,-0.62,0.15,0.13,-0.32,-0.33,-0.07,-0.03,-0.22,-0.6,,,,,,,0,0,,Cajal body,ATP binding,mitosis,,
P46087-2,P46087,Putative ribosomal RNA methyltransferase NOP2,NOP2,82.83,62.54,S812,KRKKSQSRGNSQLLLS_______________,_GNSQLLLS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,RNA binding,positive regulation of cell proliferation,,
P46087-2,P46087,Putative ribosomal RNA methyltransferase NOP2,NOP2,132.31,120.99,S786,QKQNDTPKGPQPPTVSPIRSSRPPPAKRKKS,_GPQPPTVS(ph)PIR_,0.1,0.16,0.07,0.1, ,-0.14,-0.26,-0.34,0.04,0.07,-0.1,0.04, ,-0.35,-0.45,-0.44,0.13,0.09,-0.14,-0.3,0.05,-0.03,-0.35,-0.44,,,,,,,0,0,,nucleolus,RNA binding,positive regulation of cell proliferation,,
P46087-2,P46087,Putative ribosomal RNA methyltransferase NOP2,NOP2,166.47,145.67,S732,NAPPKGTDTQTPAVLSPSKTQATLKPKDHHQ,_GTDTQTPAVLS(ph)PSK_,0.16,0.25,0.44,0.44,0.16, ,-0.76, ,-0.06,0.31,0.34,0.18,-0.01, ,-0.47, ,0.21,0.44,0.16,-0.76,0.14,0.26,-0.01,-0.47,,,,,,,0,0,,nucleolus,RNA binding,positive regulation of cell proliferation,,
P46087-2,P46087,Putative ribosomal RNA methyltransferase NOP2,NOP2,125.19,125.19,S181,ARKQKAREAAAGIQWSEEETEDEEEEKEVTP,_EAAAGIQWS(ph)EEET(ph)EDEEEEK_, , , , ,-0.34,-0.06,-0.41,-0.4, , , , ,-0.35,-0.38,-0.36,-0.26,,,-0.19,-0.4,,,-0.37,-0.31,,,,,,,NA,NA,,nucleolus,RNA binding,positive regulation of cell proliferation,,
P46087-2,P46087,Putative ribosomal RNA methyltransferase NOP2,NOP2,125.19,125.19,T185,KAREAAAGIQWSEEETEDEEEEKEVTPESGP,_EAAAGIQWS(ph)EEET(ph)EDEEEEK_, , , , ,-0.34,-0.06,-0.41,-0.4, , , , ,-0.35,-0.38,-0.36,-0.26,,,-0.19,-0.4,,,-0.37,-0.31,,,,,,,NA,NA,,nucleolus,RNA binding,positive regulation of cell proliferation,,
O00567,O00567,Nucleolar protein 56,NOP56,157.56,154.32,S519,SKPKKKKSFSKEELMSSDLEETAGSTSIPKR,_EELMS(ph)S(ph)DLEETAGSTSIPK_, , , , ,-0.04,-0.62,-0.2,-0.27, , , , ,-0.16,-0.64,-0.12,-0.32,,,-0.3,-0.23,,,-0.38,-0.22,,,,,,,NA,NA,,box C/D snoRNP complex,snoRNA binding,cell death,,
O00567,O00567,Nucleolar protein 56,NOP56,160.36,160.08,S520,KPKKKKSFSKEELMSSDLEETAGSTSIPKRK,_EELMS(ph)S(ph)DLEETAGSTSIPK_,-0.21,-0.14,-0.32,-0.23,-0.31,-0.41,-0.2,-0.24,0.06,0.14,-0.06,-0.2,-0.3,-0.64,-0.12,-0.34,-0.17,-0.28,-0.36,-0.22,0.1,-0.13,-0.46,-0.22,,,,,,,0,0,,box C/D snoRNP complex,snoRNA binding,cell death,,
Q9Y314,Q9Y314,Nitric oxide synthase-interacting protein,NOSIP,94.84,94.75,S138,SRPLNPFTAKALSGTSPDDVQPGPSVGPPSK,_ALSGTS(ph)PDDVQPGPSVGPPSK_,-0.24,-0.48,-0.26,-0.21, ,0.02, , ,-0.04,0,0.02,0.38, ,0.26, , ,-0.35,-0.23,0.02,,-0.02,0.21,0.26,,,,,U box,,,NA,NA,,cytosol,,negative regulation of nitric-oxide synthase activity,,
Q04721,Q04721,Neurogenic locus notch homolog protein 2,NOTCH2,76.82,69.87,Y2470,PGTHMSEPPHNNMQVYA______________,_GPGTHMSEPPHNNMQVY(ph)A_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell surface,calcium ion binding,atrial septum morphogenesis,,
Q04721,Q04721,Neurogenic locus notch homolog protein 2,NOTCH2,152.86,145.27,S1778,GPQPKKVKAEDEALLSEEDDPIDRRPWTQQH,_AEDEALLS(ph)EEDDPIDR_, , , , , , , ,-0.19, , , , , , , ,-0.27,,,,-0.19,,,,-0.27,,,,,,,NA,NA,,cell surface,calcium ion binding,atrial septum morphogenesis,,
P06748-2,P06748,Nucleophosmin,NPM1,229.27,228.21,S70,DELHIVEAEAMNYEGSPIKVTLATLKMSVQP,_DELHIVEAEAMNYEGS(ph)PIK_,0.13,0.03,-0.01,-0.04,-0.14,-0.16,-0.18,-0.31,0.14,0.18,0.03,0.04,-0.08,-0.1,-0.45,-0.35,0.08,-0.02,-0.15,-0.24,0.16,0.04,-0.09,-0.4,,,,,,,0,0,,cytosol,histone binding,cell aging,,
P06748-2,P06748,Nucleophosmin,NPM1,67.11,18.69,S254,KGPSSVEDIKAKMQASIEKGGSLPKVEAKFI,_M(ox)QAS(ph)IEK_,0.19,0.15,0.17,-0.08,-0.53,-0.16,-0.46,-0.4,0.24,-0.09,0,-0.24,-0.49,-0.29,-0.71,-0.83,0.17,0.05,-0.33,-0.43,0.09,-0.12,-0.39,-0.77,,,,,,,0,0,,cytosol,histone binding,cell aging,,
C9JHZ6,Q9UHY1,Nuclear receptor-binding protein,NRBP1,171.35,170.36,S2,______________MSEGESQTVLSSGSDPK,_(ac)S(ph)EGESQTVLSSGSDPK_,-0.07,-0.17,-0.19,-0.15,-0.26,-0.27,-0.08,-0.13,0.5,0.37,0.29,0.29,0.14,-0.03,0.03,-0.01,-0.12,-0.17,-0.27,-0.1,0.44,0.29,0.06,0.01,,,Other,,,,0,0,,perinuclear region of cytoplasm,,,,
C9JHZ6,Q9UHY1,Nuclear receptor-binding protein,NRBP1,123.32,121.02,S14,__MSEGESQTVLSSGSDPKVESSSSAPGLTS,_(ac)S(ph)EGESQTVLSSGS(ph)DPK_, , , , , ,-0.1, ,-0.2, , , , , ,0.3, ,-0.07,,,-0.1,-0.2,,,0.3,-0.07,,,Other,,,,NA,NA,,perinuclear region of cytoplasm,,,,
O43847-2,O43847,Nardilysin,NRD1,105.38,105.38,S94,ARLGADESEEEGRRGSLSNAGDPEIVKSPSD,_RGS(ph)LSNAGDPEIVK_,0.42,0.4,1.07,1.53, ,1.56,1.05,1.26,0.09,0.44,0.82,1.28, ,0.89,1.05,1.23,0.41,1.32,1.56,1.16,0.28,1.07,0.89,1.14, +, +,,,,,1,1,37.33,cell surface,epidermal growth factor binding,cell migration,,
P48552,P48552,Nuclear receptor-interacting protein 1,NRIP1,76.94,42.56,S365,MGIIPSSPKNAGYKNSLERNNIKQAANNSLL,_NAGYKNS(ph)LER_,-1.94,-2.61,-2.64,-2.71, , , , ,-7.05,-6.08,-6.24,-6.33, , , , ,-2.24,-2.67,,,-6.48,-6.29,,, +, +,,,,,NA,NA,,histone deacetylase complex,androgen receptor binding,androgen receptor signaling pathway,,
E7EV67,Q9P2S2,Neurexin-2-alpha,NRXN2,66.69,38.49,S667,AGYVGCVRDLFIDGRSRDLRGLAEAQGAVGV,_DLFIDGRS(ph)R_, , , ,-5.36, , , , , , , ,-0.94, , , , ,,-5.36,,,,-0.94,,, +,,,,,,NA,NA,,,,,,
Q96L73-2,Q96L73,"Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific",NSD1,52.19,34.94,S483,HDLLLNGCLKSLAFDSEHSADEKEKPCAKSR,_SLAFDS(ph)EHS(ph)ADEK_, , , , , ,0.8, , , , , , , ,1.15, , ,,,0.8,,,,1.15,,, +,,,,,NA,NA,,chromosome,androgen receptor binding,gastrulation with mouth forming second,,
Q96L73-2,Q96L73,"Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific",NSD1,52.19,34.94,S486,LLNGCLKSLAFDSEHSADEKEKPCAKSRARK,_SLAFDS(ph)EHS(ph)ADEK_, , , , , ,0.8, , , , , , , ,1.15, , ,,,0.8,,,,1.15,,, +,,,,,NA,NA,,chromosome,androgen receptor binding,gastrulation with mouth forming second,,
F2Z2K0,Q9UNZ2,NSFL1 cofactor p47,NSFL1C,196.3,196.3,S114,SERSGQQIVGPPRKKSPNELVDDLFKGAKEH,_KKS(ph)PNELVDDLFK_,0.37,0.32,0.29,0.41,0.45, , , ,0.34,0.18,0.09,-0.48,0.82, , , ,0.35,0.35,0.45,,0.27,-0.17,0.82,,,,,,,,NA,NA,,,,,,
Q9H0G5,Q9H0G5,Nuclear speckle splicing regulatory protein 1,NSRP1,549.83,549.29,S33,QLHPVLQKPSVFGNDSDDDDETSVSESLQRE,_PSVFGNDS(ph)DDDDETSVSESLQR_,0.14,0.1,0.09,0.1,0.02,0.19,0.73,0.51,0.03,0.04,-0.05,-0.04,-0.04,-0.01,-0.01,0,0.12,0.09,0.11,0.63,0.03,-0.05,-0.03,0,,,,,,,0,0,,nuclear speck,mRNA binding,developmental process,,
Q9H0G5,Q9H0G5,Nuclear speckle splicing regulatory protein 1,NSRP1,238.85,238.85,S248,ILQTDVKVEENPDADSDFDAKSSADDEIEET,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,0.47,0.17,0.32,0.18,0.17,0.27,0.27,0.16,0.11,0.29,0.16,0.2,0,0.15,0.32,0.06,0.33,0.25,0.22,0.21,0.2,0.18,0.08,0.2,,,,,,,0,0,,nuclear speck,mRNA binding,developmental process,,
Q9H0G5,Q9H0G5,Nuclear speckle splicing regulatory protein 1,NSRP1,238.85,238.85,S254,KVEENPDADSDFDAKSSADDEIEETRVNCRR,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,0.19,0.65,0.36,0.07,0.17,0.27,-1.05,0.16,0.34,0.24,0.23,0.3,0,0.15,-0.18,0.06,0.44,0.22,0.22,-0.32,0.29,0.27,0.08,-0.05,,,,,,,0,0,,nuclear speck,mRNA binding,developmental process,,
Q9H0G5,Q9H0G5,Nuclear speckle splicing regulatory protein 1,NSRP1,238.85,238.85,S255,VEENPDADSDFDAKSSADDEIEETRVNCRRE,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,0.19,0.65,0.36,0.07,0.17,0.27,-1.05,0.16,0.34,0.24,0.23,0.3,0,0.15,-0.18,0.06,0.44,0.22,0.22,-0.32,0.29,0.27,0.08,-0.05,,,,,,,0,0,,nuclear speck,mRNA binding,developmental process,,
Q9H0G5,Q9H0G5,Nuclear speckle splicing regulatory protein 1,NSRP1,143.98,128.63,T275,IEETRVNCRREKVIETPENDFKHHRSQNHSR,_VIET(ph)PENDFK_,0.14,0.07,0.17,0.37,-0.1,-0.06,0.14,-0.13,0.14,0.05,0.26,0.35,-0.31,-0.5,-0.07,0.18,0.11,0.27,-0.08,0.01,0.09,0.3,-0.4,0.06,,,,,,,0,0,,nuclear speck,mRNA binding,developmental process,,
Q08J23,Q08J23,tRNA (cytosine(34)-C(5))-methyltransferase,NSUN2,118.18,118.18,S743,PDNDVTEGQRAGEPNSPDAEEANSPDVTAGC,_AGEPNS(ph)PDAEEANS(ph)PDVTAGCDPAGVHPPR_,-0.24,-0.11,0.26, , ,0.16,0.27,0.32,-0.07,0.12,0.21, , ,-0.1,-0.05,0.06,-0.17,0.26,0.16,0.29,0.03,0.21,-0.1,0.01,,,,,,,0,0,,cytoplasm,tRNA (cytosine-5-)-methyltransferase activity,cell division,,
Q08J23,Q08J23,tRNA (cytosine(34)-C(5))-methyltransferase,NSUN2,118.18,118.18,S751,QRAGEPNSPDAEEANSPDVTAGCDPAGVHPP,_AGEPNS(ph)PDAEEANS(ph)PDVTAGCDPAGVHPPR_,-0.24,-0.11,0.26, , ,0.16,0.27,0.32,-0.07,0.12,0.21, , ,-0.1,-0.05,0.06,-0.17,0.26,0.16,0.29,0.03,0.21,-0.1,0.01,,,,,,,0,0,,cytoplasm,tRNA (cytosine-5-)-methyltransferase activity,cell division,,
Q08J23,Q08J23,tRNA (cytosine(34)-C(5))-methyltransferase,NSUN2,281.3,281.3,S456,KLQGKSAETRESTQLSPADLTEGKPTDPSKL,_ESTQLS(ph)PADLTEGKPTDPSK_,0.23,0.25,0.32,0.14,0.26,0.28,0.35,0.31,0.06,0.09,0.13,0.03,0.08,0,0.16,-0.05,0.24,0.24,0.27,0.33,0.07,0.08,0.04,0.06,,,,,,,0,0,,cytoplasm,tRNA (cytosine-5-)-methyltransferase activity,cell division,,
Q08J23,Q08J23,tRNA (cytosine(34)-C(5))-methyltransferase,NSUN2,101.81,101.69,S473,ADLTEGKPTDPSKLESPSFTGTGDTEIAHAT,_LES(ph)PSFTGTGDTEIAHATEDLENNGSK_,-0.01, , , ,-0.34, ,0.3, ,0.19, , , ,-0.52, ,0.17, ,-0.01,,-0.34,0.3,0.19,,-0.52,0.17,,,,,,,NA,NA,,cytoplasm,tRNA (cytosine-5-)-methyltransferase activity,cell division,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,150.94,149.08,S14,__MSRPVRNRKVVDYSQFQESDDADEDYGRD,_VVDYS(ph)QFQES(ph)DDADEDYGR_, , , , ,0.26,-0.02,1.09,1.16, , , , ,0.09,0.23,0.65,0.89,,,0.13,1.13,,,0.16,0.77, +,,,,,,NA,NA,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,94.38,93.81,Y13,___MSRPVRNRKVVDYSQFQESDDADEDYGR,_VVDY(ph)SQFQES(ph)DDADEDYGR_, , , , ,0.61,0.06,0.05, , , , , ,-0.16,0.15,0.43, ,,,0.36,0.05,,,0.01,0.43,,,,,,,NA,NA,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,147.24,147.24,S181,EKKMPKPRLKATVTPSPVKGKGKVGRPTASK,_LKATVT(ph)PS(ph)PVK_,0.32,0.31,0.26,0.36,0.17,0.57,0.35,0.63,0.18,0.24,0.1,0.18,0.22,0.29,0.23,0.19,0.32,0.31,0.38,0.5,0.21,0.14,0.25,0.21,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,290.39,290.39,S130,EEQEEEDEAPFQEKDSGSDEDFLMEDDDDSD,_DS(ph)GS(ph)DEDFLM(ox)EDDDDS(ph)DYGSSKK_,-0.29,-0.67,-0.19,-0.08,-0.09,-0.43,-0.01,-0.07,-0.42,-0.12,0.01,0.13,-0.15,-0.13,0.18,0.15,-0.47,-0.13,-0.25,-0.04,-0.26,0.07,-0.14,0.17,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,290.39,290.39,S132,QEEEDEAPFQEKDSGSDEDFLMEDDDDSDYG,_DS(ph)GS(ph)DEDFLM(ox)EDDDDS(ph)DYGSSKK_,-0.29,-0.67,-0.19,-0.92,-0.25,-0.42,0.1,0.09,-0.42,-0.12,0.01,-0.57,-0.16,-0.19,0.18,0.14,-0.47,-0.51,-0.33,0.09,-0.26,-0.26,-0.18,0.16,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,290.39,290.39,S144,DSGSDEDFLMEDDDDSDYGSSKKKNKKMVKK,_DS(ph)GS(ph)DEDFLMEDDDDS(ph)DYGSSK_,-0.25,-0.22,-0.2,-0.08,-0.3,-0.24,-0.15,-0.05,-0.11,-0.32,-0.04,0.13,0,-0.09,0.03,0.07,-0.24,-0.14,-0.27,-0.1,-0.21,0.04,-0.04,0.05,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,333.8,302.7,S214,KEKTPSPKEEDEEPESPPEKKTSTSPPPEKS,_TPSPKEEDEEPES(ph)PPEKK_,0.22,0.31,0.09,0.13,0.2,0.26,0.23,0.25,0.18,0.14,0.1,0.04,-0.08,0.17,0.28,0.15,0.26,0.11,0.23,0.24,0.16,0.07,0.05,0.21,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,298.42,298.42,S204,VGRPTASKASKEKTPSPKEEDEEPESPPEKK,_EKT(ph)PS(ph)PKEEDEEPES(ph)PPEK_,0.09,0.14,0.16,0.2,0.42,0.23,0.65,0.05,-0.09,0.21,0.21,0.23,0.09,-0.21,-0.04,-0.14,0.12,0.18,0.33,0.38,0.07,0.22,-0.05,-0.09,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,474.61,474.61,S113,KAASKQREMLMEDVGSEEEQEEEDEAPFQEK,_(gl)QREM(ox)LM(ox)EDVGS(ph)EEEQEEEDEAPFQEK_,0.04,0.09,-0.15,-0.05,-0.09,-0.06,-0.12,0.02,-0.03,0.03,-0.07,-0.02,-0.21,-0.16,0.07,0.17,0.06,-0.1,-0.07,-0.05,0,-0.04,-0.18,0.12,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,447.25,438.19,S19,PVRNRKVVDYSQFQESDDADEDYGRDSGPPT,_VVDYSQFQES(ph)DDADEDYGRDS(ph)GPPTK_,-0.02,-0.02,-0.03,-0.04,0.02,-0.04,-0.16,-0.03,-0.03,-0.05,-0.05,-0.06,-0.1,-0.06,-0.02,0.02,-0.02,-0.03,-0.01,-0.09,-0.04,-0.06,-0.08,0,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,185.02,185.02,S30,QFQESDDADEDYGRDSGPPTKKIRSSPREAK,_VVDYSQFQES(ph)DDADEDYGRDS(ph)GPPTK_, , , , , , ,-0.27,-0.3, , , , , , ,-0.42,-0.48,,,,-0.29,,,,-0.45,,,,,,,NA,NA,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,127.83,127.83,T179,RKEKKMPKPRLKATVTPSPVKGKGKVGRPTA,_LKATVT(ph)PS(ph)PVK_,0.22,-0.05,-0.04,0.54,-0.36,-0.39,-0.06,-0.06,0.05,-0.01,-0.4,-0.47,-0.33,-0.41,0.15,-0.07,0.09,0.28,-0.38,-0.06,0.02,-0.43,-0.37,0.04,,,,,,,0,0,,cytoplasm,,,,
Q9H1E3,Q9H1E3,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1,NUCKS1,298.42,298.42,T202,GKVGRPTASKASKEKTPSPKEEDEEPESPPE,_EKT(ph)PS(ph)PKEEDEEPES(ph)PPEK_,0.09,0.14,0.16,0.2,0.42,0.35,0.29,-0.05,-0.09,0.21,0.21,0.23,0.09,0.13,0.32,-0.17,0.12,0.18,0.39,0.13,0.07,0.22,0.11,0.1,,,,,,,0,0,,cytoplasm,,,,
Q9Y266,Q9Y266,Nuclear migration protein nudC,NUDC,395.81,395.81,S139,DAENHEAQLKNGSLDSPGKQDTEEDEEEDEK,_NGSLDS(ph)PGKQDT(ph)EEDEEEDEK_,0.18,0.2,0.24,0.29,0.19,0.22,0.25,0.17,0.27,0.29,0.22,0.18,1,0.28,0.31,0.01,0.19,0.27,0.21,0.21,0.28,0.2,0.68,0.17,,,,,,,0,0,,cytosol,,cell proliferation,,
Q9Y266,Q9Y266,Nuclear migration protein nudC,NUDC,332.95,332.95,T145,AQLKNGSLDSPGKQDTEEDEEEDEKDKGKLK,_NGSLDS(ph)PGKQDT(ph)EEDEEEDEK_,0,-0.07,-0.07,-0.1,0.17,0.23,0.19,0.01,-0.14,0.06,0.08,0.01,0.21,0.4,0.03,0.15,-0.03,-0.09,0.2,0.1,-0.04,0.05,0.31,0.09,,,,,,,0,0,,cytosol,,cell proliferation,,
Q7Z417,Q7Z417,Nuclear fragile X mental retardation-interacting protein 2,NUFIP2,300.6,296.99,S629,FLSKDYEIESQNPLASPTNTLLGSAKEQRYQ,_DYEIESQNPLAS(ph)PTNTLLGSAK_,0.18,-0.01,0.55,0.17,0.88,0.99,0.83,1.19,-0.02,0.09,0.6,2.09,0.92,0.99,0.75,1.2,0.09,0.37,0.94,1.02,0.04,1.53,0.96,0.99, +, +,,,,,2,1,24.14,nucleus,RNA binding,,,
Q7Z417,Q7Z417,Nuclear fragile X mental retardation-interacting protein 2,NUFIP2,137.87,136.55,S212,YITNGYMGKGADNDGSGSESGYTTPKKRKAR,_GADNDGS(ph)GSESGYTTPK_, ,0.46,0.04, ,-0.27, ,-0.14,-0.26, ,-0.14,-0.19, ,-0.14, ,-0.12,-0.63,0.46,0.04,-0.27,-0.2,-0.14,-0.19,-0.14,-0.35,,,,,,,0,0,,nucleus,RNA binding,,,
Q7Z417,Q7Z417,Nuclear fragile X mental retardation-interacting protein 2,NUFIP2,182.37,174.37,S652,SAKEQRYQRGLERNDSWGSFDLRAAIVYHTK,_NDS(ph)WGSFDLR_,0.54,0.63,0.93,0.99,0.57,0.52,0.36,0.4,0.12,0.17,0.63,0.61,0.27,0.38,0.09,0.2,0.58,0.96,0.54,0.38,0.15,0.62,0.33,0.15,,,,,,,0,0,,nucleus,RNA binding,,,
Q7Z417,Q7Z417,Nuclear fragile X mental retardation-interacting protein 2,NUFIP2,148.22,145.45,S112,LNGNAGEREISLKNLSSDEATNPISRVLNGN,_NLS(ph)S(ph)DEATNPISR_, ,0.22,0.11, ,-0.4,-0.38,-0.2,-0.01, ,0.15,-0.3, ,-0.42,-0.36,-0.37,-0.25,0.22,0.11,-0.39,-0.1,0.15,-0.3,-0.39,-0.31,,,,,,,0,0,,nucleus,RNA binding,,,
Q14980-2,Q14980,Nuclear mitotic apparatus protein 1,NUMA1,132.88,125.75,S1757,PRTQPDGTSVPGEPASPISQRLPPKVESLES,_TQPDGTSVPGEPAS(ph)PISQR_,-0.13,-0.25,0.4, , , ,-0.91, ,0.19,0.04,0.6, , , ,-0.01, ,-0.19,0.4,,-0.91,0.11,0.6,,-0.01,,,,,,,NA,NA,,apical part of cell,structural molecule activity,cell division,,
Q4LE47,P49790,Nuclear pore complex protein Nup153,NUP153 variant protein,84.44,84.44,S516,PINSSQALTNKVQMTSPSSTGSPMFKFSSPI,_VQMTS(ph)PSST(ph)GSPMFK_, , ,1.19, ,-0.01,-0.4,-0.1, , , ,1.17, ,0.11,-0.13,-0.82, ,,1.19,-0.19,-0.1,,1.17,0,-0.82, +, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q4LE47,P49790,Nuclear pore complex protein Nup153,NUP153 variant protein,124.4,122.54,S209,KDITVSKNTSLPPLWSPEAERSHSLSQHTAT,_NTS(ph)LPPLWS(ph)PEAER_, ,-0.16, ,-0.1,-0.32,-0.34,-0.52,-0.15, ,2.19, ,-0.18,-0.48,-0.72,-0.7,-0.52,-0.16,-0.1,-0.33,-0.32,2.19,-0.18,-0.6,-0.61,, +,,,,,0,5,7.23,cytoplasm,zinc ion binding,,,
Q4LE47,P49790,Nuclear pore complex protein Nup153,NUP153 variant protein,124.4,122.54,S203,SSRASDKDITVSKNTSLPPLWSPEAERSHSL,_NTS(ph)LPPLWS(ph)PEAER_, , , , , ,-0.34,-0.16,-0.15, , , , , ,-0.72,-0.37,-0.52,,,-0.34,-0.15,,,-0.72,-0.45,,,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q4LE47,P49790,Nuclear pore complex protein Nup153,NUP153 variant protein,62.71,56.38,S522,ALTNKVQMTSPSSTGSPMFKFSSPIVKSTEA,_VQMTS(ph)PSSTGS(ph)PMFK_, , , , ,-0.01, ,-0.1, , , , , ,0.11, ,-0.82, ,,,-0.01,-0.1,,,0.11,-0.82,,,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q5SRE5,Q5SRE5,Nucleoporin NUP188 homolog,NUP188,142.23,141.82,S1709,LLSSLSRYFRRGAPSSPATGVLPSPQGKSTS,_GAPSS(ph)PATGVLPS(ph)PQGK_, , ,0.54, ,0.87,0.91,0.66,0.59, , ,0.55, ,0.9,0.99,0.51,0.26,,0.54,0.89,0.62,,0.55,0.95,0.39,,,,,,,NA,NA,,nuclear envelope,,carbohydrate metabolic process,,
Q5SRE5,Q5SRE5,Nucleoporin NUP188 homolog,NUP188,142.23,141.82,S1717,FRRGAPSSPATGVLPSPQGKSTSLSKASPES,_GAPSS(ph)PATGVLPS(ph)PQGK_, , ,0.54, ,0.87,0.91,0.61,0.59, , ,0.55, ,0.9,0.99,0.27,0.26,,0.54,0.89,0.6,,0.55,0.95,0.26,,,,,,,NA,NA,,nuclear envelope,,carbohydrate metabolic process,,
Q92621,Q92621,Nuclear pore complex protein Nup205,NUP205,139.11,123.1,S1939,LFASRTLFKSRRLQDSFASETNLDFRSGLAI,_LQDS(ph)FAS(ph)ETNLDFR_, , , , ,-0.01,0.6,-0.49,-0.21, , , , ,-1.77,0.15,-0.65,-1.43,,,0.33,-0.35,,,-0.51,-0.99,,,,,,,NA,NA,,nuclear membrane,structural constituent of nuclear pore,carbohydrate metabolic process,,
Q92621,Q92621,Nuclear pore complex protein Nup205,NUP205,139.11,123.1,S1942,SRTLFKSRRLQDSFASETNLDFRSGLAIVSQ,_LQDS(ph)FAS(ph)ETNLDFR_, , , , ,-0.01,0.6,-0.49,-0.21, , , , ,-1.77,0.15,-0.65,-1.43,,,0.33,-0.35,,,-0.51,-0.99,,,,,,,NA,NA,,nuclear membrane,structural constituent of nuclear pore,carbohydrate metabolic process,,
Q8TEM1,Q8TEM1,Nuclear pore membrane glycoprotein 210,NUP210,114.31,110.73,T1844,HTVCTPRDLAVPAALTPRASPGHSPHYFAAS,_DLAVPAALT(ph)PR_,0.05,0.15, ,0.3,0.22,0.41,-0.11, ,-0.02,0.18, ,0.11,-0.03,0.38,-0.34, ,0.1,0.3,0.32,-0.11,0.08,0.11,0.19,-0.34,,,,,,,0,0,,endoplasmic reticulum membrane,,carbohydrate metabolic process,,
P35658-2,P35658,Nuclear pore complex protein Nup214,NUP214,160.71,157.27,S433,ERLSLEGERQPKSPGSTPTTPTSSQAPQKLD,_SPGS(ph)TPTT(ph)PTSSQAPQK_, , , , ,1.13,1.22,1.45,0.81, , , , ,1.09,1.28,1.08,0.71,,,1.18,1.17,,,1.19,0.91, +, +,,,,,NA,NA,,cytosol,nucleocytoplasmic transporter activity,carbohydrate metabolic process,,
P35658-2,P35658,Nuclear pore complex protein Nup214,NUP214,160.71,157.27,T437,LEGERQPKSPGSTPTTPTSSQAPQKLDASAA,_SPGS(ph)TPTT(ph)PTSSQAPQK_, , , , ,0.62,1.22,1.45,0.81, , , , ,0.6,1.28,1.08,0.71,,,0.95,1.17,,,0.98,0.91, +,,,,,,NA,NA,,cytosol,nucleocytoplasmic transporter activity,carbohydrate metabolic process,,
B4DYB4,Q8NFH5,Nucleoporin NUP53,NUP35,131.33,128.57,S100,KSGAPPVRSIYDDISSPGLGSTPLTSRRQPN,_SIYDDISS(ph)PGLGS(ph)TPLTSR_, , , , ,-0.4, ,0.03,-0.42, , , , ,-0.48, ,-0.73,-0.76,,,-0.4,-0.17,,,-0.48,-0.75,,,,,,,NA,NA,,intermediate filament cytoskeleton,,transmembrane transport,,
B4DYB4,Q8NFH5,Nucleoporin NUP53,NUP35,131.33,128.57,S105,PVRSIYDDISSPGLGSTPLTSRRQPNISVMQ,_SIYDDISS(ph)PGLGS(ph)TPLTSR_, , , , ,-0.4, ,0.03,-0.42, , , , ,-0.48, ,-0.73,-0.76,,,-0.4,-0.17,,,-0.48,-0.75,,,,,,,NA,NA,,intermediate filament cytoskeleton,,transmembrane transport,,
Q9UKX7-2,Q9UKX7,Nuclear pore complex protein Nup50,NUP50,308.12,284.6,S221,RNSESESNKVAAETQSPSLFGSTKLQQESTF,_VAAETQS(ph)PSLFGSTK_,-0.07,-0.2,2.16,2.2,-0.84, ,-0.27,-0.74,0.12,0.02,2.39,2.44,-0.22, ,-0.57,-0.45,-0.13,2.18,-0.84,-0.49,0.07,2.42,-0.22,-0.51, +, +,,,,,4,4,39.94,nuclear membrane,,carbohydrate metabolic process,,
Q99567,Q99567,Nuclear pore complex protein Nup88,NUP88,100.56,84.34,T525,EDVEVAESPLRVLAETPDSFEKHIRSILQRS,_VLAET(ph)PDSFEK_,-0.09, ,-0.13, , ,-2.05,-0.87, ,-0.36, ,-0.47, , ,-1.11,-0.99, ,-0.09,-0.13,-2.05,-0.87,-0.36,-0.47,-1.11,-0.99, +, +,,,,,6,6,24.48,cytosol,transporter activity,carbohydrate metabolic process,,
Q99567,Q99567,Nuclear pore complex protein Nup88,NUP88,168.67,163.92,S517,SPPLLCTREDVEVAESPLRVLAETPDSFEKH,_EDVEVAES(ph)PLR_,-0.07,-0.14,-0.13,-0.07,-0.04,-0.1,-0.41,-0.34,0.09,0.15,0.02,0.05,-0.04,-0.02,-0.57,-0.68,-0.1,-0.1,-0.07,-0.38,0.12,0.04,-0.03,-0.62,,,,,,,0,0,,cytosol,transporter activity,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,132.51,128.53,S839,DGVWPTDKTSRCLIKSPDRLADINYEGRLEA,_S(ph)PDRLADINYEGR_,-0.43,-0.42,0.35, ,-0.77, ,-0.97,-1.1,-0.57,-0.4,0.03, ,-0.94, ,-1.03,-1.14,-0.42,0.35,-0.77,-1.03,-0.48,0.03,-0.94,-1.08, +, +,,,,,6,6,39.64,cytosol,peptide binding,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,174.52,171.86,S612,IKKLVLKNLNNSNLFSPVNRDSENLASPSEY,_NLNNS(ph)NLFS(ph)PVNR_, , , , ,-0.27,1.1,1.11,1.15, , , , ,-1.36,0.63,0.45,0.67,,,0.57,1.13,,,-0.05,0.57, +,,,,,,NA,NA,,cytosol,peptide binding,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,350.58,349.45,S623,SNLFSPVNRDSENLASPSEYPENGERFSFLS,_DSENLAS(ph)PSEYPENGER_,-0.05,-0.05,0.66,0.67,0.61,0.68,0.5,0.45,0.68,0.63,1,1.22,0.34,0.46,0.11,0.13,-0.05,0.66,0.65,0.47,0.66,1.11,0.4,0.12,, +,,,,,0,4,4.97,cytosol,peptide binding,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,161.35,161.35,S608,PKKSIKKLVLKNLNNSNLFSPVNRDSENLAS,_NLNNS(ph)NLFS(ph)PVNR_, , , , ,-0.27,-1.11,-0.54,-0.14, , , , ,-1.36,-1.48,-1.57,-1.05,,,-0.63,-0.33,,,-1.42,-1.28,, +,,,,,NA,NA,,cytosol,peptide binding,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,107.25,77.2,S934,QMALNGKPAPPPQSQSPEVEQLGRVVELDSD,_PAPPPQSQS(ph)PEVEQLGR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,peptide binding,carbohydrate metabolic process,,
P52948-6,P52948,Nuclear pore complex protein Nup98-Nup96,NUP98,229.59,225.35,S888,WVFKVSHFSKYGLQDSDEEEEEHPSKTSTKK,_YGLQDS(ph)DEEEEEHPSK_,-0.09,-0.02,-0.12,-0.23,-0.07,0.04,-0.25,-0.51,-0.05,0.01,-0.09,-0.18,-0.16,-0.1,-0.44,-0.46,-0.05,-0.17,-0.01,-0.37,-0.02,-0.14,-0.13,-0.45,,,,,,,0,0,,cytosol,peptide binding,carbohydrate metabolic process,,
F8W938,O15381,Nuclear valosin-containing protein-like,NVL,50.16,46.37,S211,NPKKPITEIQDSKDSSLLESDMKRKGKLKNK,_DSS(ph)LLES(ph)DMK_, , , , , ,-0.18,0.23,-0.15, , , , , ,-0.68,-0.33,-0.17,,,-0.18,0.05,,,-0.68,-0.25,,,,,,,NA,NA,,aggresome,ATP binding,,,
F8W938,O15381,Nuclear valosin-containing protein-like,NVL,50.16,46.37,S215,PITEIQDSKDSSLLESDMKRKGKLKNKGSKR,_DSS(ph)LLES(ph)DMK_, , , , , ,-0.18,0.23,-0.15, , , , , ,-0.68,-0.33,-0.17,,,-0.18,0.05,,,-0.68,-0.25,,,,,,,NA,NA,,aggresome,ATP binding,,,
Q9NX40,Q9NX40,OCIA domain-containing protein 1,OCIAD1,193.56,193.56,S108,SYVKTCQEKFKKLENSPLGEALRSGQARRSS,_KLENS(ph)PLGEALR_,0.03,0.15,-0.28,-0.28,0.38,0.19,0,-0.1,0.32,0.45,0.38,0.38,0.05,0.02,-0.04,-0.35,0.1,-0.28,0.29,-0.05,0.39,0.38,0.04,-0.18,,,,,,,0,0,,endosome,,,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,58.98,57.62,S525,PKEGTPGSPSETPGPSPAGPAGDEPAESPSE,_EGTPGS(ph)PSETPGPS(ph)PAGPAGDEPAESPSETPGPR_, , , , ,0.14, , , , , , , ,0.31, , , ,,,0.14,,,,0.31,,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,143.62,143.24,S577,PGPRPAGPAGDEPAESPSETPGPSPAGPTRD,_PAGPAGDEPAES(ph)PSET(ph)PGPS(ph)PAGPTR_, , , , ,0.1,0.24,0.13,0.23, , , , ,-0.12,-0.02,-0.31,0.18,,,0.17,0.18,,,-0.07,-0.05,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,143.62,143.24,S585,AGDEPAESPSETPGPSPAGPTRDEPAESPSE,_PAGPAGDEPAES(ph)PSET(ph)PGPS(ph)PAGPTR_, , , , ,0.1,-0.04,-0.07,0.19, , , , ,-0.12,-0.28,-0.27,-0.1,,,0.03,0.07,,,-0.2,-0.18,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,143.62,143.24,T581,PAGPAGDEPAESPSETPGPSPAGPTRDEPAE,_PAGPAGDEPAES(ph)PSET(ph)PGPS(ph)PAGPTR_, , , , ,0.1,-0.04,-0.07,0.19, , , , ,-0.12,-0.28,-0.27,-0.1,,,0.03,0.07,,,-0.2,-0.18,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,220.96,220.96,S315,LPHPLEGSRKVEEEGSPGDPDHEASTQGRTC,_KVEEEGS(ph)PGDPDHEASTQGR_,-0.13,0.39, , ,-0.33, ,0.27, ,0.02,0.44, , ,-0.99, ,-0.33, ,0.15,,-0.33,0.27,0.25,,-0.99,-0.33,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,197.62,197.62,S378,GDEAGGHGEDRPEPLSPKESKKRKLELSRRE,_SQGDEAGGHGEDRPEPLS(ph)PK_,0.08,0.09,0.19,0.17,0.67,0.71, ,0.48,-0.01,0.04,0.19,0.12,0.5,0.76, ,0.58,0.09,0.18,0.69,0.48,0.02,0.15,0.63,0.58,,,,,,,0,0,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q9NZT2-2,Q9NZT2,Opioid growth factor receptor,OGFR,79.84,76.93,S349,HSKGGGRVDEGPQPRSVEPQDAGPLERSQGD,_S(ph)VEPQDAGPLER_,0.45,0.36,0.33, , , , ,0.65,0.46,0.26,0.32, , , , ,0.22,0.4,0.33,,0.65,0.37,0.32,,0.22,,,,,,,NA,NA,,cytoplasm,opioid receptor activity,regulation of cell growth,,
Q96CV9-3,Q96CV9,Optineurin,OPTN,103.88,102.69,S526,RQSLMEMQSRHGARTSDSDQQAYLVQRGAED,_TS(ph)DSDQQAYLVQR_, , , , , ,2.98,0.37, , , , , , ,2.71,0.74, ,,,2.98,0.37,,,2.71,0.74, +, +,,,,,NA,NA,,cytosol,,cell death,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,168.79,168.61,S351,VGSGKDQCCSGKGDMSDEDDENEFFDAPEII,_GDMS(ph)DEDDENEFFDAPEIITM(ox)PENLGHK_, , , ,-0.17, , ,-0.69,-0.93, , , ,-0.11, , ,-0.01,-0.42,,-0.17,,-0.81,,-0.11,,-0.2,,,,,,,NA,NA,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,416.16,406.91,S190,ALELAKAKAVKMLAESDESGDEESVSQTDKT,_MLAES(ph)DES(ph)GDEESVSQTDKTELQNTLR_,-0.03,0.01,-0.06,-0.04,-0.12,-0.09,-0.03,-0.05,0.02,-0.02,0.06,0.09,0.02,0,0.05,0,-0.01,-0.05,-0.1,-0.04,0,0.07,0.01,0.03,,,,,,,0,0,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,416.16,406.91,S193,LAKAKAVKMLAESDESGDEESVSQTDKTELQ,_MLAES(ph)DES(ph)GDEESVSQTDKTELQNTLR_,-0.26,-0.33,-0.68,-0.3,-0.08,-0.09,-0.13,-0.12,-0.12,0.12,0.09,-0.01,-0.02,0,0.35,0.64,-0.29,-0.48,-0.09,-0.12,0,0.04,-0.01,0.5,,,,,,,0,0,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,203.26,203.26,S379,EIITMPENLGHKRTGSNISGASSDISLDEQY,_TGS(ph)NIS(ph)GAS(ph)SDISLDEQYK_,0.57,0.77,0.08, ,0.11,0.21,0.22,0.9,-0.16,-0.17,-0.06, ,0.31,-0.13,0.43,0.33,0.67,0.08,0.16,0.6,-0.16,-0.06,0.11,0.38,,,,,,,0,0,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,203.26,203.26,S382,TMPENLGHKRTGSNISGASSDISLDEQYKHQ,_TGS(ph)NIS(ph)GAS(ph)SDISLDEQYK_,0.57,0.18,-0.5,-0.31,0.1,0.2,0.22,-0.14,-0.16,-0.11,-0.55,0.13,0.33,-0.08,0.43,-0.15,0.39,-0.4,0.15,0.05,-0.13,-0.17,0.14,0.17,,,,,,,0,0,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,203.26,203.26,S385,ENLGHKRTGSNISGASSDISLDEQYKHQLEE,_TGS(ph)NIS(ph)GAS(ph)SDISLDEQYK_,0.57,0.18,-0.5,-0.31,0.04,0.19,0.17,-0.14,-0.16,-0.11,-0.55,0.13,0.02,-0.03,0.18,-0.15,0.39,-0.4,0.12,0.02,-0.13,-0.17,-0.01,0.02,,,,,,,0,0,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,127.78,81.87,S240,NDLIAKHGTALQRSLSELESLKLPAESNEKI,_SLS(ph)ELESLK_,0.13,-0.3,0.01, , , , , ,0.02,-0.14,0.16, , , , , ,-0.07,0.01,,,-0.06,0.16,,,,,,,,,NA,NA,,Golgi membrane,oxysterol binding,lipid transport,,
P22059,P22059,Oxysterol-binding protein 1,OSBP,115.05,115.05,T377,APEIITMPENLGHKRTGSNISGASSDISLDE,_RT(ph)GSNIS(ph)GAS(ph)SDISLDEQYK_, , ,0.11, ,0.1,-0.06,0.22,-0.09, , ,-0.12, ,0.33,0.04,0.43,0.14,,0.11,0.02,0.08,,-0.12,0.19,0.29,,,,,,,NA,NA,,Golgi membrane,oxysterol binding,lipid transport,,
Q9BXB5,Q9BXB5,Oxysterol-binding protein-related protein 10,OSBPL10,263.5,263.5,S380,EPNSGSELVLSEDEKSDNEDKEETELGVMED,_S(ph)DNEDKEETELGVMEDQR_,-0.31,-0.21, ,-0.18,0.23,-0.16, ,-0.07,-0.08,-0.12, ,-0.2,-0.06,-0.25, ,0.05,-0.26,-0.18,0.05,-0.07,-0.1,-0.2,-0.15,0.05,,,,,,,0,0,,,cholesterol binding,lipid transport,,
Q9BXB4,Q9BXB4,Oxysterol-binding protein-related protein 11,OSBPL11,224.86,208.92,S181,PPLKSRSFSLASSSNSPISQRRPSQNAISFF,_SFSLAS(ph)SSNS(ph)PISQR_,-0.16,-0.09,-1.24,-1.1,-0.78,-0.82,-0.67,-0.62,0.05,0.11,-0.84,-0.93,-0.99,-1.43,-0.61,-0.53,-0.12,-1.17,-0.8,-0.64,0.08,-0.89,-1.19,-0.57, +, +,,,,,3,6,25.45,,phospholipid binding,fat cell differentiation,,
Q9BXB4,Q9BXB4,Oxysterol-binding protein-related protein 11,OSBPL11,167.36,138.19,S177,GKNNPPLKSRSFSLASSSNSPISQRRPSQNA,_SFS(ph)LAS(ph)SSNS(ph)PISQR_, , , , ,-1.19,-1.02,-1.17,-0.88, , , , ,-0.79,-0.95,-0.64,-0.75,,,-1.1,-1.02,,,-0.87,-0.69, +,,,,,,NA,NA,,,phospholipid binding,fat cell differentiation,,
Q9BXB4,Q9BXB4,Oxysterol-binding protein-related protein 11,OSBPL11,179.42,152.15,S174,EAIGKNNPPLKSRSFSLASSSNSPISQRRPS,_SFS(ph)LAS(ph)SSNS(ph)PISQR_, , , , ,0.7,0.2,0.66,0.25, , , , ,-0.15,-0.56,0.76,0.48,,,0.47,0.47,,,-0.34,0.63,,,,,,,NA,NA,,,phospholipid binding,fat cell differentiation,,
Q9BXB4,Q9BXB4,Oxysterol-binding protein-related protein 11,OSBPL11,70.34,56.83,T27,VSESEGKLEGQATAVTPNKNSSCGGGISSSS,_LEGQATAVT(ph)PNK_, , ,-0.6, ,-0.27,-0.49,-0.07,-0.14, , ,0.6, ,-0.64,0.04,-0.18,-0.26,,-0.6,-0.38,-0.1,,0.6,-0.26,-0.22,,,,,,,NA,NA,,,phospholipid binding,fat cell differentiation,,
Q9H4L5-4,Q9H4L5,Oxysterol-binding protein-related protein 3,OSBPL3,67.56,67.22,S304,IQVPKPFSGPVRLHSSNPNLSTLDFGEEKNY,_LHSS(ph)NPNLSTLDFGEEK_, , , , ,0.36, ,0.51,0.45, , , , ,0.17, ,0.39,0.45,,,0.36,0.48,,,0.17,0.42,,,,,,,NA,NA,,cytosol,cholesterol binding,lipid transport,,
Q9BZF1,Q9BZF1,Oxysterol-binding protein-related protein 8,OSBPL8,162.22,162.22,S807,KVAKGYSSPEPDIQDSSGSEAQSVKPSTRRK,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,-0.08,-0.02,-0.07,0.01,0.53,-0.55,-0.14,-0.22,-0.3,-0.25,-0.34,-0.33,0.44,-0.63,-0.44,-0.37,-0.05,-0.03,0.08,-0.18,-0.27,-0.34,0,-0.4,,,,,,,0,0,,,cholesterol binding,fat cell differentiation,,
Q9BZF1,Q9BZF1,Oxysterol-binding protein-related protein 8,OSBPL8,162.22,162.22,S808,VAKGYSSPEPDIQDSSGSEAQSVKPSTRRKK,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,-0.08,-0.02,-0.07,0.01,0.53,-0.55,-0.14,-0.22,-0.3,-0.25,-0.34,-0.33,0.44,-0.63,-0.44,-0.37,-0.05,-0.03,0.08,-0.18,-0.27,-0.34,0,-0.4,,,,,,,0,0,,,cholesterol binding,fat cell differentiation,,
Q9BZF1,Q9BZF1,Oxysterol-binding protein-related protein 8,OSBPL8,162.22,162.22,S810,KGYSSPEPDIQDSSGSEAQSVKPSTRRKKGI,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,-0.08,-0.02,-0.07,0.01,-0.3,-0.55,-0.14,-0.22,-0.3,-0.25,-0.34,-0.33,-0.39,-0.63,-0.44,-0.37,-0.05,-0.03,-0.42,-0.18,-0.27,-0.34,-0.5,-0.4,,,,,,,0,0,,,cholesterol binding,fat cell differentiation,,
Q9BZF1,Q9BZF1,Oxysterol-binding protein-related protein 8,OSBPL8,244.3,238.16,S14,__MEGGLADGEPDRTSLLGDSKDVLGPSTVV,_(ac)MEGGLADGEPDRTS(ph)LLGDSK_,0.42,0.77,0.63, ,-5.13,0.84,0.98, ,0.85,1.03,0.73, ,0.24,0.48,0.43, ,0.61,0.63,-0.13,0.98,0.94,0.73,0.36,0.43,,,,,,,0,0,,,cholesterol binding,fat cell differentiation,,
Q92882,Q92882,Osteoclast-stimulating factor 1,OSTF1,309.91,308.61,S202,SLLKKKQGTDAVRTLSNAEDYLDDEDSD___,_TLS(ph)NAEDYLDDEDS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,ossification,,
Q92882,Q92882,Osteoclast-stimulating factor 1,OSTF1,337.17,320.53,S213,VRTLSNAEDYLDDEDSD______________,_TLS(ph)NAEDYLDDEDS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,ossification,,
Q86WC4,Q86WC4,Osteopetrosis-associated transmembrane protein 1,OSTM1,116.95,113.03,S333,KRLKSSTSFANIQENSN______________,_SSTSFANIQENS(ph)N_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,RING finger,,,NA,NA,,cytosol,,ion transmembrane transport,,
Q01804-3,Q01804,OTU domain-containing protein 4,OTUD4,209.52,209.52,S1023,GANSVDSRVQRPKEESSEDENEVSNILRSGR,_VQRPKEES(ph)S(ph)EDENEVSNILR_,0.05,-0.02,0.18,0.23,-0.06,0.06,0.08,-0.12,-0.06,-0.12,0.17,0.12,0.09,0.25,0.03,-0.29,0.01,0.21,0,-0.02,-0.09,0.14,0.17,-0.12,,,,,Otubain Proteases ,,0,0,,,,,,
Q01804-3,Q01804,OTU domain-containing protein 4,OTUD4,209.52,209.52,S1024,ANSVDSRVQRPKEESSEDENEVSNILRSGRS,_VQRPKEES(ph)S(ph)EDENEVSNILR_,0.05,-0.02,0.18,0.23,-0.06,0.06,-0.9,0.07,-0.06,-0.12,0.17,0.12,0.09,0.25,0.03,0.06,0.01,0.21,0,-0.34,-0.09,0.14,0.17,0.04,,,,,Otubain Proteases ,,0,0,,,,,,
Q01804-3,Q01804,OTU domain-containing protein 4,OTUD4,112.34,100.42,S443,EDFDHTSRESNYFGLSPEERREKQAIEESRL,_ESNYFGLS(ph)PEER_,-0.09,-0.07,-0.15,-0.16,0.3,-0.17,-0.42,-0.27,-0.4,-0.3,-0.46,-0.4,-0.03,0.25,-0.32,-0.36,-0.08,-0.15,0.09,-0.34,-0.35,-0.43,0.11,-0.34,,,,,Otubain Proteases ,,0,0,,,,,,
Q01804-3,Q01804,OTU domain-containing protein 4,OTUD4,118.76,98.51,S893,QNIVLPSDEKGELDLSLENLDLSKDCGSVST,_GELDLS(ph)LENLDLS(ph)K_, , , , , , ,-0.75, , , , , , , ,-0.63, ,,,,-0.75,,,,-0.63,,,,,Otubain Proteases ,,NA,NA,,,,,,
Q01804-3,Q01804,OTU domain-containing protein 4,OTUD4,118.76,98.51,S900,DEKGELDLSLENLDLSKDCGSVSTVDEFPEA,_GELDLS(ph)LENLDLS(ph)K_, , , , , , ,-0.75, , , , , , , ,-0.63, ,,,,-0.75,,,,-0.63,,,,,Otubain Proteases ,,NA,NA,,,,,,
Q96G74-2,Q96G74,OTU domain-containing protein 5,OTUD5,176.08,175.23,S165,KRRRQAPGVGAVGGGSPEREEVGAGYNSEDE,_(gl)QAPGVGAVGGGS(ph)PEREEVGAGYNS(ph)EDEYEAAAAR_,-0.13, ,0.07, ,-0.13,-0.02,0.05,0.05,-0.31, ,0.09, ,-0.31,-0.17,-0.08,-0.2,-0.13,0.07,-0.07,0.05,-0.31,0.09,-0.24,-0.14,,,,,Otubain Proteases ,,0,0,,cytosol,ubiquitin-specific protease activity,innate immune response,,
Q96G74-2,Q96G74,OTU domain-containing protein 5,OTUD5,176.08,175.23,S177,GGGSPEREEVGAGYNSEDEYEAAAARIEAMD,_(gl)QAPGVGAVGGGS(ph)PEREEVGAGYNS(ph)EDEYEAAAAR_,-0.13, ,0.07, ,-0.13,-0.02,0.05,0.05,-0.31, ,0.09, ,-0.31,-0.17,-0.08,-0.2,-0.13,0.07,-0.07,0.05,-0.31,0.09,-0.24,-0.14,,,,,Otubain Proteases ,,0,0,,cytosol,ubiquitin-specific protease activity,innate immune response,,
F5H4P2,Q6GQQ9,OTU domain-containing protein 7B,OTUD7B,269.11,263.88,Y779,LLPPPYRVADSYSNGYREPPEPDGWAGGLRG,_VADSYSNGY(ph)REPPEPDGWAGGLR_,4.59, , , , , , , ,4.31, , , , , , , ,4.59,,,,4.31,,,, +, +,,ZnF_A22,Otubain Proteases ,,NA,NA,,,,,,
H0YAZ6,Q8N573,Oxidation resistance protein 1,OXR1,250.94,242.84,S201,TPSSTFTGIRPARVVSSTSEEEEAFTEKFLK,_VVS(ph)S(ph)TSEEEEAFTEK_, , , , ,2.01,-0.65,1.79,0.91, , , , ,2.05,-0.07,1.96,1.27,,,1.22,1.42,,,1.35,1.66, +, +,,,,,NA,NA,,,,,,
H0YAZ6,Q8N573,Oxidation resistance protein 1,OXR1,250.94,242.84,S202,PSSTFTGIRPARVVSSTSEEEEAFTEKFLKI,_VVS(ph)S(ph)TSEEEEAFTEK_, , , , ,2.01,-0.65, , , , , , ,2.05,-0.07, , ,,,1.22,,,,1.35,, +, +,,,,,NA,NA,,,,,,
H0YAZ6,Q8N573,Oxidation resistance protein 1,OXR1,183.06,182.43,S204,STFTGIRPARVVSSTSEEEEAFTEKFLKINC,_VVS(ph)STS(ph)EEEEAFTEK_, , , , , , ,1.79,2.18, , , , , , ,1.96,2.48,,,,2,,,,2.24, +, +,,,,,NA,NA,,,,,,
O95747,O95747,Serine/threonine-protein kinase OSR1,OXSR1,329.41,325.29,S339,SSGRLHKTEDGGWEWSDDEFDEESEEGKAAI,_TEDGGWEWS(ph)DDEFDEESEEGK_, ,-0.3,-0.58, ,-0.2,-0.36,-0.28,-0.28, ,-0.01,-0.21, ,-0.12,-0.2,-0.13,-0.09,-0.3,-0.58,-0.28,-0.28,-0.01,-0.21,-0.16,-0.11,,,STE,,,,0,0,,cytoplasm,ATP binding,intracellular protein kinase cascade,,
Q9BTK6,Q9BTK6,PAXIP1-associated protein 1,PA1,335.74,329.78,S237,GRDLFSLDSEDPSPASPPLRSSGSSLFPRQR,_DLFSLDSEDPSPAS(ph)PPLR_,0.32,0.39,0.12,0.42,-0.02,0.32,0.12, ,0.02,-0.13,0.27,0.34,-0.66,0.35,0.02, ,0.36,0.28,0.16,0.12,-0.05,0.3,-0.07,0.02,,,,,,,0,0,,histone methyltransferase complex,,,,
Q9BTK6,Q9BTK6,PAXIP1-associated protein 1,PA1,181.58,169.36,S143,QAEILPRRPPTPEAQSEEERSDEEPEAKEEE,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_, , , , ,0,0,0.14,-0.13, , , , ,-0.2,0.08,-0.04,0.09,,,0,0.01,,,-0.06,0.03,,,,,,,NA,NA,,histone methyltransferase complex,,,,
Q9BTK6,Q9BTK6,PAXIP1-associated protein 1,PA1,181.58,169.36,S148,PRRPPTPEAQSEEERSDEEPEAKEEEEEKPH,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_, , , , ,0,0,0.14,-0.13, , , , ,-0.2,0.08,-0.04,0.09,,,0,0.01,,,-0.06,0.03,,,,,,,NA,NA,,histone methyltransferase complex,,,,
Q9BTK6,Q9BTK6,PAXIP1-associated protein 1,PA1,181.58,169.36,T138,GTLELQAEILPRRPPTPEAQSEEERSDEEPE,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_, , , , ,0,0,0.14,-0.13, , , , ,-0.2,0.08,-0.04,0.09,,,0,0.01,,,-0.06,0.03,,,,,,,NA,NA,,histone methyltransferase complex,,,,
Q9UQ80,Q9UQ80,Proliferation-associated protein 2G4,PA2G4,199.86,195.77,T386,KKKASKTAENATSGETLEENEAGD_______,_TAENATSGET(ph)LEENEAGD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,DNA binding,cell cycle arrest,,
Q9UQ80,Q9UQ80,Proliferation-associated protein 2G4,PA2G4,303.04,299.24,S2,______________MSGEDEQQEQTIAEDLV,_(ac)S(ph)GEDEQQEQTIAEDLVVTK_,0.13,0.2,0.12,0.18,-0.14,-0.09,-0.07,-0.05,0.16,0.2,0.1,0.11,-0.12,-0.04,-0.03,-0.03,0.16,0.15,-0.11,-0.06,0.18,0.1,-0.08,-0.03,,,,,,,0,0,,cytoplasm,DNA binding,cell cycle arrest,,
Q86U42-2,Q86U42,Polyadenylate-binding protein 2,PABPN1,127.2,126.01,S150,KLKELQNEVEKQMNMSPPPGNAGPVIMSIEE,_QMNMS(ph)PPPGNAGPVIMSIEEK_, , , , ,-0.54,-0.43, , , , , , ,-0.24,-0.25,-0.62, ,,,-0.48,,,,-0.25,-0.62,,,,,,,NA,NA,,cytoplasm,nucleotide binding,modification by virus of host mRNA processing,,
Q6VY07,Q6VY07,Phosphofurin acidic cluster sorting protein 1,PACS1,97.24,60.94,S430,IGSLNSKGSLGKDTTSPMELAALEKIKSTWI,_DTTS(ph)PMELAALEK_,-0.19,0.2,-0.25,-0.12,-0.15,0.5, ,0.14,0.69,-0.17,0.1,0.26,0.23,0.67, ,-0.31,0.02,-0.18,0.21,0.14,0.32,0.18,0.47,-0.31,,,,,,,0,0,,COPI-coated vesicle,,protein targeting to Golgi,,
Q6VY07,Q6VY07,Phosphofurin acidic cluster sorting protein 1,PACS1,125.49,122.43,S529,KERQLSKPLSERTNSSDSERSPDLGHSTQIP,_TNSS(ph)DSERS(ph)PDLGHSTQIPR_,0.15,0.16,0.3,0.53, , , , ,-0.14,-0.3,-0.37,-0.13, , , , ,0.15,0.42,,,-0.22,-0.25,,,,,,,,,NA,NA,,COPI-coated vesicle,,protein targeting to Golgi,,
Q6VY07,Q6VY07,Phosphofurin acidic cluster sorting protein 1,PACS1,125.49,122.43,S534,SKPLSERTNSSDSERSPDLGHSTQIPRKVVY,_TNSS(ph)DSERS(ph)PDLGHSTQIPR_,0.15, ,0.2,0.53, , , , ,-0.14, ,-0.39,-0.13, , , , ,0.15,0.37,,,-0.14,-0.26,,,,,,,,,NA,NA,,COPI-coated vesicle,,protein targeting to Golgi,,
Q9UNF0,Q9UNF0,Protein kinase C and casein kinase substrate in neurons protein 2,PACSIN2,160.52,160.26,S399,NVSSYEKTQSYPTDWSDDESNNPFSSTDANG,_TQSYPTDWS(ph)DDESNNPFSSTDANGDSNPFDDDATSGTEVR_, , , , ,-0.14,-0.65, , , , , , ,0.29,-0.21, , ,,,-0.37,,,,0.06,,,,,,,,NA,NA,,caveola,lipid binding,actin cytoskeleton organization,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,61.74,57.47,S341,TSIVPTRDGTAPPPQSPGSPGTGQDEEWSDE,_DGTAPPPQS(ph)PGSPGTGQDEEWS(ph)DEESPRK_, , , , ,0.92, , , , , , , ,1.42, , , ,,,0.92,,,,1.42,,, +,,,,,NA,NA,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,112.7,112.7,S344,VPTRDGTAPPPQSPGSPGTGQDEEWSDEESP,_DGTAPPPQSPGS(ph)PGTGQDEEWSDEES(ph)PRK_, , , , ,0.01,0.02, , , , , , ,-0.3,-0.57, , ,,,0.01,,,,-0.43,,,,,,,,NA,NA,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,252.73,252.73,S354,PQSPGSPGTGQDEEWSDEESPRKAATGVRVR,_DGTAPPPQSPGSPGTGQDEEWS(ph)DEES(ph)PRK_,0.26,0.24,0.1,0.04,-0.08,0.34,0.22,0.16,0.01,0.03,-0.17,-0.18,0.43,0.15,-0.38,-0.06,0.25,0.07,0.15,0.19,0.02,-0.18,0.3,-0.21,,,,,,,0,0,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,127.68,127.68,S358,GSPGTGQDEEWSDEESPRKAATGVRVRALYD,_DGTAPPPQSPGSPGTGQDEEWS(ph)DEES(ph)PRK_,-0.11,-0.18,-0.3, ,0.05,-0.07,0.04,0.03,0.39,0.18,0.16, ,-0.04,0.07,0.03,0.03,-0.15,-0.3,-0.01,0.04,0.29,0.16,0.02,0.03,,,,,,,0,0,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,78.35,74.72,S276,FHELHRDLHQGIEAASDEEDLRWWRSTHGPG,_DLHQGIEAAS(ph)DEEDLR_, , , , , ,-0.12, ,0.31, , , , , ,-0.13, ,-0.91,,,-0.12,0.31,,,-0.13,-0.91,,,,,,,NA,NA,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q9UKS6,Q9UKS6,Protein kinase C and casein kinase substrate in neurons protein 3,PACSIN3,115.54,107.62,S319,LDTQRTISRKEKGGRSPDEVTLTSIVPTRDG,_GGRS(ph)PDEVTLTSIVPTR_,0.2,0.25,0.21,0.24,-0.11, , , ,-0.07,-0.04,-0.05,-0.17,-0.08, , , ,0.23,0.22,-0.11,,-0.06,-0.11,-0.08,,,,,,,,NA,NA,,cytoplasm,calcium channel inhibitor activity,endocytosis,,
Q8N7H5,Q8N7H5,RNA polymerase II-associated factor 1 homolog,PAF1,255.02,255.02,S456,EDEARAARDKEEIFGSDADSEDDADSDDEDR,_EEIFGS(ph)DADS(ph)EDDADS(ph)DDEDR_, , , , ,-0.14,-0.09,-0.21,-0.16, , , , ,-0.12,-0.19,-0.18,-0.31,,,-0.12,-0.19,,,-0.16,-0.24,,,,,,,NA,NA,,Cdc73/Paf1 complex,chromatin binding,cellular response to lipopolysaccharide,,
Q8N7H5,Q8N7H5,RNA polymerase II-associated factor 1 homolog,PAF1,255.02,255.02,S460,RAARDKEEIFGSDADSEDDADSDDEDRGQAQ,_EEIFGS(ph)DADS(ph)EDDADS(ph)DDEDR_, , , , ,-0.14,-0.09,-0.21,-0.16, , , , ,-0.12,-0.19,-0.18,-0.31,,,-0.12,-0.19,,,-0.16,-0.24,,,,,,,NA,NA,,Cdc73/Paf1 complex,chromatin binding,cellular response to lipopolysaccharide,,
Q8N7H5,Q8N7H5,RNA polymerase II-associated factor 1 homolog,PAF1,255.02,255.02,S466,EEIFGSDADSEDDADSDDEDRGQAQGGSDND,_EEIFGS(ph)DADS(ph)EDDADS(ph)DDEDR_, , , , ,-0.14,-0.09,-0.21,-0.16, , , , ,-0.12,-0.19,-0.18,-0.31,,,-0.12,-0.19,,,-0.16,-0.24,,,,,,,NA,NA,,Cdc73/Paf1 complex,chromatin binding,cellular response to lipopolysaccharide,,
P68402,P68402,Platelet-activating factor acetylhydrolase IB subunit beta,PAFAH1B2,168.52,168.52,S2,______________MSQGDSNPAAIPHAAED,_(ac)S(ph)QGDSNPAAIPHAAEDIQGDDRWMSQHNR_,0.12,0.2,-0.33,-0.3,-0.14, ,-0.07, ,0.23,0.34,-0.1,-0.28,0.03, ,-0.15, ,0.16,-0.32,-0.14,-0.07,0.28,-0.19,0.03,-0.15,,,,,,,0,0,,cytoplasm,1-alkyl-2-acetylglycerophosphocholine esterase activity,brain development,,
O75459,O75459,G antigen family B member 1,PAGE1,196.14,194.73,S105,EQMKLPAEGPEPEADSQEQVHPKTGCERGDG,_LPAEGPEPEADS(ph)QEQVHPK_, ,-0.11, , ,-0.73,-1.11,-0.89,-1.43, ,-0.15, , ,-0.27,-0.33,-0.23,0.06,-0.11,,-0.91,-1.13,-0.15,,-0.3,-0.08, +,,,,,,NA,NA,,,,cellular defense response,,
O75459,O75459,G antigen family B member 1,PAGE1,141.38,140.48,S63,DEGASAAQGQEPEADSQELVQPKTGCELGDG,_EDEGASAAQGQEPEADS(ph)QELVQPK_, , , , ,-0.87,-1.07,-0.86,-0.87, , , , ,-0.14,-0.16,-0.11,-0.09,,,-0.97,-0.87,,,-0.15,-0.1,,,,,,,NA,NA,,,,cellular defense response,,
O75459,O75459,G antigen family B member 1,PAGE1,117.16,115.25,S19,LRRLIYRRRPMIYVESSEESSDEQPDEVESP,_RRPMIYVES(ph)S(ph)EES(ph)SDEQPDEVESPTQSQDSTPAEER_, , , , , , , ,-0.59, , , , , , , ,-0.13,,,,-0.59,,,,-0.13,,,,,,,NA,NA,,,,cellular defense response,,
O75459,O75459,G antigen family B member 1,PAGE1,117.16,115.25,S20,RRLIYRRRPMIYVESSEESSDEQPDEVESPT,_RRPMIYVES(ph)S(ph)EES(ph)SDEQPDEVESPTQSQDSTPAEER_, , , , , , , ,-0.59, , , , , , , ,-0.13,,,,-0.59,,,,-0.13,,,,,,,NA,NA,,,,cellular defense response,,
P22234,P22234,Multifunctional protein ADE2,PAICS,218.12,210.85,S27,KLYEGKTKEVYELLDSPGKVLLQSKDQITAG,_EVYELLDS(ph)PGK_,-0.18,-0.19,-0.29,-0.35,-0.53,-0.4,-0.51,-0.47,-0.03,0.05,0.03,0.05,-0.48,-0.36,-0.69,-0.76,-0.18,-0.32,-0.46,-0.49,0.01,0.04,-0.42,-0.72,,,,,,,0,0,,cytosol,5-(carboxyamino)imidazole ribonucleotide mutase activity,de novo' IMP biosynthetic process,,
P22234,P22234,Multifunctional protein ADE2,PAICS,106.62,52.87,S107,EMIPIEWVCRRIATGSFLKRNPGVKEGYKFY,_IATGS(ph)FLK_,0.28,0.05,0.21,0.18, , , ,0.24,0.27,0.13,0.12,0.19, , , ,-0.04,0.17,0.19,,0.24,0.2,0.15,,-0.04,,,,,,,NA,NA,,cytosol,5-(carboxyamino)imidazole ribonucleotide mutase activity,de novo' IMP biosynthetic process,,
E9PM17,Q13153,Serine/threonine-protein kinase PAK 1,PAK1,101.9,83.67,S144,EFYNSKKTSNSQKYMSFTDKSAEDYNSSNAL,_YMS(ph)FTDK_,0.56,0.5,0.55,0.54,0.55,0.64,0.56,0.52,0.34,0.37,0.42,0.43,0.37,0.21,0.33,0.49,0.53,0.55,0.6,0.54,0.36,0.43,0.29,0.41,,,STE,,,,0,0,,axon,ATP binding,cellular response to insulin stimulus,,
E9PM17,Q13153,Serine/threonine-protein kinase PAK 1,PAK1,134.53,134.29,T230,RDVATSPISPTENNTTPPDALTRNTEKQKKK,_DVATSPISPTENNTT(ph)PPDALTR_,0.03,0.11,-0.24, , , ,-0.16, ,0.07,0.03,-0.15, , , ,0.03, ,0.07,-0.24,,-0.16,0.05,-0.15,,0.03,,,STE,,,,NA,NA,,axon,ATP binding,cellular response to insulin stimulus,,
Q13177,Q13177,Serine/threonine-protein kinase PAK 2,PAK2,68.58,61.95,S152,QKYLSFTPPEKDGFPSGTPALNAKGTEAPAV,_DGFPS(ph)GTPALNAK_,-0.68, , , ,0.96,0.97,0.4, ,-0.43, , , ,0.57,0.51,0.31, ,-0.68,,0.97,0.4,-0.43,,0.54,0.31,,,STE,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
Q13177,Q13177,Serine/threonine-protein kinase PAK 2,PAK2,273.78,273.78,S2,______________MSDNGELEDKPPAPPVR,_(ac)S(ph)DNGELEDKPPAPPVR_,0.11,-0.02,-0.14,-0.07,-0.07,-0.15,0,0.04,-0.09,-0.1,-0.1,-0.12,-0.42,-0.35,-0.25,-0.2,0.05,-0.1,-0.11,0.02,-0.1,-0.11,-0.38,-0.23,,,STE,,,,0,0,,cytosol,ATP binding,axon guidance,,
Q13177,Q13177,Serine/threonine-protein kinase PAK 2,PAK2,187.76,187.76,S141,VLKFYDSNTVKQKYLSFTPPEKDGFPSGTPA,_YLS(ph)FT(ph)PPEK_,-0.07,0.04,-0.01,-0.02,0.01,0.15,0.11,0.21,-0.08,-0.03,-0.01,-0.05,0.01,0.03,0.1,0.12,-0.01,-0.01,0.08,0.16,-0.05,-0.03,0.02,0.11,,,STE,,,,0,0,,cytosol,ATP binding,axon guidance,,
Q13177,Q13177,Serine/threonine-protein kinase PAK 2,PAK2,142.08,140.07,T143,KFYDSNTVKQKYLSFTPPEKDGFPSGTPALN,_YLS(ph)FT(ph)PPEK_,0.53,0.57,0.71,0.73,0.63,0.61,0.46,0.53,-0.02,-0.01,0.25,0.12,0.45,0.42,0.5,0.45,0.55,0.72,0.62,0.5,-0.01,0.18,0.43,0.47,,,STE,,,,0,0,,cytosol,ATP binding,axon guidance,,
Q8WX93-3,Q8WX93,Palladin,PALLD,96.5,94.01,S766,TPASSPSSSSLPSPMSPTPRQFGRAPVPPFA,_QFIAAQNLGPASGHGTPASSPSS(ph)SSLPSPMS(ph)PTPR_, , ,1.63,0.83, , , , , , ,2.25,1.41, , , , ,,1.28,,,,1.89,,, +, +,,,,,NA,NA,,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,180.11,138.87,S893,PAGFPKKASRTARIASDEEIQGTKDAVIQDL,_IAS(ph)DEEIQGTK_,-1.1, ,2.32,2.44,2.45,2.2,2.3,2.03,-0.48, ,2.55,2.82,2.73,2.47,2.57,2.54,-1.1,2.38,2.33,2.17,-0.48,2.69,2.6,2.56, +, +,,,,,1,1,40.3,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,202.76,202.76,S1118,RSPSGHPHVRRPRSRSRDSGDENEPIQERFF,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,-0.57,-0.48,-1.19,-1.29,-0.44,-1.58,-1.16,-0.87,-0.48,-0.29,-1.09,-1.17,-0.04,-0.81,-0.78,-0.55,-0.52,-1.24,-0.9,-1.01,-0.38,-1.13,-0.38,-0.66, +, +,,,,,3,3,21.39,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,202.76,202.76,S1121,SGHPHVRRPRSRSRDSGDENEPIQERFFRPH,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,-0.57,-0.48,-0.41,-0.83,-0.44,-2.08,-1.16,-0.87,-0.48,-0.29,-0.23,-0.56,-0.04,-0.98,-0.78,-0.55,-0.52,-0.61,-1.04,-1.01,-0.38,-0.39,-0.44,-0.66, +,,,,,,6,0,22.12,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,139.49,134.03,Y731,ASRSAPAMQSSGSFNYARPKQFIAAQNLGPA,_SAPAMQSSGSFNY(ph)ARPK_,0.8, ,0.22, ,-0.57, ,-0.24,-0.06,0.28, ,-0.14, ,-0.5, ,0.12,0.09,0.8,0.22,-0.57,-0.15,0.28,-0.14,-0.5,0.1,,,,,,,0,0,,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,115.57,112.25,S641,KANSNKSLPTPAVLLSPTKEPPPLLAKPKLD,_SLPTPAVLLS(ph)PTK_,0.01,0.03,0.65, ,0.72,0.78,0.62,0.47,-0.26,-0.26,0.69, ,0.9,1.01,0.76,0.52,0.02,0.65,0.75,0.55,-0.26,0.69,0.96,0.64,,,,,,,0,0,,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q8WX93-3,Q8WX93,Palladin,PALLD,202.76,202.76,S1116,SPRSPSGHPHVRRPRSRSRDSGDENEPIQER,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,-1.03,-0.64,-0.41,-0.83,-0.12,-0.48,-0.5,-0.33,-1.02,-0.42,-0.23,-0.56,-0.05,-0.38,-0.31,0.04,-0.82,-0.61,-0.29,-0.41,-0.69,-0.39,-0.2,-0.12,,,,,,,0,0,,actin filament,muscle alpha-actinin binding,cytoskeleton organization,,
Q9NP74-3,Q9NP74,Palmdelphin,PALMD,155.76,140.87,Y262,SERNSKSPTEYHEPVYANPFYRPTTPQRETV,_SPTEYHEPVY(ph)ANPFYRPTTPQR_,0.27, ,0.11, , , ,0.64,0.03,-0.03, ,-0.34, , , ,0.54,0.27,0.27,0.11,,0.37,-0.03,-0.34,,0.41,,,,,,,NA,NA,,cytoplasm,,regulation of cell shape,,
H0Y9I4,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,165.53,164.08,S955,RLSTEGSDQEKEDDGSESEEEYSAPLPALAP,_EDDGS(ph)ES(ph)EEEYSAPLPALAPSSS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
H0Y9I4,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,165.53,164.08,S957,STEGSDQEKEDDGSESEEEYSAPLPALAPSS,_EDDGS(ph)ES(ph)EEEYSAPLPALAPSSS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q9BZ23-3,Q9BZ23,"Pantothenate kinase 2, mitochondrial",PANK2,65.65,62.15,S189,AVGASAEGTRRDRLGSYSGPTSVSRQRVESL,_LGS(ph)YSGPTSVSR_, , , , , , ,2.49, , , , , , , ,1.9, ,,,,2.49,,,,1.9, +, +,,,,,NA,NA,,mitochondrial intermembrane space,ATP binding,cell death,,
E9PHT6,Q9NVE7,Pantothenate kinase 4,PANK4,104.9,86.08,T406,SASPELGPAQRARSGTFDLLEMDRLERPLVD,_SGT(ph)FDLLEMDR_, , , , , ,1.58,1.77, , , , , , ,0.34,1.24, ,,,1.58,1.77,,,0.34,1.24, +, +,,,,,NA,NA,,,ATP binding,coenzyme A biosynthetic process,,
Q5VWV2,Q8TEW0,Partitioning defective 3 homolog,PARD3,124.46,124.15,Y719,ETALDDRERRISHSLYSGIEGLDESPSRNAA,_ISHSLY(ph)SGIEGLDESPSR_,0.06, ,0.77, ,-0.54, ,-0.02, ,0.3, ,0.16, ,-0.21, ,1.12, ,0.06,0.77,-0.54,-0.02,0.3,0.16,-0.21,1.12,, +,,,,,0,2,1.19,,,,,
Q5VWV2,Q8TEW0,Partitioning defective 3 homolog,PARD3,66.54,66.37,Y1127,ARPQSPREGHMMDALYAQVKKPRNSKPSPVD,_EGHMMDALY(ph)AQVK_, , ,0.56, , , ,0.18,0.55, , ,0.75, , , ,0.43,0.9,,0.56,,0.37,,0.75,,0.69,,,,,,,NA,NA,,,,,,
Q5VWV2,Q8TEW0,Partitioning defective 3 homolog,PARD3,157.56,157.56,Y1080,AKTREFRERQARERDYAEIQDFHRTFGCDDE,_ERDY(ph)AEIQDFHR_,-0.57, ,0.05, ,-0.29,-0.46,-0.12,-0.11,-0.55, ,0.21, ,-0.39,-0.43,0.33,0.38,-0.57,0.05,-0.37,-0.12,-0.55,0.21,-0.41,0.35,,,,,,,0,0,,,,,,
Q5VWV2,Q8TEW0,Partitioning defective 3 homolog,PARD3,130.47,109.41,S852,SDASQLDFVKTRKSKSMDLGIADETKLNTVD,_S(ph)MDLGIADETK_,0,0.02,-0.43, ,-0.15,0.36,0.28,0.18,-0.06,0.04,-0.27, ,-0.2,-0.01,0.27,0.17,0.01,-0.43,0.12,0.23,-0.01,-0.27,-0.1,0.22,,,,,,,0,0,,,,,,
Q5VWV2,Q8TEW0,Partitioning defective 3 homolog,PARD3,78.9,59.59,Y388,EKNNYYSSRFSPDSQYIDNRSVNSAGLHTVQ,_FSPDSQY(ph)IDNR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q86W56-3,Q86W56,Poly(ADP-ribose) glycohydrolase,PARG,205.78,205.78,S137,NVEKLENVSQLSLDKSPTEKSTQYLNQHQTA,_LENVSQLSLDKS(ph)PTEK_,0.25,-0.32,0.03,0.17, , , , ,0.08,-0.14,0.25,0.19, , , , ,0,0.1,,,-0.03,0.22,,,,,,,,,NA,NA,,cytoplasm,poly(ADP-ribose) glycohydrolase activity,carbohydrate metabolic process,,
B4DDG8,O95453,Poly(A)-specific ribonuclease PARN,PARN,87.57,34.97,S619,GRKKAKKLKRMKKELSPAGSISKNSPATLFE,_ELS(ph)PAGSISK_,-0.44,-0.13, ,0.19,0.06,-0.12,0.41,0.15,-0.56,-0.21, ,0.12,0.1,-0.01,0.27,0.19,-0.28,0.19,-0.03,0.29,-0.37,0.12,0.04,0.23,,,,,,,0,0,,,,,,
Q86TB9-2,Q86TB9,Protein PAT1 homolog 1,PATL1,96.45,55.65,S179,DDRDLSERALPRRSTSPIIGSPPVRAVPIGT,_STS(ph)PIIGS(ph)PPVR_,0.78, , , ,-0.18,-0.58,-0.21,-0.17,0.14, , , ,-0.17,-0.76,-0.15,0.03,0.78,,-0.36,-0.19,0.14,,-0.43,-0.06,,,,,,,NA,NA,,cytoplasmic mRNA processing body,poly(G) RNA binding,cytoplasmic mRNA processing body assembly,,
Q86TB9-2,Q86TB9,Protein PAT1 homolog 1,PATL1,96.45,55.65,S184,SERALPRRSTSPIIGSPPVRAVPIGTPPKQM,_ST(ph)S(ph)PIIGS(ph)PPVR_,0.49,0.92,0.22,-1.06,0.75,0.92,0.76,0.6,-0.07,0.19,-0.29,-1.06,0.46,0.4,0.31,0.18,0.72,-0.28,0.84,0.69,0.07,-0.63,0.43,0.25,,,,,,,0,0,,cytoplasmic mRNA processing body,poly(G) RNA binding,cytoplasmic mRNA processing body assembly,,
Q86U86-6,Q86U86,Protein polybromo-1,PBRM1,83.08,82.01,S636,KRKELGPLPDDDDMASPKLKLSRKSGISPKK,_ELGPLPDDDDMAS(ph)PK_,-0.21,-0.34,-0.41, , , , ,-0.51,-0.13,0.21,-0.05, , , , ,-0.51,-0.28,-0.41,,-0.51,0.05,-0.05,,-0.51,,,,,,,NA,NA,,kinetochore,chromatin binding,chromatin remodeling,,
Q86U86-6,Q86U86,Protein polybromo-1,PBRM1,238.18,237.67,S178,DEDGQDNQGTVTEGSSPAYLKEILEQLLEAI,_GEADDEDDDEDGQDNQGTVTEGSS(ph)PAYLK_,-0.28,-0.28,-0.78, ,-0.7, , , ,0.23,0.08,-0.18, ,-0.19, , , ,-0.28,-0.78,-0.7,,0.15,-0.18,-0.19,,,,,,,,NA,NA,,kinetochore,chromatin binding,chromatin remodeling,,
P40425,P40425,Pre-B-cell leukemia transcription factor 2,PBX2,72.67,72.21,S429,VTSPTEGPGSVHSDTSN______________,_ANGSWQEAVTPSSVTSPTEGPGSVHSDT(ph)S(ph)N_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,chromatin binding,embryonic limb morphogenesis,,
F8VYL7,Q15366,Poly(rC)-binding protein 2,PCBP2,258.13,239.2,S188,SPPKGVTIPYRPKPSSSPVIFAGGQDRYSTG,_PSS(ph)SPVIFAGGQDR_,-0.14,-0.14,-0.56,-0.56,-0.65,-0.63,-0.47,-0.41,-0.27,0.01,-0.59,-0.61,-0.75,-0.83,-0.62,-0.46,-0.14,-0.56,-0.64,-0.44,-0.12,-0.6,-0.79,-0.54,,,,,,,0,0,,,,,,
F8VYL7,Q15366,Poly(rC)-binding protein 2,PCBP2,253.59,237.18,S189,PPKGVTIPYRPKPSSSPVIFAGGQDRYSTGS,_PSSS(ph)PVIFAGGQDR_,-0.19,-0.16,-0.49,-0.54,-0.62,-0.64,-0.47,-0.47,-0.34,-0.24,-0.64,-0.58,-0.8,-0.66,-0.51,-0.56,-0.17,-0.52,-0.63,-0.47,-0.29,-0.61,-0.73,-0.53,,,,,,,0,0,,,,,,
F8VYL7,Q15366,Poly(rC)-binding protein 2,PCBP2,177.09,176.35,S272,PMTHGNTGFSGIESSSPEVKGYWGLDASAQT,_LHQLAMQQSHFPMTHGNTGFSGIESSS(ph)PEVK_, , , , ,0.01, , , , , , , ,0.45, , , ,,,0.01,,,,0.45,,,,,,,,NA,NA,,,,,,
F5GWJ1,O60245,Protocadherin-7,PCDH7,65.18,44.37,S989,SPSMGRYRSVNGGPGSPDLARHYKSSSPLPT,_SVNGGPGS(ph)PDLAR_,0,-0.15,-0.19, ,-0.33,-0.17, ,-0.57,-0.15,-0.2,-0.11, ,-0.2,-0.11, ,-0.3,-0.07,-0.19,-0.25,-0.57,-0.17,-0.11,-0.16,-0.3,,,,,,,0,0,,integral to membrane,calcium ion binding,homophilic cell adhesion,,
Q9BYE7-3,Q9BYE7,Polycomb group RING finger protein 6,PCGF6,69.98,29.96,S115,DMSHFSLRLEGGRQDSEDEEERLINLSELTP,_LEGGRQDS(ph)EDEEER_, , , , , , , ,0.01, , , , , , , ,-0.53,,,,0.01,,,,-0.53,,,,RING finger,,,NA,NA,,PRC1 complex,DNA binding,"negative regulation of transcription, DNA-dependent",,
Q9H4Z3,Q9H4Z3,Phosphorylated CTD-interacting factor 1,PCIF1,62.71,62.71,S159,SPSIPGTPTLKMWGTSPEDKQQAALLRPTEV,_MWGTS(ph)PEDK_,-0.2,-0.28,-0.13,0.15, , ,-0.21, ,-0.02,-0.16,0.22,-0.04, , ,-0.13, ,-0.24,0.01,,-0.21,-0.09,0.09,,-0.13,,,,,,,NA,NA,,actin cytoskeleton,,negative regulation of phosphatase activity,,
Q9H4Z3,Q9H4Z3,Phosphorylated CTD-interacting factor 1,PCIF1,61.62,35.64,S116,VETPPAENKPRKRQLSEEQPSGNGVKKPKIE,_(gl)QLS(ph)EEQPSGNGVK_, , , , , ,0.78,0.81, , , , , , ,0.62,0.16, ,,,0.78,0.81,,,0.62,0.16,,,,,,,NA,NA,,actin cytoskeleton,,negative regulation of phosphatase activity,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,74.41,73.22,S68,GVESDKRVTNDISPESSPGVGRRRTKTPHTF,_RVTNDIS(ph)PES(ph)SPGVGR_, , , , ,0.31,0.03, ,-1.58, , , , ,-0.18,-0.6, ,-2.09,,,0.18,-1.58,,,-0.38,-2.09, +, +,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,145.02,143.16,S93,KTPHTFPHSRYMSQMSVPEQAELEKLKQRIN,_YMSQMS(ph)VPEQAELEK_, , ,2.05, , , , , , , ,2.38, , , , , ,,2.05,,,,2.38,,, +, +,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,98.54,95.29,S65,KKFGVESDKRVTNDISPESSPGVGRRRTKTP,_RVTNDIS(ph)PESSPGVGR_,-0.09,-0.22,0.42,0.49,-0.16,-0.38,-0.52,-1.4,-0.12,-0.82,0.29,-0.4,-0.44,-0.76,-0.8,-1.94,-0.15,0.45,-0.26,-0.9,-0.43,-0.01,-0.59,-1.26,, +,,,,,0,6,25.39,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,72.17,71.66,S69,VESDKRVTNDISPESSPGVGRRRTKTPHTFP,_RVTNDIS(ph)PESS(ph)PGVGR_, , , , ,-0.16,-0.79,-0.52,-1.17, , , , ,-0.44,-0.91,-0.8,-1.49,,,-0.44,-0.81,,,-0.65,-1.11,, +,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,52.57,52.23,S1257,NQLDTNGRRRQFDEESLESFSSMPDPVDPTT,_RQFDEES(ph)LES(ph)FS(ph)SMPDPVDPTTVTK_, , , , , , , ,0.16, , , , , , , ,-0.22,,,,0.16,,,,-0.22,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,52.57,52.23,S1260,DTNGRRRQFDEESLESFSSMPDPVDPTTVTK,_RQFDEES(ph)LES(ph)FS(ph)SMPDPVDPTTVTK_, , , , , , , ,0.16, , , , , , , ,-0.22,,,,0.16,,,,-0.22,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,141.61,140.81,S533,TDAVNENRKDEETEESEYDSEHENSEPVTNI,_DEET(ph)EES(ph)EYDS(ph)EHENSEPVTNIR_, , ,0.06, ,0.19,0.47,0.2,0.54, , ,0.84, ,-0.21,-0.11,0.06,0.13,,0.06,0.34,0.38,,0.84,-0.16,0.1,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,141.61,140.81,S537,NENRKDEETEESEYDSEHENSEPVTNIRNPQ,_KDEET(ph)EES(ph)EYDS(ph)EHENSEPVTNIR_, , ,0.06, ,0.19,0.47,0.2,0.37, , ,0.84, ,-0.21,-0.11,0.06,0.12,,0.06,0.34,0.29,,0.84,-0.16,0.09,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,52.53,51.39,S991,ISMQRQENLRWVSELSYVEEKEQWQEQINQL,_WVSELS(ph)YVEEK_, , , ,0.77, , , , , , , ,0.73, , , , ,,0.77,,,,0.73,,,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,141.61,140.81,T530,DMMTDAVNENRKDEETEESEYDSEHENSEPV,_DEET(ph)EES(ph)EYDS(ph)EHENSEPVTNIR_, , ,0.06, ,0.19,0.47,0.2,0.37, , ,0.84, ,-0.21,-0.11,0.06,0.12,,0.06,0.34,0.29,,0.84,-0.16,0.09,,,,,,,NA,NA,,centrosome,,,,
E7EV56,Q15154,Pericentriolar material 1 protein,PCM1,140.16,140.16,S1958,EHDEQEAESGNISQKSDEEDFVKVEDLPLKL,_S(ph)DEEDFVK_, , , , , ,0.73,0.4,0.2, , , , , ,0.18,0.14,0.07,,,0.73,0.3,,,0.18,0.11,,,,,,,NA,NA,,centrosome,,,,
Q8WW12,Q8WW12,PEST proteolytic signal-containing nuclear protein,PCNP,107.61,106.93,S119,PKTLSVAAAFNEDEDSEPEEMPPEAKMRMKN,_TLSVAAAFNEDEDS(ph)EPEEMPPEAK_, ,-0.07, , ,-0.13,-0.03,0.06,-0.03, ,0.13, , ,0.02,-0.31,0.07,0.11,-0.07,,-0.08,0.02,0.13,,-0.14,0.09,,,,,,,NA,NA,,nucleus,,cell cycle,,
Q8NBP7,Q8NBP7,Proprotein convertase subtilisin/kexin type 9,PCSK9,120.87,118.83,S688,TAVAICCRSRHLAQASQELQ___________,_HLAQAS(ph)QELQ_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome,apolipoprotein binding,apoptotic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,307.97,295.45,S362,SPANLSRHKAAAYDISEDEED__________,_AAAYDIS(ph)EDEED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,nucleotidyltransferase activity,biosynthetic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,109.44,109.44,S329,ISPKQSPSSSPTRERSPSPSFRWPFSGKTSP,_ERS(ph)PS(ph)PSFR_,0.17,0.24,0.26, ,0.2,0.05,0.12,-0.15,0.11,-0.09,0.23, ,0.17,0,-0.02,-0.08,0.2,0.26,0.13,-0.01,0.02,0.23,0.09,-0.05,,,,,,,0,0,,,nucleotidyltransferase activity,biosynthetic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,109.44,109.44,S331,PKQSPSSSPTRERSPSPSFRWPFSGKTSPPC,_ERS(ph)PS(ph)PSFR_,0.17,0.24,0.26, ,0.2,0.05,0.12,-0.15,0.11,-0.09,0.23, ,0.17,0,-0.02,-0.08,0.2,0.26,0.13,-0.01,0.02,0.23,0.09,-0.05,,,,,,,0,0,,,nucleotidyltransferase activity,biosynthetic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,179.44,179.44,S315,KHMLKEGKGRMLQAISPKQSPSSSPTRERSP,_MLQAIS(ph)PKQS(ph)PSSS(ph)PTR_,0.19,0.14,0.1,0,0,-0.03,0.09,0.01,0.3,0.2,0.06,-0.11,-0.1,-0.1,-0.07,0.06,0.17,0.05,-0.02,0.05,0.25,-0.02,-0.1,0,,,,,,,0,0,,,nucleotidyltransferase activity,biosynthetic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,179.44,179.44,S319,KEGKGRMLQAISPKQSPSSSPTRERSPSPSF,_MLQAIS(ph)PKQS(ph)PSSS(ph)PTR_,0.19,-0.01,0.1,0,0,-0.03,-0.02,-0.02,0.3,0.25,0.06,-0.11,-0.1,-0.1,-0.05,0.07,0.09,0.05,-0.02,-0.02,0.27,-0.02,-0.1,0.01,,,,,,,0,0,,,nucleotidyltransferase activity,biosynthetic process,,
B4E322,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,179.44,179.44,S323,GRMLQAISPKQSPSSSPTRERSPSPSFRWPF,_MLQAIS(ph)PKQS(ph)PSSS(ph)PTR_,0.19,0.14,0,0,0,-0.01,0.14,-0.02,0.3,0.2,0.05,-0.11,-0.1,-0.03,-0.08,0.07,0.17,0,-0.01,0.06,0.25,-0.03,-0.07,0,,,,,,,0,0,,,nucleotidyltransferase activity,biosynthetic process,,
Q13442,Q13442,28 kDa heat- and acid-stable phosphoprotein,PDAP1,225.74,208.82,S57,EGGDGAAGDPKKEKKSLDSDESEDEEDDYQQ,_S(ph)LDS(ph)DES(ph)EDEEDDYQQK_, , , , , ,0.28,0.22,0.34, , , , , ,0.27,0.42,0.58,,,0.28,0.28,,,0.27,0.5,,,,,,,NA,NA,,,,cell proliferation,,
Q13442,Q13442,28 kDa heat- and acid-stable phosphoprotein,PDAP1,387.26,378.79,S60,DGAAGDPKKEKKSLDSDESEDEEDDYQQKRK,_S(ph)LDS(ph)DES(ph)EDEEDDYQQK_,-0.68,-0.58,-0.59,-0.68,-0.13,0,-0.58,-0.02,-0.36,-0.11,-0.33,-0.47,-0.06,0.09,-0.16,-0.28,-0.63,-0.63,-0.06,-0.28,-0.23,-0.4,0.01,-0.22,,,,,,,0,0,,,,cell proliferation,,
Q13442,Q13442,28 kDa heat- and acid-stable phosphoprotein,PDAP1,387.26,378.79,S63,AGDPKKEKKSLDSDESEDEEDDYQQKRKGVE,_SLDS(ph)DES(ph)EDEEDDYQQKR_,-0.71,-0.58,-1.02,-0.97,-0.13,-0.49,-0.17,0,0.03,-0.07,-0.62,-0.45,-0.06,-0.02,0.03,0.19,-0.65,-0.99,-0.3,-0.08,-0.02,-0.53,-0.04,0.11,,,,,,,0,0,,,,cell proliferation,,
B5ME91,Q53EL6,Programmed cell death protein 4,PDCD4,174.46,139.77,S457,QLRDLCPSRGRKRFVSEGDGGRLKPESY___,_RFVS(ph)EGDGGR_,-0.18,-0.17,1.56,1.39,2.12,2.07,1.55,1.47,0.5,0.42,2.54,2.37,1.97,1.95,1.3,1.26,-0.17,1.48,2.09,1.51,0.46,2.46,1.96,1.28, +, +,,,,,1,1,23.15,,,,,
B5ME91,Q53EL6,Programmed cell death protein 4,PDCD4,188.96,176.3,S76,RRLRKNSSRDSGRGDSVSDSGSDALRSGLTV,_DSGRGDS(ph)VSDSGSDALR_, ,-0.51, , ,3.09,2.88,2.74,2.35, ,0.48, , ,2.59,2.69,1.52,1.94,-0.51,,2.99,2.56,0.48,,2.64,1.74, +, +,,,,,NA,NA,,,,,,
B5ME91,Q53EL6,Programmed cell death protein 4,PDCD4,158.11,95.75,S94,DSGSDALRSGLTVPTSPKGRLLDRRSRSGKG,_SGLTVPTS(ph)PK_,-0.23,-0.29,-0.47,-0.45,0.08,0.03,-0.17,-0.21,0.12,0.03,0.31,0.34,-0.01,-0.01,-0.34,-0.39,-0.26,-0.46,0.06,-0.19,0.07,0.32,-0.01,-0.36,,,,,,,0,0,,,,,,
O14737,O14737,Programmed cell death protein 5,PDCD5,212.03,212.03,S119,EKTTTVKFNRRKVMDSDEDDDY_________,_VMDS(ph)DEDDDY_, , , , , ,0.34,-0.2, , , , , , ,-0.37,-0.6, ,,,0.34,-0.2,,,-0.37,-0.6,,,,,,,NA,NA,,cytoplasm,DNA binding,apoptotic process,,
O75340,O75340,Programmed cell death protein 6,PDCD6,145.06,143.2,Y4,____________MAAYSYRPGPGAGPGPAAG,_(ac)AAY(ph)SYRPGPGAGPGPAAGAALPDQSFLWNVFQR_, , ,2.49, , , , , , , , , , , , , ,,2.49,,,,,,, +,,,,,,NA,NA,,cytoplasmic vesicle,"binding, bridging",activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q8WUM4,Q8WUM4,Programmed cell death 6-interacting protein,PDCD6IP,124.16,121.02,Y319,INRALAAAKKDNDFIYHDRVPDLKDLDPIGK,_DNDFIY(ph)HDRVPDLK_, , ,2.64, , , , , , , ,0.23, , , , , ,,2.64,,,,0.23,,, +,,,,,,NA,NA,,cytoplasm,,apoptotic process,,
Q13371,Q13371,Phosducin-like protein,PDCL,181.49,172.42,S293,EVLVLTSVRNSATCHSEDSDLEID_______,_NSATCHS(ph)EDS(ph)DLEID_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,negative regulation of protein refolding,,
Q13371,Q13371,Phosducin-like protein,PDCL,181.49,172.42,S296,VLTSVRNSATCHSEDSDLEID__________,_NSATCHS(ph)EDS(ph)DLEID_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,negative regulation of protein refolding,,
Q08499-6,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,78.75,63.9,S715,TLEDNREWYQSTIPQSPSPAPDDPEEGRQGQ,_EWYQSTIPQS(ph)PS(ph)PAPDDPEEGR_, , , , ,2,2.29,-0.41,1.94, , , , ,1.84,2.08,-1.24,2.18,,,2.15,1.2,,,1.96,1.31, +, +,,,,,NA,NA,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,78.22,78.17,S717,EDNREWYQSTIPQSPSPAPDDPEEGRQGQTE,_EWYQSTIPQS(ph)PS(ph)PAPDDPEEGR_, , , , ,2,2.29, ,1.94, , , , ,1.84,2.08, ,2.18,,,2.15,1.94,,,1.96,2.18, +, +,,,,,NA,NA,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,170.95,152.88,S202,RRESFLYRSDSDYDLSPKSMSRNSSIASDIH,_SDS(ph)DYDLS(ph)PK_,0.31,0.31,0.35,0.28,1.9,1.36,0.48,0.48,0.49,0.53,0.48,0.54,1.55,1.15,0.38,0.46,0.31,0.32,1.66,0.48,0.51,0.51,1.36,0.42, +, +,,,,,2,2,33.45,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,114.43,98.99,S746,TEKFQFELTLEEDGESDTEKDSGSQVEEDTS,_FQFELTLEEDGES(ph)DTEK_, , , , , , ,1.32, , , , , , , ,0.22, ,,,,1.32,,,,0.22, +,,,,,,NA,NA,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,111.65,111.65,S138,ANFVHSQRRESFLYRSDSDYDLSPKSMSRNS,_ESFLYRS(ph)DS(ph)DYDLS(ph)PK_, , , , ,0.57, ,0.57,0.85, , , , ,0.6, ,1.16,0.86,,,0.57,0.72,,,0.6,1.02,, +,,,,,NA,NA,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,186.76,160.85,S140,FVHSQRRESFLYRSDSDYDLSPKSMSRNSSI,_SDS(ph)DYDLSPK_,0.34, , , ,0.4,0.55,0.55,0.48,0.7, , , ,0.15,0.39,0.34,0.54,0.34,,0.47,0.52,0.7,,0.27,0.44,,,,,,,NA,NA,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
Q08499-6,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,225.37,225.37,S348,ISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQ,_(gl)QHEVEIPS(ph)PTQK_,0.35,0.5,0.07,0.06,-0.05, ,0.16,0.14,0.24,0.29,0.11,0.07,-0.01, ,0.13,0.19,0.42,0.07,-0.05,0.15,0.27,0.09,-0.01,0.16,,,,,,,0,0,,cytosol,"3',5'-cyclic-AMP phosphodiesterase activity",aging,,
P08559-3,P08559,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,142.89,140.22,S232,PCIFICENNRYGMGTSVERAAASTDYYKRGD,_YGMGTS(ph)VER_,1.87,1.82,2.05,1.98,0.54,0.44,0.73,0.63,0.65,0.63,0.31,0.3,1.21,1.05,1.06,0.79,1.85,2.02,0.49,0.68,0.64,0.3,1.13,0.93, +, +,,,,,5,2,8.2,mitochondrial matrix,pyruvate dehydrogenase (acetyl-transferring) activity,acetyl-CoA biosynthetic process from pyruvate,,
P08559-3,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,160.67,149.72,S298,QTYRYHGHSMSDPGVSYRTREEIQEVRSKSD,_YHGHS(ph)MSDPGVS(ph)YR_,2.06,2.04,1.94,1.85,1.17,0.82,1.16,1.59,1.22,1.08,0.98,0.65,1.36,0.66,0.95,1.69,2.05,1.9,1.01,1.39,1.15,0.82,1.06,1.37, +, +,,,,,5,2,29.12,mitochondrial matrix,pyruvate dehydrogenase (acetyl-transferring) activity,acetyl-CoA biosynthetic process from pyruvate,,
P08559-3,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,232.15,229.73,S291,GPILMELQTYRYHGHSMSDPGVSYRTREEIQ,_YHGHS(ph)MSDPGVS(ph)YR_,0.31,0.31,0.21,0.23,-0.12,0.08,0.17,0.18,0.14,0.11,-0.05,-0.13,0.24,0.4,0.28,0.32,0.31,0.22,-0.01,0.18,0.12,-0.09,0.32,0.3,,,,,,,0,0,,mitochondrial matrix,pyruvate dehydrogenase (acetyl-transferring) activity,acetyl-CoA biosynthetic process from pyruvate,,
B7Z254,Q15084,Protein disulfide-isomerase A6,PDIA6,123.24,121.17,S428,DGRDGELPVEDDIDLSDVELDDLGKDEL___,_EPWDGRDGELPVEDDIDLS(ph)DVELDDLGK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,electron carrier activity,cell redox homeostasis,,
O00151,O00151,PDZ and LIM domain protein 1,PDLIM1,109.48,95.05,Y321,YCEKHARERVTPPEGYEVVTVFPK_______,_VTPPEGY(ph)EVVTVFPK_,2, , , , , , , ,1.44, , , , , , , ,2,,,,1.44,,,, +, +,,,,,NA,NA,,cytoplasm,transcription coactivator activity,"regulation of transcription, DNA-dependent",,
O00151,O00151,PDZ and LIM domain protein 1,PDLIM1,65.18,59.29,S130,HIGSAHNRSAMPFTASPASSTTARVITNQYN,_SAMPFTAS(ph)PASSTTAR_, , , , ,-1.23,-0.2,-0.21, , , , , ,-0.54,1.38,-0.7, ,,,-0.63,-0.21,,,0.72,-0.7,,,,,,,NA,NA,,cytoplasm,transcription coactivator activity,"regulation of transcription, DNA-dependent",,
O00151,O00151,PDZ and LIM domain protein 1,PDLIM1,159.52,159.28,S90,DNLTLTVARSEHKVWSPLVTEEGKRHPYKMN,_VWS(ph)PLVTEEGK_,-0.38,-0.47,-0.15,0.03,-0.62,-0.11,-0.47,-0.27,-0.05,0.01,0.48,0.45,-0.08,0.19,0.05,0.12,-0.43,-0.06,-0.34,-0.37,-0.02,0.46,0.06,0.09,,,,,,,0,0,,cytoplasm,transcription coactivator activity,"regulation of transcription, DNA-dependent",,
Q96HC4,Q96HC4,PDZ and LIM domain protein 5,PDLIM5,130.21,130.21,Y251,KRPPRKHIVERYTEFYHVPTHSDASKKRLIE,_YTEFY(ph)HVPTHSDASK_,1.35,1.54,0.36, , , ,-0.24,-0.3,0.92,1.48,-0.39, , , ,0.34,0.39,1.44,0.36,,-0.27,1.23,-0.39,,0.36, +, +,,,,,NA,NA,,actin cytoskeleton,actin binding,regulation of dendritic spine morphogenesis,,
Q96HC4,Q96HC4,PDZ and LIM domain protein 5,PDLIM5,137.99,137.99,S111,QKGEPKEVVKPVPITSPAVSKVTSTNNMAYN,_EVVKPVPITS(ph)PAVSK_,-0.14,-0.15,-0.37,-0.49,-0.56,-0.89, ,-0.76,-0.14,-0.23,-0.04,0.02,-0.45,-0.42, ,-0.58,-0.14,-0.43,-0.72,-0.76,-0.18,-0.01,-0.43,-0.58,,,,,,,0,0,,actin cytoskeleton,actin binding,regulation of dendritic spine morphogenesis,,
Q96HC4,Q96HC4,PDZ and LIM domain protein 5,PDLIM5,79.3,79.3,S309,HLKESEADNTKKANNSQEPSPQLASSVASTR,_KANNS(ph)QEPS(ph)PQLASSVASTR_, , , , ,-0.27, , ,-0.95, , , , ,-0.2, , ,-0.41,,,-0.27,-0.95,,,-0.2,-0.41,,,,,,,NA,NA,,actin cytoskeleton,actin binding,regulation of dendritic spine morphogenesis,,
Q96HC4,Q96HC4,PDZ and LIM domain protein 5,PDLIM5,79.3,79.3,S313,SEADNTKKANNSQEPSPQLASSVASTRSMPE,_KANNS(ph)QEPS(ph)PQLASSVASTR_, ,-0.4, , ,-0.27, , ,-0.95, ,0.19, , ,-0.2, , ,-0.41,-0.4,,-0.27,-0.95,0.19,,-0.2,-0.41,,,,,,,NA,NA,,actin cytoskeleton,actin binding,regulation of dendritic spine morphogenesis,,
Q96HC4,Q96HC4,PDZ and LIM domain protein 5,PDLIM5,184.56,169.39,S360,AAAAFKPVGSTGVIKSPSWQRPNQGVPSTGR,_S(ph)PSWQRPNQGVPSTGR_,-0.42, ,0.42, ,0.05,0.08,0.11,-0.12,-0.16, ,0.3, ,0.21,0.31,0.46,0.29,-0.42,0.42,0.06,0,-0.16,0.3,0.26,0.38,,,,,,,0,0,,actin cytoskeleton,actin binding,regulation of dendritic spine morphogenesis,,
Q6A1A2,O15530,Putative 3-phosphoinositide-dependent protein kinase 2,PDPK2,153.87,153.47,S241,TAKVLSPESKQARANSFVGTAQYVSPELLTE,_ANS(ph)FVGTAQYVSPELLTEK_,0.18,0.06, ,0.18,0.07,-0.16,-0.05,-0.08,0.01,-0.11, ,-0.23,-0.02,-0.15,0.24,-0.07,0.12,0.18,-0.04,-0.06,-0.05,-0.23,-0.08,0.09,,,AGC,,,,0,0,,cytoplasm,ATP binding,,,
Q29RF7,Q29RF7,Sister chromatid cohesion protein PDS5 homolog A,PDS5A,75.2,30.33,T1208,GVSENEENPVRIISVTPVKNIDPVKNKEINS,_IISVT(ph)PVK_,0.06,0.1,-0.22,-0.31,-0.15,-0.32,-0.05,-0.14,-0.17,-0.12,-0.45,-0.43,-0.4,-0.23,0.02,-0.01,0.08,-0.26,-0.23,-0.09,-0.14,-0.44,-0.31,0,,,,,,,0,0,,chromatin,,cytokinesis,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,197,197,S1283,KRLKEDILENEDEQNSPPKKGKRGRPPKPLG,_EDILENEDEQNS(ph)PPKK_,0.04,0.32,0.09,0.31,0.51,1.48,1.95,2.01,0.45,0.52,0.46,0.54,4.11,3.75,3.18,2.97,0.18,0.2,1.08,1.98,0.48,0.5,3.94,3.08, +, +,,,,,2,2,18.05,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,210.69,210.13,S1176,SSNPSSPGRIKGRLDSSEMDHSENEDYTMSS,_GRLDS(ph)SEMDHS(ph)ENEDYTMSSPLPGK_, , , ,1.86,2.89,0.6, , , , , ,1.69,2.31,0.48, , ,,1.86,2.15,,,1.69,1.67,, +, +,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,210.69,210.13,S1182,PGRIKGRLDSSEMDHSENEDYTMSSPLPGKK,_GRLDS(ph)SEMDHS(ph)ENEDYTMSSPLPGK_, , , ,1.86,2.89,0.6, , , , , ,1.69,2.31,0.48, , ,,1.86,2.15,,,1.69,1.67,, +, +,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,113.89,109.82,S1257,KPKGSQRSRKRGHTASESDEQQWPEEKRLKE,_RGHTAS(ph)ESDEQQWPEEK_, , , ,1.68, ,1.62, , , , , ,1.9, ,1.33, , ,,1.68,1.62,,,1.9,1.33,, +, +,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,251.34,251.08,S1358,SKQHRVSRRAQQRAESPESSAIESTQSTPQK,_AES(ph)PESSAIESTQST(ph)PQK_, , ,0.42, ,0.87,0.53,0.68,0.48, , ,0.61, ,0.47,0.85,-0.14,-0.03,,0.42,0.71,0.58,,0.61,0.67,-0.08,,,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,70.95,68.66,S1177,SNPSSPGRIKGRLDSSEMDHSENEDYTMSSP,_LDS(ph)S(ph)EMDHSENEDYTMSS(ph)PLPGK_, , , , ,0.15,0.6, , , , , , ,0.07,0.48, , ,,,0.39,,,,0.29,,,,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,70.95,68.66,S1191,SSEMDHSENEDYTMSSPLPGKKSDKRDDSDL,_LDS(ph)S(ph)EMDHSENEDYTMSS(ph)PLPGK_, , , , ,0.15,0.6, , , , , , ,0.07,0.48, , ,,,0.39,,,,0.29,,,,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
Q9NTI5-2,Q9NTI5,Sister chromatid cohesion protein PDS5 homolog B,PDS5B,283.05,282.18,S1166,RMETVSNASSSSNPSSPGRIKGRLDSSEMDH,_METVSNASSSSNPSS(ph)PGR_,0.26,-0.16,0.19,0.14,0.74,0.58, , ,0.19,0.23,0.24,0.03,0.37,-0.01, , ,0.06,0.16,0.66,,0.21,0.14,0.19,,,,,,,,NA,NA,,chromatin,ATP binding,cell proliferation,,
E7EMH5,Q6P996,Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,167.55,161.28,S718,GQKPFKRSLRGSDALSETSSVSHIEDLEKVE,_GSDALS(ph)ETS(ph)S(ph)VSHIEDLEK_,0.08,0.05,-0.32,-0.5,-0.84,-0.11,0.15,-0.25,0.4,0.25,-0.1,0,-0.55,-0.24,-0.06,-0.25,0.07,-0.41,-0.43,-0.04,0.33,-0.05,-0.39,-0.15,,,,,,,0,0,,,carboxy-lyase activity,carboxylic acid metabolic process,,
E7EMH5,Q6P996,Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,167.55,161.28,S721,PFKRSLRGSDALSETSSVSHIEDLEKVERLS,_GSDALS(ph)ETS(ph)S(ph)VSHIEDLEK_,0.13,0.03,-0.32,-0.5,-0.24,-0.3,-0.13,-0.25,0.26,0.24,-0.1,0,-0.28,-0.25,-0.23,-0.25,0.08,-0.41,-0.27,-0.19,0.25,-0.05,-0.27,-0.24,,,,,,,0,0,,,carboxy-lyase activity,carboxylic acid metabolic process,,
E7EMH5,Q6P996,Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,167.55,161.28,S722,FKRSLRGSDALSETSSVSHIEDLEKVERLSS,_GSDALS(ph)ETS(ph)S(ph)VSHIEDLEK_,0.08,0.05,-0.32,-0.5,0.01,-0.11,0.06,0.04,0.4,0.25,-0.1,0,-0.37,-0.24,-0.17,-0.44,0.07,-0.41,-0.05,0.05,0.33,-0.05,-0.31,-0.3,,,,,,,0,0,,,carboxy-lyase activity,carboxylic acid metabolic process,,
E7EMH5,Q6P996,Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,84.88,84.21,S724,RSLRGSDALSETSSVSHIEDLEKVERLSSGP,_GSDALS(ph)ETS(ph)S(ph)VS(ph)HIEDLEK_, , , , ,0.5,0.02,0.74,0.24, , , , ,-0.52,-0.38,0.35,0.09,,,0.28,0.51,,,-0.45,0.23,,,,,,,NA,NA,,,carboxy-lyase activity,carboxylic acid metabolic process,,
Q15121,Q15121,Astrocytic phosphoprotein PEA-15,PEA15,164.13,164.13,S116,RIPSAKKYKDIIRQPSEEEIIKLAPPPKKA_,_QPS(ph)EEEIIK_,0.53,0.51,0.51,0.57,0.11,0.19,-0.23,-0.36,0.22,0.22,0.45,0.45,0.27,0.28,-0.12,0.02,0.52,0.54,0.15,-0.3,0.22,0.45,0.27,-0.05,,,,,,,0,0,,cytoplasm,,apoptotic process,,
Q9H792,Q9H792,Pseudopodium-enriched atypical kinase 1,PEAK1,92.39,92.39,S1214,AGSSISYELKGLDIESYDSLERPLRKERPVP,_GLDIES(ph)YDSLERPLRK_,2.24, ,0.55, , , , , ,2.15, ,0.39, , , , , ,2.24,0.55,,,2.15,0.39,,, +, +,Other,,,,NA,NA,,actin cytoskeleton,ATP binding,cell migration,,
Q9H792,Q9H792,Pseudopodium-enriched atypical kinase 1,PEAK1,96.14,91.79,Y665,ELSVKEKTTSVISHTYEEIETESKVPDNTTS,_TTSVISHTY(ph)EEIETESK_, , ,0.25, , , , , , , ,-0.55, , , , , ,,0.25,,,,-0.55,,,,,Other,,,,NA,NA,,actin cytoskeleton,ATP binding,cell migration,,
Q9H792,Q9H792,Pseudopodium-enriched atypical kinase 1,PEAK1,205.78,189.6,Y635,SKNAIKVPIVINPNAYDNLAIYKSFLGTSGE,_VPIVINPNAY(ph)DNLAIY(ph)K_,-0.75, ,-0.14, ,-0.05,0.23,0.02,-0.06,-0.18, ,0.49, ,-0.18,-0.25,0.16,0.07,-0.75,-0.14,0.09,-0.01,-0.18,0.49,-0.22,0.11,,,Other,,,,0,0,,actin cytoskeleton,ATP binding,cell migration,,
Q9H792,Q9H792,Pseudopodium-enriched atypical kinase 1,PEAK1,142.91,142.91,Y641,VPIVINPNAYDNLAIYKSFLGTSGELSVKEK,_VPIVINPNAY(ph)DNLAIY(ph)K_, , , , ,0.32, , ,0.49, , , , ,0.07, , ,0.03,,,0.32,0.49,,,0.07,0.03,,,Other,,,,NA,NA,,actin cytoskeleton,ATP binding,cell migration,,
P30086,P30086,Phosphatidylethanolamine-binding protein 1,PEBP1,220.65,220.65,S52,LGKVLTPTQVKNRPTSISWDGLDSGKLYTLV,_NRPTS(ph)ISWDGLDSGK_,-0.07,-0.11,-0.17,-0.19,0.31,0.46,0.64, ,0.08,-0.01,-0.07,-0.07,-0.24,-0.62,-1.01, ,-0.09,-0.18,0.38,0.64,0.04,-0.07,-0.42,-1.01,, +,,,,,0,6,24.33,cytoplasm,ATP binding,,,
Q9BRX2,Q9BRX2,Protein pelota homolog,PELO,114.57,112.77,S374,LTGVAAILRFPVPELSDQEGDSSSEED____,_FPVPELS(ph)DQEGDS(ph)S(ph)SEED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,endonuclease activity,cell cycle,,
Q9BRX2,Q9BRX2,Protein pelota homolog,PELO,118.36,116.36,S380,ILRFPVPELSDQEGDSSSEED__________,_FPVPELSDQEGDS(ph)S(ph)S(ph)EED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,endonuclease activity,cell cycle,,
Q9BRX2,Q9BRX2,Protein pelota homolog,PELO,118.36,116.36,S381,LRFPVPELSDQEGDSSSEED___________,_FPVPELSDQEGDS(ph)S(ph)S(ph)EED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,endonuclease activity,cell cycle,,
Q9BRX2,Q9BRX2,Protein pelota homolog,PELO,118.36,116.36,S382,RFPVPELSDQEGDSSSEED____________,_FPVPELSDQEGDS(ph)S(ph)S(ph)EED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,endonuclease activity,cell cycle,,
F8WDZ1,Q8IZL8,"Proline-, glutamic acid- and leucine-rich protein 1",PELP1,94.59,94.45,S1043,PEALPSQGEVEREGESPAAGPPPQELVEEEP,_EGES(ph)PAAGPPPQELVEEEPSAPPTLLEEETEDGS(ph)DK_, , , , ,0.14,0.52, ,0.05, , , , ,0.13,0.6, ,0.06,,,0.34,0.05,,,0.38,0.06,,,,,,,NA,NA,,,,,,
F8WDZ1,Q8IZL8,"Proline-, glutamic acid- and leucine-rich protein 1",PELP1,94.59,94.45,S1073,PSAPPTLLEEETEDGSDKVQPPPETPAEEEM,_EGES(ph)PAAGPPPQELVEEEPSAPPTLLEEETEDGS(ph)DK_, , , , ,0.14,0.52, , , , , , ,0.13,0.6, , ,,,0.34,,,,0.38,,,,,,,,NA,NA,,,,,,
F8WDZ1,Q8IZL8,"Proline-, glutamic acid- and leucine-rich protein 1",PELP1,77.53,77.38,T745,HRAGSNEDPILAPSGTPPPTIPPDETFGGRV,_AGSNEDPILAPSGT(ph)PPPTIPPDETFGGR_, ,0.04,-0.01,-0.02,0.28,0.11,-0.64, , ,0.42,0.27,0.19,-0.01,0.06,-0.38, ,0.04,-0.01,0.2,-0.64,0.42,0.23,0.03,-0.38,,,,,,,0,0,,,,,,
B7Z6I5,P40855,Peroxisomal biogenesis factor 19,PEX19,333.75,318.79,S147,TLSGLAKNATDLQNSSMSEEELTKAMEGLGM,_NATDLQNSS(ph)MSEEELTK_,-0.14,-0.07,-0.09,-0.03,-0.22,-0.05,-0.34,-0.04,0.15,-0.01,0.07,0.11,-0.11,-0.15,-0.06,0.04,-0.1,-0.06,-0.13,-0.18,0.07,0.09,-0.13,-0.01,,,,,,,0,0,,peroxisome,,,,
Q9NQP4,Q9NQP4,Prefoldin subunit 4,PFDN4,215.96,212.24,S125,RVLADLKVQLYAKFGSNINLEADES______,_FGS(ph)NINLEADES_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,chaperone binding,'de novo' posttranslational protein folding,,
Q01813,Q01813,6-phosphofructokinase type C,PFKP,136.3,132.46,S386,MDERRFQDAVRLRGRSFAGNLNTYKRLAIKL,_S(ph)FAGNLNTYK_, ,0.16, , ,-0.19,-0.02,0.23,0.1, ,0.61, , ,-0.22,0,0.23,0.04,0.16,,-0.1,0.16,0.61,,-0.11,0.14,,,,,,,NA,NA,,6-phosphofructokinase complex,6-phosphofructokinase activity,fructose 6-phosphate metabolic process,,
P18669,P18669,Phosphoglycerate mutase 1,PGAM1,49.31,35.86,Y26,HGESAWNLENRFSGWYDADLSPAGHEEAKRG,_FSGWY(ph)DADLSPAGHEEAK_, , , , , , ,-0.34, , , , , , , ,0.44, ,,,,-0.34,,,,0.44,,,,,,,NA,NA,,cytosol,bisphosphoglycerate 2-phosphatase activity,gluconeogenesis,,
P18669,P18669,Phosphoglycerate mutase 1,PGAM1,35.46,33.9,S31,WNLENRFSGWYDADLSPAGHEEAKRGGQALR,_FSGWYDADLS(ph)PAGHEEAK_, , , ,-0.55, , , , , , , ,-0.02, , , , ,,-0.55,,,,-0.02,,,,,,,,,NA,NA,,cytosol,bisphosphoglycerate 2-phosphatase activity,gluconeogenesis,,
P18669,P18669,Phosphoglycerate mutase 1,PGAM1,71.42,69.06,S118,TAAKHGEAQVKIWRRSYDVPPPPMEPDHPFY,_S(ph)YDVPPPPMEPDHPFYSNISK_,-0.11,-0.23,-0.23,-0.27,-0.04,0.08, , ,0.13,0.03,0.12,0.27,-0.35,0.34, , ,-0.17,-0.25,0.02,,0.08,0.2,0.03,,,,,,,,NA,NA,,cytosol,bisphosphoglycerate 2-phosphatase activity,gluconeogenesis,,
Q96JS3,Q96JS3,PiggyBac transposable element-derived protein 1,PGBD1,129.22,129.1,S360,KDKARVSELLQGLSFSGDSDVEKDNEPEIQP,_VSELLQGLSFS(ph)GDS(ph)DVEK_, , , , , ,0, , , , , , , ,-0.06, , ,,,0,,,,-0.06,,,,,,,,NA,NA,,membrane,scavenger receptor activity,viral reproduction,,
Q96JS3,Q96JS3,PiggyBac transposable element-derived protein 1,PGBD1,129.22,129.1,S363,ARVSELLQGLSFSGDSDVEKDNEPEIQPAQK,_VSELLQGLSFS(ph)GDS(ph)DVEK_, , , , , ,0, , , , , , , ,-0.06, , ,,,0,,,,-0.06,,,,,,,,NA,NA,,membrane,scavenger receptor activity,viral reproduction,,
Q03468,Q03468,DNA excision repair protein ERCC-6,PGBD3,87.59,85.2,S429,QKKVPVQEIDDDFFPSSGEEAEAASVGEGGG,_KVPVQEIDDDFFPS(ph)S(ph)GEEAEAASVGEGGGGGR_, , , , ,0.03, , ,-0.23, , , , ,0.15, , ,-0.26,,,0.03,-0.23,,,0.15,-0.26,,,,,,,NA,NA,,nucleolus,ATP binding,activation of JNKK activity,,
Q03468,Q03468,DNA excision repair protein ERCC-6,PGBD3,87.59,85.2,S430,KKVPVQEIDDDFFPSSGEEAEAASVGEGGGG,_KVPVQEIDDDFFPS(ph)S(ph)GEEAEAASVGEGGGGGR_, , , , ,0.03, , ,-0.23, , , , ,0.15, , ,-0.26,,,0.03,-0.23,,,0.15,-0.26,,,,,,,NA,NA,,nucleolus,ATP binding,activation of JNKK activity,,
Q03468,Q03468,DNA excision repair protein ERCC-6,PGBD3,175.39,175.39,S158,CTTSLRQINKIIEQLSPQAATSRDINRKLDS,_IIEQLS(ph)PQAATSR_,-0.51,-0.37,-0.33,-0.28, , , , ,-0.52,-0.79,-0.41,-0.47, , , , ,-0.44,-0.31,,,-0.65,-0.44,,,,,,,,,NA,NA,,nucleolus,ATP binding,activation of JNKK activity,,
E7EV46,Q8N328,PiggyBac transposable element-derived protein 3,PGBD3,90.93,90.2,S86,AESDSDDPSYAPKDDSPDEVPSTFTVQQPPP,_DDS(ph)PDEVPSTFTVQQPPPSR_, , , , ,0.08, , , , , , , ,0.15, , , ,,,0.08,,,,0.15,,,,,,,,NA,NA,,,,,,
B4DQJ8,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,129.85,129.41,Y481,HTNWTGHGGTVSSSSYNA_____________,_PGQFIHTNWTGHGGTVSSSSY(ph)NA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,NADP binding,pentose biosynthetic process,,
P36871,P36871,Phosphoglucomutase-1,PGM1,115.7,99.97,S117,IIRKIKAIGGIILTASHNPGGPNGDFGIKFN,_AIGGIILTAS(ph)HNPGGPNGDFGIK_,0.17, , , , , , , ,-0.29, , , , , , , ,0.17,,,,-0.29,,,,,,,,,,NA,NA,,actin cytoskeleton,magnesium ion binding,galactose catabolic process,,
O95394,O95394,Phosphoacetylglucosamine mutase,PGM3,141.29,140.44,S64,RSKQTKSTIGVMVTASHNPEEDNGVKLVDPL,_STIGVMVTAS(ph)HNPEEDNGVK_,-0.03,0.06,-0.27,-0.25, , , , ,0.1,-0.06,0.27,0.09, , , , ,0.02,-0.26,,,0.02,0.18,,,,,,,,,NA,NA,,cytosol,magnesium ion binding,dolichol-linked oligosaccharide biosynthetic process,,
O00264,O00264,Membrane-associated progesterone receptor component 1,PGRMC1,415.02,415.02,S181,HVGKLLKEGEEPTVYSDEEEPKDESARKND_,_LLKEGEEPTVYS(ph)DEEEPKDESAR_,-0.07,-0.02,-0.22,-0.19,0.02,0.05,0.03,0.15,0.11,0.1,0.06,0.06,0,-0.05,-0.07,0.03,-0.04,-0.2,0.03,0.09,0.11,0.06,-0.02,-0.02,,,,,,,0,0,,cell surface,heme binding,axon guidance,,
O00264,O00264,Membrane-associated progesterone receptor component 1,PGRMC1,322.13,322.13,S57,LYKIVRGDQPAASGDSDDDEPPPLPRLKRRD,_GDQPAASGDS(ph)DDDEPPPLPR_,-0.03,-0.05,-0.23,-0.22,-0.03,-0.03,0.05,-0.01,0.01,0.04,-0.09,-0.04,-0.15,-0.23,-0.07,-0.2,-0.04,-0.22,-0.03,0.02,0.02,-0.06,-0.19,-0.13,,,,,,,0,0,,cell surface,heme binding,axon guidance,,
O15173,O15173,Membrane-associated progesterone receptor component 2,PGRMC2,298.96,296.57,S90,WGRRGLGAGAGAGEESPATSLPRMKKRDFSL,_GLGAGAGAGEES(ph)PATSLPR_,-0.47,0.03,-0.04,-0.18,-0.37,-0.62,-0.33,-0.31,-0.14,0.28,0.32,0.03,-0.08,-0.75,-0.24,-0.24,-0.2,-0.11,-0.49,-0.32,0.08,0.18,-0.38,-0.24,,,,,,,0,0,,integral to membrane,heme binding,,,
O15173,O15173,Membrane-associated progesterone receptor component 2,PGRMC2,298.5,298.5,S208,KYDYVGRLLKPGEEPSEYTDEEDTKDHNKQD,_LLKPGEEPS(ph)EYT(ph)DEEDTK_,0.35,0.26,0.3,0.22,0.26,0.22,0.28,0.24,0.15,0.2,0.2,0.15,0.39,0.28,0.35,0.41,0.3,0.26,0.24,0.26,0.18,0.17,0.34,0.38,,,,,,,0,0,,integral to membrane,heme binding,,,
O15173,O15173,Membrane-associated progesterone receptor component 2,PGRMC2,352.15,352.15,T211,YVGRLLKPGEEPSEYTDEEDTKDHNKQD___,_PGEEPSEYT(ph)DEEDTK_,0.01,0.04,-0.07,-0.02,0.02,0.11,0.14,0.05,0.07,0.09,0.03,0.01,0.08,0.09,0.11,0.09,0.02,-0.04,0.06,0.1,0.08,0.02,0.08,0.1,,,,,,,0,0,,integral to membrane,heme binding,,,
Q8IZ21-3,Q8IZ21,Phosphatase and actin regulator 4,PHACTR4,128.58,128.18,S131,SSSPVQVEEEPVRLASLRKAIPEEDLKKRLG,_SSS(ph)PVQVEEEPVRLAS(ph)LRK_,1.07,1.22, , , , , , ,1.11,1.09, , , , , , ,1.15,,,,1.1,,,, +, +,,,,,NA,NA,,cytoplasm,actin binding,actin cytoskeleton organization,,
Q8IZ21-3,Q8IZ21,Phosphatase and actin regulator 4,PHACTR4,131.39,130.9,Y647,TVAELLARKILRFNEYVEVTDAQDYDRRADK,_FNEY(ph)VEVTDAQDYDRR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,actin binding,actin cytoskeleton organization,,
Q8IZ21-3,Q8IZ21,Phosphatase and actin regulator 4,PHACTR4,162.79,158.69,S118,LKNGHTTPIGNARSSSPVQVEEEPVRLASLR,_SSS(ph)PVQVEEEPVR_,-0.3,-0.32,-0.16,-0.06,-0.01, ,-0.18,0.06,-0.34,-0.34,-0.43,-0.25,-0.13, ,-0.27,-0.11,-0.31,-0.11,-0.01,-0.05,-0.34,-0.33,-0.13,-0.19,,,,,,,0,0,,cytoplasm,actin binding,actin cytoskeleton organization,,
Q9H814,Q9H814,Phosphorylated adapter RNA export protein,PHAX,251.21,251.21,S14,__MALEVGDMEDGQLSDSDSDMTVAPSDRPL,_(ac)ALEVGDMEDGQLS(ph)DS(ph)DSDMTVAPSDRPLQLPK_,-0.14,0.02,-0.3, ,0.06,-0.07,-0.26,0.11,0.25,0.11,0, ,-0.03,-0.21,-0.15,-0.18,-0.06,-0.3,0,-0.07,0.18,0,-0.12,-0.16,,,,,,,0,0,,Cajal body,RNA binding,ncRNA metabolic process,,
Q9H814,Q9H814,Phosphorylated adapter RNA export protein,PHAX,251.21,251.21,S16,MALEVGDMEDGQLSDSDSDMTVAPSDRPLQL,_(ac)ALEVGDMEDGQLS(ph)DS(ph)DSDMTVAPSDRPLQLPK_,-0.14,0.02,-0.3, ,0.06,-0.07,0.08,0.11,0.25,0.11,0, ,-0.03,-0.21,0.06,-0.18,-0.06,-0.3,0,0.09,0.18,0,-0.12,-0.06,,,,,,,0,0,,Cajal body,RNA binding,ncRNA metabolic process,,
E7EX82,Q8NDX5,Polyhomeotic-like protein 3,PHC3,223.78,223.78,S616,DECVRMDRTPPPPTLSPAAITVGRGEDLTSE,_MDRT(ph)PPPPTLS(ph)PAAITVGR_,-0.24,-0.07,0.06,-0.29,0.25,-0.3,-0.72,-0.31,-0.18,-0.14,-0.15,-0.37,0.34,-0.57,-1.12,-0.41,-0.15,-0.1,0,-0.5,-0.16,-0.26,-0.04,-0.72,,,,,,,0,0,,actin cytoskeleton,zinc ion binding,,,
E7EX82,Q8NDX5,Polyhomeotic-like protein 3,PHC3,223.78,223.78,T609,EEMPEESDECVRMDRTPPPPTLSPAAITVGR,_MDRT(ph)PPPPTLS(ph)PAAITVGR_,-0.24,-0.07,0.06,-0.29,0.25,-0.3,-0.72,-0.31,-0.18,-0.14,-0.15,-0.37,0.34,-0.57,-1.12,-0.41,-0.15,-0.1,0,-0.5,-0.16,-0.26,-0.04,-0.72,,,,,,,0,0,,actin cytoskeleton,zinc ion binding,,,
Q8WUB8-3,Q8WUB8,PHD finger protein 10,PHF10,101.48,100.78,S297,ALYEPPLDPELPALDSDGDSDDGEDGRGDEK,_YLPLNTALYEPPLDPELPALDS(ph)DGDS(ph)DDGEDGRGDEK_, , , , , , , ,0.27, , , , , , , ,-0.09,,,,0.27,,,,-0.09,,,,,,,NA,NA,,npBAF complex,zinc ion binding,nervous system development,,
Q8WUB8-3,Q8WUB8,PHD finger protein 10,PHF10,101.48,100.78,S301,PPLDPELPALDSDGDSDDGEDGRGDEKRKNK,_YLPLNTALYEPPLDPELPALDS(ph)DGDS(ph)DDGEDGRGDEK_, , , , , , , ,0.27, , , , , , , ,-0.09,,,,0.27,,,,-0.09,,,,,,,NA,NA,,npBAF complex,zinc ion binding,nervous system development,,
Q96QT6-2,Q96QT6,PHD finger protein 12,PHF12,79.88,72.01,S131,GHVNGLVDKSGKRTTSPSSDTDLLDRSASKT,_TTS(ph)PSS(ph)DTDLLDR_,-0.18,-0.53,-0.12,-0.69,-0.45, , , ,0.32,-0.19,0.01,-0.07,0.14, , , ,-0.35,-0.38,-0.45,,0.09,-0.03,0.14,,,,,,,,NA,NA,,Sin3 complex,phosphatidylinositol binding,,,
O94880,O94880,PHD finger protein 14,PHF14,133.25,86.54,S298,DEELTNDSLTLSQSKSNEDSLILEKSQNWSS,_S(ph)NEDS(ph)LILEK_, , ,0.26, , ,-1,-1.77,-0.92, , ,1.5, , ,-0.72,-0.49,-0.83,,0.26,-1,-1.28,,1.5,-0.72,-0.65, +, +,,,,,NA,NA,,,zinc ion binding,,,
O94880,O94880,PHD finger protein 14,PHF14,136.6,106.58,S302,TNDSLTLSQSKSNEDSLILEKSQNWSSQKMD,_S(ph)NEDS(ph)LILEK_,-0.32,-0.29,-0.04,-0.3, ,-1,-1.77,-0.92,-0.28,-0.39,-0.08,-0.33, ,-0.72,-0.49,-0.83,-0.31,-0.17,-1,-1.28,-0.34,-0.2,-0.72,-0.65, +,,,,,,6,0,22.73,,zinc ion binding,,,
O94880,O94880,PHD finger protein 14,PHF14,46.25,45.89,S290,VLSRNSADDEELTNDSLTLSQSKSNEDSLIL,_NSADDEELT(ph)NDS(ph)LTLSQSK_, , , , , , , ,-0.27, , , , , , , ,0.23,,,,-0.27,,,,0.23,,,,,,,NA,NA,,,zinc ion binding,,,
Q6IE81-2,Q6IE81,Protein Jade-1,PHF17,98.39,97.33,S810,KSDNENDGYVPDVEMSDSESEASEKKCIHTS,_SDNENDGYVPDVEMS(ph)DS(ph)ESEASEK_, , , , ,-0.18,-0.18,0.11,0.23, , , , ,0.2,-0.33,0.27,-0.1,,,-0.18,0.17,,,-0.04,0.1,,,,,,,NA,NA,,histone acetyltransferase complex,zinc ion binding,apoptotic process,,
Q6IE81-2,Q6IE81,Protein Jade-1,PHF17,98.39,97.33,S812,DNENDGYVPDVEMSDSESEASEKKCIHTSST,_SDNENDGYVPDVEMS(ph)DS(ph)ESEASEK_, , , , ,-0.18,-0.18,0.11,0.23, , , , ,0.2,-0.33,0.27,-0.1,,,-0.18,0.17,,,-0.04,0.1,,,,,,,NA,NA,,histone acetyltransferase complex,zinc ion binding,apoptotic process,,
Q96BD5,Q96BD5,PHD finger protein 21A,PHF21A,62.73,62.15,S455,FGALTPTSPQSSHPDSPENEKTETTFTFPAP,_YNAVLGFGALT(ph)PTS(ph)PQSSHPDS(ph)PENEK_, , , , ,1.51, , , , , , , ,1.47, , , ,,,1.51,,,,1.47,, +, +,,,,,NA,NA,,histone deacetylase complex,chromatin binding,blood coagulation,,
Q96BD5,Q96BD5,PHD finger protein 21A,PHF21A,92.47,92.11,T444,GRPPKYNAVLGFGALTPTSPQSSHPDSPENE,_YNAVLGFGALT(ph)PTS(ph)PQSS(ph)HPDSPENEK_, , , , ,1.6, , , , , , , ,1.49, , , ,,,1.6,,,,1.49,, +, +,,,,,NA,NA,,histone deacetylase complex,chromatin binding,blood coagulation,,
Q92576-2,Q92576,PHD finger protein 3,PHF3,94.12,94.12,S1133,CKICIGRMAPPVDDLSPKKVKVVVGVARKHS,_MAPPVDDLS(ph)PKK_,0.05,0.07,0.63,0.52, ,-1.63, , ,-0.24,0.33,-0.04,0.74, ,-1.14, , ,0.06,0.58,-1.63,,0.07,0.4,-1.14,, +, +,,,,,NA,NA,,nucleus,zinc ion binding,multicellular organismal development,,
B4E0G4,Q8IWS0,PHD finger protein 6,PHF6,222.92,211.64,S155,ADLEESFNEHELEPSSPKSKKKSRKGRPRKT,_TAHNSEADLEESFNEHELEPSS(ph)PK_, , ,-0.16,-0.1, , , , , , ,0.21,0.42, , , , ,,-0.13,,,,0.32,,,,,,,,,NA,NA,,,zinc ion binding,,,
B7Z911,Q9UPP1,Histone lysine demethylase PHF8,PHF8,98.98,97.8,S854,DSLGACFKDAEYIYPSLESDDDDPALKSRPK,_DAEYIYPS(ph)LES(ph)DDDDPALK_, , , , ,0.15,0.27,0.41,0.25, , , , ,0.31,0.4,0.25,-0.03,,,0.21,0.33,,,0.36,0.12,,,,,,,NA,NA,,,,,,
B7Z911,Q9UPP1,Histone lysine demethylase PHF8,PHF8,122.6,122.19,S857,GACFKDAEYIYPSLESDDDDPALKSRPKKKK,_DAEYIYPS(ph)LES(ph)DDDDPALK_,0.11,0.12,0.18,0.38,0.31,0.19,0.19,0.31,0.18,0.01,0.09,0.33,-0.03,0.49,0.16,0.13,0.11,0.29,0.25,0.25,0.1,0.21,0.25,0.15,,,,,,,0,0,,,,,,
B7Z911,Q9UPP1,Histone lysine demethylase PHF8,PHF8,121.92,110.66,S880,KSRPKKKKNSDDAPWSPKARVTPTLPKQDRP,_NSDDAPWS(ph)PK_,0.2,0.31,0.63,0.66,0.52, , ,0.18,-0.23,-0.11,0.53,0.34,0.84, , ,0.22,0.26,0.65,0.52,0.18,-0.17,0.44,0.84,0.22,,,,,,,0,0,,,,,,
E7EVJ9,Q86SQ0,Pleckstrin homology-like domain family B member 2,PHLDB2,150.86,149.59,S489,EDVQKINKELEKLQLSDEESVFEEALMSPDT,_LQLS(ph)DEESVFEEALMSPDTR_, , , , ,0.39, , ,-1.06, , , , ,0.45, , ,-0.64,,,0.39,-1.06,,,0.45,-0.64, +,,,,,,NA,NA,,,,,,
H0Y825,Q9UMS5,Putative homeodomain transcription factor 1,PHTF1,62.03,54.9,S272,EKCRREAFRRLGNGVSDDLSSEEDGEARTQM,_LGNGVS(ph)DDLS(ph)S(ph)EEDGEAR_, , , , , , , ,-0.06, , , , , , , ,-0.49,,,,-0.06,,,,-0.49,,,,,,,NA,NA,,cytoplasm,phosphatase regulator activity,cell proliferation in forebrain,,
H0Y825,Q9UMS5,Putative homeodomain transcription factor 1,PHTF1,62.03,54.9,S276,REAFRRLGNGVSDDLSSEEDGEARTQMILLR,_LGNGVS(ph)DDLS(ph)S(ph)EEDGEAR_, , , , , , , ,-0.06, , , , , , , ,-0.49,,,,-0.06,,,,-0.49,,,,,,,NA,NA,,cytoplasm,phosphatase regulator activity,cell proliferation in forebrain,,
H0Y825,Q9UMS5,Putative homeodomain transcription factor 1,PHTF1,62.03,54.9,S277,EAFRRLGNGVSDDLSSEEDGEARTQMILLRR,_LGNGVS(ph)DDLS(ph)S(ph)EEDGEAR_, , , , , , , ,-0.06, , , , , , , ,-0.49,,,,-0.06,,,,-0.49,,,,,,,NA,NA,,cytoplasm,phosphatase regulator activity,cell proliferation in forebrain,,
Q9BTU6,Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,PI4K2A,139.49,127,S462,PPVIVETARSHQRSSSESYTQSFQSRKPFFS,_SSS(ph)ESYTQSFQSR_, , ,0.81,1.05,1.67, ,2.09,1.65, , ,0.9,0.97,1.55, ,2.37,1.8,,0.94,1.67,1.88,,0.94,1.55,2.11, +, +,,,,,NA,NA,,cell junction,1-phosphatidylinositol 4-kinase activity,basophil degranulation,,
Q9BTU6,Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,PI4K2A,118.48,115.62,S5,___________MDETSPLVSPERAQPPDYTF,_(ac)MDETS(ph)PLVS(ph)PER_, , , , ,0.57,0.14,-0.04, , , , , ,0.59,0.46,0.14, ,,,0.37,-0.04,,,0.53,0.14,,,,,,,NA,NA,,cell junction,1-phosphatidylinositol 4-kinase activity,basophil degranulation,,
Q9BTU6,Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,PI4K2A,118.48,115.62,S9,_______MDETSPLVSPERAQPPDYTFPSGS,_(ac)MDETS(ph)PLVS(ph)PER_, , , , ,0.57,0.14,-0.04, , , , , ,0.59,0.46,0.14, ,,,0.37,-0.04,,,0.53,0.14,,,,,,,NA,NA,,cell junction,1-phosphatidylinositol 4-kinase activity,basophil degranulation,,
Q9BTU6,Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,PI4K2A,128.49,128.49,S47,PGGAVRVAAAAGSGPSPPGSPGHDRERQPLL,_VAAAAGSGPS(ph)PPGS(ph)PGHDRER_,-0.33, ,-0.71,0.11,0.18,0.05,0.47,-0.49,-0.31, ,-0.53,0.3,0.18,0.21,0.17,0.07,-0.33,-0.24,0.12,0.07,-0.31,-0.06,0.2,0.12,,,,,,,0,0,,cell junction,1-phosphatidylinositol 4-kinase activity,basophil degranulation,,
Q9BTU6,Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,PI4K2A,128.49,128.49,S51,VRVAAAAGSGPSPPGSPGHDRERQPLLDRAR,_VAAAAGSGPS(ph)PPGS(ph)PGHDRER_,-0.33, ,-0.71,0.11,0.18,0.05,0.47,-0.15,-0.31, ,-0.53,0.3,0.18,0.21,0.17,0.28,-0.33,-0.24,0.12,0.19,-0.31,-0.06,0.2,0.23,,,,,,,0,0,,cell junction,1-phosphatidylinositol 4-kinase activity,basophil degranulation,,
P42356,P42356,Phosphatidylinositol 4-kinase alpha,PI4KA,116.9,35.76,S172,HSLRVLEELEGVRRRSFNDFRSILPSNLLTV,_S(ph)FNDFR_,-0.58,-0.55,-0.97,-0.8,0.15,0.28,0.55, ,0.03,0.28,0.58,0.53,0.12,0.06,0.18, ,-0.56,-0.89,0.21,0.55,0.16,0.55,0.09,0.18,,,,,,,0,0,,cytosol,1-phosphatidylinositol 4-kinase activity,phosphatidylinositol biosynthetic process,,
P42356,P42356,Phosphatidylinositol 4-kinase alpha,PI4KA,98.29,87.65,S199,LLTVCQEGTLKRKTSSVSSISQVSPERGMPP,_TSS(ph)VSS(ph)ISQVSPER_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,1-phosphatidylinositol 4-kinase activity,phosphatidylinositol biosynthetic process,,
P42356,P42356,Phosphatidylinositol 4-kinase alpha,PI4KA,98.29,87.65,S202,VCQEGTLKRKTSSVSSISQVSPERGMPPPSS,_TSS(ph)VSS(ph)ISQVSPER_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,1-phosphatidylinositol 4-kinase activity,phosphatidylinositol biosynthetic process,,
O75925,O75925,E3 SUMO-protein ligase PIAS1,PIAS1,64.89,61.1,S503,SPLNNKGILSLPHQASPVSRTPSLPAVDTSY,_GILSLPHQAS(ph)PVSR_,-0.28, , ,0.33, , , , ,-0.2, , ,0.44, , , , ,-0.28,0.33,,,-0.2,0.44,,,,,,,,,NA,NA,,nuclear speck,androgen receptor binding,androgen receptor signaling pathway,,
Q7Z2X4-3,Q7Z2X4,"PTB-containing, cubilin and LRP1-interacting protein",PID1,219.79,212.36,S247,IHSNSSSEEVSQELESDDG____________,_IHSNSSSEEVSQELES(ph)DDG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,mitochondrion,,cellular response to fatty acid,,
Q92508,Q92508,Piezo-type mechanosensitive ion channel component 1,PIEZO1,103.71,94.02,S1391,DTLGPKDPGLEPGPDSPGGSSPPRRQWWRPW,_DPGLEPGPDS(ph)PGGS(ph)SPPR_, , , , ,0.07,0.05,0.6,0.35, , , , ,0.19,0,0.17,0.36,,,0.06,0.48,,,0.1,0.26,,,,,,,NA,NA,,endoplasmic reticulum,cation channel activity,detection of mechanical stimulus,,
Q92508,Q92508,Piezo-type mechanosensitive ion channel component 1,PIEZO1,184.87,184.87,S1646,REAGASLYQGLMRTASELLLDRRLRIPELEE,_TAS(ph)ELLLDR_,-0.12,0.08,-0.39,-0.21,0.66,-1.86,-0.45,-0.2,-0.15,0.41,-0.17,-0.31,-0.28,-2.22,-0.54,-0.57,-0.01,-0.3,-0.1,-0.32,0.16,-0.24,-0.94,-0.55,,,,,,,0,0,,endoplasmic reticulum,cation channel activity,detection of mechanical stimulus,,
D6RFZ0,Q9H5I5,Piezo-type mechanosensitive ion channel component 2,PIEZO2,67.06,65.19,S2054,_____MTESGMAREESDDELSLGHGRRDSSD,_EES(ph)DDELS(ph)LGHGR_,-0.43,-0.41,-0.75,-0.69,0,-0.49,-0.47,-0.17,-0.5,-0.39,-0.34,-0.63,0.02,-0.44,0.08,0.2,-0.42,-0.72,-0.23,-0.31,-0.44,-0.48,-0.19,0.14,,,,,,,0,0,,,,,,
D6RFZ0,Q9H5I5,Piezo-type mechanosensitive ion channel component 2,PIEZO2,67.06,65.19,S2059,MTESGMAREESDDELSLGHGRRDSSDSLKSI,_EES(ph)DDELS(ph)LGHGR_,-0.43,-0.41,-0.75,-0.69,0,-0.49,-0.47,-0.17,-0.5,-0.39,-0.34,-0.63,0.02,-0.44,0.08,0.2,-0.42,-0.72,-0.23,-0.31,-0.44,-0.48,-0.19,0.14,,,,,,,0,0,,,,,,
F5GWN5,O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,PIK3C2B,232.74,188.35,Y228,VLGGGGQGRLLGSVDYDGINDAITRLNLKST,_LLGSVDY(ph)DGINDAITR_,0.82, , , , , , , ,0.47, , , , , , , ,0.82,,,,0.47,,,,,,,,,,NA,NA,,,ATP binding,phosphatidylinositol phosphorylation,,
P42336,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,92.27,75.6,Y508,EEHANWSVSREAGFSYSHAGLSNRLARDNEL,_EAGFSY(ph)SHAGLSNR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,Atypical,,,,NA,NA,,"1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex",1-phosphatidylinositol-3-kinase activity,angiogenesis,,
P27986,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,344.37,344.37,Y607,KKLNEWLGNENTEDQYSLVEDDEDLPHHDEK,_KLNEWLGNENTEDQY(ph)SLVEDDEDLPHHDEK_,2.67, , , , , , , ,2.05, , , , , , , ,2.67,,,,2.05,,,, +, +,,,,,NA,NA,,"1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex",1-phosphatidylinositol binding,B cell differentiation,,
P27986,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,135.47,135.47,Y467,YNTQFQEKSREYDRLYEEYTRTSQEIQMKRT,_SREYDRLY(ph)EEYTR_,-0.62,-1.09,-0.2, ,-0.19,-0.35,-0.22,-0.14,-0.51,-0.83,-0.33, ,0.02,-0.09,0.09,0.06,-0.83,-0.2,-0.27,-0.18,-0.66,-0.33,-0.03,0.07,,,,,,,0,0,,"1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex",1-phosphatidylinositol binding,B cell differentiation,,
O00459,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,324.31,264.41,Y605,KINEWLGIKNETEDQYALMEDEDDLPHHEER,_NETEDQY(ph)ALMEDEDDLPHHEER_,3.7,3.41,3.12, ,0.82,0.78,0.74,0.82,3.63,3.17,1.65, ,0.96,0.97,1.01,1.03,3.56,3.12,0.8,0.78,3.42,1.65,0.96,1.02, +, +,,,,,5,5,23.08,cytosol,phosphatidylinositol 3-kinase regulator activity,blood coagulation,,+
O00459,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,138.55,138.55,Y464,YHQQYQDKSREYDQLYEEYTRTSQELQMKRT,_SREYDQLY(ph)EEYTR_,-0.09, ,0.38, ,0.45,0.42,0.75,0.31,-0.07, ,0.27, ,0.51,0.51,0.89,0.49,-0.09,0.38,0.44,0.55,-0.07,0.27,0.51,0.7,,,,,,,0,0,,cytosol,phosphatidylinositol 3-kinase regulator activity,blood coagulation,,+
Q92569-3,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,349.05,336.15,Y341,LNVWLGIKNEDADENYFINEEDENLPHYDEK,_NEDADENY(ph)FINEEDENLPHYDEK_,3.49, , , ,1.28, , , ,3.15, , , ,1.05, , , ,3.49,,1.28,,3.15,,1.05,, +, +,,,,,NA,NA,,cytosol,1-phosphatidylinositol-3-kinase activity,insulin receptor signaling pathway,,
Q92569-3,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,78.9,67.19,Y199,YHSQYQEKSKEYDRLYEEYTRTSQEIQMKRT,_EYDRLY(ph)EEYTR_, , ,0.42, , , , , , , ,0.4, , , , , ,,0.42,,,,0.4,,,,,,,,,NA,NA,,cytosol,1-phosphatidylinositol-3-kinase activity,insulin receptor signaling pathway,,
Q9Y2I7,Q9Y2I7,1-phosphatidylinositol 3-phosphate 5-kinase,PIKFYVE,101.32,100.58,S493,EQIAEEGDDNLANSASPSKRTSVSSFQSTVD,_FDDS(ph)DTEQIAEEGDDNLANSAS(ph)PSK_, , , , , , ,0.3,-0.1, , , , , , ,0.11,0.21,,,,0.11,,,,0.16,,,,,,,NA,NA,,cytoplasmic vesicle,1-phosphatidylinositol-3-phosphate 5-kinase activity,cellular protein metabolic process,,
Q9Y2I7,Q9Y2I7,1-phosphatidylinositol 3-phosphate 5-kinase,PIKFYVE,96.67,71.74,S307,VQEDAGKSPARNRSASITNLSLDRSGSPMVP,_SAS(ph)ITNLSLDR_, , , , ,0.85, ,-0.14,1.41, , , , ,0.39, ,-1.09,0.56,,,0.85,0.83,,,0.39,-0.04,,,,,,,NA,NA,,cytoplasmic vesicle,1-phosphatidylinositol-3-phosphate 5-kinase activity,cellular protein metabolic process,,
D6R955,P78337,Pituitary homeobox 1,PITX1,186.19,186.19,S46,FHLARPADPREPLENSASESSDTELPEKERG,_EPLENS(ph)AS(ph)ESS(ph)DTELPEK_,0.04,-0.11,-0.36,-0.21,0.39,0.57,0.1,0.41,0.1,0.17,0.05,0.15,-0.06,0.04,0.15,0.22,-0.03,-0.28,0.49,0.26,0.13,0.1,-0.01,0.19,,,,,,,0,0,,cytoplasm,protein binding transcription factor activity,branchiomeric skeletal muscle development,,
D6R955,P78337,Pituitary homeobox 1,PITX1,186.19,186.19,S48,LARPADPREPLENSASESSDTELPEKERGGE,_EPLENS(ph)AS(ph)ES(ph)SDTELPEK_,0.04,-0.11,-0.36,-0.21,0.39,0.57,0.1,0.41,0.1,0.17,0.05,0.15,-0.06,0.04,0.15,0.22,-0.03,-0.28,0.49,0.26,0.13,0.1,-0.01,0.19,,,,,,,0,0,,cytoplasm,protein binding transcription factor activity,branchiomeric skeletal muscle development,,
D6R955,P78337,Pituitary homeobox 1,PITX1,186.19,186.19,S51,PADPREPLENSASESSDTELPEKERGGEPKG,_PADPREPLENS(ph)AS(ph)ESS(ph)DTELPEK_,0.04,-0.11,-0.36,-0.21,0.39,0.89,0.03,0.23,0.1,0.17,0.05,0.15,-0.06,0.01,0.12,0.26,-0.03,-0.28,0.66,0.13,0.13,0.1,-0.03,0.19,,,,,,,0,0,,cytoplasm,protein binding transcription factor activity,branchiomeric skeletal muscle development,,
P14618,P14618,Pyruvate kinase isozymes M1/M2,PKM,87.18,86.9,Y148,ELKKGATLKITLDNAYMEKCDENILWLDYKN,_ITLDNAY(ph)MEK_,-0.55, ,-0.58, ,-0.07, , ,-1.63,-0.14, ,-0.34, ,0.07, , ,-1.81,-0.55,-0.58,-0.07,-1.63,-0.14,-0.34,0.07,-1.81, +, +,,,,,6,6,33.89,cytosol,ATP binding,glycolysis,,
P14618,P14618,Pyruvate kinase isozymes M1/M2,PKM,165.38,161.07,Y105,NVRTATESFASDPILYRPVAVALDTKGPEIR,_TATESFASDPILY(ph)RPVAVALDTK_, , , , ,-0.24, ,0.06, , , , , ,0, ,0.12, ,,,-0.24,0.06,,,0,0.12,,,,,,,NA,NA,,cytosol,ATP binding,glycolysis,,
P14618,P14618,Pyruvate kinase isozymes M1/M2,PKM,203.76,166.82,S37,MADTFLEHMCRLDIDSPPITARNTGIICTIG,_LDIDS(ph)PPITAR_,-0.47,-0.4,-0.49,-0.47,-0.51,-0.49,-0.21,-0.41,-0.27,-0.23,-0.31,-0.29,-0.27,-0.22,-0.16,-0.42,-0.43,-0.48,-0.5,-0.3,-0.25,-0.3,-0.25,-0.28,,,,,,,0,0,,cytosol,ATP binding,glycolysis,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,86.08,85.79,S533,LLRRLIPNATGTGTFSPGASPGSEARTTGDI,_LIPNATGTGTFS(ph)PGAS(ph)PGSEAR_, , , , ,-0.28,-0.22,-0.81,-0.65, , , , ,-0.08,-0.23,-0.51,-0.42,,,-0.25,-0.73,,,-0.15,-0.46,,,AGC,,,,NA,NA,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,86.08,85.79,S537,LIPNATGTGTFSPGASPGSEARTTGDISVEK,_LIPNATGTGTFS(ph)PGAS(ph)PGSEAR_, , , , ,-0.28,-0.22,-0.81,-0.65, , , , ,-0.08,-0.23,-0.51,-0.42,,,-0.25,-0.73,,,-0.15,-0.46,,,AGC,,,,NA,NA,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,64,62.81,S559,TTGDISVEKLNLGTDSDSSPQKSSRDPPSSP,_LNLGTDS(ph)DS(ph)SPQK_, , , , ,0.21,-0.07, , , , , , ,0.09,-0.13, , ,,,0.08,,,,-0.01,,,,AGC,,,,NA,NA,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,130.02,89.83,S561,GDISVEKLNLGTDSDSSPQKSSRDPPSSPSS,_LNLGTDSDS(ph)SPQK_, , , ,0.48,0.21,-0.07,0.02, , , , ,0.04,0.09,-0.13,-0.08, ,,0.48,0.08,0.02,,0.04,-0.01,-0.08,,,AGC,,,,NA,NA,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,173.28,173.28,S562,DISVEKLNLGTDSDSSPQKSSRDPPSSPSSL,_LNLGTDSDSS(ph)PQK_,0.53,0.39,0.36, ,-0.28,-0.04,0.02,-0.06,-0.03,0.08,0.07, ,-0.03,-0.06,-0.08,-0.06,0.46,0.36,-0.16,-0.02,0.03,0.07,-0.05,-0.07,,,AGC,,,,0,0,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16512,Q16512,Serine/threonine-protein kinase N1,PKN1,167.28,153.62,S916,VSNFDEEFTGEAPTLSPPRDARPLTAAEQAA,_TDVSNFDEEFTGEAPTLS(ph)PPR_, , , , , ,0.11, ,0.02, , , , , ,0.36, ,-0.18,,,0.11,0.02,,,0.36,-0.18,,,AGC,,,,NA,NA,,cleavage furrow,androgen receptor binding,activation of JUN kinase activity,,
Q16513-4,Q16513,Serine/threonine-protein kinase N2,PKN2,156.11,151.21,S583,FDLEPEPPPAPPRASSLGEIDESSELRVLDI,_ASS(ph)LGEIDESSELR_,-0.17,-0.12,1.64,1.32,1.97,2.02, ,1.76,0.37,0.45,1.72,1.38,1.84,1.76, ,1.84,-0.15,1.49,2,1.76,0.41,1.56,1.8,1.84, +, +,AGC,,,,1,1,38.4,apical junction complex,ATP binding,apical junction assembly,,
Q16513-4,Q16513,Serine/threonine-protein kinase N2,PKN2,129.59,129.59,T958,VSNFDDEFTSEAPILTPPREPRILSEEEQEM,_GREDVSNFDDEFTSEAPILT(ph)PPREPR_,-0.17,-0.53,-0.3,-0.77, , , , ,0.01,-0.07,-0.1,-0.15, , , , ,-0.34,-0.52,,,-0.03,-0.12,,,,,AGC,,,,NA,NA,,apical junction complex,ATP binding,apical junction assembly,,
B8QGS9,Q99959,Plakophilin-2,PKP2,106.6,88.97,S151,VEERSLRHPLRRLEISPDSSPERAHYTHSDY,_LEIS(ph)PDSS(ph)PER_, , , , ,-0.92,-0.45,-0.32,-0.61, , , , ,-0.14,0,-0.08,-0.02,,,-0.66,-0.45,,,-0.07,-0.05,,,,,,,NA,NA,,,,,,
B8QGS9,Q99959,Plakophilin-2,PKP2,106.6,88.97,S155,SLRHPLRRLEISPDSSPERAHYTHSDYQYSQ,_LEIS(ph)PDSS(ph)PER_, , , , , ,-0.19,-0.31,-0.41, , , , , ,-0.02,-0.05,-0.47,,,-0.19,-0.36,,,-0.02,-0.24,,,,,,,NA,NA,,,,,,
Q9Y446,Q9Y446,Plakophilin-3,PKP3,100.4,67.4,Y84,PEPEAETARGTSRGQYHTLQAGFSSRSQGLS,_GQY(ph)HTLQAGFSSR_,2.77, ,2.03, , , , , ,1.96, ,1.08, , , , , ,2.77,2.03,,,1.96,1.08,,, +, +,,,,,NA,NA,,cell-cell junction,,cell adhesion,,
Q9Y446,Q9Y446,Plakophilin-3,PKP3,74.53,57.06,Y176,PVSFHERGGVGSRADYDTLSLRSLRLGPGGL,_ADY(ph)DTLSLR_,1.29, , , , , , , ,0.67, , , , , , , ,1.29,,,,0.67,,,, +,,,,,,NA,NA,,cell-cell junction,,cell adhesion,,
Q9Y446,Q9Y446,Plakophilin-3,PKP3,148.26,132.2,S313,HGFNSYGSHRTLQRLSSGFDDIDLPSAVKYL,_TLQRLS(ph)SGFDDIDLPSAVK_, ,0.8,0.5,0.83, , , , , ,3.95,0.81,3.8, , , , ,0.8,0.67,,,3.95,2.97,,,, +,,,,,NA,NA,,cell-cell junction,,cell adhesion,,
Q9Y446,Q9Y446,Plakophilin-3,PKP3,96.85,73.62,S238,SSRAGGLDWPEATEVSPSRTIRAPAVRTLQR,_AGGLDWPEATEVS(ph)PSR_, , , , , ,-0.21,0.07, , , , , , ,-0.21,0.3, ,,,-0.21,0.07,,,-0.21,0.3,,,,,,,NA,NA,,cell-cell junction,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,60.31,49.54,Y415,DLRSAVSPDLHITPIYEGRTYYSPVYRSPNH,_SAVSPDLHITPIY(ph)EGR_, , ,1.3, , ,0.21,0.33,0.47, , ,0.69, , ,-0.3,0.31,0.27,,1.3,0.21,0.4,,0.69,-0.3,0.29, +,,,,,,NA,NA,,desmosome,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,117.41,112.11,Y1168,STDYSTQYGLKSTTNYVDFYSTKRPSYRAEQ,_STTNY(ph)VDFYSTK_,0.52, ,-0.63, ,0.1,-0.02,-0.02,0.06,0.41, ,0.39, ,0.07,-0.04,0.72,0.47,0.52,-0.63,0.04,0.02,0.41,0.39,0.01,0.6,,,,,,,0,0,,desmosome,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,99.93,98.37,Y1156,DPYFDDRVHFPASTDYSTQYGLKSTTNYVDF,_VHFPASTDY(ph)STQYGLK_, , ,0.08, , , , ,0.15, , ,0.45, , , , ,0.74,,0.08,,0.15,,0.45,,0.74,,,,,,,NA,NA,,desmosome,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,165.3,165.3,Y478,LTYQRNNYALNTTATYAEPYRPIQYRVQECN,_NNYALNTTATY(ph)AEPYRPIQYR_,-0.09, , , ,0.18,0.26,0.02,0.15,0.42, , , ,0.03,-0.06,0.36,0.41,-0.09,,0.22,0.08,0.42,,-0.02,0.38,,,,,,,NA,NA,,desmosome,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,100.45,100.03,Y372,TVHDMEQFGQQQYDIYERMVPPRPDSLTGLR,_TVHDMEQFGQQQYDIY(ph)ER_,-0.31, ,-0.09, ,0.08,0,-0.22,-0.15,-0.53, ,0.23, ,0.25,0.31,0.35,0.32,-0.31,-0.09,0.04,-0.19,-0.53,0.23,0.28,0.34,,,,,,,0,0,,desmosome,,cell adhesion,,
Q99569-2,Q99569,Plakophilin-4,PKP4,98.28,97.2,S314,PNGPTPQYQTTARVGSPLTLTDAQTRVASPS,_VGS(ph)PLTLTDAQTR_, , , , ,0.42,0.17,0.28,0.19, , , , ,0.57,0.56,0.31,0.35,,,0.3,0.23,,,0.56,0.33,,,,,,,NA,NA,,desmosome,,cell adhesion,,
E7EU42,P47712,Cytosolic phospholipase A2,PLA2G4A,61.56,32.85,S715,NTLNNIDVIKEAMVESIEYRRQNPSRCSVSL,_EAMVES(ph)IEYR_, ,1.19,1.89, , , , , , ,0.07,-0.27, , , , , ,1.19,1.89,,,0.07,-0.27,,, +,,,,,,NA,NA,,,phospholipase activity,phospholipid catabolic process,,
E7EU42,P47712,Cytosolic phospholipase A2,PLA2G4A,128.38,100.21,Y535,ELDAAVADPDEFERIYEPLDVKSKKIHVVDS,_IY(ph)EPLDVK_,0.57, ,-0.33, , , , , ,0.16, ,-0.32, , , , , ,0.57,-0.33,,,0.16,-0.32,,,,,,,,,NA,NA,,,phospholipase activity,phospholipid catabolic process,,
E7EU42,P47712,Cytosolic phospholipase A2,PLA2G4A,115.77,115.77,S434,EELENITTKHIVSNDSSDSDDESHEPKGTEN,_HIVSNDS(ph)S(ph)DS(ph)DDESHEPK_,0.21,-0.04, , ,-0.21,-0.08,0.21,0.04,0.12,0.09, , ,0.11,0.1,0.25,0.18,0.09,,-0.14,0.13,0.11,,0.1,0.22,,,,,,,NA,NA,,,phospholipase activity,phospholipid catabolic process,,
E7EU42,P47712,Cytosolic phospholipase A2,PLA2G4A,115.77,115.77,S435,ELENITTKHIVSNDSSDSDDESHEPKGTENE,_HIVSNDS(ph)S(ph)DS(ph)DDESHEPK_,0.08,0.18,-0.01, ,-0.02,-0.01,0.17,0.1,0.18,0.21,0.29, ,0.24,0.13,0.25,0.21,0.14,-0.01,-0.01,0.13,0.19,0.29,0.18,0.23,,,,,,,0,0,,,phospholipase activity,phospholipid catabolic process,,
E7EU42,P47712,Cytosolic phospholipase A2,PLA2G4A,254.83,253.68,S437,ENITTKHIVSNDSSDSDDESHEPKGTENEDA,_HIVSNDSSDS(ph)DDESHEPK_,0.09,0.24,-0.09,-0.03,0.02,0,0.2,0.25,0.07,0.1,0,0.01,0.33,0.21,0.18,0.28,0.17,-0.06,0.01,0.22,0.08,0,0.27,0.23,,,,,,,0,0,,,phospholipase activity,phospholipid catabolic process,,
Q9Y263,Q9Y263,Phospholipase A-2-activating protein,PLAA,97.18,73.38,S50,VSVSRDRTTRLWAPDSPNRSFTEMHCMSGHS,_LWAPDS(ph)PNR_,-0.51,-0.14, ,-0.04, ,-0.58,-0.11,-0.13,0.51,-0.05, ,-0.27, ,-0.61,-0.25,-0.04,-0.31,-0.04,-0.58,-0.12,0.26,-0.27,-0.61,-0.14,,,,,,,0,0,,extracellular vesicular exosome,phospholipase A2 activator activity,inflammatory response,,
G5E960,Q01970,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3",PLCB3,48.03,43.16,Y639,KAMEQLTKSPMEFVEYNKQQLSRIYPKGTRV,_SPM(ox)EFVEY(ph)NK_, ,0.65, , , , , , , ,0.31, , , , , , ,0.65,,,,0.31,,,,,,,,,,NA,NA,,,,,,
Q8N3E9,Q8N3E9,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3",PLCD3,194.88,183.35,S496,GKKLPAARSEDGRALSDREEEEEDDEEEEEE,_ALS(ph)DREEEEEDDEEEEEEVEAAAQR_, , , ,0.66, , , ,-0.23, , , ,0.43, , , ,-0.13,,0.66,,-0.23,,0.43,,-0.13,,,,,,,NA,NA,,cleavage furrow,calcium ion binding,angiogenesis,,
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,146.96,146.96,Y977,PVPFDEEKIGTERACYRDMSSFPETKAEKYV,_ACY(ph)RDMSSFPETK_,-0.2, ,-0.1, , , ,1.19,1.05,0.64, ,-0.47, , , ,1.61,1.63,-0.2,-0.1,,1.12,0.64,-0.47,,1.62, +, +,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,213.83,213.01,Y771,INEEALEKIGTAEPDYGALYEGRNPGFYVEA,_IGTAEPDY(ph)GALYEGR_,2.11,4.22,3.12, , , ,0.15,0.83,1.57,3.64,1.16, , , ,0.49,1.41,3.52,3.12,,0.53,2.95,1.16,,1.02, +, +,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,203.19,188.12,Y775,ALEKIGTAEPDYGALYEGRNPGFYVEANPMP,_IGTAEPDYGALY(ph)EGRNPGFY(ph)VEANPMPTFK_,1.77, , , , , , , ,1.32, , , , , , , ,1.77,,,,1.32,,,, +, +,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,256.35,251.59,Y783,EPDYGALYEGRNPGFYVEANPMPTFKCAVKA,_NPGFY(ph)VEANPMPTFK_,3.39,3.56,3.46, ,1.1,0.77,1,1.3,2.81,2.91,1.7, ,1.54,1.3,1.3,1.45,3.48,3.46,0.94,1.15,2.86,1.7,1.43,1.38, +, +,,,,,5,5,22.19,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,101.65,73.47,Y1253,QLFHGRAREGSFESRYQQPFEDFRISQEHLA,_Y(ph)QQPFEDFR_,3.97,3.47, , , , , , ,3.25,2.75, , , , , , ,3.74,,,,3.03,,,, +, +,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,89.6,85.84,S1221,LIKIDIFPAKENGDLSPFSGTSLRERGSDAS,_ENGDLS(ph)PFSGTSLR_, , ,0.15,1.62, , , , , , ,-0.22,0.5, , , , ,,1.06,,,,0.19,,, +,,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
P19174-2,P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",PLCG1,165.17,162.67,Y472,RKILIKHKKLAEGSAYEEVPTSMMYSENDIS,_KLAEGSAY(ph)EEVPTSMMYSENDISNSIK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,calcium ion binding,activation of MAPKK activity,,+
Q9UPR0,Q9UPR0,Inactive phospholipase C-like protein 2,PLCL2,67.03,29.47,S454,SSHNTYLIEDQFRGPSDITGYIRALKMGCRS,_GPS(ph)DIT(ph)GYIR_, , , , ,3.27, ,1.63, , , , , ,2.78, ,3.51, ,,,3.27,1.63,,,2.78,3.51, +, +,,,,,NA,NA,,cytoplasm,calcium ion binding,intracellular signal transduction,,
Q13393-2,Q13393,Phospholipase D1,PLD1,152.32,151,Y42,NLDTRELHFEGEEVDYDVSPSDPKIQEVYIP,_ELHFEGEEVDY(ph)DVSPSDPK_,3.74, , , , , , , ,2.84, , , , , , , ,3.74,,,,2.84,,,, +, +,,,,,NA,NA,,endoplasmic reticulum membrane,NAPE-specific phospholipase D activity,chemotaxis,,
Q15149-4,Q15149,Plectin,PLEC,185.84,181.46,S4622,STKGYYSPYSVSGSGSTAGSRTGSRTGSRAG,_GYYSPYSVSGSGS(ph)TAGS(ph)R_, , , , ,1.85,1.94,1.39,1.41, , , , ,2.15,1.48,0.82,0.84,,,1.9,1.4,,,1.86,0.83, +, +,,,,,NA,NA,,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
Q15149-4,Q15149,Plectin,PLEC,185.84,181.46,S4626,YYSPYSVSGSGSTAGSRTGSRTGSRAGSRRG,_GYYSPYSVSGSGS(ph)TAGS(ph)R_, , , , ,2.54,1.87,1.39,1.49, , , , ,2.16,1.51,0.81,0.7,,,2.25,1.44,,,1.87,0.75, +, +,,,,,NA,NA,,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
Q15149-4,Q15149,Plectin,PLEC,136.16,131.68,S4386,DMLSGNAGGFRSRSSSVGSSSSYPISPAVSR,_SSS(ph)VGSSSSYPISPAVSR_, ,-0.03,1.21,1.18,0.38,1.7,-0.53,0.77, ,0.48,1.54,1.52,0.43,1.72,-0.23,0.68,-0.03,1.19,1.19,0.26,0.48,1.53,1.22,0.29, +, +,,,,,1,4,29.49,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
Q15149-4,Q15149,Plectin,PLEC,130.82,122.96,S4389,SGNAGGFRSRSSSVGSSSSYPISPAVSRTQL,_SSS(ph)VGS(ph)SSSYPISPAVSR_, , , , ,1.32,1.39,1.16,1.05, , , , ,0.87,0.9,0.65,0.8,,,1.36,1.1,,,0.88,0.73, +,,,,,,NA,NA,,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
Q15149-4,Q15149,Plectin,PLEC,136.16,131.68,S4396,RSRSSSVGSSSSYPISPAVSRTQLASWSDPT,_SSS(ph)VGSSSSYPIS(ph)PAVSR_, , , , ,-0.53, , ,0.77, , , , ,1.1, , ,0.68,,,-0.53,0.77,,,1.1,0.68,, +,,,,,NA,NA,,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
Q15149-4,Q15149,Plectin,PLEC,169.91,168.77,S4613,LRLLEAAAQSTKGYYSPYSVSGSGSTAGSRT,_GYYS(ph)PYSVSGSGST(ph)AGSR_, , , , ,0.28,1.03, , , , , , ,-0.16,0.51, , ,,,0.7,,,,0.21,,,,,,,,NA,NA,,costamere,structural constituent of muscle,cellular component disassembly involved in execution phase of apoptosis,,
A0JP02,Q9HAU0,Pleckstrin homology domain-containing family A member 5,PLEKHA5,228.51,225.87,S933,REKKKGLNVIGASDQSPLQSPSNLRDNPFRT,_GLNVIGASDQS(ph)PLQS(ph)PSNLR_, , , , ,0.89,0.96,0.88,1, , , , ,0.6,0.49,0.48,0.76,,,0.92,0.94,,,0.55,0.63,,,,,,,NA,NA,,,phospholipid binding,,,
A0JP02,Q9HAU0,Pleckstrin homology domain-containing family A member 5,PLEKHA5,228.51,225.87,S937,KGLNVIGASDQSPLQSPSNLRDNPFRTTQTR,_GLNVIGASDQS(ph)PLQS(ph)PSNLR_, , , , ,0.89,0.96,0.88,0.69, , , , ,0.6,0.49,0.48,0.65,,,0.92,0.79,,,0.55,0.57,,,,,,,NA,NA,,,phospholipid binding,,,
Q9H8W4,Q9H8W4,Pleckstrin homology domain-containing family F member 2,PLEKHF2,195.05,195.05,S239,SDSYSQSLKSPLNDMSDDDDDDDSSD_____,_SPLNDMS(ph)DDDDDDDSS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,transport vesicle,metal ion binding,,,
Q9H8W4,Q9H8W4,Pleckstrin homology domain-containing family F member 2,PLEKHF2,119.41,119.2,S247,KSPLNDMSDDDDDDDSSD_____________,_SPLNDMS(ph)DDDDDDDS(ph)S(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,transport vesicle,metal ion binding,,,
Q9H8W4,Q9H8W4,Pleckstrin homology domain-containing family F member 2,PLEKHF2,195.05,195.05,S248,SPLNDMSDDDDDDDSSD______________,_SPLNDMS(ph)DDDDDDDS(ph)S(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,transport vesicle,metal ion binding,,,
Q9H7P9-3,Q9H7P9,Pleckstrin homology domain-containing family G member 2,PLEKHG2,106.5,105.81,S1261,SHVARLESSDLTPPHSPPPSSRQLLGPNAAA,_LESSDLT(ph)PPHS(ph)PPPSSR_,-0.08,-0.05,-0.25, ,-0.43,-0.21, ,-0.52,-0.01,0.15,0, ,-0.17,-0.1, ,-0.17,-0.07,-0.25,-0.32,-0.52,0.07,0,-0.14,-0.17,,,,,,,0,0,,cytosol,phospholipid binding,apoptotic signaling pathway,,
Q9H7P9-3,Q9H7P9,Pleckstrin homology domain-containing family G member 2,PLEKHG2,106.5,105.81,T1257,GSLASHVARLESSDLTPPHSPPPSSRQLLGP,_LESSDLT(ph)PPHSPPPS(ph)SR_,-0.08,-0.05,-0.25, ,-0.44,-0.32,-0.34,-0.41,-0.01,0.15,0, ,-0.16,-0.15,-0.03,-0.08,-0.07,-0.25,-0.38,-0.37,0.07,0,-0.15,-0.06,,,,,,,0,0,,cytosol,phospholipid binding,apoptotic signaling pathway,,
Q9H7P9-3,Q9H7P9,Pleckstrin homology domain-containing family G member 2,PLEKHG2,49.83,49.83,S1049,VTTPVPKQEGHLDSESPTNIPLTKQGGSRDV,_(gl)QEGHLDSES(ph)PTNIPLTK_, ,-0.8, , , , , , , ,-0.26, , , , , , ,-0.8,,,,-0.26,,,,,,,,,,NA,NA,,cytosol,phospholipid binding,apoptotic signaling pathway,,
A1L390-3,A1L390,Pleckstrin homology domain-containing family G member 3,PLEKHG3,186.89,147.82,S1037,VSQRTTSPGGRPSARSPLSPTETFSWPDVRE,_S(ph)PLS(ph)PTETFSWPDVR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
A1L390-3,A1L390,Pleckstrin homology domain-containing family G member 3,PLEKHG3,186.89,147.82,S1040,RTTSPGGRPSARSPLSPTETFSWPDVRELCS,_S(ph)PLS(ph)PTETFSWPDVR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
A1L390-3,A1L390,Pleckstrin homology domain-containing family G member 3,PLEKHG3,108.71,107.05,S643,GFGSPRLVSRSSSVLSLEGSEKGLARHGSAT,_SSSVLS(ph)LEGS(ph)EK_, , , , ,-0.02,0.03,-0.16, , , , , ,0.32,0.3,0.45, ,,,0,-0.16,,,0.31,0.45,,,,,,,NA,NA,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
A1L390-3,A1L390,Pleckstrin homology domain-containing family G member 3,PLEKHG3,108.71,107.05,S647,PRLVSRSSSVLSLEGSEKGLARHGSATDSLS,_SSSVLS(ph)LEGS(ph)EK_, , , , ,-0.02,0.03,-0.16, , , , , ,0.32,0.3,0.45, ,,,0,-0.16,,,0.31,0.45,,,,,,,NA,NA,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
A1L390-3,A1L390,Pleckstrin homology domain-containing family G member 3,PLEKHG3,121.21,96.37,S76,SNNNSSSWLNVKGPLSPFNSRAAAGPAHHKL,_GPLS(ph)PFNSR_,-0.98,-0.93,-0.44,-0.34,-0.59,-0.87,-0.65,-0.73,-0.46,-0.27,0.26,0.11,-0.12,-0.31,-0.17,-0.02,-0.96,-0.39,-0.72,-0.69,-0.36,0.19,-0.21,-0.09,,,,,,,0,0,,intracellular,phospholipid binding,regulation of Rho protein signal transduction,,
Q2M2Z5-5,Q2M2Z5,Centrosomal protein kizuna,PLK1S1,71.6,71.6,S668,EIEAALRPRNHNTDDSDDFYD__________,_NHNT(ph)DDS(ph)DDFYD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,centrosome,,spindle organization,,
Q2M2Z5-5,Q2M2Z5,Centrosomal protein kizuna,PLK1S1,71.6,71.6,T665,SNSEIEAALRPRNHNTDDSDDFYD_______,_NHNT(ph)DDS(ph)DDFYD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,centrosome,,spindle organization,,
P13797,P13797,Plastin-3,PLS3,61,35.64,S326,PKGQKEGEPRIDINMSGFNETDDLKRAESML,_IDINMS(ph)GFNETDDLK_, , , , , ,0.39, , , , , , , ,-0.03, , ,,,0.39,,,,-0.03,,,,,,,,NA,NA,,cytoplasm,calcium ion binding,,,
P13797,P13797,Plastin-3,PLS3,129.25,129.25,S339,NMSGFNETDDLKRAESMLQQADKLGCRQFVT,_RAES(ph)MLQQADK_, ,-0.03,-0.16,0.1, , , , , ,-0.05,-0.24,-0.01, , , , ,-0.03,-0.02,,,-0.05,-0.12,,,,,,,,,NA,NA,,cytoplasm,calcium ion binding,,,
P29590,P29590,Protein PML,PML,120.41,120.24,S518,RSSPEQPRPSTSKAVSPPHLDGPPSPRSPVI,_AVS(ph)PPHLDGPPS(ph)PR_,-0.14,0.03,-0.79,-0.88,-0.98,-0.88,-0.63,-0.54,-0.24,-0.24,-1.02,-1,-0.92,-0.88,-0.42,-0.3,-0.05,-0.84,-0.93,-0.58,-0.24,-1.01,-0.9,-0.36,, +,,RING finger,,,0,3,22.36,cytoplasm,cobalt ion binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
P29590,P29590,Protein PML,PML,120.41,120.24,S527,STSKAVSPPHLDGPPSPRSPVIGSEVFLPNS,_AVS(ph)PPHLDGPPS(ph)PR_,-0.14,0.03,-0.79,-0.88,-0.98,-0.88,-0.63,-0.54,-0.24,-0.24,-1.02,-1,-0.92,-0.88,-0.42,-0.3,-0.05,-0.84,-0.93,-0.58,-0.24,-1.01,-0.9,-0.36,, +,,RING finger,,,0,3,22.36,cytoplasm,cobalt ion binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,82.77,81.49,S304,DSDEEEEDTENVEAASSGKVTRSPSPVPQEE,_SKFDS(ph)DEEEEDTENVEAAS(ph)S(ph)GK_, , , , , ,0.3, ,0.69, , , , , ,0.87, ,1.03,,,0.3,0.69,,,0.87,1.03,, +,,,,,NA,NA,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,82.77,81.49,S305,SDEEEEDTENVEAASSGKVTRSPSPVPQEEH,_SKFDS(ph)DEEEEDTENVEAAS(ph)S(ph)GK_, , , , , ,0.3, ,0.69, , , , , ,0.87, ,1.03,,,0.3,0.69,,,0.87,1.03,, +,,,,,NA,NA,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,153.32,153.32,S211,QNRRERPSSFRDRQRSPIALPVKQEPPQIDA,_(gl)QRS(ph)PIALPVK_,0.24,0.2,0.29,0.23,0.14,0,0.17,0.45,0.25,0.37,0.22,0.17,-0.16,0.45,-0.31,0.25,0.22,0.26,0.07,0.31,0.31,0.2,0.17,0,,,,,,,0,0,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,107.13,107.13,S290,EGGDGPRLPQRSKFDSDEEEEDTENVEAASS,_SKFDS(ph)DEEEEDTENVEAAS(ph)S(ph)GK_, , , , , ,0.3,0.4,0.69, , , , , ,0.87,0.69,1.03,,,0.3,0.55,,,0.87,0.87,,,,,,,NA,NA,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,47.77,46.55,S311,DTENVEAASSGKVTRSPSPVPQEEHSDPEMT,_S(ph)PS(ph)PVPQEEHS(ph)DPEMTEEEK_, , , , ,0.46, ,0.37, , , , , ,0.37, ,0.38, ,,,0.46,0.37,,,0.37,0.38,,,,,,,NA,NA,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,47.77,46.55,S313,ENVEAASSGKVTRSPSPVPQEEHSDPEMTEE,_S(ph)PS(ph)PVPQEEHS(ph)DPEMTEEEK_, , , , ,0.46, ,0.37, , , , , ,0.37, ,0.38, ,,,0.46,0.37,,,0.37,0.38,,,,,,,NA,NA,,nuclear speck,,,,
Q8TF01-2,Q8TF01,Arginine/serine-rich protein PNISR,PNISR,47.77,46.55,S321,GKVTRSPSPVPQEEHSDPEMTEEEKEYQMML,_S(ph)PS(ph)PVPQEEHS(ph)DPEMTEEEK_, , , , ,0.46, ,0.37, , , , , ,0.37, ,0.38, ,,,0.46,0.37,,,0.37,0.38,,,,,,,NA,NA,,nuclear speck,,,,
Q96T60,Q96T60,Bifunctional polynucleotide phosphatase/kinase,PNKP,211.25,211.25,S114,LHPLTLRWEETRTPESQPDTPPGTPLVSQDE,_WEETRTPES(ph)QPDT(ph)PPGTPLVSQDEK_,0.63,0.6,0.73, ,-0.26,-0.22,-0.2,-0.35,0.27,0.26,-0.33, ,-0.35,-0.09,0.09,0.27,0.61,0.73,-0.24,-0.27,0.26,-0.33,-0.21,0.18,,,,,,,0,0,,nucleolus,ATP binding,"DNA damage response, detection of DNA damage",,
Q96T60,Q96T60,Bifunctional polynucleotide phosphatase/kinase,PNKP,211.25,211.25,T118,TLRWEETRTPESQPDTPPGTPLVSQDEKRDA,_WEETRTPES(ph)QPDT(ph)PPGTPLVSQDEK_,0.63,0.6,0.73, ,0.71,1.07,0.98,-0.4,0.27,0.26,-0.33, ,0.33,0.71,0.69,0.21,0.61,0.73,0.9,0.45,0.26,-0.33,0.53,0.47,,,,,,,0,0,,nucleolus,ATP binding,"DNA damage response, detection of DNA damage",,
Q9H307,Q9H307,Pinin,PNN,72.03,57.08,S450,PDKECKSLSPGKENVSALDMEKESEEKEEKE,_ENVS(ph)ALDMEK_,-1.88,-1.06,-2.84, , ,-1.47,-0.6,-0.34,-1.28,-0.82,-2.68, , ,-1.04,-0.69,-0.56,-1.41,-2.84,-1.47,-0.46,-1.03,-2.68,-1.04,-0.62, +, +,,,,,3,3,32.11,catalytic step 2 spliceosome,DNA binding,cell adhesion,,
Q9H307,Q9H307,Pinin,PNN,256.4,207.07,S347,EEAGEEEEKEIAIVHSDAEKEQEEEEQKQEM,_EIAIVHS(ph)DAEKEQEEEEQK_,-0.12,-0.06,0.02,-0.02,-0.17,-0.15,-0.25,-0.48,-0.02,-0.01,-0.06,0.02,0,0.01,-0.18,-0.24,-0.09,0,-0.16,-0.36,-0.01,-0.02,0,-0.21,,,,,,,0,0,,catalytic step 2 spliceosome,DNA binding,cell adhesion,,
Q9H307,Q9H307,Pinin,PNN,151.06,151.06,S100,RLGGERRTRRESRQESDPEDDDVKKPALQSS,_(gl)QES(ph)DPEDDDVKKPALQSSVVATSK_,-0.21, ,-0.08,-0.03, , , , ,-0.13, ,-0.15,-0.12, , , , ,-0.21,-0.05,,,-0.13,-0.14,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,DNA binding,cell adhesion,,
Q9H307,Q9H307,Pinin,PNN,51.37,51.02,S381,MEEETEVRESEKQQDSQPEEVMDVLEMVENV,_(gl)QQDS(ph)QPEEVMDVLEMVENVK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,DNA binding,cell adhesion,,
P00491,P00491,Purine nucleoside phosphorylase,PNP,49.78,28.21,Y249,RVFGFSLITNKVIMDYESLEKANHEEVLAAG,_VIMDY(ph)ESLEK_, , ,2.6, , , , , , , ,1.87, , , , , ,,2.6,,,,1.87,,, +, +,,,,,NA,NA,,cytoskeleton,drug binding,immune response,,
Q9NZ53-2,Q9NZ53,Podocalyxin-like protein 2,PODXL2,335.25,317.69,S596,GSWGALMGGKRDPEDSDVFEEDTHL______,_RDPEDS(ph)DVFEEDTHL_,0.23,0.24,0.17,0.28, , ,0.05,0.56,0.05,0.15,0.01,-0.08, , ,-0.03,-0.04,0.23,0.23,,0.33,0.1,-0.03,,-0.03,,,,,,,NA,NA,,integral to plasma membrane,glycosaminoglycan binding,leukocyte tethering or rolling,,
Q7Z3K3-5,Q7Z3K3,Pogo transposable element with ZNF domain,POGZ,101.86,86.14,S425,SLDSEPSVPSAAKPPSPEKTAPVASTPSSTP,_SLDSEPSVPSAAKPPS(ph)PEK_,-0.2,-0.13, ,-0.33, , , , ,-0.33,-0.19, ,-0.16, , , , ,-0.17,-0.33,,,-0.26,-0.16,,,,,,,,,NA,NA,,cytoplasm,DNA binding,cell division,,
Q14181,Q14181,DNA polymerase alpha subunit B,POLA2,121.21,120.47,S141,STPETPLTKRSVSTRSPHQLLSPSSFSPSAT,_S(ph)PHQLLS(ph)PSSFS(ph)PSATPSQK_,0.42,0.28,0.2, , ,-0.25,1.42,1.37,0.39,-0.27,-0.18, , ,-0.91,-0.41,-0.2,0.35,0.2,-0.25,1.39,0.1,-0.18,-0.91,-0.3, +,,,,,,2,0,3.49,alpha DNA polymerase:primase complex,DNA binding,DNA replication initiation,,
Q14181,Q14181,DNA polymerase alpha subunit B,POLA2,87.46,87.27,S147,LTKRSVSTRSPHQLLSPSSFSPSATPSQKYN,_S(ph)PHQLLS(ph)PSSFS(ph)PSATPSQK_,0.22,0.85, , , ,-0.25,1.42,1.37,-0.55,-0.55, , , ,-0.91,-0.41,-0.2,0.57,,-0.25,1.39,-0.55,,-0.91,-0.3, +,,,,,,NA,NA,,alpha DNA polymerase:primase complex,DNA binding,DNA replication initiation,,
Q14181,Q14181,DNA polymerase alpha subunit B,POLA2,121.21,120.47,S152,VSTRSPHQLLSPSSFSPSATPSQKYNSRSNR,_S(ph)PHQLLSPSSFS(ph)PSATPSQK_,0.42,0.28,0.2, , ,-0.25,1.42,1.37,0.39,-0.27,-0.18, , ,-0.91,-0.41,-0.2,0.35,0.2,-0.25,1.39,0.1,-0.18,-0.91,-0.3, +,,,,,,2,0,3.49,alpha DNA polymerase:primase complex,DNA binding,DNA replication initiation,,
Q32N00,Q15054,DNA polymerase delta subunit 3,POLD3,155.79,155.79,S307,KVLQKEKKRGKRVALSDDETKETENMRKKRR,_RVALS(ph)DDETK_,-0.3,0.05,-0.06,-0.11,0.27,0.3,0.27,-0.06,-0.13,0.1,0.09,0.17,0.11,2.71,0.18,1.12,-0.12,-0.09,0.28,0.11,-0.01,0.13,1.93,0.73,, +,,,,,0,2,19.89,mitochondrion,,DNA-dependent DNA replication,,
Q9NRF9,Q9NRF9,DNA polymerase epsilon subunit 3,POLE3,331.98,331.98,S122,KKDKDKKTDSEEQDKSRDEDNDEDEERLEEE,_S(ph)RDEDNDEDEERLEEEEQNEEEEVDN_,-0.25,-0.24,-0.06,-0.12,-0.48,-0.7,-0.71,-0.21,-0.26,-0.37,-0.48,-0.27,-0.4,-0.25,-0.41,-0.47,-0.25,-0.09,-0.59,-0.44,-0.31,-0.37,-0.33,-0.44,,,,,,,0,0,,Ada2/Gcn5/Ada3 transcription activator complex,DNA-directed DNA polymerase activity,DNA replication,,
P24928,P24928,DNA-directed RNA polymerase II subunit RPB1,POLR2A,114.2,113.56,S1966,SPTYSLTSPAISPDDSDEEN___________,_GSTYSPTSPGYSPTSPTYSLTSPAISPDDS(ph)DEEN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,"DNA-directed RNA polymerase II, core complex",DNA binding,7-methylguanosine mRNA capping,,
P24928,P24928,DNA-directed RNA polymerase II subunit RPB1,POLR2A,52.2,44.09,S1913,TSPVYTPTSPKYSPTSPTYSPTSPKYSPTSP,_YSPTS(ph)PTYS(ph)PTSPK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,"DNA-directed RNA polymerase II, core complex",DNA binding,7-methylguanosine mRNA capping,,
Q99575,Q99575,Ribonucleases P/MRP protein subunit POP1,POP1,222.39,192.18,S729,DWESRVQAYEEPSVASSPNGKESDLRRSEVP,_VQAYEEPSVAS(ph)SPNGK_,0.19,0.04,0.07,0.1,0.01,0.11,0.06,0.16,0,-0.08,-0.09,-0.1,0.05,-0.13,-0.08,-0.04,0.12,0.08,0.06,0.11,-0.04,-0.1,-0.04,-0.06,,,,,,,0,0,,nucleolar ribonuclease P complex,ribonuclease MRP activity,tRNA 5'-leader removal,,
Q99575,Q99575,Ribonucleases P/MRP protein subunit POP1,POP1,238.19,203.49,S730,WESRVQAYEEPSVASSPNGKESDLRRSEVPC,_VQAYEEPSVASS(ph)PNGK_,-0.01, ,0.05,0.05,-0.26,-0.14, ,0.08,-0.11, ,-0.06,-0.13,-0.3,-0.55, ,-0.26,-0.01,0.05,-0.2,0.08,-0.11,-0.09,-0.42,-0.26,,,,,,,0,0,,nucleolar ribonuclease P complex,ribonuclease MRP activity,tRNA 5'-leader removal,,
Q9H2U2,Q9H2U2,"Inorganic pyrophosphatase 2, mitochondrial",PPA2,200.63,198.92,S317,CTQEEARSLVESVSSSPNKESNEEEQVWHFL,_SLVESVSSS(ph)PNK_,0.47,0.47,0.38,0.45,0.11,0.2,0.18,0.25,0.25,0.25,0.23,0.17,0.63,-0.04,0.35,0.18,0.47,0.42,0.16,0.22,0.25,0.2,0.33,0.27,,,,,,,0,0,,mitochondrial matrix,inorganic diphosphatase activity,diphosphate metabolic process,,
A8MV53,Q9NQ55,Suppressor of SWI4 1 homolog,PPAN,199.61,183.25,S359,RKKSLEGMKKARVGGSDEEASGIPSRTASLE,_VGGS(ph)DEEASGIPSR_,-0.15,-0.12,-0.23,-0.07,-0.35,-0.34,-0.49,-0.33,-0.33,-0.23,-0.38,-0.34,-0.82,-0.47,-0.7,-0.49,-0.14,-0.15,-0.35,-0.41,-0.28,-0.36,-0.64,-0.59,,,,,,,0,0,,cytoplasm,,,,
Q13136-2,Q13136,Liprin-alpha-1,PPFIA1,179.24,175.38,S239,NHEQENTPSTSGKRSSDGSLSHEEDLAKVIE,_RSS(ph)DGS(ph)LSHEEDLAK_,-0.34,-0.37,-0.28,-0.24,0.03,-0.14,0.07,0.32,-0.12,-0.01,-0.07,0.18,0.17,0.73,0.68,0.33,-0.36,-0.26,-0.05,0.2,-0.06,0.06,0.48,0.52,,,,,,,0,0,,cytoplasm,signal transducer activity,cell-matrix adhesion,,
Q13136-2,Q13136,Liprin-alpha-1,PPFIA1,179.24,175.38,S242,QENTPSTSGKRSSDGSLSHEEDLAKVIELQE,_RSS(ph)DGS(ph)LSHEEDLAK_,-0.45,-0.37,-0.48,-0.24,0.02,-0.14,0.08,0.36,-0.01,-0.01,-0.17,0.18,0.26,0.73,0.53,0.42,-0.41,-0.36,-0.06,0.23,-0.01,0.01,0.51,0.48,,,,,,,0,0,,cytoplasm,signal transducer activity,cell-matrix adhesion,,
Q86W92-2,Q86W92-2,Liprin-beta-1,PPFIBP1,181.64,160.29,Y336,DTVVLAQGKKGKDGEYEELLNSSSISSLLDA,_GKDGEY(ph)EELLNSSSISSLLDAQGFSDLEK_, , ,1.58, , , , , , , ,1.07, , , , , ,,1.58,,,,1.07,,, +, +,,,,,NA,NA,,plasma membrane,,cell adhesion,,
Q86W92-2,Q86W92,Liprin-beta-1,PPFIBP1,258.62,257.37,S999,HMLKEDDMFKDFAARSPSASITDEDSNV___,_DFAARS(ph)PSAS(ph)IT(ph)DEDSNV_,0.03,-0.47,0.38, ,0.53,0.62,0.45,0.7,0.4,0.03,0.84, ,0.82,0.89,0.63,0.64,-0.2,0.38,0.57,0.58,0.22,0.84,0.85,0.63,,,,,,,0,0,,plasma membrane,,cell adhesion,,
Q86W92-2,Q86W92,Liprin-beta-1,PPFIBP1,64.26,63.85,S1001,LKEDDMFKDFAARSPSASITDEDSNV_____,_DFAARS(ph)PS(ph)ASITDEDSNV_, , , , ,0.48,0.63,0.43, , , , , ,0.75,0.97,0.7, ,,,0.56,0.43,,,0.86,0.7,,,,,,,NA,NA,,plasma membrane,,cell adhesion,,
Q86W92-2,Q86W92,Liprin-beta-1,PPFIBP1,196.8,177.5,S1003,EDDMFKDFAARSPSASITDEDSNV_______,_DFAARS(ph)PSAS(ph)IT(ph)DEDSNV_,0.03, ,0.38, ,0.58,0.61,0.45,0.7,0.4, ,0.84, ,0.89,0.81,0.63,0.64,0.03,0.38,0.59,0.58,0.4,0.84,0.85,0.63,,,,,,,0,0,,plasma membrane,,cell adhesion,,
Q86W92-2,Q86W92,Liprin-beta-1,PPFIBP1,183.27,183.27,S601,SRGIMKLFGKLRRSQSTTFNPDDMSEPEFKR,_SQS(ph)TTFNPDDMSEPEFK_,0.57,0.67,0.18,0.2,0.03,0.03,0.36,0.4,0.27,0.31,0.35,0.52,0.36,0.32,0.5,0.2,0.62,0.19,0.03,0.38,0.29,0.44,0.34,0.36,,,,,,,0,0,,plasma membrane,,cell adhesion,,
Q86W92-2,Q86W92,Liprin-beta-1,PPFIBP1,170.58,170.37,T1005,DMFKDFAARSPSASITDEDSNV_________,_DFAARS(ph)PSAS(ph)IT(ph)DEDSNV_, , , , ,0.44,0.34,0.28,0.34, , , , ,0.8,0.46,0.66,0.05,,,0.39,0.31,,,0.64,0.39,,,,,,,NA,NA,,plasma membrane,,cell adhesion,,
F8VPY7,Q8NEY8,Periphilin-1,PPHLN1,174.24,174.24,S133,RERSPYKRDNTFFRESPVGRKDSPHSRSGSS,_DNTFFRES(ph)PVGR_,-0.67,-0.36,-0.58, , , ,-0.96,-1.74,-0.52,-0.31,-0.45, , , ,-0.82,-0.54,-0.51,-0.58,,-1.3,-0.41,-0.45,,-0.68, +,,,,,,NA,NA,,cytoplasm,RNA binding,ribosome biogenesis,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,144.18,144.18,S687,NSSNNSREKKADRDQSPFSKIKQSSQDNELK,_KADRDQS(ph)PFSK_,-0.03,0.19,0.23,0.17,0.2,-0.06,-0.07,0.22,0.03,0.24,0.14,0.26,0.15,0.13,0.11,0.21,0.09,0.2,0.08,0.08,0.14,0.2,0.14,0.16,,,,,,,0,0,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,81.57,81.57,S744,ENDHVHEKNKKFDHESSPGTDEDKSG_____,_KFDHES(ph)S(ph)PGT(ph)DEDK_,0.23, , , ,0.31,0.09,-0.15,-0.3,-0.2, , , ,0.2,-0.05,0.02,0.1,0.23,,0.2,-0.22,-0.2,,0.08,0.06,,,,,,,NA,NA,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,81.57,81.57,S745,NDHVHEKNKKFDHESSPGTDEDKSG______,_KFDHES(ph)S(ph)PGT(ph)DEDK_,0.31, , , , ,0.05,0.01,0.02,0.44, , , , ,0.17,-0.11,0.2,0.31,,0.05,0.02,0.44,,0.17,0.05,,,,,,,NA,NA,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,81.57,81.57,T748,VHEKNKKFDHESSPGTDEDKSG_________,_KFDHES(ph)S(ph)PGT(ph)DEDK_,0.23, , , ,0.31,0.09,-0.15,-0.14,-0.2, , , ,0.2,-0.05,0.02,0.15,0.23,,0.2,-0.14,-0.2,,0.08,0.09,,,,,,,NA,NA,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,103.87,76.2,S356,YRTPSRSRSRDRFRRSETPPHWRQEMQRAQR,_S(ph)ET(ph)PPHWR_,-0.13,0.09,-0.12,-0.22,-0.04,-0.39,-0.36,-0.35,-0.28,-0.17,-0.08,-0.15,-0.08,-0.15,-0.09,-0.28,-0.02,-0.17,-0.2,-0.35,-0.22,-0.12,-0.11,-0.18,,,,,,,0,0,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
E9PG73,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,103.87,76.2,T358,TPSRSRSRDRFRRSETPPHWRQEMQRAQRMR,_S(ph)ET(ph)PPHWR_,-0.13,0.09,-0.12,-0.22,-0.04,-0.39,-0.36,-0.35,-0.28,-0.17,-0.08,-0.15,-0.08,-0.15,-0.09,-0.28,-0.02,-0.17,-0.2,-0.35,-0.22,-0.12,-0.11,-0.18,,,,,,,0,0,,cytoplasm,peptidyl-prolyl cis-trans isomerase activity,protein folding,,
Q9Y3C6,Q9Y3C6,Peptidyl-prolyl cis-trans isomerase-like 1,PPIL1,79.14,79.14,S149,QGIGMVNRVGMVETNSQDRPVDDVKIIKAYP,_VGMVETNS(ph)QDRPVDDVK_,-0.61, , , , , , , ,0.16, , , , , , , ,-0.61,,,,0.16,,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,peptidyl-prolyl cis-trans isomerase activity,"mRNA splicing, via spliceosome",,
Q8WUA2,Q8WUA2,Peptidyl-prolyl cis-trans isomerase-like 4,PPIL4,131.99,130.14,S178,DDPFDDPPDLLIPDRSPEPTREQLDSGRIGA,_INHTVILDDPFDDPPDLLIPDRS(ph)PEPTR_, , ,-1.12, ,0.27, , , , , ,-0.81, ,-0.31, , , ,,-1.12,0.27,,,-0.81,-0.31,, +,,,,,,NA,NA,,nucleus,nucleotide binding,protein folding,,
O43314-2,O43314,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,PPIP5K2,142.23,137.87,S1006,LHYTSGVGTGRRRRRSGEQITSSPVSPKSLA,_S(ph)GEQITSSPVS(ph)PK_, , , , ,0.67,0.71,0.55,0.48, , , , ,0.94,0.88,0.66,0.78,,,0.69,0.52,,,0.91,0.72,,,,,,,NA,NA,,cytosol,acid phosphatase activity,inositol metabolic process,,
O43314-2,O43314,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,PPIP5K2,142.23,137.87,S1016,RRRRRSGEQITSSPVSPKSLAFTSSIFGSWQ,_S(ph)GEQITSSPVS(ph)PK_, , , , ,0.67,0.71,0.55,0.48, , , , ,0.94,0.88,0.66,0.78,,,0.69,0.52,,,0.91,0.72,,,,,,,NA,NA,,cytosol,acid phosphatase activity,inositol metabolic process,,
P35813,P35813,Protein phosphatase 1A,PPM1A,87.82,87.82,T376,VYNRLNPYKNDDTDSTSTDDMW_________,_NDDTDST(ph)STDDM(ox)W_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,calmodulin-dependent protein phosphatase activity,cell cycle arrest,,
Q96QC0,Q96QC0,Serine/threonine-protein phosphatase 1 regulatory subunit 10,PPP1R10,109.72,109.72,S313,APVPGIKIKKKKKVLSPTAAKPSPFEGKTST,_VLS(ph)PTAAKPSPFEGK_,0.26,0.44,1.24,1.3,1.3,1.28, , ,0.36,0.2,1.11,1.17,1.33,1.3, , ,0.35,1.27,1.29,,0.28,1.14,1.32,, +, +,,,,,NA,NA,,chromatin,DNA binding,protein import into nucleus,,
F8VWB4,O14974,Protein phosphatase 1 regulatory subunit 12A,PPP1R12A,82.86,82.77,S862,REKRRSTGVSFWTQDSDENEQEQQSDTEEGS,_STGVSFWTQDS(ph)DENEQEQQS(ph)DTEEGSNK_, , , , , ,0.1, ,0.48, , , , , ,-0.24, ,0.76,,,0.1,0.48,,,-0.24,0.76,,,,,,,NA,NA,,,,,,
F8VWB4,O14974,Protein phosphatase 1 regulatory subunit 12A,PPP1R12A,90.96,90.91,S871,SFWTQDSDENEQEQQSDTEEGSNKKETQTDS,_STGVSFWTQDS(ph)DENEQEQQS(ph)DTEEGSNK_, , , , , ,0.66,0.71,0.48, , , , , ,0.77,0.95,0.76,,,0.66,0.6,,,0.77,0.86,,,,,,,NA,NA,,,,,,
Q8WUF5,Q8WUF5,RelA-associated inhibitor,PPP1R13L,105.38,100.47,S113,GRSESAPTLHPYSPLSPKGRPSSPRTPLYLQ,_SESAPTLHPYS(ph)PLS(ph)PK_,-0.97,-1.15,0.43,0.02,0.14,0.75,1.57, ,0.44,0.41,1.01,0.88,0.14,0.91,1.47, ,-1.06,0.24,0.48,1.57,0.42,0.94,0.57,1.47, +, +,,,,,2,1,22.45,cytoplasm,transcription corepressor activity,apoptotic process,,
Q8WUF5,Q8WUF5,RelA-associated inhibitor,PPP1R13L,59.55,56.79,S110,TPFGRSESAPTLHPYSPLSPKGRPSSPRTPL,_SESAPTLHPYS(ph)PLS(ph)PK_, ,-1.15, , ,0.14,0.39,0.02, , ,0.41, , ,0.14,1.43,0.45, ,-1.15,,0.27,0.02,0.41,,0.92,0.45, +,,,,,,NA,NA,,cytoplasm,transcription corepressor activity,apoptotic process,,
Q8WUF5,Q8WUF5,RelA-associated inhibitor,PPP1R13L,81.41,81.41,S183,QQGPPTPFDFLGRAGSPRGSPLAEGPQAFFP,_AGS(ph)PRGS(ph)PLAEGPQAFFPER_, , , , ,0.47,0.63, ,0.04, , , , ,0.27,0.43, ,0.17,,,0.55,0.04,,,0.35,0.17,,,,,,,NA,NA,,cytoplasm,transcription corepressor activity,apoptotic process,,
Q8WUF5,Q8WUF5,RelA-associated inhibitor,PPP1R13L,81.41,81.41,S187,PTPFDFLGRAGSPRGSPLAEGPQAFFPERGP,_AGS(ph)PRGS(ph)PLAEGPQAFFPER_, , , , ,0.47,0.63, ,0.04, , , , ,0.27,0.43, ,0.17,,,0.55,0.04,,,0.35,0.17,,,,,,,NA,NA,,cytoplasm,transcription corepressor activity,apoptotic process,,
Q6NYC8,Q6NYC8,Phostensin,PPP1R18,178.4,134.01,S368,TQKPEPPESAEKLLESPGVEAGEGEAEKEEA,_LLES(ph)PGVEAGEGEAEK_,-0.38,-0.52,-0.3,-0.62,0.49,0.16,0.16,0.22,-0.05,-0.32,0.07,0.4,0.75,0.67,0.79,0.94,-0.45,-0.45,0.33,0.19,-0.18,0.25,0.71,0.87,,,,,,,0,0,,cytoplasm,,,,
Q6NXS1,Q6NXS1,Putative protein phosphatase inhibitor 2-like protein 3,PPP1R2P3,394.05,392.56,S122,AEGLEPKYRIQEQESSGEEDSDLSPEEREKK,_YRIQEQES(ph)S(ph)GEEDSDLSPEER_,0.24,0.26,1.71,0.33,0.06,0.16,0.12,1.1,-0.03,0.09,0.17,-0.04,-0.07,-0.09,0.01,0.48,0.25,1.18,0.11,0.69,0.03,0.07,-0.08,0.26, +,,,,,,4,0,8.03,,protein phosphatase inhibitor activity,glycogen metabolic process,,
Q6NXS1,Q6NXS1,Putative protein phosphatase inhibitor 2-like protein 3,PPP1R2P3,394.05,392.56,S121,AAEGLEPKYRIQEQESSGEEDSDLSPEEREK,_YRIQEQES(ph)S(ph)GEEDSDLSPEER_,0.24,0.26,0.29,0.33,0.29,0.16,0.41,0.1,-0.03,0.09,0,-0.04,-0.06,-0.09,-0.18,-0.25,0.25,0.31,0.23,0.27,0.03,-0.02,-0.08,-0.21,,,,,,,0,0,,,protein phosphatase inhibitor activity,glycogen metabolic process,,
Q6NXS1,Q6NXS1,Putative protein phosphatase inhibitor 2-like protein 3,PPP1R2P3,58.34,57.1,S127,PKYRIQEQESSGEEDSDLSPEEREKKRQFEM,_IQEQES(ph)S(ph)GEEDS(ph)DLSPEER_, , , , , ,-0.04,0.01, , , , , , ,-0.17,-0.58, ,,,-0.04,0.01,,,-0.17,-0.58,,,,,,,NA,NA,,,protein phosphatase inhibitor activity,glycogen metabolic process,,
Q15435,Q15435,Protein phosphatase 1 regulatory subunit 7,PPP1R7,109.28,101.46,S24,QQQSQEMMEVDRRVESEESGDEEGKKHSSGI,_RVES(ph)EES(ph)GDEEGKK_, , , , , ,-1.51, , , , , , , ,-1.57, , ,,,-1.51,,,,-1.57,, +, +,,,,,NA,NA,,cytoplasm,protein phosphatase type 1 regulator activity,,,
Q15435,Q15435,Protein phosphatase 1 regulatory subunit 7,PPP1R7,109.28,101.46,S27,SQEMMEVDRRVESEESGDEEGKKHSSGIVAD,_RVES(ph)EES(ph)GDEEGKK_, , , , , ,-1.51, , , , , , , ,-1.57, , ,,,-1.51,,,,-1.57,, +, +,,,,,NA,NA,,cytoplasm,protein phosphatase type 1 regulator activity,,,
Q8TF05-2,Q8TF05,Serine/threonine-protein phosphatase 4 regulatory subunit 1,PPP4R1,135.61,135.61,S944,ASIHPASTKISEDAMSTASSTY_________,_ISEDAMS(ph)TAS(ph)S(ph)TY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein phosphatase 4 complex,protein phosphatase type 4 regulator activity,protein phosphorylation,,
Q8TF05-2,Q8TF05,Serine/threonine-protein phosphatase 4 regulatory subunit 1,PPP4R1,135.61,135.61,S947,HPASTKISEDAMSTASSTY____________,_ISEDAMS(ph)TAS(ph)S(ph)TY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein phosphatase 4 complex,protein phosphatase type 4 regulator activity,protein phosphorylation,,
Q8TF05-2,Q8TF05,Serine/threonine-protein phosphatase 4 regulatory subunit 1,PPP4R1,135.61,135.61,S948,PASTKISEDAMSTASSTY_____________,_ISEDAMS(ph)TAS(ph)S(ph)TY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein phosphatase 4 complex,protein phosphatase type 4 regulator activity,protein phosphorylation,,
Q8TF05-2,Q8TF05,Serine/threonine-protein phosphatase 4 regulatory subunit 1,PPP4R1,116.87,115.97,T945,SIHPASTKISEDAMSTASSTY__________,_ISEDAMST(ph)ASS(ph)TY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein phosphatase 4 complex,protein phosphatase type 4 regulator activity,protein phosphorylation,,
Q9NY27,Q9NY27,Serine/threonine-protein phosphatase 4 regulatory subunit 2,PPP4R2,149.84,143.48,S159,SNSLNRMNGVMFPGNSPSYTERSNINGPGTP,_MNGVMFPGNS(ph)PSYTER_,-0.28,-0.18,-0.45,0.02,-0.06,-0.04,0.21,-0.08,-0.16,-0.06,-0.18,-0.01,-0.08,-0.62,0.06,-0.21,-0.23,-0.2,-0.05,0.07,-0.11,-0.09,-0.33,-0.07,,,,,,,0,0,,centrosome,"protein binding, bridging",cellular protein modification process,,
Q9NY27,Q9NY27,Serine/threonine-protein phosphatase 4 regulatory subunit 2,PPP4R2,373.04,369.14,S226,NHSDSSTSESEVSSVSPLKNKHPDEDAVEAE,_NHSDSSTSESEVSSVS(ph)PLK_,0.21,0.2,0.14,0.17,0.46, , ,0.14,-0.04,-0.13,-0.15,-0.05,-0.06, , ,0.1,0.21,0.15,0.46,0.14,-0.08,-0.1,-0.06,0.1,,,,,,,0,0,,centrosome,"protein binding, bridging",cellular protein modification process,,
Q9UPN7,Q9UPN7,Serine/threonine-protein phosphatase 6 regulatory subunit 1,PPP6R1,112.23,112.2,S635,FDDDEEEEDEEEAQGSGESDGEDGAWQGSQL,_IQQFDDDEEEEDEEEAQGS(ph)GES(ph)DGEDGAWQGSQLAR_, , , , , ,-0.06, ,-0.14, , , , , ,0, ,0.4,,,-0.06,-0.14,,,0,0.4,,,,,,,NA,NA,,cytoplasm,,regulation of phosphoprotein phosphatase activity,,
Q9UPN7,Q9UPN7,Serine/threonine-protein phosphatase 6 regulatory subunit 1,PPP6R1,112.23,112.2,S638,DEEEEDEEEAQGSGESDGEDGAWQGSQLARG,_IQQFDDDEEEEDEEEAQGS(ph)GES(ph)DGEDGAWQGSQLAR_, , , , , ,-0.06, ,-0.14, , , , , ,0, ,0.4,,,-0.06,-0.14,,,0,0.4,,,,,,,NA,NA,,cytoplasm,,regulation of phosphoprotein phosphatase activity,,
E9PKF6,Q5H9R7,Serine/threonine-protein phosphatase 6 regulatory subunit 3,PPP6R3,335.59,322.17,S617,EACCKERIQQFDDGGSDEEDIWEEKHIAFTP,_IQQFDDGGS(ph)DEEDIWEEK_,0.03,0.08,-0.03,0.01,0.03,-0.03,0.05,0.1,0.16,0.1,0.2,0.22,-0.13,0,0.05,0.04,0.05,-0.01,0,0.08,0.13,0.21,-0.06,0.04,,,,,,,0,0,,,,,,
E9PKF6,Q5H9R7,Serine/threonine-protein phosphatase 6 regulatory subunit 3,PPP6R3,151.58,133.21,S579,FNDEKFADQDDIGNVSFDRVSDINFTLNTNE,_FADQDDIGNVS(ph)FDR_,-0.04,0.07,0.39,0.25,-0.37, ,-0.9,-0.81,-0.08,-0.13,-0.06,-0.26,-0.26, ,-0.25,-0.42,0.02,0.32,-0.37,-0.86,-0.1,-0.16,-0.26,-0.33,,,,,,,0,0,,,,,,
O43663,O43663,Protein regulator of cytokinesis 1,PRC1,61.34,58.15,S606,SSTVGLQRELSKASKSDATSGILNSTNIQS_,_S(ph)DATS(ph)GILNSTNIQS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,cytokinesis,,
O43663,O43663,Protein regulator of cytokinesis 1,PRC1,61.34,58.15,S610,GLQRELSKASKSDATSGILNSTNIQS_____,_S(ph)DATS(ph)GILNSTNIQS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,cytokinesis,,
A6NG79,Q92733,Proline-rich protein PRCC,PRCC,284.74,284.74,S157,KEPVKIAAPELHKGDSDSEEDEPTKKKTILQ,_IAAPELHKGDS(ph)DS(ph)EEDEPTK_,0.01,0.12,0,-0.2,-0.14,0.04,-0.13,-0.09,0.07,-0.03,0.01,-0.11,-0.05,0.06,0.03,-0.06,0.07,-0.1,-0.05,-0.11,0.02,-0.05,0.01,-0.02,,,,,,,0,0,,nucleus,,,,
A6NG79,Q92733,Proline-rich protein PRCC,PRCC,284.74,284.74,S159,PVKIAAPELHKGDSDSEEDEPTKKKTILQGS,_IAAPELHKGDS(ph)DS(ph)EEDEPTK_,0.01,0.12,0,-0.2,-0.14,0.04,-0.13,-0.09,0.07,-0.03,0.01,-0.11,-0.05,0.06,0.03,-0.06,0.07,-0.1,-0.05,-0.11,0.02,-0.05,0.01,-0.02,,,,,,,0,0,,nucleus,,,,
A6NG79,Q92733,Proline-rich protein PRCC,PRCC,191.13,189.72,S267,AALQVTKQITQEEDDSDEEVAPENFFSLPEK,_(gl)QIT(ph)QEEDDS(ph)DEEVAPENFFSLPEK_,-0.16,0.06,-0.07,-0.07,0,-0.12,-0.16,-0.12,0,0.1,-0.09,-0.02,-0.08,0.01,-0.08,0.08,-0.04,-0.07,-0.06,-0.14,0.05,-0.05,-0.03,0,,,,,,,0,0,,nucleus,,,,
A6NG79,Q92733,Proline-rich protein PRCC,PRCC,88.45,86.29,T261,KAAAKSAALQVTKQITQEEDDSDEEVAPENF,_(gl)QIT(ph)QEEDDS(ph)DEEVAPENFFSLPEK_, , , , ,-0.42, , ,-0.47, , , , ,-0.2, , ,-0.34,,,-0.42,-0.47,,,-0.2,-0.34,,,,,,,NA,NA,,nucleus,,,,
F5H4Y8,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,100.76,87.74,S40,SGGTKDGDRPKILMDSPEDADLFHSEEIKDG,_ILMDS(ph)PEDADLFHSEEIK_, , , ,0.37, , , , , , , ,0.14, , , , ,,0.37,,,,0.14,,,,,,,,,NA,NA,,,,,,
O43741,O43741,5'-AMP-activated protein kinase subunit beta-2,PRKAB2,123.36,121.75,S39,AGGHAPGKEHKIMVGSTDDPSVFSLPDSKLP,_IMVGS(ph)TDDPSVFSLPDSK_, , , , , ,1.28, , , , , , , ,-0.09, , ,,,1.28,,,,-0.09,, +,,,,,,NA,NA,,AMP-activated protein kinase complex,,carnitine shuttle,,
O43741,O43741,5'-AMP-activated protein kinase subunit beta-2,PRKAB2,133.16,126.21,S184,DSMESSETSCRDLSSSPPGPYGQEMYAFRSE,_DLSSS(ph)PPGPYGQEMYAFR_, ,0.03, , ,-0.29,-0.05,0.02,0.72, ,0.25, , ,-0.17,0.06,0.22,0.14,0.03,,-0.16,0.41,0.25,,-0.05,0.18,,,,,,,NA,NA,,AMP-activated protein kinase complex,,carnitine shuttle,,
P10644,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,197.47,197.47,S83,LQKAGTRTDSREDEISPPPPNPVVKGRRRRG,_TDSREDEIS(ph)PPPPNPVVK_,-0.23,-0.23,-0.46,-0.42,0.17,0.03,0.06,0.08,-0.05,-0.06,-0.1,-0.09,0.04,0.64,-0.02,-0.02,-0.23,-0.44,0.1,0.07,-0.06,-0.1,0.37,-0.02,,,,,,,0,0,,cAMP-dependent protein kinase complex,cAMP binding,activation of phospholipase C activity,,
C9JSK5,P31321,cAMP-dependent protein kinase type I-beta regulatory subunit,PRKAR1B,98.64,98.36,S77,NRQILARQKSNSQSDSHDEEVSPTPPNPVVK,_SNSQSDS(ph)HDEEVS(ph)PTPPNPVVK_, , , , ,-0.24, , , , , , , ,-0.14, , , ,,,-0.24,,,,-0.14,,,,,,,,NA,NA,,cAMP-dependent protein kinase complex,cAMP-dependent protein kinase regulator activity,learning or memory,,
C9JSK5,P31321,cAMP-dependent protein kinase type I-beta regulatory subunit,PRKAR1B,102.72,100,S83,RQKSNSQSDSHDEEVSPTPPNPVVKARRRRG,_SNSQSDSHDEEVS(ph)PTPPNPVVK_,-0.51,-0.26,-0.69,-0.8,-0.24,-0.55,-0.43,0.27,-0.14,-0.05,0.02,-0.44,-0.14,-0.05,-0.32,0.33,-0.38,-0.74,-0.39,-0.04,-0.1,-0.19,-0.1,0.04,,,,,,,0,0,,cAMP-dependent protein kinase complex,cAMP-dependent protein kinase regulator activity,learning or memory,,
P13861,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,378.57,377.49,S78,PPEPGPDRVADAKGDSESEEDEDLEVPVPSR,_VADAKGDS(ph)ES(ph)EEDEDLEVPVPSR_,-0.12,-0.12,-0.18,-0.06,-0.87,-0.97,-1.22,-0.44,-0.13,-0.15,-0.18,-0.14,-0.74,-0.6,-0.94,-0.27,-0.12,-0.12,-0.92,-0.78,-0.14,-0.16,-0.67,-0.56,,,,,,,0,0,,cAMP-dependent protein kinase complex,cAMP binding,activation of phospholipase C activity,,
P13861,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,378.57,377.49,S80,EPGPDRVADAKGDSESEEDEDLEVPVPSRFN,_VADAKGDS(ph)ES(ph)EEDEDLEVPVPSR_,-0.12,-0.12,-0.18,-0.06,-0.14,-0.06,-0.1,-0.1,-0.13,-0.15,-0.18,-0.14,-0.15,-0.06,-0.15,-0.14,-0.12,-0.12,-0.1,-0.1,-0.14,-0.16,-0.1,-0.15,,,,,,,0,0,,cAMP-dependent protein kinase complex,cAMP binding,activation of phospholipase C activity,,
P13861,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,130.32,130.32,S99,EDLEVPVPSRFNRRVSVCAETYNPDEEEEDT,_RVS(ph)VCAETYNPDEEEEDTDPR_,-0.13,-0.2,-0.24,-0.23,0.07,-0.38,-0.2, ,-0.1,-0.12,-0.1,0.1,-0.23,-0.73,0.85, ,-0.16,-0.23,-0.14,-0.2,-0.11,0,-0.46,0.85,,,,,,,0,0,,cAMP-dependent protein kinase complex,cAMP binding,activation of phospholipase C activity,,
P17252,P17252,Protein kinase C alpha type,PRKCA,129.02,128,S226,KTKTIRSTLNPQWNESFTFKLKPSDKDRRLS,_STLNPQWNES(ph)FTFK_,0.05,0.11,-0.21,-0.19, , , , ,0.11,0.34,0.02,0.19, , , , ,0.08,-0.2,,,0.23,0.11,,,,,AGC,,,,NA,NA,,cytosol,ATP binding,activation of adenylate cyclase activity,,
P17252,P17252,Protein kinase C alpha type,PRKCA,52.35,52.34,T638,AENFDKFFTRGQPVLTPPDQLVIANIDQSDF,_GQPVLT(ph)PPDQLVIANIDQSDFEGFSY(ph)VNPQFVHPILQSAV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,AGC,,,,NA,NA,,cytosol,ATP binding,activation of adenylate cyclase activity,,
Q05655,Q05655,Protein kinase C delta type,PRKCD,156.29,155.63,Y313,ASRRSDSASSEPVGIYQGFEKKTGVAGEDMQ,_SDSASSEPVGIY(ph)QGFEK_,0.03, ,0.41, ,-0.28, , ,-1.61,-1.14, ,-1.67, ,0.23, , ,-1.44,0.03,0.41,-0.28,-1.61,-1.14,-1.67,0.23,-1.44, +, +,AGC,,,,6,3,13.29,cell-cell junction,ATP binding,activation of phospholipase C activity,,
Q05655,Q05655,Protein kinase C delta type,PRKCD,98.9,98.9,S645,YSNFDQEFLNEKARLSYSDKNLIDSMDQSAF,_ARLS(ph)YSDK_,0.19,0.3,0.33,0.16, ,0.11,0.83,0.64,0.19,0.24,0.37,0.28, ,0.07,-0.2,0.51,0.25,0.25,0.11,0.74,0.21,0.33,0.07,0.2,,,AGC,,,,0,0,,cell-cell junction,ATP binding,activation of phospholipase C activity,,
Q969G5,Q969G5,Protein kinase C delta-binding protein,PRKCDBP,189.05,187.39,S165,QSELGPEQLEAEVGESSDEEPVESRAQRLRR,_APEPLGPADQSELGPEQLEAEVGES(ph)S(ph)DEEPVESR_, , ,-0.63, ,-0.48,-0.41,-0.4,-0.5, , ,-0.19, ,0.17,0,-0.03,0.11,,-0.63,-0.45,-0.45,,-0.19,0.09,0.04,,,,,,,NA,NA,,,,,,
Q969G5,Q969G5,Protein kinase C delta-binding protein,PRKCDBP,189.05,187.39,S166,SELGPEQLEAEVGESSDEEPVESRAQRLRRT,_APEPLGPADQSELGPEQLEAEVGES(ph)S(ph)DEEPVESR_, , ,-0.63, ,-0.48,-0.41,-0.4,-0.5, , ,-0.19, ,0.17,0,-0.03,0.11,,-0.63,-0.45,-0.45,,-0.19,0.09,0.04,,,,,,,NA,NA,,,,,,
B4DJN5,P24723,Protein kinase C eta type,PRKCH,104.55,102.83,S675,EGHLPMINQDEFRNFSYVSPELQP_______,_NFS(ph)YVSPELQP_, , , , , , , , , , , , , , , , ,,,,,,,,,,,AGC,,,,NA,NA,,cytosol,ATP binding,positive regulation of keratinocyte differentiation,,
O94806,O94806,Serine/threonine-protein kinase D3,PRKD3,68.37,67.39,S41,ASPCSSPKTGLSARLSNGSFSAPSLTNSRGS,_LS(ph)NGS(ph)FSAPSLTNSR_, , , , ,-0.36,-0.32,-0.32,-0.17, , , , ,-0.37,-0.41,-1.11,0.11,,,-0.34,-0.24,,,-0.39,-0.38,,,CAMK,,,,NA,NA,,cytoplasm,ATP binding,intracellular signal transduction,,
O94806,O94806,Serine/threonine-protein kinase D3,PRKD3,68.37,67.39,S44,CSSPKTGLSARLSNGSFSAPSLTNSRGSVHT,_LS(ph)NGS(ph)FSAPSLTNSR_, , , , ,-0.36,-0.32,-0.32,-0.17, , , , ,-0.37,-0.41,-1.11,0.11,,,-0.34,-0.24,,,-0.39,-0.38,,,CAMK,,,,NA,NA,,cytoplasm,ATP binding,intracellular signal transduction,,
P78527,P78527,DNA-dependent protein kinase catalytic subunit,PRKDC,124.17,123.82,S3205,LSKIEEKLTPLPEDNSMNVDQDGDPSDRMEV,_LTPLPEDNS(ph)MNVDQDGDPSDR_, ,0.14, ,-0.16,-0.2,-0.33,-0.29,-0.25, ,0.08, ,-0.22,-0.23,-0.55,-0.47,-0.47,0.14,-0.16,-0.27,-0.27,0.08,-0.22,-0.38,-0.47,,,Atypical,,,,0,0,,DNA-dependent protein kinase-DNA ligase 4 complex,ATP binding,apoptotic process,,
O75569,O75569,Interferon-inducible double stranded RNA-dependent protein kinase activator A,PRKRA,90.08,90.08,S18,QSRHRAEAPPLEREDSGTFSLGKMITAKPGK,_EDS(ph)GTFSLGK_,0.78,0.54,0.79,0.84, , , ,0.35,-0.15,0.48,0.02,0.84, , , ,-0.47,0.66,0.82,,0.35,0.2,0.49,,-0.47,,,,,,,NA,NA,,cytosol,double-stranded RNA binding,immune response,,
O43422,O43422,52 kDa repressor of the inhibitor of the protein kinase,PRKRIR,42.32,42.01,S141,EQKHKETNNSNAQNPSEEEGEGQDEDILPLT,_ETNNSNAQNPS(ph)EEEGEGQDEDILPLTLEEK_, , , , , , , ,0.04, , , , , , , ,-0.18,,,,0.04,,,,-0.18,,,,,,,NA,NA,,nucleus,DNA binding,negative regulation of cell proliferation,,
F5GXU2,O60678,Protein arginine N-methyltransferase 3,PRMT3,92.11,91.32,S25,GGRGAVENEEDLPELSDSGDEAAWEDEDDAD,_GAVENEEDLPELS(ph)DS(ph)GDEAAWEDEDDADLPHGK_, , ,0.05, , ,-0.35,-0.24,-1.04, , ,0.06, ,0.01,-0.28,-0.32,-0.56,,0.05,-0.35,-0.58,,0.06,-0.13,-0.44,,,,,,,NA,NA,,,,,,
F5GXU2,O60678,Protein arginine N-methyltransferase 3,PRMT3,92.11,91.32,S27,RGAVENEEDLPELSDSGDEAAWEDEDDADLP,_GAVENEEDLPELS(ph)DS(ph)GDEAAWEDEDDADLPHGK_, , ,0.05, , ,-0.35,-0.24,-1.04, , ,0.06, ,0.01,-0.28,-0.32,-0.56,,0.05,-0.35,-0.58,,0.06,-0.13,-0.44,,,,,,,NA,NA,,,,,,
Q96LA8,Q96LA8,Protein arginine N-methyltransferase 6,PRMT6,281.37,277.38,T21,KRKLESGGGGEGGEGTEEEDGAEREAALERP,_LESGGGGEGGEGT(ph)EEEDGAER_, , , , , ,0.27,-0.05,-0.37, , , , , ,0.25,0.11,-0.11,,,0.27,-0.2,,,0.25,0,,,,,,,NA,NA,,nucleus,histone binding,base-excision repair,,
O43395,O43395,U4/U6 small nuclear ribonucleoprotein Prp3,PRPF3,159.05,156.7,S619,WDEQTSNTKGDDDEESDEEAVKKTNKCVLVW,_GDDDEES(ph)DEEAVKK_, ,-0.33,-0.03,-1.02, ,0.08,-0.41,0.29, ,-0.46,0.3,-0.47, ,-0.03,0.59,0.05,-0.33,-0.44,0.08,-0.02,-0.46,-0.03,-0.03,0.35,,,,,,,0,0,,Cajal body,,"mRNA splicing, via spliceosome",,
Q8NAV1,Q8NAV1,Pre-mRNA-splicing factor 38A,PRPF38A,100.11,73.02,S209,SEEEEEEDEKLERVPSPDHRRRSYRDLDKPR,_LERVPS(ph)PDHR_,-0.18, , , , , , , ,-0.15, , , , , , , ,-0.18,,,,-0.15,,,,,,,,,,NA,NA,,spliceosomal complex,,mRNA processing,,
Q8NAV1,Q8NAV1,Pre-mRNA-splicing factor 38A,PRPF38A,288.19,286.1,S193,EPRVSALEEDMDDVESSEEEEEEDEKLERVP,_VSALEEDMDDVES(ph)S(ph)EEEEEEDEKLER_,-0.32,-0.3,-0.36,-0.32,-0.29,-0.27,-0.33,-0.33,0.03,-0.04,-0.02,-0.26,0.07,-0.11,-0.13,-0.15,-0.31,-0.34,-0.28,-0.33,-0.01,-0.13,-0.02,-0.14,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
Q8NAV1,Q8NAV1,Pre-mRNA-splicing factor 38A,PRPF38A,288.19,286.1,S194,PRVSALEEDMDDVESSEEEEEEDEKLERVPS,_VSALEEDMDDVES(ph)S(ph)EEEEEEDEKLER_,-0.32,-0.3,-0.36,-0.32,-0.29,-0.27,-0.33,-0.33,0.03,-0.04,-0.02,-0.26,0.07,-0.11,-0.13,-0.15,-0.31,-0.34,-0.28,-0.33,-0.01,-0.13,-0.02,-0.14,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
Q5VTL8,Q5VTL8,Pre-mRNA-splicing factor 38B,PRPF38B,329.56,329.56,S527,HSDSKDQSDKHDRRRSQSIEQESQEKQHKNK,_RRS(ph)QS(ph)IEQESQEK_,0.12,0.33,0.12,0.15,0.71,0.53,0.48,0.41,0.38,-0.01,-0.01,0.07,0.67,0.53,0.47,0.46,0.23,0.14,0.62,0.44,0.2,0.03,0.6,0.47,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
Q5VTL8,Q5VTL8,Pre-mRNA-splicing factor 38B,PRPF38B,329.56,329.56,S529,DSKDQSDKHDRRRSQSIEQESQEKQHKNKDE,_RRS(ph)QS(ph)IEQESQEK_,-0.11,0.33,0.12,0.15,0.71,0.59,0.49,0.43,-0.23,-0.01,-0.01,0.07,0.67,0.59,0.48,0.46,0.13,0.14,0.65,0.46,-0.12,0.03,0.63,0.47,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
Q5VTL8,Q5VTL8,Pre-mRNA-splicing factor 38B,PRPF38B,221.77,221.77,S534,SDKHDRRRSQSIEQESQEKQHKNKDETV___,_RRS(ph)QSIEQES(ph)QEK_,0.23, , , , ,0.53, ,0.33,-0.26, , , , ,0.53, ,0.47,0.23,,0.53,0.33,-0.26,,0.53,0.47,,,,,,,NA,NA,,spliceosomal complex,,mRNA processing,,
Q5VTL8,Q5VTL8,Pre-mRNA-splicing factor 38B,PRPF38B,128.74,128.74,S320,EREAKEREKERRRSRSIDRGLERRRSRSRER,_S(ph)RS(ph)IDRGLER_,0.31,-0.05,-0.04,0.07,-0.08,-0.02,0.09,0.15,-0.24,-0.29,-0.08,-0.14,0.03,0.19,-0.09,0.03,0.14,0.02,-0.05,0.12,-0.27,-0.11,0.11,-0.02,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
Q5VTL8,Q5VTL8,Pre-mRNA-splicing factor 38B,PRPF38B,128.74,128.74,S318,RLEREAKEREKERRRSRSIDRGLERRRSRSR,_S(ph)RS(ph)IDRGLER_,-0.15,-0.12,-0.11,-0.09,0.09,0.1,0.01,0.03,-0.47,-0.2,-0.24,-0.52,0.08,0.04,0.15,0.2,-0.13,-0.1,0.1,0.02,-0.33,-0.38,0.06,0.18,,,,,,,0,0,,spliceosomal complex,,mRNA processing,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,113.15,111.28,S933,SPKKKTGKDSGNWDTSGSELSEGELEKRRRT,_DSGNWDT(ph)S(ph)GS(ph)ELS(ph)EGELEK_, , , , ,0.04,-0.03,-0.34,-0.06, , , , ,0.25,-0.03,-0.46,0.1,,,0,-0.19,,,0.12,-0.15,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,113.15,111.28,S935,KKKTGKDSGNWDTSGSELSEGELEKRRRTLL,_DSGNWDT(ph)S(ph)GS(ph)ELS(ph)EGELEK_, , , , ,0.04,0.16,-0.2,-0.06, , , , ,0.25,0.02,0.25,0.1,,,0.1,-0.13,,,0.14,0.18,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,113.15,111.28,S938,TGKDSGNWDTSGSELSEGELEKRRRTLLEQL,_DSGNWDT(ph)S(ph)GS(ph)ELS(ph)EGELEK_, , , , ,0.04,-0.03,-0.34,-1, , , , ,0.25,-0.03,-0.46,0.3,,,0,-0.63,,,0.12,-0.03,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,78.71,78.71,S883,KSKKHKKKSKKRRHKSDSPESDAEREKDKKE,_HKS(ph)DS(ph)PES(ph)DAEREK_, ,-0.29, , , , ,-0.1,0.1, ,0.06, , , , ,0.13,0.11,-0.29,,,0.01,0.06,,,0.12,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,154.55,154.55,S885,KKHKKKSKKRRHKSDSPESDAEREKDKKEKD,_HKS(ph)DS(ph)PES(ph)DAEREK_, ,-0.29, , ,-0.04,-0.14,-0.15,0.04, ,0.06, , ,0.06,-0.02,0.03,-0.26,-0.29,,-0.09,-0.05,0.06,,0.02,-0.11,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,154.55,154.55,S888,KKKSKKRRHKSDSPESDAEREKDKKEKDRES,_HKS(ph)DS(ph)PES(ph)DAEREK_, ,-0.29, , ,-0.04,-0.14,-0.15,0.04, ,0.06, , ,0.06,-0.02,0.03,-0.26,-0.29,,-0.09,-0.05,0.06,,0.02,-0.11,,,,,,,NA,NA,,,,,,
E9PHJ7,O75400,Pre-mRNA-processing factor 40 homolog A,PRPF40A,99.46,98.98,T932,KSPKKKTGKDSGNWDTSGSELSEGELEKRRR,_DSGNWDT(ph)S(ph)GS(ph)ELS(ph)EGELEK_, , , , , ,0.03,-0.07,-0.17, , , , , ,-0.36,0.07,0.14,,,0.03,-0.12,,,-0.36,0.11,,,,,,,NA,NA,,,,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,120.88,117.43,S142,GKVQSGMGLILQGYESGSEEEGEIHEKARNG,_VQSGMGLILQGYES(ph)GS(ph)EEEGEIHEK_, , , , ,-0.39, , ,-1.17, , , , ,0.01, , ,-0.58,,,-0.39,-1.17,,,0.01,-0.58, +,,CMGC,,,,NA,NA,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,120.88,117.43,S144,VQSGMGLILQGYESGSEEEGEIHEKARNGNR,_VQSGMGLILQGYES(ph)GS(ph)EEEGEIHEK_, , , , ,-0.39, , ,-1.17, , , , ,0.01, , ,-0.58,,,-0.39,-1.17,,,0.01,-0.58, +,,CMGC,,,,NA,NA,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,96.76,60.85,S277,KVKIEDKSKSKDRKKSPIINESRSRDRGKKS,_S(ph)PIINESR_,-0.12,0.32,0.71,0.77,-0.06,-0.28,-0.35,-0.61,-0.09,0.27,0.29,0.88,0.02,-0.51,-0.22,-0.37,0.12,0.74,-0.17,-0.48,0.1,0.62,-0.22,-0.29,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,269.63,231.75,S23,_______MEDANSEKSINEENGEVSEDQSQN,_S(ph)INEENGEVS(ph)EDQSQNK_,-0.19,-0.52,-0.2,-0.37,-0.24,-0.23,-0.24,-0.39,-0.23,-0.4,-0.32,-0.1,-0.11,0,-0.09,-0.24,-0.34,-0.28,-0.23,-0.31,-0.31,-0.21,-0.05,-0.17,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,217.89,217.36,S32,DANSEKSINEENGEVSEDQSQNKHSRHKKKK,_S(ph)INEENGEVS(ph)EDQSQNK_, , , , ,-0.56,-0.18,-0.32,-0.55, , , , ,0.15,-0.11,-0.23,-0.29,,,-0.36,-0.43,,,0.03,-0.26,,,CMGC,,,,NA,NA,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,129.15,114.86,S366,KRRSLSPKPRDKSRRSRSPLLNDRRSKQSKS,_S(ph)RS(ph)PLLNDRR_,0.01,0.56,-0.2,-0.23,-0.33,-0.25,-0.35,-0.46,-0.42,-0.44,-0.56,-0.5,-0.33,-0.39,-0.45,-0.48,0.31,-0.21,-0.29,-0.4,-0.43,-0.53,-0.36,-0.47,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,129.15,114.86,S368,RSLSPKPRDKSRRSRSPLLNDRRSKQSKSPS,_S(ph)RS(ph)PLLNDRR_,0.01,0.56,-0.2,-0.23,-0.33,-0.25,-0.35,-0.46,-0.42,-0.44,-0.56,-0.5,-0.33,-0.39,-0.45,-0.48,0.31,-0.21,-0.29,-0.4,-0.43,-0.53,-0.36,-0.47,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,115.37,115.37,S292,SPIINESRSRDRGKKSRSPVDLRGKSKDRRS,_S(ph)RS(ph)PVDLRGK_,-0.27,-0.47,-0.31,-0.21,-0.23,-0.29,-0.48,-0.51,-0.35,-0.17,-0.46,-0.37,-0.28,-0.31,-0.42,-0.51,-0.36,-0.26,-0.26,-0.5,-0.25,-0.41,-0.3,-0.47,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,115.37,115.37,S294,IINESRSRDRGKKSRSPVDLRGKSKDRRSRS,_S(ph)RS(ph)PVDLRGK_,-0.27,-0.47,-0.31,-0.21,-0.23,-0.29,-0.48,-0.51,-0.35,-0.17,-0.46,-0.37,-0.28,-0.31,-0.42,-0.51,-0.36,-0.26,-0.26,-0.5,-0.25,-0.41,-0.3,-0.47,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,182.47,182.47,S431,PRDDILSRRERSKDASPINRWSPTRRRSRSP,_DAS(ph)PINRWS(ph)PTR_,-0.25,-0.25,-0.28,-0.34,-0.21,-0.28,-0.47,-0.5,-0.3,-0.29,-0.41,-0.47,-0.18,-0.27,-0.28,-0.39,-0.25,-0.31,-0.24,-0.49,-0.29,-0.44,-0.23,-0.33,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,182.47,182.47,S437,SRRERSKDASPINRWSPTRRRSRSPIRRRSR,_DAS(ph)PINRWS(ph)PTR_,-0.25,-0.25,-0.28,-0.34,-0.21,-0.28,-0.46,-0.5,-0.3,-0.29,-0.41,-0.47,-0.18,-0.27,-0.14,-0.39,-0.25,-0.31,-0.24,-0.48,-0.29,-0.44,-0.23,-0.26,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,263.75,262.63,Y849,DFGSASHVADNDITPYLVSRFYRAPEIIIGK,_LCDFGSASHVADNDITPY(ph)LVSR_,-0.39,0.14,-0.37, ,-0.41,-0.36,-0.6,-0.43,-0.03,-0.12,-0.38, ,-0.16,-0.11,-0.32,-0.32,-0.11,-0.37,-0.39,-0.52,-0.08,-0.38,-0.13,-0.32,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,90.48,88.81,S852,SASHVADNDITPYLVSRFYRAPEIIIGKSYD,_LCDFGSASHVADNDITPYLVS(ph)R_, ,-0.46,-0.4,-0.43,-0.41, , , , ,-0.27,-0.32,-0.19,-0.16, , , ,-0.46,-0.42,-0.41,,-0.27,-0.25,-0.16,,,,CMGC,,,,NA,NA,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,144.25,143.42,S578,VPSEPSSPQSSTRTRSPSPDDILERVAADVK,_T(ph)RS(ph)PS(ph)PDDILER_,-0.45,-0.52,-0.49, ,-0.15,-0.13,0.79,-0.01,-0.32,-0.28,-0.52, ,0.05,0.1,-0.34,-0.16,-0.49,-0.49,-0.14,0.44,-0.3,-0.52,0.07,-0.24,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
F5H2U2,Q13523,Serine/threonine-protein kinase PRP4 homolog,PRPF4B,144.25,143.42,S580,SEPSSPQSSTRTRSPSPDDILERVAADVKEY,_T(ph)RS(ph)PS(ph)PDDILER_,-0.45,-0.52,-0.49, ,-0.15,-0.13,0.79,-0.01,-0.32,-0.28,-0.52, ,0.05,0.1,-0.34,-0.16,-0.49,-0.49,-0.14,0.44,-0.3,-0.52,0.07,-0.24,,,CMGC,,,,0,0,,chromosome,ATP binding,,,
Q9ULL5-2,Q9ULL5,Proline-rich protein 12,PRR12,142.3,133.54,S560,LDEELKRNLETLPSFSSDEEDSVAKNRDLQE,_RNLETLPSFS(ph)S(ph)DEEDSVAK_,0.07,0.03,0.21,0.31,0.3,0.38,0.26,0.14,-0.02,0.11,-0.07,0.07,0.16,-0.07,-0.47,-0.49,0.05,0.26,0.34,0.2,0.04,0,0.05,-0.48,,,,,,,0,0,,,DNA binding,,,
Q9ULL5-2,Q9ULL5,Proline-rich protein 12,PRR12,142.3,133.54,S561,DEELKRNLETLPSFSSDEEDSVAKNRDLQES,_RNLETLPSFS(ph)S(ph)DEEDSVAK_,0.07,0.03,0.21,0.31,0.3,0.38,0.26,0.14,-0.02,0.11,-0.07,0.07,0.16,-0.07,-0.47,-0.49,0.05,0.26,0.34,0.2,0.04,0,0.05,-0.48,,,,,,,0,0,,,DNA binding,,,
P48634,P48634,Protein PRRC2A,PRRC2A,178.7,166.03,S1106,GSEYEEIPKRRRQRGSETGSETHESDLAPSD,_(gl)QRGS(ph)ET(ph)GSETHESDLAPSDK_,0.72,0.74,1.25,1.04,0.71,0.72,0.7,0.41,0.75,1.36,1.21,0.82,0.63,0.53,0.7,0.56,0.73,1.15,0.72,0.56,1.09,1.03,0.58,0.63, +, +,,,,,4,5,25.95,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,178.7,166.03,S1110,EEIPKRRRQRGSETGSETHESDLAPSDKEAP,_(gl)QRGS(ph)ET(ph)GS(ph)ETHESDLAPSDK_,0.72,0.74,0.99,1.04,1.45,0.64,1.01,0.76,0.75,1.36,0.83,0.82,1.91,0.18,1.21,0.96,0.73,1.01,1.11,0.89,1.09,0.83,1.29,1.09, +, +,,,,,1,1,24.95,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,178.7,166.03,T1108,EYEEIPKRRRQRGSETGSETHESDLAPSDKE,_(gl)QRGS(ph)ET(ph)GS(ph)ETHESDLAPSDK_,0.72,0.74,0.9,1.04,1.32,0.72,0.7,0.41,0.75,1.36,0.82,0.82,1.77,0.53,0.7,0.56,0.73,0.97,1.05,0.56,1.09,0.82,1.28,0.63, +, +,,,,,1,5,27.9,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,107.02,107.02,S761,PGVHPSGLVPRERSDSGGSSSEPFDRHAPAM,_SDS(ph)GGSSSEPFDR_,0.11,0.23,0.44,0.11,1.15,0.94,0.42,0.95,-0.06,-0.14,0.35,0.23,1.16,1.48,0.27,0.98,0.17,0.28,1.05,0.71,-0.1,0.29,1.33,0.67, +, +,,,,,2,2,37.58,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,175.34,175.34,S1085,TGGPNHPPAPRGRTASETRSEGSEYEEIPKR,_TAS(ph)ETRS(ph)EGS(ph)EYEEIPK_,-0.27,-0.4,0.13,0.08,0.19,-1.11,0.15,-0.26,-0.05,-0.1,0.11,0.09,0.13,0.55,-0.23,-0.07,-0.33,0.11,-0.32,-0.04,-0.07,0.1,0.35,-0.15,,,,,,,0,0,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,175.34,175.34,S1089,NHPPAPRGRTASETRSEGSEYEEIPKRRRQR,_S(ph)EGS(ph)EYEEIPK_,-0.27,-0.4,-0.57,-0.56,-0.29,0,-0.08,-0.11,-0.05,-0.1,-0.47,-0.86,-0.4,-0.42,-0.27,0.01,-0.33,-0.57,-0.14,-0.1,-0.07,-0.65,-0.41,-0.12,,,,,,,0,0,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,156.52,156.52,S1092,PAPRGRTASETRSEGSEYEEIPKRRRQRGSE,_S(ph)EGS(ph)EYEEIPK_,0.4,0.3,-0.09,0.21,-0.29,0,-0.31,-0.02,0.44,0.3,0.32,0.04,-0.4,-0.42,-0.31,-0.05,0.35,0.07,-0.14,-0.16,0.37,0.19,-0.41,-0.17,,,,,,,0,0,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,230,230,S342,AGAHEEVDYTEKLKFSDEEDGRDSDEEGAEG,_LKFS(ph)DEEDGRDS(ph)DEEGAEGHR_,0.43, ,0.26,0.59,0.14,0.05, , ,-0.22, ,-0.04,-0.02,-0.06,0.17, , ,0.43,0.43,0.1,,-0.22,-0.03,0.06,,,,,,,,NA,NA,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,230,230,S350,YTEKLKFSDEEDGRDSDEEGAEGHRDSQSAS,_LKFS(ph)DEEDGRDS(ph)DEEGAEGHR_,0.43, ,0.26,0.59,0.14,0.05, , ,-0.22, ,-0.04,-0.02,-0.06,0.17, , ,0.43,0.43,0.1,,-0.22,-0.03,0.06,,,,,,,,NA,NA,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,62.55,41.25,S1014,PNGNLSPAPRLRRDYSYERVGPTSCRGRGRG,_DYS(ph)YER_, , , , ,0.21,0.19,0.26,-0.2, , , , ,-0.26,0.07,-0.14,-0.18,,,0.2,0.05,,,-0.09,-0.16,,,,,,,NA,NA,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,118.52,118.52,S1219,PSKEPLKEKLIPGPLSPVARGGSNGGSNVGM,_LIPGPLS(ph)PVAR_,-0.08,-0.03,0.52,0.51,0.75,0.8,0.96,0.96,-0.09,-0.44,0.37,0.33,0.66,0.33,0.88,0.96,-0.05,0.51,0.77,0.96,-0.26,0.35,0.51,0.92,,,,,,,0,0,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,89.16,88.75,S1306,TTVTVAPAPRRAAAKSPDLSNQNSDQANEEW,_S(ph)PDLSNQNSDQANEEWET(ph)AS(ph)ESSDFTSER_, , , , , ,-0.24,0.18, , , , , , ,0.11,0.05, ,,,-0.24,0.18,,,0.11,0.05,,,,,,,NA,NA,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,89.16,88.75,S1325,SNQNSDQANEEWETASESSDFTSERRGDKEA,_S(ph)PDLSNQNSDQANEEWET(ph)AS(ph)ESSDFTSER_, , , , , ,-0.24,0.18, , , , , , ,0.11,0.05, ,,,-0.24,0.18,,,0.11,0.05,,,,,,,NA,NA,,cytoplasm,,,,
P48634,P48634,Protein PRRC2A,PRRC2A,89.16,88.75,T1323,DLSNQNSDQANEEWETASESSDFTSERRGDK,_S(ph)PDLSNQNSDQANEEWET(ph)AS(ph)ESSDFTSER_, , , , , ,-0.24,0.18, , , , , , ,0.11,0.05, ,,,-0.24,0.18,,,0.11,0.05,,,,,,,NA,NA,,cytoplasm,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,100.44,99.63,S1132,RPEDCPRAKPRRRVASETHSEGSEYEELPKR,_VAS(ph)ETHS(ph)EGS(ph)EYEELPK_,1.18,1.23, ,0.77,0.62,0.81,1.02,1.34,1.59,1.34, ,0.62,0.52,0.61,1.15,1.11,1.21,0.77,0.72,1.19,1.47,0.62,0.57,1.13, +, +,,,,,5,5,35.4,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,100.44,99.63,S1136,CPRAKPRRRVASETHSEGSEYEELPKRRRQR,_VAS(ph)ETHS(ph)EGS(ph)EYEELPK_,1.18,1.23, ,0.77,0.63,0.81,1.02,-0.4,1.59,1.34, ,0.62,0.55,0.61,1.15,-0.06,1.21,0.77,0.72,0.48,1.47,0.62,0.58,0.66, +, +,,,,,5,5,25.5,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,100.44,99.63,S1139,AKPRRRVASETHSEGSEYEELPKRRRQRGSE,_VAS(ph)ETHS(ph)EGS(ph)EYEELPK_,1.18,1.23, , ,1.74,1.1,1.33,-0.4,1.59,1.34, , ,1.14,1.07,1.5,-0.06,1.21,,1.45,0.71,1.47,,1.1,0.92, +, +,,,,,NA,NA,,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,78.44,67.33,S416,RPKWNSWDPRRQRQLSMSSADSADAKRTREE,_(gl)QLS(ph)MSSADSADAK_, , , , ,0.89, , , , , , , ,2.56, , , ,,,0.89,,,,2.56,,, +,,,,,NA,NA,,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,197.28,197.28,S388,AGLHEEVDYSEKLKFSDDEEEEEVVKDGRPK,_LKFS(ph)DDEEEEEVVK_,-0.2, ,-0.06,-0.11,-0.09, ,0.15, ,-0.07, ,-0.1,-0.15,-0.31, ,-0.08, ,-0.2,-0.08,-0.09,0.15,-0.07,-0.13,-0.31,-0.08,,,,,,,0,0,,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,103.14,76.69,S556,KAGEARKQAEKEVPWSPSAEKASPQENGPAV,_EVPWS(ph)PSAEK_,0.04,0.06,0.45,0.35,0.42,0.49,0.43,0.44,-0.17,-0.1,0.3,0.29,0.44,0.7,0.58,0.55,0.05,0.4,0.45,0.44,-0.14,0.29,0.57,0.56,,,,,,,0,0,,,,,,
Q5JSZ5,Q5JSZ5,Protein PRRC2B,PRRC2B,94.71,93.48,S226,EGGGRHIISATSLSTSPTELGSRNSSTGDGA,_HIISATSLSTS(ph)PTELGSR_,-0.18,0.12,-0.39, ,0.2, , , ,-0.58,-0.37,-0.62, ,0.4, , , ,-0.02,-0.39,0.2,,-0.47,-0.62,0.4,,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,154.1,154.1,S1246,IPSGPLRQREESETRSESSDFEVVPKRRRQR,_QREES(ph)ETRS(ph)ES(ph)SDFEVVPK_,0.64,0.29,-0.44,-0.5,-0.95,-0.65,0.01,-0.22,0.13,-0.3,-1,-1.1,-1.1,-0.93,-0.25,-0.71,0.47,-0.47,-0.79,-0.1,-0.07,-1.05,-1.01,-0.47,, +,,,,,0,3,15.2,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,154.1,154.1,S1248,SGPLRQREESETRSESSDFEVVPKRRRQRGS,_(gl)QREES(ph)ETRS(ph)ES(ph)SDFEVVPK_,0.64,0.29,-0.44,-0.5,0,-0.34,0.38,0.44,0.13,-0.3,-1,-1.1,-0.35,-0.7,0.53,0.48,0.47,-0.47,-0.16,0.41,-0.07,-1.05,-0.52,0.51,, +,,,,,0,3,22.39,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,107.11,79.34,S1249,GPLRQREESETRSESSDFEVVPKRRRQRGSE,_SES(ph)S(ph)DFEVVPK_,-0.03,0.52,-0.44,-0.5,-0.95,-0.04,0.38,-0.22,-0.25,0.54,-1,-1.1,-1.1,-0.46,0.53,-0.71,0.27,-0.47,-0.42,0.11,0.2,-1.05,-0.75,0.04,, +,,,,,0,3,27.19,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,191.95,134.8,S2105,QPRAGPIKAQKLPDLSPVENKEHKPGPIGKE,_LPDLS(ph)PVENK_,-0.16,-0.04,0.15,0.19,0.28,0.18,0.19,0.24,-0.07,0,0.06,-0.05,0.38,0.33,0.24,0.17,-0.1,0.17,0.23,0.22,-0.04,0.01,0.36,0.21,,,,,,,0,0,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,154.1,154.1,S1242,RAEHIPSGPLRQREESETRSESSDFEVVPKR,_QREES(ph)ETRS(ph)ES(ph)SDFEVVPK_,0.47,-0.11,0.13,-0.4,0.3,0.24,-0.75,0.38,-0.04,-0.22,0.04,-0.85,0.03,-0.09,-0.54,0.46,0.21,-0.11,0.27,-0.08,-0.13,-0.34,-0.03,0.04,,,,,,,0,0,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,217.02,205.91,S1263,SSDFEVVPKRRRQRGSETDTDSEIHESASDK,_(gl)QRGS(ph)ET(ph)DT(ph)DSEIHESASDK_,-0.04, ,0.21, , ,0.7,0.37,0.3,-0.01, ,0.27, , ,0.56,0.44,0.21,-0.04,0.21,0.7,0.33,-0.01,0.27,0.56,0.33,,,,,,,0,0,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,140.16,139.72,S1500,NQNSSDQANEEWETASESSDFNERRERDEKK,_TPDLSNQNSSDQANEEWET(ph)AS(ph)ESS(ph)DFNER_, , , , ,0.44,0.19,0.36,0, , , , ,0.39,-0.32,0.17,0.06,,,0.32,0.19,,,0.08,0.11,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,140.16,139.72,S1503,SSDQANEEWETASESSDFNERRERDEKKNAD,_TPDLSNQNSSDQANEEWET(ph)AS(ph)ESS(ph)DFNER_, , , , ,1.05,-0.11,0.36,0.04, , , , ,0.98,0.36,0.17,0.02,,,0.59,0.21,,,0.71,0.1,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,167.26,163.83,T1265,DFEVVPKRRRQRGSETDTDSEIHESASDKDS,_(gl)QRGS(ph)ET(ph)DT(ph)DSEIHESASDK_,-0.04, , , , ,0.7,0.37,0.3,-0.01, , , , ,0.56,0.44,0.21,-0.04,,0.7,0.33,-0.01,,0.56,0.33,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,167.26,163.83,T1267,EVVPKRRRQRGSETDTDSEIHESASDKDSLS,_(gl)QRGS(ph)ET(ph)DT(ph)DSEIHESASDK_,-0.04, , , , ,0.7,0.37,0.3,-0.01, , , , ,0.56,0.44,0.21,-0.04,,0.7,0.33,-0.01,,0.56,0.33,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,140.16,139.72,T1498,LSNQNSSDQANEEWETASESSDFNERRERDE,_TPDLSNQNSSDQANEEWET(ph)AS(ph)ESS(ph)DFNER_, , , , ,0.44,0.19,0.36,0.04, , , , ,0.39,-0.32,0.17,0.02,,,0.32,0.21,,,0.08,0.1,,,,,,,NA,NA,,,,,,
Q9Y520-3,Q9Y520,Protein PRRC2C,PRRC2C,97.5,81.51,S779,MIPPKPLMRRDQMEGSPNSSESFEHIARSAR,_DQMEGS(ph)PNSSESFEHIAR_, , ,-0.6, , , , , , , ,-0.12, , , , , ,,-0.6,,,,-0.12,,,,,,,,,NA,NA,,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,141.29,105.38,S1842,TEWWKASPQEGRLIESPFERELSDSSGVLEI,_LIES(ph)PFER_,-0.5,-0.38,-0.85,-0.99,0.04,-0.69,-1.36,-1.35,3.15,3.21,0.91,2.26,-0.54,-0.62,-0.5,-0.52,-0.44,-0.92,-0.28,-1.36,3.18,1.73,-0.58,-0.51, +, +,,,,,3,5,3.7,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,318.87,318.16,S595,NSERNLSLTDFVGDESPSPERLKNTGKRIPP,_NLSLTDFVGDES(ph)PS(ph)PERLK_, , , , ,-1.71,-1.63,-1.42,-1.54, , , , ,-0.91,-1.3,-0.33,-0.61,,,-1.67,-1.48,,,-1.09,-0.46, +, +,,,,,NA,NA,,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,318.87,318.16,S597,ERNLSLTDFVGDESPSPERLKNTGKRIPPTP,_NLSLTDFVGDES(ph)PS(ph)PERLK_,-0.21, , ,-0.9,-1.71,-1.63,-0.56,-1.54,0.1, , ,-0.96,-0.91,-1.3,-0.04,-0.61,-0.21,-0.9,-1.67,-0.96,0.1,-0.96,-1.09,-0.3, +, +,,,,,6,6,15.46,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,62.65,60.43,S2211,NGDNSTGLQVSEKGASPDMAPILEPVDRRIP,_GAS(ph)PDMAPILEPVDR_, ,0.27,0.06,-0.07, ,-1.34,-1.39, , ,0.14,0.15,0.3, ,-0.3,0.16, ,0.27,-0.01,-1.34,-1.39,0.14,0.23,-0.3,0.16, +,,,,,,6,0,4.98,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,53.21,52.78,S2325,NTSTGTIDDMSKLTLSEGHPETPVDGDLGKQ,_LT(ph)LS(ph)EGHPET(ph)PVDGDLGK_,-0.6,-0.53,-0.86, ,-1.22,-1.63,-1.65,-1.1,-1.22,-0.3,-0.24, ,-0.43,-0.41,-0.23,-0.35,-0.56,-0.86,-1.41,-1.35,-0.69,-0.24,-0.42,-0.29, +,,,,,,6,0,4.39,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,273.56,257.52,S586,VQRQDSPRDNSERNLSLTDFVGDESPSPERL,_NLS(ph)LTDFVGDES(ph)PS(ph)PER_, , , , , , ,-0.05,0.11, , , , , , ,0.61,0.19,,,,0.03,,,,0.41,,,,,,,NA,NA,,,,,,
E9PDC2,Q8WUY3,Protein prune homolog 2,PRUNE2,86.76,85.53,T2331,IDDMSKLTLSEGHPETPVDGDLGKQDICSSE,_LT(ph)LS(ph)EGHPET(ph)PVDGDLGK_,0.34,0.04,0.36, ,0.31,-0.71,-0.53,-1.1,0.13,0.11,0.77, ,-0.06,-0.21,0.43,-0.35,0.2,0.36,-0.11,-0.79,0.12,0.77,-0.14,0.09,,,,,,,0,0,,,,,,
E7EU68,Q9NYI0,PH and SEC7 domain-containing protein 3,PSD3,84.32,83.18,S1011,LSNDESEAAGLKKSHSSPSLNPDTSPITAKV,_SHS(ph)SPSLNPDT(ph)SPITAK_, , , , , , , ,-0.1, , , , , , , ,0.81,,,,-0.1,,,,0.81,,,,,,,NA,NA,,,,,,
F5GYI7,P49768,Presenilin-1,PSEN1,142.32,140.71,S366,HRSTPESRAAVQELSSSILAGEDPEERGVKL,_AAVQELSS(ph)S(ph)ILAGEDPEER_,-1.02, ,-0.21,0.24,-0.05,-0.39,0.09,-0.13,-0.95, ,-0.1,0.66,-0.32,0.29,0.36,-0.05,-1.02,0.03,-0.21,-0.01,-0.95,0.33,0.02,0.17, +,,,,,,1,0,23.67,,,,,
F5GYI7,P49768,Presenilin-1,PSEN1,231.29,204.16,S367,RSTPESRAAVQELSSSILAGEDPEERGVKLG,_AAVQELSS(ph)S(ph)ILAGEDPEER_,1.11,0.19,0.35,-0.08,-0.54,-0.41,-0.54,-0.35,0.54,0.18,0.36,0.45,-0.58,0.43,0.17,0.35,0.72,0.16,-0.48,-0.44,0.37,0.4,0.01,0.26,,,,,,,0,0,,,,,,
F5GYI7,P49768,Presenilin-1,PSEN1,61.62,61.62,S43,NTNDNRERQEHNDRRSLGHPEPLSNGRPQGN,_S(ph)LGHPEPLSNGRPQGNSR_, ,-0.12,-0.1, , , , , , ,0.12,0.24, , , , , ,-0.12,-0.1,,,0.12,0.24,,,,,,,,,NA,NA,,,,,,
E5RHT1,P49810,Presenilin-2,PSEN2,102.89,90.98,S22,SDSEEEVCDERTSLMSAESPTPRSCQEGRQG,_TS(ph)LMS(ph)AES(ph)PTPR_, , , , , ,0.6, ,0.42, , , , , ,0.84, ,-0.08,,,0.6,0.42,,,0.84,-0.08,,,,,,,NA,NA,,cytosol,aspartic-type endopeptidase activity,anagen,,
E5RHT1,P49810,Presenilin-2,PSEN2,102.89,90.98,S25,EEEVCDERTSLMSAESPTPRSCQEGRQGPED,_TS(ph)LMS(ph)AES(ph)PTPR_, , , , , ,0.6, ,0.42, , , , , ,0.84, ,-0.08,,,0.6,0.42,,,0.84,-0.08,,,,,,,NA,NA,,cytosol,aspartic-type endopeptidase activity,anagen,,
O75475,O75475,PC4 and SFRS1-interacting protein,PSIP1,186.72,170.96,S105,VKFSSQQAATKQSNASSDVEVEEKETSVSKE,_QSNAS(ph)SDVEVEEK_, ,-0.12, ,0.02, ,-0.21,-0.05, , ,0.06, ,0.02, ,-0.2,-0.09, ,-0.12,0.02,-0.21,-0.05,0.06,0.02,-0.2,-0.09,,,,,,,0,0,,cytosol,activating transcription factor binding,establishment of integrated proviral latency,,
O75475,O75475,PC4 and SFRS1-interacting protein,PSIP1,186.96,173.23,S106,KFSSQQAATKQSNASSDVEVEEKETSVSKED,_(gl)QSNASS(ph)DVEVEEK_,-0.01,-0.07,0,-0.2,-0.31,-0.08,-0.04,-0.1,0.07,0.1,0.16,0,-0.46,-0.17,-0.13,-0.08,-0.04,-0.09,-0.19,-0.07,0.09,0.08,-0.31,-0.1,,,,,,,0,0,,cytosol,activating transcription factor binding,establishment of integrated proviral latency,,
P25788-2,P25788,Proteasome subunit alpha type-3,PSMA3,69.49,69.49,S243,VPKDIREEAEKYAKESLKEEDESDDDNM___,_ES(ph)LKEEDESDDDNM(ox)_, ,0.03,-0.03,-0.06, ,-0.03,0.03,0.02, ,0.01,0.01,0, ,0.09,-0.12,-0.01,0.03,-0.05,-0.03,0.03,0.01,0,0.09,-0.06,,,,,,,0,0,,cytosol,threonine-type endopeptidase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
P25788-2,P25788,Proteasome subunit alpha type-3,PSMA3,294.52,290.54,S250,EAEKYAKESLKEEDESDDDNM__________,_ESLKEEDES(ph)DDDNM(ox)_,-0.01,-0.03,0.02,-0.01,-0.15,-0.1,-0.05,-0.05,0.06,0.08,0.06,0.01,0.04,-0.05,-0.1,-0.1,-0.02,0,-0.13,-0.05,0.07,0.03,0,-0.1,,,,,,,0,0,,cytosol,threonine-type endopeptidase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
H0YMZ1,P25789,Proteasome subunit alpha type,PSMA4,85.67,62.56,S13,___MSRRYDSRTTIFSPEGRLYQVEYAMEAI,_TTIFS(ph)PEGR_,-0.42,-0.5,0.06, , , , ,-0.67,-0.18,-0.37,-0.01, , , , ,-0.96,-0.46,0.06,,-0.67,-0.27,-0.01,,-0.96,,,,,,,NA,NA,,cytoplasm,threonine-type endopeptidase activity,ubiquitin-dependent protein catabolic process,,
P28066,P28066,Proteasome subunit alpha type-5,PSMA5,136.93,134.63,S16,MFLTRSEYDRGVNTFSPEGRLFQVEYAIEAI,_GVNTFS(ph)PEGR_,-0.19,-0.15,0.32,0.6, , , , ,0.15,0.07,0.42,0.62, , , , ,-0.17,0.47,,,0.11,0.52,,,,,,,,,NA,NA,,cytosol,threonine-type endopeptidase activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q99460,Q99460,26S proteasome non-ATPase regulatory subunit 1,PSMD1,167.26,166.04,T273,QQFLSSVIQNLRTVGTPIASVPGSTNTGTVP,_TVGT(ph)PIASVPGSTNTGTVPGSEK_,-0.13, ,0.08,0.09,0,0.07,0.27,-0.13,-1.09, ,-0.36,-1.03,-0.86,-0.04,-0.61,-0.03,-0.13,0.09,0.04,0.09,-1.09,-0.66,-0.39,-0.29,, +,,,,,0,3,7.78,cytosol,enzyme regulator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q99460,Q99460,26S proteasome non-ATPase regulatory subunit 1,PSMD1,134.69,134.69,S315,EEKTSSAFVGKTPEASPEPKDQTLKMIKILS,_TSSAFVGKT(ph)PEAS(ph)PEPK_,0.07,0.05, , ,0.14,0.06,0.14,0.14,0.21,-0.08, , ,0.15,0.01,0.05,-0.27,0.06,,0.1,0.14,0.07,,0.09,-0.1,,,,,,,NA,NA,,cytosol,enzyme regulator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q99460,Q99460,26S proteasome non-ATPase regulatory subunit 1,PSMD1,134.69,134.69,T311,SMETEEKTSSAFVGKTPEASPEPKDQTLKMI,_TSSAFVGKT(ph)PEAS(ph)PEPK_,0.07,0.05, , ,0.14,0.06,0.14,0.14,0.21,-0.08, , ,0.15,0.01,0.05,-0.27,0.06,,0.1,0.14,0.07,,0.09,-0.1,,,,,,,NA,NA,,cytosol,enzyme regulator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q13200,Q13200,26S proteasome non-ATPase regulatory subunit 2,PSMD2,139.61,139.61,S16,MEEGGRDKAPVQPQQSPAAAPGGTDEKPSGK,_APVQPQQS(ph)PAAAPGGTDEKPSGK_,0.04,-0.08,-0.02,-0.18,0.18,0.26,0,-0.16,0.07,0.02,0.01,-0.11,-0.12,-0.01,-0.28,-0.18,-0.02,-0.1,0.22,-0.08,0.04,-0.05,-0.07,-0.23,,,,,,,0,0,,cytosol,enzyme regulator activity,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,,
Q9BVG9,Q9BVG9,Phosphatidylserine synthase 2,PTDSS2,122.49,98.01,S16,MRRGERRDAGGPRPESPVPAGRASLEEPPDG,_DAGGPRPES(ph)PVPAGR_,0.01, ,0.34,0.07, , , , ,0.81, ,3.39,3.97, , , , ,0.01,0.21,,,0.81,3.71,,,, +,,,,,NA,NA,,endoplasmic reticulum membrane,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,phosphatidylserine biosynthetic process,,
Q15185,Q15185,Prostaglandin E synthase 3,PTGES3,124.53,123.65,S148,DEDVDLPEVDGADDDSQDSDDEKMPDLE___,_FSEM(ox)MNNMGGDEDVDLPEVDGADDDS(ph)QDS(ph)DDEKMPDLE_, ,-0.26, ,-0.16,-0.47,0,-0.01,0,0.15,-0.02, ,0.17,-0.08,0.51,0.02,-0.4,-0.26,-0.16,-0.22,0,0.07,0.17,0.24,-0.17,,,,,,,0,0,,"chromosome, telomeric region",prostaglandin-E synthase activity,chaperone cofactor-dependent protein refolding,,
Q15185,Q15185,Prostaglandin E synthase 3,PTGES3,160.02,159.95,S151,VDLPEVDGADDDSQDSDDEKMPDLE______,_FSEM(ox)MNNMGGDEDVDLPEVDGADDDS(ph)QDS(ph)DDEKMPDLE_,-0.22,-0.6,-0.16,-0.16,0,0,0.01,-0.01,0.02,0.1,0.07,0.17,0.25,0.19,0.15,0.19,-0.39,-0.16,0,0,0.06,0.12,0.22,0.17,,,,,,,0,0,,"chromosome, telomeric region",prostaglandin-E synthase activity,chaperone cofactor-dependent protein refolding,,
Q15185,Q15185,Prostaglandin E synthase 3,PTGES3,349.61,338.63,S113,WLSVDFNNWKDWEDDSDEDMSNFDRFSEMMN,_DWEDDS(ph)DEDMS(ph)NFDR_,-0.06,-0.03,-0.08,-0.04,-0.11,-0.07,-0.1,-0.08,-0.03,-0.04,-0.08,-0.07,-0.05,-0.04,-0.05,-0.04,-0.04,-0.06,-0.09,-0.09,-0.03,-0.07,-0.05,-0.05,,,,,,,0,0,,"chromosome, telomeric region",prostaglandin-E synthase activity,chaperone cofactor-dependent protein refolding,,
Q15185,Q15185,Prostaglandin E synthase 3,PTGES3,219.78,219.78,S118,FNNWKDWEDDSDEDMSNFDRFSEMMNNMGGD,_DWEDDS(ph)DEDMS(ph)NFDR_, , , , ,-0.39,-0.23,0.18,0.05, , , , ,-0.29,-0.23,0.06,-0.04,,,-0.3,0.12,,,-0.26,0.01,,,,,,,NA,NA,,"chromosome, telomeric region",prostaglandin-E synthase activity,chaperone cofactor-dependent protein refolding,,
Q9P2B2,Q9P2B2,Prostaglandin F2 receptor negative regulator,PTGFRN,96.49,96.49,S875,KKEVQETRRERRRLMSMEMD___________,_RRLMS(ph)MEMD_,0.2,0.3,1.62,1.75,0.87,1.02,0.74,0.49,0.34,0.38,1.81,1.81,1.32,1.55,1.13,1.21,0.25,1.68,0.95,0.62,0.36,1.81,1.44,1.17, +, +,,,,,4,1,23.68,endoplasmic reticulum membrane,,lipid particle organization,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,270.42,261.76,Y5,___________MAAAYLDPNLNHTPNSSTKT,_(ac)AAAY(ph)LDPNLNHTPNSSTK_,2.44, ,0.68, , , ,0.66,0.93,1.83, ,0.3, , , ,0.6,0.86,2.44,0.68,,0.8,1.83,0.3,,0.73, +, +,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,49.66,46.26,S910,ADSYNEGVKLQPQEISPPPTANLDRSNDKVY,_LQPQEIS(ph)PPPTANLDR_,0.53,0.59,0.83, , , ,1.84, ,-0.29,-0.01,0.43, , , ,0.69, ,0.56,0.83,,1.84,-0.14,0.43,,0.69, +,,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,316.48,309.74,Y397,QGMRTHAVSVSETDDYAEIIDEEDTYTMPST,_THAVSVSETDDY(ph)AEIIDEEDTYTMPSTR_,-0.16, , , ,0.07, ,0.02,0.1,-0.01, , , ,0.22, ,-0.05,0.06,-0.16,,0.07,0.06,-0.01,,0.22,0.01,,,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,99.82,99.82,Y570,SSNDCVKLGDFGLSRYMEDSTYYKASKGKLP,_Y(ph)MEDSTY(ph)YK_,-0.59, ,0.27, , , , , ,-0.98, ,0.08, , , , , ,-0.59,0.27,,,-0.98,0.08,,,,,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,109.66,97.05,Y576,KLGDFGLSRYMEDSTYYKASKGKLPIKWMAP,_YMEDSTY(ph)YK_,-0.41,-0.46,-0.04,0.06,0.67,0.63,0.53,0.62,0.06,-0.16,0.08,0.32,0.69,0.73,0.66,0.71,-0.43,0.01,0.65,0.58,-0.05,0.2,0.71,0.68,,,Tyr,,,,0,0,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,98.05,98.05,Y577,LGDFGLSRYMEDSTYYKASKGKLPIKWMAPE,_YMEDSTY(ph)Y(ph)K_,-0.79, ,-0.38,-0.38, , , , ,-0.44, ,0.12,-0.27, , , , ,-0.79,-0.38,,,-0.44,-0.06,,,,,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,146.27,124.59,T575,VKLGDFGLSRYMEDSTYYKASKGKLPIKWMA,_YMEDST(ph)YYK_,-0.33, ,0.04,0.09, , , , ,-0.11, ,0.57,0.39, , , , ,-0.33,0.06,,,-0.11,0.48,,,,,Tyr,,,,NA,NA,,cytoplasm,ATP binding,signal complex assembly,,
Q8IYN9,Q05397,Focal adhesion kinase 1,PTK2,295.27,295.27,Y861,REDGSLQGPIGNQHIYQPVGKPDPAAPPKKP,_GSIDREDGSLQGPIGNQHIY(ph)QPVGKPDPAAPPK_,-0.14, ,-0.34, ,0.54,0.46,0.36,0.32,-0.03, ,-0.29, ,0.2,0.15,0.39,0.48,-0.14,-0.34,0.5,0.34,-0.03,-0.29,0.18,0.43,,,Tyr,,,,0,0,,cytoplasm,ATP binding,signal complex assembly,,
Q14289-2,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,71.35,64.04,Y849,YMNDKSPLTPEKEVGYLEFTGPPQKPPRLGA,_EVGY(ph)LEFTGPPQKPPR_, , ,1.14, , , , , , , ,0.77, , , , , ,,1.14,,,,0.77,,, +,,Tyr,,,,NA,NA,,axon,ATP binding,activation of Janus kinase activity,,
Q14289-2,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,70.03,46,Y580,LGDFGLSRYIEDEDYYKASVTRLPIKWMSPE,_YIEDEDYY(ph)K_,0.8, ,-0.39, , , ,-0.65,-0.33,0.5, ,-0.4, , , ,0.42,0.44,0.8,-0.39,,-0.48,0.5,-0.4,,0.43,,,Tyr,,,,NA,NA,,axon,ATP binding,activation of Janus kinase activity,,
P06454-2,P06454,Prothymosin alpha,PTMA,264.08,254.59,S2,______________MSDAAVDTSSEITTKDL,_(ac)S(ph)DAAVDTSSEITTK_,0.07,0.12,-0.08,-0.07,-0.05,0.1,0.1,-0.09,0.14,-0.05,0.05,0.09,-0.42,-0.46,-0.2,0.1,0.1,-0.07,0.03,0.01,0.05,0.07,-0.44,-0.04,,,,,,,0,0,,cytoplasm,,"transcription, DNA-dependent",,
P06454-2,P06454,Prothymosin alpha,PTMA,196.71,169.62,S9,_______MSDAAVDTSSEITTKDLKEKKEVV,_(ac)SDAAVDTS(ph)SEITTK_,0.01,0.12,-0.04,-0.16,-0.2,-0.2,-0.14,-0.26,0.1,0.16,0.2,0.1,-0.31,0.01,-0.07,-0.29,0.07,-0.1,-0.2,-0.2,0.13,0.15,-0.14,-0.18,,,,,,,0,0,,cytoplasm,,"transcription, DNA-dependent",,
P06454-2,P06454,Prothymosin alpha,PTMA,146.13,140.53,T8,________MSDAAVDTSSEITTKDLKEKKEV,_(ac)SDAAVDT(ph)S(ph)SEITTK_, , , , ,0.18,0.28,0.09,0.04, , , , ,0.54,0.41,-0.32,-0.32,,,0.23,0.07,,,0.48,-0.32,,,,,,,NA,NA,,cytoplasm,,"transcription, DNA-dependent",,
P20962,P20962,Parathymosin,PTMS,58.08,41.31,S5,___________MSEKSVEAAAELSAKDLKEK,_S(ph)VEAAAELSAK_, , , , , ,-0.09, ,0.2, , , , , ,0.03, ,0.03,,,-0.09,0.2,,,0.03,0.03,,,,,,,NA,NA,,nucleus,,DNA replication,,
Q9P035,Q9P035,3-hydroxyacyl-CoA dehydratase 3,PTPLAD1,334,331.07,S114,RPLFLAPDFDRWLDESDAEMELRAKEEERLN,_WLDES(ph)DAEMELR_,-0.06,-0.04,-0.12,-0.07,-0.17,-0.15,-0.18,-0.1,-0.16,-0.12,-0.13,-0.2,-0.14,-0.16,-0.1,-0.09,-0.05,-0.1,-0.16,-0.14,-0.14,-0.17,-0.15,-0.1,,,,,,,0,0,,endoplasmic reticulum membrane,GTPase activator activity,activation of JUN kinase activity,,
B4DSN5,P18031,Tyrosine-protein phosphatase non-receptor type,PTPN1,130.73,128.52,S352,ETQEDKDCPIKEEKGSPLNAAPYGIESMSQD,_GS(ph)PLNAAPYGIESMSQDTEVR_, , , ,-0.16,0.16,0.15,0.24,-0.01, , , ,0.1,0.26,0.56,0.2,0.16,,-0.16,0.16,0.12,,0.1,0.41,0.18,,,,,,Classical,NA,NA,,cytoplasmic vesicle,protein tyrosine phosphatase activity,insulin receptor signaling pathway,,
Q06124-2,Q06124,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,290.28,223.59,Y584,PTPPCAEMREDSARVYENVGLMQQQKSFR__,_VY(ph)ENVGLMQQQK_,3.45, ,1.45, , , ,1.18,0.89,3.11, ,1.33, , , ,1.62,1.43,3.45,1.45,,1.04,3.11,1.33,,1.53, +, +,,,,,NA,NA,,cytosol,non-membrane spanning protein tyrosine phosphatase activity,activation of MAPK activity,,
Q06124-2,Q06124,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,112.11,61.33,Y546,RRIEEEQKSKRKGHEYTNIKYSLADQTSGDQ,_GHEY(ph)TNIK_,2.08, ,1.73, , , , , ,2.21, ,1.52, , , , , ,2.08,1.73,,,2.21,1.52,,, +, +,,,,,NA,NA,,cytosol,non-membrane spanning protein tyrosine phosphatase activity,activation of MAPK activity,,
Q06124-2,Q06124,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,203.78,193.64,Y62,RNGAVTHIKIQNTGDYYDLYGGEKFATLAEL,_IQNTGDY(ph)YDLYGGEK_,-0.21,-0.14,0.59, ,0.85,0.88,0.82,1.07,0.12,-0.1,0.22, ,0.89,0.83,1.18,1.29,-0.17,0.59,0.87,0.95,0.02,0.22,0.86,1.24,, +,,,,,0,2,22.66,cytosol,non-membrane spanning protein tyrosine phosphatase activity,activation of MAPK activity,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,248.62,244.11,S571,SDINYQTRKTVSLTPSPTTQVETPDLVDHDN,_TVSLT(ph)PS(ph)PTTQVETPDLVDHDNT(ph)SPLFR_, , , , ,0.88,1.13,1.08,0.63, , , , ,0.82,1.21,0.54,0.59,,,1.01,0.87,,,1.03,0.57, +, +,,,,Classical,NA,NA,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,213.66,209.27,T569,NSSDINYQTRKTVSLTPSPTTQVETPDLVDH,_TVSLT(ph)PS(ph)PTTQVETPDLVDHDNT(ph)SPLFR_, , , , , ,1.13, ,0.63, , , , , ,1.21, ,0.59,,,1.13,0.63,,,1.21,0.59, +, +,,,,Classical,NA,NA,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,248.62,244.11,T587,PTTQVETPDLVDHDNTSPLFRTPLSFTNPLH,_TVS(ph)LTPS(ph)PTTQVETPDLVDHDNT(ph)SPLFR_, , , , ,0.88,1.13,1.08, , , , , ,0.82,1.21,0.54, ,,,1.01,1.08,,,1.03,0.54, +, +,,,,Classical,NA,NA,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,202.07,202.07,S673,TTHSGAEKDVDVSEDSPPPLPERTPESFVLA,_DVDVSEDS(ph)PPPLPER_,-0.3,-0.15,-0.16,-1.49,0.21,0.13,0.06,0.1,-0.16,0.3,0.01,0.42,0.32,0.19,0.27,0.35,-0.23,-0.67,0.17,0.08,0.09,0.23,0.26,0.31,,,,,,Classical,0,0,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,104.39,35.59,S435,ESTIEQIDKKLERNLSFEIKKVPLQEGPKSF,_NLS(ph)FEIK_,0.45,0.51,0.06,0.15,0.1,0.21,0.04,-0.28,0.22,0.22,0.13,0.13,0.43,0.36,0.31,0.23,0.48,0.1,0.16,-0.11,0.22,0.13,0.39,0.27,,,,,,Classical,0,0,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,145.08,108.65,S449,LSFEIKKVPLQEGPKSFDGNTLLNRGHAIKI,_S(ph)FDGNTLLNR_,0.65,0.53, , , , , ,-0.3,0.38,0.17, , , , , ,-0.17,0.59,,,-0.3,0.28,,,-0.17,,,,,,Classical,NA,NA,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,265.59,265.59,S603,SPLFRTPLSFTNPLHSDDSDSDERNSDGAVT,_TPLSFTNPLHS(ph)DDS(ph)DSDERNSDGAVTQNK_,-0.12,-0.13,-0.15,-0.15,-0.02,0.33,-0.04,-0.01,-0.14,-0.22,-0.25,-0.21,0.21,-0.34,0,0.13,-0.13,-0.15,0.17,-0.02,-0.18,-0.23,-0.04,0.07,,,,,,Classical,0,0,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,265.59,265.59,S606,FRTPLSFTNPLHSDDSDSDERNSDGAVTQNK,_TPLSFTNPLHS(ph)DDS(ph)DSDERNSDGAVTQNK_,-0.12,-0.13,-0.15,-0.15,-0.02,-0.08,-0.04,-0.01,-0.14,-0.22,-0.25,-0.21,0.21,-0.26,0,0.13,-0.13,-0.15,-0.05,-0.02,-0.18,-0.23,-0.01,0.07,,,,,,Classical,0,0,,,,,,
E9PEH9,Q05209,Tyrosine-protein phosphatase non-receptor type 12,PTPN12,72.23,71.84,S608,TPLSFTNPLHSDDSDSDERNSDGAVTQNKTN,_TPLSFTNPLHSDDS(ph)DS(ph)DER_, , , ,-0.25, ,-0.08, , , , , ,-0.33, ,-0.26, , ,,-0.25,-0.08,,,-0.33,-0.26,,,,,,,Classical,NA,NA,,,,,,
Q96AU5,P17706,Tyrosine-protein phosphatase non-receptor type 2,PTPN2,127.97,125.43,S304,WKELSKEDLSPAFDHSPNKIMTEKYNGNRIG,_EDLSPAFDHS(ph)PNK_,0.45,0.22,0.31,0.27,0.1, ,-0.17,0.07,0.01,-0.16,-0.22,-0.32,-0.38, ,0.03,-0.03,0.34,0.29,0.1,-0.04,-0.07,-0.27,-0.38,0,,,,,,,0,0,,,,,,
F5H7G8,P18433,Receptor-type tyrosine-protein phosphatase alpha,PTPRA,159.69,159.01,Y798,FCYKVVQEYIDAFSDYANFK___________,_VVQEYIDAFSDY(ph)ANFK_,0, ,-0.56, ,0.26,0.05,-0.2,-0.11,0.03, ,0.19, ,0.41,0.37,-0.21,0.16,0,-0.56,0.16,-0.15,0.03,0.19,0.39,-0.01,,,,,,Classical,0,0,,,,,,
P10586-2,P23468,Receptor-type tyrosine-protein phosphatase delta,PTPRD,103.46,98.09,T1912,YRAALEYLGSFDHYAT_______________,_AALEYLGSFDHYAT(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,Classical,NA,NA,,integral to plasma membrane,heparin binding,cell adhesion,,
Q15262,Q15262,Receptor-type tyrosine-protein phosphatase kappa,PTPRK,127.59,106.64,Y858,LLDVPRYLCEGTESPYQTGQLHPAIRVADLL,_YLCEGTESPY(ph)QTGQLHPAIR_,0, , , , , , , ,-0.87, , , , , , , ,0,,,,-0.87,,,,,,,,,Classical,NA,NA,,adherens junction,transmembrane receptor protein tyrosine phosphatase activity,cell migration,,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,122.7,78.8,Y308,SRDKLRKSFTPDHVVYARSKTAVYKVPPFTF,_SFTPDHVVY(ph)AR_,-0.14, ,-0.67, ,-0.15,-0.07,-0.05,-0.1,-0.77, ,-0.57, ,0.29,0.19,0.13,0.28,-0.14,-0.67,-0.11,-0.07,-0.77,-0.57,0.24,0.21,,,,,,,0,0,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,61.59,51.59,Y156,NEAELLRRRNFKVMIYQDEVKLPAKLSISKS,_VMIY(ph)QDEVK_,-0.93, ,-0.08, ,-0.4, , ,-0.7,-0.79, ,-0.15, ,0.05, , ,0,-0.93,-0.08,-0.4,-0.7,-0.79,-0.15,0.05,0,,,,,,,0,0,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,324.59,324.59,S202,GEGERPEEDAAALELSSDEAVEVEEVIEESR,_EGEELGEGERPEEDAAALELS(ph)S(ph)DEAVEVEEVIEESR_, , , , ,-0.49,-0.41,-0.24,-0.33, , , , ,-0.12,0.04,-0.18,0.05,,,-0.45,-0.29,,,-0.04,-0.06,,,,,,,NA,NA,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,324.59,324.59,S203,EGERPEEDAAALELSSDEAVEVEEVIEESRA,_EGEELGEGERPEEDAAALELS(ph)S(ph)DEAVEVEEVIEESR_, , , , ,-0.49,-0.41,-0.24,-0.33, , , , ,-0.12,0.04,-0.18,0.05,,,-0.45,-0.29,,,-0.04,-0.06,,,,,,,NA,NA,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,122.96,121.12,S365,EGGAERGEAGDLRRGSSPDVHALLEITEESD,_RGS(ph)S(ph)PDVHALLEITEESDAVLVDK_, , , , , ,0.51, , , , , , , ,0.54, , ,,,0.51,,,,0.54,,,,,,,,NA,NA,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q6NZI2,Q6NZI2,Polymerase I and transcript release factor,PTRF,122.96,121.12,S366,GGAERGEAGDLRRGSSPDVHALLEITEESDA,_RGS(ph)S(ph)PDVHALLEITEESDAVLVDK_, , , , , ,0.51, , , , , , , ,0.54, , ,,,0.51,,,,0.54,,,,,,,,NA,NA,,caveola,rRNA primary transcript binding,"regulation of transcription, DNA-dependent",,
Q9NZH5-2,O95997,Securin-2,PTTG2,151.56,151.56,S165,DEEGELEKLFQLGPPSPVKMPSPPWECNLFA,_LFQLGPPS(ph)PVK_,0.78,0.71,0.13,0.13,-0.06,-0.12, , ,-0.08,-0.07,0.08,-0.05,-0.02,-0.13, , ,0.74,0.13,-0.09,,-0.07,0.02,-0.08,,,,,,,,NA,NA,,cytoplasm,,chromosome organization,,
E9PR38,Q14671,Pumilio homolog 1,PUM1,89.53,66.52,S709,TAVANSNTGSGSRRDSLTGSSDLYKRTSSSL,_RDS(ph)LTGSSDLYK_, , , , ,1.41,1.54,1.33, , , , , ,1.57,1.34,1.17, ,,,1.48,1.33,,,1.46,1.17, +, +,,,,,NA,NA,,,RNA binding,,,
Q8TB72-2,Q8TB72,Pumilio homolog 2,PUM2,117.48,115.47,S136,AETDGPEKGDQKGKASPFEEDQNRDLKQGDD,_GKAS(ph)PFEEDQNRDLK_,-0.17,0.09,0.03,0.15, , , , ,0.27,0.15,0.02,0.12, , , , ,-0.03,0.09,,,0.21,0.07,,,,,,,,,NA,NA,,cytoplasmic stress granule,RNA binding,regulation of translation,,
Q8TB72-2,Q8TB72,Pumilio homolog 2,PUM2,131.06,110.06,S182,ADCKDFNRTPGSRQASPTEVVERLGPNTNPS,_QAS(ph)PTEVVER_,-0.13,-0.12,-0.05,-0.24,0.37,0.11,0.81,0.24,-0.33,-0.07,-0.09,0.06,0.15,0.03,0.02,0.06,-0.12,-0.14,0.25,0.55,-0.19,-0.01,0.09,0.04,,,,,,,0,0,,cytoplasmic stress granule,RNA binding,regulation of translation,,
Q8TB72-2,Q8TB72,Pumilio homolog 2,PUM2,104.95,104.95,S178,NGMDADCKDFNRTPGSRQASPTEVVERLGPN,_TPGS(ph)RQAS(ph)PTEVVER_,-0.06,-0.05,-0.28,-0.34,0.16,-0.02,-0.08,0.1,-0.61,-0.53,-0.53,-0.71,-0.15,-0.2,-0.3,0.01,-0.05,-0.31,0.07,0.01,-0.57,-0.62,-0.17,-0.13,,,,,,,0,0,,cytoplasmic stress granule,RNA binding,regulation of translation,,
Q96QR8,Q96QR8,Transcriptional activator protein Pur-beta,PURB,207.92,207.92,S6,__________MADGDSGSERGGGGGPCGFQP,_(ac)ADGDS(ph)GS(ph)ERGGGGGPCGFQPASR_, ,-0.56, , ,-0.57,-0.61,-0.5,-0.65, ,-0.13, , ,-0.36,-0.14,-0.22,-0.28,-0.56,,-0.59,-0.58,-0.13,,-0.25,-0.25,,,,,,,NA,NA,,DNA replication factor A complex,double-stranded DNA binding,"negative regulation of transcription, DNA-dependent",,
Q96QR8,Q96QR8,Transcriptional activator protein Pur-beta,PURB,207.92,207.92,S8,________MADGDSGSERGGGGGPCGFQPAS,_(ac)ADGDS(ph)GS(ph)ERGGGGGPCGFQPASR_, ,-0.56, , ,-0.57,-0.61,-0.5,-0.65, ,-0.13, , ,-0.36,-0.14,-0.22,-0.28,-0.56,,-0.59,-0.58,-0.13,,-0.25,-0.25,,,,,,,NA,NA,,DNA replication factor A complex,double-stranded DNA binding,"negative regulation of transcription, DNA-dependent",,
Q96QR8,Q96QR8,Transcriptional activator protein Pur-beta,PURB,187.54,187.52,S298,QERQRDKLYERRGGGSGGGEESEGEEVDED_,_RGGGS(ph)GGGEES(ph)EGEEVDED_, , , , , ,-0.4,-0.49,-0.41, , , , , ,-0.3,-0.05,-0.12,,,-0.4,-0.45,,,-0.3,-0.09,,,,,,,NA,NA,,DNA replication factor A complex,double-stranded DNA binding,"negative regulation of transcription, DNA-dependent",,
Q96QR8,Q96QR8,Transcriptional activator protein Pur-beta,PURB,235.99,229.91,S304,KLYERRGGGSGGGEESEGEEVDED_______,_RGGGS(ph)GGGEES(ph)EGEEVDED_,-0.32,-0.23,-0.48,-0.44,-0.61,-0.31,-0.37,-0.37,-0.06,-0.07,-0.19,-0.14,-0.38,-0.07,-0.11,-0.05,-0.28,-0.46,-0.45,-0.37,-0.06,-0.17,-0.22,-0.08,,,,,,,0,0,,DNA replication factor A complex,double-stranded DNA binding,"negative regulation of transcription, DNA-dependent",,
Q9Y606-2,Q9Y606,"tRNA pseudouridine synthase A, mitochondrial",PUS1,131.13,130.09,S415,SATALTAGGTGAKVPSPLEGSEGDGDTD___,_VPS(ph)PLEGS(ph)EGDGDT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,mitochondrion,DNA binding,positive regulation of transcription from RNA polymerase II promoter,,
Q9Y606-2,Q9Y606,"tRNA pseudouridine synthase A, mitochondrial",PUS1,288,288,S420,TAGGTGAKVPSPLEGSEGDGDTD________,_VPS(ph)PLEGS(ph)EGDGDT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,mitochondrion,DNA binding,positive regulation of transcription from RNA polymerase II promoter,,
Q9Y606-2,Q9Y606,"tRNA pseudouridine synthase A, mitochondrial",PUS1,288,288,T426,AKVPSPLEGSEGDGDTD______________,_VPS(ph)PLEGS(ph)EGDGDT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,mitochondrion,DNA binding,positive regulation of transcription from RNA polymerase II promoter,,
Q15223,Q15223,Poliovirus receptor-related protein 1,PVRL1,123.72,123.23,S434,PDDSDDEKKAGPLGGSSYEEEEEEEEGGGGG,_AGPLGGS(ph)S(ph)YEEEEEEEEGGGGGER_, , , , , ,-0.25,0.03,-0.02, , , , , ,-0.02,0.08,0.28,,,-0.25,0,,,-0.02,0.18,,,,,,,NA,NA,,cell-cell adherens junction,coreceptor activity,adherens junction organization,,
Q15223,Q15223,Poliovirus receptor-related protein 1,PVRL1,123.72,123.23,S435,DDSDDEKKAGPLGGSSYEEEEEEEEGGGGGE,_AGPLGGS(ph)S(ph)YEEEEEEEEGGGGGER_, , , , , ,-0.25,0.03,-0.02, , , , , ,-0.02,0.08,0.28,,,-0.25,0,,,-0.02,0.18,,,,,,,NA,NA,,cell-cell adherens junction,coreceptor activity,adherens junction organization,,
Q9NQS3,Q9NQS3,Poliovirus receptor-related protein 3,PVRL3,71.28,70.83,Y510,WNNVENLNRFERPMDYYEDLKMGMKFVSDEH,_FERPMDY(ph)YEDLK_,3.21, , , , , , , ,2.73, , , , , , , ,3.21,,,,2.73,,,, +, +,,,,,NA,NA,,apical junction complex,protein homodimerization activity,adherens junction organization,,
Q13610,Q13610,Periodic tryptophan protein 1 homolog,PWP1,339.08,337.5,S50,LIAEAKEKLQEEGGGSDEEETGSPSEDGMQS,_LQEEGGGS(ph)DEEETGS(ph)PSEDGMQSAR_,-0.09,-0.13,-0.27,-0.15,-0.3,-0.28,-0.38,-0.41,0.08,0.06,-0.08,-0.06,-0.19,-0.14,-0.34,-0.22,-0.11,-0.21,-0.29,-0.39,0.07,-0.07,-0.16,-0.28,,,,,,,0,0,,nucleus,,"transcription, DNA-dependent",,
Q13610,Q13610,Periodic tryptophan protein 1 homolog,PWP1,297.55,290.1,S57,KLQEEGGGSDEEETGSPSEDGMQSARTQARP,_LQEEGGGS(ph)DEEETGS(ph)PSEDGMQSAR_,-0.25,-0.38,-0.36,-0.4,-0.45,-0.36,-0.58,-0.6,-0.22,-0.04,-0.12,-0.07,-0.4,-0.23,-0.37,-0.33,-0.31,-0.38,-0.4,-0.59,-0.13,-0.09,-0.31,-0.35,,,,,,,0,0,,nucleus,,"transcription, DNA-dependent",,
Q13610,Q13610,Periodic tryptophan protein 1 homolog,PWP1,134.14,131.3,S59,QEEGGGSDEEETGSPSEDGMQSARTQARPRE,_LQEEGGGS(ph)DEEETGS(ph)PS(ph)EDGMQSAR_, ,-0.28,-0.31, ,-0.56,-0.54,-0.68,-0.75, ,-0.05,-0.07, ,-0.31,-0.35,-0.48,-0.49,-0.28,-0.31,-0.55,-0.71,-0.05,-0.07,-0.33,-0.48,,,,,,,0,0,,nucleus,,"transcription, DNA-dependent",,
Q13610,Q13610,Periodic tryptophan protein 1 homolog,PWP1,188.77,188.77,T86,RPREPLEDGDPEDDRTLDDDELAEYDLDKYD,_EPLEDGDPEDDRT(ph)LDDDELAEYDLDK_,-0.36,-0.5,-0.54,-0.65,-0.61,-0.5,-0.64,-1.34,-0.23,-0.33,-0.74,-0.9,-0.6,-0.67,-0.58,-1.41,-0.43,-0.59,-0.55,-0.95,-0.28,-0.82,-0.63,-0.94,,,,,,,0,0,,nucleus,,"transcription, DNA-dependent",,
G5EA07,Q96N64,PWWP domain-containing protein 2A,PWWP2A,90.42,88.88,S81,PPLPPPPPPPGELARSPEAVGPELEAEEKLS,_S(ph)PEAVGPELEAEEK_, ,-0.67,-0.62, ,-0.63,-0.89,-0.9,-0.81, ,-0.57,-0.34, ,-0.26,-0.1,-0.07,-0.06,-0.67,-0.62,-0.75,-0.85,-0.57,-0.34,-0.18,-0.06,,,,,,,0,0,,,,,,
F5GZ78,P49023,Paxillin,PXN,144.26,137.77,S137,NKQKSAEPSPTVMSTSLGSNLSELDRLLLEL,_SAEPSPTVMSTS(ph)LGSNLSELDR_, , , , ,0.62,1.06,1.59,1.32, , , , ,0.95,1.07,0.61,0.5,,,0.85,1.46,,,1.01,0.56, +, +,,,,,NA,NA,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,153.25,152.1,S126,VGEEEHVYSFPNKQKSAEPSPTVMSTSLGSN,_S(ph)AEPS(ph)PTVMSTSLGSNLSELDR_, , , , ,0.81,0.55,0.77,0.74, , , , ,0.61,0.86,1.05,1.01,,,0.68,0.76,,,0.74,1.03,, +,,,,,NA,NA,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,144.26,137.77,T132,VYSFPNKQKSAEPSPTVMSTSLGSNLSELDR,_S(ph)AEPSPT(ph)VMSTS(ph)LGSNLSELDR_, , , , ,0.66, ,0.74,0.68, , , , ,0.74, ,1.02,0.99,,,0.66,0.71,,,0.74,1,, +,,,,,NA,NA,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,124.91,124.39,Y88,SSRFIHQQPQSSSPVYGSSAKTSSVSNPQDS,_FIHQQPQS(ph)SSPVY(ph)GSSAK_,-0.24,-0.39,0.03,0.32,0.79,0.79,0.67,0.64,0.13,0.04,0.53,0.5,0.54,0.55,0.55,0.6,-0.31,0.18,0.79,0.65,0.09,0.52,0.55,0.57,,,,,,,0,0,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,288.52,278.45,Y118,SVGSPCSRVGEEEHVYSFPNKQKSAEPSPTV,_VGEEEHVY(ph)SFPNK_,-0.21,-0.13,-0.41,-0.02,0.54,0.52,0.4,0.48,0.08,0.07,0.44,0.43,0.39,0.39,0.49,0.55,-0.17,-0.2,0.53,0.44,0.08,0.44,0.39,0.52,,,,,,,0,0,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,138.23,138.23,S303,ERCWAAGWPRDGGRSSPGGQDEGGFMAQGKT,_DGGRSS(ph)PGGQDEGGFMAQGK_,-0.43,-0.46,-0.75,-0.97,-0.38, ,0.12,-0.65,-0.17,-0.3,-0.36,-0.11,-0.34, ,-0.03,-0.95,-0.45,-0.86,-0.38,-0.22,-0.23,-0.23,-0.34,-0.42,,,,,,,0,0,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,90.06,89.79,S85,QPSSSRFIHQQPQSSSPVYGSSAKTSSVSNP,_FIHQQPQSSS(ph)PVY(ph)GSSAK_,-0.2,-0.31,-0.16,-0.24,-0.28, ,0.26,0.28,0.18,0.03,0,0.07,0.07, ,0.58,0.52,-0.25,-0.2,-0.28,0.27,0.1,0.03,0.07,0.55,,,,,,,0,0,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
F5GZ78,P49023,Paxillin,PXN,153.25,152.1,S130,EHVYSFPNKQKSAEPSPTVMSTSLGSNLSEL,_S(ph)AEPS(ph)PTVM(ox)STSLGSNLSELDR_, , , , ,0.78,0.59,0.81,0.75, , , , ,0.61,0.82,1.07,0.93,,,0.69,0.78,,,0.72,1,,,,,,,NA,NA,,cytoskeleton,zinc ion binding,cell-matrix adhesion,,
Q5T171,Q9BRQ0,Pygopus homolog 2,PYGO2,139.78,136.74,T302,NQPSFPPNSSGRGGGTPDANSLAPPGKAGGG,_GGGT(ph)PDANSLAPPGK_,-0.17,-0.06,-0.17,-0.18,0.19,0.11,0.27,-0.08,-0.06,-0.18,-0.15,-0.09,-0.44,-0.47,-0.9,-0.27,-0.11,-0.17,0.15,0.11,-0.12,-0.12,-0.46,-0.55,,,,,,,0,0,,nucleus,zinc ion binding,brain development,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,295.16,294.64,S1348,DTVAIEGFTDEEDTESGGEGQYRERDEFVVK,_GQDTVAIEGFT(ph)DEEDTES(ph)GGEGQYR_, ,-0.02, , ,0.01,-0.12,0.09,0.06, ,0.05, , ,-0.03,-0.08,0.04,0.02,-0.02,,-0.05,0.08,0.05,,-0.06,0.03,,,,,,,NA,NA,,,,,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,60.25,59.14,S1227,PSDKVDNELKNLEHLSSFSSDEDDPGYSQDA,_NLEHLS(ph)SFS(ph)S(ph)DEDDPGYSQDAYK_, , , , , ,-0.31, ,-0.03, , , , , ,-0.17, ,0.28,,,-0.31,-0.03,,,-0.17,0.28,,,,,,,NA,NA,,,,,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,221.77,213.86,S1230,KVDNELKNLEHLSSFSSDEDDPGYSQDAYKS,_NLEHLSSFS(ph)S(ph)DEDDPGYSQDAYK_,-0.07,-0.09,-0.05,-0.07,-0.11,-0.01,-0.01,-0.02,0.11,0.1,-0.08,0,0,0.03,0.24,0.08,-0.08,-0.06,-0.06,-0.01,0.11,-0.04,0.01,0.17,,,,,,,0,0,,,,,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,221.77,213.86,S1231,VDNELKNLEHLSSFSSDEDDPGYSQDAYKSV,_NLEHLSSFS(ph)S(ph)DEDDPGYSQDAYK_,-0.07,-0.09,-0.05,-0.07,-0.11,-0.01,-0.01,-0.02,0.11,0.1,-0.08,0,0,0.03,0.24,0.08,-0.08,-0.06,-0.06,-0.01,0.11,-0.04,0.01,0.17,,,,,,,0,0,,,,,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,244.71,242.93,S1211,SSTTPTPLVSETGGNSPSDKVDNELKNLEHL,_PSSTTPTPLVSETGGNS(ph)PSDK_,0.1,0.2, , ,-0.01,0.21,0.19,0.19,0.04,0.58, , ,0.29,-0.1,0.41,0.17,0.15,,0.1,0.19,0.33,,0.11,0.29,,,,,,,NA,NA,,,,,,
C9JJ88,Q2KHR3,Glutamine and serine-rich protein 1,QSER1,295.16,294.64,T1341,DQFAKGQDTVAIEGFTDEEDTESGGEGQYRE,_GQDTVAIEGFT(ph)DEEDTES(ph)GGEGQYR_, ,-0.02, , ,0.01,-0.12,0.09,0.06, ,0.05, , ,-0.08,-0.08,0.04,0.02,-0.02,,-0.05,0.08,0.05,,-0.08,0.03,,,,,,,NA,NA,,,,,,
Q6ZRP7,Q6ZRP7,Sulfhydryl oxidase 2,QSOX2,194.11,191.74,S578,GRDNLLDTYSADQGDSSEGGTLARGEEEEKR,_DNLLDTYSADQGDS(ph)SEGGTLAR_,0.47,0.7,0.87,0.02,-0.63,-0.28,-0.21,-0.11,0.36,0.45,0.29,-0.08,-0.25,-0.22,-0.23,-0.3,0.59,0.51,-0.45,-0.16,0.4,0.12,-0.23,-0.26,,,,,,,0,0,,extracellular region,thiol oxidase activity,cell redox homeostasis,,
C9JJI1,Q9UBL0,cAMP-regulated phosphoprotein 21,R3HDM1,80.63,74.36,S280,DNQMRIRLKDDRRSKSIEEREEEYQRARDRI,_S(ph)IEEREEEYQR_, , , , , ,0.95, , , , , , , ,-0.03, , ,,,0.95,,,,-0.03,,,,,,,,NA,NA,,,,,,
Q15907,P62491,Ras-related protein Rab-11B,RAB11B,171.73,139.2,Y8,________MGTRDDEYDYLFKVVLIGDSGVG,_(ac)GTRDDEY(ph)DYLFK_,2.01, ,3.09, ,0.71,0.64,1.26,0.97,1.61, ,1.81, ,1.48,1.48,1.2,1,2.01,3.09,0.68,1.12,1.61,1.81,1.48,1.1, +, +,,,,,4,5,30.37,mitochondrion,GDP binding,cell cycle,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,136.94,136.61,S190,DKIKGKNKDSGSDTASAIIPSTTPSVDSDDE,_DSGSDTAS(ph)AIIPSTTPSVDS(ph)DDESVVK_, , , , ,0.12,0.32,0.51,0.83, , , , ,-0.4,-0.3,0.17,0.55,,,0.22,0.68,,,-0.35,0.37,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,81.83,73.08,S199,SGSDTASAIIPSTTPSVDSDDESVVKDKKKK,_DSGSDTASAIIPSTTPS(ph)VDS(ph)DDESVVK_, , , , , ,0.17,0.16, , , , , , ,-0.03,0.96, ,,,0.17,0.16,,,-0.03,0.96,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,161.26,158.91,S202,DTASAIIPSTTPSVDSDDESVVKDKKKKSKI,_DSGSDTASAIIPSTTPSVDS(ph)DDESVVK_,-0.21,-0.1,-0.11,-0.21,-0.2,-0.02,0.15,0.06,0.14,0.23,0.11,0.34,0.89,-0.04,0,0.07,-0.16,-0.16,-0.11,0.11,0.19,0.23,0.5,0.04,,,,,,,0,0,,cytoplasm,,protein transport,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,91.59,90.66,S206,AIIPSTTPSVDSDDESVVKDKKKKSKIKTLL,_DSGSDTASAIIPSTTPSVDS(ph)DDES(ph)VVK_, , , , ,0.03,-0.09, , , , , , ,-0.02,0.19, , ,,,-0.03,,,,0.09,,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,267.13,246.1,S357,SSPSPKGFRKKHLFSSTENLAAGSWKEPAEG,_HLFSS(ph)TENLAAGSWKEPAEGGGLSSDR_,0.07, ,0.09, , , , , ,0.26, ,0.05, , , , , ,0.07,0.09,,,0.26,0.05,,,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q6WKZ4,Q6WKZ4,Rab11 family-interacting protein 1,RAB11FIP1,119.47,96.62,S156,EIEVDIQFMRNNMTASMFDLSMKDKSRNPFG,_NNMTAS(ph)MFDLSMK_,0.15,0.19,-0.02,-0.05,0.61,0.1,0.83, ,0.51,0.33,0.33,0.31,-0.3,-0.54,0.48, ,0.17,-0.04,0.38,0.83,0.42,0.32,-0.42,0.48,,,,,,,0,0,,cytoplasm,,protein transport,,
Q9H0U4,Q9H0U4,Ras-related protein Rab-1B,RAB1B,62.47,60.03,Y5,___________MNPEYDYLFKLLLIGDSGVG,_(ac)MNPEY(ph)DYLFK_, , ,1.47, ,0.74, , , , , ,1.44, ,1.43, , , ,,1.47,0.74,,,1.44,1.43,, +, +,,,,,NA,NA,,Golgi apparatus,GTP binding,protein transport,,
Q13637,Q13637,Ras-related protein Rab-32,RAB32,121.5,87.25,S71,ATIGVDFALKVLNWDSRTLVRLQLWDIAGQE,_VLNWDS(ph)R_,-1.26, , ,-1.5,-1.01, , ,-1.13,-0.31, , ,-0.87,-0.6, , ,-0.94,-1.26,-1.5,-1.01,-1.13,-0.31,-0.87,-0.6,-0.94, +,,,,,,3,0,19.34,mitochondrion,GTP binding,phagosome maturation,,
E9PEJ9,Q9BZG1,Ras-related protein Rab-34,RAB34,136.59,129.3,S241,EKSGARRIGDVVRINSDDSNLYLTASKKKPT,_INS(ph)DDS(ph)NLYLTASK_, , ,0.87, ,0.9,1, , , , ,0.57, ,0.41,0.76, , ,,0.87,0.95,,,0.57,0.59,,,,,,,,NA,NA,,,,,,
E9PEJ9,Q9BZG1,Ras-related protein Rab-34,RAB34,136.59,129.3,S244,GARRIGDVVRINSDDSNLYLTASKKKPTCCP,_INS(ph)DDS(ph)NLYLTASK_, , , , ,0.9,1, , , , , , ,0.41,0.76, , ,,,0.95,,,,0.59,,,,,,,,NA,NA,,,,,,
P20340-2,P20340,Ras-related protein Rab-6A,RAB6A,180.3,180.3,S2,______________MSTGGDFGNPLRKFKLV,_(ac)S(ph)TGGDFGNPLRK_,0.34,0.32,-0.04,-0.04,-0.55,-0.15, ,0.06,0.54,0.69,0.53,0.47,0.19,0.32, ,0.18,0.33,-0.04,-0.34,0.06,0.62,0.5,0.26,0.18,,,,,,,0,0,,cytoplasmic vesicle,GTP binding,minus-end-directed organelle transport along microtubule,,
P51149,P51149,Ras-related protein Rab-7a,RAB7A,342.42,317.39,Y183,TIARNALKQETEVELYNEFPEPIKLDKNDRA,_QETEVELY(ph)NEFPEPIK_,2.7, ,3.17, , , , , ,1.59, ,1.64, , , , , ,2.7,3.17,,,1.59,1.64,,, +, +,,,,,NA,NA,,alveolar lamellar body,GDP binding,antigen processing and presentation of exogenous peptide antigen via MHC class II,+,
F5GZU7,Q15276,Rab GTPase-binding effector protein 1,RABEP1,194.84,183.47,S407,KSDNDMFKDGLRRAQSTDSLGTSGSLQSKAL,_AQS(ph)TDS(ph)LGTSGSLQSK_, , , ,0.28,0.7,0.77,0.68,0.98, , , ,0.44,0.12,0.31,0.08,0.09,,0.28,0.74,0.84,,0.44,0.22,0.09,,,,,,,NA,NA,,,,,,
F5GZU7,Q15276,Rab GTPase-binding effector protein 1,RABEP1,194.84,183.47,S410,NDMFKDGLRRAQSTDSLGTSGSLQSKALGYN,_AQS(ph)TDS(ph)LGTSGSLQSK_, , , , ,0.24,0.29, ,0.37, , , , ,0.02,0, ,-0.16,,,0.27,0.37,,,0.01,-0.16,,,,,,,NA,NA,,,,,,
Q9Y3P9,Q9Y3P9,Rab GTPase-activating protein 1,RABGAP1,78.62,75.57,T996,RVKGISSTKEVLDEDTDEEKETLKNQLREME,_EVLDEDT(ph)DEEK_,0.08,0.3,-0.02,0.39, ,-0.54,0.31, ,0.04,0.1,0.07,-0.07, ,-0.21,0.27, ,0.19,0.2,-0.54,0.31,0.07,0,-0.21,0.27,,,,,,,0,0,,centrosome,DNA binding,cell cycle,,
Q9H0H5,Q9H0H5,Rac GTPase-activating protein 1,RACGAP1,57.8,55.46,T579,TPQTPDIKVSLLGPVTTPEHQLLKTPSSSSL,_VSLLGPVT(ph)TPEHQLLK_, ,-0.18, , , , , , , ,0.15, , , , , , ,-0.18,,,,0.15,,,,,,,,,,NA,NA,,acrosomal vesicle,alpha-tubulin binding,antigen processing and presentation of exogenous peptide antigen via MHC class II,,
Q9NS91,Q9NS91,E3 ubiquitin-protein ligase RAD18,RAD18,111.12,96.75,T310,KSAAEIVREIENIEKTRMRLEASKLNESVMV,_SAAEIVREIENIEKT(ph)R_, , ,-1.66, , , , , , , ,-1.86, , , , , ,,-1.66,,,,-1.86,,, +, +,,RING finger,,,NA,NA,,chromatin,damaged DNA binding,DNA repair,+,
Q9NS91,Q9NS91,E3 ubiquitin-protein ligase RAD18,RAD18,149.52,142.83,S99,SLNFARNHLLQFALESPAKSPASSSSKNLAV,_NHLLQFALES(ph)PAK_, , , ,0.99, , , , , , , ,1.21, , , , ,,0.99,,,,1.21,,,, +,,RING finger,,,NA,NA,,chromatin,damaged DNA binding,DNA repair,+,
Q9NS91,Q9NS91,E3 ubiquitin-protein ligase RAD18,RAD18,228.73,183.12,S471,AWEASHKNDLQDTEISPRQNRRTRAAESAEI,_NDLQDTEIS(ph)PR_,0.33,0.33,0.21,0.57,-0.28,-0.5,-0.24,-0.21,-0.04,-0.05,0.29,0.1,-0.19,-0.14,-0.32,-0.27,0.33,0.4,-0.38,-0.23,-0.04,0.2,-0.16,-0.29,,,,RING finger,,,0,0,,chromatin,damaged DNA binding,DNA repair,+,
P54725,P54725,UV excision repair protein RAD23 homolog A,RAD23A,163.95,163.95,S123,TSGMSHPPPAAREDKSPSEESAPTTSPESVS,_EDKS(ph)PSEESAPTTSPESVSGSVPSSGSSGR_,0.1,0.08,0.11,-0.14,0.4,0.48, , ,0,-0.11,-0.01,-0.26,-0.35,-0.21, , ,0.09,-0.01,0.44,,-0.05,-0.13,-0.28,,,,,,,,NA,NA,,nucleus,damaged DNA binding,nucleotide-excision repair,,
P54725,P54725,UV excision repair protein RAD23 homolog A,RAD23A,201.8,200.93,S133,AREDKSPSEESAPTTSPESVSGSVPSSGSSG,_SPSEESAPTTS(ph)PESVSGSVPSSGSSGR_, , , , ,-0.03,0.08,-0.1,-0.09, , , , ,-0.52,-0.28,-0.16,-0.06,,,0.03,-0.09,,,-0.4,-0.11,,,,,,,NA,NA,,nucleus,damaged DNA binding,nucleotide-excision repair,,
P54725,P54725,UV excision repair protein RAD23 homolog A,RAD23A,70.42,69.44,S136,DKSPSEESAPTTSPESVSGSVPSSGSSGREE,_SPSEESAPTTS(ph)PES(ph)VSGSVPSSGSSGR_, , , , , , , ,-0.06, , , , , , , ,-0.28,,,,-0.06,,,,-0.28,,,,,,,NA,NA,,nucleus,damaged DNA binding,nucleotide-excision repair,,
P54725,P54725,UV excision repair protein RAD23 homolog A,RAD23A,96.88,96.74,S357,FACEKNENLAANFLLSQNFDDE_________,_NENLAANFLLS(ph)QNFDDE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,damaged DNA binding,nucleotide-excision repair,,
P54727,P54727,UV excision repair protein RAD23 homolog B,RAD23B,258.05,253.23,S160,QEKPAEKPAETPVATSPTATDSTSGDSSRSN,_PAEKPAETPVATS(ph)PTATDSTSGDSSR_,0.03,0.12,0.68,0.64,1.3,1.2,1.27,1.18,0.15,0.2,0.61,0.59,0.94,0.99,1.28,1.44,0.07,0.66,1.25,1.22,0.18,0.6,0.97,1.36, +, +,,,,,2,2,33.11,cytoplasm,damaged DNA binding,"nucleotide-excision repair, DNA damage recognition",+,
F5H1Y0,Q96B01,RAD51-associated protein 1,RAD51AP1,94.71,94.71,S120,LSVKELPTVTTNVQNSQDKSIEKHGSSKIET,_ELPTVTTNVQNS(ph)QDK_,-0.22,-0.12,-0.15,0.05,-0.84, ,-0.81,-0.84,-0.47,-0.26,-0.27,-0.35,-0.5, ,-0.41,-0.71,-0.17,-0.04,-0.84,-0.83,-0.36,-0.31,-0.5,-0.55,,,,,,,0,0,,nucleus,double-stranded DNA binding,DNA repair,,
Q99638,Q99638,Cell cycle checkpoint control protein RAD9A,RAD9A,136.99,124.39,S375,KFRSLFFGSILAPVRSPQGPSPVLAEDSEGE,_S(ph)PQGPSPVLAEDS(ph)EGEG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,checkpoint clamp complex,3'-5' exonuclease activity,cellular response to ionizing radiation,,
Q99638,Q99638,Cell cycle checkpoint control protein RAD9A,RAD9A,84.67,83.53,S380,FFGSILAPVRSPQGPSPVLAEDSEGEG____,_SPQGPS(ph)PVLAEDS(ph)EGEG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,checkpoint clamp complex,3'-5' exonuclease activity,cellular response to ionizing radiation,,
Q99638,Q99638,Cell cycle checkpoint control protein RAD9A,RAD9A,250.39,246.13,S387,PVRSPQGPSPVLAEDSEGEG___________,_S(ph)PQGPSPVLAEDS(ph)EGEG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,checkpoint clamp complex,3'-5' exonuclease activity,cellular response to ionizing radiation,,
B4E1N6,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,203.45,195.1,S289,SRMIEDAIRSHSESASPSALSSSPNNLSPTG,_SHSESAS(ph)PSALSSS(ph)PNNLS(ph)PTGWSQPK_, , , , ,1.82,1.45,1.87,1.71, , , , ,1.89,3.56,1.9,1.88,,,1.65,1.79,,,2.95,1.89, +, +,TKL,,,,NA,NA,,,ATP binding,,,
B4E1N6,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,198.89,198.89,S296,IRSHSESASPSALSSSPNNLSPTGWSQPKTP,_SHSESAS(ph)PSALSSS(ph)PNNLS(ph)PTGWSQPK_, , , , ,0.54,1.32,1.86,-0.01, , , , ,0.53,5.3,1.86,0.16,,,0.99,1.21,,,4.35,1.25, +, +,TKL,,,,NA,NA,,,ATP binding,,,
B4E1N6,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,203.45,195.1,S301,ESASPSALSSSPNNLSPTGWSQPKTPVPAQR,_SHSESAS(ph)PSALSSS(ph)PNNLS(ph)PTGWSQPK_, , , , ,0.54,1.57,1.87,0.16, , , , ,0.53,1.81,1.88,0.25,,,1.14,1.25,,,1.31,1.28, +, +,TKL,,,,NA,NA,,,ATP binding,,,
B4E1N6,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,60.21,58.75,S259,SPSSEGSLSQRQRSTSTPNVHMVSTTLPVDS,_STS(ph)TPNVHMVSTTLPVDSR_, , ,1.04, ,0.14, , , , , ,-0.13, ,-0.18, , , ,,1.04,0.14,,,-0.13,-0.18,, +,,TKL,,,,NA,NA,,,ATP binding,,,
P10398,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,113.22,86.52,S621,IELLQHSLPKINRSASEPSLHRAAHTEDINA,_SAS(ph)EPSLHR_,-0.01, , , ,-0.06,0.05,0.02,0.27,-0.56, , , ,-0.4,-0.2,-0.17,-0.12,-0.01,,0,0.15,-0.56,,-0.3,-0.14,,,TKL,,,,NA,NA,,cytosol,ATP binding,negative regulation of apoptotic process,,
Q15311,Q15311,RalA-binding protein 1,RALBP1,92.04,45.97,S461,AKRQECETKIAQEIASLSKEDVSKEEMNENE,_IAQEIAS(ph)LSK_, , , ,-0.34, ,-0.49, , , , , ,-0.58, ,-0.69, , ,,-0.34,-0.49,,,-0.58,-0.69,,,,,,,,NA,NA,,cytosol,"ATPase activity, coupled to movement of substances",chemotaxis,,
Q15311,Q15311,RalA-binding protein 1,RALBP1,146.59,66.95,S463,RQECETKIAQEIASLSKEDVSKEEMNENEEV,_IAQEIASLS(ph)K_,0.1,-0.12,-0.45, ,-0.41,-0.38,-0.3,-0.27,-0.28,-0.1,-0.62, ,-0.77,-0.57,-0.22,-0.54,-0.01,-0.45,-0.39,-0.28,-0.19,-0.62,-0.67,-0.37,,,,,,,0,0,,cytosol,"ATPase activity, coupled to movement of substances",chemotaxis,,
Q15311,Q15311,RalA-binding protein 1,RALBP1,173.95,170.33,S92,KKEKRTEGYAAFQEDSSGDEAESPSKMKRSK,_RTEGYAAFQEDS(ph)S(ph)GDEAESPSK_, , , , ,-0.09,0.03,0,0.04, , , , ,0.35,-0.04,0.19,0.05,,,-0.03,0.02,,,0.17,0.12,,,,,,,NA,NA,,cytosol,"ATPase activity, coupled to movement of substances",chemotaxis,,
Q15311,Q15311,RalA-binding protein 1,RALBP1,173.95,170.33,S93,KEKRTEGYAAFQEDSSGDEAESPSKMKRSKG,_TEGYAAFQEDS(ph)S(ph)GDEAESPSK_, , , , ,-0.09,0.03,0,0.04, , , , ,0.35,-0.04,0.19,0.05,,,-0.03,0.02,,,0.17,0.12,,,,,,,NA,NA,,cytosol,"ATPase activity, coupled to movement of substances",chemotaxis,,
Q15311,Q15311,RalA-binding protein 1,RALBP1,103.53,103.53,S34,EHGSGLTRTPSSEEISPTKFPGLYRTGEPSP,_TPS(ph)SEEIS(ph)PTKFPGLYR_,0.41,0.52,0.31,0.21, , , , ,0.05,-0.04,0.08,-0.32, , , , ,0.47,0.26,,,0.01,-0.11,,,,,,,,,NA,NA,,cytosol,"ATPase activity, coupled to movement of substances",chemotaxis,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,78.55,78.55,S860,ERLRSGNASTMTRRGSSPGSLEIPKDLPDIL,_RGS(ph)S(ph)PGSLEIPK_,0.82,0.86,1.89,2.14,1.55,1.51,1.19,1.4,0.86,1.05,1.78,1.77,1.34,1.51,1.18,1.45,0.84,2.02,1.53,1.3,0.96,1.78,1.43,1.32, +, +,,,,,1,1,49.04,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,78.55,78.55,S861,RLRSGNASTMTRRGSSPGSLEIPKDLPDILN,_RGS(ph)S(ph)PGSLEIPK_,0.82,0.86,1.89,2.14,1.55,1.51,1.19,1.4,0.86,1.05,1.78,1.77,1.34,1.51,1.18,1.45,0.84,2.02,1.53,1.3,0.96,1.78,1.43,1.32, +, +,,,,,1,1,49.04,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,131.97,131.69,S1000,GSESASPVHSPLGSRSQTPSPSTLNIDHMEQ,_S(ph)QT(ph)PS(ph)PSTLNIDHMEQK_,0.1, , , ,0.02,0.06,0.01,-0.09,0.03, , , ,0,0.03,0.03,0.08,0.1,,0.04,-0.04,0.03,,0.02,0.05,,,,,,,NA,NA,,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,131.97,131.69,S1004,ASPVHSPLGSRSQTPSPSTLNIDHMEQKDLQ,_S(ph)QT(ph)PS(ph)PSTLNIDHMEQK_,0.1, , , ,0.02,0.06,0.01,-0.09,0.03, , , ,0,0.03,0.03,0.08,0.1,,0.04,-0.04,0.03,,0.02,0.05,,,,,,,NA,NA,,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,161.2,160.38,S797,VFGALNEEQPLPRSSSTSDILEPFTVERAKV,_SSS(ph)TSDILEPFTVER_, , ,0.15, ,0.77,0.23,-0.44,0.09, , ,-0.07, ,0.17,0.14,-0.39,-0.34,,0.15,0.53,-0.15,,-0.07,0.15,-0.37,,,,,,,NA,NA,,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,131.97,131.69,T1002,ESASPVHSPLGSRSQTPSPSTLNIDHMEQKD,_S(ph)QT(ph)PS(ph)PSTLNIDHMEQK_,0.1, , , ,0.02,0.06,0.01,-0.09,0.03, , , ,0,0.03,0.03,0.08,0.1,,0.04,-0.04,0.03,,0.02,0.05,,,,,,,NA,NA,,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q6GYQ0-4,Q6GYQ0,Ral GTPase-activating protein subunit alpha-1,RALGAPA1,150.05,135.61,T754,GSPGTEKARSIVRQKTVDIDDAQILPRSTRV,_T(ph)VDIDDAQILPR_,0.53,0.67,0.74, ,0.22,0.38,0.66,0.36,0.49,0.53,0.35, ,-0.04,-0.23,0.57,0.37,0.6,0.74,0.3,0.52,0.51,0.35,-0.13,0.47,,,,,,,0,0,,cytosol,Ral GTPase activator activity,activation of Ral GTPase activity,,
Q86X27,Q86X27,Ras-specific guanine nucleotide-releasing factor RalGPS2,RALGPS2,43.22,42.04,S329,KSVAAEGALLPQTPPSPRNLIPHGHRKCHSL,_SVAAEGALLPQT(ph)PPS(ph)PR_, , , , ,-0.13, ,-0.3,0.07, , , , ,-0.33, ,-0.08,-0.15,,,-0.13,-0.1,,,-0.33,-0.11,,,,,,,NA,NA,,cytoplasm,guanyl-nucleotide exchange factor activity,small GTPase mediated signal transduction,,
Q9UKM9-2,Q9UKM9,RNA-binding protein Raly,RALY,92.07,91.86,S288,ARTRDDGDEEGLLTHSEEELEHSQDTDADDG,_TRDDGDEEGLLT(ph)HS(ph)EEELEHS(ph)QDT(ph)DADDGALQ_, , , , ,-0.25,-0.53,-0.86,-0.86, , , , ,0.03,-0.1,-0.3,-0.73,,,-0.38,-0.86,,,-0.03,-0.5,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
Q9UKM9-2,Q9UKM9,RNA-binding protein Raly,RALY,92.07,91.86,S295,DEEGLLTHSEEELEHSQDTDADDGALQ____,_TRDDGDEEGLLTHS(ph)EEELEHS(ph)QDT(ph)DADDGALQ_, , , , ,-0.25, ,-0.86,-0.86, , , , ,0.03, ,-0.3,-0.73,,,-0.25,-0.86,,,0.03,-0.5,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
Q9UKM9-2,Q9UKM9,RNA-binding protein Raly,RALY,92.07,91.86,T298,GLLTHSEEELEHSQDTDADDGALQ_______,_TRDDGDEEGLLTHS(ph)EEELEHS(ph)QDT(ph)DADDGALQ_, , , , ,-0.25, ,-0.86,-0.86, , , , ,0.03, ,-0.3,-0.73,,,-0.25,-0.86,,,0.03,-0.5,,,,,,,NA,NA,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
Q9UKM9-2,Q9UKM9,RNA-binding protein Raly,RALY,69.35,69.35,S135,AASAIYRLFDYRGRLSPVPVPRAVPVKRPRV,_GRLS(ph)PVPVPR_,-0.35,-0.27,-0.24,-0.23, ,-0.62, ,-0.89,-0.26,-0.17,-0.14,-0.08, ,-0.2, ,-0.94,-0.31,-0.23,-0.62,-0.89,-0.21,-0.11,-0.2,-0.94,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,"mRNA splicing, via spliceosome",,
P43487,P43487,Ran-specific GTPase-activating protein,RANBP1,106.58,102.24,S60,EEELFKMRAKLFRFASENDLPEWKERGTGDV,_FAS(ph)ENDLPEWK_,1.3,1.31,1.11,1.82, , , , ,1.15,1.02,1.37,1.71, , , , ,1.3,1.51,,,1.09,1.55,,, +, +,,,,,NA,NA,,centrosome,GDP-dissociation inhibitor activity,intracellular transport,,
P43487,P43487,Ran-specific GTPase-activating protein,RANBP1,154.35,154.32,S14,__MAAAKDTHEDHDTSTENTDESNHDPQFEP,_DTHEDHDT(ph)S(ph)TENTDESNHDPQFEPIVSLPEQEIK_, ,0.24, , , , , , , ,-0.02, , , , , , ,0.24,,,,-0.02,,,,,,,,,,NA,NA,,centrosome,GDP-dissociation inhibitor activity,intracellular transport,,
P43487,P43487,Ran-specific GTPase-activating protein,RANBP1,154.35,154.32,T13,___MAAAKDTHEDHDTSTENTDESNHDPQFE,_DTHEDHDT(ph)S(ph)TENTDESNHDPQFEPIVSLPEQEIK_, ,0.24, , , , , ,-0.28, ,-0.02, , , , , ,-0.26,0.24,,,-0.28,-0.02,,,-0.26,,,,,,,NA,NA,,centrosome,GDP-dissociation inhibitor activity,intracellular transport,,
B3KP49,Q6VN20,Ran-binding protein 10,RANBP10,195.13,160,S361,SEVRSLSSRSPKSQDSYPGSPSLSPRHGPSS,_SQDS(ph)YPGS(ph)PSLS(ph)PR_, , , , ,-0.26,-0.16,-0.15,-0.17, , , , ,-0.41,-0.29,-0.32,-0.26,,,-0.21,-0.16,,,-0.35,-0.29,,,,,,,NA,NA,,cytoplasmic microtubule,Ran guanyl-nucleotide exchange factor activity,microtubule cytoskeleton organization,,
B3KP49,Q6VN20,Ran-binding protein 10,RANBP10,195.13,160,S365,SLSSRSPKSQDSYPGSPSLSPRHGPSSSHMH,_SQDS(ph)YPGS(ph)PSLS(ph)PR_,0.14,0.2,0.46, ,-0.26,-0.16,-0.15,-0.17,-0.03,-0.11,-0.07, ,-0.41,-0.29,-0.32,-0.26,0.17,0.46,-0.21,-0.16,-0.07,-0.07,-0.35,-0.29,,,,,,,0,0,,cytoplasmic microtubule,Ran guanyl-nucleotide exchange factor activity,microtubule cytoskeleton organization,,
B3KP49,Q6VN20,Ran-binding protein 10,RANBP10,195.13,160,S369,RSPKSQDSYPGSPSLSPRHGPSSSHMHNTGA,_SQDS(ph)YPGS(ph)PSLS(ph)PR_,0.25, ,0.46, ,-0.26,-0.16,-0.15,-0.17,-0.12, ,-0.07, ,-0.41,-0.29,-0.32,-0.26,0.25,0.46,-0.21,-0.16,-0.12,-0.07,-0.35,-0.29,,,,,,,0,0,,cytoplasmic microtubule,Ran guanyl-nucleotide exchange factor activity,microtubule cytoskeleton organization,,
P49792,P49792,E3 SUMO-protein ligase RanBP2,RANBP2,272.46,267.41,S1400,LVGPPLAETVFTPKTSPENVQDRFALVTPKK,_ELVGPPLAETVFT(ph)PKTS(ph)PENVQDR_, , , , ,-0.09,0.33,0.54,0.36, , , , ,-0.81,-0.9,-0.87,-0.85,,,0.14,0.45,,,-0.85,-0.86,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,E3 SUMO-protein ligase RanBP2,RANBP2,272.46,267.41,T1396,SNKELVGPPLAETVFTPKTSPENVQDRFALV,_ELVGPPLAETVFT(ph)PKTS(ph)PENVQDR_, , , , ,-0.09,0.36,0.54,0.36, , , , ,-0.81,-0.89,-0.87,-0.85,,,0.15,0.45,,,-0.85,-0.86,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,E3 SUMO-protein ligase RanBP2,RANBP2,128.31,128.09,S2900,VGTQSAGKVGEDEDGSDEEVVHNEDIHFEPI,_VGEDEDGS(ph)DEEVVHNEDIHFEPIVSLPEVEVK_, , , , , , ,0.04,0.01, , , , , , ,-0.12,-0.47,,,,0.03,,,,-0.28,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,E3 SUMO-protein ligase RanBP2,RANBP2,132.4,126.78,S21,ADVERYIASVQGSTPSPRQKSMKGFYFAKLY,_YIASVQGST(ph)PS(ph)PR_, , , , ,-0.68,-0.26,-0.39,-0.6, , , , ,-0.57,-0.37,-0.7,-0.78,,,-0.46,-0.49,,,-0.47,-0.74,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,E3 SUMO-protein ligase RanBP2,RANBP2,132.4,126.78,T19,SKADVERYIASVQGSTPSPRQKSMKGFYFAK,_YIASVQGST(ph)PS(ph)PR_, , , , ,-0.68,-0.26,-0.39,-0.6, , , , ,-0.57,-0.37,-0.7,-0.78,,,-0.46,-0.49,,,-0.47,-0.74,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
F5H4C2,Q9H6Z4,Ran-binding protein 3,RANBP3,85.79,85.35,S533,EQEAKMPAPEPGAAPSNEEDDSDDDDVLAPS,_MPAPEPGAAPS(ph)NEEDDS(ph)DDDDVLAPSGATAAGAGDEGDGQTTGST_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,,intracellular transport,,
F5H4C2,Q9H6Z4,Ran-binding protein 3,RANBP3,123.32,120.44,S539,PAPEPGAAPSNEEDDSDDDDVLAPSGATAAG,_MPAPEPGAAPS(ph)NEEDDS(ph)DDDDVLAPSGATAAGAGDEGDGQTTGST_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,,intracellular transport,,
F5H4C2,Q9H6Z4,Ran-binding protein 3,RANBP3,179.78,179.78,S333,SNKFVFGQNMSERVLSPPKLNEVSSDANREN,_VLS(ph)PPKLNEVSSDANR_,0.01,0.07,0.02,-0.01, ,0.1, , ,-0.03,-0.01,0.01,0.04, ,0.03, , ,0.04,0.01,0.1,,-0.02,0.03,0.03,,,,,,,,NA,NA,,nucleus,,intracellular transport,,
E9PDT1,Q13905,Rap guanine nucleotide exchange factor 1,RAPGEF1,135.24,135.24,S360,SPRLSPCSSIGKLSKSDEQLSSLDRDSGQCS,_LSKS(ph)DEQLSSLDR_,-0.44, , , , , , , ,-0.21, , , , , , , ,-0.44,,,,-0.21,,,,,,,,,,NA,NA,,,,,,
H0Y8H7,Q9Y4G8,Rap guanine nucleotide exchange factor 2,RAPGEF2,118.44,117.55,S1120,DTISNASSQLSSPPTSPQSSPRKGGSGNQLR,_QAEDTISNASSQLS(ph)SPPTS(ph)PQSSPR_, , , , ,0, ,0.12, , , , , ,-0.21, ,-0.12, ,,,0,0.12,,,-0.21,-0.12,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,small GTPase mediated signal transduction,,
Q8TEU7,Q8TEU7,Rap guanine nucleotide exchange factor 6,RAPGEF6,220.28,220.27,S1590,LQPFHPKLGDVTDADSEADENEQVSAV____,_LGDVT(ph)DADS(ph)EADENEQVSAV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,GTP-dependent protein binding,Ras protein signal transduction,,
Q8TEU7,Q8TEU7,Rap guanine nucleotide exchange factor 6,RAPGEF6,215.42,204.97,T1586,QRHNLQPFHPKLGDVTDADSEADENEQVSAV,_LGDVT(ph)DADS(ph)EADENEQVSAV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,GTP-dependent protein binding,Ras protein signal transduction,,
Q8TEU7,Q8TEU7,Rap guanine nucleotide exchange factor 6,RAPGEF6,62.34,62.34,S1094,LDVQGGAHKKRARRSSLLNAKKLYEDAQMAR,_RSS(ph)LLNAK_,-0.28,0.38,0.48,0.83, ,0.51, , ,0.14,0.53,0.53,0.62, ,0.46, , ,0.09,0.67,0.51,,0.35,0.58,0.46,,,,,,,,NA,NA,,cytoplasm,GTP-dependent protein binding,Ras protein signal transduction,,
Q8TEU7,Q8TEU7,Rap guanine nucleotide exchange factor 6,RAPGEF6,61.53,46.1,S1157,TKNLSEKRSAKSSEMSPVPMRSAGQTTKAHL,_SSEMS(ph)PVPMR_, , , , , , ,-0.04, , , , , , , ,0.11, ,,,,-0.04,,,,0.11,,,,,,,NA,NA,,cytoplasm,GTP-dependent protein binding,Ras protein signal transduction,,
Q8TEU7,Q8TEU7,Rap guanine nucleotide exchange factor 6,RAPGEF6,298.15,298.15,S230,VGDVDLTRLPEGPVDSEDDEEEDEEIDRTDP,_LPEGPVDS(ph)EDDEEEDEEIDRTDPLQGR_,0.13,0.31,0.29,0.21,-0.05,0.02,-0.18, ,0.11,0.19,-0.12,-0.2,0.08,-0.34,-0.19, ,0.22,0.25,-0.02,-0.18,0.15,-0.16,-0.12,-0.19,,,,,,,0,0,,cytoplasm,GTP-dependent protein binding,Ras protein signal transduction,,
Q70E73,Q70E73,Ras-associated and pleckstrin homology domains-containing protein 1,RAPH1,328.85,328.85,S5,___________MEQLSDEEIDHGAEEDSDKE,_(ac)M(ox)EQLS(ph)DEEIDHGAEEDS(ph)DKEDQDLDK_,0,-0.25,-0.19,-0.2,-0.03,-0.07,-0.23,0.02,0.1,-0.07,-0.16,0.01,-0.15,-0.09,0.1,-0.11,-0.12,-0.19,-0.05,-0.1,0.02,-0.07,-0.12,0,,,,,,,0,0,,cytoplasm,phospholipid binding,axon extension,,
Q70E73,Q70E73,Ras-associated and pleckstrin homology domains-containing protein 1,RAPH1,328.85,328.85,S17,EQLSDEEIDHGAEEDSDKEDQDLDKMFGAWL,_(ac)M(ox)EQLS(ph)DEEIDHGAEEDS(ph)DKEDQDLDK_,0,-0.25,-0.19,-0.2,-0.03,-0.07,-0.23,0.02,0.1,-0.07,-0.16,0.01,-0.15,-0.09,0.1,-0.11,-0.12,-0.19,-0.05,-0.1,0.02,-0.07,-0.12,0,,,,,,,0,0,,cytoplasm,phospholipid binding,axon extension,,
Q8IY67-2,Q8IY67,Ribonucleoprotein PTB-binding 1,RAVER1,231.93,231.93,S14,__MAADVSVTHRPPLSPKSGAEVEAGDAAER,_(ac)AADVSVTHRPPLS(ph)PK_,0.01,0.05,-0.04,0.03,0.18,0.13,0.03,0.23,-0.07,-0.02,-0.05,-0.05,-0.02,-0.08,-0.09,0.13,0.03,-0.01,0.15,0.14,-0.04,-0.05,-0.05,0.03,,,,,,,0,0,,cytoplasm,nucleotide binding,,,
Q8TDY2-2,Q8TDY2,RB1-inducible coiled-coil protein 1,RB1CC1,191.02,175.75,S243,DSEKAEMKRSTELVLSPDMPRTTNESLLTSF,_ST(ph)ELVLS(ph)PDMPR_, , , , ,0.74,0.47,1.44, , , , , ,0.81,0.36,1.55, ,,,0.61,1.44,,,0.6,1.55, +, +,,,,,NA,NA,,cytosol,,autophagic vacuole assembly,,
Q7Z6E9-2,Q7Z6E9,E3 ubiquitin-protein ligase RBBP6,RBBP6,60.2,59.8,S1644,TRETDEAAFEPDYNESDSESNVSVKEEESSG,_ETDEAAFEPDYNES(ph)DS(ph)ESNVSVK_, , , , ,-0.01, , ,-0.66, , , , ,0.54, , ,-1.07,,,-0.01,-0.66,,,0.54,-1.07,, +,,RING finger,,,NA,NA,,chromosome,nucleic acid binding,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,,
Q7Z6E9-2,Q7Z6E9,E3 ubiquitin-protein ligase RBBP6,RBBP6,60.2,59.8,S1646,ETDEAAFEPDYNESDSESNVSVKEEESSGNI,_ETDEAAFEPDYNESDS(ph)ES(ph)NVS(ph)VK_, , , , ,-0.01,0.01, ,-0.66, , , , ,0.54,0.32, ,-1.07,,,0,-0.66,,,0.43,-1.07,, +,,RING finger,,,NA,NA,,chromosome,nucleic acid binding,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,,
Q7Z6E9-2,Q7Z6E9,E3 ubiquitin-protein ligase RBBP6,RBBP6,89.66,88.66,S1651,AFEPDYNESDSESNVSVKEEESSGNISKDLK,_ETDEAAFEPDYNESDS(ph)ES(ph)NVS(ph)VK_, , , , , , , ,-0.66, , , , , , , ,-1.07,,,,-0.66,,,,-1.07,, +,,RING finger,,,NA,NA,,chromosome,nucleic acid binding,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,,
Q7Z6E9-2,Q7Z6E9,E3 ubiquitin-protein ligase RBBP6,RBBP6,209.61,209.61,S1328,MIQVPQSKWDKDDFESEEEDVKSTQPISSVG,_WDKDDFES(ph)EEEDVK_,-0.05,0.01,0.07,0.16,-0.1,-0.18,-0.23,-0.07,0.03,0.32,0.02,0.14,-0.13,-0.06,-0.19,-0.21,-0.02,0.12,-0.14,-0.15,0.19,0.08,-0.09,-0.2,,,,RING finger,,,0,0,,chromosome,nucleic acid binding,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,,
Q7Z6E9-2,Q7Z6E9,E3 ubiquitin-protein ligase RBBP6,RBBP6,191.63,191.63,S1179,SMKISKLEVTEIVKPSPKRKMEPDTEKMDRT,_LEVTEIVKPS(ph)PK_,0.24,0.44,0.1,0.13,0.17,0,-0.72,-0.01,0.13,0.08,0.06,0.03,-0.19,-0.03,-0.65,0.1,0.34,0.12,0.09,-0.32,0.11,0.04,-0.11,-0.23,,,,RING finger,,,0,0,,chromosome,nucleic acid binding,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,,
P98175-2,P98175,RNA-binding protein 10,RBM10,142.74,138.84,S797,GLHKQNLEIHRRAHLSENELEALEKNDMEQM,_AHLS(ph)ENELEALEK_, , ,-0.02,0.11, ,0.81, , , , ,0.4,0.42, ,1.32, , ,,0.05,0.81,,,0.41,1.32,,, +,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,275.39,272.83,S733,SDDRPSPPRGLVAAYSGESDSEEEQERGGPE,_GLVAAYS(ph)GES(ph)DS(ph)EEEQER_,-0.19,-0.21,-0.27,-0.08,0.08,0.15,0.21,0.06,-0.12,-0.2,-0.08,0.12,0.12,-1.38,0.08,0.04,-0.2,-0.17,0.12,0.14,-0.16,0.02,-0.44,0.06,,,,,,,0,0,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,319.52,317.7,S736,RPSPPRGLVAAYSGESDSEEEQERGGPEREE,_GLVAAYSGES(ph)DS(ph)EEEQER_,-0.13,-0.13,-0.26,-0.32,0.12,0.1,0.14,0.19,-0.19,-0.12,-0.24,-0.19,-0.09,-0.1,0.1,0.12,-0.13,-0.29,0.11,0.17,-0.15,-0.22,-0.09,0.11,,,,,,,0,0,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,319.52,317.7,S738,SPPRGLVAAYSGESDSEEEQERGGPEREEKL,_GLVAAYSGES(ph)DS(ph)EEEQER_,-0.13,-0.13,-0.26,-0.32,0.12,0.08,0.14,0.19,-0.19,-0.12,-0.24,-0.19,-0.09,-0.09,0.1,0.12,-0.13,-0.29,0.1,0.17,-0.15,-0.22,-0.09,0.11,,,,,,,0,0,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,106.18,106.18,S60,PREYGSQEGKHDYDDSSEEQSAEDSYEASPG,_HDYDDS(ph)S(ph)EEQS(ph)AEDSYEAS(ph)PGSETQR_, , , , ,0.86,0.51,0.45,0.44, , , , ,0.76,0.39,0.45,0.4,,,0.7,0.44,,,0.59,0.43,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,106.18,106.18,S61,REYGSQEGKHDYDDSSEEQSAEDSYEASPGS,_HDYDDS(ph)S(ph)EEQS(ph)AEDSYEAS(ph)PGSETQR_, , , , , ,0.18,0.45,0.44, , , , , ,0.46,0.45,0.4,,,0.18,0.44,,,0.46,0.43,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,106.18,106.18,S65,SQEGKHDYDDSSEEQSAEDSYEASPGSETQR,_HDYDDS(ph)S(ph)EEQS(ph)AEDSYEASPGSETQR_, , , , ,0.86,0.51,0.53,0.62, , , , ,0.76,0.39,0.46,0.41,,,0.7,0.57,,,0.59,0.43,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,106.18,106.18,S73,DDSSEEQSAEDSYEASPGSETQRRRRRRHRH,_HDYDDS(ph)S(ph)EEQS(ph)AEDSYEAS(ph)PGSETQR_, , , , ,0.86,0.51,0.44,0.79, , , , ,0.76,0.39,0.44,0.39,,,0.7,0.63,,,0.59,0.42,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,100.22,100.22,S718,LAERQHTSMDLPKLASDDRPSPPRGLVAAYS,_LAS(ph)DDRPSPPR_, ,-0.34, , ,0.12,0.28,0.56,0.04, ,-0.38, , ,0.07,0.1,0.21,0.05,-0.34,,0.2,0.32,-0.38,,0.08,0.13,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
P98175-2,P98175,RNA-binding protein 10,RBM10,112.02,112.02,S723,HTSMDLPKLASDDRPSPPRGLVAAYSGESDS,_LASDDRPS(ph)PPR_,-0.23,-0.26,-0.25,-0.4, , , , ,-0.28,-0.18,-0.31,-0.35, , , , ,-0.25,-0.33,,,-0.23,-0.33,,,,,,,,,NA,NA,,nucleus,nucleotide binding,3'-UTR-mediated mRNA stabilization,,
Q96PK6,Q96PK6,RNA-binding protein 14,RBM14,112.7,101.95,T206,FGNSTGGFDGQARQPTPPFFGRDRSPLRRSP,_(gl)QPT(ph)PPFFGR_,0.58,0.65,-0.12,0.99,-0.03,-0.02,-0.38,-0.55,0.23,0.2,-0.22,-0.21,-0.53,-0.49,-1.1,-1.08,0.61,0.54,-0.02,-0.46,0.21,-0.21,-0.51,-1.09,, +,,,,,0,6,14.59,mediator complex,ligand-dependent nuclear receptor transcription coactivator activity,DNA recombination,,
Q96T37-2,Q96T37,Putative RNA-binding protein 15,RBM15,57.18,35.51,S292,VGGHRHPPGGGGGQRSLSPGGAALGYRDYRL,_S(ph)LS(ph)PGGAALGYR_,-1.67, ,-0.32, , , ,0.18, ,-1.32, ,0.21, , , ,0.08, ,-1.67,-0.32,,0.18,-1.32,0.21,,0.08, +, +,,,,,NA,NA,,nucleus,nucleotide binding,negative regulation of myeloid cell differentiation,,
Q96T37-2,Q96T37,Putative RNA-binding protein 15,RBM15,115.87,115.87,S656,KRRLPEESGGRHLDRSPESDRPRKRHCAPSP,_HLDRS(ph)PESDRPR_,-0.14,-0.06, ,1.81, , , ,-0.13,-0.41,-0.35, ,-0.35, , , ,-0.01,-0.1,1.81,,-0.13,-0.38,-0.35,,-0.01, +,,,,,,NA,NA,,nucleus,nucleotide binding,negative regulation of myeloid cell differentiation,,
Q96T37-2,Q96T37,Putative RNA-binding protein 15,RBM15,100.23,100.23,S700,NSDNDRSSRLLLERPSPIRDRRGSLEKSQGD,_LLLERPS(ph)PIRDR_,-0.33,-0.17,0.08,-0.12,-0.02, , , ,-0.52,-0.27,-0.03,-0.02,-0.06, , , ,-0.25,-0.02,-0.02,,-0.39,-0.03,-0.06,,,,,,,,NA,NA,,nucleus,nucleotide binding,negative regulation of myeloid cell differentiation,,
Q96T37-2,Q96T37,Putative RNA-binding protein 15,RBM15,130.78,130.78,S294,GHRHPPGGGGGQRSLSPGGAALGYRDYRLQQ,_SLS(ph)PGGAALGYR_,-0.39,-0.37,-0.38,-0.32,-0.53,-0.37,-0.39,-0.59,0.13,-0.04,-0.17,-0.04,-0.34,-0.31,-0.28,-0.35,-0.38,-0.35,-0.45,-0.49,0.05,-0.1,-0.32,-0.31,,,,,,,0,0,,nucleus,nucleotide binding,negative regulation of myeloid cell differentiation,,
Q96T37-2,Q96T37,Putative RNA-binding protein 15,RBM15,136.38,136.38,T568,FGHRAPDPLRGARDRTPPLLYRDRDRDLYPD,_DRT(ph)PPLLYR_,-0.12,-0.12,-0.36,-0.28,-0.4,-1.03,-0.71,-1.24,-0.4,-0.3,-0.36,-0.32,-0.26,0.2,-0.39,-0.45,-0.12,-0.32,-0.68,-0.95,-0.35,-0.34,-0.01,-0.42,,,,,,,0,0,,nucleus,nucleotide binding,negative regulation of myeloid cell differentiation,,
Q8NDT2,Q8NDT2,Putative RNA-binding protein 15B,RBM15B,118.04,118.04,S265,LGYLPLHGGYQYKQRSLSPVAAPPLREPRAR,_(gl)QRS(ph)LS(ph)PVAAPPLREPR_,-0.18,0.2,-0.02,0.81,-0.58, ,-0.3,-0.72,-0.28,-0.34,-0.23,0.21,-0.6, ,-0.5,-0.35,0.02,0.45,-0.58,-0.5,-0.31,0,-0.6,-0.43,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA processing,,
Q8NDT2,Q8NDT2,Putative RNA-binding protein 15B,RBM15B,118.04,118.04,S267,YLPLHGGYQYKQRSLSPVAAPPLREPRARHA,_(gl)QRS(ph)LS(ph)PVAAPPLREPR_,-0.29,-0.23,-0.12,-0.21,-0.58, ,-0.3,-0.72,-0.43,-0.3,-0.2,-0.18,-0.6, ,-0.5,-0.35,-0.26,-0.17,-0.58,-0.5,-0.36,-0.19,-0.6,-0.43,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA processing,,
Q8NDT2,Q8NDT2,Putative RNA-binding protein 15B,RBM15B,112.34,81.45,S552,LYSDRDRTFLEGDWTSPSKSSDRRNSLEGYS,_TFLEGDWTS(ph)PSK_, , ,-0.45,0.19, ,-0.28,-0.33,-0.59, , ,-0.6,-0.16, ,-0.03,-0.17,-0.12,,-0.1,-0.28,-0.46,,-0.36,-0.03,-0.15,,,,,,,NA,NA,,nucleoplasm,nucleotide binding,mRNA processing,,
Q96I25,Q96I25,Splicing factor 45,RBM17,243.24,243.21,S155,DRHEASGFARRPDPDSDEDEDYERERRKRSM,_RPDPDS(ph)DEDEDYERER_,-0.32,-0.28,-0.26,-0.31,-0.09,-0.14,-0.05,-0.11,-0.12,-0.09,-0.05,-0.22,-0.1,-0.12,-0.18,-0.15,-0.3,-0.29,-0.11,-0.08,-0.11,-0.13,-0.11,-0.17,,,,,,,0,0,,nucleus,nucleotide binding,mRNA processing,,
Q9Y4C8,Q9Y4C8,Probable RNA-binding protein 19,RBM19,47.77,20.94,S138,QLEKLKEDTEFQEFLSVHQRRAQAATWANDG,_EDTEFQEFLS(ph)VHQR_, , , ,-3.64, , , , , , , ,-2.34, , , , ,,-3.64,,,,-2.34,,, +, +,,,,,NA,NA,,chromosome,nucleotide binding,multicellular organismal development,,
E7EU28,Q86U06,Probable RNA-binding protein 23,RBM23,125.92,125.92,S149,GYRYGHSKSPHFREKSPVREPVDNLSPEERD,_S(ph)PVREPVDNLSPEER_,0.09,-0.08,0.04,0.08, , ,-0.26, ,-0.56,-0.64,-0.32,-0.68, , ,0.31, ,0.01,0.06,,-0.26,-0.6,-0.49,,0.31,,,,,,,NA,NA,,,,,,
P49756,P49756,RNA-binding protein 25,RBM25,61.44,59.33,S703,KLPVDSVFNKFEDEDSDDVPRKRKLVPLDYG,_FEDEDS(ph)DDVPRK_,0.23, , , ,0.13,-0.83,-0.61, ,0.16, , , ,-0.42,0.69,-0.67, ,0.23,,-0.27,-0.61,0.16,,0.24,-0.67,,,,,,,NA,NA,,cytoplasm,mRNA binding,execution phase of apoptosis,,
P49756,P49756,RNA-binding protein 25,RBM25,145.71,142.08,S677,HRPKIGLSLKLGASNSPGQPNSVKRKKLPVD,_LGASNS(ph)PGQPNSVK_, , , , ,0.1,-0.11, ,0.34, , , , ,-0.31,0.05, ,-0.17,,,0,0.34,,,-0.12,-0.17,,,,,,,NA,NA,,cytoplasm,mRNA binding,execution phase of apoptosis,,
Q5T8P6,Q5T8P6,RNA-binding protein 26,RBM26,151.49,149.28,S127,KEEEREKKFSRRLNHSPPQSSSRYRENRSRD,_RLNHS(ph)PPQSSSR_,-0.09,0.31, ,-0.18,0.13,0.17,-0.08,0.02,-0.14,1.04, ,1.29,0.15,-0.22,0.51,0.02,0.13,-0.18,0.15,-0.03,0.57,1.29,-0.02,0.28,, +,,,,,0,4,8.2,,nucleotide binding,mRNA processing,,
P98179,P98179,Putative RNA-binding protein 3,RBM3,107.74,107.74,Y127,YGSGRYYDSRPGGYGYGYGRSRDYNGRNQGG,_YYDSRPGGYGY(ph)GYGR_,3.13, , , , , , , ,1.04, , , , , , , ,3.13,,,,1.04,,,, +, +,,,,,NA,NA,,cytoplasm,nucleotide binding,positive regulation of translation,,
P98179,P98179,Putative RNA-binding protein 3,RBM3,107.74,107.74,Y129,SGRYYDSRPGGYGYGYGRSRDYNGRNQGGYD,_YYDSRPGGYGYGY(ph)GR_, , ,2.45, , , , , , , ,1.51, , , , , ,,2.45,,,,1.51,,, +, +,,,,,NA,NA,,cytoplasm,nucleotide binding,positive regulation of translation,,
P98179,P98179,Putative RNA-binding protein 3,RBM3,109.91,106.07,S147,SRDYNGRNQGGYDRYSGGNYRDNYDN_____,_NQGGYDRYS(ph)GGNYRDNYDN_, , , , ,-0.17,-0.34,0.08, , , , , ,-0.53,0.96,-0.27, ,,,-0.25,0.08,,,0.4,-0.27,,,,,,,NA,NA,,cytoplasm,nucleotide binding,positive regulation of translation,,
Q96EV2-2,Q96EV2,RNA-binding protein 33,RBM33,328.95,328.95,S205,GGMETLELQKDIKEESDEEEEDDEESGRLRF,_DIKEES(ph)DEEEEDDEESGRLR_,0.01,0.04,-0.11,-0.05, ,-0.09,-0.11,0.01,0.22,0.1,0.14,0.08, ,-0.01,-0.06,-0.08,0.02,-0.08,-0.09,-0.05,0.16,0.11,-0.01,-0.07,,,,,,,0,0,,,nucleotide binding,,,
A2RRD3,Q14498,RNA-binding protein 39,RBM39,244.98,234.43,S136,YRRRSRSKSPFRKDKSPVREPIDNLTPEERD,_S(ph)PVREPIDNLTPEER_,0.17,0.27,0.3,0.32,0,0.29,0.15,0.13,-0.1,-0.12,-0.13,-0.19,-0.1,0.09,0.09,0.02,0.22,0.31,0.15,0.14,-0.11,-0.16,0,0.05,,,,,,,0,0,,,,,,
Q96PK6,Q9BWF3,RNA-binding protein 4,RBM4,83.44,83.44,S309,AAVTAASTSYYGRDRSPLRRATAPVPTVGEG,_DRS(ph)PLRR_,-0.04, , , , , , , ,-0.11, , , , , , , ,-0.04,,,,-0.11,,,,,,,,,,NA,NA,,mediator complex,ligand-dependent nuclear receptor transcription coactivator activity,DNA recombination,,
Q59HE6,P52756,RNA-binding protein 5,RBM5,213.1,213.1,S624,ENPLKRGLVAAYSGDSDNEEELVERLESEEE,_RGLVAAYSGDS(ph)DNEEELVER_,0.31,0.36,-0.67,0.1,0.67,0.57, ,0.23,0.19,0.32,-0.73,0.35,1.19,0.9, ,0.52,0.33,-0.24,0.62,0.23,0.26,-0.09,1.05,0.52,, +,,,,,0,2,19.45,nucleus,nucleic acid binding,,,
Q59HE6,P52756,RNA-binding protein 5,RBM5,63.1,59.95,S621,GDEENPLKRGLVAAYSGDSDNEEELVERLES,_RGLVAAYS(ph)GDS(ph)DNEEELVER_, , , , , ,0.57, ,0.23, , , , , ,0.9, ,0.52,,,0.57,0.23,,,0.9,0.52,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
G3V1T9,Q9Y580,RNA-binding protein 7,RBM7,84.37,52.77,S136,MDNMTSSAQIIQRSFSSPENFQRQAVMNSAL,_SFS(ph)SPENFQR_, , ,0.17,0.46,2.04,-0.17, , , , ,1.26,1.13,1.74,-0.22, , ,,0.32,1.32,,,1.19,1.07,, +, +,,,,,NA,NA,,,,,,
Q9Y5S9-2,Q9Y5S9,RNA-binding protein 8A,RBM8A,140.41,140.41,S56,FGSEGSRARMREDYDSVEQDGDEPGPQRSVE,_MREDYDS(ph)VEQDGDEPGPQR_,0.29,0.16,0.27, ,-0.05, ,-0.46, ,0.69,0.4,0.21, ,0.03, ,-0.55, ,0.23,0.27,-0.05,-0.46,0.55,0.21,0.03,-0.55,,,,,,,0,0,,catalytic step 2 spliceosome,mRNA binding,mRNA 3'-end processing,,
E7ETU5,P29558,"RNA-binding motif, single-stranded-interacting protein 1",RBMS1,76.12,71.74,S112,KTTNKCKGYGFVDFDSPAAAQKAVSALKASG,_GYGFVDFDS(ph)PAAAQK_, , , , , ,-0.49, , , , , , , ,-0.33, , ,,,-0.49,,,,-0.33,,,,,,,,NA,NA,,,nucleotide binding,,,
F8W1T6,Q15434,"RNA-binding motif, single-stranded-interacting protein 2",RBMS2,125.25,118.68,S106,KTTNKCKGYGFVDFDSPSAAQKAVTALKASG,_GYGFVDFDS(ph)PSAAQK_,-0.64,-0.43,-0.53,-1.17, , ,-0.49, ,0.45,-0.05,-0.05,-0.21, , ,-0.5, ,-0.53,-0.82,,-0.49,0.22,-0.13,,-0.5,,,,,,,NA,NA,,,nucleotide binding,,,
P38159,P38159,"RNA-binding motif protein, X chromosome",RBMX,108.71,101.39,Y134,TRGPPSRGGHMDDGGYSMNFNMSSSRGPLPV,_GGHMDDGGY(ph)SMNFNMSSSR_, , ,1.44, , , , , , , ,0.85, , , , , ,,1.44,,,,0.85,,, +,,,,,,NA,NA,,catalytic step 2 spliceosome,chromatin binding,cellular response to interleukin-1,,
P38159,P38159,"RNA-binding motif protein, X chromosome",RBMX,199.61,199.61,S208,PPRREPLPSRRDVYLSPRDDGYSTKDSYSSR,_DVYLS(ph)PRDDGYSTK_,-0.24,-0.2,-0.23,-0.23,-0.05,-0.2,-0.5,-0.61,-0.23,-0.22,-0.17,-0.28,0.07,-0.25,-0.43,-0.47,-0.22,-0.23,-0.12,-0.56,-0.23,-0.22,-0.08,-0.45,,,,,,,0,0,,catalytic step 2 spliceosome,chromatin binding,cellular response to interleukin-1,,
H0YF64,Q9UKA8,Calcipressin-3,RCAN3,96.71,94.64,S148,_UYLLPPQPVKQFLISPPASPPVGWKQSEDA,_(gl)QFLIS(ph)PPAS(ph)PPVGWK_, ,-0.27,-0.42,0.02, ,-0.13, , , ,-0.28,-0.1,-0.08, ,0.26, , ,-0.27,-0.18,-0.13,,-0.28,-0.09,0.26,,,,,,,,NA,NA,,,,calcium-mediated signaling,,
H0YF64,P53805,Calcipressin-3,RCAN3,96.71,94.64,S167,LPPQPVKQFLISPPASPPVGWKQSEDAMPVI,_(gl)QFLIS(ph)PPAS(ph)PPVGWK_, ,-0.27,-0.42,0.02, ,-0.13, , , ,-0.28,-0.1,-0.08, ,0.26, , ,-0.27,-0.18,-0.13,,-0.28,-0.09,0.26,,,,,,,,NA,NA,,,,calcium-mediated signaling,,
E7EMC8,Q96PM5,RING finger and CHY zinc finger domain-containing protein 1,RCHY1,62.46,20.44,S257,ICESYNTAQAGGRRISLDQQ___________,_RIS(ph)LDQQ_, , ,2.43,2.46, , , , , , ,2.77,2.28, , , , ,,2.44,,,,2.55,,, +, +,,,,,NA,NA,,cytoplasm,zinc ion binding,,,
O43598,O43598,Deoxyribonucleoside 5'-monophosphate N-glycosidase,RCL,191.46,182.93,S169,LDRYFEADPPGQVAASPDPTT__________,_YFEADPPGQVAAS(ph)PDPTT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,cell proliferation,,
Q14257,Q14257,Reticulocalbin-2,RCN2,181.66,163.25,Y311,LTSEATDYGRQLHDDYFYHDEL_________,_QLHDDY(ph)FYHDEL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,inositol phosphate metabolic process,,
Q9UKL0,Q9UKL0,REST corepressor 1,RCOR1,322.12,322.12,S257,VMDRHARKQKREREESEDELEEANGNNPIDI,_EREES(ph)EDELEEANGNNPIDIEVDQNK_,-0.26,-0.24,-0.15,-0.06,0.2,0.04,-0.04,0.03,-0.28,-0.22,-0.2,-0.17,0.04,-0.11,-0.18,-0.16,-0.25,-0.11,0.12,0,-0.25,-0.19,-0.03,-0.17,,,,,,,0,0,,transcriptional repressor complex,chromatin binding,blood coagulation,,
E9PCL7,P18615,Negative elongation factor E,RDBP,259.96,214.99,S115,EKGPVPTFQPFQRSISADDDLQESSRRPQRK,_SIS(ph)ADDDLQESSR_, ,0.42,2.14,2.4,0.6,0.82,-1.03,-0.36, ,0.59,2.27,2.52,0.88,0.92,-1.15,-0.81,0.42,2.28,0.71,-0.65,0.59,2.4,0.9,-0.97, +, +,,,,,4,4,37.49,,,,,
O94762,O94762,ATP-dependent DNA helicase Q5,RECQL5,94.73,94.73,S488,GGRKGYGDFSRYDEGSGGSGDEGRDEAHKRE,_YDEGS(ph)GGS(ph)GDEGRDEAHKR_,-0.52,0.13, , ,0.25,0.4,0.25,0.11,-0.01,0.02, , ,-0.13,-0.04,0.1,-0.46,-0.16,,0.32,0.18,0.01,,-0.09,-0.15,,,,,,,NA,NA,,cytoplasm,ATP binding,DNA recombination,,
O94762,O94762,ATP-dependent DNA helicase Q5,RECQL5,94.73,94.73,S491,KGYGDFSRYDEGSGGSGDEGRDEAHKREWNL,_YDEGS(ph)GGS(ph)GDEGRDEAHKR_,-0.52,0.13, , ,0.25,0.4,0.25,0.11,-0.01,0.02, , ,-0.13,-0.04,0.1,-0.46,-0.16,,0.32,0.18,0.01,,-0.09,-0.15,,,,,,,NA,NA,,cytoplasm,ATP binding,DNA recombination,,
Q6NUK4,Q6NUK4,Receptor expression-enhancing protein 3,REEP3,165.47,165.47,S210,KDGDEKTDEEAEGPYSDNEMLTHKGLRRSQS,_T(ph)DEEAEGPYS(ph)DNEMLTHK_,0.39, ,0.08, ,0.12,0.01,0.14,0.11,0.51, ,-0.27, ,0.22,0.24,0.13,0.3,0.39,0.08,0.07,0.12,0.51,-0.27,0.23,0.22,,,,,,,0,0,,integral to membrane,,,,
Q6NUK4,Q6NUK4,Receptor expression-enhancing protein 3,REEP3,165.47,165.47,T201,ESAGYGIPLKDGDEKTDEEAEGPYSDNEMLT,_T(ph)DEEAEGPYS(ph)DNEMLTHK_,0.39, ,0.08, ,0.12,0.01,0.14,0.11,0.51, ,-0.27, ,0.22,0.24,0.13,0.3,0.39,0.08,0.07,0.12,0.51,-0.27,0.23,0.22,,,,,,,0,0,,integral to membrane,,,,
Q9H6H4,Q9H6H4,Receptor expression-enhancing protein 4,REEP4,85.19,83.43,S194,HRRPPIGYRAGGLQDSDTEDECWSDTEAVPR,_AGGLQDS(ph)DT(ph)EDECWS(ph)DTEAVPR_, , , , ,0.03,0.1,0.32,0.15, , , , ,0.01,-0.07,0.21,0.05,,,0.07,0.24,,,-0.03,0.13,,,,,,,NA,NA,,integral to membrane,,,,
Q9H6H4,Q9H6H4,Receptor expression-enhancing protein 4,REEP4,85.19,83.43,S202,RAGGLQDSDTEDECWSDTEAVPRAPARPREK,_AGGLQDS(ph)DT(ph)EDECWS(ph)DTEAVPR_, , , , ,0.03,0.1,0.32,0.15, , , , ,0.01,-0.07,0.21,0.05,,,0.07,0.24,,,-0.03,0.13,,,,,,,NA,NA,,integral to membrane,,,,
Q9H6H4,Q9H6H4,Receptor expression-enhancing protein 4,REEP4,85.19,83.43,T196,RPPIGYRAGGLQDSDTEDECWSDTEAVPRAP,_AGGLQDS(ph)DT(ph)EDECWS(ph)DTEAVPR_, , , , ,0.03,0.1,0.32,0.15, , , , ,0.01,-0.07,0.21,0.05,,,0.07,0.24,,,-0.03,0.13,,,,,,,NA,NA,,integral to membrane,,,,
Q9H6H4,Q9H6H4,Receptor expression-enhancing protein 4,REEP4,114.86,104.15,S152,ATKSQGALAGRLRSFSMQDLRSISDAPAPAY,_SFS(ph)MQDLR_,0.83,0.76,0.25,-0.01,0.8,0.67,1.09,0.73,0.72,0.59,0.4,0.14,0.2,0.18,0.38,0.14,0.8,0.13,0.74,0.92,0.65,0.28,0.19,0.26,,,,,,,0,0,,integral to membrane,,,,
D6R992,Q01201,Transcription factor RelB,RELB,93.58,91.38,S573,FPNHYREAAFGGGLLSPGPEAT_________,_EAAFGGGLLS(ph)PGPEAT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding transcription factor activity,,,
E9PMG1,Q96D71,RalBP1-associated Eps domain-containing protein 1,REPS1,118.5,81.46,S272,RTVASATTAIEIRRQSSSYDDPWKITDEQRQ,_RQS(ph)SSYDDPWK_, , , , , ,1.51, , , , , , , ,0.71, , ,,,1.51,,,,0.71,, +,,,,,,NA,NA,,,calcium ion binding,receptor-mediated endocytosis,,
E9PMG1,Q96D71,RalBP1-associated Eps domain-containing protein 1,REPS1,117.69,117.3,S162,DTVQPRTSADAQEPASPVVSPQQSPPTSPHT,_TSADAQEPAS(ph)PVVS(ph)PQQS(ph)PPTS(ph)PHTWR_, , , , ,-0.13,-0.11,0.04,0.01, , , , ,0.02,0.01,-0.35,0.01,,,-0.12,0.03,,,0.01,-0.15,,,,,,,NA,NA,,,calcium ion binding,receptor-mediated endocytosis,,
E9PMG1,Q96D71,RalBP1-associated Eps domain-containing protein 1,REPS1,117.69,117.3,S166,PRTSADAQEPASPVVSPQQSPPTSPHTWRKH,_TSADAQEPAS(ph)PVVS(ph)PQQS(ph)PPTS(ph)PHTWR_, , , , ,-0.13,-0.09,0.04,0.01, , , , ,0.02,0.02,-0.35,0.01,,,-0.11,0.03,,,0.02,-0.15,,,,,,,NA,NA,,,calcium ion binding,receptor-mediated endocytosis,,
E9PMG1,Q96D71,RalBP1-associated Eps domain-containing protein 1,REPS1,117.69,117.3,S170,ADAQEPASPVVSPQQSPPTSPHTWRKHSRHP,_TSADAQEPAS(ph)PVVS(ph)PQQS(ph)PPTS(ph)PHTWR_, , , , ,-0.13,-0.11,0.04,0.01, , , , ,0.02,0.01,-0.35,0.01,,,-0.12,0.03,,,0.01,-0.15,,,,,,,NA,NA,,,calcium ion binding,receptor-mediated endocytosis,,
Q5T092,O15258,Protein RER1,RER1,166.75,146.58,S95,IAFLSPKVDPSLMEDSDDGPSLPTKQNEEFR,_VDPSLMEDS(ph)DDGPSLPTK_,0.18,0.33,0.44,0.14, ,0.58, , ,0.14,0.2,-0.2,0.11, ,0.17, , ,0.26,0.3,0.58,,0.17,-0.03,0.17,,,,,,,,NA,NA,,integral to membrane,,,,
Q9P2R6,Q9P2R6,Arginine-glutamic acid dipeptide repeats protein,RERE,95.44,95.41,S53,RRSCTLEGGAKNYAESDHSEDEDNDNNSATA,_NYAES(ph)DHS(ph)EDEDNDNNSATAEESTK_, , , , , ,0.2,-0.19,0.18, , , , , ,0,0.24,0.09,,,0.2,0.01,,,0,0.17,,,,,,,NA,NA,,histone deacetylase complex,chromatin binding,chromatin remodeling,,
Q9P2R6,Q9P2R6,Arginine-glutamic acid dipeptide repeats protein,RERE,95.44,95.41,S56,CTLEGGAKNYAESDHSEDEDNDNNSATAEES,_NYAES(ph)DHS(ph)EDEDNDNNSATAEESTK_, , , , , ,0.2,-0.19,0.18, , , , , ,0,0.24,0.09,,,0.2,0.01,,,0,0.17,,,,,,,NA,NA,,histone deacetylase complex,chromatin binding,chromatin remodeling,,
Q9P2R6,Q9P2R6,Arginine-glutamic acid dipeptide repeats protein,RERE,124.85,124.85,S594,GSMSTLRSGRKKQPASPDGRTSPINEDIRSS,_KQPAS(ph)PDGRTS(ph)PINEDIR_,-0.19,-0.06,-0.31, , , , ,-0.07,0.02,0.17,-0.18, , , , ,0.25,-0.12,-0.31,,-0.07,0.1,-0.18,,0.25,,,,,,,NA,NA,,histone deacetylase complex,chromatin binding,chromatin remodeling,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,79.29,37.13,S156,MKKNEENTKTKNKPLSPIKLTPTSVLDYFGT,_NKPLS(ph)PIK_,0.38,0.5,0.71,0.8,1.16,1.16,1.44,0.69,0.31,0.58,0.96,1.12,1.16,1.26,1.09,0.79,0.44,0.75,1.16,1.11,0.45,1.04,1.21,0.95, +, +,,,,,1,1,29.35,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,136.03,134.91,S1104,PSLDSEYNEELNEDDSQSDEKDQDAIETDAM,_HSTSPSLDSEYNEELNEDDS(ph)QS(ph)DEK_, , , , ,-0.06,-0.18, ,-0.34, , , , ,-0.22,-0.07, ,-0.04,,,-0.12,-0.34,,,-0.14,-0.04,,,,,,,NA,NA,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,136.03,134.91,S1106,LDSEYNEELNEDDSQSDEKDQDAIETDAMIK,_HSTSPSLDSEYNEELNEDDS(ph)QS(ph)DEK_, , , , ,-0.06,-0.18, ,-0.34, , , , ,-0.22,-0.07, ,-0.04,,,-0.12,-0.34,,,-0.14,-0.04,,,,,,,NA,NA,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,206.33,189.18,S108,SKPGKISRQDPVTYISETDEEDDFMCKKAAS,_QDPVTYIS(ph)ET(ph)DEEDDFMCK_, , , , ,-0.04,-0.13,-0.03,-0.17, , , , ,-0.84,-0.03,-0.57,-0.87,,,-0.08,-0.1,,,-0.38,-0.72,,,,,,,NA,NA,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,206.33,189.18,T110,PGKISRQDPVTYISETDEEDDFMCKKAASKS,_QDPVTYIS(ph)ET(ph)DEEDDFMCK_, , , , ,-0.04,-0.13,-0.03,-0.17, , , , ,-0.84,-0.03,-0.57,-0.87,,,-0.08,-0.1,,,-0.38,-0.72,,,,,,,NA,NA,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,308.1,297.75,S69,FKQKQPSKKKRIIYDSDSESEETLQVKNAKK,_IIYDS(ph)DS(ph)ESEETLQVK_,-0.1,0.1,0.19,0.08,0.02,0.1,0.04,0.02,-0.01,0.26,0.35,0.33,-0.13,0,-0.05,-0.06,0,0.13,0.06,0.03,0.13,0.34,-0.06,-0.05,,,,,,,0,0,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,308.1,297.75,S71,QKQPSKKKRIIYDSDSESEETLQVKNAKKPP,_IIYDS(ph)DS(ph)ESEETLQVK_,-0.1,0.1,0.19,0.08,0.02,0.13,0.04,0.02,-0.01,0.26,0.35,0.33,-0.13,0.03,-0.05,-0.06,0,0.13,0.08,0.03,0.13,0.34,-0.05,-0.05,,,,,,,0,0,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
P35251-2,P35251,Replication factor C subunit 1,RFC1,51.47,49.12,S73,QPSKKKRIIYDSDSESEETLQVKNAKKPPEK,_IIYDS(ph)DS(ph)ES(ph)EETLQVK_, , , , , , , ,-0.09, , , , , , , ,0.11,,,,-0.09,,,,0.11,,,,,,,NA,NA,,DNA replication factor C complex,ATP binding,DNA strand elongation involved in DNA replication,,
C9JN73,Q8WZ73,E3 ubiquitin-protein ligase rififylin,RFFL,111.72,111.72,S226,YLESVARVPAEDETQSIDSEDSFVPGRRASL,_VPAEDETQS(ph)IDS(ph)EDSFVPGR_,-0.26,-0.23,-0.75, ,-0.18,-0.16, ,-0.6,0.42,0.81,0.18, ,-0.33,0.06, ,0.04,-0.25,-0.75,-0.17,-0.6,0.63,0.18,-0.12,0.04,,,,RING finger,,,0,0,,,,,,
C9JN73,Q8WZ73,E3 ubiquitin-protein ligase rififylin,RFFL,111.72,111.72,S229,SVARVPAEDETQSIDSEDSFVPGRRASLSDL,_VPAEDETQS(ph)IDS(ph)EDSFVPGR_,-0.26,-0.23,-0.75, ,-0.18,-0.16, ,-0.6,0.42,0.81,0.18, ,-0.33,0.06, ,0.04,-0.25,-0.75,-0.17,-0.6,0.63,0.18,-0.12,0.04,,,,RING finger,,,0,0,,,,,,
P48380,P48380,Transcription factor RFX3,RFX3,194.25,186.66,S674,DLNAVSPGNLDKDEGSEVESEMDEELDDSSE,_DEGS(ph)EVES(ph)EMDEELDDSSEPQAK_, ,-0.04,0.28, ,-0.05,0.22,0.17,0.08, ,0.2,0.15, ,-0.08,0.11,0.15,0.1,-0.04,0.28,0.09,0.12,0.2,0.15,0.02,0.13,,,,,,,0,0,,nuclear chromatin,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity,cell maturation,,
P48380,P48380,Transcription factor RFX3,RFX3,194.25,186.66,S678,VSPGNLDKDEGSEVESEMDEELDDSSEPQAK,_DEGS(ph)EVES(ph)EMDEELDDSSEPQAK_, ,-0.04,0.28, ,-0.05,0.22,0.17,0.08, ,0.2,0.15, ,-0.08,0.11,0.15,0.1,-0.04,0.28,0.09,0.12,0.2,0.15,0.02,0.13,,,,,,,0,0,,nuclear chromatin,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity,cell maturation,,
H0YLX2,Q2KHR2,DNA-binding protein RFX7,RFX7,90.72,79.14,T891,QSLSRESPCSRLAQTTPVDSALGSSRHTPIG,_LAQTT(ph)PVDSALGSSR_, ,-1.27, , , , , , , ,0.46, , , , , , ,-1.27,,,,0.46,,,, +,,,,,,NA,NA,,,DNA binding,"regulation of transcription, DNA-dependent",,
P49792,P49792,RanBP2-like and GRIP domain-containing protein 4,RGPD4,52.25,51.1,S2287,KSALSPSKSPAKLNQSGTSVGTDEESDVTQE,_LNQS(ph)GTS(ph)VGT(ph)DEESDVTQEEER_, , , , , , ,-0.55,-1.09, , , , , , ,-0.48,-0.97,,,,-0.79,,,,-0.7,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,RanBP2-like and GRIP domain-containing protein 4,RGPD4,52.25,51.1,T2293,SKSPAKLNQSGTSVGTDEESDVTQEEERDGQ,_LNQSGTS(ph)VGT(ph)DEESDVTQEEER_, , , , , ,0,-0.55,-0.52, , , , , ,-0.04,-0.48,-0.75,,,0,-0.53,,,-0.04,-0.61,,,,,,,NA,NA,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,RanBP2-like and GRIP domain-containing protein 4,RGPD4,134.68,117.57,S2454,AKTAQEKDSLITPHVSRSSTPRESPCGKIAV,_DSLIT(ph)PHVS(ph)R_,-0.12,-0.22,-0.11,-0.14,-0.51,-0.53,-0.84,-0.93,-0.2,-0.4,-0.49,-0.44,-0.61,-0.65,-1.05,-0.91,-0.17,-0.13,-0.52,-0.89,-0.29,-0.47,-0.63,-0.98,,,,,,,0,0,,cytosol,ligase activity,carbohydrate metabolic process,,
P49792,P49792,RanBP2-like and GRIP domain-containing protein 4,RGPD4,99.93,98.34,T2450,IFDEAKTAQEKDSLITPHVSRSSTPRESPCG,_DSLIT(ph)PHVS(ph)R_,-0.02,-0.05,-0.02,-0.05,-0.51,-0.53,-0.84,-0.93,-0.31,-0.21,-0.41,-0.33,-0.61,-0.65,-1.05,-0.91,-0.04,-0.04,-0.52,-0.89,-0.26,-0.37,-0.63,-0.98,,,,,,,0,0,,cytosol,ligase activity,carbohydrate metabolic process,,
Q9NPQ8-2,Q9NPQ8,Synembryn-A,RIC8A,79.88,48.38,S502,FDKLSRNRVIQPMGMSPRGHLTSLQDAMCET,_VIQPMGMS(ph)PR_,-0.28,-0.33,-0.41,-0.33,-0.67,-0.37,-0.55, ,-0.27,-0.33,-0.31,-0.29,-0.73,-0.56,-0.33, ,-0.31,-0.37,-0.51,-0.55,-0.3,-0.3,-0.64,-0.33,,,,,,,0,0,,cytoplasm,guanyl-nucleotide exchange factor activity,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,,
Q9NPQ8-2,Q9NPQ8,Synembryn-A,RIC8A,331.71,328.25,S436,AARGLMAGGRPEGQYSEDEDTDTDEYKEAKA,_GLMAGGRPEGQYS(ph)EDEDT(ph)DTDEYK_,-0.27,-0.23,-0.23,-0.12,0.57,0.34,0.78,0.26,-0.19,0.19,0.14,0.03,1.08,0.64,0.56,0.61,-0.25,-0.17,0.46,0.54,0.02,0.08,0.88,0.59,,,,,,,0,0,,cytoplasm,guanyl-nucleotide exchange factor activity,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,,
Q9NPQ8-2,Q9NPQ8,Synembryn-A,RIC8A,331.71,328.25,T441,MAGGRPEGQYSEDEDTDTDEYKEAKASINPV,_GLMAGGRPEGQYS(ph)EDEDT(ph)DTDEYK_,-0.09,-0.08,-0.18,-0.07,-0.08,-0.07,-0.13,-0.11,-0.16,-0.09,-0.15,-0.11,-0.21,-0.17,-0.14,-0.04,-0.09,-0.12,-0.07,-0.12,-0.13,-0.13,-0.19,-0.09,,,,,,,0,0,,cytoplasm,guanyl-nucleotide exchange factor activity,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,,
Q9NPQ8-2,Q9NPQ8,Synembryn-A,RIC8A,138.02,138.02,T443,GGRPEGQYSEDEDTDTDEYKEAKASINPVTG,_GLMAGGRPEGQYS(ph)EDEDT(ph)DT(ph)DEYK_, , , , ,-0.75,-0.29, , , , , , ,-1.14,-0.23, , ,,,-0.5,,,,-0.61,,,,,,,,NA,NA,,cytoplasm,guanyl-nucleotide exchange factor activity,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,,
Q9NVN3-4,Q9NVN3,Synembryn-B,RIC8B,193.93,193.93,S468,AARGLLAGGRGDNWYSEDEDTDTEEYKNAKP,_GDNWYS(ph)EDEDT(ph)DTEEYK_, , , , ,-0.11,-0.01,-0.08,-0.09, , , , ,-0.14,0.15,0.07,0.08,,,-0.06,-0.08,,,0.02,0.08,,,,,,,NA,NA,,cell cortex,G-protein alpha-subunit binding,regulation of G-protein coupled receptor protein signaling pathway,,
Q9NVN3-4,Q9NVN3,Synembryn-B,RIC8B,193.93,193.93,T473,LAGGRGDNWYSEDEDTDTEEYKNAKPNSIEF,_GDNWYS(ph)EDEDT(ph)DTEEYK_, , , , ,-0.11,-0.01,-0.08,-0.09, , , , ,-0.14,0.15,0.07,0.08,,,-0.06,-0.08,,,0.02,0.08,,,,,,,NA,NA,,cell cortex,G-protein alpha-subunit binding,regulation of G-protein coupled receptor protein signaling pathway,,
E7ETT0,Q6R327,Rapamycin-insensitive companion of mTOR,RICTOR,117.83,85.58,S1591,CSDGVSQEGSASSTKSTELLLGVKTIPDDTP,_S(ph)TELLLGVK_,0.12,-0.17,-0.44, , , ,1.33,0.61,-0.27,-0.34,-0.3, , , ,1.39,0.76,-0.02,-0.44,,1.01,-0.31,-0.3,,1.11, +, +,,,,,NA,NA,,,,,,
E7ETT0,Q6R327,Rapamycin-insensitive companion of mTOR,RICTOR,134.81,133.67,S21,RGRSLKNLRVRGRNDSGEENVPLDLTREPSD,_NDS(ph)GEENVPLDLTREPSDNLR_,0.3,0.42,0.38, , , ,-3.27, ,0.54,0.28,0.53, , , ,-0.86, ,0.36,0.38,,-3.27,0.42,0.53,,-0.86, +,,,,,,NA,NA,,,,,,
E7ETT0,Q6R327,Rapamycin-insensitive companion of mTOR,RICTOR,116.19,96.99,S1385,SFESRLTPSRFMKALSYASLDKEDLLSPINQ,_ALS(ph)YAS(ph)LDK_, , , , ,0.51,0.32,0.84,0.95, , , , ,-0.12,-0.36,0.34,0.61,,,0.42,0.89,,,-0.23,0.48,,,,,,,NA,NA,,,,,,
E7ETT0,Q6R327,Rapamycin-insensitive companion of mTOR,RICTOR,116.19,96.99,S1388,SRLTPSRFMKALSYASLDKEDLLSPINQNTL,_ALS(ph)YAS(ph)LDK_, , , , ,0.39,0.51,0.4,0.32, , , , ,0.44,0.14,0.5,0.27,,,0.45,0.36,,,0.3,0.39,,,,,,,NA,NA,,,,,,
E7ETT0,Q6R327,Rapamycin-insensitive companion of mTOR,RICTOR,69.7,69.15,S1177,SFMGNKHIEDTGSTPSIGENDLKFTKNFGTE,_HIEDTGS(ph)TPS(ph)IGENDLK_, ,-0.09, , , ,-0.14,0.86,0.82, ,0.07, , , ,-0.47,0.68,0.66,-0.09,,-0.14,0.84,0.07,,-0.47,0.67,,,,,,,NA,NA,,,,,,
Q5UIP0-2,Q5UIP0,Telomere-associated protein RIF1,RIF1,178.34,160.71,S1579,SRKKRSGKWKNKSNESVDIQDQEEKVVKQEC,_SNES(ph)VDIQDQEEK_, , , , , , , ,0.29, , , , , , , ,1.4,,,,0.29,,,,1.4,, +,,,,,NA,NA,,"chromosome, telomeric region",,cell cycle,,
Q5UIP0-2,Q5UIP0,Telomere-associated protein RIF1,RIF1,68.21,67.91,S1552,QTRRASQGLLSSIENSESDSSEAKEEGSRKK,_ASQGLLSSIENS(ph)ES(ph)DSSEAK_, , , , , , ,-0.64, , , , , , , ,-0.82, ,,,,-0.64,,,,-0.82,,,,,,,NA,NA,,"chromosome, telomeric region",,cell cycle,,
Q5UIP0-2,Q5UIP0,Telomere-associated protein RIF1,RIF1,68.21,67.91,S1554,RRASQGLLSSIENSESDSSEAKEEGSRKKRS,_ASQGLLSSIENS(ph)ES(ph)DSSEAK_, , , , , , ,-0.64, , , , , , , ,-0.82, ,,,,-0.64,,,,-0.82,,,,,,,NA,NA,,"chromosome, telomeric region",,cell cycle,,
Q5UIP0-2,Q5UIP0,Telomere-associated protein RIF1,RIF1,61.03,58.31,S1974,LNAKEVATEEFNSDISLSDNTTPVKLNAQTE,_EVAT(ph)EEFNSDIS(ph)LSDNT(ph)TPVK_, , , , , ,-0.58,-0.22,-0.51, , , , , ,0.15,-0.7,-0.84,,,-0.58,-0.36,,,0.15,-0.77,,,,,,,NA,NA,,"chromosome, telomeric region",,cell cycle,,
Q5UIP0-2,Q5UIP0,Telomere-associated protein RIF1,RIF1,61.03,58.31,T1966,DSEADTAKLNAKEVATEEFNSDISLSDNTTP,_EVAT(ph)EEFNSDIS(ph)LSDNT(ph)TPVK_, , , , , ,-0.58,-0.22,-0.51, , , , , ,0.15,-0.7,-0.84,,,-0.58,-0.36,,,0.15,-0.77,,,,,,,NA,NA,,"chromosome, telomeric region",,cell cycle,,
Q13671-2,Q13671,Ras and Rab interactor 1,RIN1,163.74,163.74,Y36,TTGHLAREKPAQDPLYDVPNASGGQAGGPQR,_EKPAQDPLY(ph)DVPNASGGQAGGPQRPGR_,0.46,0.69,1.01, ,-0.2,-0.18,-0.28,-0.18,-0.2,-0.18,0.09, ,-0.16,0,-0.03,-0.14,0.58,1.01,-0.19,-0.23,-0.19,0.09,-0.08,-0.08, +,,,,,,4,0,5.66,cytoplasm,GTPase activator activity,endocytosis,,
Q9BRS2,Q9BRS2,Serine/threonine-protein kinase RIO1,RIOK1,152.06,150.43,S21,LLMSRVVPGQFDDADSSDSENRDLKTVKEKD,_VVPGQFDDADS(ph)S(ph)DS(ph)ENRDLK_,-0.02,0.26,-0.51,-0.55,-0.25,-0.49,-0.09,-0.73,0.4,0.3,-0.57,-0.65,-0.3,-0.41,-0.36,-0.62,0.13,-0.53,-0.36,-0.38,0.35,-0.61,-0.36,-0.48,,,Atypical,,,,0,0,,,ATP binding,,,
Q9BRS2,Q9BRS2,Serine/threonine-protein kinase RIO1,RIOK1,142.23,135.28,S22,LMSRVVPGQFDDADSSDSENRDLKTVKEKDD,_VVPGQFDDADS(ph)S(ph)DS(ph)ENRDLK_,0.11,0.13,0.17,-0.05,-0.06,-0.21,-0.25,0.07,-0.38,-0.27,-0.12,-0.56,-0.24,-0.05,0,0.05,0.12,0.06,-0.13,-0.09,-0.32,-0.32,-0.14,0.03,,,Atypical,,,,0,0,,,ATP binding,,,
Q9BRS2,Q9BRS2,Serine/threonine-protein kinase RIO1,RIOK1,69.73,67.38,S24,SRVVPGQFDDADSSDSENRDLKTVKEKDDIL,_VVPGQFDDADS(ph)S(ph)DS(ph)ENRDLK_, , , ,-0.05, ,-0.09, ,-0.2, , , ,-0.56, ,-0.17, ,-0.58,,-0.05,-0.09,-0.2,,-0.56,-0.17,-0.58,,,Atypical,,,,NA,NA,,,ATP binding,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,133.93,121.14,S350,SFSDGEVAEKAEVYGSENESERNCLEESEGC,_AEVYGS(ph)ENESER_, , , , ,-0.36,-0.63,-0.37,-0.18, , , , ,-0.26,-0.32,-0.19,-0.12,,,-0.49,-0.27,,,-0.29,-0.15,,,Atypical,,,,NA,NA,,,,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,148.64,140.51,S332,HPLGPDDKNIETKEGSEFSFSDGEVAEKAEV,_EGS(ph)EFSFS(ph)DGEVAEK_,0.65,0.72,0.4,0.43,0.18,0.11,0.07,0.58,0.3,0.2,-0.02,-0.05,-0.03,0.06,0.25,0.32,0.69,0.42,0.15,0.35,0.25,-0.04,0.01,0.28,,,Atypical,,,,0,0,,,,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,184.61,184.61,S335,GPDDKNIETKEGSEFSFSDGEVAEKAEVYGS,_EGS(ph)EFS(ph)FS(ph)DGEVAEK_,0.1,0.19,0.4,0.49,-0.12,0.12,0.18,0.35,-0.01,-0.16,-0.02,0.04,0.11,0.26,0.27,0.65,0.15,0.45,0,0.26,-0.08,0.01,0.19,0.47,,,Atypical,,,,0,0,,,,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,148.64,140.51,S337,DDKNIETKEGSEFSFSDGEVAEKAEVYGSEN,_EGS(ph)EFS(ph)FS(ph)DGEVAEK_,0.06,0.16,0.14,0.47,0.03,0.16,0.32,0.58,-0.25,0.07,-0.23,-0.21,0.04,-0.19,0.32,0.32,0.11,0.31,0.1,0.45,-0.08,-0.22,-0.07,0.32,,,Atypical,,,,0,0,,,,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,155.09,155.09,S380,CYCRSSGDPEQIKEDSLSEESADARSFEMTE,_SSGDPEQIKEDS(ph)LS(ph)EESADAR_,0.4,0.36,0.71,0.42, , , , ,0.43,0.74,0.8,1.17, , , , ,0.38,0.57,,,0.59,1,,,,,Atypical,,,,NA,NA,,,,,,
D6RDI3,Q9BVS4,Serine/threonine-protein kinase RIO2,RIOK2,155.09,155.09,S382,CRSSGDPEQIKEDSLSEESADARSFEMTEFN,_SSGDPEQIKEDS(ph)LS(ph)EESADAR_,0.4,0.36,0.71,0.42, , , , ,0.43,0.74,0.8,1.17, , , , ,0.38,0.57,,,0.59,1,,,,,Atypical,,,,NA,NA,,,,,,
O14730-2,O14730,Serine/threonine-protein kinase RIO3,RIOK3,60.95,60.84,S125,SISFENYRKVHPYEDSDSSEDEVDWQDTRDD,_VHPYEDS(ph)DS(ph)S(ph)EDEVDWQDTR_, , , , , ,-0.09, ,-0.15, , , , , ,0.35, ,0.04,,,-0.09,-0.15,,,0.35,0.04,,,Atypical,,,,NA,NA,,,ATP binding,chromosome segregation,,
O14730-2,O14730,Serine/threonine-protein kinase RIO3,RIOK3,60.95,60.84,S127,SFENYRKVHPYEDSDSSEDEVDWQDTRDDPY,_VHPYEDS(ph)DS(ph)S(ph)EDEVDWQDTR_, , , , , ,-0.09, ,-0.15, , , , , ,0.35, ,0.04,,,-0.09,-0.15,,,0.35,0.04,,,Atypical,,,,NA,NA,,,ATP binding,chromosome segregation,,
O14730-2,O14730,Serine/threonine-protein kinase RIO3,RIOK3,60.95,60.84,S128,FENYRKVHPYEDSDSSEDEVDWQDTRDDPYR,_VHPYEDS(ph)DS(ph)S(ph)EDEVDWQDTR_, , , , , ,-0.09, ,-0.15, , , , , ,0.35, ,0.04,,,-0.09,-0.15,,,0.35,0.04,,,Atypical,,,,NA,NA,,,ATP binding,chromosome segregation,,
O60930,O60930,Ribonuclease H1,RNASEH1,83.22,81.24,S74,KKFATEDEAWAFVRKSASPEVSEGHENQHGQ,_S(ph)AS(ph)PEVSEGHENQHGQESEAK_,-0.07, , , ,-0.21,-0.61, ,-0.3,0.12, , , ,-0.19,0.17, ,-0.21,-0.07,,-0.4,-0.3,0.12,,0,-0.21,,,,,,,NA,NA,,cytoplasm,magnesium ion binding,RNA catabolic process,,
O60930,O60930,Ribonuclease H1,RNASEH1,84.67,83.68,S76,FATEDEAWAFVRKSASPEVSEGHENQHGQES,_S(ph)AS(ph)PEVSEGHENQHGQESEAK_,-0.07, , , ,-0.27,-0.64,-0.48,-0.59,0.12, , , ,-0.48,-0.23,-0.5,-0.46,-0.07,,-0.44,-0.53,0.12,,-0.35,-0.48,,,,,,,NA,NA,,cytoplasm,magnesium ion binding,RNA catabolic process,,
O15541,O15541,RING finger protein 113A,RNF113A,178.94,178.04,S84,KTRDSGKQKAAYGDLSSEEEEENEPESLGVV,_AAYGDLS(ph)S(ph)EEEEENEPESLGVVYK_,0,0.12,0.03,0.13,0.07,0.15,0.15,0.17,0.14,0.1,0.09,-0.12,-0.07,0.1,0.07,0.06,0.06,0.08,0.11,0.16,0.12,-0.01,0.02,0.06,,,,RING finger,,,0,0,,,nucleic acid binding,,,
O15541,O15541,RING finger protein 113A,RNF113A,178.94,178.04,S85,TRDSGKQKAAYGDLSSEEEEENEPESLGVVY,_AAYGDLS(ph)S(ph)EEEEENEPESLGVVYK_,0,0.12,0.03,0.13,0.07,0.15,0.15,0.17,0.14,0.1,0.09,-0.12,-0.07,0.1,0.07,0.06,0.06,0.08,0.11,0.16,0.12,-0.01,0.02,0.06,,,,RING finger,,,0,0,,,nucleic acid binding,,,
O15541,O15541,RING finger protein 113A,RNF113A,197.99,193.68,S253,EGRYGVYEDENYEVGSDDEEIPFKCFICRQS,_YGVYEDENYEVGS(ph)DDEEIPFK_, , , ,-0.08,-0.07,0.06,0.12,0.47, , , ,0.09,-0.12,0.13,-0.06,0.04,,-0.08,-0.01,0.3,,0.09,0.01,-0.01,,,,RING finger,,,NA,NA,,,nucleic acid binding,,,
C9JS59,Q5XPI4,E3 ubiquitin-protein ligase RNF123,RNF123,147.7,145.85,S675,AVGGPLPLPRPGWLSSPTLGRANRFLSTAAV,_PGWLSS(ph)PTLGR_,-0.25,-0.06, ,-0.49, ,-0.88, , ,-0.34,-0.4, ,-0.34, ,-0.08, , ,-0.15,-0.49,-0.88,,-0.37,-0.34,-0.08,,,,,RING finger,,,NA,NA,,,,,,
B3KR12,O43567,E3 ubiquitin-protein ligase RNF13,RNF13,110.39,108.34,T380,VQLQPNGERDYNIANTV______________,_DYNIANT(ph)V_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,RING finger,,,NA,NA,,,zinc ion binding,,,
Q8IYW5,Q8IYW5,E3 ubiquitin-protein ligase RNF168,RNF168,53.55,53.12,S411,EAVKDPCFSAKRRKVSPESSPDQEETEINFT,_KVS(ph)PES(ph)S(ph)PDQEETEINFTQK_, , , , , , , ,-0.93, , , , , , , ,-0.82,,,,-0.93,,,,-0.82,,,,RING finger,,,NA,NA,,nucleus,histone binding,double-strand break repair,,
Q8IYW5,Q8IYW5,E3 ubiquitin-protein ligase RNF168,RNF168,53.55,53.12,S414,KDPCFSAKRRKVSPESSPDQEETEINFTQKL,_KVS(ph)PES(ph)S(ph)PDQEETEINFTQK_, , , , , , , ,-0.93, , , , , , , ,-0.82,,,,-0.93,,,,-0.82,,,,RING finger,,,NA,NA,,nucleus,histone binding,double-strand break repair,,
Q8IYW5,Q8IYW5,E3 ubiquitin-protein ligase RNF168,RNF168,53.55,53.12,S415,DPCFSAKRRKVSPESSPDQEETEINFTQKLI,_KVS(ph)PES(ph)S(ph)PDQEETEINFTQK_, , , , , , , ,-0.93, , , , , , , ,-0.82,,,,-0.93,,,,-0.82,,,,RING finger,,,NA,NA,,nucleus,histone binding,double-strand break repair,,
C9J0A5,Q5VTR2,E3 ubiquitin-protein ligase BRE1A,RNF20,215.62,215.62,S136,LTERKALVVPEPEPDSDSNQERKDD______,_ALVVPEPEPDS(ph)DS(ph)NQER_,0.09,0.16,-0.04,0.11,0.35,-0.11,2.95,0.88,0.24,0.02,0.2,-0.01,-0.11,-0.24,0.17,-0.05,0.13,0.04,0.14,2.26,0.13,0.1,-0.18,0.07, +,,,RING finger,,,2,0,1.31,,chromatin binding,histone ubiquitination,,
C9J0A5,Q5VTR2,E3 ubiquitin-protein ligase BRE1A,RNF20,181.61,181.61,S138,ERKALVVPEPEPDSDSNQERKDD________,_ALVVPEPEPDS(ph)DS(ph)NQER_,0.08,-0.01,0.11,0.04,-0.22,-0.03,0.04,0.11,0.11,0.05,0.23,0.52,-0.29,-0.13,-0.02,0,0.04,0.08,-0.12,0.08,0.08,0.38,-0.21,-0.01,,,,RING finger,,,0,0,,,chromatin binding,histone ubiquitination,,
Q63HN8,Q63HN8,E3 ubiquitin-protein ligase RNF213,RNF213,290.54,289.7,S1258,PLSEPKEDQEAAELLSEPEEESERHILELEE,_EDQEAAELLS(ph)EPEEESER_,0.48,0.66,0.43,0.84,0.2,0.26,0.23,0.3,0.22,0.22,0.38,0.35,0.12,0.17,0.33,0.14,0.58,0.65,0.23,0.27,0.22,0.37,0.14,0.24,,,,,,,0,0,,cytoplasm,ATPase activity,protein autoubiquitination,,
Q9H4A4,Q9H4A4,Aminopeptidase B,RNPEP,81.45,66.44,S7,_________MASGEHSPGSGAARRPLHSAQA,_(ac)ASGEHS(ph)PGSGAAR_, , , , ,0.76,1, , , , , , ,-0.11,-0.21, , ,,,0.89,,,,-0.16,,,,,,,,NA,NA,,extracellular region,aminopeptidase activity,leukotriene biosynthetic process,,
Q9Y6N7-4,Q9Y6N7,Roundabout homolog 1,ROBO1,135.3,102.04,T1240,LQQDELEEEEDERGPTPPVRGAASSPAAVSY,_MYLQQDELEEEEDERGPT(ph)PPVR_, , ,0.97, , , , , , , ,-0.1, , , , , ,,0.97,,,,-0.1,,,,,,,,,NA,NA,,axolemma,axon guidance receptor activity,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q13464,Q13464,Rho-associated protein kinase 1,ROCK1,95.54,92.34,S1102,IEQLRAKLLDLSDSTSVASFPSADETDGNLP,_LLDLSDSTS(ph)VAS(ph)FPSADETDGNLPESR_, , , , , ,-0.54,-0.56,-0.38, , , , , ,-0.57,-0.28,-0.24,,,-0.54,-0.46,,,-0.57,-0.26,,,AGC,,,,NA,NA,,bleb,ATP binding,actin cytoskeleton organization,,
Q13464,Q13464,Rho-associated protein kinase 1,ROCK1,95.54,92.34,S1105,LRAKLLDLSDSTSVASFPSADETDGNLPESR,_LLDLSDSTS(ph)VAS(ph)FPSADETDGNLPESR_, , , , ,-0.67,-0.54,-0.56,-0.39, , , , ,-0.61,-0.57,-0.28,-0.21,,,-0.61,-0.47,,,-0.59,-0.24,,,AGC,,,,NA,NA,,bleb,ATP binding,actin cytoskeleton organization,,
E9PF63,O75116,Rho-associated protein kinase 2,ROCK2,104.13,101.27,S1134,LRSQLQALHIGLDSSSIGSGPGDAEADDGFP,_SQLQALHIGLDSSS(ph)IGS(ph)GPGDAEADDGFPESR_, , , , ,0.22, , ,0.08, , , , ,-0.24, , ,-0.01,,,0.22,0.08,,,-0.24,-0.01,,,AGC,,,,NA,NA,,spindle pole centrosome,ATP binding,actin cytoskeleton organization,,
E9PF63,O75116,Rho-associated protein kinase 2,ROCK2,104.13,101.27,S1137,QLQALHIGLDSSSIGSGPGDAEADDGFPESR,_SQLQALHIGLDSSS(ph)IGS(ph)GPGDAEADDGFPESR_, , , , ,0.22, , ,0.08, , , , ,-0.24, , ,-0.01,,,0.22,0.08,,,-0.24,-0.01,,,AGC,,,,NA,NA,,spindle pole centrosome,ATP binding,actin cytoskeleton organization,,
Q9H6T3-2,Q9H6T3,RNA polymerase II-associated protein 3,RPAP3,99.94,99.79,S110,KLDVDRILDELDKDDSTHESLSQESESEEDG,_DDS(ph)THES(ph)LSQES(ph)ES(ph)EEDGIHVDSQK_, , , , , ,0.09,0.28,0.3, , , , , ,0.27,0.25,0.22,,,0.09,0.29,,,0.27,0.24,,,,,,,NA,NA,,,,,,
Q9H6T3-2,Q9H6T3,RNA polymerase II-associated protein 3,RPAP3,270.15,270.13,S116,ILDELDKDDSTHESLSQESESEEDGIHVDSQ,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,-0.3,-0.18,-0.32,0.06,0.01,0,0.04,0.09,-0.32,-0.13,-0.4,-0.05,0,-0.09,0.06,0,-0.24,-0.12,0,0.07,-0.22,-0.21,-0.04,0.03,,,,,,,0,0,,,,,,
Q9H6T3-2,Q9H6T3,RNA polymerase II-associated protein 3,RPAP3,270.15,270.13,S119,ELDKDDSTHESLSQESESEEDGIHVDSQKAL,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,-0.3,-0.18,-0.32,0.06,0.01,0.09,0.04,0.09,-0.32,-0.13,-0.4,-0.05,0,-0.03,0.06,0,-0.24,-0.12,0.05,0.07,-0.22,-0.21,-0.01,0.03,,,,,,,0,0,,,,,,
Q9H6T3-2,Q9H6T3,RNA polymerase II-associated protein 3,RPAP3,168.91,168.91,S121,DKDDSTHESLSQESESEEDGIHVDSQKALVL,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,-0.08,-0.12,0,0.06,0.01,0.09,0.04,0.09,-0.1,-0.14,-0.42,-0.05,0,-0.03,0.06,0,-0.1,0.03,0.05,0.07,-0.12,-0.22,-0.01,0.03,,,,,,,0,0,,,,,,
P30050,P30050,60S ribosomal protein L12,RPL12,89.43,38.14,S38,GATSALAPKIGPLGLSPKKVGDDIAKATGDW,_IGPLGLS(ph)PK_,0.59,0.46,0.44,0.52, , , ,0.98,-0.02,-0.05,-0.29,-0.1, , , ,0.75,0.53,0.48,,0.98,-0.03,-0.19,,0.75,,,,,,,NA,NA,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P50914,P50914,60S ribosomal protein L14,RPL14,101.53,101.53,S139,KNEVKKLQKAALLKASPKKAPGTKGTAAAAA,_AALLKAS(ph)PK_,0.25,0.24,0.41,0.43, , , , ,0.1,0.11,0.07,0.16, , , , ,0.24,0.42,,,0.1,0.11,,,,,,,,,NA,NA,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P61313,P61313,60S ribosomal protein L15,RPL15,82.03,52.36,S34,MRFLLRVRCWQYRQLSALHRAPRPTRPDKAR,_(gl)QLS(ph)ALHR_,-0.1,-0.12,-0.21,-0.36, , ,-0.03,-0.11,-0.09,-0.07,-0.24,-0.12, , ,-0.13,-0.14,-0.11,-0.29,,-0.07,-0.08,-0.17,,-0.14,,,,,,,NA,NA,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
C9JYQ9,Q6P5R6,60S ribosomal protein L22-like 1,RPL22L1,165.16,159.19,S118,TYELRYFQISQDEDESESED___________,_YFQISQDEDES(ph)ES(ph)ED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,ribosome,structural constituent of ribosome,translation,,
C9JYQ9,Q6P5R6,60S ribosomal protein L22-like 1,RPL22L1,152.01,147.66,S120,ELRYFQISQDEDESESED_____________,_YFQISQDEDES(ph)ES(ph)ED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,ribosome,structural constituent of ribosome,translation,,
P62750,P62750,60S ribosomal protein L23a,RPL23A,121.29,101.5,S43,VLKGVHSHKKKKIRTSPTFRRPKTLRLRRQP,_IRTS(ph)PTFR_,0.34,0.2,0.16,0.17,-0.03,0.4,0.48,0.19,0.03,0.82,-0.06,-0.06,-0.25,-0.01,-0.22,0.07,0.27,0.17,0.2,0.34,0.48,-0.06,-0.12,-0.07,,,,,,,0,0,,cytosolic large ribosomal subunit,nucleotide binding,cell proliferation,,
E5RI99,P62888,60S ribosomal protein L30,RPL30,99.57,56.77,S10,______MVAAKKTKKSLESINSRLQLVMKSG,_S(ph)LESINSR_,0.07,0.03,-0.2,-0.22,-0.71,-0.28,-0.49,-0.86,-0.27,-0.29,-0.62,-0.51,-0.56,-0.66,-0.81,-0.82,0.05,-0.21,-0.48,-0.66,-0.28,-0.56,-0.61,-0.82,,,,,,,0,0,,cytoplasm,structural constituent of ribosome,translation,,
E7EWF1,P36578,60S ribosomal protein L4,RPL4,113.07,80.75,S295,PMHKMINTDLSRILKSPEIQRALRAPRKKIH,_ILKS(ph)PEIQR_,0.04,0.1,-0.02,-0.09, , , , ,-0.13,0.13,-0.09,0.21, , , , ,0.07,-0.06,,,0.01,0.07,,,,,,,,,NA,NA,,,,,,
P05388,Q8NHW5,60S acidic ribosomal protein P0,RPLP0,123.79,89.61,Y24,WKSNYFLKIIQLLDDYPKCFIVGADNVGSKQ,_IIQLLDDY(ph)PK_,0.02, ,0.05, ,0.1,0.4,0.19,0.49,-0.11, ,-0.21, ,0.7,0.39,0.23,0.4,0.02,0.05,0.26,0.34,-0.11,-0.21,0.56,0.32,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05388,Q8NHW5,60S acidic ribosomal protein P0,RPLP0,276.89,253.9,S304,PAAAAAPAKVEAKEESEESDEDMGFGLFD__,_VEAKEES(ph)EES(ph)DEDMGFGLFD_,-0.08,-0.06,-0.05,-0.03,-0.24,-0.21,-0.24,-0.22,0.09,0.24,0.01,0.02,-0.05,-0.08,-0.06,-0.09,-0.07,-0.04,-0.22,-0.23,0.16,0.02,-0.07,-0.08,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05388,Q8NHW5,60S acidic ribosomal protein P0,RPLP0,276.89,253.9,S307,AAAPAKVEAKEESEESDEDMGFGLFD_____,_VEAKEES(ph)EES(ph)DEDMGFGLFD_,-0.08,-0.06,-0.05,-0.03,-0.24,-0.21,-0.24,-0.22,0.09,0.24,0.01,0.02,-0.05,-0.08,-0.06,-0.09,-0.07,-0.04,-0.22,-0.23,0.16,0.02,-0.07,-0.08,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05386,P05386,60S acidic ribosomal protein P1,RPLP1,294.21,290.68,S101,AAPAEEKKVEAKKEESEESDDDMGFGLFD__,_VEAKKEES(ph)EES(ph)DDDMGFGLFD_,0.06,0.59,0.04,-0.24,-0.13,-0.11,0.44,0,0.05,-0.25,-0.01,-1,-0.13,-0.07,0.42,0.03,0.35,-0.09,-0.12,0.24,-0.1,-0.42,-0.1,0.24,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05386,P05386,60S acidic ribosomal protein P1,RPLP1,294.21,290.68,S104,AEEKKVEAKKEESEESDDDMGFGLFD_____,_VEAKKEES(ph)EES(ph)DDDMGFGLFD_,0.24,0.25,0.08,0.14,0.12,0.19,0.46,0.46,0.29,0.28,-0.04,-0.03,0.18,0.19,0.39,0.43,0.24,0.11,0.16,0.46,0.29,-0.04,0.18,0.41,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05387,P05387,60S acidic ribosomal protein P2,RPLP2,294.21,290.68,S102,APAAAEEKKDEKKEESEESDDDMGFGLFD__,_KEES(ph)EES(ph)DDDMGFGLFD_,0.06,0.59,0.04,-0.24,-0.14,-0.11,0.44,0,0.05,-0.25,-0.01,-1,-0.12,-0.07,0.42,0.03,0.35,-0.09,-0.12,0.24,-0.1,-0.42,-0.1,0.24,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05387,P05386,60S acidic ribosomal protein P2,RPLP2,294.21,290.68,S104,AAEEKKDEKKEESEESDDDMGFGLFD_____,_KEES(ph)EES(ph)DDDMGFGLFD_,0.24,0.25,0.08,0.14,0.12,0.19,0.46,0.46,0.29,0.28,-0.04,-0.03,0.18,0.19,0.39,0.43,0.24,0.11,0.16,0.46,0.29,-0.04,0.18,0.41,,,,,,,0,0,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P05387,P05387,60S acidic ribosomal protein P2,RPLP2,64.07,63.53,S79,SVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK,_LASVPAGGAVAVSAAPGS(ph)AAPAAGSAPAAAEEK_,-0.59,0.42,-0.01,-0.1, , , , ,0.08,0.64,0.05,0.13, , , , ,0,-0.05,,,0.39,0.09,,,,,,,,,NA,NA,,cytosolic large ribosomal subunit,RNA binding,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
P78345,P78345,Ribonuclease P protein subunit p38,RPP38,147.51,142.59,S235,ETEPLESQDRELLDTSFEDLSKPKRKLADGR,_ELLDTS(ph)FEDLSKPK_,0.09,0.2,0.21,0,0.05,0.09, ,-0.35,-0.07,0.19,-0.14,-0.06,-0.08,0.59, ,-0.26,0.15,0.11,0.07,-0.35,0.07,-0.1,0.29,-0.26,,,,,,,0,0,,nucleolar ribonuclease P complex,ribonuclease P activity,tRNA processing,,
Q9NQG5,Q9NQG5,Regulation of nuclear pre-mRNA domain-containing protein 1B,RPRD1B,75.02,75.02,S134,GEFIQQLKLSMEDSKSPPPKATEEKKSLKRT,_LSMEDSKS(ph)PPPK_,0.22,0.17,0.84, ,0.67,0.61,0.52,0.49,0.14,0,0.51, ,0.79,0.36,0.37,0.3,0.19,0.84,0.64,0.5,0.07,0.51,0.59,0.34,,,,,,,0,0,,"DNA-directed RNA polymerase II, holoenzyme",RNA polymerase II core binding,dephosphorylation of RNA polymerase II C-terminal domain,,
Q9NQG5,Q9NQG5,Regulation of nuclear pre-mRNA domain-containing protein 1B,RPRD1B,193.84,193.84,S166,QQIQEEEDDDYPGSYSPQDPSAGPLLTEELI,_RTFQQIQEEEDDDYPGSYS(ph)PQDPSAGPLLTEELIK_,-0.06,-0.13,0.07, ,0.14,-0.01,0.18, ,0.33,-0.12,0.08, ,-0.05,-0.32,-0.21, ,-0.09,0.07,0.07,0.18,0.13,0.08,-0.18,-0.21,,,,,,,0,0,,"DNA-directed RNA polymerase II, holoenzyme",RNA polymerase II core binding,dephosphorylation of RNA polymerase II C-terminal domain,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,199.01,199.01,T723,FQRGPTSTSIDNIDGTPVRDERSGTPTQDEM,_GPTSTSIDNIDGT(ph)PVRDER_,0.1,0.04,-0.01,-0.18,-0.9,-0.98,-0.43,-0.55,0.06,0.21,0.22,0.25,-0.89,-1.17,-0.67,-0.4,0.07,-0.09,-0.94,-0.49,0.14,0.24,-1.02,-0.53,, +,,,,,0,6,35.71,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,116.62,115.18,T732,IDNIDGTPVRDERSGTPTQDEMMDKPTSSSV,_SGT(ph)PTQDEMMDKPTSSSVDTMSLLSK_, , ,0.39, , , , , , , ,-1.63, , , , , ,,0.39,,,,-1.63,,,, +,,,,,NA,NA,,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,249.52,243.98,S374,PEPVTDNRDVEDMELSDVEDDGSKIIVEDRK,_DVEDMELS(ph)DVEDDGSK_,-0.02,-0.1,-0.17,-0.4,0.01,0.04,-0.14,0.11,0.07,0.07,-0.01,0,0.1,0.06,-0.04,0.07,-0.06,-0.28,0.03,-0.01,0.07,0,0.08,0.02,,,,,,,0,0,,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,129.05,127.86,S665,QSSEVSKPKLESESTSPSLEMKIHNFLKGNP,_LESESTS(ph)PSLEMK_, , ,-0.07, ,0.87, ,0.24,0.35, , ,0.27, ,0.5, ,0.11,0.26,,-0.07,0.87,0.3,,0.27,0.5,0.18,,,,,,,NA,NA,,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,242.03,241.91,S356,MGGEESQSPTMESEKSATPEPVTDNRDVEDM,_S(ph)AT(ph)PEPVTDNRDVEDMELS(ph)DVEDDGSK_, ,-0.03, , ,0.08,0.02,-0.46,-0.2, ,-0.26, , ,-0.19,-0.32,-0.5,-0.04,-0.03,,0.05,-0.33,-0.26,,-0.25,-0.25,,,,,,,NA,NA,,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,194.77,187.26,S593,LPSSAQPFIPKSFNYSPNSSTSEVSSTSASK,_SFNYS(ph)PNSSTSEVSSTSASK_, ,-0.11,-0.18,-0.16,0,-0.18,-0.45,-0.09, ,0.1,0.1,0.42,-0.09,0.1,-0.17,-0.26,-0.11,-0.17,-0.09,-0.26,0.1,0.27,0.01,-0.21,,,,,,,0,0,,,,,,
B4E2Q6,Q5VT52,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2,242.03,241.91,T358,GEESQSPTMESEKSATPEPVTDNRDVEDMEL,_S(ph)AT(ph)PEPVTDNRDVEDMELS(ph)DVEDDGSK_, ,0.18,0.14, ,0.08,0.02,-0.46,-0.2, ,-0.21,-0.38, ,-0.19,-0.32,-0.5,-0.04,0.18,0.14,0.05,-0.33,-0.21,-0.38,-0.25,-0.25,,,,,,,0,0,,,,,,
P46783,P46783,40S ribosomal protein S10,RPS10,70.4,37.14,Y12,____MLMPKKNRIAIYELLFKEGVMVAKKDV,_IAIY(ph)ELLFK_,0.15, , , , , , , ,-0.35, , , , , , , ,0.15,,,,-0.35,,,,,,,,,,NA,NA,,cytosolic small ribosomal subunit,,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",,
Q5T4L4,P42677,40S ribosomal protein S27,RPS27,201.3,173.02,S11,_____MPLAKDLLHPSPEEEKRKHKKKRLVQ,_DLLHPS(ph)PEEEK_,0.33,0.36,0.56,0.43,-0.15,-0.1,0.14,0.23,0.03,0.09,-0.09,-0.13,-0.21,-0.25,-0.1,-0.02,0.35,0.5,-0.13,0.18,0.06,-0.11,-0.23,-0.06,,,,,,,0,0,,ribosome,structural constituent of ribosome,translation,,
Q5T4L4,Q71UM5,40S ribosomal protein S27-like,RPS27L,77.78,51.06,Y31,KKKHKKKRLVQSPNSYFMDVKCPGCYKITTV,_LVQSPNSY(ph)FMDVK_,0.03, , , , , , , ,-0.18, , , , , , , ,0.03,,,,-0.18,,,,,,,,,,NA,NA,,ribosome,structural constituent of ribosome,translation,,
P23396,P23396,40S ribosomal protein S3,RPS3,114.54,111.34,T220,PDHVSIVEPKDEILPTTPISEQKGGKPEPPA,_DEILPT(ph)TPISEQK_,0.37, ,0.32,0.29, , , , ,0.38, ,0.15,0.16, , , , ,0.37,0.31,,,0.38,0.16,,,,,,,,,NA,NA,,cytosolic small ribosomal subunit,damaged DNA binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
P23396,P23396,40S ribosomal protein S3,RPS3,134.49,125.46,T221,DHVSIVEPKDEILPTTPISEQKGGKPEPPAM,_DEILPTT(ph)PISEQK_,0.26,0.29,0.14,0.43,0.21,0.1,0.25,0.34,0.23,0.24,0.02,0.19,0.29,0.23,0.38,0.43,0.27,0.29,0.16,0.29,0.23,0.11,0.26,0.41,,,,,,,0,0,,cytosolic small ribosomal subunit,damaged DNA binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
P61247,P61247,40S ribosomal protein S3a,RPS3A,184.59,184.59,S263,AKVERADGYEPPVQESV______________,_VERADGYEPPVQES(ph)V_,-0.08,0.02,-0.05,0.04,0.15,0.12,0.06,0.02,0.11,0.17,-0.12,-0.02,-0.05,-0.12,-0.25,-0.11,-0.03,0,0.13,0.04,0.14,-0.07,-0.08,-0.18,,,,,,,0,0,,cytosolic small ribosomal subunit,RNA binding,cell differentiation,,
P62753,P62753,40S ribosomal protein S6,RPS6,167.64,167.64,S235,AKEKRQEQIAKRRRLSSLRASTSKSESSQK_,_RRLS(ph)S(ph)LR_,2.45,2.97,5,4.95,3.95,4.03,3.88,3.46,1.44,2.07,3.89,3.74,4.07,4.17,3.7,3.35,2.73,4.98,3.99,3.69,1.78,3.82,4.12,3.54, +, +,,,,,1,1,35.77,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,167.64,167.64,S236,KEKRQEQIAKRRRLSSLRASTSKSESSQK__,_RRLS(ph)S(ph)LR_,2.72,3.33,2.67,5.05,4.06,3.74,3.9,3.74,1.35,1.5,0.09,3.06,3.39,3.58,3.51,3.37,3.06,4.3,3.91,3.82,1.42,2.23,3.49,3.44, +, +,,,,,1,1,24.88,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,222.18,218.32,S240,QEQIAKRRRLSSLRASTSKSESSQK______,_LSS(ph)LRAS(ph)TSK_,2.83,2.61,3.19,2.54,2.79,2.7,2.78,2.69,1.17,0.63,2.77,0.17,2.56,2.63,2.6,2.69,2.72,2.9,2.75,2.73,0.93,1.99,2.6,2.65, +, +,,,,,1,1,27.63,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,222.18,218.32,S244,AKRRRLSSLRASTSKSESSQK__________,_LSSLRAST(ph)SKS(ph)ESS(ph)QK_,2.69, ,3.48,3.25,3.83,3.34,3.04,2.44,2.07, ,3.6,3.21,4.01,3.35,3.26,2.81,2.69,3.37,3.61,2.77,2.07,3.42,3.72,3.05, +, +,,,,,1,1,36,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,125.08,125.08,S246,RRRLSSLRASTSKSESSQK____________,_LSSLRAST(ph)SKSES(ph)S(ph)QK_, , ,2.85,2.88,3.9, , , , , ,2.4,2.39,3.94, , , ,,2.87,3.9,,,2.4,3.94,, +, +,,,,,NA,NA,,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,214.13,213.99,S247,RRLSSLRASTSKSESSQK_____________,_LSSLRAS(ph)TSKS(ph)ESS(ph)QK_,2.69, ,3.57, ,3.78,3.78,4.11,4.2,2.07, ,3.42, ,3.78,3.87,4.52,4.6,2.69,3.57,3.78,4.16,2.07,3.42,3.82,4.56, +, +,,,,,1,1,37.84,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
P62753,P62753,40S ribosomal protein S6,RPS6,214.13,213.99,T241,EQIAKRRRLSSLRASTSKSESSQK_______,_LSSLRAST(ph)SKS(ph)ESS(ph)QK_, , , , ,3.88,5.14,4.8,1.92, , , , ,3.89,5.44,4.81,2.28,,,4.64,3.99,,,4.87,4.04, +, +,,,,,NA,NA,,cytosolic small ribosomal subunit,structural constituent of ribosome,glucose homeostasis,,
Q15418-3,Q15418,Ribosomal protein S6 kinase,RPS6KA1,82.75,59.97,S732,IESSILAQRRVRKLPSTTL____________,_KLPS(ph)TTL_,1.26,1.29,3.85,3.88, , , , ,1.96,1.61,4,3.98, , , , ,1.28,3.87,,,1.79,3.99,,, +, +,AGC,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
P51812,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,109.53,109.04,S369,TFYFDPEFTAKTPKDSPGIPPSANAHQLFRG,_T(ph)PKDS(ph)PGIPPS(ph)ANAHQLFR_, , ,0.51, ,1.96,1.24,1.64,1.71, , ,0.34, ,1.49,0.93,0.94,1.33,,0.51,1.64,1.68,,0.34,1.24,1.15, +, +,AGC,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
P51812,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,109.53,109.04,S375,EFTAKTPKDSPGIPPSANAHQLFRGFSFVAI,_T(ph)PKDS(ph)PGIPPS(ph)ANAHQLFR_, , , , ,1.96,1.74,2.17,1.71, , , , ,1.49,1.41,1.78,1.33,,,1.85,1.96,,,1.45,1.57, +, +,AGC,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
P51812,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,109.53,109.04,T365,RPEDTFYFDPEFTAKTPKDSPGIPPSANAHQ,_T(ph)PKDS(ph)PGIPPS(ph)ANAHQLFR_, , ,0.51, ,1.96,1.24,1.64,1.71, , ,0.34, ,1.49,0.93,0.94,1.33,,0.51,1.64,1.68,,0.34,1.24,1.15, +, +,AGC,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
P51812,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,56.46,55.33,S715,KGAMAATYSALNRNQSPVLEPVGRSTLAQRR,_NQS(ph)PVLEPVGR_, , , , ,0.98, ,0.53, , , , , ,0.92, ,0.75, ,,,0.98,0.53,,,0.92,0.75,,,AGC,,,,NA,NA,,cytosol,ATP binding,axon guidance,,
G3XAA9,O75676,Ribosomal protein S6 kinase,RPS6KA4,108.44,106.87,S343,VGNFAEEFTRLEPVYSPPGSPPPGDPRIFQG,_LEPVYS(ph)PPGS(ph)PPPGDPR_, , , , ,1.23,1.13, , , , , , ,1.47,1.41, , ,,,1.18,,,,1.44,, +, +,AGC,,,,NA,NA,,,ATP binding,,,
G3XAA9,O75676,Ribosomal protein S6 kinase,RPS6KA4,108.44,106.87,S347,AEEFTRLEPVYSPPGSPPPGDPRIFQGYSFV,_LEPVYS(ph)PPGS(ph)PPPGDPR_, , ,1.66, ,1.23,1.13, , , , ,1.4, ,1.47,1.41, , ,,1.66,1.18,,,1.4,1.44,, +, +,AGC,,,,NA,NA,,,ATP binding,,,
B4DLT4,P23443,Ribosomal protein S6 kinase beta-1,RPS6KB1,91.34,89.71,S441,FSFEPKIRSPRRFIGSPRTPVSPVKFSPGDF,_FIGS(ph)PRT(ph)PVS(ph)PVK_,0.58,0.21,0.88,-0.06,2.2,2.51,2.19,1.87,0.89,0.53,1.03,0.26,1.89,2.02,2.04,2.09,0.41,0.48,2.36,2.04,0.72,0.7,1.96,2.07, +, +,AGC,,,,2,2,45.73,cell surface,ATP binding,aging,,
B4DLT4,P23443,Ribosomal protein S6 kinase beta-1,RPS6KB1,91.34,89.71,S447,IRSPRRFIGSPRTPVSPVKFSPGDFWGRGAS,_FIGS(ph)PRT(ph)PVS(ph)PVK_,0.58,0.21,0.88,-0.06,2.2,2.51,2.19,1.87,0.89,0.53,1.03,0.26,1.89,2.02,2.04,2.09,0.41,0.48,2.36,2.04,0.72,0.7,1.96,2.07, +, +,AGC,,,,2,2,45.73,cell surface,ATP binding,aging,,
B4DLT4,P23443,Ribosomal protein S6 kinase beta-1,RPS6KB1,91.34,89.71,T444,EPKIRSPRRFIGSPRTPVSPVKFSPGDFWGR,_FIGS(ph)PRT(ph)PVS(ph)PVK_,0.58,0.21,2.53,2.15,2.2,2.51,2.19,1.87,0.89,0.53,2.46,2.44,1.89,2.02,2.04,2.09,0.41,2.35,2.36,2.04,0.72,2.45,1.96,2.07, +, +,AGC,,,,1,1,45.74,cell surface,ATP binding,aging,,
B4DLT4,P23443,Ribosomal protein S6 kinase beta-1,RPS6KB1,83.21,77.67,S427,TYVAPSVLESVKEKFSFEPKIRSPRRFIGSP,_EKFS(ph)FEPK_, , , ,-0.33, , , , , , , ,-0.33, , , , ,,-0.33,,,,-0.33,,,,,AGC,,,,NA,NA,,cell surface,ATP binding,aging,,
B4DHE1,Q96S38,Ribosomal protein S6 kinase delta-1,RPS6KC1,105.59,105.59,S423,EGGKLWSYISKFLNRSPEESFDIKEVKKPTL,_FLNRS(ph)PEES(ph)FDIK_,0.03,0.08,-0.1,-0.26,0.06,0.28,-0.2,0.07,0.07,0.46,0.23,0,-0.1,0.12,0.15,0.04,0.06,-0.18,0.17,-0.06,0.28,0.12,0.01,0.09,,,Other,,,,0,0,,ribosome,ATP binding,,,
B4DHE1,Q96S38,Ribosomal protein S6 kinase delta-1,RPS6KC1,105.59,105.59,S427,LWSYISKFLNRSPEESFDIKEVKKPTLAKVH,_FLNRS(ph)PEES(ph)FDIK_,0.03,0.08,-0.1,-0.26,0.06,0.28,-0.2,0.07,0.07,0.46,0.23,0,-0.1,0.12,0.15,0.04,0.06,-0.18,0.17,-0.06,0.28,0.12,0.01,0.09,,,Other,,,,0,0,,ribosome,ATP binding,,,
F5H7J5,Q8N122,Regulatory-associated protein of mTOR,RPTOR,254.83,254.14,S859,NARPQRVLDTSSLTQSAPASPTNKGVHIHQA,_VLDTSSLTQS(ph)APAS(ph)PTNK_,0.26,0.43, , ,0.39,0.43,0.45,0.44,0.36,0.4, , ,0.07,0.04,0.18,0.15,0.35,,0.41,0.44,0.38,,0.05,0.17,,,,,,,NA,NA,,TORC1 complex,,TOR signaling cascade,,
F5H7J5,Q8N122,Regulatory-associated protein of mTOR,RPTOR,254.83,254.14,S863,QRVLDTSSLTQSAPASPTNKGVHIHQAGGSP,_VLDTSSLTQS(ph)APAS(ph)PTNK_,-0.03,0.14,0.23,-0.25,0.63,0.49,0.38,0.69,-0.03,-0.06,0.18,-0.3,0.44,0.6,0.46,0.42,0.06,0.01,0.56,0.54,-0.05,-0.04,0.52,0.44,,,,,,,0,0,,TORC1 complex,,TOR signaling cascade,,
F5H6I4,Q8IZ73,RNA pseudouridylate synthase domain-containing protein 2,RPUSD2,95.07,95.07,S68,HQQNGDAGGDAKVELSPGPPKPAGREVEPAP,_VELS(ph)PGPPKPAGR_,0.26,0.39,0.48,0.38, , , , ,0.05,-0.09,0.08,-0.1, , , , ,0.33,0.43,,,-0.02,-0.01,,,,,,,,,NA,NA,,,,,,
Q9HB90,Q9HB90,Ras-related GTP-binding protein C,RRAGC,103.05,102.52,S21,GAEETPLAGSYGAADSFPKDFGYGVEEEEEE,_(ac)S(ph)LQYGAEETPLAGS(ph)YGAADS(ph)FPK_, , , , ,1.54,1.67, ,1.75, , , , ,1.3,1.41, ,1.41,,,1.61,1.75,,,1.36,1.41, +, +,,,,,NA,NA,,lysosome,GDP binding,apoptotic process,,
Q9HB90,Q9HB90,Ras-related GTP-binding protein C,RRAGC,222.34,221.56,S2,______________MSLQYGAEETPLAGSYG,_(ac)S(ph)LQYGAEETPLAGS(ph)YGAADSFPK_, , , , ,1.17,0.85,0.66,0.72, , , , ,0.86,0.34,0.66,0.55,,,1.01,0.69,,,0.63,0.6, +,,,,,,NA,NA,,lysosome,GDP binding,apoptotic process,,
Q9HB90,Q9HB90,Ras-related GTP-binding protein C,RRAGC,222.34,221.56,S15,_MSLQYGAEETPLAGSYGAADSFPKDFGYGV,_(ac)S(ph)LQYGAEETPLAGS(ph)YGAADSFPK_,-0.27,-0.22,-0.66, ,-0.32,0.85,0.66,-0.53,0.08,0.04,-0.11, ,-0.8,0.34,0.66,-0.25,-0.25,-0.66,0.38,0.18,0.06,-0.11,-0.12,0.27,,,,,,,0,0,,lysosome,GDP binding,apoptotic process,,
Q9HB90,Q9HB90,Ras-related GTP-binding protein C,RRAGC,231.38,230.24,S95,VVFHKMSPNETLFLESTNKIYKDDISNSSFV,_MSPNETLFLES(ph)TNK_,0.43,0.44,0.06,0.23,0.26, ,0.05,0.2,0.54,0.51,0.66,0.5,0.43, ,0.64,0.46,0.44,0.15,0.26,0.13,0.52,0.58,0.43,0.55,,,,,,,0,0,,lysosome,GDP binding,apoptotic process,,
Q92766-3,Q92766,Ras-responsive element-binding protein 1,RREB1,173.21,172.49,S1174,MRSRPRANSGGVDLDSSGEFASIEKMLATTD,_ANSGGVDLDS(ph)S(ph)GEFASIEK_, , , , ,-1.36, ,-0.51,-0.79, , , , ,-0.44, ,-0.75,-0.79,,,-1.36,-0.64,,,-0.44,-0.77, +,,,,,,NA,NA,,cytoplasm,DNA binding,multicellular organismal development,,
Q92766-3,Q92766,Ras-responsive element-binding protein 1,RREB1,173.21,172.49,S1175,RSRPRANSGGVDLDSSGEFASIEKMLATTDT,_ANSGGVDLDS(ph)S(ph)GEFASIEK_, , , , ,-1.36, ,-0.51,-0.79, , , , ,-0.44, ,-0.75,-0.79,,,-1.36,-0.64,,,-0.44,-0.77, +,,,,,,NA,NA,,cytoplasm,DNA binding,multicellular organismal development,,
P31350,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,263.95,259.27,S20,RVPLAPITDPQQLQLSPLKGLSLVDKENTPP,_VPLAPITDPQQLQLS(ph)PLK_,-0.79,-0.6,-0.54,-0.47,-0.93, , , ,-0.2,-0.09,-0.15,-0.15,-0.85, , , ,-0.69,-0.51,-0.93,,-0.14,-0.15,-0.85,,,,,,,,NA,NA,,cytosol,"ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor",deoxyribonucleoside diphosphate metabolic process,,
F5H456,Q5JTH9,RRP12-like protein,RRP12,121.72,121.3,S1072,EEEEEEEEPAQGKGDSIEEILADSEDEEDNE,_GDS(ph)IEEILADS(ph)EDEEDNEEEER_, , , , , ,-0.56,-0.16,-0.33, , , , , ,-0.35,-0.35,-0.56,,,-0.56,-0.24,,,-0.35,-0.45,,,,,,,NA,NA,,,,,,
F5H456,Q5JTH9,RRP12-like protein,RRP12,188.39,180.97,S1080,PAQGKGDSIEEILADSEDEEDNEEEERSRGK,_GDS(ph)IEEILADS(ph)EDEEDNEEEER_,0.12,0.03,0.26, ,-0.1,-0.12,0.13,0.06,-0.02,0.03,-0.08, ,0.11,0.09,0.22,0.35,0.07,0.26,-0.11,0.09,0.01,-0.08,0.1,0.29,,,,,,,0,0,,,,,,
Q9Y3B9,Q9Y3B9,RRP15-like protein,RRP15,109.44,106.55,S11,_____MAAAAPDSRVSEEENLKKTPKKKMKM,_(ac)AAAAPDSRVS(ph)EEENLK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,mitochondrion,,,,
Q9Y3B9,Q9Y3B9,RRP15-like protein,RRP15,76.56,76.55,S58,SDSEGSCGSEKDHFYSDDDAIEADSEGDAEP,_DHFYS(ph)DDDAIEADS(ph)EGDAEPCDK_, , , , , ,-0.11,-0.5,-0.25, , , , , ,0.02,-0.43,-0.1,,,-0.11,-0.37,,,0.02,-0.26,,,,,,,NA,NA,,mitochondrion,,,,
Q9Y3B9,Q9Y3B9,RRP15-like protein,RRP15,76.56,76.55,S67,EKDHFYSDDDAIEADSEGDAEPCDKENENDG,_DHFYS(ph)DDDAIEADS(ph)EGDAEPCDK_, , , , , ,-0.11,-0.5,-0.25, , , , , ,0.02,-0.43,-0.1,,,-0.11,-0.37,,,0.02,-0.26,,,,,,,NA,NA,,mitochondrion,,,,
Q14684-2,Q14684,Ribosomal RNA processing protein 1 homolog B,RRP1B,87.86,63.77,S706,NMTAEFKKTDKSILVSPTGPSRVAFDPEQKP,_SILVS(ph)PTGPSR_,-0.07,0.54,0.69,0.95,-0.65, ,-0.13,-0.43,-0.47,-0.59,-0.06,-0.01,-1.21, ,-1.13,-1.16,0.27,0.83,-0.65,-0.27,-0.53,-0.04,-1.21,-1.14,, +,,,,,0,6,11.68,cytosol,,negative regulation of phosphatase activity,,
Q14684-2,Q14684,Ribosomal RNA processing protein 1 homolog B,RRP1B,102.84,99.26,S732,PEQKPLHGVLKTPTSSPASSPLVAKKPLTTT,_TPTSS(ph)PAS(ph)SPLVAK_, , , , , ,-0.14, , , , , , , ,-0.43, , ,,,-0.14,,,,-0.43,,,,,,,,NA,NA,,cytosol,,negative regulation of phosphatase activity,,
Q14684-2,Q14684,Ribosomal RNA processing protein 1 homolog B,RRP1B,180.45,176.81,S245,ETMEEQKTKVGDGDLSAEEIPENEVSLRRAV,_VGDGDLS(ph)AEEIPENEVSLR_,-0.39,-0.05,-0.28,-0.29,-0.19,0.16,-0.38, ,-0.11,0.05,-0.14,-0.23,0.07,0.18,-0.91, ,-0.21,-0.29,-0.01,-0.38,-0.03,-0.18,0.13,-0.91,,,,,,,0,0,,cytosol,,negative regulation of phosphatase activity,,
O43818,O43818,U3 small nucleolar RNA-interacting protein 2,RRP9,186.35,184.61,S50,DRGKSKGGGKMNEEISSDSESESLAPRKPEE,_MNEEIS(ph)S(ph)DS(ph)ESESLAPR_, , , , ,-0.37,-0.17,-0.12,-0.08, , , , ,-0.22,-0.07,-0.28,-0.14,,,-0.26,-0.1,,,-0.14,-0.21,,,,,,,NA,NA,,small nuclear ribonucleoprotein complex,RNA binding,rRNA processing,,
O43818,O43818,U3 small nucleolar RNA-interacting protein 2,RRP9,186.35,184.61,S51,RGKSKGGGKMNEEISSDSESESLAPRKPEEE,_MNEEIS(ph)S(ph)DS(ph)ESESLAPR_, , , , ,-0.37,-0.17,-0.12,-0.08, , , , ,-0.22,-0.07,-0.28,-0.14,,,-0.26,-0.1,,,-0.14,-0.21,,,,,,,NA,NA,,small nuclear ribonucleoprotein complex,RNA binding,rRNA processing,,
O43818,O43818,U3 small nucleolar RNA-interacting protein 2,RRP9,186.35,184.61,S53,KSKGGGKMNEEISSDSESESLAPRKPEEEEE,_MNEEIS(ph)S(ph)DS(ph)ESESLAPR_, , , , ,-0.37,-0.17,-0.12,-0.08, , , , ,-0.22,-0.07,-0.28,-0.14,,,-0.26,-0.1,,,-0.14,-0.21,,,,,,,NA,NA,,small nuclear ribonucleoprotein complex,RNA binding,rRNA processing,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,193.34,193.34,S397,IPLKKREIKLSDDFDSPVKGPLCKSVTPTKE,_LSDDFDS(ph)PVK_,-0.22,-0.1,-0.41,-0.39,-1.42,-1.39,-0.51,-0.41,-0.1,-0.17,-0.54,-0.41,-1.1,-1.11,-0.53,-0.55,-0.16,-0.4,-1.4,-0.46,-0.14,-0.47,-1.1,-0.54, +, +,,,,,6,6,34.63,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,284.72,284.72,S1345,LPSEQESTKKPYRIESDEEEDFENVGKVGSP,_IES(ph)DEEEDFENVGK_,-0.14,-0.02,0.1,0.03,-0.57,-0.71,-0.42,-0.33,0.01,-0.05,0.13,0.14,-0.4,-0.36,-0.37,-0.34,-0.08,0.07,-0.64,-0.37,-0.02,0.13,-0.38,-0.35,,,,,,,0,0,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,120.23,120.23,S1359,ESDEEEDFENVGKVGSPLDYSLVDLPSTNGQ,_VGS(ph)PLDYSLVDLPSTNGQS(ph)PGK_, ,-0.16, , ,-0.22,-0.98,-0.62,-0.16, ,0.03, , ,-0.58,-0.33,-0.6,0.02,-0.16,,-0.55,-0.37,0.03,,-0.45,-0.26,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,71.87,71.85,S1364,EDFENVGKVGSPLDYSLVDLPSTNGQSPGKA,_VGS(ph)PLDYS(ph)LVDLPSTNGQS(ph)PGK_, , , , , , ,-0.38,0.06, , , , , , ,-0.07,0.16,,,,-0.14,,,,0.05,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,120.23,120.23,S1375,PLDYSLVDLPSTNGQSPGKAIENLIGKPTEK,_VGS(ph)PLDYSLVDLPSTNGQS(ph)PGK_, , , , ,-0.22,-0.98,-0.62,-0.16, , , , ,-0.58,-0.33,-0.6,0.02,,,-0.55,-0.37,,,-0.45,-0.26,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,72.38,69.41,S1096,AAARRKKRRRLNDLDSDSNLDEEESEDEFKI,_LNDLDS(ph)DS(ph)NLDEEES(ph)EDEFK_, , , , , , , ,-0.24, , , , , , , ,0.11,,,,-0.24,,,,0.11,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,72.38,69.41,S1098,ARRKKRRRLNDLDSDSNLDEEESEDEFKISD,_LNDLDS(ph)DS(ph)NLDEEES(ph)EDEFK_, , , , , , , ,-0.24, , , , , , , ,0.11,,,,-0.24,,,,0.11,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,72.38,69.41,S1105,RLNDLDSDSNLDEEESEDEFKISDGSQDEFV,_LNDLDS(ph)DS(ph)NLDEEES(ph)EDEFK_, , , , , , , ,-0.24, , , , , , , ,0.11,,,,-0.24,,,,0.11,,,,,,,NA,NA,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
Q96T23-2,Q96T23,Remodeling and spacing factor 1,RSF1,99.41,99.41,S604,EKSKKTFLDKDAQRLSPIPEEVPKSTLESEK,_DAQRLS(ph)PIPEEVPK_,0,0.02,0.19,0.12,-0.54,-0.76,-0.3,-0.2,-0.05,0.03,0.23,0.21,-0.11,-0.49,0.03,-0.07,0.01,0.15,-0.64,-0.25,-0.01,0.22,-0.29,-0.02,,,,,,,0,0,,nucleoplasm,histone binding,CENP-A containing nucleosome assembly at centromere,,
O76021,O76021,Ribosomal L1 domain-containing protein 1,RSL1D1,282.34,281.76,S361,KKRGRGKAQVKATNESEDEIPQLVPIGKKTP,_ATNES(ph)EDEIPQLVPIGK_,-0.06,-0.1,-0.2,-0.15,-0.35,-0.41,-0.52,-0.55,-0.26,-0.23,-0.33,-0.35,-0.3,-0.32,-0.38,-0.4,-0.08,-0.17,-0.38,-0.54,-0.25,-0.34,-0.31,-0.39,,,,,,,0,0,,large ribosomal subunit,RNA binding,regulation of protein localization,,
Q7L4I2,Q7L4I2,Arginine/serine-rich coiled-coil protein 2,RSRC2,126.29,126.29,S4,____________MAASDTERDGLAPEKTSPD,_(ac)AAS(ph)DTERDGLAPEK_,0.36,0.02,0.73,0.05,0.37,0.5,0.31,0.2,-0.11,-0.22,0.02,-0.17,0.25,0.3,0.17,0.1,0.2,0.43,0.44,0.26,-0.17,-0.07,0.27,0.13,,,,,,,0,0,,,,,,
Q7L4I2,Q7L4I2,Arginine/serine-rich coiled-coil protein 2,RSRC2,152.68,152.68,S32,SPDRDKKKEQSEVSVSPRASKHHYSRSRSRS,_KKEQSEVSVS(ph)PR_,0.28,0.4,0.45,0.25,0.01,0.11,0.15,0.28,-0.03,0.29,0.23,0,0.02,0.11,0.1,0.01,0.34,0.36,0.06,0.22,0.14,0.12,0.06,0.05,,,,,,,0,0,,,,,,
Q92541,Q92541,RNA polymerase-associated protein RTF1 homolog,RTF1,242.53,238.99,S313,ELLAKKQPLKTSEVYSDDEEEEEDDKSSEKS,_TSEVYS(ph)DDEEEEEDDKS(ph)SEK_,-0.08,0.14,0.24,0.28, ,-0.29,-0.42, ,-0.04,0.05,0.27,0.18, ,-0.02,-0.08, ,0.03,0.26,-0.29,-0.42,0,0.23,-0.02,-0.08,,,,,,,0,0,,Cdc73/Paf1 complex,single-stranded DNA binding,"DNA-dependent transcription, initiation",,
Q92541,Q92541,RNA polymerase-associated protein RTF1 homolog,RTF1,240.12,235.96,S324,SEVYSDDEEEEEDDKSSEKSDRSSRTSSSDE,_TSEVYS(ph)DDEEEEEDDKS(ph)SEK_,-0.08,0.19,0.24,0.28, ,-0.29,-0.42, ,-0.04,0.09,0.27,0.18, ,-0.02,-0.08, ,0.06,0.26,-0.29,-0.42,0.03,0.23,-0.02,-0.08,,,,,,,0,0,,Cdc73/Paf1 complex,single-stranded DNA binding,"DNA-dependent transcription, initiation",,
Q92541,Q92541,RNA polymerase-associated protein RTF1 homolog,RTF1,242.53,238.99,S325,EVYSDDEEEEEDDKSSEKSDRSSRTSSSDEE,_TSEVYS(ph)DDEEEEEDDKSS(ph)EK_,-0.08,0.14,0.24,0.28, ,-0.29,-0.42, ,-0.04,0.05,0.27,0.18, ,-0.02,-0.08, ,0.03,0.26,-0.29,-0.42,0,0.23,-0.02,-0.08,,,,,,,0,0,,Cdc73/Paf1 complex,single-stranded DNA binding,"DNA-dependent transcription, initiation",,
F5H774,O95197,Reticulon-3,RTN3,109.72,106.8,S229,PTEYSKVEGIYTYSLSPSKVSGDDVIEKDSP,_VEGIYTYSLS(ph)PSK_,0.48,0.28,0.24, , , ,0.47,0.41,0.2,0.17,0.37, , , ,0.96,0.7,0.38,0.24,,0.44,0.19,0.37,,0.84,,,,,,,NA,NA,,,,,,
F5H774,O95197,Reticulon-3,RTN3,57.83,57.65,S30,SSSFGAEPSAPGGGGSPGACPALGTKSCSSS,_(ac)AEPSAATQSHSISSSSFGAEPSAPGGGGS(ph)PGACPALGTK_, , , , ,-0.89, , , , , , , ,0.37, , , ,,,-0.89,,,,0.37,,,,,,,,NA,NA,,,,,,
Q9NQC3-2,Q9NQC3,Reticulon-4,RTN4,332.46,332.21,S7,_________MEDLDQSPLVSSSDSPPRPQPA,_(ac)M(ox)EDLDQS(ph)PLVSSSDS(ph)PPRPQPAFK_,-0.11,-0.68,-0.11,1.46,1.9,0.2,-0.13,-0.13,-0.05,-0.49,0.17,2.46,1.91,0.22,0.05,-0.05,-0.37,0.88,1.29,-0.13,-0.25,1.73,1.3,0, +, +,,,,,1,4,16.38,cell projection,,angiogenesis,,
Q9NQC3-2,Q9NQC3,Reticulon-4,RTN4,366.77,366.77,S15,_MEDLDQSPLVSSSDSPPRPQPAFKYQFVRE,_(ac)M(ox)EDLDQSPLVSSSDS(ph)PPRPQPAFK_,0,0.03,-0.07,-0.06,-0.12,-0.12,-0.06,-0.03,-0.07,-0.01,-0.08,-0.07,0,-0.01,0.01,0.05,0.01,-0.07,-0.12,-0.05,-0.04,-0.08,-0.01,0.03,,,,,,,0,0,,cell projection,,angiogenesis,,
Q8N488,Q8N488,RING1 and YY1-binding protein,RYBP,90.38,90.38,S221,TDKGSSRSSTPKGDMSAVNDESF________,_GDMS(ph)AVNDES(ph)F_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,DNA binding,apoptotic process,,
Q8N488,Q8N488,RING1 and YY1-binding protein,RYBP,90.38,90.38,S227,RSSTPKGDMSAVNDESF______________,_GDMS(ph)AVNDES(ph)F_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,DNA binding,apoptotic process,,
Q96FQ6,Q96FQ6,Protein S100-A16,S100A16,128.21,124.77,S102,TGPIAKLIHEQEQQSSS______________,_LIHEQEQQSS(ph)S_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,calcium ion binding,response to calcium ion,,
Q96FQ6,Q96FQ6,Protein S100-A16,S100A16,138.2,133.39,S103,GPIAKLIHEQEQQSSS_______________,_LIHEQEQQSSS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,calcium ion binding,response to calcium ion,,
P06702,P06702,Protein S100-A9,S100A9,288.61,287.82,T113,DEGPGHHHKPGLGEGTP______________,_LTWASHEKMHEGDEGPGHHHKPGLGEGT(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoskeleton,antioxidant activity,actin cytoskeleton reorganization,,
F8WC89,A6NKF1,SAC3 domain-containing protein 1,SAC3D1,228.35,220.93,S402,VVMAEEEDEGTDRPGSPA_____________,_TLEEVVMAEEEDEGTDRPGS(ph)PA_, , , , ,-0.11, , ,0.27, , , , ,0.16, , ,0.11,,,-0.11,0.27,,,0.16,0.11,,,,,,,NA,NA,,centrosome,,centrosome duplication,,
Q9NZJ4-2,Q9NZJ4,Sacsin,SACS,100.62,78.72,S4264,EESSQSRDSAPSTPTSPTEFLTPGLRSIPPL,_DSAPSTPTS(ph)PTEFLTPGLR_, , , , ,0.05,0.82,0.91, , , , , ,0.03,1.13,0.5, ,,,0.49,0.91,,,0.68,0.5,,,,,,,NA,NA,,axon,ATP binding,cell death,,
Q15424,Q15424,Scaffold attachment factor B1,SAFB,183.1,183.1,S383,APKESSTSEGADQKMSSPEDDSDTKRLSKEE,_ESSTSEGADQKMS(ph)S(ph)PEDDSDTK_,-0.27,-0.31,-0.34, , ,-0.43,-0.89,-0.67,0.13,-0.13,-0.11, , ,0.22,-0.38,-0.32,-0.29,-0.34,-0.43,-0.78,0.01,-0.11,0.22,-0.35,,,,,,,0,0,,nucleus,chromatin binding,chromatin organization,,
Q15424,Q15424,Scaffold attachment factor B1,SAFB,183.1,183.1,S384,PKESSTSEGADQKMSSPEDDSDTKRLSKEEK,_ESSTSEGADQKMS(ph)S(ph)PEDDSDTK_,-0.27,-0.31,-0.34, , ,-0.43,-0.89,-0.67,0.13,-0.13,-0.11, , ,0.22,-0.38,-0.32,-0.29,-0.34,-0.43,-0.78,0.01,-0.11,0.22,-0.35,,,,,,,0,0,,nucleus,chromatin binding,chromatin organization,,
Q15424,Q15424,Scaffold attachment factor B1,SAFB,125.24,43.23,S604,SQDRKSASREKRSVVSFDKVKEPRKSRDSES,_RSVVS(ph)FDK_,-0.01,-0.17,-0.29,0.01,-0.48,-0.5,-0.76,-1.17,-0.14,0.05,-0.56,-0.5,-0.6,-0.1,-0.61,-0.5,-0.09,-0.13,-0.49,-0.95,-0.04,-0.53,-0.33,-0.56,,,,,,,0,0,,nucleus,chromatin binding,chromatin organization,,
A8MXT5,Q14151,Scaffold attachment factor B2,SAFB2,280.08,277.21,S109,KMEEEGTEDNGLEDDSRDGQEDMEASLENLQ,_MEEEGTEDNGLEDDS(ph)R_, ,-0.41,-0.15,0.17, ,-0.56,-0.83,-0.78, ,-0.52,-0.21,-0.54, ,-0.57,-0.33,-0.61,-0.41,0.02,-0.56,-0.81,-0.52,-0.37,-0.57,-0.46,,,,,,,0,0,,,,,,
Q9Y3Z3-2,Q9Y3Z3,SAM domain and HD domain-containing protein 1,SAMHD1,221.55,221.53,S33,SPRTPSNTPSAEADWSPGLELHPDYKTWGPE,_TPSNTPSAEADWS(ph)PGLELHPDYK_,-0.1,-0.23,-0.83, , , , , ,-0.04,-0.02,-0.67, , , , , ,-0.16,-0.83,,,-0.03,-0.67,,,,,,,,,NA,NA,,nucleus,metal ion binding,defense response to virus,,
Q9H0E3-2,Q9H0E3,Histone deacetylase complex subunit SAP130,SAP130,194.03,191.53,S855,QHVISTEEGDMMETNSTDDEKSTAKSLLVKA,_(gl)QQHVISTEEGDMMETNS(ph)T(ph)DDEK_, , , , ,-0.01,-0.13,-0.25,-0.17, , , , ,0.29,0.13,0.15,0.15,,,-0.07,-0.21,,,0.21,0.15,,,,,,,NA,NA,,STAGA complex,transcription coactivator activity,histone H3 acetylation,,
Q9H0E3-2,Q9H0E3,Histone deacetylase complex subunit SAP130,SAP130,194.03,191.53,T856,HVISTEEGDMMETNSTDDEKSTAKSLLVKAE,_(gl)QQHVISTEEGDMMETNS(ph)T(ph)DDEK_, , , , ,-0.01,-0.13,-0.25,-0.17, , , , ,0.29,0.13,0.15,0.15,,,-0.07,-0.21,,,0.21,0.15,,,,,,,NA,NA,,STAGA complex,transcription coactivator activity,histone H3 acetylation,,
Q9UHR5,Q9UHR5,SAP30-binding protein,SAP30BP,89.56,88.93,S43,IEAVGSAAEEKGGLVSDAYGEDDFSRLGGDE,_GGLVS(ph)DAYGEDDFSR_,0.72, , ,0.68, , , , ,0.04, , ,0.56, , , , ,0.72,0.68,,,0.04,0.56,,,,,,,,,NA,NA,,intermediate filament cytoskeleton,,apoptotic process,,
Q9UHR5,Q9UHR5,SAP30-binding protein,SAP30BP,192.59,186.05,S69,LGGDEDGYEEEEDENSRQSEDDDSETEKPEA,_LGGDEDGYEEEEDENS(ph)RQS(ph)EDDDS(ph)ETEKPEADDPK_, ,-0.33, , ,0.01,-0.74,-0.14,0.14, ,0.02, , ,0.08,-0.24,-0.18,-0.01,-0.33,,-0.32,0,0.02,,-0.08,-0.09,,,,,,,NA,NA,,intermediate filament cytoskeleton,,apoptotic process,,
Q9UHR5,Q9UHR5,SAP30-binding protein,SAP30BP,278.95,270.33,S72,DEDGYEEEEDENSRQSEDDDSETEKPEADDP,_LGGDEDGYEEEEDENS(ph)RQS(ph)EDDDS(ph)ETEKPEADDPK_, ,0.1,-0.36, ,-0.26,0.39,0.33,0.04, ,-0.42,-0.34, ,-0.26,0.73,0.1,-0.02,0.1,-0.36,0.1,0.19,-0.42,-0.34,0.31,0.04,,,,,,,0,0,,intermediate filament cytoskeleton,,apoptotic process,,
Q9UHR5,Q9UHR5,SAP30-binding protein,SAP30BP,278.95,270.33,S77,EEEEDENSRQSEDDDSETEKPEADDPKDNTE,_LGGDEDGYEEEEDENSRQS(ph)EDDDS(ph)ETEKPEADDPK_, ,-0.33,-0.36, ,-0.26,0.39,0.33,0.04, ,0.02,-0.34, ,-0.26,0.73,0.1,-0.02,-0.33,-0.36,0.1,0.19,0.02,-0.34,0.31,0.04,,,,,,,0,0,,intermediate filament cytoskeleton,,apoptotic process,,
Q9UHR5,Q9UHR5,SAP30-binding protein,SAP30BP,74.53,62.94,S113,PQELVASFSERVRNMSPDEIKIPPEPPGRCS,_NMS(ph)PDEIK_, , , , , ,0.16,-0.12,-0.5, , , , , ,0.06,-0.06,-0.61,,,0.16,-0.3,,,0.06,-0.31,,,,,,,NA,NA,,intermediate filament cytoskeleton,,apoptotic process,,
Q9NR31,Q9NR31,GTP-binding protein SAR1a,SAR1A,63.69,27.09,T139,ISNVPILILGNKIDRTDAISEEKLREIFGLY,_IDRT(ph)DAISEEK_,-0.24, , , , , , , ,-0.19, , , , , , , ,-0.24,,,,-0.19,,,,,,,,,,NA,NA,,endoplasmic reticulum,GTP binding,ER to Golgi vesicle-mediated transport,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,91.08,91.08,S448,GDFGSRLRGRGRRRVSEVEEEKEPVPQPLPS,_RVS(ph)EVEEEK_, , ,1.95, ,1.75,2.09,1.81,2.03, , ,2.04, ,1.93,1.76,1.85,1.75,,1.95,1.93,1.92,,2.04,1.84,1.8, +, +,,,,,NA,NA,,,,,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,173.81,170.03,S591,EEQEELMDFERDEERSANGGSESDGEENIGW,_S(ph)ANGGS(ph)ES(ph)DGEENIGWSTVNLDEEK_, , , , ,-0.26,-0.3,-0.12,-0.19, , , , ,-0.25,-0.4,-0.45,-0.08,,,-0.28,-0.16,,,-0.32,-0.26,,,,,,,NA,NA,,,,,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,173.81,170.03,S596,LMDFERDEERSANGGSESDGEENIGWSTVNL,_S(ph)ANGGS(ph)ES(ph)DGEENIGWSTVNLDEEK_, , , , ,-0.4,-0.25,-0.26,-0.22, , , , ,-0.21,-0.07,-0.11,-0.1,,,-0.32,-0.24,,,-0.14,-0.11,,,,,,,NA,NA,,,,,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,173.81,170.03,S598,DFERDEERSANGGSESDGEENIGWSTVNLDE,_S(ph)ANGGS(ph)ES(ph)DGEENIGWSTVNLDEEK_, , , , ,-0.33,-0.25,-0.26,-0.22, , , , ,-0.23,-0.07,-0.11,-0.1,,,-0.29,-0.24,,,-0.15,-0.11,,,,,,,NA,NA,,,,,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,81.79,80.24,S474,QPLPSDDTRVENMDISDEEEGGAPPPGSPQV,_VENM(ox)DIS(ph)DEEEGGAPPPGS(ph)PQVLEEDEAELELQK_, , , , ,-0.27,-0.27,-0.11,-0.4, , , , ,-0.13,0.11,-0.01,-0.94,,,-0.27,-0.25,,,-0.01,-0.4,,,,,,,NA,NA,,,,,,
G3V1T2,O43290,U4/U6.U5 tri-snRNP-associated protein 1,SART1,81.79,80.24,S486,MDISDEEEGGAPPPGSPQVLEEDEAELELQK,_VENM(ox)DIS(ph)DEEEGGAPPPGS(ph)PQVLEEDEAELELQK_, , , , ,-0.27,-0.27,-0.11,-0.4, , , , ,-0.13,0.11,-0.01,-0.94,,,-0.27,-0.25,,,-0.01,-0.4,,,,,,,NA,NA,,,,,,
F8VV04,Q15020,Squamous cell carcinoma antigen recognized by T-cells 3,SART3,54.23,51.8,S8,________MATAAETSASEPEAESKAGPKAD,_(ac)ATAAETS(ph)AS(ph)EPEAESK_, , , , , , , ,0.53, , , , , , , ,0.38,,,,0.53,,,,0.38,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,RNA processing,,
A3KN83-3,A3KN83,Protein strawberry notch homolog 1,SBNO1,41.85,41.78,S754,ASDNEESDYESSKNMSSGDDDDFNPFLDESN,_NMS(ph)S(ph)GDDDDFNPFLDES(ph)NEDDENDPWLIR_, , , , , , ,0.03,0.28, , , , , , ,-0.1,0.12,,,,0.16,,,,0.01,,,,,,,NA,NA,,,,"regulation of transcription, DNA-dependent",,
A3KN83-3,A3KN83,Protein strawberry notch homolog 1,SBNO1,41.85,41.78,S755,SDNEESDYESSKNMSSGDDDDFNPFLDESNE,_NMS(ph)S(ph)GDDDDFNPFLDES(ph)NEDDENDPWLIR_, , , , , , ,0.03,0.28, , , , , , ,-0.1,0.12,,,,0.16,,,,0.01,,,,,,,NA,NA,,,,"regulation of transcription, DNA-dependent",,
A3KN83-3,A3KN83,Protein strawberry notch homolog 1,SBNO1,41.85,41.78,S768,MSSGDDDDFNPFLDESNEDDENDPWLIRKDH,_NMS(ph)S(ph)GDDDDFNPFLDES(ph)NEDDENDPWLIR_, , , , , , ,0.03,0.28, , , , , , ,-0.1,0.12,,,,0.16,,,,0.01,,,,,,,NA,NA,,,,"regulation of transcription, DNA-dependent",,
Q9H7N4,Q9H7N4,"Splicing factor, arginine/serine-rich 19",SCAF1,140.63,138.86,S734,SPAPASSPKREVLYDSEGLSGEERGGKSSQK,_REVLYDS(ph)EGLS(ph)GEER_,-0.42, , , ,-0.23,-0.6,-0.95,-0.87,0.2, , , ,2.76,1.11,-0.47,-0.48,-0.42,,-0.4,-0.91,0.2,,2.16,-0.48,, +,,,,,NA,NA,,nucleus,RNA binding,mRNA processing,,
Q9H7N4,Q9H7N4,"Splicing factor, arginine/serine-rich 19",SCAF1,140.63,138.86,S738,ASSPKREVLYDSEGLSGEERGGKSSQKDRRR,_EVLYDS(ph)EGLS(ph)GEER_,-0.42, , , ,-0.23,-0.6,-0.95,-0.87,0.2, , , ,2.76,1.11,-0.47,-0.48,-0.42,,-0.4,-0.91,0.2,,2.16,-0.48,, +,,,,,NA,NA,,nucleus,RNA binding,mRNA processing,,
Q9H7N4,Q9H7N4,"Splicing factor, arginine/serine-rich 19",SCAF1,91.36,76.56,S965,CSQAAGTKGAEETSWSGEERAAKVPSTPPPK,_GAEETSWS(ph)GEER_,-0.63,-0.68,-0.87, ,-0.75,-0.75,-0.7,-1.17,-0.96,-0.8,-1.08, ,0.17,-0.62,-0.86,-1.08,-0.66,-0.87,-0.75,-0.91,-0.88,-1.08,-0.17,-0.96,, +,,,,,0,3,24.27,nucleus,RNA binding,mRNA processing,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,83.23,48.3,S796,IDKTKKPRTRRSRFHSPSTTWSPNKDTPQEK,_FHS(ph)PS(ph)TTWSPNK_,-0.08,-0.12,0.04,-0.22,-0.42,-0.51,-0.43,-0.45,-0.31,-0.38,-0.03,-0.34,-0.26,0.72,-0.28,-0.16,-0.1,-0.09,-0.47,-0.44,-0.34,-0.18,0.31,-0.22,,,,,,,0,0,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,79.35,65.92,S798,KTKKPRTRRSRFHSPSTTWSPNKDTPQEKKR,_FHS(ph)PS(ph)TTWSPNK_, , , , , , ,-0.43, , , , , , , ,-0.27, ,,,,-0.43,,,,-0.27,,,,,,,NA,NA,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,83.23,48.3,S802,PRTRRSRFHSPSTTWSPNKDTPQEKKRPQSP,_FHS(ph)PSTTWS(ph)PNK_,-0.08,-0.11,0.04,-0.22,-0.42,-0.51,-0.43,-0.35,-0.31,-0.24,-0.03,-0.34,-0.4,0.72,-0.48,-0.32,-0.1,-0.09,-0.46,-0.39,-0.28,-0.18,0.26,-0.4,,,,,,,0,0,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,72.16,71.09,S405,LRSSVAAPEKSSSNDSVDEETAESDTSPVLE,_SSSNDS(ph)VDEET(ph)AES(ph)DTSPVLEK_, , , , , ,-0.86,-0.58,-0.67, , , , , ,-0.36,-0.57,-0.33,,,-0.86,-0.63,,,-0.36,-0.45,,,,,,,NA,NA,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,72.16,71.09,S413,EKSSSNDSVDEETAESDTSPVLEKEHQPDVD,_SSSNDS(ph)VDEET(ph)AES(ph)DTSPVLEK_, , , , , ,-0.86,-0.76,-0.67, , , , , ,-0.36,-0.46,-0.33,,,-0.86,-0.72,,,-0.36,-0.39,,,,,,,NA,NA,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,86.08,86.08,S771,NMPSSDLADEKVETVSQPSESPKDTIDKTKK,_VETVS(ph)QPSES(ph)PKDTIDK_,-0.5,-0.69,-0.29, ,-0.53,-0.22,-0.09,-0.12,-0.4,-0.69,-0.19, ,0,-0.3,0.17,-0.04,-0.59,-0.29,-0.37,-0.1,-0.54,-0.19,-0.14,0.07,,,,,,,0,0,,nucleus,zinc ion binding,spliceosomal complex assembly,,
Q99590-2,Q99590,Protein SCAF11,SCAF11,72.16,71.09,T410,AAPEKSSSNDSVDEETAESDTSPVLEKEHQP,_SSSNDS(ph)VDEET(ph)AES(ph)DTSPVLEK_, , , , , ,-0.86,-0.76,-0.67, , , , , ,-0.36,-0.46,-0.33,,,-0.86,-0.72,,,-0.36,-0.39,,,,,,,NA,NA,,nucleus,zinc ion binding,spliceosomal complex assembly,,
O15126-2,O15126,Secretory carrier-associated membrane protein 1,SCAMP1,233.54,232.92,Y73,NTQPAIMKPTEEHPAYTQIAKEHALAQAELL,_MPNVPNTQPAIMKPTEEHPAY(ph)TQIAK_,2.67, ,0.41, , , , , ,2.09, ,-1.39, , , , , ,2.67,0.41,,,2.09,-1.39,,, +, +,,,,,NA,NA,,Golgi apparatus,,post-Golgi vesicle-mediated transport,,
O14828-2,O14828,Secretory carrier-associated membrane protein 3,SCAMP3,67.55,67.55,S76,LPPPSAPSLQPSRKLSPTEPKNYGSYSTQAS,_KLS(ph)PTEPK_, , , , , ,0.74,0.37,0.76, , , , , ,0.98,0.49,0.62,,,0.74,0.58,,,0.98,0.55,,,,,,,NA,NA,,Golgi membrane,,post-Golgi vesicle-mediated transport,,
Q12770-4,Q12770,Sterol regulatory element-binding protein cleavage-activating protein,SCAP,95.9,91.73,S851,RLSDGGKAGPEEPGDSPPLRHRPRGPPPPSL,_AGPEEPGDS(ph)PPLR_, ,2.37, , , , , ,0.9, ,-0.06, , , , , ,-0.11,2.37,,,0.9,-0.06,,,-0.11, +,,,,,,NA,NA,,endoplasmic reticulum,unfolded protein binding,aging,,
B7Z5N7,Q8WVM8,Sec1 family domain-containing protein 1,SCFD1,252.84,252.84,S303,HLNRVNLEESSGVENSPAGARPKRKNKKSYD,_VNLEESSGVENS(ph)PAGARPK_,0.27, ,0.36,0.28,-0.58, , , ,-0.1, ,-0.02,0.1,-1.19, , , ,0.27,0.32,-0.58,,-0.1,0.04,-1.19,,, +,,,,,NA,NA,,Golgi transport complex,,post-Golgi vesicle-mediated transport,,
Q9P0W5-4,Q9P0W5,Schwannomin-interacting protein 1,SCHIP1,172.96,122.06,S330,DADDSKTETSLDTPLSPMSKQSSSYSDRDTT,_TETSLDTPLS(ph)PMSK_, , ,0.31, , , ,1.48,1.17, , ,0.19, , , ,1.8,0.69,,0.31,,1.33,,0.19,,1.35, +, +,,,,,NA,NA,,cytoplasm,,,,
H0Y6S1,Q9UQR0,Sex comb on midleg-like protein 2,SCML2,118.04,116.18,S499,_UAKEDVTERQSTKRSPQQTVPYVVPLSPKL,_S(ph)PQQTVPYVVPLS(ph)PK_, , ,0.5, ,0.73,1.17, ,1.21, , ,0.57, ,0.68,0.98, ,0.72,,0.5,0.97,1.21,,0.57,0.84,0.72, +,,,,,,NA,NA,,,,,,
H0Y6S1,Q9UQR0,Sex comb on midleg-like protein 2,SCML2,118.04,116.18,S511,TKRSPQQTVPYVVPLSPKLPKTKEYASEGEP,_S(ph)PQQTVPYVVPLS(ph)PK_, , ,0.5, ,0.73,1.17, ,1.21, , ,0.57, ,0.68,0.98, ,0.72,,0.5,0.97,1.21,,0.57,0.84,0.72, +,,,,,,NA,NA,,,,,,
H0Y6S1,Q9UQR0,Sex comb on midleg-like protein 2,SCML2,60.35,51.8,S590,RSVPGTTSSPLVGDISPKSSPHEVKFQMQRK,_SVPGTTSSPLVGDIS(ph)PK_, , , , , , ,0.93, , , , , , , ,-0.16, ,,,,0.93,,,,-0.16,,,,,,,NA,NA,,,,,,
Q9BWG6-2,Q9BWG6,Sodium channel modifier 1,SCNM1,141.79,126.56,S219,DGRGRWVKDENVEFDSDEEEPPDLPLD____,_DENVEFDS(ph)DEEEPPDLPLD_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nuclear speck,metal ion binding,mRNA processing,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,101.89,99.25,S1448,PPWASPSPTSRQSPASPPPLGGGAPVRTAKA,_(gl)QSPAS(ph)PPPLGGGAPVR_,0.35, ,1.15, ,0.66, ,0.92, ,-0.68, ,1.1, ,0.65, ,0.4, ,0.35,1.15,0.66,0.92,-0.68,1.1,0.65,0.4, +, +,,,,,1,1,12.43,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,86.34,20.15,S1508,LEAEKRALWRAARMKSLEQDALRAQMVLSRS,_S(ph)LEQDALR_, , , , ,-0.29, , ,1.52, , , , ,-1.33, , ,0.84,,,-0.29,1.52,,,-1.33,0.84, +, +,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,175.83,175.65,S835,ENAVTITPLRPEDDYSPRERRGGGLRLPLLP,_MVEPENAVTIT(ph)PLRPEDDYS(ph)PR_,1.03,0.43,1.01,1.11,-0.9,1.11,0.74,-0.02,0.04,-0.01,0.53,0.43,-0.77,1.02,0.49,-0.08,0.76,1.06,0.43,0.41,0.01,0.48,0.39,0.24, +,,,,,,4,0,10.34,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,93.56,47.16,S1486,LRVQSPEPPAPERALSPAELRALEAEKRALW,_ALS(ph)PAELR_,-0.46,-0.36,-0.47,-0.34,-0.12,-0.03,-0.35,-0.45,-0.41,-0.42,-0.34,-0.25,-0.16,-0.25,-0.31,-0.33,-0.41,-0.41,-0.08,-0.4,-0.42,-0.29,-0.21,-0.32,,,,,,,0,0,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,198.85,191.65,S1547,PLERLAEAPSPAPTPSPTPVEDLGPQTSTSP,_LAEAPSPAPTPS(ph)PT(ph)PVEDLGPQTSTSPGRLS(ph)PDFAEELR_, , , , , ,0.2,0.34, , , , , , ,-0.1,0.16, ,,,0.2,0.34,,,-0.1,0.16,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,235.91,231,S1559,PTPSPTPVEDLGPQTSTSPGRLSPDFAEELR,_LAEAPSPAPTPSPTPVEDLGPQTS(ph)TSPGRLS(ph)PDFAEELR_, , , , , ,0.63, , , , , , , ,0, , ,,,0.63,,,,0,,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,253.3,252.97,S1566,VEDLGPQTSTSPGRLSPDFAEELRSLEPSPS,_LAEAPSPAPTPSPTPVEDLGPQTS(ph)TSPGRLS(ph)PDFAEELR_,0.21, ,-0.02, ,0.3,0.38,0.21,-0.04,-0.3, ,-0.13, ,0,-0.04,0.07,-0.1,0.21,-0.02,0.34,0.09,-0.3,-0.13,-0.02,-0.01,,,,,,,0,0,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,79.84,27.31,S853,ERRGGGLRLPLLPPESPGPLRQRHVACLARS,_LPLLPPES(ph)PGPLR_, , ,0.51, , , , , , , ,0.67, , , , , ,,0.51,,,,0.67,,,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,134.41,133.49,T1545,RGPLERLAEAPSPAPTPSPTPVEDLGPQTST,_LAEAPSPAPT(ph)PSPTPVEDLGPQTST(ph)SPGRLS(ph)PDFAEELR_, , , , , , , ,-0.04, , , , , , , ,-0.1,,,,-0.04,,,,-0.1,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,253.3,252.97,T1549,ERLAEAPSPAPTPSPTPVEDLGPQTSTSPGR,_LAEAPSPAPTPSPT(ph)PVEDLGPQTSTSPGRLS(ph)PDFAEELR_, , , , ,0.55, ,0.21, , , , , ,0.12, ,0.07, ,,,0.55,0.21,,,0.12,0.07,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,108.95,102.59,S1306,KMAESPCSPSGQQPPSPPSPDELPANVKQAY,_MAESPCSPSGQQPPS(ph)PPS(ph)PDELPANVK_, , , , ,-0.08,0.01, ,0.36, , , , ,-0.14,-0.19, ,0.21,,,-0.03,0.36,,,-0.17,0.21,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,108.95,102.59,S1309,ESPCSPSGQQPPSPPSPDELPANVKQAYRAF,_MAESPCSPSGQQPPS(ph)PPS(ph)PDELPANVK_, , , , ,-0.08,0.01, ,0.36, , , , ,-0.14,-0.19, ,0.21,,,-0.03,0.36,,,-0.17,0.21,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,88.93,88.93,S1220,GVIANPFAAGIGHRNSLESISSIDRELSPEG,_NS(ph)LES(ph)ISS(ph)IDR_, , , , ,0.48,-0.05,0.54,-0.66, , , , ,0.02,0.4,0.17,-0.44,,,0.24,0.06,,,0.22,-0.1,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,88.93,88.93,S1223,ANPFAAGIGHRNSLESISSIDRELSPEGPGK,_NS(ph)LES(ph)ISS(ph)IDR_, , , , ,0.48,0.74,0.54,0.49, , , , ,0.02,0.33,0.17,0.35,,,0.61,0.51,,,0.18,0.27,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,110.94,110.94,S1226,FAAGIGHRNSLESISSIDRELSPEGPGKEKE,_NS(ph)LES(ph)ISS(ph)IDRELSPEGPGK_, , ,0.1, ,0.48,0.74,0.54,0.26, , ,-0.02, ,0.02,0.33,0.17,0.04,,0.1,0.61,0.4,,-0.02,0.18,0.11,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,153.83,153.83,S1232,HRNSLESISSIDRELSPEGPGKEKELPGQTL,_NSLESISSIDRELS(ph)PEGPGK_,0.27,0.35,0.4,0.46, , , , ,-0.1,0.17,0.11,0.23, , , , ,0.31,0.43,,,0.05,0.17,,,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q14160-2,Q14160,Protein scribble homolog,SCRIB,175.83,175.65,T826,VWRERMVEPENAVTITPLRPEDDYSPRERRG,_MVEPENAVTIT(ph)PLRPEDDYS(ph)PR_, , ,0.28, ,-0.9,-0.94,0.06,-0.09, , ,-0.19, ,-0.77,-0.95,-0.67,-0.63,,0.28,-0.92,-0.01,,-0.19,-0.85,-0.65,,,,,,,NA,NA,,basolateral plasma membrane,,activation of Rac GTPase activity,,
Q96KG9-3,Q96KG9,N-terminal kinase-like protein,SCYL1,328.7,309.74,S754,FATLSARPSTQPRPDSWGEDNWEGLETDSRQ,_PSTQPRPDS(ph)WGEDNWEGLETDSR_,1.36,1.08,1.13,1.54,0.49,1.24,1.15,0.8,0,0.16,0.73,0.23,-0.01,1.01,0.66,0.49,1.23,1.35,0.91,0.99,0.08,0.5,0.59,0.58, +,,Other,,,,5,0,10.19,cis-Golgi network,ATP binding,"regulation of transcription, DNA-dependent",,
Q6P3W7,Q6P3W7,SCY1-like protein 2,SCYL2,62.23,29.97,S677,SENKEDGLQNKHKRASLTLEEKQKLAKEQEQ,_RAS(ph)LTLEEK_, , , , , ,0.1, , , , , , , ,0.36, , ,,,0.1,,,,0.36,,,,Other,,,,NA,NA,,clathrin-coated vesicle,ATP binding,endosome to lysosome transport,,
Q9NVU7-2,Q9NVU7,Protein SDA1 homolog,SDAD1,318.32,318.32,S585,AAPGKSQKRKYIEIDSDEEPRGELLSLRDIE,_YIEIDS(ph)DEEPRGELLSLR_,0.19,0.18,0.18,0.18,-0.07,-0.02,-0.08,-0.22,-0.03,0.03,-0.06,-0.14,-0.25,-0.23,-0.29,-0.37,0.18,0.18,-0.04,-0.15,0,-0.1,-0.24,-0.33,,,,,,,0,0,,nucleolus,metal ion binding,actin cytoskeleton organization,,
O00560,O00560,Syntenin-1,SDCBP,115.53,114.34,Y91,APLQGQLVARPSSINYMVAPVTGNDVGIRRA,_PSSINY(ph)MVAPVTGNDVGIRR_, , ,0.19, , ,1.88, , , , ,-1.49, , ,0.07, , ,,0.19,1.88,,,-1.49,0.07,, +, +,,,,,NA,NA,,adherens junction,cytoskeletal adaptor activity,actin cytoskeleton organization,,
O00560,O00560,Syntenin-1,SDCBP,278.6,274.9,Y46,ILSEASAPIPHDGNLYPRLYPELSQYMGLSL,_VIQAQTAFSANPANPAILSEASAPIPHDGNLY(ph)PR_, , ,2.66, , , , , , , ,1.14, , , , , ,,2.66,,,,1.14,,, +, +,,,,,NA,NA,,adherens junction,cytoskeletal adaptor activity,actin cytoskeleton organization,,
Q96C92-4,Q96C92,Serologically defined colon cancer antigen 3,SDCCAG3,143.54,141.5,S243,PSWALSDTDSRVSPASPAGSPSADFAVHGES,_VSPAS(ph)PAGS(ph)PSADFAVHGESLGDR_,0.12,0.21,0.34,0.53,0.44,0.01,0.18,0.11,0.39,0.43,0.1,0.32,0.71,0.46,0.59,0.43,0.17,0.44,0.24,0.15,0.41,0.22,0.59,0.51,,,,,,,0,0,,cytoplasm,,,,
Q96C92-4,Q96C92,Serologically defined colon cancer antigen 3,SDCCAG3,143.54,141.5,S247,LSDTDSRVSPASPAGSPSADFAVHGESLGDR,_VSPAS(ph)PAGS(ph)PSADFAVHGESLGDR_,0.12,0.21,0.34,0.53,0.44,0.01,0.15,-0.13,0.39,0.43,0.1,0.32,0.71,0.46,0.73,0.38,0.17,0.44,0.24,0.01,0.41,0.22,0.59,0.57,,,,,,,0,0,,cytoplasm,,,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,126.47,117.43,S1786,LLPSAPQTLPDGPLASPARVPMFPVPLPPGP,_LLPSAPQTLPDGPLAS(ph)PAR_,-0.48,-0.47,1.05,0.91,1.01, , , ,-0.2,-0.4,1.01,1.01,0.66, , , ,-0.47,0.98,1.01,,-0.3,1.01,0.66,, +, +,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,116,99.53,S136,ESTFRQNPRIVNHWASPELRQNPGVKNEHRP,_IVNHWAS(ph)PELR_,-0.17,0,-0.38,-0.44,-0.89, , , ,-0.19,-0.17,-0.34,-0.1,-1.41, , , ,-0.08,-0.41,-0.89,,-0.18,-0.21,-1.41,,, +,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,47.71,47.41,S891,LERAQQELVPPQQQASPPQLPKAMFSELSNP,_AQQELVPPQQQAS(ph)PPQLPK_, ,-0.06,-0.08, ,0.13,-0.02,0.26,0.14, ,-0.05,-0.14, ,-0.03,-0.04,0.19,0.02,-0.06,-0.08,0.06,0.2,-0.05,-0.14,-0.04,0.1,,,,,,,0,0,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,172.35,172.01,S411,ETDETTVSQNYRGSVSQPSTPSPPKPTGIFQ,_GSVS(ph)QPST(ph)PS(ph)PPKPTGIFQTSANSSFEPVK_,-0.33,-0.15, , , , , , ,0.46,0.03, , , , , , ,-0.24,,,,0.26,,,,,,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,172.35,172.01,S417,VSQNYRGSVSQPSTPSPPKPTGIFQTSANSS,_GSVS(ph)QPST(ph)PS(ph)PPKPTGIFQTSANSSFEPVK_,-0.33,-0.15, , , , , , ,0.46,0.03, , , , , , ,-0.24,,,,0.26,,,,,,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,300.04,293.29,S391,PEDEASGSFFKQIDSSPVGGETDETTVSQNY,_QIDSS(ph)PVGGETDETTVSQNYR_,-0.01,-0.16,-0.32,-0.33,0.01,-0.2,-0.02,-0.11,-0.09,-0.04,-0.13,-0.08,-0.06,-0.12,-0.04,-0.09,-0.08,-0.32,-0.09,-0.06,-0.06,-0.11,-0.09,-0.07,,,,,,,0,0,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,172.35,172.01,T415,TTVSQNYRGSVSQPSTPSPPKPTGIFQTSAN,_GSVS(ph)QPST(ph)PS(ph)PPKPTGIFQTSANSSFEPVK_,-0.33,-0.15, , , , , , ,0.46,0.03, , , , , , ,-0.24,,,,0.26,,,,,,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,180.23,177.97,S1905,WDRADSGPTQPPLSLSPAPETKRPGQAAKKE,_ADSGPTQPPLSLS(ph)PAPETK_,-0.14,-0.13,0.3,0.38,0.34,0.19,0.45,0.28,-0.04,0.03,0.4,0.29,0.3,0.2,0.15,0.19,-0.14,0.34,0.26,0.37,0,0.35,0.25,0.17,,,,,,,0,0,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,64.57,64.57,S1149,EKRDNNWRYDPRFTGSFDDDPDPHRDPYGEE,_FTGS(ph)FDDDPDPHRDPYGEEVDRR_,-0.02,0.03, , , , , , ,-0.25,-0.29, , , , , , ,0.01,,,,-0.27,,,,,,,,,,NA,NA,,cytosol,,COPII vesicle coating,,
O15027,O15027,Protein transport protein Sec16A,SEC16A,121.9,97.91,T1876,SELSEENFDGKFANLTPSRTVPDSEAPPGWD,_FANLT(ph)PSR_,-0.47,-0.21,0.71,0.46,-0.22,-0.51,-0.23,0.25,-0.32,0.17,0.9,0.98,-0.32,-0.29,0.23,0.52,-0.34,0.59,-0.35,0.03,-0.05,0.94,-0.3,0.39,,,,,,,0,0,,cytosol,,COPII vesicle coating,,
O75396,O75396,Vesicle-trafficking protein SEC22b,SEC22B,195.55,186.98,S137,TKKLYIDSCARRNLGSINTELQDVQRIMVAN,_NLGS(ph)INTELQDVQR_,0.65, ,1.35,-1.01,1.29, ,1.48, ,1.68, ,1.84,1.07,0.92, ,0.87, ,0.65,0.6,1.29,1.48,1.68,1.5,0.92,0.87, +, +,,,,,2,5,7.91,endoplasmic reticulum membrane,,ER to Golgi vesicle-mediated transport,,
O94979-3,O94979,Protein transport protein Sec31A,SEC31A,164.28,163.89,S527,DGANVALKDSDQVAQSDGEESPAAEEQLLGE,_DSDQVAQS(ph)DGEES(ph)PAAEEQLLGEHIK_,2.18,0.11,1.65,0.01,0.14,0.21,-0.1,0.96,-0.9,0.07,-1.3,-3.1,-0.03,0.15,0.11,0.12,1.49,1.05,0.17,0.53,-0.33,-1.93,0.06,0.11, +, +,,,,,5,3,6.2,COPII vesicle coat,,activation of signaling protein activity involved in unfolded protein response,,
O94979-3,O94979,Protein transport protein Sec31A,SEC31A,164.28,163.89,S532,ALKDSDQVAQSDGEESPAAEEQLLGEHIKEE,_DSDQVAQS(ph)DGEES(ph)PAAEEQLLGEHIK_,0.21,0.11,0.24,0.59,0.11,0.02,-0.1,0.29,0.09,0.07,0.06,0.23,0.08,-0.15,0.11,0.2,0.16,0.43,0.07,0.11,0.08,0.15,-0.03,0.16,,,,,,,0,0,,COPII vesicle coat,,activation of signaling protein activity involved in unfolded protein response,,
O94979-3,O94979,Protein transport protein Sec31A,SEC31A,106.11,106.11,S799,DRLCRAQGEPVAGHESPKIPYEKQQLPKGRP,_AQGEPVAGHES(ph)PKIPYEK_,0.33,0.47,0.26,0.37,0.58,0.43, , ,0.13,0.37,0.32,0.36,0.76,0.61, , ,0.4,0.32,0.51,,0.25,0.34,0.68,,,,,,,,NA,NA,,COPII vesicle coat,,activation of signaling protein activity involved in unfolded protein response,,
P60468,P60468,Protein transport protein Sec61 subunit beta,SEC61B,298.43,298.43,S17,PGPTPSGTNVGSSGRSPSKAVAARAAGSTVR,_PGPTPSGTNVGSSGRS(ph)PSK_,0.05,0.11,0.06,-0.06,0.11,0.12,0.08,0.11,0.07,-0.05,0.02,-0.16,0.16,0.17,-0.09,-0.03,0.08,0.01,0.12,0.1,0.01,-0.07,0.16,-0.06,,,,,,,0,0,,endoplasmic reticulum Sec complex,ribosome binding,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",,
Q9NPR2,Q9NPR2,Semaphorin-4B,SEMA4B,105.08,95.76,S825,VEVSPVCPRPRVRLGSEIRDSVV________,_LGS(ph)EIRDSVV_,-0.12,0.27,0.62,0.75, ,0.78, , ,1.07,0.72,1.39,1.04, ,1.84, , ,0.09,0.69,0.78,,0.91,1.23,1.84,,, +,,,,,NA,NA,,integral to membrane,receptor activity,cell differentiation,,
Q9GZR1-2,Q9GZR1,Sentrin-specific protease 6,SENP6,135.69,131.7,S1111,EAPLGEGTEQYVNSISD______________,_DTYSTEAPLGEGTEQYVNSIS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,SUMO-specific protease activity,protein desumoylation,,
Q9GZR1-2,Q9GZR1,Sentrin-specific protease 6,SENP6,98.73,97.67,S335,ERKTSLSDLNDPIILSSDDDDDNDRTNRRES,_TSLSDLNDPIILS(ph)S(ph)DDDDDNDR_, , , , , ,-0.26,-0.4,-0.09, , , , , ,-0.19,-0.27,0.09,,,-0.26,-0.24,,,-0.19,-0.08,,,,,,,NA,NA,,cytoplasm,SUMO-specific protease activity,protein desumoylation,,
Q9GZR1-2,Q9GZR1,Sentrin-specific protease 6,SENP6,98.73,97.67,S336,RKTSLSDLNDPIILSSDDDDDNDRTNRRESI,_TSLSDLNDPIILS(ph)S(ph)DDDDDNDR_, , , , , ,-0.26,-0.4,-0.09, , , , , ,-0.19,-0.27,0.09,,,-0.26,-0.24,,,-0.19,-0.08,,,,,,,NA,NA,,cytoplasm,SUMO-specific protease activity,protein desumoylation,,
D6RGI3,Q9NVA2,Septin-11,Sep-11,70.34,64.8,S9,_______MAVAVGRPSNEELRNLSLSGHVGF,_(ac)AVAVGRPS(ph)NEELR_,0.41,0.14,0.07, , , , , ,0.98,0.93,0.61, , , , , ,0.28,0.07,,,0.96,0.61,,,,,,,,,NA,NA,,cytoplasm,GTP binding,cell cycle,,
Q15019,Q15019,Septin-2,Sep-02,305.67,305.67,S218,IEEHNIKIYHLPDAESDEDEDFKEQTRLLKA,_IYHLPDAES(ph)DEDEDFKEQTR_,-0.14,-0.12,-0.26,-0.23,-0.02,-0.02,-0.01,0.04,-0.03,0.03,-0.09,0.01,-0.03,0.02,-0.03,0.04,-0.13,-0.25,-0.02,0.02,0,-0.04,-0.01,0.01,,,,,,,0,0,,actin cytoskeleton,enzyme regulator activity,cell division,,
C9J2Q4,Q15019,Sep-02,Sep-02,109.48,109.12,S218,IEEHNIKIYHLPDAESDEDEDF_________,_IYHLPDAES(ph)DEDEDF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell surface,enzyme regulator activity,cell cycle,,
Q16181-2,Q16181,Septin-7,Sep-07,130.4,130.4,T426,WEAQQRILEQQNSSRTLEKNKKKGKIF____,_ILEQQNSSRT(ph)LEK_, , , , ,0.46,0.53,0.61,0.82, , , , ,0.06,0.05,0.19,0.55,,,0.5,0.72,,,0.05,0.38,,,,,,,NA,NA,,axon terminus,GTP binding,cilium morphogenesis,,
Q16181-2,Q16181,Septin-7,Sep-07,66,43.47,Y319,VHYENYRSRKLAAVTYNGVDNNKNKGQLTKS,_LAAVTY(ph)NGVDNNK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,axon terminus,GTP binding,cilium morphogenesis,,
Q16181-2,Q16181,Septin-7,Sep-07,162.94,162.94,S334,YNGVDNNKNKGQLTKSPLAQMEEERREHVAK,_S(ph)PLAQMEEERR_,-0.26,-0.12,-0.37,-0.32,-0.44,0.02,-0.4,-0.9,-0.22,-0.3,-0.2,-0.32,-0.01,-0.18,-0.32,-0.36,-0.19,-0.35,-0.19,-0.63,-0.26,-0.26,-0.1,-0.34,,,,,,,0,0,,axon terminus,GTP binding,cilium morphogenesis,,
Q9UHD8-7,Q9UHD8,Septin-9,Sep-09,194.77,194.77,S85,NSEPSARHVDSLSQRSPKASLRRVELSGPKA,_HVDSLSQRS(ph)PK_,-0.08,0.06,-0.41,-0.24,-0.03,-0.07,0.06,0.12,-0.06,0.05,-0.51,-0.46,-0.17,-0.07,-0.03,-0.15,-0.01,-0.32,-0.05,0.09,0,-0.48,-0.12,-0.09,,,,,,,0,0,,microtubule,GTP binding,cell cycle,,
Q9UHD8-7,Q9UHD8-7,Septin-9,Sep-09,200.99,178.94,S11,_____MKKSYSALKRSFEVEEVETPNSTPPR,_S(ph)FEVEEVETPNSTPPRR_,0.55,0.65,-0.28,-1.29,-0.38,-0.57,-0.67,-0.32,0.33,0.2,-0.1,-0.63,-0.29,-0.38,-0.25,-0.18,0.6,-0.7,-0.47,-0.49,0.27,-0.34,-0.34,-0.21,,,,,,,0,0,,microtubule,GTP binding,cell cycle,,
Q8NC51,Q8NC51,Plasminogen activator inhibitor 1 RNA-binding protein,SERBP1,390.52,390.52,S234,SGSHNWGTVKDELTESPKYIQKQISYNYSDL,_DELTES(ph)PK_,0.16,0.34,1.04,1.04,1.16,1.26,1.04,1.14,0.85,0.64,1.21,1.23,1.15,1.3,1.42,1.55,0.25,1.04,1.21,1.09,0.75,1.22,1.23,1.48, +, +,,,,,1,1,24.42,cytoplasm,mRNA 3'-UTR binding,regulation of mRNA stability,,
Q8NC51,Q8NC51,Plasminogen activator inhibitor 1 RNA-binding protein,SERBP1,135.8,114.82,Y207,EFDRHSGSDRSSFSHYSGLKHEDKRGGSGSH,_SSFSHY(ph)SGLK_,1.13, , , , , , , ,0.77, , , , , , , ,1.13,,,,0.77,,,, +,,,,,,NA,NA,,cytoplasm,mRNA 3'-UTR binding,regulation of mRNA stability,,
Q8NC51,Q8NC51,Plasminogen activator inhibitor 1 RNA-binding protein,SERBP1,113.53,113.53,S197,GDGFDSRGKREFDRHSGSDRSSFSHYSGLKH,_EFDRHS(ph)GSDR_,0.17,0.32,0.38, , ,-0.05,0.22,0.44,-0.12,0.01,0, , ,-0.07,0.3,0.18,0.25,0.38,-0.05,0.33,-0.05,0,-0.07,0.24,,,,,,,0,0,,cytoplasm,mRNA 3'-UTR binding,regulation of mRNA stability,,
Q5H936,Q13530,Serine incorporator 3,SERINC3,97.81,95.37,S371,STNSQVDKLTLSGSDSVILGDTTTSGASDEE,_LTLS(ph)GSDS(ph)VILGDTTTSGASDEEDGQPR_, , , , ,0.26, , , , , , , ,-0.45, , , ,,,0.26,,,,-0.45,,,,,,,,NA,NA,,Golgi apparatus,,induction of apoptosis,,
O15047,O15047,Histone-lysine N-methyltransferase SETD1A,SETD1A,99.36,99.36,S468,REEVRTSPRPASPARSGSPAPETTNESVPFA,_S(ph)GS(ph)PAPETTNESVPFAQHSSLDSR_, , , , ,-0.06,-0.02,-0.07,0, , , , ,-0.1,-0.19,-0.01,-0.31,,,-0.04,-0.03,,,-0.15,-0.15,,,,,,,NA,NA,,chromosome,histone methyltransferase activity (H3-K4 specific),"regulation of transcription, DNA-dependent",,
O15047,O15047,Histone-lysine N-methyltransferase SETD1A,SETD1A,99.36,99.36,S470,EVRTSPRPASPARSGSPAPETTNESVPFAQH,_S(ph)GS(ph)PAPETTNESVPFAQHSSLDSR_, ,-0.21, ,-0.41,-0.06,-0.02,-0.07,0, ,-0.29, ,-0.1,-0.1,-0.19,-0.01,-0.31,-0.21,-0.41,-0.04,-0.03,-0.29,-0.1,-0.15,-0.15,,,,,,,0,0,,chromosome,histone methyltransferase activity (H3-K4 specific),"regulation of transcription, DNA-dependent",,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,84.37,83.08,S1980,SNGTKLEEPINEETPSQDEEEGVSDVESERS,_LEEPINEETPS(ph)QDEEEGVS(ph)DVES(ph)ER_, , , , , ,0.17,-0.08,-1.05, , , , , ,-0.12,-0.12,-0.4,,,0.17,-0.49,,,-0.12,-0.25,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,94.03,90.5,S1988,PINEETPSQDEEEGVSDVESERSQEQPDKTV,_LEEPINEETPS(ph)QDEEEGVS(ph)DVES(ph)ER_, , , , ,0.58,0.74,0.42,-0.07, , , , ,0.93,0.59,0.44,-0.24,,,0.67,0.2,,,0.77,0.14,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,94.03,90.5,S1992,ETPSQDEEEGVSDVESERSQEQPDKTVDISD,_LEEPINEETPS(ph)QDEEEGVS(ph)DVES(ph)ER_, , , , ,0.58,0.74,0.42,-0.07, , , , ,0.93,0.59,0.44,-0.24,,,0.67,0.2,,,0.77,0.14,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,74.18,73.49,S1995,SQDEEEGVSDVESERSQEQPDKTVDISDLAT,_LEEPINEETPS(ph)QDEEEGVS(ph)DVES(ph)ERS(ph)QEQPDK_, , , , ,-0.14, ,-0.44,-0.07, , , , ,0.21, ,-0.35,-0.24,,,-0.14,-0.24,,,0.21,-0.29,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,224.83,221.47,S321,GSKKKSSQSEGIFLGSESDEDSVRTSSSQRS,_SSQSEGIFLGS(ph)ES(ph)DEDSVR_, , , , ,-0.26,-0.21,-0.37,-0.3, , , , ,0.01,-0.1,-0.09,0.04,,,-0.24,-0.33,,,-0.04,-0.02,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q9BYW2,Q9BYW2,Histone-lysine N-methyltransferase SETD2,SETD2,224.83,221.47,S323,KKKSSQSEGIFLGSESDEDSVRTSSSQRSHD,_SSQSEGIFLGS(ph)ES(ph)DEDSVR_, , , , ,-0.26,-0.21,-0.37,-0.3, , , , ,0.01,-0.1,-0.09,0.04,,,-0.24,-0.33,,,-0.04,-0.02,,,,,,,NA,NA,,chromosome,DNA binding,angiogenesis,,
Q7Z333-3,Q7Z333,Probable helicase senataxin,SETX,210.14,210.14,S1017,QNNVGDTSRGQVIIISDSDDDDDERILSLEK,_GQVIIIS(ph)DS(ph)DDDDDER_,0.63, , , ,0,0.19,0.1,0,-0.48, , , ,0.01,-0.05,-0.05,-0.12,0.63,,0.1,0.05,-0.48,,-0.02,-0.08,,,,,,,NA,NA,,cytoplasm,ATP binding,cell death,,
Q7Z333-3,Q7Z333,Probable helicase senataxin,SETX,210.14,210.14,S1019,NVGDTSRGQVIIISDSDDDDDERILSLEKLT,_GQVIIIS(ph)DS(ph)DDDDDER_,0.63, , , ,0,0.19,0.1,0,-0.48, , , ,0.01,-0.05,-0.05,-0.12,0.63,,0.1,0.05,-0.48,,-0.02,-0.08,,,,,,,NA,NA,,cytoplasm,ATP binding,cell death,,
Q15637-6,Q15637,Splicing factor 1,SF1,344.33,344.27,S80,LRTGDLGIPPNPEDRSPSPEPIYNSEGKRLN,_S(ph)PS(ph)PEPIYNSEGK_,0.36,0.3,0.28,0.34,0.34,0.24,0.23,0.23,-0.01,0,-0.15,-0.08,-0.17,-0.17,-0.06,-0.05,0.33,0.31,0.29,0.23,-0.01,-0.11,-0.17,-0.06,,,,,,,0,0,,ribosome,RNA binding,cell cycle process,,
Q15637-6,Q15637,Splicing factor 1,SF1,344.33,344.27,S82,TGDLGIPPNPEDRSPSPEPIYNSEGKRLNTR,_S(ph)PS(ph)PEPIYNSEGK_,0.36,0.3,0.28,0.34,0.34,0.24,0.23,0.23,-0.01,0,-0.15,-0.08,-0.17,-0.17,-0.06,-0.05,0.33,0.31,0.29,0.23,-0.01,-0.11,-0.17,-0.06,,,,,,,0,0,,ribosome,RNA binding,cell cycle process,,
Q15459,Q15459,Splicing factor 3A subunit 1,SF3A1,148.91,148.79,S359,SQLDQDTQVQDMDEGSDDEEEGQKVPPPPET,_AEEPPSQLDQDTQVQDM(ox)DEGS(ph)DDEEEGQK_, , , ,-0.43,-0.17,-0.14,-0.24,-0.19, , , ,-0.12,-0.02,0.12,-0.06,-0.03,,-0.43,-0.15,-0.21,,-0.12,0.05,-0.04,,,,,,,NA,NA,,catalytic step 2 spliceosome,RNA binding,mRNA 3'-splice site recognition,,
Q15459,Q15459,Splicing factor 3A subunit 1,SF3A1,220.69,214.09,S329,YEKFGESEEVEMEVESDEEDDKQEKAEEPPS,_FGESEEVEM(ox)EVES(ph)DEEDDKQEK_, , ,-0.24,-0.11,-0.16,-0.2,-0.15,-0.18, , ,-0.03,-0.09,-0.07,0.09,0.1,-0.11,,-0.17,-0.18,-0.17,,-0.06,0.01,0,,,,,,,NA,NA,,catalytic step 2 spliceosome,RNA binding,mRNA 3'-splice site recognition,,
O75533,O75533,Splicing factor 3B subunit 1,SF3B1,147.67,131.61,S488,QYFDKLLVDVDESTLSPEEQKERKIMKLLLK,_LLVDVDESTLS(ph)PEEQK_,-0.19,-0.23,0.1,-0.43, , ,-0.31,0.21,-0.3,-0.34,-0.28,-0.17, , ,-0.18,0.61,-0.21,-0.14,,-0.03,-0.32,-0.22,,0.27,,,,,,,NA,NA,,catalytic step 2 spliceosome,chromatin binding,anterior/posterior pattern specification,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,274.74,274.74,S309,EEMETDARSSLGQSASETEEDTVSVSKKEKN,_SSLGQS(ph)AS(ph)ET(ph)EEDTVSVSK_,0.16,-0.05,0.09,0.24,0.28,0.45,0.33,0.4,0.16,-0.12,1.58,0.28,0.4,0.64,0.3,0.23,0.06,0.17,0.37,0.36,0.02,1.07,0.52,0.27,, +,,,,,0,4,10.77,nucleus,nucleic acid binding,,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,310.21,310.21,S431,SAAPKKKGFEEEHKDSDDDSSDDEQEKKPEA,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,0.08,0.02, , ,0.09,0.24,0.3,0.09,0.06,0.1, , ,0.22,0.13,0.22,0.11,0.05,,0.17,0.2,0.08,,0.17,0.17,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,310.21,310.21,S435,KKKGFEEEHKDSDDDSSDDEQEKKPEAPKLS,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,0.08,0.02, , ,0.09,0.24,0.3,0.09,0.06,0.1, , ,0.22,0.13,0.22,0.11,0.05,,0.17,0.2,0.08,,0.17,0.17,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,310.21,310.21,S436,KKGFEEEHKDSDDDSSDDEQEKKPEAPKLSK,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,0.08,0.02, , ,0.09,0.24,0.3,0.09,0.06,0.1, , ,0.22,0.13,0.22,0.11,0.05,,0.17,0.2,0.08,,0.17,0.17,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,274.74,274.74,S307,EEEEMETDARSSLGQSASETEEDTVSVSKKE,_SSLGQS(ph)AS(ph)ETEEDTVSVSK_,-0.29,-0.05,-0.05,-0.06,0.41,0.32,0.33,0.42,0.49,-0.12,0.17,0.01,0.63,0.32,0.3,0.33,-0.16,-0.06,0.36,0.38,0.22,0.09,0.48,0.32,,,,,,,0,0,,nucleus,nucleic acid binding,,,
E9PPJ0,Q13435,Splicing factor 3B subunit 2,SF3B2,205.2,189.15,T311,METDARSSLGQSASETEEDTVSVSKKEKNRK,_SSLGQS(ph)AS(ph)ET(ph)EEDTVSVSK_, , , , ,0.23,0.47,0.55,0.49, , , , ,0.18,0.72,0.37,0.37,,,0.36,0.52,,,0.48,0.37,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q9UHJ3-2,Q9UHJ3,Scm-like with four MBT domains protein 1,SFMBT1,80.79,79.77,S765,LPPDRQRRKRELRTFSFSDDENKPPSPKEID,_TFS(ph)FS(ph)DDENKPPS(ph)PK_,0.32,-0.13,1.51, ,0.75,0.64, ,2.39,1.38,0.79,1.93, ,0.69,0.85, ,2.36,0.11,1.51,0.69,2.39,1.12,1.93,0.77,2.36, +, +,,,,,1,1,35.57,nucleus,,cell differentiation,,
Q9UHJ3-2,Q9UHJ3,Scm-like with four MBT domains protein 1,SFMBT1,80.79,79.77,S767,PDRQRRKRELRTFSFSDDENKPPSPKEIDGQ,_TFS(ph)FS(ph)DDENKPPS(ph)PK_,0.32,-0.13,1.51, ,0.75,0.64, ,2.39,1.38,0.79,1.93, ,0.69,0.85, ,2.36,0.11,1.51,0.69,2.39,1.12,1.93,0.77,2.36, +, +,,,,,1,1,35.57,nucleus,,cell differentiation,,
Q9UHJ3-2,Q9UHJ3-2,Scm-like with four MBT domains protein 1,SFMBT1,80.79,79.77,S775,ELRTFSFSDDENKPPSPKEIDGQALLLLTLP,_TFS(ph)FS(ph)DDENKPPS(ph)PK_,0.32,-0.13,1.51, ,0.75,0.64, ,2.39,1.38,0.79,1.93, ,0.69,0.85, ,2.36,0.11,1.51,0.69,2.39,1.12,1.93,0.77,2.36, +, +,,,,,1,1,35.57,nucleus,,cell differentiation,,
Q9UHJ3-2,Q9UHJ3,Scm-like with four MBT domains protein 1,SFMBT1,69.26,34.93,S276,SYLFKDKQVIGIHTFSVNMKLEAVDPWSPFG,_DKQVIGIHT(ph)FS(ph)VNM(ox)K_, , , ,4.12, , , , , , , ,0.72, , , , ,,4.12,,,,0.72,,, +,,,,,,NA,NA,,nucleus,,cell differentiation,,
P31947-2,P31947,14-3-3 protein sigma,SFN,139.15,137.28,S248,DNAGEEGGEAPQEPQS_______________,_DNLTLWTADNAGEEGGEAPQEPQS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasmic vesicle membrane,protein kinase C inhibitor activity,cellular membrane organization,,
Q12872,Q12872,"Splicing factor, suppressor of white-apricot homolog",SFSWAP,169.15,166.48,S283,LAENKSDEKKKSGVSSDNEDDDDEEDGNYLH,_SGVSS(ph)DNEDDDDEEDGNYLHPSLFASK_,-0.18,-0.17,-0.38,0.04, ,-0.07,-0.26, ,-0.05,-0.02,-0.53,-0.12, ,0.17,0.03, ,-0.18,-0.16,-0.07,-0.26,-0.04,-0.31,0.17,0.03,,,,,,,0,0,,nucleus,RNA binding,mRNA splice site selection,,
Q86YV5,Q86YV5,Tyrosine-protein kinase SgK223,SGK223,264.85,262.57,Y862,LSHSETNVHDESHFSYSLSPGNRHHPVFSSS,_LNLSHSETNVHDESHFSY(ph)SLSPGNR_,1.6, ,0.72, , , , , ,1.6, ,0.12, , , , , ,1.6,0.72,,,1.6,0.12,,, +, +,Other,,,,NA,NA,,,ATP binding,,,
Q86YV5,Q86YV5,Tyrosine-protein kinase SgK223,SGK223,173.44,173.44,Y411,QPPAHPREATQPEPIYAESTKRKKAAPVPSK,_EATQPEPIY(ph)AESTK_,0.52,0.61,-0.02,0.32,0.08,0.18,-0.03,-0.03,0.37,0.7,-0.38,0.06,0.07,0.21,0.09,0.08,0.57,0.16,0.13,-0.03,0.55,-0.14,0.14,0.08,,,Other,,,,0,0,,,ATP binding,,,
Q9BX95,Q9BX95,Sphingosine-1-phosphate phosphatase 1,SGPP1,231.21,231.21,S112,LGPASPRRAGALRRNSLTGEEGQLARVSNWP,_RNS(ph)LTGEEGQLAR_,0.55,0.3,0.34,0.22,-0.03,0.13,0.19,0.12,0.13,0.03,0.11,0.26,0.13,-0.03,0.29,0.16,0.43,0.28,0.05,0.16,0.08,0.19,0.06,0.23,,,,,,,0,0,,endoplasmic reticulum membrane,sphingosine-1-phosphate phosphatase activity,apoptotic process,,
E7EMJ6,O43765,Small glutamine-rich tetratricopeptide repeat-containing protein alpha,SGTA,67.4,67.4,S77,FEAAATGKEMPQDLRSPARTPPSEEDSAEAE,_EMPQDLRS(ph)PART(ph)PPSEEDSAEAER_, ,-0.18,-0.07, , , , , , ,-0.28,-0.16, , , , , ,-0.18,-0.07,,,-0.28,-0.16,,,,,,,,,NA,NA,,,,,,
Q96EQ0,Q96EQ0,Small glutamine-rich tetratricopeptide repeat-containing protein beta,SGTB,230.96,199.81,S297,ELIEQLRNHIRSRSFSSSAEEHS________,_SFS(ph)SSAEEHS_, , ,2.31, ,0.94, , , , , ,2.4, ,0.25, , , ,,2.31,0.94,,,2.4,0.25,, +, +,,,,,NA,NA,,,,,,
Q96EQ0,Q96EQ0,Small glutamine-rich tetratricopeptide repeat-containing protein beta,SGTB,132.01,126.95,S295,NPELIEQLRNHIRSRSFSSSAEEHS______,_SRS(ph)FSSSAEEHS_,0.3, ,-0.03, , ,1.01, , ,-0.19, ,-0.45, , ,0.68, , ,0.3,-0.03,1.01,,-0.19,-0.45,0.68,, +,,,,,,NA,NA,,,,,,
B4DLN5,Q9NRF2,SH2B adapter protein 1,SH2B1,136.64,134.07,Y624,IPLESGGSSDVVLVSYVPSSQRQQGREQAGS,_VHPIPLESGGSSDVVLVSY(ph)VPSSQR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,phospholipid binding,,,
O14492,O14492,SH2B adapter protein 2,SH2B2,76.1,76.1,Y629,PPEAAPGRARAVENQYSFY____________,_AVENQY(ph)SFY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,JAK pathway signal transduction adaptor activity,blood coagulation,,
Q9BRG2,Q9BRG2,SH2 domain-containing protein 3A,SH2D3A,105.53,82.7,S125,VSRPVTWQGPLRRSFSEDTLMDGPARIEPLR,_SFS(ph)EDTLMDGPAR_,0.23,0.53,0.03,0.56, , , , ,0.16,0.94,-0.16,0.31, , , , ,0.39,0.32,,,0.6,0.09,,,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,JNK cascade,,
Q9BRG2,Q9BRG2,SH2 domain-containing protein 3A,SH2D3A,84.48,46.51,S180,MEASTMPISALPRTSSDPVLLKAPAPLGTVA,_TSS(ph)DPVLLK_,0.46,0.38, , ,-0.79, , , ,0.3,0.17, , ,-0.56, , , ,0.42,,-0.79,,0.24,,-0.56,,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,JNK cascade,,
Q9H788,Q9H788,SH2 domain-containing protein 4A,SH2D4A,214.45,180.02,S315,YPQKPLRNQGVVRTLSSSAQEDIIRWFKEEQ,_TLS(ph)SSAQEDIIR_,1.15,0.57,2.39,2.91,1.04,0.82, ,1.11,-0.1,0.33,2.45,2.69,0.44,0.73, ,0.77,0.89,2.67,0.94,1.11,0.13,2.58,0.59,0.77, +, +,,,,,4,4,27.46,cytoplasm,phosphatase binding,negative regulation of phosphatase activity,,
Q9H788,Q9H788,SH2 domain-containing protein 4A,SH2D4A,65.48,54.43,Y131,THSEEFTNSLKTKSQYHDLQAPDNQQTKDIW,_SQY(ph)HDLQAPDNQQTK_,3.23, , , , , , , ,2.54, , , , , , , ,3.23,,,,2.54,,,, +, +,,,,,NA,NA,,cytoplasm,phosphatase binding,negative regulation of phosphatase activity,,
Q9P0V3,Q9P0V3,SH3 domain-binding protein 4,SH3BP4,86.02,86.02,S279,SFFTGLKSPAPEQFQSREDFRTAWLNHRKLA,_SPAPEQFQS(ph)REDFR_,-1.65,-1.29,-2.3, , ,-0.02,-0.58,-0.49,-1.32,-0.88,-1.78, , ,-0.03,-0.55,-0.68,-1.46,-2.3,-0.02,-0.54,-1.09,-1.78,-0.03,-0.62, +, +,,,,,3,3,42.64,clathrin-coated vesicle,GDP-dissociation inhibitor activity,cellular response to amino acid stimulus,,
Q9P0V3,Q9P0V3,SH3 domain-binding protein 4,SH3BP4,225.65,222.93,S131,NSTLSDSGMIDNLPDSPDEVAKELELLGGWT,_NST(ph)LS(ph)DSGMIDNLPDS(ph)PDEVAK_,-0.06,0.01,0.39,0.7,0.51,0.68,0.37,0.56,0.48,0.37,0.87,0.84,0.88,1.21,1.09,1.23,-0.03,0.55,0.6,0.47,0.43,0.85,1.06,1.16,, +,,,,,0,1,17.09,clathrin-coated vesicle,GDP-dissociation inhibitor activity,cellular response to amino acid stimulus,,
Q9P0V3,Q9P0V3,SH3 domain-binding protein 4,SH3BP4,137.36,136.21,T118,YIPSSYVQPLNYRNSTLSDSGMIDNLPDSPD,_NS(ph)T(ph)LSDSGMIDNLPDS(ph)PDEVAK_,-0.12,-1.19,-0.66, ,-1.19,0.26,-0.05,-1.85,-0.11,-0.64,-0.27, ,-1.07,0.49,-0.87,-1.15,-0.56,-0.66,-0.29,-0.69,-0.35,-0.27,-0.09,-1,, +,,,,,0,6,15.2,clathrin-coated vesicle,GDP-dissociation inhibitor activity,cellular response to amino acid stimulus,,
Q9P0V3,Q9P0V3,SH3 domain-binding protein 4,SH3BP4,112.12,102.47,S246,PVRRDNPFFRSKRSYSLSELSVLQAKSDAPT,_SYS(ph)LSELSVLQAK_, , , , , ,0.07, , , , , , , ,-0.13, , ,,,0.07,,,,-0.13,,,,,,,,NA,NA,,clathrin-coated vesicle,GDP-dissociation inhibitor activity,cellular response to amino acid stimulus,,
Q7L8J4,Q7L8J4,SH3 domain-binding protein 5-like,SH3BP5L,186.6,184.74,S362,KCDSVEHLRGLSDHVSLDGQELGTRSGGRRG,_GLSDHVS(ph)LDGQELGTR_,-0.09,-0.09,-0.25,-0.14,-0.26,0, , ,0.02,0,-0.07,0.17,-0.19,-0.29, , ,-0.09,-0.19,-0.12,,0.01,0.05,-0.24,,,,,,,,NA,NA,,,,,,
Q5HYK7-3,Q5HYK7,SH3 domain-containing protein 19,SH3D19,56.77,56.3,S65,SGKPSVAPKPAANRASGEWDSGTENRLKVTS,_PAANRAS(ph)GEWDSGTENR_, , , , ,0.72, , , , , , , ,0.66, , , ,,,0.72,,,,0.66,,,,,,,,NA,NA,,cytosol,,cellular membrane organization,,
Q99961,Q99961,Endophilin-A2,SH3GL1,136.02,39.68,S288,GGFPCTTAPKIAASSSFRSSDKPIRTPSRSM,_IAASSS(ph)FR_,0.72,0.87,-0.67,-0.93,0.35,0.45,0.48,0.44,1.59,1.57,0.83,0.7,0.12,0.06,0.22,0.18,0.79,-0.8,0.4,0.46,1.58,0.77,0.09,0.2,, +,,,,,0,5,5.27,cell junction,lipid binding,central nervous system development,,
Q5JPT1,Q96B97,SH3 domain-containing kinase-binding protein 1,SH3KBP1,181.51,163.33,S230,FGDIFKDKPIKLRPRSIEVENDFLPVEKTIG,_S(ph)IEVENDFLPVEK_,-0.22,-0.13,0.23,0.3,0.47,0.44,0.43,0.44,-0.1,-0.14,0.18,0.08,0.45,0.48,0.25,0.28,-0.17,0.26,0.46,0.44,-0.12,0.13,0.46,0.27,,,,,,,0,0,,,,,,
A1X283,A1X283,SH3 and PX domain-containing protein 2B,SH3PXD2B,144.44,144.44,Y508,DVLRKASSDMSASAGYEEISDPDMEEKPSLP,_ASSDMSASAGY(ph)EEISDPDMEEKPSLPPRK_,2.09, , , , , , , ,1.15, , , , , , , ,2.09,,,,1.15,,,, +, +,,,,,NA,NA,,cell junction,"phosphatidylinositol-3,5-bisphosphate binding",adipose tissue development,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,289.95,289.95,Y246,ESGAGKKDKVTIADDYSDPFDAKNDLKSKAG,_DKVTIADDY(ph)SDPFDAK_,1.45,1.67,0.95, ,0.2,0.19,0.19,0.18,1.38,1.18,0.15, ,0.52,0.54,0.7,0.73,1.56,0.95,0.19,0.18,1.28,0.15,0.53,0.71, +, +,,,,,5,5,8.14,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,272.51,272.51,Y336,RESKLPQDDDRPADEYDQPWEWNRVTIPALA,_LPQDDDRPADEY(ph)DQPWEWNR_,2.22, ,1.35, ,0.14, ,0.01,0.06,1.75, ,0.15, ,-0.03, ,0.52,0.54,2.22,1.35,0.14,0.03,1.75,0.15,-0.03,0.53, +, +,,,,,5,5,9.68,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,117.17,111.18,S310,QLYDTPYEPEGQSVDSDSESTVSPRLRESKL,_GIQLYDTPYEPEGQSVDS(ph)DSESTVS(ph)PR_, , , , ,0.42,0.43, ,0.06, , , , ,1.17,0.86, ,-0.12,,,0.43,0.06,,,1.03,-0.12,, +,,,,,NA,NA,,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,117.17,111.18,S317,EPEGQSVDSDSESTVSPRLRESKLPQDDDRP,_GIQLYDTPYEPEGQSVDS(ph)DSESTVS(ph)PR_, , , , ,0.47,0.46, , , , , , ,1.07,0.98, , ,,,0.46,,,,1.03,,, +,,,,,NA,NA,,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,268.93,264.38,Y268,KNDLKSKAGKGESAGYMEPYEAQRIMTEFQR,_GESAGY(ph)MEPYEAQR_,0.49,0.65,0.63,0.58,-0.01,0.05,0.04,0.02,0.24,0.38,0.25,0.45,0.33,0.34,0.61,0.55,0.57,0.6,0.02,0.03,0.31,0.35,0.34,0.58,,,,,,,0,0,,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,140.28,137.66,Y96,IRAYRAQKERDFEDPYNGPGSSLRKLRAMCR,_ERDFEDPY(ph)NGPGSSLRK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
Q15464,Q15464,SH2 domain-containing adapter protein B,SHB,107.75,105.12,Y297,QRQESVRSQHKGIQLYDTPYEPEGQSVDSDS,_GIQLY(ph)DTPYEPEGQSVDSDSESTVSPR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,SH3/SH2 adaptor activity,angiogenesis,,
P29353,P29353,SHC-transforming protein 1,SHC1,349.2,326.83,Y427,PPPPCPGRELFDDPSYVNVQNLDKARQAVGG,_ELFDDPSY(ph)VNVQNLDK_,4.23,4.24,3.85,3.7,3.26,3.29,2.68,2.64,4.02,3.99,2.97,2.91,3.58,3.58,3.05,2.96,4.23,3.78,3.27,2.66,4.01,2.94,3.58,3.01, +, +,,,,,5,5,31.86,cytosol,epidermal growth factor receptor binding,actin cytoskeleton reorganization,,
P29353,P29353,SHC-transforming protein 1,SHC1,394.01,386.78,Y349,GSAWDEEEEEPPDHQYYNDFPGKEPPLGGVV,_MAGFDGSAWDEEEEEPPDHQY(ph)Y(ph)NDFPGKEPPLGGVVDMR_,2.81, ,2.5, ,2.12,1.21,1.97,2.14,2.18, ,1.79, ,2.29,1.5,2.27,2.39,2.81,2.5,1.74,2.05,2.18,1.79,1.95,2.33, +, +,,,,,5,5,26.59,cytosol,epidermal growth factor receptor binding,actin cytoskeleton reorganization,,
P29353,P29353,SHC-transforming protein 1,SHC1,381.44,381.35,Y350,SAWDEEEEEPPDHQYYNDFPGKEPPLGGVVD,_MAGFDGSAWDEEEEEPPDHQY(ph)Y(ph)NDFPGKEPPLGGVVDMR_,2.93, ,2.31, ,2.12,1.96,1.84,2.14,2.27, ,1.92, ,2.29,2.15,2.24,2.3,2.93,2.31,2.04,2,2.27,1.92,2.22,2.27, +, +,,,,,5,5,29.01,cytosol,epidermal growth factor receptor binding,actin cytoskeleton reorganization,,
Q8TF72,Q8TF72,Protein Shroom3,SHROOM3,135.8,135.8,S910,SSEPEREPEWRDRPGSPESPLLDAPFSRAYR,_DRPGS(ph)PES(ph)PLLDAPFSR_, , , , ,0.33,0.16,0.44,0.07, , , , ,0.51,1.04,0.47,0.43,,,0.25,0.27,,,0.8,0.45,,,,,,,NA,NA,,adherens junction,,actin cytoskeleton organization,,
Q8TF72,Q8TF72,Protein Shroom3,SHROOM3,135.8,135.8,S913,PEREPEWRDRPGSPESPLLDAPFSRAYRNSI,_DRPGS(ph)PES(ph)PLLDAPFSR_, , , , ,0.33,0.16,0.44,0.07, , , , ,0.51,1.04,0.47,0.43,,,0.25,0.27,,,0.8,0.45,,,,,,,NA,NA,,adherens junction,,actin cytoskeleton organization,,
Q96ST3,Q96ST3,Paired amphipathic helix protein Sin3a,SIN3A,195.6,187.74,S1112,RWSDYVERYMNSDTTSPELREHLAQKPVFLP,_YMNSDTTS(ph)PELR_,-0.2,-0.18,-0.45,-0.19,1.06, ,-0.35,0.44,0.08,-0.01,0.57,0.82,1.5, ,0.03,0.38,-0.19,-0.31,1.06,0.1,0.04,0.7,1.5,0.21, +, +,,,,,2,1,13.45,kinetochore,chromatin binding,activation of innate immune response,,
Q96ST3,Q96ST3,Paired amphipathic helix protein Sin3a,SIN3A,328.8,328.8,S832,HHFIPDLLFAQRGDLSDVEEEEEEEMDVDEA,_GDLS(ph)DVEEEEEEEMDVDEATGAVKK_,-0.2,-0.04,-0.25,-0.25,-0.21,0.04,-0.15,-0.19,-0.27,-0.29,-0.23,-0.01,0.01,0.13,-0.03,0.04,-0.12,-0.25,-0.08,-0.17,-0.28,-0.12,0.07,0.01,,,,,,,0,0,,kinetochore,chromatin binding,activation of innate immune response,,
F6RY50,Q96FS4,Signal-induced proliferation-associated protein 1,SIPA1,190.94,190.94,S884,PSADSETPLTQDRPGSPSGSEDKGNPAPELR,_PSVPSADSETPLTQDRPGS(ph)PSGSEDK_,0.08,-0.09,-0.24,0.24,-0.28,-0.01,0.17,-0.08,0.24,0.01,0.24,0.45,-0.17,0.14,0.03,0.3,-0.01,0.02,-0.14,0.05,0.13,0.35,-0.01,0.17,,,,,,,0,0,,,GTPase activator activity,positive regulation of GTPase activity,,
F6RY50,Q96FS4,Signal-induced proliferation-associated protein 1,SIPA1,74.49,74.49,S888,SETPLTQDRPGSPSGSEDKGNPAPELRASFL,_PSVPSADSETPLTQDRPGSPSGS(ph)EDK_,0.23, , ,0.24, , , , ,0.59, , ,0.45, , , , ,0.23,0.24,,,0.59,0.45,,,,,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
F6RY50,Q96FS4,Signal-induced proliferation-associated protein 1,SIPA1,84.82,74.23,S1036,ESAATRLLLASKQLGSPTADLA_________,_QLGS(ph)PTADLA_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
F5GYF8,O43166,Signal-induced proliferation-associated 1-like protein 1,SIPA1L1,167.56,143.08,S1585,FPSTPTSRRALHRTLSDESIYNSQREHFFTS,_TLS(ph)DESIYNSQR_,-0.76,-1.29,-0.83,-0.53, , ,-0.32,-0.45,-0.92,-0.92,-0.68,-0.4, , ,0.03,-0.16,-1,-0.68,,-0.38,-0.92,-0.53,,-0.06,,,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
Q9P2F8-2,Q9P2F8,Signal-induced proliferation-associated 1-like protein 2,SIPA1L2,83.6,72.6,S1650,DPGSGKEFMDTTGERSPSPLTGKVNQLELIL,_EFMDTTGERS(ph)PS(ph)PLTGK_, , ,1, ,0.76,1.16,1.44,0.59, , ,0.81, ,1.1,1.22,1.53,1.19,,1,0.97,1.08,,0.81,1.16,1.37, +, +,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
Q9P2F8-2,Q9P2F8,Signal-induced proliferation-associated 1-like protein 2,SIPA1L2,83.6,72.6,S1652,GSGKEFMDTTGERSPSPLTGKVNQLELILRQ,_EFMDTTGERS(ph)PS(ph)PLTGK_, , ,1, ,0.76,1.16,1.44,0.59, , ,0.81, ,1.1,1.22,1.53,1.19,,1,0.97,1.08,,0.81,1.16,1.37, +, +,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
Q9P2F8-2,Q9P2F8,Signal-induced proliferation-associated 1-like protein 2,SIPA1L2,71.14,61.61,S1461,HVLSKEDFLKLMLPDSPLVEEGRRKFSFYGN,_LMLPDS(ph)PLVEEGR_, , ,-0.12, , , ,0.51, , , ,-0.26, , , ,0.57, ,,-0.12,,0.51,,-0.26,,0.57,,,,,,,NA,NA,,,GTPase activator activity,positive regulation of GTPase activity,,
Q96EB6,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,179.71,179.63,S14,__MADEAALALQPGGSPSAAGADREAASSPA,_(ac)ADEAALALQPGGS(ph)PSAAGADR_,-0.06,0.01,-0.08,-0.19,0.13,-0.05,-0.17,-0.21,-0.2,-0.16,-0.25,0.04,0.01,-0.37,-0.3,-0.4,-0.02,-0.13,0.04,-0.19,-0.18,-0.1,-0.17,-0.35,,,,,,,0,0,,chromatin silencing complex,metal ion binding,angiogenesis,,
Q96EB6,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,179.71,179.63,S27,GGSPSAAGADREAASSPAGEPLRKRPRRDGP,_(ac)ADEAALALQPGGS(ph)PSAAGADREAASS(ph)PAGEPLR_, , , , ,-0.42, , , , , , , ,-0.9, , , ,,,-0.42,,,,-0.9,,,,,,,,NA,NA,,chromatin silencing complex,metal ion binding,angiogenesis,,
Q8IXJ6-4,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,SIRT2,154.35,153.48,S23,HPLETQAGKVQEAQDSDSDSEGGAAGGEADM,_VQEAQDS(ph)DS(ph)DSEGGAAGGEADMDFLR_, , , , ,0.24,0.42,0.34,0.38, , , , ,0.25,0.27,0.24,0.36,,,0.34,0.36,,,0.26,0.3,,,,,,,NA,NA,,chromatin silencing complex,NAD+ binding,cell division,,
Q8IXJ6-4,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,SIRT2,154.35,153.48,S25,LETQAGKVQEAQDSDSDSEGGAAGGEADMDF,_VQEAQDS(ph)DS(ph)DSEGGAAGGEADMDFLR_, , , , ,0.26,0.3,0.4,0.38, , , , ,0.27,0.09,0.25,0.36,,,0.28,0.39,,,0.18,0.3,,,,,,,NA,NA,,chromatin silencing complex,NAD+ binding,cell division,,
Q8IXJ6-4,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,SIRT2,54.51,53.69,S27,TQAGKVQEAQDSDSDSEGGAAGGEADMDFLR,_VQEAQDSDS(ph)DS(ph)EGGAAGGEADM(ox)DFLR_, , , , ,0.26, ,0.46, , , , , ,0.29, ,0.2, ,,,0.26,0.46,,,0.29,0.2,,,,,,,NA,NA,,chromatin silencing complex,NAD+ binding,cell division,,
Q9Y6E7,Q9Y6E7,NAD-dependent protein deacetylase sirtuin-4,SIRT4,121.29,79.64,S54,LDPEKVKELQRFITLSKRLLVMTGAGISTES,_FITLS(ph)KR_,-8.77, , ,-8.44, , , , ,-1.24, , ,-1.73, , , , ,-8.77,-8.44,,,-1.24,-1.73,,, +, +,,,,,NA,NA,,mitochondrial matrix,hydrolase activity,chromatin silencing,,
Q8IX90-3,Q8IX90,Spindle and kinetochore-associated protein 3,SKA3,108.41,92.86,S155,DPPVASSCISEKSPRSPQLSDFGLERYIVSQ,_S(ph)PQLSDFGLER_,-0.23,-0.09, ,0.65,1.11,1.2,0.64,0.88,-0.19,-0.02, ,0.58,0.59,0.84,0.39,0.85,-0.16,0.65,1.15,0.76,-0.1,0.58,0.72,0.64, +,,,,,,1,0,34.09,condensed chromosome outer kinetochore,,cell division,,
Q8IX90-3,Q8IX90,Spindle and kinetochore-associated protein 3,SKA3,83.7,81.04,S152,DLSDPPVASSCISEKSPRSPQLSDFGLERYI,_S(ph)PRS(ph)PQLSDFGLER_, , , , ,1.03, , , , , , , ,0.83, , , ,,,1.03,,,,0.83,, +,,,,,,NA,NA,,condensed chromosome outer kinetochore,,cell division,,
F8VS23,Q15477,Helicase SKI2W,SKIV2L,128.68,111.56,S256,TVSASPCSAPLARASSLEDLVLKEASTAVST,_ASS(ph)LEDLVLK_,0.08,0.13,0.02,0.24,0.11,0.09,0.06,0,0.1,0.1,0.1,0.24,0.05,0.04,0.07,0.02,0.11,0.13,0.1,0.03,0.1,0.17,0.04,0.04,,,,,,,0,0,,,,,,
Q9UP95-3,Q9UP95,Solute carrier family 12 member 4,SLC12A4,102.73,94.06,S964,EAQLVKDRHSALRLESLYSDEEDESAVGADK,_LES(ph)LYS(ph)DEEDESAVGADK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to plasma membrane,potassium:chloride symporter activity,cell volume homeostasis,,
Q9UP95-3,Q9UP95,Solute carrier family 12 member 4,SLC12A4,280.21,266.06,S967,LVKDRHSALRLESLYSDEEDESAVGADKIQM,_LESLYS(ph)DEEDESAVGADK_,0.09,-0.05,-0.03,-0.04,-0.29,-0.01,-0.22,-0.15,-0.02,-0.23,0.12,-0.04,0.14,0.14,-0.07,-0.1,0.02,-0.04,-0.14,-0.19,-0.12,0.04,0.14,-0.08,,,,,,,0,0,,integral to plasma membrane,potassium:chloride symporter activity,cell volume homeostasis,,
Q9UHW9-3,Q9UHW9,Solute carrier family 12 member 6,SLC12A6,187.16,187.16,S1029,EAQLVKDRNSMLRLTSIGSDEDEETETYQEK,_LTS(ph)IGS(ph)DEDEETETYQEK_, , , , ,1.75,0.73,0.98,0.48, , , , ,2.21,1.41,1.4,1.38,,,1.33,0.75,,,1.86,1.39, +, +,,,,,NA,NA,,basolateral plasma membrane,potassium:chloride symporter activity,angiogenesis,,
Q9UHW9-3,Q9UHW9,Solute carrier family 12 member 6,SLC12A6,230,213.99,S1032,LVKDRNSMLRLTSIGSDEDEETETYQEKVHM,_LTS(ph)IGS(ph)DEDEETETYQEK_,0.35,0.02,-0.31, ,-0.17,0.03,0.05,0.05,0.04,-0.3,-0.67, ,0.25,0.38,0.14,0.35,0.19,-0.31,-0.07,0.05,-0.12,-0.67,0.32,0.25,,,,,,,0,0,,basolateral plasma membrane,potassium:chloride symporter activity,angiogenesis,,
H0YB78,Q9Y666,Solute carrier family 12 member 7,SLC12A7,135.43,88.61,T980,AARTQAPPTPDKVQMTWTREKLIAE______,_VQMT(ph)WTR_,1.37,1.29,1.24,1.29,1.98,2.19,1.59,2.13,0.83,0.76,0.89,1.04,0.55,0.07,0.67,1.05,1.33,1.27,2.09,1.89,0.8,0.97,0.33,0.87, +,,,,,,2,0,8.9,,,,,
P53985,P53985,Monocarboxylate transporter 1,SLC16A1,279.77,279.77,S467,QKANEQKKESKEEETSIDVAGKPNEVTKAAE,_EEETS(ph)IDVAGKPNEVTK_,0.09,-0.06,-0.05,-0.06,0.24,0.03,0.67,0.03,0.06,-0.06,-0.01,-0.03,0.13,-0.17,0.53,0.2,0.01,-0.06,0.14,0.39,0,-0.02,-0.02,0.37,,,,,,,0,0,,integral to membrane,mevalonate transmembrane transporter activity,blood coagulation,,
O15427,O15427,Monocarboxylate transporter 4,SLC16A3,228.17,225.8,S464,AEPEKNGEVVHTPETSV______________,_NGEVVHTPETS(ph)V_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cytoskeleton,monocarboxylic acid transmembrane transporter activity,blood coagulation,,
O15427,O15427,Monocarboxylate transporter 4,SLC16A3,112.12,109.7,T460,HFLKAEPEKNGEVVHTPETSV__________,_NGEVVHT(ph)PET(ph)SV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cytoskeleton,monocarboxylic acid transmembrane transporter activity,blood coagulation,,
O15427,O15427,Monocarboxylate transporter 4,SLC16A3,234.83,233.06,T463,KAEPEKNGEVVHTPETSV_____________,_NGEVVHTPET(ph)SV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cytoskeleton,monocarboxylic acid transmembrane transporter activity,blood coagulation,,
F5H843,O60669,Monocarboxylate transporter 2,SLC16A7,119.72,108.12,S469,SKHSEDVNVKVSNAQSVTSERETNI______,_VSNAQS(ph)VTS(ph)ERETNI_, , , , ,0.23, , ,0.41, , , , ,-0.24, , ,0.07,,,0.23,0.41,,,-0.24,0.07,,,,,,,NA,NA,,integral to membrane,secondary active monocarboxylate transmembrane transporter activity,,,
F5H843,O60669,Monocarboxylate transporter 2,SLC16A7,119.72,108.12,S472,SEDVNVKVSNAQSVTSERETNI_________,_VSNAQS(ph)VTS(ph)ERETNI_, , , , ,0.23, , ,0.41, , , , ,-0.24, , ,0.07,,,0.23,0.41,,,-0.24,0.07,,,,,,,NA,NA,,integral to membrane,secondary active monocarboxylate transmembrane transporter activity,,,
H0Y7R2,P43005,Excitatory amino acid transporter 3,SLC1A1,85.08,82,S517,SYVNGGFAVDKSDTISFTQTSQF________,_SDTIS(ph)FTQTSQF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,membrane,sodium:dicarboxylate symporter activity,,,
H0Y7R2,P43005,Excitatory amino acid transporter 3,SLC1A1,75.76,75.06,S522,GFAVDKSDTISFTQTSQF_____________,_SDTIS(ph)FTQTS(ph)QF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,membrane,sodium:dicarboxylate symporter activity,,,
Q08357,Q08357,Sodium-dependent phosphate transporter 2,SLC20A2,185.92,126.31,S256,KITGKLQKEGALSRVSDESLSKVQEAESPVF,_EGALSRVS(ph)DES(ph)LSK_,0.28,0.1,0.43,0.47,0.32,0.4,0.13,0.44,0.16,0.04,0.14,0.2,0.18,0.04,0.07,0.25,0.19,0.45,0.36,0.29,0.1,0.17,0.11,0.16,,,,,,,0,0,,integral to plasma membrane,inorganic phosphate transmembrane transporter activity,virus-host interaction,,
Q08357,Q08357,Sodium-dependent phosphate transporter 2,SLC20A2,185.92,126.31,S259,GKLQKEGALSRVSDESLSKVQEAESPVFKEL,_EGALSRVS(ph)DES(ph)LSK_,0.28,0.1,0.43,0.62,0.32,0.4,0.13,0.44,0.16,0.04,0.14,0.11,0.18,0.04,0.07,0.25,0.19,0.52,0.36,0.29,0.1,0.13,0.11,0.16,,,,,,,0,0,,integral to plasma membrane,inorganic phosphate transmembrane transporter activity,virus-host interaction,,
B4DJZ1,Q9UGH3,Solute carrier family 23 member 2,SLC23A2,169.33,167.46,S78,ENGIAEKSSLAETLDSTGSLDPQRSDMIYTI,_SS(ph)LAETLDS(ph)TGS(ph)LDPQR_, , , , ,0.32,0.13,0.22,-0.7, , , , ,0.63,0.57,0.31,-0.4,,,0.22,-0.17,,,0.6,0,,,,,,,NA,NA,,membrane,transporter activity,transmembrane transport,,
B4DJZ1,Q9UGH3,Solute carrier family 23 member 2,SLC23A2,169.33,167.46,S81,IAEKSSLAETLDSTGSLDPQRSDMIYTIEDV,_SSLAETLDS(ph)TGS(ph)LDPQR_, , , , ,0.34,0.13,0.22,-0.7, , , , ,0.56,0.57,0.31,-0.4,,,0.24,-0.17,,,0.56,0,,,,,,,NA,NA,,membrane,transporter activity,transmembrane transport,,
P50443,P50443,Sulfate transporter,SLC26A2,83.98,83.58,S12,____MSSESKEQHNVSPRDSAEGNDSYPSGI,_EQHNVS(ph)PRDS(ph)AEGNDSYPSGIHLELQR_, , ,-0.92, , , , , , , ,-0.65, , , , , ,,-0.92,,,,-0.65,,,,,,,,,NA,NA,,integral to plasma membrane,secondary active sulfate transmembrane transporter activity,ossification,,
G3XAC1,Q9BXS9,Solute carrier family 26 member 6,SLC26A6,122.01,119.59,S752,DAVTFALQHPRPVPDSPVSVTRL________,_PVPDS(ph)PVS(ph)VTRL_,0.09,0.02,0.13,-0.19,0.05,0.29,0.37,0,-0.12,-0.47,-0.08,-0.21,-0.25,0.7,0.38,0.08,0.05,-0.02,0.17,0.19,-0.29,-0.14,0.3,0.24,,,,,,,0,0,,integral to membrane,secondary active sulfate transmembrane transporter activity,sulfate transport,,
G3XAC1,Q9BXS9,Solute carrier family 26 member 6,SLC26A6,122.01,119.59,S755,TFALQHPRPVPDSPVSVTRL___________,_PVPDS(ph)PVS(ph)VTRL_, , , , ,0.05,-0.13,-0.12,0, , , , ,-0.25,-0.11,-0.08,0.08,,,-0.04,-0.06,,,-0.18,0,,,,,,,NA,NA,,integral to membrane,secondary active sulfate transmembrane transporter activity,sulfate transport,,
Q14542-3,Q14542,Equilibrative nucleoside transporter 2,SLC29A2,112.64,111.71,S252,TKAELLQSDENGIPSSPQKVALTLDLDLEKE,_AELLQSDENGIPSS(ph)PQK_,-0.12,0.15,0.82,1.2, , , , ,-0.25,-0.27,0.82,0.53, , , , ,0.02,1.02,,,-0.26,0.68,,, +,,,,,,NA,NA,,basolateral plasma membrane,nucleoside transmembrane transporter activity,cell proliferation,,
F8WC15,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,192.22,189.69,S490,SDKTPEELFHPLGADSQV_____________,_TPEELFHPLGADS(ph)QV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q96QE2,Q96QE2,Proton myo-inositol cotransporter,SLC2A13,141,140.6,S640,RYIEYIRVKGSNYHLSDNDASDVE_______,_GSNYHLS(ph)DNDAS(ph)DVE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,substrate-specific transmembrane transporter activity,transmembrane transport,,
Q96QE2,Q96QE2,Proton myo-inositol cotransporter,SLC2A13,144.51,130.81,S645,IRVKGSNYHLSDNDASDVE____________,_GSNYHLS(ph)DNDAS(ph)DVE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,substrate-specific transmembrane transporter activity,transmembrane transport,,
B4DDM2,Q8TB61,Adenosine 3'-phospho 5'-phosphosulfate transporter 1,SLC35B2,83.09,64.67,S427,RGRLKQRGKKAVPVESPVQKV__________,_AVPVES(ph)PVQKV_,-0.02,-0.09,-0.24,-0.18,-0.01,0.04,0.16,0.08,0.12,0.17,0.18,0.15,0.21,0.25,0.07,-0.1,-0.05,-0.21,0.02,0.12,0.15,0.17,0.23,-0.01,,,,,,,0,0,,integral to membrane,,transmembrane transport,,
Q8TBE7,Q8TBE7,Solute carrier family 35 member G2,SLC35G2,111.7,103.98,S409,YWRNLRKQDYQEILDSPIK____________,_QDYQEILDS(ph)PIK_, , ,0.96, , , ,1.82, , , ,1.45, , , ,1.98, ,,0.96,,1.82,,1.45,,1.98, +, +,,,,,NA,NA,,Golgi apparatus,,,,
F8VX12,Q9H2H9,Sodium-coupled neutral amino acid transporter 1,SLC38A1,188.26,115.99,S52,GQINSKFISDRESRRSLTNSHLEKKKCDEYI,_S(ph)LTNS(ph)HLEK_,1.55,1.56,1.92,1.74,0.95,0.68,0.82,0.91,0.76,0.84,0.77,0.78,1.16,0.87,0.58,0.6,1.56,1.83,0.82,0.86,0.8,0.78,1.02,0.59, +, +,,,,,5,1,14.56,axon,L-glutamine transmembrane transporter activity,,,
F8VX12,Q9H2H9,Sodium-coupled neutral amino acid transporter 1,SLC38A1,146.59,89.63,S56,SKFISDRESRRSLTNSHLEKKKCDEYIPGTT,_S(ph)LTNS(ph)HLEK_,1.38,1.57,2.1, ,1.08,1.25,0.82,0.91,0.64,0.9,1.32, ,1.18,1.31,0.58,0.6,1.48,2.1,1.17,0.86,0.77,1.32,1.25,0.59, +, +,,,,,4,4,20.41,axon,L-glutamine transmembrane transporter activity,,,
F8VX12,Q9H2H9,Sodium-coupled neutral amino acid transporter 1,SLC38A1,127.13,127.02,S25,LTELQNMTVPEDDNISNDSNDFTEVENGQIN,_SGLELTELQNMTVPEDDNIS(ph)NDS(ph)NDFTEVENGQINSK_, ,0.37, , ,-0.12, , , , ,-0.11, , ,0.23, , , ,0.37,,-0.12,,-0.11,,0.23,,,,,,,,NA,NA,,axon,L-glutamine transmembrane transporter activity,,,
F8VX12,Q9H2H9,Sodium-coupled neutral amino acid transporter 1,SLC38A1,150.44,98.91,T54,INSKFISDRESRRSLTNSHLEKKKCDEYIPG,_SLT(ph)NSHLEK_, , , , , , ,0.83,1.08, , , , , , ,1.03,0.96,,,,0.96,,,,0.99,,,,,,,NA,NA,,axon,L-glutamine transmembrane transporter activity,,,
F8VUY8,Q96QD8,Sodium-coupled neutral amino acid transporter 2,SLC38A2,246.31,245.46,Y41,FNYSYPTKQAALKSHYADVDPENQNFLLESN,_SHY(ph)ADVDPENQNFLLESNLGK_,0.17, ,1.53, ,0.51,0.32,0.4,0.34,0.2, ,0.62, ,0.68,0.56,0.66,0.57,0.17,1.53,0.41,0.37,0.2,0.62,0.62,0.62, +,,,,,,4,0,12.03,,,,,
F8VUY8,Q96QD8,Sodium-coupled neutral amino acid transporter 2,SLC38A2,98.76,92.33,S22,GRFSISPDEDSSSYSSNSDFNYSYPTKQAAL,_FSISPDEDSSS(ph)YSS(ph)NSDFNYSYPTK_, , , , , ,0.17,0.27,0.3, , , , , ,0.2,0.57,0.55,,,0.17,0.29,,,0.2,0.56,,,,,,,NA,NA,,,,,,
C9JJU1,Q8WUX1,Sodium-coupled neutral amino acid transporter 5,SLC38A5,109.79,105.03,Y19,QDPKMNGALPSDAVGYRQEREGFLPSRGPAP,_MNGALPSDAVGY(ph)RQER_, , ,2.32, ,2.64, , , , , ,1.61, ,2.63, , , ,,2.32,2.64,,,1.61,2.63,, +, +,,,,,NA,NA,,integral to membrane,glycine transmembrane transporter activity,,,
C9JJU1,Q8WUX1,Sodium-coupled neutral amino acid transporter 5,SLC38A5,91.59,90.9,S14,__MELQDPKMNGALPSDAVGYRQEREGFLPS,_MNGALPS(ph)DAVGYRQER_, , ,3.1, , , , , , , ,2.37, , , , , ,,3.1,,,,2.37,,, +, +,,,,,NA,NA,,integral to membrane,glycine transmembrane transporter activity,,,
Q9ULF5,Q9ULF5,Zinc transporter ZIP10,SLC39A10,277.76,238.21,S591,RLNETELTDLEGQQESPPKNYLCIEEEKIID,_PLAGTDDS(ph)VVS(ph)EDRLNETELTDLEGQQES(ph)PPK_,0.08,-0.02,-0.12,0.23,-0.02,-0.11,0.08,-0.03,0.15,0.08,0.09,0.28,-0.05,0.18,-0.05,0.7,0.03,0.07,-0.07,0.02,0.11,0.19,0.07,0.38,,,,,,,0,0,,integral to membrane,metal ion transmembrane transporter activity,transmembrane transport,,
Q9ULF5,Q9ULF5,Zinc transporter ZIP10,SLC39A10,167.99,164.24,S570,DSDWLQLKPLAGTDDSVVSEDRLNETELTDL,_PLAGTDDS(ph)VVS(ph)EDR_, , , , , ,0.11,0.12,-0.16, , , , , ,-0.02,0.04,-0.12,,,0.11,-0.01,,,-0.02,-0.03,,,,,,,NA,NA,,integral to membrane,metal ion transmembrane transporter activity,transmembrane transport,,
Q9ULF5,Q9ULF5,Zinc transporter ZIP10,SLC39A10,167.99,164.24,S573,WLQLKPLAGTDDSVVSEDRLNETELTDLEGQ,_PLAGTDDS(ph)VVS(ph)EDR_, , , , , ,0.11,0.12,-0.16, , , , , ,-0.02,0.04,-0.12,,,0.11,-0.01,,,-0.02,-0.03,,,,,,,NA,NA,,integral to membrane,metal ion transmembrane transporter activity,transmembrane transport,,
B4DWH6,Q13433,Zinc transporter ZIP6,SLC39A6,168,161.72,S478,DVEIKKQLSKYESQLSTNEEKVDTDDRTEGY,_YESQLS(ph)TNEEK_, , ,1.09,1.45,1.2,0.93,0.87, , , ,1.48,1.84,1.72,1.46,0.9, ,,1.28,1.07,0.87,,1.67,1.6,0.9, +, +,,,,,NA,NA,,membrane,metal ion transmembrane transporter activity,apoptotic signaling pathway,,
P08195-2,P08195-2,4F2 cell-surface antigen heavy chain,SLC3A2,77.28,76.37,S2,______________MSQDTEVDMKEVELNEL,_(ac)S(ph)QDTEVDMK_, , ,-0.75,-0.65, , , , , , ,-1.06,-1.11, , , , ,,-0.7,,,,-1.09,,,, +,,,,,NA,NA,,apical plasma membrane,calcium:sodium antiporter activity,blood coagulation,,
C9JSZ2,Q96NT5,Proton-coupled folate transporter,SLC46A1,152.68,132.08,S458,LEKADPHLEFQQFPQSP______________,_ADPHLEFQQFPQS(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,transporter activity,transmembrane transport,,
Q9BWU0,Q9BWU0,Kanadaptin,SLC4A1AP,154.66,137.94,S712,THFKETQTHENMSQLSEEEQNKDYQDCSKTT,_ETQTHENMSQLS(ph)EEEQNK_,0.67,0.56, , ,-0.31, , ,-0.02,0.3,0.21, , ,-0.2, , ,-0.11,0.62,,-0.31,-0.02,0.26,,-0.2,-0.11,,,,,,,NA,NA,,cytoplasm,double-stranded RNA binding,,,
Q9BWU0,Q9BWU0,Kanadaptin,SLC4A1AP,316.52,316.52,S312,KQQQILLEKKMLGEDSDEEEEMDTSERKINA,_MLGEDS(ph)DEEEEMDTSERK_,-0.03,-0.07,-0.1,-0.06,-0.07,-0.13,0.07,-0.12,0.04,0.04,-0.04,-0.02,0,0.01,0.03,0.1,-0.05,-0.08,-0.1,-0.03,0.04,-0.03,0,0.07,,,,,,,0,0,,cytoplasm,double-stranded RNA binding,,,
Q9BWU0,Q9BWU0,Kanadaptin,SLC4A1AP,355.1,348.87,S466,RKRKAKNWEDEDFYDSDDDTFLDRTGLIEKK,_NWEDEDFYDS(ph)DDDTFLDR_,-0.05,-0.13,-0.14,-0.19,-0.19,-0.1,-0.09,-0.15,-0.07,-0.08,-0.08,-0.03,0,0.12,-0.05,0.03,-0.09,-0.16,-0.15,-0.12,-0.08,-0.05,0.06,-0.01,,,,,,,0,0,,cytoplasm,double-stranded RNA binding,,,
P04920-2,P04920,Anion exchange protein 2,SLC4A2,72.29,70.92,Y73,GGEEPGRSYGEEDFEYHRQSSHHIHHPLSTH,_SYGEEDFEY(ph)HR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,basolateral plasma membrane,anion transmembrane transporter activity,bicarbonate transport,,
Q9Y6M7-4,Q9Y6M7,Sodium bicarbonate cotransporter 3,SLC4A7,119.66,118.96,S403,DNSKSGEIKGNGSGGSRENSTVDFSKVDMNF,_GNGSGGS(ph)RENSTVDFSK_,0.89,0.96,1.08,1.13,-0.03, , ,-0.64,0.4,0.31,0.11,0.3,-0.3, , ,-0.77,0.92,1.11,-0.03,-0.64,0.35,0.21,-0.3,-0.77, +,,,,,,5,0,26.36,apical plasma membrane,inorganic anion exchanger activity,auditory receptor cell development,+,
Q9Y6M7-4,Q9Y6M7,Sodium bicarbonate cotransporter 3,SLC4A7,112.41,107.68,S1213,SFEDEPRKKYVDAETSL______________,_YVDAETS(ph)L_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,apical plasma membrane,inorganic anion exchanger activity,auditory receptor cell development,+,
Q9H2J7,Q9H2J7,Sodium-dependent neutral amino acid transporter B(0)AT2,SLC6A15,83.88,83.88,S55,IVDGQEEKDTDVEEGSEVEDERPAWNSKLQY,_DTDVEEGS(ph)EVEDERPAWNSK_,0.31, ,0.69,0.65, , , , ,0.09, ,-0.24,-0.31, , , , ,0.31,0.67,,,0.09,-0.28,,,,,,,,,NA,NA,,integral to membrane,neurotransmitter transporter activity,leucine transport,,
Q9H2J7,Q9H2J7,Sodium-dependent neutral amino acid transporter B(0)AT2,SLC6A15,130.87,82.64,S687,DDTSLIHGKIPSEMPSPNFGKNIYRKQSGSP,_IPSEMPS(ph)PNFGK_, , , ,0.46,0.38,0.2,0.09, , , , ,0.12,0.49,0.33,0.06, ,,0.46,0.29,0.09,,0.12,0.41,0.06,,,,,,,NA,NA,,integral to membrane,neurotransmitter transporter activity,leucine transport,,
P52569,P52569,Low affinity cationic amino acid transporter 2,SLC7A2,43.7,42.19,Y621,SLEGHLRDENNEEDAYPDNVHAAAEEKSAIQ,_DENNEEDAY(ph)PDNVHAAAEEK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,basic amino acid transmembrane transporter activity,cellular amino acid metabolic process,,
Q01650,Q01650,Large neutral amino acids transporter small subunit 1,SLC7A5,121.91,118.05,S31,AEEKEEAREKMLAAKSADGSAPAGEGEGVTL,_S(ph)ADGSAPAGEGEGVTLQR_, , , , ,-0.19,-0.04,-0.04,-0.01, , , , ,-0.66,-0.02,-0.18,-0.06,,,-0.11,-0.02,,,-0.31,-0.12,,,,,,,NA,NA,,apical plasma membrane,L-amino acid transmembrane transporter activity,blood coagulation,,
Q01650,Q01650,Large neutral amino acids transporter small subunit 1,SLC7A5,250.27,249.09,S35,EEAREKMLAAKSADGSAPAGEGEGVTLQRNI,_SADGS(ph)APAGEGEGVTLQR_,-0.3,-0.26,-0.2,-0.52,-0.24,-0.34,-0.19,-0.15,-0.36,-0.23,-0.14,-0.41,-0.1,-0.17,-0.09,-0.27,-0.28,-0.35,-0.29,-0.17,-0.29,-0.27,-0.14,-0.18,,,,,,,0,0,,apical plasma membrane,L-amino acid transmembrane transporter activity,blood coagulation,,
Q96CW6,Q96CW6,Probable RNA polymerase II nuclear localization protein SLC7A6OS,SLC7A6OS,241.29,241.29,S302,WSKYPLDVQKEFGYDSPHDLDSD________,_EFGYDS(ph)PHDLDS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q96CW6,Q96CW6,Probable RNA polymerase II nuclear localization protein SLC7A6OS,SLC7A6OS,275.82,217.5,S308,DVQKEFGYDSPHDLDSD______________,_EFGYDS(ph)PHDLDS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,,protein transport,,
Q5TBB2,P19634,Sodium/hydrogen exchanger,SLC9A1,106.14,73.85,S703,AHKLDSPTMSRARIGSDPLAYEPKEDLPVIT,_IGS(ph)DPLAYEPK_, ,-0.17,0.36,0.24,2.03,1.65,1.38,1.38, ,0.47,0.65,0.39,1.94,2.1,1.84,1.35,-0.17,0.3,1.85,1.38,0.47,0.52,2.02,1.62, +, +,,,,,2,2,32.08,,,,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,83.69,70.57,S2,______________MSADAAAGAPLPRLCCL,_(ac)S(ph)ADAAAGAPLPR_,1.13, , , ,0.66,0.72,0.24,0.42,0.82, , , ,0.1,0.17,-0.39,-0.05,1.13,,0.69,0.33,0.82,,0.14,-0.21, +,,,,,,NA,NA,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,262.21,262.21,S280,QKENSREALAEAALESPRPALVRSASSDTSE,_EALAEAALES(ph)PRPALVR_,-0.04,-0.08,0.24,0.23,0.16,0.2,0.04, ,-0.11,-0.1,0.56,0.37,-0.12,-0.26,-0.2, ,-0.06,0.24,0.18,0.04,-0.11,0.47,-0.19,-0.2,,,,,,,0,0,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,384.31,382.75,S290,EAALESPRPALVRSASSDTSEELNSQDSPPK,_SAS(ph)SDTSEELNSQDSPPK_,0.26,0.22,0.69,0.74,0.7,0.63,0.57,0.45,0.19,0.17,0.73,0.73,0.37,0.35,0.31,0.29,0.24,0.72,0.67,0.51,0.18,0.73,0.36,0.3,,,,,,,0,0,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,318.51,314.03,S291,AALESPRPALVRSASSDTSEELNSQDSPPKQ,_SASS(ph)DTS(ph)EELNSQDSPPK_, , ,0.75, ,0.56,0.81,0.48,0.57, , ,0.54, ,0.31,0.38,0.27,0.27,,0.75,0.69,0.53,,0.54,0.34,0.27,,,,,,,NA,NA,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,101.6,100.64,S294,ESPRPALVRSASSDTSEELNSQDSPPKQDST,_SASS(ph)DTS(ph)EELNSQDSPPK_, , , , ,0.56,0.81,0.58,0.68, , , , ,0.31,0.38,0.32,0.47,,,0.69,0.63,,,0.34,0.4,,,,,,,NA,NA,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
O14745,O14745,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,SLC9A3R1,115.2,111.67,T293,LESPRPALVRSASSDTSEELNSQDSPPKQDS,_SAS(ph)SDT(ph)SEELNSQDSPPK_, , , , , ,0.55,0.28,0.68, , , , , ,-0.39,0.25,0.25,,,0.55,0.5,,,-0.39,0.25,,,,,,,NA,NA,,actin cytoskeleton,chloride channel regulator activity,actin cytoskeleton organization,,
Q5JPP8,Q92581,Sodium/hydrogen exchanger,SLC9A6,156.18,155.52,S589,SPQAYENQEQLKDDDSDLILNDGDISLTYGD,_DDDS(ph)DLILNDGDIS(ph)LTYGDSTVNTEPATSSAPR_, , , , ,0.07,0.32, ,0.18, , , , ,0.02,0.34, ,0.45,,,0.2,0.18,,,0.19,0.45,,,,,,,NA,NA,,,,,,
Q5JPP8,Q92581,Sodium/hydrogen exchanger,SLC9A6,156.18,155.52,S599,LKDDDSDLILNDGDISLTYGDSTVNTEPATS,_DDDS(ph)DLILNDGDIS(ph)LTYGDSTVNTEPATSSAPR_, , , , ,0.07,0.32, , , , , , ,0.02,0.34, , ,,,0.2,,,,0.19,,,,,,,,NA,NA,,,,,,
B4DIV9,Q9Y2E8,Sodium/hydrogen exchanger 8,SLC9A8,166.77,166.77,S571,KTLTNKWYEEVRQGPSGSEDDEQELL_____,_(gl)QGPS(ph)GS(ph)EDDEQELL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,Golgi apparatus,potassium:hydrogen antiporter activity,regulation of intracellular pH,,
B4DIV9,Q9Y2E8,Sodium/hydrogen exchanger 8,SLC9A8,166.77,166.77,S573,LTNKWYEEVRQGPSGSEDDEQELL_______,_(gl)QGPS(ph)GS(ph)EDDEQELL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,Golgi apparatus,potassium:hydrogen antiporter activity,regulation of intracellular pH,,
C9JMF3,Q96BD0,Solute carrier organic anion transporter family member 4A1,SLCO4A1,113.86,109.13,S40,DHTPPSRRASPGTPLSPGSLRSAAHSPLDTS,_ASPGT(ph)PLS(ph)PGSLR_, , , ,0.7,-0.5,-0.38,-0.42, , , , ,1.43,-0.85,-0.4,-0.72, ,,0.7,-0.44,-0.42,,1.43,-0.61,-0.72,, +,,,,,NA,NA,,,,,,
C9JMF3,Q96BD0,Solute carrier organic anion transporter family member 4A1,SLCO4A1,80.36,53.87,S43,PPSRRASPGTPLSPGSLRSAAHSPLDTSKQP,_ASPGTPLSPGS(ph)LR_, , , , , , ,-0.42,0.59, , , , , , ,-0.72,0.74,,,,0.17,,,,0.18,,,,,,,NA,NA,,,,,,
C9JMF3,Q96BD0,Solute carrier organic anion transporter family member 4A1,SLCO4A1,113.86,109.13,T37,NGLDHTPPSRRASPGTPLSPGSLRSAAHSPL,_ASPGT(ph)PLS(ph)PGSLR_, , , , ,-0.5,-0.38,-0.42, , , , , ,-0.85,-0.4,-0.72, ,,,-0.44,-0.42,,,-0.61,-0.72,,,,,,,NA,NA,,,,,,
B4DSH5,O94991,SLIT and NTRK-like protein 5,SLITRK5,89.91,84.54,Y945,NEYLELKAKLNVEPDYLEVLEKQTTFSQF__,_LNVEPDY(ph)LEVLEK_,3.61,2.46, , , , , , ,3.8,2.62, , , , , , ,3.15,,,,3.33,,,, +, +,,,,,NA,NA,,cytoplasm,guanylate kinase activity,axon guidance,,
Q9H2G2-2,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,111.88,94.21,S779,NLSISSFLSKTKDSGSISLQETRRQKKTLKK,_DSGS(ph)ISLQETR_, , , , ,0.61,-1.02,1.25, , , , , ,2.35,-0.1,0.87, ,,,0.02,1.25,,,1.59,0.87, +, +,STE,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
Q9H2G2-2,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,290.57,262.45,S340,EETENSLPIPASKRASSDLSIASSEEDKLSQ,_RAS(ph)SDLSIASSEEDK_, , , , ,1.37, , , , , , , ,1.35, , , ,,,1.37,,,,1.35,, +, +,STE,,,,NA,NA,,cytoplasm,ATP binding,apoptotic process,,
Q14BN4-2,Q14BN4,Sarcolemmal membrane-associated protein,SLMAP,161.24,122.9,S452,ENQTRAKESDFSDTLSPSKEKSSDDTTDAQM,_ESDFSDTLS(ph)PSK_,-0.02,0.03,0.15,-0.02,-0.15,0.31,-0.15,-0.23,-0.12,-0.11,-0.14,0.04,0.3,0.49,-0.01,-0.32,0.01,0.07,0.1,-0.19,-0.11,-0.05,0.4,-0.15,,,,,,,0,0,,integral to plasma membrane,,muscle contraction,,
O00193,O00193,Small acidic protein,SMAP,436.42,419.95,S147,SPDDSESDSESEKEESAEELQAAEHPDEVED,_EES(ph)AEELQAAEHPDEVEDPK_,0.17,0.14,0.1,0.08,-0.03,0.04,0.1,0.12,0.18,0.15,0.07,0.06,-0.02,0.1,0.05,0.17,0.15,0.09,0.01,0.11,0.16,0.06,0.04,0.11,,,,,,,0,0,,,,,,
O00193,O00193,Small acidic protein,SMAP,257.64,257.55,S15,_MSAARESHPHGVKRSASPDDDLGSSNWEAA,_S(ph)AS(ph)PDDDLGSSNWEAADLGNEERK_,0.2,0.1,0.11,0.33,0.54,0.24,0.03,0.15,0,-0.19,-0.08,-0.06,0.04,0.05,-0.38,-0.01,0.15,0.22,0.4,0.09,-0.09,-0.07,0.05,-0.18,,,,,,,0,0,,,,,,
O00193,O00193,Small acidic protein,SMAP,428.26,428.26,S17,SAARESHPHGVKRSASPDDDLGSSNWEAADL,_S(ph)AS(ph)PDDDLGSSNWEAADLGNEERK_,0.1,0.1,0.13,0.16,0.08,0.02,0.03,0.07,-0.08,-0.06,-0.13,-0.08,0,-0.05,-0.02,-0.04,0.1,0.14,0.05,0.05,-0.07,-0.1,-0.03,-0.03,,,,,,,0,0,,,,,,
F6TQG2,P28370,Probable global transcription activator SNF2L1,SMARCA1,145.08,145.08,S116,QTELFAHFIQPSAQKSPTSPLNMKLGRPRIK,_S(ph)PTS(ph)PLNMK_, , , , , , ,0.18, , , , , , , ,0.34, ,,,,0.18,,,,0.34,,,,,,,NA,NA,,nucleus,ATP binding,ATP-dependent chromatin remodeling,,
F6TQG2,P28370,Probable global transcription activator SNF2L1,SMARCA1,145.08,145.08,S119,LFAHFIQPSAQKSPTSPLNMKLGRPRIKKDE,_S(ph)PTS(ph)PLNMK_, , , , ,0.3,0.18,0.18,-0.07, , , , ,0.28,0.3,0.34,0.24,,,0.24,0.06,,,0.29,0.29,,,,,,,NA,NA,,nucleus,ATP binding,ATP-dependent chromatin remodeling,,
F6TQG2,P28370,Probable global transcription activator SNF2L1,SMARCA1,142.51,142.51,T118,ELFAHFIQPSAQKSPTSPLNMKLGRPRIKKD,_SPT(ph)S(ph)PLNMK_, , , , ,0.3,0.18, ,-0.07, , , , ,0.28,0.3, ,0.24,,,0.24,-0.07,,,0.29,0.24,,,,,,,NA,NA,,nucleus,ATP binding,ATP-dependent chromatin remodeling,,
P51531-2,P51531,Probable global transcription activator SNF2L2,SMARCA2,240.18,240.18,S1568,KGKKRPNRGKAKPVVSDFDSDEEQDEREQSE,_PVVS(ph)DFDS(ph)DEEQDER_,0.25,0.65,0.25,0.76,-0.01,0,0.14,-0.08,0.11,0.08,-0.05,0.38,-0.08,-0.01,0.07,-0.09,0.47,0.53,-0.01,0.04,0.1,0.18,-0.04,-0.01,,,,,,,0,0,,intermediate filament cytoskeleton,ATP binding,aortic smooth muscle cell differentiation,,
P51531-2,P51531,Probable global transcription activator SNF2L2,SMARCA2,240.18,240.18,S1572,RPNRGKAKPVVSDFDSDEEQDEREQSEGSGT,_PVVS(ph)DFDS(ph)DEEQDER_,0.25,0.65,0.25,0.76,-0.01,0,0.14,-0.6,0.11,0.08,-0.05,0.38,-0.08,-0.01,0.07,-0.88,0.47,0.53,-0.01,-0.18,0.1,0.18,-0.04,-0.33,,,,,,,0,0,,intermediate filament cytoskeleton,ATP binding,aortic smooth muscle cell differentiation,,
P51531-2,P51531,Probable global transcription activator SNF2L2,SMARCA2,286.8,286.8,S1512,SVFKSARQKIAKEEESEDESNEEEEEEDEEE,_IAKEEES(ph)EDES(ph)NEEEEEEDEEES(ph)ESEAK_, ,-0.54,-0.82,-0.19, ,-0.54,-0.08,-1.12, ,-0.1,0.01,-0.1, ,-0.5,-0.15,-0.35,-0.54,-0.47,-0.54,-0.51,-0.1,-0.04,-0.5,-0.25,,,,,,,0,0,,intermediate filament cytoskeleton,ATP binding,aortic smooth muscle cell differentiation,,
P51531-2,P51531,Probable global transcription activator SNF2L2,SMARCA2,286.8,286.8,S1516,SARQKIAKEEESEDESNEEEEEEDEEESESE,_IAKEEES(ph)EDES(ph)NEEEEEEDEEES(ph)ESEAK_, ,-0.54,-0.82,-0.19, ,-0.54,-0.08,-1.12, ,-0.1,0.01,-0.1, ,-0.5,-0.15,-0.35,-0.54,-0.47,-0.54,-0.51,-0.1,-0.04,-0.5,-0.25,,,,,,,0,0,,intermediate filament cytoskeleton,ATP binding,aortic smooth muscle cell differentiation,,
P51531-2,P51531,Probable global transcription activator SNF2L2,SMARCA2,286.8,286.8,S1528,EDESNEEEEEEDEEESESEAKSVKVKIKLNK,_IAKEEES(ph)EDES(ph)NEEEEEEDEEES(ph)ESEAK_, ,-0.54,-0.82,-0.19, ,-0.54,0.03,-0.37, ,-0.1,0.01,-0.1, ,-0.5,-0.23,-0.09,-0.54,-0.47,-0.54,-0.16,-0.1,-0.04,-0.5,-0.16,,,,,,,0,0,,intermediate filament cytoskeleton,ATP binding,aortic smooth muscle cell differentiation,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,127.58,127.58,S610,QTPAIGPDGEPLDETSQMSDLPVKVIHVESG,_AENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK_, , ,0.16, ,-0.52,0.09,-0.09,-0.09, , ,0.25, ,-1,-0.43,0.09,0.01,,0.16,-0.18,-0.09,,0.25,-0.68,0.05,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,127.58,127.58,S613,AIGPDGEPLDETSQMSDLPVKVIHVESGKIL,_KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK_, , ,0.16, ,-0.52,-0.51,-0.1,-0.06, , ,0.25, ,-1,-0.55,0.14,-0.02,,0.16,-0.52,-0.08,,0.25,-0.75,0.06,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,126.32,126.32,S1627,GRRRPSRGSRAKPVVSDDDSEEEQEEDRSGS,_AKPVVS(ph)DDDS(ph)EEEQEEDR_, , , ,-0.14, ,-0.17,0.07,0.23, , , ,-0.59, ,0.27,0.46,0.13,,-0.14,-0.17,0.15,,-0.59,0.27,0.3,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,126.32,126.32,S1631,PSRGSRAKPVVSDDDSEEEQEEDRSGSGSEE,_AKPVVS(ph)DDDS(ph)EEEQEEDR_, , , ,-0.14, ,-0.17,0.07,0.23, , , ,-0.59, ,0.27,0.46,0.13,,-0.14,-0.17,0.15,,-0.59,0.27,0.3,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,176.8,176.37,S1570,SVFTSVRQKIEKEDDSEGEESEEEEEGEEEG,_EDDS(ph)EGEES(ph)EEEEEGEEEGSESESR_, ,-0.53, , , ,-0.37,-0.36,-0.1, ,-0.21, , , ,-0.09,-0.12,0.22,-0.53,,-0.37,-0.23,-0.21,,-0.09,0.06,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,176.8,176.37,S1575,VRQKIEKEDDSEGEESEEEEEGEEEGSESES,_EDDS(ph)EGEES(ph)EEEEEGEEEGSESESR_, ,-0.53, , , ,-0.37,-0.36,-0.1, ,-0.21, , , ,-0.09,-0.12,0.22,-0.53,,-0.37,-0.23,-0.21,,-0.09,0.06,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,176.8,176.37,S1586,EGEESEEEEEGEEEGSESESRSVKVKIKLGR,_EDDS(ph)EGEES(ph)EEEEEGEEEGS(ph)ESESR_, ,-0.53, , , ,-0.37,-0.35,-0.35, ,-0.21, , , ,-0.09,-0.17,-0.27,-0.53,,-0.37,-0.35,-0.21,,-0.09,-0.22,,,,,,,NA,NA,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,136.59,136.59,S695,PTLPVEEKKKIPDPDSDDVSEVDARHIIENA,_KIPDPDS(ph)DDVSEVDAR_,-0.16,-0.27,-0.27,-0.03,-0.02, ,0.07,0.31,-0.11,-0.3,-0.21,-0.04,0.09, ,-0.3,-0.12,-0.21,-0.14,-0.02,0.2,-0.2,-0.12,0.09,-0.21,,,,,,,0,0,,,,,,
B1A8Z4,P51532,Transcription activator BRG1,SMARCA4,76.42,75.99,T609,GQTPAIGPDGEPLDETSQMSDLPVKVIHVES,_KAENAEGQTPAIGPDGEPLDET(ph)S(ph)QMSDLPVK_, , , , , ,0.69,-0.24,-0.28, , , , , ,-0.31,0.16,0.01,,,0.69,-0.26,,,-0.31,0.09,,,,,,,NA,NA,,,,,,
O60264,O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,143.24,142.19,S66,AGPADAEMEEIFDDASPGKQKEIQEPDPTYE,_GGPEGVAAQAVASAASAGPADAEMEEIFDDAS(ph)PGK_, , , , , ,-0.08,0.18, , , , , , ,0.3,-0.3, ,,,-0.08,0.18,,,0.3,-0.3,,,,,,,NA,NA,,chromatin silencing complex,ATP binding,CENP-A containing nucleosome assembly at centromere,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,75.66,75.25,S239,DDQSIKKTRLDHGEESNESAESSSNWEKQES,_LDHGEES(ph)NES(ph)AES(ph)SSNWEK_, , , , ,-0.26,-0.36, ,0.04, , , , ,0.28,-0.02, ,0.36,,,-0.31,0.04,,,0.14,0.36,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,75.66,75.25,S242,SIKKTRLDHGEESNESAESSSNWEKQESIVL,_LDHGEES(ph)NES(ph)AES(ph)SSNWEK_, , , , ,-0.26,-0.36, ,0.04, , , , ,0.28,-0.02, ,0.36,,,-0.31,0.04,,,0.14,0.36,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,200.07,197.57,S124,TVQEKTFNKDTVIIVSEPSEDEESQGLPTMA,_DTVIIVS(ph)EPS(ph)EDEESQGLPTMAR_, ,0.15, ,0.03,-0.03,-0.02,-0.16,-0.15, ,0.1, ,0.07,0.13,0.19,0.06,-0.09,0.15,0.03,-0.02,-0.16,0.1,0.07,0.16,-0.01,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,200.07,197.57,S127,EKTFNKDTVIIVSEPSEDEESQGLPTMARRN,_DTVIIVS(ph)EPS(ph)EDEESQGLPTMAR_, ,0.15, ,0.03,-0.03,-0.02,-0.16,-0.15, ,0.1, ,0.07,0.13,0.19,0.06,-0.09,0.15,0.03,-0.02,-0.16,0.1,0.07,0.16,-0.01,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,123.52,120.35,S132,KDTVIIVSEPSEDEESQGLPTMARRNDDISE,_DTVIIVS(ph)EPS(ph)EDEES(ph)QGLPTMAR_, , , , ,-0.2,-0.36,0.26,0.04, , , , ,-0.37,-0.43,0.28,0.24,,,-0.28,0.15,,,-0.4,0.26,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,87.24,86.05,S96,SYFKNQRGIQYIDLSSDSEDVVSPNCSNTVQ,_GIQYIDLSS(ph)DS(ph)EDVVSPNCSNTVQEK_, , , , ,-0.3,-0.29,-0.38, , , , , ,0.19,0.28,0.21, ,,,-0.3,-0.38,,,0.24,0.21,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,87.24,86.05,S98,FKNQRGIQYIDLSSDSEDVVSPNCSNTVQEK,_GIQYIDLSS(ph)DS(ph)EDVVSPNCSNTVQEK_, , , , ,-0.3,-0.29,-0.38, , , , , ,0.19,0.28,0.21, ,,,-0.3,-0.38,,,0.24,0.21,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,203.51,203.51,S211,LMFGDAGGGPRKRKLSSSSEPYEEDEFNDDQ,_KLS(ph)S(ph)SS(ph)EPYEEDEFNDDQSIK_,0.23,0.2,0.37,0.23,0.36,-0.37,0.57,0.85,0.16,0.22,0.25,0.03,0.54,-0.88,0.55,0.8,0.22,0.3,0.04,0.71,0.19,0.15,-0.01,0.68,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,203.51,203.51,S212,MFGDAGGGPRKRKLSSSSEPYEEDEFNDDQS,_KLS(ph)S(ph)SS(ph)EPYEEDEFNDDQSIK_,0.23,0.2,0.37,0.23,-0.25,-0.37,0.57,0.67,0.16,0.22,0.25,0.03,-0.53,-0.88,0.55,0.65,0.22,0.3,-0.31,0.62,0.19,0.15,-0.7,0.6,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,194.37,194.37,S213,FGDAGGGPRKRKLSSSSEPYEEDEFNDDQSI,_KLSS(ph)S(ph)S(ph)EPYEEDEFNDDQSIK_,0.23,0.2,0.37,0.23,-0.25,-0.37, ,0.48,0.16,0.22,0.25,0.03,-0.53,-0.88, ,0.48,0.22,0.3,-0.31,0.48,0.19,0.15,-0.7,0.48,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,203.51,203.51,S214,GDAGGGPRKRKLSSSSEPYEEDEFNDDQSIK,_KLSS(ph)S(ph)S(ph)EPYEEDEFNDDQSIK_,0.23,0.35,0.37,0.23,0.88,0.38,0.57,-0.29,0.16,0.11,0.25,0.03,1.08,0.41,0.55,-0.24,0.29,0.3,0.66,0.2,0.14,0.15,0.78,0.21,,,,,,,0,0,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,57.06,56.54,S28,KRNKIEEAPEATPQPSQPGPSSPISLSAEEE,_IEEAPEATPQPS(ph)QPGPS(ph)SPISLS(ph)AEEENAEGEVSR_, , , , , , , ,-0.5, , , , , , , ,0.38,,,,-0.5,,,,0.38,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,63.4,63.29,S37,EATPQPSQPGPSSPISLSAEEENAEGEVSRA,_IEEAPEATPQPSQPGPSS(ph)PIS(ph)LS(ph)AEEENAEGEVSR_, , , , ,-0.36,-0.47,-1.15,-0.25, , , , ,-0.23,-0.48,0.01,0.12,,,-0.41,-0.63,,,-0.35,0.07,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,141.16,137.69,S39,TPQPSQPGPSSPISLSAEEENAEGEVSRANT,_IEEAPEATPQPSQPGPSS(ph)PISLS(ph)AEEENAEGEVS(ph)R_, ,0.12, , ,-0.18,-0.55,-0.3,-0.36, ,0.28, , ,0.02,0.74,0.43,0.12,0.12,,-0.35,-0.33,0.28,,0.43,0.28,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q9H4L7,Q9H4L7,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1,SMARCAD1,141.16,137.69,S50,PISLSAEEENAEGEVSRANTPDSDITEKTED,_IEEAPEATPQPSQPGPSS(ph)PISLS(ph)AEEENAEGEVS(ph)R_, ,0.58, , ,-0.33,-0.16,-0.03,-0.12, ,0.75, , ,-0.2,-0.04,0.05,0.08,0.58,,-0.24,-0.07,0.75,,-0.12,0.07,,,,,,,NA,NA,,heterochromatin,ATP binding,ATP-dependent chromatin remodeling,,
Q92922,Q92922,SWI/SNF complex subunit SMARCC1,SMARCC1,129.77,47.87,S310,SFRQRISTKNEEPVRSPERRDRKASANARKR,_NEEPVRS(ph)PERR_,-0.31,-0.29,-0.26, ,-0.06,0.07,0.1,0.02,-0.25,-0.45,-0.28, ,-0.27,0.31,0.03,-0.23,-0.3,-0.26,0,0.06,-0.35,-0.28,0.05,-0.1,,,,,,,0,0,,nBAF complex,chromatin binding,chromatin remodeling,,
Q92922,Q92922,SWI/SNF complex subunit SMARCC1,SMARCC1,122.51,122.51,S328,RRDRKASANARKRKHSPSPPPPTPTESRKKS,_RKHS(ph)PS(ph)PPPPTPTESR_,0.11,-0.21,-0.09,0.08,-0.28,-0.1, , ,-0.08,-0.05,-0.23,-0.05,-0.11,0.01, , ,-0.04,0,-0.19,,-0.06,-0.14,-0.05,,,,,,,,NA,NA,,nBAF complex,chromatin binding,chromatin remodeling,,
Q92922,Q92922,SWI/SNF complex subunit SMARCC1,SMARCC1,122.51,122.51,S330,DRKASANARKRKHSPSPPPPTPTESRKKSGK,_RKHS(ph)PS(ph)PPPPTPTESR_,0.11,-0.21,-0.09,0.08,-0.28,-0.1, , ,-0.08,-0.05,-0.23,-0.05,-0.11,0.01, , ,-0.04,0,-0.19,,-0.06,-0.14,-0.05,,,,,,,,NA,NA,,nBAF complex,chromatin binding,chromatin remodeling,,
Q8TAQ2-2,Q8TAQ2,SWI/SNF complex subunit SMARCC2,SMARCC2,123.83,123.83,S286,KISAKTLTDEVNSPDSDRRDKKGGNYKKRKR,_TLTDEVNSPDS(ph)DRR_,-0.09,-0.23,-0.22,-0.29, , ,-1.1, ,-0.12,-0.06,-0.1,0.12, , ,-0.74, ,-0.16,-0.25,,-1.1,-0.09,0.01,,-0.74, +,,,,,,NA,NA,,nBAF complex,chromatin binding,chromatin remodeling,,
Q8TAQ2-2,Q8TAQ2,SWI/SNF complex subunit SMARCC2,SMARCC2,132.94,132.46,S347,REEEQEDLTKDMDEPSPVPNVEEVTLPKTVN,_DMDEPS(ph)PVPNVEEVTLPK_,-0.14,-0.1,-0.23,-0.06,-0.26,-0.06,-0.09,-0.21,0.08,0.08,0.04,0.05,-0.02,0.08,-0.08,0.15,-0.12,-0.14,-0.15,-0.15,0.08,0.04,0.03,0.04,,,,,,,0,0,,nBAF complex,chromatin binding,chromatin remodeling,,
Q8TAQ2-2,Q8TAQ2,SWI/SNF complex subunit SMARCC2,SMARCC2,220.14,216.37,S283,RRKKISAKTLTDEVNSPDSDRRDKKGGNYKK,_TLTDEVNS(ph)PDSDRR_,-0.29,-0.21,-0.37,-0.47,-0.13, ,-0.37, ,-0.26,-0.12,-0.06,-0.32,0.45, ,-0.48, ,-0.25,-0.42,-0.13,-0.37,-0.19,-0.18,0.45,-0.48,,,,,,,0,0,,nBAF complex,chromatin binding,chromatin remodeling,,
Q9UQE7,Q9UQE7,Structural maintenance of chromosomes protein 3,SMC3,220.52,220.52,S1067,KATLVMKKGDVEGSQSQDEGEGSGESERGSG,_KGDVEGSQS(ph)QDEGEGSGESER_,-0.15, ,-0.13,0.76, ,0.02,-0.08,-0.03,0.19, ,0.12,0.31, ,0.06,-0.06,-0.08,-0.15,0.38,0.02,-0.05,0.19,0.22,0.06,-0.07,,,,,,,0,0,,basement membrane,ATP binding,cytokinesis,,
Q9NTJ3,Q9NTJ3,Structural maintenance of chromosomes protein 4,SMC4,347.66,327.67,S41,ASSDAEPEPPSGRTESPATAAETASEELDNR,_TES(ph)PATAAETASEELDNR_,-0.26,-0.2,-0.35,-0.27,-0.29,-0.17,-0.15,-0.17,-0.06,-0.08,-0.11,-0.13,-0.12,-0.16,-0.18,-0.22,-0.23,-0.31,-0.23,-0.16,-0.07,-0.12,-0.14,-0.2,,,,,,,0,0,,condensin complex,ATP binding,cell division,,
Q9NTJ3,Q9NTJ3,Structural maintenance of chromosomes protein 4,SMC4,231.18,231.18,S22,QPSTARRREEGPPPPSPDGASSDAEPEPPSG,_RREEGPPPPS(ph)PDGASS(ph)DAEPEPPSGR_,0.16,0.26,0.26,0.2,0.46,0.26,0.16, ,-0.01,0.04,0.15,0.34,-0.08,0.42,-0.07, ,0.21,0.23,0.36,0.16,0.02,0.25,0.19,-0.07,,,,,,,0,0,,condensin complex,ATP binding,cell division,,
Q9NTJ3,Q9NTJ3,Structural maintenance of chromosomes protein 4,SMC4,231.18,231.18,S28,RREEGPPPPSPDGASSDAEPEPPSGRTESPA,_RREEGPPPPS(ph)PDGASS(ph)DAEPEPPSGR_,-0.06,-0.06,-0.2,-0.26,-0.04,0.25,-0.45, ,-0.4,-0.22,0.07,1.16,-0.39,0.42,-0.88, ,-0.06,-0.23,0.11,-0.45,-0.31,0.72,0.07,-0.88,,,,,,,0,0,,condensin complex,ATP binding,cell division,,
Q8TEV9-2,Q8TEV9,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,SMCR8,40.41,40.41,S489,VLGTEKSTSVLSKSDSQASLTVPLSPQVVRS,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_, , , , , ,-0.61, , , , , , , ,-0.36, , ,,,-0.61,,,,-0.36,,,,,,,,NA,NA,,nucleus,,,,
Q8TEV9-2,Q8TEV9,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,SMCR8,40.41,40.41,S492,TEKSTSVLSKSDSQASLTVPLSPQVVRSKAV,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_, , , , , ,-0.61, , , , , , , ,-0.36, , ,,,-0.61,,,,-0.36,,,,,,,,NA,NA,,nucleus,,,,
Q8TEV9-2,Q8TEV9,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,SMCR8,40.41,40.41,S498,VLSKSDSQASLTVPLSPQVVRSKAVSHRTIS,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_, , , , , ,-0.61, , , , , , , ,-0.36, , ,,,-0.61,,,,-0.36,,,,,,,,NA,NA,,nucleus,,,,
Q8TEV9-2,Q8TEV9,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,SMCR8,77.74,43.87,S417,SLEECPIPKVLISVGSYKSSVESVLIKMEQE,_VLISVGS(ph)YK_,0.22,0.24,0.15,0.56, , , , ,0,-0.08,-0.15,0.15, , , , ,0.23,0.37,,,-0.04,0.01,,,,,,,,,NA,NA,,nucleus,,,,
Q6IN85,Q6IN85,Serine/threonine-protein phosphatase 4 regulatory subunit 3A,SMEK1,57.9,57.88,S771,LTSQSSTTNLPGSPGSPGSPGSPGSPGSVPK,_TNLTSQSSTTNLPGSPGS(ph)PGSPGS(ph)PGS(ph)PGSVPK_, , , , ,0.23,0.05,0.19, , , , , ,0.35,-0.12,0.06, ,,,0.14,0.19,,,0.13,0.06,,,,,,,NA,NA,,cytoplasm,,positive regulation of gluconeogenesis,,
Q6IN85,Q6IN85,Serine/threonine-protein phosphatase 4 regulatory subunit 3A,SMEK1,69.39,68.33,S774,QSSTTNLPGSPGSPGSPGSPGSPGSVPKNTS,_TNLTSQSSTTNLPGSPGS(ph)PGS(ph)PGSPGS(ph)PGSVPK_, , , , ,0.23,0.05, ,-0.03, , , , ,0.35,-0.12, ,0.06,,,0.14,-0.03,,,0.13,0.06,,,,,,,NA,NA,,cytoplasm,,positive regulation of gluconeogenesis,,
Q6IN85,Q6IN85,Serine/threonine-protein phosphatase 4 regulatory subunit 3A,SMEK1,313.16,304.1,S117,GKDPSVDITQDLVDESEEERFDDMSSPGLEL,_DPSVDITQDLVDES(ph)EEER_, , , ,0.52,0.57,0.74,0.33,0.41, , , ,0.39,0.03,0.85,0.19,0.21,,0.52,0.65,0.37,,0.39,0.5,0.2,,,,,,,NA,NA,,cytoplasm,,positive regulation of gluconeogenesis,,
Q96Q15-2,Q96Q15,Serine/threonine-protein kinase SMG1,SMG1,150.22,148.99,S3570,MSQNARKLIQKNLATSADTPPSTVPGTGKSV,_NLATS(ph)ADT(ph)PPSTVPGTGK_,0.36,0.31,0.01,0.12,-0.1,-0.07,0.13,0.09,-0.15,0.01,-0.47,-0.25,-0.21,-0.07,0.09,0.03,0.33,0.06,-0.09,0.11,-0.07,-0.35,-0.14,0.06,,,Atypical,,,,0,0,,cytosol,ATP binding,DNA repair,,
Q96Q15-2,Q96Q15,Serine/threonine-protein kinase SMG1,SMG1,150.22,148.99,T3573,NARKLIQKNLATSADTPPSTVPGTGKSVACS,_NLATS(ph)ADT(ph)PPSTVPGTGK_,0.36,0.31,0.01,0.12,-0.1,-0.07,0.13,0.09,-0.15,0.01,-0.47,-0.25,-0.21,-0.07,0.09,0.03,0.33,0.06,-0.09,0.11,-0.07,-0.35,-0.14,0.06,,,Atypical,,,,0,0,,cytosol,ATP binding,DNA repair,,
Q86US8,Q86US8,Telomerase-binding protein EST1A,SMG6,211.25,208.13,S484,TQTPQLHFLDTDDEVSPTSWGDSRQAQASYY,_TQTPQLHFLDT(ph)DDEVS(ph)PTSWGDSR_, , , , ,1.02, , , , , , , ,0.9, , , ,,,1.02,,,,0.9,, +,,,,,,NA,NA,,"chromosome, telomeric region",endoribonuclease activity,gene expression,,
Q86US8,Q86US8,Telomerase-binding protein EST1A,SMG6,211.25,208.13,T479,KPALKTQTPQLHFLDTDDEVSPTSWGDSRQA,_TQTPQLHFLDT(ph)DDEVS(ph)PTSWGDSR_, , , , ,1.02, , , , , , , ,0.9, , , ,,,1.02,,,,0.9,, +,,,,,,NA,NA,,"chromosome, telomeric region",endoribonuclease activity,gene expression,,
Q9H0W8-2,Q9H0W8,Protein SMG9,SMG9,141.91,136.38,S2,______________MSESGHSQPGLYGIERR,_(ac)S(ph)ESGHS(ph)QPGLYGIER_, , , , , ,0.54,0.71, , , , , , ,0.14,0.48, ,,,0.54,0.71,,,0.14,0.48,,,,,,,NA,NA,,cytosol,,gene expression,,
Q9H0W8-2,Q9H0W8,Protein SMG9,SMG9,226.23,218.96,S4,____________MSESGHSQPGLYGIERRRR,_(ac)SES(ph)GHS(ph)QPGLYGIER_, , , , ,0.44,0.36,0.52,0.21, , , , ,0.24,-0.16,0.1,0.13,,,0.4,0.37,,,0.05,0.12,,,,,,,NA,NA,,cytosol,,gene expression,,
Q9H0W8-2,Q9H0W8,Protein SMG9,SMG9,226.23,218.96,S7,_________MSESGHSQPGLYGIERRRRWKE,_(ac)SES(ph)GHS(ph)QPGLYGIER_, , , , ,0.44,-0.15,0.16,0.59, , , , ,0.24,-0.38,-0.03,0.21,,,0.18,0.39,,,-0.04,0.09,,,,,,,NA,NA,,cytosol,,gene expression,,
Q9H0W8-2,Q9H0W8,Protein SMG9,SMG9,110.1,110.1,S32,RRRWKEPGSGGPQNLSGPGGRERDYIAPWER,_WKEPGSGGPQNLS(ph)GPGGR_,0.36,0.07,-0.05, , ,0.39,0.2,0.15,0.49,0.23,0.01, , ,0.28,0.15,-0.11,0.22,-0.05,0.39,0.18,0.37,0.01,0.28,0.03,,,,,,,0,0,,cytosol,,gene expression,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,80.36,78.95,S4,____________MAMSSGGSGGGVPEQEDSV,_(ac)AMS(ph)S(ph)GGS(ph)GGGVPEQEDSVLFR_, , , ,3.44, , ,1.57,0.28, , , ,0.31, , ,-0.1,0.22,,3.44,,1.06,,0.31,,0.07, +,,,,,,NA,NA,,cytoplasm,RNA binding,mRNA processing,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,80.36,78.95,S5,___________MAMSSGGSGGGVPEQEDSVL,_(ac)AMS(ph)S(ph)GGS(ph)GGGVPEQEDSVLFR_, , , ,3.44, , ,1.57,0.28, , , ,0.31, , ,-0.1,0.22,,3.44,,1.06,,0.31,,0.07, +,,,,,,NA,NA,,cytoplasm,RNA binding,mRNA processing,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,80.36,78.95,S8,________MAMSSGGSGGGVPEQEDSVLFRR,_(ac)AMS(ph)S(ph)GGS(ph)GGGVPEQEDSVLFR_, , , ,3.44, , ,1.57,0.28, , , ,0.31, , ,-0.1,0.22,,3.44,,1.06,,0.31,,0.07, +,,,,,,NA,NA,,cytoplasm,RNA binding,mRNA processing,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,309.58,292.51,S28,PEQEDSVLFRRGTGQSDDSDIWDDTALIKAY,_RGT(ph)GQS(ph)DDS(ph)DIWDDTALIK_,-0.06,-0.12,-0.07,-0.04,0.17,0.01,0.11,0.11,-0.18,-0.18,-0.07,-0.08,0.07,0.26,0.04,0.07,-0.09,-0.05,0.09,0.11,-0.18,-0.07,0.17,0.05,,,,,,,0,0,,cytoplasm,RNA binding,mRNA processing,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,295.8,295.8,S31,EDSVLFRRGTGQSDDSDIWDDTALIKAYDKA,_RGT(ph)GQS(ph)DDS(ph)DIWDDTALIK_,0.05,-0.05,0.01,0.01,0.17,0.43,0.24,0.22,0.07,0.25,0.12,0.14,0.06,0.37,0.16,0.16,0,0.01,0.3,0.23,0.16,0.13,0.22,0.16,,,,,,,0,0,,cytoplasm,RNA binding,mRNA processing,,
B4DP61,Q16637,Survival motor neuron protein,SMN2,205.83,205.34,T25,GGVPEQEDSVLFRRGTGQSDDSDIWDDTALI,_RGT(ph)GQS(ph)DDS(ph)DIWDDTALIK_, ,0.06,0.07, ,-0.02,0.12,0.06,0.22, ,0.11,0.06, ,-0.08,0.15,-0.03,0.17,0.06,0.07,0.05,0.14,0.11,0.06,0.04,0.07,,,,,,,0,0,,cytoplasm,RNA binding,mRNA processing,,
O95863,O95863,Zinc finger protein SNAI1,SNAI1,42.62,42.37,S92,LRLQESPRVAELTSLSDEDSGKGSQPPSPPS,_VAELTSLS(ph)DEDS(ph)GK_, , , , ,-0.28, , ,-0.54, , , , ,0.29, , ,-0.02,,,-0.28,-0.54,,,0.29,-0.02,,,,,,,NA,NA,,cytoplasm,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,cartilage morphogenesis,,
O95863,O95863,Zinc finger protein SNAI1,SNAI1,42.62,42.37,S96,ESPRVAELTSLSDEDSGKGSQPPSPPSPAPS,_VAELTSLS(ph)DEDS(ph)GK_, , , , ,-0.28, , ,-0.54, , , , ,0.29, , ,-0.02,,,-0.28,-0.54,,,0.29,-0.02,,,,,,,NA,NA,,cytoplasm,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription,cartilage morphogenesis,,
O00161,O00161,Synaptosomal-associated protein 23,SNAP23,117.8,105.88,S5,___________MDNLSSEEIQQRAHQITDES,_(ac)MDNLS(ph)SEEIQQR_, , , , ,-0.29, , ,-0.49, , , , ,1.32, , ,0.16,,,-0.29,-0.49,,,1.32,0.16,, +,,,,,NA,NA,,azurophil granule,,cellular membrane fusion,,
Q5SXM2,Q5SXM2,snRNA-activating protein complex subunit 4,SNAPC4,225.07,225.07,S599,RGGAGAWLGGPAASLSPPKGSSASQGGSKEA,_GGAGAWLGGPAASLS(ph)PPKGSSASQGGSK_,0.11,0.22,0.2,0.14, ,-0.04,-0.08,0.01,-0.11,-0.13,-0.23,-0.08, ,0.04,-0.06,-0.2,0.17,0.17,-0.04,-0.04,-0.12,-0.15,0.04,-0.12,,,,,,,0,0,,snRNA-activating protein complex,chromatin binding,snRNA transcription from RNA polymerase II promoter,,
Q5SXM2,Q5SXM2,snRNA-activating protein complex subunit 4,SNAPC4,181.89,180.94,S1398,PQGVRTTLSVPSRVGSESEDEDLLSELELAD,_VGS(ph)ES(ph)EDEDLLS(ph)ELELADR_, , , , ,-0.24, , ,-0.1, , , , ,-0.04, , ,0.2,,,-0.24,-0.1,,,-0.04,0.2,,,,,,,NA,NA,,snRNA-activating protein complex,chromatin binding,snRNA transcription from RNA polymerase II promoter,,
Q5SXM2,Q5SXM2,snRNA-activating protein complex subunit 4,SNAPC4,181.89,180.94,S1400,GVRTTLSVPSRVGSESEDEDLLSELELADRD,_VGS(ph)ES(ph)EDEDLLS(ph)ELELADR_, , , , ,-0.24, , ,-0.1, , , , ,-0.04, , ,0.2,,,-0.24,-0.1,,,-0.04,0.2,,,,,,,NA,NA,,snRNA-activating protein complex,chromatin binding,snRNA transcription from RNA polymerase II promoter,,
Q5SXM2,Q5SXM2,snRNA-activating protein complex subunit 4,SNAPC4,181.89,180.94,S1407,VPSRVGSESEDEDLLSELELADRDGQPGCTT,_VGS(ph)ES(ph)EDEDLLS(ph)ELELADR_, , , , ,-0.24, , ,-0.1, , , , ,-0.04, , ,0.2,,,-0.24,-0.1,,,-0.04,0.2,,,,,,,NA,NA,,snRNA-activating protein complex,chromatin binding,snRNA transcription from RNA polymerase II promoter,,
O75971-2,O75971,snRNA-activating protein complex subunit 5,SNAPC5,337.43,334.3,S96,KSHVTEEEEEEEEEESDS_____________,_SHVTEEEEEEEEEES(ph)DS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleoplasm,sequence-specific DNA binding transcription factor activity,transcription from RNA polymerase II promoter,,
O75971-2,O75971,snRNA-activating protein complex subunit 5,SNAPC5,249.86,247.71,S98,HVTEEEEEEEEEESDS_______________,_SHVTEEEEEEEEEESDS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleoplasm,sequence-specific DNA binding transcription factor activity,transcription from RNA polymerase II promoter,,
O75971-2,O75971,snRNA-activating protein complex subunit 5,SNAPC5,171.13,170.53,T85,SINQTTLELSTKSHVTEEEEEEEEEESDS__,_SHVT(ph)EEEEEEEEEESDS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleoplasm,sequence-specific DNA binding transcription factor activity,transcription from RNA polymerase II promoter,,
O95295,O95295,SNARE-associated protein Snapin,SNAPIN,117.48,94.3,S133,ARRRAMLDSGIYPPGSPGK____________,_AMLDSGIYPPGS(ph)PGK_, , , , , ,0.41,0.42, , , , , , ,0.16,0.15, ,,,0.41,0.42,,,0.16,0.15,,,,,,,NA,NA,,BLOC-1 complex,SNARE binding,anterograde axon cargo transport,,
Q7KZF4,Q7KZF4,Staphylococcal nuclease domain-containing protein 1,SND1,52.17,51.48,Y728,NMRNDIASHPPVEGSYAPRRGEFCIAKFVDG,_NDIASHPPVEGSY(ph)APR_, , ,1.96, , , , , , , ,2.26, , , , , ,,1.96,,,,2.26,,, +, +,,,,,NA,NA,,cytoplasm,nuclease activity,gene silencing by RNA,,
Q7KZF4,Q7KZF4,Staphylococcal nuclease domain-containing protein 1,SND1,114.63,112.24,S727,ENMRNDIASHPPVEGSYAPRRGEFCIAKFVD,_NDIASHPPVEGS(ph)YAPR_, , ,2.26, , , , , , , ,2.42, , , , , ,,2.26,,,,2.42,,, +, +,,,,,NA,NA,,cytoplasm,nuclease activity,gene silencing by RNA,,
E7EVG1,Q8TAD8,Smad nuclear-interacting protein 1,SNIP1,188.71,187.79,S394,IDRKDDEDEEEEEEVSDS_____________,_KDDEDEEEEEEVS(ph)DS_, , , , , ,-0.24,0.01,-0.26, , , , , ,-0.14,-0.14,-0.08,,,-0.24,-0.12,,,-0.14,-0.11,,,,,,,NA,NA,,,,,,
E7EVG1,Q8TAD8,Smad nuclear-interacting protein 1,SNIP1,242.79,238.17,S396,RKDDEDEEEEEEVSDS_______________,_DDEDEEEEEEVSDS(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
E7EVG1,Q8TAD8,Smad nuclear-interacting protein 1,SNIP1,94.28,94.28,S35,VKSEREGVVVKQERLSPEVAPPAHRRPDHSG,_(gl)QERLS(ph)PEVAPPAHR_,-0.34,-0.47,-0.21,-0.06,-0.42,-0.11,-0.49,-0.47,-0.09,-0.11,-0.23,-0.2,0.07,0.38,-0.05,-0.27,-0.41,-0.14,-0.26,-0.48,-0.1,-0.21,0.23,-0.15,,,,,,,0,0,,,,,,
O75643,O75643,U5 small nuclear ribonucleoprotein 200 kDa helicase,SNRNP200,337.95,313.52,S225,EEGDEDVYGEVREEASDDDMEGDEAVVRCTL,_EEAS(ph)DDDMEGDEAVVR_,-0.34,-0.35,-0.5,-0.46,-0.37,-0.34,-0.39,-0.38,-0.19,-0.14,-0.25,-0.26,-0.28,-0.26,-0.32,-0.35,-0.34,-0.48,-0.35,-0.38,-0.17,-0.26,-0.27,-0.34,,,,,,,0,0,,catalytic step 2 spliceosome,ATP binding,cis assembly of pre-catalytic spliceosome,,
P08621,P08621,U1 small nuclear ribonucleoprotein 70 kDa,SNRNP70,54.19,34.19,Y126,NYDTTESKLRREFEVYGPIKRIHMVYSKRSG,_EFEVY(ph)GPIK_, , ,1, , , ,-0.1, , , ,1.48, , , ,0.35, ,,1,,-0.1,,1.48,,0.35,, +,,,,,NA,NA,,nuclear speck,nucleotide binding,"mRNA splicing, via spliceosome",,
P08621,P08621,U1 small nuclear ribonucleoprotein 70 kDa,SNRNP70,109.72,109.72,S226,SGRDDTSRYDERPGPSPLPHRDRDRDRERER,_YDERPGPS(ph)PLPHR_,-0.9,-0.56,-0.26,-0.51, , , ,-0.31,-1.23,-1.18,-0.34,-0.65, , , ,0.2,-0.72,-0.38,,-0.31,-1.2,-0.49,,0.2,, +,,,,,NA,NA,,nuclear speck,nucleotide binding,"mRNA splicing, via spliceosome",,
P08621,P08621,U1 small nuclear ribonucleoprotein 70 kDa,SNRNP70,57.15,56.83,S320,RKEELRGGGGDMAEPSEAGDAPPDDGPPGEL,_GGGGDMAEPS(ph)EAGDAPPDDGPPGELGPDGPDGPEEK_, , , , , , ,-0.04, , , , , , , ,-0.12, ,,,,-0.04,,,,-0.12,,,,,,,NA,NA,,nuclear speck,nucleotide binding,"mRNA splicing, via spliceosome",,
P08621,P08621,U1 small nuclear ribonucleoprotein 70 kDa,SNRNP70,260.44,253.51,S410,GGGGQDNGLEGLGNDSRDMYMESEGGDGYLA,_GGGGGQDNGLEGLGNDS(ph)R_,-0.57,-0.38,-0.28,-0.16,-0.4,-0.71,-0.42,-0.25,-0.31,-0.31,-0.06,0.07,-0.25,-0.29,-0.04,0.08,-0.47,-0.22,-0.55,-0.33,-0.31,0,-0.27,0.02,,,,,,,0,0,,nuclear speck,nucleotide binding,"mRNA splicing, via spliceosome",,
P09661,P09661,U2 small nuclear ribonucleoprotein A',SNRPA1,328.17,309.96,S236,KGLLQSGQIPGRERRSGPTDDGEEEMEEDTV,_S(ph)GPTDDGEEEMEEDTVTNGS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,catalytic step 2 spliceosome,RNA binding,"mRNA splicing, via spliceosome",,
Q13424,Q13424,Alpha-1-syntrophin,SNTA1,184.06,180.53,S189,PYFKNSTGGTSVGWDSPPASPLQRQPSSPGP,_NSTGGTSVGWDS(ph)PPAS(ph)PLQR_, , , , ,0.81,0.65,0.87,0.73, , , , ,0.87,0.84,0.86,0.84,,,0.74,0.8,,,0.86,0.85,,,,,,,NA,NA,,cell junction,phospholipid binding,muscle contraction,,
Q13424,Q13424,Alpha-1-syntrophin,SNTA1,184.06,180.53,S193,NSTGGTSVGWDSPPASPLQRQPSSPGPTPRN,_NSTGGTSVGWDS(ph)PPAS(ph)PLQR_, , , , ,0.81,0.65,0.87,0.73, , , , ,0.87,0.84,0.86,0.84,,,0.74,0.8,,,0.86,0.85,,,,,,,NA,NA,,cell junction,phospholipid binding,muscle contraction,,
Q13425-2,Q13425,Beta-2-syntrophin,SNTB2,68.98,53.16,S95,GDSLPGSPSRGLGPPSPPAPPRGPAGEAGAS,_GLGPPS(ph)PPAPPRGPAGEAGAS(ph)PPVRR_, , ,-0.1,0.17, , ,0.13,-0.1, , ,-0.33,0.05, , ,-0.19,0.12,,0.04,,0.02,,-0.13,,-0.02,,,,,,,NA,NA,,cell junction,phospholipid binding,,,
O95149,O95149,Snurportin-1,SNUPN,59.61,58.47,S75,NHARRLAEDDWTGMESEEENKKDDEEMDIDT,_RLAEDDWTGMES(ph)EEENK_, , , , , , ,-0.16, , , , , , , ,-0.09, ,,,,-0.16,,,,-0.09,,,,,,,NA,NA,,cytosol,protein transporter activity,ncRNA metabolic process,,
Q13573,Q13573,SNW domain-containing protein 1,SNW1,146.25,146.25,S224,PPRFKINKKIPRGPPSPPAPVMHSPSRKMTV,_GPPS(ph)PPAPVMHS(ph)PSRK_, , , , ,0.33,0.72,0.37,0.3, , , , ,0,0.45,0.31,-0.01,,,0.53,0.33,,,0.24,0.16,,,,,,,NA,NA,,catalytic step 2 spliceosome,retinoic acid receptor binding,cellular response to retinoic acid,,
Q13573,Q13573,SNW domain-containing protein 1,SNW1,146.25,146.25,S232,KIPRGPPSPPAPVMHSPSRKMTVKEQQEWKI,_GPPS(ph)PPAPVMHS(ph)PSRK_, , , , ,0.33,0.72,0.31,0.3, , , , ,0,0.45,0.33,-0.01,,,0.53,0.31,,,0.24,0.17,,,,,,,NA,NA,,catalytic step 2 spliceosome,retinoic acid receptor binding,cellular response to retinoic acid,,
Q13596-2,Q13596,Sorting nexin-1,SNX1,93.34,93.05,S32,PFPGLEPESEGAAGGSEPEAGDSDTEGEDIF,_LPPPFPGLEPESEGAAGGS(ph)EPEAGDS(ph)DT(ph)EGEDIFTGAAVVSK_, , , , ,-0.33,0.13,-0.2,-0.56, , , , ,0.11,-0.11,-0.01,-0.03,,,-0.08,-0.37,,,0.01,-0.02,,,,,,,NA,NA,,cytosol,phosphatidylinositol binding,cell communication,,
Q13596-2,Q13596,Sorting nexin-1,SNX1,93.34,93.05,S39,ESEGAAGGSEPEAGDSDTEGEDIFTGAAVVS,_LPPPFPGLEPESEGAAGGS(ph)EPEAGDS(ph)DT(ph)EGEDIFTGAAVVSK_, , , , ,-0.33,0.13,-0.2,-0.56, , , , ,0.11,-0.11,-0.01,-0.03,,,-0.08,-0.37,,,0.01,-0.02,,,,,,,NA,NA,,cytosol,phosphatidylinositol binding,cell communication,,
Q13596-2,Q13596,Sorting nexin-1,SNX1,93.34,93.05,T41,EGAAGGSEPEAGDSDTEGEDIFTGAAVVSKH,_LPPPFPGLEPESEGAAGGS(ph)EPEAGDS(ph)DT(ph)EGEDIFTGAAVVSK_, , , , ,-0.33,0.13,-0.2,-0.56, , , , ,0.11,-0.11,-0.01,-0.03,,,-0.08,-0.37,,,0.01,-0.02,,,,,,,NA,NA,,cytosol,phosphatidylinositol binding,cell communication,,
Q9UMY4-2,Q9UMY4,Sorting nexin-12,SNX12,77.78,77.78,S73,LPIFKLKESCVRRRYSDFEWLKNELERDSKI,_RYS(ph)DFEWLK_,0.1,0, ,-0.24, , , , ,-0.02,0.04, ,0.14, , , , ,0.05,-0.24,,,0.01,0.14,,,,,,,,,NA,NA,,membrane,phosphatidylinositol binding,cell communication,,
B4DQM7,Q15036,Sorting nexin-17,SNX17,60.06,56.97,S415,VGGTLRRSDSQQAVKSPPLLESPDATRESMV,_S(ph)PPLLES(ph)PDATR_, , , , ,-0.01, , , , , , , ,-0.02, , , ,,,-0.01,,,,-0.02,,,,,,,,NA,NA,,,,,,
B4DQM7,Q15036,Sorting nexin-17,SNX17,60.06,56.97,S421,RSDSQQAVKSPPLLESPDATRESMVKLSSKL,_S(ph)PPLLES(ph)PDATR_, , , , ,-0.01, , , , , , , ,-0.02, , , ,,,-0.01,,,,-0.02,,,,,,,,NA,NA,,,,,,
Q8TEQ0,Q8TEQ0,Sorting nexin-29,SNX29,87.02,84.43,S639,RQELIDLRGPVPGDLSQTSEDQSLSDFEISN,_GPVPGDLS(ph)QTS(ph)EDQSLSDFEISNR_, , , , , ,-0.61,-0.53,-0.22, , , , , ,-0.03,0.17,0.19,,,-0.61,-0.37,,,-0.03,0.18,,,,,,,NA,NA,,,phosphatidylinositol binding,cell communication,,
Q8TEQ0,Q8TEQ0,Sorting nexin-29,SNX29,87.02,84.43,S642,LIDLRGPVPGDLSQTSEDQSLSDFEISNRAL,_GPVPGDLS(ph)QTS(ph)EDQS(ph)LSDFEISNR_, , , , , ,-0.61,-0.53,-0.22, , , , , ,-0.03,0.18,0.19,,,-0.61,-0.37,,,-0.03,0.18,,,,,,,NA,NA,,,phosphatidylinositol binding,cell communication,,
Q8TEQ0,Q8TEQ0,Sorting nexin-29,SNX29,87.02,84.43,S646,RGPVPGDLSQTSEDQSLSDFEISNRALINVW,_GPVPGDLS(ph)QTS(ph)EDQS(ph)LSDFEISNR_, , , , , ,-0.4,-0.54,-0.22, , , , , ,0,0.19,0.19,,,-0.4,-0.37,,,0,0.19,,,,,,,NA,NA,,,phosphatidylinositol binding,cell communication,,
Q8TEQ0,Q8TEQ0,Sorting nexin-29,SNX29,91.12,91.12,S810,LSRGQPRETRNVEPQSGDL____________,_NVEPQS(ph)GDL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,phosphatidylinositol binding,cell communication,,
O60493,O60493,Sorting nexin-3,SNX3,84.75,84.75,S72,LPIFKLKESTVRRRYSDFEWLRSELERESKV,_RYS(ph)DFEWLR_, ,-0.19, ,-0.11, , , , , ,-0.39, ,-0.35, , , , ,-0.19,-0.11,,,-0.39,-0.35,,,,,,,,,NA,NA,,early endosome,phosphatidylinositol-3-phosphate binding,cell communication,,
Q9Y5X1,Q9Y5X1,Sorting nexin-9,SNX9,90.45,87.98,Y56,EGRNIKGERGLVPTDYVEILPSDGKDQFSCG,_GLVPTDY(ph)VEILPSDGK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,clathrin-coated vesicle,1-phosphatidylinositol binding,cell communication,,
A8MQ54,Q9Y4B5,Protein SOGA2,SOGA2,103.04,98.92,S549,EQELQKYKSLYGDVDSPLPTGEAGGPPSTRE,_SLYGDVDS(ph)PLPTGEAGGPPSTR_, , , , ,2.03, , , , , , , ,1.9, , , ,,,2.03,,,,1.9,, +, +,,,,,NA,NA,,,,,,
A8MQ54,Q9Y4B5,Protein SOGA2,SOGA2,161.1,124.32,S1421,GLPSTSSKEDVTPPLSPDDLKYIEEFNKSWD,_EDVT(ph)PPLS(ph)PDDLK_, ,-0.49, , ,0.64,0.66,0.66,0.35, ,0.4, , ,0.54,0.59,0.57,0.26,-0.49,,0.65,0.51,0.4,,0.57,0.42,,,,,,,NA,NA,,,,,,
A8MQ54,Q9Y4B5,Protein SOGA2,SOGA2,148.49,148.49,S776,SRLPQPKREGPVGGESDSEEMFEKTSGFGSG,_REGPVGGES(ph)DSEEMFEK_,-0.35,-0.56,-0.44,-0.25,0.56,0.06,-0.02, ,-0.45,-0.38,-0.41,-0.14,1.14,-0.26,0.16, ,-0.45,-0.34,0.34,-0.02,-0.42,-0.27,0.6,0.16,,,,,,,0,0,,,,,,
A8MQ54,Q9Y4B5,Protein SOGA2,SOGA2,161.1,124.32,T1417,LPEKGLPSTSSKEDVTPPLSPDDLKYIEEFN,_EDVT(ph)PPLS(ph)PDDLK_, ,-0.49, , ,0.64,0.66,0.66,0.35, ,0.4, , ,0.54,0.59,0.57,0.26,-0.49,,0.65,0.51,0.4,,0.57,0.42,,,,,,,NA,NA,,,,,,
P18583-6,P18583,Protein SON,SON,175.01,154.89,S1697,PLPVKESDQTLAALLSPKESSGGEKEVPPPP,_ESDQTLAALLS(ph)PK_,-0.01,-0.09,-0.22,-0.1,-0.16,0.38,-0.24,-0.25,-0.09,-0.13,-0.42,-0.16,0.04,0.24,-0.18,0.07,-0.05,-0.16,0.14,-0.24,-0.11,-0.28,0.15,-0.05,,,,,,,0,0,,nuclear speck,DNA binding,cytokinesis,,
P18583-6,P18583,Protein SON,SON,104.3,104.3,S2011,SRRRRSRSVVRRRSFSISPVRLRRSRTPLRR,_RRS(ph)FS(ph)IS(ph)PVR_,-0.41,-0.49,-0.7,-0.65,-0.21,-0.03,0.05,0.08,-0.14,-0.29,-0.5,-0.6,0.04,0.13,0,0.14,-0.45,-0.68,-0.11,0.07,-0.21,-0.55,0.08,0.07,,,,,,,0,0,,nuclear speck,DNA binding,cytokinesis,,
P18583-6,P18583,Protein SON,SON,104.3,104.3,S2013,RRRSRSVVRRRSFSISPVRLRRSRTPLRRRF,_RRS(ph)FS(ph)IS(ph)PVR_,-0.41,-0.49,-0.7,-0.65,-0.21,-0.03,0.05,0.08,-0.14,-0.29,-0.5,-0.6,0.04,0.13,0,0.14,-0.45,-0.68,-0.11,0.07,-0.21,-0.55,0.08,0.07,,,,,,,0,0,,nuclear speck,DNA binding,cytokinesis,,
P18583-6,P18583,Protein SON,SON,51.73,51.73,S1950,SRRRRSRSVGRRRSFSISPSRRSRTPSRRSR,_SFS(ph)IS(ph)PSR_, , , , , ,0.03,0.48,-0.19, , , , , ,-0.17,0.37,0.04,,,0.03,0.18,,,-0.17,0.21,,,,,,,NA,NA,,nuclear speck,DNA binding,cytokinesis,,
P18583-6,P18583,Protein SON,SON,51.73,51.73,S1952,RRRSRSVGRRRSFSISPSRRSRTPSRRSRTP,_SFS(ph)IS(ph)PSRR_, , , , , ,0.03,0.48,-0.19, , , , , ,-0.17,0.37,0.04,,,0.03,0.18,,,-0.17,0.21,,,,,,,NA,NA,,nuclear speck,DNA binding,cytokinesis,,
P18583-6,P18583,Protein SON,SON,116.06,101.66,T1691,SKDTEEPLPVKESDQTLAALLSPKESSGGEK,_ESDQT(ph)LAALLSPK_, , , , , ,-0.04, , , , , , , ,0.21, , ,,,-0.04,,,,0.21,,,,,,,,NA,NA,,nuclear speck,DNA binding,cytokinesis,,
E9PAS5,O94875,Sorbin and SH3 domain-containing protein 2,SORBS2,57.8,57.8,S278,VGPPRGLGDQSASRTSPGRVDLPGSSTTLTK,_TS(ph)PGRVDLPGSSTTLTK_, , , , ,-0.27, ,-0.7, , , , , ,0.17, ,-0.1, ,,,-0.27,-0.7,,,0.17,-0.1,,,,,,,NA,NA,,actin cytoskeleton,cytoskeletal adaptor activity,,,
O60504-2,O60504,Vinexin,SORBS3,110.77,106.62,S530,EPRLRLCDDGPQLPTSPRLTAAARSARHPSS,_LCDDGPQLPTS(ph)PR_, , , , ,0.27,0.17,0.24,0.15, , , , ,0.18,1.67,1.8,0.21,,,0.22,0.19,,,1.11,1.21,, +,,,,,NA,NA,,cytoskeleton,structural constituent of cytoskeleton,cell adhesion,,
O60504-2,O60504-2,Vinexin,SORBS3,159.77,159.77,S6,__________MADGGSPFLGRRDFVYPSSTR,_(ac)ADGGS(ph)PFLGRR_,-0.14,0.24,0.06,-0.01,-0.1,-0.01,0.06,0.01,0.61,0.67,0.57,0.5,-0.31,-0.25,0.01,-0.07,0.06,0.03,-0.06,0.03,0.64,0.54,-0.28,-0.03,,,,,,,0,0,,cytoskeleton,structural constituent of cytoskeleton,cell adhesion,,
B4DWI3,Q99523,Sortilin,SORT1,74.43,47.59,S819,VDGVDALDTASHTNKSGYHDDSDEDLLE___,_S(ph)GYHDDS(ph)DEDLLE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
B4DWI3,Q99523,Sortilin,SORT1,173.59,136.65,S825,LDTASHTNKSGYHDDSDEDLLE_________,_SGYHDDS(ph)DEDLLE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
G5E9C8,G5E9C8,Son of sevenless homolog 1,SOS1,85.18,63.63,S1119,VFDSDHSSPFHSRSASVSSISLTKGTDEVPV,_SAS(ph)VSS(ph)ISLTK_, , , , , ,2.55,1.55,1.18, , , , , ,2.2,1.49,1.24,,,2.55,1.38,,,2.2,1.37, +, +,,,,,NA,NA,,intracellular,DNA binding,regulation of Rho protein signal transduction,,
G5E9C8,Q07889,Son of sevenless homolog 1,SOS1,85.18,63.63,S1137,SDHSSPFHSRSASVSSISLTKGTDEVPVPPP,_SAS(ph)VSS(ph)ISLTK_, , , , , ,2.55,1.55,1.18, , , , , ,2.2,1.49,1.24,,,2.55,1.38,,,2.2,1.37, +, +,,,,,NA,NA,,intracellular,DNA binding,regulation of Rho protein signal transduction,,
Q53LP3,Q53LP3,Ankyrin repeat domain-containing protein SOWAHC,SOWAHC,110.44,50.28,S213,QRPARQNLRDLVMGSSPQLKRSVCPGGSSPG,_DLVMGSS(ph)PQLK_,0.03,-0.06,-0.74,-0.64,-0.27,-0.3,0.13,0.17,0.15,0.25,-0.75,-0.62,-0.36,-0.49,0.05,0.09,-0.01,-0.69,-0.29,0.15,0.2,-0.69,-0.42,0.07,,,,,,,0,0,,,,,,
Q9UN79,Q9UN79,Transcription factor SOX-13,SOX13,170.22,159.58,S613,MYRYSEDEDSEGEEKSDGELVVLTD______,_S(ph)DGELVVLT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding,anatomical structure morphogenesis,,
Q9UN79,Q9UN79,Transcription factor SOX-13,SOX13,170.22,159.58,T621,DSEGEEKSDGELVVLTD______________,_S(ph)DGELVVLT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,sequence-specific DNA binding,anatomical structure morphogenesis,,
P08047,P08047,Transcription factor Sp1,SP1,215.75,213.83,S2,______________MSDQDHSMDEMTAVVKI,_(ac)S(ph)DQDHS(ph)MDEMTAVVK_,-0.04,0.06,-0.03,-0.34,0.39,-0.65,-0.16,-0.21,0.15,0.24,-0.07,-0.19,0.56,-0.53,-0.36,0.1,0.01,-0.18,-0.03,-0.18,0.19,-0.13,0.12,-0.11,,,,,,,0,0,,cytoplasm,bHLH transcription factor binding,cellular lipid metabolic process,,
P08047,P08047,Transcription factor Sp1,SP1,212.94,201.23,S7,_________MSDQDHSMDEMTAVVKIEKGVG,_(ac)S(ph)DQDHS(ph)MDEMTAVVK_,0.12,0.07,-0.38,-0.1,0.04,0.06,-0.2,0.07,0.13,0.01,-0.23,-0.06,0.19,0.14,-0.07,-0.01,0.09,-0.23,0.05,-0.06,0.07,-0.15,0.17,-0.04,,,,,,,0,0,,cytoplasm,bHLH transcription factor binding,cellular lipid metabolic process,,
P23497,P23497,Nuclear autoantigen Sp-100,SP100,269.48,269.28,S362,APRSEPVINNDNPLESNDEKEGQEATCSRPQ,_SEPVINNDNPLES(ph)NDEK_,-0.19,0.03,-0.51,-0.34,0.09,0.2,0.05,0.11,-0.31,-0.06,-0.14,0.04,0.31,0.47,0.14,0.15,-0.08,-0.42,0.14,0.08,-0.18,-0.05,0.39,0.14,,,,,,,0,0,,cytoplasm,DNA binding,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",,
P23497,P23497,Nuclear autoantigen Sp-100,SP100,58.53,56.77,S407,RESFKKRVIGQDHDFSESSEEEAPAEASSGA,_VIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_, , , , , , , ,-0.06, , , , , , , ,0.1,,,,-0.06,,,,0.1,,,,,,,NA,NA,,cytoplasm,DNA binding,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",,
P23497,P23497,Nuclear autoantigen Sp-100,SP100,58.53,56.77,S409,SFKKRVIGQDHDFSESSEEEAPAEASSGALR,_VIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_, , , , , , , ,-0.06, , , , , , , ,0.1,,,,-0.06,,,,0.1,,,,,,,NA,NA,,cytoplasm,DNA binding,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",,
P23497,P23497,Nuclear autoantigen Sp-100,SP100,58.53,56.77,S410,FKKRVIGQDHDFSESSEEEAPAEASSGALRS,_VIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_, , , , , , , ,-0.06, , , , , , , ,0.1,,,,-0.06,,,,0.1,,,,,,,NA,NA,,cytoplasm,DNA binding,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",,
P23497,P23497,Nuclear autoantigen Sp-100,SP100,125.51,125.51,S157,KGFENVIHDKLPLQESEEEEREERSGLQLSL,_LPLQES(ph)EEEEREER_, ,-0.24, , ,0.6,-0.44,-0.16,0.03, ,-0.19, , ,-0.23,-0.7,0,-0.02,-0.24,,0.17,-0.06,-0.19,,-0.45,-0.01,,,,,,,NA,NA,,cytoplasm,DNA binding,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",,
O75391,O75391,Sperm-associated antigen 7,SPAG7,77.64,56.81,S202,KTYGCVPVANKRDTRSIEEAMNEIRAKKRLR,_S(ph)IEEAMNEIR_, , ,1.83, , , , , , , ,2.47, , , , , ,,1.83,,,,2.47,,, +, +,,,,,NA,NA,,nucleus,nucleic acid binding,,,
O75391,O75391,Sperm-associated antigen 7,SPAG7,64.45,61.83,S114,DDCRYVMIFKKEFAPSDEELDSYRRGEEWDP,_EFAPS(ph)DEELDSYR_, ,0.27,0,0.05, ,-0.24, , , ,-0.08,-0.06,-0.17, ,-1.04, , ,0.27,0.02,-0.24,,-0.08,-0.12,-1.04,,, +,,,,,NA,NA,,nucleus,nucleic acid binding,,,
O75391,O75391,Sperm-associated antigen 7,SPAG7,231.41,200.84,S158,QRQEEEAAQQGPVVVSPASDYKDKYSHLIGK,_QEEEAAQQGPVVVS(ph)PASDYK_,-0.57,-0.38,-0.21, ,0.08,0.33,-0.5,-0.06,-0.2,-0.25,0.19, ,0.01,0.56,0.36,0.66,-0.47,-0.21,0.21,-0.26,-0.22,0.19,0.31,0.52,,,,,,,0,0,,nucleus,nucleic acid binding,,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,171.05,171.05,S730,DVAGLDTEGSKQRSASQSSLDKLDQELKEQQ,_SAS(ph)QSS(ph)LDKLDQELK_,0.16,0.04,0.56,0.52,1.13,0.95, , ,0.2,0.37,0.68,0.47,1.25,1.3, , ,0.1,0.54,1.05,,0.29,0.58,1.28,, +, +,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,171.05,171.05,S733,GLDTEGSKQRSASQSSLDKLDQELKEQQKEL,_SAS(ph)QSS(ph)LDKLDQELK_,0.13,0.11,-1.6,-1.3,1.13,0.95, , ,-0.19,0,-1.82,-1.41,1.25,1.3, , ,0.12,-1.44,1.05,,-0.09,-1.6,1.28,, +, +,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,99.06,98.59,S183,HNYMEHLERTKLHQLSGSDQLESTAHSRIRK,_LHQLS(ph)GS(ph)DQLESTAHSR_,0.11, ,-0.18,0.1, , , , ,-0.25, ,-0.46,-0.64, , , , ,0.11,-0.03,,,-0.25,-0.55,,,,,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,52.27,50.86,S185,YMEHLERTKLHQLSGSDQLESTAHSRIRKER,_LHQLS(ph)GS(ph)DQLESTAHSR_, , ,0.4, , , , , , , ,0.23, , , , , ,,0.4,,,,0.23,,,,,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,82.38,81.57,S347,SAENEEKSEVQAIIESTPELDMDKDLSGYKG,_SEVQAIIES(ph)T(ph)PELDMDK_, , , , ,0, , , , , , , ,0.28, , , ,,,0,,,,0.28,,,,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
O60271-4,O60271,C-Jun-amino-terminal kinase-interacting protein 4,SPAG9,82.38,81.57,T348,AENEEKSEVQAIIESTPELDMDKDLSGYKGS,_SEVQAIIES(ph)T(ph)PELDMDK_, , , , ,0, , , , , , , ,0.28, , , ,,,0,,,,0.28,,,,,,,,NA,NA,,acrosomal vesicle,,activation of JUN kinase activity,,
F5H3K3,Q9UM82,Spermatogenesis-associated protein 2,SPATA2,122.46,115.02,Y260,PRVTKPSRSVDAYDSYWESRKPPLKASLSLR,_SVDAYDSY(ph)WESR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
C9JLY8,Q69YQ0,Cytospin-A,SPECC1L,84.11,80.34,S220,ELRDMRAQLGINEDHSEGDEKSEKETIMAHQ,_AQLGINEDHS(ph)EGDEK_,-0.86,-0.14,-0.13,-0.64, , , ,0.9,-1.72,-0.39,-0.46,-0.73, , , ,0.18,-0.46,-0.36,,0.9,-0.9,-0.59,,0.18,,,,,,,NA,NA,,,,,,
Q96T58,Q96T58,Msx2-interacting protein,SPEN,47.33,40.48,S1380,LRKRSVRDLEPGEVPSDSDEDGEHKSHSPRA,_DLEPGEVPS(ph)DS(ph)DEDGEHK_, , , , , ,-0.33, ,-0.19, , , , , ,-0.17, ,-0.1,,,-0.33,-0.19,,,-0.17,-0.1,,,,,,,NA,NA,,transcriptional repressor complex,nucleotide binding,Notch signaling pathway,,
Q96T58,Q96T58,Msx2-interacting protein,SPEN,47.33,40.48,S1382,KRSVRDLEPGEVPSDSDEDGEHKSHSPRASA,_DLEPGEVPS(ph)DS(ph)DEDGEHK_, , , , , ,-0.33, ,-0.19, , , , , ,-0.17, ,-0.1,,,-0.33,-0.19,,,-0.17,-0.1,,,,,,,NA,NA,,transcriptional repressor complex,nucleotide binding,Notch signaling pathway,,
Q96T58,Q96T58,Msx2-interacting protein,SPEN,63.68,55.61,S2120,AAAQAGERESGVVAVSPEKSESPQKEDGLSS,_ESGVVAVS(ph)PEK_, , , , ,0.07,0.05,0.1, , , , , ,0.24,-0.05,-0.03, ,,,0.06,0.1,,,0.11,-0.03,,,,,,,NA,NA,,transcriptional repressor complex,nucleotide binding,Notch signaling pathway,,
Q9NZD8-2,Q9NZD8,Maspardin,SPG21,87.03,59.11,S304,VSAEELEVQKGSLGISQEEQ___________,_GSLGIS(ph)QEEQ_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,,antigen receptor-mediated signaling pathway,,
Q9Y657,Q9Y657,Spindlin-1,SPIN1,106.44,105.68,S199,DYKEGDLRIMPDSNDSPPAEREPGEVVDSLV,_IMPDSNDS(ph)PPAEREPGEVVDSLVGK_,-0.28,0.47,-0.43,-0.27,0.17,0.04,0.5, ,-0.01,0.15,-0.09,-0.04,0.66,-0.21,0.23, ,0.14,-0.34,0.11,0.5,0.07,-0.06,0.29,0.23,,,,,,,0,0,,nucleus,DNA binding,cell cycle,,
Q08AE8-4,Q08AE8,Protein spire homolog 1,SPIRE1,178.79,177.52,S464,QRKKLLRAPTLAELDSSESEEETLHKSTSSS,_APTLAELDS(ph)S(ph)ES(ph)EEETLHK_,0.11,0.14,0.14, ,-0.28,-0.18,-0.13,0.13,-0.25,-0.19,-0.11, ,-0.21,0.07,-0.19,-0.15,0.12,0.14,-0.23,0.01,-0.22,-0.11,-0.06,-0.17,,,,,,,0,0,,cell cortex,,cleavage furrow formation,,
Q08AE8-4,Q08AE8,Protein spire homolog 1,SPIRE1,178.79,177.52,S465,RKKLLRAPTLAELDSSESEEETLHKSTSSSS,_APTLAELDS(ph)S(ph)ES(ph)EEETLHK_,0.11,0.14,0.14, ,-0.28,-0.18,-0.13,0.13,-0.25,-0.19,-0.11, ,-0.21,0.07,-0.19,-0.15,0.12,0.14,-0.23,0.01,-0.22,-0.11,-0.06,-0.17,,,,,,,0,0,,cell cortex,,cleavage furrow formation,,
Q08AE8-4,Q08AE8,Protein spire homolog 1,SPIRE1,178.79,177.52,S467,KLLRAPTLAELDSSESEEETLHKSTSSSSVS,_APTLAELDS(ph)S(ph)ES(ph)EEETLHK_,0.11,0.14,0.14, ,-0.28,-0.18,-0.13,0.13,-0.25,-0.19,-0.11, ,-0.21,0.07,-0.19,-0.15,0.12,0.14,-0.23,0.01,-0.22,-0.11,-0.06,-0.17,,,,,,,0,0,,cell cortex,,cleavage furrow formation,,
Q08AE8-4,Q08AE8,Protein spire homolog 1,SPIRE1,112.17,91.59,T509,VSTRKKPPKFLPISSTPQPERRQPPQRRHSI,_FLPISST(ph)PQPER_,0.85,1,0.14, , ,0.01, , ,0.14,0.05,-0.23, , ,0, , ,0.93,0.14,0.01,,0.1,-0.23,0,,,,,,,,NA,NA,,cell cortex,,cleavage furrow formation,,
Q9C004-2,Q9C004,Protein sprouty homolog 4,SPRY4,73.67,73.34,Y52,ILPIDQVKTSHVENDYIDNPSLALTTGPKRT,_TSHVENDY(ph)IDNPSLALTTGPK_, , ,2.6, , , , , , , ,0.76, , , , , ,,2.6,,,,0.76,,, +,,,,,,NA,NA,,cytoplasm,,multicellular organismal development,,
Q13813-3,Q13813,"Spectrin alpha chain, non-erythrocytic 1",SPTAN1,158.89,158.89,S1217,VATFNSIKELNERWRSLQQLAEERSQLLGSA,_WRS(ph)LQQLAEER_,-0.82, ,-0.41,-0.64, , , , ,-0.14, ,-0.44,-0.47, , , , ,-0.82,-0.52,,,-0.14,-0.46,,,,,,,,,NA,NA,,cuticular plate,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,92.44,87.52,T2320,AISSDKHEVSASTQSTPASSRAQTLPTSVVT,_HEVSASTQST(ph)PASSR_, , , , ,-0.79, ,-0.6, , , , , ,-1.53, ,-1.09, ,,,-0.79,-0.6,,,-1.53,-1.09,, +,,,,,NA,NA,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,192.58,192.58,S2338,SSRAQTLPTSVVTITSESSPGKREKDKEKDK,_AQTLPTSVVTITS(ph)ESSPGKR_, , ,-0.8, ,-0.78, , , , , ,-0.73, ,-0.9, , , ,,-0.8,-0.78,,,-0.73,-0.9,,,,,,,,NA,NA,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,236.64,236.64,S2340,RAQTLPTSVVTITSESSPGKREKDKEKDKEK,_AQTLPTSVVTITSES(ph)SPGKR_,-0.36,-0.39,-0.75,-0.5, , , , ,-0.2,-0.22,-0.66,-0.37, , , , ,-0.38,-0.62,,,-0.21,-0.51,,,,,,,,,NA,NA,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,136.85,136.85,S2165,MVNGATEQRTSSKESSPIPSPTSDRKAKTAL,_ESS(ph)PIPS(ph)PTSDRK_,-0.29,-0.13,-0.13,-0.46,0.01,-0.02,-0.31,-0.39,-0.18,0.02,-0.14,-0.47,-0.15,-0.06,-0.28,-0.45,-0.21,-0.29,-0.01,-0.35,-0.08,-0.3,-0.1,-0.36,,,,,,,0,0,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,136.85,136.85,S2169,ATEQRTSSKESSPIPSPTSDRKAKTALPAQS,_ESS(ph)PIPS(ph)PTSDRK_,-0.29,-0.13,-0.13,-0.07,0.02,-0.03,-0.12,-0.24,-0.18,0.02,-0.14,-0.05,-0.09,-0.08,-0.21,-0.13,-0.21,-0.1,-0.01,-0.18,-0.08,-0.1,-0.08,-0.17,,,,,,,0,0,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,308.77,302.34,S2138,KGEQVSQNGLPAEQGSPRMAETVDTSEMVNG,_GEQVSQNGLPAEQGS(ph)PR_,-0.43,-0.53,-0.42,-0.47,-0.45,-0.29,-0.36,-0.52,-0.1,-0.09,-0.1,-0.16,-0.3,-0.19,-0.12,-0.27,-0.48,-0.45,-0.37,-0.44,-0.09,-0.13,-0.24,-0.19,,,,,,,0,0,,axolemma,actin binding,actin filament capping,,
Q01082,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,135.86,135.86,S2102,VRRQQEEEERKRRPPSPEPSTKVSEEAESQQ,_RRPPS(ph)PEPSTK_,-0.13,-0.12,-0.21,0.22,0.23,0.24,-0.05,-0.27,-0.03,-0.1,-0.03,0.15,-0.1,-0.05,-0.2,-0.45,-0.12,0.02,0.23,-0.15,-0.06,0.06,-0.07,-0.32,,,,,,,0,0,,axolemma,actin binding,actin filament capping,,
O15020-2,O15020,"Spectrin beta chain, non-erythrocytic 2",SPTBN2,93.6,93.59,S2171,QRLEHSSFPEGPGPGSGDEANGPRGERQTRT,_LEHSSFPEGPGPGS(ph)GDEANGPR_, , , , , , ,-0.51,-0.39, , , , , , ,-0.24,-0.26,,,,-0.45,,,,-0.25,,,,,,,NA,NA,,cytosol,actin binding,actin filament capping,,
Q9NRC6,Q9NRC6,"Spectrin beta chain, non-erythrocytic 5",SPTBN5,63.09,24.09,S2071,RECGRLEEILAAQEVSLKTSALGSSVEEVEQ,_LEEILAAQEVS(ph)LK_,-2.77, , , , , , , ,-0.27, , , , , , , ,-2.77,,,,-0.27,,,, +,,,,,,NA,NA,,cytosol,actin binding,actin cytoskeleton organization,,
Q13501,Q13501,Sequestosome-1,SQSTM1,152.94,101.97,S272,IDVEHGGKRSRLTPVSPESSSTEEKSSSQPS,_LTPVS(ph)PESSSTEEK_,0.86,0.66,1.02,1.15,0.34,0.35,0.48,0.31,-0.07,0.02,0.11,0.08,0.41,0.3,0.34,0.29,0.76,1.09,0.35,0.4,-0.02,0.09,0.36,0.32, +,,,,,,4,0,10.69,autophagic vacuole,protein kinase binding,apoptotic signaling pathway,,
Q13501,Q13501,Sequestosome-1,SQSTM1,85.17,73.51,T269,EVDIDVEHGGKRSRLTPVSPESSSTEEKSSS,_RSRLT(ph)PVS(ph)PESSSTEEK_,0.86,0.6,0.92,1.17,0.48, , , ,0.08,-0.01,0.12,0.36,0.7, , , ,0.73,1.05,0.48,,0.03,0.25,0.7,, +,,,,,,NA,NA,,autophagic vacuole,protein kinase binding,apoptotic signaling pathway,,
Q6ZRS2-3,Q6ZRS2,Helicase SRCAP,SRCAP,60.94,57.97,S562,DDFGVEYLLARDEEQSEADAGSGPPTPGPTT,_DEEQS(ph)EADAGS(ph)GPPT(ph)PGPTTLGPK_, , , , , ,0.31, , , , , , , ,0.16, , ,,,0.31,,,,0.16,,,,,,,,NA,NA,,Golgi apparatus,ATP binding,regulation of transcription from RNA polymerase II promoter,,
Q6ZRS2-3,Q6ZRS2,Helicase SRCAP,SRCAP,60.94,57.97,S568,YLLARDEEQSEADAGSGPPTPGPTTLGPKKE,_DEEQS(ph)EADAGS(ph)GPPT(ph)PGPTTLGPK_, , , , , ,0.31, , , , , , , ,0.16, , ,,,0.31,,,,0.16,,,,,,,,NA,NA,,Golgi apparatus,ATP binding,regulation of transcription from RNA polymerase II promoter,,
Q6ZRS2-3,Q6ZRS2,Helicase SRCAP,SRCAP,60.94,57.97,T572,RDEEQSEADAGSGPPTPGPTTLGPKKEITDI,_DEEQS(ph)EADAGS(ph)GPPT(ph)PGPTTLGPK_, , , , , ,0.31, , , , , , , ,0.16, , ,,,0.31,,,,0.16,,,,,,,,NA,NA,,Golgi apparatus,ATP binding,regulation of transcription from RNA polymerase II promoter,,
B0I4X3,P36956,Sterol regulatory element-binding protein 1,SREBP-1a (delta),126.15,121.65,S457,SLGSRGSGSGGSGSDSEPDSPVFEDSKTE__,_GS(ph)GSGGSGSDS(ph)EPDSPVFEDSK_, , ,-0.03, , ,-0.46,0.16,0.09, , ,-0.15, , ,-0.5,0.25,-0.01,,-0.03,-0.46,0.12,,-0.15,-0.5,0.12,,,,,,,NA,NA,,,,,,
Q8NEF9,Q8NEF9,Serum response factor-binding protein 1,SRFBP1,147.26,145.59,S264,GGEEFCEEEKEYFDDSTEERFYKQSSMSEDS,_EYFDDS(ph)TEER_,0.16,0.2,-0.01,0.13,-0.17,-0.25,-0.15,-0.23,-0.14,-0.07,-0.27,-0.29,-0.15,-0.28,-0.15,-0.1,0.18,0.06,-0.21,-0.19,-0.11,-0.28,-0.22,-0.13,,,,,,,0,0,,nucleus,,"regulation of transcription, DNA-dependent",,
O75044,O75044,SLIT-ROBO Rho GTPase-activating protein 2,SRGAP2,46.42,45.91,S990,DTLEPLKTSPVVAPTSEPSSPLHTQLLKDPE,_TSPVVAPTS(ph)EPSS(ph)PLHTQLLK_, , ,0.32, , , , , , , ,1.05, , , , , ,,0.32,,,,1.05,,,, +,,,,,NA,NA,,cell junction,protein homodimerization activity,actin filament severing,,
O75044,P0DJJ0,SLIT-ROBO Rho GTPase-activating protein 2,SRGAP2,73.25,69.74,S427,CFQYSNSMESVKSTVSETFMSKPSIAKRRAN,_S(ph)TVS(ph)ETFMSK_, , , , ,0.09,0.11, ,-0.51, , , , ,0.3,-0.29, ,-0.11,,,0.1,-0.51,,,0.04,-0.11,,,,,,,NA,NA,,cell junction,protein homodimerization activity,actin filament severing,,
O76094,O76094,Signal recognition particle 72 kDa protein,SRP72,118.46,118.46,S620,ATAGASSELDASKTVSSPPTSPRPGSAATVS,_TVS(ph)SPPTS(ph)PRPGSAATVSASTSNIIPPR_,0.38,0.28,0.63, , , , , ,-0.24,-0.01,0.15, , , , , ,0.33,0.63,,,-0.12,0.15,,,,,,,,,NA,NA,,cytosol,7S RNA binding,response to drug,,
Q5R363,Q96SB4,SRSF protein kinase 1,SRPK1,204.71,204.71,S309,KESGPGQKRPNKQEESESPVERPLKENPPNK,_QEES(ph)ES(ph)PVERPLK_,0.3,0.3, , ,0.39,0.19,0.44,0.34,-0.4,0.02, , ,0.3,0.26,0.31,0.23,0.3,,0.29,0.39,-0.18,,0.28,0.27,,,CMGC,,,,NA,NA,,cytoplasm,ATP binding,,,
Q5R363,Q96SB4,SRSF protein kinase 1,SRPK1,216.71,216.71,S311,SGPGQKRPNKQEESESPVERPLKENPPNKMT,_QEES(ph)ES(ph)PVERPLK_,0.15,-0.26,-0.39,0.34,-0.08,-0.15,-0.35,-0.06,-0.19,-0.37,-0.43,-0.01,-0.07,-0.11,-0.08,-0.13,-0.04,0.02,-0.12,-0.2,-0.28,-0.2,-0.09,-0.11,,,CMGC,,,,0,0,,cytoplasm,ATP binding,,,
P78362,P78362,SRSF protein kinase 2,SRPK2,87.67,53.34,S494,EQEESSPSHDRSRTVSASSTGDLPKAKTRAA,_TVS(ph)ASS(ph)TGDLPK_, , , , ,1.74,2.81,2.68,2.64, , , , ,1.84,2.76,2.89,2.56,,,2.37,2.66,,,2.37,2.73, +, +,CMGC,,,,NA,NA,,cytoplasm,14-3-3 protein binding,angiogenesis,,
P78362,P78362,SRSF protein kinase 2,SRPK2,87.67,53.34,S497,ESSPSHDRSRTVSASSTGDLPKAKTRAADLL,_TVS(ph)ASS(ph)TGDLPK_, , , , ,1.74,2.81,2.68,2.64, , , , ,1.84,2.76,2.89,2.56,,,2.37,2.66,,,2.37,2.73, +, +,CMGC,,,,NA,NA,,cytoplasm,14-3-3 protein binding,angiogenesis,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,277.31,277.31,S769,SGSPEPAAKKPPAPPSPVQSQSPSTNWSPAV,_KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPVKK_,0.02,0.03,0.05,0.09,0.31,0.15,0.62,1.34,-0.27,-0.17,-0.23,-0.22,0.22,0.34,0.31,0.3,0.02,0.07,0.23,1.02,-0.22,-0.23,0.28,0.31, +,,,,,,2,0,10.23,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,277.31,277.31,S775,AAKKPPAPPSPVQSQSPSTNWSPAVPVKKAK,_KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPVK_,0.02,0.03,0.05,0.11,0.31,0.15,0.62,1.34,-0.27,-0.17,-0.23,-0.24,0.22,0.34,0.31,0.3,0.02,0.08,0.23,1.02,-0.22,-0.24,0.28,0.31, +,,,,,,2,0,10.08,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,110.22,110.22,S605,SPSPRRYSPPIQRRYSPSPPPKRRTASPPPP,_RYS(ph)PS(ph)PPPK_,-0.02,0.03,-0.09,-0.01,-2.45,-1.27,-0.22,-0.16,0.06,0,-0.18,-0.08,-0.27,-1.44,-0.3,-0.27,0.01,-0.05,-1.74,-0.19,0.03,-0.13,-0.74,-0.29, +,,,,,,6,0,25.91,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,110.22,110.22,S607,SPRRYSPPIQRRYSPSPPPKRRTASPPPPPK,_RYS(ph)PS(ph)PPPK_,-0.02,0.03,-0.09,-0.01,-2.45,-1.27,-0.22,-0.16,0.06,0,-0.18,-0.08,-0.27,-1.44,-0.3,-0.27,0.01,-0.05,-1.74,-0.19,0.03,-0.13,-0.74,-0.29, +,,,,,,6,0,25.91,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,81.13,78.45,S738,RVSRTPEPKKIKKAASPSPQSVRRVSSSRSV,_AAS(ph)PS(ph)PQSVR_, , , , ,0.05,0.12,-0.15,-0.36, , , , ,-0.07,0.19,-0.3,-0.37,,,0.08,-0.25,,,0.06,-0.33,,,,,,,NA,NA,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,81.13,78.45,S740,SRTPEPKKIKKAASPSPQSVRRVSSSRSVSG,_AAS(ph)PS(ph)PQSVR_, , , , ,-0.99, ,0.1,-0.39, , , , ,-0.01, ,-0.08,0.27,,,-0.99,-0.13,,,-0.01,0.11,,,,,,,NA,NA,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,97.27,67.8,S696,RHSPSPRPRAPQTSSSPPPVRRGASSSPQRR,_APQTSSS(ph)PPPVRR_, , , , , , ,-0.12,-0.19, , , , , , ,-0.37,-0.17,,,,-0.16,,,,-0.27,,,,,,,NA,NA,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,413.29,413.29,S874,QEEPVAAPEPKKETESEAEDNLDDLEKHLRE,_KET(ph)ES(ph)EAEDNLDDLEK_,0.07,0.13,0.01,0.09,0.09,0.24,0.19,0.24,0.08,0.11,0,0.02,0.03,0.07,0.09,0.17,0.1,0.05,0.17,0.21,0.09,0.01,0.05,0.13,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,135.21,133.28,S402,RLSPSASPPRRRHRPSPPATPPPKTRHSPTP,_HRPS(ph)PPAT(ph)PPPK_,0.1,0.14,0.01,0.1,0.21,0.2,0.13,0.23,0.02,-0.01,-0.06,0.02,-0.12,0.07,0,0.07,0.12,0.06,0.2,0.18,0,-0.02,-0.02,0.03,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,166.87,166.87,S773,EPAAKKPPAPPSPVQSQSPSTNWSPAVPVKK,_KPPAPPS(ph)PVQS(ph)QS(ph)PSTNWS(ph)PAVPVK_, , , , ,-1.39,-0.63,-0.44,-0.36, , , , ,-0.31,-0.36,-0.32,-0.47,,,-0.96,-0.4,,,-0.34,-0.39,,,,,,,NA,NA,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,232.19,232.19,S781,APPSPVQSQSPSTNWSPAVPVKKAKSPTPSP,_KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPVK_,0.29,0.27,0.17,0.28,0.06,0.24,0.17,0.16,-0.01,0.01,0.09,0.09,-0.24,-0.11,-0.24,-0.14,0.28,0.23,0.15,0.16,0,0.09,-0.18,-0.19,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,258.61,258.61,S463,RESPSPAPKPRKVELSESEEDKGGKMAAADS,_VELS(ph)ES(ph)EEDK_,0.09,0.03,0.12,0.04,0.01,0.23,0.1,0.05,0.09,0.08,0.01,0.01,0.06,0.14,0.15,0.17,0.06,0.08,0.13,0.08,0.08,0.01,0.1,0.16,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,281.68,281.68,S465,SPSPAPKPRKVELSESEEDKGGKMAAADSVQ,_VELS(ph)ES(ph)EEDK_,0.04,0.18,-0.04,0.28,0.08,0.13,0.05,0.05,0.01,0.14,-0.16,0.18,0.26,0.15,0.17,0.07,0.11,0.13,0.1,0.05,0.08,0.02,0.2,0.12,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,155.1,155.1,S713,PPVRRGASSSPQRRQSPSPSTRPIRRVSRTP,_RQS(ph)PS(ph)PSTRPIR_,-0.03,0.07,0.02,0.05,0.07,0.07,0.08,0.07,-0.31,-0.23,-0.25,-0.31,-0.13,-0.06,-0.06,-0.15,0.02,0.04,0.07,0.08,-0.27,-0.28,-0.09,-0.1,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,155.1,155.1,S715,VRRGASSSPQRRQSPSPSTRPIRRVSRTPEP,_(gl)QS(ph)PS(ph)PSTRPIR_,-0.04,0.05,0.02,0.05,0.07,0.06,0.08,0.06,-0.28,-0.21,-0.22,-0.31,-0.13,-0.1,-0.01,-0.22,0.01,0.04,0.07,0.07,-0.24,-0.26,-0.12,-0.11,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,125.77,125.77,S717,RGASSSPQRRQSPSPSTRPIRRVSRTPEPKK,_RQS(ph)PSPS(ph)TRPIR_,-0.02,0.12,0.03,0.1, ,0.07,0.26,0.4,-0.32,-0.26,-0.25,-0.33, ,-0.02,-0.05,0.46,0.05,0.06,0.07,0.33,-0.29,-0.29,-0.02,0.23,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,94.01,94.01,S450,GRTSVTKHKGTEKRESPSPAPKPRKVELSES,_RES(ph)PS(ph)PAPKPR_,0.13,0.03,0.06,0.3,0.18,0.04,0.09,-0.15,1.33,-0.11,-0.22,0.13,0.04,0.22,0.18,0.03,0.08,0.18,0.11,-0.02,0.78,-0.03,0.13,0.1,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,94.01,94.01,S452,TSVTKHKGTEKRESPSPAPKPRKVELSESEE,_RES(ph)PS(ph)PAPKPR_,0.32,0.03,0.06,0.3,0.18,0.04,0.09,-0.15,0.18,-0.11,-0.22,0.13,0.04,0.22,0.18,0.03,0.18,0.18,0.11,-0.02,0.04,-0.03,0.13,0.1,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,120.75,115.65,S389,PPKRTSSPPRKTRRLSPSASPPRRRHRPSPP,_RLS(ph)PS(ph)AS(ph)PPR_,-0.12,0.1,-0.1,-0.25,0.03,0.02,-0.08,-0.03,-0.06,0.45,0.14,-0.11,0.15,0.25,-0.18,-0.1,-0.01,-0.17,0.02,-0.06,0.22,0.02,0.2,-0.14,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,105.53,105.53,S391,KRTSSPPRKTRRLSPSASPPRRRHRPSPPAT,_RLS(ph)PS(ph)AS(ph)PPR_,-0.12, ,-0.29,-0.25,0.03,0.03,-0.08,0.06,-0.05, ,-0.17,-0.11,0.23,0.31,-0.06,0.03,-0.12,-0.27,0.03,-0.01,-0.05,-0.14,0.27,-0.01,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,120.75,115.65,S393,TSSPPRKTRRLSPSASPPRRRHRPSPPATPP,_RLS(ph)PS(ph)AS(ph)PPR_,-0.12,0.1,-0.1,-0.13,0.04,-0.05,-0.06,-0.08,-0.06,0.45,0.14,-0.53,0.03,-0.04,-0.35,-0.27,-0.01,-0.11,0,-0.07,0.22,-0.16,0,-0.31,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,130.47,130.47,S560,RRRRSPSPPPTRRRRSPSPAPPPRRRRTPTP,_RRS(ph)PS(ph)PAPPPR_,0,-0.07,-0.12,-0.05,0,-0.03,-0.03,0.01,-0.14,-0.25,-0.29,-0.22,-0.19,-0.19,-0.24,-0.12,-0.03,-0.08,-0.02,-0.01,-0.2,-0.25,-0.19,-0.18,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,130.47,130.47,S562,RRSPSPPPTRRRRSPSPAPPPRRRRTPTPPP,_RRS(ph)PS(ph)PAPPPR_,0,-0.07,-0.12,-0.05,0,-0.03,-0.03,0.01,-0.14,-0.25,-0.29,-0.22,-0.19,-0.19,-0.24,-0.12,-0.03,-0.08,-0.02,-0.01,-0.2,-0.25,-0.19,-0.18,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,E9PCT1,Serine/arginine repetitive matrix protein 1,SRRM1,85.98,85.98,S561,KRWQSPVTKSGRRRRSPSPPPTRRRRSPSPA,_RRS(ph)PS(ph)PPPTR_,-0.15, ,-0.2,-0.32,0.16,0.03,-0.12,0.09,-0.18, ,-0.14,-0.23,-0.04,-0.1,-0.24,0.98,-0.15,-0.26,0.1,-0.02,-0.18,-0.18,-0.07,0.5,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,85.98,85.98,S551,WQSPVTKSGRRRRSPSPPPTRRRRSPSPAPP,_RRS(ph)PS(ph)PPPTR_,-0.15, ,-0.2,-0.32,0.16,0.03,-0.12,0.09,-0.18, ,-0.14,-0.23,-0.04,-0.1,-0.24,0.98,-0.15,-0.26,0.1,-0.02,-0.18,-0.18,-0.07,0.5,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,117.2,117.2,S616,QRRYSPSPPPKRRTASPPPPPKRRASPSPPP,_RRT(ph)AS(ph)PPPPPK_,0.12,0.28,0.13,0.19,0.26,0.5,0.22,0.22,-0.07,0.04,-0.16,-0.15,0.27,0.36,0.29,0.28,0.2,0.16,0.39,0.22,-0.01,-0.15,0.32,0.28,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,114.87,114.87,S583,RRRRTPTPPPRRRTPSPPPRRRSPSPRRYSP,_RRT(ph)PS(ph)PPPR_,-0.03,-0.06,-0.07,-0.1,0.05,-0.01,-0.03,-0.04,-0.27,-0.28,-0.3,-0.26,-0.11,-0.16,-0.2,-0.26,-0.05,-0.08,0.02,-0.04,-0.27,-0.28,-0.14,-0.23,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,115.65,82.49,S597,PSPPPRRRSPSPRRYSPPIQRRYSPSPPPKR,_RYS(ph)PPIQR_,-0.13,-0.12,-0.3,-0.16,-0.1,-0.02,0.09,-0.04,-0.28,-0.22,-0.24,-0.32,-0.1,0.15,0.02,-0.26,-0.12,-0.23,-0.06,0.03,-0.25,-0.28,0.03,-0.12,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,113.86,109.12,S429,SPTPQQSNRTRKSRVSVSPGRTSVTKHKGTE,_SRVS(ph)VS(ph)PGR_,-0.09,-0.04,-0.14,-0.11,0.02,0.02,0.04,-0.07,-0.16,-0.06,-0.24,-0.09,-0.08,0.02,-0.03,-0.08,-0.07,-0.13,0.02,-0.01,-0.11,-0.16,-0.03,-0.05,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,E9PCT1,Serine/arginine repetitive matrix protein 1,SRRM1,113.86,109.12,S431,TPQQSNRTRKSRVSVSPGRTSVTKHKGTEKR,_SRVS(ph)VS(ph)PGR_,-0.09,-0.04,-0.14,-0.11,0.02,0,0.04,-0.07,-0.16,-0.06,-0.24,-0.09,-0.08,0.01,-0.03,-0.08,-0.07,-0.13,0.01,-0.01,-0.11,-0.16,-0.03,-0.05,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,413.29,413.29,T872,LAQEEPVAAPEPKKETESEAEDNLDDLEKHL,_KET(ph)ES(ph)EAEDNLDDLEK_,-0.11,0.24,-0.14,-0.53,0.08,-0.05,0.04,-0.07,-0.05,-0.59,-0.13,0.11,-0.04,0.48,0.49,0.05,0.08,-0.32,0.01,-0.02,-0.3,0,0.24,0.29,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,135.21,133.28,T406,SASPPRRRHRPSPPATPPPKTRHSPTPQQSN,_HRPS(ph)PPAT(ph)PPPK_,0.1,0.14,0.01,0.1,0.21,0.2,0.13,0.23,0.02,-0.01,-0.06,0.02,-0.12,0.07,0,0.07,0.12,0.06,0.2,0.18,0,-0.02,-0.02,0.03,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,117.2,117.2,T614,PIQRRYSPSPPPKRRTASPPPPPKRRASPSP,_RRT(ph)AS(ph)PPPPPK_,0.12,0.28,0.13,0.19,0.26,0.5,0.22,0.22,-0.07,0.04,-0.16,-0.15,0.27,0.36,0.29,0.28,0.2,0.16,0.39,0.22,-0.01,-0.15,0.32,0.28,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,114.87,114.87,T581,PPRRRRTPTPPPRRRTPSPPPRRRSPSPRRY,_RRT(ph)PS(ph)PPPR_,-0.03,-0.06,-0.07,-0.1,0.05,-0.01,-0.03,-0.04,-0.27,-0.28,-0.3,-0.26,-0.11,-0.16,-0.2,-0.26,-0.05,-0.08,0.02,-0.04,-0.27,-0.28,-0.14,-0.23,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,203.66,203.66,S260,LKVPKPEPIPEPKEPSPEKNSKKEKEKEKTR,_VPKPEPIPEPKEPS(ph)PEK_,0.14,0.21,0.15,0.31,0.3,0.39,0.23,0.37,0.07,0.01,0.02,0.17,0.11,0.26,0.31,0.2,0.17,0.23,0.34,0.3,0.04,0.09,0.19,0.26,,,,,,,0,0,,,,mRNA processing,,
E9PCT1,Q8IYB3,Serine/arginine repetitive matrix protein 1,SRRM1,237.4,237.4,T220,TKSRSPSPAPEKKEKTPELPEPSVKVKEPSV,_T(ph)PELPEPSVK_,0.28,0.2,0.1,0.25,0.26,0.15,0.31,0.25,0.09,0.15,0.07,0.24,0.17,0.17,0.19,0.15,0.24,0.18,0.21,0.28,0.12,0.16,0.17,0.17,,,,,,,0,0,,,,mRNA processing,,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,168.64,152.02,S2272,ADSRTPAAAAAMNLASPRTAVAPSAVNLADP,_TPAAAAAM(ox)NLAS(ph)PR_,-0.05,0.07,1.45,1.32, , , , ,0.18,0.06,1.84,1.91, , , , ,0.01,1.39,,,0.12,1.87,,, +, +,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,206.16,206.16,S358,KEKSATRPSPSPERSSTGPEPPAPTPLLAER,_SATRPS(ph)PS(ph)PERSS(ph)TGPEPPAPTPLLAER_,0.01, ,-0.03, ,1.04, , , ,-0.04, ,-0.1, ,-0.38, , , ,0.01,-0.03,1.04,,-0.04,-0.1,-0.38,, +,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,108.36,33.17,S2030,RRRSRSRTPPAIRRRSRSRTPLLPRKRSRSR,_S(ph)RS(ph)RT(ph)PLLPR_,-0.46,-0.22,-0.1,-0.62,-0.9,-0.17,-0.38,-2.37,-0.6,-0.4,-0.55,-0.66,-0.43,-0.11,-0.13,-0.77,-0.33,-0.33,-0.49,-1.05,-0.5,-0.6,-0.26,-0.41, +,,,,,,6,0,6.59,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,87.89,79.41,S994,VKPETPPRQSHSGSISPYPKVKAQTPPGPSL,_(gl)QSHSGS(ph)IS(ph)PYPK_,0.13,-0.13,0.06,0.07,0.13,-0.11,-0.09,0.68,0,-0.14,-0.24,-0.29,0.98,1.08,1.3,1.59,0,0.07,0.01,0.35,-0.06,-0.27,1.03,1.46,, +,,,,,0,2,9.32,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,77.2,77.2,S1693,PKTKSRTPPRRRSSRSSPELTRKARLSRRSR,_SSRS(ph)S(ph)PELTR_, , , , ,0.91,0.9,0.64,0.31, , , , ,1.25,0.78,0.84,0.33,,,0.91,0.48,,,1.03,0.6,, +,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,288.32,288.32,S322,DAPFSEPGTTSTQRPSSPETATKQPSSPYED,_RGEGDAPFSEPGTTSTQRPS(ph)S(ph)PETATK_,0.13,0.13,0.16,0.13,-0.18,0.04,-0.11,-0.24,-0.08,-0.1,-0.4,-0.14,-0.22,-0.21,-0.15,-0.2,0.13,0.14,-0.07,-0.17,-0.09,-0.26,-0.22,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,288.32,288.32,S323,APFSEPGTTSTQRPSSPETATKQPSSPYEDK,_RGEGDAPFSEPGTTSTQRPS(ph)S(ph)PETATK_,0.37,0.19,-0.06,0.16,0.16,0.1,0.18,-0.19,-0.39,-0.31,-0.14,0.03,0.06,-0.24,0.06,-0.26,0.28,0.05,0.13,0.01,-0.35,-0.05,-0.08,-0.09,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,168.13,168.13,S333,TQRPSSPETATKQPSSPYEDKDKDKKEKSAT,_QPSS(ph)PYEDK_, , ,-0.01, , , ,-0.05, , , ,-0.12, , , ,-0.19, ,,-0.01,,-0.05,,-0.12,,-0.19,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,91.07,91.07,S506,KRGRSRSRTPTKRGHSRSRSPQWRRSRSAQR,_GHS(ph)RS(ph)RS(ph)PQWR_, , , , ,-0.15,-0.47,-0.08, , , , , ,-0.25,-0.47,-0.6, ,,,-0.3,-0.08,,,-0.36,-0.6,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,97.45,97.45,S508,GRSRSRTPTKRGHSRSRSPQWRRSRSAQRWG,_S(ph)RS(ph)PQWRR_,-0.11,-0.06,-0.08,0.02,-0.13,-0.13,0.03,-0.2,-0.3,-0.18,-0.22,-0.29,-0.25,-0.16,-0.08,-0.08,-0.09,-0.03,-0.13,-0.08,-0.24,-0.26,-0.2,-0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,97.45,97.45,S510,SRSRTPTKRGHSRSRSPQWRRSRSAQRWGRS,_S(ph)RS(ph)PQWRR_,-0.11,-0.06,-0.08,0.02,-0.13,-0.13,0.03,-0.2,-0.3,-0.18,-0.22,-0.29,-0.25,-0.16,-0.08,-0.08,-0.09,-0.03,-0.13,-0.08,-0.24,-0.26,-0.2,-0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,212.81,212.81,S377,EPPAPTPLLAERHGGSPQPLATTPLSQEPVN,_HGGS(ph)PQPLAT(ph)TPLSQEPVNPPSEAS(ph)PTR_,0.02,0.03,0.02,0.03,-0.14,-0.07,-0.02,-0.05,0.1,0.14,-0.01,0.06,-0.01,-0.02,0.17,-0.09,0.03,0.03,-0.11,-0.04,0.12,0.02,-0.02,0.04,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,130.04,130.04,S387,ERHGGSPQPLATTPLSQEPVNPPSEASPTRD,_HGGS(ph)PQPLATT(ph)PLS(ph)QEPVNPPSEAS(ph)PTR_, ,-0.07, ,-0.12,-0.13,0.02,-0.06,-0.11, ,0.06, ,0.21,0.01,0.13,-0.06,-0.1,-0.07,-0.12,-0.05,-0.08,0.06,0.21,0.07,-0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,183.02,183.02,S395,PLATTPLSQEPVNPPSEASPTRDRSPPKSPE,_HGGS(ph)PQPLATT(ph)PLSQEPVNPPS(ph)EAS(ph)PTR_,0.01,-0.07,-0.19, ,-0.34,-0.09,0,-0.09,0.1,0.06,0, ,-0.13,0,0.21,-0.17,-0.03,-0.19,-0.21,-0.05,0.08,0,-0.06,0.03,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,212.81,212.81,S398,TTPLSQEPVNPPSEASPTRDRSPPKSPEKLP,_HGGS(ph)PQPLATTPLSQEPVNPPS(ph)EAS(ph)PTR_,0.02,0.01,0.03,0.03,-0.14,-0.09,-0.03,-0.05,0.1,0.04,-0.03,0.06,-0.01,-0.03,-0.02,-0.09,0.02,0.03,-0.11,-0.04,0.07,0.02,-0.02,-0.06,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,212.53,212.53,S351,EDKDKDKKEKSATRPSPSPERSSTGPEPPAP,_SATRPS(ph)PS(ph)PER_,0.01,0.02,0.08,0.11,-0.07,-0.28,-0.03,-0.09,-0.42,-0.54,-0.34,-0.12,0.2,-0.28,-0.19,-0.18,0.02,0.09,-0.17,-0.06,-0.48,-0.23,-0.02,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,212.53,212.53,S353,KDKDKKEKSATRPSPSPERSSTGPEPPAPTP,_SATRPS(ph)PS(ph)PER_,0.01,0,0.09,0.11,-0.07,-0.28,-0.03,-0.09,-0.42,-0.54,-0.27,-0.12,0.2,-0.28,-0.23,-0.18,0.01,0.1,-0.17,-0.06,-0.48,-0.19,-0.02,-0.2,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,199.94,199.94,S357,KKEKSATRPSPSPERSSTGPEPPAPTPLLAE,_SATRPS(ph)PS(ph)PERS(ph)STGPEPPAPTPLLAER_,0.02,0.02, ,-0.04, , ,-0.44,0.06,-0.41,-0.24, ,0.14, , ,-0.02,-0.45,0.02,-0.04,,-0.17,-0.32,0.14,,-0.22,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,145.39,145.39,S534,AQRWGRSRSPQRRGRSRSPQRPGWSRSRNTQ,_S(ph)RS(ph)PQRPGWSR_,-0.06,-0.01,-0.13,-0.04,0.02,-0.11,-0.1,-0.01,-0.28,-0.26,-0.25,-0.27,-0.11,-0.15,-0.13,-0.02,-0.03,-0.08,-0.04,-0.05,-0.27,-0.26,-0.13,-0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,145.39,145.39,S536,RWGRSRSPQRRGRSRSPQRPGWSRSRNTQRR,_S(ph)RS(ph)PQRPGWSR_,-0.06,-0.01,-0.13,-0.04,0.02,-0.11,-0.1,-0.01,-0.28,-0.26,-0.25,-0.27,-0.11,-0.15,-0.13,-0.02,-0.03,-0.08,-0.04,-0.05,-0.27,-0.26,-0.13,-0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,267.25,267.25,S295,RSAAAKTHTTALAGRSPSPASGRRGEGDAPF,_THTTALAGRS(ph)PS(ph)PASGR_,-0.09,-0.09,0,-0.07,-0.09,-0.12,-0.16,-0.05,-0.22,-0.22,-0.28,-0.26,-0.19,-0.26,-0.19,-0.41,-0.09,-0.04,-0.11,-0.11,-0.22,-0.27,-0.23,-0.3,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,267.25,267.25,S297,AAAKTHTTALAGRSPSPASGRRGEGDAPFSE,_THTTALAGRS(ph)PS(ph)PASGR_,-0.09,-0.09,0,-0.07,-0.09,-0.12,-0.16,-0.05,-0.22,-0.22,-0.28,-0.26,-0.19,-0.26,-0.19,-0.41,-0.09,-0.04,-0.11,-0.11,-0.22,-0.27,-0.23,-0.3,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,183.96,182.3,T383,PLLAERHGGSPQPLATTPLSQEPVNPPSEAS,_HGGS(ph)PQPLAT(ph)TPLSQEPVNPPSEAS(ph)PTR_,-0.12,-0.05,0.09,0.04,0.32,0.07,0.01,0.12,0.03,-0.02,0.19,0.07,0.41,0.21,0,0.24,-0.08,0.07,0.2,0.07,0,0.13,0.31,0.13,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,138.27,138.27,T384,LLAERHGGSPQPLATTPLSQEPVNPPSEASP,_HGGS(ph)PQPLATT(ph)PLSQEPVNPPS(ph)EAS(ph)PTR_, , ,-0.15, ,0.18,0.07,0.16,-0.01, , ,-0.28, ,0.3,0.05,0.25,-0.03,,-0.15,0.12,0.08,,-0.28,0.18,0.12,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,87.99,81.06,S1397,SSSELSPDAVEKAGMSSNQSISSPVLDAVPR,_AGMS(ph)S(ph)NQS(ph)ISS(ph)PVLDAVPR_, , , , , ,-0.45,-0.48,-0.28, , , , , ,-0.31,-0.4,-0.32,,,-0.45,-0.38,,,-0.31,-0.36,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,115.7,103.23,S1398,SSELSPDAVEKAGMSSNQSISSPVLDAVPRT,_AGMS(ph)S(ph)NQS(ph)ISS(ph)PVLDAVPR_, , , , ,-0.19,-0.36,-0.09,-0.28, , , , ,-0.09,-0.05,-0.06,-0.32,,,-0.27,-0.18,,,-0.07,-0.19,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,300.69,292.18,S1401,LSPDAVEKAGMSSNQSISSPVLDAVPRTPSR,_AGMSSNQS(ph)ISS(ph)PVLDAVPR_,-0.47,-0.39,-0.22,-0.22,-0.18,-0.22,-0.1,0.03,0.23,0.14,-0.01,0.22,-0.1,-0.08,-0.07,-0.04,-0.43,-0.22,-0.2,-0.03,0.18,0.11,-0.09,-0.06,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,325.37,323.39,S1404,DAVEKAGMSSNQSISSPVLDAVPRTPSRERS,_AGMSSNQSISS(ph)PVLDAVPRT(ph)PSR_,0.14,-0.05,-0.05,-0.01,0.13,-0.03,0.26,0.05,0.07,-0.23,-0.1,0.02,0.19,0.35,0.06,-0.04,0.05,-0.03,0.05,0.16,-0.07,-0.04,0.27,0.01,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,122.18,17.43,S924,PSRSSSPQPKVKAIISPRQRSHSGSSSPSPS,_AIIS(ph)PR_, ,-0.15,-0.11,-0.11, ,0.01, , , ,-0.16,-0.23,-0.18, ,0.03, , ,-0.15,-0.11,0.01,,-0.16,-0.2,0.03,,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,106.11,106.11,S1010,PYPKVKAQTPPGPSLSGSKSPCPQEKSKDSL,_AQT(ph)PPGPSLS(ph)GSKSPCPQEK_, ,-0.13,-0.02, ,0.04,-0.36, ,-0.7, ,0.09,-0.25, ,0.21,0.48, ,-0.18,-0.13,-0.02,-0.15,-0.7,0.09,-0.25,0.35,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,83.33,83.33,S1014,VKAQTPPGPSLSGSKSPCPQEKSKDSLVQSC,_AQT(ph)PPGPSLSGSKS(ph)PCPQEK_, , , , , ,0.12,0.12, , , , , , ,0.25,0.26, ,,,0.12,0.12,,,0.25,0.26,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,180.03,180.03,S2407,RVSGRTSPPLLDRARSRTPPSAPSQSRMTSE,_ARS(ph)RT(ph)PPSAPSQSR_,0.23,0.14,0.15, ,-0.13,0.31,-0.01,-0.16,-0.28,0.37,0.03, ,-0.1,0.1,-0.11,-0.21,0.18,0.15,0.11,-0.08,0.08,0.03,0,-0.16,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,179.89,179.89,S1458,SSPGLRDGSGTPSRHSLSGSSPGMKDIPRTP,_DGSGT(ph)PSRHS(ph)LSGSS(ph)PGMK_,0.16,0.2,0.12,0.46,0.09,0.12,0.06,0.28,-0.04,-0.03,-0.14,0.17,-0.01,0.45,0.66,0.16,0.18,0.3,0.1,0.17,-0.04,0.02,0.24,0.43,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,84.82,79.7,S1188,QEDATASPPRQKDKFSPFPVQDRPESSLVFK,_DKFS(ph)PFPVQDRPESSLVFK_, ,0.42, ,0.64, , , , , ,-0.51, ,-0.15, , , , ,0.42,0.64,,,-0.51,-0.15,,,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,124.45,102.14,S2690,SRSPRKPIDSLRDSRSLSYSPVERRRPSPQP,_S(ph)LS(ph)YS(ph)PVER_,-0.67,-0.97,0,-0.1,-0.24,-0.4,-0.29,-0.18,-0.49,-0.49,-0.29,-0.41,-0.26,0.2,-0.02,0.06,-0.81,-0.05,-0.31,-0.23,-0.49,-0.35,-0.01,0.02,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,151.52,134.51,S2692,SPRKPIDSLRDSRSLSYSPVERRRPSPQPSP,_S(ph)LS(ph)YS(ph)PVER_,-0.28,-0.34,-0.05,-0.3,0.48,0.56,0.68,0.43,-0.17,-0.22,-0.12,-0.1,0.45,0.12,0.6,0.1,-0.31,-0.17,0.52,0.56,-0.19,-0.11,0.29,0.37,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,151.52,134.51,S2694,RKPIDSLRDSRSLSYSPVERRRPSPQPSPRD,_SLS(ph)YS(ph)PVER_,-0.64,-0.53,-0.45,-0.57,-0.23,-0.15,0.08,-0.38,-0.53,-0.41,-0.16,-0.22,-0.18,-0.35,0.24,-0.01,-0.59,-0.51,-0.19,-0.13,-0.47,-0.19,-0.26,0.12,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,224.9,195.32,S1318,SSWGGPHFSPEHKELSNSPLRENSFGSPLEF,_ELS(ph)NS(ph)PLRENSFGS(ph)PLEFR_,0.1,-0.25,0.02,0.06,-0.04,-0.16,-0.31,-0.25,0,-0.03,-0.15,-0.16,0.17,-0.16,-0.13,-0.11,-0.07,0.04,-0.1,-0.28,-0.01,-0.15,0.02,-0.12,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,389.37,350.78,S1320,WGGPHFSPEHKELSNSPLRENSFGSPLEFRN,_ELS(ph)NS(ph)PLRENSFGS(ph)PLEFR_,-0.14,-0.16,-0.16,-0.11,-0.23,-0.22,-0.21,-0.05,-0.24,-0.22,-0.42,-0.26,-0.24,-0.34,-0.45,-0.09,-0.15,-0.14,-0.23,-0.13,-0.23,-0.34,-0.29,-0.26,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,261.09,220.46,S1326,SPEHKELSNSPLRENSFGSPLEFRNSGPLGT,_ENS(ph)FGS(ph)PLEFR_,-0.09,-0.26,-0.17,-0.32,-0.42,-0.44,-0.08,-0.26,-0.26,0.58,0.99,-0.65,0.03,0.17,-0.12,-0.25,-0.17,-0.24,-0.43,-0.17,0.22,0.39,0.1,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,389.37,350.78,S1329,HKELSNSPLRENSFGSPLEFRNSGPLGTEMN,_ENS(ph)FGS(ph)PLEFR_,-0.28,-0.35,-0.23,-0.47,-0.04,-0.33,-0.33,-0.52,-0.11,-0.39,-0.39,-0.48,0.01,-0.14,-0.41,-0.24,-0.31,-0.34,-0.18,-0.42,-0.24,-0.43,-0.06,-0.32,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,178.19,163.55,S1270,HLSSELKEMSTSNFESSPEVEERPAVSLTLD,_EMSTSNFES(ph)S(ph)PEVEER_, , , , ,-0.32,-0.45,-0.08,-0.07, , , , ,-0.2,-0.06,-0.25,-0.49,,,-0.38,-0.08,,,-0.13,-0.36,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,178.19,163.55,S1271,LSSELKEMSTSNFESSPEVEERPAVSLTLDQ,_EMSTSNFES(ph)S(ph)PEVEER_, , , , ,-0.32,-0.45,-0.08,-0.07, , , , ,-0.2,-0.06,-0.25,-0.49,,,-0.38,-0.08,,,-0.13,-0.36,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,111.4,110.68,S1233,SSPETKEQNSALPTSSQDEELMEVVEKSEEP,_EQNSALPTSS(ph)QDEELMEVVEK_,-0.17,-0.1,-0.36, ,0.7,-0.41,-0.35,0.02,0.26,0.16,-0.16, ,0.04,-0.15,-0.28,-0.24,-0.13,-0.36,0.25,-0.15,0.21,-0.16,-0.05,-0.26,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,142.51,124.78,S1124,ASRSPIRQDRGEFSASPMLKSGMSPEQSRFQ,_GEFS(ph)AS(ph)PMLK_,0,0.07,0,0.1,-0.39,-0.35,-0.3,-0.42,-0.04,-0.02,-0.03,0.04,-0.26,-0.19,-0.51,-0.55,0.04,0.05,-0.37,-0.36,-0.03,0,-0.22,-0.53,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,138.66,136.86,S1179,SKEKMALPPQEDATASPPRQKDKFSPFPVQD,_MALPPQEDATAS(ph)PPRQK_,-0.05,-0.15,-0.03,-0.12,0.07,-0.1,-0.13,-0.07,0.05,0.1,-0.04,-0.11,0.04,0.08,-0.25,0.05,-0.1,-0.08,-0.01,-0.1,0.07,-0.07,0.06,-0.1,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,191.65,191.65,S2449,APSQSLLPPAQDQPRSPVPSAFSDQSRCLIA,_S(ph)PVPSAFSDQSR_,-0.11,0.43,0.08,0.65,-0.43,-0.16,-0.07,-0.14,-0.2,-0.1,-0.01,0.12,0.14,-0.25,-0.37,-0.4,0.18,0.39,-0.29,-0.11,-0.15,0.05,-0.04,-0.38,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,172.3,172.3,S2121,PVALNSSRMSCFSRPSMSPTPLDRCRSPGML,_MSCFSRPS(ph)MS(ph)PTPLDR_,0.03,-0.07,0.06, ,-0.26,-0.14,-0.16,-0.11,-0.37,-0.18,-0.36, ,-0.38,-0.26,-0.09,-0.12,-0.02,0.06,-0.2,-0.14,-0.27,-0.36,-0.32,-0.1,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,172.3,172.3,S2123,ALNSSRMSCFSRPSMSPTPLDRCRSPGMLEP,_PSMS(ph)PTPLDR_,-0.07,-0.05,-0.11,0.17,0.08,-0.09,-0.12,0.05,-0.01,-0.03,0.02,0.18,-0.11,-0.23,-0.13,0.04,-0.06,0.03,0,-0.03,-0.02,0.1,-0.16,-0.04,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,180.36,179.78,S2100,SDRSRSATPPATRNHSGSRTPPVALNSSRMS,_NHS(ph)GS(ph)RT(ph)PPVALNSSR_,-0.02,0.02,-0.04,0.1,-0.14,0.21,-0.06,-0.08,-0.22,-0.15,-0.3,-0.36,-0.28,-0.21,-0.2,-0.22,0,0.03,0.05,-0.07,-0.19,-0.33,-0.24,-0.21,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,180.36,179.78,S2102,RSRSATPPATRNHSGSRTPPVALNSSRMSCF,_NHS(ph)GS(ph)RT(ph)PPVALNSSR_,-0.02,-0.1,0.07,0.55,-0.35,0.68,-0.16,-0.43,-0.3,-0.21,-0.39,-0.4,-0.16,-0.4,-0.22,-0.36,-0.06,0.33,0.26,-0.29,-0.26,-0.4,-0.28,-0.29,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,108.74,108.74,S854,SPHPKVKSGTPPRQGSITSPQANEQSVTPQR,_QGS(ph)ITS(ph)PQANEQSVT(ph)PQRR_, , ,0.22, ,0.21,-0.05,0.05,0.01, , ,0.18, ,0.5,-0.02,0.3,0.07,,0.22,0.08,0.03,,0.18,0.26,0.19,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,162.27,162.27,S857,PKVKSGTPPRQGSITSPQANEQSVTPQRRSC,_SGT(ph)PPRQGSITS(ph)PQANEQSVT(ph)PQRR_,0.04,-0.01,-0.01,-0.39,-0.22,-0.55,-0.25,0.18,0,0,-0.2,-0.46,-0.19,-0.08,-0.23,-0.26,0.01,-0.19,-0.38,-0.02,0,-0.33,-0.13,-0.24,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,89.92,85.31,S1083,RSDTSSPEVRQSHSESPSLQSKSQTSPKGGR,_(gl)QSHSES(ph)PSLQSK_,0.53, ,0.08, , ,-0.17, ,-0.19,0.52, ,-0.04, , ,-0.26, ,0.08,0.53,0.08,-0.17,-0.19,0.52,-0.04,-0.26,0.08,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,91.1,91.1,S992,TKVKPETPPRQSHSGSISPYPKVKAQTPPGP,_(gl)QSHSGS(ph)IS(ph)PYPK_,0.08, , , ,-0.09,-0.43,-0.39,0.07,0.05, , , ,-0.44,-0.41,-0.38,-0.88,0.08,,-0.25,-0.14,0.05,,-0.42,-0.61,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,104,104,S2702,DSRSLSYSPVERRRPSPQPSPRDQQSSSSER,_RRPS(ph)PQPS(ph)PR_,-0.4,-0.35,-0.31,-0.45,-0.28,-0.2,-0.14,-0.11,-0.75,-0.53,-0.47,-0.66,-0.28,-0.34,-0.23,-0.22,-0.37,-0.38,-0.24,-0.13,-0.64,-0.56,-0.31,-0.23,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,104,104,S2706,LSYSPVERRRPSPQPSPRDQQSSSSERGSRR,_RRPS(ph)PQPS(ph)PR_,-0.4,-0.35,-0.31,-0.45,-0.28,-0.2,-0.14,-0.11,-0.75,-0.53,-0.47,-0.66,-0.28,-0.34,-0.23,-0.22,-0.37,-0.38,-0.24,-0.13,-0.64,-0.56,-0.31,-0.23,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,109.64,109.64,S1691,PEPKTKSRTPPRRRSSRSSPELTRKARLSRR,_RSS(ph)RSS(ph)PELTR_, , , , ,0.63,0.24,-0.07,0.42, , , , ,0.33,-0.21,0.09,0.28,,,0.45,0.2,,,0.09,0.19,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,109.64,109.64,S1694,KTKSRTPPRRRSSRSSPELTRKARLSRRSRS,_S(ph)SRSS(ph)PELTR_, , , , ,0.75,0.41,0.31,0.24, , , , ,0.56,0.3,0.21,0.21,,,0.59,0.27,,,0.43,0.21,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,83.47,80.93,S875,ANEQSVTPQRRSCFESSPDPELKSRTPSRHS,_SCFES(ph)S(ph)PDPELK_, , , , , ,-0.08,0.14,-0.1, , , , , ,-0.17,0.13,-0.3,,,-0.08,0.02,,,-0.17,-0.07,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,95.07,93.57,S876,NEQSVTPQRRSCFESSPDPELKSRTPSRHSC,_SCFES(ph)S(ph)PDPELK_,-0.03,0.06,0.06,0.03,-0.08,0.1,0.1,-0.05,-0.41,-0.4,-0.42,-0.03,-0.05,0.2,0.08,-0.06,0.01,0.04,0.01,0.03,-0.41,-0.21,0.08,0.01,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,59.13,51.09,S1132,DRGEFSASPMLKSGMSPEQSRFQSDSSSYPT,_SGMS(ph)PEQSR_, , , , ,-0.16,-0.14,-0.26,-0.41, , , , ,-0.05,-0.38,-0.22,-0.27,,,-0.15,-0.34,,,-0.2,-0.24,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.45,154.45,S1541,KTVARTPLGQRSRSGSSQELDVKPSASPQER,_SGS(ph)S(ph)QELDVKPSAS(ph)PQER_,-0.39,-0.48,-0.12,-0.37,0.1,-0.09,0.07,-0.08,-0.09,-0.6,0.01,-0.1,0.64,0.34,-0.06,-0.07,-0.43,-0.24,0.01,0,-0.32,-0.04,0.5,-0.07,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.45,154.45,S1542,TVARTPLGQRSRSGSSQELDVKPSASPQERS,_SGS(ph)S(ph)QELDVKPSAS(ph)PQER_,0.1,-0.29, , ,0.14,-0.45,0.15,-0.15,-0.46,-0.25, , ,0.62,-0.21,-0.06,-0.17,-0.08,,-0.13,0.01,-0.35,,0.26,-0.11,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.45,154.45,S1552,SRSGSSQELDVKPSASPQERSESDSSPDSKA,_SGS(ph)S(ph)QELDVKPSAS(ph)PQER_,-0.39,-0.48,-0.12,-0.37,0.12,-0.45,0.11,-0.15,-0.09,-0.6,0.01,-0.1,0.63,-0.21,-0.06,-0.07,-0.43,-0.24,-0.14,-0.01,-0.32,-0.04,0.27,-0.07,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,125.14,125.14,S2067,RRSRSRTPRTARGKRSLTRSPPAIRRRSASG,_S(ph)LT(ph)RS(ph)PPAIR_,-0.84,-0.45,-0.43,-0.12,-0.94,-0.41,-1.02,-0.62,-0.92,-0.55,-0.68,-0.24,-0.46,-0.07,-0.54,-0.3,-0.63,-0.26,-0.65,-0.81,-0.72,-0.44,-0.25,-0.42,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,125.14,125.14,S2071,SRTPRTARGKRSLTRSPPAIRRRSASGSSSD,_S(ph)LT(ph)RS(ph)PPAIR_,-0.84,-0.45,-0.36,-0.47,-0.92,-0.41,-1.02,-0.62,-0.92,-0.55,-0.23,-0.8,-0.49,-0.07,-0.54,-0.3,-0.63,-0.41,-0.64,-0.81,-0.72,-0.49,-0.27,-0.42,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,121.99,120.4,S2132,FSRPSMSPTPLDRCRSPGMLEPLGSSRTPMS,_S(ph)PGMLEPLGSSR_,-0.17,-0.08,0.02,0.06,-0.14,-0.36,-0.23,-0.02,0.22,-0.11,0.28,0.4,-0.24,-0.19,-0.2,0.12,-0.13,0.04,-0.24,-0.12,0.06,0.34,-0.21,-0.03,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.67,56.89,S2044,RSRSRTPLLPRKRSRSRSPLAIRRRSRSRTP,_S(ph)RS(ph)RS(ph)PLAIR_,-0.16,-0.14,-0.12,-0.13,-0.15,-0.02,-0.14,-0.15,-0.04,-0.03,-0.31,-0.28,-0.14,-0.07,-0.17,-0.13,-0.15,-0.13,-0.08,-0.14,-0.03,-0.29,-0.11,-0.15,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.67,56.89,S2046,RSRTPLLPRKRSRSRSPLAIRRRSRSRTPRT,_S(ph)RS(ph)RS(ph)PLAIR_,-0.16,-0.14,-0.12,-0.13,-0.15,-0.02,-0.14,-0.15,-0.04,-0.03,-0.31,-0.28,-0.14,-0.07,-0.17,-0.13,-0.15,-0.13,-0.08,-0.14,-0.03,-0.29,-0.11,-0.15,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,116.86,116.86,S2042,RRRSRSRTPLLPRKRSRSRSPLAIRRRSRSR,_S(ph)RS(ph)RS(ph)PLAIR_,-0.03,-0.08,-0.05,-0.02, ,-0.06,-0.03,-0.04,-0.25,-0.23,-0.15,-0.22, ,-0.1,-0.12,-0.24,-0.05,-0.04,-0.06,-0.03,-0.24,-0.19,-0.1,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,100.48,100.48,S1876,WKRSRSRASPATHRRSRSRTPLISRRRSRSR,_S(ph)RS(ph)RT(ph)PLISR_,-0.26,-0.29,-0.16,-0.16,0.08,0.03,-0.06,-0.05,0.85,0.7,0.42,0.62,-0.18,-0.14,-0.21,-0.16,-0.27,-0.16,0.05,-0.06,0.78,0.52,-0.16,-0.18,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,142.47,57.87,S1878,RSRSRASPATHRRSRSRTPLISRRRSRSRTS,_S(ph)RT(ph)PLISR_,0.14,-0.03,-0.06,-0.04,-0.09,-0.13,-0.01,0.03,0.24,-0.06,-0.01,-0.01,-0.16,-0.08,-0.06,-0.12,0.06,-0.05,-0.11,0.01,0.1,-0.01,-0.12,-0.09,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,131.06,102.97,S2032,RSRSRTPPAIRRRSRSRTPLLPRKRSRSRSP,_S(ph)RT(ph)PLLPR_,-0.04,-0.13,-0.12,-0.02,-0.06,0.03,0.01,0.03,-0.09,-0.06,-0.89,-1.01,-0.14,-0.09,-0.1,-0.1,-0.08,-0.07,-0.01,0.02,-0.08,-0.95,-0.11,-0.1,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,118.61,118.61,S1925,RSRSRASPVSRRRSRSRTPPVTRRRSRSRTP,_S(ph)RT(ph)PPVTR_,-0.14, ,-0.28, ,-0.05,-0.05,-0.1,-0.08,-0.31, ,0.08, ,-0.11,-0.01,-0.12,-0.2,-0.14,-0.28,-0.05,-0.09,-0.31,0.08,-0.06,-0.16,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,212.47,212.47,S1099,PSLQSKSQTSPKGGRSRSSSPVTELASRSPI,_S(ph)RS(ph)SS(ph)PVTELASR_,-0.1,-0.18,-0.18,0.05,-0.19,-0.2,-0.16,-0.15,-0.28,-0.2,-0.4,-0.35,-0.07,-0.19,-0.23,-0.23,-0.14,-0.06,-0.2,-0.15,-0.24,-0.38,-0.13,-0.23,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,243.23,243.23,S1101,LQSKSQTSPKGGRSRSSSPVTELASRSPIRQ,_S(ph)RS(ph)SS(ph)PVTELASR_,-0.04,-0.13,-0.12,0.05,-0.1,-0.12,-0.05,-0.1,-0.2,-0.23,-0.38,-0.35,-0.15,-0.11,-0.16,-0.23,-0.08,-0.03,-0.11,-0.07,-0.22,-0.37,-0.13,-0.19,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,240.4,240.19,S1102,QSKSQTSPKGGRSRSSSPVTELASRSPIRQD,_SS(ph)S(ph)PVTELASRS(ph)PIRQDR_,-0.04,-0.03,-0.12,-0.03,-0.12,-0.18,-0.18,-0.14,-0.2,-0.21,-0.38,-0.29,-0.18,-0.18,-0.25,-0.2,-0.03,-0.07,-0.15,-0.16,-0.21,-0.33,-0.18,-0.23,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,243.23,243.23,S1103,SKSQTSPKGGRSRSSSPVTELASRSPIRQDR,_SS(ph)S(ph)PVTELASRS(ph)PIRQDR_,-0.53,-0.59,-0.62,-0.56,-0.09,0,-0.1,-0.06,-0.34,-0.37,-0.3,-0.44,-0.28,-0.17,-0.17,-0.25,-0.56,-0.59,-0.04,-0.08,-0.35,-0.37,-0.23,-0.21,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,99.59,99.59,S2020,RSRSRTSPVTRRRSRSRTPPAIRRRSRSRTP,_S(ph)RT(ph)PPAIR_,-0.23,-0.32,-0.04,-0.22,-0.1,0.03,-0.11,-0.08,-0.24,-0.18,-0.32,0.02,-0.13,-0.21,-0.04,-0.1,-0.27,-0.13,-0.03,-0.1,-0.21,-0.14,-0.17,-0.07,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,110.97,110.97,S1854,RGRSRTPPTSRKRSRSRTSPAPWKRSRSRAS,_S(ph)RTS(ph)PAPWKR_,0.08,-0.36,-0.06,-0.5,-0.34,0.2,-0.25,-0.04,-0.02,-0.33,-0.22,-0.62,-0.42,0.1,-0.05,-0.01,-0.12,-0.26,-0.04,-0.14,-0.17,-0.41,-0.14,-0.03,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,110.97,110.97,S1857,SRTPPTSRKRSRSRTSPAPWKRSRSRASPAT,_S(ph)RTS(ph)PAPWKR_,0.08,-0.28,0.05,-0.38,-0.29,0.2,-0.25,0.16,-0.02,-0.29,-0.03,-0.47,-0.45,0.1,-0.05,0.03,-0.09,-0.15,-0.02,-0.03,-0.15,-0.23,-0.15,-0.01,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,87.03,87.03,S1972,RSRSRTPPVTRRRSRSRTSPITRRRSRSRTS,_S(ph)RT(ph)SPITR_, , ,-0.01, ,-0.07, ,-0.04,-0.22, , ,-0.26, ,-0.19, ,-0.08,-0.25,,-0.01,-0.07,-0.13,,-0.26,-0.19,-0.16,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,84.35,84.35,S1975,SRTPPVTRRRSRSRTSPITRRRSRSRTSPVT,_S(ph)RTS(ph)PITR_, , , , , , ,-0.04, , , , , , , ,-0.08, ,,,,-0.04,,,,-0.08,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,191.9,168.96,S1382,PSLDMKEQSTRSSGHSSSELSPDAVEKAGMS,_SSGHS(ph)SSELS(ph)PDAVEK_,-0.26,-0.04,-0.13,-0.32,-1.67,-0.21,-0.22,-0.17,-0.07,0.21,-0.16,0.07,-1.01,-0.03,-0.27,0.06,-0.14,-0.22,-0.76,-0.19,0.08,-0.04,-0.43,-0.09,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,265.19,253.82,S1387,KEQSTRSSGHSSSELSPDAVEKAGMSSNQSI,_SSGHS(ph)SSELS(ph)PDAVEK_,-0.06,-0.09,-0.31,-0.27,-0.15,-0.06,0.99,-0.07,-0.27,-0.14,-0.44,-0.45,0.32,0.13,0.79,-0.2,-0.08,-0.29,-0.1,0.56,-0.2,-0.45,0.23,0.38,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,243.23,243.23,S1112,GRSRSSSPVTELASRSPIRQDRGEFSASPML,_S(ph)SS(ph)PVTELASRS(ph)PIRQDR_,-0.09,-0.38,-0.27,0.04,-0.09,0.13,-0.07,0.01,-0.18,-0.2,-0.25,-0.33,-0.28,-0.24,-0.26,-0.25,-0.23,-0.1,0.02,-0.03,-0.19,-0.29,-0.26,-0.25,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,66.74,52.76,S952,SPSRVTSRTTPRRSRSVSPCSNVESRLLPRY,_S(ph)VS(ph)PCSNVESR_, , , , ,-0.17,-0.23,-0.02,-0.37, , , , ,-0.2,-0.15,-0.03,0.04,,,-0.2,-0.18,,,-0.18,0,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,66.74,52.76,S954,SRVTSRTTPRRSRSVSPCSNVESRLLPRYSH,_S(ph)VS(ph)PCSNVESR_, , , , ,-0.17,-0.23,-0.02,-0.37, , , , ,-0.2,-0.15,-0.03,0.04,,,-0.2,-0.18,,,-0.18,0,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,154.51,154.51,S2398,PRVPLSAYERVSGRTSPPLLDRARSRTPPSA,_VSGRTS(ph)PPLLDR_,-0.08,-0.05,-0.07,-0.03,-0.15,-0.13,0,-0.05,-0.24,-0.26,-0.27,-0.27,-0.31,-0.39,-0.15,-0.16,-0.06,-0.05,-0.14,-0.02,-0.25,-0.27,-0.35,-0.16,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,325.37,323.39,T1413,SNQSISSPVLDAVPRTPSRERSSSASSPEMK,_AGMSSNQSISS(ph)PVLDAVPRT(ph)PSR_,0.48,0.4,0.37,0.59,0.15,0.35,0.36,0.65,-0.2,-0.08,-0.23,0.09,0.06,-0.02,0.16,0.26,0.44,0.49,0.26,0.51,-0.14,-0.06,0.02,0.21,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,106.11,106.11,T1003,SHSGSISPYPKVKAQTPPGPSLSGSKSPCPQ,_AQT(ph)PPGPSLS(ph)GSKSPCPQEK_,-0.29,0.11,-0.02, ,0.18,0.05,0.12,0.11,-0.23,0.11,-0.25, ,0.12,0.07,-0.04,0.08,-0.08,-0.02,0.12,0.12,-0.05,-0.25,0.1,0.02,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,180.03,180.03,T2409,SGRTSPPLLDRARSRTPPSAPSQSRMTSERA,_ARS(ph)RT(ph)PPSAPSQSR_,0.23,0.14,0.15, ,-0.13,0.31,-0.01,-0.16,-0.28,0.37,0.03, ,-0.1,0.1,-0.11,-0.21,0.18,0.15,0.11,-0.08,0.08,0.03,0,-0.16,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,100.73,100.73,T1434,SSSASSPEMKDGLPRTPSRRSRSGSSPGLRD,_DGLPRT(ph)PSRR_,0.25,0.07,0.21,0.28,-0.36,0.1,0.21,-0.36,-0.17,-0.12,-0.2,-0.14,-0.5,-0.24,-0.02,-0.06,0.16,0.24,-0.11,-0.05,-0.15,-0.17,-0.36,-0.04,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,179.89,179.89,T1453,RSRSGSSPGLRDGSGTPSRHSLSGSSPGMKD,_DGSGT(ph)PSRHS(ph)LSGSS(ph)PGMK_,0.16,0.2,0.12,0.46,0.09,0.12,0.07,0.28,-0.04,-0.03,-0.14,0.17,-0.01,0.45,0.64,0.16,0.18,0.3,0.1,0.18,-0.04,0.02,0.24,0.42,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,128.61,108.34,T1208,QDRPESSLVFKDTLRTPPRERSGAGSSPETK,_DTLRT(ph)PPRER_,-0.02,-0.12,-0.09,-0.03,-0.32,0.25,-0.09,0.03,-0.3,-0.23,-0.5,-0.39,-0.17,-0.19,-0.24,-0.25,-0.07,-0.06,0,-0.03,-0.27,-0.44,-0.18,-0.24,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,178.79,178.79,T2104,RSATPPATRNHSGSRTPPVALNSSRMSCFSR,_NHS(ph)GS(ph)RT(ph)PPVALNSSR_,0.21,0.31,-0.35,-0.82,-0.14,-0.12,-0.06,-0.08,-0.33,-0.2,-0.13,-0.86,-0.28,-0.1,-0.2,-0.22,0.26,-0.57,-0.13,-0.07,-0.26,-0.45,-0.19,-0.21,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,102.57,102.57,T856,HPKVKSGTPPRQGSITSPQANEQSVTPQRRS,_SGT(ph)PPRQGS(ph)IT(ph)SPQANEQSVT(ph)PQR_,-0.25, ,-0.22, , ,-0.54,0.18,-0.16,-0.32, ,-0.27, , ,-0.47,-0.38,-0.39,-0.25,-0.22,-0.54,0.02,-0.32,-0.27,-0.47,-0.38,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,162.27,162.27,T866,RQGSITSPQANEQSVTPQRRSCFESSPDPEL,_SGT(ph)PPRQGSIT(ph)SPQANEQSVT(ph)PQR_,0.17,-0.01,-0.01,-0.39,-0.24,-0.41,-0.13,0.15,0.2,0,-0.2,-0.56,-0.23,-0.18,-0.23,-0.19,0.08,-0.19,-0.32,0.02,0.11,-0.37,-0.21,-0.21,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,162.27,162.27,T848,QSHSSSSPHPKVKSGTPPRQGSITSPQANEQ,_SGT(ph)PPRQGSITS(ph)PQANEQSVT(ph)PQRR_,-0.25,-0.14,-0.27,-0.37,-0.27,0.29,0.08,0.21,-0.32,-0.26,-0.38,-0.38,-0.92,0.01,-0.43,0,-0.2,-0.32,0.04,0.14,-0.29,-0.38,-0.38,-0.19,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,125.14,125.14,T2069,SRSRTPRTARGKRSLTRSPPAIRRRSASGSS,_S(ph)LT(ph)RS(ph)PPAIR_,-0.6,-0.4,-0.43,-0.47,-0.95,-0.41,-0.2,-0.09,-0.87,-0.64,-0.68,-0.8,-0.42,-0.07,-0.14,-0.16,-0.5,-0.45,-0.66,-0.14,-0.75,-0.74,-0.24,-0.15,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,142.47,57.87,T1880,RSRASPATHRRSRSRTPLISRRRSRSRTSPV,_S(ph)RT(ph)PLISR_,0.22,0.12,-0.02,0.59,-0.09,-0.13,-0.01,0.03,-0.02,-0.06,-0.03,-0.08,-0.16,-0.08,-0.06,-0.12,0.17,0.32,-0.11,0.01,-0.04,-0.06,-0.12,-0.09,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,131.06,102.97,T2034,RSRTPPAIRRRSRSRTPLLPRKRSRSRSPLA,_S(ph)RT(ph)PLLPR_,-0.03,-0.05,-0.01,-0.06,-0.04,0.03,0.01,0.03,-0.03,-0.02,-0.23,-0.08,-0.11,-0.09,-0.1,-0.08,-0.04,-0.04,-0.01,0.02,-0.02,-0.15,-0.1,-0.09,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,118.61,118.61,T1927,RSRASPVSRRRSRSRTPPVTRRRSRSRTPTT,_S(ph)RT(ph)PPVTR_,-0.14, ,-0.28, ,-0.05,-0.05,-0.1,-0.08,-0.31, ,0.08, ,-0.11,-0.01,-0.12,-0.2,-0.14,-0.28,-0.05,-0.09,-0.31,0.08,-0.06,-0.16,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,99.59,99.59,T2022,RSRTSPVTRRRSRSRTPPAIRRRSRSRTPLL,_S(ph)RT(ph)PPAIR_,-0.23,-0.32,-0.04,-0.22,-0.1,0.03,-0.11,-0.08,-0.24,-0.18,-0.32,0.02,-0.13,-0.21,-0.04,-0.1,-0.27,-0.13,-0.03,-0.1,-0.21,-0.14,-0.17,-0.07,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,87.03,87.03,T1974,RSRTPPVTRRRSRSRTSPITRRRSRSRTSPV,_S(ph)RT(ph)SPITR_, , ,-0.01, ,-0.07, , ,-0.22, , ,-0.26, ,-0.19, , ,-0.25,,-0.01,-0.07,-0.22,,-0.26,-0.19,-0.25,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,164.89,162.07,T1043,SCPGSLSLCAGVKSSTPPGESYFGVSSLQLK,_SST(ph)PPGESYFGVSSLQLK_,-0.2,-0.07, ,-0.15,-0.14,-0.08, , ,-0.12,0.07, ,-0.17,-0.08,-0.09, , ,-0.14,-0.15,-0.11,,-0.02,-0.17,-0.09,,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,134.14,134.14,T2397,SPRVPLSAYERVSGRTSPPLLDRARSRTPPS,_VSGRT(ph)SPPLLDR_,-0.07,-0.18,-0.11,-0.12,0.21,0.07,-0.14,-0.12,-0.25,-0.27,-0.28,-0.25,-0.22,-0.15,-0.09,-0.18,-0.13,-0.11,0.14,-0.13,-0.26,-0.26,-0.19,-0.13,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,82.07,43.77,T1531,RSGSESSVDQKTVARTPLGQRSRSGSSQELD,_TVART(ph)PLGQR_,-0.12,-0.17,-0.04,-0.15, , , , ,-0.14,-0.29,-0.17,-0.35, , , , ,-0.14,-0.09,,,-0.22,-0.25,,,,,,,,,NA,NA,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9UQ35,Q9UQ35,Serine/arginine repetitive matrix protein 2,SRRM2,91.1,91.1,T983,SHSGSSSPDTKVKPETPPRQSHSGSISPYPK,_VKPET(ph)PPRQSHSGS(ph)ISPYPK_,0.08,-0.13,0.06,-0.21,0.15, ,-0.12,0.44,0,-0.14,-0.24,-0.4,-0.22, ,-0.03,0,-0.02,-0.07,0.15,0.19,-0.06,-0.32,-0.22,-0.01,,,,,,,0,0,,Cajal body,C2H2 zinc finger domain binding,"mRNA splicing, via spliceosome",,
Q9BXP5-5,Q9BXP5,Serrate RNA effector molecule homolog,SRRT,89.15,89.14,T544,HTLDDRTQLWASEPGTPPLPTSLPSQNPILK,_TQLWASEPGT(ph)PPLPTSLPSQNPILK_, , , , ,0.08, , , , , , , ,0.3, , , ,,,0.08,,,,0.3,,,,,,,,NA,NA,,cytoplasm,DNA binding,cell proliferation,,
Q9BXP5-5,Q9BXP5,Serrate RNA effector molecule homolog,SRRT,206.56,201.8,S67,RGEYRDYDRNRRERFSPPRHELSPPQKRMRR,_ERFS(ph)PPRHELS(ph)PPQK_,0.12,0.1,0.13,0.08,0.17,0.28,0.23,0.23,-0.01,-0.07,-0.06,0,0.09,-0.01,0.18,0.05,0.11,0.11,0.22,0.23,-0.04,-0.03,0.04,0.12,,,,,,,0,0,,cytoplasm,DNA binding,cell proliferation,,
Q9BXP5-5,Q9BXP5,Serrate RNA effector molecule homolog,SRRT,206.56,201.8,S74,DRNRRERFSPPRHELSPPQKRMRRDWDEHSS,_ERFS(ph)PPRHELS(ph)PPQK_,0.12,0.1,0.13,0.08,0.17,0.28,0.23,0.23,-0.01,-0.07,-0.06,0,0.09,-0.01,0.18,0.05,0.11,0.11,0.22,0.23,-0.04,-0.03,0.04,0.12,,,,,,,0,0,,cytoplasm,DNA binding,cell proliferation,,
Q9BXP5-5,Q9BXP5,Serrate RNA effector molecule homolog,SRRT,196.15,175.42,S4,____________MGDSDDEYDRRRRDKFRRE,_(ac)GDS(ph)DDEYDRRR_,-0.55,-0.09,-0.11,0.1,0.1,-0.01,-0.02,0.09,-0.1,-0.14,-0.08,-0.01,-0.06,-0.07,-0.07,-0.16,-0.3,0,0.05,0.04,-0.12,-0.05,-0.07,-0.12,,,,,,,0,0,,cytoplasm,DNA binding,cell proliferation,,
Q07955,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,90.38,90.38,S234,SNSRSRSYSPRRSRGSPRYSPRHSRSRSRT_,_SRGS(ph)PRYS(ph)PR_,-0.21,-0.25,-0.23,-0.4,-0.04,-0.07,-0.15,-0.07,-0.16,-0.27,-0.42,-0.35,-0.15,-0.3,-0.21,-0.29,-0.23,-0.31,-0.06,-0.11,-0.21,-0.38,-0.23,-0.25,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,cardiac muscle contraction,,
Q07955,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,90.38,90.38,S238,SRSYSPRRSRGSPRYSPRHSRSRSRT_____,_SRGS(ph)PRYS(ph)PR_,-0.21,-0.25,-0.23,-0.4,-0.04,-0.07,-0.15,-0.07,-0.16,-0.27,-0.42,-0.35,-0.15,-0.3,-0.21,-0.29,-0.23,-0.31,-0.06,-0.11,-0.21,-0.38,-0.23,-0.25,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,cardiac muscle contraction,,
Q07955,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,198.04,198.04,S199,EGETAYIRVKVDGPRSPSYGRSRSRSRSRSR,_VDGPRS(ph)PS(ph)YGR_,-0.28,-0.2,-0.27,-0.28,-0.08,0.02,-0.1,-0.12,-0.33,-0.29,-0.35,-0.34,-0.23,0.03,-0.2,-0.14,-0.24,-0.28,-0.03,-0.11,-0.31,-0.34,-0.09,-0.17,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,cardiac muscle contraction,,
Q07955,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,124.77,124.77,S201,ETAYIRVKVDGPRSPSYGRSRSRSRSRSRSR,_VDGPRS(ph)PS(ph)YGR_,0.03,0.1,0.02,-0.11,-0.01,-0.06,0.04,0.07,-0.03,-0.05,0.02,-0.02,-0.17,-0.12,0.03,0.01,0.06,-0.04,-0.04,0.05,-0.04,0,-0.14,0.02,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,cardiac muscle contraction,,
Q07955,Q07955,Serine/arginine-rich splicing factor 1,SRSF1,80.02,80.02,S205,IRVKVDGPRSPSYGRSRSRSRSRSRSRSRSN,_VDGPRS(ph)PS(ph)YGRS(ph)R_,-0.3,-0.47,-0.24,-0.3,0.05,0.08,-0.29,-0.24,0.01,-0.28,0.18,0.04,0.03,-0.14,-0.14,-0.19,-0.38,-0.27,0.06,-0.26,-0.13,0.11,-0.06,-0.17,,,,,,,0,0,,catalytic step 2 spliceosome,nucleotide binding,cardiac muscle contraction,,
B4DJP9,O75494,Serine/arginine-rich splicing factor 10,SRSF10,188.4,145.88,S133,RSRSRSYERRRSRSRSFDYNYRRSYSPRKPN,_S(ph)RS(ph)FDYNYR_,-0.4,-0.33,-0.25,-0.33,-0.33,-0.25,-0.39,-0.32,-0.5,-0.5,-0.39,-0.41,-0.02,0.04,-0.05,-0.06,-0.37,-0.29,-0.29,-0.35,-0.5,-0.4,0.01,-0.06,,,,,,,0,0,,,,,,
B4DJP9,O75494,Serine/arginine-rich splicing factor 10,SRSF10,188.4,145.88,S131,YRRSRSRSYERRRSRSRSFDYNYRRSYSPRK,_S(ph)RS(ph)FDYNYRR_,-0.35,-0.34,-0.21,-0.24,-0.29,-0.24,-0.28,-0.22,-0.41,-0.43,-0.34,-0.42,-0.1,-0.13,-0.05,-0.04,-0.35,-0.22,-0.26,-0.25,-0.42,-0.38,-0.12,-0.05,,,,,,,0,0,,,,,,
Q8IWE6,Q05519,Serine/arginine-rich splicing factor 11,SRSF11,112.58,108.81,S207,STVDPKLNHVAAGLVSPSLKSDTSSKEIEEA,_LNHVAAGLVS(ph)PSLK_,-0.19,0.07,1.28,1.5,0.52, , , ,0.09,-0.34,1.56,1.53,0.4, , , ,-0.05,1.39,0.52,,-0.11,1.55,0.4,, +, +,,,,,NA,NA,,,,,,
Q8IWE6,Q05519,Serine/arginine-rich splicing factor 11,SRSF11,300.32,283.11,S434,VKVTRDYDEEEQGYDSEKEKKEEKKPIETGS,_VTRDYDEEEQGYDS(ph)EK_,0,-0.04,-0.04,-0.04,-0.03,0.05,0.04,0.07,-0.03,0,-0.01,-0.05,-0.18,-0.05,0.07,0.06,-0.02,-0.04,0.01,0.05,-0.01,-0.03,-0.11,0.07,,,,,,,0,0,,,,,,
Q8IWE6,Q05519,Serine/arginine-rich splicing factor 11,SRSF11,361.61,353.4,S483,SKVNGDDHHEEDMDMSD______________,_VNGDDHHEEDMDM(ox)S(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,134.99,134.99,S206,SPPPVSKRESKSRSRSKSPPKSPEEEGAVSS,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_, ,0.22,0.22,0.38,-0.27,0.08,0.21,0.16, ,-0.05,0.28,0.24,0.04,0.22,0.5,0.46,0.22,0.3,-0.08,0.18,-0.05,0.26,0.13,0.48,,,,,,,0,0,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,134.99,134.99,S208,PPVSKRESKSRSRSKSPPKSPEEEGAVSS__,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_, ,0.22,0.22,0.38,-0.27,0.08,0.21,0.16, ,-0.05,0.28,0.24,0.04,0.22,0.5,0.46,0.22,0.3,-0.08,0.18,-0.05,0.26,0.13,0.48,,,,,,,0,0,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,134.99,134.99,S212,KRESKSRSRSKSPPKSPEEEGAVSS______,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_, ,0.22,0.22,0.38,0.24,0.4,0.35,0.28, ,-0.05,0.28,0.24,0.05,0.37,0.26,0.19,0.22,0.3,0.33,0.32,-0.05,0.26,0.22,0.22,,,,,,,0,0,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,94.63,70.6,S189,SSVSRSRSRSRSRSRSRSPPPVSKRESKSRS,_S(ph)RS(ph)PPPVSK_, , ,0.18, ,0.25,0.17,0.11,0.09, , ,-0.08, ,0.17,0.2,-0.05,0.04,,0.18,0.21,0.1,,-0.08,0.18,0,,,,,,,NA,NA,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,94.63,70.6,S191,VSRSRSRSRSRSRSRSPPPVSKRESKSRSRS,_S(ph)RS(ph)PPPVSK_, , ,0.18, ,0.25,0.17,0.11,0.09, , ,-0.08, ,0.17,0.2,-0.05,0.04,,0.18,0.21,0.1,,-0.08,0.18,0,,,,,,,NA,NA,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,224.57,224.57,S26,EGMTSLKVDNLTYRTSPDTLRRVFEKYGRVG,_VDNLTYRTS(ph)PDTLR_,-0.33,-0.29,-0.41,-0.4,-0.14,-0.18,-0.41,-0.24,-0.3,-0.24,-0.29,-0.28,-0.09,-0.13,-0.12,-0.22,-0.31,-0.4,-0.16,-0.32,-0.27,-0.29,-0.11,-0.17,,,,,,,0,0,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
Q01130,Q01130,Serine/arginine-rich splicing factor 2,SRSF2,158.98,158.98,T25,VEGMTSLKVDNLTYRTSPDTLRRVFEKYGRV,_VDNLTYRT(ph)SPDTLRR_,-0.27,-0.39, , , ,-0.04, , ,-0.37,-0.27, , , ,-0.21, , ,-0.33,,-0.04,,-0.32,,-0.21,,,,,,,,NA,NA,,nuclear speck,nucleotide binding,mRNA 3'-end processing,,
P84103,P84103,Serine/arginine-rich splicing factor 3,SRSF3,126.5,67.3,S138,RSRSRSLSRDRRRERSLSRERNHKPSRSFSR,_ERS(ph)LS(ph)RER_,-0.12,-0.09,-0.18,-0.08,-0.08,-0.08,-0.04,-0.09,-0.22,-0.21,-0.25,-0.12,-0.13,-0.15,-0.12,-0.17,-0.1,-0.13,-0.08,-0.06,-0.22,-0.18,-0.14,-0.14,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
P84103,P84103,Serine/arginine-rich splicing factor 3,SRSF3,126.5,67.3,S140,RSRSLSRDRRRERSLSRERNHKPSRSFSRSR,_ERS(ph)LS(ph)RER_,-0.12,-0.09,-0.18,-0.08,-0.08,-0.08,-0.04,-0.09,-0.22,-0.21,-0.25,-0.12,-0.13,-0.15,-0.12,-0.17,-0.1,-0.13,-0.08,-0.06,-0.22,-0.18,-0.14,-0.14,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
Q13247,Q13247,Serine/arginine-rich splicing factor 6,SRSF6,68.97,68.97,S314,SRSNSPLPVPPSKARSVSPPPKRATSRSRSR,_S(ph)VS(ph)PPPKR_,0.18,0.08,-0.16,-0.04,-0.08,0.11,0.1,0.26,0.16,-0.07,-1.26,-0.04,-0.01,-0.04,0.08,0.17,0.13,-0.1,0.02,0.19,0.05,-0.52,-0.02,0.12,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
Q13247,Q13247,Serine/arginine-rich splicing factor 6,SRSF6,68.97,68.97,S316,SNSPLPVPPSKARSVSPPPKRATSRSRSRSR,_S(ph)VS(ph)PPPKR_,0.18,0.08,-0.16,-0.04,-0.08,0.11,0.1,0.26,0.16,-0.07,-1.26,-0.04,-0.01,-0.04,0.08,0.17,0.13,-0.1,0.02,0.19,0.05,-0.52,-0.02,0.12,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
Q13247,Q13247,Serine/arginine-rich splicing factor 6,SRSF6,48.29,48.29,S301,KGDIKSKSRSRSQSRSNSPLPVPPSKARSVS,_S(ph)NS(ph)PLPVPPSK_, , , , ,0.29,0.22,0.36,0.29, , , , , ,0.28,0.23,0.12,,,0.25,0.32,,,0.28,0.17,,,,,,,NA,NA,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
Q13247,Q13247,Serine/arginine-rich splicing factor 6,SRSF6,109.14,85.07,S303,DIKSKSRSRSQSRSNSPLPVPPSKARSVSPP,_S(ph)NS(ph)PLPVPPSK_,0.15,0.21,0.23,0.29,0.33,0.38,0.08,0.27,0.02,0.08,0.02,0.2,0.38,0.47,0.33,0.18,0.18,0.26,0.35,0.18,0.05,0.12,0.43,0.26,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
G5E9M3,Q16629,Serine/arginine-rich splicing factor 7,SRSF7,103.19,98.46,S192,RRSRSGSIKGSRYFQSPSRSRSRSRSISRPR,_YFQS(ph)PS(ph)R_, ,-0.46,0.21, ,-0.11,-0.33,-0.41,-0.46, ,-0.5,-0.65, ,0.07,-0.06,-0.05,-0.16,-0.46,0.21,-0.21,-0.43,-0.5,-0.65,0.01,-0.11,,,,,,,0,0,,,,,,
G5E9M3,Q16629,Serine/arginine-rich splicing factor 7,SRSF7,73.5,73.5,S194,SRSGSIKGSRYFQSPSRSRSRSRSISRPRSS,_YFQS(ph)PS(ph)R_, ,-0.46, , ,-0.11,-0.33,-0.41,-0.46, ,-0.5, , ,0.07,-0.06,-0.05,-0.16,-0.46,,-0.21,-0.43,-0.5,,0.01,-0.11,,,,,,,NA,NA,,,,,,
Q13242,Q13242,Serine/arginine-rich splicing factor 9,SRSF9,141.13,140.23,S211,RSGSRGRDSPYQSRGSPHYFSPFRPY_____,_GS(ph)PHYFS(ph)PFRPY_,-0.15,0.05,-0.35,-0.2,-0.79,-0.33,-0.7,-0.68,0,-0.11,-0.37,0.11,-0.43,-0.35,-0.26,-0.45,-0.05,-0.27,-0.54,-0.69,-0.05,-0.11,-0.39,-0.35,,,,,,,0,0,,nucleolus,nucleotide binding,mRNA 3'-end processing,,
Q13242,Q13242,Serine/arginine-rich splicing factor 9,SRSF9,141.13,140.23,S216,GRDSPYQSRGSPHYFSPFRPY__________,_GS(ph)PHYFS(ph)PFRPY_,-0.15,0.05,-0.16,-0.23,-0.31,-0.33,-0.27,-0.32,0,-0.11,-0.19,-0.19,-0.4,-0.35,-0.29,-0.23,-0.05,-0.19,-0.32,-0.29,-0.05,-0.19,-0.37,-0.26,,,,,,,0,0,,nucleolus,nucleotide binding,mRNA 3'-end processing,,
P05455,P05455,Lupus La protein,SSB,266.94,266.94,S366,GKGKVQFQGKKTKFASDDEHDEHDENGATGP,_TKFAS(ph)DDEHDEHDENGATGPVK_,0.05,0,0.02,-0.07,-0.1,-0.2,0.05,0.02,-0.06,0.03,-0.04,-0.03,0.02,-0.03,0.04,0.05,0.03,-0.02,-0.15,0.04,-0.02,-0.03,-0.01,0.04,,,,,,,0,0,,nucleus,mRNA binding,histone mRNA metabolic process,,
Q9NW25,Q9BWW4,Single-stranded DNA-binding protein 3,SSBP3,185.64,185.07,S347,NGSLGSGDIDGLPKNSPNNISGISNPPGTPR,_NS(ph)PNNISGISNPPGT(ph)PR_,-0.51,-0.51,-1.03,-1.08,-0.42,-0.34,-0.71,-0.6,-0.09,-0.33,-0.38,-0.92,-0.67,-0.45,-0.69,-0.84,-0.51,-1.06,-0.38,-0.66,-0.21,-0.63,-0.55,-0.76, +,,,,,,3,0,19.3,nucleus,single-stranded DNA binding,head morphogenesis,,
Q9NW25,Q9BWW4,Single-stranded DNA-binding protein 3,SSBP3,183.12,177.48,T360,KNSPNNISGISNPPGTPRDDGELGGNFLHSF,_NS(ph)PNNISGISNPPGT(ph)PR_, , , , ,-0.65,-0.59,-0.29,-0.3, , , , ,-0.94,-1.16,-0.94,-0.73,,,-0.62,-0.29,,,-1.04,-0.83,, +,,,,,NA,NA,,nucleus,single-stranded DNA binding,head morphogenesis,,
E9PHV5,P28290,Sperm-specific antigen 2,SSFA2,181.51,179.2,S92,KIAIWLKDCRTPLGASLDEQSSSTLKGVLVR,_TPLGAS(ph)LDEQSSSTLK_, , , , , ,1.1,0.3,0.32, , , , , ,0.61,0.49,0.29,,,1.1,0.31,,,0.61,0.39, +,,,,,,NA,NA,,plasma membrane,,,,
E9PHV5,P28290,Sperm-specific antigen 2,SSFA2,153.36,150.49,S739,RYLFAKAGYPLRRSQSLPTTLLSPVRVVSSV,_SQS(ph)LPTTLLS(ph)PVR_, , , ,0.8,0.14,-1.14,-0.31,-0.13, , , ,0.87,0.22,-1.55,-0.33,-0.16,,0.8,-0.36,-0.22,,0.87,-0.41,-0.24,,,,,,,NA,NA,,plasma membrane,,,,
E9PHV5,P28290,Sperm-specific antigen 2,SSFA2,153.36,150.49,S746,GYPLRRSQSLPTTLLSPVRVVSSVNVRLSPG,_SQS(ph)LPTTLLS(ph)PVR_, , , , ,0.14,-1.14,-0.31,-0.13, , , , ,0.22,-1.55,-0.33,-0.16,,,-0.36,-0.22,,,-0.41,-0.24,,,,,,,NA,NA,,plasma membrane,,,,
E9PHV5,P28290,Sperm-specific antigen 2,SSFA2,87.81,86.29,T1168,VALTPTAPSRTGSVQTPPDLESSEEVDAAEG,_TGS(ph)VQT(ph)PPDLES(ph)SEEVDAAEGAPEVVGPK_, , , , , ,0.26, , , , , , , ,0.76, , ,,,0.26,,,,0.76,,,,,,,,NA,NA,,plasma membrane,,,,
Q08945,Q08945,FACT complex subunit SSRP1,SSRP1,166.32,160.74,S437,KLNIKNRGLKEGMNPSYDEYADSDEDQHDAY,_EGMNPS(ph)YDEYADS(ph)DEDQHDAYLER_, ,-0.27,-0.16,-0.4,0.02,0.11,-0.03,-0.12, ,0.11,0.16,0,0.21,0.08,-0.13,-0.05,-0.27,-0.28,0.07,-0.07,0.11,0.08,0.15,-0.09,,,,,,,0,0,,chromosome,chromatin binding,DNA repair,,
Q08945,Q08945,FACT complex subunit SSRP1,SSRP1,309.19,303,S444,GLKEGMNPSYDEYADSDEDQHDAYLERMKEE,_EGMNPSYDEYADS(ph)DEDQHDAYLER_,-0.03,-0.02,-0.11,-0.09,-0.17,-0.11,-0.01,-0.17,0.03,0.04,-0.02,-0.05,-0.11,-0.07,-0.18,-0.1,-0.02,-0.1,-0.14,-0.09,0.03,-0.04,-0.09,-0.14,,,,,,,0,0,,chromosome,chromatin binding,DNA repair,,
Q08945,Q08945,FACT complex subunit SSRP1,SSRP1,125.97,69.16,S659,SRGSSSKSSSRQLSESFKSKEFVSSDESSSG,_QLSES(ph)FK_,-0.38,-0.3,-0.43,-0.43,-0.28,-0.34,-0.18,-0.37,-0.03,-0.06,-0.11,-0.07,-0.24,-0.43,-0.38,-0.34,-0.34,-0.43,-0.31,-0.27,-0.05,-0.09,-0.33,-0.36,,,,,,,0,0,,chromosome,chromatin binding,DNA repair,,
Q08945,Q08945,FACT complex subunit SSRP1,SSRP1,47.65,47.39,S688,SGENKSKKKRRRSEDSEEEELASTPPSSEDS,_SEDS(ph)EEEELASTPPS(ph)SEDSASGSDE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,chromosome,chromatin binding,DNA repair,,
P50502,P50502,Hsc70-interacting protein,ST13,207.1,205.16,S75,PDSKKVEEDLKADEPSSEESDLEIDKEGVIE,_VEEDLKADEPS(ph)S(ph)EES(ph)DLEIDK_,0.12,0.11,0.09,0.08,0.06,0.18,0.22,0.3,0.21,0.23,0.14,0.18,0.1,0.24,0.35,0.34,0.12,0.08,0.12,0.26,0.22,0.16,0.17,0.35,,,,,,,0,0,,cytoplasm,dATP binding,chaperone cofactor-dependent protein refolding,,
P50502,P50502,Hsc70-interacting protein,ST13,215.88,215.88,S76,DSKKVEEDLKADEPSSEESDLEIDKEGVIEP,_VEEDLKADEPS(ph)S(ph)EES(ph)DLEIDK_,0.13,0.25,0.23,0.23,0.31,0.07,0.02,-0.02,0.18,0.22,0.08,0.13,0.34,-0.09,0,0,0.19,0.23,0.2,0,0.2,0.11,0.14,0,,,,,,,0,0,,cytoplasm,dATP binding,chaperone cofactor-dependent protein refolding,,
P50502,P50502,Hsc70-interacting protein,ST13,242.8,242.8,S79,KVEEDLKADEPSSEESDLEIDKEGVIEPDTD,_VEEDLKADEPS(ph)S(ph)EES(ph)DLEIDK_,0.35,0.41,0.21,0.22,-0.17,-0.2,0.25,0.18,0.07,0.05,-0.09,-0.29,-0.4,-0.57,0.26,0.29,0.38,0.22,-0.18,0.21,0.06,-0.19,-0.48,0.28,,,,,,,0,0,,cytoplasm,dATP binding,chaperone cofactor-dependent protein refolding,,
E9PQA9,P78524,Suppression of tumorigenicity 5 protein,ST5,68.54,49.4,Y501,NAYEDIVGDLPKENPYEDVDLKSRRAGRKSQ,_ENPY(ph)EDVDLK_,0.05, ,-0.52, ,-0.31, ,0.36,-0.05,0.27, ,-0.28, ,-0.11, ,1.04,0.52,0.05,-0.52,-0.31,0.17,0.27,-0.28,-0.11,0.8,,,,,,,0,0,,,,,,
Q6ZMT1,Q6ZMT1,SH3 and cysteine-rich domain-containing protein 2,STAC2,148.56,108.17,S48,RFKRSLSLKTILRSKSLENFFLRSGSELKCP,_S(ph)LENFFLR_, ,0.44, ,0.02,0.26,0.41,0.23, , ,0.37, ,0.24,0.17,-0.03,0.26, ,0.44,0.02,0.34,0.23,0.37,0.24,0.07,0.26,,,,,,,0,0,,,metal ion binding,intracellular signal transduction,,
F8WAK8,Q8N3U4,Cohesin subunit SA-2,STAG2,247.62,245.64,S1061,NSLLAGGDDDTMSVISGISSRGSTVRSKKSK,_NSLLAGGDDDTMSVIS(ph)GIS(ph)SR_, , , , , ,-0.35,-0.33, , , , , , ,-0.67,-0.11, ,,,-0.35,-0.33,,,-0.67,-0.11,,,,,,,NA,NA,,,,,,
F8WAK8,Q8N3U4,Cohesin subunit SA-2,STAG2,247.62,245.64,S1064,LAGGDDDTMSVISGISSRGSTVRSKKSKPST,_NSLLAGGDDDTMSVIS(ph)GIS(ph)SR_, , , , , ,-0.24,-0.37, , , , , , ,-0.44,-0.25, ,,,-0.24,-0.37,,,-0.44,-0.25,,,,,,,NA,NA,,,,,,
Q92783-2,Q92783,Signal transducing adapter molecule 1,STAM,205.02,203.59,Y198,SLKEQRQQSTTLSTLYPSTSSLLTNHQHEGR,_QQSTTLSTLY(ph)PSTSSLLTNHQHEGRK_, , ,3.6, , , , , , , ,1.59, , , , , ,,3.6,,,,1.59,,, +, +,,,,,NA,NA,,cytosol,SH3/SH2 adaptor activity,cellular membrane organization,,
Q92783-2,Q92783,Signal transducing adapter molecule 1,STAM,131.66,107.41,Y381,EALSLYTKLMNEDPMYSMYAKLQNQPGSGPT,_LMNEDPMY(ph)SMYAK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,SH3/SH2 adaptor activity,cellular membrane organization,,
O75886,O75886,Signal transducing adapter molecule 2,STAM2,119.65,99.53,Y291,DDDVEEIKKSEPEPVYIDEDKMDRALQVLQS,_SEPEPVY(ph)IDEDK_, , ,4.55, , , , , , , ,2.72, , , , , ,,4.55,,,,2.72,,, +, +,,,,,NA,NA,,cytosol,,cellular membrane organization,,
O75886,O75886,Signal transducing adapter molecule 2,STAM2,253.14,189.93,Y192,SLQEQKQQHTETKSLYPSSEIQLNNKVARKV,_SLY(ph)PSSEIQLNNK_, , ,4.8, , , , , , , ,2.86, , , , , ,,4.8,,,,2.86,,, +, +,,,,,NA,NA,,cytosol,,cellular membrane organization,,
F5GY11,Q9Y365,PCTP-like protein,STARD10,92.8,91.72,S284,AESREERMGGAGGEGSDDDTSLT________,_MGGAGGEGS(ph)DDDTSLT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,85.65,85.24,S210,RAALIPGGLSDGQFYSPPESEAGSEEAEEKQ,_AALIPGGLSDGQFYS(ph)PPES(ph)EAGS(ph)EEAEEK_, , , ,0,0.01,0.01,0.55,0.19, , , ,-0.15,0.32,-0.13,-0.07,-0.01,,0,0.01,0.38,,-0.15,0.11,-0.04,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,85.65,85.24,S214,IPGGLSDGQFYSPPESEAGSEEAEEKQDSEK,_AALIPGGLSDGQFYS(ph)PPES(ph)EAGS(ph)EEAEEK_, , , ,0,0.24,0.01,0.55,0.19, , , ,-0.15,0.41,-0.13,-0.07,-0.01,,0,0.13,0.38,,-0.15,0.16,-0.04,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,85.65,85.24,S218,LSDGQFYSPPESEAGSEEAEEKQDSEKPLLE,_AALIPGGLSDGQFYS(ph)PPES(ph)EAGS(ph)EEAEEK_, , , ,0,0.24,0.01,0.55,0.19, , , ,-0.15,0.41,-0.13,-0.07,-0.01,,0,0.13,0.38,,-0.15,0.16,-0.04,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,173.2,172.13,S15,_MNHLPEDMENALTGSQSSHASLRNIHSINP,_(ac)MNHLPEDMENALTGS(ph)QSS(ph)HAS(ph)LR_, , , , ,0.24,-0.06,0.22,0, , , , ,0.25,0.33,0.33,-0.05,,,0.1,0.11,,,0.29,0.15,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,173.2,172.13,S18,HLPEDMENALTGSQSSHASLRNIHSINPTQL,_(ac)MNHLPEDMENALTGS(ph)QSS(ph)HAS(ph)LR_, , , , ,0.24,-0.06, ,0, , , , ,0.25,0.33, ,-0.05,,,0.1,0,,,0.29,-0.05,,,,,,,NA,NA,,,,,,
C9JKL2,O95772,MLN64 N-terminal domain homolog,STARD3NL,173.2,172.13,S21,EDMENALTGSQSSHASLRNIHSINPTQLMAR,_(ac)MNHLPEDMENALTGS(ph)QSS(ph)HAS(ph)LR_, , , , ,0.24,-0.06,0.22,0, , , , ,0.25,0.33,0.33,-0.05,,,0.1,0.11,,,0.29,0.15,,,,,,,NA,NA,,,,,,
P42224,P42224,Signal transducer and activator of transcription 1-alpha/beta,STAT1,172.8,171.99,S727,VHPSRLQTTDNLLPMSPEEFDEVSRIVGSVE,_LQTTDNLLPMS(ph)PEEFDEVSR_, , ,0.03, ,0.47,0.46,0.39,0.41, , ,0.87, ,0.51,0.43,-0.06,-0.01,,0.03,0.46,0.4,,0.87,0.47,-0.04,,,,,,,NA,NA,,axon,calcium ion binding,blood circulation,,
P40763,P40763,Signal transducer and activator of transcription 3,STAT3,140.28,138.01,Y539,QLTTLAEKLLGPGVNYSGCQITWAKFCKENM,_LLGPGVNY(ph)SGCQITWAK_,2.77, , , , , , , , , , , , , , , ,2.77,,,,,,,, +,,,,,,NA,NA,,cytosol,calcium ion binding,acute-phase response,,
P40763,P40763,Signal transducer and activator of transcription 3,STAT3,187.79,187.79,Y705,ESQEHPEADPGSAAPYLKTKFICVTPTTCSN,_YCRPESQEHPEADPGSAAPY(ph)LK_,1.06, ,1.4, , , ,-1.08,-0.6,0.21, ,0.62, , , ,-0.73,-0.68,1.06,1.4,,-0.82,0.21,0.62,,-0.7, +,,,,,,NA,NA,,cytosol,calcium ion binding,acute-phase response,,
P51692,P42229,Signal transducer and activator of transcription 5B,STAT5B,201.46,141.06,Y694,TPVPCESATAKAVDGYVKPQIKQVVPEFVNA,_AVDGY(ph)VKPQIK_,6.32, ,4.9,5.03,6.1,5.22, , ,5.84, ,3.64,4.09,6.25,5.35, , ,6.32,4.97,5.72,,5.84,3.88,5.87,, +, +,,,,,NA,NA,,cytosol,calcium ion binding,2-oxoglutarate metabolic process,,
P51692,P51692,Signal transducer and activator of transcription 5B,STAT5B,140.31,137.7,S128,LYNEQRLVREANNGSSPAGSLADAMSQKHLQ,_EANNGSS(ph)PAGSLADAMSQK_,0.2,0.21,0.14, , , , ,0.1,0.09,0.32,0.14, , , , ,0.17,0.21,0.14,,0.1,0.21,0.14,,0.17,,,,,,,NA,NA,,cytosol,calcium ion binding,2-oxoglutarate metabolic process,,
E9PNJ4,Q13586,Stromal interaction molecule 1,STIM1,84.61,52.52,S575,IEGVHPGSLVEKLPDSPALAKKALLALNHGL,_LPDS(ph)PALAK_, , , , ,0.01,-0.03,0.12,0.06, , , , ,-0.18,-0.43,-0.19,-0.08,,,-0.01,0.09,,,-0.3,-0.13,,,,,,,NA,NA,,endoplasmic reticulum,,cation transport,,
Q9P246,Q9P246,Stromal interaction molecule 2,STIM2,60.94,42.6,S523,RSSSLCRSRRSIVPSSPQPQRAQLAPHAPHP,_SIVPSS(ph)PQPQR_, , , , ,0.39,0.06, , , , , , ,0.71,0.37, , ,,,0.23,,,,0.55,,,,,,,,NA,NA,,endoplasmic reticulum,calcium channel regulator activity,activation of store-operated calcium channel activity,,
O94804,O94804,Serine/threonine-protein kinase 10,STK10,271.91,185.36,S438,QVAQEKQVAEQGGDLSPAANRSQKASQSRPN,_(gl)QVAEQGGDLS(ph)PAANR_,1.18,0.99,1.25,2.26,-0.27,-0.13,0.23,0.05,-0.36,-0.47,-0.63,-0.68,-0.47,-0.78,-0.23,-0.36,1.09,1.84,-0.2,0.14,-0.42,-0.66,-0.62,-0.29, +,,STE,,,,4,0,8.4,plasma membrane,ATP binding,cell cycle,,
O94804,O94804,Serine/threonine-protein kinase 10,STK10,170.06,168.65,S450,GDLSPAANRSQKASQSRPNSSALETLGGEKL,_ASQS(ph)RPNS(ph)SALETLGGEK_,-0.3,-0.29,-0.32,-0.28,0.47,0.39,0.71,0.44,-0.11,-0.2,0.9,0.64,1.22,2.26,0.22,0.31,-0.29,-0.3,0.43,0.58,-0.15,0.78,1.83,0.27,, +,STE,,,,0,1,7.27,plasma membrane,ATP binding,cell cycle,,
O94804,O94804,Serine/threonine-protein kinase 10,STK10,170.06,168.65,S454,PAANRSQKASQSRPNSSALETLGGEKLANGS,_ASQS(ph)RPNS(ph)SALETLGGEK_,-0.34,-0.52,-0.29,-0.28,0.47,0.36,0.83,0.59,-0.26,-0.47,-0.13,0.64,1.22,2.95,0.26,0.63,-0.42,-0.28,0.41,0.71,-0.36,0.3,2.33,0.45,, +,STE,,,,0,2,11.48,plasma membrane,ATP binding,cell cycle,,
H0Y469,Q8N1F8,Serine/threonine-protein kinase 11-interacting protein,STK11IP,137.72,137.72,S398,PLLHKVKSRVRVRRASISEPSDTDPEPRTLN,_RAS(ph)IS(ph)EPS(ph)DTDPEPR_, , , , ,0.38,0.31,0.34,0.4, , , , ,0.64,0.3,0.23,0.22,,,0.35,0.37,,,0.48,0.22,,,,,,,NA,NA,,,,,,
H0Y469,Q8N1F8,Serine/threonine-protein kinase 11-interacting protein,STK11IP,137.72,137.72,S400,LHKVKSRVRVRRASISEPSDTDPEPRTLNPS,_RAS(ph)IS(ph)EPS(ph)DTDPEPR_, , , , ,0.38,0.31,0.34,0.4, , , , ,0.64,0.3,0.23,0.22,,,0.35,0.37,,,0.48,0.22,,,,,,,NA,NA,,,,,,
H0Y469,Q8N1F8,Serine/threonine-protein kinase 11-interacting protein,STK11IP,137.72,137.72,S403,VKSRVRVRRASISEPSDTDPEPRTLNPSPAG,_RAS(ph)IS(ph)EPS(ph)DTDPEPR_, , , , ,0.38,0.31,0.34,0.4, , , , ,0.64,0.3,0.23,0.22,,,0.35,0.37,,,0.48,0.22,,,,,,,NA,NA,,,,,,
E5RFQ9,Q13188,Serine/threonine-protein kinase 3,STK3,162.61,145.24,S316,RHEEQQRELEEEEENSDEDELDSHTMVKTSV,_ELEEEEENS(ph)DEDELDSHTMVK_,-0.04,-0.15,-0.3,-0.06,-0.24,-0.03, , ,-0.06,-0.12,-0.3,-0.06,0.03,0.27, , ,-0.09,-0.17,-0.13,,-0.09,-0.17,0.15,,,,STE,,,,NA,NA,,,ATP binding,,,
F8WAK5,Q9BYT3,Serine/threonine-protein kinase 33,STK33,113.71,111.65,S441,KSYQPWGNVPDANYTSDEEEEKQSTAYEKQF,_SYQPWGNVPDANYT(ph)S(ph)DEEEEK_, , , , ,0.1,-0.02,-0.05, , , , , ,0.38,0.44,0.15, ,,,0.04,-0.05,,,0.41,0.15,,,CAMK,,,,NA,NA,,,ATP binding,protein autophosphorylation,,
F8WAK5,Q9BYT3,Serine/threonine-protein kinase 33,STK33,113.71,111.65,T440,LKSYQPWGNVPDANYTSDEEEEKQSTAYEKQ,_SYQPWGNVPDANYT(ph)S(ph)DEEEEK_, , , , ,0.1,-0.02,-0.05, , , , , ,0.38,0.44,0.15, ,,,0.04,-0.05,,,0.41,0.15,,,CAMK,,,,NA,NA,,,ATP binding,protein autophosphorylation,,
Q9UEW8,Q9UEW8,STE20/SPS1-related proline-alanine-rich protein kinase,STK39,316.75,313.78,S385,SSGHLHKTEDGDWEWSDDEMDEKSEEGKAAF,_TEDGDWEWS(ph)DDEM(ox)DEK_,0.03,0.01,-0.1,0.01,-0.3,-0.29,-0.26,-0.25,0.27,0.08,0.02,0.04,-0.11,-0.08,0.02,-0.03,0.02,-0.04,-0.29,-0.25,0.18,0.03,-0.09,0,,,STE,,,,0,0,,apical plasma membrane,ATP binding,positive regulation of potassium ion transport,,
F5H5B4,Q13043,Serine/threonine-protein kinase 4,STK4,136.3,128.63,S320,QESQQREVDQDDEENSEEDEMDSGTMVRAVG,_EVDQDDEENS(ph)EEDEMDSGTMVR_, , , , ,-0.06, , ,-0.26, , , , ,-0.01, , ,0.06,,,-0.06,-0.26,,,-0.01,0.06,,,STE,,,,NA,NA,,cytoplasm,ATP binding,signal transduction,,
P16949,P16949,Stathmin,STMN1,220.5,220.5,S16,MASSDIQVKELEKRASGQAFELILSPRSKES,_RAS(ph)GQAFELILSPR_,0.37,0.13,1.17,1.1,-0.54,0.47,-0.01,0.01,0.41,0.41,1.8,1.69,-0.94,0.38,0.07,0.1,0.25,1.13,0.05,0,0.41,1.75,-0.13,0.09, +, +,,,,,4,4,28.96,cytosol,signal transducer activity,axonogenesis,,
P16949,P16949,Stathmin,STMN1,220.5,220.5,S25,ELEKRASGQAFELILSPRSKESVPEFPLSPP,_RASGQAFELILS(ph)PR_,-0.18,0.08,2.08,1.67,0.4,0.47,-0.01,0.01,-0.08,0.47,2.38,2.17,0.36,0.38,0.07,0.1,-0.04,1.89,0.44,0,0.22,2.28,0.37,0.09, +, +,,,,,4,4,28.19,cytosol,signal transducer activity,axonogenesis,,
P16949,P16949,Stathmin,STMN1,151.8,151.8,S38,ILSPRSKESVPEFPLSPPKKKDLSLEEIQKK,_ESVPEFPLS(ph)PPK_,-0.18,-0.09,0.61,-0.03,0.71,0.8,0.57,0.41,0.25,0.13,0.84,0.5,0.67,0.73,0.34,0.49,-0.13,0.32,0.76,0.49,0.19,0.68,0.7,0.42,,,,,,,0,0,,cytosol,signal transducer activity,axonogenesis,,
P16949,P16949,Stathmin,STMN1,133.75,107.69,S63,EEIQKKLEAAEERRKSHEAEVLKQLAEKREH,_S(ph)HEAEVLK_,-0.45,-0.33,-0.24,-0.39,0.29,0.6,0.15,0.03,-0.02,0.23,0.35,0.29,0.26,0.2,0.01,-0.02,-0.39,-0.31,0.46,0.09,0.11,0.32,0.23,0,,,,,,,0,0,,cytosol,signal transducer activity,axonogenesis,,
P16949,P16949,Stathmin,STMN2,122.18,80.58,S46,SEAPRTLASPKKKDLSLEEIQKKLEAAEERR,_DLS(ph)LEEIQK_,-0.08,-0.36,-0.47,-0.21,0.23,0.06,-0.31,-0.61,0.26,-0.01,0.35,0.13,-0.01,-0.17,0.04,0.39,-0.22,-0.33,0.15,-0.45,0.13,0.25,-0.09,0.22,,,,,,,0,0,,cytosol,signal transducer activity,axonogenesis,,
Q9UJZ1,Q9UJZ1,Stomatin-like protein 2,STOML2,78.42,57.47,T327,AMGVYGALTKAPVPGTPDSLSSGSSRDVQGT,_APVPGT(ph)PDSLSSGSSR_, , , , ,0.29, , , , , , , ,0.16, , , ,,,0.29,,,,0.16,,,,,,,,NA,NA,,cytoskeleton,cardiolipin binding,"CD4-positive, alpha-beta T cell activation",,
G3V340,Q13033,Striatin-3,STRN3,213.02,189.84,S229,SVETKNLEQILNGGESPKQKGQEIKRSSGDV,_NLEQILNGGES(ph)PK_,0.17,0.04,0.04,0.08,0.1,0.03,0.22,0.17,0.03,-0.01,0.07,0.05,0.28,0.39,0.47,0.15,0.11,0.06,0.07,0.2,0.01,0.06,0.34,0.32,,,,,,,0,0,,,,,,
Q8TCJ2,Q8TCJ2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B,STT3B,138.03,138.03,S498,YLGDDMKRENPPVEDSSDEDDKRNQGNLYDK,_ENPPVEDS(ph)S(ph)DEDDKRNQGNLYDK_,0.28,0.35,0.31,0.26, ,0.27,0.32,0.27,-0.14,-0.45,-0.47,0.19, ,0.73,0.29,0.25,0.31,0.28,0.27,0.29,-0.28,-0.1,0.73,0.27,,,,,,,0,0,,integral to membrane,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,co-translational protein modification,,
Q8TCJ2,Q8TCJ2,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B,STT3B,138.03,138.03,S499,LGDDMKRENPPVEDSSDEDDKRNQGNLYDKA,_ENPPVEDS(ph)S(ph)DEDDKRNQGNLYDK_,0.28,0.35,0.31,0.26, ,0.27,0.43,0.25,-0.14,-0.45,-0.47,0.19, ,0.73,0.15,0.28,0.31,0.28,0.27,0.34,-0.28,-0.1,0.73,0.21,,,,,,,0,0,,integral to membrane,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,co-translational protein modification,,
Q9UNE7,Q9UNE7,E3 ubiquitin-protein ligase CHIP,STUB1,278.61,253.29,S19,KEEKEGGARLGAGGGSPEKSPSAQELKEQGN,_LGAGGGS(ph)PEKS(ph)PSAQELK_,0.13,0.05,-0.09,0.12,-0.02,-0.27,-1.21,0.06,-0.14,-0.16,0.07,-0.02,0.07,0.13,-0.99,0.12,0.09,0.02,-0.14,-0.44,-0.15,0.03,0.1,-0.33,,,,U box,,,0,0,,cytosol,Hsp70 protein binding,cellular response to misfolded protein,,
Q9UNE7,Q9UNE7,E3 ubiquitin-protein ligase CHIP,STUB1,278.61,253.29,S23,EGGARLGAGGGSPEKSPSAQELKEQGNRLFV,_LGAGGGS(ph)PEKS(ph)PSAQELK_,-0.02,0.05,-0.09,0.12,-0.02,-0.15,-0.01,0.06,-0.21,-0.16,0.07,-0.02,0.07,-0.02,0.02,0.12,0.01,0.02,-0.08,0.03,-0.18,0.03,0.02,0.07,,,,U box,,,0,0,,cytosol,Hsp70 protein binding,cellular response to misfolded protein,,
B1AJQ6,Q86Y82,Syntaxin-12,STX12,127.59,126.44,Y9,_______MSYGPLDMYRNPGPSGPQLRDFSS,_(ac)SYGPLDMY(ph)RNPGPSGPQLR_, , ,2.22, , , , , , , ,1.67, , , , , ,,2.22,,,,1.67,,, +, +,,,,,NA,NA,,membrane,,vesicle-mediated transport,,
B1AJQ6,Q86Y82,Syntaxin-12,STX12,110.56,101.71,Y3,_____________MSYGPLDMYRNPGPSGPQ,_(ac)SY(ph)GPLDMY(ph)RNPGPSGPQLR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,membrane,,vesicle-mediated transport,,
B1AJQ6,Q86Y82,Syntaxin-12,STX12,127.36,83.68,S142,KEKESIARARAGSRLSAEERQREEQLVSFDS,_AGSRLS(ph)AEER_,0.47,0.26,0.35,0.2,0.25,0.24,0.29,0.42,-0.21,-0.26,-0.26,-0.2,0.23,0.34,0.55,0.58,0.37,0.28,0.24,0.36,-0.23,-0.23,0.28,0.56,,,,,,,0,0,,membrane,,vesicle-mediated transport,,
C9JFM5,Q12846,Syntaxin-4,STX4,134.81,134.81,S117,KAIEPQKEEADENYNSVNTRMR_________,_AIEPQKEEADENYNS(ph)VNTR_, ,0.33,0.25,0.19, , , , , ,0.08,0.12,0.65, , , , ,0.33,0.22,,,0.08,0.41,,,,,,,,,NA,NA,,membrane,,vesicle-mediated transport,,
B4DH37,O15400,Syntaxin-7,STX7,136.81,134.06,Y3,_____________MSYTPGVGGDPAQLAQRI,_(ac)SY(ph)TPGVGGDPAQLAQR_, , ,2.15, , , , , , , ,0.5, , , , , ,,2.15,,,,0.5,,, +,,,,,,NA,NA,,membrane,,intracellular protein transport,,
B4DH37,O15400,Syntaxin-7,STX7,93.22,93.22,S129,YIKEFVARVRASSRVSGSFPEDSSKERNLVS,_ASSRVS(ph)GSFPEDSSK_,0.33, ,0.47,0.54,0.84,1.21, ,0.73,0.65, ,0.41,0.7,0.61,0.74, ,0.65,0.33,0.51,1.04,0.73,0.65,0.56,0.68,0.65, +,,,,,,2,0,21.48,membrane,,intracellular protein transport,,
Q5T5C0-2,Q5T5C0,Syntaxin-binding protein 5,STXBP5,155.76,155.76,S759,DRCKSPTSAKMSRKLSLPTDLKPDLDVKDNS,_KLS(ph)LPTDLKPDLDVK_, , ,1.59,1.37, , , , , , ,1.71,1.5, , , , ,,1.49,,,,1.61,,, +, +,,,,,NA,NA,,acetylcholine-gated channel complex,syntaxin-1 binding,exocytosis,,
P53999,P53999,Activated RNA polymerase II transcriptional coactivator p15,SUB1,153.32,96.1,S118,ISLNPEQWSQLKEQISDIDDAVRKL______,_EQIS(ph)DIDDAVR_,-0.03,-0.04,-0.12,-0.1,-0.22,-0.2,-0.18,-0.16,-0.07,-0.05,-0.11,-0.16,-0.2,-0.06,-0.19,-0.13,-0.03,-0.11,-0.21,-0.17,-0.06,-0.14,-0.12,-0.16,,,,,,,0,0,,nucleolus,single-stranded DNA binding,regulation of transcription from RNA polymerase II promoter,,
P53999,P53999,Activated RNA polymerase II transcriptional coactivator p15,SUB1,124.39,124.39,S13,___MPKSKELVSSSSSGSDSDSEVDKKLKRK,_ELVSSSSS(ph)GSDS(ph)DSEVDK_, , , , , , ,0.12,0.12, , , , , , ,0.31,0.46,,,,0.12,,,,0.39,,,,,,,NA,NA,,nucleolus,single-stranded DNA binding,regulation of transcription from RNA polymerase II promoter,,
P53999,P53999,Activated RNA polymerase II transcriptional coactivator p15,SUB1,210.33,195.76,S17,PKSKELVSSSSSGSDSDSEVDKKLKRKKQVA,_ELVSSSSSGSDS(ph)DSEVDK_,0.65,0.49,0.06,0.18,0.32,0.25,0.37,0.41,0.72,0.42,0.01,-0.09,0.01,0.08,0.41,0.53,0.57,0.12,0.28,0.39,0.58,-0.04,0.05,0.48,,,,,,,0,0,,nucleolus,single-stranded DNA binding,regulation of transcription from RNA polymerase II promoter,,
Q9H7L9,Q9H7L9,Sin3 histone deacetylase corepressor complex component SDS3,SUDS3,167.28,167.28,S45,LESAEDDERSCRGRESDEDTEDASETDLAKH,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,0.27, ,-0.36,0.06, ,0.2,0.44,-0.22,0.09, ,-0.31,0.05, ,0.07,0.04,-0.22,0.27,-0.14,0.2,0.15,0.09,-0.12,0.07,-0.08,,,,,,,0,0,,Sin3 complex,histone deacetylase binding,apoptotic process,,
Q9H7L9,Q9H7L9,Sin3 histone deacetylase corepressor complex component SDS3,SUDS3,167.28,167.28,S53,RSCRGRESDEDTEDASETDLAKHDEEDYVEM,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,0.27, ,-0.36,0.06, ,-0.01,-0.18,-0.22,0.09, ,-0.31,0.05, ,-0.07,-0.18,-0.22,0.27,-0.14,-0.01,-0.2,0.09,-0.12,-0.07,-0.2,,,,,,,0,0,,Sin3 complex,histone deacetylase binding,apoptotic process,,
Q9H7L9,Q9H7L9,Sin3 histone deacetylase corepressor complex component SDS3,SUDS3,212.01,212.01,S234,DLRTLNKLKSPKRPASPSSPEHLPATPAESP,_RPAS(ph)PSS(ph)PEHLPATPAESPAQR_,0.05,0.08,-0.02,0.18,0.21,0.38,-0.14,0.07,-0.02,0.08,-0.01,0.57,0.08,0.17,-0.14,-0.01,0.07,0.08,0.3,-0.03,0.03,0.31,0.12,-0.07,,,,,,,0,0,,Sin3 complex,histone deacetylase binding,apoptotic process,,
Q9H7L9,Q9H7L9,Sin3 histone deacetylase corepressor complex component SDS3,SUDS3,212.01,212.01,S237,TLNKLKSPKRPASPSSPEHLPATPAESPAQR,_RPAS(ph)PSS(ph)PEHLPATPAESPAQR_,0.05,0.09,-0.09, ,-0.05,0.38,-0.14,0.07,-0.02,-0.04,-0.06, ,-0.09,0.17,-0.14,-0.01,0.07,-0.09,0.18,-0.03,-0.03,-0.06,0.04,-0.07,,,,,,,0,0,,Sin3 complex,histone deacetylase binding,apoptotic process,,
Q9H7L9,Q9H7L9,Sin3 histone deacetylase corepressor complex component SDS3,SUDS3,167.28,167.28,T49,EDDERSCRGRESDEDTEDASETDLAKHDEED,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,0.27, ,-0.36,0.06, ,0.2,0.44,-0.22,0.09, ,-0.31,0.05, ,0.07,0.04,-0.22,0.27,-0.14,0.2,0.15,0.09,-0.12,0.07,-0.08,,,,,,,0,0,,Sin3 complex,histone deacetylase binding,apoptotic process,,
Q8IWZ8,Q8IWZ8,SURP and G-patch domain-containing protein 1,SUGP1,109.5,106.93,S411,LPPAELVQRDVDASPSPLSVQDLKGLGYEKG,_DVDASPS(ph)PLSVQDLK_, ,0.58,1.54, , ,-1.96, , , ,0.93,2.16, , ,-1.73, , ,0.58,1.54,-1.96,,0.93,2.16,-1.73,, +, +,,,,,NA,NA,,nucleoplasm,RNA binding,"mRNA splicing, via spliceosome",,
F5H5A9,Q9Y2Z0,Suppressor of G2 allele of SKP1 homolog,SUGT1,112.17,81.97,T284,FVADVKNLYPSSSPYTRNWDKLVGEIKEEEK,_NLYPSSSPYT(ph)R_, , , , , ,-0.05, , , , , , , ,-0.13, , ,,,-0.05,,,,-0.13,,,,,,,,NA,NA,,,,,,
P63165,P63165,Small ubiquitin-related modifier 1,SUMO1,253.58,253.58,S2,______________MSDQEAKPSTEDLGDKK,_(ac)S(ph)DQEAKPSTEDLGDKK_,0.12,0.38,0.02,0.11,0.28,0.38,0.12,0.12,0.21,0.26,0.17,0.1,-0.2,-0.26,-0.09,0.07,0.26,0.06,0.33,0.12,0.23,0.13,-0.23,-0.01,,,,,,,0,0,,cytoplasm,SUMO ligase activity,DNA repair,,
Q9UH99,Q9UH99,SUN domain-containing protein 2,SUN2,202.69,202.26,S12,____MSRRSQRLTRYSQGDDDGSSSSGGSSV,_LTRYS(ph)QGDDDGSSSSGGSSVAGSQSTLFK_, , , ,1.24,1.59, ,0.94, , , , ,1.63,1.56, ,0.81, ,,1.24,1.59,0.94,,1.63,1.56,0.81, +, +,,,,,NA,NA,,endosome membrane,lamin binding,centrosome localization,,
Q7KZ85,Q7KZ85,Transcription elongation factor SPT6,SUPT6H,351.41,351.41,S125,VKVKRGQKYRRVKKMSDDEDDDEEEYGKEEH,_KMS(ph)DDEDDDEEEYGK_,0.03,0.03,-0.08,-0.37, ,0.28,0.27,0.37,-0.47,-0.4,-0.17,-0.52, ,-0.01,0.09,-0.09,0.03,-0.22,0.28,0.32,-0.43,-0.33,-0.01,0,,,,,,,0,0,,nucleus,"hydrolase activity, acting on ester bonds",chromatin remodeling,,
Q7KZ85,Q7KZ85,Transcription elongation factor SPT6,SUPT6H,162,160.76,S2,______________MSDFVESEAEESEEEYN,_(ac)S(ph)DFVES(ph)EAEES(ph)EEEYNDEGEVVPR_, , , , ,-1.46,-0.08,-0.05,-0.05, , , , ,-0.26,0.01,-0.1,-0.21,,,-0.61,-0.05,,,-0.12,-0.15,,,,,,,NA,NA,,nucleus,"hydrolase activity, acting on ester bonds",chromatin remodeling,,
Q7KZ85,Q7KZ85,Transcription elongation factor SPT6,SUPT6H,213.19,208.56,S7,_________MSDFVESEAEESEEEYNDEGEV,_(ac)S(ph)DFVES(ph)EAEES(ph)EEEYNDEGEVVPR_, , , , ,-0.03,0.09,0.05,0.26, , , , ,-0.06,-0.01,0,-0.04,,,0.03,0.16,,,-0.04,-0.02,,,,,,,NA,NA,,nucleus,"hydrolase activity, acting on ester bonds",chromatin remodeling,,
Q7KZ85,Q7KZ85,Transcription elongation factor SPT6,SUPT6H,213.19,208.56,S12,____MSDFVESEAEESEEEYNDEGEVVPRVT,_(ac)SDFVES(ph)EAEES(ph)EEEYNDEGEVVPR_, , , , ,-0.03,0.09,0.05,0.26, , , , ,-0.06,-0.01,0,-0.04,,,0.03,0.16,,,-0.04,-0.02,,,,,,,NA,NA,,nucleus,"hydrolase activity, acting on ester bonds",chromatin remodeling,,
Q15527,Q15527,Surfeit locus protein 2,SURF2,289.66,289.66,T195,DLGSTEDGDGTDDFLTDKEDEKAKPPREKAT,_DLGSTEDGDGT(ph)DDFLT(ph)DKEDEK_,0.39,0.97,0.09,0.24,0.61,0.46,0.51,0.38,1.33,0.78,0.57,0.29,0.12,0.1,0.32,0.29,0.71,0.17,0.54,0.45,1.08,0.43,0.11,0.31,, +,,,,,0,5,13.52,,,,,
Q15527,Q15527,Surfeit locus protein 2,SURF2,289.66,289.66,T190,LFTRKDLGSTEDGDGTDDFLTDKEDEKAKPP,_DLGSTEDGDGT(ph)DDFLT(ph)DKEDEK_,0.03,0.01,0,0.05,-0.32,-0.04,-0.06,-0.21,0.25,0.37,0.31,0.15,-0.03,0.02,-0.18,-0.34,0.02,0.03,-0.18,-0.13,0.31,0.24,0,-0.26,,,,,,,0,0,,,,,,
O75683,O75683,Surfeit locus protein 6,SURF6,158.3,46.78,S138,EKIQEARGQGSAKELSPAALEKRRRRKQERD,_ELS(ph)PAALEK_,0.41,0.37,0.31,0.29,-0.2, ,-0.52,-0.43,-0.06,-0.02,-0.17,-0.2,-0.38, ,-0.55,-0.52,0.39,0.3,-0.2,-0.48,-0.04,-0.19,-0.38,-0.53,,,,,,,0,0,,granular component,DNA binding,ribosome biogenesis,,
Q15022,Q15022,Polycomb protein SUZ12,SUZ12,186.81,171.26,S546,CRPKRTKASMSEFLESEDGEVEQQRTYSSGH,_ASMSEFLES(ph)EDGEVEQQR_,-0.02,-0.25,-0.36,-0.1,-0.43,-0.4,-0.38,-0.22,-0.23,-0.11,-0.34,0.25,0.23,-0.6,-0.58,-0.37,-0.13,-0.22,-0.41,-0.3,-0.17,-0.02,-0.12,-0.47,,,,,,,0,0,,ESC/E(Z) complex,chromatin binding,histone ubiquitination,,
O95425,O95425,Supervillin,SVIL,92.61,88.75,S707,LSVAAKRLLFREMEKSFDEQNVPKRRSRNTA,_S(ph)FDEQNVPK_, , , , ,0.71, , , , , , , ,2.32, , , ,,,0.71,,,,2.32,,, +,,,,,NA,NA,,actin cytoskeleton,actin filament binding,cytoskeleton organization,,
O95425,O95425,Supervillin,SVIL,113.52,113.52,S245,FSFSGRDSSFTEVPRSPKHAHSSSLQQAASR,_DSSFTEVPRS(ph)PK_, ,-0.93,-0.24,-0.5, , , , , ,-0.18,0.52,1.18, , , , ,-0.93,-0.37,,,-0.18,0.89,,,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,cytoskeleton organization,,
O95425,O95425,Supervillin,SVIL,80.03,78.98,T852,NRIDTRQRRMNARYQTQPVTLGEVEQVQSGK,_YQT(ph)QPVTLGEVEQVQSGK_, , , , , , ,0.7, , , , , , , ,-0.05, ,,,,0.7,,,,-0.05,,,,,,,NA,NA,,actin cytoskeleton,actin filament binding,cytoskeleton organization,,
Q6ZW31-2,Q6ZW31,Rho GTPase-activating protein SYDE1,SYDE1,96.92,96.84,S231,AAGPGGTRSPRAGYLSDGDSPERPAGPPSPT,_AGYLS(ph)DGDS(ph)PERPAGPPS(ph)PTSFRPYEVGPAAR_, , , , , ,0.47, ,0.07, , , , , ,0.42, ,-0.15,,,0.47,0.07,,,0.42,-0.15,,,,,,,NA,NA,,cytosol,Rho GTPase activator activity,activation of Rho GTPase activity,,
Q6ZW31-2,Q6ZW31,Rho GTPase-activating protein SYDE1,SYDE1,96.92,96.84,S235,GGTRSPRAGYLSDGDSPERPAGPPSPTSFRP,_AGYLS(ph)DGDS(ph)PERPAGPPS(ph)PTSFRPYEVGPAAR_, , , , , ,0.47, ,0.07, , , , , ,0.42, ,-0.15,,,0.47,0.07,,,0.42,-0.15,,,,,,,NA,NA,,cytosol,Rho GTPase activator activity,activation of Rho GTPase activity,,
Q6ZW31-2,Q6ZW31,Rho GTPase-activating protein SYDE1,SYDE1,96.92,96.84,S244,YLSDGDSPERPAGPPSPTSFRPYEVGPAARA,_AGYLS(ph)DGDS(ph)PERPAGPPS(ph)PTSFRPYEVGPAAR_, , , , , ,0.47, ,0.07, , , , , ,0.42, ,-0.15,,,0.47,0.07,,,0.42,-0.15,,,,,,,NA,NA,,cytosol,Rho GTPase activator activity,activation of Rho GTPase activity,,
Q6ZW31-2,Q6ZW31,Rho GTPase-activating protein SYDE1,SYDE1,234.49,233.17,S681,GRDFLSGPDYDHVTGSDSEDEDEEVGEPRVT,_DFLSGPDYDHVTGS(ph)DS(ph)EDEDEEVGEPR_, ,-0.17,-0.26, ,-0.26,-0.32,-0.09,-0.05, ,-0.04,0.01, ,-0.09,0.01,0.22,0.07,-0.17,-0.26,-0.29,-0.07,-0.04,0.01,-0.04,0.15,,,,,,,0,0,,cytosol,Rho GTPase activator activity,activation of Rho GTPase activity,,
Q6ZW31-2,Q6ZW31,Rho GTPase-activating protein SYDE1,SYDE1,234.49,233.17,S683,DFLSGPDYDHVTGSDSEDEDEEVGEPRVTGD,_DFLSGPDYDHVTGS(ph)DS(ph)EDEDEEVGEPR_, ,-0.17,-0.26, ,-0.26,-0.32,-0.09,-0.05, ,-0.04,0.01, ,-0.09,0.01,0.22,0.07,-0.17,-0.26,-0.29,-0.07,-0.04,0.01,-0.04,0.15,,,,,,,0,0,,cytosol,Rho GTPase activator activity,activation of Rho GTPase activity,,
Q8NF91-4,Q8NF91,Nesprin-1,SYNE1,59.35,56.7,S8223,KKLIRLPLPDDEHDLSDRELELEDSAALSDL,_LPLPDDEHDLS(ph)DR_, , , , ,-0.66,-0.59,-0.63,-1.25, , , , ,-0.72,-0.47,-0.36,-0.31,,,-0.62,-0.91,,,-0.59,-0.34,,,,,,,NA,NA,,cytoskeleton,actin binding,cell death,,
C9JIE4,O15061,Synemin,SYNM,119.39,119.39,S1044,KAVESVVRESLSRQRSPAPGSPDEEGGAEAP,_(gl)QRS(ph)PAPGS(ph)PDEEGGAEAPAAGIR_, , , , ,-0.65,-0.61,-0.9,-0.47, , , , ,-0.65,-0.84,-0.94,-0.74,,,-0.63,-0.67,,,-0.74,-0.84,,,,,,,NA,NA,,intermediate filament,structural molecule activity,,,
C9JIE4,O15061,Synemin,SYNM,119.39,119.39,S1049,VVRESLSRQRSPAPGSPDEEGGAEAPAAGIR,_(gl)QRS(ph)PAPGS(ph)PDEEGGAEAPAAGIR_, , , , ,-0.65,-0.61,-0.9,-0.47, , , , ,-0.65,-0.84,-0.94,-0.74,,,-0.63,-0.67,,,-0.74,-0.84,,,,,,,NA,NA,,intermediate filament,structural molecule activity,,,
Q8N3V7-2,Q8N3V7,Synaptopodin,SYNPO,119.8,117.13,S580,YTETLSTAPLASWVRSPPSYSVLYPSSDPKS,_S(ph)PPSYSVLYPSSDPK_, , , , , , ,0.27,0.55, , , , , , ,0.6,0.91,,,,0.41,,,,0.76,,,,,,,NA,NA,,actin cytoskeleton,actin binding,positive regulation of actin filament bundle assembly,,
Q9UMZ2-4,Q9UMZ2,Synergin gamma,SYNRG,105.94,45.4,S812,AVAFRHTKEDSASVKSLDLPSIGGSSVGKED,_S(ph)LDLPSIGGSS(ph)VGK_,0.16,0.14, , , ,-0.21,0.03,-0.14,1.9,0.1, , , ,-0.37,-0.01,-0.12,0.15,,-0.21,-0.05,1.26,,-0.37,-0.07,, +,,,,,NA,NA,,AP-1 adaptor complex,calcium ion binding,endocytosis,,
Q9UMZ2-4,Q9UMZ2,Synergin gamma,SYNRG,92.91,85.38,S752,NSTAASTKYDVFRQLSLEGSGLGVEDLKDNT,_(gl)QLS(ph)LEGSGLGVEDLK_, , , , ,0.26, , , , , , , ,0.14, , , ,,,0.26,,,,0.14,,,,,,,,NA,NA,,AP-1 adaptor complex,calcium ion binding,endocytosis,,
Q9UMZ2-4,Q9UMZ2,Synergin gamma,SYNRG,68.55,48.77,S1075,ATFDLSVQGSHKRSLSLGDKEISRSSPSPAL,_RSLS(ph)LGDK_,0.54,0.37, , , , , , ,1.35,0.32, , , , , , ,0.46,,,,0.92,,,,,,,,,,NA,NA,,AP-1 adaptor complex,calcium ion binding,endocytosis,,
Q96C24,Q96C24,Synaptotagmin-like protein 4,SYTL4,49.45,20.15,S609,HMCLELTVWDREPLASNDFLGGVRLGVGTGI,_EPLAS(ph)NDFLGGVR_,-2.79,-2.41,-2.27, , , , , ,0.08,0.06,0, , , , , ,-2.58,-2.27,,,0.07,0,,, +,,,,,,NA,NA,,centrosome,neurexin family protein binding,exocytosis,,
Q96C24,Q96C24,Synaptotagmin-like protein 4,SYTL4,278.24,260.13,S201,PKLKSGKSALEAESESLDSFTADSDSTSRRD,_SALEAESES(ph)LDS(ph)FTADSDSTSR_, , , , ,0.25,0.43,0.11,0.38, , , , ,0.14,0.14,-0.34,0.25,,,0.35,0.25,,,0.14,-0.02,,,,,,,NA,NA,,centrosome,neurexin family protein binding,exocytosis,,
Q96C24,Q96C24,Synaptotagmin-like protein 4,SYTL4,278.24,260.13,S204,KSGKSALEAESESLDSFTADSDSTSRRDSLD,_SALEAESES(ph)LDS(ph)FTADSDSTSR_, , , , ,0.24,0.43,0.11,0.38, , , , ,0.07,0.14,-0.34,0.25,,,0.34,0.25,,,0.11,-0.02,,,,,,,NA,NA,,centrosome,neurexin family protein binding,exocytosis,,
G8JLK4,O75410,Transforming acidic coiled-coil-containing protein 1,TACC1,65.14,64.93,S44,EDEAGGPEGDPEEEDSQAETKSLSFSSDSEG,_GGAAGEDEAGGPEGDPEEEDS(ph)QAET(ph)K_, , , , , ,-0.22, ,0.26, , , , , ,-0.14, ,0.18,,,-0.22,0.26,,,-0.14,0.18,,,,,,,NA,NA,,cytoplasm,,,,
G8JLK4,O75410,Transforming acidic coiled-coil-containing protein 1,TACC1,45.34,45.11,T48,GGPEGDPEEEDSQAETKSLSFSSDSEGNFET,_GGAAGEDEAGGPEGDPEEEDS(ph)QAET(ph)K_, , , , , ,-0.22, ,-0.07, , , , , ,-0.14, ,0.03,,,-0.22,-0.07,,,-0.14,0.03,,,,,,,NA,NA,,cytoplasm,,,,
O95359-2,O95359,Transforming acidic coiled-coil-containing protein 2,TACC2,105.19,88.93,S2512,QPSDLSTFVNETKFSSPTEELDYRNSYEIEY,_FSS(ph)PTEELDYR_,-0.31,-0.39,-0.05,-0.23, ,-0.25,-0.27, ,-0.25,-0.5,-0.18,-0.19, ,-0.1,0.24, ,-0.35,-0.14,-0.25,-0.27,-0.37,-0.19,-0.1,0.24,,,,,,,0,0,,Golgi apparatus,nuclear hormone receptor binding,astral microtubule organization,,
O95359-2,O95359,Transforming acidic coiled-coil-containing protein 2,TACC2,163.06,163.06,S2317,PKMKKTPEKLDNTPASPPRSPAEPNDIPIAK,_LDNTPAS(ph)PPRS(ph)PAEPNDIPIAK_,0.26,0.24,0.79,0.62,-0.06,0.53,0.39,0.35,0.34,0.49,0.74,0.51,0.01,0.67,0.33,0.53,0.25,0.71,0.26,0.37,0.42,0.63,0.38,0.43,,,,,,,0,0,,Golgi apparatus,nuclear hormone receptor binding,astral microtubule organization,,
O95359-2,O95359,Transforming acidic coiled-coil-containing protein 2,TACC2,163.06,163.06,S2321,KTPEKLDNTPASPPRSPAEPNDIPIAKGTYT,_LDNTPAS(ph)PPRS(ph)PAEPNDIPIAK_,0.26,0.24,0.79,0.62,-0.06,0.53,0.39,0.35,0.34,0.49,0.74,0.51,0.01,0.67,0.33,0.53,0.25,0.71,0.26,0.37,0.42,0.63,0.38,0.43,,,,,,,0,0,,Golgi apparatus,nuclear hormone receptor binding,astral microtubule organization,,
Q16514-2,Q16514,Transcription initiation factor TFIID subunit 12,TAF12,130.26,130.26,S51,AVVKIPGTPGAGGRLSPENNQVLTKKKLQDL,_IPGTPGAGGRLS(ph)PENNQVLTK_,0.03,0.12,0.13,0.14,0.1,-0.24,0.04,0.14,0.14,-0.01,0.13,-0.17,-0.06,-0.02,-0.02,0.64,0.08,0.13,-0.06,0.09,0.06,-0.02,-0.04,0.35,,,,,,,0,0,,PCAF complex,DNA binding,histone H3 acetylation,,
F5H535,Q15573,TATA box-binding protein-associated factor RNA polymerase I subunit A,TAF1A,75.74,65.28,S2,______________MSDFSEELKGPVTDDEE,_(ac)S(ph)DFS(ph)EELK_, , , , , ,-0.16,-0.26,-0.22, , , , , ,0.26,-0.12,-0.05,,,-0.16,-0.24,,,0.26,-0.08,,,,,,,NA,NA,,,,,,
F5H535,Q15573,TATA box-binding protein-associated factor RNA polymerase I subunit A,TAF1A,75.74,65.28,S5,___________MSDFSEELKGPVTDDEEVET,_(ac)S(ph)DFS(ph)EELK_, , , , , ,-0.16,-0.26,-0.22, , , , , ,0.26,-0.12,-0.05,,,-0.16,-0.24,,,0.26,-0.08,,,,,,,NA,NA,,,,,,
P37802,P37802,Transgelin-2,TAGLN2,85.67,85.67,Y8,________MANRGPAYGLSREVQQKIEKQYD,_(ac)ANRGPAY(ph)GLSR_,1.8, ,0.93, , , , , ,1.4, ,0.21, , , , , ,1.8,0.93,,,1.4,0.21,,, +, +,,,,,NA,NA,,,,muscle organ development,,
P37802,P37802,Transgelin-2,TAGLN2,210.38,209.24,Y192,QMGTNRGASQAGMTGYGMPRQIL________,_GASQAGMTGY(ph)GMPR_,1.74, ,1.04, , , , , ,1.28, ,0.16, , , , , ,1.74,1.04,,,1.28,0.16,,, +, +,,,,,NA,NA,,,,muscle organ development,,
P37802,P37802,Transgelin-2,TAGLN2,110.25,106.67,S163,PNWFPKKSKENPRNFSDNQLQEGKNVIGLQM,_NFS(ph)DNQLQEGK_, ,-0.06, , ,0.36, , , , ,0.32, , ,0.2, , , ,-0.06,,0.36,,0.32,,0.2,,,,,,,,NA,NA,,,,muscle organ development,,
Q9HCD6,Q9HCD6,Protein TANC2,TANC2,394.38,361.77,Y1919,NKTNNAQNGHLLEDDYYSPHGMLANGSRGDL,_TNNAQNGHLLEDDY(ph)YSPHGMLANGSR_,4.1, , , , , , , ,3.41, , , , , , , ,4.1,,,,3.41,,,, +, +,,,,,NA,NA,,,,in utero embryonic development,,
Q9HCD6,Q9HCD6,Protein TANC2,TANC2,102.16,98.04,S1442,LQTEARPSQGLPVIQSPPSSPPHRDSAYISS,_PSQGLPVIQS(ph)PPS(ph)SPPHR_, , , , , ,0.3,0.46,1.74, , , , , ,0.22,0.07,0.16,,,0.3,1.24,,,0.22,0.11, +,,,,,,NA,NA,,,,in utero embryonic development,,
Q9HCD6,Q9HCD6,Protein TANC2,TANC2,78.44,78.44,S1530,RFSPPPVGGQGKEYPSPPPSPLRRGPQYRAS,_EYPS(ph)PPPS(ph)PLR_, ,0.42,0.74, ,0.36,0.29,0.41,0.32, ,1.75,0.84, ,0.35,0.32,0.46,0.43,0.42,0.74,0.33,0.37,1.75,0.84,0.34,0.45,, +,,,,,0,5,14.63,,,in utero embryonic development,,
Q9HCD6,Q9HCD6,Protein TANC2,TANC2,78.44,78.44,S1534,PPVGGQGKEYPSPPPSPLRRGPQYRASPPAE,_EYPS(ph)PPPS(ph)PLR_, ,0.42,0.74, ,0.4,0.29,0.48,0.31, ,1.75,0.84, ,0.38,0.32,0.7,0.4,0.42,0.74,0.35,0.4,1.75,0.84,0.35,0.56,, +,,,,,0,5,12.13,,,in utero embryonic development,,
Q9H2K8,Q9H2K8,Serine/threonine-protein kinase TAO3,TAOK3,100.95,96.45,S324,KKILFQETRNGPLNESQEDEEDSEHGTSLNR,_NGPLNES(ph)QEDEEDSEHGTSLNR_, , , , ,0.55, , , , , , , ,0.9, , , ,,,0.55,,,,0.9,,,,STE,,,,NA,NA,,mitochondrion,ATP binding,DNA repair,,
Q9BXI6,Q9BXI6,TBC1 domain family member 10A,TBC1D10A,81.99,81.62,S43,QGPDAATTDELSSLGSDSEANGFAERRIDKF,_ESLAQGPDAATTDELS(ph)SLGS(ph)DSEANGFAER_, , , , ,-0.24,0.07,-0.13,-0.31, , , , ,0.71,0.41,0.33,0.11,,,-0.08,-0.22,,,0.57,0.22,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,activation of cysteine-type endopeptidase activity,,
Q9BXI6,Q9BXI6,TBC1 domain family member 10A,TBC1D10A,109.5,107.99,S494,SAPQDLAPQVSAHHRSQESLTSQESEDTYL_,_S(ph)QES(ph)LTSQESEDTYL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,activation of cysteine-type endopeptidase activity,,
Q9BXI6,Q9BXI6,TBC1 domain family member 10A,TBC1D10A,109.5,107.99,S497,QDLAPQVSAHHRSQESLTSQESEDTYL____,_S(ph)QES(ph)LTSQESEDTYL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,activation of cysteine-type endopeptidase activity,,
Q9BXI6,Q9BXI6,TBC1 domain family member 10A,TBC1D10A,45.99,43.23,S500,APQVSAHHRSQESLTSQESEDTYL_______,_SQESLTS(ph)QES(ph)EDTYL_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,intracellular,guanyl-nucleotide exchange factor activity,activation of cysteine-type endopeptidase activity,,
F8WDP1,Q8WUA7,TBC1 domain family member 22A,TBC1D22A,58.71,58.71,S132,GPGLQQKPRPEAEPPSPPSGDLRLVKSVSES,_PRPEAEPPS(ph)PPSGDLR_, ,0.79, , , ,0.48,0.79, , ,0.1, , ,-0.7,0.15,-0.02, ,0.79,,0.48,0.79,0.1,,-0.21,-0.02,,,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q9NU19,Q9NU19,TBC1 domain family member 22B,TBC1D22B,51.5,45.97,S194,TVREKTRLEKFRQLLSSQNTDLDELRKCSWP,_QLLS(ph)S(ph)QNT(ph)DLDELR_, , ,-0.33, , , , , , , ,-0.1, , , , , ,,-0.33,,,,-0.1,,,,,,,,,NA,NA,,intracellular,Rab GTPase activator activity,positive regulation of Rab GTPase activity,,
Q9NU19,Q9NU19,TBC1 domain family member 22B,TBC1D22B,51.5,45.97,S195,VREKTRLEKFRQLLSSQNTDLDELRKCSWPG,_QLLS(ph)S(ph)QNT(ph)DLDELR_, , ,-0.33, , , , , , , ,-0.1, , , , , ,,-0.33,,,,-0.1,,,,,,,,,NA,NA,,intracellular,Rab GTPase activator activity,positive regulation of Rab GTPase activity,,
B4DE92,Q3MII6,TBC1 domain family member 25,TBC1D25,153.26,153.26,S506,ASQGPGGGGRLLRQASLDGLQQLRDNMGSRR,_QAS(ph)LDGLQQLR_,0.12,0.08,0.13,0.46,0.12,0.28,0.79,0.16,0.15,0.07,0.39,0.36,0.54,0.11,0.3,0.23,0.1,0.31,0.2,0.51,0.11,0.37,0.34,0.27,,,,,,,0,0,,intracellular,Rab GTPase activator activity,positive regulation of Rab GTPase activity,,
Q9UPU7,Q9UPU7,TBC1 domain family member 2B,TBC1D2B,203.06,203.06,S957,FLRERDTSPDKGELVSDEEEDT_________,_GELVS(ph)DEEEDT_,0,-0.16,-0.12,-0.11,-0.63,-0.28,-0.29,-0.55,0.08,-0.15,-0.16,-0.13,-0.24,-0.03,0.06,-0.02,-0.08,-0.12,-0.44,-0.42,-0.03,-0.14,-0.13,0.02,,,,,,,0,0,,intracellular,phospholipid binding,positive regulation of Rab GTPase activity,,
O60343-2,O60343,TBC1 domain family member 4,TBC1D4,171.37,156.58,S341,VHEGSQKSQPRRRHASAPSHVQPSDSEKNRT,_HAS(ph)APSHVQPSDSEK_,0.03, ,0.48, , , , ,1.79,0.16, ,0.36, , , , ,1.17,0.03,0.48,,1.79,0.16,0.36,,1.17, +, +,,,,,NA,NA,,cytoplasmic vesicle membrane,Rab GTPase activator activity,cellular membrane organization,,
O60343-2,O60343,TBC1 domain family member 4,TBC1D4,163.59,118.28,S588,NIFSRGANRMRGRLGSVDSFERSNSLASEKD,_LGS(ph)VDS(ph)FER_,0.39,0.68,1.71,2.14,2.36,2.46,2.25,2.34,1.38,1.3,2.28,2.52,2.15,2.16,2.05,2.17,0.54,1.94,2.41,2.29,1.34,2.41,2.15,2.11, +, +,,,,,1,1,28.93,cytoplasmic vesicle membrane,Rab GTPase activator activity,cellular membrane organization,,
O60343-2,O60343,TBC1 domain family member 4,TBC1D4,162.72,122.34,S591,SRGANRMRGRLGSVDSFERSNSLASEKDYSP,_LGS(ph)VDS(ph)FER_,0.54,0.63,-2.15,-2.01,-0.19,-0.39,-1.02,-0.31,0.21,0.2,-2.43,-2.01,-0.21,-0.36,-1.82,-0.37,0.58,-2.08,-0.29,-0.62,0.21,-2.21,-0.28,-0.92, +, +,,,,,3,3,33.68,cytoplasmic vesicle membrane,Rab GTPase activator activity,cellular membrane organization,,
Q66K14-2,Q66K14,TBC1 domain family member 9B,TBC1D9B,169.94,169.53,S435,SPAPQEGSEQPASPASPLSSRQSFCAQEAPT,_ASVVDPSTESSPAPQEGSEQPASPAS(ph)PLSSR_,0.33,0.89,-0.01, ,0.24,1.5,-0.28,-0.05,0.07,0.21,-0.02, ,-0.08,1.75,-0.29,0.03,0.64,-0.01,1,-0.16,0.14,-0.02,1.11,-0.12, +, +,,,,,5,2,21.49,integral to membrane,calcium ion binding,positive regulation of Rab GTPase activity,,
Q66K14-2,Q66K14,TBC1 domain family member 9B,TBC1D9B,81.26,79.97,S1138,ESQVVVEGGSGEGQGSPSQLLSDDETKDDMS,_APQESQVVVEGGSGEGQGS(ph)PSQLLS(ph)DDETK_, , , , , , , ,0.05, , , , , , , ,-0.09,,,,0.05,,,,-0.09,,,,,,,NA,NA,,integral to membrane,calcium ion binding,positive regulation of Rab GTPase activity,,
Q66K14-2,Q66K14,TBC1 domain family member 9B,TBC1D9B,81.26,79.97,S1144,EGGSGEGQGSPSQLLSDDETKDDMSMSSYSV,_APQESQVVVEGGSGEGQGS(ph)PSQLLS(ph)DDETK_, , , , , , , ,0.05, , , , , , , ,-0.09,,,,0.05,,,,-0.09,,,,,,,NA,NA,,integral to membrane,calcium ion binding,positive regulation of Rab GTPase activity,,
Q99426,Q99426,Tubulin-folding cofactor B,TBCB,156.08,125.01,Y98,CRIHVIDHSGARLGEYEDVSRVEKYTISQEA,_LGEY(ph)EDVSRVEK_,2.84, , , , , , , ,2.55, , , , , , , ,2.84,,,,2.55,,,, +, +,,,,,NA,NA,,cytoplasm,,de novo' posttranslational protein folding,,
P21731,P21731,Thromboxane A2 receptor,TBXA2R,159.75,140.77,S329,AVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ_,_S(ph)LSLQPQLTQR_,0.03,-0.04, , ,0.05, ,-0.2,-0.2,0.25,0.26, , ,-0.15, ,0.05,-0.58,-0.01,,0.05,-0.2,0.26,,-0.15,-0.23,,,,,,,NA,NA,,acrosomal vesicle,guanyl-nucleotide exchange factor activity,elevation of cytosolic calcium ion concentration,,
P21731,P21731,Thromboxane A2 receptor,TBXA2R,144.8,115.96,S331,LRRLQPRLSTRPRSLSLQPQLTQRSGLQ___,_SLS(ph)LQPQLTQR_,0.37,0.38,-0.43, ,0.87,0.76,0.8,0.99,0.82,0.83,0.71, ,0.59,0.14,0.43,0.63,0.37,-0.43,0.82,0.9,0.82,0.71,0.39,0.54,,,,,,,0,0,,acrosomal vesicle,guanyl-nucleotide exchange factor activity,elevation of cytosolic calcium ion concentration,,
P23193,P23193,Transcription elongation factor A protein 1,TCEA1,279.77,279.77,S100,DLDEKKKEPAITSQNSPEAREESTSSGNVSN,_KKEPAITSQNS(ph)PEAR_,0.36,0.35,0.4,0.41,0.24,0.21,0.33,0.34,0.17,0.17,0.15,0.19,0.24,0.21,0.12,0.23,0.35,0.4,0.23,0.34,0.17,0.17,0.23,0.18,,,,,,,0,0,,nucleolus,DNA binding,erythrocyte differentiation,,
Q969E4,Q969E4,Transcription elongation factor A protein-like 3,TCEAL3,182.46,175.86,S121,VPRKAKRKTDRGTDDSPKDSQEDLQERHLSS,_GTDDS(ph)PKDSQEDLQER_,2.72,2.17,1.92, , , , , ,0.31,-0.01,-0.15, , , , , ,2.47,1.92,,,0.16,-0.15,,, +,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H6Z6,Q99081,Transcription factor 12,TCF12,95.29,94.06,S67,DERGGTTSWGTSGQPSPSYDSSRGFTDSPHY,_GGTTSWGTSGQPS(ph)PSYDSSR_, , ,1.1, , ,-0.16, , , , ,1.42, , ,0.64, , ,,1.1,-0.16,,,1.42,0.64,, +, +,,,,,NA,NA,,,,,,
F5H6Z6,Q99081,Transcription factor 12,TCF12,89.46,75.58,S559,SSQKDIKVSSRGRTSSTNEDEDLNPEQKIER,_TSS(ph)TNEDEDLNPEQK_, , , , , , ,0.61, , , , , , , ,0.86, ,,,,0.61,,,,0.86,,,,,,,NA,NA,,,,,,
P15923-2,P15923,Transcription factor E2-alpha,TCF3,94.04,56.54,S379,AGTSQWPRAGAPGALSPSYDGGLHGLQSKIE,_AGAPGALS(ph)PSYDGGLHGLQSK_,-0.25, ,0.6,0.23, , , , ,0.16, ,0.43,0.47, , , , ,-0.25,0.43,,,0.16,0.45,,,,,,,,,NA,NA,,cytoplasm,chromatin binding,B cell lineage commitment,,
Q13428-2,Q13428,Treacle protein,TCOF1,180.03,179.28,S1376,SKKKKKLGAGEGGEASVSPEKTSTTSKGKAK,_LGAGEGGEAS(ph)VS(ph)PEK_, ,0.24,-0.19,-0.12,0.05,0.75,0.67,0.88, ,0.3,0.02,0,-0.03,0.54,0.15,0.04,0.24,-0.16,0.44,0.78,0.3,0.01,0.28,0.1,,,,,,,0,0,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,335.64,315.87,S1378,KKKKLGAGEGGEASVSPEKTSTTSKGKAKRD,_LGAGEGGEAS(ph)VS(ph)PEK_,0.16,0.17,0.14,0.2,0.35,0.2,0.49,0.32,0.01,0.02,-0.1,-0.1,0.36,0.18,0.02,0.25,0.17,0.17,0.28,0.41,0.02,-0.1,0.27,0.14,,,,,,,0,0,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,87.73,87.73,S1350,KESSRKGWESRKRKLSGDQPAARTPRSKKKK,_RKLS(ph)GDQPAAR_,0.25,0.42, ,-0.51,0.49,0.57,0.58,0.42,0,-0.25, ,0.05,0.44,0.33,0.11,0.13,0.34,-0.51,0.53,0.5,-0.12,0.05,0.39,0.12,,,,,,,0,0,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,87.23,84.26,S1227,TPANSQASKATPKLDSSPSVSSTLAAKDDPD,_LDS(ph)S(ph)PSVSSTLAAK_, , , , ,-0.1,-0.17,0.68,0.81, , , , ,-0.42,-0.52,0.03,0.15,,,-0.14,0.75,,,-0.47,0.09,,,,,,,NA,NA,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,152.37,123.56,S1228,PANSQASKATPKLDSSPSVSSTLAAKDDPDG,_LDS(ph)S(ph)PSVSSTLAAK_,-0.04,-0.01,0.01,0.12,0.16,0.2,0.1,-0.05,-0.06,-0.04,-0.08,-0.18,0.17,0.15,-0.14,-0.26,-0.03,0.06,0.18,0.03,-0.05,-0.13,0.16,-0.2,,,,,,,0,0,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,290.12,288.91,S171,SPRKSAEPSANTTLVSETEEEGSVPAFGAAA,_SAEPSANTTLVS(ph)ET(ph)EEEGSVPAFGAAAK_,0.02,0.15,0.21,0.11,0.13,0.22,0.21,0.13,-0.09,-0.02,-0.08,-0.02,0.3,0.21,-0.01,-0.03,0.09,0.16,0.18,0.17,-0.05,-0.05,0.26,-0.02,,,,,,,0,0,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,99.31,97.74,T168,SGKSPRKSAEPSANTTLVSETEEEGSVPAFG,_SAEPSANTT(ph)LVS(ph)ETEEEGSVPAFGAAAK_, , , , ,-0.3,0.03,0.26,0.41, , , , ,-0.53,-0.64,-0.18,-0.04,,,-0.13,0.34,,,-0.58,-0.11,,,,,,,NA,NA,,cytoplasm,transporter activity,skeletal system development,,
Q13428-2,Q13428,Treacle protein,TCOF1,93.97,92.83,T173,RKSAEPSANTTLVSETEEEGSVPAFGAAAKP,_SAEPSANTTLVS(ph)ET(ph)EEEGSVPAFGAAAK_, , , , ,0.46,-0.22,0.89,0.06, , , , ,0.15,0.31,0.38,-0.24,,,0.16,0.54,,,0.23,0.1,,,,,,,NA,NA,,cytoplasm,transporter activity,skeletal system development,,
P17987,P17987,T-complex protein 1 subunit alpha,TCP1,355.85,354.15,S544,DLIKLHPESKDDKHGSYEDAVHSGALND___,_HGS(ph)YEDAVHSGALND_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell junction,ATP binding,de novo' posttranslational protein folding,,
P17987,P17987,T-complex protein 1 subunit alpha,TCP1,164.9,161.66,S551,ESKDDKHGSYEDAVHSGALND__________,_HGSYEDAVHS(ph)GALND_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell junction,ATP binding,de novo' posttranslational protein folding,,
P28347,P28347,Transcriptional enhancer factor TEF-1,TEAD1,159.66,157.04,S7,_________MEPSSWSGSESPAENMERMSDS,_(ac)MEPSSWS(ph)GSES(ph)PAENMER_, , , , ,0.05,-0.2,0.19,0.4, , , , ,0.21,-0.39,-0.37,-0.15,,,-0.07,0.3,,,-0.06,-0.26,,,,,,,NA,NA,,nucleoplasm,DNA binding,hippo signaling cascade,,
P28347,P28347,Transcriptional enhancer factor TEF-1,TEAD1,80.66,78.8,S9,_______MEPSSWSGSESPAENMERMSDSAD,_(ac)MEPSSWS(ph)GS(ph)ES(ph)PAENMER_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleoplasm,DNA binding,hippo signaling cascade,,
P28347,P28347,Transcriptional enhancer factor TEF-1,TEAD1,159.66,157.04,S11,_____MEPSSWSGSESPAENMERMSDSADKP,_(ac)MEPSSWS(ph)GS(ph)ES(ph)PAENMER_, , , , ,0.05,-0.2,0.19,0.4, , , , ,0.21,-0.39,-0.37,-0.15,,,-0.07,0.3,,,-0.06,-0.26,,,,,,,NA,NA,,nucleoplasm,DNA binding,hippo signaling cascade,,
Q99594,Q99594,Transcriptional enhancer factor TEF-5,TEAD3,139.72,139.72,S11,_____MASNSWNASSSPGEAREDGPEGLDKG,_(ac)ASNSWNASSS(ph)PGEAREDGPEGLDK_, , , , , , , ,0.17, , , , , , , ,0.13,,,,0.17,,,,0.13,,,,,,,NA,NA,,nucleoplasm,DNA binding,female pregnancy,,
Q9Y4R8,Q9Y4R8,Telomere length regulation protein TEL2 homolog,TELO2,178.87,131.02,S836,LLLLQRLKNRLLPPASP______________,_LLPPAS(ph)P_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,"chromosome, telomeric region",protein complex binding,regulation of TOR signaling cascade,,
B3KYA3,Q63HR2,Tensin-like C1 domain-containing phosphatase,TENC1,133.47,133.47,Y483,DGSLTHTRGPLDGSPYAQVQRPPRQTPPAPS,_GPLDGSPY(ph)AQVQRPPR_,-0.3, ,-0.91, ,-0.05,0.12,0.25,0.19,-0.04, ,-0.4, ,0.25,0.21,0.15,0.38,-0.3,-0.91,0.04,0.22,-0.04,-0.4,0.23,0.27,,,,,,PTENs,0,0,,,metal ion binding,intracellular signal transduction,,
B3KYA3,Q63HR2,Tensin-like C1 domain-containing phosphatase,TENC1,118.72,118.72,S481,SVDGSLTHTRGPLDGSPYAQVQRPPRQTPPA,_GPLDGS(ph)PYAQVQRPPR_,-0.04, , , , , , , ,0.71, , , , , , , ,-0.04,,,,0.71,,,,,,,,,PTENs,NA,NA,,,metal ion binding,intracellular signal transduction,,
Q9NYB0,Q9NYB0,Telomeric repeat-binding factor 2-interacting protein 1,TERF2IP,196.71,173.25,S203,LRGQEHKYLLGDAPVSPSSQKLKRKAEEDPE,_YLLGDAPVS(ph)PSSQK_,0.49,0.55,0.56,0.95,0.36,0.27,0.11,0.23,0,0.06,0.04,0.26,0.13,0.1,0.07,0.17,0.52,0.77,0.32,0.17,0.03,0.15,0.12,0.12,,,,,,,0,0,,cytoplasm,DNA binding,negative regulation of DNA recombination at telomere,,
Q15569,Q15569,Dual specificity testis-specific protein kinase 1,TESK1,53.3,52.25,S437,PETLVQPGTPARRCRSLPSSPELPRRMETAL,_S(ph)LPSS(ph)PELPR_, , , , , ,0.17, , , , , , , ,-0.09, , ,,,0.17,,,,-0.09,,,,TKL,,,,NA,NA,,cytosol,ATP binding,cell junction assembly,,
Q8IWB9,Q8IWB9,Testis-expressed sequence 2 protein,TEX2,52.72,40.28,S266,TQPRNTGGDSKTAPSSPLTSPSDTRSFFKVP,_TAPSS(ph)PLTS(ph)PSDTR_, , , , , ,1.69,1.22, , , , , , ,1.76,1.76, ,,,1.69,1.22,,,1.76,1.76, +, +,,,,,NA,NA,,integral to membrane,phospholipid binding,signal transduction,,
Q01664,Q01664,Transcription factor AP-4,TFAP4,159.54,150.88,S139,SPKRRRAEDKDEGIGSPDIWEDEKAEDLRRE,_DEGIGS(ph)PDIWEDEK_,0.48,0.3,1.04,0.31,0.27,0.37,0.22,-0.01,-0.2,-0.01,0.7,-0.05,0.26,0.4,0.45,0.47,0.39,0.72,0.32,0.11,-0.1,0.38,0.34,0.46,,,,,,,0,0,,transcriptional repressor complex,E-box binding,cellular response to dexamethasone stimulus,,
Q01664,Q01664,Transcription factor AP-4,TFAP4,67.42,67.42,S123,QQNTQLKRFIQELSGSSPKRRRAEDKDEGIG,_RFIQELSGS(ph)SPK_, , ,-0.5,0.3, , , , , , ,-0.83,-0.61, , , , ,,-0.04,,,,-0.72,,,,,,,,,NA,NA,,transcriptional repressor complex,E-box binding,cellular response to dexamethasone stimulus,,
Q01664,Q01664,Transcription factor AP-4,TFAP4,113.01,107.51,S124,QNTQLKRFIQELSGSSPKRRRAEDKDEGIGS,_RFIQELSGSS(ph)PK_,0.1,0.14,0.33,0.48, , ,-0.01, ,-0.08,-0.12,-0.01,0.17, , ,-0.1, ,0.12,0.41,,-0.01,-0.1,0.08,,-0.1,,,,,,,NA,NA,,transcriptional repressor complex,E-box binding,cellular response to dexamethasone stimulus,,
Q14186,Q14186,Transcription factor Dp-1,TFDP1,189.23,170.59,S23,IEANGELKVFIDQNLSPGKGVVSLVAVHPST,_VFIDQNLS(ph)PGK_,0.42,0.42,0.24,0.57,0.1,0.42,0.04,0.22,-0.15,-0.37,-0.36,-0.38,-0.14,0.14,0.1,-0.01,0.42,0.42,0.27,0.13,-0.25,-0.37,0.01,0.04,,,,,,,0,0,,nucleoplasm,DNA binding,cell proliferation,,
P19532,P19532,Transcription factor E3,TFE3,97.6,97.13,S548,VGGLSGGALSPLRAASDPLLSSVSPAVSKAS,_AAS(ph)DPLLSSVS(ph)PAVS(ph)K_, , , , , , , ,-0.13, , , , , , , ,-0.36,,,,-0.13,,,,-0.36,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,humoral immune response,,
P19532,P19532,Transcription factor E3,TFE3,225.34,220.29,S556,LSPLRAASDPLLSSVSPAVSKASSRRSSFSM,_AASDPLLSSVS(ph)PAVS(ph)K_,-0.85,-0.13,0.16, ,0.09,0.1,0.19,0.62,-0.08,-0.37,0.17, ,-0.26,-0.2,0.23,0.23,-0.44,0.16,0.1,0.42,-0.22,0.17,-0.23,0.23,,,,,,,0,0,,cytoplasm,sequence-specific DNA binding transcription factor activity,humoral immune response,,
P19532,P19532,Transcription factor E3,TFE3,225.34,220.29,S560,RAASDPLLSSVSPAVSKASSRRSSFSMEEES,_AASDPLLSSVS(ph)PAVS(ph)K_,-0.39,-0.22, , ,0.09,0.1,0.19,0.19,0.23,-0.14, , ,-0.26,-0.2,0.23,0.38,-0.3,,0.1,0.19,0.06,,-0.23,0.31,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,humoral immune response,,
P19532,P19532,Transcription factor E3,TFE3,122.66,122.66,S568,SSVSPAVSKASSRRSSFSMEEES________,_RSS(ph)FSMEEES_, , ,0.94, ,0.74, ,0.4,0.59, , ,0.72, ,0.47, ,0.23,0.57,,0.94,0.74,0.5,,0.72,0.47,0.41,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,humoral immune response,,
P19484,P19484,Transcription factor EB,TFEB,116.85,116.85,S109,EYLSETYGNKFAAHISPAQGSPKPPPAASPG,_FAAHIS(ph)PAQGS(ph)PKPPPAAS(ph)PGVR_, , , , ,-0.3,-0.03,1.14,0.79, , , , ,-1.34,-1.04,0.08,0.08,,,-0.16,0.97,,,-1.19,0.08,, +,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,116.85,116.85,S114,TYGNKFAAHISPAQGSPKPPPAASPGVRAGH,_FAAHIS(ph)PAQGS(ph)PKPPPAAS(ph)PGVR_, , , , ,-0.3,-0.03,1.14,0.79, , , , ,-1.34,-1.04,0.08,0.08,,,-0.16,0.97,,,-1.19,0.08,, +,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,116.85,116.85,S122,HISPAQGSPKPPPAASPGVRAGHVLSSSAGN,_FAAHIS(ph)PAQGS(ph)PKPPPAAS(ph)PGVR_, , , , ,-0.3,-0.03,1.14,0.79, , , , ,-1.34,-1.04,0.08,0.08,,,-0.16,0.97,,,-1.19,0.08,, +,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,89.46,89.46,S462,SDPLLSTMSPEASKASSRRSSFSMEEGDVL_,_AS(ph)S(ph)RRSS(ph)FSMEEGDVL_, ,-0.64, , ,0.22,0.2,0.3,0.07, ,-0.29, , ,0.14,0.01,0.15,0.3,-0.64,,0.21,0.19,-0.29,,0.08,0.23,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,96.13,96.13,S463,DPLLSTMSPEASKASSRRSSFSMEEGDVL__,_AS(ph)S(ph)RRSS(ph)FSMEEGDVL_, ,-0.64, , ,0.22,0.26,0.3,0.07, ,-0.29, , ,0.14,0.06,0.15,0.3,-0.64,,0.24,0.19,-0.29,,0.1,0.23,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,148.52,124.04,S466,LSTMSPEASKASSRRSSFSMEEGDVL_____,_RS(ph)S(ph)FS(ph)MEEGDVL_, ,-0.64, , ,0.22,0.2,0.3,-0.23, ,-0.29, , ,0.14,0.01,0.15,0.11,-0.64,,0.21,0.06,-0.29,,0.08,0.13,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,148.52,124.04,S467,STMSPEASKASSRRSSFSMEEGDVL______,_RS(ph)S(ph)FS(ph)MEEGDVL_,-0.59,-0.64, ,0.76,0.22,0.2,0.3,-0.23,-0.44,-0.29, ,0.51,0.14,0.01,0.15,0.11,-0.61,0.76,0.21,0.06,-0.36,0.51,0.08,0.13,,,,,,,0,0,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,141.58,124.35,S469,MSPEASKASSRRSSFSMEEGDVL________,_RS(ph)S(ph)FS(ph)MEEGDVL_, , , , , , , ,-0.75, , , , , , , ,-0.41,,,,-0.75,,,,-0.41,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,86.48,85.49,S138,PGVRAGHVLSSSAGNSAPNSPMAMLHIGSNP,_AGHVLSSS(ph)AGNS(ph)APNS(ph)PMAMLHIGS(ph)NPER_, , , , , ,-0.05, , , , , , , ,-0.29, , ,,,-0.05,,,,-0.29,,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,86.48,85.49,S142,AGHVLSSSAGNSAPNSPMAMLHIGSNPEREL,_AGHVLSSS(ph)AGNS(ph)APNS(ph)PMAMLHIGS(ph)NPER_, , , , , ,-0.05, , , , , , , ,-0.29, , ,,,-0.05,,,,-0.29,,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
P19484,P19484,Transcription factor EB,TFEB,86.48,85.49,S151,GNSAPNSPMAMLHIGSNPERELDDVIDNIMR,_AGHVLSSS(ph)AGNS(ph)APNS(ph)PMAMLHIGS(ph)NPER_, , , , , ,-0.05, , , , , , , ,-0.29, , ,,,-0.05,,,,-0.29,,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,autophagy,,
G5E9V1,Q92734,Protein TFG,TFG,71.6,70.59,Y399,NRPPFGQGYTQPGPGYR______________,_NRPPFGQGYTQPGPGY(ph)R_, , ,2.8, , , , , , , ,1.49, , , , , ,,2.8,,,,1.49,,, +, +,,,,,NA,NA,,,,,,
G5E9V1,Q92734,Protein TFG,TFG,170.45,169.79,S193,NKNVMSAFGLTDDQVSGPPSAPAEDRSGTPD,_NVMSAFGLTDDQVS(ph)GPPS(ph)APAEDR_, , , , ,-0.52,-0.26, ,-0.49, , , , ,-0.26,-0.04, ,-0.39,,,-0.38,-0.49,,,-0.15,-0.39,,,,,,,NA,NA,,,,,,
G5E9V1,Q92734,Protein TFG,TFG,170.45,169.79,S197,MSAFGLTDDQVSGPPSAPAEDRSGTPDSIAS,_NVMSAFGLTDDQVS(ph)GPPS(ph)APAEDR_, , , , ,-0.52,-0.26, ,-0.49, , , , ,-0.26,-0.04, ,-0.39,,,-0.38,-0.49,,,-0.15,-0.39,,,,,,,NA,NA,,,,,,
Q9UBB9,Q9UBB9,Tuftelin-interacting protein 11,TFIP11,167.6,166.04,S210,SERTTQSMQDFPVVDSEEEAEEEFQKELSQW,_TTQSMQDFPVVDS(ph)EEEAEEEFQK_,-0.23,-0.19,-0.27,-0.23, ,-0.46,0,0.02,0,-0.1,-0.01,-0.3, ,-0.07,0.33,0.01,-0.21,-0.25,-0.46,0.01,-0.05,-0.15,-0.07,0.18,,,,,,,0,0,,catalytic step 2 spliceosome,DNA binding,biomineral tissue development,,
Q9UBB9,Q9UBB9,Tuftelin-interacting protein 11,TFIP11,210.64,210.64,S98,AGLKKGAAEEAELEDSDDEEKPVKQDDFPKD,_GAAEEAELEDS(ph)DDEEKPVK_,-0.04,0.05,0.05,-0.31, ,-0.13,0.47,0.28,-0.62,-0.62,-0.4,-0.57, ,-0.16,-0.06,0.1,0,-0.12,-0.13,0.38,-0.62,-0.48,-0.16,0.03,,,,,,,0,0,,catalytic step 2 spliceosome,DNA binding,biomineral tissue development,,
G5E9B5,P0C1Z6,TCF3 fusion partner,TFPT,188,172.49,S249,VSRGPDKLLPYPTLASPASD___________,_LLPYPTLAS(ph)PAS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin filament,DNA binding,induction of apoptosis,,
G5E9B5,P0C1Z6,TCF3 fusion partner,TFPT,188,172.49,S252,GPDKLLPYPTLASPASD______________,_LLPYPTLAS(ph)PAS(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin filament,DNA binding,induction of apoptosis,,
O43294-2,O43294,Transforming growth factor beta-1-induced transcript 1 protein,TGFB1I1,146.4,146.4,S137,SGEQKEDQSEDKKRPSLPSSPSPGLPKASAT,_KRPS(ph)LPSS(ph)PSPGLPK_,-0.18,-0.12,0.28,0.36,0.26,0.6,0.11,0.01,-0.07,0.04,0.76,0.83,0.52,0.42,0.52,0.52,-0.15,0.32,0.44,0.06,-0.01,0.79,0.47,0.52,,,,,,,0,0,,cytoplasm,androgen receptor binding,androgen receptor signaling pathway,,
O43294-2,O43294,Transforming growth factor beta-1-induced transcript 1 protein,TGFB1I1,146.4,146.4,S141,KEDQSEDKKRPSLPSSPSPGLPKASATSATL,_KRPS(ph)LPSS(ph)PS(ph)PGLPK_,-0.18,-0.12,0.29,0.36,0.18,0.23,0.28,-0.13,-0.07,0.04,0.75,0.83,0.57,0.45,0.53,0.46,-0.15,0.33,0.2,0.09,-0.01,0.79,0.51,0.49,,,,,,,0,0,,cytoplasm,androgen receptor binding,androgen receptor signaling pathway,,
O43294-2,O43294,Transforming growth factor beta-1-induced transcript 1 protein,TGFB1I1,106.61,106.61,S143,DQSEDKKRPSLPSSPSPGLPKASATSATLEL,_KRPS(ph)LPSS(ph)PS(ph)PGLPK_,0.06, , ,0.37,0.51,0.68,0.31,0.22,0.11, , ,0.52,0.64,1.07,0.6,0.69,0.06,0.37,0.59,0.27,0.11,0.52,0.87,0.64,,,,,,,0,0,,cytoplasm,androgen receptor binding,androgen receptor signaling pathway,,
Q9GZN2,Q9GZN2,Homeobox protein TGIF2,TGIF2,195.13,189.33,S2,______________MSDSDLGEDEGLLSLAG,_(ac)S(ph)DS(ph)DLGEDEGLLSLAGK_, ,0.1, , ,0.05,-0.2,0.14,-0.4, ,0.04, , ,-0.01,-0.42,0.9,-0.32,0.1,,-0.07,-0.11,0.04,,-0.2,0.42,,,,,,,NA,NA,,nucleoplasm,sequence-specific DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
Q9GZN2,Q9GZN2,Homeobox protein TGIF2,TGIF2,195.13,189.33,S4,____________MSDSDLGEDEGLLSLAGKR,_(ac)S(ph)DS(ph)DLGEDEGLLSLAGK_, ,0.1, , ,0.05,-0.2,0.14,-0.4, ,0.04, , ,-0.01,-0.42,0.9,-0.32,0.1,,-0.07,-0.11,0.04,,-0.2,0.42,,,,,,,NA,NA,,nucleoplasm,sequence-specific DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
Q96RS0,Q96RS0,Trimethylguanosine synthase,TGS1,137.94,137.56,S154,QESWRKEYEEDDILASDDPSSIEQYENTRTY,_EYEEDDILAS(ph)DDPSSIEQYENTR_, , ,0.41, ,-0.01, ,0.51,0.18, , ,0.17, ,2.88, ,0.51,0.11,,0.41,-0.01,0.35,,0.17,2.88,0.32,, +,,,,,NA,NA,,Cajal body,RNA trimethylguanosine synthase activity,7-methylguanosine RNA capping,,
Q96RS0,Q96RS0,Trimethylguanosine synthase,TGS1,292.05,269.48,S89,SHDSKGIGLDESELDSEAELMRSMGLPLQFG,_GIGLDES(ph)ELDS(ph)EAELMR_, ,0.24, ,0.13,0.91,-0.26, ,0.48, ,1.02, ,0.1,0.14,1.4, ,-0.05,0.24,0.13,0.44,0.48,1.02,0.1,0.9,-0.05,, +,,,,,0,5,2.83,Cajal body,RNA trimethylguanosine synthase activity,7-methylguanosine RNA capping,,
Q96RS0,Q96RS0,Trimethylguanosine synthase,TGS1,292.05,269.48,S85,GTAESHDSKGIGLDESELDSEAELMRSMGLP,_GIGLDES(ph)ELDS(ph)EAELMR_, , , , ,0.91,0.57, , , , , , ,0.14,0.09, , ,,,0.75,,,,0.11,,,,,,,,NA,NA,,Cajal body,RNA trimethylguanosine synthase activity,7-methylguanosine RNA capping,,
Q13769,Q13769,THO complex subunit 5 homolog,THOC5,143.62,143.62,S307,GSVDEAKALFKPPEDSQDDESDSDAEEEQTT,_ALFKPPEDS(ph)QDDES(ph)DS(ph)DAEEEQTTK_, , , , , ,-0.17,-0.13,-0.38, , , , , ,-0.14,-0.26,-0.26,,,-0.17,-0.25,,,-0.14,-0.26,,,,,,,NA,NA,,cytoplasm,RNA binding,intronless viral mRNA export from host nucleus,,
Q13769,Q13769,THO complex subunit 5 homolog,THOC5,339.29,339.29,S312,AKALFKPPEDSQDDESDSDAEEEQTTKRRRP,_ALFKPPEDSQDDES(ph)DS(ph)DAEEEQTTK_,-0.23,-0.26,-0.13,-0.08,-0.14,-0.17,-0.39,-0.39,-0.36,-0.35,-0.44,-0.33,0.11,-0.07,-0.21,-0.23,-0.25,-0.1,-0.16,-0.39,-0.35,-0.38,0.02,-0.22,,,,,,,0,0,,cytoplasm,RNA binding,intronless viral mRNA export from host nucleus,,
Q13769,Q13769,THO complex subunit 5 homolog,THOC5,339.29,339.29,S314,ALFKPPEDSQDDESDSDAEEEQTTKRRRPTL,_ALFKPPEDSQDDES(ph)DS(ph)DAEEEQTTK_,-0.23,-0.26,-0.13,-0.08,-0.14,-0.17,-0.39,-0.39,-0.36,-0.35,-0.44,-0.33,0.11,-0.07,-0.21,-0.23,-0.25,-0.1,-0.16,-0.39,-0.35,-0.38,0.02,-0.22,,,,,,,0,0,,cytoplasm,RNA binding,intronless viral mRNA export from host nucleus,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,166.65,166.34,S575,SFSITREAQVNVRMDSFDEDLARPSGLLAQE,_MDS(ph)FDEDLARPSGLLAQER_,-0.08,0,0.24,0.48,0.08,0.06,-0.65, ,0.33,-0.4,1.3,0.9,0.52,0.5,-0.27, ,-0.04,0.36,0.07,-0.65,0.01,1.12,0.51,-0.27,, +,,,,,0,4,15.47,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,251.91,249.64,S243,YGTGSASRASAVSELSPRERSPALKSPLQSV,_ASAVSELS(ph)PR_,-0.18,-0.22,-0.14,-0.15,-0.07,-0.08,-0.21,-0.15,-0.19,-0.17,-0.22,-0.15,-0.09,-0.08,-0.2,-0.22,-0.2,-0.15,-0.08,-0.18,-0.18,-0.18,-0.09,-0.21,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,232.32,232.32,S248,ASRASAVSELSPRERSPALKSPLQSVVVRRR,_ERS(ph)PALKS(ph)PLQSVVVR_,-0.11,-0.19,-0.07,0.11,0.01,0.25,-0.15,0.37,-0.15,-0.31,-0.05,0.05,-0.06,0.3,-0.03,-0.1,-0.15,0.02,0.14,0.13,-0.22,0,0.13,-0.06,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,232.32,232.32,S253,AVSELSPRERSPALKSPLQSVVVRRRSPRPS,_ERS(ph)PALKS(ph)PLQSVVVR_,-0.39,-0.43,0.28,0.31,0.06,0.06,-0.22,-0.23,-0.34,-0.36,0.33,0.35,0.09,0.06,-0.25,-0.17,-0.41,0.3,0.06,-0.22,-0.35,0.34,0.08,-0.21,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,299.32,299.32,S928,FRKSSTSPKWAHDKFSGEEGEIEDDESGTEN,_WAHDKFS(ph)GEEGEIEDDES(ph)GTENREEK_,0.05,0.2,0.21,0.17,-0.23,-0.24,-0.34,-0.21,0.45,0.01,0.22,-0.19,-0.12,-0.22,-0.15,0.08,0.13,0.19,-0.24,-0.28,0.25,0.03,-0.17,-0.03,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,359.9,359.9,S939,HDKFSGEEGEIEDDESGTENREEKDNIQPTT,_FSGEEGEIEDDES(ph)GTENREEK_,-0.11,-0.11,-0.17,-0.01,-0.16,-0.1,-0.22,-0.18,-0.1,-0.03,-0.13,-0.08,-0.1,-0.04,-0.07,-0.04,-0.11,-0.08,-0.13,-0.2,-0.06,-0.1,-0.07,-0.05,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,164.56,146.97,S379,QTNTDKEKIKEKGSFSDTGLGDGKMKSDSFA,_GSFS(ph)DTGLGDGK_,-0.03,-0.08,-0.15,-0.02,-0.3,-0.28,-0.35,-0.44,-0.04,0,-0.14,-0.03,-0.06,-0.05,-0.15,-0.23,-0.06,-0.08,-0.29,-0.39,-0.02,-0.09,-0.05,-0.19,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,214.67,157.47,S682,AKNKKSPEIHRRIDISPSTFRKHGLAHDEMK,_IDIS(ph)PSTFR_,-0.12,-0.05,-0.02,0.05,-0.1,-0.01,-0.13,-0.32,-0.13,-0.08,-0.13,-0.16,-0.12,-0.17,-0.02,-0.32,-0.08,0.01,-0.05,-0.22,-0.1,-0.14,-0.15,-0.16,,,,,,,0,0,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,69.86,69.86,S315,GQFDHGSGSLSPSKKSPVGKSPPSTGSTYGS,_KS(ph)PVGKS(ph)PPSTGSTYGSSQK_, , , , ,0.2,0.36,0.16,0.12, , , , ,0.19,0.29,0.29,0.08,,,0.28,0.14,,,0.24,0.19,,,,,,,NA,NA,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,69.86,69.86,S320,GSGSLSPSKKSPVGKSPPSTGSTYGSSQKEE,_S(ph)PVGKS(ph)PPSTGSTYGSSQK_, , , , ,0.2,0.36,0.16,0.12, , , , ,0.19,0.29,0.29,0.08,,,0.28,0.14,,,0.24,0.19,,,,,,,NA,NA,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,64.53,60.49,S406,DSFAPKTDSEKPFRGSQSPKRYKLRDDFEKK,_PFRGS(ph)QS(ph)PK_, , , , , , ,-0.06,0, , , , , , ,0.22,0.26,,,,-0.03,,,,0.24,,,,,,,NA,NA,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9Y2W1,Q9Y2W1,Thyroid hormone receptor-associated protein 3,THRAP3,64.53,60.49,S408,FAPKTDSEKPFRGSQSPKRYKLRDDFEKKMA,_PFRGS(ph)QS(ph)PK_, , , , , , ,-0.06,0, , , , , , ,0.22,0.26,,,,-0.03,,,,0.24,,,,,,,NA,NA,,mediator complex,ATP binding,androgen receptor signaling pathway,,
Q9NXG2,Q9NXG2,THUMP domain-containing protein 1,THUMPD1,261.83,261.83,S86,DMYGPEKFTDKDQQPSGSEGEDDDAEAALKK,_FTDKDQQPS(ph)GS(ph)EGEDDDAEAALKK_,0.11,0.11,0.21,0.07,-0.03,-0.04,0.03,-0.03,0.11,0.15,0.07,-0.1,0.03,-0.03,0.04,-0.02,0.11,0.14,-0.04,0,0.13,-0.01,0,0.01,,,,,,,0,0,,,RNA binding,,,
Q9NXG2,Q9NXG2,THUMP domain-containing protein 1,THUMPD1,261.83,261.83,S88,YGPEKFTDKDQQPSGSEGEDDDAEAALKKEV,_FTDKDQQPS(ph)GS(ph)EGEDDDAEAALKK_,-0.16,0.11,0.21,0.07,-0.03,-0.04,0.03,-0.03,-0.24,0.15,0.07,-0.1,0.03,-0.03,0.04,-0.02,-0.02,0.14,-0.04,0,-0.03,-0.01,0,0.01,,,,,,,0,0,,,RNA binding,,,
Q9BV44,Q9BV44,THUMP domain-containing protein 3,THUMPD3,316.44,298.42,Y187,KKEFTSHALDSHILDYYENPAIKEDVSTLIG,_EFTSHALDSHILDY(ph)YENPAIK_,2.43, , , , , , , ,1.77, , , , , , , ,2.43,,,,1.77,,,, +, +,,,,,NA,NA,,,methyltransferase activity,,,
Q7Z2Z1-2,Q7Z2Z1,Treslin,TICRR,118.23,104.28,S838,LSVPFLSSARRSVSGSPESDELQELRTRSAK,_SVSGS(ph)PES(ph)DELQELR_, ,-0.03, , , , ,-1.48,-0.9, ,-0.61, , , , ,-1.14,-0.79,-0.03,,,-1.16,-0.61,,,-0.96, +,,,,,,NA,NA,,nucleus,chromatin binding,cell cycle,,
Q7Z2Z1-2,Q7Z2Z1,Treslin,TICRR,114.46,112.16,S841,PFLSSARRSVSGSPESDELQELRTRSAKKRR,_SVSGS(ph)PES(ph)DELQELR_, , , , , , ,-1.48,-0.9, , , , , , ,-1.14,-0.79,,,,-1.16,,,,-0.96, +,,,,,,NA,NA,,nucleus,chromatin binding,cell cycle,,
Q7Z2Z1-2,Q7Z2Z1,Treslin,TICRR,74.62,74.62,S1430,AAPTDSRDDQKGLSLSPQSPPERRGYPGPGL,_GLSLS(ph)PQS(ph)PPERR_, , , , ,-0.23,-0.41, ,-0.32, , , , ,-0.26,-0.1, ,-0.49,,,-0.32,-0.32,,,-0.18,-0.49,,,,,,,NA,NA,,nucleus,chromatin binding,cell cycle,,
Q7Z2Z1-2,Q7Z2Z1,Treslin,TICRR,74.62,74.62,S1433,TDSRDDQKGLSLSPQSPPERRGYPGPGLRSD,_GLSLS(ph)PQS(ph)PPERR_, , , , ,-0.23,-0.41, ,-0.32, , , , ,-0.26,-0.1, ,-0.49,,,-0.32,-0.32,,,-0.18,-0.49,,,,,,,NA,NA,,nucleus,chromatin binding,cell cycle,,
Q7Z2Z1-2,Q7Z2Z1,Treslin,TICRR,142.91,142.91,S923,EVTKVRRNLFNQELLSPSKRSLKRGLPRSHS,_NLFNQELLS(ph)PSK_,0.22,0.21,-0.02, , , ,0.25, ,-0.34,-0.11,-0.1, , , ,-0.37, ,0.22,-0.02,,0.25,-0.22,-0.1,,-0.37,,,,,,,NA,NA,,nucleus,chromatin binding,cell cycle,,
Q9UNS1-2,Q9UNS1,Protein timeless homolog,TIMELESS,237,236.4,S1173,KEPLKAAPKKRQLLDSDEEQEEDEGRNRAPE,_RQLLDS(ph)DEEQEEDEGR_,0,0.06,-0.31,-0.15,-0.23,-0.09,-0.19,-0.34,0.04,-0.06,-0.07,-0.21,-0.24,-0.29,-0.3,-0.24,0.03,-0.22,-0.16,-0.26,-0.01,-0.14,-0.26,-0.27,,,,,,,0,0,,nuclear chromatin,,branching morphogenesis of an epithelial tube,,
Q5JTD0-4,Q5JTD0,Tight junction-associated protein 1,TJAP1,201.04,200.51,S300,PQPNGECHSLGTARGSPEEELPLPAFEKLNP,_GS(ph)PEEELPLPAFEK_,-0.02, ,-0.05,-0.1,0.16,0.22,0.08,0.24,-0.09, ,0,-0.04,0.39,0.25,0.27,0.13,-0.02,-0.07,0.19,0.17,-0.09,-0.02,0.32,0.2,,,,,,,0,0,,Golgi apparatus,,,,
Q5JTD0-4,Q5JTD0,Tight junction-associated protein 1,TJAP1,246.13,246.13,S545,RSPKRMGVHHLHRKDSLTQAQEQGNLLN___,_KDS(ph)LTQAQEQGNLLN_,0.6,0.37,0.22,0.28,0.39,0.37,0.41,0.28,0.74,0.44,0.46,0.43,0.53,0.38,0.48,0.6,0.49,0.25,0.38,0.35,0.6,0.44,0.46,0.54,,,,,,,0,0,,Golgi apparatus,,,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,145.03,142.19,S275,VQRDERATLLNVPDLSDSIHSANASERDDIS,_ATLLNVPDLS(ph)DS(ph)IHS(ph)ANASER_, , , , ,-1.06,-1.19,-1.49,-0.97, , , , ,-0.43,-0.2,-0.67,-0.37,,,-1.13,-1.21,,,-0.31,-0.51, +,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,216.21,216.21,S277,RDERATLLNVPDLSDSIHSANASERDDISEI,_ATLLNVPDLS(ph)DS(ph)IHS(ph)ANASER_,-0.72,-0.72,-0.58,-0.55,-0.85,-1.04,-1.37,-0.94,-0.57,-0.64,-0.44,-0.41,-0.34,-0.25,-0.35,-0.32,-0.72,-0.56,-0.94,-1.14,-0.6,-0.43,-0.29,-0.33, +,,,,,,6,0,7.56,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,143.92,143.4,S1617,YQINNISTVPKAIPVSPSAVEEDEDEDGHTV,_AIPVS(ph)PSAVEEDEDEDGHTVVATAR_,-0.68,-0.55,-0.04,0.01,-0.14, , , ,0.85,1.24,0.24,0.9,0.38, , , ,-0.61,-0.01,-0.14,,1.06,0.6,0.38,,, +,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,155.61,155.61,Y1354,DIVRSNHYDPEEDEEYYRKQLSYFDRRSFEN,_SNHYDPEEDEEY(ph)YRK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,141.48,138.72,S834,RLSYLSAPGSEYSMYSTDSRHTSDYEDTDTE,_LSYLSAPGSEYSMYS(ph)T(ph)DSR_, , , , , ,-0.79,-0.32,-0.55, , , , , ,-0.51,-0.9,-0.71,,,-0.79,-0.43,,,-0.51,-0.8,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,217.61,182.69,S617,WRFRGLRSSKRNLRKSREDLSAQPVQTKFPA,_S(ph)REDLSAQPVQTK_,-0.53,-0.57,-0.61,-0.38,-0.43,-0.63,-0.27,-0.62,-0.09,-0.32,-0.6,0.01,-0.42,-0.47,-0.09,-0.52,-0.55,-0.49,-0.52,-0.43,-0.2,-0.26,-0.44,-0.29,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,129.36,129.11,T846,SMYSTDSRHTSDYEDTDTEGGAYTDQELDET,_HTS(ph)DYEDT(ph)DTEGGAYT(ph)DQELDETLNDEVGTPPESAITR_, , , , , ,-0.3,0.04,0.08, , , , , ,0.6,0.22,0.76,,,-0.3,0.06,,,0.6,0.51,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,129.36,129.11,T854,HTSDYEDTDTEGGAYTDQELDETLNDEVGTP,_HTSDY(ph)EDT(ph)DTEGGAYT(ph)DQELDETLNDEVGT(ph)PPESAITR_, , , , , ,-0.3,0.04,0.21, , , , , ,0.6,0.22,0.97,,,-0.3,0.13,,,0.6,0.64,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,99.07,98.4,T868,YTDQELDETLNDEVGTPPESAITRSSEPVRE,_HTSDY(ph)EDT(ph)DTEGGAYT(ph)DQELDETLNDEVGT(ph)PPESAITR_, , , , , ,-0.3, , , , , , , ,0.6, , ,,,-0.3,,,,0.6,,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,141.48,138.72,T835,LSYLSAPGSEYSMYSTDSRHTSDYEDTDTEG,_LSYLSAPGSEYSMYS(ph)T(ph)DSR_, , , , , ,-0.78,-0.74,-0.49, , , , , ,-0.53,-0.3,-0.85,,,-0.78,-0.61,,,-0.53,-0.55,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,216.21,216.21,S280,RATLLNVPDLSDSIHSANASERDDISEIQSL,_ATLLNVPDLSDS(ph)IHS(ph)ANAS(ph)ER_,-0.72,-0.72,-0.58,-0.55,-0.84,-0.83,-0.87,-0.94,-0.57,-0.64,-0.44,-0.41,-0.26,-0.33,-0.33,-0.32,-0.72,-0.56,-0.83,-0.9,-0.6,-0.43,-0.3,-0.33,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,98.76,97.77,S284,LNVPDLSDSIHSANASERDDISEIQSLASDH,_ATLLNVPDLSDS(ph)IHS(ph)ANAS(ph)ER_, , , , ,-0.63,-0.58,0.11,0.15, , , , ,-0.7,-0.95,-0.26,-0.04,,,-0.6,0.13,,,-0.82,-0.15,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,76.89,76.18,S294,HSANASERDDISEIQSLASDHSGRSHDRPPR,_DDISEIQS(ph)LAS(ph)DHS(ph)GR_, , , , ,-0.59,-0.51,-0.5,-0.45, , , , ,0.41,-0.41,-0.05,-0.15,,,-0.55,-0.47,,,0.06,-0.1,,,,,,,NA,NA,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,149.8,149.06,S297,NASERDDISEIQSLASDHSGRSHDRPPRRSR,_DDISEIQS(ph)LAS(ph)DHS(ph)GR_,-0.81,-0.79,-0.64, ,-0.73,-0.67,-1.03,-0.95,-0.65,-0.82,-0.68, ,-0.02,0.01,-0.54,-0.53,-0.8,-0.64,-0.7,-0.99,-0.73,-0.68,-0.01,-0.53,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,149.8,149.06,S300,ERDDISEIQSLASDHSGRSHDRPPRRSRSRS,_DDISEIQS(ph)LAS(ph)DHS(ph)GR_,-0.81,-0.79,-0.64, ,-0.73,-0.67,-1.03,-0.95,-0.65,-0.82,-0.68, ,-0.02,0.01,-0.54,-0.53,-0.8,-0.64,-0.7,-0.99,-0.73,-0.68,-0.01,-0.53,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,275.66,275.66,S125,KKVQIPVSRPDPEPVSDNEEDSYDEEIHDPR,_VQIPVSRPDPEPVS(ph)DNEEDS(ph)YDEEIHDPR_,-0.71,-0.34,-0.23,-0.18,-0.4,-0.54,-0.38,-0.33,-0.56,-0.19,-0.23,-0.3,-0.24,-0.3,-0.29,-0.16,-0.51,-0.2,-0.47,-0.36,-0.37,-0.27,-0.27,-0.22,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q07157-2,Q07157,Tight junction protein ZO-1,TJP1,275.66,275.66,S131,VSRPDPEPVSDNEEDSYDEEIHDPRSGRSGV,_VQIPVSRPDPEPVS(ph)DNEEDS(ph)YDEEIHDPR_,-0.22,-0.36,-0.23,-0.18,-0.4,-0.54,-0.38,-0.33,-0.5,-0.38,-0.23,-0.3,-0.24,-0.3,-0.29,-0.16,-0.29,-0.2,-0.47,-0.36,-0.44,-0.27,-0.27,-0.22,,,,,,,0,0,,apical part of cell,histone acetyltransferase activity,blastocyst formation,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,167.1,154.01,Y1118,VQHEEIEIAQKHPDIYAVPIKTHKPDPGTPQ,_HPDIY(ph)AVPIK_,0.2, ,-0.36, , , , ,0.24,0.02, ,-0.16, , , , ,0.39,0.2,-0.36,,0.24,0.02,-0.16,,0.39,,,,,,,NA,NA,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,98.87,98.87,S244,FGPSRDRDRDRSRGRSIDQDYERAYHRAYDP,_GRS(ph)IDQDYER_,-0.4,-0.63,-0.78,-0.52,0.04,-0.38,-0.3,-1.01,-0.38,-0.3,-0.51,-0.49,-0.12,-0.25,-0.43,-0.46,-0.51,-0.64,-0.16,-0.61,-0.34,-0.5,-0.18,-0.44,,,,,,,0,0,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,181.96,180.74,S1159,KAPSRPYQDTRGSYGSDAEEEEYRQQLSEHS,_GSYGS(ph)DAEEEEYRQQLSEHSK_,-0.58,-0.45,-0.46,-0.42,-0.36,-0.77,-0.23,-0.13,0.06,0.09,0.2,-0.09,-0.57,-0.85,-0.04,-0.26,-0.51,-0.44,-0.55,-0.18,0.07,0.06,-0.7,-0.15,,,,,,,0,0,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,128.66,125.41,S920,TAMGADYLSCDSRLISDFEDTDGEGGAYTDN,_LIS(ph)DFEDT(ph)DGEGGAYT(ph)DNELDEPAEEPLVSSITR_, ,-0.58, , ,-0.5, , ,-0.14, ,-0.12, , ,-0.62, , ,0.2,-0.58,,-0.5,-0.14,-0.12,,-0.62,0.2,,,,,,,NA,NA,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,134.6,134.1,T925,DYLSCDSRLISDFEDTDGEGGAYTDNELDEP,_LIS(ph)DFEDT(ph)DGEGGAYT(ph)DNELDEPAEEPLVSSITR_, ,-0.58, , ,-0.32, , ,-0.12, ,-0.12, , ,-0.07, , ,-0.07,-0.58,,-0.32,-0.12,-0.12,,-0.07,-0.07,,,,,,,NA,NA,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,134.6,134.1,T933,LISDFEDTDGEGGAYTDNELDEPAEEPLVSS,_LISDFEDT(ph)DGEGGAYT(ph)DNELDEPAEEPLVSSITR_, ,-0.58, , ,-0.32, ,-0.82,-0.65, ,-0.12, , ,-0.07, ,0.05,-0.25,-0.58,,-0.32,-0.73,-0.12,,-0.07,-0.09,,,,,,,NA,NA,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,204.12,203.11,S130,VVKRPRKVQVAALQASPPLDQDDRAFEVMDE,_VQVAALQAS(ph)PPLDQDDR_,-0.55,-0.52,-0.5,-0.5,-0.46,-0.2,-0.29,-0.3,-0.47,-0.72,-0.23,-0.31,0.64,-0.07,-0.63,-0.53,-0.54,-0.5,-0.32,-0.29,-0.59,-0.27,0.33,-0.58,,,,,,,0,0,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,148.41,148.41,S170,YSERSRLNSHGGRSRSWEDSPERGRPHERAR,_SRS(ph)WEDS(ph)PER_,-0.32,-0.59,-0.56,-0.4,0.1,-0.56,0.16,-0.73,-0.47,-0.54,-0.42,-0.13,0.15,-0.47,0.54,-0.4,-0.45,-0.48,-0.19,-0.22,-0.51,-0.27,-0.13,0.15,,,,,,,0,0,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
Q9UDY2-4,Q9UDY2,Tight junction protein ZO-2,TJP2,148.41,148.41,S174,SRLNSHGGRSRSWEDSPERGRPHERARSRER,_SRS(ph)WEDS(ph)PER_,-0.32,-0.34,-0.31, ,-0.65,-0.56,-0.58,-0.6,-0.11,-0.16,-0.15, ,-0.57,-0.47,-0.43,-0.5,-0.33,-0.31,-0.6,-0.59,-0.13,-0.15,-0.52,-0.47,,,,,,,0,0,,adherens junction,guanylate kinase activity,cellular component disassembly involved in execution phase of apoptosis,,
P29401,P29401,Transketolase,TKT,94.97,94.78,Y202,LGQSDPAPLQHQMDIYQKRCEAFGWHAIIVD,_LGQSDPAPLQHQMDIY(ph)QK_,0.31,1.48,-0.69, , , , , ,0.3,1.33,-0.25, , , , , ,1.01,-0.69,,,0.91,-0.25,,, +,,,,,,NA,NA,,cytosol,cofactor binding,energy reserve metabolic process,,
P29401,P29401,Transketolase,TKT,150.03,147.62,S295,SKKKILATPPQEDAPSVDIANIRMPSLPSYK,_ILATPPQEDAPS(ph)VDIANIR_,0.55,0.43,0.34,0.25, ,0.23, , ,-0.18,0.2,0.06,0.6, ,0.1, , ,0.49,0.3,0.23,,0.02,0.36,0.1,,,,,,,,NA,NA,,cytosol,cofactor binding,energy reserve metabolic process,,
P29401,P29401,Transketolase,TKT,187.56,187.56,T287,QEIYSQIQSKKKILATPPQEDAPSVDIANIR,_ILAT(ph)PPQEDAPSVDIANIR_,-0.15,-0.11,-0.37,-0.35, ,0.13,0.01, ,0.08,0.07,-0.03,-0.03, ,-0.22,-0.3, ,-0.13,-0.36,0.13,0.01,0.07,-0.03,-0.22,-0.3,,,,,,,0,0,,cytosol,cofactor binding,energy reserve metabolic process,,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,150.11,144.95,S217,VSPSESLRASEKHRGSADYSMEAKKRKAEEK,_HRGS(ph)ADYSMEAK_,-2.06, , , ,-0.12,0.3, , ,-2.03, , , ,0.15,0.31, , ,-2.06,,0.11,,-2.03,,0.23,, +, +,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,85.34,84.41,Y238,EAKKRKAEEKDSLSRYDSDGDKSDDLVVDVS,_Y(ph)DS(ph)DGDKSDDLVVDVSNEDPATPR_,0.42,0.1,0.28, , ,0.83,0.56, ,0.66,0.31,0.54, , ,1.09,0.52, ,0.27,0.28,0.83,0.56,0.5,0.54,1.09,0.52,, +,,,,,0,1,31.61,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,153.38,153.29,S240,KKRKAEEKDSLSRYDSDGDKSDDLVVDVSNE,_YDS(ph)DGDKS(ph)DDLVVDVSNEDPAT(ph)PR_,0.44,0.14,0.28, ,0.77,0.83,0.56,0.29,0.64,-0.22,0.54, ,1.05,1.09,0.52,0.48,0.3,0.28,0.8,0.43,0.28,0.54,1.07,0.5,, +,,,,,0,1,31.82,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,285.34,241.43,S203,ELDHRERESSANNSVSPSESLRASEKHRGSA,_ERESSANNSVS(ph)PSESLR_,-0.14,-0.12,-0.13,-0.2,-0.29,-0.35,-1.02,-0.15,-0.13,0.03,-0.07,-0.14,-0.1,-0.21,-0.52,-0.25,-0.13,-0.16,-0.32,-0.52,-0.05,-0.11,-0.15,-0.38,,,,,,,0,0,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,75.7,74.29,S207,RERESSANNSVSPSESLRASEKHRGSADYSM,_ESSANNSVS(ph)PSES(ph)LRASEK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,117.61,117.44,S286,NGLDKARSLKKDAPTSPASVASSSSTPSSKT,_DAPTS(ph)PASVASSSSTPSSK_, , ,-0.11,-0.1,0.72,0.51,0.42,0.39, , ,0.23,-0.04,0.22,0.25,0.36,0.28,,-0.11,0.62,0.41,,0.1,0.24,0.32,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,153.38,153.29,S245,EEKDSLSRYDSDGDKSDDLVVDVSNEDPATP,_S(ph)DDLVVDVSNEDPAT(ph)PR_,0.39,0.1,0.28, ,0.31,0.14,0.12,0.08,0.68,0.31,0.54, ,0.33,0.08,-0.19,0.35,0.25,0.28,0.23,0.1,0.51,0.54,0.21,0.11,,,,,,,0,0,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,152.13,152.13,S263,LVVDVSNEDPATPRVSPAHSPPENGLDKARS,_VS(ph)PAHS(ph)PPENGLDK_, ,0.14, , ,0.36,0.17,0.18,-0.06, ,-0.22, , ,0.53,0.69,0.59,0.06,0.14,,0.27,0.06,-0.22,,0.61,0.35,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,152.13,152.13,S267,VSNEDPATPRVSPAHSPPENGLDKARSLKKD,_VS(ph)PAHS(ph)PPENGLDK_, ,0.14, , ,0.36,0.17,0.18,-0.06, ,-0.22, , ,0.53,0.69,0.59,0.06,0.14,,0.27,0.06,-0.22,,0.61,0.35,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,144.18,143.16,T328,PGLKSNTPTPRNDAPTPGTSTTPGLRSMPAS,_NDAPT(ph)PGTSTT(ph)PGLR_, , , , ,-0.99,-0.9,-0.13,-0.09, , , , ,-0.53,-1.11,-0.6,-0.04,,,-0.94,-0.11,,,-0.79,-0.3,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,144.18,143.16,T334,TPTPRNDAPTPGTSTTPGLRSMPASALRTPI,_NDAPT(ph)PGTSTT(ph)PGLR_, , , , ,-0.99,-0.9,-0.52,-0.25, , , , ,-0.53,-1.11,-0.48,-0.27,,,-0.94,-0.38,,,-0.79,-0.37,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F5H7D6,Q04726,Transducin-like enhancer protein 3,TLE3,153.38,153.29,T259,KSDDLVVDVSNEDPATPRVSPAHSPPENGLD,_YDS(ph)DGDKS(ph)DDLVVDVSNEDPAT(ph)PR_, ,0.14, , ,-0.15,0.14,-0.19,0.07, ,-0.22, , ,-0.4,0.08,-0.23,0.26,0.14,,0,-0.05,-0.22,,-0.14,0.03,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,157.34,157.34,S269,LVVDVSNEDPSSPRGSPAHSPRENGLDKTRL,_S(ph)DDNLVVDVSNEDPSS(ph)PRGS(ph)PAHS(ph)PR_, , , , ,-0.27,-0.3, ,-0.27, , , , ,-0.69,-0.22, ,-0.49,,,-0.28,-0.27,,,-0.44,-0.49,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,157.34,157.34,S273,VSNEDPSSPRGSPAHSPRENGLDKTRLLKKD,_S(ph)DDNLVVDVSNEDPSS(ph)PRGS(ph)PAHS(ph)PR_, , , , ,-0.27,-0.3, ,-0.27, , , , ,-0.69,-0.22, ,-0.49,,,-0.28,-0.27,,,-0.44,-0.49,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,68.58,51.03,S208,NDHQRDRDSIKSSSVSPSASFRGAEKHRNSA,_SSS(ph)VS(ph)PSASFR_, , , , ,-0.2,-0.06,-0.07,-0.12, , , , ,-0.46,-0.21,-0.35,-0.4,,,-0.13,-0.1,,,-0.33,-0.38,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,158.29,155.19,S250,EEKEIAARYDSDGEKSDDNLVVDVSNEDPSS,_S(ph)DDNLVVDVSNEDPSS(ph)PRGS(ph)PAHS(ph)PR_, , , , ,0.31,0.05,0.4,0.24, , , , ,0.05,0.23,0.2,-0.03,,,0.18,0.32,,,0.14,0.09,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,158.29,155.19,S264,KSDDNLVVDVSNEDPSSPRGSPAHSPRENGL,_S(ph)DDNLVVDVSNEDPS(ph)SPR_, , , , ,0.31,0.16,0.4,0.17, , , , ,0.05,0.56,0.2,-0.12,,,0.24,0.29,,,0.33,0.05,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
F8W6T6,Q04727,Transducin-like enhancer protein 4,TLE4,157.34,157.34,S265,SDDNLVVDVSNEDPSSPRGSPAHSPRENGLD,_S(ph)DDNLVVDVSNEDPSS(ph)PRGS(ph)PAHS(ph)PR_, , , , ,-0.27,-0.07, ,-0.21, , , , ,-0.69,-0.11, ,-0.49,,,-0.16,-0.21,,,-0.37,-0.49,,,,,,,NA,NA,,nucleus,,"regulation of transcription, DNA-dependent",,
Q9Y490,Q9Y490,Talin-1,TLN1,54.9,43.95,Y127,LMTICARIGITNHDEYSLVRELMEEKKEEIT,_IGITNHDEY(ph)SLVR_, , ,1.25, , , , , , , , , , , , , ,,1.25,,,,,,, +,,,,,,NA,NA,,actin cytoskeleton,structural constituent of cytoskeleton,activation of signaling protein activity involved in unfolded protein response,,
Q9Y490,Q9Y490,Talin-1,TLN1,93.16,68.29,Y70,DPKKGIWLEAGKALDYYMLRNGDTMEYRKKQ,_ALDY(ph)YMLR_,-0.43, ,-0.44,-0.22,0.03,0.11, ,0.16,-0.4, ,-0.16,-0.04,0.44,0.35, ,0.6,-0.43,-0.33,0.07,0.16,-0.4,-0.1,0.4,0.6,,,,,,,0,0,,actin cytoskeleton,structural constituent of cytoskeleton,activation of signaling protein activity involved in unfolded protein response,,
Q9Y4G6,Q9Y4G6,Talin-2,TLN2,102.87,80.88,T1843,MVDAIAEAMSKLDEGTPPEPKGTFVDYQTTV,_LDEGT(ph)PPEPK_, ,0.17,0.03,0.01,0.32,0.14,0.18, , ,-0.05,-0.04,-0.02,0.16,-0.11,-0.14, ,0.17,0.02,0.24,0.18,-0.05,-0.03,0.03,-0.14,,,,,,,0,0,,actin cytoskeleton,actin binding,cell adhesion,,
C9JAP5,Q969X1,Protein lifeguard 3,TMBIM1,52.61,51.47,S81,NYGPGHGYDGEERAVSDSFGPGEWDDR____,_AVS(ph)DSFGPGEWDDR_,0.09, , , , , , , ,-0.02, , , , , , , ,0.09,,,,-0.02,,,,,,,,,,NA,NA,,,,,,
Q8NE00-2,Q8NE00,Transmembrane protein 104,TMEM104,96.13,91.16,S90,HWKRMENLKEEEDDDSSTASDSDVLIRDNYE,_EEEDDDS(ph)S(ph)TAS(ph)DSDVLIR_, , , , , ,-0.13,-0.16,-0.21, , , , , ,-0.01,0.19,0.14,,,-0.13,-0.18,,,-0.01,0.16,,,,,,,NA,NA,,integral to membrane,,,,
Q8NE00-2,Q8NE00,Transmembrane protein 104,TMEM104,96.13,91.16,S91,WKRMENLKEEEDDDSSTASDSDVLIRDNYER,_EEEDDDS(ph)S(ph)TAS(ph)DSDVLIR_, , , , , ,-0.13,-0.23,-0.21, , , , , ,-0.01,0.2,0.14,,,-0.13,-0.22,,,-0.01,0.17,,,,,,,NA,NA,,integral to membrane,,,,
Q8NE00-2,Q8NE00,Transmembrane protein 104,TMEM104,96.13,91.16,S94,MENLKEEEDDDSSTASDSDVLIRDNYERAEK,_EEEDDDS(ph)S(ph)TAS(ph)DSDVLIR_, , , , , ,-0.13,-0.23,-0.21, , , , , ,-0.01,0.2,0.14,,,-0.13,-0.22,,,-0.01,0.17,,,,,,,NA,NA,,integral to membrane,,,,
Q8NE00-2,Q8NE00,Transmembrane protein 104,TMEM104,60.47,57.7,T92,KRMENLKEEEDDDSSTASDSDVLIRDNYERA,_EEEDDDSS(ph)T(ph)AS(ph)DSDVLIR_, , , , , ,-0.13,-0.23, , , , , , ,-0.01,0.2, ,,,-0.13,-0.23,,,-0.01,0.2,,,,,,,NA,NA,,integral to membrane,,,,
F2Z3N7,Q9NUM4,Transmembrane protein 106B,TMEM106B,55.72,37.59,Y18,KSLSHLPLHSSKEDAYDGVTSENMRNGLVNS,_EDAY(ph)DGVTSENMR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q12893,Q12893,Transmembrane protein 115,TMEM115,130.89,130.89,T329,SGAKVDSPLPSDKAPTPPGKGAAPESSLITF,_VDS(ph)PLPSDKAPT(ph)PPGK_,0.24,0.32,0.07,0.15,-0.29,-0.17,-0.07, ,0.09,0.09,-0.01,-0.1,-0.69,-0.26,0.07, ,0.28,0.11,-0.23,-0.07,0.09,-0.06,-0.46,0.07,,,,,,,0,0,,Golgi apparatus,,negative regulation of cell proliferation,,
Q9Y519,Q9Y519,Transmembrane protein 184B,TMEM184B,86.88,85.21,S402,HSLSGARDNEKTLLLSSDDEF__________,_TLLLS(ph)S(ph)DDEF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q9Y519,Q9Y519,Transmembrane protein 184B,TMEM184B,118.91,85.19,S403,SLSGARDNEKTLLLSSDDEF___________,_TLLLS(ph)S(ph)DDEF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
C9JI98,C9JI98,Transmembrane protein 238,TMEM238,66.12,63.82,S175,QLATLEAGPGAAGAGSE______________,_LQLATLEAGPGAAGAGS(ph)E_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,101.02,100.85,S330,PTLSTSPSPSSPSPTSPSPTLGRRRPEIGTF,_GESAPTLSTSPSPSSPS(ph)PTS(ph)PS(ph)PTLGR_, , , , , ,0.42,0.91,0.49, , , , , ,0.58,1.29,1.08,,,0.42,0.71,,,0.58,1.19,, +,,,,,NA,NA,,,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,71.69,71.69,S15,_MADGGGPKDAPSLRSSPGPAPRVPRAVGPS,_DAPSLRS(ph)SPGPAPR_, , , , , ,-0.17, , , , , , , ,-0.51, , ,,,-0.17,,,,-0.51,,,,,,,,NA,NA,,,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,151.37,141.99,S320,AEAVDRGESAPTLSTSPSPSSPSPTSPSPTL,_GESAPTLSTS(ph)PSPSS(ph)PSPT(ph)SPSPTLGR_, , , , ,0.59, , , , , , , ,0.71, , , ,,,0.59,,,,0.71,,,,,,,,NA,NA,,,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,151.37,141.99,S325,RGESAPTLSTSPSPSSPSPTSPSPTLGRRRP,_GESAPTLSTS(ph)PSPSS(ph)PSPTSPS(ph)PTLGR_, , , , ,0.59,0.56, , , , , , ,0.71,0.42, , ,,,0.57,,,,0.57,,,,,,,,NA,NA,,,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,172.37,170.39,S332,LSTSPSPSSPSPTSPSPTLGRRRPEIGTFLR,_GESAPTLSTSPSPSSPS(ph)PTS(ph)PS(ph)PTLGR_, ,-0.07,-0.51,-0.1,-0.45, ,-0.2,0.49, ,0.81,0.26,0.35,-0.2, ,-0.14,1.08,-0.07,-0.29,-0.45,0.19,0.81,0.31,-0.2,0.6,,,,,,,0,0,,,,,,
C9K005,Q9H330,Transmembrane protein 245,TMEM245,151.37,141.99,T329,APTLSTSPSPSSPSPTSPSPTLGRRRPEIGT,_GESAPTLSTS(ph)PSPSS(ph)PSPT(ph)SPSPTLGR_, , , , ,0.59, , , , , , , ,0.71, , , ,,,0.59,,,,0.71,,,,,,,,NA,NA,,,,,,
Q96B21,Q96B21,Transmembrane protein 45B,TMEM45B,76.67,75.28,S270,IQKLNSDDTYQTALLSGSDEE__________,_LNSDDTYQTALLS(ph)GS(ph)DEE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q96B21,Q96B21,Transmembrane protein 45B,TMEM45B,76.67,75.28,S272,KLNSDDTYQTALLSGSDEE____________,_LNSDDTYQTALLS(ph)GS(ph)DEE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,,,,
Q5T3F8-2,Q5T3F8,Transmembrane protein 63B,TMEM63B,72.36,55.11,S114,HGDSHDRYERLTSVSSSVDFDQRDNGFCSWL,_LTSVSS(ph)S(ph)VDFDQR_, , , , ,0.82,1.81, ,1.22, , , , ,1.39,2.19, ,1.75,,,1.4,1.22,,,1.85,1.75, +, +,,,,,NA,NA,,integral to membrane,nucleotide binding,,,
Q5T3F8-2,Q5T3F8,Transmembrane protein 63B,TMEM63B,72.36,55.11,S115,GDSHDRYERLTSVSSSVDFDQRDNGFCSWLT,_LTSVSS(ph)S(ph)VDFDQR_, , , , ,0.82,1.81, ,1.22, , , , ,1.39,2.19, ,1.75,,,1.4,1.22,,,1.85,1.75, +, +,,,,,NA,NA,,integral to membrane,nucleotide binding,,,
Q8NBN3-3,Q8NBN3,Transmembrane protein 87A,TMEM87A,225.88,225.8,S475,WRPSANNQRFAFSPLSEEEEEDEQKEPMLKE,_FAFSPLS(ph)EEEEEDEQKEPMLK_,0.29,0.43,0.22,0.35,0.05,0.06, ,0.42,0.31,0.88,0.52,0.46,0.55,0.91, ,0.07,0.36,0.29,0.06,0.42,0.62,0.49,0.74,0.07,,,,,,,0,0,,integral to membrane,,,,
Q8NBN3-3,Q8NBN3,Transmembrane protein 87A,TMEM87A,174.93,173.4,S540,VPSSVTDVALPALLDSDEERMITHFERSKME,_WVEENVPSSVTDVALPALLDS(ph)DEER_,0.08,0.18,0.22,0.24, , , , ,0.01,-0.15,-0.1,-0.1, , , , ,0.13,0.23,,,-0.07,-0.1,,,,,,,,,NA,NA,,integral to membrane,,,,
E7EWX9,P82094,TATA element modulatory factor,TMF1,175.56,127.03,S344,FSVQSLDSRSVSEINSDDELSGKGYALVPII,_SVSEINS(ph)DDELSGK_,0.31,0.52,0.55,0.44,0.31,0.22,0.35,0.23,0.36,0.29,0.43,0.84,1.28,0.88,0.37,0.09,0.42,0.49,0.26,0.29,0.33,0.65,1.1,0.24,, +,,,,,0,1,13.22,,,,,
E7EWX9,P82094,TATA element modulatory factor,TMF1,94.97,83.77,S330,ESCCSSDAFERIDSFSVQSLDSRSVSEINSD,_IDSFS(ph)VQS(ph)LDSR_, , , , , , ,-0.46,-0.54, , , , , , ,-0.4,-0.59,,,,-0.5,,,,-0.49,,,,,,,NA,NA,,,,,,
E7EWX9,P82094,TATA element modulatory factor,TMF1,94.97,83.77,S333,CSSDAFERIDSFSVQSLDSRSVSEINSDDEL,_IDSFS(ph)VQS(ph)LDSR_, , , , , , ,-0.46,-0.54, , , , , , ,-0.4,-0.59,,,,-0.5,,,,-0.49,,,,,,,NA,NA,,,,,,
Q9NYL9,Q9NYL9,Tropomodulin-3,TMOD3,244.49,212.87,S25,EKYKDLDEDELLGNLSETELKQLETVLDDLD,_YKDLDEDELLGNLS(ph)ETELK_,-0.2,-0.03,-0.17,-0.22,-0.58,-0.51,-0.49,-0.42,-0.1,0.17,-0.11,-0.15,-0.32,-0.27,-0.31,-0.33,-0.11,-0.19,-0.54,-0.45,0.04,-0.13,-0.3,-0.32,,,,,,,0,0,,striated muscle thin filament,tropomyosin binding,,,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,120.82,120.18,S159,KKLLKLREQGTESRSSTPLPTISSSAENTRQ,_LREQGTESRS(ph)S(ph)T(ph)PLPTISSSAENTR_, , , , ,-0.87,-0.92,-1.35,-1.13, , , , ,-1.04,-1.28,-1.44,-1.74,,,-0.9,-1.23,,,-1.15,-1.58, +, +,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,97.39,96.97,T154,RKLYEKKLLKLREQGTESRSSTPLPTISSSA,_LREQGT(ph)ESRS(ph)ST(ph)PLPTISSSAENTR_, , , , ,-1.07,-1.33, ,-0.84, , , , ,-1.98,-1.07, ,-1.86,,,-1.19,-0.84,,,-1.45,-1.86, +, +,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,119.45,106.05,S424,QKRIDQSKFQETEFLSPPRKVPRLSEKSVEE,_FQETEFLS(ph)PPR_,-0.51, ,-0.72, , , , , ,2.26, ,2.32, , , , , ,-0.51,-0.72,,,2.26,2.32,,,, +,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,291.23,291.23,T74,SKGPPDFSSDEEREPTPVLGSGAAAAGRSRA,_GPPDFS(ph)S(ph)DEEREPT(ph)PVLGSGAAAAGR_,1.06,0.63,0.8,0.97,-0.83,-0.79,-0.75,-0.62,0.3,0.33,0.42,0.38,-1.37,-1.33,-0.98,-0.83,0.86,0.89,-0.81,-0.68,0.31,0.4,-1.35,-0.91,, +,,,,,0,6,28.01,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,66.71,66.71,S184,AENTRQNGSNDSDRYSDNEEGKKKEHKKVKS,_QNGSNDSDRYS(ph)DNEEGK_, , , , , , ,0.05,0.13, , , , , , ,-0.5,-0.34,,,,0.09,,,,-0.42,,,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,194.99,167.77,S351,GIQPLCPERSHISDQSPLSSKRKALEESESS,_SHISDQS(ph)PLSSK_, ,-0.42, , , , , , , ,0.7, , , , , , ,-0.42,,,,0.7,,,,,,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,396.15,396.15,S66,PPLPAGTNSKGPPDFSSDEEREPTPVLGSGA,_GPPDFS(ph)S(ph)DEEREPT(ph)PVLGSGAAAAGR_,-0.07,0.07,0.17,0.15,0.12,0.26,0.18,0,-0.48,-0.22,0.09,0.09,0.05,0.27,-0.07,-0.22,0,0.16,0.19,0.09,-0.35,0.09,0.17,-0.15,,,,,,,0,0,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,396.15,396.15,S67,PLPAGTNSKGPPDFSSDEEREPTPVLGSGAA,_GPPDFS(ph)S(ph)DEEREPT(ph)PVLGSGAAAAGR_,-0.08,-0.23,0.25,-0.09,0.28,0.09,-0.01,0.21,-0.28,-0.17,0.15,0.08,0.28,-0.07,-0.21,-0.12,-0.15,0.09,0.19,0.1,-0.23,0.12,0.12,-0.16,,,,,,,0,0,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42167,P42167,"Lamina-associated polypeptide 2, isoforms beta/gamma",TMPO,120.32,120.32,S177,LPTISSSAENTRQNGSNDSDRYSDNEEDSKI,_(gl)QNGS(ph)NDS(ph)DRYS(ph)DNEEDSKIELK_, , , , ,-0.07, , ,-0.4, , , , ,-0.12, , ,-0.43,,,-0.07,-0.4,,,-0.12,-0.43,,,,,,,NA,NA,,integral to membrane,DNA binding,,,
P42167,P42167,"Lamina-associated polypeptide 2, isoforms beta/gamma",TMPO,368.67,368.67,S180,ISSSAENTRQNGSNDSDRYSDNEEDSKIELK,_(gl)QNGSNDS(ph)DRYS(ph)DNEEDSKIELK_,0.07,-0.04,-0.18,-0.14,-0.16,-0.16,-0.2,-0.25,0.36,0.3,0.38,0.36,-0.09,-0.25,-0.25,-0.26,0.02,-0.16,-0.16,-0.22,0.33,0.37,-0.17,-0.25,,,,,,,0,0,,integral to membrane,DNA binding,,,
P42167,P42167,"Lamina-associated polypeptide 2, isoforms beta/gamma",TMPO,453.4,453.4,S184,AENTRQNGSNDSDRYSDNEEDSKIELKLEKR,_(gl)QNGSNDS(ph)DRYS(ph)DNEEDSKIELK_,-0.15,-0.11,-0.25,-0.23,-0.07,-0.23,-0.25,0.01,0.22,0.09,0.02,0.07,0.04,-0.06,-0.11,0.1,-0.13,-0.24,-0.15,-0.12,0.16,0.05,-0.01,0,,,,,,,0,0,,integral to membrane,DNA binding,,,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,122.47,120.77,S167,QGTESRSSTPLPTISSSAENTRQNGSNDSDR,_SSTPLPTISS(ph)S(ph)AENTR_, , , , ,-0.16,-0.29,-0.6,-0.37, , , , ,0.15,-0.84,0.02,-0.47,,,-0.22,-0.48,,,-0.26,-0.21,,,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,186.01,185.87,S168,GTESRSSTPLPTISSSAENTRQNGSNDSDRY,_SSTPLPTISSS(ph)AENTR_,-0.11,-0.14,-0.58,-0.56,-0.39,-0.4,-0.19,-0.51,0.28,0.22,-0.17,0.11,-0.54,-0.61,-0.54,-0.84,-0.13,-0.57,-0.4,-0.34,0.25,-0.02,-0.57,-0.68,,,,,,,0,0,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
P42166,P42166,"Lamina-associated polypeptide 2, isoform alpha",TMPO,192.6,192.37,T160,KLLKLREQGTESRSSTPLPTISSSAENTRQN,_SST(ph)PLPTISSSAENTR_, , , , ,0.1,-0.03,0.45,0.39, , , , ,-0.54,-0.79,-0.44,-0.57,,,0.03,0.42,,,-0.66,-0.5,,,,,,,NA,NA,,chromatin,DNA binding,"regulation of transcription, DNA-dependent",,
Q5T4B6,P62328,Thymosin beta-4,TMSL4,183,183,S2,______________MSDKPDMAEIEKFDKSK,_(ac)S(ph)DKPDMAEIEK_,-0.45,-0.39,-0.54,-0.78,0.06,0.11,0.12,0.11,0,-0.05,-0.07,-0.06,-0.91,-1,-0.05,0.12,-0.42,-0.65,0.09,0.12,-0.03,-0.06,-0.95,0.04,,,,,,,0,0,,cytoplasm,,actin cytoskeleton organization,,
Q9H3N1,Q9H3N1,Thioredoxin-related transmembrane protein 1,TMX1,130.47,127.39,S270,EGTNKDFPQNAIRQRSLGPSLATDKS_____,_(gl)QRS(ph)LGPSLATDKS_,1.29, ,1.98,1.78, , , , ,0.15, ,1.62,1.3, , , , ,1.29,1.88,,,0.15,1.47,,, +, +,,,,,NA,NA,,endoplasmic reticulum membrane,arsenate reductase (thioredoxin) activity,cell proliferation,,
Q9H3N1,Q9H3N1,Thioredoxin-related transmembrane protein 1,TMX1,559.53,559.53,S247,LKKVEEEQEADEEDVSEEEAESKEGTNKDFP,_VEEEQEADEEDVS(ph)EEEAESK_,0.03,0.08,0,0.06,0,-0.02,0.15,0.11,0.09,0.12,0.06,0.02,0.03,0.03,0.18,0.18,0.06,0.03,-0.01,0.13,0.11,0.04,0.03,0.18,,,,,,,0,0,,endoplasmic reticulum membrane,arsenate reductase (thioredoxin) activity,cell proliferation,,
Q9Y320-2,Q9Y320,Thioredoxin-related transmembrane protein 2,TMX2,184.62,184.62,S288,NIPEEQPVASTPTTVSDGENKKDK_______,_AGDNIPEEQPVASTPTTVS(ph)DGENKK_,0.62,0.53,0.72,0.84,0.4, ,0.49, ,0.46,0.48,0.46,0.57,0.79, ,0.89, ,0.57,0.78,0.4,0.49,0.47,0.52,0.79,0.89,,,,,,,0,0,,integral to membrane,,cell redox homeostasis,,
Q9H1E5,Q9H1E5,Thioredoxin-related transmembrane protein 4,TMX4,359.07,359.07,S251,HRAEQLQDAEEEKDDSNEEENKDSLVDDEEE,_DDS(ph)NEEENKDS(ph)LVDDEEEK_,0.62,0.29,0.27,0.04, ,-0.05,-0.24,0.04,0.71,0.49,0.48,0.24, ,-0.12,-0.1,0.02,0.46,0.16,-0.05,-0.09,0.6,0.37,-0.12,-0.04,,,,,,,0,0,,integral to membrane,,cell redox homeostasis,,
Q9H1E5,Q9H1E5,Thioredoxin-related transmembrane protein 4,TMX4,359.07,359.07,S259,AEEEKDDSNEEENKDSLVDDEEEKEDLGDED,_DDSNEEENKDS(ph)LVDDEEEK_,0.08,-0.34,-0.35,-0.57, ,-0.05,-0.66,-0.16,-0.03,0.14,-0.08,-0.07, ,-0.12,-0.64,0.11,-0.12,-0.46,-0.05,-0.39,0.06,-0.08,-0.12,-0.22,,,,,,,0,0,,integral to membrane,,cell redox homeostasis,,
H0YKI8,Q03169,Tumor necrosis factor alpha-induced protein 2,TNFAIP2,103.34,102.82,S2,______________MSEASSEDLVPPLEAGA,_(ac)S(ph)EAS(ph)SEDLVPPLEAGAAPYREEEEAAK_, , , , , ,-0.17, , , , , , , ,0.23, , ,,,-0.17,,,,0.23,,,,,,,,NA,NA,,exocyst,,exocytosis,,
H0YKI8,Q03169,Tumor necrosis factor alpha-induced protein 2,TNFAIP2,103.34,102.82,S5,___________MSEASSEDLVPPLEAGAAPY,_(ac)S(ph)EAS(ph)SEDLVPPLEAGAAPYREEEEAAK_, , , , , ,-0.17, , , , , , , ,0.23, , ,,,-0.17,,,,0.23,,,,,,,,NA,NA,,exocyst,,exocytosis,,
O00220,O00220,Tumor necrosis factor receptor superfamily member 10A,TNFRSF10A,172.56,148.9,S463,LVDSGKFIYLEDGTGSAVSLE__________,_FIYLEDGTGS(ph)AVS(ph)LE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,death receptor activity,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
O00220,O00220,Tumor necrosis factor receptor superfamily member 10A,TNFRSF10A,172.56,148.9,S466,SGKFIYLEDGTGSAVSLE_____________,_FIYLEDGTGS(ph)AVS(ph)LE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,death receptor activity,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q07912,Q07912,Activated CDC42 kinase 1,TNK2,112.17,109.2,Y284,GDFGLMRALPQNDDHYVMQEHRKVPFAWCAP,_ALPQNDDHY(ph)VMQEHRK_,0.42,0.27,0.24, , , ,-3.27,-3.02,0.34,0.24,-0.43, , , ,-2.43,-2.45,0.34,0.24,,-3.14,0.29,-0.43,,-2.44, +, +,Tyr,,,,NA,NA,,adherens junction,ATP binding,cell surface receptor signaling pathway,,
Q07912,Q07912,Activated CDC42 kinase 1,TNK2,186.97,186.97,Y859,ILPIVRDGKKVSSTHYYLLPERPSYLERYQR,_KVSSTHY(ph)Y(ph)LLPERPSYLER_,2.08, ,1.73, ,0.17,0.29,-1.14,-1.01,2.15, ,1.68, ,0.58,0.65,-0.86,-0.82,2.08,1.73,0.23,-1.07,2.15,1.68,0.61,-0.84, +, +,Tyr,,,,5,5,39.8,adherens junction,ATP binding,cell surface receptor signaling pathway,,
Q07912,Q07912,Activated CDC42 kinase 1,TNK2,161.35,156.47,Y860,LPIVRDGKKVSSTHYYLLPERPSYLERYQRF,_KVSSTHY(ph)Y(ph)LLPERPSYLER_,2.42, ,1.66, ,1.4, , ,0.18,2.37, ,0.68, ,1.44, , ,0.37,2.42,1.66,1.4,0.18,2.37,0.68,1.44,0.37, +, +,Tyr,,,,5,5,18.16,adherens junction,ATP binding,cell surface receptor signaling pathway,,
Q07912,Q07912,Activated CDC42 kinase 1,TNK2,135.81,135.81,T857,PCILPIVRDGKKVSSTHYYLLPERPSYLERY,_VSST(ph)HYYLLPERPSYLER_,2.42,1.72, , , , , , ,2.37,1.92, , , , , , ,2.11,,,,2.16,,,, +, +,Tyr,,,,NA,NA,,adherens junction,ATP binding,cell surface receptor signaling pathway,,
Q07912,Q07912,Activated CDC42 kinase 1,TNK2,357.92,357.92,Y518,TSRPPQHLGGVKKPTYDPVSEDQDPLSSDFK,_KPTY(ph)DPVSEDQDPLSSDFK_,0.11, , , , , , , ,0.01, , , , , , , ,0.11,,,,0.01,,,,,,Tyr,,,,NA,NA,,adherens junction,ATP binding,cell surface receptor signaling pathway,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,287.09,246,S1666,LSPSALKAKLRPRNRSAEEGELAESKSSQKE,_NRS(ph)AEEGELAESK_,0.16,0.17,1.12,1.25,0.73,1.25,0.9,1.15,0.34,0.51,1.21,1.29,0.93,1.49,1.05,1.3,0.17,1.18,1.01,1.03,0.43,1.25,1.24,1.18, +, +,,,,,1,1,37.13,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,118.25,117.94,S893,SRDVSLGDWEFGKRDSLGAYASQDANEQGQD,_RDS(ph)LGAYASQDANEQGQDLGK_, ,-2.02, ,0.42,-0.24, ,-0.27, , ,-1.69, ,0.14,-0.08, ,-0.33, ,-2.02,0.42,-0.24,-0.27,-1.69,0.14,-0.08,-0.33, +, +,,,,,4,1,37.79,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,197.15,187.08,S836,QDRVVGKPAQLGTQRSQEADVQDWEFRKRDS,_S(ph)QEADVQDWEFR_,0.08,0.18,1.35,1.32,1.05,1.68,1.14,0.57,0.2,0.38,1.96,1.85,1.23,1.75,0.81,0.65,0.13,1.33,1.4,0.88,0.29,1.91,1.51,0.73, +, +,,,,,1,4,29.39,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,316.75,316.75,S1620,HLFQDSTEPRASRVPSSDEEVVEEPQSRRTR,_VPS(ph)S(ph)DEEVVEEPQSR_,-0.33,-0.28,-0.37,-0.41,-0.24,-0.23,-0.21,-0.26,-0.28,-0.25,-0.32,-0.34,-0.21,-0.16,-0.13,-0.12,-0.3,-0.39,-0.23,-0.24,-0.26,-0.33,-0.19,-0.12,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,316.75,316.75,S1621,LFQDSTEPRASRVPSSDEEVVEEPQSRRTRM,_VPS(ph)S(ph)DEEVVEEPQSR_,-0.33,-0.28,-0.37,-0.41,-0.24,-0.23,-0.21,-0.26,-0.28,-0.25,-0.32,-0.34,-0.21,-0.16,-0.13,-0.12,-0.3,-0.39,-0.23,-0.24,-0.26,-0.33,-0.19,-0.12,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,183.85,160.2,S872,SRDAELQDQEFGKRDSLGTYSSRDVSLGDWE,_RDS(ph)LGTYSSR_,-0.49,-0.39,-0.32,-0.33, , , , ,-0.43,-0.13,-0.1,0.12, , , , ,-0.44,-0.33,,,-0.28,0.01,,,,,,,,,NA,NA,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,157.74,122.03,S1103,GEFSLSVGPQREAAFSPGQQDWSRDFCIEAS,_EAAFS(ph)PGQQDWSR_,-0.45,-0.3,0.45, , ,-0.72,-0.55, ,-0.27,-0.29,0.79, , ,-0.14,-0.13, ,-0.37,0.45,-0.72,-0.55,-0.28,0.79,-0.14,-0.13,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,157.73,156.19,S435,PTSLVQRRFSEGVLQSPSQDQEKLGGSLAAL,_FSEGVLQS(ph)PSQDQEK_, ,-0.43,-0.4,-0.64,-0.25,0.22,-0.09,-0.42, ,0.28,0.34,0.5,-0.22,0.43,0.05,0.1,-0.43,-0.52,0,-0.24,0.28,0.42,0.14,0.07,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,297.9,297.77,S494,TFPTRPSGLGVWRLDSPPPSPITEASEAAEA,_LDS(ph)PPPS(ph)PITEASEAAEAAEAGNLAVSSR_, ,-0.15,0.53, ,0.45,0.57,0.56,0.64, ,0.38,0.68, ,0.76,0.71,0.63,0.73,-0.15,0.53,0.51,0.6,0.38,0.68,0.73,0.68,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,297.9,297.77,S498,RPSGLGVWRLDSPPPSPITEASEAAEAAEAG,_LDS(ph)PPPS(ph)PITEASEAAEAAEAGNLAVSSR_, ,-0.15,0.53, ,0.45,0.57,0.56,0.64, ,0.38,0.68, ,0.76,0.71,0.63,0.73,-0.15,0.53,0.51,0.6,0.38,0.68,0.73,0.68,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,297.26,297.26,S983,RTLDAQDRSFGTRPLSSGFSPEEAQQQDEEF,_SFGTRPLS(ph)SGFSPEEAQQQDEEFEK_,-0.97,-0.49,-1.06,-0.04,0.16,-1.09,-0.75,-0.16,-0.31,0.37,0.42,0.28,0.81,-0.49,-0.76,-0.73,-0.71,-0.47,-0.33,-0.43,0.07,0.35,0.3,-0.75,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,132.99,132.99,S987,AQDRSFGTRPLSSGFSPEEAQQQDEEFEKKI,_SFGTRPLS(ph)SGFS(ph)PEEAQQQDEEFEK_, , , , ,0.16, , , , , , , ,0.06, , , ,,,0.16,,,,0.06,,,,,,,,NA,NA,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,101.05,101.05,S691,PGPESSSRWLDDLLASPPPSGGGARRGAGAE,_WLDDLLAS(ph)PPPSGGGAR_, , , ,0.47,0.65,0.54, , , , , ,0.65,0.91,0.91, , ,,0.47,0.6,,,0.65,0.91,,,,,,,,NA,NA,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,245.53,236.07,S601,AEERYESQEPLAGQESPLPLATREAALPILE,_YESQEPLAGQES(ph)PLPLATR_,-0.32,-0.26,-0.31,-0.26,-0.22,0.05,-0.03,-0.11,-0.06,0.01,-0.03,0.5,-0.05,0.33,0.03,0.15,-0.29,-0.29,-0.08,-0.07,-0.03,0.26,0.15,0.09,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
Q9C0C2,Q9C0C2,182 kDa tankyrase-1-binding protein,TNKS1BP1,164.53,164.53,S178,EILAKMEQPRKEVLASPDRLWGSRLTFNHDG,_EVLAS(ph)PDRLWGSR_,-0.29,-0.28,-0.41,-0.15, ,-0.24,-0.11,-0.39,-0.35,-0.38,-0.21,-0.16, ,-0.04,0.02,-0.73,-0.29,-0.28,-0.24,-0.25,-0.36,-0.19,-0.04,-0.3,,,,,,,0,0,,CCR4-NOT complex,ankyrin binding,nuclear-transcribed mRNA poly(A) tail shortening,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,159.36,158.98,S1915,EERQSLLGTEFEYTDSESEVKVRKRSPAGLL,_QSLLGTEFEYT(ph)DS(ph)ESEVK_, , , , ,-0.58, , ,-1.55, , , , ,0.29, , ,-0.06,,,-0.58,-1.55,,,0.29,-0.06, +,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,159.36,158.98,T1913,KKEERQSLLGTEFEYTDSESEVKVRKRSPAG,_QSLLGTEFEYT(ph)DS(ph)ESEVK_, , , , ,-0.58, , ,-1.55, , , , ,0.29, , ,-0.06,,,-0.58,-1.55,,,0.29,-0.06, +,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,110.91,96.55,S1989,LRGPKEPGFEAGPEASDDDLWTRRRSERIFL,_EPGFEAGPEAS(ph)DDDLWTR_, , , , , , ,-0.32, , , , , , , ,0.1, ,,,,-0.32,,,,0.1,,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,101.43,101.43,S991,PGLAAGPAGTYGKAVSPPPSPRASPVAALKA,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_, , , , ,-0.3,-0.18,-0.14,-0.38, , , , ,-0.32,-0.25,-0.04,-0.08,,,-0.24,-0.26,,,-0.28,-0.06,,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,101.43,101.43,S995,AGPAGTYGKAVSPPPSPRASPVAALKAKVIQ,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_, , , , ,-0.3,-0.18,-0.14,-0.38, , , , ,-0.32,-0.25,-0.04,-0.08,,,-0.24,-0.26,,,-0.28,-0.06,,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,101.43,101.43,S999,GTYGKAVSPPPSPRASPVAALKAKVIQKLED,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_, , , , ,-0.3,-0.18,-0.14,-0.38, , , , ,-0.32,-0.25,-0.04,-0.08,,,-0.24,-0.26,,,-0.28,-0.06,,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,94.28,94.28,S1127,PDVPLPADGPERLALSPEDKPIRLSPSKITE,_LALS(ph)PEDKPIRLS(ph)PSK_,0.24,0.52,0.71,0.18, , , , ,-0.18,0.03,1.2,0.33, , , , ,0.39,0.47,,,-0.07,0.83,,,,,,,,,NA,NA,,,DNA binding,,,
O15417,O15417,Trinucleotide repeat-containing gene 18 protein,TNRC18,94.28,94.28,S1136,PERLALSPEDKPIRLSPSKITEPLREGPEEE,_LALS(ph)PEDKPIRLS(ph)PSK_,0.24,0.52,0.71,0.18, , , , ,-0.18,0.03,1.2,0.33, , , , ,0.39,0.47,,,-0.07,0.83,,,,,,,,,NA,NA,,,DNA binding,,,
C9JA83,Q8NDV7,Trinucleotide repeat-containing gene 6A protein,TNRC6A,79.03,78.27,S991,PAPAKEEEPTGWEEPSPESIRRKMEIDDGTS,_EEEPTGWEEPS(ph)PESIR_, ,-0.13, , , , ,-0.05, , ,-0.14, , , , ,-0.61, ,-0.13,,,-0.05,-0.14,,,-0.61,,,,,,,NA,NA,,,,,,
Q9UPQ9-1,Q9UPQ9,Trinucleotide repeat-containing gene 6B protein,TNRC6B,110.27,109.07,S1816,SLWGVPTVEDPHRMGSPAPLLPGDLLGGGSD,_M(ox)GS(ph)PAPLLPGDLLGGGSDS(ph)I_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasmic mRNA processing body,nucleotide binding,epidermal growth factor receptor signaling pathway,,
Q9UPQ9-1,Q9UPQ9,Trinucleotide repeat-containing gene 6B protein,TNRC6B,110.27,109.07,S1832,PAPLLPGDLLGGGSDSI______________,_M(ox)GS(ph)PAPLLPGDLLGGGSDS(ph)I_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasmic mRNA processing body,nucleotide binding,epidermal growth factor receptor signaling pathway,,
Q9UPQ9-1,Q9UPQ9,Trinucleotide repeat-containing gene 6B protein,TNRC6B,169.9,138.54,S879,PATPKDEEPSGWEEPSPQSISRKMDIDDGTS,_DEEPSGWEEPS(ph)PQSISR_, ,0.11, , ,-0.08, ,0.21,0.09, ,-0.31, , ,-0.31, ,-0.22,-0.3,0.11,,-0.08,0.15,-0.31,,-0.31,-0.26,,,,,,,NA,NA,,cytoplasmic mRNA processing body,nucleotide binding,epidermal growth factor receptor signaling pathway,,
E9PGF5,Q9HBL0,Tensin-1,TNS1,83.79,80.55,Y1323,GSVVPGSPCLDRHVAYGGYSTPEDRRPTLSR,_HVAY(ph)GGYSTPEDRRPTLSR_,2.12, , , , , , , ,1.91, , , , , , , ,2.12,,,,1.91,,,, +, +,,,,PTENs,NA,NA,,focal adhesion,,,,
E9PGF5,Q9HBL0,Tensin-1,TNS1,144.68,144.1,Y1326,VPGSPCLDRHVAYGGYSTPEDRRPTLSRQSS,_HVAYGGY(ph)STPEDRRPTLSR_,2.18,1.85, , , , , , ,1.92,1.51, , , , , , ,2.02,,,,1.73,,,, +, +,,,,PTENs,NA,NA,,focal adhesion,,,,
E9PGF5,Q9HBL0,Tensin-1,TNS1,64.8,37.79,Y1404,KRRMSVGDRAGSLPNYATINGKVSSPVASGM,_AGSLPNY(ph)ATINGK_,0.26, , , , , , , ,0.87, , , , , , , ,0.26,,,,0.87,,,,,,,,,PTENs,NA,NA,,focal adhesion,,,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,152.01,148.87,Y802,QLPFSKCAWGKAGVDYAPNLPPFPSPADVKE,_AGVDY(ph)APNLPPFPSPADVK_,2.35, , , , , , , ,1.73, , , , , , , ,2.35,,,,1.73,,,, +, +,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,202.35,178.91,Y855,SMCSTPAFPVSPETPYVKTALRHPPFSPPEP,_ESMCSTPAFPVSPETPY(ph)VK_,1.82, , , , , , , ,1.56, , , , , , , ,1.82,,,,1.56,,,, +, +,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,135.09,133.23,Y823,PFPSPADVKETMTPGYPQDLDIIDGRILSSK,_ETMTPGY(ph)PQDLDIIDGR_,5.19, , , , , , , ,4.49, , , , , , , ,5.19,,,,4.49,,,, +, +,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,309.59,293.06,Y780,EQPLGGRLRKLSLGQYDNDAGGQLPFSKCAW,_LSLGQY(ph)DNDAGGQLPFSK_,2.22,2.3,1.69, ,0.93,0.91,0.46,0.56,1.82,2.12,1.26, ,1.63,1.59,0.87,0.79,2.26,1.69,0.92,0.51,1.98,1.26,1.61,0.83, +, +,,,,,5,5,18.61,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,200.99,200.22,Y601,TQTWVRQQQMVVAHQYSFAPDGEARLVSRCP,_(gl)QQQMVVAHQY(ph)SFAPDGEAR_,4.03,3.39,1.49, ,0.51,0.24, , ,3.93,3.11,1.06, ,1.06,0.79, , ,3.75,1.49,0.38,,3.58,1.06,0.93,, +, +,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,306.02,304.8,S776,GSSAEQPLGGRLRKLSLGQYDNDAGGQLPFS,_KLS(ph)LGQYDNDAGGQLPFSK_,0.66,1.06,1.82,1.85,1.68,1.61,1.37,2.82,0.92,0.73,2.25,2.23,1.51,1.66,1.31,3.61,0.87,1.84,1.65,2.27,0.83,2.24,1.59,2.88, +, +,,,,,1,1,34.74,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,255.8,254.69,Y354,DGEVLHTQGPVDGSLYAKVRKKSSSDPGIPG,_WDS(ph)YENLSADGEVLHTQGPVDGSLY(ph)AK_,1.13, , , ,-0.29,-0.15,-0.74,-0.2,0.95, , , ,-0.22,-0.01,-0.55,-0.18,1.13,,-0.22,-0.45,0.95,,-0.11,-0.35, +,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,255.8,254.69,S332,VIVDYNTTDPLIRWDSYENLSADGEVLHTQG,_WDS(ph)YENLSADGEVLHTQGPVDGSLY(ph)AK_,1.13, , , ,-0.43,-0.26,-0.74,-0.33,0.95, , , ,-0.12,0.08,-0.55,-0.08,1.13,,-0.34,-0.52,0.95,,-0.02,-0.3, +,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,59.91,59.91,S1441,PASAIVNFVSKVMIGSPKKV___________,_VMIGS(ph)PK_,-0.06,-0.21, , ,-0.34, ,-0.18,-0.17,-0.05,0.01, , ,-0.04, ,0.18,0.07,-0.13,,-0.34,-0.17,-0.02,,-0.04,0.13,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,75.91,72.2,S1149,FPNVLPDFSKASEAASPLPDSPGDKLVIVKF,_ASEAAS(ph)PLPDS(ph)PGDK_, , , , , ,-0.45,-0.74, , , , , , ,-0.56,-0.2, ,,,-0.45,-0.74,,,-0.56,-0.2,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,75.91,72.2,S1154,PDFSKASEAASPLPDSPGDKLVIVKFVQDTS,_ASEAAS(ph)PLPDS(ph)PGDK_, , , , , ,-0.45,-0.74, , , , , , ,-0.56,-0.2, ,,,-0.45,-0.74,,,-0.56,-0.2,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,68.31,66.64,Y321,QGSEHLYNDHGVIVDYNTTDPLIRWDSYENL,_IQGSEHLYNDHGVIVDY(ph)NTTDPLIR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,75.54,75.11,Y549,QGTLVPDLGLGMDGPYERERTFGSREPKQPQ,_SSQNSLLSDGFGSNVGEDPQGTLVPDLGLGMDGPY(ph)ERER_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q68CZ2,Q68CZ2,Tensin-3,TNS3,174.73,173.54,S690,VNGAGPELSTGPSPGSPTLDIDQSIEQLNRL,_FPGDQVVNGAGPELSTGPSPGS(ph)PTLDIDQSIEQLNR_, , , , ,0.54, , , , , , , ,0.45, , , ,,,0.54,,,,0.45,,,,,,,,NA,NA,,focal adhesion,,cell migration,,
Q96GM8,Q96GM8,Target of EGR1 protein 1,TOE1,165.4,142.33,S5,___________MAADSDDGAVSAPAASDGGV,_AADS(ph)DDGAVSAPAASDGGVSK_,-0.28,-0.12,-0.38,-0.5,-0.02,0.07,0.13,-0.2,-0.11,-0.04,-0.11,-0.64,0.03,0.03,-0.14,-0.06,-0.2,-0.44,0.03,-0.03,-0.07,-0.35,0.03,-0.09,,,,,,,0,0,,nuclear speck,nucleic acid binding,,,
E7EN89,Q9H0E2,Toll-interacting protein,TOLLIP,106.14,87.31,Y83,YGMTRMDPYCRLRLGYAVYETPTAHNGAKNP,_LGY(ph)AVYETPTAHNGAK_, , ,0.84, , , , , , , ,0.66, , , , , ,,0.84,,,,0.66,,,,,,,,,NA,NA,,,,,,
B7Z9E2,O75674,TOM1-like protein 1,TOM1L1,54.09,53,S321,TTSEPSAPSQDLLDLSPSPRMPRATLGELNT,_EATNTTSEPSAPSQDLLDLS(ph)PS(ph)PR_, , , , , ,-0.17, , , , , , , ,0.07, , ,,,-0.17,,,,0.07,,,,,,,,NA,NA,,intracellular,protein kinase activator activity,intracellular protein transport,,
B7Z9E2,O75674,TOM1-like protein 1,TOM1L1,123.99,108.49,S323,SEPSAPSQDLLDLSPSPRMPRATLGELNTMN,_EATNTTSEPSAPSQDLLDLS(ph)PS(ph)PR_, ,-0.37,-0.36, ,-0.41,-0.53,-0.36,-0.06, ,0.1,0.04, ,-0.62,-0.63,-0.41,-0.12,-0.37,-0.36,-0.47,-0.2,0.1,0.04,-0.62,-0.26,,,,,,,0,0,,intracellular,protein kinase activator activity,intracellular protein transport,,
Q6ZVM7-3,Q6ZVM7,TOM1-like protein 2,TOM1L2,260.08,256.59,Y404,QTRGNSLAEQRKTVTYEDPQAVGGLASALDN,_TVTY(ph)EDPQAVGGLASALDNRK_,5.12,1.23,5.28, , , , , ,4.58,0.79,3.23, , , , , ,4.21,5.28,,,3.68,3.23,,, +, +,,,,,NA,NA,,intracellular,,intracellular protein transport,+,
Q15388,Q15388,Mitochondrial import receptor subunit TOM20 homolog,TOMM20,123.14,120.06,S135,QMLLTKLPTISQRIVSAQSLAEDDVE_____,_IVS(ph)AQS(ph)LAEDDVE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,cellular protein metabolic process,,
Q15388,Q15388,Mitochondrial import receptor subunit TOM20 homolog,TOMM20,123.14,120.06,S138,LTKLPTISQRIVSAQSLAEDDVE________,_IVS(ph)AQS(ph)LAEDDVE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,cellular protein metabolic process,,
Q9NS69,Q9NS69,Mitochondrial import receptor subunit TOM22 homolog,TOMM22,214.81,211.33,S15,_MAAAVAAAGAGEPQSPDELLPKGDAEKPEE,_(ac)AAAVAAAGAGEPQS(ph)PDELLPK_,-0.36,-0.25,0.42,0.4,0.92,0.83,0.6,0.75,0.39,0.71,1.02,0.89,1.03,0.98,0.88,0.85,-0.3,0.41,0.88,0.67,0.56,0.95,1,0.86,, +,,,,,0,1,16.33,integral to membrane,protein transmembrane transporter activity,cellular protein metabolic process,,
O94826,O94826,Mitochondrial import receptor subunit TOM70,TOMM70A,106.71,106.42,S91,GLKRNSERKTPEGRASPAPGSGHPEGPGAHL,_AS(ph)PAPGSGHPEGPGAHLDMNSLDR_,0.24,0.36,0.01,0.17,-0.11,-0.15,0.67,0.1,0.23,0.35,0.07,-0.01,-0.24,-0.04,-0.14,-0.14,0.3,0.09,-0.13,0.42,0.29,0.03,-0.14,-0.14,,,,,,,0,0,,integral to membrane,protein transmembrane transporter activity,cellular protein metabolic process,,
P11387,P11387,DNA topoisomerase 1,TOP1,75.54,74.41,S2,______________MSGDHLHNDSQIEADFR,_(ac)S(ph)GDHLHNDS(ph)QIEADFR_, , , , ,-0.08,0.23,-0.02, , , , , ,-0.58,-0.05,-0.7, ,,,0.08,-0.02,,,-0.29,-0.7,,,,,,,NA,NA,,cytoplasmic mRNA processing body,ATP binding,chromatin remodeling,,
P11387,P11387,DNA topoisomerase 1,TOP1,176.68,174.41,S10,______MSGDHLHNDSQIEADFRLNDSHKHK,_(ac)S(ph)GDHLHNDS(ph)QIEADFR_,-0.05,0.09,-0.36,-0.72,-0.39,-0.55,-0.5,-0.47,0.68,0.55,0.14,0.23,-0.71,-0.29,-0.07,-0.16,0.02,-0.53,-0.47,-0.49,0.62,0.19,-0.48,-0.11,,,,,,,0,0,,cytoplasmic mRNA processing body,ATP binding,chromatin remodeling,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,282.51,279.07,S1247,EKKNKKKIKNENTEGSPQEDGVELEGLKQRL,_NENTEGS(ph)PQEDGVELEGLK_,-0.49,-0.53,-0.17,-0.08,-0.91,-1.24,-0.56,-0.78,-0.55,-0.52,-0.2,-0.23,-0.47,-0.37,0.08,-0.18,-0.51,-0.12,-1.07,-0.66,-0.53,-0.21,-0.42,-0.04, +,,,,,,6,0,4.7,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,58.71,50.01,S1213,GKAKGKKTQMAEVLPSPRGQRVIPRITIEMK,_TQMAEVLPS(ph)PR_,-1.4,-1.26,-1.59, , , , , ,-0.56,-0.67,-0.64, , , , , ,-1.33,-1.59,,,-0.61,-0.64,,, +,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,157.37,155.9,S1374,KTSPKLSNKELKPQKSVVSDLEADDVKGSVP,_S(ph)VVS(ph)DLEADDVK_, , ,0.56, ,-0.29,-0.47,-0.04,-0.17, , ,1.19, ,-0.13,-0.15,-0.03,-0.04,,0.56,-0.38,-0.1,,1.19,-0.14,-0.04,, +,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,357.25,357.25,S1106,KEAQQKVPDEEENEESDNEKETEKSDSVTDS,_VPDEEENEES(ph)DNEK_,-0.41,-0.4,-0.12,-0.09, ,-0.52,-0.33,-0.34,-0.66,-0.77,-0.25,-0.3, ,-0.1,-0.03,0.11,-0.41,-0.1,-0.52,-0.33,-0.71,-0.27,-0.1,0.04,,,,,,,0,0,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,244.68,239.83,S1332,PRRAATKTKFTMDLDSDEDFSDFDEKTDDED,_FTM(ox)DLDS(ph)DEDFS(ph)DFDEK_, ,-0.45, , ,-0.64,-0.74,-0.44,-0.38, ,-0.56, , ,-0.21,-0.32,0.1,0.07,-0.45,,-0.69,-0.41,-0.56,,-0.26,0.08,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,244.68,239.83,S1337,TKTKFTMDLDSDEDFSDFDEKTDDEDFVPSD,_FTM(ox)DLDS(ph)DEDFS(ph)DFDEK_, ,-0.45, , ,-0.64,-0.74,-0.44,-0.38, ,-0.56, , ,-0.21,-0.32,0.1,0.07,-0.45,,-0.69,-0.41,-0.56,,-0.26,0.08,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,146.72,144.69,S4,____________MEVSPLQPVNENMQVNKIK,_(ac)MEVS(ph)PLQPVNENMQVNK_,-0.35,-0.67,0.02,-0.75, , , ,0.64,-0.44,-0.5,-0.14,-0.3, , , ,-0.79,-0.5,-0.32,,0.64,-0.47,-0.22,,-0.79,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,182.52,159.09,S1377,PKLSNKELKPQKSVVSDLEADDVKGSVPLSS,_S(ph)VVS(ph)DLEADDVK_,-0.47,-0.43,-0.08,-0.01,-0.52,-0.36,-0.07,-0.02,-0.58,-0.44,-0.04,0.04,-0.45,-0.17,0.11,-0.06,-0.45,-0.04,-0.44,-0.04,-0.51,0,-0.31,0.02,,,,,,,0,0,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,125.23,123.16,S1351,FSDFDEKTDDEDFVPSDASPPKTKTSPKLSN,_T(ph)DDEDFVPS(ph)DAS(ph)PPK_, , , , ,-0.57,-0.66,-0.25,-0.14, , , , ,-0.37,-0.43,0.19,0.13,,,-0.62,-0.19,,,-0.4,0.16,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,116.45,114.01,S1354,FDEKTDDEDFVPSDASPPKTKTSPKLSNKEL,_T(ph)DDEDFVPS(ph)DAS(ph)PPK_, , , , ,-1.01,-0.9,-0.59,-0.51, , , , ,-0.47,-0.34,0.04,0.04,,,-0.96,-0.55,,,-0.41,0.04,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,146.16,143.37,S1525,AKSVRAKKPIKYLEESDEDDLF_________,_YLEES(ph)DEDDLF_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
P11388,P11388,DNA topoisomerase 2-alpha,TOP2A,125.23,123.16,T1343,MDLDSDEDFSDFDEKTDDEDFVPSDASPPKT,_T(ph)DDEDFVPS(ph)DAS(ph)PPK_, ,-0.23, ,-0.2,-0.06,0.53,0.4,0.58, ,-0.48, ,-0.26,-0.17,0.58,0.33,0.4,-0.23,-0.2,0.26,0.49,-0.48,-0.26,0.25,0.37,,,,,,,0,0,,cytoplasm,ATP binding,apoptotic chromosome condensation,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,117.96,113.74,S1526,PKQKKVVEAVNSDSDSEFGIPKKTTTPKGKG,_VVEAVNS(ph)DS(ph)DS(ph)EFGIPKK_,-0.34,-0.5,-0.39, , ,-1.12, ,0.41,-0.64,-0.18,0.17, , ,-0.42, ,0.26,-0.42,-0.39,-1.12,0.41,-0.39,0.17,-0.42,0.26, +,,,,,,6,0,15.4,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,293.2,290.86,S1344,VKKRNPWSDDESKSESDLEETEPVVIPRDSL,_S(ph)ES(ph)DLEETEPVVIPR_,-0.76,-0.85,-0.97,-1.46,-0.31,-0.24,-0.04,0.03,-0.43,-0.38,-0.69,-0.8,0.04,0.25,0.46,0.2,-0.81,-1.2,-0.27,0,-0.4,-0.74,0.15,0.34, +,,,,,,3,0,18.02,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,150.09,150.09,S1400,DDDDNNDLEELKVKASPITNDGEDEFVPSDG,_VKAS(ph)PITNDGEDEFVPS(ph)DGLDK_,-0.73,-0.86,-0.69,-0.3,-0.2,-0.2,0.04,0.49,-0.29,-0.45,-0.22,0.62,0.18,1.09,0.6,0.51,-0.79,-0.48,-0.2,0.28,-0.37,0.26,0.7,0.55,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,150.09,150.09,S1413,KASPITNDGEDEFVPSDGLDKDEYTFSPGKS,_VKAS(ph)PITNDGEDEFVPS(ph)DGLDK_,-0.75,-0.62,-0.4,-0.3,-0.2,-2.3,-0.45,0.26,-0.37,-0.29,0.74,0.62,0.18,-1.29,-0.11,0.53,-0.68,-0.35,-0.9,-0.05,-0.33,0.69,-0.38,0.24,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,106.38,105.69,S1424,EFVPSDGLDKDEYTFSPGKSKATPEKSLHDK,_DEYTFS(ph)PGK_,-0.67,-0.49,-0.25,-0.09,-0.28,0.08,-0.05,-0.11,-0.5,-0.38,0.36,0.51,0.09,0.48,0.26,0.1,-0.58,-0.17,-0.09,-0.08,-0.44,0.44,0.3,0.18,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,217.65,216.46,S1466,PSYSQKSEDDSAKFDSNEEDSASVFSPSFGL,_FDS(ph)NEEDSASVFSPSFGLK_,-0.63,-0.68,-0.39, ,0.13,-0.35,0.57,0.21,-0.32,-0.24,0.2, ,0.34,0.29,0.92,0.57,-0.66,-0.39,-0.09,0.4,-0.28,0.2,0.31,0.76,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,157.73,157.73,S1581,KTTSKKPKKTSFDQDSDVDIFPSDFPTEPPS,_KTSFDQDS(ph)DVDIFPSDFPTEPPSLPR_,-0.62,-0.65,-0.54,-0.69, , , , ,-0.37,-0.66,-0.03,-0.29, , , , ,-0.64,-0.61,,,-0.5,-0.15,,,,,,,,,NA,NA,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,240.79,240.79,S1522,PKRAPKQKKVVEAVNSDSDSEFGIPKKTTTP,_VVEAVNS(ph)DS(ph)DS(ph)EFGIPKK_,-0.62,-0.68,-0.42,-0.57,-0.11,-0.21,0.22,0.24,-0.3,-0.69,-0.41,-0.46,0.19,0.23,0.47,0.52,-0.65,-0.49,-0.16,0.23,-0.48,-0.44,0.21,0.49,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,240.79,240.79,S1524,RAPKQKKVVEAVNSDSDSEFGIPKKTTTPKG,_VVEAVNS(ph)DS(ph)DS(ph)EFGIPKK_,-0.62,-0.62,-0.39,-0.36,-0.11,-0.16,0.22,0.24,-0.3,-0.19,0.27,0.19,0.19,0.14,0.47,0.52,-0.62,-0.38,-0.13,0.23,-0.25,0.23,0.16,0.49,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q02880-2,Q02880,DNA topoisomerase 2-beta,TOP2B,242.95,237.74,S1342,KKVKKRNPWSDDESKSESDLEETEPVVIPRD,_S(ph)ES(ph)DLEETEPVVIPR_,-0.69,-0.7,-0.57,-1.46,-0.31,-0.24,-0.04,0.03,-0.44,-0.39,-0.07,-0.8,0.04,0.25,0.46,0.2,-0.69,-0.95,-0.27,0,-0.41,-0.39,0.15,0.34,,,,,,,0,0,,cytosol,ATP binding,axonogenesis,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,189.24,187.9,S215,YPRYEATSVQQKVNFSEEGETEEDDQDSSHS,_VNFS(ph)EEGET(ph)EEDDQDSSHSSVTTVK_,0.92,1.03,0.6,0.77,0.25,0.75,0.59,0.69,0.22,0.21,1.52,2.22,0.15,0.95,0.49,0.6,0.98,0.69,0.52,0.64,0.22,1.91,0.61,0.54,, +,,,,,0,4,13.17,integral to membrane,,nuclear membrane organization,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,142.56,142.56,S154,PLQPSPVMTRRGLRDSHSSEEDEASSQTDLS,_GLRDS(ph)HS(ph)S(ph)EEDEASSQTDLSQTISK_,-0.19, , ,0.59,-0.5, ,0.76,0.93,-0.28, , ,0.18,-0.34, ,0.47,0.77,-0.19,0.59,-0.5,0.85,-0.28,0.18,-0.34,0.63,,,,,,,0,0,,integral to membrane,,nuclear membrane organization,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,414.6,394.47,S156,QPSPVMTRRGLRDSHSSEEDEASSQTDLSQT,_GLRDS(ph)HS(ph)S(ph)EEDEASSQTDLSQTISK_,-0.18,-0.24,-0.27,-0.23,-0.3,-0.19,-0.19,-0.19,0.12,-0.13,0,-0.08,-0.12,-0.15,-0.1,-0.11,-0.21,-0.25,-0.24,-0.19,0,-0.04,-0.14,-0.11,,,,,,,0,0,,integral to membrane,,nuclear membrane organization,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,414.6,394.47,S157,PSPVMTRRGLRDSHSSEEDEASSQTDLSQTI,_GLRDS(ph)HS(ph)S(ph)EEDEASSQTDLSQTISK_,-0.08,-0.18,-0.26,-0.22,-0.3,-0.19,-0.19,-0.19,-0.04,-0.13,0.01,-0.05,-0.12,-0.15,-0.1,-0.11,-0.13,-0.24,-0.24,-0.19,-0.08,-0.02,-0.14,-0.11,,,,,,,0,0,,integral to membrane,,nuclear membrane organization,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,86.88,86.02,S227,VNFSEEGETEEDDQDSSHSSVTTVKARSRDS,_VNFSEEGET(ph)EEDDQDS(ph)SHSSVTTVK_, , , , ,0, , , , , , , ,0.12, , , ,,,0,,,,0.12,,,,,,,,NA,NA,,integral to membrane,,nuclear membrane organization,,
Q5JTV8,Q5JTV8,Torsin-1A-interacting protein 1,TOR1AIP1,221.77,218.91,T220,ATSVQQKVNFSEEGETEEDDQDSSHSSVTTV,_VNFS(ph)EEGET(ph)EEDDQDSSHSSVTTVK_,0.12,-0.21,0.18,0.09,0.17,0.4,-0.06,-0.14,0.38,0.45,0.56,0.58,0.18,0.45,0.18,0.29,-0.04,0.14,0.29,-0.1,0.42,0.57,0.32,0.24,,,,,,,0,0,,integral to membrane,,nuclear membrane organization,,
F6TTN0,O94842,TOX high mobility group box family member 4,TOX4,96.79,96.79,S178,LPPAQSPEDRLSTTPSPTSSLHEDGVEDFRR,_LSTT(ph)PS(ph)PTSS(ph)LHEDGVEDFRR_,0.05,0.18,0.01,-0.32,-0.1,0.04,1.05,1.11,-0.11,-0.11,-0.11,-0.07,2.29,1.86,0.46,0.3,0.12,-0.15,-0.03,1.08,-0.11,-0.09,2.09,0.38, +, +,,,,,2,2,3.54,,,,,
F6TTN0,O94842,TOX high mobility group box family member 4,TOX4,96.79,96.79,S182,QSPEDRLSTTPSPTSSLHEDGVEDFRRQLPS,_LSTTPS(ph)PTSS(ph)LHEDGVEDFRR_,-0.19,0.18,0.01,-0.32,-0.1,0.04,1.05,1.11,-0.39,-0.11,-0.11,-0.07,2.29,1.86,0.46,0.3,0.01,-0.15,-0.03,1.08,-0.24,-0.09,2.09,0.38, +, +,,,,,2,2,3.27,,,,,
F6TTN0,O94842,TOX high mobility group box family member 4,TOX4,94.19,94.19,T176,TILPPAQSPEDRLSTTPSPTSSLHEDGVEDF,_LSTT(ph)PS(ph)PTSS(ph)LHEDGVEDFRR_,0.05,0.18,0.17,0.09,-0.1,0.04,1.05,1.11,-0.11,-0.11,-0.04,-0.04,2.29,1.86,0.46,0.3,0.12,0.13,-0.03,1.08,-0.11,-0.04,2.09,0.38, +, +,,,,,2,2,4.15,,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,183.74,183.74,S523,LTGDSCKLMLSTSEYSQSPKMESLSSHRIDE,_LMLSTSEYS(ph)QS(ph)PK_,0.61,0.55,-0.12,0.02,-0.86,-0.98,-0.98,-1.1,-0.15,-0.15,-0.2,0.1,-0.88,-0.83,-0.97,-1.08,0.58,-0.05,-0.92,-1.04,-0.15,-0.04,-0.85,-1.02, +, +,,,,,6,6,33.95,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,183.74,183.74,S525,GDSCKLMLSTSEYSQSPKMESLSSHRIDEDG,_LMLSTSEYS(ph)QS(ph)PK_,-0.27,0.48,0.54,0.02,-0.86,-0.98,-0.98,-1.1,0.24,-0.17,0.13,0.1,-0.88,-0.83,-0.97,-1.08,0.15,0.3,-0.92,-1.04,0.05,0.12,-0.85,-1.02, +, +,,,,,6,6,53.59,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,133.93,113.82,S1618,GPYEAVTPLTKAADISLDNLVEGKRKRRSNV,_AADIS(ph)LDNLVEGK_,1.82,1.53, ,0.88,-0.43,-0.44,-0.42,-0.47,-0.22,-0.09, ,0.05,-0.32,-0.19,-0.61,-0.46,1.68,0.88,-0.44,-0.45,-0.15,0.05,-0.25,-0.53, +,,,,,,5,0,14.73,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,123.03,122.22,S999,KLCLRMKLVSPETEASEESLQFNLEKPATGE,_LVSPETEAS(ph)EES(ph)LQFNLEK_, , , , ,-0.7,-0.58,-1.09,-1.22, , , , ,-0.37,-0.26,-0.8,-0.96,,,-0.64,-1.15,,,-0.32,-0.88, +,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,123.03,122.22,S1002,LRMKLVSPETEASEESLQFNLEKPATGERKN,_LVSPETEAS(ph)EES(ph)LQFNLEK_, , , , ,-0.7,-0.58,-1.09,-1.22, , , , ,-0.37,-0.26,-0.8,-0.96,,,-0.64,-1.15,,,-0.32,-0.88, +,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,222.13,215.11,S1028,GERKNGSTAVAESVASPQKTMSVLSCICEAR,_NGSTAVAESVAS(ph)PQK_,-0.31,-0.29,-0.13,-0.4, ,0.08, , ,0.89,1.08,1.25,1.69, ,1.11, , ,-0.3,-0.26,0.08,,0.99,1.49,1.11,,, +,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,156.05,155.7,S1426,LRETAVPGPLGIEDISPNLSPDDKSFSRVVP,_ETAVPGPLGIEDIS(ph)PNLS(ph)PDDK_,-0.22,-0.18,-0.5, ,-0.56,-0.36,-0.6,-0.7,-0.26,-0.15,-0.32, ,0.4,0.13,-0.53,-0.43,-0.2,-0.5,-0.46,-0.65,-0.2,-0.32,0.27,-0.48,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,156.05,155.7,S1430,AVPGPLGIEDISPNLSPDDKSFSRVVPRVPD,_ETAVPGPLGIEDIS(ph)PNLS(ph)PDDK_,0.01,0.03,0.24, ,-0.41,0.13,-0.14,-0.37,-0.34,-0.29,-0.18, ,-0.47,0.42,0.16,0.23,0.02,0.24,-0.12,-0.25,-0.32,-0.18,0.04,0.2,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,107.72,107.67,S1068,PPTTPIRGNLLHFPSSQGEEEKEKLEGDHTI,_GNLLHFPSS(ph)QGEEEK_,-0.27,-0.28,-0.76,-0.66, ,-0.45,-1,-0.51,-0.03,-0.19,-0.44,-0.3, ,-0.43,-0.38,-0.19,-0.27,-0.71,-0.45,-0.74,-0.11,-0.36,-0.43,-0.28,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,110.09,75.16,S1673,RASMGVLSGKRKLITSEEERSPAKRGRKSAT,_LITS(ph)EEERS(ph)PAK_,0.36,0.51, , ,-0.21,-0.51,-0.82,-0.78,-0.24,-0.21, , ,0.04,0.03,-0.44,-0.45,0.44,,-0.35,-0.8,-0.23,,0.03,-0.45,,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,229.02,229.02,S1678,VLSGKRKLITSEEERSPAKRGRKSATVKPGA,_LITS(ph)EEERS(ph)PAK_,0.12,0.01,-0.12,-0.23,-0.32,0.32,-0.38,-0.38,-0.14,-0.22,-0.39,-0.31,-0.92,-0.31,0.1,-0.49,0.07,-0.17,0.04,-0.38,-0.18,-0.35,-0.58,-0.17,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,180.54,180.54,S1758,DKLASRSKLPDGPTGSSEEEEEFLEIPPFNK,_SKLPDGPTGS(ph)S(ph)EEEEEFLEIPPFNK_, , , , ,-0.63,-0.17,-0.93,-0.67, , , , ,0.03,0.17,-0.52,-0.47,,,-0.38,-0.79,,,0.1,-0.5,,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,180.54,180.54,S1759,KLASRSKLPDGPTGSSEEEEEFLEIPPFNKQ,_LPDGPTGS(ph)S(ph)EEEEEFLEIPPFNK_, , , , ,-0.63,-0.17,-0.93,-0.67, , , , ,0.03,0.17,-0.52,-0.47,,,-0.38,-0.79,,,0.1,-0.5,,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,186.37,185.78,S1114,PVSPASQKMVIQGPSSPQGEAMVTDVLEDQK,_MVIQGPSS(ph)PQGEAMVTDVLEDQK_,0.04,-0.19,-0.08,-0.24,-0.47,-0.36,-0.54,-0.45,0.14,-0.01,-0.02,-0.1,-0.01,-0.05,-0.19,-0.17,-0.07,-0.16,-0.42,-0.5,0.07,-0.06,-0.03,-0.18,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,317.29,317.29,S1094,GDHTIRQSQQPMKPISPVKDPVSPASQKMVI,_QSQQPMKPIS(ph)PVKDPVS(ph)PASQK_,0.2,0.17,0.13,0.23,0.27, , , ,-0.02,-0.03,-0.02,0.22,0.06, , , ,0.18,0.18,0.27,,-0.03,0.11,0.06,,,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,317.29,317.29,S1101,SQQPMKPISPVKDPVSPASQKMVIQGPSSPQ,_QSQQPMKPIS(ph)PVKDPVS(ph)PASQK_,0.18,0.17,0.13,0.23,0.27, , , ,-0.03,-0.03,-0.02,0.22,0.06, , , ,0.18,0.18,0.27,,-0.03,0.11,0.06,,,,,,,,NA,NA,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,126.76,126.03,S580,DSILMNPAQDGEVQLSQNDDKTKGDDTDTRD,_FVPAENDS(ph)ILMNPAQDGEVQLS(ph)QNDDK_,-0.21,-0.29,-0.47,-0.4,-0.57,-0.72, ,-0.73,-0.11,-0.27,-0.32, ,-0.79,-0.28, ,-0.75,-0.25,-0.44,-0.64,-0.73,-0.19,-0.32,-0.51,-0.75,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,275.37,272.79,S552,DEDGENTQIEDTEPMSPVLNSKFVPAENDSI,_IDEDGENTQIEDTEPMS(ph)PVLNSK_,-0.37,-0.26,-0.17,-0.16,-0.38,-0.18,-0.27,-0.32,-0.09,-0.01,0.04,-0.04,0.03,0.15,0,-0.03,-0.31,-0.17,-0.28,-0.3,-0.05,0,0.09,-0.01,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,130.56,130.56,S265,KEQNPPPARSEDMPFSPKASVAAMEAKEQLS,_SEDMPFS(ph)PK_,-0.23,-0.21,0.06,0.09,0,0.11,-0.21,-0.26,-0.17,-0.25,0.26,0.26,0.16,0.19,-0.05,-0.14,-0.22,0.07,0.05,-0.24,-0.21,0.26,0.18,-0.1,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,193.45,193.43,S294,LSAQELMESGLQIQKSPEPEVLSTQEDLFDQ,_S(ph)PEPEVLSTQEDLFDQSNK_,0.15,0.02,0.1,0.33,-0.5,-0.15,-0.24,-0.1,-0.03,-0.01,0.06,-0.06,-0.07,-0.02,0.03,-0.07,0.09,0.22,-0.31,-0.17,-0.02,0,-0.05,-0.02,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,203.23,198.26,S380,PSPDAFRSTPFIVPSSPTEQEGRQDKPMDTS,_STPFIVPSS(ph)PTEQEGR_,-0.1,-0.13,0.14,0.03,0.02,-0.18,-0.15,-0.29,-0.12,-0.2,-0.03,-0.08,0.11,0.14,0.01,-0.14,-0.11,0.09,-0.07,-0.22,-0.16,-0.06,0.13,-0.06,,,,,,,0,0,,nucleus,,,,
A6NNK5,Q12888,Tumor suppressor p53-binding protein 1,TP53BP1,106.67,75.94,S809,IEPCAENRLDTKEEKSVEYEGDLKSGTAETE,_S(ph)VEYEGDLK_,-0.26,-0.14,-0.07,-0.13,-0.5,-0.34,-0.53,-0.47,-0.16,-0.24,-0.06,-0.03,-0.15,0.01,-0.4,-0.43,-0.2,-0.1,-0.42,-0.5,-0.2,-0.05,-0.07,-0.41,,,,,,,0,0,,nucleus,,,,
Q13625-2,Q13625,Apoptosis-stimulating of p53 protein 2,TP53BP2,91.96,82.31,S480,QSNAPPSFGTLRKNQSSEDILRDAQVANKNV,_NQS(ph)SEDILR_, ,-0.45,-1.01,-0.82,1.24, , , , ,-0.65,-0.99,-0.71,3.61, , , ,-0.45,-0.91,1.24,,-0.65,-0.84,3.61,, +, +,,,,,NA,NA,,cytoplasm,SH3/SH2 adaptor activity,apoptotic process,,
Q96S44,Q96S44,TP53-regulating kinase,TP53RK,190.24,188.86,T8,________MAAARATTPADGEEPAPEAEALA,_ATT(ph)PADGEEPAPEAEALAAAR_,0.02,0.32,0.23,0.28,0.15,-0.03, , ,-0.04,0.21,0.29,0.04,0.29,-0.07, , ,0.18,0.25,0.06,,0.09,0.17,0.12,,,,Other,,,,NA,NA,,membrane,ATP binding,lipopolysaccharide biosynthetic process,,
Q13641,Q13641,Trophoblast glycoprotein,TPBG,69.26,69.26,S415,HYRYEINADPRLTNLSSNSDV__________,_LTNLS(ph)S(ph)NSDV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endoplasmic reticulum,,cell adhesion,,
Q13641,Q13641,Trophoblast glycoprotein,TPBG,98.34,97.09,S418,YEINADPRLTNLSSNSDV_____________,_LTNLS(ph)SNS(ph)DV_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,endoplasmic reticulum,,cell adhesion,,
P55327-2,P55327,Tumor protein D52,TPD52,180.93,180.93,S171,SVGSVITKKLEDVKNSPTFKSFEEKVENLKS,_KLEDVKNS(ph)PTFK_, ,0.37,1.53,1.52, , , , , ,0.59,1.77,1.94, , , , ,0.37,1.52,,,0.59,1.86,,, +, +,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,anatomical structure morphogenesis,,
P55327-2,P55327,Tumor protein D52,TPD52,95.07,95.07,S176,ITKKLEDVKNSPTFKSFEEKVENLKSKVGGT,_NSPTFKS(ph)FEEK_, ,0.14,-0.74,-0.87, , , , , ,0.35,0.21,-0.73, , , , ,0.14,-0.81,,,0.35,-0.18,,,,,,,,,NA,NA,,endoplasmic reticulum,calcium ion binding,anatomical structure morphogenesis,,
O43399,O43399,Tumor protein D54,TPD52L2,296.44,261.65,S21,QDINLNSPNKGLLSDSMTDVPVDTGVAARTP,_GLLSDS(ph)MTDVPVDTGVAAR_,-0.22,-0.24,-0.36,-0.4,-0.45,-0.42,-0.49,-0.48,-0.11,-0.09,-0.2,-0.25,-0.47,-0.48,-0.62,-0.65,-0.23,-0.38,-0.43,-0.48,-0.1,-0.22,-0.47,-0.64,,,,,,,0,0,,perinuclear region of cytoplasm,protein homodimerization activity,regulation of cell proliferation,,
O43399,O43399,Tumor protein D54,TPD52L2,57.83,54.07,S3,_____________MDSAGQDINLNSPNKGLL,_(ac)MDS(ph)AGQDINLNS(ph)PNK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,perinuclear region of cytoplasm,protein homodimerization activity,regulation of cell proliferation,,
O43399,O43399,Tumor protein D54,TPD52L2,260.09,260.09,S12,____MDSAGQDINLNSPNKGLLSDSMTDVPV,_(ac)MDS(ph)AGQDINLNS(ph)PNK_,-0.42, ,-0.33,-0.4,-0.18,-0.1,-0.07,-0.15,-0.05, ,0.01,-0.02,-0.01,0.1,-0.09,-0.13,-0.42,-0.36,-0.14,-0.11,-0.05,0,0.05,-0.11,,,,,,,0,0,,perinuclear region of cytoplasm,protein homodimerization activity,regulation of cell proliferation,,
O43399,O43399,Tumor protein D54,TPD52L2,143.21,95.64,S166,ISRKLGDMRNSATFKSFEDRVGTIKSKVVGD,_S(ph)FEDRVGTIK_,0.39,0.22,-0.19,-0.22,0.19,0.24,0.58,0.61,0.66,0.58,0.42,0.23,0.28,0.32,0.32,0.37,0.31,-0.2,0.21,0.59,0.62,0.33,0.3,0.35,,,,,,,0,0,,perinuclear region of cytoplasm,protein homodimerization activity,regulation of cell proliferation,,
P60174-1,P60174,Triosephosphate isomerase,TPI1,128.98,128.98,S58,KFFVGGNWKMNGRKQSLGELIGTLNAAKVPA,_KQS(ph)LGELIGTLNAAK_,0.84,1.14,0.27,0.33, ,0.24, , ,0.17,0.06,0.17,0.1, ,0.41, , ,1,0.3,0.24,,0.12,0.14,0.41,, +,,,,,,NA,NA,,cytosol,triose-phosphate isomerase activity,embryo development,,
P09493-3,P09493-3,Tropomyosin alpha-1 chain,TPM1,78.51,46.76,S252,TRAEFAERSVTKLEKSIDDLEEKVAHAKEEN,_S(ph)IDDLEEK_,-0.64, ,-0.78,-0.66, ,-0.92,-1.56,-1.51,-0.19, ,-0.23,-0.48, ,-0.98,-1.65,-1.31,-0.64,-0.72,-0.92,-1.54,-0.19,-0.35,-0.98,-1.47, +, +,,,,,6,6,32.95,bleb,actin binding,cardiac muscle contraction,+,
P51580,P51580,Thiopurine S-methyltransferase,TPMT,54.46,54.44,T16,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQD,_TSLDIEEYSDT(ph)EVQK_, ,0.18, , , , , , , ,0.15, , , , , , ,0.18,,,,0.15,,,,,,,,,,NA,NA,,cytosol,thiopurine S-methyltransferase activity,nucleobase-containing compound metabolic process,,
P12270,P12270,Nucleoprotein TPR,TPR,75.18,74.03,S2050,QNSGEGNTGAAESSFSQEVSREQQPSSASER,_AADS(ph)QNSGEGNTGAAESSFS(ph)QEVSR_, , , , ,-0.12, , , , , , , ,-1.15, , , ,,,-0.12,,,,-1.15,,, +,,,,,NA,NA,,cytoplasmic dynein complex,ATP binding,carbohydrate metabolic process,,
P12270,P12270,Nucleoprotein TPR,TPR,77.79,77.04,S2034,EESMGGGEGNHRAADSQNSGEGNTGAAESSF,_AADS(ph)QNS(ph)GEGNTGAAESSFSQEVSR_, , , , ,-0.12,-0.15, , , , , , ,-1.15,-0.18, , ,,,-0.13,,,,-0.58,,,,,,,,NA,NA,,cytoplasmic dynein complex,ATP binding,carbohydrate metabolic process,,
P12270,P12270,Nucleoprotein TPR,TPR,77.79,77.04,S2037,MGGGEGNHRAADSQNSGEGNTGAAESSFSQE,_AADS(ph)QNS(ph)GEGNTGAAESSFSQEVSR_, , , , , ,-0.15, , , , , , , ,-0.18, , ,,,-0.15,,,,-0.18,,,,,,,,NA,NA,,cytoplasmic dynein complex,ATP binding,carbohydrate metabolic process,,
P12270,P12270,Nucleoprotein TPR,TPR,145.73,140.67,S1185,VVASVKEGVQGPLNVSLSEEGKSQEQILEIL,_EGVQGPLNVS(ph)LSEEGK_,0.62,0.54,0.08,0.17, ,-0.42,-0.65,-0.4,0.16,0.01,-0.25,0.44, ,-0.5,-0.67,-0.74,0.58,0.13,-0.42,-0.52,0.08,0.13,-0.5,-0.71,,,,,,,0,0,,cytoplasmic dynein complex,ATP binding,carbohydrate metabolic process,,
Q9ULW0,Q9ULW0,Targeting protein for Xklp2,TPX2,142.94,141.85,S738,GLEIKSSDQPLTVPVSPKFSTRFHC______,_SSDQPLTVPVS(ph)PK_,-0.27,-0.27,0.4,0.39,-0.1,-0.4,-0.25,-0.28,-0.11,-0.02,0.56,0.52,0.24,-0.3,-0.41,-0.4,-0.27,0.39,-0.24,-0.27,-0.06,0.54,-0.01,-0.41,,,,,,,0,0,,cytoplasm,ATP binding,activation of protein kinase activity,,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,281.55,281.55,S14,__MSDVEENNFEGRESRSQSKSPTGTPARVK,_(ac)S(ph)DVEENNFEGRES(ph)RS(ph)QS(ph)K_,-0.91,-0.73,-0.52,-0.52,-0.4,-0.35,-0.51,-0.88,-0.79,-0.89,-0.37,-0.51,-0.13,-0.11,-0.15,-0.36,-0.82,-0.52,-0.37,-0.68,-0.84,-0.44,-0.12,-0.25,,,,,,,0,0,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,87.03,87.03,S16,MSDVEENNFEGRESRSQSKSPTGTPARVKSE,_(ac)S(ph)DVEENNFEGRES(ph)RS(ph)QS(ph)K_, , , , ,-0.37,-0.04,-0.34,-0.37, , , , ,0.16,0.24,0.12,0.08,,,-0.19,-0.35,,,0.2,0.1,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,87.03,87.03,S18,DVEENNFEGRESRSQSKSPTGTPARVKSESR,_(ac)S(ph)DVEENNFEGRES(ph)RS(ph)QS(ph)K_, , , , ,-0.37,-0.04,-0.34,-0.37, , , , ,0.16,0.24,0.12,0.08,,,-0.19,-0.35,,,0.2,0.1,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,68.49,39.37,S86,SRSHSHSHRRRSRSRSYTPEYRRRRSRSHSP,_S(ph)RS(ph)YT(ph)PEYR_, , , , , ,-0.33,-0.4,-0.49, , , , , ,-0.2,0.07,0.18,,,-0.33,-0.44,,,-0.2,0.13,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,68.49,39.37,T88,SHSHSHRRRSRSRSYTPEYRRRRSRSHSPMS,_S(ph)YT(ph)PEYR_, , , , , ,-0.33,-0.4,-0.49, , , , , ,-0.2,0.07,0.18,,,-0.33,-0.44,,,-0.2,0.13,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,281.55,281.55,S2,______________MSDVEENNFEGRESRSQ,_(ac)S(ph)DVEENNFEGRES(ph)RS(ph)QS(ph)K_,0.59,0.79,0.14,-0.52,0.23,0.8,-0.51,-0.1,-0.42,-0.16,-0.38,-0.51,0.05,-0.04,-0.15,0.06,0.69,-0.16,0.55,-0.29,-0.29,-0.44,0.01,-0.04,,,,,,,0,0,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog alpha,TRA2A,77.12,77.12,S236,GGGGGGGGGGGRRRDSYYDRGYDRGYDRYED,_RRDS(ph)YYDR_,-0.29,-0.19, , ,0.4,0.78, ,0.24,0,-0.47, , ,0.43,1.05, ,-0.19,-0.24,,0.6,0.24,-0.22,,0.78,-0.19,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
E7EQD1,P62995,Transformer-2 protein homolog beta,TRA2B,89.91,89.91,S95,RSRSRSYSRDYRRRHSHSHSPMSTRRRHVGN,_RHS(ph)HS(ph)HS(ph)PMSTR_, , , , ,-0.25,-0.35, , , , , , ,-0.19,-0.49, , ,,,-0.3,,,,-0.33,,,,,,,,NA,NA,,,,,,
E7EQD1,P62995,Transformer-2 protein homolog beta,TRA2B,89.91,89.91,S97,RSRSYSRDYRRRHSHSHSPMSTRRRHVGNRA,_RHS(ph)HS(ph)HS(ph)PMSTR_, , , , ,-0.25,-0.35, , , , , , ,-0.19,-0.49, , ,,,-0.3,,,,-0.33,,,,,,,,NA,NA,,,,,,
E7EQD1,P62995,Transformer-2 protein homolog beta,TRA2B,89.91,89.91,S99,RSYSRDYRRRHSHSHSPMSTRRRHVGNRANP,_RHS(ph)HS(ph)HS(ph)PMSTR_, , , , ,-0.25,-0.35, , , , , , ,-0.19,-0.49, , ,,,-0.3,,,,-0.33,,,,,,,,NA,NA,,,,,,
E7EQD1,P62995,Transformer-2 protein homolog beta,TRA2B,244.31,244.31,S2,______________MSDSGEQNYGERESRSA,_(ac)S(ph)DSGEQNYGERES(ph)R_,-0.38,-0.5,-0.54,-0.31,-0.37,-0.27,-0.47,-0.39,-0.68,-0.37,-0.32,-0.19,-0.12,-0.18,-0.16,-0.15,-0.44,-0.42,-0.32,-0.43,-0.51,-0.25,-0.15,-0.16,,,,,,,0,0,,,,,,
E7EQD1,P62995,Transformer-2 protein homolog beta,TRA2B,254.82,254.82,S14,__MSDSGEQNYGERESRSASRSGSAHGSGKS,_(ac)SDSGEQNYGERES(ph)R_,-0.38,-0.12,-0.41,-0.28,-0.16,-0.19,-0.19,-0.38,-0.68,-0.72,-0.86,-0.58,-0.21,-0.45,0.09,-0.24,-0.25,-0.34,-0.18,-0.29,-0.7,-0.71,-0.33,-0.06,,,,,,,0,0,,,,,,
Q13595,P62995,Transformer-2 protein homolog beta,TRA2B,197.73,192.97,S264,GWRAAQDRDQIYRRRSPSPYYSRGGYRSRSR,_RS(ph)PS(ph)PYYSR_,-0.32,-0.27,-0.29,-0.24,-0.22,-0.21,-0.23,-0.24,-0.49,-0.39,-0.41,-0.39,-0.14,-0.12,-0.12,-0.15,-0.3,-0.27,-0.22,-0.24,-0.44,-0.4,-0.13,-0.14,,,,,,,0,0,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,Q13595,Transformer-2 protein homolog beta,TRA2B,197.73,192.97,S262,DRYEDYDYRYRRRSPSPYYSRYRSRSRSRSY,_RRS(ph)PS(ph)PYYSR_,-0.32,-0.27,-0.29,-0.24,-0.21,-0.24,-0.22,-0.27,-0.49,-0.39,-0.41,-0.39,-0.15,-0.12,-0.13,-0.16,-0.3,-0.27,-0.22,-0.24,-0.44,-0.4,-0.13,-0.14,,,,,,,0,0,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q13595,P62995,Transformer-2 protein homolog beta,TRA2B,164.3,164.3,S270,DRDQIYRRRSPSPYYSRGGYRSRSRSRSYSP,_RRS(ph)PSPYYS(ph)R_,-0.34, , , ,-0.23,-0.17,-0.25,-0.04,-0.43, , , ,-0.13,-0.08,-0.07,-0.15,-0.34,,-0.2,-0.14,-0.43,,-0.11,-0.11,,,,,,,NA,NA,,nucleus,nucleotide binding,"mRNA splicing, via spliceosome",,
Q8TDR0-2,Q8TDR0,TRAF3-interacting protein 1,TRAF3IP1,109.36,109.36,S476,PGSARPAPPRVKRQDSMEALQMDRSGSGKTV,_RQDS(ph)MEALQMDR_,0.11,0.12,0.29,0.24,0.25,0.39, , ,-0.09,0.2,0.11,0.12,-0.66,0.58, , ,0.12,0.26,0.32,,0.06,0.11,0.09,,,,,,,,NA,NA,,cytoplasm,,,,
Q6Q0C0,Q6Q0C0,E3 ubiquitin-protein ligase TRAF7,TRAF7,61.96,58.25,S61,KADGTSTYKQHCRTPSSSSTLAYSPRDEEDS,_TPS(ph)SS(ph)STLAYSPR_, , , , , , , ,0.76, , , , , , , ,0.78,,,,0.76,,,,0.78,,,,RING finger,,,NA,NA,,cytoplasmic membrane-bounded vesicle,ubiquitin-protein ligase activity,activation of MAPKKK activity,,
O14545,O14545,TRAF-type zinc finger domain-containing protein 1,TRAFD1,52.11,51.97,Y433,LPRRRVRHQGDLSSGYLDDTKQETANGPTSC,_HQGDLSSGY(ph)LDDTK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,metal ion binding,negative regulation of innate immune response,,
O14545,O14545,TRAF-type zinc finger domain-containing protein 1,TRAFD1,85.97,84.95,S409,ATATNHVTEGIPRLDSQPQETSPELPRRRVR,_LDS(ph)QPQETS(ph)PELPR_, , , , ,0.16,-0.57,-0.53,-0.27, , , , ,0.27,-0.1,-0.28,-0.09,,,-0.16,-0.39,,,0.1,-0.18,,,,,,,NA,NA,,,metal ion binding,negative regulation of innate immune response,,
O14545,O14545,TRAF-type zinc finger domain-containing protein 1,TRAFD1,210.43,209.24,S415,VTEGIPRLDSQPQETSPELPRRRVRHQGDLS,_LDSQPQETS(ph)PELPR_,-0.34,-0.33,-0.55,-0.6,-0.12,-0.18,-0.06,-0.25,0.86,0.34,0.57,0.21,-0.21,-0.37,-0.15,-0.45,-0.33,-0.58,-0.15,-0.15,0.62,0.4,-0.29,-0.29,,,,,,,0,0,,,metal ion binding,negative regulation of innate immune response,,
O14545,O14545,TRAF-type zinc finger domain-containing protein 1,TRAFD1,228.76,224.56,S326,SCNPSRALPSLNTGSSSPRGVEEPDVIFQNF,_ALPSLNTGSS(ph)SPR_, , ,-0.4, , ,0.17, ,0.1, , ,0.03, , ,-0.06, ,-0.07,,-0.4,0.17,0.1,,0.03,-0.06,-0.07,,,,,,,NA,NA,,,metal ion binding,negative regulation of innate immune response,,
O14545,O14545,TRAF-type zinc finger domain-containing protein 1,TRAFD1,239.58,235.39,S327,CNPSRALPSLNTGSSSPRGVEEPDVIFQNFL,_ALPSLNTGSSS(ph)PR_,-0.32,-0.35,-0.42,-0.4,0.1,0.14,0.09,0.04,-0.09,0.03,0.07,0,0.01,-0.11,-0.04,-0.09,-0.33,-0.41,0.12,0.06,-0.03,0.04,-0.05,-0.06,,,,,,,0,0,,,metal ion binding,negative regulation of innate immune response,,
G3XAN4,Q15629,Translocating chain-associated membrane protein 1,TRAM1,201.31,195.34,S365,TENGVNGTLTSNVADSPRNKKEKSS______,_KGTENGVNGTLTSNVADS(ph)PR_,0.17,0.25,-0.31,-0.24,-0.52,-0.44,-0.15,-0.33,0.21,0.28,0.02,-0.05,-0.58,-0.39,-0.29,-0.45,0.21,-0.27,-0.48,-0.24,0.24,-0.01,-0.48,-0.37,,,,,,,0,0,,integral to membrane,,,,
E7ENL7,Q8WVT3,Trafficking protein particle complex subunit 12,TRAPPC12,82.94,80.81,S182,APPASGDGFEPQMVKSPSFGGASEASARTPP,_S(ph)PSFGGASEASAR_, , , , ,1.45, , , , , , , ,2, , , ,,,1.45,,,,2,, +, +,,,,,NA,NA,,,,,,
Q96PN7-2,Q96PN7,Transcriptional-regulating factor 1,TRERF1,123.16,121.89,S758,TPLTPTPRVLLCRSNSIDGSNVTVTPGPGEQ,_SNS(ph)IDGSNVTVT(ph)PGPGEQTVDVEPR_, , , , ,0.82, ,0.93, , , , , ,0.66, ,0.82, ,,,0.82,0.93,,,0.66,0.82,,,,,,,NA,NA,,nucleus,chromatin binding,cholesterol catabolic process,,
Q96PN7-2,Q96PN7,Transcriptional-regulating factor 1,TRERF1,123.16,121.89,T767,LLCRSNSIDGSNVTVTPGPGEQTVDVEPRIN,_SNS(ph)IDGSNVTVT(ph)PGPGEQTVDVEPR_, , , , ,0.82, ,0.95, , , , , ,0.66, ,0.75, ,,,0.82,0.95,,,0.66,0.75,,,,,,,NA,NA,,nucleus,chromatin binding,cholesterol catabolic process,,
O95361,O95361,Tripartite motif-containing protein 16,TRIM16,101.77,101.69,S24,PGPLPRATAQPPAPLSPDSGSPSPDSGSASP,_ATAQPPAPLS(ph)PDSGSPSPDSGSASPVEEEDVGSSEK_, , , , ,0.27,0.88,0.68,0.96, , , , ,0.56,0.87,0.92,0.96,,,0.61,0.83,,,0.72,0.94,,,,,,,NA,NA,,cytoplasm,DNA binding,histone H3 acetylation,,
O95361,O95361,Tripartite motif-containing protein 16,TRIM16,66.28,66.06,S38,LSPDSGSPSPDSGSASPVEEEDVGSSEKLGR,_ATAQPPAPLS(ph)PDSGSPSPDS(ph)GSAS(ph)PVEEEDVGSSEK_, , , , ,-0.28, , ,-0.27, , , , ,-0.13, , ,-0.33,,,-0.28,-0.27,,,-0.13,-0.33,,,,,,,NA,NA,,cytoplasm,DNA binding,histone H3 acetylation,,
O95361,O95361,Tripartite motif-containing protein 16,TRIM16,228.47,201.24,S60,VGSSEKLGRETEEQDSDSAEQGDPAGEGKEV,_LGRETEEQDS(ph)DSAEQGDPAGEGK_,-0.62,-0.4,-0.57,-0.46, , , ,-0.16,-0.35,-0.38,-0.43,-0.24, , , ,-0.38,-0.5,-0.51,,-0.16,-0.36,-0.33,,-0.38,,,,,,,NA,NA,,cytoplasm,DNA binding,histone H3 acetylation,,
O95361,O95361,Tripartite motif-containing protein 16,TRIM16,72.34,72.17,T55,VEEEDVGSSEKLGRETEEQDSDSAEQGDPAG,_ET(ph)EEQDSDSAEQGDPAGEGK_, , , , , , ,0.3,-0.26, , , , , , ,0.06,-0.17,,,,0.05,,,,-0.05,,,,,,,NA,NA,,cytoplasm,DNA binding,histone H3 acetylation,,
B4DYZ9,O15164,Transcription intermediary factor 1-alpha,TRIM24,78.86,75.84,S811,NSSNGKSEWLDPSQKSPLHVGETRKEDDPNE,_S(ph)PLHVGETR_,-0.09,0,-0.22, , , , , ,-0.05,-0.21,0.25, , , , , ,-0.04,-0.22,,,-0.13,0.25,,,,,,RING finger,,,NA,NA,,cytoplasm,chromatin binding,calcium ion homeostasis,,
B4DYZ9,O15164,Transcription intermediary factor 1-alpha,TRIM24,161.46,161.46,S1019,LYPEKRFPKPEFRNESEDNKFSDDSDDDFVQ,_NES(ph)EDNKFS(ph)DDS(ph)DDDFVQPR_, , , , ,0.01,0.11,0.08,0.08, , , , ,0.01,-0.04,-0.12,-0.22,,,0.06,0.08,,,-0.02,-0.17,,,,RING finger,,,NA,NA,,cytoplasm,chromatin binding,calcium ion homeostasis,,
B4DYZ9,O15164,Transcription intermediary factor 1-alpha,TRIM24,289.76,289.76,S1025,FPKPEFRNESEDNKFSDDSDDDFVQPRKKRL,_NES(ph)EDNKFS(ph)DDS(ph)DDDFVQPR_,-0.25,-0.14,-0.19,-0.18,-0.08,0.06,-0.1,-0.02,-0.29,-0.1,-0.06,-0.18,-0.06,-0.15,-0.3,-0.14,-0.2,-0.18,-0.01,-0.06,-0.19,-0.12,-0.1,-0.22,,,,RING finger,,,0,0,,cytoplasm,chromatin binding,calcium ion homeostasis,,
B4DYZ9,O15164,Transcription intermediary factor 1-alpha,TRIM24,289.76,289.76,S1028,PEFRNESEDNKFSDDSDDDFVQPRKKRLKSI,_NES(ph)EDNKFS(ph)DDS(ph)DDDFVQPR_,-0.25,-0.14,-0.19,-0.18,-0.08,0.06,-0.1,-0.02,-0.29,-0.1,-0.06,-0.18,-0.06,-0.15,-0.3,-0.14,-0.2,-0.18,-0.01,-0.06,-0.19,-0.12,-0.1,-0.22,,,,RING finger,,,0,0,,cytoplasm,chromatin binding,calcium ion homeostasis,,
Q13263,Q13263,Transcription intermediary factor 1-beta,TRIM28,241.56,206.81,S473,YSSAEPHVSGVKRSRSGEGEVSGLMRKVPRV,_S(ph)GEGEVSGLMR_,-0.16,-0.14,0.32,0.11,1.44,1.53,1.08,1.13,-0.12,0.08,0.69,0.27,1.46,1.5,0.97,1.02,-0.15,0.22,1.48,1.11,-0.01,0.49,1.48,0.99, +, +,,RING finger,,,2,2,38.05,nuclear euchromatin,DNA binding,convergent extension involved in axis elongation,+,
Q13263,Q13263,Transcription intermediary factor 1-beta,TRIM28,354.08,354.08,S19,SAAAASAAAASAASGSPGPGEGSAGGEKRST,_(ac)AASAAAASAAAASAASGS(ph)PGPGEGSAGGEK_,-0.13,-0.13,-0.24,-0.2,-0.16,-0.27,-0.2,-0.2,0.12,0.15,0.07,0.12,0.03,-0.1,-0.26,-0.18,-0.13,-0.22,-0.21,-0.2,0.13,0.09,-0.03,-0.22,,,,RING finger,,,0,0,,nuclear euchromatin,DNA binding,convergent extension involved in axis elongation,+,
Q13263,Q13263,Transcription intermediary factor 1-beta,TRIM28,98.44,95.16,S26,AAASAASGSPGPGEGSAGGEKRSTAPSAAAS,_(ac)AASAAAASAAAASAASGS(ph)PGPGEGS(ph)AGGEK_, , , , , ,0, , , , , , , ,0.27, , ,,,0,,,,0.27,,,,,RING finger,,,NA,NA,,nuclear euchromatin,DNA binding,convergent extension involved in axis elongation,+,
Q13263,Q13263,Transcription intermediary factor 1-beta,TRIM28,137.9,129.11,S681,CSLCHVLPDLKEEDGSLSLDGADSTGVVAKL,_EEDGS(ph)LS(ph)LDGADSTGVVAK_, , , , ,0.37,0.28,-0.13,0, , , , ,0.4,-0.03,0.1,-1.05,,,0.32,-0.07,,,0.2,-0.36,,,,RING finger,,,NA,NA,,nuclear euchromatin,DNA binding,convergent extension involved in axis elongation,+,
Q13263,Q13263,Transcription intermediary factor 1-beta,TRIM28,137.9,129.11,S683,LCHVLPDLKEEDGSLSLDGADSTGVVAKLSP,_EEDGS(ph)LS(ph)LDGADSTGVVAK_, , , , ,0.37,0.28,-0.13,0, , , , ,0.4,-0.03,0.1,-1.05,,,0.32,-0.07,,,0.2,-0.36,,,,RING finger,,,NA,NA,,nuclear euchromatin,DNA binding,convergent extension involved in axis elongation,+,
E9PMW5,O75382,Tripartite motif-containing protein 3,TRIM3,97.46,96.16,S7,_________MAKREDSPGPEVQPMDKQFLVC,_REDS(ph)PGPEVQPMDK_,-0.35,-0.26,-0.53, ,-0.43,-0.24,0.08,-0.34,0.11,0.28,0.08, ,-0.22,-0.16,0.28,-0.55,-0.31,-0.53,-0.33,-0.12,0.2,0.08,-0.19,-0.07,,,,RING finger,,,0,0,,cytoplasm,zinc ion binding,,,
Q13049,Q13049,E3 ubiquitin-protein ligase TRIM32,TRIM32,91.56,90.56,S335,VTFREMDMSPEEVVASPRASPAKQRGPEAAS,_EMDMSPEEVVAS(ph)PRAS(ph)PAK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,RING finger,,,NA,NA,,cytoplasm,myosin binding,fat cell differentiation,,
Q13049,Q13049,E3 ubiquitin-protein ligase TRIM32,TRIM32,91.56,90.56,S339,EMDMSPEEVVASPRASPAKQRGPEAASNIQQ,_EMDMSPEEVVAS(ph)PRAS(ph)PAK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,RING finger,,,NA,NA,,cytoplasm,myosin binding,fat cell differentiation,,
H0Y612,Q9UPN9,E3 ubiquitin-protein ligase TRIM33,TRIM33,110.32,106.62,S1105,PEFEQEEDDGEVTEDSDEDFIQPRRKRLKSD,_TFAPLPEFEQEEDDGEVT(ph)EDS(ph)DEDFIQPR_, , , , ,0.11,-0.03,0.33,0.06, , , , ,0.02,0.64,0.2,0.12,,,0.04,0.2,,,0.37,0.16,,,,RING finger,,,NA,NA,,nucleus,zinc ion binding,,,
H0Y612,Q9UPN9,E3 ubiquitin-protein ligase TRIM33,TRIM33,110.32,106.62,T1102,APLPEFEQEEDDGEVTEDSDEDFIQPRRKRL,_TFAPLPEFEQEEDDGEVT(ph)EDS(ph)DEDFIQPR_, , , , ,0.11,-0.03,0.33,0.06, , , , ,0.02,0.64,0.2,0.12,,,0.04,0.2,,,0.37,0.16,,,,RING finger,,,NA,NA,,nucleus,zinc ion binding,,,
Q96LD4,Q96LD4,Tripartite motif-containing protein 47,TRIM47,52.45,41.08,S588,RRLKASRPRRGGIPASPIDPFQSRLDSHFAG,_RGGIPAS(ph)PIDPFQSR_, , , , , ,0.49, , , , , , , ,0.51, , ,,,0.49,,,,0.51,,,,,RING finger,,,NA,NA,,cytoplasm,zinc ion binding,,,
Q9BRZ2,Q9BRZ2,E3 ubiquitin-protein ligase TRIM56,TRIM56,88.35,88.07,S469,GGRPNKKKKFKGRLKSISREPSPALGPNLDG,_S(ph)IS(ph)REPS(ph)PALGPNLDGSGLLPR_, , , , ,0.01, , ,-0.21, , , , ,0.13, , ,-0.37,,,0.01,-0.21,,,0.13,-0.37,,,,RING finger,,,NA,NA,,cytoplasm,ubiquitin-protein ligase activity,defense response to virus,,
Q9BRZ2,Q9BRZ2,E3 ubiquitin-protein ligase TRIM56,TRIM56,88.35,88.07,S471,RPNKKKKFKGRLKSISREPSPALGPNLDGSG,_S(ph)IS(ph)REPS(ph)PALGPNLDGSGLLPR_, , , , ,0.01, , ,-0.21, , , , ,0.13, , ,-0.37,,,0.01,-0.21,,,0.13,-0.37,,,,RING finger,,,NA,NA,,cytoplasm,ubiquitin-protein ligase activity,defense response to virus,,
Q9BRZ2,Q9BRZ2,E3 ubiquitin-protein ligase TRIM56,TRIM56,88.35,88.07,S475,KKKFKGRLKSISREPSPALGPNLDGSGLLPR,_S(ph)IS(ph)REPS(ph)PALGPNLDGSGLLPR_, , , , ,0.01, , ,-0.21, , , , ,0.13, , ,-0.37,,,0.01,-0.21,,,0.13,-0.37,,,,RING finger,,,NA,NA,,cytoplasm,ubiquitin-protein ligase activity,defense response to virus,,
O75962-4,O75962,Triple functional domain protein,TRIO,215.2,205.06,S2455,SLGTLPLGKPRAGAASPLNSPLSSAVPSLGK,_AGAAS(ph)PLNS(ph)PLSSAVPSLGK_, ,0.85,2.1,1.66,1.27,1.34,1.18,1.07, ,0.44,2.16,2.13,1.51,1.37,1.62,1.43,0.85,1.9,1.31,1.13,0.44,2.15,1.44,1.52, +, +,CAMK,,,,4,1,26.7,cytosol,ATP binding,apoptotic signaling pathway,,
O75962-4,O75962,Triple functional domain protein,TRIO,215.2,205.06,S2459,LPLGKPRAGAASPLNSPLSSAVPSLGKEPFP,_AGAAS(ph)PLNS(ph)PLSSAVPSLGK_, ,0.85,2.1,1.66,1.27,1.34,1.18,1.07, ,0.44,2.16,2.13,1.51,1.37,1.62,1.43,0.85,1.9,1.31,1.13,0.44,2.15,1.44,1.52, +, +,CAMK,,,,4,1,26.7,cytosol,ATP binding,apoptotic signaling pathway,,
O75962-4,O75962,Triple functional domain protein,TRIO,44.31,43.17,S1627,PATRQKGRRDGEDLDSQGDGSSQPDTISIAS,_DGEDLDS(ph)QGDGS(ph)SQPDTISIASR_, , , , , , , ,-0.37, , , , , , , ,-0.66,,,,-0.37,,,,-0.66,,,CAMK,,,,NA,NA,,cytosol,ATP binding,apoptotic signaling pathway,,
O75962-4,O75962,Triple functional domain protein,TRIO,98.58,98.58,S1724,GLVPCGSLCIAHSRSSMEMEGIFNHKDSLSV,_SS(ph)MEMEGIFNHK_,-0.34,-0.55,-0.78,-0.6, , , ,-0.11,-0.04,0.06,-0.24,0.02, , , ,0,-0.44,-0.69,,-0.11,0.01,-0.11,,0,,,CAMK,,,,NA,NA,,cytosol,ATP binding,apoptotic signaling pathway,,
Q15642-5,Q15642,Cdc42-interacting protein 4,TRIP10,177.36,177.36,S296,DVEFEDFSQPMNRAPSDSSLGTPSDGRPELR,_APS(ph)DSS(ph)LGTPSDGRPELR_,-0.52,-0.44,-0.49,-0.54,-0.83,-0.36,-0.51,0.03,-0.71,-0.63,-0.51,-0.5,-0.26,-0.49,-0.65,-0.42,-0.48,-0.52,-0.58,-0.21,-0.67,-0.51,-0.37,-0.53,,,,,,,0,0,,cell cortex,lipid binding,actin cytoskeleton organization,,
Q15642-5,Q15642,Cdc42-interacting protein 4,TRIP10,177.36,177.36,S299,FEDFSQPMNRAPSDSSLGTPSDGRPELRGPG,_APS(ph)DSS(ph)LGTPSDGRPELR_,0.2,0.22,0.06,0.15,0.69,0.64,0.56,0.49,0.11,0.16,0.22,0.27,0.74,0.68,0.54,0.52,0.21,0.11,0.66,0.53,0.14,0.24,0.71,0.53,,,,,,,0,0,,cell cortex,lipid binding,actin cytoskeleton organization,,
Q15643,Q15643,Thyroid receptor-interacting protein 11,TRIP11,107.75,96.91,S464,NNEYEVIKSTATRDISLDSELHDLRLNLEAK,_DIS(ph)LDSELHDLR_, , , ,-0.26, , , , , , , ,-0.09, , , , ,,-0.26,,,,-0.09,,,,,,,,,NA,NA,,cytoskeleton,transcription coactivator activity,protein targeting to Golgi,,
Q9UI30,Q9UI30,tRNA methyltransferase 112 homolog,TRMT112,110.84,108.09,S119,GRMFPISRGIPNMLLSEEETES_________,_GIPNMLLS(ph)EEETES_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein complex,protein methyltransferase activity,peptidyl-glutamine methylation,,
Q9UI30,Q9UI30,tRNA methyltransferase 112 homolog,TRMT112,175.62,175.62,S125,SRGIPNMLLSEEETES_______________,_GIPNMLLSEEETES(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,protein complex,protein methyltransferase activity,peptidyl-glutamine methylation,,
Q8IZ69,Q8IZ69,tRNA (uracil-5-)-methyltransferase homolog A,TRMT2A,54.86,47.92,S602,ERVEHPNGTGVLGPHSPPAQPTPGPPDNTLQ,_VEHPNGTGVLGPHS(ph)PPAQPTPGPPDNTLQETGTFPSS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,nucleotide binding,RNA methylation,,
Q5LJ98,P10155,60 kDa SS-A/Ro ribonucleoprotein,TROVE2,85.65,84.33,S19,SVNQMQPLNEKQIANSQDGYVWQVTDMNRLH,_QIANS(ph)QDGYVWQVTDMNR_,-0.05,-0.16, ,-0.52, , , , ,0.06,-0.03, ,-0.2, , , , ,-0.11,-0.52,,,0.02,-0.2,,,,,,,,,NA,NA,,,,,,
H0YAV4,Q9UHF7,Zinc finger transcription factor Trps1,TRPS1,157.27,145.2,S1081,SPIEKYMRPAKHPNYSPPGSPIEKYQYPLFG,_HPNYS(ph)PPGS(ph)PIEK_, , ,0.53, ,0.81,0.76,0.87,0.75, , ,3.06, ,0.39,0.42,0.51,0.42,,0.53,0.78,0.81,,3.06,0.4,0.47,, +,,,,,NA,NA,,,sequence-specific DNA binding,,,
H0YAV4,Q9UHF7,Zinc finger transcription factor Trps1,TRPS1,157.27,145.2,S1085,KYMRPAKHPNYSPPGSPIEKYQYPLFGLPFV,_HPNYS(ph)PPGS(ph)PIEK_, , ,0.53, ,0.81,0.76,0.87,0.75, , ,3.06, ,0.39,0.42,0.51,0.42,,0.53,0.78,0.81,,3.06,0.4,0.47,, +,,,,,NA,NA,,,sequence-specific DNA binding,,,
E7ESJ2,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,68.13,24.45,Y814,EASARDRQSAQPEEVYLRQFSGSLKPEDAEV,_QSAQPEEVY(ph)LR_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to membrane,ion channel activity,,,
B7Z897,Q92574,Hamartin,TSC1,100.09,92.87,S505,TTAEAEPVVPRGGFDSPFYRDSLPGSQRKTH,_GGFDS(ph)PFYR_, , , , ,-0.08,0.03,-0.49,-0.04, , , , ,-0.42,0.01,0.49,-0.27,,,-0.02,-0.24,,,-0.19,0.16,,,,,,,NA,NA,,,,,,
P49815-6,P49815,Tuberin,TSC2,86.8,86.8,S1411,DILGDPGDKADVGRLSPEVKARSQSGTLDGE,_ADVGRLS(ph)PEVK_,0.42,-0.06,0.08,-0.18,-0.39,0.65,-0.03, ,0.1,0.11,-0.07,0.13,-0.24,0.83,0.13, ,0.2,-0.04,0.22,-0.03,0.11,0.03,0.39,0.13,,,,,,,0,0,,caveola,GTPase activator activity,acute-phase response,,
Q9Y3Q8,Q9Y3Q8,TSC22 domain family protein 4,TSC22D4,100.18,98.3,S279,SPALYFTHDASLVHKSPDPFGAVAAQKFSLA,_S(ph)PDPFGAVAAQK_, , , ,0.6,1.99,2.29,2.06,1.52, , , ,1.03,1.86,2.08,2.13,1.8,,0.6,2.14,1.82,,1.03,1.97,1.97, +, +,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,"negative regulation of transcription, DNA-dependent",,
Q9Y3Q8,Q9Y3Q8,TSC22 domain family protein 4,TSC22D4,103.73,30.94,S225,ATPLPSLRVEAEAGGSGARTPPLSRRKAVDM,_VEAEAGGS(ph)GARTPPLSR_,-0.15,1.19,-0.11,-0.32, ,0,-0.1,-0.52,-0.26,0.07,-0.4,-0.44, ,-0.05,-0.41,-0.14,0.67,-0.22,0,-0.29,-0.09,-0.42,-0.05,-0.27,,,,,,,0,0,,cytoplasm,sequence-specific DNA binding transcription factor activity,"negative regulation of transcription, DNA-dependent",,
Q9Y3Q8,Q9Y3Q8,TSC22 domain family protein 4,TSC22D4,153.76,153.76,T229,PSLRVEAEAGGSGARTPPLSRRKAVDMRLRM,_VEAEAGGSGART(ph)PPLSR_,-0.1,-0.24,-0.45,0.47,-0.33,-0.24, , ,-0.25,-0.23,-0.54,-0.49,-0.08,-0.13, , ,-0.17,0.08,-0.28,,-0.24,-0.51,-0.11,,,,,,,,NA,NA,,cytoplasm,sequence-specific DNA binding transcription factor activity,"negative regulation of transcription, DNA-dependent",,
Q99598,Q99598,Translin-associated protein X,TSNAX,124.78,97.01,S33,FPHNQRREGKDVNSSSPVMLAFKSFQQELDA,_DVNSSS(ph)PVMLAFK_,0.08,0.22,0.06,-0.11, ,0.05,0.14,-0.17,0.24,0.01,-0.05,-0.45, ,-1.35,-0.66,-0.72,0.15,-0.02,0.05,0,0.13,-0.24,-1.35,-0.69,, +,,,,,0,6,1.17,Golgi apparatus,DNA binding,cell differentiation,,
Q6PID6,Q6PID6,Tetratricopeptide repeat protein 33,TTC33,38.18,38.18,S197,QRIKKSEAPAEVTHFSPKSIPDYDFESDEIV,_KSEAPAEVTHFS(ph)PK_, , , ,0.39, , , , , , , ,0.22, , , , ,,0.39,,,,0.22,,,,,,,,,NA,NA,,,,,,
Q9ULT0,Q9ULT0,Tetratricopeptide repeat protein 7A,TTC7A,107.88,97.44,S697,ASRLEEAMSELTMPSSVLKQGPMQLWTTLEQ,_LEEAMS(ph)ELT(ph)MPSS(ph)VLK_, , , , , ,-0.51,-0.11,0.3, , , , , ,-1.5,-0.17,0.25,,,-0.51,0.11,,,-1.5,0.06,, +,,,,,NA,NA,,,,cellular iron ion homeostasis,,
Q9ULT0,Q9ULT0,Tetratricopeptide repeat protein 7A,TTC7A,83.06,82.57,S51,LQTLSMPGGGGNRRGSPSAAFTFPDTDDFGK,_RGS(ph)PSAAFTFPDTDDFGK_,-0.43,-0.49,-1.17,-0.7,-0.52,-0.71, , ,0.15,0,-0.2,-0.15,-0.1,-1.34, , ,-0.46,-0.91,-0.61,,0.08,-0.17,-0.59,,,,,,,,NA,NA,,,,cellular iron ion homeostasis,,
Q9ULT0,Q9ULT0,Tetratricopeptide repeat protein 7A,TTC7A,130.78,119.07,S647,TLYSFSQLGGLEKDGSFGEGLTMKKQSGMHL,_DGS(ph)FGEGLTMK_,-0.03,-0.07,-0.29,-0.25,0.03,0.04,-0.18,-0.21,0.08,0.15,-0.08,-0.06,-0.1,0.17,-0.08,-0.15,-0.05,-0.27,0.03,-0.19,0.11,-0.07,0.04,-0.11,,,,,,,0,0,,,,cellular iron ion homeostasis,,
Q9ULT0,Q9ULT0,Tetratricopeptide repeat protein 7A,TTC7A,179.19,176.38,S690,RRASSIAASRLEEAMSELTMPSSVLKQGPMQ,_LEEAMS(ph)ELT(ph)MPSS(ph)VLK_, , , , ,-0.25,-0.51,0.14,0.5, , , , ,-0.3,-1.5,0.28,0.32,,,-0.37,0.34,,,-0.78,0.3,,,,,,,NA,NA,,,,cellular iron ion homeostasis,,
Q9ULT0,Q9ULT0,Tetratricopeptide repeat protein 7A,TTC7A,179.19,176.38,T693,SSIAASRLEEAMSELTMPSSVLKQGPMQLWT,_LEEAMS(ph)ELT(ph)MPSS(ph)VLK_, , , , ,-0.25,-0.51,0.14,0.5, , , , ,-0.3,-1.5,0.28,0.32,,,-0.37,0.34,,,-0.78,0.3,,,,,,,NA,NA,,,,cellular iron ion homeostasis,,
F8WDV8,Q15361,Transcription termination factor 1,TTF1,188.15,185.59,S478,EHNVETAEDSEIRYLSADSGDADDSDADLGS,_YLS(ph)ADS(ph)GDADDS(ph)DADLGSAVK_, , , , , ,0.15,0.35,-0.69, , , , , ,-0.45,-0.46,-0.1,,,0.15,-0.07,,,-0.45,-0.27,,,,,,,NA,NA,,,,,,
F8WDV8,Q15361,Transcription termination factor 1,TTF1,188.15,185.59,S481,VETAEDSEIRYLSADSGDADDSDADLGSAVK,_YLS(ph)ADS(ph)GDADDS(ph)DADLGSAVK_, , , , , ,0.15,0.35,-0.69, , , , , ,-0.45,-0.46,-0.1,,,0.15,-0.07,,,-0.45,-0.27,,,,,,,NA,NA,,,,,,
F8WDV8,Q15361,Transcription termination factor 1,TTF1,188.15,185.59,S487,SEIRYLSADSGDADDSDADLGSAVKQLQEFI,_YLS(ph)ADS(ph)GDADDS(ph)DADLGSAVK_, , , , , ,-0.13,-0.76,-0.69, , , , , ,0.28,-0.4,-0.1,,,-0.13,-0.72,,,0.28,-0.25,,,,,,,NA,NA,,,,,,
A6NKB1,Q8WZ42,Titin,TTN,89.51,27.22,S9559,QEEETHRLEIEEIERSERDEKEFEELVSFIQ,_LEIEEIERS(ph)ER_, ,-6.25,-4.94,-5.2, , , , , ,-7.66,-7.58,-7.01, , , , ,-6.25,-5.06,,,-7.66,-7.27,,, +, +,CAMK,,,,NA,NA,,,,,,
Q9BQE3,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,195.02,187.51,S439,DMAALEKDYEEVGADSADGEDEGEEY_____,_DYEEVGADS(ph)ADGEDEGEEY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasmic microtubule,GTP binding,de novo' posttranslational protein folding,,
A8MUB1,P68366,Tubulin alpha-4A chain,TUBA4A,59.42,58.89,Y440,MAALEKDYEEVGIDSYEDEDEGEE_______,_DYEEVGIDSY(ph)EDEDEGEE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasm,GTP binding,microtubule-based process,,
F8WA97,Q9H6E5,Speckle targeted PIP5K1A-regulated poly(A) polymerase,TUT1,106.6,88.64,S6,__________MAAVDSDVESLPRGGFRCCLC,_(ac)AAVDS(ph)DVESLPR_,3.1, , , , , , , ,-0.02, , , , , , , ,3.1,,,,-0.02,,,, +,,,,,,NA,NA,,,nucleic acid binding,,,
Q12792,Q12792,Twinfilin-1,TWF1,75.91,75.21,T349,GIRRLIRGPAETEATTD______________,_LIRGPAETEATT(ph)D_,-0.28,-0.54, , ,-0.5, , ,-0.31,0,0.05, , ,-0.31, , ,-0.33,-0.41,,-0.5,-0.31,0.03,,-0.31,-0.33,,,,,,,NA,NA,,actin cytoskeleton,actin monomer binding,barbed-end actin filament capping,,
P40222,P40222,Alpha-taxilin,TXLNA,100.82,98.61,S515,GPERRPEGPGAQAPSSPRVTEAPCYPGAPST,_RPEGPGAQAPSS(ph)PR_,-0.1,0.22,0.9,-0.61,0.84,0.58,-1.46,0.62,0.04,0.28,0.66,0.73,0.81,0.58,-1.36,0.55,0.07,0.33,0.72,-0.07,0.16,0.7,0.7,-0.11,,,,,,,0,0,,cytoplasm,cytokine activity,cell proliferation,,
Q9H3M7,Q9H3M7,Thioredoxin-interacting protein,TXNIP,89.19,87.92,S358,RLESPTTPLLDDMDGSQDSPIFMYAPEFKFM,_LESPTT(ph)PLLDDMDGS(ph)QDS(ph)PIFMYAPEFK_, , ,1.21, ,0.76, , ,1.35, , ,1.56, ,1.07, , ,2.03,,1.21,0.76,1.35,,1.56,1.07,2.03, +, +,,,,,NA,NA,,cytosol,enzyme inhibitor activity,cell cycle,,
Q9H3M7,Q9H3M7,Thioredoxin-interacting protein,TXNIP,89.19,87.92,S361,SPTTPLLDDMDGSQDSPIFMYAPEFKFMPPP,_LES(ph)PTTPLLDDMDGS(ph)QDS(ph)PIFMYAPEFK_, , ,1.21, ,0.76, , ,1.35, , ,1.56, ,1.07, , ,2.03,,1.21,0.76,1.35,,1.56,1.07,2.03, +, +,,,,,NA,NA,,cytosol,enzyme inhibitor activity,cell cycle,,
E7ESI6,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,89.23,87.53,Y281,YRVALREKKVVYENAYGQFIGPHRIKATNNK,_VVYENAY(ph)GQFIGPHR_, , ,-0.33, , , , , , , ,0, , , , , ,,-0.33,,,,0,,,,,,,,,NA,NA,,cytoplasm,flavin adenine dinucleotide binding,cell redox homeostasis,,
H0YE41,P29597,Tyrosine-protein kinase,TYK2,210.64,210.64,Y292,VCHLRLLAQAEGEPCYIRDSGVAPTDPGPES,_LLAQAEGEPCY(ph)IR_,-0.28, ,-0.09, , , ,-0.25,-0.19,-0.45, ,-0.29, , , ,-0.02,-0.04,-0.28,-0.09,,-0.22,-0.45,-0.29,,-0.03,,,Tyr,,,,NA,NA,,,,,,
P26368-2,P26368,Splicing factor U2AF 65 kDa subunit,U2AF2,168.05,168.05,S79,PLTRGAKEEHGGLIRSPRHEKKKKVRKYWDV,_EEHGGLIRS(ph)PR_,0,0.13,0.03,0.05,0.16,0.23,0.31,0.26,-0.16,-0.12,-0.16,-0.16,0.07,0.08,0.01,-0.04,0.06,0.04,0.19,0.29,-0.14,-0.16,0.07,-0.01,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
P26368-2,P26368,Splicing factor U2AF 65 kDa subunit,U2AF2,213.85,191.86,S2,______________MSDFDEFERQLNENKQE,_S(ph)DFDEFER_,-0.22,-0.19,-0.29,-0.27,-0.18,-0.21,-0.28,-0.29,-0.11,-0.06,-0.19,-0.11,-0.17,-0.21,-0.3,-0.32,-0.2,-0.28,-0.19,-0.28,-0.09,-0.15,-0.19,-0.31,,,,,,,0,0,,nucleoplasm,nucleotide binding,mRNA 3'-end processing,,
O15042-2,O15042,U2 snRNP-associated SURP motif-containing protein,U2SURP,153.22,122.66,S485,HVYYRWKLYSILQGDSPTKWRTEDFRMFKNG,_LYSILQGDS(ph)PTK_,0.23,-0.01,0.13,-0.12, , , , ,-0.05,-0.1,-0.1,0.07, , , , ,0.11,0.01,,,-0.07,-0.02,,,,,,,,,NA,NA,,nucleus,nucleotide binding,RNA processing,,
P22314,P22314,Ubiquitin-like modifier-activating enzyme 1,UBA1,198.09,189.75,S46,SEVPSVPTNGMAKNGSEADIDEGLYSRQLYV,_NGS(ph)EADIDEGLYSR_,-0.09,0.09,0.25,0.32,1.5,0.61,0.98,1.03,-0.01,0.18,0.41,0.7,0.62,0.64,0.98,0.94,0,0.29,1.12,1.01,0.09,0.56,0.63,0.96, +,,,,,,2,0,28.89,,ATP binding,cell death,+,
A6NCA8,Q5T6F2,Ubiquitin-associated protein 2,UBAP2,75.42,62.02,Y1116,QPKSQASKPAYGNSPYWTN____________,_PAYGNSPY(ph)WTN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,164.99,164.99,S467,PSSPLPSKSTSAPQMSPGSSDNQSSSPQPAQ,_STSAPQMS(ph)PGSSDNQSSSPQPAQQK_, , ,-0.1, ,0.1,0.38,0.21,0.25, , ,1.32, ,0.17,0.34,0.61,0.22,,-0.1,0.25,0.23,,1.32,0.26,0.43,, +,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,50.87,47.83,S416,LVQYDLKNPSDSAVHSPFTKRQAFTPSSTMM,_NPSDSAVHS(ph)PFTK_, , , , ,0.47,0.33,0.92,0.42, , , , ,-0.01,0.3,0.78,-0.05,,,0.4,0.69,,,0.15,0.42,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,76.76,76.48,S439,FTPSSTMMEVFLQEKSPAVATSTAAPPPPSS,_S(ph)PAVATSTAAPPPPS(ph)SPLPSK_, , , , ,-0.07,-0.22,-0.11,-0.33, , , , ,-0.17,-0.06,-0.27,-0.27,,,-0.14,-0.22,,,-0.11,-0.27,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,211.14,210.98,S453,KSPAVATSTAAPPPPSSPLPSKSTSAPQMSP,_SPAVATSTAAPPPPS(ph)SPLPSK_,-0.4, , , ,0.26,0.37,0.28,0.38,0.01, , , ,0.17,0.13,0.17,0.36,-0.4,,0.32,0.33,0.01,,0.15,0.27,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,148.78,147.64,S477,SAPQMSPGSSDNQSSSPQPAQQKLKQQKKKA,_STSAPQMS(ph)PGSSDNQSSS(ph)PQPAQQK_, , , , ,-0.47,-0.29,-0.16,-0.08, , , , ,-0.17,-0.1,0.07,-0.1,,,-0.38,-0.12,,,-0.13,-0.02,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,146.37,146.37,S604,GPLYEQRSTQTRRYPSSISSSPQKDLTQAKN,_RYPS(ph)SISS(ph)SPQK_,-0.32, , , ,-0.01,0,0.18,0.32,-0.12, , , ,-0.04,-0.19,0.04,-0.06,-0.32,,0,0.25,-0.12,,-0.11,-0.01,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,146.37,146.37,S605,PLYEQRSTQTRRYPSSISSSPQKDLTQAKNG,_RYPSS(ph)ISSS(ph)PQK_, ,0.12, , ,-0.06,0.03,0.17,0.16, ,0.29, , ,-0.1,-0.1,-0.07,-0.02,0.12,,-0.02,0.17,0.29,,-0.1,-0.04,,,,,,,NA,NA,,,,binding of sperm to zona pellucida,,
Q14157-4,Q14157,Ubiquitin-associated protein 2-like,UBAP2L,202.52,191,S609,QRSTQTRRYPSSISSSPQKDLTQAKNGFSSV,_RYPSSISSS(ph)PQK_,0.12,0.11,-0.05,-0.07,0.09,-0.05,0.26,0.23,-0.04,0,-0.33,-0.25,0.02,-0.11,-0.36,0.15,0.11,-0.06,0.02,0.24,-0.02,-0.29,-0.05,-0.08,,,,,,,0,0,,,,binding of sperm to zona pellucida,,
F5GYU3,P62987,Polyubiquitin-B,UBC,208.96,208.96,T55,QQRLIFAGKQLEDGRTLSDYNIQKESTLHLV,_LIFAGK(gl)QLEDGRT(ph)LSDYNIQK_, ,0.67,0.5,0.41, ,0.62, ,0.37, ,0.97,0.8,0.26, ,0.88, ,0.31,0.67,0.45,0.62,0.37,0.97,0.55,0.88,0.31,,,,,,,0,0,,,,,,
Q9C0C9,Q9C0C9,Ubiquitin-conjugating enzyme E2 O,UBE2O,93.74,92.45,S1196,GQQEPEDGGPAPGEASQGSDSEGGAQGLASA,_ASSS(ph)PEPPAVAELSDSGQQEPEDGGPAPGEAS(ph)QGS(ph)DSEGGAQGLASASR_, , , , , ,-0.02,-0.02, , , , , , ,0.05,0.21, ,,,-0.02,-0.02,,,0.05,0.21,,,,,,,NA,NA,,,ATP binding,,,
Q9C0C9,Q9C0C9,Ubiquitin-conjugating enzyme E2 O,UBE2O,93.74,92.45,S1199,EPEDGGPAPGEASQGSDSEGGAQGLASASRD,_ASSS(ph)PEPPAVAELSDSGQQEPEDGGPAPGEAS(ph)QGS(ph)DSEGGAQGLASASR_, , , , , ,-0.13,-0.02, , , , , , ,0.05,0.21, ,,,-0.13,-0.02,,,0.05,0.21,,,,,,,NA,NA,,,ATP binding,,,
Q9C0C9,Q9C0C9,Ubiquitin-conjugating enzyme E2 O,UBE2O,277.84,265.71,S87,GSVHFGLVRLIHGEDSDSEGEEEGRGSSGCS,_LIHGEDS(ph)DS(ph)EGEEEGR_,0.05,0.16,0.14,0.14,0.05,-0.07,0.05,0.11,-0.18,0.11,-0.06,0,-0.07,-0.16,-0.07,-0.14,0.1,0.14,-0.01,0.08,-0.03,-0.03,-0.12,-0.1,,,,,,,0,0,,,ATP binding,,,
Q9C0C9,Q9C0C9,Ubiquitin-conjugating enzyme E2 O,UBE2O,277.84,265.71,S89,VHFGLVRLIHGEDSDSEGEEEGRGSSGCSEA,_LIHGEDS(ph)DS(ph)EGEEEGR_,0.05,0.16,0.14,0.14,0.05,-0.07,0.05,0.11,-0.18,0.11,-0.06,0,-0.07,-0.16,-0.07,-0.14,0.1,0.14,-0.01,0.08,-0.03,-0.03,-0.12,-0.1,,,,,,,0,0,,,ATP binding,,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,96.75,86.88,S78,ATSPIGASGVAHRSQSSEGVSSLSSSPSNSL,_SQS(ph)SEGVSS(ph)LSSS(ph)PSNSLETQSQSLSR_, , , , , , ,1.18, , , , , , , ,1.37, ,,,,1.18,,,,1.37, +, +,,U box,,,NA,NA,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,106.97,98.05,S101,SSSPSNSLETQSQSLSRSQSMDIDGVSCEKS,_SQSSEGVSS(ph)LS(ph)SSPSNSLETQSQSLS(ph)R_, , , , ,0.55,0.91, ,-1.02, , , , ,0.85,0.82, ,-0.61,,,0.75,-1.02,,,0.84,-0.61, +,,,U box,,,NA,NA,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,188.71,172.83,S803,RTVEDLKNNESQWKDSPLATRHREMLKRCKT,_NNESQWKDS(ph)PLATR_,-0.36,-0.25,-0.6,-0.55,-0.59,-0.28, , ,-0.2,0.11,0.14,0.09,-0.49,0.09, , ,-0.31,-0.57,-0.43,,-0.04,0.11,-0.17,,,,,U box,,,NA,NA,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,140.36,138.79,S83,GASGVAHRSQSSEGVSSLSSSPSNSLETQSQ,_SQSSEGVS(ph)SLSSS(ph)PSNSLETQSQSLSR_,-0.29,-0.1, , ,-0.11, , , ,-0.07,-0.29, , ,-0.42, , , ,-0.19,,-0.11,,-0.18,,-0.42,,,,,U box,,,NA,NA,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,218.4,202.46,S84,ASGVAHRSQSSEGVSSLSSSPSNSLETQSQS,_SQSSEGVSS(ph)LSSS(ph)PSNSLETQSQSLSR_,-0.07, , ,-0.66,-0.21,-0.24,-0.15,-0.09,-0.05, , ,-0.73,-0.27,-0.33,-0.22,-0.17,-0.07,-0.66,-0.22,-0.12,-0.05,-0.73,-0.3,-0.2,,,,U box,,,0,0,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
O95155-2,O95155,Ubiquitin conjugation factor E4 B,UBE4B,218.4,202.46,S88,AHRSQSSEGVSSLSSSPSNSLETQSQSLSRS,_SQSSEGVSS(ph)LSSS(ph)PSNSLETQSQSLSR_,-0.17,-0.11,-0.28,-0.66,0.33,0.24,-0.33,0.15,-0.14,-0.07,0.02,-0.73,0.22,0.21,-0.21,-0.27,-0.14,-0.46,0.29,-0.07,-0.11,-0.31,0.22,-0.24,,,,U box,,,0,0,,cytoplasm,enzyme binding,granzyme-mediated apoptotic signaling pathway,,
Q96S82,Q96S82,Ubiquitin-like protein 7,UBL7,167.48,163.86,S230,SSYRDMPGGFLFEGLSDDEDDFHPNTRSTPS,_DMPGGFLFEGLS(ph)DDEDDFHPNTR_,-0.24,-0.23,-0.37,-0.36,-0.18,0.03,0.01, ,0.03,0.01,-0.03,-0.05,0.07,0.11,-0.08, ,-0.23,-0.37,-0.07,0.01,0.02,-0.04,0.09,-0.08,,,,,,,0,0,,,,,,
Q9NPG3-2,Q9NPG3,Ubinuclein-1,UBN1,104.94,89.75,S173,GGFYINSGTLQFRQASESEDDFIKEKKKKSP,_QAS(ph)ES(ph)EDDFIK_, , , , ,-0.2,-0.2,-0.69,-0.35, , , , ,-0.13,0,-0.25,-0.16,,,-0.2,-0.51,,,-0.07,-0.2,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
Q9NPG3-2,Q9NPG3,Ubinuclein-1,UBN1,104.94,89.75,S175,FYINSGTLQFRQASESEDDFIKEKKKKSPKK,_QAS(ph)ES(ph)EDDFIK_, , , , ,-0.2,-0.2,-0.69,-0.35, , , , ,-0.13,0,-0.25,-0.16,,,-0.2,-0.51,,,-0.07,-0.2,,,,,,,NA,NA,,nucleus,DNA binding,chromatin modification,,
Q8IWV7,Q8IWV7,E3 ubiquitin-protein ligase UBR1,UBR1,140.3,138.32,T21,AGGTERMEISAELPQTPQRLASWWDQQVDFY,_MEISAELPQT(ph)PQR_,0.15, ,0.53, , , , , ,0.04, ,0.49, , , , , ,0.15,0.53,,,0.04,0.49,,,,,,RING finger,,,NA,NA,,cytosol,leucine binding,cellular response to leucine,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,239.56,238.6,S619,EKAAPPPPPPPPPLESSPRVKSPSKQAPGEK,_AAPPPPPPPPPLES(ph)SPR_,0.04,0.09,0.01,0.01,-0.16,-0.12,-0.18, ,-0.15,-0.13,-0.04,-0.17,-0.33,-0.24,-0.25, ,0.07,0.01,-0.14,-0.18,-0.14,-0.1,-0.28,-0.25,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,113.54,84.01,S178,TVKTLSDVEDQKELASPVSPELRQKEVQMNF,_ELAS(ph)PVS(ph)PELR_,-0.35,-0.44,-0.47, ,-0.07,-0.15,-0.21,-0.17,0.57,0.55,0.06, ,-0.04,0.05,-0.01,0.14,-0.39,-0.47,-0.11,-0.19,0.56,0.06,0,0.07,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,111.66,94.66,S181,TLSDVEDQKELASPVSPELRQKEVQMNFLNQ,_ELAS(ph)PVS(ph)PELR_,-0.45,-0.27,-0.04,-0.16,-0.53,-0.2,-0.5,-0.27,0.05,-0.05,-0.04,-0.2,-0.09,0.21,-0.07,0.36,-0.36,-0.1,-0.36,-0.38,0,-0.12,0.07,0.16,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,137.89,85.32,S2718,RVLRPRNKRRHVTLPSSPRSNTPMGDKDDDD,_HVTLPS(ph)SPR_, ,0.17,0.34,0.52,0.06,0.1,0.36,0.21, ,-0.18,-0.16,-0.07,-0.07,-0.12,-0.28,-0.13,0.17,0.43,0.08,0.29,-0.18,-0.12,-0.1,-0.2,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,146.16,138.88,S2719,VLRPRNKRRHVTLPSSPRSNTPMGDKDDDDD,_HVTLPSS(ph)PRS(ph)NT(ph)PMGDK_,0.39,0.02,0.13,0.52,0.13,0.1,0.13,0.17,-0.01,-0.11,-0.09,-0.11,-0.53,-0.12,-0.11,-0.1,0.21,0.34,0.11,0.15,-0.06,-0.1,-0.31,-0.11,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,141.45,141.45,S2722,PRNKRRHVTLPSSPRSNTPMGDKDDDDDDDA,_HVTLPSS(ph)PRS(ph)NT(ph)PMGDK_,0.01,0.11,0.11,0.2,0.22,0.02,0.07,0.11,-0.14,0.1,-0.03,0.08,0.2,0.17,0.21,0.02,0.06,0.16,0.13,0.09,-0.02,0.03,0.19,0.12,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,100.38,98.32,T2715,ALIRVLRPRNKRRHVTLPSSPRSNTPMGDKD,_HVT(ph)LPS(ph)SPR_, , , , ,0.13,0.2,0.36,-0.19, , , , ,-0.53,-0.17,-0.28,-0.27,,,0.16,0.11,,,-0.34,-0.27,,,,RING finger,,,NA,NA,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
Q5T4S7-3,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,141.45,141.45,T2724,NKRRHVTLPSSPRSNTPMGDKDDDDDDDADE,_HVTLPSS(ph)PRS(ph)NT(ph)PMGDK_,0.01,0.11,0.11,0.2,0.22,0.02,0.07,0.11,-0.14,0.1,-0.03,0.08,0.2,0.17,0.21,0.02,0.06,0.16,0.13,0.09,-0.02,0.03,0.19,0.12,,,,RING finger,,,0,0,,cytoplasm,ubiquitin-protein ligase activity,virus-host interaction,,
E7EMW7,O95071,E3 ubiquitin-protein ligase UBR5,UBR5,45.85,44.08,S2486,SEKVQENRKRHGSSRSVVDMDLDDTDDGDDN,_S(ph)VVDMDLDDTDDGDDNAPLFYQPGK_, , , , ,0.39, , , , , , , ,0.56, , , ,,,0.39,,,,0.56,,,,,HECT,,,NA,NA,,intracellular,RNA binding,protein ubiquitination,,
B7Z8N2,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,137.86,120.12,S539,NFGDRYFGTDAVPDGSDEEEVAYTG______,_YFGTDAVPDGS(ph)DEEEVAYTG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
Q92890,Q92890,Ubiquitin fusion degradation protein 1 homolog,UFD1L,94.28,94.28,S247,GNRLDGKKKGVEPSPSPIKPGDIKRGIPNYE,_GVEPSPS(ph)PIKPGDIK_,0.15,0.23,0.14,0.24,-0.29,-0.08,-0.16,0.1,-0.07,0.05,-0.02,-0.24,-0.2,-0.14,0.07,-0.09,0.19,0.19,-0.18,-0.02,-0.01,-0.12,-0.17,-0.01,,,,,,,0,0,,cytosol,ubiquitin-specific protease activity,proteasomal ubiquitin-dependent protein catabolic process,,
O94874-2,O94874,E3 UFM1-protein ligase 1,UFL1,53.45,20.39,S776,QEDVASTTRKELQELSSSIKDLVLKSRKSSV,_ELQELS(ph)S(ph)S(ph)IK_,0.19,0.24,0.23, , ,-0.05,-0.01,0.06,0.05,0.11,0.03, , ,0.08,0.05,0.11,0.22,0.23,-0.05,0.03,0.08,0.03,0.08,0.08,,,,,,,0,0,,endoplasmic reticulum,UFM1 conjugating enzyme activity,negative regulation of NF-kappaB transcription factor activity,,
O94874-2,O94874,E3 UFM1-protein ligase 1,UFL1,53.45,20.39,S777,EDVASTTRKELQELSSSIKDLVLKSRKSSVT,_ELQELS(ph)S(ph)S(ph)IK_,0.19,0.24,0.23, , ,-0.05,-0.01,0.06,0.05,0.11,0.03, , ,0.08,0.05,0.11,0.22,0.23,-0.05,0.03,0.08,0.03,0.08,0.08,,,,,,,0,0,,endoplasmic reticulum,UFM1 conjugating enzyme activity,negative regulation of NF-kappaB transcription factor activity,,
O94874-2,O94874,E3 UFM1-protein ligase 1,UFL1,53.45,20.39,S778,DVASTTRKELQELSSSIKDLVLKSRKSSVTE,_ELQELS(ph)S(ph)S(ph)IK_,0.19,0.24,0.23, , ,-0.05,-0.01,0.06,0.05,0.11,0.03, , ,0.08,0.05,0.11,0.22,0.23,-0.05,0.03,0.08,0.03,0.08,0.08,,,,,,,0,0,,endoplasmic reticulum,UFM1 conjugating enzyme activity,negative regulation of NF-kappaB transcription factor activity,,
Q16851-2,Q16851-2,UTP--glucose-1-phosphate uridylyltransferase,UGP2,165.58,163.28,S2,______________MSQDGASQFQEVIRQEL,_(ac)S(ph)QDGASQFQEVIR_,-0.64,-0.72,-1.12,-0.93,0.28,1.04,-0.01,-0.14,0.06,0.02,-0.38,0.67,-0.45,0.86,-0.15,-0.57,-0.68,-1.03,0.71,-0.07,0.04,0.24,0.35,-0.35, +,,,,,,3,0,2.34,cytosol,metal ion binding,glucose metabolic process,,
F5GXG0,Q96T88,E3 ubiquitin-protein ligase UHRF1,UHRF1,59.61,59.61,S287,IFVDEVFKIERPGEGSPMVDNPMRRKSGPSC,_IERPGEGS(ph)PMVDNPMR_,-0.13,-0.48, , , , , , ,0.1,-0.31, , , , , , ,-0.29,,,,-0.09,,,,,,,,,,NA,NA,,,,,,
Q6BDS2,Q6BDS2,UHRF1-binding protein 1,UHRF1BP1,68.43,62.19,S1103,GGAARLRFFSMKRTVSQQSFDGVSLDSSGPE,_RT(ph)VS(ph)QQSFDGVSLDSSGPEDR_, , , , , ,1, ,1.32, , , , , ,-0.13, ,-0.1,,,1,1.32,,,-0.13,-0.1, +,,,,,,NA,NA,,,,,,
Q6BDS2,Q6BDS2,UHRF1-binding protein 1,UHRF1BP1,59.59,52.64,S1106,ARLRFFSMKRTVSQQSFDGVSLDSSGPEDRI,_RTVS(ph)QQS(ph)FDGVSLDSSGPEDR_, , , , , ,1, , , , , , , ,-0.13, , ,,,1,,,,-0.13,, +,,,,,,NA,NA,,,,,,
Q96RL1-2,Q96RL1,BRCA1-A complex subunit RAP80,UIMC1,69.94,69.94,S101,ALALKMSEQEAREVNSQEEEEEELLRKAIAE,_EVNS(ph)QEEEEEELLRK_,-1.31,-1.32,-1, , , , , ,-1.18,-1.09,-1.09, , , , , ,-1.31,-1,,,-1.14,-1.09,,, +, +,,,,,NA,NA,,BRCA1-A complex,histone binding,double-strand break repair,+,
Q96RL1-2,Q96RL1,BRCA1-A complex subunit RAP80,UIMC1,59.07,27.57,S677,SREMQSSFTRRDLNESPVKSFVSISEATDCL,_DLNES(ph)PVK_, , , , , , , ,-0.54, , , , , , , ,-0.54,,,,-0.54,,,,-0.54,,,,,,,NA,NA,,BRCA1-A complex,histone binding,double-strand break repair,+,
Q96RL1-2,Q96RL1,BRCA1-A complex subunit RAP80,UIMC1,159.64,159.64,S463,TQLSSSETFDLEREVSPGSRDILDGVRIIMA,_EVS(ph)PGSRDILDGVR_,0.05,0.04,0.19,0.2,0.32,0.38,0.2,0.34,-0.05,-0.13,-0.07,-0.22,0.26,0.1,-0.46,-0.16,0.04,0.2,0.35,0.27,-0.09,-0.15,0.18,-0.3,,,,,,,0,0,,BRCA1-A complex,histone binding,double-strand break repair,+,
Q96RL1-2,Q96RL1,BRCA1-A complex subunit RAP80,UIMC1,52.96,52.96,S44,SVKRKRRLEDAFIVISDSDGEEPKEENGLQK,_RLEDAFIVIS(ph)DS(ph)DGEEPK_, , , , ,0.38, , ,0.32, , , , ,0.21, , ,0.58,,,0.38,0.32,,,0.21,0.58,,,,,,,NA,NA,,BRCA1-A complex,histone binding,double-strand break repair,+,
Q96RL1-2,Q96RL1,BRCA1-A complex subunit RAP80,UIMC1,52.96,52.96,S46,KRKRRLEDAFIVISDSDGEEPKEENGLQKTK,_RLEDAFIVIS(ph)DS(ph)DGEEPK_, , , , ,0.38, , ,0.32, , , , ,0.21, , ,0.58,,,0.38,0.32,,,0.21,0.58,,,,,,,NA,NA,,BRCA1-A complex,histone binding,double-strand break repair,+,
O75385,O75385,Serine/threonine-protein kinase ULK1,ULK1,109.95,93.61,S467,TQFQTPRSSAIRRSGSTSPLGFARASPSPPA,_SGS(ph)TS(ph)PLGFAR_, , , , ,0.59,0.39,0.51,0.33, , , , ,0.73,0.66,0.64,-0.09,,,0.5,0.42,,,0.7,0.32,,,Other,,,,NA,NA,,autophagic vacuole,ATP binding,autophagic vacuole assembly,,
O75385,O75385,Serine/threonine-protein kinase ULK1,ULK1,109.95,93.61,S469,FQTPRSSAIRRSGSTSPLGFARASPSPPAHA,_SGS(ph)TS(ph)PLGFAR_, , , , ,0.59,0.39,0.51,0.33, , , , ,0.73,0.66,0.64,-0.09,,,0.5,0.42,,,0.7,0.32,,,Other,,,,NA,NA,,autophagic vacuole,ATP binding,autophagic vacuole assembly,,
Q9H1C4,Q9H1C4,Protein unc-93 homolog B1,UNC93B1,251.76,251.55,S547,PQHKVRGYRYLEEDNSDESDAEGEHGDGAEE,_YLEEDNS(ph)DES(ph)DAEGEHGDGAEEEAPPAGPRPGPEPAGLGR_,0.04,-0.01,-0.06,-0.21,-0.29,-0.03,0.23,0.27,-0.14,0.03,-0.16,-0.23,-0.13,-0.1,0.24,0.18,0.01,-0.13,-0.15,0.25,-0.05,-0.19,-0.12,0.21,,,,,,,0,0,,early phagosome,,defense response to virus,,
Q9H1C4,Q9H1C4,Protein unc-93 homolog B1,UNC93B1,251.76,251.55,S550,KVRGYRYLEEDNSDESDAEGEHGDGAEEEAP,_YLEEDNS(ph)DES(ph)DAEGEHGDGAEEEAPPAGPRPGPEPAGLGR_,0.04,-0.01,-0.06,-0.21,-0.29,-0.03,0.23,0.27,-0.14,0.03,-0.16,-0.23,-0.13,-0.1,0.24,0.18,0.01,-0.13,-0.15,0.25,-0.05,-0.19,-0.12,0.21,,,,,,,0,0,,early phagosome,,defense response to virus,,
P13051,P13051,Uracil-DNA glycosylase,UNG,136.87,136.73,S63,AKKAPAGQEEPGTPPSSPLSAEQLDRIQRNK,_KAPAGQEEPGT(ph)PPS(ph)SPLSAEQLDR_,-0.07,-0.23,0.36,0.15,-0.04,0.13,0.15,0.23,0.01,0.06,0.58,0.48,-0.28,-0.42,-0.09,0.09,-0.14,0.26,0.05,0.19,0.03,0.53,-0.34,0,,,,,,,0,0,,mitochondrion,uracil DNA N-glycosylase activity,base-excision repair,,
P13051,P13051,Uracil-DNA glycosylase,UNG,183.55,182.71,S64,KKAPAGQEEPGTPPSSPLSAEQLDRIQRNKA,_KAPAGQEEPGT(ph)PPSS(ph)PLSAEQLDR_,-0.03,-0.07,0.38, ,0.12,0.01,0.07,0.21,-0.01,-0.01,0.64, ,0.14,0.2,0.08,-0.11,-0.05,0.38,0.07,0.14,-0.01,0.64,0.17,-0.01,,,,,,,0,0,,mitochondrion,uracil DNA N-glycosylase activity,base-excision repair,,
P13051,P13051,Uracil-DNA glycosylase,UNG,183.55,182.71,T60,AIPAKKAPAGQEEPGTPPSSPLSAEQLDRIQ,_KAPAGQEEPGT(ph)PPS(ph)SPLSAEQLDR_,0.2,0.18,0.02,0.05,-0.04,0.05,0.26,0.23,-0.05,-0.02,-0.27,-0.27,-0.41,-0.11,-0.13,-0.11,0.19,0.04,0.01,0.25,-0.04,-0.27,-0.25,-0.12,,,,,,,0,0,,mitochondrion,uracil DNA N-glycosylase activity,base-excision repair,,
Q92900-2,Q92900,Regulator of nonsense transcripts 1,UPF1,256.89,255.38,S1107,SYLGDEFKSQIDVALSQDSTYQGERAYQHGG,_SQIDVALS(ph)QDS(ph)TYQGER_, ,1.03, , ,0.52,0.47,0.96,0.84, ,0.5, , ,0.16,0.19,0.67,0.65,1.03,,0.49,0.9,0.5,,0.17,0.66, +,,,,,,NA,NA,,chromatin,ATP binding,cell cycle,,
Q92900-2,Q92900,Regulator of nonsense transcripts 1,UPF1,256.89,255.38,S1110,GDEFKSQIDVALSQDSTYQGERAYQHGGVTG,_SQIDVALS(ph)QDS(ph)TYQGER_, ,1.03, , ,0.52,0.47,0.96,0.83, ,0.5, , ,0.16,0.19,0.67,0.61,1.03,,0.49,0.89,0.5,,0.17,0.64, +,,,,,,NA,NA,,chromatin,ATP binding,cell cycle,,
Q92900-2,Q92900,Regulator of nonsense transcripts 1,UPF1,137.39,136.93,S1127,YQGERAYQHGGVTGLSQY_____________,_AYQHGGVTGLS(ph)QY_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,chromatin,ATP binding,cell cycle,,
Q92900-2,Q92900,Regulator of nonsense transcripts 1,UPF1,165.3,154.71,S1100,QPELSQDSYLGDEFKSQIDVALSQDSTYQGE,_S(ph)QIDVALS(ph)QDS(ph)TYQGER_, , , , , ,0.57, ,0.9, , , , , ,-0.28, ,0.43,,,0.57,0.9,,,-0.28,0.43,,,,,,,NA,NA,,chromatin,ATP binding,cell cycle,,
Q9HAU5,Q9HAU5,Regulator of nonsense transcripts 2,UPF2,173.77,162.4,T1088,EENTDYLTDSNKENETDEENTEVMIKGGGLK,_ENET(ph)DEENTEVMIK_, ,-0.33, , ,-0.11,-0.3,-0.26,-0.1, ,-0.1, , ,-0.06,-0.06,0.05,0.09,-0.33,,-0.2,-0.18,-0.1,,-0.06,0.07,,,,,,,NA,NA,,cytosol,DNA binding,gene expression,,
Q9BZI7-2,Q9BZI7,Regulator of nonsense transcripts 3B,UPF3B,120.75,85.79,T169,IDDDPEYRKFLESYATDNEKMTSTPETLLEE,_FLESYAT(ph)DNEK_, , , , , ,-1.27,-1.54, , , , , , ,-1.86,-1.87, ,,,-1.27,-1.54,,,-1.86,-1.87, +, +,,,,,NA,NA,,cytosol,mRNA binding,mRNA 3'-end processing,,
O60763,O60763,General vesicular transport factor p115,USO1,307.16,299.26,S942,LKDLGHPVEEEDELESGDQEDEDDESEDPGK,_DLGHPVEEEDELES(ph)GDQEDEDDESEDPGK_, , ,-0.16,-0.14,-0.15,-0.1,-0.04,-0.04, , ,-0.12,-0.15,0.13,-0.2,0.24,0.25,,-0.15,-0.12,-0.04,,-0.14,-0.02,0.25,,,,,,,NA,NA,,cytosol,protein transporter activity,intracellular protein transport,,
O94782,O94782,Ubiquitin carboxyl-terminal hydrolase 1,USP1,132.84,94.54,S475,VQEDELSKVEESSEISPEPKTEMKTLRWAIS,_VEESSEIS(ph)PEPK_,0.16,0.25, , , ,0.09,0.32,0.25,-0.15,0.03, , , ,0.22,0.22,0.23,0.21,,0.09,0.28,-0.05,,0.22,0.22,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,nucleoplasm,cysteine-type endopeptidase activity,DNA repair,,
Q14694,Q14694,Ubiquitin carboxyl-terminal hydrolase 10,USP10,350.55,349.7,S576,NHSVNEEEQEEQGEGSEDEWEQVGPRNKTSV,_NHSVNEEEQEEQGEGS(ph)EDEWEQVGPR_,-0.05,-0.04,0.02,0.02,-0.05,-0.05,0.02,0.06,-0.13,-0.1,0,-0.09,0.04,-0.2,3.08,0.06,-0.04,0.02,-0.05,0.04,-0.12,-0.05,-0.08,2.25,, +,,,Ubiquitin-Specific Proteases ,,0,2,7.14,early endosome,cysteine-type endopeptidase activity,autophagy,,
B4DYF3,Q92995,Ubiquitin carboxyl-terminal hydrolase 13,USP13,123.68,107.98,T122,ALPKRRNSKIFLDLDTDDDLNSDDYEYEDEA,_IFLDLDT(ph)DDDLNSDDYEYEDEAK_, , , , , , , ,0.03, , , , , , , ,0.15,,,,0.03,,,,0.15,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,,,,
Q9Y4E8,Q9Y4E8,Ubiquitin carboxyl-terminal hydrolase 15,USP15,122.08,119.6,S229,KNEDGTWPRGPSTPKSPGASNFSTLPKISPS,_S(ph)PGASNFSTLPK_, ,0.07,0.51,0.56,0.71,0.91,0.7,0.72, ,0.19,0.79,0.54,0.68,1.57,0.69,0.79,0.07,0.54,0.81,0.71,0.19,0.67,1.19,0.74,, +,,,Ubiquitin-Specific Proteases ,,0,1,37.74,cytoplasm,cysteine-type endopeptidase activity,BMP signaling pathway,,
Q9Y4E8,Q9Y4E8,Ubiquitin carboxyl-terminal hydrolase 15,USP15,128.06,127.19,S961,RETKGASAATGIPLESDEDSNDNDNDIENEN,_GASAATGIPLES(ph)DEDS(ph)NDNDNDIENENCMHTN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,cysteine-type endopeptidase activity,BMP signaling pathway,,
Q9Y4E8,Q9Y4E8,Ubiquitin carboxyl-terminal hydrolase 15,USP15,128.06,127.19,S965,GASAATGIPLESDEDSNDNDNDIENENCMHT,_GASAATGIPLES(ph)DEDS(ph)NDNDNDIENENCMHTN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,cysteine-type endopeptidase activity,BMP signaling pathway,,
Q9Y5T5-3,Q9Y5T5,Ubiquitin carboxyl-terminal hydrolase 16,USP16,279.79,277.86,S552,MKNINMDNDLEVLTSSPTRNLNGAYLTEGSN,_NINMDNDLEVLTSS(ph)PTR_, , , , ,0.01, ,-0.12, , , , , ,-0.21, ,-0.07, ,,,0.01,-0.12,,,-0.21,-0.07,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,cysteine-type endopeptidase activity,cell division,,
Q9Y2K6,Q9Y2K6,Ubiquitin carboxyl-terminal hydrolase 20,USP20,249.91,249.91,S132,HPLKAVPIAVADEGESESEDDDLKPRGLTGM,_AVPIAVADEGES(ph)ES(ph)EDDDLKPR_,0.2,0.15,0.06,0.07,0.32,0.14,0.19,0.36,0.3,0.25,-0.06,0.02,-0.07,-0.21,0.08,0.03,0.18,0.07,0.24,0.28,0.28,-0.02,-0.14,0.06,,,,,Ubiquitin-Specific Proteases ,,0,0,,centrosome,cysteine-type endopeptidase activity,endocytosis,,
Q9Y2K6,Q9Y2K6,Ubiquitin carboxyl-terminal hydrolase 20,USP20,204.53,204.53,S134,LKAVPIAVADEGESESEDDDLKPRGLTGMKN,_AVPIAVADEGES(ph)ES(ph)EDDDLKPR_,0.18,0.29,0.06,0.07,0.32,0.14,0.19,0.36,0.28,0.09,-0.06,0.02,-0.07,-0.21,0.08,0.03,0.24,0.07,0.24,0.28,0.18,-0.02,-0.14,0.06,,,,,Ubiquitin-Specific Proteases ,,0,0,,centrosome,cysteine-type endopeptidase activity,endocytosis,,
Q9UPU5,Q9UPU5,Ubiquitin carboxyl-terminal hydrolase 24,USP24,58.33,57.59,Y101,GGSTGGGGGFDPPPAYHEVVDAEKNDENGNC,_GGSTGGGGGFDPPPAY(ph)HEVVDAEK_, , ,0.17, , , , , , , ,-1.15, , , , , ,,0.17,,,,-1.15,,,, +,,,Ubiquitin-Specific Proteases ,,NA,NA,,,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
Q9UPU5,Q9UPU5,Ubiquitin carboxyl-terminal hydrolase 24,USP24,173.26,150.94,S2047,WNAYMLFYQRVSDQNSPVLPKKSRVSVVRQE,_VSDQNS(ph)PVLPK_,0.15,0.31,0.14,0.03,0.46,0.34,0.13,0.48,0.19,0.28,0.08,0.22,0.05,-0.15,0.1,-0.19,0.24,0.08,0.4,0.32,0.23,0.15,-0.05,-0.04,,,,,Ubiquitin-Specific Proteases ,,0,0,,,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
Q8NFA0,Q8NFA0,Ubiquitin carboxyl-terminal hydrolase 32,USP32,106.93,106.93,S1361,DAQSSAGEEDVLLSKSPSSLSANIISSPKGS,_S(ph)PSSLSANIIS(ph)SPK_, , , , ,0.75,0.67, ,0.82, , , , ,0.76,0.73, ,0.68,,,0.71,0.82,,,0.75,0.68,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,Golgi apparatus,calcium ion binding,protein deubiquitination,,
Q8NFA0,Q8NFA0,Ubiquitin carboxyl-terminal hydrolase 32,USP32,113.28,112.12,S1376,SPSSLSANIISSPKGSPSSSRKSGTSCPSSK,_SPS(ph)SLSANIIS(ph)SPKGS(ph)PSSSR_, , , , ,0.49, , , , , , , ,0.91, , , ,,,0.49,,,,0.91,,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,Golgi apparatus,calcium ion binding,protein deubiquitination,,
C9JV64,Q70CQ2,Ubiquitin carboxyl-terminal hydrolase,USP34,119.3,115.22,S1469,IRRESTGSYSDLYPDSDDSSEDQVENSKNSW,_ESTGSYSDLYPDS(ph)DDSS(ph)EDQVENSK_, , , , ,-2.48,-2.42,-2.07,-1.43, , , , ,-2.1,-1.88,-1.76,-1.82,,,-2.45,-1.71,,,-1.99,-1.79, +, +,,,Ubiquitin-Specific Proteases ,,NA,NA,,,,,,
C9JV64,Q70CQ2,Ubiquitin carboxyl-terminal hydrolase,USP34,99.31,93.13,S1472,ESTGSYSDLYPDSDDSSEDQVENSKNSWSCK,_ESTGSYSDLYPDS(ph)DDS(ph)SEDQVENSK_, , , , , ,-2.42,-2.07,-1.4, , , , , ,-1.88,-1.76,-1.78,,,-2.42,-1.69,,,-1.88,-1.77, +, +,,,Ubiquitin-Specific Proteases ,,NA,NA,,,,,,
C9JV64,Q70CQ2,Ubiquitin carboxyl-terminal hydrolase,USP34,100.23,97.17,S3406,RDSSIIDPGTEQDLPSPENSSVKEYRMEVPS,_DSSIIDPGTEQDLPS(ph)PENS(ph)SVK_,-0.04,-0.13, ,-0.28,-0.25,-0.53,-1.1,0.09,-0.06,-0.01, ,0.09,-0.11,-0.4,-1.59,0.38,-0.08,-0.28,-0.38,-0.38,-0.03,0.09,-0.25,-0.29,,,,,Ubiquitin-Specific Proteases ,,0,0,,,,,,
B8ZZD1,Q53GS9,U4/U6.U5 tri-snRNP-associated protein 2,USP39,223.15,223.15,S82,VPFVRVKREREVDEDSEPEREVRAKNGRVDS,_EVDEDS(ph)EPEREVR_,-0.22,-0.1,-0.1,-0.14,-0.3,-0.42,-0.16,-0.4,-0.05,-0.1,-0.28,-0.19,-0.37,-0.59,-0.11,-0.4,-0.16,-0.12,-0.36,-0.28,-0.08,-0.23,-0.47,-0.25,,,,,Ubiquitin-Specific Proteases ,,0,0,,,,,,
Q13107-2,Q13107,Ubiquitin carboxyl-terminal hydrolase 4,USP4,138.29,138.29,S675,DEEEMEHQEEGKEQLSETEGSGEDEPGNDPS,_EQLS(ph)ETEGS(ph)GEDEPGNDPSETTQKK_, , , , ,0.02,0.02,-0.08,-0.16, , , , ,0.08,-0.11,-0.18,0.07,,,0.02,-0.12,,,-0.02,-0.05,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,lysosome,metal ion binding,negative regulation of protein ubiquitination,,
Q13107-2,Q13107,Ubiquitin carboxyl-terminal hydrolase 4,USP4,138.29,138.29,S680,EHQEEGKEQLSETEGSGEDEPGNDPSETTQK,_EQLS(ph)ETEGS(ph)GEDEPGNDPSETTQKK_, , , , ,0.02,0.02,0.01,-0.17, , , , ,0.08,-0.11,-0.31,0.07,,,0.02,-0.08,,,-0.02,-0.11,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,lysosome,metal ion binding,negative regulation of protein ubiquitination,,
Q13107-2,Q13107,Ubiquitin carboxyl-terminal hydrolase 4,USP4,46.8,46.8,T677,EEMEHQEEGKEQLSETEGSGEDEPGNDPSET,_EQLS(ph)ET(ph)EGS(ph)GEDEPGNDPSETTQK_, , , , , , ,-0.19,-0.27, , , , , , ,0.04,0.06,,,,-0.23,,,,0.05,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,lysosome,metal ion binding,negative regulation of protein ubiquitination,,
C9JPC9,Q9H9J4,Ubiquitin carboxyl-terminal hydrolase 42,USP42,124.08,121.05,S856,EGPRDSALAEAPEGLSPAPPARSEEPCEQPL,_DSALAEAPEGLS(ph)PAPPAR_, , , , , ,-0.26,-0.71, , , , , , ,-0.32,-0.61, ,,,-0.26,-0.71,,,-0.32,-0.61,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,ubiquitin thiolesterase activity,protein deubiquitination,,
C9JPC9,Q9H9J4,Ubiquitin carboxyl-terminal hydrolase 42,USP42,71.38,70.12,S611,KSKLNSSVLVPYGAESSEDSDEESKGLGKEN,_LNSSVLVPYGAES(ph)S(ph)EDS(ph)DEESK_, , , , , ,-0.09, ,0.46, , , , , ,0.07, ,-0.29,,,-0.09,0.46,,,0.07,-0.29,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,ubiquitin thiolesterase activity,protein deubiquitination,,
C9JPC9,Q9H9J4,Ubiquitin carboxyl-terminal hydrolase 42,USP42,71.38,70.12,S612,SKLNSSVLVPYGAESSEDSDEESKGLGKENG,_LNSSVLVPYGAES(ph)S(ph)EDS(ph)DEESK_, , , , , ,-0.09, ,0.46, , , , , ,0.07, ,-0.29,,,-0.09,0.46,,,0.07,-0.29,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,ubiquitin thiolesterase activity,protein deubiquitination,,
C9JPC9,Q9H9J4,Ubiquitin carboxyl-terminal hydrolase 42,USP42,71.38,70.12,S615,NSSVLVPYGAESSEDSDEESKGLGKENGIGT,_LNSSVLVPYGAES(ph)S(ph)EDS(ph)DEESK_, , , , , ,-0.09, ,0.46, , , , , ,0.07, ,-0.29,,,-0.09,0.46,,,0.07,-0.29,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,ubiquitin thiolesterase activity,protein deubiquitination,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,231.68,225.41,S1013,ANEGKKETWDTAEEDSGTDSEYDESGKSRGE,_ETWDTAEEDS(ph)GT(ph)DSEYDESGK_, , , , ,-0.14,0.08,-0.08,-0.01, , , , ,0.09,0.09,0.11,0.08,,,-0.03,-0.04,,,0.09,0.09,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,101.87,99.18,S1017,KKETWDTAEEDSGTDSEYDESGKSRGEMQYM,_ETWDTAEEDS(ph)GT(ph)DS(ph)EYDESGK_, , , , , ,-0.39, ,-0.29, , , , , ,-0.41, ,-0.01,,,-0.39,-0.29,,,-0.41,-0.01,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,231.68,225.41,T1015,EGKKETWDTAEEDSGTDSEYDESGKSRGEMQ,_ETWDTAEEDS(ph)GT(ph)DS(ph)EYDESGK_, , , , ,-0.14,0.08,-0.08,-0.01, , , , ,0.09,0.09,0.11,0.08,,,-0.03,-0.04,,,0.09,0.09,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,69.33,69,S933,SASVDNRELEQHIQTSDPENFQSEERSDSDV,_ELEQHIQTS(ph)DPENFQSEER_,-0.08,-0.1,-0.26,-0.39,-0.07,-0.41, ,0.12,-0.02,0.22,-0.17,-0.1,0.26,0.07, ,-0.29,-0.09,-0.32,-0.23,0.12,0.11,-0.13,0.17,-0.29,,,,,Ubiquitin-Specific Proteases ,,0,0,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,204.65,198.05,S910,DSSKSTETSDFENIESPLNERDSSASVDNRE,_STETSDFENIES(ph)PLNER_,0.08,-0.1,0.02,0.14,-0.03,-0.16,0.11,0.06,0.6,0.35,0.27,0.2,0.68,0.14,0.3,0.29,-0.01,0.08,-0.09,0.08,0.48,0.24,0.44,0.29,,,,,Ubiquitin-Specific Proteases ,,0,0,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q96K76-2,Q96K76,Ubiquitin carboxyl-terminal hydrolase,USP47,49.07,48.91,T932,SSASVDNRELEQHIQTSDPENFQSEERSDSD,_ELEQHIQT(ph)SDPENFQSEER_,-0.08, , , , , , , ,-0.02, , , , , , , ,-0.08,,,,-0.02,,,,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,cytoplasm,ubiquitin thiolesterase activity,base-excision repair,,
Q86UV5,Q86UV5,Ubiquitin carboxyl-terminal hydrolase 48,USP48,217.65,213.61,S886,DNKKVMKDSAPELNVSSSETEEDKEEAKPDG,_DSAPELNVS(ph)SS(ph)ETEEDKEEAKPDGEK_, , , , ,0.12,0.09,0.36,0.26, , , , ,0.09,0.04,0.3,0.14,,,0.11,0.31,,,0.06,0.22,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,mitochondrion,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
Q86UV5,Q86UV5,Ubiquitin carboxyl-terminal hydrolase 48,USP48,217.65,213.61,S888,KKVMKDSAPELNVSSSETEEDKEEAKPDGEK,_DSAPELNVS(ph)SS(ph)ETEEDK_, , , , ,-0.3,0.09,0.31,0.31, , , , ,-0.13,0.04,0.31,0.29,,,-0.09,0.31,,,-0.04,0.3,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,mitochondrion,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
P45974-2,P45974,Ubiquitin carboxyl-terminal hydrolase 5,USP5,118.15,115.18,S783,AEAAMDISEGRSAADSISESVPVGPKVRDGP,_SAADS(ph)ISESVPVGPK_,0,0.12,0.54,0.91,-0.18,0.31, ,-0.04,0.97,0.92,0.84,1.43,-0.35,0.34, ,0.52,0.06,0.74,0.09,-0.04,0.94,1.17,0.04,0.52,, +,,,Ubiquitin-Specific Proteases ,,0,5,7.19,lysosome,cysteine-type endopeptidase activity,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,,
Q92738,Q92738,USP6 N-terminal-like protein,USP6NL,113.91,113.52,S714,EVLPVDTGAGGYSGNSGSPKNGKLIIPPVDY,_IEVLPVDTGAGGYSGNS(ph)GSPK_, , ,0.19,0.39, , , , , , ,0.11,0.52, , , , ,,0.29,,,,0.33,,,,,,,,,NA,NA,,cytoplasmic membrane-bounded vesicle,Rab GTPase activator activity,Golgi organization,,
Q93009,Q93009,Ubiquitin carboxyl-terminal hydrolase 7,USP7,334.89,329.99,S18,HQQQQQQQKAGEQQLSEPEDMEMEAGDTDDP,_AGEQQLS(ph)EPEDMEMEAGDTDDPPR_,0.01,0.07,-0.02,-0.02,0.07,-0.01,0.02,-0.04,0.12,0.19,0.11,0.07,0.31,0.04,0.02,0.06,0.04,-0.02,0.04,-0.01,0.16,0.09,0.18,0.04,,,,,Ubiquitin-Specific Proteases ,,0,0,,cytosol,cysteine-type endopeptidase activity,maintenance of DNA methylation,,
B4DKA8,P40818,Ubiquitin carboxyl-terminal hydrolase,USP8,271.55,271.55,S718,PAERDREPSKLKRSYSSPDITQAIQEEEKRK,_SYS(ph)SPDITQAIQEEEK_,0,0.06,-0.06,0.15,0.46,-0.07,-0.07,-0.01,0.01,0.06,-0.18,-0.06,1.63,-0.08,-0.26,-2.01,0.03,0.05,0.22,-0.04,0.04,-0.12,1.02,-0.88,, +,,,Ubiquitin-Specific Proteases ,,0,5,17.31,,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
B4DKA8,P40818,Ubiquitin carboxyl-terminal hydrolase,USP8,196.43,196.43,S716,QIPAERDREPSKLKRSYSSPDITQAIQEEEK,_RS(ph)YSSPDITQAIQEEEK_,-0.24,0.02,0.07,-0.13,0.06,-0.06, ,-0.08,-0.34,-0.12,-0.16,-0.17,-0.11,-0.09, ,-0.03,-0.1,-0.02,0,-0.08,-0.23,-0.17,-0.1,-0.03,,,,,Ubiquitin-Specific Proteases ,,0,0,,,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
B4DKA8,P40818,Ubiquitin carboxyl-terminal hydrolase,USP8,115.41,113.64,S392,ISTPVEPVAASKSDVSPIIQPVPSIKNVPQI,_SDVS(ph)PIIQPVPSIK_,-0.18,-0.31,-0.11,-0.25, , , , ,-0.43,-0.22,-0.28,-0.5, , , , ,-0.24,-0.18,,,-0.32,-0.38,,,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,,cysteine-type peptidase activity,ubiquitin-dependent protein catabolic process,,
Q93008-1,Q93008,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,USP9X,34.7,28.89,S2563,TGQRAQENYEGSEEVSPPQTKDQ________,_AQENYEGSEEVS(ph)PPQTK_, , , , , , ,-0.31, , , , , , , ,-1.18, ,,,,-0.31,,,,-1.18,, +,,,Ubiquitin-Specific Proteases ,,NA,NA,,apical part of cell,cysteine-type endopeptidase activity,BMP signaling pathway,,
Q93008-1,Q93008,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,USP9X,121.9,121.9,S1593,IPSIRNGILAIEGTGSDVDDDMSGDEKQDNE,_NGILAIEGTGS(ph)DVDDDMS(ph)GDEK_, , , , , , ,-0.05, , , , , , , ,0.29, ,,,,-0.05,,,,0.29,,,,,Ubiquitin-Specific Proteases ,,NA,NA,,apical part of cell,cysteine-type endopeptidase activity,BMP signaling pathway,,
Q93008-1,Q93008,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,USP9X,219.67,219.67,S1600,ILAIEGTGSDVDDDMSGDEKQDNESNVDPRD,_NGILAIEGTGSDVDDDMS(ph)GDEK_,-0.15,-0.25,-0.31,-0.46,-0.34,-0.38,-0.19,-0.08,0.07,0.07,-0.04,0.12,-0.01,0.15,0.07,0.18,-0.2,-0.38,-0.36,-0.13,0.07,0.04,0.07,0.13,,,,,Ubiquitin-Specific Proteases ,,0,0,,apical part of cell,cysteine-type endopeptidase activity,BMP signaling pathway,,
E9PEL7,Q9BVJ6,U3 small nucleolar RNA-associated protein 14 homolog A,UTP14A,257.66,257.66,S29,SQQEELADLPKDYLLSESEDEGDNDGERKHQ,_DYLLS(ph)ES(ph)EDEGDNDGERK_,0.51,0.5,0.51,0.56,0.25,0.23,0.36,0.26,0.27,0.26,-0.11,0.05,0.4,0.36,0.29,0.27,0.5,0.54,0.24,0.31,0.26,-0.03,0.38,0.28,,,,,,,0,0,,,,,,
E9PEL7,Q9BVJ6,U3 small nucleolar RNA-associated protein 14 homolog A,UTP14A,257.66,257.66,S31,QEELADLPKDYLLSESEDEGDNDGERKHQKL,_DYLLS(ph)ES(ph)EDEGDNDGERK_,0.51,0.5,0.51,0.56,0.25,0.23,0.36,0.26,0.27,0.26,-0.11,0.05,0.4,0.36,0.29,0.27,0.5,0.54,0.24,0.31,0.26,-0.03,0.38,0.28,,,,,,,0,0,,,,,,
E9PEL7,Q9BVJ6,U3 small nucleolar RNA-associated protein 14 homolog A,UTP14A,84.2,78.11,S453,QDAEPAGSQETKDSGSQEVLSELRVLSQKLK,_DSGS(ph)QEVLSELR_,-0.18, , , , , , , ,-0.15, , , , , , , ,-0.18,,,,-0.15,,,,,,,,,,NA,NA,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,79.67,79.67,S205,MGGVPAWAETTKRKTSSDDESEEDEDDLLQR,_KTS(ph)S(ph)DDES(ph)EEDEDDLLQR_,0.09,-0.14, ,0.02,0.34,0.61,0.42,0.81,-0.05,-0.08, ,-0.28,-0.1,0.18,0.23,0.12,-0.02,0.02,0.48,0.63,-0.06,-0.28,0.05,0.18,,,,,,,0,0,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,218.6,212.11,S206,GGVPAWAETTKRKTSSDDESEEDEDDLLQRT,_TSS(ph)DDES(ph)EEDEDDLLQR_,0.81,0.77, ,0.02,0.14,0.13,0.07,0.2,-0.18,-0.04, ,-0.28,-0.5,-0.45,0,-0.03,0.79,0.02,0.13,0.14,-0.11,-0.28,-0.47,-0.01,,,,,,,0,0,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,218.6,212.11,S210,AWAETTKRKTSSDDESEEDEDDLLQRTGNFI,_TSS(ph)DDES(ph)EEDEDDLLQR_,0.81,0.77,-0.38,0.06,0.14,0.13,0.07,0.2,-0.18,-0.06,-0.42,-0.59,-0.5,-0.45,0,-0.03,0.79,-0.14,0.13,0.14,-0.12,-0.5,-0.47,-0.01,,,,,,,0,0,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,128.01,123.66,S121,LLRRLRGPRVQEHEDSGDSEVENEAKGNFPP,_VQEHEDS(ph)GDS(ph)EVENEAK_,0.3,0.02,0.18, , ,0.1,0.22,0.14,0.12,0.06,0.19, , ,0,0.33,0.09,0.16,0.18,0.1,0.18,0.09,0.19,0,0.21,,,,,,,0,0,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,128.01,123.66,S124,RLRGPRVQEHEDSGDSEVENEAKGNFPPQKK,_VQEHEDS(ph)GDS(ph)EVENEAK_,0.3,0.02,0.18, , ,0.1,0.22,0.14,0.12,0.06,0.19, , ,0,0.33,0.09,0.16,0.18,0.1,0.18,0.09,0.19,0,0.21,,,,,,,0,0,,,,,,
B2RAX6,Q9Y5J1,U3 small nucleolar RNA-associated protein 18 homolog,UTP18,190.15,190.15,T204,AMGGVPAWAETTKRKTSSDDESEEDEDDLLQ,_KT(ph)S(ph)S(ph)DDESEEDEDDLLQR_,0.09,-0.14, ,0.02,0.34,0.61,-0.08,0.81,-0.05,-0.08, ,-0.28,-0.1,0.18,-0.27,0.12,-0.02,0.02,0.48,0.43,-0.06,-0.28,0.05,-0.06,,,,,,,0,0,,,,,,
Q2YD98,Q2YD98,UV-stimulated scaffold protein A,UVSSA,167.5,167.35,S281,AGGGAQPSQTATGDPSDEDEDSDLEEFVRSH,_AGGGAQPSQTATGDPS(ph)DEDEDS(ph)DLEEFVR_, , , , ,0.06,-0.19,0.1,0.1, , , , ,-0.01,-0.18,0.15,-0.09,,,-0.06,0.1,,,-0.09,0.04,,,,,,,NA,NA,,chromosomal part,RNA polymerase II core binding,protein ubiquitination,,
Q2YD98,Q2YD98,UV-stimulated scaffold protein A,UVSSA,167.5,167.35,S287,PSQTATGDPSDEDEDSDLEEFVRSHGLGSHK,_AGGGAQPSQTATGDPS(ph)DEDEDS(ph)DLEEFVR_, , , , ,0.06,-0.19,0.1,0.1, , , , ,-0.01,-0.18,0.15,-0.09,,,-0.06,0.1,,,-0.09,0.04,,,,,,,NA,NA,,chromosomal part,RNA polymerase II core binding,protein ubiquitination,,
O75379,O75379,Vesicle-associated membrane protein 4,VAMP4,235.26,226.76,S30,TGSVKSERRNLLEDDSDEEEDFFLRGPSGPR,_NLLEDDS(ph)DEEEDFFLR_, ,-0.08, ,-0.19, ,-0.48,0.11,-0.04, ,0.17, ,-0.09, ,-0.19,0.2,0.1,-0.08,-0.19,-0.48,0.03,0.17,-0.09,-0.19,0.15,,,,,,,0,0,,endosome,,Golgi to plasma membrane protein transport,,
O95292,O95292,Vesicle-associated membrane protein-associated protein B/C,VAPB,147.12,110.83,S158,TTASKTETPIVSKSLSSSLDDTEVKKVMEEC,_SLS(ph)SSLDDTEVK_, , ,1.87,1.02, , , , , , ,1.89,1.18, , , , ,,1.51,,,,1.58,,, +, +,,,,,NA,NA,,endoplasmic reticulum membrane,beta-tubulin binding,activation of signaling protein activity involved in unfolded protein response,,
O95292,O95292,Vesicle-associated membrane protein-associated protein B/C,VAPB,145.04,139.14,S156,ISTTASKTETPIVSKSLSSSLDDTEVKKVME,_S(ph)LSSS(ph)LDDTEVK_,0.19,0.64,1.01, ,-0.48,-0.42,-0.33,-0.32,-0.18,0.2,0.97, ,-0.63,-0.45,-0.71,-0.63,0.43,1.01,-0.45,-0.32,0.03,0.97,-0.54,-0.66, +,,,,,,4,0,24.57,endoplasmic reticulum membrane,beta-tubulin binding,activation of signaling protein activity involved in unfolded protein response,,
O95292,O95292,Vesicle-associated membrane protein-associated protein B/C,VAPB,106.14,73.41,S159,TASKTETPIVSKSLSSSLDDTEVKKVMEECK,_SLSS(ph)SLDDTEVK_, ,0.26,-0.34, ,-1.13,-0.18,-0.07,-0.31, ,0.29,0.43, ,-0.5,-0.26,-0.2,-0.27,0.26,-0.34,-0.58,-0.19,0.29,0.43,-0.38,-0.23,,,,,,,0,0,,endoplasmic reticulum membrane,beta-tubulin binding,activation of signaling protein activity involved in unfolded protein response,,
O95292,O95292,Vesicle-associated membrane protein-associated protein B/C,VAPB,145.04,139.14,S160,ASKTETPIVSKSLSSSLDDTEVKKVMEECKR,_S(ph)LSSS(ph)LDDTEVK_,0.19,0.16,-0.1, , ,-0.42,-0.33,-0.32,-0.18,0.34,-0.08, , ,-0.45,-0.71,-0.63,0.18,-0.1,-0.42,-0.32,0.11,-0.08,-0.45,-0.66,,,,,,,0,0,,endoplasmic reticulum membrane,beta-tubulin binding,activation of signaling protein activity involved in unfolded protein response,,
P50552,P50552,Vasodilator-stimulated phosphoprotein,VASP,124.51,104.92,Y39,LPAGTGPQAFSRVQIYHNPTANSFRVVGRKM,_VQIY(ph)HNPTANSFR_,-0.28, ,-0.56, ,0.03, ,0.06,0.14,-0.25, ,-0.44, ,0.21, ,0.28,0.27,-0.28,-0.56,0.03,0.1,-0.25,-0.44,0.21,0.27,,,,,,,0,0,,actin cytoskeleton,,actin polymerization or depolymerization,,
P52735-3,P52735,Guanine nucleotide exchange factor VAV2,VAV2,300.24,297.74,Y142,RPFPSEETTENDDDVYRSLEELADEHDLGED,_GIRPFPSEETTENDDDVY(ph)R_,5.8,3.87,4.14, , , ,1.06, ,4.81,2.86,2.01, , , ,1.29, ,5.13,4.14,,1.06,4.14,2.01,,1.29, +, +,,,,,NA,NA,,cytosol,guanyl-nucleotide exchange factor activity,angiogenesis,,+
Q9UKW4,Q9UKW4,Guanine nucleotide exchange factor VAV3,VAV3,357.61,351.36,Y141,IRPFPTEESINDEDIYKGLPDLIDETLVEDE,_TPIALATGIRPFPTEESINDEDIY(ph)K_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,GTPase activator activity,angiogenesis,,
P18206-2,P18206,Vinculin,VCL,219.96,219.17,S290,SKLNQAKGWLRDPSASPGDAGEQAIRQILDE,_DPSAS(ph)PGDAGEQAIR_,-0.75,0.71,-0.72,0.36,-0.42,-0.58,-0.53,-0.46,-0.45,-0.31,-0.34,-0.55,-0.39,-0.75,-0.27,-0.07,0.16,-0.08,-0.49,-0.5,-0.38,-0.44,-0.56,-0.17,,,,,,,0,0,,actin cytoskeleton,actin binding,adherens junction assembly,,
P18206-2,P18206,Vinculin,VCL,256.49,212.1,Y692,SAARILLRNPGNQAAYEHFETMKNQWIDNVE,_ILLRNPGNQAAY(ph)EHFETMK_,-0.21,-0.39,-0.6, ,0.3,0.31,0.45,0.34,-0.06,-0.35,-0.3, ,0.09,0.02,0.48,0.38,-0.3,-0.6,0.31,0.4,-0.2,-0.3,0.06,0.43,,,,,,,0,0,,actin cytoskeleton,actin binding,adherens junction assembly,,
P18206-2,P18206,Vinculin,VCL,161.02,117.21,Y822,NISDPGLQKSFLDSGYRILGAVAKVREAFQP,_SFLDSGY(ph)R_,-0.16,0.1,-0.28,-0.1,0.33,0.29,0.18,0.11,-0.13,-0.04,0.02,-0.08,-0.29,-0.09,0.11,0.22,-0.02,-0.19,0.31,0.14,-0.09,-0.03,-0.19,0.16,,,,,,,0,0,,actin cytoskeleton,actin binding,adherens junction assembly,,
P18206-2,P18206,Vinculin,VCL,71.35,40.79,S579,GESPQARALASQLQDSLKDLKARMQEAMTQE,_ALASQLQDS(ph)LK_,0.03, ,-0.31, , , , , ,0.01, ,0.1, , , , , ,0.03,-0.31,,,0.01,0.1,,,,,,,,,NA,NA,,actin cytoskeleton,actin binding,adherens junction assembly,,
P18206-2,P18206,Vinculin,VCL,97.27,97.27,S820,AGNISDPGLQKSFLDSGYRILGAVAKVREAF,_SFLDS(ph)GYR_, , , ,0.29, , , ,0.89, , , ,0.05, , , ,0.39,,0.29,,0.89,,0.05,,0.39,,,,,,,NA,NA,,actin cytoskeleton,actin binding,adherens junction assembly,,
P18206-2,P18206,Vinculin,VCL,175.66,148.39,S721,VEKMTGLVDEAIDTKSLLDASEEAIKKDLDK,_S(ph)LLDASEEAIKK_,-0.27,-0.3,-0.52,-0.47,-0.12,-0.22,-0.18,-0.22,-0.03,-0.02,-0.04,-0.05,-0.16,-0.26,-0.09,0.1,-0.29,-0.5,-0.17,-0.2,-0.02,-0.05,-0.21,0.01,,,,,,,0,0,,actin cytoskeleton,actin binding,adherens junction assembly,,
P55072,P55072,Transitional endoplasmic reticulum ATPase,VCP,101.91,101.09,S784,GSFRFPSGNQGGAGPSQGSGGGTGGSVYTED,_FPSGNQGGAGPS(ph)QGS(ph)GGGTGGSVYTEDNDDDLYG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,ATP binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
P55072,P55072,Transitional endoplasmic reticulum ATPase,VCP,89.9,88.87,S787,RFPSGNQGGAGPSQGSGGGTGGSVYTEDNDD,_FPSGNQGGAGPS(ph)QGS(ph)GGGTGGSVYTEDNDDDLYG_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,ATP binding,activation of cysteine-type endopeptidase activity involved in apoptotic process,,
Q96JH7,Q96JH7,Deubiquitinating protein VCIP135,VCPIP1,133.72,132.97,S1198,LGAAFATRSKAQRGNSVEELEEMDSQDAEMT,_GNS(ph)VEELEEMDS(ph)QDAEMTNTTEPMDHS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,Otubain Proteases ,,NA,NA,,cytoplasm,ubiquitin-specific protease activity,endoplasmic reticulum membrane fusion,,
Q96JH7,Q96JH7,Deubiquitinating protein VCIP135,VCPIP1,92.59,92.55,S1207,KAQRGNSVEELEEMDSQDAEMTNTTEPMDHS,_GNS(ph)VEELEEMDS(ph)QDAEMTNTTEPMDHS_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,Otubain Proteases ,,NA,NA,,cytoplasm,ubiquitin-specific protease activity,endoplasmic reticulum membrane fusion,,
Q96JH7,Q96JH7,Deubiquitinating protein VCIP135,VCPIP1,79.51,74.22,S994,VKEAVSQVRAEATTRSRESSPSHGLLKLGSG,_S(ph)RES(ph)SPSHGLLK_,0.26,-0.09,-0.15,-0.19, ,-0.64,-0.61,-0.73,0.22,0.07,-0.04,0.01, ,-0.1,-0.54,-0.65,0.09,-0.17,-0.64,-0.67,0.15,-0.02,-0.1,-0.59,,,,,Otubain Proteases ,,0,0,,cytoplasm,ubiquitin-specific protease activity,endoplasmic reticulum membrane fusion,,
Q96JH7,Q96JH7,Deubiquitinating protein VCIP135,VCPIP1,95.75,69.64,S997,AVSQVRAEATTRSRESSPSHGLLKLGSGGVV,_SRES(ph)S(ph)PSHGLLK_,0.29,-0.09,-0.15,-0.19,-0.45,-0.64,-0.48,-0.73,0.33,0.07,-0.04,0.01,0.13,-0.1,-0.35,-0.65,0.11,-0.17,-0.54,-0.6,0.21,-0.02,0.02,-0.49,,,,,Otubain Proteases ,,0,0,,cytoplasm,ubiquitin-specific protease activity,endoplasmic reticulum membrane fusion,,
Q96JH7,Q96JH7,Deubiquitinating protein VCIP135,VCPIP1,95.75,69.64,S998,VSQVRAEATTRSRESSPSHGLLKLGSGGVVK,_S(ph)RESS(ph)PSHGLLK_,0.29,-0.09,-0.15,-0.19,-0.45,-0.69,-0.48,-0.73,0.33,0.07,-0.04,0.01,0.13,-0.14,-0.35,-0.65,0.11,-0.17,-0.57,-0.6,0.21,-0.02,0.01,-0.49,,,,,Otubain Proteases ,,0,0,,cytoplasm,ubiquitin-specific protease activity,endoplasmic reticulum membrane fusion,,
P21796,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,190.24,190.24,S104,DQLARGLKLTFDSSFSPNTGKKNAKIKTGYK,_LTFDSSFS(ph)PNTGKK_,0.2,0.3,0.17,0.19,0.18,0.06,0.28,0.35,0.09,0.09,0.07,0,0.33,0.1,0.14,0.23,0.25,0.18,0.12,0.31,0.09,0.04,0.22,0.19,,,,,,,0,0,,mitochondrial inner membrane,porin activity,apoptotic process,,
P45880-2,P45880,Voltage-dependent anion-selective channel protein 2,VDAC2,144.68,144.68,S115,DQICQGLKLTFDTTFSPNTGKKSGKIKSSYK,_LTFDTTFS(ph)PNTGKK_,0.27,-0.01,0.3,-0.02,0.2, , , ,0.27,0.07,0.36,0.25,0.35, , , ,0.14,0.15,0.2,,0.17,0.31,0.35,,,,,,,,NA,NA,,mitochondrial inner membrane,nucleotide binding,negative regulation of intrinsic apoptotic signaling pathway,,
P08670,P08670,Vimentin,VIM,220.36,196.49,S459,IKTVETRDGQVINETSQHHDDLE________,_DGQVINETS(ph)QHHDDLE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell leading edge,structural constituent of cytoskeleton,astrocyte development,,
P08670,P08670,Vimentin,VIM,132.64,130.53,S55,LGSALRPSTSRSLYASSPGGVYATRSSAVRL,_SLYAS(ph)SPGGVYATR_, , , , ,-0.46,-0.52,-1.28,-0.65, , , , ,-0.4,-0.22,-0.95,-1.01,,,-0.49,-0.93,,,-0.31,-0.98,,,,,,,NA,NA,,cell leading edge,structural constituent of cytoskeleton,astrocyte development,,
P08670,P08670,Vimentin,VIM,114.96,112.04,S56,GSALRPSTSRSLYASSPGGVYATRSSAVRLR,_SLYASS(ph)PGGVYATR_, ,-0.05, , , ,-0.44, ,-0.87, ,-0.3, , , ,-0.48, ,-1,-0.05,,-0.44,-0.87,-0.3,,-0.48,-1,,,,,,,NA,NA,,cell leading edge,structural constituent of cytoskeleton,astrocyte development,,
Q7Z7G8-3,Q7Z7G8,Vacuolar protein sorting-associated protein 13B,VPS13B,78.85,63.92,S999,VPLVMPVCRRKEDEVSIGSAPLAKQQSYQAS,_EDEVS(ph)IGS(ph)APLAK_, , , , ,0.47,0.29,0.63,-0.03, , , , ,0.06,0.25,0.06,0.26,,,0.38,0.33,,,0.15,0.16,,,,,,,NA,NA,,,,protein transport,,
Q7Z7G8-3,Q7Z7G8,Vacuolar protein sorting-associated protein 13B,VPS13B,78.85,63.92,S1002,VMPVCRRKEDEVSIGSAPLAKQQSYQASEYA,_EDEVS(ph)IGS(ph)APLAK_, , , , ,0.47,0.29,0.63,-0.03, , , , ,0.06,0.25,0.06,0.26,,,0.38,0.33,,,0.15,0.16,,,,,,,NA,NA,,,,protein transport,,
Q5THJ4-2,Q5THJ4,Vacuolar protein sorting-associated protein 13D,VPS13D,95.46,92.89,S1042,SFDIPTGSLRDSRAQSPVSGPNVAHLTDGAT,_AQS(ph)PVSGPNVAHLTDGATLNDR_,0.08,0.19,0.02, , , , , ,0.34,0.24,0.39, , , , , ,0.13,0.02,,,0.29,0.39,,,,,,,,,NA,NA,,,,,,
Q5THJ4-2,Q5THJ4,Vacuolar protein sorting-associated protein 13D,VPS13D,129.43,127.1,S1765,QKEVQDKDYPLTPPPSPTVDEPKILVGKSKF,_DYPLT(ph)PPPS(ph)PTVDEPK_, ,0.48,0.61,0.68,0.56,0.47,0.34, , ,0.9,0.91,0.72,0.62,0.68,0.56, ,0.48,0.65,0.51,0.34,0.9,0.82,0.65,0.56,,,,,,,0,0,,,,,,
Q5THJ4-2,Q5THJ4,Vacuolar protein sorting-associated protein 13D,VPS13D,129.43,127.1,T1761,SRKKQKEVQDKDYPLTPPPSPTVDEPKILVG,_DYPLT(ph)PPPS(ph)PTVDEPK_,0.44,0.48,0.61,0.68,0.75,0.47,0.34, ,0.8,0.9,0.91,0.72,0.43,0.68,0.56, ,0.46,0.65,0.62,0.34,0.85,0.82,0.56,0.56,,,,,,,0,0,,,,,,
O75436,O75436,Vacuolar protein sorting-associated protein 26A,VPS26A,190.23,180.43,S315,EKLRKQRTNFHQRFESPESQASAEQPEM___,_FES(ph)PES(ph)QASAEQPEM_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,protein transporter activity,"retrograde transport, endosome to Golgi",,
O75436,O75436,Vacuolar protein sorting-associated protein 26A,VPS26A,89.86,71.63,S318,RKQRTNFHQRFESPESQASAEQPEM______,_FES(ph)PES(ph)QASAEQPEM_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,protein transporter activity,"retrograde transport, endosome to Golgi",,
H0YJL5,Q9UEU0,Vesicle transport through interaction with t-SNAREs homolog 1B,VTI1B,109,103.28,Y115,LTATPGGRGDMKYGIYAVENEHMNRLQSQRA,_YGIY(ph)AVENEHMNR_, , ,1.67, , , , , , , , , , , , , ,,1.67,,,,,,, +,,,,,,NA,NA,,,,,,
Q7Z5K2,Q7Z5K2,Wings apart-like protein homolog,WAPAL,262.44,227.35,S221,ETNDTWNSQFGKRPESPSEISPIKGSVRTGL,_RPES(ph)PSEIS(ph)PIK_,0.1,0.1,-0.03,-0.05,0.08,0.06,-0.49,0.14,0.12,0.14,-0.04,-0.02,-0.34,-0.27,-0.65,0.28,0.1,-0.04,0.07,-0.14,0.13,-0.03,-0.31,-0.11,,,,,,,0,0,,chromatin,,cytokinesis,,
Q7Z5K2,Q7Z5K2,Wings apart-like protein homolog,WAPAL,262.44,227.35,S226,WNSQFGKRPESPSEISPIKGSVRTGLFEWDN,_RPES(ph)PSEIS(ph)PIK_,-1.16,-0.12,-1.01,-0.54,0.15,-0.05,0.05,0.14,-1.22,-0.28,-0.82,0.3,0.18,0.02,0.17,0.28,-0.55,-0.76,0.05,0.1,-0.68,-0.15,0.1,0.23,,,,,,,0,0,,chromatin,,cytokinesis,,
Q7Z5K2,Q7Z5K2,Wings apart-like protein homolog,WAPAL,184.19,184.19,S77,PKVEEESTGDPFGFDSDDESLPVSSKNLAQV,_VEEESTGDPFGFDS(ph)DDESLPVSSK_,-0.28,-0.12,-0.3,-0.09,-0.11,-0.12,0.04,0.01,-0.24,0.06,-0.26,-0.05,-0.03,-0.07,-0.01,0.03,-0.2,-0.19,-0.11,0.03,-0.08,-0.15,-0.05,0.01,,,,,,,0,0,,chromatin,,cytokinesis,,
P23381,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,89.05,61.91,S467,VTDEIVKEFMTPRKLSFDFQ___________,_KLS(ph)FDFQ_,1.11,1.11,1.18,1.6, , , ,0.6,0.48,0.53,0.29,0.65, , , ,0.62,1.11,1.41,,0.6,0.5,0.48,,0.62, +,,,,,,NA,NA,,cytosol,ATP binding,angiogenesis,,
O00401,O00401,Neural Wiskott-Aldrich syndrome protein,WASL,120.15,71.59,Y256,ISEAQLKDRETSKVIYDFIEKTGGVEAVKNE,_VIY(ph)DFIEK_,-0.45,-0.47,-1.39,-1.35,-2.57,-2.13,-2.61,-2.55,-0.33,-0.32,-1.4,-1.39,-2.19,-2.13,-2.08,-1.94,-0.46,-1.37,-2.33,-2.58,-0.32,-1.4,-2.16,-2.01, +, +,,,,,6,6,35.14,actin cap,small GTPase regulator activity,actin polymerization or depolymerization,,
O00401,O00401,Neural Wiskott-Aldrich syndrome protein,WASL,271.77,270.31,S484,GALMEVMQKRSKAIHSSDEDEDEDDEEDFED,_AIHS(ph)S(ph)DEDEDEDDEEDFEDDDEWED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cap,small GTPase regulator activity,actin polymerization or depolymerization,,
O00401,O00401,Neural Wiskott-Aldrich syndrome protein,WASL,271.77,270.31,S485,ALMEVMQKRSKAIHSSDEDEDEDDEEDFEDD,_AIHS(ph)S(ph)DEDEDEDDEEDFEDDDEWED_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,actin cap,small GTPase regulator activity,actin polymerization or depolymerization,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,143.67,140.91,S237,ALDLPPRRRDEDMLYSPELAQRGHDDDVSST,_DEDMLYS(ph)PELAQR_,-0.38,-0.47,-0.33, ,0.41, , , ,-0.09,-0.12,0.05, ,0.27, , , ,-0.43,-0.33,0.41,,-0.1,0.05,0.27,,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,212.95,212.95,S353,AGQEIPEEGREVEEFSEDDDEDDSDDSEAEK,_M(ox)AGQEIPEEGREVEEFS(ph)EDDDEDDS(ph)DDS(ph)EAEK_, ,-0.04,-0.15, ,-0.03,0.18,0.04,0.02, ,0.14,0, ,-0.3,0.21,-0.1,0.05,-0.04,-0.15,0.08,0.03,0.14,0,-0.02,-0.02,,,,,,,0,0,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,212.95,212.95,S361,GREVEEFSEDDDEDDSDDSEAEKQSQKQHKE,_M(ox)AGQEIPEEGREVEEFS(ph)EDDDEDDS(ph)DDS(ph)EAEK_, ,-0.04,-0.15, ,-0.03,0.18,-0.05,-0.07, ,0.14,0, ,-0.3,0.21,-0.2,0.01,-0.04,-0.15,0.08,-0.06,0.14,0,-0.02,-0.09,,,,,,,0,0,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,212.95,212.95,S364,VEEFSEDDDEDDSDDSEAEKQSQKQHKEESH,_M(ox)AGQEIPEEGREVEEFS(ph)EDDDEDDS(ph)DDS(ph)EAEK_, ,-0.04,-0.15, ,-0.03,-0.03,-0.63,-0.99, ,0.14,0, ,-0.3,-0.11,-1.08,-0.65,-0.04,-0.15,-0.03,-0.8,0.14,0,-0.2,-0.85,,,,,,,0,0,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,65.73,65.73,S250,LYSPELAQRGHDDDVSSTSEDDGYPEDMDQD,_GHDDDVS(ph)S(ph)TS(ph)EDDGYPEDMDQDK_, , , , , ,-0.18,-0.33,-0.23, , , , , ,-0.12,-0.15,-0.05,,,-0.18,-0.28,,,-0.12,-0.1,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,65.73,65.73,S251,YSPELAQRGHDDDVSSTSEDDGYPEDMDQDK,_GHDDDVS(ph)S(ph)TS(ph)EDDGYPEDMDQDK_, , , , , ,-0.18,-0.33,-0.23, , , , , ,-0.12,-0.15,-0.05,,,-0.18,-0.28,,,-0.12,-0.1,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,65.73,65.73,S253,PELAQRGHDDDVSSTSEDDGYPEDMDQDKHD,_GHDDDVS(ph)S(ph)TS(ph)EDDGYPEDMDQDK_, , , , , ,-0.18,-0.33,-0.34, , , , , ,-0.12,-0.15,-0.19,,,-0.18,-0.34,,,-0.12,-0.17,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,59.69,55.47,S279,QDKHDDSTDDSDTDKSDGESDGDEFVHRDNG,_S(ph)DGES(ph)DGDEFVHR_, , , , , , ,0.01,0, , , , , , ,-0.01,-0.24,,,,0,,,,-0.12,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
F5H721,Q9Y2W2,WW domain-binding protein 11,WBP11,59.69,55.47,S283,DDSTDDSDTDKSDGESDGDEFVHRDNGERDN,_S(ph)DGES(ph)DGDEFVHR_, , , , , , ,0.01,0, , , , , , ,-0.01,-0.24,,,,0,,,,-0.12,,,,,,,NA,NA,,endoplasmic reticulum,,RNA processing,,
O75717,O75717,WD repeat and HMG-box DNA-binding protein 1,WDHD1,138.78,138.14,S374,DDEDLMMASGRPRQRSHILEDDENSVDISML,_(gl)QRS(ph)HILEDDENS(ph)VDISMLK_, , , , ,1.18, , , , , , , ,1.37, , , ,,,1.18,,,,1.37,, +, +,,,,,NA,NA,,"chromosome, centromeric region",chromatin binding,heterochromatin maintenance,,
O75717,O75717,WD repeat and HMG-box DNA-binding protein 1,WDHD1,138.78,138.14,S383,GRPRQRSHILEDDENSVDISMLKTGSSLLKE,_(gl)QRS(ph)HILEDDENS(ph)VDISMLK_, , , , ,1.18, , , , , , , ,1.37, , , ,,,1.18,,,,1.37,, +, +,,,,,NA,NA,,"chromosome, centromeric region",chromatin binding,heterochromatin maintenance,,
O75083,O75083,WD repeat-containing protein 1,WDR1,33.94,32.86,Y238,KVCALGGSKAHDGGIYAISWSPDSTHLLSAS,_AHDGGIY(ph)AISWSPDSTHLLSASGDK_,-0.26, , , , , , , ,0.08, , , , , , , ,-0.26,,,,0.08,,,,,,,,,,NA,NA,,cell junction,,platelet activation,,
Q9H1Z4,Q9H1Z4,WD repeat-containing protein 13,WDR13,91.1,91.1,S70,LRLRGQLLGQRYGPLSEPGSARAYSNSIVRS,_YGPLS(ph)EPGS(ph)AR_, , , , ,-0.46,-0.09,-0.31,-0.06, , , , ,-0.84,-0.89,-0.29,-0.41,,,-0.27,-0.18,,,-0.87,-0.35,,,,,,,NA,NA,,cytoplasm,,,,
Q9H1Z4,Q9H1Z4,WD repeat-containing protein 13,WDR13,91.1,91.1,S74,GQLLGQRYGPLSEPGSARAYSNSIVRSSRTT,_YGPLS(ph)EPGS(ph)AR_, , , , ,-0.46,-0.09,-0.31,-0.06, , , , ,-0.84,-0.89,-0.29,-0.41,,,-0.27,-0.18,,,-0.87,-0.35,,,,,,,NA,NA,,cytoplasm,,,,
Q9H7D7-2,Q9H7D7,WD repeat-containing protein 26,WDR26,102.36,102.36,S121,ATPELGSSLKKKKRLSQSDEDVIRLIGQHLN,_RLS(ph)QSDEDVIR_, ,0.04, , ,0.41, ,0.44,0.4, ,2.46, , ,0.38, ,0.47,4.72,0.04,,0.41,0.42,2.46,,0.38,3.79,, +,,,,,NA,NA,,cytoplasm,,,,
Q9UNX4,Q9UNX4,WD repeat-containing protein 3,WDR3,150.48,146.94,S240,EIEDPEEPDPKKIKGSSPGIQDTLEAEDGAF,_GS(ph)SPGIQDTLEAEDGAFETDEAPEDR_, , , , ,-0.52, ,0.37, , , , , ,0.2, ,-0.07, ,,,-0.52,0.37,,,0.2,-0.07,,,,,,,NA,NA,,nuclear membrane,,,,
Q9C0J8,Q9C0J8,pre-mRNA 3' end processing protein WDR33,WDR33,92.41,92.41,S1210,FRDTPRPDHPPHDGHSPASRERSSSLQGMDM,_DTPRPDHPPHDGHS(ph)PASR_,-0.2,-0.56,-0.58, , , , , ,-0.3,-0.48,-0.45, , , , , ,-0.37,-0.58,,,-0.39,-0.45,,,,,,,,,NA,NA,,collagen,,mRNA processing,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,50.17,41.83,S666,GEDRDTASEKELNGDSDLDPENESEEE____,_ELNGDS(ph)DLDPENES(ph)EEE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,,,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,50.17,41.83,S674,EKELNGDSDLDPENESEEE____________,_ELNGDS(ph)DLDPENES(ph)EEE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,,,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,88.28,86,S603,ATSPGQKAKLVYEEESSEEESDDEIADKDSE,_LVYEEES(ph)S(ph)EEES(ph)DDEIADK_, , , , , , , ,0.28, , , , , , , ,0.27,,,,0.28,,,,0.27,,,,,,,NA,NA,,nucleolus,,,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,88.28,86,S604,TSPGQKAKLVYEEESSEEESDDEIADKDSED,_LVYEEES(ph)S(ph)EEES(ph)DDEIADK_, , , , , , , ,0.28, , , , , , , ,0.27,,,,0.28,,,,0.27,,,,,,,NA,NA,,nucleolus,,,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,88.28,86,S608,QKAKLVYEEESSEEESDDEIADKDSEDNWDE,_LVYEEES(ph)S(ph)EEES(ph)DDEIADK_, , , , , , , ,0.28, , , , , , , ,0.27,,,,0.28,,,,0.27,,,,,,,NA,NA,,nucleolus,,,,
Q15061,Q15061,WD repeat-containing protein 43,WDR43,90.73,65.2,S431,KPAPPQTEQVESKRKSGGNEVSIEERLGAMD,_S(ph)GGNEVSIEER_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,177.76,177.76,S262,PPPPSRPAPPPRKRKSELEFETLKTPDIDVP,_RKS(ph)ELEFETLK_,1.15,1.44,0.69,0.41,0.86,0.51,0.69, ,0.72,1.11,0.43,0.33,0.59,0.42,0.48, ,1.3,0.56,0.7,0.69,0.93,0.38,0.51,0.48, +,,,,,,5,0,56.55,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,242.41,205.16,S50,TFKETENTAYKVGNESPVQELKQDVSKKIIE,_VGNES(ph)PVQELK_,-0.03,0.18,0.07,0.11,0.31,0.4,0.4,0.67,-0.01,0.03,0.07,0.07,0.1,0.11,0.07,-0.12,0.08,0.09,0.36,0.54,0.01,0.07,0.11,-0.02,,,,,,,0,0,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,198.78,197.27,S3,_____________MASESDTEEFYDAPEDVH,_(ac)AS(ph)ES(ph)DTEEFYDAPEDVHLGGGYPVGSPGK_, ,0.31, , ,0.4,0.41,0.41, , ,0.42, , ,0.27,0.2,0.67, ,0.31,,0.41,0.41,0.42,,0.23,0.67,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,188.93,188,S5,___________MASESDTEEFYDAPEDVHLG,_(ac)AS(ph)ES(ph)DTEEFYDAPEDVHLGGGYPVGSPGK_, ,0.31, , ,0.4,0.45,0.56,0.05, ,0.42, , ,0.27,0.25,0.44,0.28,0.31,,0.43,0.33,0.42,,0.26,0.36,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,198.78,197.27,S27,DAPEDVHLGGGYPVGSPGKVGLSTFKETENT,_(ac)ASES(ph)DTEEFYDAPEDVHLGGGYPVGS(ph)PGK_, , , , ,0.44,0.5,0.68,0.49, , , , ,0.38,0.29,0.48,0.41,,,0.47,0.59,,,0.34,0.44,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,110.67,110.5,S470,KSVRDEVFHTDQDDPSSSDDEGMPYTRPVKF,_DEVFHTDQDDPS(ph)S(ph)S(ph)DDEGMPYTRPVK_,0.06,0.02,-0.06, , , , , ,-0.23,-0.24,-0.05, , , , , ,0.04,-0.06,,,-0.24,-0.05,,,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,110.67,110.5,S471,SVRDEVFHTDQDDPSSSDDEGMPYTRPVKFK,_DEVFHTDQDDPS(ph)S(ph)S(ph)DDEGMPYTRPVK_,0.06,0.02,-0.06, , , , , ,-0.23,-0.24,-0.05, , , , , ,0.04,-0.06,,,-0.24,-0.05,,,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,110.67,110.5,S472,VRDEVFHTDQDDPSSSDDEGMPYTRPVKFKA,_DEVFHTDQDDPS(ph)S(ph)S(ph)DDEGMPYTRPVK_,0.06,0.02,-0.06, , , , , ,-0.23,-0.24,-0.05, , , , , ,0.04,-0.06,,,-0.24,-0.05,,,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,197.28,150.48,S96,SLDSKGKELSDQATASPIVARTDLSNIPGLL,_ELSDQATAS(ph)PIVAR_,0,-0.04,-0.37,-0.4,-0.68,-0.44,-0.53,-0.44,-0.15,-0.2,-0.44,-0.57,-0.87,-0.63,-0.6,-0.28,-0.02,-0.38,-0.56,-0.48,-0.18,-0.5,-0.75,-0.43,,,,,,,0,0,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,335.14,327.22,S403,IMRRTKEYVSNDAAQSDDEEKLQSQPTDTDG,_EYVSNDAAQS(ph)DDEEK_,0.1,0.04,0.04,-0.08,0.36,0.43,0.18,0.31,0.13,0.13,0.08,0.16,0.21,0.36,0.18,0.23,0.07,-0.02,0.4,0.25,0.13,0.12,0.29,0.21,,,,,,,0,0,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,84.97,84.6,S561,YFNNMRMKYNTEGRVSPSPSQESLSSSKSDT,_YNTEGRVS(ph)PSPS(ph)QES(ph)LSSSK_, , , , ,0.8,0.81,0.74,0.74, , , , ,0.86,0.39,0.15,0.65,,,0.81,0.74,,,0.64,0.42,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,84.97,84.6,S565,MRMKYNTEGRVSPSPSQESLSSSKSDTDTGV,_YNTEGRVS(ph)PSPS(ph)QES(ph)LSSSK_, , , , ,0.8,0.81,0.74,0.74, , , , ,0.86,0.39,0.15,0.65,,,0.81,0.74,,,0.64,0.42,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,84.97,84.6,S568,KYNTEGRVSPSPSQESLSSSKSDTDTGVCSG,_YNTEGRVS(ph)PSPS(ph)QES(ph)LSSSK_, , , , ,0.8,0.81,0.74,0.74, , , , ,0.86,0.39,0.15,0.65,,,0.81,0.74,,,0.64,0.42,,,,,,,NA,NA,,cytosol,,,,
Q5JSH3-2,Q5JSH3,WD repeat-containing protein 44,WDR44,175.69,133.37,T94,DDSLDSKGKELSDQATASPIVARTDLSNIPG,_ELSDQAT(ph)ASPIVAR_,0.03, , , , , , , ,-0.13, , , , , , , ,0.03,,,,-0.13,,,,,,,,,,NA,NA,,cytosol,,,,
Q6PJI9-4,Q6PJI9,WD repeat-containing protein 59,WDR59,100.47,99.73,S822,AGREAEHLSSPWGESSPEELRFGSLTYSDPR,_EAEHLSSPWGESS(ph)PEELR_,-0.46, ,0.01, ,0.2,-0.44, , ,-0.32, ,-0.13, ,0.16,-0.11, , ,-0.46,0.01,-0.09,,-0.32,-0.13,0.03,,,,,,,,NA,NA,,,,,,
O43379,O43379,WD repeat-containing protein 62,WDR62,93.22,93.22,T46,QSSPPPAPPICLRRRTRLSTASEETVQNRVS,_T(ph)RLS(ph)TASEETVQNR_, , ,0.86,0.69, , , , , , ,1.09,0.8, , , , ,,0.78,,,,0.95,,,,,,,,,NA,NA,,cytoplasm,,cerebral cortex development,,
Q9NW82,Q9NW82,WD repeat-containing protein 70,WDR70,292.65,278.39,S638,AYSKTQPKTMFAQVESDDEEAKNEPEWKKRK,_TMFAQVES(ph)DDEEAK_,0.04,0.04,-0.02,0.01,-0.06,0.04,0.11,0.09,0.12,0.07,0.04,-0.03,-0.08,-0.01,0,0.04,0.04,-0.01,-0.01,0.1,0.09,0.01,-0.05,0.02,,,,,,,0,0,,,,,,
Q8IWA0,Q8IWA0,WD repeat-containing protein 75,WDR75,192.69,186.78,S779,AKEIPEDVDMEEEKESEDSDEENDFTEKVQD,_EIPEDVDMEEEKES(ph)EDS(ph)DEENDFTEK_,-0.02,0.18,0.19,0.13,-0.03,-0.06,-0.04,-0.22,0.15,0.27,-0.02,-0.14,-0.06,0.22,-0.08,-0.38,0.08,0.16,-0.05,-0.13,0.21,-0.08,0.09,-0.22,,,,,,,0,0,,nucleus,,,,
Q8IWA0,Q8IWA0,WD repeat-containing protein 75,WDR75,192.69,186.78,S782,IPEDVDMEEEKESEDSDEENDFTEKVQDTSN,_EIPEDVDMEEEKES(ph)EDS(ph)DEENDFTEK_,-0.02,0.18,0.19,0.13,-0.03,-0.06,-0.04,-0.22,0.15,0.27,-0.02,-0.14,-0.06,0.22,-0.08,-0.38,0.08,0.16,-0.05,-0.13,0.21,-0.08,0.09,-0.22,,,,,,,0,0,,nucleus,,,,
Q9BQA1,Q9BQA1,Methylosome protein 50,WDR77,61.82,61.82,T5,___________MRKETPPPLVPPAAREWNLP,_KET(ph)PPPLVPPAAR_,0.21,0.31,0.33,1.57,-0.16,-0.31,-0.38,-0.08,0.18,0.09,-0.06,0.04,0.02,0.02,0,0.06,0.26,1.08,-0.24,-0.22,0.14,-0.01,0.02,0.03, +,,,,,,4,0,1.96,cytosol,ligand-dependent nuclear receptor transcription coactivator activity,ncRNA metabolic process,,
P30291,P30291,Wee1-like protein kinase,WEE1,60.54,54.9,Y132,EGFGSSSPVKSPAAPYFLGSSFSPVRCGGPG,_SPAAPY(ph)FLGSSFSPVR_, , , , , , , ,0.49, , , , , , , ,-0.9,,,,0.49,,,,-0.9,,,Other,,,,NA,NA,,cytoplasm,ATP binding,blood coagulation,,
G1K385,Q8TF30,"WASP homolog-associated protein with actin, membranes and microtubules",WHAMM,73.94,70.32,S795,SIKAALQRIKRVSADSEEDSDEQDPGQWDG_,_RVSADS(ph)EEDS(ph)DEQDPGQWDG_, , , , , ,-0.39,0.03,0.15, , , , , ,-0.29,-0.39,-0.1,,,-0.39,0.1,,,-0.29,-0.24,,,,,,,NA,NA,,,,,,
G1K385,Q8TF30,"WASP homolog-associated protein with actin, membranes and microtubules",WHAMM,73.94,70.32,S799,ALQRIKRVSADSEEDSDEQDPGQWDG_____,_RVSADS(ph)EEDS(ph)DEQDPGQWDG_, , , , , ,-0.39,-0.12,1.44, , , , , ,-0.29,-0.36,-0.09,,,-0.39,0.86,,,-0.29,-0.22,,,,,,,NA,NA,,,,,,
D6RIS1,O96028,Probable histone-lysine N-methyltransferase NSD2,WHSC1,72.58,68.79,T110,DAKLRFESQEMKGIGTPPNTTPIKNGSPEIK,_GIGT(ph)PPNTT(ph)PIK_, , , , ,-0.77,-0.83,-0.56,-0.95, , , , ,0.88,0.54,0.85,0.08,,,-0.8,-0.74,,,0.72,0.52,,,,RING finger,,,NA,NA,,nucleus,chromatin binding,atrial septum primum morphogenesis,,
Q9H3P2,Q9H3P2,Negative elongation factor A,WHSC2,120.59,86.54,T277,LDMVGAGREAKRRRKTLDAEVVEKPAKEETV,_T(ph)LDAEVVEK_, , ,2.69,2.31,1.13, , , , , ,3.4,2.82,1.12, , , ,,2.51,1.13,,,3.14,1.12,, +, +,,,,,NA,NA,,NELF complex,chromatin binding,multicellular organismal development,,
E9PB87,O43516,WAS/WASL-interacting protein family member 1,WIPF1,57.83,36.56,S350,PQRNLSLSSSTPPLPSPGRSGPLPPPPSERP,_NLSLSS(ph)STPPLPS(ph)PGR_, , , , ,-0.19,-1.04, , , , , , ,-0.06,-0.67, , ,,,-0.55,,,,-0.34,,,,,,,,NA,NA,,,,,,
B3KVH1,O95785,Protein Wiz,WIZ,149.33,149.33,S1012,PTPKNPEDKSPQLSLSPRPASPKAQWPQSED,_SPQLSLS(ph)PRPAS(ph)PK_,0.12,0,1.4,-0.34,-0.05,0.73,0.57,0.03,0.22,0.14,1.64,-0.54,0.02,0.57,0.06,-0.06,0.06,0.78,0.39,0.33,0.18,0.93,0.32,0,,,,,,,0,0,,,zinc ion binding,,,
B3KVH1,O95785,Protein Wiz,WIZ,149.33,149.33,S1017,PEDKSPQLSLSPRPASPKAQWPQSEDEGPLN,_SPQLSLS(ph)PRPAS(ph)PK_,0.07,0.17,-0.24,-0.04,0.6,0.73,0.57,0.03,0.29,0.49,-0.4,-0.47,0.67,0.57,0.06,-0.06,0.12,-0.14,0.66,0.33,0.39,-0.44,0.62,0,,,,,,,0,0,,,zinc ion binding,,,
F5GWT4,Q9H4A3,Serine/threonine-protein kinase WNK1,WNK1,70.44,57.81,S1261,SLTQVVHSAGRRFIVSPVPESRLRESKVFPS,_FIVS(ph)PVPESR_,-1.07,-1.15,-1.37, , , ,-0.36, ,-0.28,-0.54,-0.27, , , ,-0.49, ,-1.11,-1.37,,-0.36,-0.4,-0.27,,-0.49, +,,Other,,,,NA,NA,,,ATP binding,,,
F5GWT4,Q9H4A3,Serine/threonine-protein kinase WNK1,WNK1,267.57,265.84,S2011,KEKPELSEPSHLNGPSSDPEAAFLSRDVDDG,_EKPELSEPSHLNGPS(ph)S(ph)DPEAAFLSR_, ,0.04,0.2, ,-0.18,1.42,0.94, , ,0.11,0.42, ,-0.62,1.84,1.2, ,0.04,0.2,0.83,0.94,0.11,0.42,1.08,1.2,, +,Other,,,,0,2,41.21,,ATP binding,,,
F5GWT4,Q9H4A3,Serine/threonine-protein kinase WNK1,WNK1,267.57,265.84,S2012,EKPELSEPSHLNGPSSDPEAAFLSRDVDDGS,_EKPELSEPSHLNGPS(ph)S(ph)DPEAAFLSR_,-0.17,-0.1,0.2,-0.28,0.21,1.42,0.52, ,0.01,0.09,0.01,0.01,-0.2,1.84,0.06, ,-0.13,-0.02,0.94,0.52,0.05,0.01,1.15,0.06,, +,Other,,,,0,2,12.41,,ATP binding,,,
F5GWT4,Q9H4A3,Serine/threonine-protein kinase WNK1,WNK1,73.66,72.73,S2029,PEAAFLSRDVDDGSGSPHSPHQLSSKSLPSQ,_DVDDGS(ph)GS(ph)PHS(ph)PHQLSSK_,-0.19,-0.06,-0.23,-0.16,0.17,0.24,0.46,0.12,0.14,0.17,0.27,0.23,0.29,0.44,-0.02,0.29,-0.13,-0.2,0.21,0.3,0.16,0.25,0.36,0.15,,,Other,,,,0,0,,,ATP binding,,,
F5GWT4,Q9H4A3,Serine/threonine-protein kinase WNK1,WNK1,73.66,72.73,S2032,AFLSRDVDDGSGSPHSPHQLSSKSLPSQNLS,_DVDDGSGS(ph)PHS(ph)PHQLSSK_,-0.19,-0.06,-0.23,-0.16,0.17,0.24,0.46,0.12,0.14,0.17,0.27,0.23,0.29,0.44,-0.02,0.29,-0.13,-0.2,0.21,0.3,0.16,0.25,0.36,0.15,,,Other,,,,0,0,,,ATP binding,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,205.73,180.4,S491,LATASGQRVFPEPTESGDEGEELGLPLLSTR,_VFPEPTES(ph)GDEGEELGLPLLSTR_, ,-0.24,-0.47, ,-0.37,-0.32,-0.24, , ,0.02,-0.17, ,-0.17,-0.28,-0.23, ,-0.24,-0.47,-0.34,-0.24,0.02,-0.17,-0.23,-0.23,,,,,,,0,0,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,218.12,217.37,S85,GDPVSLSTPLETEFGSPSELSPRIEEQELSE,_EGDPVSLSTPLETEFGS(ph)PSELS(ph)PR_, ,-0.64, , ,0.08,-0.29,-0.52,-0.09, ,-0.06, , ,-0.1,-0.29,-0.07,0.03,-0.64,,-0.09,-0.29,-0.06,,-0.19,-0.02,,,,,,,NA,NA,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,218.12,217.37,S90,LSTPLETEFGSPSELSPRIEEQELSENTSLP,_EGDPVSLSTPLETEFGS(ph)PSELS(ph)PR_,-0.49,-0.13,-0.42, ,-0.27,0.33,-0.04,-0.23,-0.03,0.14,0.04, ,-0.51,0.27,-0.07,-0.1,-0.3,-0.42,0.06,-0.13,0.06,0.04,-0.07,-0.09,,,,,,,0,0,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,68.09,68.09,S54,ELMPPPPERGDPPRLSPDPVAGSAVSQELRE,_GDPPRLS(ph)PDPVAGSAVSQELR_,-0.24,-0.37,-0.69, ,-0.5, , , ,-0.49,-0.55,-0.62, ,-0.6, , , ,-0.3,-0.69,-0.5,,-0.52,-0.62,-0.6,,,,,,,,NA,NA,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,83.7,83.16,S103,ELSPRIEEQELSENTSLPAEEANGSLSEEEA,_IEEQELSENTS(ph)LPAEEANGS(ph)LS(ph)EEEANGPELGSGK_, , , , , ,-0.46,-0.65,-0.65, , , , , ,-0.58,-0.02,-0.24,,,-0.46,-0.65,,,-0.58,-0.12,,,,,,,NA,NA,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,105.92,105.46,S112,ELSENTSLPAEEANGSLSEEEANGPELGSGK,_IEEQELSENTS(ph)LPAEEANGS(ph)LS(ph)EEEANGPELGSGK_, , , , ,-0.26,-0.27,-0.19,-0.4, , , , ,-0.08,-0.17,-0.4,-0.08,,,-0.26,-0.29,,,-0.13,-0.23,,,,,,,NA,NA,,,,,,
E9PMG4,Q9BUR4,Telomerase Cajal body protein 1,WRAP53,105.92,105.46,S114,SENTSLPAEEANGSLSEEEANGPELGSGKAM,_IEEQELSENTSLPAEEANGS(ph)LS(ph)EEEANGPELGSGK_, , , , ,-0.26,-0.27,-0.24,-0.4, , , , ,-0.08,-0.17,-0.34,-0.09,,,-0.26,-0.32,,,-0.13,-0.21,,,,,,,NA,NA,,,,,,
Q96S55-2,Q96S55,ATPase WRNIP1,WRNIP1,129.37,60.83,S75,RAKGPSPPGAKRRRLSESSALKQPATPTAAE,_RLS(ph)ESSALK_,0.47,0.24,1.32,1.25,1.27,1.49,1.32,1.09,0.68,0.34,1.36,1.45,1.32,1.39,1.93,1.46,0.36,1.29,1.38,1.21,0.52,1.4,1.35,1.72, +, +,,,,,1,1,27.26,mitochondrion,ATP binding,DNA replication,,
Q96S55-2,Q96S55,ATPase WRNIP1,WRNIP1,101.04,101,S91,ESSALKQPATPTAAESSEGEGEEGDDGGETE,_(gl)QPAT(ph)PTAAES(ph)S(ph)EGEGEEGDDGGETESR_, , , , , ,0.11,-0.28,-0.33, , , , , ,-0.11,-0.19,-0.17,,,0.11,-0.3,,,-0.11,-0.18,,,,,,,NA,NA,,mitochondrion,ATP binding,DNA replication,,
Q96S55-2,Q96S55,ATPase WRNIP1,WRNIP1,101.04,101,S92,SSALKQPATPTAAESSEGEGEEGDDGGETES,_(gl)QPAT(ph)PTAAES(ph)S(ph)EGEGEEGDDGGETESR_, , , , , ,0.11,-0.28,-0.33, , , , , ,-0.11,-0.19,-0.17,,,0.11,-0.3,,,-0.11,-0.18,,,,,,,NA,NA,,mitochondrion,ATP binding,DNA replication,,
Q96S55-2,Q96S55,ATPase WRNIP1,WRNIP1,141.53,103.57,S153,GSGKRPAAAAAAGSASPRSWDEAEAQEEEEA,_RPAAAAAAGSAS(ph)PR_,-0.21,0.1,-0.05,0,-0.18,-0.06,-0.14,-0.15,-0.16,-0.18,-0.16,-0.23,-0.15,-0.14,-0.18,-0.07,-0.04,-0.02,-0.12,-0.14,-0.17,-0.19,-0.14,-0.12,,,,,,,0,0,,mitochondrion,ATP binding,DNA replication,,
Q15007,Q15007,Pre-mRNA-splicing regulator WTAP,WTAP,279.79,279.79,S306,GFHREGNTTEDDFPSSPGNGNKSSNSSEERT,_EGNTTEDDFPSS(ph)PGNGNK_,-0.37,-0.18,-0.13,-0.07,-0.39,-0.52,-0.92,-0.71,-0.29,-0.23,-0.19,-0.27,-0.05,-0.11,-0.3,-0.16,-0.27,-0.1,-0.46,-0.81,-0.26,-0.23,-0.08,-0.23,,,,,,,0,0,,nuclear membrane,,cell cycle,,
H0YBE8,Q8IX03,Protein KIBRA,WWC1,78.9,74.01,S876,VEEEEGEEDVFTEKASPDMDGYPALKVDKET,_AS(ph)PDMDGYPALK_, ,-0.22,0.01, , , , , , ,-0.01,0.08, , , , , ,-0.22,0.01,,,-0.01,0.08,,,,,,,,,NA,NA,,Golgi apparatus,,,,
Q01831,Q01831,DNA repair protein complementing XP-C cells,XPC,285.36,283.77,S883,KSEAAAPHTDAGGGLSSDEEEGTSSQAEAAR,_SEAAAPHTDAGGGLS(ph)S(ph)DEEEGTSSQAEAAR_,-0.34,-0.4,-0.32, ,-0.29,-0.43,-0.57,-0.28,0.06,0.04,0.08, ,-0.07,0.04,-0.1,0.03,-0.37,-0.32,-0.36,-0.42,0.05,0.08,-0.01,-0.03,,,,,,,0,0,,cytoplasm,bubble DNA binding,cell cycle checkpoint,,
Q01831,Q01831,DNA repair protein complementing XP-C cells,XPC,285.36,283.77,S884,SEAAAPHTDAGGGLSSDEEEGTSSQAEAARI,_SEAAAPHTDAGGGLS(ph)S(ph)DEEEGTSSQAEAAR_,-0.34,-0.4,-0.32, ,-0.29,-0.43,-0.57,-0.28,0.06,0.04,0.08, ,-0.07,0.04,-0.1,0.03,-0.37,-0.32,-0.36,-0.42,0.05,0.08,-0.01,-0.03,,,,,,,0,0,,cytoplasm,bubble DNA binding,cell cycle checkpoint,,
Q01831,Q01831,DNA repair protein complementing XP-C cells,XPC,95.93,95.93,S94,TVKSENLKVIKDEALSDGDDLRDFPSDLKKA,_VIKDEALS(ph)DGDDLRDFPSDLK_,0.74, ,0.46,0.65, ,-0.11,-0.25,0.21,0.11, ,0.42,0.53, ,0.18,0.02,0.69,0.74,0.56,-0.11,0,0.11,0.48,0.18,0.39,,,,,,,0,0,,cytoplasm,bubble DNA binding,cell cycle checkpoint,,
Q9C0E2,Q9C0E2,Exportin-4,XPO4,147.02,145.61,S521,RLHGQLQRHQQQLLASPGSSTVDNKMLDDLY,_HQQQLLAS(ph)PGSSTVDNK_,0.32,0.46,0.73,0.58,0.41,0.52, ,0.36,0.21,0.2,0.58,0.49,0.49,-0.04, ,-0.23,0.39,0.66,0.47,0.36,0.2,0.54,0.25,-0.23,,,,,,,0,0,,cytoplasm,,positive regulation of protein export from nucleus,,
Q9UBH6-2,Q9UBH6,Xenotropic and polytropic retrovirus receptor 1,XPR1,83.2,78.86,T690,ASQSKARDTKVLIEDTDDEANT_________,_VLIEDT(ph)DDEANT_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,integral to plasma membrane,G-protein coupled receptor activity,response to virus,,
F5H8D7,P18887,DNA repair protein XRCC1,XRCC1,108.24,108.24,T453,KPTQAAGPSSPQKPPTPEETKAASPVLQEDI,_TKPTQAAGPS(ph)SPQKPPT(ph)PEETK_,0.26,0.38,0.01,0.06,0.48,0.36,0.18,0.09,0.29,0.38,0.26,0.22,-0.21,0.02,0.28,-0.3,0.32,0.03,0.42,0.13,0.33,0.24,-0.09,0.02,,,,,,,0,0,,nucleus,damaged DNA binding,single strand break repair,,
Q13426-2,Q13426,DNA repair protein XRCC4,XRCC4,176.29,142.51,S327,EHISAENMSLETLRNSSPEDLFDEI______,_NS(ph)S(ph)PEDLFDEI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,,cellular response to lithium ion,,
Q13426-2,Q13426,DNA repair protein XRCC4,XRCC4,176.29,142.51,S328,HISAENMSLETLRNSSPEDLFDEI_______,_NS(ph)S(ph)PEDLFDEI_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytosol,,cellular response to lithium ion,,
P12956,P12956,X-ray repair cross-complementing protein 6,XRCC6,125.57,98.78,S2,______________MSGWESYYKTEGDEEAE,_(ac)S(ph)GWES(ph)YYK_,-0.89,-0.94,-0.83,-0.16,-0.22,-0.24,0.25,-0.47,0,-0.23,-0.37,-0.03,-0.55,-0.16,-0.02,-0.88,-0.91,-0.46,-0.23,-0.07,-0.11,-0.19,-0.34,-0.39,,,,,,,0,0,,cytoplasm,5'-deoxyribose-5-phosphate lyase activity,DNA ligation,,
P12956,P12956,X-ray repair cross-complementing protein 6,XRCC6,120.03,120.03,S6,__________MSGWESYYKTEGDEEAEEEQE,_(ac)S(ph)GWES(ph)YYK_,0.15,0.24,-0.05,0.47,-0.09,-0.17,0.22,0.51,0.67,0.59,0.13,0.25,-0.49,-0.61,0.03,0.12,0.2,0.23,-0.13,0.37,0.63,0.19,-0.55,0.07,,,,,,,0,0,,cytoplasm,5'-deoxyribose-5-phosphate lyase activity,DNA ligation,,
P12956,P12956,X-ray repair cross-complementing protein 6,XRCC6,66.06,66.06,S520,DLTLPKVEAMNKRLGSLVDEFKELVYPPDYN,_RLGS(ph)LVDEFK_,0.17,0, ,-0.07, , , , ,0.68,0.4, ,0.28, , , , ,0.09,-0.07,,,0.55,0.28,,,,,,,,,NA,NA,,cytoplasm,5'-deoxyribose-5-phosphate lyase activity,DNA ligation,,
Q9H0D6-2,Q9H0D6,5'-3' exoribonuclease 2,XRN2,182.67,182.67,S499,GSPSPLGGIKRKAEDSDSEPEPEDNVRLWEA,_RKAEDS(ph)DS(ph)EPEPEDNVR_,-0.07,0,-0.22,-0.16,-0.03,-0.06,-0.07,-0.22,0.11,0.25,-0.06,-0.02,-0.05,-0.03,-0.01,-0.1,-0.03,-0.19,-0.05,-0.14,0.18,-0.04,-0.04,-0.06,,,,,,,0,0,,aggresome,5'-3' exoribonuclease activity,cell growth,,
Q9H0D6-2,Q9H0D6,5'-3' exoribonuclease 2,XRN2,182.67,182.67,S501,PSPLGGIKRKAEDSDSEPEPEDNVRLWEAGW,_RKAEDS(ph)DS(ph)EPEPEDNVR_,-0.07,0,-0.22,-0.16,-0.03,-0.06,-0.07,-0.22,0.11,0.25,-0.06,-0.02,-0.05,-0.03,-0.01,-0.1,-0.03,-0.19,-0.05,-0.14,0.18,-0.04,-0.04,-0.06,,,,,,,0,0,,aggresome,5'-3' exoribonuclease activity,cell growth,,
Q9H0D6-2,Q9H0D6,5'-3' exoribonuclease 2,XRN2,81.72,80.05,S475,AAYEMRMQNNSSPSISPNTSFTSDGSPSPLG,_MQNNS(ph)SPSIS(ph)PNTSFTSDGSPSPLGGIK_, , , , , , , ,-0.72, , , , , , , ,-0.4,,,,-0.72,,,,-0.4,,,,,,,NA,NA,,aggresome,5'-3' exoribonuclease activity,cell growth,,
F5GWC5,P46937,Yorkie homolog,YAP1,230.63,214.9,S109,SFFKPPEPKSHSRQASTDAGTAGALTPQHVR,_(gl)QAS(ph)TDAGTAGALTPQHVR_,0.78,0.65,0.53,0.16,-0.56,-0.56,-0.37,-0.39,0,0.15,-0.28,-0.21,-0.51,-0.57,-0.23,-0.03,0.72,0.36,-0.56,-0.38,0.08,-0.24,-0.54,-0.13,,,,,,,0,0,,,,,,
F5GWC5,P46937,Yorkie homolog,YAP1,119.45,98.77,T119,HSRQASTDAGTAGALTPQHVRAHSSPASLQL,_(gl)QAST(ph)DAGTAGALT(ph)PQHVR_, , , , , ,-0.82, , , , , , , ,-1, , ,,,-0.82,,,,-1,,,,,,,,NA,NA,,,,,,
P67809,P67809,Nuclease-sensitive element-binding protein 1,YBX1,266.29,266.29,S174,QQNYQNSESGEKNEGSESAPEGQAQQRRPYR,_NEGS(ph)ESAPEGQAQQR_, , ,1.26, ,-0.23,-0.32,0.41,0.03, , ,-0.01, ,-0.23,-0.13,-0.23,-0.22,,1.26,-0.27,0.23,,-0.01,-0.18,-0.23, +,,,,,,NA,NA,,CRD-mediated mRNA stability complex,double-stranded DNA binding,CRD-mediated mRNA stabilization,,
P67809,P67809,Nuclease-sensitive element-binding protein 1,YBX1,161.5,156.61,S314,DGKETKAADPPAENSSAPEAEQGGAE_____,_AADPPAENSS(ph)APEAEQGGAE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,CRD-mediated mRNA stability complex,double-stranded DNA binding,CRD-mediated mRNA stabilization,,
P67809,P67809,Nuclease-sensitive element-binding protein 1,YBX1,353.92,334.26,S165,RRRGPPRNYQQNYQNSESGEKNEGSESAPEG,_NYQQNYQNS(ph)ESGEK_,0.12,0.1,-0.03,-0.04,-0.31,-0.21,-0.08,-0.07,0.07,0.05,-0.04,-0.05,-0.23,-0.13,-0.01,0.09,0.11,-0.04,-0.26,-0.08,0.06,-0.04,-0.18,0.05,,,,,,,0,0,,CRD-mediated mRNA stability complex,double-stranded DNA binding,CRD-mediated mRNA stabilization,,
Q86U90,Q86U90,"YrdC domain-containing protein, mitochondrial",YRDC,98.29,98.29,S37,EGPAGSRSGRLFRPPSPAPAAPGARLLRLPG,_LFRPPS(ph)PAPAAPGAR_,0.6,0.58,0.73,0.72, , , , ,-0.25,0,-0.29,-0.27, , , , ,0.59,0.72,,,-0.12,-0.28,,,,,,,,,NA,NA,,membrane,double-stranded RNA binding,negative regulation of transport,,
Q96MU7-2,Q96MU7,YTH domain-containing protein 1,YTHDC1,171.74,171.74,S308,GSDEKKKERKRARGISPIVFDRSGSSASESY,_GIS(ph)PIVFDR_,-0.28,-0.23,-0.37,-0.35,-0.29,-0.37,-0.28,-0.28,-0.18,-0.13,-0.22,-0.28,-0.18,-0.21,-0.27,-0.36,-0.25,-0.36,-0.33,-0.28,-0.15,-0.25,-0.2,-0.31,,,,,,,0,0,,nucleus,,mRNA processing,,
E9PE26,Q9H6S0,Probable ATP-dependent RNA helicase YTHDC2,YTHDC2,273.6,272.69,S1089,LQEPSSFRVDGIPNDSSDSEMEDKTTANLAA,_VDGIPNDS(ph)S(ph)DSEMEDK_,0.1, ,-0.23, ,-0.25,-0.12,-0.62,-0.65,0.17, ,-0.04, ,-0.08,0.2,-0.18,-0.1,0.1,-0.23,-0.18,-0.63,0.17,-0.04,0.07,-0.14,,,,,,,0,0,,,,,,
E9PE26,Q9H6S0,Probable ATP-dependent RNA helicase YTHDC2,YTHDC2,153.83,150.62,S1090,QEPSSFRVDGIPNDSSDSEMEDKTTANLAAL,_VDGIPNDS(ph)S(ph)DSEMEDK_,0.03,0.08,0.02,0.06,-0.05,0.18,0.1,0.13,0.05,0.09,0.08,0.08,-0.05,-0.19,0.06,0.05,0.06,0.04,0.07,0.11,0.07,0.08,-0.12,0.05,,,,,,,0,0,,,,,,
E9PE26,Q9H6S0,Probable ATP-dependent RNA helicase YTHDC2,YTHDC2,107.56,106.17,S1092,PSSFRVDGIPNDSSDSEMEDKTTANLAALKL,_VDGIPNDSS(ph)DS(ph)EMEDK_,0.13,0.2,-0.21, ,0.31,0.05,0.01,0.13,0.05,0.09,0.1, ,0.08,-0.04,-0.02,-0.03,0.17,-0.21,0.18,0.07,0.07,0.1,0.03,-0.03,,,,,,,0,0,,,,,,
F5H8I7,Q9Y5A9,YTH domain family protein 2,YTHDF2,213.82,211.39,S39,HQKDGLNDDDFEPYLSPQARPNNAYTAMSDS,_DGLNDDDFEPYLS(ph)PQAR_,-0.25,-0.25,0.83,0.62,0.95,0.28,0.21,0.17,0.04,-0.05,0.57,0.31,0.98,0.37,0.42,0.36,-0.25,0.73,0.65,0.19,0,0.45,0.71,0.39,,,,,,,0,0,,,,,,
P62258,P62258,14-3-3 protein epsilon,YWHAE,248.19,244.81,S210,AKAAFDDAIAELDTLSEESYKDSTLIMQLLR,_AAFDDAIAELDTLS(ph)EESYK_,-0.12,-0.22,-0.26, ,-0.18,-0.08,-0.56,0.09,0.93,0.04,-0.04, ,-0.35,0.03,-0.16,0.03,-0.17,-0.26,-0.13,-0.2,0.55,-0.04,-0.15,-0.06,,,,,,,0,0,,cytoplasmic vesicle membrane,,cellular membrane organization,,
P61981,P61981,14-3-3 protein gamma,YWHAG,88.57,87.71,S235,TLIMQLLRDNLTLWTSDQQDDDGGEGNN___,_DNLTLWTS(ph)DQQDDDGGEGNN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cytoplasmic vesicle membrane,protein kinase C inhibitor activity,cellular membrane organization,,
P31947-2,P31946,14-3-3 protein theta,YWHAZ,89.73,67.39,S47,AGMDVELTVEERNLLSVAYKNVIGARRASWR,_NLLS(ph)VAYK_,-0.26,-0.2,-0.21,0.79, , , , ,-0.08,-0.04,-0.03,-0.01, , , , ,-0.23,0.37,,,-0.06,-0.02,,,,,,,,,NA,NA,,cytoplasmic vesicle membrane,protein kinase C inhibitor activity,cellular membrane organization,,
P63104,P63104,14-3-3 protein zeta/delta,YWHAZ,247.13,246.29,T232,IMQLLRDNLTLWTSDTQGDEAEAGEGGEN__,_DNLTLWTSDT(ph)QGDEAEAGEGGEN_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell leading edge,,cellular membrane organization,,
P63104,P63104,14-3-3 protein zeta/delta,YWHAZ,267.25,262.61,S207,AKTAFDEAIAELDTLSEESYKDSTLIMQLLR,_TAFDEAIAELDTLS(ph)EESYK_, , , , , ,-0.05, , , , , , , ,-0.27, , ,,,-0.05,,,,-0.27,,,,,,,,NA,NA,,cell leading edge,,cellular membrane organization,,
P25490,P25490,Transcriptional repressor protein YY1,YY1,85.36,55.82,S118,VILVQTREEVVGGDDSDGLRAEDGFEDQILI,_EEVVGGDDS(ph)DGLR_,0.55,0.32,0.26, , ,-0.21, , ,0.2,-0.17,0.04, , ,-0.22, , ,0.44,0.26,-0.21,,0.02,0.04,-0.22,,,,,,,,NA,NA,,Ino80 complex,four-way junction DNA binding,anterior/posterior pattern specification,,
P86452,P86452,Zinc finger BED domain-containing protein 6,ZBED6,55.39,55.31,S366,KSTGSQDLTAEDLSDSDSDEPMLEVENRSES,_STGSQDLTAEDLSDS(ph)DS(ph)DEPMLEVENR_, , , , , , , ,-0.39, , , , , , , ,0.23,,,,-0.39,,,,0.23,,,,,,,NA,NA,,nucleolus,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
P86452,P86452,Zinc finger BED domain-containing protein 6,ZBED6,55.39,55.31,S368,TGSQDLTAEDLSDSDSDEPMLEVENRSESPI,_STGSQDLTAEDLSDS(ph)DS(ph)DEPMLEVENR_, , , , , , , ,-0.39, , , , , , , ,0.23,,,,-0.39,,,,0.23,,,,,,,NA,NA,,nucleolus,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
O95625,O95625,Zinc finger and BTB domain-containing protein 11,ZBTB11,131.17,79.73,S1050,VAEAIQTVKVEVAHISGGE____________,_VEVAHIS(ph)GGE_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,BTB,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
O95365,O95365,Zinc finger and BTB domain-containing protein 7A,ZBTB7A,98.56,83.37,S337,QMMSSVGRAGAAAGDSDEESRADDKGVMDYY,_AGAAAGDS(ph)DEESRADDK_, , , , , , ,-0.03, , , , , , , ,0.1, ,,,,-0.03,,,,0.1,,,,BTB,,,NA,NA,,nucleus,DNA binding,cell differentiation,,
O95365,O95365,Zinc finger and BTB domain-containing protein 7A,ZBTB7A,188.19,188.19,S549,QEKHFKDEDEDEDVASPDGLGRLNVAGAGGG,_HFKDEDEDEDVAS(ph)PDGLGR_,0.3, , , , ,0.25,0.13,-0.15,-0.16, , , , ,-0.39,-0.03,-0.14,0.3,,0.25,0,-0.16,,-0.39,-0.08,,,,BTB,,,NA,NA,,nucleus,DNA binding,cell differentiation,,
B4DLG2,O75152,Zinc finger CCCH domain-containing protein 11A,ZC3H11A,104.75,103.88,S758,SGPSSSQMSMKTRRLSSASTGKPPLSVEDDF,_RLS(ph)SAS(ph)TGKPPLSVEDDFEK_, , ,2.22,1.71, , , , , , ,1.88,1.34, , , , ,,1.99,,,,1.63,,, +, +,,,,,NA,NA,,,,,,
B4DLG2,O75152,Zinc finger CCCH domain-containing protein 11A,ZC3H11A,104.75,103.88,S761,SSSQMSMKTRRLSSASTGKPPLSVEDDFEKL,_RLS(ph)SAS(ph)TGKPPLSVEDDFEK_, , ,2.22,1.71, , , , , , ,1.88,1.34, , , , ,,1.99,,,,1.63,,, +, +,,,,,NA,NA,,,,,,
B4DLG2,O75152,Zinc finger CCCH domain-containing protein 11A,ZC3H11A,116.85,101.33,S108,LFLPPSKTVLPTVPESPEEEVKASQLSVQQN,_TVLPTVPES(ph)PEEEVK_,0.46,0.39,0.26,0.62,0.54,-0.08,-0.07,0.08,-0.08,-0.16,-0.01,0.33,1.5,-0.18,-0.35,-0.26,0.42,0.45,0.27,0.01,-0.12,0.17,0.89,-0.3,,,,,,,0,0,,,,,,
B4DLG2,O75152,Zinc finger CCCH domain-containing protein 11A,ZC3H11A,72.62,71.04,S171,VINAADDDEDDDDQFSEEGDETKTPTLQPTP,_VESSENVPSPTHPPVVINAADDDEDDDDQFS(ph)EEGDETK_, , , , ,0.08, ,-0.47, , , , , ,0.32, ,-0.01, ,,,0.08,-0.47,,,0.32,-0.01,,,,,,,NA,NA,,,,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,139.3,137.41,S877,RLLSQVVRPQESRSLSPSHLTEDRQGRWKEE,_S(ph)LS(ph)PSHLTEDR_,-0.09,-0.58,-0.2,-0.03,-0.52,-0.26,3.53,3.39,-0.54,-0.53,-0.41,-0.28,-0.17,-0.32,-0.32,-0.22,-0.31,-0.11,-0.38,3.46,-0.53,-0.34,-0.24,-0.27, +,,,,,,2,0,1.15,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,106.35,99.46,S242,SSSASKKDRKTSAVSSPLLDQQRNSKTNQSK,_TSAVSS(ph)PLLDQQR_,-0.52,-0.38,-0.51, ,-0.81,-2.21,-0.83,-0.99,-0.52,-0.32,-0.21, ,-0.45,-1.62,-0.46,-0.45,-0.45,-0.51,-1.34,-0.91,-0.42,-0.21,-0.92,-0.46, +,,,,,,6,0,23.14,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,83.37,83.37,S207,IIKKEVSPEVVRSKLSPSPSLRKSSKSPKRK,_SKLS(ph)PS(ph)PSLR_,0.09, , ,0.16,-0.18,0.11, , ,-0.4, , ,1.01,0.21,0, , ,0.09,0.16,-0.03,,-0.4,1.01,0.1,,, +,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,83.37,83.37,S209,KKEVSPEVVRSKLSPSPSLRKSSKSPKRKSS,_SKLS(ph)PS(ph)PSLR_,0.09, , ,0.16,-0.18,0.11, , ,-0.4, , ,1.01,0.21,0, , ,0.09,0.16,-0.03,,-0.4,1.01,0.1,,, +,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,93.41,93.41,S137,REKEDIKITKERTPESEEENVEWETNRDDSD,_ERT(ph)PES(ph)EEENVEWETNR_, , , , ,0.15, ,-0.58,-0.36, , , , ,-0.03, ,0.26,0.11,,,0.15,-0.46,,,-0.03,0.19,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,120.63,85.15,S875,KHRLLSQVVRPQESRSLSPSHLTEDRQGRWK,_S(ph)LS(ph)PSHLTEDR_,-0.64,-0.54,0.18,0.32,-0.68,-0.75,-0.89,0,-0.67,-0.65,-0.42,-0.38,-0.41,-0.53,-0.36,-0.41,-0.59,0.25,-0.72,-0.38,-0.66,-0.4,-0.47,-0.38,,,,,,,0,0,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,93.41,93.41,T134,GRHREKEDIKITKERTPESEEENVEWETNRD,_ERT(ph)PES(ph)EEENVEWETNR_, , , , ,0.15, ,-0.58,-0.36, , , , ,-0.03, ,0.26,0.11,,,0.15,-0.46,,,-0.03,0.19,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,154.42,152.06,S1065,NGILEDSQKKEDTAFSDWSDEDVPDRTEVTE,_EDTAFS(ph)DWS(ph)DEDVPDR_, , , , ,-0.54,-0.5,-0.5,-0.25, , , , ,-0.08,-0.08,-0.33,-0.29,,,-0.52,-0.37,,,-0.08,-0.31,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,154.42,152.06,S1068,LEDSQKKEDTAFSDWSDEDVPDRTEVTEAEH,_EDTAFS(ph)DWS(ph)DEDVPDR_, , , , ,-0.54,-0.5,-0.5,-0.25, , , , ,-0.08,-0.08,-0.33,-0.29,,,-0.52,-0.37,,,-0.08,-0.31,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,85.62,39.22,S198,ENMEKREEIIIKKEVSPEVVRSKLSPSPSLR,_EVS(ph)PEVVR_,-0.83,-0.47,-0.34,-0.28,-0.43,-0.41,-0.56,-0.33,-0.76,-0.63,-0.41,-0.46,-0.24,-0.07,-0.18,0.04,-0.64,-0.31,-0.42,-0.44,-0.69,-0.43,-0.15,-0.07,,,,,,,0,0,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,106.6,106.6,S265,NSKTNQSKKKGPRTPSPPPPIPEDIALGKKY,_T(ph)PS(ph)PPPPIPEDIALGK_, , , , ,-0.05,-0.27,-0.34,-0.18, , , , ,0.06,-0.02,-0.21,-0.15,,,-0.16,-0.25,,,0.02,-0.18,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,179.66,177.27,S370,PSPSYQRTLTPPLRRSASPYPSHSLSSPQRK,_S(ph)AS(ph)PYPSHSLSS(ph)PQR_, , , , ,-0.45,-0.52,-0.55,-0.63, , , , ,-0.32,-0.29,-0.23,-0.31,,,-0.48,-0.59,,,-0.31,-0.27,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,179.66,177.27,S372,PSYQRTLTPPLRRSASPYPSHSLSSPQRKQS,_S(ph)AS(ph)PYPSHSLS(ph)SPQR_, , , , ,-0.45,-0.52,-0.55,-0.63, , , , ,-0.32,-0.29,-0.23,-0.31,,,-0.48,-0.59,,,-0.31,-0.27,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,175.79,173.31,S380,PPLRRSASPYPSHSLSSPQRKQSPPRHRSPM,_S(ph)AS(ph)PYPSHSLS(ph)SPQR_, , , , , , ,-0.6,-0.7, , , , , , ,-0.25,-0.3,,,,-0.65,,,,-0.27,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,179.66,177.27,S381,PLRRSASPYPSHSLSSPQRKQSPPRHRSPMR,_S(ph)AS(ph)PYPSHSLSS(ph)PQR_, , , , ,-0.48,-0.59,-0.51,-0.61, , , , ,-0.44,-0.29,-0.21,-1.37,,,-0.54,-0.56,,,-0.36,-0.68,,,,,,,NA,NA,,,nucleic acid binding,,,
Q5T200-2,Q5T200,Zinc finger CCCH domain-containing protein 13,ZC3H13,106.6,106.6,T263,QRNSKTNQSKKKGPRTPSPPPPIPEDIALGK,_T(ph)PS(ph)PPPPIPEDIALGK_, , , , ,-0.05,-0.27,-0.34,-0.18, , , , ,0.06,-0.02,-0.21,-0.15,,,-0.16,-0.25,,,0.02,-0.18,,,,,,,NA,NA,,,nucleic acid binding,,,
H0YJA2,Q6PJT7,Zinc finger CCCH domain-containing protein 14,ZC3H14,99.34,99.34,S515,HLMQTRDLVQPDKPASPKFIVTLDGVPSPP_,_DLVQPDKPAS(ph)PK_,0.21,0.33,0.51, ,-0.36,0.54,0.02,0.01,0.47,0.52,-0.41, ,-0.49,0.43,0.2,0.25,0.27,0.51,0.16,0.02,0.5,-0.41,0.04,0.23,,,,,,,0,0,,cytoplasm,nucleic acid binding,,,
F5H0F5,Q8WU90,Zinc finger CCCH domain-containing protein 15,ZC3H15,234.04,234.04,S381,KLSEASGGRAENGERSDLEEDNERHVL____,_AENGERS(ph)DLEEDNER_,0.02,0.12,0.04,0.27, ,-0.03,-0.1,-0.12,-0.14,-0.12,-0.14,-0.04, ,0.14,-0.16,-0.04,0.07,0.16,-0.03,-0.11,-0.13,-0.09,0.14,-0.1,,,,,,,0,0,,,,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,175.63,174.48,S34,QPQGLSDDDILRDSGSDQDLDGAGVRASDLE,_DS(ph)GS(ph)DQDLDGAGVRAS(ph)DLEDEESAAR_, , , , ,0.08,0.03,3.77,3.63, , , , ,0.1,-0.23,-0.06,0.11,,,0.05,3.7,,,-0.06,0.03, +,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,101.75,100.94,S6,__________MDVAESPERDPHSPEDEEQPQ,_(ac)MDVAES(ph)PERDPHS(ph)PEDEEQPQGLS(ph)DDDILR_, , , , ,-1.37,-1.11,0.51,-1.39, , , , ,-0.11,-0.1,-0.12,-0.27,,,-1.24,-0.15,,,-0.1,-0.2, +,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,250.39,239.05,S83,DEEDRASEPKSQDQDSEVNELSRGPTSSPCE,_S(ph)QDQDS(ph)EVNELSR_, ,-0.1,-0.45, ,0.34,0.5,-0.14,0.24, ,1.5,2.4, ,0.75,1.12,0.56,0.94,-0.1,-0.45,0.42,0.06,1.5,2.4,0.95,0.76,, +,,,,,0,4,6.69,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,175.63,174.48,S32,EEQPQGLSDDDILRDSGSDQDLDGAGVRASD,_DS(ph)GS(ph)DQDLDGAGVRAS(ph)DLEDEESAAR_, , , , ,0.15,0.03,-0.11,-0.13, , , , ,2.45,-0.23,-0.26,0.52,,,0.09,-0.12,,,1.66,0.18,, +,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,140.77,140.77,S532,DPWRRSKSPKKKLGVSVSPSRARRRRKTSAS,_LGVS(ph)VS(ph)PSR_,0.02,0.4,0.07,0.14,0.09,0.19,0.04,0,-0.16,0.19,-0.28,-0.27,-0.01,0.05,0.09,0.01,0.22,0.11,0.14,0.02,0.03,-0.28,0.02,0.05,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,171.09,120.74,S534,WRRSKSPKKKLGVSVSPSRARRRRKTSASSA,_LGVSVS(ph)PSR_,-0.18,-0.19,-0.28,-0.24,0.02,-0.2,-0.17,-0.15,-0.13,-0.16,-0.18,-0.15,-0.09,-0.24,-0.05,-0.15,-0.19,-0.26,-0.08,-0.16,-0.15,-0.16,-0.17,-0.1,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,76.84,76.84,S868,PDRGSRDRKSGGRLGSPKPERQRGQNSKAPA,_LGS(ph)PKPER_, , , , ,0.19,0.3,0.17,0.09, , , , ,0.07,0.18,-0.12,0.09,,,0.25,0.13,,,0.12,-0.01,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,250.39,239.05,S78,EDNHSDEEDRASEPKSQDQDSEVNELSRGPT,_S(ph)QDQDS(ph)EVNELSR_,0.09,0.05, , ,-0.02,0.06,-0.11,-0.17,0.37,1.19, , ,0.12,0.37,-0.01,-0.13,0.07,,0.02,-0.14,0.84,,0.25,-0.07,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,175.63,174.48,S46,DSGSDQDLDGAGVRASDLEDEESAARGPSQE,_AS(ph)DLEDEESAAR_,-0.26,-0.36,-0.34,-0.29,-0.25,0.08,-0.03,0.04,-0.18,-0.32,-0.22,-0.25,-0.13,-0.14,-0.12,-0.13,-0.31,-0.31,-0.08,0.01,-0.24,-0.24,-0.14,-0.13,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,137.17,137.08,S13,___MDVAESPERDPHSPEDEEQPQGLSDDDI,_(ac)MDVAES(ph)PERDPHS(ph)PEDEEQPQGLS(ph)DDDILR_, , , , ,0.05,-0.31,-0.24,-0.04, , , , ,-0.15,-0.07,-0.12,0.21,,,-0.12,-0.14,,,-0.11,0.06,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,137.17,137.08,S24,RDPHSPEDEEQPQGLSDDDILRDSGSDQDLD,_(ac)MDVAES(ph)PERDPHS(ph)PEDEEQPQGLS(ph)DDDILR_, , , , ,0.05,-0.31,-0.24,-0.04, , , , ,-0.15,-0.07,-0.12,0.21,,,-0.12,-0.14,,,-0.11,0.06,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,167.26,167.26,S67,ESAARGPSQEEEDNHSDEEDRASEPKSQDQD,_GPSQEEEDNHS(ph)DEEDRAS(ph)EPK_,-0.24,-0.19,-0.03, , ,0.08,0.1,-0.05,-0.16,-0.24,0.04, , ,-0.11,0.09,-0.14,-0.22,-0.03,0.08,0.03,-0.2,0.04,-0.11,-0.02,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q86VM9,Q86VM9,Zinc finger CCCH domain-containing protein 18,ZC3H18,167.26,167.26,S74,SQEEEDNHSDEEDRASEPKSQDQDSEVNELS,_GPSQEEEDNHS(ph)DEEDRAS(ph)EPK_,-0.24,-0.19,-0.03, , ,0.08,0.1,-0.05,-0.16,-0.24,0.04, , ,-0.11,0.09,-0.14,-0.22,-0.03,0.08,0.03,-0.2,0.04,-0.11,-0.02,,,,,,,0,0,,nucleus,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,156.35,155.35,S1104,TASSRAAKPGPAEAPSPTASPSGDASPPATA,_AAKPGPAEAPS(ph)PTAS(ph)PSGDAS(ph)PPATAPYDPR_, ,0.1,0.1, ,0.21,0.27,-0.04,0.22, ,-0.16,-0.05, ,0.13,0.23,-0.05,-0.14,0.1,0.1,0.24,0.1,-0.16,-0.05,0.18,-0.09,,,,,,,0,0,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,149.59,149.35,S1108,RAAKPGPAEAPSPTASPSGDASPPATAPYDP,_AAKPGPAEAPS(ph)PTAS(ph)PSGDAS(ph)PPATAPYDPR_, , , , ,0.32,0.11,-0.03, , , , , ,0.82,0.18,0.02, ,,,0.22,-0.03,,,0.53,0.02,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,156.35,155.35,S1114,PAEAPSPTASPSGDASPPATAPYDPRVLAAG,_PGPAEAPSPTASPSGDAS(ph)PPATAPYDPR_, , ,0.1, ,0.18,0.27,-0.04,0.2, , ,-0.05, ,-0.29,0.23,-0.05,0.32,,0.1,0.22,0.09,,-0.05,-0.01,0.15,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,243.55,243.55,S807,KQDRENEEGDTGNWYSSDEDEGGSSVTSILK,_ENEEGDTGNWYS(ph)S(ph)DEDEGGSSVTSILK_, ,-0.32, , ,-0.42,-0.15,-0.11,-0.11, ,-0.25, , ,-0.08,-0.23,-0.05,-0.12,-0.32,,-0.28,-0.11,-0.25,,-0.15,-0.08,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,243.55,243.55,S808,QDRENEEGDTGNWYSSDEDEGGSSVTSILKT,_(gl)QDRENEEGDTGNWYS(ph)S(ph)DEDEGGSSVTSILK_, ,-0.32, , ,-0.42,-0.15,-0.11,-0.11, ,-0.25, , ,-0.08,-0.23,-0.05,-0.12,-0.32,,-0.28,-0.11,-0.25,,-0.15,-0.08,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,166.14,166.14,S1269,TLFGTVKQTPKTGSGSPFAGNSPAREGEQDA,_TGSGS(ph)PFAGNS(ph)PAREGEQDAASLK_, ,-0.54,-0.47, ,-0.6,-0.45,-0.6,-0.34, ,-0.09,0.02, ,-0.45,-0.56,-0.76,-0.6,-0.54,-0.47,-0.53,-0.47,-0.09,0.02,-0.5,-0.68,,,,,,,0,0,,,nucleic acid binding,,,
Q9UPT8,Q9UPT8,Zinc finger CCCH domain-containing protein 4,ZC3H4,166.14,166.14,S1275,KQTPKTGSGSPFAGNSPAREGEQDAASLKDV,_TGSGS(ph)PFAGNS(ph)PAREGEQDAASLK_, ,-0.54,-0.47, ,-0.6,-0.45,-0.6,-0.34, ,-0.09,0.02, ,-0.45,-0.56,-0.76,-0.6,-0.54,-0.47,-0.53,-0.47,-0.09,0.02,-0.5,-0.68,,,,,,,0,0,,,nucleic acid binding,,,
Q8IWR0,Q8IWR0,Zinc finger CCCH domain-containing protein 7A,ZC3H7A,49.52,46.9,T210,KALNHSVEDIEPDLLTPRQEAVPVVSLPAPS,_ALNHSVEDIEPDLLT(ph)PR_, , ,0.5, , , , , , , ,-0.55, , , , , ,,0.5,,,,-0.55,,,,,,,,,NA,NA,,nucleus,nucleic acid binding,,,
Q7Z2W4,Q7Z2W4,Zinc finger CCCH-type antiviral protein 1,ZC3HAV1,63.69,59.9,S284,ERSCTPSPDQISHRASLEDAPVDDLTRKFTY,_AS(ph)LEDAPVDDLTR_, , , , ,1.09, ,1.05,1.22, , , , ,2.81, ,0.06,-0.05,,,1.09,1.14,,,2.81,0, +, +,,,,,NA,NA,,cytoplasm,NAD+ ADP-ribosyltransferase activity,cellular response to exogenous dsRNA,,
Q7Z2W4,Q7Z2W4,Zinc finger CCCH-type antiviral protein 1,ZC3HAV1,83.24,79.23,S378,TSWTNDQGARRKTVFSPTLPAARSSLGSLQT,_TVFS(ph)PTLPAAR_,-0.19,-0.08,0.23,0.47, , ,-0.3,0.11,-0.34,-0.2,0.13,0.13, , ,-0.08,0.28,-0.13,0.35,,-0.08,-0.27,0.13,,0.11,,,,,,,NA,NA,,cytoplasm,NAD+ ADP-ribosyltransferase activity,cellular response to exogenous dsRNA,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,46.73,26.21,S344,SQDATFSPGSEQAEKSPGPIVSRTRSWDSSS,_S(ph)PGPIVSR_, , , , ,1.14,1.4, , , , , , ,1.27,1.08, , ,,,1.28,,,,1.18,, +, +,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,106.33,105.83,S354,EQAEKSPGPIVSRTRSWDSSSPVDRPEPEAA,_S(ph)WDSSSPVDRPEPEAAS(ph)PTTR_, , ,2.39,1.94,1.43, , , , , ,2.73,2.36,1.18, , , ,,2.18,1.43,,,2.56,1.18,, +, +,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,154.7,154.7,S359,SPGPIVSRTRSWDSSSPVDRPEPEAASPTTR,_SWDSSS(ph)PVDRPEPEAAS(ph)PTTR_,-0.4,-0.12,-0.24,-0.09,-1.13,-0.69,-0.96,-1.11,-0.47,-0.23,-0.19,0.35,-1,-1.22,-1.57,-1.4,-0.26,-0.17,-0.9,-1.03,-0.35,0.11,-1.1,-1.48, +, +,,,,,6,6,30.99,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,154.7,154.7,S370,WDSSSPVDRPEPEAASPTTRTRPVTRSMGTG,_TRS(ph)WDSSSPVDRPEPEAAS(ph)PTTR_,0.46,0.41,0.06,0,1.24,-0.98,-0.96,-1.11,0.25,0.52,0.5,0.85,1.12,-1.19,-1.57,-1.4,0.44,0.03,0.52,-1.03,0.39,0.68,0.38,-1.48, +, +,,,,,5,4,21.85,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,223.82,223.42,S335,ESPRRMMTRSQDATFSPGSEQAEKSPGPIVS,_SQDATFS(ph)PGSEQAEK_, ,1.05, ,0.89,0.6,0.26, ,1.06, ,0.92, ,0.48,0.85,0.36, ,0.96,1.05,0.89,0.44,1.06,0.92,0.48,0.63,0.96, +,,,,,,5,0,25.87,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,80.59,77.65,S24,AFAVGVEKNWGAVVRSPEGTPQKIRQLIDEG,_NWGAVVRS(ph)PEGTPQK_, , , ,0.56, ,-0.76, , , , , ,-0.3, ,-1.22, , ,,0.56,-0.76,,,-0.3,-1.22,,, +,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,153.75,119,S321,PGLEGRPERLPLVPESPRRMMTRSQDATFSP,_LPLVPES(ph)PRR_,0.15,0.14,0.64,0.68,0.81,0.86,-0.03, ,0.01,0.03,0.39,0.45,0.49,0.57,-0.37, ,0.15,0.66,0.84,-0.03,0.02,0.42,0.53,-0.37,,,,,,,0,0,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,234.3,234.3,S395,RSMGTGDTPGLEVPSSPLRKAKRARLCSSSS,_SMGTGDTPGLEVPSS(ph)PLRK_,0.79,-0.85,0.76,0.68,0.7,0.47,0.29,0.21,-0.03,0.35,0.65,0.58,0.42,0.41,-0.39,-0.64,0.2,0.72,0.59,0.25,0.17,0.61,0.41,-0.51,,,,,,,0,0,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,77,70.29,S338,RRMMTRSQDATFSPGSEQAEKSPGPIVSRTR,_SQDATFS(ph)PGS(ph)EQAEK_, , , , ,0.6,0.26, , , , , , ,0.85,0.36, , ,,,0.44,,,,0.63,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,83.36,82.29,S53,EGIAPEEGGVDAKDTSATSQSVNGSPQAEQP,_DTS(ph)ATSQSVNGS(ph)PQAEQPSLESTSK_, , , , ,-0.24, , , , , , , ,-0.21, , , ,,,-0.24,,,,-0.21,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,158.89,157.27,S58,EEGGVDAKDTSATSQSVNGSPQAEQPSLEST,_DTSATSQS(ph)VNGS(ph)PQAEQPSLESTSK_, , , , ,-0.28, , , , , , , ,-0.47, , , ,,,-0.28,,,,-0.47,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
C9J0I9,Q86WB0,Nuclear-interacting partner of ALK,ZC3HC1,244.18,243.42,S62,VDAKDTSATSQSVNGSPQAEQPSLESTSKEA,_DTSATSQSVNGS(ph)PQAEQPSLESTSK_,-0.08,0.02,-0.23,-0.31,0.24,0.07,-0.33,-0.32,0.39,0.38,0.28,0.55,0.29,0.2,-0.74,-0.91,-0.03,-0.27,0.16,-0.33,0.38,0.42,0.25,-0.82,,,,,,,0,0,,nucleus,zinc ion binding,,,
Q5VYS8-4,Q5VYS8,Terminal uridylyltransferase 7,ZCCHC6,87.44,86.29,S886,DGMANEDELDNTYTGSGDEDALSEEDDELGE,_EDEDGMANEDELDNTYTGS(ph)GDEDALS(ph)EEDDELGEAAK_, , , , ,0.01, , , , , , , ,-0.12, , , ,,,0.01,,,,-0.12,,,,,,,,NA,NA,,,nucleic acid binding,RNA 3'-end processing,,
Q5VYS8-4,Q5VYS8,Terminal uridylyltransferase 7,ZCCHC6,87.44,86.29,S893,ELDNTYTGSGDEDALSEEDDELGEAAKYEDV,_EDEDGMANEDELDNTYTGS(ph)GDEDALS(ph)EEDDELGEAAK_, , , , ,0.01, , , , , , , ,-0.12, , , ,,,0.01,,,,-0.12,,,,,,,,NA,NA,,,nucleic acid binding,RNA 3'-end processing,,
G3V1V1,Q8TBF4,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,ZCRB1,282.91,271.87,S210,SDDSRRPRIKKSTYFSDEEELSD________,_STYFS(ph)DEEELS(ph)D_, , , , ,-0.04,-0.27,-0.14,-0.29, , , , ,-0.25,-0.13,-0.16,0.03,,,-0.15,-0.21,,,-0.19,-0.06,,,,,,,NA,NA,,,nucleic acid binding,,,
G3V1V1,Q8TBF4,Zinc finger CCHC-type and RNA-binding motif-containing protein 1,ZCRB1,282.91,271.87,S216,PRIKKSTYFSDEEELSD______________,_STYFS(ph)DEEELS(ph)D_, , , , ,-0.04,-0.27,-0.14,-0.29, , , , ,-0.25,-0.13,-0.16,0.03,,,-0.15,-0.21,,,-0.19,-0.06,,,,,,,NA,NA,,,nucleic acid binding,,,
Q9C0B5-2,Q9C0B5,Palmitoyltransferase ZDHHC5,ZDHHC5,104.6,104.6,Y533,LVPTGPTHREPSPVRYDNLSRHIVASLQERE,_EPS(ph)PVRY(ph)DNLSR_,0.06,0.14,-0.24, ,0.03, ,-0.02,-0.06,0.05,0.13,-0.3, ,-0.25, ,0.38,0.23,0.1,-0.24,0.03,-0.04,0.09,-0.3,-0.25,0.3,,,,,,,0,0,,integral to membrane,palmitoyltransferase activity,protein palmitoylation,,
Q9C0B5-2,Q9C0B5,Palmitoyltransferase ZDHHC5,ZDHHC5,104.6,104.6,S529,RHPRLVPTGPTHREPSPVRYDNLSRHIVASL,_EPS(ph)PVRY(ph)DNLSR_,-0.03,0.14,-0.24, ,-0.05,-0.16,-0.02,0.01,0.01,0.13,-0.3, ,-0.15,-0.02,0.38,0.24,0.06,-0.24,-0.1,0,0.07,-0.3,-0.08,0.31,,,,,,,0,0,,integral to membrane,palmitoyltransferase activity,protein palmitoylation,,
Q9C0B5-2,Q9C0B5,Palmitoyltransferase ZDHHC5,ZDHHC5,108.45,106.23,S621,PRFGKPDGLRGRGVGSPEPGPTAPYLGRSMS,_GVGS(ph)PEPGPTAPYLGR_, , ,-0.72, , , ,-0.23, , , ,-0.21, , , ,-0.36, ,,-0.72,,-0.23,,-0.21,,-0.36,,,,,,,NA,NA,,integral to membrane,palmitoyltransferase activity,protein palmitoylation,,
Q9ULC8-2,Q9ULC8,Probable palmitoyltransferase ZDHHC8,ZDHHC8,78.69,78.69,Y541,SPVLGPRPREPSPVRYDNLSRTIMASIQERK,_EPS(ph)PVRY(ph)DNLSR_,0.15, ,-0.22, ,0.03, , ,0.03,0.09, ,0.07, ,-0.25, , ,0.27,0.15,-0.22,0.03,0.03,0.09,0.07,-0.25,0.27,,,,,,,0,0,,cytoplasmic vesicle membrane,"transferase activity, transferring acyl groups",behavior,,
Q9ULC8-2,Q9ULC8,Probable palmitoyltransferase ZDHHC8,ZDHHC8,78.69,78.69,S537,PRSFSPVLGPRPREPSPVRYDNLSRTIMASI,_EPS(ph)PVRY(ph)DNLSR_,0.15, ,-0.22, ,0.03, , ,0.03,0.09, ,0.07, ,-0.25, , ,0.27,0.15,-0.22,0.03,0.03,0.09,0.07,-0.25,0.27,,,,,,,0,0,,cytoplasmic vesicle membrane,"transferase activity, transferring acyl groups",behavior,,
F5H1R1,P37275,Zinc finger E-box-binding homeobox 1,ZEB1,216.28,215.99,S31,RRNNVTNYNTVVETNSDSDDEDKLHIVEEES,_NNVTNYNTVVETNS(ph)DS(ph)DDEDK_,0.15,0.78, ,1.21,-0.16,-0.42,-0.14,-0.29,-0.29,-0.3, ,-0.11,-0.12,-0.25,-0.07,-0.1,0.5,1.21,-0.29,-0.21,-0.29,-0.11,-0.18,-0.08, +,,,,,,4,0,4.68,,,,,
F5H1R1,P37275,Zinc finger E-box-binding homeobox 1,ZEB1,216.28,215.99,S33,NNVTNYNTVVETNSDSDDEDKLHIVEEESVT,_NNVTNYNTVVETNS(ph)DS(ph)DDEDK_,0.15,0.78, ,1.21,-0.16,-0.42,-0.14,-0.13,-0.29,-0.3, ,-0.11,-0.12,-0.25,-0.07,-0.05,0.5,1.21,-0.29,-0.13,-0.29,-0.11,-0.18,-0.06, +,,,,,,4,0,5.28,,,,,
F5H1R1,P37275,Zinc finger E-box-binding homeobox 1,ZEB1,115.58,112.7,S642,KWFEKMQAGQISVQSSEPSSPEPGKVNIPAK,_MQAGQISVQSS(ph)EPSS(ph)PEPGK_, , , , ,-0.96,-0.96, , , , , , ,-0.63,-1.07, , ,,,-0.96,,,,-0.83,,,,,,,,NA,NA,,,,,,
F5H1R1,P37275,Zinc finger E-box-binding homeobox 1,ZEB1,68.16,67.98,S646,KMQAGQISVQSSEPSSPEPGKVNIPAKNNDQ,_MQAGQISVQSS(ph)EPSS(ph)PEPGK_, , , , ,-0.77,-0.96,-0.82,-0.64, , , , ,-0.62,-1.07,-0.91,-0.78,,,-0.86,-0.73,,,-0.83,-0.84,,,,,,,NA,NA,,,,,,
F5H1R1,P37275,Zinc finger E-box-binding homeobox 1,ZEB1,72.12,71.53,S679,SANANEPQDSTVNLQSPLKMTNSPVLPVGST,_NNDQPQSANANEPQDSTVNLQS(ph)PLK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,,,,
F5H814,O60315,Zinc finger E-box-binding homeobox 2,ZEB2,45.14,45.13,S36,RRKNVVNYDNVVDTGSETDEEDKLHIAEDDG,_NVVNYDNVVDT(ph)GS(ph)ET(ph)DEEDK_, , , , , , , ,0.13, , , , , , , ,0.54,,,,0.13,,,,0.54,,,,,,,NA,NA,,,,,,
F5H814,O60315,Zinc finger E-box-binding homeobox 2,ZEB2,45.14,45.13,T34,NPRRKNVVNYDNVVDTGSETDEEDKLHIAED,_NVVNYDNVVDT(ph)GS(ph)ET(ph)DEEDK_, , , , , , , ,0.13, , , , , , , ,0.54,,,,0.13,,,,0.54,,,,,,,NA,NA,,,,,,
F5H814,O60315,Zinc finger E-box-binding homeobox 2,ZEB2,45.14,45.13,T38,KNVVNYDNVVDTGSETDEEDKLHIAEDDGIA,_NVVNYDNVVDT(ph)GS(ph)ET(ph)DEEDK_, , , , , , , ,0.13, , , , , , , ,0.54,,,,0.13,,,,0.54,,,,,,,NA,NA,,,,,,
Q5QPB1,O76080,AN1-type zinc finger protein 5,ZFAND5,107.36,105.91,S48,CYKEHLQRQQNSGRMSPMGTASGSNSPTSDS,_MS(ph)PMGTAS(ph)GSNS(ph)PTSDSASVQR_,0.35,0.24,0.24,0.51,-0.03, ,0.55,-0.56,-0.02,0.19,-0.06,-0.01,0.23, ,0.03,-0.47,0.3,0.38,-0.03,0.1,0.09,-0.03,0.23,-0.2,,,,ZnF_A27,,,0,0,,,DNA binding,,,
Q5QPB1,O76080,AN1-type zinc finger protein 5,ZFAND5,81.84,78.79,S58,NSGRMSPMGTASGSNSPTSDSASVQRADTSL,_MS(ph)PMGTAS(ph)GSNS(ph)PTSDSASVQR_, , , , , , , ,-0.56, , , , , , , ,-0.47,,,,-0.56,,,,-0.47,,,,ZnF_A27,,,NA,NA,,,DNA binding,,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,194.66,194.66,S1303,WKPKFWRKPISDNSFSSDEEQSTGPIKYAFQ,_PISDNSFS(ph)S(ph)DEEQSTGPIK_,0.04,0.43,0.3,0.05,0.41,0.25,0.11,0.12,-0.27,0.19,0.05,-0.25,0.36,0.14,0.15,0.22,0.25,0.18,0.33,0.11,-0.02,-0.09,0.26,0.18,,,,,,,0,0,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,194.66,194.66,S1304,KPKFWRKPISDNSFSSDEEQSTGPIKYAFQP,_PISDNSFS(ph)S(ph)DEEQSTGPIK_,0.39,0.43,0.3,0.05,0.41,0.25,0.11,0.12,0.17,0.19,0.05,-0.25,0.36,0.14,0.15,0.22,0.41,0.18,0.33,0.11,0.18,-0.09,0.26,0.18,,,,,,,0,0,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,208.58,197.24,S714,ISLPKHKSVVVTLNDSDDSESDGEASKSTNS,_SVVVTLNDS(ph)DDS(ph)ES(ph)DGEASK_, , , , ,0.08,0.16,0.18,0.16, , , , ,0.13,0.19,0.42,0.19,,,0.12,0.17,,,0.16,0.31,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,208.58,197.24,S717,PKHKSVVVTLNDSDDSESDGEASKSTNSVFG,_SVVVTLNDS(ph)DDS(ph)ES(ph)DGEASK_, , , , ,0.08,0.16,0.18,0.16, , , , ,0.13,0.19,0.42,0.19,,,0.12,0.17,,,0.16,0.31,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,208.58,197.24,S719,HKSVVVTLNDSDDSESDGEASKSTNSVFGGL,_SVVVTLNDS(ph)DDS(ph)ES(ph)DGEASK_, , , , ,0.08,0.16,0.19,0.16, , , , ,0.13,0.19,0.36,0.19,,,0.12,0.18,,,0.16,0.27,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,110.6,109.5,S805,KQRLIKSDQLKTSSSSPANSDVEIDGIGRIA,_TSSSS(ph)PANS(ph)DVEIDGIGR_, , , , ,-0.43,-0.42, ,-0.33, , , , ,-0.88,-0.97, ,-0.8,,,-0.42,-0.33,,,-0.93,-0.8,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,110.6,109.5,S809,IKSDQLKTSSSSPANSDVEIDGIGRIAMVTK,_TSSSS(ph)PANS(ph)DVEIDGIGR_, , , , ,-0.43,-0.44,-0.16,-0.21, , , , ,-0.88,-1,-0.89,-0.75,,,-0.44,-0.18,,,-0.94,-0.82,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
O60293-2,O60293,Zinc finger C3H1 domain-containing protein,ZFC3H1,244.78,237.03,S28,GLSPKEEGELEDGEISDDDNNSQIRSRSSSS,_EEGELEDGEIS(ph)DDDNNSQIR_, , , , , ,0.04,-0.28,-0.42, , , , , ,-0.04,-0.17,-0.34,,,0.04,-0.35,,,-0.04,-0.25,,,,,,,NA,NA,,intracellular,metal ion binding,RNA processing,,
E9PE29,Q9H2Y7,Zinc finger protein 106 homolog,ZFP106,110.95,108.95,S1025,DGQSIRKKRRATGDGSSPELPSLERKNKRRK,_ATGDGS(ph)S(ph)PELPSLER_, , , , ,0.37,0.48,0.55, , , , , ,0.21,-0.14,0.2, ,,,0.43,0.55,,,0.05,0.2,,,,,,,NA,NA,,nucleolus,zinc ion binding,rRNA processing,,
E9PE29,Q9H2Y7,Zinc finger protein 106 homolog,ZFP106,110.95,108.95,S1026,GQSIRKKRRATGDGSSPELPSLERKNKRRKI,_ATGDGS(ph)S(ph)PELPSLER_, , , , ,0.37,0.48,0.55, , , , , ,0.21,-0.14,0.2, ,,,0.43,0.55,,,0.05,0.2,,,,,,,NA,NA,,nucleolus,zinc ion binding,rRNA processing,,
Q96KR1,Q96KR1,Zinc finger RNA-binding protein,ZFR,205.49,200.44,S1054,SQRFNIHNNRKRRRDSDGVDGFEAEGKKDKK,_RRDS(ph)DGVDGFEAEGK_,0.27,0.48,1.26,1.22,1.51,1.54,1.07,0.94,0.09,0.2,1.01,0.8,1.39,1.6,1.2,1.14,0.38,1.24,1.52,1.01,0.14,0.91,1.5,1.17, +, +,,,,,1,1,30.42,chromosome,DNA binding,multicellular organismal development,,
Q7Z3T8,Q7Z3T8,Zinc finger FYVE domain-containing protein 16,ZFYVE16,187.76,180.99,S939,PNNETGDITRNEIIQSPISQVPSVEKLSMNT,_NEIIQS(ph)PISQVPSVEK_, ,-0.14,2.25, , , , , , ,-0.08,2.15, , , , , ,-0.14,2.25,,,-0.08,2.15,,, +, +,,,,,NA,NA,,early endosome membrane,1-phosphatidylinositol binding,BMP signaling pathway,,
Q7Z3T8,Q7Z3T8,Zinc finger FYVE domain-containing protein 16,ZFYVE16,248.25,237.15,Y221,ELGIKVDTTLSDSYNYSGTENLKDKKIFNQL,_VDTTLSDSYNY(ph)SGTENLK_, , ,1.9, , , , , , , ,-0.91, , , , , ,,1.9,,,,-0.91,,, +,,,,,,NA,NA,,early endosome membrane,1-phosphatidylinositol binding,BMP signaling pathway,,
Q96K21-3,Q96K21,Zinc finger FYVE domain-containing protein 19,ZFYVE19,414.29,376.85,S354,KGGGPVTLQDYRLPDSDDDEDEETAIQRVLQ,_LPDS(ph)DDDEDEETAIQR_,0.01,0.04,-0.12,-0.2,-0.21,-0.11,-0.3,-0.18,0,0.04,0.03,-0.06,-0.14,0.29,0.08,0.02,0.03,-0.16,-0.16,-0.24,0.02,-0.01,0.09,0.05,,,,,,,0,0,,,zinc ion binding,,,
Q96K21-3,Q96K21,Zinc finger FYVE domain-containing protein 19,ZFYVE19,42.21,41.01,S144,HEVLTRGSSANASKWSPPQNYKKRVAALEAK,_WS(ph)PPQNYK_,0.2,0.19,0.2,-0.18,0.12, , ,-0.05,-0.01,0.11,0.19,-0.23,0.09, , ,0.18,0.19,0.02,0.12,-0.05,0.05,0,0.09,0.18,,,,,,,0,0,,,zinc ion binding,,,
Q9H1K0,Q9H1K0,Rabenosyn-5,ZFYVE20,92.93,88.55,Y571,PFQLEPSREPRTHLAYALDLGSSPVPSSTAP,_THLAY(ph)ALDLGSSPVPSSTAPK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,early endosome membrane,zinc ion binding,blood coagulation,,
Q5W0Q3,Q9UBW7,Zinc finger MYM-type protein 2,ZMYM2,130.1,120.44,T1376,VKDIYDKDNYELDEDTD______________,_DNYELDEDT(ph)D_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,,zinc ion binding,,,
Q5VZL5-2,Q5VZL5,Zinc finger MYM-type protein 4,ZMYM4,233.29,211.61,S122,TDDSLEVERRVTQHESDNENEIQIQNKLKKD,_VTQHES(ph)DNENEIQIQNK_,0.09,0.02,-0.05,0.02,0.12,0.28,0.1,0.2,-0.02,-0.01,0.16,0.13,0.15,0.17,0.11,0.13,0.06,-0.01,0.2,0.15,-0.01,0.14,0.16,0.12,,,,,,,0,0,,,DNA binding,cytoskeleton organization,,
Q9ULU4-4,Q9ULU4,Protein kinase C-binding protein 1,ZMYND8,66.51,66.51,S406,IDKQEKVKLNFDMTASPKILMSKPVLSGGTG,_LNFDMTAS(ph)PK_,-0.6,-0.36,-0.54, , , , , ,-0.35,-0.1,-0.21, , , , , ,-0.48,-0.54,,,-0.22,-0.21,,,,,,,,,NA,NA,,nucleus,repressing transcription factor binding,activation of protein kinase B activity,,
Q6ZND3,Q99676,Zinc finger protein 184,ZNF184,78.68,75.64,S117,ETRLENSVSAPEPDISEEELSPEVIVEKHKR,_LENSVSAPEPDIS(ph)EEELS(ph)PEVIVEK_, , , , , ,0.01, , , , , , , ,-0.23, , ,,,0.01,,,,-0.23,,,,,,,,NA,NA,,intracellular,nucleic acid binding,"regulation of transcription, DNA-dependent",,
Q6ZND3,Q99676,Zinc finger protein 184,ZNF184,78.68,75.64,S122,NSVSAPEPDISEEELSPEVIVEKHKRDDSWS,_LENSVSAPEPDIS(ph)EEELS(ph)PEVIVEK_, , , , , ,0.01, , , , , , , ,-0.23, , ,,,0.01,,,,-0.23,,,,,,,,NA,NA,,intracellular,nucleic acid binding,"regulation of transcription, DNA-dependent",,
O75362,O75362,Zinc finger protein 217,ZNF217,46.9,46.4,S441,APLDENGAVDRGEGGSEDGSEDGLPEGIHLD,_GEGGS(ph)EDGS(ph)EDGLPEGIHLDK_, , , , ,0.03, , ,0.12, , , , ,0.24, , ,0.01,,,0.03,0.12,,,0.24,0.01,,,,,,,NA,NA,,histone deacetylase complex,sequence-specific DNA binding transcription factor activity,"negative regulation of transcription, DNA-dependent",,
O75362,O75362,Zinc finger protein 217,ZNF217,46.9,46.4,S445,ENGAVDRGEGGSEDGSEDGLPEGIHLDKNDD,_GEGGS(ph)EDGS(ph)EDGLPEGIHLDK_, , , , ,0.03, , ,0.12, , , , ,0.24, , ,0.01,,,0.03,0.12,,,0.24,0.01,,,,,,,NA,NA,,histone deacetylase complex,sequence-specific DNA binding transcription factor activity,"negative regulation of transcription, DNA-dependent",,
Q9ULJ3-2,Q9ULJ3,Zinc finger protein 295,ZNF295,127.64,80.27,S411,DDRPQVLQPHRLRSFSASQSTDREGASPVTE,_SFS(ph)ASQSTDREGASPVTEVR_, , ,-1.06, ,-1.69, , , , , ,-0.81, ,-2.34, , , ,,-1.06,-1.69,,,-0.81,-2.34,, +, +,,BTB,,,NA,NA,,nucleus,methyl-CpG binding,"negative regulation of transcription, DNA-dependent",,
Q9ULJ3-2,Q9ULJ3,Zinc finger protein 295,ZNF295,127.64,80.27,S422,LRSFSASQSTDREGASPVTEVRIKTEPSSPL,_SFS(ph)ASQSTDREGAS(ph)PVTEVR_, , , , ,-1.69, , , , , , , ,-2.34, , , ,,,-1.69,,,,-2.34,, +, +,,BTB,,,NA,NA,,nucleus,methyl-CpG binding,"negative regulation of transcription, DNA-dependent",,
Q9ULJ3-2,Q9ULJ3,Zinc finger protein 295,ZNF295,89.37,87.45,S435,GASPVTEVRIKTEPSSPLSDPSDIIRVTVGD,_TEPSS(ph)PLSDPSDIIR_, ,0.79,0.78,0.56, , , ,-1.21, ,-0.1,0.08,0.03, , , ,-1.8,0.79,0.68,,-1.21,-0.1,0.05,,-1.8, +, +,,BTB,,,NA,NA,,nucleus,methyl-CpG binding,"negative regulation of transcription, DNA-dependent",,
A6NFI3,A6NFI3,Zinc finger protein 316,ZNF316,233.7,232.27,S10,______MAALHTTPDSPAAQLERAEDGSECD,_(ac)AALHTTPDS(ph)PAAQLER_,0.01,0.05,-0.14,-0.03,0.07,0.15,-0.07,0.91,-0.12,-0.1,-0.13,-0.17,-0.07,-0.16,-0.43,-0.37,0.03,-0.08,0.11,0.5,-0.11,-0.15,-0.12,-0.4,,,,,,,0,0,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
Q5VUA4,Q5VUA4,Zinc finger protein 318,ZNF318,94.75,72.38,S527,SMLADSTSTQEKRRRSFPDIEDEEKFLYGDE,_S(ph)FPDIEDEEK_, , ,1.87, ,1.56,1.28, , , , ,1.63, ,1.7,0.89, , ,,1.87,1.43,,,1.63,1.35,, +, +,,,,,NA,NA,,cytoplasm,nucleic acid binding,meiosis,,
Q5VUA4,Q5VUA4,Zinc finger protein 318,ZNF318,92.11,49.88,S2101,EGERNSPNPRSVRIPSPNILKTGLTENVDRG,_IPS(ph)PNILK_,0.32,0.15,-0.04,0.17,0.61,0.18,0.29,0.08,0.17,0.37,0.11,0.11,0.04,-0.19,0.28,0.28,0.24,0.07,0.41,0.19,0.27,0.11,-0.07,0.28,,,,,,,0,0,,cytoplasm,nucleic acid binding,meiosis,,
Q5VUA4,Q5VUA4,Zinc finger protein 318,ZNF318,110.17,102.3,S173,CVSTPERRRLSDRLGSPVDNLEDMDRDDLTD,_LGS(ph)PVDNLEDMDRDDLTDDSVFTR_, , , , , , ,0.43, , , , , , , ,-0.12, ,,,,0.43,,,,-0.12,,,,,,,NA,NA,,cytoplasm,nucleic acid binding,meiosis,,
Q5VUA4,Q5VUA4,Zinc finger protein 318,ZNF318,56.55,23.36,S709,PHPPSPVDPYLLTKNSPPFLKSDHPVGHISG,_NS(ph)PPFLK_,0.04,0.03, ,-0.09,0.38, ,-0.08,0.58,0.06,0.02, ,0,0.29, ,0.14,0.14,0.04,-0.09,0.38,0.29,0.04,0,0.29,0.14,,,,,,,0,0,,cytoplasm,nucleic acid binding,meiosis,,
Q7RTV3,Q7RTV3,Zinc finger protein 367,ZNF367,48.69,44.11,S310,QKADQEQQDPLEYLQSDEEDDEKRGAQRRLQ,_ADQEQQDPLEYLQS(ph)DEEDDEK_, , , , , , , ,-0.48, , , , , , , ,-0.1,,,,-0.48,,,,-0.1,,,,,,,NA,NA,,cytoplasm,DNA binding,regulation of transcription from RNA polymerase II promoter,,
Q8NAF0,Q8NAF0,Zinc finger protein 579,ZNF579,84.31,79.92,S194,PSTLAAPTSAAEPRESESEEAEAGAAELRAE,_ES(ph)ESEEAEAGAAELR_, , , , , , , ,-0.01, , , , , , , ,-0.49,,,,-0.01,,,,-0.49,,,,,,,NA,NA,,nucleus,DNA binding,"regulation of transcription, DNA-dependent",,
O00488,O00488,Zinc finger protein 593,ZNF593,146.67,142.28,T134,VPTEVSTEVPEMDTST_______________,_LAVPTEVSTEVPEMDTST(ph)_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleolus,DNA binding,negative regulation of transcription from RNA polymerase II promoter,,
Q86UK7-2,Q86UK7,Zinc finger protein 598,ZNF598,205.63,205.29,Y306,PRHSRRNEGVVGGEDYEEVDRYSRQGRVARA,_RNEGVVGGEDY(ph)EEVDRYSR_,3.12, , , , , , , ,2.21, , , , , , , ,3.12,,,,2.21,,,, +, +,,RING finger,,,NA,NA,,,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,94.4,54.82,S1055,WKQKPSIPPTLTKAPSLTDLVKSGPGKAKEP,_APS(ph)LTDLVK_, ,0.54, , , , , , , ,2.24, , , , , , ,0.54,,,,2.24,,,,, +,,,,,NA,NA,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,76.01,73.86,S743,KKKDKKKKESSKELESPLTPGKVCRAEEGKS,_ELES(ph)PLT(ph)PGK_, , , , ,0.23,-0.04,-0.17,-0.16, , , , ,0.08,-0.04,0.02,-0.17,,,0.1,-0.16,,,0.02,-0.07,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,52.73,51.7,S576,PARSATPKVRLVEPHSPSPSSKFSTKGLCKK,_LVEPHS(ph)PS(ph)PSSK_, , , , ,0.14, , , , , , , ,0, , , ,,,0.14,,,,0,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,62.08,53.46,S467,SSSEDSKGSKRVRTNSMGSATGPLPGTKVEP,_TNS(ph)MGS(ph)ATGPLPGTK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,62.08,53.46,S470,EDSKGSKRVRTNSMGSATGPLPGTKVEPTVL,_TNS(ph)MGS(ph)ATGPLPGTK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,190.46,190.46,S842,VVTQNGAEASSVKTNSPAYSDISDAGEDGEG,_TNS(ph)PAYS(ph)DIS(ph)DAGEDGEGK_,-0.34, ,-0.17, ,-0.12,-0.21,0,-0.13,0.02, ,0.29, ,-0.08,-0.09,0.1,-0.04,-0.34,-0.17,-0.16,-0.06,0.02,0.29,-0.08,0.03,,,,,,,0,0,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,190.46,190.46,S846,NGAEASSVKTNSPAYSDISDAGEDGEGKVDS,_TNS(ph)PAYS(ph)DIS(ph)DAGEDGEGK_,-0.34, ,-0.17, ,-0.12,-0.21,0,-0.13,0.02, ,0.29, ,-0.08,-0.09,0.1,-0.04,-0.34,-0.17,-0.16,-0.06,0.02,0.29,-0.08,0.03,,,,,,,0,0,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,190.46,190.46,S849,EASSVKTNSPAYSDISDAGEDGEGKVDSVKS,_TNS(ph)PAYS(ph)DIS(ph)DAGEDGEGK_,-0.34, ,-0.17, ,-0.12,-0.21,0,-0.13,0.02, ,0.29, ,-0.08,-0.09,0.1,-0.04,-0.34,-0.17,-0.16,-0.06,0.02,0.29,-0.08,0.03,,,,,,,0,0,,nucleus,zinc ion binding,,,
O15014,O15014,Zinc finger protein 609,ZNF609,116.51,57.7,T746,DKKKKESSKELESPLTPGKVCRAEEGKSPFR,_ELES(ph)PLT(ph)PGK_,-0.2,-0.05, , ,-0.18,0.03,0.04,0.24,0.47,0.43, , ,0.05,-0.01,0.27,0.45,-0.13,,-0.08,0.14,0.45,,0.02,0.36,,,,,,,NA,NA,,nucleus,zinc ion binding,,,
Q6ZNC4,Q6ZNC4,Zinc finger protein 704,ZNF704,149.93,149.63,S225,IQKHIRTIHLGRVGDSDYSDGEEDFYYTEIK,_VGDS(ph)DYS(ph)DGEEDFYYTEIK_, , , , ,-0.31,-0.19,-0.39,-0.31, , , , ,-0.35,-0.17,-0.18,-0.07,,,-0.25,-0.35,,,-0.26,-0.12,,,,,,,NA,NA,,,zinc ion binding,,,
Q6ZNC4,Q6ZNC4,Zinc finger protein 704,ZNF704,149.93,149.63,S228,HIRTIHLGRVGDSDYSDGEEDFYYTEIKLNT,_VGDS(ph)DYS(ph)DGEEDFYYTEIK_, , , , ,-0.31,-0.19,-0.39,-0.31, , , , ,-0.35,-0.17,-0.18,-0.07,,,-0.25,-0.35,,,-0.26,-0.12,,,,,,,NA,NA,,,zinc ion binding,,,
B7Z2Y7,Q9H5H4,Zinc finger protein 768,ZNF768,118.08,115.29,S83,QSPEFEPQSPRFEPESPGFESRSPGLVPPSP,_FEPES(ph)PGFESR_,1.72,0.02,0.19, ,0.17,0.33,0.49,0.01,-0.04,-0.02,0.08, ,0.06,0.35,0.12,-0.01,1.11,0.19,0.25,0.27,-0.03,0.08,0.21,0.05, +,,,,,,5,0,4.74,"DNA-directed RNA polymerase II, core complex",DNA binding,transcription from RNA polymerase II promoter,,
B7Z2Y7,Q9H5H4,Zinc finger protein 768,ZNF768,41.56,40.89,S107,GLVPPSPEFAPRSPESDSQSPEFESQSPRYE,_S(ph)PES(ph)DSQSPEFESQS(ph)PR_, , , , , , , ,-0.22, , , , , , , ,-0.2,,,,-0.22,,,,-0.2,,,,,,,NA,NA,,"DNA-directed RNA polymerase II, core complex",DNA binding,transcription from RNA polymerase II promoter,,
B7Z2Y7,Q9H5H4,Zinc finger protein 768,ZNF768,104.23,102.35,S90,QSPRFEPESPGFESRSPGLVPPSPEFAPRSP,_S(ph)PGLVPPS(ph)PEFAPR_,0.14,0.16,0.36,0.53,0.28,0.27,0.55,0.19,-0.17,-0.07,0.16,0.27,0.07,0.22,0.03,0.16,0.15,0.45,0.28,0.38,-0.12,0.22,0.15,0.1,,,,,,,0,0,,"DNA-directed RNA polymerase II, core complex",DNA binding,transcription from RNA polymerase II promoter,,
B7Z2Y7,Q9H5H4,Zinc finger protein 768,ZNF768,104.23,102.35,S97,ESPGFESRSPGLVPPSPEFAPRSPESDSQSP,_S(ph)PGLVPPS(ph)PEFAPR_,0.14,0.16,0.36,0.53,0.28,0.27,0.55,0.19,-0.17,-0.07,0.16,0.27,0.07,0.22,0.03,0.16,0.15,0.45,0.28,0.38,-0.12,0.22,0.15,0.1,,,,,,,0,0,,"DNA-directed RNA polymerase II, core complex",DNA binding,transcription from RNA polymerase II promoter,,
B7Z2Y7,Q9H5H4,Zinc finger protein 768,ZNF768,70.26,64.76,S125,QSPEFESQSPRYEPQSPGYEPRSPGYEPRSP,_YEPQS(ph)PGYEPR_, , , , ,0.18, , , , , , , ,0.04, , , ,,,0.18,,,,0.04,,,,,,,,NA,NA,,"DNA-directed RNA polymerase II, core complex",DNA binding,transcription from RNA polymerase II promoter,,
Q96NB3,Q96NB3,Zinc finger protein 830,ZNF830,210.11,210.11,S351,LTIKELQKKEEENADSDDEGELQDLLSQDWR,_KEEENADS(ph)DDEGELQDLLSQDWR_, , , , ,-0.3,-0.12,-0.42,-0.05, , , , ,-0.41,-0.5,-0.48,-0.32,,,-0.21,-0.22,,,-0.45,-0.4,,,,,,,NA,NA,,cytoplasm,metal ion binding,blastocyst growth,,
Q8NHG8,Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,ZNRF2,170.77,169.7,S19,KQSGPAAANGRTRAYSGSDLPSSSSGGANGT,_AYS(ph)GSDLPSSSSGGANGTAGGGGGAR_, , , , ,0.58, ,0.26, , , , , ,0.22, ,-0.15, ,,,0.58,0.26,,,0.22,-0.15,,,,RING finger,,,NA,NA,,cell junction,ligase activity,protein ubiquitination,,
Q8NHG8,Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,ZNRF2,124.46,122.73,S113,QSPFSIPNSSSGPYGSQDSVHSSPEDGGGGR,_AAQSPFSIPNSSSGPYGS(ph)QDS(ph)VHS(ph)SPEDGGGGR_, , , , , ,0.3,0.38,0.36, , , , , ,0.31,0.2,0.43,,,0.3,0.37,,,0.31,0.32,,,,RING finger,,,NA,NA,,cell junction,ligase activity,protein ubiquitination,,
Q8NHG8,Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,ZNRF2,124.46,122.73,S116,FSIPNSSSGPYGSQDSVHSSPEDGGGGRDRP,_AAQSPFSIPNSSSGPYGS(ph)QDS(ph)VHS(ph)SPEDGGGGR_, , , , , ,0.3,0.38,0.35, , , , , ,0.31,0.2,0.42,,,0.3,0.36,,,0.31,0.32,,,,RING finger,,,NA,NA,,cell junction,ligase activity,protein ubiquitination,,
Q8NHG8,Q8NHG8,E3 ubiquitin-protein ligase ZNRF2,ZNRF2,124.46,122.73,S119,PNSSSGPYGSQDSVHSSPEDGGGGRDRPVGG,_AAQSPFSIPNSSSGPYGS(ph)QDS(ph)VHS(ph)SPEDGGGGR_, , , , , ,0.3,0.38,0.36, , , , , ,0.31,0.2,0.43,,,0.3,0.37,,,0.31,0.32,,,,RING finger,,,NA,NA,,cell junction,ligase activity,protein ubiquitination,,
O95218-2,O95218,Zinc finger Ran-binding domain-containing protein 2,ZRANB2,262.15,262.15,S181,KYKLDEDEDEDDADLSKYNLDASEEEDSNKK,_YKLDEDEDEDDADLS(ph)K_,0.66,0.45,0.61,-0.14,0.46,0.39,0.59,0.91,1.54,1.15,1.37,1.12,-0.14,-0.15,0.21,0.4,0.56,0.28,0.43,0.76,1.36,1.25,-0.14,0.31,, +,,,,,0,5,5,nucleus,RNA binding,mRNA processing,,
O95218-2,O95218,Zinc finger Ran-binding domain-containing protein 2,ZRANB2,373.93,373.93,S120,GFNERENVEYIEREESDGEYDEFGRKKKKYR,_ENVEYIEREES(ph)DGEYDEFGRK_,0.04,0.05,-0.02,0.03,0.04,0.09,0.14,0.19,0.05,0.07,0.09,0.2,0,0.26,0.12,-0.08,0.05,0,0.07,0.17,0.06,0.15,0.14,0.02,,,,,,,0,0,,nucleus,RNA binding,mRNA processing,,
O95218-2,O95218,Zinc finger Ran-binding domain-containing protein 2,ZRANB2,575.05,575.05,S153,AVGPASILKEVEDKESEGEEEDEDEDLSKYK,_EVEDKES(ph)EGEEEDEDEDLSK_,0.12,0.16,0.05,0.06,0.12,0.2,0.34,0.24,0.18,0.24,0.14,0.19,0.25,0.19,0.24,0.16,0.14,0.05,0.16,0.29,0.21,0.17,0.22,0.2,,,,,,,0,0,,nucleus,RNA binding,mRNA processing,,
O95218-2,O95218,Zinc finger Ran-binding domain-containing protein 2,ZRANB2,307.52,279.75,S188,EDEDDADLSKYNLDASEEEDSNKKKSNRRSR,_YNLDAS(ph)EEEDSNKK_,0.22,0.11,0,0.09,0.25,0.48,0.3,0.34,0,0.11,0.01,0.12,0.33,0.15,0.18,0.43,0.17,0.04,0.37,0.32,0.05,0.06,0.25,0.31,,,,,,,0,0,,nucleus,RNA binding,mRNA processing,,
O95218-2,O95218,Zinc finger Ran-binding domain-containing protein 2,ZRANB2,145.19,128.88,S193,ADLSKYNLDASEEEDSNKKKSNRRSRSKSRS,_YNLDAS(ph)EEEDS(ph)NK_, , , , ,-0.16,-0.19,-0.15,-0.17, , , , ,-0.22,-0.24,0.12,0.05,,,-0.17,-0.16,,,-0.23,0.09,,,,,,,NA,NA,,nucleus,RNA binding,mRNA processing,,
Q15696,Q15696,U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2,ZRSR2,82.42,82.42,S349,NPNNEFWEANRDIYLSPDRTGSSFGKNSERR,_DIYLS(ph)PDR_,0.12, ,-0.03, , , , , ,-0.09, ,-0.37, , , , , ,0.12,-0.03,,,-0.09,-0.37,,,,,,,,,NA,NA,,U12-type spliceosomal complex,nucleotide binding,spliceosomal complex assembly,,
Q15942,Q15942,Zyxin,ZYX,103.13,76.04,S344,QHPVPPPAQNQNQVRSPGAPGPLTLKEVEEL,_S(ph)PGAPGPLTLK_,-0.51,-0.46,0.23,0.21,0.79,0.78,0.64,0.52,-0.01,-0.04,0.63,0.62,0.9,0.89,1.02,1.03,-0.48,0.22,0.79,0.58,-0.03,0.62,0.9,1.03,, +,,,,,0,1,20.43,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,199.75,193.52,S143,EAPIPPPPQPREKVSSIDLEIDSLSSLLDDM,_VSS(ph)IDLEIDSLSSLLDDMTK_, , , , , , , , , , , , , , , , ,,,,,,,,,,,,,,,NA,NA,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,98,98,S281,FSPVTPKFTPVASKFSPGAPGGSGSQPNQKL,_FTPVASKFS(ph)PGAPGGSGSQPNQK_,-0.17,-0.47, , , , , , ,-0.7,-0.7, , , , , , ,-0.32,,,,-0.7,,,,,,,,,,NA,NA,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,117.04,117.04,S258,QPVSLANTQPRGPPASSPAPAPKFSPVTPKF,_GPPAS(ph)SPAPAPKFS(ph)PVTPK_, , , , ,-0.9, ,-0.8,-0.66, , , , ,-0.75, ,-0.9,-0.13,,,-0.9,-0.73,,,-0.75,-0.47,,,,,,,NA,NA,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,119.8,119.8,S259,PVSLANTQPRGPPASSPAPAPKFSPVTPKFT,_GPPASS(ph)PAPAPKFS(ph)PVTPK_,-0.43,-0.54,0.89, ,-0.05,-0.82,0.76, ,-0.23,-0.53,0.01, ,-0.48,-0.77,-0.67, ,-0.48,0.89,-0.39,0.76,-0.38,0.01,-0.62,-0.67,,,,,,,0,0,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,119.8,119.8,S267,PRGPPASSPAPAPKFSPVTPKFTPVASKFSP,_GPPAS(ph)SPAPAPKFS(ph)PVT(ph)PK_,-0.43,-0.24,0.89, ,-0.05,-0.82,0.76,-0.66,-0.23,-0.32,0.01, ,-0.48,-0.77,-0.67,-0.13,-0.33,0.89,-0.39,0.22,-0.28,0.01,-0.62,-0.37,,,,,,,0,0,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
Q15942,Q15942,Zyxin,ZYX,119.8,119.8,T270,PPASSPAPAPKFSPVTPKFTPVASKFSPGAP,_GPPAS(ph)SPAPAPKFS(ph)PVT(ph)PK_, , , , ,-0.9,-0.82,-0.8,-0.66, , , , ,-0.75,-0.77,-0.9,-0.13,,,-0.86,-0.73,,,-0.76,-0.47,,,,,,,NA,NA,,cell-cell adherens junction,zinc ion binding,cell adhesion,,
O43149,O43149,Zinc finger ZZ-type and EF-hand domain-containing protein 1,ZZEF1,86.77,83.58,S1537,PTRRPPFTRGRLRLLSFRSMEEARLVPTVKE,_LLS(ph)FRS(ph)MEEAR_, , ,4.35,3.21, , ,1.96, , , ,5.09,3.94, , ,1.6, ,,3.89,,1.96,,4.63,,1.6, +, +,,,,,NA,NA,,,calcium ion binding,,,
O43149,O43149,Zinc finger ZZ-type and EF-hand domain-containing protein 1,ZZEF1,86.77,83.58,S1540,RPPFTRGRLRLLSFRSMEEARLVPTVKEKYP,_LLS(ph)FRS(ph)MEEAR_, , ,4.35,3.21, , ,1.96, , , ,5.09,3.94, , ,1.6, ,,3.89,,1.96,,4.63,,1.6, +, +,,,,,NA,NA,,,calcium ion binding,,,
O43149,O43149,Zinc finger ZZ-type and EF-hand domain-containing protein 1,ZZEF1,144.69,142.58,S1518,LPAADVSPATAEEPLSPSTPTRRPPFTRGRL,_LPSSSGLPAADVSPATAEEPLS(ph)PST(ph)PTR_, , ,0.94, ,2.24,2.27, , , , ,1.09, ,1.49,0.74, , ,,0.94,2.25,,,1.09,1.16,, +, +,,,,,NA,NA,,,calcium ion binding,,,
